Citrus Sinensis ID: 015257

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410
Protein Sequence
MFRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLRRDNTTQDSN
Secondary Structure (PSIPRED)
cccccHHHHHcccccEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHccccccccccccccccccccccccccccccccEEEEEEEccccEEEEEEEEEcccccEEEEEEEEccccccccccccccHHHHHHHHHHHHHHcccccEEEEEEEEEcccccEEEEEEEEEccccccEEccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEEEEcccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHHHcccccccccHHHHHHHHHcccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccEEEEccccccccccccccccccccccccccccEEHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEEccccccEEEEEEEcccccEEEEEEEcHHHHHHcccccccHHHHHHHHHHHHHHHcccccEEEEEEEEEcccccEEEEEEEEccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEcccccccccccccccccccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccHHHHHcccHHccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mfrktcswirdmgccscfgftrrkpkqalrpitglnyrisrdfllgddiddddddnsyngeatntadgdggemqnhakRSEEIFRERELNglicrqfpvkesnklirsedengTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLsklrvapsetamtDVRREVLIMKMLQHPNIVNLIEviddpnsdhFYMVLEYVegkwdndgfgqpgaigESMARKYLRDIVSGLMYlhghnvvhgdikpdnllvapsgtvkigdfsvsqvfeddndvlrrspgtpvftapecclgltyggkaadtWAVGVTLYYMIIGqypflgetlQDTYDKIVnnslvfpdamnPELRNLLEgllckdptrrltlndvakhtwvlgdngpipqylcwckrdrlrrdnttqdsn
Flexible Loop (DISEMBL)
mfrktcswirdmgccscfgftrrkpkqalrpitglnyRISRDFLLGDDIDDDDDDNSYNGEatntadgdggemqNHAKRSEEIFRERELNglicrqfpvkesnklirsedengtKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFhkshlsklrvapsetamTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKhtwvlgdngpipqylcwckrdrlrrdnttqdsn
Low Complexity Region (SEG)
MFRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGddiddddddNSYNGEATNTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLRRDNTTQDSN
Disordered region (IsUnstruct)
****TCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGD****************************************ELNGLICRQFPVK*************TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRD************
Disordered Region (DISOPRED)
*****CSWIRDMGCCSC******************************************************************************************************YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSH***************VRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCW****************
Disordered Region (DISEMBL)
MFRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLR*********
Disordered Region (DISPRO)
MFRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDD******************************************************************KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCW****************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MFRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLRRDNTTQDSN
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	410	2.2.26 [Sep-21-2011]
Q5HZ38	407	Serine/threonine-protein	yes	no	0.924	0.931	0.652	1e-154
Q93V58	396	Serine/threonine-protein	no	no	0.921	0.954	0.631	1e-146
Q54WW7	695	Probable serine/threonine	yes	no	0.673	0.397	0.430	9e-59
P50526	652	Serine/threonine-protein	yes	no	0.682	0.429	0.420	2e-50
O88831	587	Calcium/calmodulin-depend	yes	no	0.636	0.444	0.377	3e-46
Q8C078	588	Calcium/calmodulin-depend	yes	no	0.636	0.443	0.377	3e-46
Q96RR4	588	Calcium/calmodulin-depend	yes	no	0.636	0.443	0.377	4e-46
P97756	505	Calcium/calmodulin-depend	no	no	0.685	0.556	0.372	6e-45
Q8VBY2	505	Calcium/calmodulin-depend	no	no	0.685	0.556	0.366	6e-44
Q8N5S9	505	Calcium/calmodulin-depend	no	no	0.717	0.582	0.363	1e-43

>sp|Q5HZ38|GRIK2_ARATH Serine/threonine-protein kinase GRIK2 OS=Arabidopsis thaliana GN=GRIK2 PE=1 SV=1

 Score =  545 bits (1403), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 265/406 (65%), Positives = 322/406 (79%), Gaps = 27/406 (6%)

Query: 1   MFRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNG 60
           MFR +  + R +GC  CFG +  + +Q+ +P                    DDD +S + 
Sbjct: 1   MFRDSFLFARTIGCFGCFGSSGSRNQQSPKPY-------------------DDDTHSCDS 41

Query: 61  EATNTADGDGGE------MQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGT 114
           + T+TA G+  E       ++ +KRSEEI + R  NGLICR  PV+E+N+LIR EDENG 
Sbjct: 42  DVTSTARGEEEEDEEEVEQKSRSKRSEEILKYRLDNGLICRHIPVRETNELIRGEDENGD 101

Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           K INEYV V KIG+GSYGKVVLYRS+LDG++YAIKAFHKSHL +LRVAPSETAM+DV RE
Sbjct: 102 KTINEYVRVCKIGSGSYGKVVLYRSTLDGQYYAIKAFHKSHLLRLRVAPSETAMSDVLRE 161

Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           V+IMK+L+HPNIVNLIEVIDDP +DHFYMVLEYV+GKW  DG G PGA+GE  ARKYLRD
Sbjct: 162 VMIMKILEHPNIVNLIEVIDDPETDHFYMVLEYVDGKWVYDGSGPPGALGEKTARKYLRD 221

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           IV+GLMYLH H+V+HGDIKPDNLLV  SGTVKIGDFSVSQVF+DD+D LRRSPGTPVFTA
Sbjct: 222 IVTGLMYLHAHDVIHGDIKPDNLLVTSSGTVKIGDFSVSQVFKDDDDQLRRSPGTPVFTA 281

Query: 295 PECCL--GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNP 352
           PECCL  G+TY G+AADTWAVGVTLY MI+GQYPFL +TLQDTYDKIVNN L+ PD +NP
Sbjct: 282 PECCLVSGITYSGRAADTWAVGVTLYCMILGQYPFLADTLQDTYDKIVNNPLIIPDGLNP 341

Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRD 398
            LR+L+EGLLCKDP++R+TL +V++H WV+G++G +P+Y CWCKR+
Sbjct: 342 LLRDLIEGLLCKDPSQRMTLKNVSEHPWVIGEDGHVPEYFCWCKRN 387

Activates SnRK1.1/KIN10 and SnRK1.2/KIN11 by phosphorylation of their activation-loop 'Thr-198' and 'Thr-176', respectively. Required for the regulation by SnRK1 kinases of the transcription of a large set of genes, the modification the activity of metabolic enzymes, and the control of various nutrient-responsive cellular developmental processes.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q93V58|GRIK1_ARATH Serine/threonine-protein kinase GRIK1 OS=Arabidopsis thaliana GN=GRIK1 PE=1 SV=1

 Score =  518 bits (1333), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 255/404 (63%), Positives = 306/404 (75%), Gaps = 26/404 (6%)

Query: 1   MFRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNG 60
           MF  + ++ + M C  CFG + R  + +  P                   DDD  +  +G
Sbjct: 1   MFCDSFAFAQVMSCFGCFGGSERS-RHSPNPY------------------DDDTYSHDSG 41

Query: 61  EATNTADGDGGEMQ-------NHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENG 113
           E +N    D    +       + +KRSEEI + +  NGL+CRQFPVKE+NKL R EDE+G
Sbjct: 42  ETSNPGGDDEEGEEEEEVEELSRSKRSEEILKCKLQNGLVCRQFPVKETNKLTRGEDEDG 101

Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
            K INE+V  RKIG+GSYGKVVLYRS++D KHYAIKAFHKSHLS+LRVAPSETAM DV R
Sbjct: 102 NKTINEFVRERKIGSGSYGKVVLYRSTVDDKHYAIKAFHKSHLSRLRVAPSETAMGDVLR 161

Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
           EV+IMK L+HPNIVNLIEVIDDP  D FYMVLEYV+GKW  D  G PGA+GE  ARKYLR
Sbjct: 162 EVMIMKTLEHPNIVNLIEVIDDPEFDDFYMVLEYVDGKWAYDDSGPPGALGEITARKYLR 221

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
           D+V+GLMYLH HNV+HGDIKPDNLLV  +G VKIGDFSVSQVF+DD+D LRRSPGTPVFT
Sbjct: 222 DVVAGLMYLHAHNVIHGDIKPDNLLVTSTGRVKIGDFSVSQVFKDDDDQLRRSPGTPVFT 281

Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPE 353
           APECCLG+TY G++ADTWAVGVTLY MI+GQYPFLG+TLQDTYDKIV+N L+ P+ +NP 
Sbjct: 282 APECCLGITYSGRSADTWAVGVTLYCMILGQYPFLGDTLQDTYDKIVHNPLIIPEGLNPR 341

Query: 354 LRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKR 397
           LR+L+EGLLCKDP +R+TL  VA+H W+ G++G I +Y CWCKR
Sbjct: 342 LRDLIEGLLCKDPNQRMTLKAVAEHPWITGEDGAISEYCCWCKR 385

Activates SnRK1.1/KIN10 and SnRK1.2/KIN11 by phosphorylation of their activation-loop 'Thr-198' and 'Thr-176', respectively. Required for the regulation by SnRK1 kinases of the transcription of a large set of genes, the modification the activity of metabolic enzymes, and the control of various nutrient-responsive cellular developmental processes.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54WW7|Y0010_DICDI Probable serine/threonine-protein kinase DDB_G0279405 OS=Dictyostelium discoideum GN=DDB_G0279405 PE=3 SV=1

 Score =  228 bits (580), Expect = 9e-59,   Method: Compositional matrix adjust.
 Identities = 123/286 (43%), Positives = 172/286 (60%), Gaps = 10/286 (3%)

Query: 100 KESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKL 159
           KE+ +  +   ++G KM+NEYV VRK+G G++GKV L         YAIK F+K  L K 
Sbjct: 181 KETLRAHKKRHKDGHKMVNEYVFVRKLGKGTFGKVKLAYHHDTHHLYAIKIFNKIRLKKQ 240

Query: 160 RVAPSE-TAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG 218
            +      A  DV +E+ IMK + H N+V L EVI+DP  ++ Y+V+EY+EG        
Sbjct: 241 TMGIGRPNAFDDVLKEIAIMKKMNHINVVKLYEVINDPQEEYIYIVMEYIEG----GSIM 296

Query: 219 QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278
                 E +ARKY RDIV GL YLH   V+H D+KP+NLLV   G VKI DF VS +F+D
Sbjct: 297 SANETSEDLARKYFRDIVFGLEYLHEQKVIHKDLKPENLLVNSEGVVKITDFGVSHIFDD 356

Query: 279 DNDVLRRSPGTPVFTAPECCLGLT--YGGKAADTWAVGVTLYYMIIGQYPFLGET--LQD 334
           D DV+R S G+P F APE C   +    GK  D WA+GV+LY +I  + PF+ +T  L D
Sbjct: 357 D-DVVRCSRGSPAFLAPELCRNESQPISGKGVDVWALGVSLYCLIFARTPFISKTNSLLD 415

Query: 335 TYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
            YD+IVN+   +P  ++ +L +L + LL K+P  R+ + ++  H W
Sbjct: 416 IYDQIVNHEPTYPREISNDLMDLFKRLLDKNPLTRIQIAEIKSHKW 461

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P50526|SSP1_SCHPO Serine/threonine-protein kinase ssp1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ssp1 PE=1 SV=1

 Score =  200 bits (508), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 127/302 (42%), Positives = 172/302 (56%), Gaps = 22/302 (7%)

Query: 99  VKESNKLIRSEDE-NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHL- 156
           VKE+ K+ +  D  +G K IN Y  ++++G G +GKV L R ++  +  AIK   K+   
Sbjct: 113 VKETKKIRKRFDRFSGRKYINHYEIIKELGRGMHGKVKLGRDTVTRELLAIKIIPKTERR 172

Query: 157 SKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG---KW- 212
            KL  A + +    VRRE+ I+K   HPN+V L EVIDDP+S   Y+VLEY+ G    W 
Sbjct: 173 PKLGRANASSQKEKVRREIAILKKCVHPNVVRLREVIDDPSSTKVYLVLEYMSGGEVPWT 232

Query: 213 DNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272
           D D       +  S AR+Y RD+V GL YLH   ++H DIKP NLL+  S  VKI DF V
Sbjct: 233 DCDS----PVLSISEARQYFRDVVLGLEYLHYQGIIHRDIKPANLLLNSSNCVKISDFGV 288

Query: 273 SQV----FEDDNDV-LRRSPGTPVFTAPECCLG-----LTYGGKAADTWAVGVTLYYMII 322
           S +      +DNDV L ++ GTP F APE C            +A D WA+GVTL+ ++ 
Sbjct: 289 SYIANAGLNEDNDVELAKTVGTPAFFAPELCWTDLDRPRPKISEAIDVWALGVTLFCLLF 348

Query: 323 GQYPFLGETLQDTYDKIVNNSLVFPDA--MNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
           G+ PF      + +DKIVN  L  P    +  E R+LL+ LLCKDP +R+TL +V  H W
Sbjct: 349 GRCPFNASMEYELFDKIVNERLNIPSTPDIGEEGRDLLKRLLCKDPEQRITLVEVKLHPW 408

Query: 381 VL 382
            L
Sbjct: 409 TL 410

Involved in actin localization and thus in polarized cell growth.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O88831|KKCC2_RAT Calcium/calmodulin-dependent protein kinase kinase 2 OS=Rattus norvegicus GN=Camkk2 PE=1 SV=1

 Score =  186 bits (472), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 109/289 (37%), Positives = 157/289 (54%), Gaps = 28/289 (9%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR---------------- 160
           +N+Y    +IG GSYG V L  +  D  +YA+K   K  L +                  
Sbjct: 161 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 220

Query: 161 --VAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGF 217
             + P    +  V +E+ I+K L HPN+V L+EV+DDPN DH YMV E V +G       
Sbjct: 221 GCIQP-RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT 279

Query: 218 GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277
            +P  + E  AR Y +D++ G+ YLH   ++H DIKP NLLV   G +KI DF VS  F+
Sbjct: 280 LKP--LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 337

Query: 278 DDNDVLRRSPGTPVFTAPECCLGLT---YGGKAADTWAVGVTLYYMIIGQYPFLGETLQD 334
             + +L  + GTP F APE  L  T   + GKA D WA+GVTLY  + GQ PF+ E +  
Sbjct: 338 GSDALLSNTVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 396

Query: 335 TYDKIVNNSLVFPDA--MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            + KI + +L FPD   +  +L++L+  +L K+P  R+ + ++  H WV
Sbjct: 397 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 445

Calcium/calmodulin-dependent protein kinase belonging to a proposed calcium-triggered signaling cascade involved in a number of cellular processes. Phosphorylates CAMK1 and CAMK4. Phosphorylates CAMK1D (By similarity). Seems to be involved in hippocampal activation of CREB1.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|Q8C078|KKCC2_MOUSE Calcium/calmodulin-dependent protein kinase kinase 2 OS=Mus musculus GN=Camkk2 PE=1 SV=2

 Score =  186 bits (471), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 109/289 (37%), Positives = 157/289 (54%), Gaps = 28/289 (9%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR---------------- 160
           +N+Y    +IG GSYG V L  +  D  +YA+K   K  L +                  
Sbjct: 162 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGARPAPG 221

Query: 161 --VAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGF 217
             + P    +  V +E+ I+K L HPN+V L+EV+DDPN DH YMV E V +G       
Sbjct: 222 GCIQP-RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT 280

Query: 218 GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277
            +P  + E  AR Y +D++ G+ YLH   ++H DIKP NLLV   G +KI DF VS  F+
Sbjct: 281 LKP--LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 338

Query: 278 DDNDVLRRSPGTPVFTAPECCLGLT---YGGKAADTWAVGVTLYYMIIGQYPFLGETLQD 334
             + +L  + GTP F APE  L  T   + GKA D WA+GVTLY  + GQ PF+ E +  
Sbjct: 339 GSDALLSNTVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 397

Query: 335 TYDKIVNNSLVFPDA--MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            + KI + +L FPD   +  +L++L+  +L K+P  R+ + ++  H WV
Sbjct: 398 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 446

Calcium/calmodulin-dependent protein kinase belonging to a proposed calcium-triggered signaling cascade involved in a number of cellular processes. Phosphorylates CAMK1, CAMK4 and CAMK1D (By similarity). Seems to be involved in hippocampal activation of CREB1.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|Q96RR4|KKCC2_HUMAN Calcium/calmodulin-dependent protein kinase kinase 2 OS=Homo sapiens GN=CAMKK2 PE=1 SV=2

 Score =  186 bits (471), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 109/289 (37%), Positives = 157/289 (54%), Gaps = 28/289 (9%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR---------------- 160
           +N+Y    +IG GSYG V L  +  D  +YA+K   K  L +                  
Sbjct: 162 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 221

Query: 161 --VAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGF 217
             + P    +  V +E+ I+K L HPN+V L+EV+DDPN DH YMV E V +G       
Sbjct: 222 GCIQP-RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT 280

Query: 218 GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277
            +P  + E  AR Y +D++ G+ YLH   ++H DIKP NLLV   G +KI DF VS  F+
Sbjct: 281 LKP--LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 338

Query: 278 DDNDVLRRSPGTPVFTAPECCLGLT---YGGKAADTWAVGVTLYYMIIGQYPFLGETLQD 334
             + +L  + GTP F APE  L  T   + GKA D WA+GVTLY  + GQ PF+ E +  
Sbjct: 339 GSDALLSNTVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 397

Query: 335 TYDKIVNNSLVFPDA--MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            + KI + +L FPD   +  +L++L+  +L K+P  R+ + ++  H WV
Sbjct: 398 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 446

Calcium/calmodulin-dependent protein kinase belonging to a proposed calcium-triggered signaling cascade involved in a number of cellular processes. Isoform 1, isoform 2 and isoform 3 phosphorylate CAMK1 and CAMK4. Isoform 3 phosphorylates CAMK1D. Isoform 4, isoform 5 and isoform 6 lacking part of the calmodulin-binding domain are inactive. Seems to be involved in hippocampal activation of CREB1.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|P97756|KKCC1_RAT Calcium/calmodulin-dependent protein kinase kinase 1 OS=Rattus norvegicus GN=Camkk1 PE=1 SV=1

 Score =  181 bits (460), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 114/306 (37%), Positives = 168/306 (54%), Gaps = 25/306 (8%)

Query: 98  PVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIK-------- 149
           P  ES+ +  S+ E+  ++ N+Y    +IG G+YG V L  +  + +HYA+K        
Sbjct: 107 PTIESHHVAISDTEDCVQL-NQYKLQSEIGKGAYGVVRLAYNEREDRHYAMKVLSKKKLL 165

Query: 150 ---AFHKSHLSKLRVAPSE------TAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH 200
               F +    +   AP          +  V +E+ I+K L H N+V LIEV+DDP  D+
Sbjct: 166 KQYGFPRRPPPRGSQAPQGGPAKQLLPLERVYQEIAILKKLDHVNVVKLIEVLDDPAEDN 225

Query: 201 FYMVLEYV-EGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV 259
            Y+V + + +G        +P    E  AR YLRDI+ GL YLH   +VH DIKP NLL+
Sbjct: 226 LYLVFDLLRKGPVMEVPCDKP--FPEEQARLYLRDIILGLEYLHCQKIVHRDIKPSNLLL 283

Query: 260 APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC--LGLTYGGKAADTWAVGVTL 317
              G VKI DF VS  FE ++  L  + GTP F APE     G ++ GKA D WA GVTL
Sbjct: 284 GDDGHVKIADFGVSNQFEGNDAQLSSTAGTPAFMAPEAISDTGQSFSGKALDVWATGVTL 343

Query: 318 YYMIIGQYPFLGETLQDTYDKIVNNSLVFPD--AMNPELRNLLEGLLCKDPTRRLTLNDV 375
           Y  + G+ PF+ E +   + KI N ++VFP+   ++ EL++L+  +L K+P  R+ ++D+
Sbjct: 344 YCFVYGKCPFIDEYILALHRKIKNEAVVFPEEPEVSEELKDLILKMLDKNPETRIGVSDI 403

Query: 376 AKHTWV 381
             H WV
Sbjct: 404 KLHPWV 409

Calcium/calmodulin-dependent protein kinase that belongs to a proposed calcium-triggered signaling cascade involved in a number of cellular processes. Phosphorylates CAMK1, CAMK1D, CAMK1G and CAMK4. Involved in regulating cell apoptosis. Promotes cell survival by phosphorylating AKT1/PKB that inhibits pro-apoptotic BAD/Bcl2-antagonist of cell death.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|Q8VBY2|KKCC1_MOUSE Calcium/calmodulin-dependent protein kinase kinase 1 OS=Mus musculus GN=Camkk1 PE=1 SV=1

 Score =  178 bits (452), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 112/306 (36%), Positives = 170/306 (55%), Gaps = 25/306 (8%)

Query: 98  PVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIK-------- 149
           P  ES+++  S+ E+  ++ N+Y    +IG G+YG V L  +  + +HYA+K        
Sbjct: 107 PTIESHRVAISDTEDCVQL-NQYKLQSEIGKGAYGVVRLAYNESEDRHYAMKVLSKKKLL 165

Query: 150 ---AFHK------SHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH 200
               F +      S  ++   A     +  V +E+ I+K L H N+V LIEV+DDP  D+
Sbjct: 166 KQYGFPRRPPPRGSQATQGGPAKQLLPLERVYQEIAILKKLDHVNVVKLIEVLDDPAEDN 225

Query: 201 FYMVLEYV-EGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV 259
            Y+V + + +G        +P    E  AR YLRDI+ GL YLH   +VH DIKP NLL+
Sbjct: 226 LYLVFDLLRKGPVMEVPCDKP--FPEEQARLYLRDIILGLEYLHCQKIVHRDIKPSNLLL 283

Query: 260 APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC--LGLTYGGKAADTWAVGVTL 317
              G VKI DF VS  FE ++  L  + GTP F APE     G ++ GKA D WA GVTL
Sbjct: 284 GDDGHVKIADFGVSNQFEGNDAQLSSTAGTPAFMAPEAISDSGQSFSGKALDVWATGVTL 343

Query: 318 YYMIIGQYPFLGETLQDTYDKIVNNSLVFPD--AMNPELRNLLEGLLCKDPTRRLTLNDV 375
           Y  + G+ PF+ + +   + KI N ++VFP+   ++ +L++L+  +L K+P  R+ ++D+
Sbjct: 344 YCFVYGKCPFIDDYILTLHRKIKNEAVVFPEEPEVSEDLKDLILRMLDKNPETRIGVSDI 403

Query: 376 AKHTWV 381
             H WV
Sbjct: 404 KLHPWV 409

Calcium/calmodulin-dependent protein kinase that belongs to a proposed calcium-triggered signaling cascade involved in a number of cellular processes. Phosphorylates CAMK1, CAMK1D, CAMK1G and CAMK4. Involved in regulating cell apoptosis. Promotes cell survival by phosphorylating AKT1/PKB that inhibits pro-apoptotic BAD/Bcl2-antagonist of cell death.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|Q8N5S9|KKCC1_HUMAN Calcium/calmodulin-dependent protein kinase kinase 1 OS=Homo sapiens GN=CAMKK1 PE=1 SV=2

 Score =  177 bits (449), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 117/322 (36%), Positives = 173/322 (53%), Gaps = 28/322 (8%)

Query: 98  PVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIK-------- 149
           P  ES+ +  S+ E+  ++ N+Y    +IG G+YG V L  +  + +HYA+K        
Sbjct: 107 PTIESHHVAISDAEDCVQL-NQYKLQSEIGKGAYGVVRLAYNESEDRHYAMKVLSKKKLL 165

Query: 150 ---AFHK------SHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH 200
               F +      S  ++   A     +  V +E+ I+K L H N+V LIEV+DDP  D+
Sbjct: 166 KQYGFPRRPPPRGSQAAQGGPAKQLLPLERVYQEIAILKKLDHVNVVKLIEVLDDPAEDN 225

Query: 201 FYMVLEYV-EGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV 259
            Y+V + + +G        +P    E  AR YLRD++ GL YLH   +VH DIKP NLL+
Sbjct: 226 LYLVFDLLRKGPVMEVPCDKP--FSEEQARLYLRDVILGLEYLHCQKIVHRDIKPSNLLL 283

Query: 260 APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC--LGLTYGGKAADTWAVGVTL 317
              G VKI DF VS  FE ++  L  + GTP F APE     G ++ GKA D WA GVTL
Sbjct: 284 GDDGHVKIADFGVSNQFEGNDAQLSSTAGTPAFMAPEAISDSGQSFSGKALDVWATGVTL 343

Query: 318 YYMIIGQYPFLGETLQDTYDKIVNNSLVFPD--AMNPELRNLLEGLLCKDPTRRLTLNDV 375
           Y  + G+ PF+ + +   + KI N  +VFP+   ++ EL++L+  +L K+P  R+ + D+
Sbjct: 344 YCFVYGKCPFIDDFILALHRKIKNEPVVFPEEPEISEELKDLILKMLDKNPETRIGVPDI 403

Query: 376 AKHTWVLGDNG--PIPQYLCWC 395
             H WV   NG  P+P     C
Sbjct: 404 KLHPWVT-KNGEEPLPSEEEHC 424

Calcium/calmodulin-dependent protein kinase that belongs to a proposed calcium-triggered signaling cascade involved in a number of cellular processes. Phosphorylates CAMK1, CAMK1D, CAMK1G and CAMK4. Involved in regulating cell apoptosis. Promotes cell survival by phosphorylating AKT1/PKB that inhibits pro-apoptotic BAD/Bcl2-antagonist of cell death.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	410
255578876	423	calcium/calmodulin-dependent protein kin	0.982	0.952	0.760	1e-173
225435291	414	PREDICTED: probable serine/threonine-pro	0.980	0.971	0.736	1e-173
449455998	426	PREDICTED: probable serine/threonine-pro	0.968	0.931	0.715	1e-170
449502498	416	PREDICTED: probable serine/threonine-pro	0.941	0.927	0.727	1e-168
147860766	411	hypothetical protein VITISV_016074 [Viti	0.953	0.951	0.722	1e-168
224106748	435	predicted protein [Populus trichocarpa]	0.965	0.910	0.730	1e-165
356543468	409	PREDICTED: probable serine/threonine-pro	0.968	0.970	0.679	1e-158
356550186	410	PREDICTED: probable serine/threonine-pro	0.973	0.973	0.674	1e-155
357453879	404	Calcium/calmodulin-dependent protein kin	0.960	0.975	0.665	1e-154
356542523	399	PREDICTED: probable serine/threonine-pro	0.946	0.972	0.701	1e-153

>gi|255578876|ref|XP_002530292.1| calcium/calmodulin-dependent protein kinase kinase, putative [Ricinus communis] gi|223530190|gb|EEF32099.1| calcium/calmodulin-dependent protein kinase kinase, putative [Ricinus communis]

 Score =  614 bits (1583), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 308/405 (76%), Positives = 343/405 (84%), Gaps = 2/405 (0%)

Query: 1   MFRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNG 60
           M+RK+ S  R MGCCSCFGF+  KPK+  RP+TG NY +S++ LL D+  +D+DD SYNG
Sbjct: 1   MYRKSYSIARAMGCCSCFGFSW-KPKRQSRPVTGRNYNLSQELLL-DEEIEDEDDGSYNG 58

Query: 61  EATNTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEY 120
           + T+T   D GE+ N  KRSEEI R RE NG+ICRQFPVKE+  LIRSEDENG KMINEY
Sbjct: 59  DITDTTYEDDGELPNRVKRSEEILRFREQNGMICRQFPVKETQILIRSEDENGNKMINEY 118

Query: 121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
           V   KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHL KLRVAPSETAM+DV REVLIMKM
Sbjct: 119 VRECKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLLKLRVAPSETAMSDVLREVLIMKM 178

Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
           L HPNIVNLIEVIDDPN+DHFYMVLEYV+GKW  +G G PG I E  ARKYLRDIV+GLM
Sbjct: 179 LDHPNIVNLIEVIDDPNTDHFYMVLEYVDGKWVWEGSGPPGGIEEITARKYLRDIVAGLM 238

Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
           YLH HN+VHGDIKPDNLLV  SG VKIGDFSVSQVFEDDND LRRSPGTPVFTAPECCLG
Sbjct: 239 YLHAHNIVHGDIKPDNLLVTRSGRVKIGDFSVSQVFEDDNDELRRSPGTPVFTAPECCLG 298

Query: 301 LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEG 360
           LTY GKAADTWAVGVTLY MI+GQYPFLGETLQDTYDKIVNN LV PD MN +LR+LLEG
Sbjct: 299 LTYHGKAADTWAVGVTLYCMILGQYPFLGETLQDTYDKIVNNPLVLPDEMNAQLRDLLEG 358

Query: 361 LLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLRRDNT 405
           LLCKDP  RLTL+ V KH+WV+G++GPI QY CWCKR+ L+++ +
Sbjct: 359 LLCKDPKLRLTLDSVVKHSWVIGEDGPISQYFCWCKRNSLQKEQS 403

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225435291|ref|XP_002282279.1| PREDICTED: probable serine/threonine-protein kinase DDB_G0279405-like [Vitis vinifera]

 Score =  613 bits (1582), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 299/406 (73%), Positives = 339/406 (83%), Gaps = 4/406 (0%)

Query: 1   MFRKTCSWIR--DMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSY 58
           MF K  S  R  +MGCC CFGF R KP+   RP +G    +S++FLL +DI++ DD  SY
Sbjct: 1   MFSKDYSIARVTEMGCCGCFGFVR-KPESLSRPGSGSTNCLSQEFLLEEDIEEVDD-RSY 58

Query: 59  NGEATNTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMIN 118
           NGE ++TA GD GE+Q+  +RSEEI   R  NG+ICR+FPVKE++KLIRSEDENG K IN
Sbjct: 59  NGEVSDTAHGDDGELQSRVQRSEEILMLRTQNGMICREFPVKETHKLIRSEDENGNKTIN 118

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           EYV   KIG+GSYGKVVLYRS  DG HYAIKAFHKSHL KLRVAPSETAMTDV REVLIM
Sbjct: 119 EYVREYKIGSGSYGKVVLYRSLKDGNHYAIKAFHKSHLLKLRVAPSETAMTDVLREVLIM 178

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           KML HPNIVNLIEVIDDP++DHFYMVLE+VEGKW  +G G PG IGE+ ARKYLRDIVSG
Sbjct: 179 KMLNHPNIVNLIEVIDDPSTDHFYMVLEFVEGKWVCEGSGPPGGIGENTARKYLRDIVSG 238

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L+YLH HN+VHGDIKPDNLLV  +GTVKI DFSVSQVFEDDND LRRSPGTPVFTAPECC
Sbjct: 239 LIYLHAHNIVHGDIKPDNLLVTRTGTVKIADFSVSQVFEDDNDELRRSPGTPVFTAPECC 298

Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLL 358
           LGLTY GKAADTWAVGVTLY M++GQYPFLGE+LQDTYDKIVNN L  PD +NP+LRNLL
Sbjct: 299 LGLTYHGKAADTWAVGVTLYCMVLGQYPFLGESLQDTYDKIVNNLLSLPDNINPQLRNLL 358

Query: 359 EGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLRRDN 404
           EGLLCKDP  R+TL+ VAKH WV+G+ GPIPQYLCWC+R+ L R++
Sbjct: 359 EGLLCKDPNERMTLDAVAKHAWVIGEEGPIPQYLCWCRRNILLRED 404

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449455998|ref|XP_004145737.1| PREDICTED: probable serine/threonine-protein kinase DDB_G0279405-like [Cucumis sativus]

 Score =  603 bits (1556), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 286/400 (71%), Positives = 337/400 (84%), Gaps = 3/400 (0%)

Query: 1   MFRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNG 60
           M++K+ S  + MGCC CFGFT+ KPK+ LRP +G N R+S DFLLG+D++D++  +S N 
Sbjct: 1   MYKKSFSISKMMGCCGCFGFTK-KPKRVLRPASGFN-RLSEDFLLGEDMEDEESCSS-ND 57

Query: 61  EATNTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEY 120
           + T+    +  E  +  K SEEI + R  NGLICRQFPVKE+N++IRSEDENG KM+NEY
Sbjct: 58  DMTSPTHEEETESHSRVKNSEEILQHRTQNGLICRQFPVKETNRVIRSEDENGNKMVNEY 117

Query: 121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
           V   KIGAGSYGKVVLYRS +DGK+YAIKAFHKSHLSKLRVAPSETAMTDV REVLIMKM
Sbjct: 118 VREYKIGAGSYGKVVLYRSRMDGKYYAIKAFHKSHLSKLRVAPSETAMTDVLREVLIMKM 177

Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
           L+HPNIVNL+EVIDDP  D FYMVLEYVEGKW  +G+  P  + E++ARKYLRDIVSGL+
Sbjct: 178 LEHPNIVNLVEVIDDPEDDRFYMVLEYVEGKWACEGYDPPRGLDENIARKYLRDIVSGLI 237

Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
           YLH HN+VHGDIKPDNLL+   GT+KIGDFSVSQVFED+ND LRRSPGTPVFTAPECCLG
Sbjct: 238 YLHDHNIVHGDIKPDNLLITLDGTIKIGDFSVSQVFEDENDELRRSPGTPVFTAPECCLG 297

Query: 301 LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEG 360
           +TY GKAADTWAVGVTLY MI+GQYPFLGETLQDTYDKIVNN L+ PD MNP LR+LLEG
Sbjct: 298 ITYHGKAADTWAVGVTLYCMILGQYPFLGETLQDTYDKIVNNPLLLPDDMNPHLRDLLEG 357

Query: 361 LLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRL 400
           +LCKDP++R+TL  +++H+WV+G+ GPIPQYLCWCKR  L
Sbjct: 358 ILCKDPSQRMTLKAISQHSWVIGEEGPIPQYLCWCKRKSL 397

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449502498|ref|XP_004161657.1| PREDICTED: probable serine/threonine-protein kinase DDB_G0279405-like [Cucumis sativus]

 Score =  598 bits (1542), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 283/389 (72%), Positives = 330/389 (84%), Gaps = 3/389 (0%)

Query: 12  MGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTADGDGG 71
           MGCC CFGFT+ KPK+ LRP +G N R+S DFLLG+D++D++  +S N + T+    +  
Sbjct: 2   MGCCGCFGFTK-KPKRVLRPASGFN-RLSEDFLLGEDMEDEESCSS-NDDMTSPTHEEET 58

Query: 72  EMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSY 131
           E  +  K SEEI + R  NGLICRQFPVKE+N++IRSEDENG KM+NEYV   KIGAGSY
Sbjct: 59  ESHSRVKNSEEILQHRTQNGLICRQFPVKETNRVIRSEDENGNKMVNEYVREYKIGAGSY 118

Query: 132 GKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191
           GKVVLYRS +DGK+YAIKAFHKSHLSKLRVAPSETAMTDV REVLIMKML+HPNIVNL+E
Sbjct: 119 GKVVLYRSRMDGKYYAIKAFHKSHLSKLRVAPSETAMTDVLREVLIMKMLEHPNIVNLVE 178

Query: 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGD 251
           VIDDP  D FYMVLEYVEGKW  +G+  P  + E++ARKYLRDIVSGL+YLH HN+VHGD
Sbjct: 179 VIDDPEDDRFYMVLEYVEGKWACEGYDPPRGLDENIARKYLRDIVSGLIYLHDHNIVHGD 238

Query: 252 IKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTW 311
           IKPDNLL+   GT+KIGDFSVSQVFED+ND LRRSPGTPVFTAPECCLG+TY GKAADTW
Sbjct: 239 IKPDNLLITLDGTIKIGDFSVSQVFEDENDELRRSPGTPVFTAPECCLGITYHGKAADTW 298

Query: 312 AVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLT 371
           AVGVTLY MI+GQYPFLGETLQDTYDKIVNN L+ PD MNP LR+LLEG+LCKDP++R+T
Sbjct: 299 AVGVTLYCMILGQYPFLGETLQDTYDKIVNNPLLLPDDMNPHLRDLLEGILCKDPSQRMT 358

Query: 372 LNDVAKHTWVLGDNGPIPQYLCWCKRDRL 400
           L  +++H+WV+G+ GPIPQYLCWCKR  L
Sbjct: 359 LKAISQHSWVIGEEGPIPQYLCWCKRKSL 387

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147860766|emb|CAN82578.1| hypothetical protein VITISV_016074 [Vitis vinifera]

 Score =  596 bits (1537), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 291/403 (72%), Positives = 331/403 (82%), Gaps = 12/403 (2%)

Query: 12  MGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTADGDGG 71
           MGCC CFGF R KP+   RP +G    +S++FLL +DI++ DD  SYNGE ++TA GD G
Sbjct: 1   MGCCGCFGFVR-KPESLSRPGSGSTNCLSQEFLLEEDIEEVDD-RSYNGEVSDTAHGDDG 58

Query: 72  EMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSY 131
           E+Q+  +RSEEI   R  NG+ICR+FPVKE++KLIRSEDENG K INEYV   KIG+GSY
Sbjct: 59  ELQSRVQRSEEILMLRTQNGMICREFPVKETHKLIRSEDENGNKTINEYVREYKIGSGSY 118

Query: 132 GKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191
           GKVVLYRS  DG HYAIKAFHKSHL KLRVAPSETAMTDV REVLIMKML HPNIVNLIE
Sbjct: 119 GKVVLYRSLKDGNHYAIKAFHKSHLLKLRVAPSETAMTDVLREVLIMKMLNHPNIVNLIE 178

Query: 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGD 251
           VIDDP++DHFYMVLE+VEGKW  +G G PG IGE+ ARKYLRDIVSGL+YLH HN+VHGD
Sbjct: 179 VIDDPSTDHFYMVLEFVEGKWVCEGSGPPGGIGENTARKYLRDIVSGLIYLHAHNIVHGD 238

Query: 252 IKPDNLLVAPSGTVKIGDFSVSQVF----------EDDNDVLRRSPGTPVFTAPECCLGL 301
           IKPDNLLV  +GTVKI DFSVSQ            +DDND LRRSPGTPVFTAPECCLGL
Sbjct: 239 IKPDNLLVTRTGTVKIADFSVSQSLVIQDVTCIDIKDDNDELRRSPGTPVFTAPECCLGL 298

Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
           TY GKAADTWAVGVTLY M++GQYPFLGE+LQDTYDKIVNN L  PD +NP+LRNLLEGL
Sbjct: 299 TYHGKAADTWAVGVTLYCMVLGQYPFLGESLQDTYDKIVNNLLSLPDNINPQLRNLLEGL 358

Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLRRDN 404
           LCKDP  R+TL+ VAKH WV+G+ GPIPQYLCWC+R+ L R++
Sbjct: 359 LCKDPXERMTLDAVAKHAWVIGEEGPIPQYLCWCRRNILLRED 401

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224106748|ref|XP_002314272.1| predicted protein [Populus trichocarpa] gi|222850680|gb|EEE88227.1| predicted protein [Populus trichocarpa]

 Score =  586 bits (1511), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 298/408 (73%), Positives = 334/408 (81%), Gaps = 12/408 (2%)

Query: 1   MFRKTCSWIRDMGCCSCFGFTRRKPKQALRPIT--GLNYR-------ISRDFLLGDDIDD 51
           M  K+ S+ R MGCCSCFGF R KPK+   PI+  G NY        +S++ LL  +IDD
Sbjct: 1   MIHKSYSFARAMGCCSCFGFLR-KPKRRPVPISSGGRNYHHHNNNNHLSQELLLDSEIDD 59

Query: 52  DDDDN--SYNGEATNTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSE 109
           D  ++  S+NG+ T T+  D  E+ N AKRSEE  R RELNGL+CR+ PVKE++ L+RSE
Sbjct: 60  DGGEDDGSFNGDITGTSYCDYAELPNRAKRSEENLRLRELNGLVCRKSPVKETHLLVRSE 119

Query: 110 DENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMT 169
           DE+G KMINEYV   KIGAGSYGKVVLY+SS+DG   AIKAFHKSHL KLRVAPSETAMT
Sbjct: 120 DEDGNKMINEYVRQYKIGAGSYGKVVLYQSSIDGNLCAIKAFHKSHLLKLRVAPSETAMT 179

Query: 170 DVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR 229
           DV REV IMKML HPNIVNLIEVIDDPN+DHFYMVLEYV+GKW  +G G PG IGE  AR
Sbjct: 180 DVLREVQIMKMLDHPNIVNLIEVIDDPNTDHFYMVLEYVDGKWVWEGSGPPGGIGEDTAR 239

Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
           KYLRDIVSGLMYLH HN+VHGDIKPDNLLV  SGTVKIGDFSVSQV EDDND LRRSPGT
Sbjct: 240 KYLRDIVSGLMYLHAHNIVHGDIKPDNLLVTRSGTVKIGDFSVSQVVEDDNDELRRSPGT 299

Query: 290 PVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA 349
           PVFTAPECCLGLTY GKAADTWAVGVTLY MI+GQYPFLGETLQDTYDKIVNN LV PD 
Sbjct: 300 PVFTAPECCLGLTYHGKAADTWAVGVTLYCMILGQYPFLGETLQDTYDKIVNNPLVLPDE 359

Query: 350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKR 397
           +N +L+ LLEGLLCKDP +R+TL+ VA HTWV+GD+GPIPQ+LCWCKR
Sbjct: 360 LNSQLKELLEGLLCKDPAQRMTLDAVANHTWVIGDDGPIPQFLCWCKR 407

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356543468|ref|XP_003540182.1| PREDICTED: probable serine/threonine-protein kinase DDB_G0279405-like [Glycine max]

 Score =  563 bits (1450), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 278/409 (67%), Positives = 326/409 (79%), Gaps = 12/409 (2%)

Query: 4   KTCSWIRDMGCCSCFGFTRR-KPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEA 62
           K+ S+ + MGCC CFGF ++ +P++A R I+ L   +S+  LL  + + ++   +Y+G+ 
Sbjct: 5   KSFSFSKMMGCCGCFGFVQKPRPRRAKRSISNL---LSQGLLLDGETEGEE---TYSGDV 58

Query: 63  T-NTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYV 121
           T N   GD  E+Q    RSE+I   R  NG++CR FPVKE+ KL RSEDENG KMINEYV
Sbjct: 59  TSNCTSGDDNEVQAVRNRSEDILNFRAENGMVCRPFPVKETCKLDRSEDENGNKMINEYV 118

Query: 122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
              KIG GSYGKV LYRSS+DGKHYAIK+FHKSHL KLRVAPSETAMTDV REVLIMKM+
Sbjct: 119 REYKIGCGSYGKVALYRSSVDGKHYAIKSFHKSHLQKLRVAPSETAMTDVLREVLIMKMV 178

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
           +HPNIVNLIEVIDDP SD FYMVLEYVE KW  +G G P A+GE  ARKYLRDIVSGL Y
Sbjct: 179 EHPNIVNLIEVIDDPESDDFYMVLEYVESKWVCEGTGHPCALGEETARKYLRDIVSGLTY 238

Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           LH HN+VHGDIKPDNLL+   GTVKIGDFSVSQ FED ND LRRSPGTPVFTAPECCLGL
Sbjct: 239 LHAHNIVHGDIKPDNLLITRHGTVKIGDFSVSQAFEDGNDELRRSPGTPVFTAPECCLGL 298

Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
           TY GKA+DTWAVGVTLY MI+G+YPFLG+TLQDTYDKIVN+ LV P+ +NP+L+NL+EGL
Sbjct: 299 TYHGKASDTWAVGVTLYCMILGEYPFLGDTLQDTYDKIVNDPLVLPEDINPQLKNLIEGL 358

Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLRRDNTTQDSN 410
           LCKDP  R+TL DVA+H WV+GD+GPIP YLCWCKR  +     T+DS+
Sbjct: 359 LCKDPELRMTLGDVAEHIWVIGDDGPIPGYLCWCKRKSM----VTEDSD 403

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356550186|ref|XP_003543469.1| PREDICTED: probable serine/threonine-protein kinase DDB_G0279405-like [Glycine max]

 Score =  553 bits (1424), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 275/408 (67%), Positives = 323/408 (79%), Gaps = 9/408 (2%)

Query: 4   KTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEAT 63
           K+ S+ + MGCC CFGF + KP++  R   G++  +S+  LL  + + D+   +Y+G+ T
Sbjct: 5   KSFSFSKMMGCCGCFGFVQ-KPRRRRRDKRGISNLLSQGLLLDGETEGDE---TYSGDVT 60

Query: 64  -NTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVH 122
            N    D  E+Q    RSE+I   R  NG++CR FPVKE+ KL RSEDENG KMIN YV 
Sbjct: 61  SNCTSVDDNEVQAVRNRSEDILNFRAKNGMVCRPFPVKETCKLDRSEDENGNKMINGYVR 120

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
             KIG+GSYGKV LYRSS+DGKHYAIK+FHKS L KLRVAPSETAMTDV REVLIMKM++
Sbjct: 121 EYKIGSGSYGKVALYRSSVDGKHYAIKSFHKSQLQKLRVAPSETAMTDVLREVLIMKMVE 180

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           HPNIVNLIEVIDDP SD FYMVLEYVE KW  +G G+P A+GE  ARKYLRDIVSGL YL
Sbjct: 181 HPNIVNLIEVIDDPESDDFYMVLEYVESKWVCEGTGRPCALGEETARKYLRDIVSGLTYL 240

Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
           H HN+VHGDIKPDNLL+   GTVKIGDFSVSQ FED ND LRRSPGTPVFTAPECCLGLT
Sbjct: 241 HAHNIVHGDIKPDNLLITHHGTVKIGDFSVSQAFEDGNDELRRSPGTPVFTAPECCLGLT 300

Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLL 362
           Y GKA+DTWAVGVTLY MI+G+YPFLG+TLQDTYDKIVN+ LV PD +NP+L+NL+EGLL
Sbjct: 301 YHGKASDTWAVGVTLYCMILGEYPFLGDTLQDTYDKIVNDPLVLPDDINPQLKNLIEGLL 360

Query: 363 CKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLRRDNTTQDSN 410
           CKDP  R+TL DVA+H WV+G++GPIP YLCWCKR  +     T+DS+
Sbjct: 361 CKDPELRMTLGDVAEHIWVIGEDGPIPGYLCWCKRKSM----VTEDSD 404

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357453879|ref|XP_003597220.1| Calcium/calmodulin-dependent protein kinase kinase [Medicago truncatula] gi|355486268|gb|AES67471.1| Calcium/calmodulin-dependent protein kinase kinase [Medicago truncatula]

 Score =  549 bits (1415), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 265/398 (66%), Positives = 321/398 (80%), Gaps = 4/398 (1%)

Query: 4   KTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEAT 63
           ++ S+ + +GC SCFG  +++P++  R   G+   +S+  L   D + + D+ SY+G+ T
Sbjct: 5   RSFSFTKMIGCWSCFGLIKKQPRRG-RTKRGIKNFLSQGLLT--DGETEYDEVSYSGDYT 61

Query: 64  -NTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVH 122
            NT  GD  E QN   RSEEI   R  NG+ICR FPVKE+ KL+RSEDENG KM+NEY+ 
Sbjct: 62  SNTTSGDDSEPQNLRNRSEEILNFRAENGMICRPFPVKETVKLVRSEDENGNKMLNEYIR 121

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
             KIG+GSYGKV LY+SS+DG+HYAIK+FHKSHL KLRVAPSETAMTDV REVLIMKML+
Sbjct: 122 EYKIGSGSYGKVALYQSSIDGQHYAIKSFHKSHLRKLRVAPSETAMTDVLREVLIMKMLE 181

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           HPNIVNLIEVIDDP SD FYMVLEYVEGKW  +G G+  AIGE  ARKY+RDIVSGL YL
Sbjct: 182 HPNIVNLIEVIDDPESDDFYMVLEYVEGKWVCEGSGRQCAIGEETARKYMRDIVSGLTYL 241

Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
           H HN+VHGDIKPDNLL+  +GTVKIGDFSVSQ FE+ ND LRRSPGTPVFTAPECCLGLT
Sbjct: 242 HAHNIVHGDIKPDNLLITRNGTVKIGDFSVSQAFENGNDELRRSPGTPVFTAPECCLGLT 301

Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLL 362
           Y GK +DTWAVGVTLY MI+G+YPFLG+TLQDTYD+IVNN +  PD +NP+L+NL+EGLL
Sbjct: 302 YHGKLSDTWAVGVTLYCMILGEYPFLGDTLQDTYDRIVNNPIEIPDDINPQLKNLIEGLL 361

Query: 363 CKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRL 400
           CKDP +R+TL +VA+H WV+G++GP+ +Y CWCKR  +
Sbjct: 362 CKDPEQRMTLAEVAEHVWVIGNDGPLGEYSCWCKRKSM 399

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356542523|ref|XP_003539716.1| PREDICTED: probable serine/threonine-protein kinase DDB_G0279405-like [Glycine max]

 Score =  547 bits (1410), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 273/389 (70%), Positives = 312/389 (80%), Gaps = 1/389 (0%)

Query: 12  MGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTADGDGG 71
           MGCCSCFGF R   +Q+ R     N  + ++ LL DDI+D++ +  YN E TN + GD G
Sbjct: 1   MGCCSCFGFIRTPNRQSQRSKPTTNNNLCQEPLLDDDIEDEEGEPLYNDEVTNNS-GDEG 59

Query: 72  EMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSY 131
             +   KRSEEI   R  NG+ICRQFPVKE+ KL+RSEDENG KMINEY+   KIG+GSY
Sbjct: 60  AEETRPKRSEEILNFRVENGMICRQFPVKETRKLVRSEDENGNKMINEYIREYKIGSGSY 119

Query: 132 GKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE 191
           GKV LYRSS+D KHYAIKAFHKS+L KLRVAPSETAM DV REVLIMKML+HPNIVNLIE
Sbjct: 120 GKVALYRSSVDDKHYAIKAFHKSYLLKLRVAPSETAMMDVLREVLIMKMLEHPNIVNLIE 179

Query: 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGD 251
           VIDDP +D+FYMVLEYVEGKW  +G G    +GE  AR+YLRDIVSGL YLH HN+VH D
Sbjct: 180 VIDDPETDNFYMVLEYVEGKWICEGSGPTCGLGEETARRYLRDIVSGLTYLHAHNIVHLD 239

Query: 252 IKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTW 311
           IKPDNLL+   GTVKIGDFSVSQ FEDD D LRRSPGTPVFTAPEC LG+ YGGKAADTW
Sbjct: 240 IKPDNLLITCHGTVKIGDFSVSQAFEDDKDELRRSPGTPVFTAPECILGVKYGGKAADTW 299

Query: 312 AVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLT 371
           AVGVTLY MI+G+YPFLG+TLQDTYDKIVNN LV P+ MNP L+NL+EGLL KDP+ R+T
Sbjct: 300 AVGVTLYCMILGEYPFLGDTLQDTYDKIVNNPLVLPNDMNPPLKNLIEGLLSKDPSLRMT 359

Query: 372 LNDVAKHTWVLGDNGPIPQYLCWCKRDRL 400
           L  VA+ +WV+GD+GPIP YLCWCKR  L
Sbjct: 360 LGAVAEDSWVIGDDGPIPDYLCWCKRKSL 388

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	410
TAIR|locus:2175113	407	GRIK2 "geminivirus rep interac	0.939	0.945	0.652	1.1e-140
TAIR|locus:2096930	396	GRIK1 "geminivirus rep interac	0.939	0.972	0.637	1.8e-135
DICTYBASE|DDB_G0279405	695	DDB_G0279405 "Meta subfamily p	0.668	0.394	0.437	5.9e-57
POMBASE|SPCC297.03	652	ssp1 "serine/threonine protein	0.682	0.429	0.427	2.8e-50
UNIPROTKB|G4N7H1	651	MGG_06421 "CAMKK/META protein	0.556	0.350	0.394	3.4e-49
UNIPROTKB|Q148H3	579	CAMKK2 "Uncharacterized protei	0.658	0.466	0.380	2.9e-48
UNIPROTKB|F8W9H1	543	CAMKK1 "Calcium/calmodulin-dep	0.4	0.302	0.438	6.5e-48
WB|WBGene00000518	541	ckk-1 [Caenorhabditis elegans	0.658	0.499	0.403	2e-47
UNIPROTKB|F1NKZ8	506	CAMKK1 "Uncharacterized protei	0.704	0.571	0.377	2.3e-46
UNIPROTKB|F1RNP6	579	CAMKK2 "Uncharacterized protei	0.704	0.499	0.367	2.3e-46

TAIR|locus:2175113 GRIK2 "geminivirus rep interacting kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1376 (489.4 bits), Expect = 1.1e-140, P = 1.1e-140
 Identities = 261/400 (65%), Positives = 317/400 (79%)

Query:     1 MFRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGXXXXXXXXXNSYNG 60
             MFR +  + R +GC  CFG +  + +Q+ +P     +    D             ++  G
Sbjct:     1 MFRDSFLFARTIGCFGCFGSSGSRNQQSPKPYDDDTHSCDSDV-----------TSTARG 49

Query:    61 EATNTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEY 120
             E     D +  E ++ +KRSEEI + R  NGLICR  PV+E+N+LIR EDENG K INEY
Sbjct:    50 EEEE--DEEEVEQKSRSKRSEEILKYRLDNGLICRHIPVRETNELIRGEDENGDKTINEY 107

Query:   121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
             V V KIG+GSYGKVVLYRS+LDG++YAIKAFHKSHL +LRVAPSETAM+DV REV+IMK+
Sbjct:   108 VRVCKIGSGSYGKVVLYRSTLDGQYYAIKAFHKSHLLRLRVAPSETAMSDVLREVMIMKI 167

Query:   181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
             L+HPNIVNLIEVIDDP +DHFYMVLEYV+GKW  DG G PGA+GE  ARKYLRDIV+GLM
Sbjct:   168 LEHPNIVNLIEVIDDPETDHFYMVLEYVDGKWVYDGSGPPGALGEKTARKYLRDIVTGLM 227

Query:   241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL- 299
             YLH H+V+HGDIKPDNLLV  SGTVKIGDFSVSQVF+DD+D LRRSPGTPVFTAPECCL 
Sbjct:   228 YLHAHDVIHGDIKPDNLLVTSSGTVKIGDFSVSQVFKDDDDQLRRSPGTPVFTAPECCLV 287

Query:   300 -GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLL 358
              G+TY G+AADTWAVGVTLY MI+GQYPFL +TLQDTYDKIVNN L+ PD +NP LR+L+
Sbjct:   288 SGITYSGRAADTWAVGVTLYCMILGQYPFLADTLQDTYDKIVNNPLIIPDGLNPLLRDLI 347

Query:   359 EGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRD 398
             EGLLCKDP++R+TL +V++H WV+G++G +P+Y CWCKR+
Sbjct:   348 EGLLCKDPSQRMTLKNVSEHPWVIGEDGHVPEYFCWCKRN 387

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS;IDA;IMP

GO:0009615 "response to virus" evidence=IEP

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2096930 GRIK1 "geminivirus rep interacting kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1327 (472.2 bits), Expect = 1.8e-135, P = 1.8e-135
 Identities = 253/397 (63%), Positives = 305/397 (76%)

Query:     1 MFRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGXXXXXXXXXNSYNG 60
             MF  + ++ + M C  CFG + R  + +  P     Y  S D             ++  G
Sbjct:     1 MFCDSFAFAQVMSCFGCFGGSERS-RHSPNPYDDDTY--SHD---------SGETSNPGG 48

Query:    61 EATNTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEY 120
             +     + +  E  + +KRSEEI + +  NGL+CRQFPVKE+NKL R EDE+G K INE+
Sbjct:    49 DDEEGEEEEEVEELSRSKRSEEILKCKLQNGLVCRQFPVKETNKLTRGEDEDGNKTINEF 108

Query:   121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
             V  RKIG+GSYGKVVLYRS++D KHYAIKAFHKSHLS+LRVAPSETAM DV REV+IMK 
Sbjct:   109 VRERKIGSGSYGKVVLYRSTVDDKHYAIKAFHKSHLSRLRVAPSETAMGDVLREVMIMKT 168

Query:   181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
             L+HPNIVNLIEVIDDP  D FYMVLEYV+GKW  D  G PGA+GE  ARKYLRD+V+GLM
Sbjct:   169 LEHPNIVNLIEVIDDPEFDDFYMVLEYVDGKWAYDDSGPPGALGEITARKYLRDVVAGLM 228

Query:   241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
             YLH HNV+HGDIKPDNLLV  +G VKIGDFSVSQVF+DD+D LRRSPGTPVFTAPECCLG
Sbjct:   229 YLHAHNVIHGDIKPDNLLVTSTGRVKIGDFSVSQVFKDDDDQLRRSPGTPVFTAPECCLG 288

Query:   301 LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEG 360
             +TY G++ADTWAVGVTLY MI+GQYPFLG+TLQDTYDKIV+N L+ P+ +NP LR+L+EG
Sbjct:   289 ITYSGRSADTWAVGVTLYCMILGQYPFLGDTLQDTYDKIVHNPLIIPEGLNPRLRDLIEG 348

Query:   361 LLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKR 397
             LLCKDP +R+TL  VA+H W+ G++G I +Y CWCKR
Sbjct:   349 LLCKDPNQRMTLKAVAEHPWITGEDGAISEYCCWCKR 385

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS;IMP;IDA

GO:0009615 "response to virus" evidence=IEP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

DICTYBASE|DDB_G0279405 DDB_G0279405 "Meta subfamily protein kinase DDB_G0279405" [Dictyostelium discoideum (taxid:44689)]

 Score = 586 (211.3 bits), Expect = 5.9e-57, P = 5.9e-57
 Identities = 126/288 (43%), Positives = 175/288 (60%)

Query:   100 KESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVL-YRSSLDGKH-YAIKAFHKSHLS 157
             KE+ +  +   ++G KM+NEYV VRK+G G++GKV L Y    D  H YAIK F+K  L 
Sbjct:   181 KETLRAHKKRHKDGHKMVNEYVFVRKLGKGTFGKVKLAYHH--DTHHLYAIKIFNKIRLK 238

Query:   158 KLRVAPSE-TAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG 216
             K  +      A  DV +E+ IMK + H N+V L EVI+DP  ++ Y+V+EY+EG      
Sbjct:   239 KQTMGIGRPNAFDDVLKEIAIMKKMNHINVVKLYEVINDPQEEYIYIVMEYIEG----GS 294

Query:   217 FGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
                     E +ARKY RDIV GL YLH   V+H D+KP+NLLV   G VKI DF VS +F
Sbjct:   295 IMSANETSEDLARKYFRDIVFGLEYLHEQKVIHKDLKPENLLVNSEGVVKITDFGVSHIF 354

Query:   277 EDDNDVLRRSPGTPVFTAPECCLGLTY--GGKAADTWAVGVTLYYMIIGQYPFLGET--L 332
             +DD DV+R S G+P F APE C   +    GK  D WA+GV+LY +I  + PF+ +T  L
Sbjct:   355 DDD-DVVRCSRGSPAFLAPELCRNESQPISGKGVDVWALGVSLYCLIFARTPFISKTNSL 413

Query:   333 QDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
              D YD+IVN+   +P  ++ +L +L + LL K+P  R+ + ++  H W
Sbjct:   414 LDIYDQIVNHEPTYPREISNDLMDLFKRLLDKNPLTRIQIAEIKSHKW 461

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

POMBASE|SPCC297.03 ssp1 "serine/threonine protein kinase Ssp1" [Schizosaccharomyces pombe (taxid:4896)]

 Score = 523 (189.2 bits), Expect = 2.8e-50, P = 2.8e-50
 Identities = 129/302 (42%), Positives = 174/302 (57%)

Query:    99 VKESNKLIRSEDE-NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS 157
             VKE+ K+ +  D  +G K IN Y  ++++G G +GKV L R ++  +  AIK   K+   
Sbjct:   113 VKETKKIRKRFDRFSGRKYINHYEIIKELGRGMHGKVKLGRDTVTRELLAIKIIPKTERR 172

Query:   158 -KLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG---KW- 212
              KL  A + +    VRRE+ I+K   HPN+V L EVIDDP+S   Y+VLEY+ G    W 
Sbjct:   173 PKLGRANASSQKEKVRREIAILKKCVHPNVVRLREVIDDPSSTKVYLVLEYMSGGEVPWT 232

Query:   213 DNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272
             D D    P  +  S AR+Y RD+V GL YLH   ++H DIKP NLL+  S  VKI DF V
Sbjct:   233 DCDS---P-VLSISEARQYFRDVVLGLEYLHYQGIIHRDIKPANLLLNSSNCVKISDFGV 288

Query:   273 SQV----FEDDNDV-LRRSPGTPVFTAPECC-LGLTYG----GKAADTWAVGVTLYYMII 322
             S +      +DNDV L ++ GTP F APE C   L        +A D WA+GVTL+ ++ 
Sbjct:   289 SYIANAGLNEDNDVELAKTVGTPAFFAPELCWTDLDRPRPKISEAIDVWALGVTLFCLLF 348

Query:   323 GQYPFLGETLQDTYDKIVNNSLVFPDA--MNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             G+ PF      + +DKIVN  L  P    +  E R+LL+ LLCKDP +R+TL +V  H W
Sbjct:   349 GRCPFNASMEYELFDKIVNERLNIPSTPDIGEEGRDLLKRLLCKDPEQRITLVEVKLHPW 408

Query:   381 VL 382
              L
Sbjct:   409 TL 410

GO:0004674 "protein serine/threonine kinase activity" evidence=ISM

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005516 "calmodulin binding" evidence=ISS

GO:0005524 "ATP binding" evidence=ISM

GO:0005737 "cytoplasm" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=ISM

GO:0006995 "cellular response to nitrogen starvation" evidence=IMP

GO:0007165 "signal transduction" evidence=IC

GO:0030042 "actin filament depolymerization" evidence=IGI

GO:0030428 "cell septum" evidence=IDA

GO:0030950 "establishment or maintenance of actin cytoskeleton polarity" evidence=IMP

GO:0033554 "cellular response to stress" evidence=IMP

GO:0034613 "cellular protein localization" evidence=IMP

GO:0042149 "cellular response to glucose starvation" evidence=IMP

GO:0051285 "cell cortex of cell tip" evidence=IDA

GO:0051519 "activation of bipolar cell growth" evidence=IMP

GO:0070317 "negative regulation of G0 to G1 transition" evidence=IMP

GO:0071963 "establishment or maintenance of cell polarity regulating cell shape" evidence=IMP

UNIPROTKB|G4N7H1 MGG_06421 "CAMKK/META protein kinase" [Magnaporthe oryzae 70-15 (taxid:242507)]

 Score = 444 (161.4 bits), Expect = 3.4e-49, Sum P(2) = 3.4e-49
 Identities = 92/233 (39%), Positives = 134/233 (57%)

Query:   154 SHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKW 212
             S L++ R A ++ A+  +R E+ IMK L HPN+V LIEV+DDP  D  +MVLE  + G  
Sbjct:   169 SRLNEYRTAEAKDALYLIREEIAIMKKLNHPNLVQLIEVLDDPEEDSLWMVLEMCKKGVI 228

Query:   213 DNDGFGQPGA-IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                G  Q     GE   R + RD++ G+ YLH   +VH DIKPDNLL+     +K+ DF 
Sbjct:   229 MKVGLDQAAEPYGEEQCRHWFRDLILGIEYLHAQGIVHRDIKPDNLLLTEDDILKVVDFG 288

Query:   272 VSQVFEDDNDV-LRRSPGTPVFTAPECCLGL--TYGGKAADTWAVGVTLYYMIIGQYPFL 328
             VS++FE  N++   +S G+P F  PE C+       G AAD W++G +LY M  G+ PF 
Sbjct:   289 VSEMFEKPNEMQTAKSAGSPAFLPPELCVARHGNVSGAAADIWSMGASLYCMRYGRIPFD 348

Query:   329 GETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
               T  + Y+ I    L  P   NP+  +LL  ++ KDP +R+ + ++ +H WV
Sbjct:   349 RSTPLEIYEAITTEPLKLPADENPDFVDLLSRIMQKDPGQRIRMEELREHPWV 401

GO:0005575 "cellular_component" evidence=ND

UNIPROTKB|Q148H3 CAMKK2 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 482 (174.7 bits), Expect = 2.9e-48, Sum P(2) = 2.9e-48
 Identities = 113/297 (38%), Positives = 161/297 (54%)

Query:   117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSK------------LRVAPS 164
             +N+Y    +IG GSYG V L  +  D  +YA+K   K  L +             R AP 
Sbjct:   155 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 214

Query:   165 -----ETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGFG 218
                     +  V +E+ I+K L HPN+V L+EV+DDPN DH YMV E V +G        
Sbjct:   215 GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL 274

Query:   219 QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278
             +P  + E  AR Y +D++ G+ YLH   ++H DIKP NLLV   G +KI DF VS  F+ 
Sbjct:   275 KP--LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 332

Query:   279 DNDVLRRSPGTPVFTAPECCLGLT---YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDT 335
              + +L  + GTP F APE  L  T   + GKA D WA+GVTLY  + GQ PF+ E +   
Sbjct:   333 SDALLSNTVGTPAFMAPES-LSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 391

Query:   336 YDKIVNNSLVFPDAMN--PELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG-PIP 389
             + KI + +L FPD  +   +L++L+  +L K+P  R+ + ++  H WV      P+P
Sbjct:   392 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTRHGAEPLP 448

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|F8W9H1 CAMKK1 "Calcium/calmodulin-dependent protein kinase kinase 1" [Homo sapiens (taxid:9606)]

 Score = 352 (129.0 bits), Expect = 6.5e-48, Sum P(3) = 6.5e-48
 Identities = 75/171 (43%), Positives = 103/171 (60%)

Query:   225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR 284
             E  AR YLRD++ GL YLH   +VH DIKP NLL+   G VKI DF VS  FE ++  L 
Sbjct:   287 EEQARLYLRDVILGLEYLHCQKIVHRDIKPSNLLLGDDGHVKIADFGVSNQFEGNDAQLS 346

Query:   285 RSPGTPVFTAPECCL--GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN 342
              + GTP F APE     G ++ GKA D WA GVTLY  + G+ PF+ + +   + KI N 
Sbjct:   347 STAGTPAFMAPEAISDSGQSFSGKALDVWATGVTLYCFVYGKCPFIDDFILALHRKIKNE 406

Query:   343 SLVFPDA--MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG--PIP 389
              +VFP+   ++ EL++L+  +L K+P  R+ + D+  H WV   NG  P+P
Sbjct:   407 PVVFPEEPEISEELKDLILKMLDKNPETRIGVPDIKLHPWVT-KNGEEPLP 456

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

WB|WBGene00000518 ckk-1 [Caenorhabditis elegans (taxid:6239)]

 Score = 496 (179.7 bits), Expect = 2.0e-47, P = 2.0e-47
 Identities = 119/295 (40%), Positives = 166/295 (56%)

Query:   117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHL--------------SKLRVA 162
             +N+Y  + +IG GSYG V L  +  D   YA+K   K  L              +K   A
Sbjct:   127 LNQYRLMEEIGQGSYGIVKLAYNEEDKNLYALKVLDKMKLLKNFACFRQPPPRRNKENAA 186

Query:   163 PS--ETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQ 219
             PS     +  V++E+ I+K L HPN+V L+EV+DDPN ++ YMV E+VE G        +
Sbjct:   187 PSVLRNPLQLVQKEIAILKKLSHPNVVKLVEVLDDPNDNYLYMVFEFVEKGSILEIPTDK 246

Query:   220 PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
             P  + E  A  Y RD + GL YLH   +VH DIKP NLL++  G VKI DF VS  FE  
Sbjct:   247 P--LDEDTAWSYFRDTLCGLEYLHYQKIVHRDIKPSNLLLSDIGQVKIADFGVSCEFEGI 304

Query:   280 NDVLRRSPGTPVFTAPECCL-GLT--YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTY 336
             +  L  + GTP F APE    G    Y G+A D W++G+TLY  +IG  PF+   +   +
Sbjct:   305 DAFLSGTAGTPAFMAPEALTEGANHFYSGRAQDIWSLGITLYAFVIGTVPFVDNYIIALH 364

Query:   337 DKIVNNSLVFPDA--MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIP 389
              KI N+ +VFP+A  ++  L++++ G+L KDP  RL L++V  HTWV  D G +P
Sbjct:   365 KKIKNDPIVFPEAPILSEALQDIILGMLKKDPGHRLMLHEVKVHTWVTRD-GTVP 418

GO:0006468 "protein phosphorylation" evidence=IEA;ISS;IDA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IDA

GO:0019722 "calcium-mediated signaling" evidence=TAS

GO:0005634 "nucleus" evidence=IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS;IDA

GO:0045860 "positive regulation of protein kinase activity" evidence=IDA

GO:0005516 "calmodulin binding" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0032793 "positive regulation of CREB transcription factor activity" evidence=IDA

UNIPROTKB|F1NKZ8 CAMKK1 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 486 (176.1 bits), Expect = 2.3e-46, P = 2.3e-46
 Identities = 119/315 (37%), Positives = 175/315 (55%)

Query:    98 PVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS 157
             P  ESN++  S+ E+  ++ N+Y    +IG GSYG V L  +  D K+YA+K   K  L 
Sbjct:   108 PTIESNRVSISDAEDCVQL-NQYKLQSEIGKGSYGVVKLAYNKDDDKYYAMKVLSKKKLL 166

Query:   158 KL-----RVAP--SETAMTD----------VRREVLIMKMLQHPNIVNLIEVIDDPNSDH 200
             K      R  P  S+T+  +          V +E+ I+K L H N+V LIEV+DDP  D+
Sbjct:   167 KQYGFPRRPPPRGSKTSTGEHSKTMAPLDRVYQEIAILKKLDHVNVVKLIEVLDDPAEDN 226

Query:   201 FYMVLEYV-EGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV 259
              YMV + + +G        +P    E  AR Y RDIV G+ YLH   ++H DIKP NLL+
Sbjct:   227 LYMVFDLLRKGAVMEVPSDKP--FSEDQARLYFRDIVLGIEYLHYQKIIHRDIKPSNLLL 284

Query:   260 APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC--LGLTYGGKAADTWAVGVTL 317
                G VKI DF VS  FE ++  L  + GTP F APE     G ++ GKA D WA+G+TL
Sbjct:   285 GDDGHVKIADFGVSNQFEGNDAQLSSTAGTPAFMAPEAISDTGKSFSGKALDVWAMGITL 344

Query:   318 YYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA--MNPELRNLLEGLLCKDPTRRLTLNDV 375
             Y  + G+ PF+ E +   ++KI +  + FP+   ++ EL+ L+  +L K+P  R+T+ ++
Sbjct:   345 YCFVYGKCPFIDEYILGLHNKIKSKPVEFPEESQISDELKELILRMLDKNPETRITVPEI 404

Query:   376 AKHTWVL-GDNGPIP 389
               H W+  G   P+P
Sbjct:   405 KVHPWLTKGGEEPLP 419

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1RNP6 CAMKK2 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 486 (176.1 bits), Expect = 2.3e-46, P = 2.3e-46
 Identities = 116/316 (36%), Positives = 168/316 (53%)

Query:    98 PVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS 157
             P  ES+ +  +  +     +N+Y    +IG GSYG V L  +  D  +YA+K   K  L 
Sbjct:   136 PTVESHHVSITGMQQDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLI 195

Query:   158 K------------LRVAPS-----ETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH 200
             +             R AP         +  V +E+ I+K L HPN+V L+EV+DDPN DH
Sbjct:   196 RQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH 255

Query:   201 FYMVLEYV-EGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV 259
              YMV E V +G        +P  + E  AR Y +D++ G+ YLH   ++H DIKP NLLV
Sbjct:   256 LYMVFELVNQGPVMEVPTLKP--LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 313

Query:   260 APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT---YGGKAADTWAVGVT 316
                G +KI DF VS  F+  + +L  + GTP F APE  L  T   + GKA D WA+GVT
Sbjct:   314 GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPES-LSETRKIFSGKALDVWAMGVT 372

Query:   317 LYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN--PELRNLLEGLLCKDPTRRLTLND 374
             LY  + GQ PF+ E +   + KI + +L FPD  +   +L++L+  +L K+P  R+ + +
Sbjct:   373 LYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPE 432

Query:   375 VAKHTWVLGDNG-PIP 389
             +  H WV      P+P
Sbjct:   433 IKLHPWVTRHGAEPLP 448

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q5HZ38	GRIK2_ARATH	2, ., 7, ., 1, 1, ., 1	0.6527	0.9243	0.9312	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	410
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-78
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-65
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-64
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-58
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-57
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-54
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-50
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-49
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-49
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-45
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-43
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-43
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-42
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-42
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-42
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-41
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	9e-41
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-40
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-39
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-38
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-38
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-38
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-38
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-38
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-37
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-37
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-37
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-37
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-36
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-36
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-36
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-36
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-36
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-36
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-35
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-35
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-35
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-34
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-34
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-34
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-34
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-34
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-34
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-33
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-33
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-33
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-33
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-33
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-32
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-32
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-32
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-32
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-31
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-31
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-31
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-31
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-31
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-30
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-30
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-30
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-29
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-29
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-29
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-29
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-29
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-29
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-29
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-29
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-29
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-29
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-28
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-28
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-28
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-28
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-28
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-28
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-28
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-28
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-27
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-27
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-27
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-27
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-27
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-27
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-26
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-26
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-26
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-26
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-26
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-26
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-26
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-26
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-26
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-26
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-25
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-25
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-25
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-25
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-25
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-25
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-25
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-25
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-25
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-25
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-25
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-25
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-25
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-25
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-24
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-24
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-24
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-24
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-24
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-24
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-24
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-23
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-23
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-23
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-23
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-23
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-23
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-23
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-23
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-22
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-22
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-22
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-22
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-22
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-21
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-21
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-21
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-21
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-21
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-21
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-21
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-20
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-20
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-20
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-20
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-20
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-20
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-20
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-20
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-20
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-20
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-20
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-19
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-19
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-19
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-19
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-19
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-19
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-19
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-19
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-19
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-19
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-19
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-19
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-19
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-18
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-18
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-18
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-18
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-18
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-18
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-18
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-18
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-18
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	8e-18
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	9e-18
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-17
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-17
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-17
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-17
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-17
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-17
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-17
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	8e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	9e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-17
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	9e-17
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-16
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-16
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-16
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-16
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-16
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	9e-16
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-15
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-15
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-15
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-15
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-13
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-13
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-13
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-13
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-13
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-12
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-12
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-12
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-12
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-11
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	9e-11
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-10
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-10
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	9e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-09
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-08
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-08
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	5e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-07
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	7e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-06
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-05
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	6e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-04
cd05144	198	cd05144, RIO2_C, RIO kinase family; RIO2, C-termin	1e-04
COG4248	637	COG4248, COG4248, Uncharacterized protein with pro	2e-04
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	3e-04
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-04
COG0478	304	COG0478, COG0478, RIO-like serine/threonine protei	5e-04
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	0.002
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.003
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.003
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  242 bits (619), Expect = 3e-78
 Identities = 104/271 (38%), Positives = 143/271 (52%), Gaps = 26/271 (9%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y  + K+G GS+GKV L R    GK  AIK   K  + K R          + RE+ I+K
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRE--------RILREIKILK 52

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG-----KWDNDGFGQPGAIGESMARKYLRD 234
            L+HPNIV L +V +D   D  Y+V+EY EG          G      + E  AR YLR 
Sbjct: 53  KLKHPNIVRLYDVFEDE--DKLYLVMEYCEGGDLFDLLKKRGR-----LSEDEARFYLRQ 105

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           I+S L YLH   +VH D+KP+N+L+   G VK+ DF ++    D  + L    GTP + A
Sbjct: 106 ILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLA-RQLDPGEKLTTFVGTPEYMA 164

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG-ETLQDTYDKIVNNSLVFPDAMN-- 351
           PE  LG  Y GKA D W++GV LY ++ G+ PF G + L + + KI      FP      
Sbjct: 165 PEVLLGKGY-GKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDI 223

Query: 352 -PELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            PE ++L+  LL KDP +RLT  +  +H + 
Sbjct: 224 SPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  209 bits (534), Expect = 1e-65
 Identities = 94/261 (36%), Positives = 139/261 (53%), Gaps = 18/261 (6%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+GKV+L R    GK YA+K   K  + K +    E   T    E  I+  + HP 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRK----EVEHT--LTERNILSRINHPF 54

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG---QPGAIGESMARKYLRDIVSGLMYL 242
           IV L         +  Y+VLEY  G    + F    + G   E  AR Y  +IV  L YL
Sbjct: 55  IVKLHYAFQTE--EKLYLVLEYAPG---GELFSHLSKEGRFSEERARFYAAEIVLALEYL 109

Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
           H   +++ D+KP+N+L+   G +K+ DF +++    +        GTP + APE  LG  
Sbjct: 110 HSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG 169

Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLL 362
           YG KA D W++GV LY M+ G+ PF  E  ++ Y+KI+ + L FP+ ++PE R+L+ GLL
Sbjct: 170 YG-KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLL 228

Query: 363 CKDPTRRLT---LNDVAKHTW 380
            KDPT+RL      ++  H +
Sbjct: 229 QKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  204 bits (522), Expect = 9e-64
 Identities = 90/269 (33%), Positives = 139/269 (51%), Gaps = 16/269 (5%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y  +RK+G+GS+G V   +    GK  A+K   K      +   +       RRE+ I++
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTA-------RREIRILR 53

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
            L HPNIV LI+  +D   DH Y+V+EY EG    D   + G + E  A+K    I+ GL
Sbjct: 54  RLSHPNIVRLIDAFEDK--DHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGL 111

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
            YLH + ++H D+KP+N+L+  +G VKI DF +++     +  L    GTP + APE  L
Sbjct: 112 EYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL 171

Query: 300 GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN-------SLVFPDAMNP 352
           G    G   D W++GV LY ++ G+ PF GE + D    I                + + 
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSE 231

Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           E ++L++  L KDP++R T  ++ +H W 
Sbjct: 232 EAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  188 bits (480), Expect = 6e-58
 Identities = 84/260 (32%), Positives = 126/260 (48%), Gaps = 53/260 (20%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G +G V L R    GK  AIK   K   S L          ++ RE+ I+K L HPN
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--------EELLREIEILKKLNHPN 52

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG------FGQPGAIGESMARKYLRDIVSGL 239
           IV L  V +D N  H Y+V+EY EG     G          G + E    + L  I+ GL
Sbjct: 53  IVKLYGVFEDEN--HLYLVMEYCEG-----GSLKDLLKENEGKLSEDEILRILLQILEGL 105

Query: 240 MYLHGHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
            YLH + ++H D+KP+N+L+ + +G VK+ DF +S++   D  +L+   GTP + APE  
Sbjct: 106 EYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVL 165

Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLL 358
           LG  Y  + +D W++GV LY +                               PEL++L+
Sbjct: 166 LGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLI 194

Query: 359 EGLLCKDPTRRLTLNDVAKH 378
             +L KDP +R +  ++ +H
Sbjct: 195 RKMLQKDPEKRPSAKEILEH 214

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  187 bits (477), Expect = 5e-57
 Identities = 87/270 (32%), Positives = 129/270 (47%), Gaps = 33/270 (12%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y  +++IG GS+GKV L R   DGK Y +K   +  LS +    SE    D   EV I+K
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLK---EIDLSNM----SEKEREDALNEVKILK 54

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----------KWDNDGFGQPGAIGESMAR 229
            L HPNI+   E  ++       +V+EY +G          K +   F       E    
Sbjct: 55  KLNHPNIIKYYESFEEK--GKLCIVMEYADGGDLSQKIKKQKKEGKPFP------EEQIL 106

Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
            +   +   L YLH   ++H DIKP N+ +  +G VK+GDF +S+V     D+ +   GT
Sbjct: 107 DWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGT 166

Query: 290 PVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA 349
           P + +PE C    Y  K +D W++G  LY +   ++PF GE L +   KI+         
Sbjct: 167 PYYLSPELCQNKPYNYK-SDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ---YPP 222

Query: 350 MNP----ELRNLLEGLLCKDPTRRLTLNDV 375
           +      ELRNL+  LL KDP  R ++  +
Sbjct: 223 IPSQYSSELRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  181 bits (462), Expect = 1e-54
 Identities = 86/271 (31%), Positives = 137/271 (50%), Gaps = 19/271 (7%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           E+     +G GS+G V L      G+  A+K+   S  S+  +         + RE+ I+
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEA-------LEREIRIL 53

Query: 179 KMLQHPNIVNLI--EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
             LQHPNIV     E  ++ N     + LEYV G   +    + G + E + RKY R I+
Sbjct: 54  SSLQHPNIVRYYGSERDEEKN--TLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL 111

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSP-GTPVFTA 294
            GL YLH + +VH DIK  N+LV   G VK+ DF  + ++ + +      S  GTP + A
Sbjct: 112 EGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLV--FPDAM 350
           PE   G    G+AAD W++G T+  M  G+ P+  LG  +   Y KI ++      P+ +
Sbjct: 172 PEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY-KIGSSGEPPEIPEHL 229

Query: 351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           + E ++ L   L +DP +R T +++ +H ++
Sbjct: 230 SEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  171 bits (436), Expect = 1e-50
 Identities = 83/287 (28%), Positives = 128/287 (44%), Gaps = 48/287 (16%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +++   + IG GS+  VVL +     K YAIK   K  L K      E  +  V+ E  +
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK------EKKVKYVKIEKEV 54

Query: 178 MKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMAR 229
           +  L  HP I+ L     D  +   Y VLEY          G       + G++ E   R
Sbjct: 55  LTRLNGHPGIIKLYYTFQDEEN--LYFVLEYAPN-------GELLQYIRKYGSLDEKCTR 105

Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--------D 281
            Y  +I+  L YLH   ++H D+KP+N+L+     +KI DF  ++V + ++         
Sbjct: 106 FYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDA 165

Query: 282 VLRRSP------------GTPVFTAPECCLGLTYG--GKAADTWAVGVTLYYMIIGQYPF 327
               S             GT  + +PE    L     GK++D WA+G  +Y M+ G+ PF
Sbjct: 166 TNIDSQIEKNRRRFASFVGTAEYVSPEL---LNEKPAGKSSDLWALGCIIYQMLTGKPPF 222

Query: 328 LGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLND 374
            G     T+ KI+     FP    P+ ++L+E LL  DP  RL +N+
Sbjct: 223 RGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNE 269

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  167 bits (425), Expect = 4e-49
 Identities = 84/271 (30%), Positives = 135/271 (49%), Gaps = 28/271 (10%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           I  G+YG+V L +    G  YAIK   K+ + +      +  +T    E  I+   Q P 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQ--VDQVLT----ERDILSQAQSPY 54

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG---QPGAIGESMARKYLRDIVSGLMYL 242
           +V L          + Y+V+EY+ G    D        G++ E +AR Y+ +IV  L YL
Sbjct: 55  VVKLYYSFQG--KKNLYLVMEYLPG---GDLASLLENVGSLDEDVARIYIAEIVLALEYL 109

Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV--------FEDDNDVLRRSPGTPVFTA 294
           H + ++H D+KPDN+L+  +G +K+ DF +S+V          DD    +R  GTP + A
Sbjct: 110 HSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN--P 352
           PE  LG  +  K  D W++G  LY  ++G  PF GET ++ +  I+N  + +P+ +    
Sbjct: 170 PEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSD 228

Query: 353 ELRNLLEGLLCKDPTRRLTLN---DVAKHTW 380
           E  +L+  LL  DP +RL      ++  H +
Sbjct: 229 EAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  166 bits (424), Expect = 8e-49
 Identities = 93/274 (33%), Positives = 145/274 (52%), Gaps = 29/274 (10%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR-VAPSETAMTDVRREVL 176
           +++  ++ +G GS+G+V+L R    GK+YA+K   K+ + KL+ V         V  E  
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVE-------HVLNEKR 53

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG-----FGQPGAIGESMARKY 231
           I++ ++HP +VNL     D ++   Y+V+EYV G     G       + G   E +AR Y
Sbjct: 54  ILQSIRHPFLVNLYGSFQDDSN--LYLVMEYVPG-----GELFSHLRKSGRFPEPVARFY 106

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
              +V  L YLH  ++V+ D+KP+NLL+   G +KI DF  ++  +     L    GTP 
Sbjct: 107 AAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL---CGTPE 163

Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
           + APE  L   YG KA D WA+G+ +Y M+ G  PF  +     Y+KI+   + FP   +
Sbjct: 164 YLAPEIILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFS 222

Query: 352 PELRNLLEGLLCKDPTRRL-TL----NDVAKHTW 380
           P+ ++L+  LL  D T+RL  L    ND+  H W
Sbjct: 223 PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  156 bits (397), Expect = 7e-45
 Identities = 82/299 (27%), Positives = 133/299 (44%), Gaps = 56/299 (18%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y  + K+G G+YG V   R    G+  A+K   K  L         TA+    RE+ ++K
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALK---KIRLDNEEEGIPSTAL----REISLLK 53

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDI 235
            L+HPNIV L++VI        Y+V EY     D D       +PG +  ++ +  +  +
Sbjct: 54  ELKHPNIVKLLDVIHTERK--LYLVFEYC----DMDLKKYLDKRPGPLSPNLIKSIMYQL 107

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF-----EDDNDVLRRSPGTP 290
           + GL Y H H ++H D+KP N+L+   G +K+ DF +++ F        ++V+     T 
Sbjct: 108 LRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-----TL 162

Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKI----------- 339
            + APE  LG  +   A D W+VG     MI G+  F G++  D   KI           
Sbjct: 163 WYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES 222

Query: 340 -------VNNSLVFP-----------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
                   +    FP             ++PE  +LL  +L  +P +R++  +  KH +
Sbjct: 223 WPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  150 bits (381), Expect = 7e-43
 Identities = 79/267 (29%), Positives = 138/267 (51%), Gaps = 23/267 (8%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           ++ I  G++G V L +    G ++AIK   KS +       ++  +T+V+ E  IM M+Q
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI------AKNQVTNVKAERAIM-MIQ 53

Query: 183 --HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
              P +  L       + D+ Y+V+EY+ G          G + E  A++Y+ ++V G+ 
Sbjct: 54  GESPYVAKLYYSFQ--SKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVE 111

Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
            LH   ++H DIKP+NLL+  +G +K+ DF +S+         ++  GTP + APE  LG
Sbjct: 112 DLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL----ENKKFVGTPDYLAPETILG 167

Query: 301 LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD----AMNPELRN 356
           +    K +D W++G  ++  + G  PF  ET    +D I++  + +P+      +PE  +
Sbjct: 168 VG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVD 226

Query: 357 LLEGLLCKDPTRRLTLN---DVAKHTW 380
           L+  LLC DP +RL  N   ++  H +
Sbjct: 227 LINRLLCMDPAKRLGANGYQEIKSHPF 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  154 bits (388), Expect = 7e-43
 Identities = 92/288 (31%), Positives = 138/288 (47%), Gaps = 37/288 (12%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
            Y  +RK+G GS+G+V L   + D K  A+K   K   SK         +    RE+ I+
Sbjct: 1   SYRILRKLGEGSFGEVYL---ARDRKLVALKVLAKKLESK------SKEVERFLREIQIL 51

Query: 179 KMLQHP-NIVNLIEVIDDPNSDHFYMVLEYVEG---KWDNDGFGQPGAIGESMARKYLRD 234
             L HP NIV L +   D      Y+V+EYV+G   +      G+ G + ES A   L  
Sbjct: 52  ASLNHPPNIVKLYDFFQDEG--SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQ 109

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGT-VKIGDFSVSQVFEDDND------VLRRSP 287
           I+S L YLH   ++H DIKP+N+L+   G  VK+ DF ++++  D         +   S 
Sbjct: 110 ILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169

Query: 288 GTPVFTAPECCLGLT--YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV 345
           GTP + APE  LGL+  Y   ++D W++G+TLY ++ G  PF GE       + +   L 
Sbjct: 170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229

Query: 346 -------------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
                         P+ ++    +LL+ LL KDP  RL+ +    H  
Sbjct: 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDL 277

Length = 384

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  149 bits (378), Expect = 2e-42
 Identities = 77/264 (29%), Positives = 120/264 (45%), Gaps = 21/264 (7%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           + KIG G +G+V   R    GK  AIK         +++  S+     +  E+ I+K  +
Sbjct: 5   LEKIGKGGFGEVYKARHKRTGKEVAIK--------VIKL-ESKEKKEKIINEIQILKKCK 55

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDND---GFGQPGAIGESMARKYLRDIVSGL 239
           HPNIV           D  ++V+E+  G    D      Q   + ES      ++++ GL
Sbjct: 56  HPNIVKYYGSYLKK--DELWIVMEFCSGGSLKDLLKSTNQT--LTESQIAYVCKELLKGL 111

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
            YLH + ++H DIK  N+L+   G VK+ DF +S    D         GTP + APE   
Sbjct: 112 EYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV-GTPYWMAPEVIN 170

Query: 300 GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS---LVFPDAMNPELRN 356
           G  Y  K AD W++G+T   +  G+ P+          KI  N    L  P+  + E ++
Sbjct: 171 GKPYDYK-ADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKD 229

Query: 357 LLEGLLCKDPTRRLTLNDVAKHTW 380
            L+  L K+P +R T   + KH +
Sbjct: 230 FLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  149 bits (377), Expect = 3e-42
 Identities = 78/266 (29%), Positives = 126/266 (47%), Gaps = 23/266 (8%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKS-HLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           R IG G++GKV + +     K +A+K  +K   + K  V        +V  E  I++ L 
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVR-------NVLNERRILQELN 58

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEG---KWDNDGFGQPGAIGESMARKYLRDIVSGL 239
           HP +VNL     D   ++ Y+V++ + G   ++      Q     E   + ++ +IV  L
Sbjct: 59  HPFLVNLWYSFQD--EENMYLVVDLLLGGDLRYH---LSQKVKFSEEQVKFWICEIVLAL 113

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
            YLH   ++H DIKPDN+L+   G V I DF+++     D      S GTP + APE   
Sbjct: 114 EYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS-GTPGYMAPEVLC 172

Query: 300 GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYD---KIVNNSLVFPDAMNPELRN 356
              Y   A D W++GVT Y  + G+ P+ G +         K     +++P   + E  +
Sbjct: 173 RQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAID 231

Query: 357 LLEGLLCKDPTRRL--TLNDVAKHTW 380
            +  LL +DP +RL   L D+  H +
Sbjct: 232 AINKLLERDPQKRLGDNLKDLKNHPY 257

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  148 bits (376), Expect = 7e-42
 Identities = 80/260 (30%), Positives = 124/260 (47%), Gaps = 17/260 (6%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G++G+V L R  +   +YA+K      + +L+          V  E  ++K + HP 
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLK------QEQHVHNEKRVLKEVSHPF 62

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           I+ L     D      YM++EYV G          G    S    Y  +IV  L YLH  
Sbjct: 63  IIRLFWTEHDQR--FLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
            +V+ D+KP+N+L+   G +K+ DF  ++   D    L    GTP + APE  +      
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL---CGTPEYLAPEV-IQSKGHN 176

Query: 306 KAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKD 365
           KA D WA+G+ +Y M++G  PF  +     Y+KI+   L FP  ++   ++L++ LL  D
Sbjct: 177 KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVD 236

Query: 366 PTRRL-----TLNDVAKHTW 380
            TRRL       +DV  H W
Sbjct: 237 RTRRLGNMKNGADDVKNHRW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  145 bits (368), Expect = 4e-41
 Identities = 81/262 (30%), Positives = 122/262 (46%), Gaps = 19/262 (7%)

Query: 125 KIGAGSYGKVVLYRS--SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
            IG G++G V  Y+      G   AIK      +        E A+  + +E+ ++K L+
Sbjct: 7   LIGRGAFGVV--YKGLNLETGDFVAIKQISLEKIK-------EEALKSIMQEIDLLKNLK 57

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           HPNIV  I  I    SD  Y++LEY E         + G   ES+   Y+  ++ GL YL
Sbjct: 58  HPNIVKYIGSI--ETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYL 115

Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL--G 300
           H   V+H DIK  N+L    G VK+ DF V+    D +       GTP + APE     G
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG 175

Query: 301 LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNLLE 359
            +    A+D W++G T+  ++ G  P+          +IV +     P+ ++PEL++ L 
Sbjct: 176 AS---TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLM 232

Query: 360 GLLCKDPTRRLTLNDVAKHTWV 381
               KDP  R T   + KH W+
Sbjct: 233 QCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  146 bits (370), Expect = 9e-41
 Identities = 90/248 (36%), Positives = 129/248 (52%), Gaps = 9/248 (3%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IG GS+GKV+  R     + YA+K   K+H+    V+ SE   T   R VL    +  P 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI----VSRSEVTHTLAERTVL--AQVNCPF 54

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           IV L      P  +  Y+VL ++ G        + G    S AR Y  +++  L  LH  
Sbjct: 55  IVPLKFSFQSP--EKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKF 112

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
           NV++ D+KP+N+L+   G + + DF + ++   D+D      GTP + APE  LG  Y  
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT- 171

Query: 306 KAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKD 365
           KA D W +GV LY M+ G  PF  E + + Y KI+   L FPD  + + ++LL GLL +D
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRD 231

Query: 366 PTRRLTLN 373
           PTRRL  N
Sbjct: 232 PTRRLGYN 239

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  143 bits (362), Expect = 7e-40
 Identities = 76/290 (26%), Positives = 122/290 (42%), Gaps = 41/290 (14%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y  + KIG G+YG V   R  L G+  AIK       S       E       RE+ ++K
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-------EGIPKTALREIKLLK 53

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
            L HPNI+ L++V         Y+V E+++         +   + ES+ + YL  ++ GL
Sbjct: 54  ELNHPNIIKLLDVFRHKG--DLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGL 111

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
            + H H ++H D+KP+NLL+   G +K+ DF +++ F            T  + APE  L
Sbjct: 112 AFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLL 171

Query: 300 GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKI-------------------- 339
           G        D W+VG     ++  +  F G++  D   KI                    
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231

Query: 340 -----------VNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
                      +    +FP+A +P+  +LL  +L  DP +R+T      H
Sbjct: 232 NYKFSFPKKAGMPLPKLFPNA-SPQALDLLSQMLHYDPHKRITAEQALAH 280

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  140 bits (355), Expect = 5e-39
 Identities = 80/265 (30%), Positives = 125/265 (47%), Gaps = 17/265 (6%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           V+ +G GS G V   R    GK YA+K  H     + R          + RE+  ++  +
Sbjct: 6   VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQ--------LLRELKTLRSCE 57

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
            P +V               +VLEY++G    D   + G I E +     R I+ GL YL
Sbjct: 58  SPYVVKCYGAFYKEGE--ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYL 115

Query: 243 HG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   +++H DIKP NLL+   G VKI DF +S+V E+  D      GT  + +PE   G 
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE 175

Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYD---KIVNNSLVFPDA--MNPELRN 356
           +Y   AAD W++G+TL    +G++PFL       ++    I +       A   +PE R+
Sbjct: 176 SY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD 234

Query: 357 LLEGLLCKDPTRRLTLNDVAKHTWV 381
            +   L KDP +R +  ++ +H ++
Sbjct: 235 FISACLQKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  140 bits (355), Expect = 1e-38
 Identities = 82/310 (26%), Positives = 135/310 (43%), Gaps = 73/310 (23%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE-----TAMTDVRRE 174
           Y  + +IG G+YG+V   R+   G+  A+K        K+R+   +     TA+    RE
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALK--------KIRMENEKEGFPITAI----RE 48

Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG---QPGA-IGESMARK 230
           + +++ L+HPNIV L E++        YMV EY+    D+D  G    P     ES  + 
Sbjct: 49  IKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM----DHDLTGLLDSPEVKFTESQIKC 104

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
           Y++ ++ GL YLH + ++H DIK  N+L+   G +K+ DF +++ +   N          
Sbjct: 105 YMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS--------A 156

Query: 291 VFT---------APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN 341
            +T          PE  LG T  G   D W+VG  L  + +G+  F G T  +  +KI  
Sbjct: 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216

Query: 342 -----------------------------NSL--VFPDAMNPELRNLLEGLLCKDPTRRL 370
                                          L   F   ++P   +LL+ LL  DP +R+
Sbjct: 217 LCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI 276

Query: 371 TLNDVAKHTW 380
           + +   +H +
Sbjct: 277 SADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  138 bits (350), Expect = 2e-38
 Identities = 82/269 (30%), Positives = 140/269 (52%), Gaps = 19/269 (7%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +YV V+KIG GS+GK +L +S  DGK Y IK  + S     +++P E    + R+EV ++
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINIS-----KMSPKER--EESRKEVAVL 53

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF----GQPG-AIGESMARKYLR 233
             ++HPNIV   E  ++  + + Y+V++Y EG    D +     Q G    E     +  
Sbjct: 54  SNMKHPNIVQYQESFEE--NGNLYIVMDYCEG---GDLYKKINAQRGVLFPEDQILDWFV 108

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
            I   L ++H   ++H DIK  N+ +   GT+K+GDF +++V     ++ R   GTP + 
Sbjct: 109 QICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYL 168

Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFPDAMNP 352
           +PE C    Y  K +D WA+G  LY M   ++ F    +++   KI+  S        + 
Sbjct: 169 SPEICENRPYNNK-SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSY 227

Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           +LRNL+  L  ++P  R ++N + +  ++
Sbjct: 228 DLRNLVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  138 bits (350), Expect = 3e-38
 Identities = 74/267 (27%), Positives = 126/267 (47%), Gaps = 25/267 (9%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G +G+V L +     + +A+K   K H+ +            +  E  I++   HP 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETG------QQEHIFSEKEILEECNHPF 54

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           IV L     D    + YM++EY  G          G   E  AR Y+  +V    YLH  
Sbjct: 55  IVKLYRTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR 112

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS---PGTPVFTAPECCLGLT 302
            +++ D+KP+NLL+  +G VK+ DF  ++  +       ++    GTP + APE  L   
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWTFCGTPEYVAPEIILNKG 168

Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQD--TYDKIV--NNSLVFPDAMNPELRNLL 358
           Y   + D W++G+ LY ++ G+ PF  +       Y+ I+  N  L FP+ ++   ++L+
Sbjct: 169 Y-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLI 227

Query: 359 EGLLCKDPTRRL-----TLNDVAKHTW 380
           + LL ++P  RL      + D+ KH W
Sbjct: 228 KQLLRRNPEERLGNLKGGIKDIKKHKW 254

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  139 bits (352), Expect = 4e-38
 Identities = 75/247 (30%), Positives = 120/247 (48%), Gaps = 8/247 (3%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           + +G GS+GKV+L       + YA+K   K     + +   +   T   + VL +   +H
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKD----VILQDDDVECTMTEKRVLALAG-KH 55

Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           P +  L         D  + V+EYV G        + G   E  AR Y  +IV GL +LH
Sbjct: 56  PFLTQLHSCFQTK--DRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113

Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTY 303
              +++ D+K DN+L+   G +KI DF + +             GTP + APE      Y
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY 173

Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
           G  A D WA+GV LY M+ GQ PF G+   + +  I+ + + +P  ++ E +++L+  L 
Sbjct: 174 G-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLT 232

Query: 364 KDPTRRL 370
           K+P +RL
Sbjct: 233 KNPEKRL 239

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  139 bits (353), Expect = 4e-38
 Identities = 89/265 (33%), Positives = 135/265 (50%), Gaps = 17/265 (6%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+G+V + +    G++YAIK   K  + K++       +  V +E  I+  L HP 
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMK------QVQHVAQEKSILMELSHPF 79

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           IVN++    D   +  Y +LE+V G        + G     +A+ Y  ++V    YLH  
Sbjct: 80  IVNMMCSFQD--ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
           ++++ D+KP+NLL+   G VK+ DF  ++   D    L    GTP + APE      +G 
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL---CGTPEYLAPEVIQSKGHG- 193

Query: 306 KAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKD 365
           KA D W +GV LY  I G  PF  +T    Y+KI+   L FP+  +   R+L++GLL  D
Sbjct: 194 KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTD 253

Query: 366 PTRRL-TLN----DVAKHTWVLGDN 385
            T+RL TL     DV  H +  G N
Sbjct: 254 HTKRLGTLKGGVADVKNHPYFHGAN 278

Length = 329

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  137 bits (346), Expect = 3e-37
 Identities = 85/245 (34%), Positives = 121/245 (49%), Gaps = 8/245 (3%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IG GS+GKV+L +   DGK YA+K   K  + K      E       R VL+ K ++HP 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK----KKEQKHIMAERNVLL-KNVKHPF 57

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           +V L        +D  Y VL+YV G        +  +  E  AR Y  +I S L YLH  
Sbjct: 58  LVGLHYSFQ--TADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL 115

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
           N+++ D+KP+N+L+   G V + DF + +   + +       GTP + APE      Y  
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD- 174

Query: 306 KAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKD 365
           +  D W +G  LY M+ G  PF      + YD I+N  L     ++   R+LLEGLL KD
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKD 234

Query: 366 PTRRL 370
            T+RL
Sbjct: 235 RTKRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  137 bits (348), Expect = 4e-37
 Identities = 95/305 (31%), Positives = 143/305 (46%), Gaps = 50/305 (16%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +++  ++ IG G++G+V L R    G+ YA+K   KS +    +  ++ A   VR E  I
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM----IKRNQIAH--VRAERDI 54

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG---QPGAIGESMARKYLRD 234
           +     P IV L     D   +H Y+V+EY+ G    D      +     E  AR Y+ +
Sbjct: 55  LADADSPWIVKLYYSFQD--EEHLYLVMEYMPG---GDLMNLLIRKDVFPEETARFYIAE 109

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND------------- 281
           +V  L  +H    +H DIKPDN+L+   G +K+ DF + +      D             
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169

Query: 282 ---------------VLRRSP-GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQY 325
                          V   S  GTP + APE   G  YG +  D W++GV LY M+ G  
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFP 228

Query: 326 PFLGETLQDTYDKIVN--NSLVFP--DAMNPELRNLLEGLLCKDPTRRLT-LNDVAKHTW 380
           PF  +TLQ+TY+KI+N   SL FP    ++PE  +L+  LLC DP  RL    ++  H +
Sbjct: 229 PFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287

Query: 381 VLGDN 385
             G +
Sbjct: 288 FKGID 292

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  135 bits (342), Expect = 6e-37
 Identities = 79/223 (35%), Positives = 119/223 (53%), Gaps = 9/223 (4%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            +Y ++  +G GSYG V+  +    G+  AIK F +S   K      + AM    RE+ +
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK---MVKKIAM----REIRM 53

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +K L+H N+VNLIEV         Y+V E+V+    +D    P  + ES  RKYL  I+ 
Sbjct: 54  LKQLRHENLVNLIEVFR--RKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILR 111

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPEC 297
           G+ + H HN++H DIKP+N+LV+ SG VK+ DF  ++      +V      T  + APE 
Sbjct: 112 GIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPEL 171

Query: 298 CLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV 340
            +G T  G+A D WAVG  +  M+ G+  F G++  D    I+
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  136 bits (344), Expect = 9e-37
 Identities = 85/248 (34%), Positives = 127/248 (51%), Gaps = 13/248 (5%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSH-LSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           +G G +GKV+L      G+ YAIKA  K   +++  V   E+ M + +R        +HP
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEV---ESLMCE-KRIFETANSERHP 62

Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
            +VNL         DH   V+EY  G  D           E  A  Y   +V GL YLH 
Sbjct: 63  FLVNLFACFQ--TEDHVCFVMEYAAGG-DLMMHIHTDVFSEPRAVFYAACVVLGLQYLHE 119

Query: 245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLT 302
           + +V+ D+K DNLL+   G VKI DF + +  E      R S   GTP F APE     +
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAPEVLTETS 177

Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLL 362
           Y  +A D W +GV +Y M++G+ PF G+  ++ +D IVN+ + +P  ++ E  +++  LL
Sbjct: 178 YT-RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLL 236

Query: 363 CKDPTRRL 370
            ++P RRL
Sbjct: 237 RRNPERRL 244

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  134 bits (339), Expect = 1e-36
 Identities = 75/272 (27%), Positives = 116/272 (42%), Gaps = 42/272 (15%)

Query: 124 RKIGAGSYGKVVL--YRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +K+G G++G+V     +   +G     A+K         L+   SE    +   E  IMK
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVK--------TLKEGASEEEREEFLEEASIMK 56

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG--------QPGAIGESMARKY 231
            L HPNIV L+ V      +  Y+V EY+ G       G            +      + 
Sbjct: 57  KLSHPNIVRLLGVC--TQGEPLYIVTEYMPG-------GDLLDFLRKHGEKLTLKDLLQM 107

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSPGTP 290
              I  G+ YL   N VH D+   N LV  +  VKI DF +S  ++EDD    R     P
Sbjct: 108 ALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167

Query: 291 VF-TAPECCLGLTYGG--KAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS-LV 345
           +   APE    L  G     +D W+ GV L+ +  +G+ P+ G + ++  + + +   L 
Sbjct: 168 IKWMAPES---LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLP 224

Query: 346 FPDAMNPELRNLLEGLLC--KDPTRRLTLNDV 375
            P+    EL  L+  L C   DP  R T +++
Sbjct: 225 RPENCPDELYELM--LQCWAYDPEDRPTFSEL 254

Length = 258

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  134 bits (339), Expect = 2e-36
 Identities = 79/302 (26%), Positives = 133/302 (44%), Gaps = 61/302 (20%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAM-TDVRREVLIM 178
           Y  + +IG G+YG V   R    G+  A+K        K+RV  SE  +     RE+ ++
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALK--------KVRVPLSEEGIPLSTLREIALL 52

Query: 179 KMLQ---HPNIVNLIEVIDDPNSDH---FYMVLEYVEGKWDNDGF----GQPGAIGESMA 228
           K L+   HPNIV L++V   P +D      +V E+V+   D   +     +PG +     
Sbjct: 53  KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD--QDLATYLSKCPKPG-LPPETI 109

Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           +  +R ++ G+ +LH H +VH D+KP N+LV   G VKI DF +++++  +         
Sbjct: 110 KDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE------MAL 163

Query: 289 TPV-----FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-- 341
           T V     + APE  L  +Y     D W+VG     +   +  F G +  D  DKI +  
Sbjct: 164 TSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVI 222

Query: 342 ----------NSLVFPDA---------------MNPELRNLLEGLLCKDPTRRLTLNDVA 376
                     N  +   +               +  E  +LL+ +L  +P +R++  +  
Sbjct: 223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282

Query: 377 KH 378
           +H
Sbjct: 283 QH 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  135 bits (341), Expect = 2e-36
 Identities = 87/265 (32%), Positives = 133/265 (50%), Gaps = 14/265 (5%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G++GKV+L R    G++YA+K   K    ++ +A  E A T     VL  +  +HP 
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRK----EVIIAKDEVAHTVTESRVL--QNTRHPF 56

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           +  L         D    V+EY  G        +     E  AR Y  +IVS L YLH  
Sbjct: 57  LTALKYAFQ--THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 114

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
           +VV+ DIK +NL++   G +KI DF + +    D   ++   GTP + APE      YG 
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG- 173

Query: 306 KAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKD 365
           +A D W +GV +Y M+ G+ PF  +  +  ++ I+   + FP  ++PE ++LL GLL KD
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 233

Query: 366 PTRRL-----TLNDVAKHTWVLGDN 385
           P +RL        +V +H + L  N
Sbjct: 234 PKQRLGGGPSDAKEVMEHRFFLSIN 258

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  133 bits (337), Expect = 3e-36
 Identities = 82/298 (27%), Positives = 138/298 (46%), Gaps = 50/298 (16%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
            Y  + +IG G++G V   +    G+  A+K   K  L +L       A+    RE+  +
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALK---KVALRRLEGGIPNQAL----REIKAL 53

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           +  QHP +V L++V   P+   F +V+EY+          +   + E+  + Y+R ++ G
Sbjct: 54  QACQHPYVVKLLDVF--PHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKG 111

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT----A 294
           + Y+H + ++H D+KP NLL++  G +KI DF ++++F ++     R     V T    A
Sbjct: 112 VAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP---RLYSHQVATRWYRA 168

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET----------------------- 331
           PE   G        D WAVG     ++ G   F GE                        
Sbjct: 169 PELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGL 228

Query: 332 --LQDTYDKIV---NNSL----VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             L D Y+KI    +  +    +FPDA +PE  +LL+GLL  DP++RL+  +  +H +
Sbjct: 229 TSLPD-YNKITFPESKPIPLEEIFPDA-SPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  134 bits (338), Expect = 4e-36
 Identities = 83/245 (33%), Positives = 125/245 (51%), Gaps = 9/245 (3%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G++GKV+L R    GK+YA+K   K  +    +A  E A T     VL  +  +HP 
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVI----IAKDEVAHTLTESRVL--QNTRHPF 56

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           +  L         D    V+EY  G        +     E  AR Y  +IVS L YLH  
Sbjct: 57  LTALKYSFQ--THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC 114

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
           +VV+ D+K +NL++   G +KI DF + +    D   ++   GTP + APE      YG 
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG- 173

Query: 306 KAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKD 365
           +A D W +GV +Y M+ G+ PF  +  +  ++ I+   + FP  ++PE ++LL GLL KD
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 233

Query: 366 PTRRL 370
           P +RL
Sbjct: 234 PKQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  131 bits (332), Expect = 9e-36
 Identities = 76/258 (29%), Positives = 127/258 (49%), Gaps = 9/258 (3%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G+GS+G V    +  DG  +A+K    +   +      + A+  + +E+ ++  LQHPN
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT----GQEAVKQLEQEIALLSKLQHPN 63

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           IV  +    +   D+ Y+ LE V G        + G+  E + R Y R I+ GL YLH  
Sbjct: 64  IVQYLGTERE--EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR 121

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
           N VH DIK  N+LV  +G VK+ DF +++    +    +   G+P + APE        G
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFAKSFKGSPYWMAPEVIAQQGGYG 180

Query: 306 KAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--FPDAMNPELRNLLEGLLC 363
            AAD W++G T+  M  G+ P+          KI  +  +   PD ++ E ++ +   L 
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ 240

Query: 364 KDPTRRLTLNDVAKHTWV 381
           +DP+ R T  ++ +H +V
Sbjct: 241 RDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  132 bits (334), Expect = 1e-35
 Identities = 85/268 (31%), Positives = 132/268 (49%), Gaps = 27/268 (10%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++ KIG G+ G+V        GK  AIK   K  L K            +  E+LIMK
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIK---KMRLRKQN-------KELIINEILIMK 70

Query: 180 MLQHPNIVNLIE-VIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVS 237
             +HPNIV+  +  +     D  ++V+EY++G    D   Q    + E       R+++ 
Sbjct: 71  DCKHPNIVDYYDSYLVG---DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQ 127

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSP--GTPVFTA 294
           GL YLH  NV+H DIK DN+L++  G+VK+ DF  + Q+     +  +R+   GTP + A
Sbjct: 128 GLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL---TKEKSKRNSVVGTPYWMA 184

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKIVNN---SLVFPDAM 350
           PE      YG K  D W++G+    M  G+ P+L E  L+  +  I       L  P+  
Sbjct: 185 PEVIKRKDYGPK-VDIWSLGIMCIEMAEGEPPYLREPPLRALF-LITTKGIPPLKNPEKW 242

Query: 351 NPELRNLLEGLLCKDPTRRLTLNDVAKH 378
           +PE ++ L   L KDP +R +  ++ +H
Sbjct: 243 SPEFKDFLNKCLVKDPEKRPSAEELLQH 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  132 bits (333), Expect = 1e-35
 Identities = 84/302 (27%), Positives = 131/302 (43%), Gaps = 58/302 (19%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           N+Y  +  +G G+YG V+  R+   G+  AIK F +S   +      +TA+    REV +
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE---DVKKTAL----REVKV 53

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           ++ L+H NIVNL E          Y+V EYVE          PG +     R Y+  ++ 
Sbjct: 54  LRQLRHENIVNLKEAFR--RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQ 111

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT---- 293
            + Y H HN++H DIKP+N+LV+ SG +K+ DF  ++          R+      T    
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARAL--------RARPASPLTDYVA 163

Query: 294 -----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKI--------- 339
                APE  +G T  GK  D WA+G  +  ++ G+  F G++  D    I         
Sbjct: 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP 223

Query: 340 ----------VNNSLVFPDAMNPELR-------------NLLEGLLCKDPTRRLTLNDVA 376
                         + FP+   PE               + L+  L  DP  RLT +++ 
Sbjct: 224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283

Query: 377 KH 378
           +H
Sbjct: 284 QH 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  131 bits (332), Expect = 3e-35
 Identities = 86/287 (29%), Positives = 147/287 (51%), Gaps = 30/287 (10%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            ++  ++ I  G+YG V L R     + +A+K  +K +L  LR   ++     V R++L 
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI-LR---NQIQQVFVERDILT 56

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
               ++P +V++    +     H  MV+EYVEG          GA+   MAR Y  + V 
Sbjct: 57  FA--ENPFVVSMFCSFE--TKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL 112

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV---------FEDDNDVLRRS-- 286
            L YLH + +VH D+KPDNLL+   G +K+ DF +S++         +E   +   R   
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172

Query: 287 ----PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN 342
                GTP + APE  L   Y GK  D WA+G+ LY  ++G  PF G+T ++ + +++++
Sbjct: 173 DKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 231

Query: 343 SLVFP---DAMNPELRNLLEGLLCKDPTRRLTLN---DVAKHTWVLG 383
            + +P   +A+  + ++L+  LL ++P  RL      +V +H + LG
Sbjct: 232 DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  129 bits (327), Expect = 2e-34
 Identities = 82/254 (32%), Positives = 131/254 (51%), Gaps = 9/254 (3%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+GKV+L       + +AIKA  K     + +   +   T V R VL +   +HP 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKD----VVLEDDDVECTMVERRVLALAW-EHPF 57

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           + +L         +H + V+EY+ G          G   E+ AR Y  +I+ GL +LH  
Sbjct: 58  LTHLFCTFQ--TKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK 115

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
            +++ D+K DN+L+   G +KI DF + +   +         GTP + APE   G  Y  
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYN- 174

Query: 306 KAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKD 365
           ++ D W+ GV LY M+IGQ PF GE   + +D I+N+   FP  ++ E ++ L  L  +D
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERD 234

Query: 366 PTRRLTLN-DVAKH 378
           PT+RL ++ D+ +H
Sbjct: 235 PTKRLGVDGDIRQH 248

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  127 bits (322), Expect = 3e-34
 Identities = 77/275 (28%), Positives = 123/275 (44%), Gaps = 44/275 (16%)

Query: 124 RKIGAGSYGKVVL--YRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +K+G G++G+V     +   DGK    A+K         L+   SE  + +  RE  IM+
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVK--------TLKEDASEQQIEEFLREARIMR 56

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG---------QPGAIGESMARK 230
            L HPNIV L+ V  +   +   +V+EY+ G       G         +P  +  S    
Sbjct: 57  KLDHPNIVKLLGVCTEE--EPLMIVMEYMPG-------GDLLDYLRKNRPKELSLSDLLS 107

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT- 289
           +   I  G+ YL   N +H D+   N LV  +  VKI DF +S+    D+D  +   G  
Sbjct: 108 FALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKL 166

Query: 290 PVF-TAPECCLGLTYG--GKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVN-NSL 344
           P+   APE    L  G     +D W+ GV L+ +  +G+ P+ G +  +  + +     L
Sbjct: 167 PIRWMAPES---LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRL 223

Query: 345 VFPDAMNPELRNLLEGLLC--KDPTRRLTLNDVAK 377
             P    PEL  L+  L C  +DP  R T +++ +
Sbjct: 224 PKPPNCPPELYKLM--LQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  127 bits (321), Expect = 3e-34
 Identities = 71/260 (27%), Positives = 118/260 (45%), Gaps = 17/260 (6%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           +K+G GSYG V   +   D + YA+K   +  L  +     E A+ ++R    I+  + H
Sbjct: 6   KKLGKGSYGSVYKVKRLSDNQFYALK---EVDLGSMSQKEREDAVNEIR----ILASVNH 58

Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMARKYLRDIVSGL 239
           PNI++  E   D N     +V+EY       K  +    +   I E    +    ++ GL
Sbjct: 59  PNIISYKEAFLDGNK--LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
             LH   ++H D+K  N+L+  +  VKIGD  +S+V +   ++ +   GTP + APE   
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKTQIGTPHYMAPEVWK 174

Query: 300 GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFPDAMNPELRNLL 358
           G  Y  K +D W++G  LY M     PF   ++QD   K+        P   + +L+N +
Sbjct: 175 GRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFI 233

Query: 359 EGLLCKDPTRRLTLNDVAKH 378
             +L   P  R   + +   
Sbjct: 234 RSMLQVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  126 bits (320), Expect = 5e-34
 Identities = 74/266 (27%), Positives = 123/266 (46%), Gaps = 27/266 (10%)

Query: 124 RKIGAGSYGKVVL--YRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +K+G G++G+V     +     K    A+K         L+   SE  + +  RE  IM+
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVK--------TLKEDASEQQIEEFLREARIMR 56

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVS 237
            L HPN+V L+ V  +   +  Y+V+EY+EG  D   +       +  S    +   I  
Sbjct: 57  KLDHPNVVKLLGVCTEE--EPLYIVMEYMEGG-DLLSYLRKNRPKLSLSDLLSFALQIAR 113

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSPGTPVF-TAP 295
           G+ YL   N +H D+   N LV  +  VKI DF +S  +++DD    R     P+   AP
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAP 172

Query: 296 ECCLGLTYG--GKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVN-NSLVFPDAMN 351
           E    L  G     +D W+ GV L+ +  +G+ P+ G + ++  + + N   L  P    
Sbjct: 173 ES---LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCP 229

Query: 352 PELRNLLEGLLCKDPTRRLTLNDVAK 377
           PEL +L+     +DP  R T +++ +
Sbjct: 230 PELYDLMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  126 bits (319), Expect = 6e-34
 Identities = 78/259 (30%), Positives = 126/259 (48%), Gaps = 13/259 (5%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y+ +R +G G++G+  LYR + D      K  + + LS       E    D   E++I+ 
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-------EKERRDALNEIVILS 54

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA--IGESMARKYLRDIVS 237
           +LQHPNI+       D N+    + +EY  G    D   +       E M   YL  IVS
Sbjct: 55  LLQHPNIIAYYNHFMDDNT--LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVS 112

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPEC 297
            + Y+H   ++H DIK  N+ +  +G +K+GDF +S++   +  +     GTP + +PE 
Sbjct: 113 AVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPEL 172

Query: 298 CLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-NSLVFPDAMNPELRN 356
           C G+ Y  K +D WA+G  LY ++  +  F      +   KIV  N        + EL +
Sbjct: 173 CQGVKYNFK-SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELIS 231

Query: 357 LLEGLLCKDPTRRLTLNDV 375
           L+  LL +DP +R T ++V
Sbjct: 232 LVHSLLQQDPEKRPTADEV 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  128 bits (323), Expect = 8e-34
 Identities = 78/271 (28%), Positives = 124/271 (45%), Gaps = 34/271 (12%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G +G+V + R    G  YA+K   KS      V  ++  ++    E  I+ +   P 
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKS------VLLAQETVSFFEEERDILSISNSPW 62

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMARKYLRDIVS 237
           I  L     D   D+ Y+V+EY  G        +++           E MA+ YL ++V 
Sbjct: 63  IPQLQYAFQD--KDNLYLVMEYQPGGDLLSLLNRYE-------DQFDEDMAQFYLAELVL 113

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP-GTPVFTAPE 296
            +  +H    VH DIKP+N+L+  +G +K+ DF  +     +  V  + P GTP + APE
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173

Query: 297 CCLGLTYGGKAA-----DTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFPD- 348
               +   GK       D W++GV  Y MI G+ PF   T   TY+ I+N    L FP+ 
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED 233

Query: 349 -AMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
             ++ +  +L++ LLC     RL    +  H
Sbjct: 234 PKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  127 bits (321), Expect = 1e-33
 Identities = 84/265 (31%), Positives = 133/265 (50%), Gaps = 14/265 (5%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G++GKV+L R    GK+YA+K   K    ++ +A  E A T     VL  K  +HP 
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKK----EVIIAKDEVAHTLTESRVL--KNTRHPF 56

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           + +L         D    V+EYV G        +     E   R Y  +IVS L YLH  
Sbjct: 57  LTSLKYSFQ--TKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG 114

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
            +V+ D+K +NL++   G +KI DF + +    D   ++   GTP + APE      YG 
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYG- 173

Query: 306 KAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKD 365
           +A D W +GV +Y M+ G+ PF  +  +  ++ I+   + FP  ++ + ++LL GLL KD
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKD 233

Query: 366 PTRRL-----TLNDVAKHTWVLGDN 385
           P +RL        ++ +H++  G N
Sbjct: 234 PNKRLGGGPDDAKEIMRHSFFTGVN 258

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  127 bits (321), Expect = 1e-33
 Identities = 85/249 (34%), Positives = 120/249 (48%), Gaps = 8/249 (3%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IG GS+GKV+L R   + K YA+K   K  + K +    E       R VL +K ++HP 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKK----EEKHIMSERNVL-LKNVKHPF 57

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           +V L        +D  Y VL+Y+ G        +     E  AR Y  +I S L YLH  
Sbjct: 58  LVGLHFSFQ--TADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 115

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
           N+V+ D+KP+N+L+   G + + DF + +   + N       GTP + APE      Y  
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD- 174

Query: 306 KAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKD 365
           +  D W +G  LY M+ G  PF      + YD I+N  L     +    R+LLEGLL KD
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKD 234

Query: 366 PTRRLTLND 374
            T+RL   D
Sbjct: 235 RTKRLGAKD 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  126 bits (319), Expect = 2e-33
 Identities = 84/310 (27%), Positives = 137/310 (44%), Gaps = 58/310 (18%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y   +K+G G+Y  V   R    G+  AIK        + +   + TA+    RE+ +++
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL----REIKLLQ 57

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKW-----DNDGFGQPGAIGESMARKYLRD 234
            L+HPNI+ L++V    +  +  +V E++E        D      P  I     + Y+  
Sbjct: 58  ELKHPNIIGLLDVF--GHKSNINLVFEFMETDLEKVIKDKSIVLTPADI-----KSYMLM 110

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP-VFT 293
            + GL YLH + ++H D+KP+NLL+A  G +K+ DF +++ F   N  +     T  V T
Sbjct: 111 TLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM-----THQVVT 165

Query: 294 ----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL-GETLQDTYDKI--------- 339
               APE   G  + G   D W+VG     +++ + PFL G++  D   KI         
Sbjct: 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPFLPGDSDIDQLGKIFEALGTPTE 224

Query: 340 ----VNNSL----------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                  SL                +FP A +  L +LL+ LL  +P +R+T     +H 
Sbjct: 225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDAL-DLLQRLLTLNPNKRITARQALEHP 283

Query: 380 WVLGDNGPIP 389
           +   D  P P
Sbjct: 284 YFSNDPAPTP 293

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  127 bits (319), Expect = 2e-33
 Identities = 83/246 (33%), Positives = 126/246 (51%), Gaps = 10/246 (4%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G++GKV+L +    G++YA+K   K    ++ VA  E A T     VL  +  +HP 
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKK----EVIVAKDEVAHTLTENRVL--QNSRHPF 56

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           +  L         D    V+EY  G        +     E  AR Y  +IVS L YLH  
Sbjct: 57  LTALKYSFQ--THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 114

Query: 246 -NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYG 304
            NVV+ D+K +NL++   G +KI DF + +    D   ++   GTP + APE      YG
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYG 174

Query: 305 GKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCK 364
            +A D W +GV +Y M+ G+ PF  +  +  ++ I+   + FP  ++PE ++LL GLL K
Sbjct: 175 -RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKK 233

Query: 365 DPTRRL 370
           DP +RL
Sbjct: 234 DPKQRL 239

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  124 bits (314), Expect = 4e-33
 Identities = 75/261 (28%), Positives = 124/261 (47%), Gaps = 12/261 (4%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G++G+V L      G+  A+K       S      ++  +  +  E+ ++K LQH  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSP----ETKKEVNALECEIQLLKNLQHER 65

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           IV     + D   +   + +EY+ G    D     GA+ E++ RKY R I+ G+ YLH +
Sbjct: 66  IVQYYGCLRDD--ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVS---QVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
            +VH DIK  N+L   +G VK+GDF  S   Q        ++   GTP + +PE   G  
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183

Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--NNSLVFPDAMNPELRNLLEG 360
           YG K AD W+VG T+  M+  + P+          KI     +   P  ++P+ RN L  
Sbjct: 184 YGRK-ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRR 242

Query: 361 LLCKDPTRRLTLNDVAKHTWV 381
              ++  +R +  ++ +H +V
Sbjct: 243 TFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  123 bits (311), Expect = 1e-32
 Identities = 73/273 (26%), Positives = 117/273 (42%), Gaps = 31/273 (11%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHY-----AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +K+G G++G+V  Y+  L GK       A+K         L+   SE    D  +E  +M
Sbjct: 1   KKLGEGAFGEV--YKGKLKGKDGKTTEVAVK--------TLKEDASEEERKDFLKEARVM 50

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG---------KWDNDGFGQPGAIGESMAR 229
           K L HPN+V L+ V  +   +  Y+VLEY+EG                 +   +      
Sbjct: 51  KKLGHPNVVRLLGVCTEE--EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLL 108

Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSPG 288
            +   I  G+ YL     VH D+   N LV     VKI DF +S  V++DD    +    
Sbjct: 109 SFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGK 168

Query: 289 TPVF-TAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS-LV 345
            P+   APE      +  K +D W+ GV L+ +  +G  P+ G + ++  + +     L 
Sbjct: 169 LPIRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLP 227

Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            P+    EL  L+      DP  R T +++ + 
Sbjct: 228 KPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  123 bits (310), Expect = 1e-32
 Identities = 79/263 (30%), Positives = 127/263 (48%), Gaps = 10/263 (3%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IG+GS+G V L  ++  G+  A+K      +S        + +  + RE+ ++K LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           IV  +      ++DH  + LEYV G          GA  E++ R ++R I+ GL YLH  
Sbjct: 68  IVQYLG--SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF------TAPECCL 299
            ++H DIK  N+LV   G +KI DF +S+  E ++   + +   P         APE   
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185

Query: 300 GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFPDAMNPELRNLL 358
             +Y  K AD W++G  +  M+ G++PF   T      KI  N+    P  ++ E  + L
Sbjct: 186 QTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFL 244

Query: 359 EGLLCKDPTRRLTLNDVAKHTWV 381
           E     D  +R T  ++ KH ++
Sbjct: 245 EKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  124 bits (312), Expect = 2e-32
 Identities = 78/247 (31%), Positives = 125/247 (50%), Gaps = 8/247 (3%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G GS+GKV+L R    G+ YA+K   K  +  L+    E  MT+ R   ++     H
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKR---ILSLARNH 55

Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           P +  L      P  D  + V+E+V G        +     E+ AR Y  +I S LM+LH
Sbjct: 56  PFLTQLYCCFQTP--DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH 113

Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTY 303
              +++ D+K DN+L+   G  K+ DF + +    +        GTP + APE    + Y
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY 173

Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
           G  + D WA+GV LY M+ G  PF  E   D ++ I+N+ +V+P  ++ +  ++L+  + 
Sbjct: 174 G-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMT 232

Query: 364 KDPTRRL 370
           K+PT RL
Sbjct: 233 KNPTMRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  122 bits (308), Expect = 3e-32
 Identities = 74/271 (27%), Positives = 131/271 (48%), Gaps = 25/271 (9%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD-VRREVLIMKMLQ 182
            KIG G++GKV    +   G+  A+K        ++R+  ++      +  E+ ++++L+
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVK--------EIRIQDNDPKTIKEIADEMKVLELLK 57

Query: 183 HPNIVNL--IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
           HPN+V    +EV  +      Y+ +EY  G    +       + E + R Y   ++ GL 
Sbjct: 58  HPNLVKYYGVEVHRE----KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLA 113

Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS----PGTPVFTAPE 296
           YLH H +VH DIKP N+ +  +G +K+GDF  +   +++   +        GTP + APE
Sbjct: 114 YLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173

Query: 297 CCLGLTYGGK--AADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFPD--AM 350
              G    G   AAD W++G  +  M  G+ P+  L    Q  +     +    PD   +
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQL 233

Query: 351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           +PE ++ L+  L  DP +R T +++ +H +V
Sbjct: 234 SPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  122 bits (307), Expect = 1e-31
 Identities = 79/245 (32%), Positives = 118/245 (48%), Gaps = 8/245 (3%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+GKV+L       + YAIK   K  +  ++    E  M + R   L  K    P 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVI--IQDDDVECTMVEKRVLALPGK---PPF 62

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           +  L         D  Y V+EYV G        Q G   E  A  Y  +I  GL +LH  
Sbjct: 63  LTQLHSCFQTM--DRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
            +++ D+K DN+++   G +KI DF + +         R   GTP + APE      YG 
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYG- 179

Query: 306 KAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKD 365
           K+ D WA GV LY M+ GQ PF GE   + +  I+ +++ +P +++ E  ++ +GLL K 
Sbjct: 180 KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKH 239

Query: 366 PTRRL 370
           P +RL
Sbjct: 240 PAKRL 244

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  122 bits (306), Expect = 2e-31
 Identities = 80/245 (32%), Positives = 115/245 (46%), Gaps = 8/245 (3%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IG GS+GKV+L +   DG  YA+K   K  + K +    E       R VL +K L+HP 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKK----EQNHIMAERNVL-LKNLKHPF 57

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           +V L         +  Y VL+YV G        +     E  AR Y  ++ S + YLH  
Sbjct: 58  LVGLHYSFQTA--EKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
           N+++ D+KP+N+L+   G V + DF + +   +  +      GTP + APE      Y  
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD- 174

Query: 306 KAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKD 365
           +  D W +G  LY M+ G  PF    +   YD I++  L  P        +LL GLL KD
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKD 234

Query: 366 PTRRL 370
             RRL
Sbjct: 235 QRRRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  122 bits (307), Expect = 3e-31
 Identities = 86/273 (31%), Positives = 134/273 (49%), Gaps = 21/273 (7%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
             ++  ++ IG G++G+V L R     + YA+K   K  + K     S++A     R+  
Sbjct: 42  AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIK----RSDSAFFWEERD-- 95

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           IM       IV L     D    + YMV+EY+ G  D         I E  AR Y  ++V
Sbjct: 96  IMAHANSEWIVQLHYAFQDDK--YLYMVMEYMPGG-DLVNLMSNYDIPEKWARFYTAEVV 152

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTA 294
             L  +H    +H D+KPDN+L+  SG +K+ DF    +  D N ++R     GTP + +
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRCDTAVGTPDYIS 211

Query: 295 PECCL---GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFPD- 348
           PE      G  Y G+  D W+VGV LY M++G  PF  ++L  TY KI++  NSL FPD 
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD 271

Query: 349 -AMNPELRNLLEGLLCKDPTR--RLTLNDVAKH 378
             ++ + ++L+   L     R  R  ++++  H
Sbjct: 272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  121 bits (304), Expect = 4e-31
 Identities = 82/251 (32%), Positives = 128/251 (50%), Gaps = 11/251 (4%)

Query: 123 VRKIGAGSYGKVVLYR---SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           ++ +G G YGKV   R    +  GK +A+K   K+ + +      +TA T   R   I++
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR---NQKDTAHTKAERN--ILE 55

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
            ++HP IV+LI           Y++LEY+ G        + G   E  A  YL +I   L
Sbjct: 56  AVKHPFIVDLIYAFQ--TGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLAL 113

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
            +LH   +++ D+KP+N+L+   G VK+ DF + +    +  V     GT  + APE  L
Sbjct: 114 EHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI-L 172

Query: 300 GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLE 359
             +  GKA D W++G  +Y M+ G  PF  E  + T DKI+   L  P  + PE R+LL+
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLK 232

Query: 360 GLLCKDPTRRL 370
            LL ++P+ RL
Sbjct: 233 KLLKRNPSSRL 243

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 7e-31
 Identities = 89/315 (28%), Positives = 136/315 (43%), Gaps = 73/315 (23%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSH-LSKLRVAPSETAMTDVRREVLIMKML 181
           ++ IG G++G+V L +    G  YA+K   KS  L K +VA        VR E  I+   
Sbjct: 6   IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVA-------HVRAERDILAEA 58

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMARKYLR 233
            +P +V L     D N  + Y+++EY+ G        K D           E   R Y+ 
Sbjct: 59  DNPWVVKLYYSFQDEN--YLYLIMEYLPGGDMMTLLMKKD--------TFTEEETRFYIA 108

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS----------------VSQVFE 277
           + +  +  +H    +H DIKPDNLL+   G +K+ DF                 +S    
Sbjct: 109 ETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP 168

Query: 278 DDNDVLRRSP----------------------GTPVFTAPECCLGLTYGGKAADTWAVGV 315
            +       P                      GTP + APE  L   Y  K  D W++GV
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGV 227

Query: 316 TLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFPDAMN--PELRNLLEGLLCKDPTRRL- 370
            +Y M++G  PF  +  Q+TY KI+N   +L FPD +   PE ++L++ L C +  RRL 
Sbjct: 228 IMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLG 286

Query: 371 --TLNDVAKHTWVLG 383
              +N++  H +  G
Sbjct: 287 NNGVNEIKSHPFFKG 301

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  119 bits (300), Expect = 1e-30
 Identities = 84/257 (32%), Positives = 124/257 (48%), Gaps = 12/257 (4%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IG GS+GKV+L +  LDGK YA+K   K    K+ +   E       R VL +K ++HP 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQK----KIVLNRKEQKHIMAERNVL-LKNVKHPF 57

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           +V L        ++  Y VL++V G        +  +  E  AR Y  +I S L YLH  
Sbjct: 58  LVGLHYSFQ--TTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
           N+V+ D+KP+N+L+   G V + DF + +     +D      GTP + APE      Y  
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPY-D 174

Query: 306 KAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKD 365
              D W +G  LY M+ G  PF    + + YD I++  LV     +    ++LE LL KD
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKD 234

Query: 366 PTRRL----TLNDVAKH 378
             RRL       ++ +H
Sbjct: 235 RQRRLGAKEDFLEIQEH 251

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  117 bits (294), Expect = 2e-30
 Identities = 75/269 (27%), Positives = 130/269 (48%), Gaps = 18/269 (6%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
            Y  VR +G GSYG+V L R   DGK Y IK  +  + S+     +E       +E  ++
Sbjct: 1   AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAE-------QEAQLL 53

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF----GQPGAI-GESMARKYLR 233
             L+HPNIV   E  +  +    Y+V+ + EG    D +     Q G +  E+   ++  
Sbjct: 54  SQLKHPNIVAYRESWEGEDG-LLYIVMGFCEG---GDLYHKLKEQKGKLLPENQVVEWFV 109

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
            I   L YLH  +++H D+K  N+ +  +  +K+GD  +++V E+  D+     GTP + 
Sbjct: 110 QIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYM 169

Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFPDAMNP 352
           +PE      Y  K +D WA+G  +Y M   ++ F  + +     +I+   L   P   +P
Sbjct: 170 SPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSP 228

Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           EL  L+  +L K P +R ++  + +  ++
Sbjct: 229 ELGELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  117 bits (296), Expect = 7e-30
 Identities = 83/307 (27%), Positives = 136/307 (44%), Gaps = 63/307 (20%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR---REVL 176
           Y  ++ IG+G+YG V        G+  AIK          +++     + D +   RE+ 
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIK----------KISNVFDDLIDAKRILREIK 51

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVE---GKWDNDGFGQPGAIGESMARK 230
           +++ L+H NI+ L++++  P+ + F   Y+V E +E    K        P  + +   + 
Sbjct: 52  LLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKV----IKSPQPLTDDHIQY 107

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
           +L  I+ GL YLH  NV+H D+KP N+LV  +  +KI DF +++  + D D       T 
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG--FLTE 165

Query: 291 -VFT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN---- 341
            V T    APE  L  +   KA D W+VG     ++  +  F G    D  + IV     
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT 225

Query: 342 ------------------NSL----------VFPDAMNPELRNLLEGLLCKDPTRRLTLN 373
                              SL          +FP A +PE  +LLE +L  DP +R+T +
Sbjct: 226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGA-SPEAIDLLEKMLVFDPKKRITAD 284

Query: 374 DVAKHTW 380
           +   H +
Sbjct: 285 EALAHPY 291

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 1e-29
 Identities = 77/250 (30%), Positives = 122/250 (48%), Gaps = 14/250 (5%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHP 184
           IG G++G+V   R     + YA+K   K    K  VA  E A T   R +L+  +L + P
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK----KEIVAKKEVAHTIGERNILVRTLLDESP 56

Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGK---WDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
            IV L       +    Y+V +Y+ G    W      + G   E  A+ Y+ ++V  L +
Sbjct: 57  FIVGLKFSFQTDSD--LYLVTDYMSGGELFWH---LQKEGRFSEDRAKFYIAELVLALEH 111

Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           LH +++V+ D+KP+N+L+  +G + + DF +S+    DN       GT  + APE  L  
Sbjct: 112 LHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE 171

Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP-DAMNPELRNLLEG 360
               K  D W++GV ++ M  G  PF  E  Q  Y  I    + FP + ++ E R  ++G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKG 231

Query: 361 LLCKDPTRRL 370
           LL ++P  RL
Sbjct: 232 LLNRNPQHRL 241

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  114 bits (288), Expect = 2e-29
 Identities = 82/273 (30%), Positives = 129/273 (47%), Gaps = 40/273 (14%)

Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE-----VLIMK 179
           KIG GS G V +      G+  A+K   K  L K +           RRE     V+IM+
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQ-----------RRELLFNEVVIMR 71

Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
             QHPNIV +       +S    D  ++V+E++EG    D       + E         +
Sbjct: 72  DYQHPNIVEMY------SSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAV 124

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS-VSQVFEDDNDVLRRSP--GTPVF 292
           +  L +LH   V+H DIK D++L+   G VK+ DF   +QV +   +V RR    GTP +
Sbjct: 125 LKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK---EVPRRKSLVGTPYW 181

Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDA 349
            APE    L YG +  D W++G+ +  M+ G+ P+  E       +I +N    L     
Sbjct: 182 MAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHK 240

Query: 350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL 382
           ++P LR+ L+ +L +DP +R T  ++  H ++ 
Sbjct: 241 VSPRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  115 bits (290), Expect = 3e-29
 Identities = 74/245 (30%), Positives = 121/245 (49%), Gaps = 8/245 (3%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+GKV+L       + YAIK   K  +  L+    +  MT+ R   L  K   HP 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAK---HPF 57

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           +  L         D  + V+EYV G        +     E  +R Y  ++   LM+LH H
Sbjct: 58  LTALHCCFQTK--DRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH 115

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
            V++ D+K DN+L+   G  K+ DF + +    +        GTP + APE    L YG 
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYG- 174

Query: 306 KAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKD 365
            + D WA+GV +Y M+ GQ PF  +   D ++ I+++ +++P  ++ E  ++L+  + K+
Sbjct: 175 PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKN 234

Query: 366 PTRRL 370
           P +RL
Sbjct: 235 PNKRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  114 bits (286), Expect = 5e-29
 Identities = 76/252 (30%), Positives = 125/252 (49%), Gaps = 18/252 (7%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G +G+V   +    GK YA K   K  L K +       M    +++L  + +    
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRK----GEQMALNEKKIL--EKVSSRF 54

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEG---KWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           IV+L    +    D   +V+  + G   K+     G+PG   E+ A  Y   I+ GL +L
Sbjct: 55  IVSLAYAFETK--DDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHL 111

Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
           H   +V+ D+KP+N+L+   G V+I D  ++   +    +  R+ GTP + APE   G  
Sbjct: 112 HQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA-GTPGYMAPEVLQGEV 170

Query: 303 YGGKAADTWAVGVTLYYMIIGQYPF--LGETL--QDTYDKIVNNSLVFPDAMNPELRNLL 358
           Y   + D +A+G TLY MI G+ PF    E +  ++   + +  ++ +PD  +PE ++L 
Sbjct: 171 Y-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLC 229

Query: 359 EGLLCKDPTRRL 370
           E LL KDP +RL
Sbjct: 230 EALLQKDPEKRL 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  114 bits (287), Expect = 6e-29
 Identities = 78/245 (31%), Positives = 122/245 (49%), Gaps = 8/245 (3%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+GKV+L       + YAIK   K     + +   +   T V + VL ++  + P 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKD----VVIQDDDVECTMVEKRVLALQD-KPPF 62

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           +  L         D  Y V+EYV G        Q G   E  A  Y  +I  GL +LH  
Sbjct: 63  LTQLHSCFQ--TVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
            +++ D+K DN+++   G +KI DF + +    D    R   GTP + APE      YG 
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYG- 179

Query: 306 KAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKD 365
           K+ D WA GV LY M+ GQ PF GE   + +  I+ +++ +P +++ E  ++ +GL+ K 
Sbjct: 180 KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKH 239

Query: 366 PTRRL 370
           P++RL
Sbjct: 240 PSKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  114 bits (286), Expect = 6e-29
 Identities = 80/262 (30%), Positives = 130/262 (49%), Gaps = 15/262 (5%)

Query: 123 VRKIGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +R +G G+YGKV L R       GK YA+K   K+ + + +   +E   T+  R+VL   
Sbjct: 5   LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQ-KAKTAEHTRTE--RQVL-EA 60

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
           + + P +V L            +++L+YV G        Q     ES  R Y+ +IV  L
Sbjct: 61  VRRCPFLVTLHYAFQ--TDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLAL 118

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS-PGTPVFTAPECC 298
            +LH   +++ DIK +N+L+   G V + DF +S+ F  + +    S  GT  + APE  
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178

Query: 299 LGLTYG-GKAADTWAVGVTLYYMIIGQYPFLGETLQDTYD----KIVNNSLVFPDAMNPE 353
            G + G  KA D W++GV  + ++ G  PF  +  Q++      +I+ +   FP  M+ E
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE 238

Query: 354 LRNLLEGLLCKDPTRRLTLNDV 375
            R+ ++ LL KDP +RL  N  
Sbjct: 239 ARDFIQKLLEKDPKKRLGANGA 260

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  113 bits (286), Expect = 6e-29
 Identities = 86/303 (28%), Positives = 130/303 (42%), Gaps = 63/303 (20%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL-IM 178
           Y  ++++G G++G V L R+   G+  AIK        K +    E  M    REV  + 
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM------KKKFYSWEECMN--LREVKSLR 52

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKW-----DNDGFGQPGAIGESMARKYLR 233
           K+ +HPNIV L EV  +  +D  Y V EY+EG       D  G        ES+ R  + 
Sbjct: 53  KLNEHPNIVKLKEVFRE--NDELYFVFEYMEGNLYQLMKDRKG----KPFSESVIRSIIY 106

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP-VF 292
            I+ GL ++H H   H D+KP+NLLV+    VKI DF +++      ++  R P T  V 
Sbjct: 107 QILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR------EIRSRPPYTDYVS 160

Query: 293 T----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV------NN 342
           T    APE  L  T      D WA+G  +  +   +  F G +  D   KI         
Sbjct: 161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTK 220

Query: 343 SL-------------------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
                                      + P+A +PE  +L++ +L  DP +R T +   +
Sbjct: 221 QDWPEGYKLASKLGFRFPQFAPTSLHQLIPNA-SPEAIDLIKDMLRWDPKKRPTASQALQ 279

Query: 378 HTW 380
           H +
Sbjct: 280 HPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  114 bits (288), Expect = 6e-29
 Identities = 80/299 (26%), Positives = 128/299 (42%), Gaps = 54/299 (18%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           ++ +G G  G+V L R    GK +A+K   K  + K         +  V  E  I+  L 
Sbjct: 6   IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK------RNKVKRVLTEQEILATLD 59

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG----QPGA-IGESMARKYLRDIVS 237
           HP +  L          +  +V++Y  G    + F     QPG  + E +AR Y  +++ 
Sbjct: 60  HPFLPTLYASFQ--TETYLCLVMDYCPG---GELFRLLQRQPGKCLSEEVARFYAAEVLL 114

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS---------------------QVF 276
            L YLH   +V+ D+KP+N+L+  SG + + DF +S                      V 
Sbjct: 115 ALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174

Query: 277 EDDNDVLRRSP--------GTPVFTAPECCLGLTYG-GKAADTWAVGVTLYYMIIGQYPF 327
              ++     P        GT  + APE   G   G G A D W +G+ LY M+ G  PF
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILLYEMLYGTTPF 232

Query: 328 LGETLQDTYDKIVNNSLVFPDAMNP--ELRNLLEGLLCKDPTRRL----TLNDVAKHTW 380
            G    +T+  I+   + FP +       R+L+  LL KDP++RL       ++ +H +
Sbjct: 233 KGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  113 bits (285), Expect = 8e-29
 Identities = 84/303 (27%), Positives = 127/303 (41%), Gaps = 63/303 (20%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +  + K+G G+Y  V   R+   G+  A+K  H   L      PS TA+    RE+ +MK
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIH---LDAEEGTPS-TAI----REISLMK 53

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG--KWDNDGFGQPGAIGESMARKYLRDIVS 237
            L+H NIV L +VI   N     +V EY++   K   D  G  GA+  +  + +   ++ 
Sbjct: 54  ELKHENIVRLHDVIHTENK--LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLK 111

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT---- 293
           G+ + H + V+H D+KP NLL+   G +K+ DF            L R+ G PV T    
Sbjct: 112 GIAFCHENRVLHRDLKPQNLLINKRGELKLADFG-----------LARAFGIPVNTFSNE 160

Query: 294 -------APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN----- 341
                  AP+  LG      + D W+VG  +  MI G+  F G   +D   KI       
Sbjct: 161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTP 220

Query: 342 NSLVFPDAMN-PELRN-----------------------LLEGLLCKDPTRRLTLNDVAK 377
               +P     PE +                        LL  LL  +P  R++ +D  +
Sbjct: 221 TESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280

Query: 378 HTW 380
           H W
Sbjct: 281 HPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  115 bits (289), Expect = 9e-29
 Identities = 90/276 (32%), Positives = 134/276 (48%), Gaps = 19/276 (6%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +Y  V+ IG G++G+V L R     K YA+K   K  + K     S++A     R+  IM
Sbjct: 44  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK----RSDSAFFWEERD--IM 97

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
                P +V L     D    + YMV+EY+ G  D         + E  AR Y  ++V  
Sbjct: 98  AFANSPWVVQLFYAFQD--DRYLYMVMEYMPGG-DLVNLMSNYDVPEKWARFYTAEVVLA 154

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV-LRRSPGTPVFTAPEC 297
           L  +H    +H D+KPDN+L+  SG +K+ DF        +  V    + GTP + +PE 
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 214

Query: 298 CL---GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFPD--AM 350
                G  Y G+  D W+VGV LY M++G  PF  ++L  TY KI+N  NSL FPD   +
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 274

Query: 351 NPELRNLLEGLLCKDPTR--RLTLNDVAKHTWVLGD 384
           + E +NL+   L     R  R  + ++ +H +   D
Sbjct: 275 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  112 bits (282), Expect = 2e-28
 Identities = 83/299 (27%), Positives = 130/299 (43%), Gaps = 65/299 (21%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREVLIMKML 181
           V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+ ++K L
Sbjct: 5   VEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREISLLKEL 56

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEG--KWDNDGFGQPGAIGESMARKYLRDIVSGL 239
            HPNIV L++VI   N    Y+V E++    K   D       I   + + YL  ++ GL
Sbjct: 57  NHPNIVKLLDVIHTENK--LYLVFEFLHQDLKKFMDA-SPLSGIPLPLIKSYLFQLLQGL 113

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT------ 293
            + H H V+H D+KP NLL+   G +K+ DF +++ F           G PV T      
Sbjct: 114 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-----------GVPVRTYTHEVV 162

Query: 294 -----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NS 343
                APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + 
Sbjct: 163 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 222

Query: 344 LVFPDA------------------------MNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
           +V+P                          ++ + R+LL  +L  DP +R++      H
Sbjct: 223 VVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  111 bits (280), Expect = 3e-28
 Identities = 72/281 (25%), Positives = 122/281 (43%), Gaps = 40/281 (14%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR----- 173
           +Y  +  IG GS+G V   R   DGK    K     +            MT+  +     
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN------------MTEKEKQQLVS 48

Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----------KWDNDGFGQPGAI 223
           EV I++ L+HPNIV   + I D ++   Y+V+EY EG          K +         I
Sbjct: 49  EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK------YI 102

Query: 224 GESMARKYLRDIVSGLMYLH-----GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278
            E    + L  ++  L   H     G+ V+H D+KP N+ +  +  VK+GDF ++++   
Sbjct: 103 EEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162

Query: 279 DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDK 338
           D+   +   GTP + +PE    ++Y  K +D W++G  +Y +     PF          K
Sbjct: 163 DSSFAKTYVGTPYYMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFTARNQLQLASK 221

Query: 339 IVNNSLV-FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
           I        P   + EL  +++ +L  DP +R +  ++ + 
Sbjct: 222 IKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  113 bits (284), Expect = 3e-28
 Identities = 85/287 (29%), Positives = 137/287 (47%), Gaps = 19/287 (6%)

Query: 100 KESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYR-SSLDGKHYAIKAFHKSHLSK 158
           K+S+     + +N  K   ++  +R +G GS+G+V+L    + D    AIK F KS + K
Sbjct: 13  KDSDSTKEPKRKNKMKY-EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK 71

Query: 159 LRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG 218
                 +  +  V  E  I+  + HP  VNL     D    + Y+VLE+V G        
Sbjct: 72  ------QKQVDHVFSERKILNYINHPFCVNLYGSFKD--ESYLYLVLEFVIGGEFFTFLR 123

Query: 219 QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278
           +       +   Y   IV    YL   N+V+ D+KP+NLL+   G +K+ DF  ++V + 
Sbjct: 124 RNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183

Query: 279 DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDK 338
               L    GTP + APE  L + +G KAAD W +G+ +Y +++G  PF        Y K
Sbjct: 184 RTYTL---CGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLLIYQK 239

Query: 339 IVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
           I+   + FP  ++   ++L++ LL  D T+R         +V +H W
Sbjct: 240 ILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286

Length = 340

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  111 bits (280), Expect = 6e-28
 Identities = 79/249 (31%), Positives = 129/249 (51%), Gaps = 16/249 (6%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+GKV+L      G+++A+KA  K     + +   +   T V + VL +   ++P 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKD----VVLIDDDVECTMVEKRVLALAW-ENPF 57

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           + +L         +H + V+E++ G          G      A  Y  +IV GL +LH  
Sbjct: 58  LTHLYCTFQ--TKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK 115

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQ--VFEDDNDVLRRSP--GTPVFTAPECCLGL 301
            +++ D+K DN+++   G +KI DF + +  VF D+    R S   GTP + APE   GL
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN----RASTFCGTPDYIAPEILQGL 171

Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y   + D W+ GV LY M+IGQ PF G+   + ++ I  ++  +P  +  E +++LE L
Sbjct: 172 KYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKL 230

Query: 362 LCKDPTRRL 370
             +DPTRRL
Sbjct: 231 FERDPTRRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  112 bits (282), Expect = 6e-28
 Identities = 78/286 (27%), Positives = 143/286 (50%), Gaps = 32/286 (11%)

Query: 114 TKMINEYVHVRKIGAGSYGKV--VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDV 171
            K ++E   V +IG+G+ G V  V++R +  G+ YA+K  + +H         +T    +
Sbjct: 70  AKSLSELERVNRIGSGAGGTVYKVIHRPT--GRLYALKVIYGNH--------EDTVRRQI 119

Query: 172 RREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARK 230
            RE+ I++ + HPN+V   ++ D  ++    ++LE+++ G  +         + + +AR+
Sbjct: 120 CREIEILRDVNHPNVVKCHDMFD--HNGEIQVLLEFMDGGSLEGTHIADEQFLAD-VARQ 176

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
               I+SG+ YLH  ++VH DIKP NLL+  +  VKI DF VS++     D    S GT 
Sbjct: 177 ----ILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTI 232

Query: 291 VFTAPE-----CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV----- 340
            + +PE        G  Y G A D W++GV++    +G++PF G   Q  +  ++     
Sbjct: 233 AYMSPERINTDLNHGA-YDGYAGDIWSLGVSILEFYLGRFPF-GVGRQGDWASLMCAICM 290

Query: 341 NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG 386
           +     P   + E R+ +   L ++P +R +   + +H ++L    
Sbjct: 291 SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP 336

Length = 353

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  112 bits (281), Expect = 6e-28
 Identities = 85/278 (30%), Positives = 135/278 (48%), Gaps = 35/278 (12%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IG G++G+V + +    G+ YA+K  +K  + K     +ETA     R+VL+    +   
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLK----RAETACFREERDVLVNGDRRW-- 62

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMARKYLRDIVS 237
           I NL     D N  + Y+V++Y  G        K+++        + E MAR YL ++V 
Sbjct: 63  ITNLHYAFQDEN--NLYLVMDYYVGGDLLTLLSKFED-------RLPEDMARFYLAEMVL 113

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR-SPGTPVFTAPE 296
            +  +H    VH DIKPDN+L+  +G +++ DF        D  V    + GTP + +PE
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173

Query: 297 CCLGLTYG----GKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFPDA- 349
               +  G    G   D W++GV +Y M+ G+ PF  E+L +TY KI+N      FP   
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV 233

Query: 350 --MNPELRNLLEGLLCKDPTR--RLTLNDVAKHTWVLG 383
             ++ E ++L+  L+C   TR  R  L D   H +  G
Sbjct: 234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  112 bits (280), Expect = 6e-28
 Identities = 84/279 (30%), Positives = 131/279 (46%), Gaps = 21/279 (7%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+GKV+L       + YAIK   K     + +   +   T V + VL +   + P 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKD----VVIQDDDVECTMVEKRVLALSG-KPPF 62

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           +  L         D  Y V+EYV G        Q G   E  A  Y  +I  GL +LH  
Sbjct: 63  LTQLHSCFQ--TMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
            +++ D+K DN+++   G +KI DF + +    D    +   GTP + APE      YG 
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYG- 179

Query: 306 KAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKD 365
           K+ D WA GV LY M+ GQ PF GE   + +  I+ +++ +P +M+ E   + +GL+ K 
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH 239

Query: 366 PTRRLTLN-----DVAKHTWVLGDNGPIPQYLCWCKRDR 399
           P +RL        D+ +H +         +Y+ W K +R
Sbjct: 240 PGKRLGCGPEGERDIKEHAFF--------RYIDWEKLER 270

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  111 bits (280), Expect = 7e-28
 Identities = 77/324 (23%), Positives = 132/324 (40%), Gaps = 72/324 (22%)

Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE-----TA 167
           G   + +Y  + K+G G++G+V   R    G+  A+K        K+ +   +     TA
Sbjct: 3   GCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK--------KILMHNEKDGFPITA 54

Query: 168 MTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH------FYMVLEYVE----GKWDNDGF 217
           +    RE+ I+K L+HPN+V LI++  +            YMV  Y++    G  +N   
Sbjct: 55  L----REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV 110

Query: 218 GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277
                + ES  + Y+  ++ G+ YLH ++++H DIK  N+L+   G +KI DF +++ ++
Sbjct: 111 ----KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166

Query: 278 DDNDVLRRSPG------TPV-----FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYP 326
                 +   G      T +     +  PE  LG      A D W +G     M   +  
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI 226

Query: 327 FLGETLQDTYDKI--------------------VNNSLVFPDA----------MNPELRN 356
             G++  D    I                          F +           + PE  +
Sbjct: 227 LQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLD 286

Query: 357 LLEGLLCKDPTRRLTLNDVAKHTW 380
           LL  LL  DP +RLT +D  +H +
Sbjct: 287 LLSKLLSLDPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  110 bits (278), Expect = 1e-27
 Identities = 84/299 (28%), Positives = 128/299 (42%), Gaps = 45/299 (15%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           ++EY  + +I  G+YG V   R    G+  A+K        K+        +T +R E+ 
Sbjct: 4   VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL------KMEKEKEGFPITSLR-EIN 56

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG--KWDNDGFGQPGAIGESMARKYL-R 233
           I+  LQHPNIV + EV+   N D  YMV+EYVE   K   +   QP    E    K L  
Sbjct: 57  ILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSE---VKCLML 113

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
            ++SG+ +LH + ++H D+K  NLL+   G +KI DF +++ +        +   T  + 
Sbjct: 114 QLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR 173

Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN------------ 341
           APE  LG      A D W+VG     ++  +  F G++  D  +KI              
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG 233

Query: 342 -------NSLVFPDAMNPELRN-------------LLEGLLCKDPTRRLTLNDVAKHTW 380
                      F      +LR              LL  LL  DP +R++  D  KH +
Sbjct: 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 1e-27
 Identities = 85/311 (27%), Positives = 134/311 (43%), Gaps = 79/311 (25%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV------APSETAMTDVRR 173
           Y  V KIG G+YG V   R  L G+  A+K        K+R+       PS TA+    R
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALK--------KIRLETEDEGVPS-TAI----R 47

Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDH-FYMVLEYVEG--KWDNDGFGQPGAIGESMARK 230
           E+ ++K L HPNIV L++V+   +S++  Y+V E+++   K   D     G +   + + 
Sbjct: 48  EISLLKELNHPNIVRLLDVV---HSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKS 103

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
           YL  ++ G+ Y H H V+H D+KP NLL+   G +K+ DF            L R+ G P
Sbjct: 104 YLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFG-----------LARAFGVP 152

Query: 291 VFT-----------APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKI 339
           V T           APE  LG        D W++G     M+  +  F G++  D   +I
Sbjct: 153 VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI 212

Query: 340 ------------------------------VNNSLVFPDAMNPELRNLLEGLLCKDPTRR 369
                                          + S V P  ++ +  +LL  +L  DP +R
Sbjct: 213 FRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVP-NLDEDGLDLLSKMLVYDPAKR 271

Query: 370 LTLNDVAKHTW 380
           ++     +H +
Sbjct: 272 ISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  109 bits (273), Expect = 2e-27
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 22/263 (8%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           ++KIG GS+GK+ L ++  D +H  IK      L+K+ V   E +    ++EV+++  ++
Sbjct: 5   IKKIGEGSFGKIYLAKAKSDSEHCVIKEID---LTKMPVKEKEAS----KKEVILLAKMK 57

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAI-GESMARKYLRDIVS 237
           HPNIV       +      ++V+EY +G    K  N    Q G +  E     +   I  
Sbjct: 58  HPNIVTFFASFQENG--RLFIVMEYCDGGDLMKRINR---QRGVLFSEDQILSWFVQISL 112

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTV-KIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           GL ++H   ++H DIK  N+ ++ +G V K+GDF +++   D  ++     GTP + +PE
Sbjct: 113 GLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPE 172

Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL--VFPDAMNPEL 354
            C    Y  K  D W++G  LY +   ++PF G  L     KI       + P+  + +L
Sbjct: 173 ICQNRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPN-FSRDL 230

Query: 355 RNLLEGLLCKDPTRRLTLNDVAK 377
           R+L+  L    P  R ++  + K
Sbjct: 231 RSLISQLFKVSPRDRPSITSILK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  109 bits (274), Expect = 3e-27
 Identities = 84/268 (31%), Positives = 127/268 (47%), Gaps = 39/268 (14%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G +G+V   +    GK YA K  +K  L K +    E AM + R    I+  +    
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRK--GYEGAMVEKR----ILAKVHSRF 54

Query: 186 IVNLIEVIDDPNSD---------------HFYMVLEYVEGKWDNDGFGQPGAIGESMARK 230
           IV+L        +D               H Y V E      +N GF +P A        
Sbjct: 55  IVSLAYAFQT-KTDLCLVMTIMNGGDLRYHIYNVDE------ENPGFPEPRAC------F 101

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
           Y   I+SGL +LH   +++ D+KP+N+L+   G V+I D  ++   +D     +   GTP
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP 161

Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQ--DTYDKIVNNSLVF 346
            F APE   G  Y   + D +A+GVTLY MI  + PF   GE ++  +   +I+N+S+ +
Sbjct: 162 GFMAPELLQGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTY 220

Query: 347 PDAMNPELRNLLEGLLCKDPTRRLTLND 374
           PD  +P  ++  E LL KDP +RL   D
Sbjct: 221 PDKFSPASKSFCEALLAKDPEKRLGFRD 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  109 bits (273), Expect = 3e-27
 Identities = 73/271 (26%), Positives = 123/271 (45%), Gaps = 36/271 (13%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IG G+YG V  YR    GKH  +       L  + +   +  ++D++REV ++  L+   
Sbjct: 9   IGRGAYGAV--YR----GKH--VPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQ 60

Query: 186 IVNLIE----VIDDPNSDHFYMVLEYVEGKWDNDG----FGQPGAIGESMARKYLRDIVS 237
             N+ +     +  P     ++++EY EG     G      + G I E      +R+++ 
Sbjct: 61  PPNITKYYGSYLKGPR---LWIIMEYAEG-----GSVRTLMKAGPIAEKYISVIIREVLV 112

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAP 295
            L Y+H   V+H DIK  N+LV  +G VK+ DF V+ +   ++   +RS   GTP + AP
Sbjct: 113 ALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAP 170

Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP-----DAM 350
           E      Y    AD W++G+T+Y M  G  P+           I  +    P     +  
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK---PPRLEDNGY 227

Query: 351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           +  LR  +   L ++P  RL+  ++ K  W+
Sbjct: 228 SKLLREFVAACLDEEPKERLSAEELLKSKWI 258

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  108 bits (272), Expect = 5e-27
 Identities = 82/295 (27%), Positives = 130/295 (44%), Gaps = 50/295 (16%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKS----HLSKLRVAPSETAMTDVRREV 175
           Y  + KIG GSYG V   R+   G+  AIK F +S     + K+       A+    RE+
Sbjct: 3   YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI-------AL----REI 51

Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++K L+HPN+VNLIEV       H  +V EY +    N+    P  + E + +K +   
Sbjct: 52  RMLKQLKHPNLVNLIEVFRRKRKLH--LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQT 109

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           +  + + H HN +H D+KP+N+L+   G +K+ DF  +++     D       T  + AP
Sbjct: 110 LQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAP 169

Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN------------- 342
           E  +G T  G   D WA+G     ++ GQ  + G++  D    I                
Sbjct: 170 ELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229

Query: 343 -------------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
                                 FP+  +P L + L+G L  DPT RL+  ++ +H
Sbjct: 230 TNQFFKGLSIPEPETREPLESKFPNISSPAL-SFLKGCLQMDPTERLSCEELLEH 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  108 bits (271), Expect = 1e-26
 Identities = 74/256 (28%), Positives = 123/256 (48%), Gaps = 9/256 (3%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           + +G GS+GKV L       + +AIKA  K     + +   +   T V + VL +   +H
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKD----VVLMDDDVECTMVEKRVLSLAW-EH 55

Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           P + +L         ++ + V+EY+ G                 A  Y  +I+ GL +LH
Sbjct: 56  PFLTHLYCTFQ--TKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113

Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTY 303
              +V+ D+K DN+L+   G +KI DF + +     +       GTP + APE  LG  Y
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKY 173

Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
              + D W+ GV LY M+IGQ PF G   ++ +  I  ++  +P  +  E +++L  L  
Sbjct: 174 N-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFV 232

Query: 364 KDPTRRLTLN-DVAKH 378
           ++P RRL +  D+ +H
Sbjct: 233 REPERRLGVKGDIRQH 248

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  109 bits (273), Expect = 1e-26
 Identities = 84/276 (30%), Positives = 134/276 (48%), Gaps = 19/276 (6%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +Y  V+ IG G++G+V L R     K YA+K   K  + K     S++A     R+  IM
Sbjct: 44  DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK----RSDSAFFWEERD--IM 97

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
                P +V L     D    + YMV+EY+ G  D         + E  A+ Y  ++V  
Sbjct: 98  AFANSPWVVQLFCAFQD--DKYLYMVMEYMPGG-DLVNLMSNYDVPEKWAKFYTAEVVLA 154

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV-LRRSPGTPVFTAPEC 297
           L  +H   ++H D+KPDN+L+   G +K+ DF      ++   V    + GTP + +PE 
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214

Query: 298 CL---GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFPD--AM 350
                G  Y G+  D W+VGV L+ M++G  PF  ++L  TY KI++  NSL FP+   +
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEI 274

Query: 351 NPELRNLLEGLLCKDPTR--RLTLNDVAKHTWVLGD 384
           +   +NL+   L     R  R  + ++ +H +   D
Sbjct: 275 SKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  107 bits (268), Expect = 2e-26
 Identities = 70/275 (25%), Positives = 124/275 (45%), Gaps = 22/275 (8%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           ++  ++ ++GAG+ G V        GK  A+K         +R+  +E     + RE+ I
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVK--------TIRLEINEAIQKQILRELDI 52

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIV 236
           +     P IV       +       + +EY++G   +    +  G I E +  K    ++
Sbjct: 53  LHKCNSPYIVGFYGAFYNNGD--ISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVL 110

Query: 237 SGLMYLH-GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
            GL YLH  H ++H D+KP N+LV   G +K+ DF VS      N + +   GT  + AP
Sbjct: 111 KGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV--NSLAKTFVGTSSYMAP 168

Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ-----DTYDKIVNN-SLVFP-D 348
           E   G  Y  K +D W++G++L  +  G++P+  E        +    IVN      P  
Sbjct: 169 ERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG 227

Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
             +P+ ++ +   L KDP  R +  ++ +H ++  
Sbjct: 228 KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 2e-26
 Identities = 85/323 (26%), Positives = 139/323 (43%), Gaps = 81/323 (25%)

Query: 125 KIGAGSYGKVVLYRS--SLDGKHYAIKAF--HKSHLSKLRVAPSETAMTDVRREVLIMKM 180
            IG G+YG+V   +     DGK YAIK F   K   + +    S++A     RE+ +++ 
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGI----SQSAC----REIALLRE 58

Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG------QPGA--IGESMARKYL 232
           L+H N+V+L+EV  +      Y++ +Y E    +D +       Q     I  SM +  L
Sbjct: 59  LKHENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQAKRVSIPPSMVKSLL 114

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
             I++G+ YLH + V+H D+KP N+LV       G VKIGD  ++++F  +  +   +  
Sbjct: 115 WQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF--NAPLKPLADL 172

Query: 289 TPV-----FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ---------D 334
            PV     + APE  LG  +  KA D WA+G     ++  +  F G   +         D
Sbjct: 173 DPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232

Query: 335 TYDKIV---------------------------------NNSLVFPD----AMNPELRNL 357
             ++I                                  +NSL          + +  +L
Sbjct: 233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292

Query: 358 LEGLLCKDPTRRLTLNDVAKHTW 380
           L  LL  DPT+R+T  +  +H +
Sbjct: 293 LRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  107 bits (268), Expect = 3e-26
 Identities = 80/253 (31%), Positives = 121/253 (47%), Gaps = 14/253 (5%)

Query: 126 IGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +G G+YGKV L R       GK YA+K   K+ L + +    E   T+  R VL   + Q
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ-KAKTVEHTRTE--RNVLEH-VRQ 63

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
            P +V L          H  ++L+YV G        Q     E   R Y  +I+  L +L
Sbjct: 64  SPFLVTLHYAFQTEAKLH--LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121

Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF-EDDNDVLRRSPGTPVFTAPECCLGL 301
           H   +V+ DIK +N+L+   G V + DF +S+ F  ++ +      GT  + APE   G 
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181

Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGE----TLQDTYDKIVNNSLVFPDAMNPELRNL 357
              GKA D W++G+ ++ ++ G  PF  E    T  +   +I+     FP  + PE ++L
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDL 241

Query: 358 LEGLLCKDPTRRL 370
           L  LL KDP +RL
Sbjct: 242 LHKLLRKDPKKRL 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  105 bits (263), Expect = 5e-26
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 17/265 (6%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +Y  +R +G G++G V L R   D K   IK      ++K             + E  ++
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-------DERLAAQNECQVL 53

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYM-VLEYVEGKWDNDGFGQPGA--IGESMARKYLRDI 235
           K+L HPNI   IE  ++   D   M V+EY  G    +   +     + E     +   I
Sbjct: 54  KLLSHPNI---IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI 110

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTV-KIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           +  L ++H   ++H D+K  N+L+     V KIGDF +S++    +       GTP + +
Sbjct: 111 LLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA-YTVVGTPCYIS 169

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV-FPDAMNPE 353
           PE C G  Y  K +D WA+G  LY +   +  F    L     KI++ +     D  +P+
Sbjct: 170 PELCEGKPYNQK-SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPD 228

Query: 354 LRNLLEGLLCKDPTRRLTLNDVAKH 378
           LR L+  +L  DP++R  L+ +   
Sbjct: 229 LRQLILSMLNLDPSKRPQLSQIMAQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  105 bits (265), Expect = 5e-26
 Identities = 78/297 (26%), Positives = 129/297 (43%), Gaps = 52/297 (17%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE-----TAMTDVRR 173
           +Y  + KIG G+YG V   R+   G+  A+K        K+R+   E     TA+    R
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMK--------KIRLESEEEGVPSTAI----R 48

Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV--EGKWDNDGFGQPGAIGESMARKY 231
           E+ ++K LQHPNIV L +V+   +    Y++ E++  + K   D   +   +   + + Y
Sbjct: 49  EISLLKELQHPNIVCLQDVLMQES--RLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSY 106

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  I+ G+++ H   V+H D+KP NLL+   G +K+ DF +++ F     V      T  
Sbjct: 107 LYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLW 166

Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG---------------------- 329
           + APE  LG        D W++G     M   +  F G                      
Sbjct: 167 YRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVW 226

Query: 330 ---ETLQD---TYDKIVNNSLV--FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
               +L D   T+ K    SL     + ++ +  +LLE +L  DP +R++      H
Sbjct: 227 PGVTSLPDYKNTFPKWKKGSLRSAVKN-LDEDGLDLLEKMLIYDPAKRISAKKALNH 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  105 bits (265), Expect = 6e-26
 Identities = 80/282 (28%), Positives = 123/282 (43%), Gaps = 27/282 (9%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            + V + ++G G+ G V   R    G  +A+K         +   P+      + RE+ I
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKT--------ITTDPNPDLQKQILRELEI 52

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLR 233
            K  + P IV       D +S    + +EY EG   +  +     + G IGE +  K   
Sbjct: 53  NKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAE 112

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
            ++ GL YLH   ++H DIKP N+L+   G VK+ DF VS   E  N +     GT  + 
Sbjct: 113 SVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGTFTGTSFYM 170

Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ-----DTYDKIVNNS-LVFP 347
           APE   G  Y    +D W++G+TL  +   ++PF  E        +    IVN       
Sbjct: 171 APERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229

Query: 348 DAMNP------ELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
           D          E ++ ++  L KDPTRR T  D+ +H W+  
Sbjct: 230 DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  104 bits (262), Expect = 7e-26
 Identities = 72/272 (26%), Positives = 116/272 (42%), Gaps = 36/272 (13%)

Query: 123 VRKIGAGSYGKV--VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
           + K+G GSYG V   +++ +  G+  AIK           V P E  + ++ +E+ I+K 
Sbjct: 8   LEKLGEGSYGSVYKAIHKET--GQVVAIK-----------VVPVEEDLQEIIKEISILKQ 54

Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY--------L 232
              P IV          +   ++V+EY      +D       I +   +          L
Sbjct: 55  CDSPYIVKYYGSYF--KNTDLWIVMEYCGAGSVSD-------IMKITNKTLTEEEIAAIL 105

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
              + GL YLH +  +H DIK  N+L+   G  K+ DF VS    D         GTP +
Sbjct: 106 YQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFW 165

Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDA 349
            APE    + Y  K AD W++G+T   M  G+ P+           I N    +L  P+ 
Sbjct: 166 MAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEK 224

Query: 350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            +PE  + ++  L KDP  R +   + +H ++
Sbjct: 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  105 bits (263), Expect = 8e-26
 Identities = 76/266 (28%), Positives = 127/266 (47%), Gaps = 16/266 (6%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +Y    KIG G+ G V        G+  AIK  +      L+  P +  + +   E+L+M
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN------LQKQPKKELIIN---EILVM 70

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           K L++PNIVN ++       D  ++V+EY+ G    D   +   + E+      R+ +  
Sbjct: 71  KELKNPNIVNFLDSF--LVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQA 127

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L +LH + V+H DIK DN+L+   G+VK+ DF        +        GTP + APE  
Sbjct: 128 LEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187

Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKIVNNS--LVFPDAMNPELR 355
               YG K  D W++G+    M+ G+ P+L E  L+  Y    N +  L  P+ ++P  R
Sbjct: 188 TRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFR 246

Query: 356 NLLEGLLCKDPTRRLTLNDVAKHTWV 381
           + L   L  D  +R +  ++ +H ++
Sbjct: 247 DFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  105 bits (265), Expect = 1e-25
 Identities = 83/326 (25%), Positives = 133/326 (40%), Gaps = 63/326 (19%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR---EV 175
            Y  +  IG+G+YG V     +  GK  AIK          ++  +    T  +R   E+
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIK----------KIPHAFDVPTLAKRTLREL 55

Query: 176 LIMKMLQHPNIVNLIEVIDDPNSD--HFYMVLEYVEGKWDND-----GFGQPGAIGESMA 228
            I++  +H NI+ + +++  P +D    Y+V++ +E    +D        QP  + E   
Sbjct: 56  KILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME----SDLHHIIHSDQP--LTEEHI 109

Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF----SVSQVFEDDNDVLR 284
           R +L  ++ GL Y+H  NV+H D+KP NLLV     ++IGDF     +S    +    + 
Sbjct: 110 RYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT 169

Query: 285 RSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII---------------------G 323
               T  + APE  L L     A D W+VG     M+                      G
Sbjct: 170 EYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG 229

Query: 324 QYP--FLGETLQDTYDKIVNN---------SLVFPDAMNPELRNLLEGLLCKDPTRRLTL 372
                 L     D   K + N         S +FP A +PE  +LL  +L  DP  R+T+
Sbjct: 230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITV 288

Query: 373 NDVAKHTWVLGDNGPIPQYLCWCKRD 398
               +H ++   + P  +  C    D
Sbjct: 289 EQALQHPFLAQYHDPDDEPTCPPPFD 314

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  104 bits (260), Expect = 1e-25
 Identities = 76/258 (29%), Positives = 116/258 (44%), Gaps = 21/258 (8%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           ++  + KIG GS+G V       D + YA+K   +  LSK+     E A+     E  ++
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMK---QIDLSKMNRREREEAI----DEARVL 53

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMARKYLRD 234
             L    I+   E   D       +V+EY E     K      G+P  + E    ++   
Sbjct: 54  AKLDSSYIIRYYESFLDKGK--LNIVMEYAENGDLHKLLKMQRGRP--LPEDQVWRFFIQ 109

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           I+ GL +LH   ++H DIK  NL +     VKIGD  V+++  D+ +      GTP + +
Sbjct: 110 ILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLS 169

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP---DAMN 351
           PE C    Y  K +D WA+GV LY    G++PF          KI+    VFP      +
Sbjct: 170 PELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDANNQGALILKIIRG--VFPPVSQMYS 226

Query: 352 PELRNLLEGLLCKDPTRR 369
            +L  L++  L KD  +R
Sbjct: 227 QQLAQLIDQCLTKDYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  104 bits (261), Expect = 2e-25
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 21/208 (10%)

Query: 123 VRKIGAGSYGKVVLYRSSLD------GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           ++++G G +GKV L R   D      G+  A+K         L  +  E   +D  RE+ 
Sbjct: 9   IKQLGEGHFGKVELCR--YDPLGDNTGEQVAVK--------SLNHSGEEQHRSDFEREIE 58

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDI 235
           I++ L H NIV    V + P      +++EY+  G   +        I       +   I
Sbjct: 59  ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI 118

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPG-TPVF- 292
             G+ YL     +H D+   N+LV     VKI DF +++V  +D D    + PG +P+F 
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178

Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYM 320
            APE CL  +    A+D W+ GVTLY +
Sbjct: 179 YAPE-CLRTSKFSSASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  106 bits (265), Expect = 2e-25
 Identities = 77/312 (24%), Positives = 133/312 (42%), Gaps = 77/312 (24%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            ++  V+ IG G++G+V L +    GK YA+K   KS + K      +  +  V+ E  +
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFK------KDQLAHVKAERDV 54

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMAR 229
           +     P +V+L     D  + + Y+++E++ G        K+D           E + R
Sbjct: 55  LAESDSPWVVSLYYSFQD--AQYLYLIMEFLPGGDLMTMLIKYD--------TFSEDVTR 104

Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF--EDDNDVLRR-- 285
            Y+ + V  +  +H    +H DIKPDN+L+   G +K+ DF +S  F  + D+   ++  
Sbjct: 105 FYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL 164

Query: 286 -------------------------------------------SPGTPVFTAPECCLGLT 302
                                                      + GTP + APE  L   
Sbjct: 165 QGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG 224

Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFPD--AMNPELRNLL 358
           Y G+  D W++G  ++  +IG  PF  E   +TY KI+N   +L FPD   ++ E  +L+
Sbjct: 225 Y-GQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLI 283

Query: 359 EGLLCKDPTRRL 370
             L+  +   RL
Sbjct: 284 RRLIT-NAENRL 294

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  103 bits (259), Expect = 2e-25
 Identities = 75/276 (27%), Positives = 119/276 (43%), Gaps = 26/276 (9%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +  +   +KIG G +  V      LDG+  A+K      +   +      A  D  +E+ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK------ARQDCLKEID 54

Query: 177 IMKMLQHPNIVN-LIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMARKY 231
           ++K L HPN++  L   I++   +   +VLE  +     +       Q   I E    KY
Sbjct: 55  LLKQLDHPNVIKYLASFIEN---NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
              + S L ++H   ++H DIKP N+ +  +G VK+GD  + + F           GTP 
Sbjct: 112 FVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171

Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE--TLQDTYDKIVNNSLVFP-- 347
           + +PE      Y  K +D W++G  LY M   Q PF G+   L     KI      +P  
Sbjct: 172 YMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD--YPPL 228

Query: 348 --DAMNPELRNLLEGLLCKDPTRRL---TLNDVAKH 378
             D  + ELR+L+   +  DP +R     +  VAK 
Sbjct: 229 PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  103 bits (259), Expect = 3e-25
 Identities = 66/239 (27%), Positives = 105/239 (43%), Gaps = 41/239 (17%)

Query: 166 TAMTDVRREVLIMKMLQHPNIVN----LIEVIDDPNSDHFYMVLEYVEG---------KW 212
           T++ ++R+EV  M    HPN+V      +        D  ++V+ Y+ G          +
Sbjct: 41  TSVDELRKEVQAMSQCNHPNVVKYYTSFVV------GDELWLVMPYLSGGSLLDIMKSSY 94

Query: 213 DNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272
              G        E++    L++++ GL YLH +  +H DIK  N+L+   G+VKI DF V
Sbjct: 95  PRGGLD------EAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGV 148

Query: 273 SQVFEDDNDVLRRSP----GTPVFTAPECCLGLT-YGGKAADTWAVGVTLYYMIIGQYPF 327
           S    D  D  R+      GTP + APE    +  Y  K AD W+ G+T   +  G  P+
Sbjct: 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFK-ADIWSFGITAIELATGAAPY 207

Query: 328 --------LGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
                   L  TLQ+    +           +   R ++   L KDP++R T  ++ KH
Sbjct: 208 SKYPPMKVLMLTLQNDPPSLETG--ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  103 bits (259), Expect = 4e-25
 Identities = 77/301 (25%), Positives = 123/301 (40%), Gaps = 60/301 (19%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y  + KIG G++ +V+  +S   GK+YAIK   K   S  +V           RE+  ++
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL--------REIQALR 52

Query: 180 MLQ-HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
            L  HPNI+ LIEV+ D  +    +V E ++        G+   + E   + Y+  ++  
Sbjct: 53  RLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKS 112

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF-SVSQVFEDDNDVLRRSPGTPVFT---- 293
           L ++H + + H DIKP+N+L+     +K+ DF S   ++             P +T    
Sbjct: 113 LDHMHRNGIFHRDIKPENILIK-DDILKLADFGSCRGIY-----------SKPPYTEYIS 160

Query: 294 -----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN------- 341
                APEC L   Y G   D WAVG   + ++     F G    D   KI +       
Sbjct: 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA 220

Query: 342 -----------NSLVFPDA-----------MNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                       +  FP              + E  +LL+ LL  DP  R+T     +H 
Sbjct: 221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP 280

Query: 380 W 380
           +
Sbjct: 281 Y 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 5e-25
 Identities = 74/261 (28%), Positives = 124/261 (47%), Gaps = 11/261 (4%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G++G+V L   +  G+  A+K       S+     +   +  +  E+ ++K L+H  
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQ----ETSKEVNALECEIQLLKNLRHDR 65

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           IV     + DP      + +EY+ G    D     GA+ E++ R+Y R I+ G+ YLH +
Sbjct: 66  IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVS---QVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
            +VH DIK  N+L   +G VK+GDF  S   Q        ++   GTP + +PE   G  
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG 185

Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL--VFPDAMNPELRNLLEG 360
           YG K AD W+V  T+  M+  + P+          KI       + PD ++   R+ L+ 
Sbjct: 186 YGRK-ADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQ 244

Query: 361 LLCKDPTRRLTLNDVAKHTWV 381
           +  ++  RR T   + +H +V
Sbjct: 245 IFVEE-KRRPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  103 bits (258), Expect = 5e-25
 Identities = 76/266 (28%), Positives = 126/266 (47%), Gaps = 22/266 (8%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +Y    KIG G+ G V        G+  AIK  +     K  +         +  E+L+M
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL---------IINEILVM 70

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           +  +HPNIVN ++       D  ++V+EY+ G    D   +   + E       R+ +  
Sbjct: 71  RENKHPNIVNYLDSY--LVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQA 127

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS-VSQVFEDDNDVLRRSP--GTPVFTAP 295
           L +LH + V+H DIK DN+L+   G+VK+ DF   +Q+  + +   +RS   GTP + AP
Sbjct: 128 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAP 184

Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKIVNNS--LVFPDAMNP 352
           E      YG K  D W++G+    M+ G+ P+L E  L+  Y    N +  L  P+ ++ 
Sbjct: 185 EVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 243

Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKH 378
             R+ L   L  D  +R +  ++ +H
Sbjct: 244 IFRDFLNRCLEMDVEKRGSAKELLQH 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 6e-25
 Identities = 69/281 (24%), Positives = 122/281 (43%), Gaps = 44/281 (15%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
             +  +  IG GS+G+V         +  AIK              +E  + D+++E+  
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--------AEDEIEDIQQEIQF 52

Query: 178 MKMLQHPNIVNLIE-VIDDPNSDHFYMVLEYVEGKWDNDGFG------QPGAIGESMARK 230
           +   + P I       +        ++++EY  G       G      +PG + E+    
Sbjct: 53  LSQCRSPYITKYYGSFLKGSK---LWIIMEYCGG-------GSCLDLLKPGKLDETYIAF 102

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSP-- 287
            LR+++ GL YLH    +H DIK  N+L++  G VK+ DF VS Q+    + + +R+   
Sbjct: 103 ILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQL---TSTMSKRNTFV 159

Query: 288 GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYD-----KIVNN 342
           GTP + APE      Y  K AD W++G+T   +  G+ P     L D +       I  N
Sbjct: 160 GTPFWMAPEVIKQSGYDEK-ADIWSLGITAIELAKGEPP-----LSDLHPMRVLFLIPKN 213

Query: 343 S--LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           +   +  +  +   ++ +   L KDP  R +  ++ KH ++
Sbjct: 214 NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFI 254

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  102 bits (256), Expect = 6e-25
 Identities = 73/264 (27%), Positives = 109/264 (41%), Gaps = 14/264 (5%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD-VRREVLIMKMLQHP 184
           IG G+YG+V L  +   G+  A+K          R    +  M   +R E+  +K L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           NIV  +           +  LEYV G          G   E + R +   ++ GL YLH 
Sbjct: 69  NIVQYLGFETTEEYLSIF--LEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126

Query: 245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED--DNDVLRRSPGTPVFTAPECC--LG 300
             ++H D+K DNLLV   G  KI DF +S+  +D  DND      G+  + APE      
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186

Query: 301 LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP------DAMNPEL 354
             Y  K  D W++G  +  M  G+ P+  E       K+ N     P        ++P  
Sbjct: 187 QGYSAK-VDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVA 245

Query: 355 RNLLEGLLCKDPTRRLTLNDVAKH 378
            + L      +P  R T  ++ +H
Sbjct: 246 LDFLNACFTINPDNRPTARELLQH 269

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  102 bits (257), Expect = 7e-25
 Identities = 81/301 (26%), Positives = 131/301 (43%), Gaps = 46/301 (15%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + Y  + KIG G+YGKV   R    GK  A+K   K+ L         TA+    RE+ +
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTAL----REISL 53

Query: 178 MKMLQH-PNIVNLIEV---IDDPNSDHFYMVLEYVEG---KW-DNDGFGQPGAIGESMAR 229
           ++ML     IV L++V    +       Y+V EY++    K+ D++G G    +     +
Sbjct: 54  LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIK 113

Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPG 288
            ++  ++ G+ + H H V+H D+KP NLLV    G +KI D  + + F            
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173

Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET----------------- 331
           T  + APE  LG T+     D W+VG     M   Q  F G++                 
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233

Query: 332 --------LQDTYD----KIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                   L+D ++    K  + S   PD ++PE  +LL+ +L  DP +R++      H 
Sbjct: 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRISAKAALTHP 292

Query: 380 W 380
           +
Sbjct: 293 Y 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  102 bits (254), Expect = 8e-25
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 8/205 (3%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G++G+V L      G+  A K       S      +   ++ +  E+ ++K LQH  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPES----PETSKEVSALECEIQLLKNLQHER 65

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           IV     + D       + +EY+ G    D     GA+ ES+ RKY R I+ G+ YLH +
Sbjct: 66  IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED---DNDVLRRSPGTPVFTAPECCLGLT 302
            +VH DIK  N+L   +G VK+GDF  S+  +        +R   GTP + +PE   G  
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185

Query: 303 YGGKAADTWAVGVTLYYMIIGQYPF 327
           YG K AD W++G T+  M+  + P+
Sbjct: 186 YGRK-ADVWSLGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  102 bits (256), Expect = 8e-25
 Identities = 74/279 (26%), Positives = 126/279 (45%), Gaps = 42/279 (15%)

Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR---------EV 175
           KIG GS G V + R    G+  A+K                  M D+R+         EV
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVK------------------MMDLRKQQRRELLFNEV 69

Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
           +IM+  QH N+V + +       +  ++++E+++G    D   Q     E +A      +
Sbjct: 70  VIMRDYQHQNVVEMYK--SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA-TVCESV 126

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           +  L YLH   V+H DIK D++L+   G VK+ DF        D    +   GTP + AP
Sbjct: 127 LQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186

Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-------LQDTYDKIVNNSLVFPD 348
           E      YG +  D W++G+ +  M+ G+ P+  ++       L+D+    + N+     
Sbjct: 187 EVISRTPYGTE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNA----H 241

Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
            ++P LR+ LE +L ++P  R T  ++  H ++L    P
Sbjct: 242 KISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  101 bits (253), Expect = 9e-25
 Identities = 68/254 (26%), Positives = 126/254 (49%), Gaps = 14/254 (5%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +Y  +R +G GS+G+ +L +     + YA+K        ++R+  S +A+ D R+E +++
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMK--------EIRLPKSSSAVEDSRKEAVLL 52

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAI-GESMARKYLRDIV 236
             ++HPNIV   E  +     H Y+V+EY + G        Q G +  E    ++   + 
Sbjct: 53  AKMKHPNIVAFKESFE--ADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMC 110

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
            G+ ++H   V+H DIK  N+ +  +G VK+GDF  +++            GTP +  PE
Sbjct: 111 LGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE 170

Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV-FPDAMNPELR 355
               + Y  K +D W++G  LY +   ++PF   + ++   K+   S    P   + ELR
Sbjct: 171 IWENMPYNNK-SDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELR 229

Query: 356 NLLEGLLCKDPTRR 369
           +L++ +  ++P  R
Sbjct: 230 SLIKQMFKRNPRSR 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  103 bits (257), Expect = 1e-24
 Identities = 84/284 (29%), Positives = 139/284 (48%), Gaps = 37/284 (13%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           ++ IG G++G+V + +     + YA+K  +K  + K     +ETA     R VL+    Q
Sbjct: 6   IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLK----RAETACFREERNVLVNGDCQ 61

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMARKYLRD 234
              I  L     D N  + Y+V++Y  G        K+++        + E MAR Y+ +
Sbjct: 62  W--ITTLHYAFQDEN--YLYLVMDYYVGGDLLTLLSKFED-------RLPEDMARFYIAE 110

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR-SPGTPVFT 293
           +V  +  +H  + VH DIKPDN+L+  +G +++ DF        D  V    + GTP + 
Sbjct: 111 MVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYI 170

Query: 294 APECCLGLTYG----GKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFP 347
           +PE    +  G    G   D W++GV +Y M+ G+ PF  E+L +TY KI+N+     FP
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230

Query: 348 DAM---NPELRNLLEGLLCKDPTRRLTLN---DVAKHTWVLGDN 385
             +   + E ++L++ L+C    RRL  N   D  KH +  G +
Sbjct: 231 SHITDVSEEAKDLIQRLICSR-ERRLGQNGIEDFKKHAFFEGID 273

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  102 bits (255), Expect = 1e-24
 Identities = 77/294 (26%), Positives = 123/294 (41%), Gaps = 47/294 (15%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           + ++G G++GKV   +    G   A         +K+    SE  + D   E+ I+   +
Sbjct: 10  IGELGDGAFGKVYKAQHKETGLFAA---------AKIIQIESEEELEDFMVEIDILSECK 60

Query: 183 HPNIVNLIEV-IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIG-----------ESMARK 230
           HPNIV L E    +      ++++E+ +G          GA+            E   R 
Sbjct: 61  HPNIVGLYEAYFYENK---LWILIEFCDG----------GALDSIMLELERGLTEPQIRY 107

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--G 288
             R ++  L +LH H V+H D+K  N+L+   G VK+ DF VS   +      +R    G
Sbjct: 108 VCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIG 165

Query: 289 TPVFTAPECCLGLTYGGKA----ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN-- 342
           TP + APE     T+        AD W++G+TL  +   + P           KI+ +  
Sbjct: 166 TPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP 225

Query: 343 -SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV--LGDNGPIPQYLC 393
            +L  P   +    + L+  L KDP  R T  ++ KH +V    DN  I   L 
Sbjct: 226 PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDLLA 279

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  102 bits (255), Expect = 2e-24
 Identities = 78/299 (26%), Positives = 129/299 (43%), Gaps = 47/299 (15%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           + E+  + +IG G+YG  ++YR+  D     I A  K  +   R     +++    RE+ 
Sbjct: 6   VTEFEKLNRIGEGTYG--IVYRAR-DTTSGEIVALKKVRMDNERDGIPISSL----REIT 58

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           ++  L+HPNIV L EV+   + D  ++V+EY E    +     P    ES  +  +  ++
Sbjct: 59  LLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLL 118

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV----- 291
            GL YLH + ++H D+K  NLL+   G +KI DF +++ +          P TP      
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-----KPMTPKVVTLW 173

Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVF 346
           + APE  LG T    A D WAVG  L  ++  +    G++  +  D I+      N  ++
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233

Query: 347 PD------AMNPELR-------------------NLLEGLLCKDPTRRLTLNDVAKHTW 380
           P            L                     LL  LL  DP +R T  +  + ++
Sbjct: 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  101 bits (253), Expect = 2e-24
 Identities = 87/290 (30%), Positives = 135/290 (46%), Gaps = 31/290 (10%)

Query: 122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           +  KIG GS G V +      GK  A+K         LR       + +   EV+IM+  
Sbjct: 24  NFIKIGEGSTGIVCIATVKSSGKLVAVKKM------DLRKQQRRELLFN---EVVIMRDY 74

Query: 182 QHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           QH N+V +       NS    D  ++V+E++EG    D         E +A   L  ++ 
Sbjct: 75  QHENVVEMY------NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCL-AVLK 127

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS-VSQVFEDDNDVLRRSP--GTPVFTA 294
            L  LH   V+H DIK D++L+   G VK+ DF   +QV     +V RR    GTP + A
Sbjct: 128 ALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMA 184

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDAMN 351
           PE    L YG +  D W++G+ +  M+ G+ P+  E        I +N    L     ++
Sbjct: 185 PELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVS 243

Query: 352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLR 401
           P L+  L+ LL +DP +R T  ++ KH + L   GP    +   +++R+R
Sbjct: 244 PSLKGFLDRLLVRDPAQRATAAELLKHPF-LAKAGPPSCIVPLMRQNRMR 292

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  100 bits (250), Expect = 4e-24
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 17/210 (8%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIK--AFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           +G G+YG V    ++  G+  A+K      S+     V  +E     ++ EV ++K L+H
Sbjct: 8   LGKGAYGTVYCGLTN-QGQLIAVKQVELDTSN-----VLAAEKEYEKLQEEVDLLKSLKH 61

Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
            NIV  +    D N+   +M  E+V G   +    + G + E +  KY + I+ G+ YLH
Sbjct: 62  VNIVQYLGTCLDDNTISIFM--EFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119

Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE------DDNDVLRRSPGTPVFTAPEC 297
            + VVH DIK +N+++ P+G +K+ DF  ++           +++L+   GTP + APE 
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 298 CLGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
                YG K +D W++G T++ M  G+ P 
Sbjct: 180 INESGYGRK-SDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  101 bits (253), Expect = 4e-24
 Identities = 75/256 (29%), Positives = 125/256 (48%), Gaps = 23/256 (8%)

Query: 123 VRKIGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           ++ +G GS+GKV L R       G+ YA+K   K+ L K+R    +   T + R++L   
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVR----DRVRTKMERDILAE- 54

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESMARKYLRDIV 236
            + HP IV L            Y++L+++ G    D F    +     E   + YL ++ 
Sbjct: 55  -VNHPFIVKLHYAFQTEGK--LYLILDFLRG---GDLFTRLSKEVMFTEEDVKFYLAELA 108

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
             L +LH   +++ D+KP+N+L+   G +K+ DF +S+   D         GT  + APE
Sbjct: 109 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 168

Query: 297 CC--LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPEL 354
                G T    +AD W+ GV ++ M+ G  PF G+  ++T   I+   L  P  ++PE 
Sbjct: 169 VVNRRGHTQ---SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEA 225

Query: 355 RNLLEGLLCKDPTRRL 370
           ++LL  L  ++P  RL
Sbjct: 226 QSLLRALFKRNPANRL 241

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  100 bits (251), Expect = 7e-24
 Identities = 73/314 (23%), Positives = 131/314 (41%), Gaps = 65/314 (20%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +++Y  + KIG G++G+V   R     +  A+K   K  +   +     TA+    RE+ 
Sbjct: 11  VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALK---KVLMENEKEGFPITAL----REIK 63

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDH------FYMVLEYVEGKWDNDGFGQPGAIGESMA-- 228
           I+++L+H N+VNLIE+     + +      FY+V E+ E   D  G      +  +++  
Sbjct: 64  ILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE--HDLAGLLSNKNVKFTLSEI 121

Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           +K ++ +++GL Y+H + ++H D+K  N+L+   G +K+ DF +++ F      L ++  
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF-----SLSKNSK 176

Query: 289 TPVFT---------APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL-GETLQDTYDK 338
              +T          PE  LG    G   D W  G  +  M   + P + G T Q     
Sbjct: 177 PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQHQLTL 235

Query: 339 IVN-----NSLVFPDAMNPELRN---------------------------LLEGLLCKDP 366
           I          V+P     EL                             L++ LL  DP
Sbjct: 236 ISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDP 295

Query: 367 TRRLTLNDVAKHTW 380
            +R+  +    H +
Sbjct: 296 AKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 99.7 bits (248), Expect = 1e-23
 Identities = 78/257 (30%), Positives = 128/257 (49%), Gaps = 15/257 (5%)

Query: 123 VRKIGAGSYGKVVLYR--SSLD-GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           ++ +G G+YGKV L R  S  D GK YA+K   K+ + +       T  T   R+VL   
Sbjct: 5   LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ---KAKTTEHTRTERQVL-EH 60

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
           + Q P +V L          H  ++L+Y+ G        Q     E   + Y  +IV  L
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLH--LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF-EDDNDVLRRSPGTPVFTAPECC 298
            +LH   +++ DIK +N+L+  +G V + DF +S+ F ED+ +      GT  + AP+  
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178

Query: 299 LGLTYG-GKAADTWAVGVTLYYMIIGQYPFL--GE--TLQDTYDKIVNNSLVFPDAMNPE 353
            G   G  KA D W++GV +Y ++ G  PF   GE  +  +   +I+ +   +P  M+  
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238

Query: 354 LRNLLEGLLCKDPTRRL 370
            +++++ LL KDP +RL
Sbjct: 239 AKDIIQRLLMKDPKKRL 255

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 98.6 bits (245), Expect = 1e-23
 Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 8/205 (3%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G++G+V L   +  G+  A+K       S      +   +  +  E+ ++K L H  
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPES----PETSKEVNALECEIQLLKNLLHER 65

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           IV     + DP      + +E++ G    D     GA+ E++ RKY R I+ G+ YLH +
Sbjct: 66  IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED---DNDVLRRSPGTPVFTAPECCLGLT 302
            +VH DIK  N+L    G VK+GDF  S+  +        ++   GTP + +PE   G  
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG 185

Query: 303 YGGKAADTWAVGVTLYYMIIGQYPF 327
           YG K AD W+VG T+  M+  + P+
Sbjct: 186 YGRK-ADIWSVGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  100 bits (250), Expect = 2e-23
 Identities = 82/312 (26%), Positives = 129/312 (41%), Gaps = 62/312 (19%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSH-LSKLRVAPSETAMTDVRREVLIM 178
           +V ++ IG G++G+V L R       YA+K   K+  L + + A        V+ E  I+
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAA-------HVKAERDIL 55

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
               +  +V L     D   D+ Y V++Y+ G        + G   E +AR Y+ ++   
Sbjct: 56  AEADNEWVVKLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCA 113

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE--------------------- 277
           +  +H    +H DIKPDN+L+   G +K+ DF +   F                      
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEP 173

Query: 278 ----DDNDVLRRSP------------------GTPVFTAPECCLGLTYGGKAADTWAVGV 315
                + D  R  P                  GTP + APE  L   Y  +  D W+VGV
Sbjct: 174 SEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGV 232

Query: 316 TLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFPDAMN--PELRNLLEGLLCKDPTRRLT 371
            LY M++GQ PFL +T  +T  K++N   +L  P       E  +L+   LC     RL 
Sbjct: 233 ILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLG 291

Query: 372 LN---DVAKHTW 380
            N   ++  H +
Sbjct: 292 KNGADEIKAHPF 303

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 98.6 bits (245), Expect = 3e-23
 Identities = 75/269 (27%), Positives = 124/269 (46%), Gaps = 22/269 (8%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +Y    KIG G+ G V        G+  AI+  +      L+  P +  + +   E+L+M
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN------LQQQPKKELIIN---EILVM 71

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           +  ++PNIVN ++       D  ++V+EY+ G    D   +   + E       R+ +  
Sbjct: 72  RENKNPNIVNYLDSY--LVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQA 128

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L +LH + V+H DIK DN+L+   G+VK+ DF        +        GTP + APE  
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKIVNNSLVFPDAMNPE---- 353
               YG K  D W++G+    MI G+ P+L E  L+  Y    N +   P+  NPE    
Sbjct: 189 TRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT---PELQNPEKLSA 244

Query: 354 -LRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
             R+ L   L  D  +R +  ++ +H ++
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 98.6 bits (245), Expect = 3e-23
 Identities = 76/269 (28%), Positives = 124/269 (46%), Gaps = 22/269 (8%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +Y    KIG G+ G V        G+  AIK  +      L+  P +  + +   E+L+M
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN------LQQQPKKELIIN---EILVM 70

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           +  ++PNIVN ++       D  ++V+EY+ G    D   +   + E       R+ +  
Sbjct: 71  RENKNPNIVNYLDSY--LVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQA 127

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L +LH + V+H DIK DN+L+   G+VK+ DF        +        GTP + APE  
Sbjct: 128 LDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187

Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKIVNNSLVFPDAMNPE---- 353
               YG K  D W++G+    M+ G+ P+L E  L+  Y    N +   P+  NPE    
Sbjct: 188 TRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT---PELQNPERLSA 243

Query: 354 -LRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
             R+ L   L  D  RR +  ++ +H ++
Sbjct: 244 VFRDFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 98.0 bits (244), Expect = 4e-23
 Identities = 67/256 (26%), Positives = 114/256 (44%), Gaps = 18/256 (7%)

Query: 122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           H R +G G +G+V   +    GK YA K   K  + K +    E    + ++   I++ +
Sbjct: 4   HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK---GEAMALNEKQ---ILEKV 57

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEG---KWDNDGFGQPGAIGESMARKYLRDIVSG 238
               +V+L    +    D   +VL  + G   K+     G PG   E  A  Y  +I  G
Sbjct: 58  NSRFVVSLAYAYE--TKDALCLVLTLMNGGDLKFHIYNMGNPG-FDEERAVFYAAEITCG 114

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L  LH   +V+ D+KP+N+L+   G ++I D  ++ V   + + +R   GT  + APE  
Sbjct: 115 LEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVV 173

Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE----TLQDTYDKIVNNSLVFPDAMNPEL 354
               Y   + D W +G  +Y MI G+ PF         ++   ++  +   + +  +   
Sbjct: 174 KNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAA 232

Query: 355 RNLLEGLLCKDPTRRL 370
           R++   LL KDP  RL
Sbjct: 233 RSICRQLLTKDPGFRL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 97.2 bits (242), Expect = 6e-23
 Identities = 72/291 (24%), Positives = 125/291 (42%), Gaps = 26/291 (8%)

Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           ++G G+YG V        G   A+K        ++R+   E+    +  E+ I+     P
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMK--------EIRLELDESKFNQIIMELDILHKAVSP 59

Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVE-GKWDN--DGFGQPGAIGESMARKYLRDIVSGLMY 241
            IV+         +   YM +EY++ G  D    G      I E + R+    +V GL +
Sbjct: 60  YIVDFYGAFFIEGA--VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117

Query: 242 L-HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
           L   HN++H D+KP N+LV  +G VK+ DF VS        + + + G   + APE    
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV--ASLAKTNIGCQSYMAPERIKS 175

Query: 301 LTYGGKA-----ADTWAVGVTLYYMIIGQYPFLGETLQDTYDK---IVNNS-LVFPDAMN 351
                       +D W++G+++  M +G+YP+  ET  + + +   IV+      P   +
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS 235

Query: 352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLRR 402
            + ++ +   L K P RR T   + +H W++           W     L+R
Sbjct: 236 DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWVT-GALKR 285

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 96.6 bits (240), Expect = 9e-23
 Identities = 72/248 (29%), Positives = 121/248 (48%), Gaps = 10/248 (4%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IG G +G+V   R +  GK YA+K   K    ++++   ET   + R  + ++     P 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKK---RIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           IV +      P  D    +L+ + G   +    Q G   E   R Y  +I+ GL ++H  
Sbjct: 59  IVCMTYAFHTP--DKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
            VV+ D+KP N+L+   G V+I D  ++  F         S GT  + APE     T   
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGTAYD 174

Query: 306 KAADTWAVGVTLYYMIIGQYPFLGETLQDTYD---KIVNNSLVFPDAMNPELRNLLEGLL 362
            +AD +++G  L+ ++ G  PF     +D ++     +  ++  PD+ +PEL++LLEGLL
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLL 234

Query: 363 CKDPTRRL 370
            +D ++RL
Sbjct: 235 QRDVSKRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 97.5 bits (243), Expect = 1e-22
 Identities = 78/267 (29%), Positives = 123/267 (46%), Gaps = 30/267 (11%)

Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL----IMKM 180
           ++G G YG+V L +    G+  A+K   KS L KL          +  R VL    I+  
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKL----------NEVRHVLTERDILTT 57

Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
            +   +V L+    D    + Y+ +EYV G          G + E  AR Y+ ++   + 
Sbjct: 58  TKSEWLVKLLYAFQDDE--YLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVD 115

Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLRRSPGTPVFTAPECCL 299
            LH    +H D+KP+N L+  SG +K+ DF +S+ +    N V+    G+P + APE   
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV----GSPDYMAPEVLR 171

Query: 300 GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFPDAMNP--ELR 355
           G  Y     D W++G  LY  + G  PF G T  +T++ +     +L  P   +P   L 
Sbjct: 172 GKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLS 230

Query: 356 NLLEGLLCK---DPTRRL-TLNDVAKH 378
           +    L+ K   DP+RR  +L D+  H
Sbjct: 231 DEAWDLITKLINDPSRRFGSLEDIKNH 257

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 96.3 bits (240), Expect = 2e-22
 Identities = 73/309 (23%), Positives = 125/309 (40%), Gaps = 75/309 (24%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREVLIM 178
           Y  + KIG G+YG V   ++    +  A+K        ++R+    E   +   RE+ ++
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALK--------RVRLDDDDEGVPSSALREICLL 53

Query: 179 KMLQHPNIVNLIEVIDDPNSDH-FYMVLEYVEGK----WDNDGFGQPGAIGESMARKYLR 233
           K L+H NIV L +V+   +SD    +V EY +      +D+      G I   + + ++ 
Sbjct: 54  KELKHKNIVRLYDVL---HSDKKLTLVFEYCDQDLKKYFDSCN----GDIDPEIVKSFMF 106

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-- 291
            ++ GL + H HNV+H D+KP NLL+  +G +K+ DF            L R+ G PV  
Sbjct: 107 QLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFG-----------LARAFGIPVRC 155

Query: 292 ---------FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYP-FLGETLQD------- 334
                    +  P+   G      + D W+ G     +     P F G  + D       
Sbjct: 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 215

Query: 335 -----------------------TYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLT 371
                                   Y    +   V P  +N   R+LL+ LL  +P +R++
Sbjct: 216 LLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPK-LNSTGRDLLQNLLVCNPVQRIS 274

Query: 372 LNDVAKHTW 380
             +  +H +
Sbjct: 275 AEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 80/307 (26%), Positives = 134/307 (43%), Gaps = 64/307 (20%)

Query: 123 VRKIGAGSYGKV--VLYRSSLDGKHYAIK----AFHKSHLSKLRVAPSETAMTDVRREVL 176
           ++++G G+YG V       + + +  AIK     F K  L+K  +           RE+ 
Sbjct: 5   IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-----------RELK 53

Query: 177 IMKMLQ-HPNIVNLI--EVIDDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESMARK 230
           +++  + H NI  L   +++   N +  Y+  E +E   D       GQP  + ++  + 
Sbjct: 54  LLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME--ADLHQIIRSGQP--LTDAHFQS 109

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF----SVSQVFEDDNDVLRRS 286
           ++  I+ GL Y+H  NV+H D+KP NLLV     +KI DF      S+   ++   +   
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169

Query: 287 PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG----------------- 329
             T  + APE  L      KA D W+VG  L  ++  +  F G                 
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP 229

Query: 330 --ETLQD-------TYDKIVNN------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLND 374
             ETL          Y + + N        +FP+A NP   +LLE LL  DPT+R+++ +
Sbjct: 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNA-NPLALDLLEKLLAFDPTKRISVEE 288

Query: 375 VAKHTWV 381
             +H ++
Sbjct: 289 ALEHPYL 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 94.2 bits (234), Expect = 6e-22
 Identities = 63/263 (23%), Positives = 114/263 (43%), Gaps = 16/263 (6%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G++      R    G   A+K       +    +  E  +  +R+E+ +M  L HP+
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS---SEQEEVVEALRKEIRLMARLNHPH 64

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           I+ ++         HF + +E++ G   +    + GA  E++   Y   ++ GL YLH +
Sbjct: 65  IIRMLGATC--EDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN 122

Query: 246 NVVHGDIKPDNLLVAPSGT-VKIGDFSVSQVFEDD----NDVLRRSPGTPVFTAPECCLG 300
            ++H D+K  NLL+  +G  ++I DF  +           +   +  GT  F APE   G
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182

Query: 301 LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKI-----VNNSLVFPDAMNPELR 355
             Y G++ D W+VG  +  M   + P+  E   +    I        +   P+ ++P LR
Sbjct: 183 EQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLR 241

Query: 356 NLLEGLLCKDPTRRLTLNDVAKH 378
           ++    L   P  R    ++ KH
Sbjct: 242 DVTLRCLELQPEDRPPSRELLKH 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 95.5 bits (237), Expect = 6e-22
 Identities = 80/281 (28%), Positives = 140/281 (49%), Gaps = 35/281 (12%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           ++ IG G++G+V + +     K +A+K  +K  + K     +ETA     R+VL+     
Sbjct: 6   LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK----RAETACFREERDVLVNG--D 59

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMARKYLRD 234
           +  I  L     D N+   Y+V++Y  G        K+++        + E MAR YL +
Sbjct: 60  NQWITTLHYAFQDENN--LYLVMDYYVGGDLLTLLSKFED-------RLPEDMARFYLAE 110

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF-SVSQVFEDDNDVLRRSPGTPVFT 293
           +V  +  +H  + VH DIKPDN+L+  +G +++ DF S  ++ ED       + GTP + 
Sbjct: 111 MVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 170

Query: 294 APECCLGLTYG----GKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFP 347
           +PE    +  G    G   D W++GV +Y M+ G+ PF  E+L +TY KI+N+     FP
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 230

Query: 348 DA---MNPELRNLLEGLLCKDPTR--RLTLNDVAKHTWVLG 383
                ++ + ++L+  L+C    R  +  + D  +H +  G
Sbjct: 231 AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 94.0 bits (233), Expect = 7e-22
 Identities = 70/265 (26%), Positives = 122/265 (46%), Gaps = 15/265 (5%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +  + KIG GS+G+V     +   K  AIK         + +  +E  + D+++E+ ++ 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI--------IDLEEAEDEIEDIQQEITVLS 57

Query: 180 MLQHPNIVNLI-EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
               P +       + D      ++++EY+ G    D   +PG + E+     LR+I+ G
Sbjct: 58  QCDSPYVTKYYGSYLKDTK---LWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKG 113

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L YLH    +H DIK  N+L++  G VK+ DF V+    D         GTP + APE  
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 173

Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLG-ETLQDTYDKIVNNSLVFPDAMNPELRNL 357
               Y  K AD W++G+T   +  G+ P      ++  +    NN        +  L+  
Sbjct: 174 KQSAYDSK-ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEF 232

Query: 358 LEGLLCKDPTRRLTLNDVAKHTWVL 382
           +E  L K+P+ R T  ++ KH +++
Sbjct: 233 VEACLNKEPSFRPTAKELLKHKFIV 257

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 74/275 (26%), Positives = 120/275 (43%), Gaps = 32/275 (11%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHP 184
           IG G+YGKV   R    G+  AIK               E    +++ E  I++    HP
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMD----------IIEDEEEEIKEEYNILRKYSNHP 63

Query: 185 NIVNL----IEVIDDPNSDHFYMVLEYVEGKWDND---GF-GQPGAIGESMARKYLRDIV 236
           NI       I+     N D  ++V+E   G    D   G   +   + E      LR+ +
Sbjct: 64  NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL 123

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR--SPGTPVFTA 294
            GL YLH + V+H DIK  N+L+  +  VK+ DF VS   + D+ + RR    GTP + A
Sbjct: 124 RGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTPYWMA 181

Query: 295 PE---CCLGL--TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS---LVF 346
           PE   C      +Y  + +D W++G+T   +  G+ P           KI  N    L  
Sbjct: 182 PEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS 240

Query: 347 PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           P+  + +  + +   L K+  +R  + ++ +H ++
Sbjct: 241 PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 92.7 bits (230), Expect = 2e-21
 Identities = 73/248 (29%), Positives = 120/248 (48%), Gaps = 10/248 (4%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IG G +G+V   R +  GK YA+K   K    ++++   ET   + R  + ++     P 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKK---RIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           IV +      P  D    +L+ + G   +    Q G   E+  R Y  +I+ GL ++H  
Sbjct: 59  IVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
            VV+ D+KP N+L+   G V+I D  ++  F         S GT  + APE         
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGVAYD 174

Query: 306 KAADTWAVGVTLYYMIIGQYPFLGETLQDTYD---KIVNNSLVFPDAMNPELRNLLEGLL 362
            +AD +++G  L+ ++ G  PF     +D ++     +  ++  PD+ +PELR+LLEGLL
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 234

Query: 363 CKDPTRRL 370
            +D  RRL
Sbjct: 235 QRDVNRRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 93.3 bits (232), Expect = 2e-21
 Identities = 83/315 (26%), Positives = 139/315 (44%), Gaps = 60/315 (19%)

Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
           G + ++++  + +IG G+YG+V   R    G+  A+K   K  L   +     TA+    
Sbjct: 2   GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAI---- 54

Query: 173 REVLIMKMLQHPNIVNLIEVIDD--------PNSDHFYMVLEYVEGKWDNDGFG--QPGA 222
           RE+ I++ L H NIVNL E++ D         +   FY+V EY+    D+D  G  + G 
Sbjct: 55  REIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM----DHDLMGLLESGL 110

Query: 223 I--GESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN 280
           +   E   + +++ ++ GL Y H  N +H DIK  N+L+   G +K+ DF +++++  + 
Sbjct: 111 VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170

Query: 281 DVLRRSPGTPVFT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG--ETLQ- 333
               R     V T     PE  LG    G A D W+ G  L  +   +  F    E  Q 
Sbjct: 171 ---SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL 227

Query: 334 DTYDKIVN--NSLVFPD--------AMNPE------LR-----------NLLEGLLCKDP 366
           +   ++       V+PD         M P+      LR           +LL+ +L  DP
Sbjct: 228 ELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDP 287

Query: 367 TRRLTLNDVAKHTWV 381
           ++R T  +     W+
Sbjct: 288 SKRCTAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 92.0 bits (229), Expect = 3e-21
 Identities = 71/264 (26%), Positives = 112/264 (42%), Gaps = 23/264 (8%)

Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           +IG+G+YG V   R    G+  AIK         +++ P +     +++E+ ++K  +HP
Sbjct: 10  RIGSGTYGDVYKARDIATGELVAIKV--------IKLEPGDD-FEIIQQEISMLKECRHP 60

Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLH 243
           NIV           D  ++V+EY  G    D +    G + E       R+ + GL YLH
Sbjct: 61  NIVAYFGSYL--RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118

Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
               +H DIK  N+L+   G VK+ DF VS        + +R    GTP + APE     
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL--TATIAKRKSFIGTPYWMAPEVAAVE 176

Query: 302 TYGG--KAADTWAVGVTLYYMIIGQYPFLG-----ETLQDTYDKIVNNSLVFPDAMNPEL 354
             GG     D WA+G+T   +   Q P             +        L   +  +P  
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF 236

Query: 355 RNLLEGLLCKDPTRRLTLNDVAKH 378
            + ++  L KDP +R T   + +H
Sbjct: 237 HDFIKKCLTKDPKKRPTATKLLQH 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 91.8 bits (228), Expect = 4e-21
 Identities = 84/295 (28%), Positives = 126/295 (42%), Gaps = 57/295 (19%)

Query: 110 DENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMT 169
           DENG +++        +G G+YG V           YA +       +++R+A  E    
Sbjct: 8   DENGERVV--------LGKGTYGIV-----------YAARDLS----TQVRIAIKEIPER 44

Query: 170 DVR------REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG---------KWDN 214
           D R       E+ +   L+H NIV  +    D  +  F + +E V G         KW  
Sbjct: 45  DSRYVQPLHEEIALHSYLKHRNIVQYLG--SDSENGFFKIFMEQVPGGSLSALLRSKWG- 101

Query: 215 DGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDFSVS 273
                P    E     Y + I+ GL YLH + +VH DIK DN+LV   SG VKI DF  S
Sbjct: 102 -----PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTS 156

Query: 274 QVFEDDNDVLRRSPGTPVFTAPECC-LGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGE 330
           +     N       GT  + APE    G    G  AD W++G T+  M  G+ PF  LGE
Sbjct: 157 KRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216

Query: 331 TLQDTYD----KIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
                +     KI       P++++ E +N +      DP +R + +D+ +  ++
Sbjct: 217 PQAAMFKVGMFKIHPE---IPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 92.9 bits (231), Expect = 4e-21
 Identities = 84/311 (27%), Positives = 127/311 (40%), Gaps = 69/311 (22%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR------R 173
           Y+ +R +G GS G V    S++D                 RVA  +  +TD +      R
Sbjct: 7   YMDLRPLGCGSNGLVF---SAVDSD------------CDKRVAVKKIVLTDPQSVKHALR 51

Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSD---------HF---YMVLEYVEGKWDNDGFGQPG 221
           E+ I++ L H NIV + EV+    SD              Y+V EY+E   D     + G
Sbjct: 52  EIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET--DLANVLEQG 109

Query: 222 AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTV-KIGDFSVSQVFEDD- 279
            + E  AR ++  ++ GL Y+H  NV+H D+KP N+ +     V KIGDF ++++ +   
Sbjct: 110 PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY 169

Query: 280 --NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG----ETLQ 333
                L     T  + +P   L      KA D WA G     M+ G+  F G    E +Q
Sbjct: 170 SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229

Query: 334 DTYDKI-------------VNNSLVFPDA-------------MNPELRNLLEGLLCKDPT 367
              + +             V  S V  D              +NPE  + LE +L  +P 
Sbjct: 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPM 289

Query: 368 RRLTLNDVAKH 378
            RLT  +   H
Sbjct: 290 DRLTAEEALMH 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 91.3 bits (227), Expect = 5e-21
 Identities = 73/261 (27%), Positives = 104/261 (39%), Gaps = 29/261 (11%)

Query: 125 KIGAGSYGKVVLYR---SSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           K+G GS+G  V+ R   S+  GK    A+K      LS          M D  +E  IM 
Sbjct: 2   KLGDGSFG--VVRRGEWSTSGGKVIPVAVKCLKSDKLSD--------IMDDFLKEAAIMH 51

Query: 180 MLQHPNIVNLIEVI-DDPNSDHFYMVLEYVEGK--WDNDGFGQPGAIGESMARKYLRDIV 236
            L H N++ L  V+   P      MV E        D       G    S    Y   I 
Sbjct: 52  SLDHENLIRLYGVVLTHP----LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA 107

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV---FT 293
           +G+ YL     +H D+   N+L+A    VKIGDF + +    + D         V   + 
Sbjct: 108 NGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWC 167

Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LVFPDAM 350
           APE     T+   A+D W  GVTL+ M   G+ P+ G +      KI      L  P+A 
Sbjct: 168 APESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEAC 226

Query: 351 NPELRNLLEGLLCKDPTRRLT 371
             ++ N++      +P  R T
Sbjct: 227 PQDIYNVMLQCWAHNPADRPT 247

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 91.2 bits (226), Expect = 7e-21
 Identities = 64/267 (23%), Positives = 129/267 (48%), Gaps = 13/267 (4%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y+  +++G GS+G V L +         +K   +  + +L   P+ET   +   E  ++ 
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELN--PNETVQANQ--EAQLLS 57

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR----KYLRDI 235
            L HP IV       +   D F ++ EY EG+  +    +    G++++     ++   +
Sbjct: 58  KLDHPAIVKFHASFLE--RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + G+ Y+H   ++H D+K  N+ +  +  +KIGDF VS++     D+     GTP + +P
Sbjct: 116 LLGVHYMHQRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174

Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-NSLVFPDAMNPEL 354
           E      Y  K +D W++G  LY M    + F G+       +IV   +   P+  + +L
Sbjct: 175 EALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQL 233

Query: 355 RNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            ++++ +L KDP+ R +  ++ ++ ++
Sbjct: 234 NSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 91.7 bits (227), Expect = 7e-21
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 11/223 (4%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + Y  + K+G GSY  V   +S ++GK  A+K         +R+   E       RE  +
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKV--------IRLQEEEGTPFTAIREASL 56

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +K L+H NIV L ++I     +   +V EYV           PG +     + +L  ++ 
Sbjct: 57  LKGLKHANIVLLHDIIH--TKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR 114

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPEC 297
           GL Y+H   ++H D+KP NLL++ +G +K+ DF +++     +        T  +  P+ 
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDV 174

Query: 298 CLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG-ETLQDTYDKI 339
            LG T      D W VG     MI G   F G + +QD  ++I
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERI 217

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 81/312 (25%), Positives = 139/312 (44%), Gaps = 71/312 (22%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR--REVL 176
            Y ++  IG G+YG V        G   AIK          +++P E      R  RE+ 
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIK----------KISPFEHQTFCQRTLREIK 55

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEG---------KWDNDGFGQPGAIG 224
           I++  +H NI+ ++++I  P+ + F   Y+V E +E             ND         
Sbjct: 56  ILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSND--------- 106

Query: 225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--- 281
               + +L  I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF ++++ + ++D   
Sbjct: 107 --HIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTG 164

Query: 282 VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQ--YP------------- 326
            L     T  + APE  L      KA D W+VG  L  M+  +  +P             
Sbjct: 165 FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILG 224

Query: 327 FLGETLQDTYDKIVN-------NSL----------VFPDAMNPELRNLLEGLLCKDPTRR 369
            LG   Q+  + I++        SL          +FP+A +P+  +LL+ +L  +P +R
Sbjct: 225 VLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNA-DPKALDLLDKMLTFNPHKR 283

Query: 370 LTLNDVAKHTWV 381
           +T+ +   H ++
Sbjct: 284 ITVEEALAHPYL 295

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 90.8 bits (225), Expect = 1e-20
 Identities = 76/286 (26%), Positives = 121/286 (42%), Gaps = 43/286 (15%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G+YG V+  R     +  AIK F  S         +E       RE+ +++ L+  N
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSE-------ENEEVKETTLRELKMLRTLKQEN 61

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           IV L E          Y+V EYVE          P  +     R Y+  ++  + + H +
Sbjct: 62  IVELKEAFR--RRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119

Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV-LRRSPGTPVFTAPECCLGLTYG 304
           ++VH DIKP+NLL++ +  +K+ DF  ++   + ++        T  + +PE  LG  Y 
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY- 178

Query: 305 GKAADTWAVGVTLYYMIIGQYPFLGETLQD---TYDKIVN----------------NSLV 345
           GKA D W+VG  L  +  GQ  F GE+  D   T  K++                 + L 
Sbjct: 179 GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238

Query: 346 FPDAMNPE-------------LRNLLEGLLCKDPTRRLTLNDVAKH 378
           FP   +P+             L +L++ LL  +PT R        H
Sbjct: 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 91.4 bits (227), Expect = 1e-20
 Identities = 75/297 (25%), Positives = 126/297 (42%), Gaps = 50/297 (16%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR--REV 175
           N YV ++ +G G++G V   R  L G++ AIK   K         P  T +   R  RE+
Sbjct: 10  NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMK---------PFSTPVLAKRTYREL 60

Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++K L+H NI++L ++   P  D  Y V E +    D         + +   + +L  I
Sbjct: 61  KLLKHLRHENIISLSDIFISPLED-IYFVTELLGT--DLHRLLTSRPLEKQFIQYFLYQI 117

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H   VVH D+KP N+L+  +  +KI DF ++++ +     +     T  + AP
Sbjct: 118 LRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---MTGYVSTRYYRAP 174

Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIG-----------QYPFLGETLQDTYDKIVNN-- 342
           E  L         D W+ G     M+ G           Q+  + + L    D ++N   
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234

Query: 343 -------------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
                              S  F +A +P   +LLE +L  DP +R++  +   H +
Sbjct: 235 SENTLRFVQSLPKREPVPFSEKFKNA-DPSAIDLLEKMLVFDPQKRISAAEALAHPY 290

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 90.1 bits (223), Expect = 2e-20
 Identities = 79/270 (29%), Positives = 118/270 (43%), Gaps = 28/270 (10%)

Query: 124 RKIGAGSYGKVVLYRSS--LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           +KIG G + +V  YR++  LDG   A+K      L   +      A  D  +E+ ++K L
Sbjct: 8   KKIGRGQFSEV--YRATCLLDGVPVALKKVQIFDLMDAK------ARADCIKEIDLLKQL 59

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMARKYLRDIVS 237
            HPN++       + N     +VLE  +     +       Q   I E    KY   + S
Sbjct: 60  NHPNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPEC 297
            L ++H   V+H DIKP N+ +  +G VK+GD  + + F           GTP + +PE 
Sbjct: 118 ALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 298 CLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE--TLQDTYDKIVNNSLVFP----DAMN 351
                Y  K +D W++G  LY M   Q PF G+   L     KI      +P    D  +
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--EQCDYPPLPSDHYS 234

Query: 352 PELRNLLEGLLCKDPTRRLTLN---DVAKH 378
            ELR L+   +  DP +R  +    DVAK 
Sbjct: 235 EELRQLVNMCINPDPEKRPDITYVYDVAKR 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 91.1 bits (227), Expect = 2e-20
 Identities = 84/309 (27%), Positives = 137/309 (44%), Gaps = 72/309 (23%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIK----AFHKSHLSKLRVAPSETAMTDVRR---EV 175
           ++K+G G+YG V         +  A+K    AF  +              TD +R   E+
Sbjct: 12  LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA--------------TDAQRTFREI 57

Query: 176 LIMKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY-LR 233
           + ++ L  HPNIV L+ VI   N    Y+V EY+E   D     +   I E + ++Y + 
Sbjct: 58  MFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET--DLHAVIRAN-ILEDVHKRYIMY 114

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
            ++  L Y+H  NV+H D+KP N+L+     VK+ DF +++   +  +    +P  PV T
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE----NPENPVLT 170

Query: 294 ---------APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--- 341
                    APE  LG T   K  D W+VG  L  M++G+  F G +  +  +KI+    
Sbjct: 171 DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG 230

Query: 342 -------------------NSL----------VFPDAMNPELRNLLEGLLCKDPTRRLTL 372
                              +SL          + P A + +  +LL+ LL  +P +RLT 
Sbjct: 231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKA-SDDALDLLKKLLVFNPNKRLTA 289

Query: 373 NDVAKHTWV 381
            +  +H +V
Sbjct: 290 EEALEHPYV 298

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 90.0 bits (223), Expect = 2e-20
 Identities = 72/235 (30%), Positives = 111/235 (47%), Gaps = 30/235 (12%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAM-TDVRREVLI 177
           +Y  V +IG G+YG V   R    G   A+K+        +RV  +E  +     REV +
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKS--------VRVQTNEDGLPLSTVREVAL 52

Query: 178 MKMLQ---HPNIVNLIEVIDDPNSDH---FYMVLEYVEGKWDN--DGFGQPGAIGESMAR 229
           +K L+   HPNIV L++V     +D      +V E+V+       D    PG   E++ +
Sbjct: 53  LKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETI-K 111

Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
             +R  + GL +LH + +VH D+KP+N+LV   G VK+ DF +++++     +      T
Sbjct: 112 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL------T 165

Query: 290 PV-----FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKI 339
           PV     + APE  L  TY     D W+VG     M   +  F G +  D   KI
Sbjct: 166 PVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 219

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 91.2 bits (226), Expect = 3e-20
 Identities = 84/308 (27%), Positives = 132/308 (42%), Gaps = 63/308 (20%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSH-LSKLRVAPSETAMTDVRREVLIM 178
           +V ++ +G G++G+V L R       YA+K   K   L + +VA        V+ E  I+
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVA-------HVKAERDIL 55

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
               +  +V L     D   D+ Y V++Y+ G        + G   E +AR Y+ ++   
Sbjct: 56  AEADNEWVVRLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCA 113

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND----------------- 281
           +  +H    +H DIKPDN+L+   G +K+ DF +   F   +D                 
Sbjct: 114 VESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDF 173

Query: 282 ------------------VLRRSP------------GTPVFTAPECCLGLTYGGKAADTW 311
                             + RR+             GTP + APE  L   Y  +  D W
Sbjct: 174 SNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWW 232

Query: 312 AVGVTLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFP--DAMNPELRNLLEGLLCKDPT 367
           +VGV LY M++GQ PFL +T  +T  K++N   SL  P    ++PE  +L+   LC+ P 
Sbjct: 233 SVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPE 291

Query: 368 RRLTLNDV 375
            RL  N  
Sbjct: 292 DRLGKNGA 299

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 90.1 bits (223), Expect = 3e-20
 Identities = 77/267 (28%), Positives = 127/267 (47%), Gaps = 30/267 (11%)

Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           KIG GS G V +      GK  A+K         LR       + +   EV+IM+   H 
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKM------DLRKQQRRELLFN---EVVIMRDYHHE 79

Query: 185 NIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
           N+V++       NS    D  ++V+E++EG    D         E +A   L  ++  L 
Sbjct: 80  NVVDMY------NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCL-SVLRALS 132

Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS-VSQVFEDDNDVLRRSP--GTPVFTAPEC 297
           YLH   V+H DIK D++L+   G +K+ DF   +QV     +V +R    GTP + APE 
Sbjct: 133 YLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKSLVGTPYWMAPEV 189

Query: 298 CLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDAMNPEL 354
              L YG +  D W++G+ +  MI G+ P+  E       +I +N    +     ++  L
Sbjct: 190 ISRLPYGTE-VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVL 248

Query: 355 RNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           R  L+ +L ++P++R T  ++ +H ++
Sbjct: 249 RGFLDLMLVREPSQRATAQELLQHPFL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 89.7 bits (222), Expect = 3e-20
 Identities = 70/232 (30%), Positives = 111/232 (47%), Gaps = 19/232 (8%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMT-DVRREVLI 177
           +Y  V +IG G+YGKV   R   +G  +         L ++RV   E  M     REV +
Sbjct: 2   QYECVAEIGEGAYGKVFKARDLKNGGRFVA-------LKRVRVQTGEEGMPLSTIREVAV 54

Query: 178 MKMLQ---HPNIVNLIEVIDDPNSDH---FYMVLEYVEGKWDN--DGFGQPGAIGESMAR 229
           ++ L+   HPN+V L +V     +D      +V E+V+       D   +PG   E++ +
Sbjct: 55  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI-K 113

Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
             +  ++ GL +LH H VVH D+KP N+LV  SG +K+ DF +++++      L     T
Sbjct: 114 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTSVVVT 172

Query: 290 PVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN 341
             + APE  L  +Y     D W+VG     M   +  F G +  D   KI++
Sbjct: 173 LWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 223

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 89.3 bits (221), Expect = 5e-20
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 10/210 (4%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y+++ K+G GSY  V    S ++G+  A+K           +   E       RE  ++K
Sbjct: 7   YLNLEKLGEGSYATVYKGISRINGQLVALKVIS--------MKTEEGVPFTAIREASLLK 58

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
            L+H NIV L ++I    +  F  V EY+           PG +     R ++  ++ GL
Sbjct: 59  GLKHANIVLLHDIIHTKETLTF--VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGL 116

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
            Y+HG +++H D+KP NLL++  G +K+ DF +++     +        T  +  P+  L
Sbjct: 117 AYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLL 176

Query: 300 GLTYGGKAADTWAVGVTLYYMIIGQYPFLG 329
           G T    A D W  G     M+ GQ  F G
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQPAFPG 206

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 88.5 bits (219), Expect = 9e-20
 Identities = 78/295 (26%), Positives = 123/295 (41%), Gaps = 48/295 (16%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           YV + K+G G+Y  V   RS L     A+K        ++R+   E A     REV ++K
Sbjct: 7   YVKLDKLGEGTYATVFKGRSKLTENLVALK--------EIRLEHEEGAPCTAIREVSLLK 58

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMA----RKYLRDI 235
            L+H NIV L ++I         +V EY+    D+D        G  M+    + ++  +
Sbjct: 59  NLKHANIVTLHDIIHTERC--LTLVFEYL----DSDLKQYLDNCGNLMSMHNVKIFMFQL 112

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y H   ++H D+KP NLL+   G +K+ DF +++              T  +  P
Sbjct: 113 LRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPP 172

Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL---------------QDTYDKIV 340
           +  LG T      D W VG  LY M  G+  F G T+               ++T+  I 
Sbjct: 173 DVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232

Query: 341 NN----SLVFPDAMNPELRN-----------LLEGLLCKDPTRRLTLNDVAKHTW 380
           +N    S +FP      L N           LL  LL  +   R++     +H++
Sbjct: 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 87.8 bits (217), Expect = 9e-20
 Identities = 61/196 (31%), Positives = 94/196 (47%), Gaps = 13/196 (6%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +++IG+G+YG V   R+   G+  AIK         +++ P E     V++E+++MK  +
Sbjct: 14  IQRIGSGTYGDVYKARNVNTGELAAIKV--------IKLEPGED-FAVVQQEIIMMKDCK 64

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           H NIV           D  ++ +E+  G    D +   G + ES      R+ + GL YL
Sbjct: 65  HSNIVAYFGSY--LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYL 122

Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
           H    +H DIK  N+L+  +G VK+ DF VS          +   GTP + APE      
Sbjct: 123 HSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182

Query: 303 YGG--KAADTWAVGVT 316
            GG  +  D WAVG+T
Sbjct: 183 KGGYNQLCDIWAVGIT 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 89.1 bits (221), Expect = 1e-19
 Identities = 70/257 (27%), Positives = 118/257 (45%), Gaps = 19/257 (7%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
           R IG GSY KV+L       + YA+K   K  ++       +  +  V+ E  + +    
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN------DDEDIDWVQTEKHVFETASN 54

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           HP +V L       +    + V+E+V G        +   + E  AR Y  +I   L +L
Sbjct: 55  HPFLVGLHSCFQTES--RLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFL 112

Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
           H   +++ D+K DN+L+   G +K+ D+ + +      D      GTP + APE   G  
Sbjct: 113 HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGED 172

Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDK---------IVNNSLVFPDAMNPE 353
           Y G + D WA+GV ++ M+ G+ PF    + D  D+         I+   +  P +++ +
Sbjct: 173 Y-GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 231

Query: 354 LRNLLEGLLCKDPTRRL 370
             ++L+G L KDP  RL
Sbjct: 232 ASSVLKGFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 19/267 (7%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +  + +IG GS+G+V     +   +  AIK         + +  +E  + D+++E+ ++ 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKI--------IDLEEAEDEIEDIQQEITVLS 57

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
               P I               ++++EY+ G    D   +PG + E+     LR+I+ GL
Sbjct: 58  QCDSPYITRYYGSY--LKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGL 114

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
            YLH    +H DIK  N+L++  G VK+ DF V+    D         GTP + APE   
Sbjct: 115 DYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK 174

Query: 300 GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPE----LR 355
              Y  K AD W++G+T   +  G+ P            I  NS   P  +  +     +
Sbjct: 175 QSAYDFK-ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS---PPTLEGQYSKPFK 230

Query: 356 NLLEGLLCKDPTRRLTLNDVAKHTWVL 382
             +E  L KDP  R T  ++ KH ++ 
Sbjct: 231 EFVEACLNKDPRFRPTAKELLKHKFIT 257

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 90.3 bits (224), Expect = 2e-19
 Identities = 52/159 (32%), Positives = 84/159 (52%), Gaps = 8/159 (5%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I E+V V+ I  G++GKV L R   + K YA+K   K+ +    +  +        R+ L
Sbjct: 3   IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM----INKNMVHQVQAERDAL 58

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
            +   + P IV+L   +   N  + Y+V+EY+ G          G   E MA KY+ ++ 
Sbjct: 59  ALS--KSPFIVHLYYSLQSAN--NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVA 114

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275
             L YLH H ++H D+KPDN+L++  G +K+ DF +S+V
Sbjct: 115 LALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 79/315 (25%), Positives = 134/315 (42%), Gaps = 64/315 (20%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSH-LSKLRVAPSETAMTDVRREVLIM 178
           +V ++ +G G++G+V L         YA+K   K   L++ +VA        V+ E  I+
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVA-------HVKAERDIL 55

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
               +  +V L     D   D+ Y V++Y+ G        +     E +AR Y+ ++   
Sbjct: 56  AEADNEWVVKLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLA 113

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV---------SQVFEDDNDVLRRS--- 286
           +  +H    +H DIKPDN+L+   G +K+ DF +         S+ ++  + + + S   
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173

Query: 287 -----------------------------------PGTPVFTAPECCLGLTYGGKAADTW 311
                                               GTP + APE  L   Y  +  D W
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWW 232

Query: 312 AVGVTLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFPD--AMNPELRNLLEGLLCKDPT 367
           +VGV L+ M++GQ PFL  T  +T  K++N  N+L  P    ++PE  +L+  L C    
Sbjct: 233 SVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEE 292

Query: 368 R--RLTLNDVAKHTW 380
           R  R   +D+  H +
Sbjct: 293 RLGRNGADDIKAHPF 307

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 88.2 bits (218), Expect = 2e-19
 Identities = 74/257 (28%), Positives = 119/257 (46%), Gaps = 19/257 (7%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
           R IG GSY KV+L R     + YA+K   K       +   +  +  V+ E  + +    
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKK------ELVNDDEDIDWVQTEKHVFEQASN 54

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           HP +V L            + V+EYV G        +   + E  AR Y  +I   L YL
Sbjct: 55  HPFLVGLHSCFQ--TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 112

Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
           H   +++ D+K DN+L+   G +K+ D+ + +      D      GTP + APE   G  
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 172

Query: 303 YGGKAADTWAVGVTLYYMIIGQYPF--LGET---LQDTYDK----IVNNSLVFPDAMNPE 353
           Y G + D WA+GV ++ M+ G+ PF  +G +    Q+T D     I+   +  P +++ +
Sbjct: 173 Y-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 231

Query: 354 LRNLLEGLLCKDPTRRL 370
             ++L+  L KDP  RL
Sbjct: 232 AASVLKSFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 87.8 bits (217), Expect = 2e-19
 Identities = 76/271 (28%), Positives = 115/271 (42%), Gaps = 24/271 (8%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +  +R+IG GS+G V   R     +  AIK    S         S     D+ +EV  ++
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG------KQSNEKWQDIIKEVKFLQ 80

Query: 180 MLQHPNIVNLIEVIDDPNSDHF-YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
            ++HPN    IE       +H  ++V+EY  G   +        + E          + G
Sbjct: 81  RIKHPNS---IEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 137

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L YLH HN++H DIK  N+L+   G VK+ DF  + +    N  +    GTP + APE  
Sbjct: 138 LAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV----GTPYWMAPEVI 193

Query: 299 LGL---TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPE-- 353
           L +    Y GK  D W++G+T   +   + P            I  N    P   + E  
Sbjct: 194 LAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--SPTLQSNEWS 250

Query: 354 --LRNLLEGLLCKDPTRRLTLNDVAKHTWVL 382
              RN ++  L K P  R T  ++ KH +VL
Sbjct: 251 DYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 87.7 bits (217), Expect = 2e-19
 Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 18/226 (7%)

Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
           G   +  Y+ + K+G G+Y  V   RS L     A+K        ++R+   E A     
Sbjct: 1   GFGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALK--------EIRLEHEEGAPCTAI 52

Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMA---- 228
           REV ++K L+H NIV L +++    S    +V EY+    D D        G  M+    
Sbjct: 53  REVSLLKDLKHANIVTLHDIVHTDKS--LTLVFEYL----DKDLKQYMDDCGNIMSMHNV 106

Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           + +L  I+ GL Y H   V+H D+KP NLL+   G +K+ DF +++              
Sbjct: 107 KIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV 166

Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQD 334
           T  +  P+  LG +      D W VG   + M  G+  F G T++D
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED 212

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 86.6 bits (214), Expect = 3e-19
 Identities = 81/277 (29%), Positives = 125/277 (45%), Gaps = 31/277 (11%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +  IG G+YGKV    +  +G   A+K             P      ++  E  I+K L 
Sbjct: 23  IETIGKGTYGKVFKVLNKKNGSKAAVKILD----------PIHDIDEEIEAEYNILKALS 72

Query: 183 -HPNIVNLIEVI---DDPNSDHFYMVLEYVEGKWDND---GFGQPGA-IGESMARKYLRD 234
            HPN+V    +    D  N D  ++VLE   G    D   GF + G  + E +    L +
Sbjct: 73  DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR--SPGTPVF 292
            + GL +LH +  +H D+K +N+L+   G VK+ DF VS      +  LRR  S GTP +
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFW 190

Query: 293 TAPE--CC---LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SL 344
            APE   C   L  TY  +  D W++G+T   +  G  P           KI  N   +L
Sbjct: 191 MAPEVIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTL 249

Query: 345 VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
             P+  + E  + +   L KD  +R T++D+ +H ++
Sbjct: 250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 86.2 bits (213), Expect = 4e-19
 Identities = 71/256 (27%), Positives = 114/256 (44%), Gaps = 21/256 (8%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           +KIG G + +V      LD K  A+K   K  + ++  A    A  D  +E+ ++K L H
Sbjct: 8   KKIGRGQFSEVYRATCLLDRKPVALK---KVQIFEMMDA---KARQDCVKEIDLLKQLNH 61

Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF----GQPGAIGESMARKYLRDIVSGL 239
           PN++  ++   + N     +VLE  +    +        Q   I E    KY   + S +
Sbjct: 62  PNVIKYLDSFIEDN--ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
            ++H   V+H DIKP N+ +  +G VK+GD  + + F           GTP + +PE   
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 300 GLTYGGKAADTWAVGVTLYYMIIGQYPFLGE--TLQDTYDKIVNNSLVFP----DAMNPE 353
              Y  K +D W++G  LY M   Q PF G+   L     KI      +P    +  + +
Sbjct: 180 ENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI--EQCDYPPLPTEHYSEK 236

Query: 354 LRNLLEGLLCKDPTRR 369
           LR L+   +  DP +R
Sbjct: 237 LRELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 86.8 bits (215), Expect = 4e-19
 Identities = 83/306 (27%), Positives = 128/306 (41%), Gaps = 62/306 (20%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +++Y  V KIG G+YG V   R  +  +  A+K   K  L +       TA+    RE+ 
Sbjct: 1   MDQYEKVEKIGEGTYGVVYKARDRVTNETIALK---KIRLEQEDEGVPSTAI----REIS 53

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDI 235
           ++K +QH NIV L +V+   +    Y+V EY++          P  A    + + YL  I
Sbjct: 54  LLKEMQHGNIVRLQDVVH--SEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQI 111

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT- 293
           + G+ Y H H V+H D+KP NLL+      +K+ DF +++ F           G PV T 
Sbjct: 112 LRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF-----------GIPVRTF 160

Query: 294 ----------APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-- 341
                     APE  LG  +     D W+VG     M+  +  F G++  D   KI    
Sbjct: 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRIL 220

Query: 342 -----------NSL-----VFPD-----------AMNPELRNLLEGLLCKDPTRRLTLND 374
                       SL      FP             + P   +LL  +L  DP++R+T   
Sbjct: 221 GTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARA 280

Query: 375 VAKHTW 380
             +H +
Sbjct: 281 ALEHEY 286

Length = 294

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 86.6 bits (214), Expect = 4e-19
 Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 14/224 (6%)

Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
           G   +  Y+ + K+G G+Y  V   RS L     A+K        ++R+   E A     
Sbjct: 1   GFGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALK--------EIRLEHEEGAPCTAI 52

Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDN--DGFGQPGAIGESMARK 230
           REV ++K L+H NIV L ++I    S    +V EY++       D  G   +I     + 
Sbjct: 53  REVSLLKDLKHANIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLDDCGN--SINMHNVKL 108

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
           +L  ++ GL Y H   V+H D+KP NLL+   G +K+ DF +++              T 
Sbjct: 109 FLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTL 168

Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQD 334
            +  P+  LG T      D W VG   Y M  G+  F G T+++
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 85.9 bits (213), Expect = 4e-19
 Identities = 68/261 (26%), Positives = 117/261 (44%), Gaps = 29/261 (11%)

Query: 119 EYVHVRKIGAGSYGKVV--LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           E+   RK+G+G +G+V   L+++ +     AIK      L K +         D ++EV 
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNRV---RVAIKILKSDDLLKQQ---------DFQKEVQ 54

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDI 235
            +K L+H ++++L  V      +  Y++ E +E K     F   P   G+ +    L D+
Sbjct: 55  ALKRLRHKHLISLFAVCS--VGEPVYIITELME-KGSLLAFLRSPE--GQVLPVASLIDM 109

Query: 236 VS----GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
                 G+ YL   N +H D+   N+LV      K+ DF ++++ ++D   L      P 
Sbjct: 110 ACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPY 168

Query: 292 -FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPD 348
            +TAPE     T+  K +D W+ G+ LY M   GQ P+ G    + YD+I     +  P 
Sbjct: 169 KWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPA 227

Query: 349 AMNPELRNLLEGLLCKDPTRR 369
               E+  ++      +P  R
Sbjct: 228 KCPQEIYKIMLECWAAEPEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 87.0 bits (215), Expect = 5e-19
 Identities = 74/273 (27%), Positives = 125/273 (45%), Gaps = 27/273 (9%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ- 182
           R IG GSY KV+L R   + + YA+K   K       +   +  +  V+ E  + +    
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKK------ELVHDDEDIDWVQTEKHVFEQASS 54

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           +P +V L        +   ++V+EYV G        +   + E  AR Y  +I   L +L
Sbjct: 55  NPFLVGLHSCFQ--TTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFL 112

Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
           H   +++ D+K DN+L+   G +K+ D+ + +      D      GTP + APE   G  
Sbjct: 113 HERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE 172

Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDK---------IVNNSLVFPDAMNPE 353
           Y G + D WA+GV ++ M+ G+ PF  + + D  D          I+   +  P  ++ +
Sbjct: 173 Y-GFSVDWWALGVLMFEMMAGRSPF--DIITDNPDMNTEDYLFQVILEKPIRIPRFLSVK 229

Query: 354 LRNLLEGLLCKDPTRRL------TLNDVAKHTW 380
             ++L+G L KDP  RL        +D+  HT+
Sbjct: 230 ASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTF 262

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 85.8 bits (212), Expect = 8e-19
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 29/213 (13%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R +G G +GKV L R   +G +   +   KS    L+       + D+++E+ I++ L 
Sbjct: 9   IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS----LKPESGGNHIADLKKEIEILRNLY 64

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR-----------KY 231
           H NIV    +  +   +   +++E++            G++ E + R           KY
Sbjct: 65  HENIVKYKGICTEDGGNGIKLIMEFLPS----------GSLKEYLPRNKNKINLKQQLKY 114

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGT 289
              I  G+ YL     VH D+   N+LV     VKIGDF +++  E D +   ++    +
Sbjct: 115 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDS 174

Query: 290 PVF-TAPECCLGLTYGGKAADTWAVGVTLYYMI 321
           PVF  APEC +   +   A+D W+ GVTLY ++
Sbjct: 175 PVFWYAPECLIQSKF-YIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 85.5 bits (212), Expect = 9e-19
 Identities = 71/228 (31%), Positives = 106/228 (46%), Gaps = 25/228 (10%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y  + K+G GSY  V   RS L G+  A+K        ++R+   E A     RE  ++K
Sbjct: 7   YKKLDKLGEGSYATVYKGRSKLTGQLVALK--------EIRLEHEEGAPFTAIREASLLK 58

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
            L+H NIV L ++I    +     V EY++           G +     R +L  ++ GL
Sbjct: 59  DLKHANIVTLHDIIHTKKTLTL--VFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF------SV-SQVFEDDNDVLRRSPGTPVF 292
            Y H   V+H D+KP NLL++  G +K+ DF      SV S+ +   N+V+     T  +
Sbjct: 117 AYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS--NEVV-----TLWY 169

Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKI 339
             P+  LG T    + D W VG   Y M  G+  F G T ++D   KI
Sbjct: 170 RPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI 217

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 79/266 (29%), Positives = 113/266 (42%), Gaps = 35/266 (13%)

Query: 126 IGAGSYGKVVLYRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           IG G +G+V   R  L GK     AIK         L+   S+    D   E  IM    
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKT--------LKAGSSDKQRLDFLTEASIMGQFD 63

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWD-----NDGFGQPGAIGESMARKYLRDIV 236
           HPNI+ L  V+    S    ++ EY+E G  D     NDG    G +        LR I 
Sbjct: 64  HPNIIRLEGVVT--KSRPVMIITEYMENGSLDKFLRENDGKFTVGQL-----VGMLRGIA 116

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TPV-FTA 294
           SG+ YL   N VH D+   N+LV  +   K+ DF +S+  ED         G  P+ +TA
Sbjct: 117 SGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTA 176

Query: 295 PECCLGLTYG--GKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
           PE    + Y     A+D W+ G+ ++  M  G+ P+   + QD    +  +    P  M+
Sbjct: 177 PE---AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-EDGYRLPPPMD 232

Query: 352 -PE-LRNLLEGLLCKDPTRRLTLNDV 375
            P  L  L+     KD   R T + +
Sbjct: 233 CPSALYQLMLDCWQKDRNERPTFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 73/268 (27%), Positives = 115/268 (42%), Gaps = 20/268 (7%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +  +R+IG GS+G V   R   + +  AIK    S         S     D+ +EV  ++
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG------KQSNEKWQDIIKEVRFLQ 70

Query: 180 MLQHPNIVNLIEVIDDPNSDHF-YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
            L+HPN    I+       +H  ++V+EY  G   +        + E          + G
Sbjct: 71  KLRHPNT---IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L YLH HN++H D+K  N+L++  G VK+GDF  + +    N  +    GTP + APE  
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV----GTPYWMAPEVI 183

Query: 299 LGL---TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFPDAMNPE 353
           L +    Y GK  D W++G+T   +   + P            I  N    +     +  
Sbjct: 184 LAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242

Query: 354 LRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            RN ++  L K P  R T   + KH +V
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFV 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 73/301 (24%), Positives = 125/301 (41%), Gaps = 71/301 (23%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR--REV 175
           + Y ++  +G+G+YG+V     +  G+  AIK        KL   P ++A+   R  RE+
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK--------KLS-RPFQSAIHAKRTYREL 65

Query: 176 LIMKMLQHPNIVNLIEVI--DDPNSD--HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
            ++K + H N++ L++V        D    Y+V   +      D       +   +  + 
Sbjct: 66  RLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM----GAD-------LNNIVKCQK 114

Query: 232 LRD---------IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
           L D         I+ GL Y+H   ++H D+KP N+ V     +KI DF +++  +D+   
Sbjct: 115 LSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--- 171

Query: 283 LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN- 341
           +     T  + APE  L   +  +  D W+VG  +  ++ G+  F G    D   +I+N 
Sbjct: 172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNL 231

Query: 342 ---------------------NSL----------VFPDAMNPELRNLLEGLLCKDPTRRL 370
                                 SL          VF    NP   +LLE +L  DP +R+
Sbjct: 232 VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFS-GANPLAIDLLEKMLVLDPDKRI 290

Query: 371 T 371
           T
Sbjct: 291 T 291

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 78/283 (27%), Positives = 122/283 (43%), Gaps = 38/283 (13%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +  +R+IG GS+G V   R     +  AIK    S         S     D+ +EV  ++
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ------SNEKWQDIIKEVRFLQ 70

Query: 180 MLQHPNIVNLIEVIDDPNSDHF-YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI--- 235
            L+HPN    IE       +H  ++V+EY          G    I E + +K L+++   
Sbjct: 71  QLRHPNT---IEYKGCYLREHTAWLVMEYC--------LGSASDILE-VHKKPLQEVEIA 118

Query: 236 ------VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
                 + GL YLH H  +H DIK  N+L+   GTVK+ DF  + +    N  +    GT
Sbjct: 119 AICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV----GT 174

Query: 290 PVFTAPECCLGL---TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--L 344
           P + APE  L +    Y GK  D W++G+T   +   + P            I  N    
Sbjct: 175 PYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT 233

Query: 345 VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
           +  +  +   RN ++  L K P  R +  ++ KH +VL +  P
Sbjct: 234 LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPP 276

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 75/302 (24%), Positives = 135/302 (44%), Gaps = 60/302 (19%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR---EVL 176
           YV ++ IG G+YG V   ++S   +  AIK    +  ++           D +R   E+ 
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR----------IDAKRTLREIK 56

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQ----PGAIGESMAR 229
           +++ L H N++ + +++  P+ + F   Y+V E +    D D   Q       + +   +
Sbjct: 57  LLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM----DTD-LHQIIRSSQTLSDDHCQ 111

Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
            +L  ++ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++   +  D +     T
Sbjct: 112 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVT 171

Query: 290 PVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF----------------LGETLQ 333
             + APE  L  +    A D W+VG  ++  ++G+ P                 LG   +
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGC-IFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230

Query: 334 DTYDKIVNN-----------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVA 376
           +    I N                  + +FP A NP   +LLE +L  DP++R+T+ +  
Sbjct: 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHA-NPLAIDLLEKMLVFDPSKRITVEEAL 289

Query: 377 KH 378
            H
Sbjct: 290 AH 291

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 86.8 bits (215), Expect = 2e-18
 Identities = 77/297 (25%), Positives = 134/297 (45%), Gaps = 36/297 (12%)

Query: 91  GLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKA 150
           G +CR FP          ++    +   +Y   R +G+G+ G V+  +   DG+ +A+K 
Sbjct: 10  GRVCRTFP-----DTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKV 64

Query: 151 FHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE--VIDDPNSDH----FYMV 204
                +S       E      + EV  +      +IV   E     DP +        +V
Sbjct: 65  VDMEGMS-------EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALV 117

Query: 205 LEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL---------HGHNVVHGDIKPD 255
           L+Y      N G  +      +   +  R+  +GL+++         H  +++H DIK  
Sbjct: 118 LDYA-----NAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSA 172

Query: 256 NLLVAPSGTVKIGDFSVSQVFED--DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAV 313
           N+L+  +G VK+GDF  S+++     +DV R   GTP + APE      Y  K AD +++
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSL 231

Query: 314 GVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFPDAMNPELRNLLEGLLCKDPTRR 369
           GV LY ++  + PF GE +++   K +       P +++PE++ ++  LL  DP RR
Sbjct: 232 GVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRR 288

Length = 496

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 72/254 (28%), Positives = 118/254 (46%), Gaps = 18/254 (7%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G+V   +    GK YA K   K  + K +    E+   +   E  I++ +  
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRK---GESMALN---EKQILEKVNS 59

Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEG---KWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
             +VNL    +    D   +VL  + G   K+     G PG   E  A  Y  +I+ GL 
Sbjct: 60  QFVVNLAYAYE--TKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLE 116

Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
            LH  N V+ D+KP+N+L+   G ++I D  ++ V   + + +R   GT  + APE    
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRVGTVGYMAPEVLNN 175

Query: 301 LTYGGKAADTWAVGVTLYYMIIGQYPFLGE----TLQDTYDKIVNNSLVFPDAMNPELRN 356
             Y   + D W +G  +Y MI GQ PF G       ++   +++    V+    + E ++
Sbjct: 176 QRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKS 234

Query: 357 LLEGLLCKDPTRRL 370
           + + LL KDP +RL
Sbjct: 235 ICKMLLTKDPKQRL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 83.6 bits (207), Expect = 3e-18
 Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 25/221 (11%)

Query: 124 RKIGAGSYGKVV--LYRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +++G G++G VV  +Y     GK    A+K   + H++  +         +  RE  +M 
Sbjct: 1   KELGHGNFGSVVKGVYLMK-SGKEVEVAVKTLKQEHIAAGK--------KEFLREASVMA 51

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
            L HP IV LI V          +V+E            +   I  S  ++    +  G+
Sbjct: 52  QLDHPCIVRLIGVCKGEP---LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGM 108

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PV-FTAPE 296
            YL   + VH D+   N+L+      KI DF +S+     +D  R +     P+ + APE
Sbjct: 109 AYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE 168

Query: 297 CCLGLTYG--GKAADTWAVGVTLYYMI-IGQYPFLGETLQD 334
           C   + YG     +D W+ GVTL+     G  P+      +
Sbjct: 169 C---INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE 206

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 85.1 bits (210), Expect = 3e-18
 Identities = 72/268 (26%), Positives = 120/268 (44%), Gaps = 48/268 (17%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSH-LSKLRVAPSETAMTDVRREVL 176
           +++  ++ IG G++G+V L +    G  YA+K   K+  L K +VA        +R E  
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVA-------HIRAERD 53

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           I+       +V +     D  +   Y+++E++ G        +   + E   + Y+ + V
Sbjct: 54  ILVEADGAWVVKMFYSFQDKRN--LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV 111

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV------------------------ 272
             +  +H    +H DIKPDNLL+   G VK+ DF +                        
Sbjct: 112 LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171

Query: 273 ----------SQVFEDDNDVLRRSP-GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMI 321
                     ++ ++ +   L  S  GTP + APE  +   Y  K  D W++GV +Y M+
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEML 230

Query: 322 IGQYPFLGETLQDTYDKIVN--NSLVFP 347
           IG  PF  ET Q+TY K++N   +LVFP
Sbjct: 231 IGYPPFCSETPQETYRKVMNWKETLVFP 258

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 83.1 bits (206), Expect = 5e-18
 Identities = 71/264 (26%), Positives = 116/264 (43%), Gaps = 39/264 (14%)

Query: 123 VRKIGAGSYGKV--VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
            RK+GAG +G+V    +  +      A+K      +S               +E  IMK 
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTK---VAVKTLKPGTMSP----------EAFLQEAQIMKK 57

Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQ----PGAIGESMARKYL 232
           L+H  +V L  V  +   +  Y+V EY+       +   G G+    P  +   MA +  
Sbjct: 58  LRHDKLVQLYAVCSE--EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD--MAAQ-- 111

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV- 291
             I  G+ YL   N +H D+   N+LV  +   KI DF ++++ EDD    R     P+ 
Sbjct: 112 --IAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK 169

Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDA 349
           +TAPE      +  K +D W+ G+ L  ++  G+ P+ G T ++  +++     +  P  
Sbjct: 170 WTAPEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPN 228

Query: 350 MNPELRNLLEGLLC--KDPTRRLT 371
              EL +L+  L C  KDP  R T
Sbjct: 229 CPEELYDLM--LQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 82.9 bits (205), Expect = 5e-18
 Identities = 61/231 (26%), Positives = 104/231 (45%), Gaps = 12/231 (5%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHY-AIKA--FHKSHLSKLRVAPSETAMTDVRREV 175
           EY  +  +G+G++G V   R   +G++  A+K    H     K +    ++    V    
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
           +I + L+HPNIV   +   +  +D  Y+V++ +EG    + F       +    + + +I
Sbjct: 61  IIKEQLRHPNIVRYYKTFLE--NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118

Query: 236 VSGLM----YLHGHN-VVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
              ++    YLH    +VH D+ P+N+++     V I DF +++  +     L    GT 
Sbjct: 119 FVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ-KQPESKLTSVVGTI 177

Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN 341
           +++ PE      YG KA D WA G  LY M   Q PF    +     KIV 
Sbjct: 178 LYSCPEIVKNEPYGEKA-DVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE 227

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 84.0 bits (208), Expect = 6e-18
 Identities = 77/314 (24%), Positives = 125/314 (39%), Gaps = 58/314 (18%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFH----KSHLSKLRVAPSETAMT-DVRREVLIMKM 180
           +G G+YGKV     +L GK  AIK        + ++K R       +     RE+ IM  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEG---KWDNDGFGQPGAIGESMARKYLRDIVS 237
           ++H NI+ L++V      D   +V++ +     K  +        + ES  +  L  I++
Sbjct: 77  IKHENIMGLVDVY--VEGDFINLVMDIMASDLKKVVDRKI----RLTESQVKCILLQILN 130

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF----------EDDNDVLRRSP 287
           GL  LH    +H D+ P N+ +   G  KI DF +++ +          +D+    R   
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190

Query: 288 GTPVFT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-- 341
            + V T    APE  +G      A D W+VG     ++ G+  F GE   D   +I    
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELL 250

Query: 342 ---NSLVFPDAMNPELR-----------------------NLLEGLLCKDPTRRLTLNDV 375
              N   +P A    L                        +LL+ LL  +P  R++  + 
Sbjct: 251 GTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA 310

Query: 376 AKHTWVLGDNGPIP 389
            KH +   D  P+P
Sbjct: 311 LKHEYFKSD--PLP 322

Length = 335

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 82.6 bits (205), Expect = 8e-18
 Identities = 61/270 (22%), Positives = 114/270 (42%), Gaps = 50/270 (18%)

Query: 129 GSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIV 187
           G +GKV + +     K +  K     + + +              E ++ ++++ +PN +
Sbjct: 27  GKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------------EPMVHQLMKDNPNFI 72

Query: 188 NLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG---QPGAIGESMARKYLRDIVSGLMYLHG 244
            L   +         ++++Y++   D D F    + G + E+  +K +R +V  L  LH 
Sbjct: 73  KLYYSVTTLK--GHVLIMDYIK---DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127

Query: 245 HNVVHGDIKPDNLL---------VAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           HN++H DIK +N+L         +   G  KI    +      D        GT  + +P
Sbjct: 128 HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI----IGTPSCYD--------GTLDYFSP 175

Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF---LGETLQ-DTYDKIVNNSLVFPDAMN 351
           E   G  Y   + D WAVGV  Y ++ G++PF     E L  ++  K     L F   ++
Sbjct: 176 EKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVS 234

Query: 352 PELRNLLEGLLCKDPTRRL-TLNDVAKHTW 380
               + ++ +L  +   RL   N++ KH +
Sbjct: 235 KNANDFVQSMLKYNINYRLTNYNEIIKHPF 264

Length = 267

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 82.8 bits (205), Expect = 9e-18
 Identities = 72/280 (25%), Positives = 122/280 (43%), Gaps = 30/280 (10%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS--KLRVAPSETAMTDVRRE 174
           +N+  ++ +IG+G+ G+V   R    G   A+K   ++       R+      + D+   
Sbjct: 14  LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRI------LMDLD-- 65

Query: 175 VLIMKMLQHPNIVN----LIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARK 230
            +++K    P IV      I      +SD F + +E +    D       G I E +  K
Sbjct: 66  -VVLKSHDCPYIVKCYGYFIT-----DSDVF-ICMELMSTCLDKLLKRIQGPIPEDILGK 118

Query: 231 YLRDIVSGLMYL-HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
               IV  L YL   H V+H D+KP N+L+  SG VK+ DF +S     D+    RS G 
Sbjct: 119 MTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG-RLVDSKAKTRSAGC 177

Query: 290 PVFTAPECCLGLTYGGK---AADTWAVGVTLYYMIIGQYPFLG-ETLQDTYDKIVNNSL- 344
             + APE         K    AD W++G++L  +  GQ+P+   +T  +   KI+     
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237

Query: 345 VFPDAMN--PELRNLLEGLLCKDPTRRLTLNDVAKHTWVL 382
             P      P+  + ++  L KD  +R    ++ +H ++ 
Sbjct: 238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 85.2 bits (211), Expect = 1e-17
 Identities = 67/268 (25%), Positives = 109/268 (40%), Gaps = 47/268 (17%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR--RE 174
           +  Y  +R IG G  G+V L         Y      +  L K+R   SE  +   R  RE
Sbjct: 1   MQRYDIIRLIGKGGMGEVYL--------AYDPVCSRRVALKKIREDLSENPLLKKRFLRE 52

Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK---------WDNDGFGQPGAIGE 225
             I   L HP IV +  +  D   D  Y  + Y+EG          W  +   +  A   
Sbjct: 53  AKIAADLIHPGIVPVYSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKT 110

Query: 226 SMARKYLR---DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
           S+   +L     I + + Y+H   V+H D+KPDN+L+   G V I D+  +   + + + 
Sbjct: 111 SVG-AFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEED 169

Query: 283 LR------------------RSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQ 324
           L                   +  GTP + APE  LG     ++ D +A+GV LY M+   
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLS 228

Query: 325 YPFLGETLQDTYDKIVNNSLVFPDAMNP 352
           +P+  +  +    +   + ++ P  + P
Sbjct: 229 FPYRRKKGRKISYR---DVILSPIEVAP 253

Length = 932

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 71/225 (31%), Positives = 103/225 (45%), Gaps = 31/225 (13%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKH---YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
           + IGAG +G+V   R  L GK     AIK         L+   +E    D   E  IM  
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKT--------LKAGYTEKQRRDFLSEASIMGQ 61

Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWD-----NDG-FGQPGAIGESMARKYLR 233
             HPNI++L  V+    S    +V EY+E G  D     +DG F     +G       LR
Sbjct: 62  FDHPNIIHLEGVVT--KSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVG------MLR 113

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-- 291
            I SG+ YL     VH D+   N+LV  +   K+ DF +S+V EDD +    + G  +  
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 173

Query: 292 -FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQD 334
            +TAPE  +       A+D W+ G+ ++  M  G+ P+   + QD
Sbjct: 174 RWTAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD 217

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 72/267 (26%), Positives = 120/267 (44%), Gaps = 48/267 (17%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSH-LSKLRVAPSETAMTDVRREVLI 177
           ++  ++ IG G++G+V L +    G  YA+K   K+  L K +V         +R E  I
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG-------HIRAERDI 54

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +       +V +     D    + Y+++E++ G        +   + E   + Y+ + V 
Sbjct: 55  LVEADSLWVVKMFYSFQD--KLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVL 112

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV---------SQVFEDDNDVL----- 283
            +  +H    +H DIKPDNLL+   G VK+ DF +         ++ + + N  L     
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172

Query: 284 ----------------RR-----SPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII 322
                           RR     + GTP + APE  +   Y  K  D W++GV +Y M+I
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLI 231

Query: 323 GQYPFLGETLQDTYDKIVN--NSLVFP 347
           G  PF  ET Q+TY K++N   +L+FP
Sbjct: 232 GYPPFCSETPQETYKKVMNWKETLIFP 258

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 81.3 bits (200), Expect = 2e-17
 Identities = 64/264 (24%), Positives = 116/264 (43%), Gaps = 13/264 (4%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +  + +IG GS+G+V      +D +   + A     L +     +E  + D+++E+ ++ 
Sbjct: 6   FTKLERIGKGSFGEVF---KGIDNRTQQVVAIKIIDLEE-----AEDEIEDIQQEITVLS 57

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
               P +               ++++EY+ G    D   + G   E      L++I+ GL
Sbjct: 58  QCDSPYVTKYYGSY--LKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGL 114

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
            YLH    +H DIK  N+L++  G VK+ DF V+    D         GTP + APE   
Sbjct: 115 DYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ 174

Query: 300 GLTYGGKAADTWAVGVTLYYMIIGQYPFLG-ETLQDTYDKIVNNSLVFPDAMNPELRNLL 358
              Y  K AD W++G+T   +  G+ P      ++  +    NN        +   +  +
Sbjct: 175 QSAYDSK-ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFI 233

Query: 359 EGLLCKDPTRRLTLNDVAKHTWVL 382
           +  L KDP+ R T  ++ KH +++
Sbjct: 234 DACLNKDPSFRPTAKELLKHKFIV 257

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 81.0 bits (200), Expect = 3e-17
 Identities = 66/247 (26%), Positives = 105/247 (42%), Gaps = 53/247 (21%)

Query: 126 IGAGSYGKVVLYRSSLDGKHY-------AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +G G++GKV  Y+  L G +        AIK   ++   K++         + R+E  +M
Sbjct: 13  LGEGAFGKV--YKGELTGPNERLSATSVAIKTLKENAEPKVQ--------QEFRQEAELM 62

Query: 179 KMLQHPNIVNLIEVI--DDPNSDHFYMVLEY------------------VEGKWDNDGFG 218
             LQHPNIV L+ V   + P      M+ EY                  V  +  ++   
Sbjct: 63  SDLQHPNIVCLLGVCTKEQPTC----MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118

Query: 219 QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFE 277
                 + +       I +G+ YL  H+ VH D+   N LV    TVKI DF +S+ ++ 
Sbjct: 119 SSLDCSDFLHIAI--QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176

Query: 278 DD-NDVLRRSPGTPV-FTAPECCLGLTYGGKAADT--WAVGVTLYYMI-IGQYPFLGETL 332
            D   V  +S   PV +  PE  L   YG    ++  W+ GV L+ +   G  P+ G + 
Sbjct: 177 ADYYRVQSKSL-LPVRWMPPEAIL---YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232

Query: 333 QDTYDKI 339
           Q+  + I
Sbjct: 233 QEVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 81.9 bits (202), Expect = 3e-17
 Identities = 80/314 (25%), Positives = 134/314 (42%), Gaps = 56/314 (17%)

Query: 107 RSEDENGT--KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPS 164
             E+ N T  ++   Y  ++++G+G+YG V        G+  AIK          R   S
Sbjct: 2   YREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS-------RPFQS 54

Query: 165 ETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH----FYMVLEYVEGKWDNDGFGQP 220
           E       RE+ ++K +QH N++ L++V     S      FY+V+ Y++        G P
Sbjct: 55  EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI-MGHP 113

Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV--FED 278
             + E   +  +  ++ GL Y+H   ++H D+KP NL V     +KI DF +++    E 
Sbjct: 114 --LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM 171

Query: 279 DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG--------- 329
              V+ R      + APE  L   +  +  D W+VG  +  M+ G+  F G         
Sbjct: 172 TGYVVTRW-----YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ 226

Query: 330 ----------ETLQDTYDKIVNN-------------SLVFPDAMNPELRNLLEGLLCKDP 366
                     E +Q   DK   +             S +FP A +P+  +LLE +L  D 
Sbjct: 227 ILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKA-SPQAVDLLEKMLELDV 285

Query: 367 TRRLTLNDVAKHTW 380
            +RLT  +  +H +
Sbjct: 286 DKRLTATEALEHPY 299

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 82.0 bits (202), Expect = 4e-17
 Identities = 73/316 (23%), Positives = 135/316 (42%), Gaps = 66/316 (20%)

Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYREL 74

Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI+ L+ V     S       Y+V+E ++         Q     E M+   
Sbjct: 75  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ--VIQMELDHERMSY-L 131

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV----FEDDNDVLRRSP 287
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     F     V+ R  
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR-- 189

Query: 288 GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN----- 342
               + APE  LG+ Y  +  D W+VG  +  MI G   F G    D ++K++       
Sbjct: 190 ---YYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245

Query: 343 --------------------------SLVFPDAMNP-----------ELRNLLEGLLCKD 365
                                       +FPD + P           + R+LL  +L  D
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305

Query: 366 PTRRLTLNDVAKHTWV 381
            ++R+++++  +H ++
Sbjct: 306 ASKRISVDEALQHPYI 321

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 79.8 bits (197), Expect = 5e-17
 Identities = 73/265 (27%), Positives = 109/265 (41%), Gaps = 45/265 (16%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDV---RREVL---- 176
            KIG G++G V  Y+  L G                 VA      T     +R+ L    
Sbjct: 1   EKIGKGNFGDV--YKGVLKGN--------------TEVAVKTCRSTLPPDLKRKFLQEAE 44

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL---- 232
           I+K   HPNIV LI V         Y+V+E V G        +       +  K L    
Sbjct: 45  ILKQYDHPNIVKLIGVCVQ--KQPIYIVMELVPGGSLLTFLRKKKN---RLTVKKLLQMS 99

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--- 289
            D  +G+ YL   N +H D+   N LV  +  +KI DF +S+  E++  +   S G    
Sbjct: 100 LDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQI 157

Query: 290 PV-FTAPECCLGLTYG--GKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN-SL 344
           P+ +TAPE    L YG     +D W+ G+ L+    +G  P+ G + Q T ++I +   +
Sbjct: 158 PIKWTAPE---ALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM 214

Query: 345 VFPDAMNPELRNLLEGLLCKDPTRR 369
             P     E+  L+      DP  R
Sbjct: 215 PAPQLCPEEIYRLMLQCWAYDPENR 239

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 79.8 bits (197), Expect = 6e-17
 Identities = 69/264 (26%), Positives = 117/264 (44%), Gaps = 39/264 (14%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           +RK+GAG +G+V  +    +     A+K           + P      D   E  IMK L
Sbjct: 11  LRKLGAGQFGEV--WEGLWNNTTPVAVKT----------LKPGTMDPKDFLAEAQIMKKL 58

Query: 182 QHPNIVNLIEV--IDDPNSDHFYMV---------LEYVEGKWDNDGFGQPGAIGESMARK 230
           +HP ++ L  V  +++P     Y+V         LEY++G         P  I   MA +
Sbjct: 59  RHPKLIQLYAVCTLEEP----IYIVTELMKYGSLLEYLQGG-AGRALKLPQLID--MAAQ 111

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
               + SG+ YL   N +H D+   N+LV  +   K+ DF +++V ++D    R     P
Sbjct: 112 ----VASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP 167

Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFP 347
           + +TAPE  L   +  K +D W+ G+ L  ++  G+ P+ G T  +   ++     +  P
Sbjct: 168 IKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCP 226

Query: 348 DAMNPELRNLLEGLLCKDPTRRLT 371
                EL +++     +DP  R T
Sbjct: 227 PGCPKELYDIMLDCWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 80.1 bits (197), Expect = 7e-17
 Identities = 75/285 (26%), Positives = 128/285 (44%), Gaps = 24/285 (8%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           + ++G G++GKV  Y++    K   + A  K   +K     SE  + D   E+ I+    
Sbjct: 10  IGELGDGAFGKV--YKAQ--NKETGVLAAAKVIDTK-----SEEELEDYMVEIDILASCD 60

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEG-KWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
           HPNIV L++     N+   ++++E+  G   D         + E   R   +  +  L Y
Sbjct: 61  HPNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNY 118

Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCL 299
           LH + ++H D+K  N+L    G +K+ DF VS   ++   + RR    GTP + APE  +
Sbjct: 119 LHENKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVM 176

Query: 300 GLTYGGK----AADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDAMNP 352
             T   +     AD W++G+TL  M   + P           KI  +   +L  P   + 
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 236

Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWV-LGDNGPIPQYLCWCK 396
           E ++ L+  L K+   R T   + +H +V +  N PI + +   K
Sbjct: 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIRELIAEAK 281

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 80.5 bits (198), Expect = 8e-17
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 44/215 (20%)

Query: 125 KIGAGSYGKVVLYR--SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           K+G G+YG V   +     D K YA+K    + +S               RE+ +++ L+
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-----------MSACREIALLRELK 56

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGK-WDNDGF-------GQPGAIGESMARKYLRD 234
           HPN++ L +V    +    +++ +Y E   W    F        +P  +  SM +  L  
Sbjct: 57  HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
           I+ G+ YLH + V+H D+KP N+LV       G VKI D   +++F         SP  P
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN--------SPLKP 168

Query: 291 V-----------FTAPECCLGLTYGGKAADTWAVG 314
           +           + APE  LG  +  KA D WA+G
Sbjct: 169 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 79.4 bits (196), Expect = 9e-17
 Identities = 69/275 (25%), Positives = 111/275 (40%), Gaps = 49/275 (17%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVA----PSETAMTDVRR---EVL 176
           R IG G +G V          +  +  +      K+ VA     + T+ +   +   E  
Sbjct: 12  RCIGEGQFGDV----------YQGV--YMSPENEKIAVAVKTCKNCTSPSVREKFLQEAY 59

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR------- 229
           IM+   HP+IV LI VI +      ++V+E              G +   +         
Sbjct: 60  IMRQFDHPHIVKLIGVITENPV---WIVME----------LAPLGELRSYLQVNKYSLDL 106

Query: 230 ----KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR 285
                Y   + + L YL     VH DI   N+LV+    VK+GDF +S+  ED+    + 
Sbjct: 107 ASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE-SYYKA 165

Query: 286 SPGT-PV-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVN- 341
           S G  P+ + APE  +       A+D W  GV ++  +++G  PF G    D   +I N 
Sbjct: 166 SKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG 224

Query: 342 NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVA 376
             L  P    P L +L+      DP++R    ++ 
Sbjct: 225 ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELK 259

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 79.7 bits (196), Expect = 9e-17
 Identities = 72/254 (28%), Positives = 119/254 (46%), Gaps = 18/254 (7%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G+V   +    GK YA K   K  + K +    E+   +   E  I++ +  
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK---GESMALN---EKQILEKVNS 59

Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEG---KWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
             +V+L    +    D   +VL  + G   K+     G+ G   E  A  Y  +I  GL 
Sbjct: 60  RFVVSLAYAYE--TKDALCLVLTLMNGGDLKFHIYHMGEAG-FEEGRAVFYAAEICCGLE 116

Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
            LH   +V+ D+KP+N+L+   G ++I D  ++ V   +   ++   GT  + APE    
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVVKN 175

Query: 301 LTYGGKAADTWAVGVTLYYMIIGQYPFL---GETLQDTYDKIVNN-SLVFPDAMNPELRN 356
             Y   + D WA+G  LY MI GQ PF     +  ++  +++V      + +  +P+ R+
Sbjct: 176 ERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARS 234

Query: 357 LLEGLLCKDPTRRL 370
           L + LLCKDP  RL
Sbjct: 235 LCKMLLCKDPKERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 80.9 bits (200), Expect = 9e-17
 Identities = 58/196 (29%), Positives = 98/196 (50%), Gaps = 14/196 (7%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKL-RVAPSETAMTDVRREVLIMKMLQ 182
           R IG G++G V       DGK  A+K        K+  V  +  +   V RE+ ++   +
Sbjct: 6   RPIGYGAFGVVWSVTDPRDGKRVALK--------KMPNVFQNLVSCKRVFRELKMLCFFK 57

Query: 183 HPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
           H N+++ ++++  P+ D F   Y+V E ++          P  +     + +L  I+ GL
Sbjct: 58  HDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKI-IVSPQPLSSDHVKVFLYQILRGL 116

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE-DDNDVLRRSPGTPVFTAPECC 298
            YLH   ++H DIKP NLLV  +  +KI DF +++V E D++  + +   T  + APE  
Sbjct: 117 KYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176

Query: 299 LGLTYGGKAADTWAVG 314
           +G  +   A D W+VG
Sbjct: 177 MGSRHYTSAVDIWSVG 192

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 74/296 (25%), Positives = 129/296 (43%), Gaps = 47/296 (15%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y  ++++G+G+YG V    S+LD +  A  A  K +    R   SE       RE+ ++K
Sbjct: 17  YRDLKQVGSGAYGTVC---SALDRRTGAKVAIKKLY----RPFQSELFAKRAYRELRLLK 69

Query: 180 MLQHPNIVNLIEVID-DPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V   D + D F   Y+V+ ++    D     +   + E   +  +  +
Sbjct: 70  HMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGT--DLGKLMKHEKLSEDRIQFLVYQM 127

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H   ++H D+KP NL V     +KI DF +++  + D+++      T  + AP
Sbjct: 128 LKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYVV-TRWYRAP 184

Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN----------NSLV 345
           E  L   +  +  D W+VG  +  M+ G+  F G    D   +I+             L 
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244

Query: 346 FPDAMN-----PELR----------------NLLEGLLCKDPTRRLTLNDVAKHTW 380
             DA N     P  R                N+LE +L  D   R+T  +   H +
Sbjct: 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 79.1 bits (195), Expect = 1e-16
 Identities = 61/262 (23%), Positives = 111/262 (42%), Gaps = 30/262 (11%)

Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           K+G G YG+V            A+K   +  +           + +  +E  +MK ++HP
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----------EVEEFLKEAAVMKEIKHP 62

Query: 185 NIVNLIEVI--DDPNSDHFYMVLEY------VEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           N+V L+ V   + P    FY++ E+      ++   + +       +   MA +    I 
Sbjct: 63  NLVQLLGVCTREPP----FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ----IS 114

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAP 295
           S + YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ +TAP
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 174

Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPE 353
           E      +  K +D WA GV L+ +   G  P+ G  L   Y+ +     +  P+   P+
Sbjct: 175 ESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPK 233

Query: 354 LRNLLEGLLCKDPTRRLTLNDV 375
           +  L+      +P+ R +  ++
Sbjct: 234 VYELMRACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 64/258 (24%), Positives = 120/258 (46%), Gaps = 32/258 (12%)

Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y  ++ IG+G+ G V     ++ G + A+K          R   ++T      RE+
Sbjct: 19  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-------RPFQNQTHAKRAYREL 71

Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGK------WDNDGFGQPGAIGE 225
           +++K + H NI++L+ V     S       Y+V+E ++         + D         E
Sbjct: 72  VLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDH--------E 123

Query: 226 SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR 285
            M+   L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     N ++  
Sbjct: 124 RMSY-LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-ACTNFMMTP 181

Query: 286 SPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--- 342
              T  + APE  LG+ Y  +  D W+VG  +  ++ G   F G    D ++K++     
Sbjct: 182 YVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT 240

Query: 343 -SLVFPDAMNPELRNLLE 359
            S  F + + P +RN +E
Sbjct: 241 PSAEFMNRLQPTVRNYVE 258

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 66/259 (25%), Positives = 116/259 (44%), Gaps = 20/259 (7%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           + H R +G G +G+V   +    GK YA K   K  + K +    E    + +R   I++
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK---GEAMALNEKR---ILE 55

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG---KWDNDGFGQPGAIGESMARKYLRDIV 236
            +    +V+L    +    D   +VL  + G   K+     G PG   E  A  Y  ++ 
Sbjct: 56  KVNSRFVVSLAYAYE--TKDALCLVLTIMNGGDLKFHIYNMGNPG-FDEQRAIFYAAELC 112

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSPGTPVFTAP 295
            GL  L    +V+ D+KP+N+L+   G ++I D  ++ Q+ E   + +R   GT  + AP
Sbjct: 113 CGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE--GETVRGRVGTVGYMAP 170

Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYD----KIVNNSLVFPDAMN 351
           E      Y   + D W +G  +Y MI GQ PF     +   +    ++  +   + +  +
Sbjct: 171 EVINNEKY-TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFS 229

Query: 352 PELRNLLEGLLCKDPTRRL 370
            + +++   LL K+P  RL
Sbjct: 230 EDAKSICRMLLTKNPKERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 37/275 (13%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +  +GAG+ G V   +    G   A K  H    S +R          + RE+ IM   +
Sbjct: 10  ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR--------KQILRELQIMHECR 61

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG-FGQPGAIGESMARKYLRDIVSGLMY 241
            P IV+        N ++  M +E+++     D  + + G I   +  K    +V GL Y
Sbjct: 62  SPYIVSFYGAF--LNENNICMCMEFMD-CGSLDRIYKKGGPIPVEILGKIAVAVVEGLTY 118

Query: 242 LHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
           L+  H ++H DIKP N+LV   G +K+ DF VS   E  N +     GT  + +PE   G
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG--ELINSIADTFVGTSTYMSPERIQG 176

Query: 301 LTYGGKAADTWAVGVTLYYMIIGQYPF-LGETLQDTYD----------KIVNN------S 343
             Y  K +D W++G+++  + +G++PF       D  D          +IV        S
Sbjct: 177 GKYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235

Query: 344 LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
             FP     +LR+ ++  L KDPT R T   +   
Sbjct: 236 SDFP----EDLRDFVDACLLKDPTERPTPQQLCAM 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 70/312 (22%), Positives = 137/312 (43%), Gaps = 58/312 (18%)

Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYREL 67

Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI++L+ V     S       Y+V+E ++         Q     E M+   
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQ--VIQMELDHERMSY-L 124

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRY 183

Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  M+  +  F G    D ++K++           
Sbjct: 184 YRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242

Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD++ P           + R+LL  +L  DP +R
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302

Query: 370 LTLNDVAKHTWV 381
           +++++  +H ++
Sbjct: 303 ISVDEALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 65/219 (29%), Positives = 96/219 (43%), Gaps = 28/219 (12%)

Query: 123 VRKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLS-------KLRVAPSETAMTDVRRE 174
           V K+G G +G+V L  +  L        A + +  +        LR   S+ A  D  +E
Sbjct: 10  VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKE 69

Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQ---PGAIGESMARK 230
           V I+  L  PNI  L+ V          M++EY+E G  D + F Q       G +   K
Sbjct: 70  VKILSRLSDPNIARLLGVC--TVDPPLCMIMEYMENG--DLNQFLQKHVAETSGLACNSK 125

Query: 231 YLR---------DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDN 280
            L           I SG+ YL   N VH D+   N LV  + T+KI DF +S+ ++  D 
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185

Query: 281 DVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLY 318
             ++     P+ + A E  L   +  K +D WA GVTL+
Sbjct: 186 YRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLW 223

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 70/274 (25%), Positives = 112/274 (40%), Gaps = 20/274 (7%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +V + +IG GS+G V    +S   +  A+K    S         +     D+ +EV  ++
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSG------KQTNEKWQDIIKEVKFLQ 76

Query: 180 MLQHPNIVNLIEVIDDPNSDHF-YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
            L+HPN    IE       +H  ++V+EY  G   +        + E          + G
Sbjct: 77  QLKHPNT---IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 133

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L YLH HN++H DIK  N+L+   G VK+ DF  +      N  +    GTP + APE  
Sbjct: 134 LAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV----GTPYWMAPEVI 189

Query: 299 LGL---TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFPDAMNPE 353
           L +    Y GK  D W++G+T   +   + P            I  N    +  +     
Sbjct: 190 LAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDS 248

Query: 354 LRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
            R  ++  L K P  R    ++ +H +V  D   
Sbjct: 249 FRGFVDYCLQKIPQERPASAELLRHDFVRRDRPA 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 78.6 bits (194), Expect = 4e-16
 Identities = 86/329 (26%), Positives = 141/329 (42%), Gaps = 95/329 (28%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR--REV 175
             Y +++ IG+G+ G V     ++ G++ AIK      LS+    P +      R  RE+
Sbjct: 16  KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIK-----KLSR----PFQNVTHAKRAYREL 66

Query: 176 LIMKMLQHPNIVNLIEVID-DPNSDHF---YMVLEYVEG------KWDNDGFGQPGAIGE 225
           ++MK++ H NI+ L+ V     + + F   Y+V+E ++       + D D         E
Sbjct: 67  VLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH--------E 118

Query: 226 SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR 285
            M+   L  ++ G+ +LH   ++H D+KP N++V    T+KI DF            L R
Sbjct: 119 RMSY-LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LAR 166

Query: 286 SPG-----TP-VFT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDT 335
           + G     TP V T    APE  LG+ Y     D W+VG  +  MI G   F G    D 
Sbjct: 167 TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIRGTVLFPGTDHIDQ 225

Query: 336 YDKI------------------VNN-------------SLVFPDAMNP------------ 352
           ++KI                  V N               +FPD + P            
Sbjct: 226 WNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKAS 285

Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           + R+LL  +L  DP +R++++D  +H ++
Sbjct: 286 QARDLLSKMLVIDPEKRISVDDALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 76.6 bits (188), Expect = 8e-16
 Identities = 67/272 (24%), Positives = 124/272 (45%), Gaps = 22/272 (8%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           ++Y  ++++G+G+YG V   R+   G+  A+K         +++ P +   + +++E+ +
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKI--------IKLEPGDD-FSLIQQEIFM 59

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +K  +H NIV         + +  ++ +EY  G    D +   G + E       R+ + 
Sbjct: 60  VKECKHCNIVAYFGSY--LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ 117

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPEC 297
           GL YLH    +H DIK  N+L+  +G VK+ DF V+          +   GTP + APE 
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177

Query: 298 CLGLTYGG--KAADTWAVGVTLYYMIIGQYP-FLGETLQDTYDKIVNNSLVFPDAM---- 350
                 GG  +  D WAVG+T   +   Q P F    ++  +  +++ S   P  +    
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LMSKSNFQPPKLKDKT 235

Query: 351 --NPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             +    N ++  L K+P +R T   +  H +
Sbjct: 236 KWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 76.2 bits (187), Expect = 9e-16
 Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 28/221 (12%)

Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
           V+K+GAG +G+V +  Y +S      A+K           + P   ++     E  +MK 
Sbjct: 11  VKKLGAGQFGEVWMGYYNNS---TKVAVKT----------LKPGTMSVQAFLEEANLMKT 57

Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARK---YLRDIVS 237
           LQH  +V L  V+     +  Y++ EY+  K     F +    G+ +  K   +   I  
Sbjct: 58  LQHDKLVRLYAVVT--KEEPIYIITEYM-AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 114

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPE 296
           G+ Y+   N +H D++  N+LV+ S   KI DF +++V ED+    R     P+ +TAPE
Sbjct: 115 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 174

Query: 297 CCLGLTYGGKA--ADTWAVGVTLYYMII-GQYPFLGETLQD 334
               + +G     +D W+ G+ LY ++  G+ P+ G +  D
Sbjct: 175 ---AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 78.1 bits (192), Expect = 1e-15
 Identities = 46/140 (32%), Positives = 74/140 (52%), Gaps = 4/140 (2%)

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVF 292
           IV  L  +H   ++H D+K  N+ + P+G +K+GDF  S+ + D    DV     GTP +
Sbjct: 178 IVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYY 237

Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV-NNSLVFPDAMN 351
            APE      Y  K AD W++GV LY ++    PF G + ++   +++      FP  ++
Sbjct: 238 LAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVS 296

Query: 352 PELRNLLEGLLCKDPTRRLT 371
             ++ LL+ LL K+P  R T
Sbjct: 297 SGMKALLDPLLSKNPALRPT 316

Length = 478

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 66/251 (26%), Positives = 107/251 (42%), Gaps = 28/251 (11%)

Query: 126 IGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           IG G +G V+L  YR    G+  A+K   K            TA      E  +M  L+H
Sbjct: 14  IGKGEFGDVMLGDYR----GQKVAVKCL-KDDS---------TAAQAFLAEASVMTTLRH 59

Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMY 241
           PN+V L+ V+     +  Y+V EY+      D     G   I  +    +  D+  G+ Y
Sbjct: 60  PNLVQLLGVVLQ--GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117

Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECCLG 300
           L   N VH D+   N+LV+     K+ DF +++      D  +     PV +TAPE  L 
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK----LPVKWTAPE-ALR 172

Query: 301 LTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNLL 358
                  +D W+ G+ L+ +   G+ P+    L+D    +     +  P+   PE+  ++
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVM 232

Query: 359 EGLLCKDPTRR 369
           +     DP +R
Sbjct: 233 KDCWELDPAKR 243

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 44/215 (20%)

Query: 125 KIGAGSYGKV--VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           K+G G+YG V     +   D + YA+K    + +S               RE+ +++ L+
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----------MSACREIALLRELK 56

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGK-WDNDGF-------GQPGAIGESMARKYLRD 234
           HPN+++L +V         +++ +Y E   W    F        +P  +   M +  L  
Sbjct: 57  HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
           I+ G+ YLH + V+H D+KP N+LV       G VKI D   +++F         SP  P
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN--------SPLKP 168

Query: 291 V-----------FTAPECCLGLTYGGKAADTWAVG 314
           +           + APE  LG  +  KA D WA+G
Sbjct: 169 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 79/291 (27%), Positives = 127/291 (43%), Gaps = 39/291 (13%)

Query: 124 RKIGAGSYGKVVL-----YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           R++G G++GKV L        + D    A+KA            P+  A  D +RE  ++
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD---------PTLAARKDFQREAELL 61

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-------------GQP----G 221
             LQH +IV    V  D   D   MV EY++   D + F             GQP    G
Sbjct: 62  TNLQHEHIVKFYGVCGD--GDPLIMVFEYMK-HGDLNKFLRAHGPDAMILVDGQPRQAKG 118

Query: 222 AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDN 280
            +G S        I SG++YL   + VH D+   N LV  +  VKIGDF +S+ V+  D 
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178

Query: 281 DVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDK 338
             +      P+ +  PE  +   +  + +D W+ GV L+ +   G+ P+   +  +  + 
Sbjct: 179 YRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237

Query: 339 IVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI 388
           I     L  P     E+ +++ G   ++P +RL + ++ K    LG   PI
Sbjct: 238 ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPI 288

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 78/300 (26%), Positives = 125/300 (41%), Gaps = 78/300 (26%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHK--SHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           IG GSYG V     +  G+  AIK  +    H+S           T + RE+ ++++L+H
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSD---------ATRILREIKLLRLLRH 58

Query: 184 PNIVNLIEVIDDPNSDHF---YMVLEYVEG------KWDNDGFGQPGAIGESMARKYLRD 234
           P+IV +  ++  P+   F   Y+V E +E       K ++D       +     + +L  
Sbjct: 59  PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-------LTPEHHQFFLYQ 111

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT- 293
           ++  L Y+H  NV H D+KP N+L      +KI DF +++V  +D      +P    +T 
Sbjct: 112 LLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND------TPTAIFWTD 165

Query: 294 --------APECCLGLTYG--GKAADTWAVGVTLYYMIIGQ--YP-------------FL 328
                   APE C G  +     A D W++G     ++ G+  +P              L
Sbjct: 166 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL 224

Query: 329 GETLQDTYDKIVNN-----------------SLVFPDAMNPELRNLLEGLLCKDPTRRLT 371
           G    +T  ++ N                  S  FP+A +P    LLE LL  DP  R T
Sbjct: 225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNA-DPLALRLLERLLAFDPKDRPT 283

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 75/276 (27%), Positives = 116/276 (42%), Gaps = 29/276 (10%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML- 181
           +  IG G+YGKV    +  DG   A+K             P      ++  E  I++ L 
Sbjct: 27  IETIGKGTYGKVYKVTNKKDGSLAAVKILD----------PISDVDEEIEAEYNILQSLP 76

Query: 182 QHPNIVNLIEVI---DDPNSDHFYMVLEYVEGKWDND---GFGQPGA-IGESMARKYLRD 234
            HPN+V    +    D       ++VLE   G    +   G    G  + E+M    L  
Sbjct: 77  NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR--SPGTPVF 292
            + GL +LH + ++H D+K +N+L+   G VK+ DF VS         LRR  S GTP +
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFW 194

Query: 293 TAPE---CCLGLTYGGKA-ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLV 345
            APE   C     Y   A  D W++G+T   +  G  P        T  KI  N   +L+
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254

Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            P+       + +   L KD   R ++  + +H ++
Sbjct: 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 12/204 (5%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G +G+V   +    GK YA K   K  L K     S   M  + +E+L  + +  P 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK----KSGEKMALLEKEIL--EKVNSPF 54

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLMYLH 243
           IVNL    +  +  H  +V+  + G          G  G  M R   Y   I  G+++LH
Sbjct: 55  IVNLAYAFE--SKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH 112

Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTY 303
             ++V+ D+KP+N+L+   G  ++ D  ++   +D   + +R+ GT  + APE      Y
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA-GTNGYMAPEILKEEPY 171

Query: 304 GGKAADTWAVGVTLYYMIIGQYPF 327
                D +A+G ++Y M+ G+ PF
Sbjct: 172 -SYPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 69/244 (28%), Positives = 106/244 (43%), Gaps = 40/244 (16%)

Query: 126 IGAGSYGKVVLYRSSLD--GKH---YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
           IGAG +G+V  +R  L   G+     AIK     +  K R         D   E  IM  
Sbjct: 13  IGAGEFGEV--FRGILKMPGRKEVAVAIKTLKPGYTEKQRQ--------DFLSEASIMGQ 62

Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKW------DNDG-FGQPGAIGESMARKYLR 233
             H NI+ L  V+         ++ EY+E         D+DG F     +G       LR
Sbjct: 63  FSHHNIIRLEGVVT--KFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG------MLR 114

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-- 291
            I +G+ YL   N VH D+   N+LV  +   K+ DF +S+V EDD +    + G  +  
Sbjct: 115 GIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174

Query: 292 -FTAPECCLGLTYG--GKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVNNSLVFP 347
            +TAPE    + Y     A+D W+ G+ ++  M  G+ P+   +  +   K +N+    P
Sbjct: 175 RWTAPE---AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM-KAINDGFRLP 230

Query: 348 DAMN 351
             M+
Sbjct: 231 APMD 234

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 74.4 bits (183), Expect = 5e-15
 Identities = 72/278 (25%), Positives = 121/278 (43%), Gaps = 34/278 (12%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV---APSETAMTDVRREVLIMK 179
            R++G G++GKV L      G+ Y ++  +   L  ++      S  A  D  RE  ++ 
Sbjct: 10  KRELGEGAFGKVFL------GECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLT 63

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDN------------DGFGQP-GAIGE 225
             QH NIV    V  +   D   MV EY+E G  +                  P G +  
Sbjct: 64  NFQHENIVKFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121

Query: 226 SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLR 284
           S   +    I SG++YL   + VH D+   N LV     VKIGDF +S+ V+  D   + 
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVG 181

Query: 285 RSPGTPV-FTAPECCLGLTYG--GKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIV 340
                P+ +  PE  +   Y      +D W+ GV L+ +   G+ P+ G + ++  + I 
Sbjct: 182 GHTMLPIRWMPPESIM---YRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238

Query: 341 NNSLVF-PDAMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
              L+  P     E+ +++ G   +DP +R+ + D+ +
Sbjct: 239 QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 73.8 bits (181), Expect = 9e-15
 Identities = 45/181 (24%), Positives = 82/181 (45%), Gaps = 22/181 (12%)

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           +V GL YL    ++H D+KP N+LV   G VK+ DF VS      N + +   GT  + A
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMA 161

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG-----------ETLQDTYDKIVNNS 343
           PE   G  Y G  +D W++G++   + +G++P+             + LQ   D+   + 
Sbjct: 162 PERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE---DP 217

Query: 344 LVFPDAM-NPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL----GDNGPIPQYLCWCKRD 398
            V P    + +  + +   + K P  R    ++  H +++    G+   +  ++C    +
Sbjct: 218 PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEVVSMWVCRALEE 277

Query: 399 R 399
           R
Sbjct: 278 R 278

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 69/255 (27%), Positives = 113/255 (44%), Gaps = 26/255 (10%)

Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           +IG G++G+V   R   D    A+K+  ++    L+            +E  I+K   HP
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK--------AKFLQEARILKQYSHP 53

Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLMYL 242
           NIV LI V         Y+V+E V+G  D   F +       +    + + +  +G+ YL
Sbjct: 54  NIVRLIGVCTQKQP--IYIVMELVQGG-DFLTFLRTEGPRLKVKELIQMVENAAAGMEYL 110

Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG---TPV-FTAPECC 298
              + +H D+   N LV     +KI DF +S+  E+++ V   + G    PV +TAPE  
Sbjct: 111 ESKHCIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPE-- 166

Query: 299 LGLTYG--GKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN-SLVFPDAMNPEL 354
             L YG     +D W+ G+ L+    +G  P+   + Q T + I     L  P+     +
Sbjct: 167 -ALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAV 225

Query: 355 RNLLEGLLCKDPTRR 369
             L+E     DP +R
Sbjct: 226 YRLMERCWEYDPGQR 240

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 72/230 (31%), Positives = 105/230 (45%), Gaps = 33/230 (14%)

Query: 126 IGAGSYGKVVLYRSSLDGK---HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           IGAG +G+V   R  L GK     AIK         L+   +E    D   E  IM    
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKT--------LKSGYTEKQRRDFLSEASIMGQFD 63

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWD-----NDG-FGQPGAIGESMARKYLRDI 235
           HPNI++L  V+    S    ++ E++E G  D     NDG F     +G       LR I
Sbjct: 64  HPNIIHLEGVVT--KSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVG------MLRGI 115

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD--NDVLRRSPG--TPV 291
            +G+ YL   N VH D+   N+LV  +   K+ DF +S+  EDD  +     S G   P+
Sbjct: 116 AAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPI 175

Query: 292 -FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKI 339
            +TAPE  +       A+D W+ G+ ++  M  G+ P+   + QD  + I
Sbjct: 176 RWTAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 68/275 (24%), Positives = 117/275 (42%), Gaps = 36/275 (13%)

Query: 125 KIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           ++G G++GKV L          D    A+KA  ++         SE+A  D +RE  ++ 
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---------SESARQDFQREAELLT 62

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYV--------------EGKWDNDGFGQP-GAIG 224
           +LQH +IV    V  +       MV EY+              + K    G     G + 
Sbjct: 63  VLQHQHIVRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLT 120

Query: 225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVL 283
                     I SG++YL   + VH D+   N LV     VKIGDF +S+ ++  D   +
Sbjct: 121 LGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180

Query: 284 RRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVN 341
                 P+ +  PE  L   +  + +D W+ GV L+ +   G+ P+   +  +  + I  
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239

Query: 342 N-SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDV 375
              L  P    PE+  +++G   ++P +R+ + D+
Sbjct: 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 70.9 bits (174), Expect = 6e-14
 Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 24/202 (11%)

Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
           ++++G+G +G V L  +R  +D    AIK   +  +S+           D   E  +M  
Sbjct: 9   LKELGSGQFGVVHLGKWRGKID---VAIKMIREGAMSE----------DDFIEEAKVMMK 55

Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
           L HPN+V L  V         ++V EY+  G   N    + G +G         D+   +
Sbjct: 56  LSHPNLVQLYGVCTKQRP--IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAM 113

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PV-FTAPE 296
            YL  +  +H D+   N LV     VK+ DF +++   DD      S GT  PV +  PE
Sbjct: 114 EYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT--SSQGTKFPVKWAPPE 171

Query: 297 CCLGLTYGGKAADTWAVGVTLY 318
                 +  K +D W+ GV ++
Sbjct: 172 VFDYSRFSSK-SDVWSFGVLMW 192

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 70.8 bits (173), Expect = 6e-14
 Identities = 63/257 (24%), Positives = 109/257 (42%), Gaps = 28/257 (10%)

Query: 126 IGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           IG G +G V+L  YR    G   A+K       ++  +A           E  +M  L+H
Sbjct: 14  IGKGEFGDVMLGDYR----GNKVAVKCIKNDATAQAFLA-----------EASVMTQLRH 58

Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMY 241
            N+V L+ VI +      Y+V EY+      D     G   +G     K+  D+   + Y
Sbjct: 59  SNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117

Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECCLG 300
           L  +N VH D+   N+LV+     K+ DF +++      D  +     PV +TAPE    
Sbjct: 118 LEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALRE 173

Query: 301 LTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNLL 358
             +  K +D W+ G+ L+ +   G+ P+    L+D   ++     +  PD   P + +++
Sbjct: 174 KKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVM 232

Query: 359 EGLLCKDPTRRLTLNDV 375
           +     D   R +   +
Sbjct: 233 KQCWHLDAATRPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 74/281 (26%), Positives = 115/281 (40%), Gaps = 47/281 (16%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           + ++G G++GKV   ++   G   A K              SE  + D   E+ I+    
Sbjct: 17  IGELGDGAFGKVYKAKNKETGALAAAKVIETK---------SEEELEDYMVEIEILATCN 67

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGK-WDNDGFGQPGAIGESM-----------ARK 230
           HP IV L+                Y +GK W    F   GA+   M            + 
Sbjct: 68  HPYIVKLLGAF-------------YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 114

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--G 288
             R ++  L YLH   ++H D+K  N+L+   G +K+ DF VS   ++   + RR    G
Sbjct: 115 ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIG 172

Query: 289 TPVFTAPECCLGLT-----YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN- 342
           TP + APE  +  T     Y  K AD W++G+TL  M   + P           KI  + 
Sbjct: 173 TPYWMAPEVVMCETMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE 231

Query: 343 --SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
             +L  P   + E R+ L+  L K P  R +   + +H +V
Sbjct: 232 PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV 272

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 70/258 (27%), Positives = 117/258 (45%), Gaps = 28/258 (10%)

Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
           V+K+GAG +G+V +  Y         AIK+  +  +S     P          E  +MK 
Sbjct: 11  VKKLGAGQFGEVWMGYYNGH---TKVAIKSLKQGSMS-----PEA-----FLAEANLMKQ 57

Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD----IV 236
           LQHP +V L  V+     +  Y++ EY+E     D    P  I  ++ +  L D    I 
Sbjct: 58  LQHPRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPEGIKLTINK--LIDMAAQIA 112

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAP 295
            G+ ++   N +H D++  N+LV+ +   KI DF ++++ ED+    R     P+ +TAP
Sbjct: 113 EGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 172

Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPE 353
           E     T+  K +D W+ G+ L  ++  G+ P+ G T  +    +     +  PD    E
Sbjct: 173 EAINYGTFTIK-SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEE 231

Query: 354 LRNLLEGLLCKDPTRRLT 371
           L  L+     + P  R T
Sbjct: 232 LYELMRLCWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 17/206 (8%)

Query: 123 VRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +R +G G +GKV LY     +   G+  A+K         L+    +   +  ++E+ I+
Sbjct: 9   IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKT--------LKRECGQQNTSGWKKEINIL 60

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           K L H NIV       +       +++EYV      D +     +  +    + + I  G
Sbjct: 61  KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD-YLPKHKLNLAQLLLFAQQICEG 119

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPG-TPVF-TAP 295
           + YLH  + +H D+   N+L+     VKIGDF +++   + ++  R R  G +PVF  A 
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179

Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMI 321
           E CL       A+D W+ GVTLY ++
Sbjct: 180 E-CLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 67/281 (23%), Positives = 108/281 (38%), Gaps = 55/281 (19%)

Query: 126 IGAGSYGKVV--LYRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           +G+G++G V   ++    +      AIK         LR   S  A  ++  E  +M  +
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKV--------LREETSPKANKEILDEAYVMASV 66

Query: 182 QHPNIVNLIEVIDDPNSDHF----YM----VLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
            HP++V L+ +    +S        M    +L+YV    DN        IG      +  
Sbjct: 67  DHPHVVRLLGIC--LSSQVQLITQLMPLGCLLDYVRNHKDN--------IGSQYLLNWCV 116

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TPV- 291
            I  G+ YL    +VH D+   N+LV     VKI DF ++++ + D        G  P+ 
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176

Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVNNS-LVFPD- 348
           + A E  L   Y  K +D W+ GVT++  M  G  P+ G    +  D +     L  P  
Sbjct: 177 WMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPI 235

Query: 349 -----------------AMNPELRNLLEGL--LCKDPTRRL 370
                               P  + L+     + +DP R L
Sbjct: 236 CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQRYL 276

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 72/265 (27%), Positives = 119/265 (44%), Gaps = 44/265 (16%)

Query: 125 KIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           K+G G +G+V  +  + +G    AIK           + P   +     +E  +MK L+H
Sbjct: 13  KLGQGCFGEV--WMGTWNGTTRVAIKT----------LKPGTMSPEAFLQEAQVMKKLRH 60

Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGFGQPGAIGESMARKYLR--------- 233
             +V L  V+ +   +  Y+V EY+ +G   +   G+ G        KYLR         
Sbjct: 61  EKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGEMG--------KYLRLPQLVDMAA 109

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-F 292
            I SG+ Y+   N VH D++  N+LV  +   K+ DF ++++ ED+    R+    P+ +
Sbjct: 110 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 169

Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
           TAPE  L   +  K +D W+ G+ L  +   G+ P+ G   ++  D+ V      P    
Sbjct: 170 TAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMP--CP 225

Query: 352 PELRNLLEGLLC----KDPTRRLTL 372
           PE    L  L+C    K+P  R T 
Sbjct: 226 PECPESLHDLMCQCWRKEPEERPTF 250

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 63/204 (30%), Positives = 92/204 (45%), Gaps = 18/204 (8%)

Query: 123 VRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           ++++G G++G V L R        G+  A+K    S    LR         D  RE+ I+
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR---------DFEREIEIL 59

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA-IGESMARKYLRDIVS 237
           K LQH NIV    V       +  +V+EY+      D   +    +       Y   I  
Sbjct: 60  KSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICK 119

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPG-TPVF-TA 294
           G+ YL     VH D+   N+LV     VKIGDF +++V   D +  + R PG +P+F  A
Sbjct: 120 GMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179

Query: 295 PECCLGLTYGGKAADTWAVGVTLY 318
           PE  L  +    A+D W+ GV LY
Sbjct: 180 PE-SLTESKFSVASDVWSFGVVLY 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 68.1 bits (166), Expect = 6e-13
 Identities = 52/214 (24%), Positives = 98/214 (45%), Gaps = 23/214 (10%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           +K+GAG +G+V +   +   K  A+K           + P   ++     E  +MK LQH
Sbjct: 12  KKLGAGQFGEVWMATYNKHTK-VAVKT----------MKPGSMSVEAFLAEANVMKTLQH 60

Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLMY 241
             +V L  V+     +  Y++ E++      D         + + +   +   I  G+ +
Sbjct: 61  DKLVKLHAVV---TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 117

Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECCLG 300
           +   N +H D++  N+LV+ S   KI DF +++V ED+    R     P+ +TAPE    
Sbjct: 118 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE---A 174

Query: 301 LTYGGKA--ADTWAVGVTLYYMI-IGQYPFLGET 331
           + +G     +D W+ G+ L  ++  G+ P+ G +
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 75/282 (26%), Positives = 121/282 (42%), Gaps = 43/282 (15%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV-LIMKML 181
           V  +G G+YG+V   R    G+  AIK    +          E    +++ E+ ++ K  
Sbjct: 21  VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----------EDEEEEIKLEINMLKKYS 70

Query: 182 QHPNIVN----LIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDI 235
            H NI       I+     + D  ++V+E+       D        A+ E       R+I
Sbjct: 71  HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREI 130

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFT 293
           + GL +LH H V+H DIK  N+L+  +  VK+ DF VS   + D  V RR+   GTP + 
Sbjct: 131 LRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWM 188

Query: 294 APECCL-----GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD 348
           APE          TY  + +D W++G+T   M  G  P     L D +   +    + P 
Sbjct: 189 APEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPP-----LCDMHP--MRALFLIPR 240

Query: 349 AMNPELR---------NLLEGLLCKDPTRRLTLNDVAKHTWV 381
              P+L+         + +EG L K+   R +   + KH ++
Sbjct: 241 NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 67.7 bits (165), Expect = 7e-13
 Identities = 64/260 (24%), Positives = 117/260 (45%), Gaps = 30/260 (11%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           ++K+G G +G+V  +  + +G    A+K           + P   +      E  IMK L
Sbjct: 11  IKKLGNGQFGEV--WMGTWNGNTKVAVKT----------LKPGTMSPESFLEEAQIMKKL 58

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGE--SMARKYLRDI 235
           +H  +V L  V+ +   +  Y+V EY+       +  DG G+   +     MA +    +
Sbjct: 59  RHDKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQ----V 111

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTA 294
            +G+ Y+   N +H D++  N+LV      KI DF ++++ ED+    R+    P+ +TA
Sbjct: 112 AAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTA 171

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNP 352
           PE  L   +  K +D W+ G+ L  ++  G+ P+ G   ++  +++     +  P     
Sbjct: 172 PEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPI 230

Query: 353 ELRNLLEGLLCKDPTRRLTL 372
            L  L+     KDP  R T 
Sbjct: 231 SLHELMLQCWKKDPEERPTF 250

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 68.0 bits (166), Expect = 7e-13
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 21/215 (9%)

Query: 118 NEYVHVRKIGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           +E   ++++G+G +G V L  +R+ +     AIKA ++  +S+           D   E 
Sbjct: 4   SELTFMKELGSGQFGVVHLGKWRAQI---KVAIKAINEGAMSE----------EDFIEEA 50

Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRD 234
            +M  L HP +V L  V         Y+V E++E G   N    + G + + M     +D
Sbjct: 51  KVMMKLSHPKLVQLYGVCTQQKP--LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FT 293
           +  G+ YL  ++ +H D+   N LV+ +G VK+ DF +++   DD          PV ++
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWS 168

Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMII-GQYPF 327
            PE      Y  K +D W+ GV ++ +   G+ PF
Sbjct: 169 PPEVFNFSKYSSK-SDVWSFGVLMWEVFTEGKMPF 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 74/287 (25%), Positives = 116/287 (40%), Gaps = 38/287 (13%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSS--LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           N   +VR IG G++G+V   R+   L  + + + A     +  L+   S     D +RE 
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVA-----VKMLKEEASADMQADFQREA 59

Query: 176 LIMKMLQHPNIVNLIEV--IDDPNSDHF-YMVL----EYVEGKWDNDGFGQPGAI-GESM 227
            +M    HPNIV L+ V  +  P    F YM      E++          Q       S 
Sbjct: 60  ALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR---HRSPRAQCSLSHSTSS 116

Query: 228 ARKYL---------------RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272
           ARK                 + + +G+ YL     VH D+   N LV  +  VKI DF +
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 176

Query: 273 SQ-VFEDDNDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLG 329
           S+ ++  D      +   P+ +  PE      Y  + +D WA GV L+ +   G  P+ G
Sbjct: 177 SRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPYYG 235

Query: 330 ETLQDTYDKIVN-NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDV 375
              ++    + + N L  PD    EL NL+     K P+ R +   +
Sbjct: 236 MAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 65/220 (29%), Positives = 96/220 (43%), Gaps = 27/220 (12%)

Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSH------LSKLRVAPSETAMTDVRREVLIM 178
           K+G G +G+V L  +    +     A           +  LR   ++TA  D  +E+ IM
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 179 KMLQHPNIVNLIEVI--DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGE--------SMA 228
             L++PNI+ L+ V   DDP      M+ EY+E    N    Q              S++
Sbjct: 72  SRLKNPNIIRLLGVCVSDDP----LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127

Query: 229 RKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVL 283
              L      I SG+ YL   N VH D+   N LV    T+KI DF +S+ ++  D   +
Sbjct: 128 IANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187

Query: 284 RRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMII 322
           +     P+ + A E  L L     A+D WA GVTL+ M  
Sbjct: 188 QGRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 67/298 (22%), Positives = 122/298 (40%), Gaps = 49/298 (16%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
            Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLL 70

Query: 179 KMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           K ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  
Sbjct: 71  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQ 128

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           I+ GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + A
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 185

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV-------------- 340
           PE  L   +  +  D W+VG  +  ++ G+  F G    D    I+              
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245

Query: 341 ------------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
                             N + VF  A NP   +LLE +L  D  +R+T      H +
Sbjct: 246 SSESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAY 302

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 59/188 (31%), Positives = 86/188 (45%), Gaps = 30/188 (15%)

Query: 159 LRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWD---- 213
           LR   ++ A  D  +EV I+  L+ PNI+ L+ V  D   D   M+ EY+E G  +    
Sbjct: 54  LRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLS 111

Query: 214 -----------NDGFGQPG---AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV 259
                      ND         AI  S        I SG+ YL   N VH D+   N LV
Sbjct: 112 SHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV 171

Query: 260 APSGTVKIGDFSVSQ-VFEDDNDVLRRSPGTPV-FTAPECCLGLTYGGK---AADTWAVG 314
             + T+KI DF +S+ ++  D   ++     P+ + A EC L     GK   A+D WA G
Sbjct: 172 GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL----MGKFTTASDVWAFG 227

Query: 315 VTLYYMII 322
           VTL+ +++
Sbjct: 228 VTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 76/284 (26%), Positives = 124/284 (43%), Gaps = 47/284 (16%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV-LIMKML 181
           V  +G G+YG+V   R    G+  AIK         + V   E    ++++E+ ++ K  
Sbjct: 11  VELVGNGTYGQVYKGRHVKTGQLAAIKV--------MDVTGDEE--EEIKQEINMLKKYS 60

Query: 182 QHPNIVNLIEVIDDPN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL----R 233
            H NI          N     D  ++V+E+       D        G ++  +++    R
Sbjct: 61  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICR 118

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPV 291
           +I+ GL +LH H V+H DIK  N+L+  +  VK+ DF VS   + D  V RR+   GTP 
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPY 176

Query: 292 FTAPECCL-----GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF 346
           + APE          TY  K +D W++G+T   M  G  P     L D +   +    + 
Sbjct: 177 WMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPP-----LCDMHP--MRALFLI 228

Query: 347 PDAMNPELR---------NLLEGLLCKDPTRRLTLNDVAKHTWV 381
           P    P L+         + +E  L K+ ++R T   + KH ++
Sbjct: 229 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 24/215 (11%)

Query: 172 RREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK-----WDNDGFGQPGAIGES 226
           RRE  +   L HPNIV L++  + P     + V EYV G+        DG    G  G  
Sbjct: 26  RRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYVPGRTLREVLAADGALPAGETGRL 84

Query: 227 MARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT---VKIGDFSVSQVFEDDNDVL 283
           M +     ++  L   H   +VH D+KP N++V+ +G     K+ DF +  +     D  
Sbjct: 85  MLQ-----VLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDAD 139

Query: 284 RRSP-------GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTY 336
             +        GTP + APE   G       +D +A G+     + GQ    G ++ +  
Sbjct: 140 VATLTRTTEVLGTPTYCAPEQLRGEPVTPN-SDLYAWGLIFLECLTGQRVVQGASVAEIL 198

Query: 337 DKIVNNSLV-FPDAMNPE-LRNLLEGLLCKDPTRR 369
            + ++   V  P  +    L  +L   L KDP +R
Sbjct: 199 YQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQR 233

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 16/203 (7%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +E   V++IG+G +G +V     L+ +  AIK   +  +S+           D   E  +
Sbjct: 4   SELTLVQEIGSGQFG-LVWLGYWLEKRKVAIKTIREGAMSE----------EDFIEEAQV 52

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIV 236
           M  L HP +V L  V  + +     +V E++E    +D    Q G   +        D+ 
Sbjct: 53  MMKLSHPKLVQLYGVCTERSP--ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVC 110

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAP 295
            G+ YL   NV+H D+   N LV  +  VK+ DF +++   DD          PV +++P
Sbjct: 111 EGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSP 170

Query: 296 ECCLGLTYGGKAADTWAVGVTLY 318
           E      Y  K +D W+ GV ++
Sbjct: 171 EVFSFSKYSSK-SDVWSFGVLMW 192

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 68.6 bits (167), Expect = 2e-12
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 39/250 (15%)

Query: 108 SEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETA 167
            + ++G   +NEY  ++KIG G +G+V L +     + +  KA     L        E  
Sbjct: 3   GKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-------KERE 55

Query: 168 MTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAI 223
            + +  EV +M+ L+H NIV  I+   +  +   Y+++E+ +     +     +   G I
Sbjct: 56  KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKI 115

Query: 224 GESMARKYLRDIVSGLMYLH-------GHNVVHGDIKPDNLLVAPS----GTV------- 265
            E       R ++  L Y H       G  V+H D+KP N+ ++      G +       
Sbjct: 116 EEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175

Query: 266 ------KIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT--YGGKAADTWAVGVTL 317
                 KIGDF +S+    ++ +     GTP + +PE  L  T  Y  K +D WA+G  +
Sbjct: 176 NGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCII 233

Query: 318 YYMIIGQYPF 327
           Y +  G+ PF
Sbjct: 234 YELCSGKTPF 243

Length = 1021

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 66.0 bits (161), Expect = 2e-12
 Identities = 62/244 (25%), Positives = 114/244 (46%), Gaps = 36/244 (14%)

Query: 133 KVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192
           KV+L   +   + + +K   KS         S   +T +   V        PN+V L + 
Sbjct: 8   KVLLVMDTRTQQTFILKGLRKSSEY------SRERLTIIPHCV--------PNMVCLHKY 53

Query: 193 IDDPNSDHFYMVLEYVEGK--WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHG 250
           I   + D  ++VL++ EG   W +    +   I E   +++  ++V  L  LH   +V  
Sbjct: 54  I--VSEDSVFLVLQHAEGGKLWSH--ISKFLNIPEECVKRWAAEMVVALDALHREGIVCR 109

Query: 251 DIKPDNLLVAPSGTVKIGDFSVSQVFED--DNDVLRRSPGTPVFTAPECCLGLTYGGKAA 308
           D+ P+N+L+   G +++  FS     ED  D + +       ++ APE   G++   +A 
Sbjct: 110 DLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVEN-----MYCAPEVG-GISEETEAC 163

Query: 309 DTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFPDAMNPELRNLLEGLLCKDP 366
           D W++G  L+ ++ G+      TL + +   +N   +L  P+ ++ E R+LL+ LL  +P
Sbjct: 164 DWWSLGAILFELLTGK------TLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNP 217

Query: 367 TRRL 370
           T RL
Sbjct: 218 TERL 221

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 20/213 (9%)

Query: 118 NEYVHVRKIGAGSYGKV--VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           +++  + ++GAG+ G V  V ++ S  G   A K  H      L + P+      + RE+
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPS--GLIMARKLIH------LEIKPA--IRNQIIREL 54

Query: 176 LIMKMLQHPNIVNLIEVIDDPNSD-HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
            ++     P IV          SD    + +E+++G   +    + G I E +  K    
Sbjct: 55  QVLHECNSPYIVGFYGAF---YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA 111

Query: 235 IVSGLMYL-HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
           ++ GL YL   H ++H D+KP N+LV   G +K+ DF VS    D   +     GT  + 
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYM 169

Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYP 326
           +PE   G  Y  + +D W++G++L  M IG+YP
Sbjct: 170 SPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 27/223 (12%)

Query: 126 IGAGSYGKVVLYRSSL-DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           +G G++G+V  ++ +L D    A+K   +    +L++            E  I+K   HP
Sbjct: 3   LGKGNFGEV--FKGTLKDKTPVAVKTCKEDLPQELKIK--------FLSEARILKQYDHP 52

Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVSGLMYL 242
           NIV LI V         Y+V+E V G  D   F   +   +      K+  D  +G+ YL
Sbjct: 53  NIVKLIGVCTQRQP--IYIVMELVPGG-DFLSFLRKKKDELKTKQLVKFALDAAAGMAYL 109

Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS--PGTPV-FTAPECCL 299
              N +H D+   N LV  +  +KI DF +S+  ++D+ +   S     P+ +TAPE   
Sbjct: 110 ESKNCIHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPE--- 164

Query: 300 GLTYG--GKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKI 339
            L YG     +D W+ G+ L+    +G  P+ G T Q   +++
Sbjct: 165 ALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 65.5 bits (159), Expect = 5e-12
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 13/207 (6%)

Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +E  IMK L+H  +V L  V+ +   +  Y+V E++ GK     F + G  G+ +    L
Sbjct: 50  QEAQIMKKLRHDKLVPLYAVVSE---EPIYIVTEFM-GKGSLLDFLKEGD-GKYLKLPQL 104

Query: 233 RDIVS----GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
            D+ +    G+ Y+   N +H D++  N+LV  +   KI DF ++++ ED+    R+   
Sbjct: 105 VDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAK 164

Query: 289 TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLV 345
            P+ +TAPE  L   +  K +D W+ G+ L  ++  G+ P+ G   ++  +++     + 
Sbjct: 165 FPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP 223

Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTL 372
            P      L  L++    KDP  R T 
Sbjct: 224 CPQGCPESLHELMKLCWKKDPDERPTF 250

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 24/215 (11%)

Query: 125 KIGAGSYGKVVLYRSS----LDGKHYAIKAFHKSHL----SKLRVAPSETAMTDVRREVL 176
           K+G G +G+V L  +        K +++       +      LR   ++ A  D  +E+ 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDND-----GFGQPGAIGESMARKY 231
           IM  L+ PNI+ L+ V     SD   M+ EY+E    N         +     + +   Y
Sbjct: 72  IMSRLKDPNIIRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129

Query: 232 ------LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLR 284
                    I SG+ YL   N VH D+   N LV  + T+KI DF +S+ ++  D   ++
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 285 RSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLY 318
                P+ + + E  L L     A+D WA GVTL+
Sbjct: 190 GRAVLPIRWMSWESIL-LGKFTTASDVWAFGVTLW 223

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 66/240 (27%), Positives = 103/240 (42%), Gaps = 37/240 (15%)

Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
           +R +G G++G+V   LYR   DG    ++   K+    L  + SE   +D   E LIM  
Sbjct: 11  LRALGHGAFGEVYEGLYRG-RDGDAVELQVAVKT----LPESCSEQDESDFLMEALIMSK 65

Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--------GQPGAIGESMARKYL 232
             H NIV LI V  +      +++LE + G  D   F         +P ++         
Sbjct: 66  FNHQNIVRLIGVSFERLP--RFILLELMAGG-DLKSFLRENRPRPERPSSLTMKDLLFCA 122

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLR----R 285
           RD+  G  YL  ++ +H DI   N L+    P    KI DF +++      D+ R    R
Sbjct: 123 RDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR------DIYRASYYR 176

Query: 286 SPGT---PV-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIV 340
             G    P+ +  PE  L   +  K  D W+ GV L+    +G  P+ G T Q+  + + 
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 19/210 (9%)

Query: 125 KIGAGSYGKVV--LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           ++G+G++G V   +Y+        AIK         L+    ++   ++ RE  IM  L 
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKV--------LKNENEKSVRDEMMREAEIMHQLD 53

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIVSGLMY 241
           +P IV +I V +   ++   +V+E   G   N    G+   I  S   + +  +  G+ Y
Sbjct: 54  NPYIVRMIGVCE---AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKY 110

Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF-EDDNDVLRRSPGT-PV-FTAPECC 298
           L G N VH D+   N+L+      KI DF +S+    DD+    RS G  P+ + APEC 
Sbjct: 111 LEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI 170

Query: 299 LGLTYGGKAADTWAVGVTLYYMI-IGQYPF 327
               +  + +D W+ G+T++     GQ P+
Sbjct: 171 NFRKFSSR-SDVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 52/227 (22%), Positives = 104/227 (45%), Gaps = 20/227 (8%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR--REVLI 177
           Y ++  +G+G+YG V           Y  +   K  + KL   P ++ +   R  RE+ +
Sbjct: 17  YQNLTPVGSGAYGSVC--------SAYDTRLRQKVAVKKLS-RPFQSLIHARRTYRELRL 67

Query: 178 MKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
           +K ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  + 
Sbjct: 68  LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIY 125

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
            ++ GL Y+H   ++H D+KP N+ V     ++I DF +++  +D+   +     T  + 
Sbjct: 126 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE---MTGYVATRWYR 182

Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV 340
           APE  L   +  +  D W+VG  +  ++ G+  F G    D   +I+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIM 229

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 64/281 (22%), Positives = 120/281 (42%), Gaps = 36/281 (12%)

Query: 126 IGAGSYGKVV-LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           +G G +GKVV      L G+      +    +  L+   S + + D+  E  ++K + HP
Sbjct: 8   LGEGEFGKVVKATAFRLKGR----AGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP 63

Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVE----------------------GKWDNDGFGQPG- 221
           +++ L             +++EY +                      G  ++     P  
Sbjct: 64  HVIKLYGACS--QDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121

Query: 222 -AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDD 279
            A+       +   I  G+ YL    +VH D+   N+LVA    +KI DF +S+ V+E+D
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181

Query: 280 NDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYD 337
           + V R     PV + A E      Y  + +D W+ GV L+ ++ +G  P+ G   +  ++
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240

Query: 338 KI-VNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
            +     +  P+  + E+ NL+     ++P +R T  D++K
Sbjct: 241 LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 63/247 (25%), Positives = 115/247 (46%), Gaps = 22/247 (8%)

Query: 125 KIGAGSYGKVV--LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD-VRREVLIMKML 181
           ++G+G++G V   +Y+     K  A+K         L+   ++ A+ D + RE  +M+ L
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKI--------LKNDNNDPALKDELLREANVMQQL 53

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
            +P IV +I + +   ++ + +V+E  E    N    +   + E    + +  +  G+ Y
Sbjct: 54  DNPYIVRMIGICE---AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKY 110

Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF-EDDNDVLRRSPGT-PV-FTAPECC 298
           L   N VH D+   N+L+      KI DF +S+    D+N    ++ G  PV + APEC 
Sbjct: 111 LEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170

Query: 299 LGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS-LVFPDAMNPELRN 356
               +  K +D W+ GV ++     GQ P+ G    +    I +   +  P    PE+ +
Sbjct: 171 NYYKFSSK-SDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYD 229

Query: 357 LLEGLLC 363
           L++  LC
Sbjct: 230 LMK--LC 234

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 63.2 bits (153), Expect = 4e-11
 Identities = 57/219 (26%), Positives = 89/219 (40%), Gaps = 20/219 (9%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           E   V+ +G+G++G V       +G+   I       +  L       A  +   E LIM
Sbjct: 8   ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPV----AIKILNETTGPKANVEFMDEALIM 63

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMV------LEYVEGKWDNDGFGQPGAIGESMARKYL 232
             + HP++V L+ V   P       +      L+YV    DN        IG  +   + 
Sbjct: 64  ASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDN--------IGSQLLLNWC 115

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TPV 291
             I  G+MYL    +VH D+   N+LV     VKI DF ++++ E D        G  P+
Sbjct: 116 VQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI 175

Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
                 C+        +D W+ GVT++  M  G  P+ G
Sbjct: 176 KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 14/210 (6%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +++  + ++GAG+ G V   +    G   A K  H      L + P+      + RE+ +
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIH------LEIKPA--IRNQIIRELQV 56

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +     P IV         +     + +E+++G   +    +   I E +  K    ++ 
Sbjct: 57  LHECNSPYIVGFYGAF--YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLR 114

Query: 238 GLMYL-HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           GL YL   H ++H D+KP N+LV   G +K+ DF VS    D   +     GT  + +PE
Sbjct: 115 GLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPE 172

Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYP 326
              G  Y  + +D W++G++L  + IG+YP
Sbjct: 173 RLQGTHYSVQ-SDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 62.0 bits (150), Expect = 9e-11
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 23/229 (10%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAP-SETAMTDVRREVLIMKMLQ 182
           + +G G +G V+     L+     +K   K+    +++A  + + M D   E + MK   
Sbjct: 5   KTLGEGEFGSVM--EGQLNQDDSILKVAVKT----MKIAICTRSEMEDFLSEAVCMKEFD 58

Query: 183 HPNIVNLIEVIDDPNSDHFY----MVLEYVEGKWDNDGF-------GQPGAIGESMARKY 231
           HPN++ LI V         Y    ++L +++   D   F         P  +   M  K+
Sbjct: 59  HPNVMRLIGVCLQTVESEGYPSPVVILPFMK-HGDLHSFLLYSRLGDCPQYLPTQMLVKF 117

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSPGTP 290
           + DI SG+ YL   + +H D+   N ++  +  V + DF +S +++  D     R    P
Sbjct: 118 MTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177

Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYD 337
           V + A E      Y  K +D W+ GVT++ +   GQ P+ G    + YD
Sbjct: 178 VKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSEIYD 225

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 35/94 (37%), Positives = 53/94 (56%), Gaps = 4/94 (4%)

Query: 288 GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP 347
           GTP + APE  LG  +G  A D WA+GV L+  + G  PF  ET Q  +  I+N  + +P
Sbjct: 542 GTPDYLAPELLLGKPHG-PAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600

Query: 348 D---AMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
           +    ++   +N +E LL  DPT+R  L ++ +H
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQH 634

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 66/273 (24%), Positives = 110/273 (40%), Gaps = 42/273 (15%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVA---PSETAMTDVRREVL---- 176
           R++G GS+G V  Y     G              + RVA    +E A    R E L    
Sbjct: 12  RELGQGSFGMV--YEGLAKGV--------VKGEPETRVAIKTVNENASMRERIEFLNEAS 61

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLE---------YVEGKWDNDGFGQPGAIGESM 227
           +MK     ++V L+ V+         +V+E         Y+  +                
Sbjct: 62  VMKEFNCHHVVRLLGVVST--GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP--PT 117

Query: 228 ARKYLR---DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVL 283
            +K+++   +I  G+ YL     VH D+   N +VA   TVKIGDF +++ ++E   D  
Sbjct: 118 LQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE--TDYY 175

Query: 284 RRSPGT--PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKI 339
           R+      PV + APE  L        +D W+ GV L+ M  + + P+ G + ++    +
Sbjct: 176 RKGGKGLLPVRWMAPE-SLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234

Query: 340 V-NNSLVFPDAMNPELRNLLEGLLCKDPTRRLT 371
           +    L  P+    +L  L+      +P  R T
Sbjct: 235 IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPT 267

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 36/225 (16%)

Query: 124 RKIGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           ++IG G +GKV+L    S        +K        +LRV+ S         E    + L
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVK--------ELRVSASVQEQMKFLEEAQPYRSL 52

Query: 182 QHPNIVNLI----EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMA------RKY 231
           QH N++  +    EV        + +V+E+     D  G+ +     E M       ++ 
Sbjct: 53  QHSNLLQCLGQCTEVTP------YLLVMEFCP-LGDLKGYLRSCRKAELMTPDPTTLQRM 105

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV-FEDDNDVLRRSPGTP 290
             +I  GL++LH +N +H D+   N L+    TVKIGD+ +S   +++D  V       P
Sbjct: 106 ACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVP 165

Query: 291 V-FTAPECC------LGLTYGGKAADTWAVGVTLYYMI-IGQYPF 327
           + + APE        L +    K ++ W++GVT++ +  +G  P+
Sbjct: 166 LRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 23/223 (10%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKH-YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           ++++G G +G VV Y     G++  AIK   +  +S+           +   E  +M  L
Sbjct: 9   LKELGTGQFG-VVKY-GKWRGQYDVAIKMIKEGSMSE----------DEFIEEAKVMMKL 56

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGFGQPGAIGESMAR--KYLRDIVSG 238
            H  +V L  V         Y+V EY+  G   N  + +        ++  +  +D+  G
Sbjct: 57  SHEKLVQLYGVCTKQRP--IYIVTEYMSNGCLLN--YLREHGKRFQPSQLLEMCKDVCEG 112

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPEC 297
           + YL     +H D+   N LV   G VK+ DF +S+   DD          PV ++ PE 
Sbjct: 113 MAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172

Query: 298 CLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKI 339
            L   +  K +D WA GV ++ +  +G+ P+      +T +K+
Sbjct: 173 LLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 55/233 (23%), Positives = 103/233 (44%), Gaps = 30/233 (12%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM-KMLQHP 184
           IG G++G+V+      DG          + +  L+   SE    D   E+ ++ K+  HP
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMN------AAIKMLKEFASENDHRDFAGELEVLCKLGHHP 63

Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEG-------------KWDNDGFGQPGAIGESMARKY 231
           NI+NL+   +  N  + Y+ +EY                + D     + G      +++ 
Sbjct: 64  NIINLLGACE--NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 232 LR---DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           L+   D+ +G+ YL     +H D+   N+LV  +   KI DF +S+    +   ++++ G
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMG 178

Query: 289 T-PVFTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKI 339
             PV       L  +     +D W+ GV L+ ++ +G  P+ G T  + Y+K+
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 39/109 (35%), Positives = 59/109 (54%), Gaps = 8/109 (7%)

Query: 221 GAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
           G I E++  K    ++ GL YL   H ++H D+KP N+LV   G +K+ DF VS    D 
Sbjct: 94  GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153

Query: 280 --NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYP 326
             N  +    GT  + +PE   G  Y  + +D W++G++L  M IG+YP
Sbjct: 154 MANSFV----GTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 51/177 (28%), Positives = 80/177 (45%), Gaps = 17/177 (9%)

Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEV-IDDPNSDHFYMVLEYVEGKWDNDGFGQPGA 222
           SE  +T + +E  ++  L H NI+ ++ V I+D        VL       +   F Q   
Sbjct: 48  SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE---PPFVLYPYMNWGNLKLFLQQCR 104

Query: 223 IGESMARKYLR---------DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
           +GE+   + L           I  G+ YLH   V+H DI   N ++     VKI D ++S
Sbjct: 105 LGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS 164

Query: 274 Q-VFEDDNDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPF 327
           + +F  D   L  +   PV + A E  +   Y   A+D W+ GV L+  M +GQ P+
Sbjct: 165 RDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPY 220

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 59.4 bits (144), Expect = 6e-10
 Identities = 58/255 (22%), Positives = 105/255 (41%), Gaps = 40/255 (15%)

Query: 158 KLRVAPSETAMTDVRREVLIMKMLQHPNIVNL---IEVIDDPNSDHFYMVLEYVEG---- 210
           K+R  P+ T M   R    +    Q   +++L   +  +D P +  FY  L + EG    
Sbjct: 19  KMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL-FREGDVWI 77

Query: 211 ----------KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLV 259
                     K+    + +   I E +  K    IV  L YLH   +V+H D+KP N+L+
Sbjct: 78  CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI 137

Query: 260 APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT----YGGKAADTWAVGV 315
             +G VK+ DF +S    D         G   + APE          Y  K +D W++G+
Sbjct: 138 NRNGQVKLCDFGISGYLVDSV-AKTIDAGCKPYMAPERINPELNQKGYDVK-SDVWSLGI 195

Query: 316 TLYYMIIGQYPF---------LGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDP 366
           T+  +  G++P+         L + +++   ++           +PE ++ +   L K+ 
Sbjct: 196 TMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF------SPEFQDFVNKCLKKNY 249

Query: 367 TRRLTLNDVAKHTWV 381
             R    ++ +H + 
Sbjct: 250 KERPNYPELLQHPFF 264

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 59.1 bits (143), Expect = 7e-10
 Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 22/224 (9%)

Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIG 224
           +E  +M    HPNIV L+ V     ++  Y+++E +EG            + FG P    
Sbjct: 48  KEAHLMSNFNHPNIVKLLGVCLL--NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTL 105

Query: 225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-----TVKIGDFSVSQ-VFED 278
           + +    L D+  G +YL   + +H D+   N LV+  G      VKIGDF +++ +++ 
Sbjct: 106 KELLDICL-DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS 164

Query: 279 DNDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTY 336
           D          PV + APE  L   +  + +D W+ GV ++  + +GQ P+     Q+  
Sbjct: 165 DYYRKEGEGLLPVRWMAPESLLDGKFTTQ-SDVWSFGVLMWEILTLGQQPYPALNNQEVL 223

Query: 337 DKIVNNSLVFPDAMNPE-LRNLLEGLLCKDPTRRLTLNDVAKHT 379
             +     +      P+ +  L+     +DP+ R T  D  +  
Sbjct: 224 QHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTF-DRIQEI 266

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 59.3 bits (143), Expect = 7e-10
 Identities = 71/291 (24%), Positives = 121/291 (41%), Gaps = 36/291 (12%)

Query: 124 RKIGAGSYGKVVLYR-----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           R++G G++GKV L          D    A+K    +         S+ A  D  RE  ++
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---------SDNARKDFHREAELL 61

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--------------GQPGAIG 224
             LQH +IV    V  +   D   MV EY++   D + F               +P  + 
Sbjct: 62  TNLQHEHIVKFYGVCVE--GDPLIMVFEYMK-HGDLNKFLRAHGPDAVLMAEGNRPAELT 118

Query: 225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVL 283
           +S      + I +G++YL   + VH D+   N LV  +  VKIGDF +S+ V+  D   +
Sbjct: 119 QSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 178

Query: 284 RRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN 342
                 P+   P   +        +D W++GV L+ +   G+ P+   +  +  + I   
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238

Query: 343 S-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL 392
             L  P     E+ +L+ G   ++P  RL + ++  H+ +       P YL
Sbjct: 239 RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEI--HSLLQNLAKASPVYL 287

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 59/272 (21%), Positives = 112/272 (41%), Gaps = 33/272 (12%)

Query: 126 IGAGSYGKVVL--YRSSLDGKHYA---IKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
           +G G +G+V L   +   +        +KA  K+          E   ++ RRE+ + + 
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--------KDENLQSEFRRELDMFRK 64

Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVE-----------GKWDNDGFGQPGAIGESMAR 229
           L H N+V L+ +  +  ++  YM+LEY +              D      P +  + +A 
Sbjct: 65  LSHKNVVRLLGLCRE--AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122

Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
                I  G+ +L     VH D+   N LV+    VK+   S+S+   +      R+   
Sbjct: 123 CT--QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180

Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNSLVFP 347
           P+ + APE      +  K +D W+ GV ++ +   G+ PF G + ++  +++    L  P
Sbjct: 181 PLRWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239

Query: 348 DAMN-PE-LRNLLEGLLCKDPTRRLTLNDVAK 377
                P  L  L+      +P  R + +++  
Sbjct: 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 58.2 bits (140), Expect = 2e-09
 Identities = 53/233 (22%), Positives = 104/233 (44%), Gaps = 30/233 (12%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM-KMLQHP 184
           IG G++G+V+  R   DG          + + +++   S+    D   E+ ++ K+  HP
Sbjct: 3   IGEGNFGQVLKARIKKDGLRM------DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 56

Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVE-GKW-----------DNDGFGQPGAIGESMA-RKY 231
           NI+NL+   +  +  + Y+ +EY   G              +  F    +   +++ ++ 
Sbjct: 57  NIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 232 LR---DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           L    D+  G+ YL     +H D+   N+LV  +   KI DF +S+        ++++ G
Sbjct: 115 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMG 171

Query: 289 T-PVFTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKI 339
             PV       L  +     +D W+ GV L+ ++ +G  P+ G T  + Y+K+
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 74/288 (25%), Positives = 122/288 (42%), Gaps = 44/288 (15%)

Query: 123 VRKIGAGSYGKVVLYRSSLDG-------KHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           + ++G   +GKV  Y+  L G       +  AIK         LR         + + E 
Sbjct: 10  MEELGEDRFGKV--YKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR--------EEFKHEA 59

Query: 176 LIMKMLQHPNIVNLIEVIDD-----------PNSD-HFYMVLEYVE---GKWDNDGFGQP 220
           ++   LQHPNIV L+ V+              +SD H ++V+       G  D+D   + 
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK- 118

Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV-SQVFEDD 279
             +  +     +  I +G+ +L  H+VVH D+   N+LV     VKI D  +  +V+  D
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAAD 178

Query: 280 NDVLRRSPGTPV-FTAPECCLGLTYGGKAADT--WAVGVTLYYMI-IGQYPFLGETLQDT 335
              L  +   P+ + +PE    + YG  + D+  W+ GV L+ +   G  P+ G + QD 
Sbjct: 179 YYKLMGNSLLPIRWMSPE---AIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235

Query: 336 YDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK--HTW 380
            + I N   L  PD     +  L+     + P+RR    D+     TW
Sbjct: 236 IEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 31/94 (32%), Positives = 45/94 (47%), Gaps = 4/94 (4%)

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
           + I+ GL YLH   ++H D+K +N+ +     V IGD   +Q        L  + GT   
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA-GTVET 222

Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYP 326
            APE      Y  K AD W+ G+ L+ M+   YP
Sbjct: 223 NAPEVLARDKYNSK-ADIWSAGIVLFEML--AYP 253

Length = 357

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 69/285 (24%), Positives = 116/285 (40%), Gaps = 45/285 (15%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           E+  ++ +G+G++G V       +G+   I    K    +LR A S  A  ++  E  +M
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK----ELREATSPKANKEILDEAYVM 63

Query: 179 KMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
             + +P++  L+ +              F  +L+YV    DN        IG      + 
Sbjct: 64  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNWC 115

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TPV 291
             I  G+ YL    +VH D+   N+LV     VKI DF ++++   D        G  P+
Sbjct: 116 VQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175

Query: 292 -FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPF-------------LGETLQ--- 333
            + A E  L   Y  + +D W+ GVT++  M  G  P+              GE L    
Sbjct: 176 KWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 234

Query: 334 ----DTYDKIVNNSLVFPDAMNPELRNLLEGL--LCKDPTRRLTL 372
               D Y  +V   ++  D+  P+ R L+     + +DP R L +
Sbjct: 235 ICTIDVYMIMVKCWMIDADS-RPKFRELIIEFSKMARDPQRYLVI 278

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 56.3 bits (136), Expect = 6e-09
 Identities = 52/210 (24%), Positives = 81/210 (38%), Gaps = 20/210 (9%)

Query: 177 IMKMLQHPNIVNLIEV-IDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRD 234
           +M  L H ++V L  V + D N     MV EYV+ G  D     +   +         + 
Sbjct: 54  LMSQLSHKHLVKLYGVCVRDENI----MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQ 109

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVA-------PSGTVKIGDFSVSQVFEDDNDVLRRSP 287
           + S L YL    +VHG++   N+LVA           +K+ D  +        + + R P
Sbjct: 110 LASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP 169

Query: 288 GTPVFTAPECCLGLTYG-GKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLV 345
               + APEC          AAD W+ G TL  +   G+ P    +  +      +    
Sbjct: 170 ----WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH-R 224

Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDV 375
            P     EL NL+      DPT+R +   +
Sbjct: 225 LPMPDCAELANLINQCWTYDPTKRPSFRAI 254

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 56.6 bits (136), Expect = 9e-09
 Identities = 79/323 (24%), Positives = 129/323 (39%), Gaps = 72/323 (22%)

Query: 102 SNKLIRSEDENGTKMINEYVHVRK---------IGAGSYGKVVLYRSSLDGKHYAIKAFH 152
           S+     EDE+  KMI+  ++            IG GS+G  V+Y +        I    
Sbjct: 41  SHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFG--VVYEA------ICIDTSE 92

Query: 153 KSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNL-----IEVIDDPNSDHFY-MVLE 206
           K  + K+   P         RE+LIMK L H NI+ L      E       + F  +V+E
Sbjct: 93  KVAIKKVLQDPQYK-----NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME 147

Query: 207 YVEG---KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-S 262
           ++     K+         A+   + + Y   +   L Y+H   + H D+KP NLL+ P +
Sbjct: 148 FIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT 207

Query: 263 GTVKIGDFSVSQVFEDDNDVL--RRSPG---TPVFTAPECCLGLTYGGKAADTWAVGVTL 317
            T+K+ DF  ++      ++L  +RS     +  + APE  LG T      D W++G  +
Sbjct: 208 HTLKLCDFGSAK------NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCII 261

Query: 318 YYMIIGQYPFLGETLQDTYDKIVN-----------------NSLVFPDAMNPELR----- 355
             MI+G   F G++  D   +I+                    + FPD    +L+     
Sbjct: 262 AEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPK 321

Query: 356 -------NLLEGLLCKDPTRRLT 371
                  N +   L  +P +RL 
Sbjct: 322 GTPDDAINFISQFLKYEPLKRLN 344

Length = 440

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 56.0 bits (135), Expect = 9e-09
 Identities = 63/264 (23%), Positives = 113/264 (42%), Gaps = 30/264 (11%)

Query: 124 RKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML- 181
           + +GAG++GKVV   +  L      +K   K        +  E  M+    E+ IM  L 
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS----ELKIMSHLG 96

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL--RDIVS-- 237
            H NIVNL+            ++ EY         +G            +L   D++S  
Sbjct: 97  NHENIVNLLGACT--IGGPILVITEYCC-------YGDLLNFLRRKRESFLTLEDLLSFS 147

Query: 238 -----GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLRRSPGTPV 291
                G+ +L   N +H D+   N+L+     VKI DF +++ +  D N V++ +   PV
Sbjct: 148 YQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207

Query: 292 -FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LVFP 347
            + APE      Y  + +D W+ G+ L+ +  +G  P+ G  +   + K++     +  P
Sbjct: 208 KWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP 266

Query: 348 DAMNPELRNLLEGLLCKDPTRRLT 371
           +    E+ ++++     DP +R T
Sbjct: 267 EHAPAEIYDIMKTCWDADPLKRPT 290

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 55.8 bits (134), Expect = 9e-09
 Identities = 64/280 (22%), Positives = 121/280 (43%), Gaps = 40/280 (14%)

Query: 123 VRKIGAGSYGKVV---LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           + ++G  ++GK+    LY   +D  H  + A     +  L+   +     + ++E  +M 
Sbjct: 10  MEELGECAFGKIYKGHLYLPGMD--HAQLVA-----IKTLKDINNPQQWGEFQQEASLMA 62

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--------------GQPGAIGE 225
            L HPNIV L+ V+         M+ EY+  + D   F               + G +  
Sbjct: 63  ELHHPNIVCLLGVVTQEQP--VCMLFEYL-NQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119

Query: 226 SMAR-KYLR---DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDN 280
           S+    +L     I +G+ YL  H  VH D+   N+L+     VKI D  +S +++  D 
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADY 179

Query: 281 DVLRRSPGTPV-FTAPECCLGLTYGGKAADT--WAVGVTLYYMI-IGQYPFLGETLQDTY 336
             ++     P+ +  PE    + YG  ++D+  W+ GV L+ +   G  P+ G + Q+  
Sbjct: 180 YRVQPKSLLPIRWMPPE---AIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236

Query: 337 DKIVNNSLV-FPDAMNPELRNLLEGLLCKDPTRRLTLNDV 375
           + +    L+   +   P + +L+     + P+RR    D+
Sbjct: 237 EMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 52/227 (22%), Positives = 90/227 (39%), Gaps = 40/227 (17%)

Query: 122 HVRKIG---AGSYGKVVL----------YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAM 168
           H R I    AG++GK+ +                      K   +  ++K RV     A 
Sbjct: 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAK-RVKAGSRAA 207

Query: 169 TDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDND--GFGQPGAIGES 226
             +  E+L +  L H NI+ + E++      + YM+ +    K+D D   F    A    
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSE--ANTYMITQ----KYDFDLYSFMYDEAFDWK 261

Query: 227 ------MARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN 280
                   R  ++ ++  + Y+H   ++H DIK +N+ +   G + +GDF  +  FE + 
Sbjct: 262 DRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE- 320

Query: 281 DVLRRSP------GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMI 321
               R        GT    +PE   G  Y  +  D W+ G+ L  M+
Sbjct: 321 ----REAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 65/256 (25%), Positives = 97/256 (37%), Gaps = 24/256 (9%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G++      L  K     A H      LR   S+        E L +    H
Sbjct: 11  RILGTGRFGELCRGCLKLPSKRELPVAIHT-----LRAGCSDKQRRGFLAEALTLGQFDH 65

Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVSGLMY 241
            NIV L  VI   N+    +V EY+      D F     G +        L  + SG+ Y
Sbjct: 66  SNIVRLEGVITRGNT--MMIVTEYM-SNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKY 122

Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG--TPV-FTAPECC 298
           L     VH  +    +LV      KI  F   Q  ED ++ +  +    +PV + APE  
Sbjct: 123 LSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ--EDKSEAIYTTMSGKSPVLWAAPE-- 178

Query: 299 LGLTYG--GKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN--PE 353
             + Y     A+D W+ G+ ++  M  G+ P+   + QD   K V +    P   N    
Sbjct: 179 -AIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI-KAVEDGFRLPAPRNCPNL 236

Query: 354 LRNLLEGLLCKDPTRR 369
           L  L+     K+   R
Sbjct: 237 LHQLMLDCWQKERGER 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 60/229 (26%), Positives = 93/229 (40%), Gaps = 15/229 (6%)

Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEV---IDDPNSDHFYMVLEYVEGKWDNDGF--- 217
           + + + +   E   MK   HPN++ LI V             MV+       D   F   
Sbjct: 41  TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLY 100

Query: 218 ----GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
               G P  +      K++ DI  G+ YL   N +H D+   N ++    TV + DF +S
Sbjct: 101 SRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160

Query: 274 Q-VFEDDNDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLGE 330
           + ++  D     R    PV + A E      Y  K +D WA GVT++     GQ P+ G 
Sbjct: 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGV 219

Query: 331 TLQDTYDKIVN-NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
              + YD + + N L  P+    EL +L+      DP  R T   + + 
Sbjct: 220 ENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 51.6 bits (124), Expect = 5e-08
 Identities = 34/155 (21%), Positives = 62/155 (40%), Gaps = 27/155 (17%)

Query: 121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
             ++ +  G     V Y      + Y            L++ PS     D  REV I+++
Sbjct: 1   SSIKLLKGG-LTNRV-YLLGTKDEDYV-----------LKINPSREKGADREREVAILQL 47

Query: 181 LQHPNIVNLIEVID-DPNSDHFYMVLEYVEGK-WDNDGFGQPGAIGESMARKYLRDIVSG 238
           L     + + +V+    +    Y+++E++EG+  D     +   I E +A + L      
Sbjct: 48  LAR-KGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLA-ELLAK---- 101

Query: 239 LMYLHGHN---VVHGDIKPDNLLVAPSGTVKIGDF 270
              LH      + HGD+ P N+LV     + I D+
Sbjct: 102 ---LHQLPLLVLCHGDLHPGNILVDDGKILGIIDW 133

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 53.3 bits (128), Expect = 9e-08
 Identities = 37/147 (25%), Positives = 74/147 (50%), Gaps = 6/147 (4%)

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLRRSPGTPV-F 292
           +  G+ +L   N +H D+   N+L+      KI DF +++ +  D N V++ +   PV +
Sbjct: 221 VAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKW 280

Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN--SLVFPDA 349
            APE      Y  + +D W+ G+ L+ +  +G+ P+ G  +   + K+V     +  PD 
Sbjct: 281 MAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDF 339

Query: 350 MNPELRNLLEGLLCKDPTRRLTLNDVA 376
             PE+ ++++     +PT R T + ++
Sbjct: 340 APPEIYSIMKMCWNLEPTERPTFSQIS 366

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 43/222 (19%)

Query: 126 IGAGSYGKV--VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV-LIMKMLQ 182
           IG G++G V  +L++ S  G   A+K        ++R    E     +  ++ ++M+   
Sbjct: 12  IGRGAFGTVNKMLHKPS--GTIMAVK--------RIRSTVDEKEQKRLLMDLDVVMRSSD 61

Query: 183 HPNIVNL-------------IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR 229
            P IV               +E++D  + D FY    YV              I E +  
Sbjct: 62  CPYIVKFYGALFREGDCWICMELMD-ISLDKFYK---YVYEV-------LKSVIPEEILG 110

Query: 230 KYLRDIVSGLMYL-HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSP 287
           K     V  L YL     ++H D+KP N+L+  +G +K+ DF +S    D   + + R  
Sbjct: 111 KIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD--SIAKTRDA 168

Query: 288 GTPVFTAPECCLGLTYGGK--AADTWAVGVTLYYMIIGQYPF 327
           G   + APE        G    +D W++G+TLY +  G++P+
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY 210

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 39/159 (24%), Positives = 77/159 (48%), Gaps = 9/159 (5%)

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR-SPGT 289
           Y   +  G+ +L     +H D+   N+L++ +  VKI DF +++    D D +R+ S   
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LV 345
           P+ + APE      Y  + +D W+ GV L+ +  +G  P+ G  + + + + + +   + 
Sbjct: 239 PLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR 297

Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD 384
            P+   PE+  ++      DP  R T + + +   +LGD
Sbjct: 298 APENATPEIYRIMLACWQGDPKERPTFSALVE---ILGD 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 48/221 (21%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           ++IG G +GKV+L       + Y      +  + +L+   S     +  ++    ++LQH
Sbjct: 1   QEIGNGWFGKVLL------SEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQH 54

Query: 184 PNIVNLI----EVIDDPNSDHFYMVLEYVEG-------KWDNDGFGQPGAIGESMA-RKY 231
           PNI+  +    E I       + +V EY E          +           + +  ++ 
Sbjct: 55  PNILQCLGQCVEAIP------YLLVFEYCELGDLKSYLSQEQWHRRN----SQLLLLQRM 104

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV--SQVFED----DNDVLRR 285
             +I +G+ ++H HN +H D+   N  +    TVK+GD+ +  S+  ED    ++D    
Sbjct: 105 ACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKC-- 162

Query: 286 SPGTPV-FTAPECCLGLTYGG-------KAADTWAVGVTLY 318
               P+ + APE  +G  +GG       K ++ WA+GVTL+
Sbjct: 163 ---VPLRWLAPE-LVGEFHGGLITAEQTKPSNVWALGVTLW 199

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 58/242 (23%), Positives = 102/242 (42%), Gaps = 48/242 (19%)

Query: 126 IGAGSYGKVVLYRSSLDG----------KHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           IG G++G+V+  R   DG          K YA K  H+    +L V              
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-------------- 60

Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV-EGKW-----------DNDGFGQPGAI 223
            + K+  HPNI+NL+   +  +  + Y+ +EY   G              +  F    + 
Sbjct: 61  -LCKLGHHPNIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 117

Query: 224 GESMARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
             +++ + L     D+  G+ YL     +H D+   N+LV  +   KI DF +S+  E  
Sbjct: 118 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-- 175

Query: 280 NDVLRRSPGT-PVFTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYD 337
              ++++ G  PV       L  +     +D W+ GV L+ ++ +G  P+ G T  + Y+
Sbjct: 176 -VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234

Query: 338 KI 339
           K+
Sbjct: 235 KL 236

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 45/227 (19%), Positives = 81/227 (35%), Gaps = 41/227 (18%)

Query: 123 VRKIGAGSYGK--VVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
           +  IG        V L +        A+K  +      L     E  +  +++E++  + 
Sbjct: 3   LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKIN------LDSCSKED-LKLLQQEIITSRQ 55

Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ---------PGAIGESMARKY 231
           LQHPNI+  +      +    Y+V   +        +G          P  + E      
Sbjct: 56  LQHPNILPYVTSFIVDSE--LYVVSPLM-------AYGSCEDLLKTHFPEGLPELAIAFI 106

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L+D+++ L Y+H    +H  +K  ++L++  G V +     S          R     P 
Sbjct: 107 LKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166

Query: 292 F-------TAPECC----LGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
                    +PE       G  Y  K +D ++VG+T   +  G  PF
Sbjct: 167 SSVKNLPWLSPEVLQQNLQG--YNEK-SDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 49/201 (24%), Positives = 92/201 (45%), Gaps = 13/201 (6%)

Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KY 231
           E  +M  L H N+V L+ VI     +  Y+V+E +      +     G    S+ +  ++
Sbjct: 49  ETAVMTKLHHKNLVRLLGVI---LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQF 105

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
             D+  G+ YL    +VH D+   N+LV+  G  K+ DF +++V     D  +     PV
Sbjct: 106 SLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSK----LPV 161

Query: 292 -FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN-SLVFPD 348
            +TAPE      +  K +D W+ GV L+ +   G+ P+   +L++  + +     +  P+
Sbjct: 162 KWTAPEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPE 220

Query: 349 AMNPELRNLLEGLLCKDPTRR 369
               ++  L+      +P +R
Sbjct: 221 GCPADVYVLMTSCWETEPKKR 241

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 17/218 (7%)

Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDH---FYMVLEYVEGKWDNDGFGQPGAIGES--- 226
           RE   MK   HPN++ LI V     +       MV+       D   F     IGE    
Sbjct: 50  REAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT 109

Query: 227 ----MARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
                  +++ DI SG+ YL   N +H D+   N ++  + TV + DF +S+      D 
Sbjct: 110 LPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIY-SGDY 168

Query: 283 LRRSPGT--PV-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDK 338
            R+   +  PV + A E      Y    +D WA GVT++  M  GQ P+ G    + Y+ 
Sbjct: 169 YRQGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY 227

Query: 339 IVN-NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDV 375
           ++  N L  P     ++  L+      +P  R +   +
Sbjct: 228 LIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHL 265

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 48/213 (22%), Positives = 94/213 (44%), Gaps = 31/213 (14%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
            +IG G +GKV+L      G+ +   +  +  + +LR + +        +EV   + L H
Sbjct: 1   DEIGNGWFGKVLL------GEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNH 54

Query: 184 PNIVNL----IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMA---RKYLR--- 233
           PN++      IE I       + +VLE+     D   + +      +         R   
Sbjct: 55  PNVLQCLGQCIESIP------YLLVLEFCP-LGDLKNYLRSNRGMVAQMAQKDVLQRMAC 107

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSPGTPV- 291
           ++ SGL++LH  + +H D+   N  +    +VKIGD+ ++ + + +D  + +     P+ 
Sbjct: 108 EVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR 167

Query: 292 FTAPECC------LGLTYGGKAADTWAVGVTLY 318
           + APE        L      K ++ W++GVT++
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMW 200

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 50.3 bits (120), Expect = 6e-07
 Identities = 43/176 (24%), Positives = 74/176 (42%), Gaps = 11/176 (6%)

Query: 166 TAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGFGQPGAIG 224
             +TD    +L M  L H  IV L+ +    +     +V +    G   +       ++ 
Sbjct: 54  QEITD---HMLAMGSLDHAYIVRLLGICPGAS---LQLVTQLSPLGSLLDHVRQHRDSLD 107

Query: 225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVL 283
                 +   I  G+ YL  H +VH ++   N+L+     V+I DF V+  ++ DD    
Sbjct: 108 PQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF 167

Query: 284 RRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYD 337
                TP+ + A E  L   Y  + +D W+ GVT++ M+  G  P+ G    +  D
Sbjct: 168 YSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.9 bits (119), Expect = 7e-07
 Identities = 49/176 (27%), Positives = 75/176 (42%), Gaps = 14/176 (7%)

Query: 203 MVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP 261
           MV E+VE G  D     + G +  +      + + S L YL   N+VHG++   N+L+A 
Sbjct: 93  MVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLAR 152

Query: 262 SGT-------VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVG 314
            G        +K+ D  VS       + + R P    + APEC  G      AAD W+ G
Sbjct: 153 LGLAEGTSPFIKLSDPGVSFTALSREERVERIP----WIAPECVPGGNSLSTAADKWSFG 208

Query: 315 VTLYYMII-GQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRR 369
            TL  +   G+ P    T  +  ++        P+    EL  L+   L  +PT+R
Sbjct: 209 TTLLEICFDGEVPLKERTPSEK-ERFYEKKHRLPEPSCKELATLISQCLTYEPTQR 263

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 29/93 (31%), Positives = 44/93 (47%), Gaps = 2/93 (2%)

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN-DVLRRSPGTPV 291
           R ++  + YLH + ++H DIK +N+ +   G V +GDF  +    D N +      GT  
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIA 248

Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQ 324
             APE      Y G A D W+ G+ L+ M    
Sbjct: 249 TNAPELLARDPY-GPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 41/169 (24%), Positives = 67/169 (39%), Gaps = 26/169 (15%)

Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYM------VLEYVEGKWDNDGFGQPGAIGES 226
           RE+ I+K + H  I+NLI      ++    M      +  YV+           G +   
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS---------GPLPLE 185

Query: 227 MARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS 286
            A    R ++  L YLHG  ++H D+K +N+ +       +GDF  +   +   D    +
Sbjct: 186 QAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD----T 241

Query: 287 P------GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG 329
           P      GT    +PE      Y  K  D W+ G+ L+ M +      G
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFG 289

Length = 392

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 55/248 (22%), Positives = 107/248 (43%), Gaps = 54/248 (21%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
           + +G G +G+VV+  +    K    +A   + +  L+   +E  ++D+  E+ +MKM+ +
Sbjct: 21  KPLGEGCFGQVVMAEALGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 79

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR--------- 233
           H NI+NL+           Y+++EY                 +   R+YLR         
Sbjct: 80  HKNIINLLGACTQDGP--LYVIVEYA---------------SKGNLREYLRARRPPGMEY 122

Query: 234 ---------------DIVS-------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                          D+VS       G+ YL     +H D+   N+LV  +  +KI DF 
Sbjct: 123 SYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 182

Query: 272 VSQVFEDDNDVLRRSPGT-PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFL 328
           +++   + +   + + G  PV + APE      Y  + +D W+ GV ++ +  +G  P+ 
Sbjct: 183 LARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYP 241

Query: 329 GETLQDTY 336
           G  +++ +
Sbjct: 242 GIPVEELF 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 38/159 (23%), Positives = 77/159 (48%), Gaps = 9/159 (5%)

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT- 289
           Y   +  G+ +L     +H D+   N+L++ +  VKI DF +++    D D +R+     
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LV 345
           P+ + APE      Y  + +D W+ GV L+ +  +G  P+ G  + + + + +     + 
Sbjct: 244 PLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 302

Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD 384
            PD   PE+   +      +P++R T +++ +H   LG+
Sbjct: 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH---LGN 338

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 58/250 (23%), Positives = 106/250 (42%), Gaps = 58/250 (23%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
           + +G G +G+VV+  +    K    +   K  +  L+   +E  ++D+  E+ +MKM+ +
Sbjct: 24  KPLGEGCFGQVVMAEAIGLDKEKPNRV-TKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82

Query: 183 HPNIVNLIEVI--DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR------- 233
           H NI+NL+     D P     Y+++EY                 +   R+YLR       
Sbjct: 83  HKNIINLLGACTQDGP----LYVIVEYA---------------SKGNLREYLRARRPPGM 123

Query: 234 -----------------DIVS-------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGD 269
                            D+VS       G+ YL     +H D+   N+LV     +KI D
Sbjct: 124 EYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 183

Query: 270 FSVSQVFEDDNDVLRRSPGT-PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYP 326
           F +++     +   + + G  PV + APE      Y  + +D W+ GV L+ +  +G  P
Sbjct: 184 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSP 242

Query: 327 FLGETLQDTY 336
           + G  +++ +
Sbjct: 243 YPGVPVEELF 252

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 6/140 (4%)

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLRRSPGTPV-F 292
           +  G+ +L   N VH D+   N+L+A    VKI DF +++ +  D N V + S   PV +
Sbjct: 246 VARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKW 305

Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDT-YDKIVNN-SLVFPDA 349
            APE      Y    +D W+ G+ L+ +  +G  P+ G  +  T Y+KI +   +  PD 
Sbjct: 306 MAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDH 364

Query: 350 MNPELRNLLEGLLCKDPTRR 369
              E+ +++      +P +R
Sbjct: 365 ATQEVYDIMVKCWNSEPEKR 384

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 38/233 (16%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVA-----PSETAMTDVRREVLIM 178
           + +G G +G+VV        + Y I          + V       ++  + D+  E+ +M
Sbjct: 18  KPLGEGCFGQVV------RAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 179 KML-QHPNIVNLIEVI--DDPNSDHFYMVLEYV-EGKWD-----------NDGFGQPGAI 223
           K++ +H NI+NL+ V   + P     Y+++EY  +G              +  F      
Sbjct: 72  KLIGKHKNIINLLGVCTQEGP----LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP 127

Query: 224 GESMARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
            E ++ K L      +  G+ YL     +H D+   N+LV     +KI DF +++   D 
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI 187

Query: 280 NDVLRRSPG-TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLG 329
           +   + S G  PV + APE      Y  + +D W+ G+ ++ +  +G  P+ G
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPYPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 21/42 (50%), Positives = 28/42 (66%)

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
           +R +++GL  LH   +VH DIKP+NLLV   G VKI DF  +
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 57/236 (24%), Positives = 110/236 (46%), Gaps = 30/236 (12%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
           + +G G +G+VV+  +    K    K    + +  L+   ++  ++D+  E+ +MKM+ +
Sbjct: 18  KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVA-VKMLKDDATDKDLSDLVSEMEMMKMIGK 76

Query: 183 HPNIVNLIEVI--DDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESMARKYL----- 232
           H NI+NL+     D P     Y+++EY   K +   +    +P  +  S     L     
Sbjct: 77  HKNIINLLGACTQDGP----LYVLVEYA-SKGNLREYLRARRPPGMDYSFDTCKLPEEQL 131

Query: 233 --RDIVS-------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVL 283
             +D+VS       G+ YL     +H D+   N+LV     +KI DF +++   + +   
Sbjct: 132 TFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK 191

Query: 284 RRSPGT-PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTY 336
           + + G  PV + APE      Y  + +D W+ GV L+ +  +G  P+ G  +++ +
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 58/244 (23%), Positives = 105/244 (43%), Gaps = 44/244 (18%)

Query: 123 VRKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
            + +G G++G+VV   +  LD  +       K     L+   +E  ++D+  E+ +MKM+
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVK----MLKDDATEKDLSDLVSEMEMMKMI 72

Query: 182 -QHPNIVNLIEVI--DDPNSDHFYMVLEY---------------VEGKWDNDGFGQPGAI 223
            +H NI+NL+ V   + P     Y+V+EY                      D    P   
Sbjct: 73  GKHKNIINLLGVCTQEGP----LYVVVEYAAHGNLRDFLRARRPPGEYASPDD---PRPP 125

Query: 224 GESMARKYLRDIVS-------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
            E++     +D+VS       G+ +L     +H D+   N+LV     +KI DF +++  
Sbjct: 126 EETLT---QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI 182

Query: 277 EDDNDVLRRSPG-TPV-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQ 333
              +   + + G  PV + APE      Y    +D W+ GV L+    +G  P+ G  ++
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241

Query: 334 DTYD 337
           + + 
Sbjct: 242 ELFK 245

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 11/149 (7%)

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLRRSPGT--- 289
           +I  G+ YL+    VH D+   N +VA   TVKIGDF +++ ++E D     R  G    
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD---YYRKGGKGLL 183

Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYM-IIGQYPFLGETLQDTYDKIVN-NSLVF 346
           PV + APE      +   ++D W+ GV L+ +  + + P+ G + +     +++   L  
Sbjct: 184 PVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ 242

Query: 347 PDAMNPELRNLLEGLLCKDPTRRLTLNDV 375
           PD     + +L+      +P  R T  ++
Sbjct: 243 PDNCPERVTDLMRMCWQFNPKMRPTFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 35/237 (14%)

Query: 148 IKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNL--IEVIDDPNSDHFYMVL 205
           +K    SH   + +A  ETA         +M+ + H +IV L  + V D  N     MV 
Sbjct: 37  LKVLDPSH-RDISLAFFETAS--------MMRQVSHKHIVLLYGVCVRDVEN----IMVE 83

Query: 206 EYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT 264
           E+VE G  D     +   +      K  + + S L YL   ++VHG++   N+L+A  G 
Sbjct: 84  EFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGI 143

Query: 265 -------VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTL 317
                  +K+ D  +        + + R P    + APEC         AAD W+ G TL
Sbjct: 144 DGECGPFIKLSDPGIPITVLSRQECVERIP----WIAPECVEDSKNLSIAADKWSFGTTL 199

Query: 318 YYMII-GQYPFLGETLQDT---YDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL 370
           + +   G+ P   +TL +    Y+      LV P     EL +L+   +  DP +R 
Sbjct: 200 WEICYNGEIPLKDKTLAEKERFYEG--QCMLVTPSC--KELADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 54/273 (19%), Positives = 105/273 (38%), Gaps = 69/273 (25%)

Query: 136 LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNL----IE 191
           +Y+   + K   I+ F K H         +  +     E+  ++ +   NI+ +    I+
Sbjct: 36  IYKGIFNNKEVIIRTFKKFHKG------HKVLIDITENEIKNLRRIDSNNILKIYGFIID 89

Query: 192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR------------------ 233
           ++DD       ++LEY                     R YLR                  
Sbjct: 90  IVDDLPR--LSLILEYCT-------------------RGYLREVLDKEKDLSFKTKLDMA 128

Query: 234 -DIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSVSQV-----FEDDNDVLRRS 286
            D   GL  L+ + N  + ++   + LV  +  +KI    + ++     F++ N ++  S
Sbjct: 129 IDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFS 188

Query: 287 PG--TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--NN 342
                 +F+         Y  K  D +++GV L+ +  G+ PF   T ++ YD I+  NN
Sbjct: 189 YKMLNDIFS--------EYTIKD-DIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN 239

Query: 343 SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDV 375
           SL  P     E++ ++E     D  +R  + ++
Sbjct: 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272

Length = 283

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.1 bits (104), Expect = 8e-05
 Identities = 34/148 (22%), Positives = 72/148 (48%), Gaps = 6/148 (4%)

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLRRSPGTPV-F 292
           +  G+ +L   N +H D+   N+L+      KI DF +++ +  D N V++ +   PV +
Sbjct: 223 VAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKW 282

Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LVFPDA 349
            APE      Y  + +D W+ G+ L+ +  +G  P+ G  +   + K++     ++ P+ 
Sbjct: 283 MAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPEC 341

Query: 350 MNPELRNLLEGLLCKDPTRRLTLNDVAK 377
              E+ ++++     DP +R T   + +
Sbjct: 342 APSEMYDIMKSCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 32/104 (30%), Positives = 54/104 (51%), Gaps = 10/104 (9%)

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLRRSPGT--- 289
           +I  G+ YL+ +  VH D+   N +VA   TVKIGDF +++ ++E D     R  G    
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD---YYRKGGKGLL 183

Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYM-IIGQYPFLGET 331
           PV + +PE      +    +D W+ GV L+ +  + + P+ G +
Sbjct: 184 PVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMS 226

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain

 Score = 42.1 bits (100), Expect = 1e-04
 Identities = 38/185 (20%), Positives = 75/185 (40%), Gaps = 43/185 (23%)

Query: 110 DENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMT 169
           D +G  +    +   ++G  S+ KV   R  L  + +A       +LS+L       A  
Sbjct: 36  DPDGNPVA---LKFHRLGRTSFRKVKRKRDYLGDRKHA----SWLYLSRL------AAQ- 81

Query: 170 DVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG-------KWDNDGFGQPGA 222
              +E   +K L +     + + ID   + H  +V+EY++G         ++        
Sbjct: 82  ---KEFAALKAL-YEEGFPVPKPID--WNRHA-VVMEYIDGVELYRVRVLED-------- 126

Query: 223 IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF--SVSQVFEDDN 280
                  + L +I+  ++  + H ++HGD+   N+LV     + I D+   VS    +  
Sbjct: 127 -----PEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDHPNAE 181

Query: 281 DVLRR 285
           ++L R
Sbjct: 182 ELLDR 186

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198

>gnl|CDD|226699 COG4248, COG4248, Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 27/103 (26%), Positives = 48/103 (46%), Gaps = 8/103 (7%)

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP-GTPV 291
           R++ S    LH H  V GD+  ++ LV+    V + D    Q+  + N  L   P G   
Sbjct: 124 RNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI--NANGTLHLCPVGVSE 181

Query: 292 FTAPECCLGLTYGGKAA----DTWAVGVTLYYMII-GQYPFLG 329
           FT PE     ++ G       D + + V +++++  G++P+ G
Sbjct: 182 FTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224

Length = 637

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 41.4 bits (98), Expect = 3e-04
 Identities = 30/100 (30%), Positives = 47/100 (47%), Gaps = 20/100 (20%)

Query: 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMY--LHGHNVVHGDI 252
           DP++    +V+EY+EGK   D         E    + LR+I  G +   LH   +VHGD+
Sbjct: 68  DPDN--KTIVMEYIEGKPLKDVI-------EEGNDELLREI--GRLVGKLHKAGIVHGDL 116

Query: 253 KPDNLLVAPSGTVKIGDFSVSQVFEDDND------VLRRS 286
              N++V       I DF + +  ++  D      VL+RS
Sbjct: 117 TTSNIIVRDDKLYLI-DFGLGKYSDEIEDKAVDLHVLKRS 155

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 63/275 (22%), Positives = 108/275 (39%), Gaps = 33/275 (12%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           E   V+ +G+G++G V       DG++  I    K     LR   S  A  ++  E  +M
Sbjct: 8   ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKV----LRENTSPKANKEILDEAYVM 63

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
             +  P +  L+ +           ++ Y  G   +        IG      +   I  G
Sbjct: 64  AGVGSPYVCRLLGICLTSTVQLVTQLMPY--GCLLDYVRENKDRIGSQDLLNWCVQIAKG 121

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TPV-FTAPE 296
           + YL    +VH D+   N+LV     VKI DF ++++ + D        G  P+ + A E
Sbjct: 122 MSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181

Query: 297 CCLGLTYGGKAADTWAVGVTLY-YMIIGQYPF-------------LGETL-------QDT 335
             L   +  + +D W+ GVT++  M  G  P+              GE L        D 
Sbjct: 182 SILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV 240

Query: 336 YDKIVNNSLVFPDAMNPELRNLLEGL--LCKDPTR 368
           Y  +V   ++  +   P  R L++    + +DP+R
Sbjct: 241 YMIMVKCWMIDSEC-RPRFRELVDEFSRMARDPSR 274

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

 Score = 41.5 bits (98), Expect = 5e-04
 Identities = 39/165 (23%), Positives = 64/165 (38%), Gaps = 32/165 (19%)

Query: 109 EDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAM 168
            D  G K+    V   ++G  S+ KV   R  L  K       H S L   R+A      
Sbjct: 111 IDPKGRKVA---VKFHRLGRTSFRKVKRNRDYLADKE------HGSWLYVSRLA------ 155

Query: 169 TDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGE 225
               RE   ++ L +P  V + + I    + H  +V+EY+EG               +  
Sbjct: 156 --AEREFEALQRL-YPEGVKVPKPIA--WNRH-AVVMEYIEGV--------ELYRLRLDV 201

Query: 226 SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270
               + L  I+  +   +   +VHGD+   N+LV   G + + D+
Sbjct: 202 ENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDW 246

Length = 304

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 42/215 (19%)

Query: 124 RKIGAGSYGKVVLYRSSL---DGK--HYAIKAFHKSHLSKLRVAPSETAMTDVR---REV 175
           R IG G +G V  Y  +L   DG+  H A+K+     L+++      T + +V    +E 
Sbjct: 1   RVIGKGHFGCV--YHGTLIDSDGQKIHCAVKS-----LNRI------TDLEEVEQFLKEG 47

Query: 176 LIMKMLQHPNIVNLIEV-IDDPNSDHF---YM----VLEYVEGKWDNDGFGQPGAIGESM 227
           +IMK   HPN+++L+ + +    S      YM    +  ++  +  N         G  +
Sbjct: 48  IIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV 107

Query: 228 ARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLRRS 286
           A+        G+ YL     VH D+   N ++  S TVK+ DF +++ +++ +   +   
Sbjct: 108 AK--------GMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159

Query: 287 PGT--PV-FTAPECCLGLTYGGKAADTWAVGVTLY 318
            G   PV + A E      +  K +D W+ GV L+
Sbjct: 160 TGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLW 193

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 16/134 (11%)

Query: 209 EGKWDNDGFGQPGA------IGESMARKYLR------DIVSGLMYLHGHNVVHGDIKPDN 256
           E  +D      P        I ES A  Y+        + +G+ +L   N VH D+   N
Sbjct: 210 ESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269

Query: 257 LLVAPSGTVKIGDFSVSQ-VFEDDNDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVG 314
           +L+     VKI DF +++ +  D N + + S   P+ + APE      Y    +D W+ G
Sbjct: 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFG 328

Query: 315 VTLYYMI-IGQYPF 327
           + L+ +  +G  P+
Sbjct: 329 ILLWEIFTLGGTPY 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 38/158 (24%), Positives = 68/158 (43%), Gaps = 27/158 (17%)

Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF----GQPGAIGESMAR 229
           E  +++ L HP ++ L++V          +VL     K+ +D +     +   +G +   
Sbjct: 210 EARLLRRLSHPAVLALLDV--RVVGGLTCLVLP----KYRSDLYTYLGARLRPLGLAQVT 263

Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
              R ++S + Y+HG  ++H DIK +N+LV     + +GDF  +          R S  T
Sbjct: 264 AVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAAC-------FARGSWST 316

Query: 290 PVF---------TAPECCLGLTYGGKAADTWAVGVTLY 318
           P            APE   G  Y   + D W+ G+ ++
Sbjct: 317 PFHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIF 353

Length = 461

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 37/159 (23%), Positives = 76/159 (47%), Gaps = 9/159 (5%)

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR-SPGT 289
           Y   +  G+ +L     +H D+   N+L++ +  VKI DF +++    D D +R+     
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237

Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LV 345
           P+ + APE      Y  + +D W+ GV L+ +  +G  P+ G  + + + + +     + 
Sbjct: 238 PLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR 296

Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD 384
            P+   PE+ +++      +P  R T +++ +    LGD
Sbjct: 297 APEYATPEIYSIMLDCWHNNPEDRPTFSELVEI---LGD 332

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 38.4 bits (90), Expect = 0.003
 Identities = 21/98 (21%), Positives = 40/98 (40%), Gaps = 30/98 (30%)

Query: 203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMY--------LHGHNVVHGDIKP 254
           +V+EY+EG+               + +  L +    L+         LH   +VHGD+  
Sbjct: 76  IVMEYIEGE---------------LLKDALEEARPDLLREVGRLVGKLHKAGIVHGDLTT 120

Query: 255 DNLLVAPSGTVKIGDFSVSQVFEDDND------VLRRS 286
            N++++      I DF + +  ++  D      VL R+
Sbjct: 121 SNIILSGGRIYFI-DFGLGEFSDEVEDKAVDLHVLERA 157

Length = 204

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 39.8 bits (93), Expect = 0.003
 Identities = 26/89 (29%), Positives = 41/89 (46%), Gaps = 16/89 (17%)

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMA----RKYLR 233
           M  LQHPNIV LI +         Y++ EY+EGK           +  +++    RK   
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGA--YLIHEYIEGK-------NLSEVLRNLSWERRRKIAI 787

Query: 234 DIVSGLMYLHGH---NVVHGDIKPDNLLV 259
            I   L +LH      VV G++ P+ +++
Sbjct: 788 GIAKALRFLHCRCSPAVVVGNLSPEKIII 816

Length = 968

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 16/45 (35%), Positives = 30/45 (66%)

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
           ++D+++ L Y+H H + HGDIKP+N++V  +    I D+ ++  F
Sbjct: 132 MKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHF 176

Length = 294

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	410
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
PRK10345	210	hypothetical protein; Provisional	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
smart00090	237	RIO RIO-like kinase.	99.85
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.75
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.73
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.67
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.54
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.52
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.52
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.51
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.5
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.47
KOG1243	690	consensus Protein kinase [General function predict	99.36
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.29
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.29
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.25
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.19
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.17
KOG3087	229	consensus Serine/threonine protein kinase [General	99.13
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.01
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.0
COG4248	637	Uncharacterized protein with protein kinase and he	98.98
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.93
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.87
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.81
PRK09902	216	hypothetical protein; Provisional	98.72
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.68
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.67
PF01636	239	APH: Phosphotransferase enzyme family This family	98.59
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.58
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.55
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.54
PLN02876	822	acyl-CoA dehydrogenase	98.43
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.3
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.3
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.2
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.16
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.12
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.11
PRK10593	297	hypothetical protein; Provisional	98.07
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.03
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.0
KOG2270	520	consensus Serine/threonine protein kinase involved	97.92
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.92
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.91
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.8
PRK05231	319	homoserine kinase; Provisional	97.79
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.75
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.65
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.58
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.52
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.51
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.47
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.46
PLN02756	418	S-methyl-5-thioribose kinase	97.2
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.1
PRK12396	409	5-methylribose kinase; Reviewed	97.08
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.07
PLN02236	344	choline kinase	97.06
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.97
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.75
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.46
PRK06148	1013	hypothetical protein; Provisional	96.35
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	96.24
COG2334	331	Putative homoserine kinase type II (protein kinase	96.14
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.05
PRK10271	188	thiK thiamine kinase; Provisional	95.84
PF07914	414	DUF1679: Protein of unknown function (DUF1679); In	95.83
PRK11768	325	serine/threonine protein kinase; Provisional	95.8
PTZ00296	442	choline kinase; Provisional	94.89

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-70  Score=508.27  Aligned_cols=373  Identities=24%  Similarity=0.346  Sum_probs=293.7

Q ss_pred             CCcccchhhhcccccc-ccCCccccCCCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCccchhhhh
Q 015257            1 MFRKTCSWIRDMGCCS-CFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTADGDGGEMQNHAKR   79 (410)
Q Consensus         1 ~~~~~~~~~~~~~c~~-~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   79 (410)
                      ++++.|+|||+..||. |....-+.....+..+++.++.+++.--...+...+.+|+|.||++.|......+......+.
T Consensus        61 ~~nd~f~fGR~~~~d~~ln~~~~s~~~~~i~~~~~~~~~~f~~dr~~~sn~~y~~DhS~nGT~VN~e~i~k~~~r~lkN~  140 (475)
T KOG0615|consen   61 LANDEFTFGRGDSCDAPLNLNNVSNKHFKILLYNKISKIHFRIDRDKNSNRVYLHDHSRNGTFVNDEMIGKGLSRILKNG  140 (475)
T ss_pred             eccceEEecCCCcccccccCccccccchheeeeeeeeeeeecccCCCccceEEEEecccCcccccHhHhhccccccccCC
Confidence            3578899999988876 444433333444445555555554422224455677899999999998876666666655555


Q ss_pred             hHHHHHHhhhcccccccCCccccccccccccccccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeeccccccc
Q 015257           80 SEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKL  159 (410)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~  159 (410)
                      ++..++......++..+.....       +-.....+.+.|.+.+.||+|+||.|.+|..+.+|+.||||++++......
T Consensus       141 dei~is~p~~~~~v~~~~s~d~-------~~~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~  213 (475)
T KOG0615|consen  141 DEISISIPALKIFVFEDLSRDS-------SKVPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGC  213 (475)
T ss_pred             CEEEeccchhheeeeecccchh-------ccCccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccc
Confidence            4443333222222222221111       111223456778999999999999999999999999999999998754432


Q ss_pred             ccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHH
Q 015257          160 RVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL  239 (410)
Q Consensus       160 ~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL  239 (410)
                      .  ...+....+.+|+++|++|+|||||+++++|..+  +..||||||++||.|.+.+..++.+.+...+.+++||+.||
T Consensus       214 s--~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~--ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~av  289 (475)
T KOG0615|consen  214 S--RAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP--DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAV  289 (475)
T ss_pred             c--ccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC--CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHH
Confidence            1  1223334578999999999999999999999874  47899999999999999999999999999999999999999


Q ss_pred             HHHHhCCcEeccCCCCcEEEcCC---CcEEEeeccccccccCCccccccCCCcccccccccccCCc--CCCchhhHHHHH
Q 015257          240 MYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT--YGGKAADTWAVG  314 (410)
Q Consensus       240 ~yLH~~~iiHrDlkp~NIll~~~---~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlG  314 (410)
                      .|||++||+||||||+|||+..+   ..+||+|||+|+... ....+.+.||||.|.|||++.+..  ++..++||||||
T Consensus       290 kYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlG  368 (475)
T KOG0615|consen  290 KYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLG  368 (475)
T ss_pred             HHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc-cceehhhhcCCccccChhheecCCeecccchheeeecc
Confidence            99999999999999999999877   679999999999876 456789999999999999997654  334579999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          315 VTLYYMIIGQYPFLGETLQD-TYDKIVNNSLVFP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       315 ~il~elltG~~Pf~~~~~~~-~~~~i~~~~~~~p----~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      |+||.+|+|.+||.+..... ..++|.++.+.|-    ..++.+..+||++||.+||++|||++|+|+||||+..+
T Consensus       369 cvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  369 CVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             ceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            99999999999999876665 8899999988654    36899999999999999999999999999999998654

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-61  Score=453.06  Aligned_cols=315  Identities=45%  Similarity=0.760  Sum_probs=276.4

Q ss_pred             hcccccccCCccccccccccccccccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHH-
Q 015257           89 LNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETA-  167 (410)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~-  167 (410)
                      .+...+....++++.+........+.+.+++|.+.+.||+|.||.|.+|++..+++.||||++.+..+.+......... 
T Consensus        68 ~~~~~~~~~~vket~k~~~~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~  147 (576)
T KOG0585|consen   68 QNNSPRSWRRVKETNKIVRYDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAM  147 (576)
T ss_pred             cccccccccccceeeeeeeecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhccccccccc
Confidence            3344566677788888888888888999999999999999999999999999999999999998876655444443333 


Q ss_pred             ----HHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 015257          168 ----MTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH  243 (410)
Q Consensus       168 ----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH  243 (410)
                          .+...+||.+|++++|||||+|+++..++....+|||+|||..|.+...--....+++.+++.|+++++.||+|||
T Consensus       148 ~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH  227 (576)
T KOG0585|consen  148 KLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLH  227 (576)
T ss_pred             ccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHH
Confidence                3589999999999999999999999999999999999999998877665444434999999999999999999999


Q ss_pred             hCCcEeccCCCCcEEEcCCCcEEEeecccccccc-----CCccccccCCCcccccccccccC---CcCCCchhhHHHHHH
Q 015257          244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE-----DDNDVLRRSPGTPVFTAPECCLG---LTYGGKAADTWAVGV  315 (410)
Q Consensus       244 ~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~-----~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~  315 (410)
                      .+|||||||||+|+||+.+|+|||+|||.+....     +.........|||.|+|||.+.+   ..+.+.+.||||+||
T Consensus       228 ~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGV  307 (576)
T KOG0585|consen  228 YQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGV  307 (576)
T ss_pred             hcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhh
Confidence            9999999999999999999999999999998662     23334556789999999998876   345578999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC-CCCCchhh
Q 015257          316 TLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA--MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD-NGPIPQYL  392 (410)
Q Consensus       316 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~-~~~~~~~~  392 (410)
                      +||.|+.|+.||.+....+.+++|....+.||..  +...+++||++||++||.+|.++.+|..|||+... ..+.++.-
T Consensus       308 TLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~~~s~~  387 (576)
T KOG0585|consen  308 TLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSPQSSEP  387 (576)
T ss_pred             hHHHhhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCCccCCc
Confidence            9999999999999999999999999999999975  79999999999999999999999999999999977 88999999


Q ss_pred             hhhhccccccc
Q 015257          393 CWCKRDRLRRD  403 (410)
Q Consensus       393 ~~~~~~~~~~~  403 (410)
                      +||.+..+...
T Consensus       388 ~~c~~v~v~ee  398 (576)
T KOG0585|consen  388 SSCSRVEVTEE  398 (576)
T ss_pred             ccceeeeeecc
Confidence            99998766443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-60  Score=460.70  Aligned_cols=260  Identities=31%  Similarity=0.511  Sum_probs=243.5

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ..|...+.||+|||+.||.+++..+|+.||+|++.+..+.+      ....+.+.+||+|.+.|+|||||+++++|+|  
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k------~~~reKv~~EIeIHr~L~HpnIV~f~~~FED--   89 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK------PKQREKVLNEIEIHRSLKHPNIVQFYHFFED--   89 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC------cchHHHHHHHHHHHHhcCCCcEEeeeeEeec--
Confidence            57999999999999999999999999999999998876543      3455789999999999999999999999998  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ..++|||+|+|..+++..+++..+.++|.+++.++.||+.||.|||+++|||||||..|+||+++.+|||+|||+|..+.
T Consensus        90 s~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le  169 (592)
T KOG0575|consen   90 SNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE  169 (592)
T ss_pred             CCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeec
Confidence            56899999999999999999999999999999999999999999999999999999999999999999999999999988


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNL  357 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~l  357 (410)
                      .+.....+.||||.|+|||++....+ +..+||||+||+||.||+|++||...+..+.+.+|....+.+|..++.++++|
T Consensus       170 ~~~Erk~TlCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dL  248 (592)
T KOG0575|consen  170 YDGERKKTLCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDL  248 (592)
T ss_pred             CcccccceecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHH
Confidence            77777789999999999999986655 67799999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          358 LEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       358 i~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      |.+||..||.+|||+++||.|+||...-.
T Consensus       249 I~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~  277 (592)
T KOG0575|consen  249 IRKLLRPNPSERPSLDEVLDHPFFKSGFT  277 (592)
T ss_pred             HHHHhcCCcccCCCHHHHhcCHhhhCCCc
Confidence            99999999999999999999999966533

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-59  Score=428.18  Aligned_cols=260  Identities=28%  Similarity=0.500  Sum_probs=234.9

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++.+.++.||+|..|+||+++++.+++.||+|++...        ...+..+++.+|+++++..+||+||.+|++|.
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--------~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~  147 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--------IDPALQKQILRELEILRSCQSPYIVGFYGAFY  147 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--------CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence            3445678899999999999999999999999999998432        35677789999999999999999999999999


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .+.. .++|+||||+||+|...+...+.++|.....++.+|++||.|||+ ++||||||||+|||++..|.|||||||.+
T Consensus       148 ~~~~-~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS  226 (364)
T KOG0581|consen  148 SNGE-EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVS  226 (364)
T ss_pred             eCCc-eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEecccccc
Confidence            8543 699999999999999999988999999999999999999999995 89999999999999999999999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCC-CCCC
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE-----TLQDTYDKIVNNS-LVFP  347 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~-----~~~~~~~~i~~~~-~~~p  347 (410)
                      +.+.+.  ...++.||..|||||.+.+..+ +.++||||||++++||++|+.||...     ...+++..|..+. ...|
T Consensus       227 ~~lvnS--~a~tfvGT~~YMsPERi~g~~Y-s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP  303 (364)
T KOG0581|consen  227 GILVNS--IANTFVGTSAYMSPERISGESY-SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLP  303 (364)
T ss_pred             HHhhhh--hcccccccccccChhhhcCCcC-CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCC
Confidence            887654  6688999999999999999877 55699999999999999999999875     6677888888854 4677


Q ss_pred             CC-CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          348 DA-MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       348 ~~-~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      .. +|+++++||..||++||.+|||+.|+++|||+++...
T Consensus       304 ~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  304 EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             cccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence            76 9999999999999999999999999999999997644

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-58  Score=425.88  Aligned_cols=260  Identities=35%  Similarity=0.605  Sum_probs=240.2

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      -.++|.+++.||+|+||+||+++.+.+++.||+|++++....+      ....+....|..+|..++||.||+++-.|++
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~------~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt   96 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE------KKEVRHTKAERNILSKIKHPFIVKLIYSFQT   96 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh------hhhHHHHHHHHHHHHhCCCCcEeeeEEeccc
Confidence            3568999999999999999999999999999999998775432      3456789999999999999999999999997


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                        ...+|+|+||++||.|..++.+.+.++|..++.|+..|+.||.|||++|||||||||+|||||.+|+++|+|||+++.
T Consensus        97 --~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~  174 (357)
T KOG0598|consen   97 --EEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKE  174 (357)
T ss_pred             --CCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchh
Confidence              458999999999999999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCCCCHHH
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV-FPDAMNPEL  354 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~~~~l  354 (410)
                      .........++|||+.|||||++.+..+ ++++|.||||+++|+|++|.+||.+.+...++++|..++.. .|..+++++
T Consensus       175 ~~~~~~~t~tfcGT~eYmAPEil~~~gy-~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~a  253 (357)
T KOG0598|consen  175 DLKDGDATRTFCGTPEYMAPEILLGKGY-DKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEA  253 (357)
T ss_pred             cccCCCccccccCCccccChHHHhcCCC-CcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHH
Confidence            7777777888999999999999998876 77899999999999999999999999999999999999954 455599999


Q ss_pred             HHHHHHhcccCCCCCC----CHHHHhhCCcccCC
Q 015257          355 RNLLEGLLCKDPTRRL----TLNDVAKHTWVLGD  384 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rp----t~~ell~h~~~~~~  384 (410)
                      ++|++++|..||++|.    ++.++-+||||.+-
T Consensus       254 rdll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i  287 (357)
T KOG0598|consen  254 RDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI  287 (357)
T ss_pred             HHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence            9999999999999996    79999999999764

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-57  Score=404.67  Aligned_cols=257  Identities=33%  Similarity=0.590  Sum_probs=239.5

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|++++.||.|+||.|.+++++.+|..||+|++++...-+      -.+.+...+|..+|+.+.||.++++++.|.
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVk------lKQveH~~nEk~vL~~v~~PFlv~l~~t~~  114 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVK------LKQVEHTHNEKRVLKAVSHPFLVKLYGTFK  114 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHH------HHHHHHHhhHHHHHhhccCceeEEEEEeec
Confidence            45678999999999999999999999999999999998775543      346678899999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      +  ..++||||||++||.+..++.+.+++++..++.|+.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+|+
T Consensus       115 d--~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK  192 (355)
T KOG0616|consen  115 D--NSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAK  192 (355)
T ss_pred             c--CCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceE
Confidence            7  56899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPEL  354 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l  354 (410)
                      ...+.   .-+.||||.|+|||+++...+ .+++|.|||||++|||+.|.+||...+..+.+++|+.+.+.||..+++++
T Consensus       193 ~v~~r---T~TlCGTPeYLAPEii~sk~y-nkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~  268 (355)
T KOG0616|consen  193 RVSGR---TWTLCGTPEYLAPEIIQSKGY-NKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDA  268 (355)
T ss_pred             EecCc---EEEecCCccccChHHhhcCCC-CcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHH
Confidence            76553   457899999999999988877 78899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcccCCCCC-----CCHHHHhhCCcccC
Q 015257          355 RNLLEGLLCKDPTRR-----LTLNDVAKHTWVLG  383 (410)
Q Consensus       355 ~~li~~~L~~dp~~R-----pt~~ell~h~~~~~  383 (410)
                      ++||.++|++|-.+|     ....+|..||||.+
T Consensus       269 kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~  302 (355)
T KOG0616|consen  269 KDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG  302 (355)
T ss_pred             HHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence            999999999999999     36789999999985

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-55  Score=424.61  Aligned_cols=263  Identities=36%  Similarity=0.683  Sum_probs=240.1

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVI  193 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~  193 (410)
                      .....|.+.+.||+|+||.|+++.+..+|..||||++.+.....   .. ....+.+.+|+.+++.+. ||||+++++++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~---~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~   89 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSS---KS-QKLDELIKREISILRRLRSHPNIIRLLEVF   89 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccc---cc-cccchhhHHHHHHHHHhccCCCEeEEEEEE
Confidence            45578999999999999999999999999999999877652211   11 133456779999999999 99999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC-CcEEEeeccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-GTVKIGDFSV  272 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~-~~~kl~DfG~  272 (410)
                      ..+  ..+|+||||+.||.|.+.+...+++.|..++.++.||+.||+|+|++||+||||||+|||++.+ +++||+|||+
T Consensus        90 ~t~--~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   90 ATP--TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             ecC--CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccc
Confidence            874  4599999999999999999988999999999999999999999999999999999999999999 9999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCc-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCC-
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLT-YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAM-  350 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~-  350 (410)
                      +...........+.+||+.|+|||++.+.. +.++++||||+||+||.|++|+.||...+...++..|..+.+.+|..+ 
T Consensus       168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~  247 (370)
T KOG0583|consen  168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLL  247 (370)
T ss_pred             ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcC
Confidence            998754456788999999999999999877 878999999999999999999999999999999999999999999999 


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                      |++++.|+.+||..||.+|+|+.+++.||||+.
T Consensus       248 S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  248 SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            999999999999999999999999999999997

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-55  Score=426.57  Aligned_cols=261  Identities=32%  Similarity=0.592  Sum_probs=243.4

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      +.-|++.+.||.|+-|.|.+|++..+|+..|||++.+..      .........+.+||.||+.+.||||+.++++|.. 
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~------~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-   83 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS------ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-   83 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeecccc------ccccccccchhhhhHHHHHhcCCCeeeeeeeecc-
Confidence            346899999999999999999999999999999997652      1133455678899999999999999999999986 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       ..++|+|+||++||.|++++...+++++.++.++++||+.||.|.|..+|+||||||+|+||+..+++||+|||+|...
T Consensus        84 -~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe  162 (786)
T KOG0588|consen   84 -KQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE  162 (786)
T ss_pred             -CceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc
Confidence             6799999999999999999999999999999999999999999999999999999999999999999999999999864


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN  356 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~  356 (410)
                      . ......+.||+|.|+|||++.+..|.+.++||||.|||||.||+|+.||.+.+...++.++..+.+.+|..+++++++
T Consensus       163 ~-~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQd  241 (786)
T KOG0588|consen  163 V-PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQD  241 (786)
T ss_pred             c-CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHH
Confidence            4 456788999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          357 LLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       357 li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      ||.+||.+||.+|.|++||++|||+++...
T Consensus       242 LLr~ml~VDp~~RiT~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  242 LLRRMLDVDPSTRITTEEILKHPFLSGYTS  271 (786)
T ss_pred             HHHHHhccCccccccHHHHhhCchhhcCCC
Confidence            999999999999999999999999998754

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.9e-55  Score=393.22  Aligned_cols=258  Identities=29%  Similarity=0.486  Sum_probs=228.7

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      +.|+.+.++|+|+||.||+++++.+|+.||||++...       ..+....+-.++||.+|++|+|||+|.++++|..  
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-------edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--   72 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-------EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--   72 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-------CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--
Confidence            5788999999999999999999999999999998543       1234455678999999999999999999999976  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+++|+|||+...|.++-.....+++..++.|++|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+.
T Consensus        73 krklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   73 KRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLS  152 (396)
T ss_pred             cceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhc
Confidence            56899999999998888887778889999999999999999999999999999999999999999999999999999988


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------C
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------------S  343 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--------------~  343 (410)
                      .+....+.++.|.+|+|||.+.+...+++++||||+||++.||++|.+.|.+.+..+++..|...              .
T Consensus       153 ~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  153 APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence            77788888899999999999999777788899999999999999999999999888877666441              0


Q ss_pred             -----CCCCC------------CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          344 -----LVFPD------------AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       344 -----~~~p~------------~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                           +.+|.            .++.-+.+|+++||+.||.+|++.+|++.||||.+.
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence                 11221            356678999999999999999999999999999654

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3e-54  Score=401.42  Aligned_cols=260  Identities=31%  Similarity=0.598  Sum_probs=234.4

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ....+|...+.||+|+||+||+++++.++..||||.+.+..+       .....+.+..|+.+|+.++|||||.+++++.
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-------~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~   79 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-------NKKLVELLLSEIKILKELKHPNIVRLLDCIE   79 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-------CHHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence            456789999999999999999999999999999999977643       3456778999999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC------CcEEEe
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS------GTVKIG  268 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~------~~~kl~  268 (410)
                      .  .+.+|+|||||.||.|.+++...+.++|.+++.++.||+.||++||+++||||||||.||||+..      -.+||+
T Consensus        80 ~--~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIA  157 (429)
T KOG0595|consen   80 D--DDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIA  157 (429)
T ss_pred             c--CCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEec
Confidence            7  45899999999999999999999999999999999999999999999999999999999999875      358999


Q ss_pred             eccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---
Q 015257          269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV---  345 (410)
Q Consensus       269 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---  345 (410)
                      |||+|+.+.. .....+.||+|.|||||++...+| +-++|+||+|+|||+|++|+.||...+..+....+..+.-.   
T Consensus       158 DFGfAR~L~~-~~~a~tlcGSplYMAPEV~~~~~Y-dAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~  235 (429)
T KOG0595|consen  158 DFGFARFLQP-GSMAETLCGSPLYMAPEVIMSQQY-DAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV  235 (429)
T ss_pred             ccchhhhCCc-hhHHHHhhCCccccCHHHHHhccc-cchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc
Confidence            9999998764 446678999999999999988777 45599999999999999999999999999988877776543   


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       346 ~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      ++...++.+.+|+...|+.+|..|.+..+-+.|+++...+
T Consensus       236 ~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  236 LPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            4457788888999999999999999999999999998765

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-54  Score=414.55  Aligned_cols=261  Identities=33%  Similarity=0.556  Sum_probs=236.7

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEV  192 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~  192 (410)
                      .+...+|...+.||+|+|++|++|+++.+++.||||++.+..+.+      +...+.+.+|-.+|.+| .||.||+|+-.
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik------e~KvkYV~~Ek~~l~~L~~hPgivkLy~T  142 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK------EKKVKYVTREKEALTQLSGHPGIVKLYFT  142 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh------hcccchhhHHHHHHHHhhCCCCeEEEEEE
Confidence            455678999999999999999999999999999999998876543      33445677899999999 89999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      |+|.  ..+|+|+||+++|.|.+++.+-+.|++..++.|+.||+.||+|||++|||||||||+|||||.++++||+|||.
T Consensus       143 FQD~--~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGs  220 (604)
T KOG0592|consen  143 FQDE--ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGS  220 (604)
T ss_pred             eecc--cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccc
Confidence            9984  57999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCcc-----------cc--ccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015257          273 SQVFEDDND-----------VL--RRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKI  339 (410)
Q Consensus       273 a~~~~~~~~-----------~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i  339 (410)
                      |+.+.....           ..  ..++||..|.+||++..... ++.+|||+||||||.|+.|.+||.+.+.--.+++|
T Consensus       221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI  299 (604)
T KOG0592|consen  221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI  299 (604)
T ss_pred             cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence            987653211           11  34789999999998776655 77899999999999999999999999998999999


Q ss_pred             HhCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          340 VNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       340 ~~~~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                      +.-.+.||+.+++.+++||+++|..||++|+|+.||.+||||.+
T Consensus       300 ~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  300 QALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             HHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence            99999999999999999999999999999999999999999965

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.6e-54  Score=412.81  Aligned_cols=259  Identities=34%  Similarity=0.614  Sum_probs=231.9

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+++.||+|+||.||+|+.+.+|..||+|++++..+.      ...+.+.++.|-.+|...++|+||+++-.|+
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~------~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ  211 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML------KKNQVEHVRAERDILAEVDSPWVVKLYYSFQ  211 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHH------hhhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence            3467899999999999999999999999999999999887654      3467789999999999999999999999999


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      +  ..++||||||++||....++...+.|++..++.|+.+++.|+.-||+.|||||||||+|+|||..|++||+|||++.
T Consensus       212 D--~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  212 D--KEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             C--CCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccc
Confidence            8  56999999999999999999999999999999999999999999999999999999999999999999999999984


Q ss_pred             cccC---------------------Ccc-c-------------------------cccCCCcccccccccccCCcCCCch
Q 015257          275 VFED---------------------DND-V-------------------------LRRSPGTPVFTAPECCLGLTYGGKA  307 (410)
Q Consensus       275 ~~~~---------------------~~~-~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~~  307 (410)
                      -+..                     +.. .                         ....+|||.|+|||++.+..+ +..
T Consensus       290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY-~~~  368 (550)
T KOG0605|consen  290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY-GKE  368 (550)
T ss_pred             hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC-Ccc
Confidence            2210                     000 0                         012359999999999998886 778


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCC--CCCHHHHHHHHHhcccCCCCCC---CHHHHhhCCc
Q 015257          308 ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFPD--AMNPELRNLLEGLLCKDPTRRL---TLNDVAKHTW  380 (410)
Q Consensus       308 ~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~~~~l~~li~~~L~~dp~~Rp---t~~ell~h~~  380 (410)
                      +|.||||||+||||.|.+||.+++..+.+.+|....  +.+|.  .+++++.+||.+||+ ||.+|.   ++.||.+|||
T Consensus       369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPf  447 (550)
T KOG0605|consen  369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPF  447 (550)
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCc
Confidence            999999999999999999999999999999998876  56775  578999999999999 999999   5999999999


Q ss_pred             ccC
Q 015257          381 VLG  383 (410)
Q Consensus       381 ~~~  383 (410)
                      |.+
T Consensus       448 F~~  450 (550)
T KOG0605|consen  448 FKG  450 (550)
T ss_pred             ccc
Confidence            986

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.6e-53  Score=386.67  Aligned_cols=287  Identities=26%  Similarity=0.405  Sum_probs=241.9

Q ss_pred             ccccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccce
Q 015257          111 ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLI  190 (410)
Q Consensus       111 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  190 (410)
                      -.++..+++|+.++.|++|+||.||+++++.+++.||+|.++...-.   ....    -..++||.+|.+++|||||.+.
T Consensus        69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek---~GFP----ItsLREIniLl~~~H~NIV~vk  141 (419)
T KOG0663|consen   69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK---EGFP----ITSLREINILLKARHPNIVEVK  141 (419)
T ss_pred             ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc---CCCc----chhHHHHHHHHhcCCCCeeeeE
Confidence            45678889999999999999999999999999999999998765311   1111    1356999999999999999999


Q ss_pred             eEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeec
Q 015257          191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       191 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                      ++....+-+.+|||||||+...-..+-....++...+++.++.|+++||+|||.++|+||||||+|+|++..|.+||+||
T Consensus       142 EVVvG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDF  221 (419)
T KOG0663|consen  142 EVVVGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADF  221 (419)
T ss_pred             EEEeccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEeccc
Confidence            99988777789999999987532222233468999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------
Q 015257          271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------  342 (410)
Q Consensus       271 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--------  342 (410)
                      |+|+.++.+...++..+-|.+|+|||.+.+...++.++|+||+|||+.||+++++.|.+....++.++|..-        
T Consensus       222 GLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i  301 (419)
T KOG0663|consen  222 GLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI  301 (419)
T ss_pred             chhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence            999999888777888888999999999999988899999999999999999999999999988888877641        


Q ss_pred             -----------CCCCCC------------C-CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCC-----chhhh
Q 015257          343 -----------SLVFPD------------A-MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI-----PQYLC  393 (410)
Q Consensus       343 -----------~~~~p~------------~-~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~-----~~~~~  393 (410)
                                 ...++.            . ++....+|++.+|..||.+|.|++|.|+|.||.+.+.|.     |++-.
T Consensus       302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~  381 (419)
T KOG0663|consen  302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPA  381 (419)
T ss_pred             CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCcc
Confidence                       111221            1 457889999999999999999999999999999975554     44555


Q ss_pred             hhhcccccccc
Q 015257          394 WCKRDRLRRDN  404 (410)
Q Consensus       394 ~~~~~~~~~~~  404 (410)
                      .++.+++.+.-
T Consensus       382 k~~~~~~~~~~  392 (419)
T KOG0663|consen  382 KSEQQRVKRGT  392 (419)
T ss_pred             ccccccCCCCC
Confidence            56666654443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-54  Score=384.07  Aligned_cols=250  Identities=29%  Similarity=0.496  Sum_probs=222.9

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCccccee-E
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE-V  192 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-~  192 (410)
                      .....+|+++++||+|+||+||++.+..+|..+|.|.++...+       +......+..|+.+|++|+|||||++++ -
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-------d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~   87 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-------DAKARQDCVKEISLLKQLNHPNIVQYYAHS   87 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-------cHHHHHHHHHHHHHHHhcCCchHHHHHHHh
Confidence            3445679999999999999999999999999999998874432       3556678899999999999999999998 3


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccC----CCCCCCHHHHHHHHHHHHHHHHHHHh--CC--cEeccCCCCcEEEcCCCc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDIVSGLMYLHG--HN--VVHGDIKPDNLLVAPSGT  264 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~gL~yLH~--~~--iiHrDlkp~NIll~~~~~  264 (410)
                      |.+ +..-++||||||.+|.|...++    +...++|..+|+++.|++.||..+|+  ..  |+||||||.||+|+.+|.
T Consensus        88 f~~-~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv  166 (375)
T KOG0591|consen   88 FIE-DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV  166 (375)
T ss_pred             hhc-cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc
Confidence            433 3445999999999999887664    45679999999999999999999998  44  999999999999999999


Q ss_pred             EEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Q 015257          265 VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL  344 (410)
Q Consensus       265 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~  344 (410)
                      |||+|||+++.+..........+|||.||+||.+....+ +.++|||||||++|||+.-++||.+.+..++..+|.++.+
T Consensus       167 vKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y-~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~  245 (375)
T KOG0591|consen  167 VKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGY-NFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY  245 (375)
T ss_pred             eeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCC-CcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC
Confidence            999999999999888888888999999999999988877 6679999999999999999999999999999999999877


Q ss_pred             C-CC-CCCCHHHHHHHHHhcccCCCCCCCH
Q 015257          345 V-FP-DAMNPELRNLLEGLLCKDPTRRLTL  372 (410)
Q Consensus       345 ~-~p-~~~~~~l~~li~~~L~~dp~~Rpt~  372 (410)
                      + .| ..+|.++..||..|+++||..||+.
T Consensus       246 ~~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  246 PPLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            4 66 6899999999999999999999985

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-53  Score=396.10  Aligned_cols=260  Identities=28%  Similarity=0.512  Sum_probs=221.2

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      .+|...+.||+|+||.||++.+..+|..+|||.+....        .. ..+.+.+|+.+|++++|||||+++|......
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--------~~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~   87 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--------SP-TSESLEREIRILSRLNHPNIVQYYGSSSSRE   87 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--------ch-hHHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence            46888999999999999999999999999999986541        11 1667999999999999999999999744322


Q ss_pred             CCEEEEEEeecCCCCcccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC-CCcEEEeecccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDFSVSQV  275 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~-~~~~kl~DfG~a~~  275 (410)
                      ...++|+|||+++|++.+++...+ .+++..++.+.+||++||+|||++|||||||||+|||++. ++.+||+|||+++.
T Consensus        88 ~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen   88 NDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKK  167 (313)
T ss_pred             CeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence            237999999999999999998876 7999999999999999999999999999999999999999 79999999999987


Q ss_pred             ccC---CccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCCC
Q 015257          276 FED---DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG-ETLQDTYDKIVNNS--LVFPDA  349 (410)
Q Consensus       276 ~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~-~~~~~~~~~i~~~~--~~~p~~  349 (410)
                      ...   .........||+.|||||++.......+++|||||||++.||+||..||.. ....+....+....  +.+|..
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~  247 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDS  247 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcc
Confidence            653   122334578999999999998643434589999999999999999999987 34444444444333  468889


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      ++++++++|.+||..||.+||||+++|+|||++....
T Consensus       248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            9999999999999999999999999999999987654

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-52  Score=399.38  Aligned_cols=264  Identities=28%  Similarity=0.451  Sum_probs=226.7

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ....+.|+.+++||+|.||.||+|++..+|+.||+|.+..+..       .........+||.||++|+|||||+|.++.
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-------~~~~~~t~~REI~ILr~l~HpNIikL~eiv  185 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-------KEGFPITAIREIKILRRLDHPNIIKLEEIV  185 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-------CCcchHHHHHHHHHHHhcCCCcccceeeEE
Confidence            3445679999999999999999999999999999999875532       233445677999999999999999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .+...+.+|||+|||+..+........-.|++.+++.|+.||+.||+|+|++||+|||||.+|||||.+|.+||+|||+|
T Consensus       186 t~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLA  265 (560)
T KOG0600|consen  186 TSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLA  265 (560)
T ss_pred             EecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccce
Confidence            88656799999999997654443343457999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCc-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C-------
Q 015257          274 QVFEDDN-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--S-------  343 (410)
Q Consensus       274 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--~-------  343 (410)
                      +++.... ..++..+-|.+|+|||.+++...++.++|+||.||||.||++|++.|.+.+..++++.|..-  .       
T Consensus       266 r~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~  345 (560)
T KOG0600|consen  266 RFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP  345 (560)
T ss_pred             eeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence            9776543 34666677999999999999998899999999999999999999999999988888888651  0       


Q ss_pred             -CCCC-------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          344 -LVFP-------------------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       344 -~~~p-------------------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                       ..+|                   ..+++...+|+..||+.||.+|.|+.++|.++||...
T Consensus       346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence             1111                   1357888999999999999999999999999999543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.1e-53  Score=407.88  Aligned_cols=256  Identities=34%  Similarity=0.599  Sum_probs=241.2

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+.+.||+|+||.||+++.+.+.+.||+|.+.+..       ..+..++.+.+|++|++.++|||||.+++.|+.  
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-------r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--   72 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-------RNEKELKNLRQEVRILRSLKHPNIVEMLESFET--   72 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-------CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--
Confidence            57999999999999999999999999999999998754       245677899999999999999999999999976  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ..++++|.||+.| .|..++...+.++|+.++.++.|++.||.|||+++|+|||+||.|||+...|.+|+||||+|+.+.
T Consensus        73 ~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~  151 (808)
T KOG0597|consen   73 SAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMS  151 (808)
T ss_pred             cceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcc
Confidence            5799999999998 899999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNL  357 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~l  357 (410)
                      ....+.+...|||.|||||.+.+..+ +..+|+||||||+|||.+|++||......+....|......+|..++..+.+|
T Consensus       152 ~~t~vltsikGtPlYmAPElv~e~py-d~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nf  230 (808)
T KOG0597|consen  152 TNTSVLTSIKGTPLYMAPELVEEQPY-DHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNF  230 (808)
T ss_pred             cCceeeeeccCcccccCHHHHcCCCc-cchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHH
Confidence            88888889999999999998886665 77799999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          358 LEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       358 i~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      +..+|.+||.+|.|..+++.|||+++.
T Consensus       231 l~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  231 LQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             HHHHhhcChhhcccHHHHhcChHHhhh
Confidence            999999999999999999999999875

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-52  Score=409.32  Aligned_cols=260  Identities=32%  Similarity=0.553  Sum_probs=238.4

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEV  192 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~  192 (410)
                      ....++|..+++||+|+||+|+++..+.+++.||||++++....      ..+..+..+.|..|+.... ||.++.++..
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il------~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~  437 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDIL------QRDEVESLMCEKRIFELANRHPFLVNLFSC  437 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeecccee------ccccHHHHHHHHHHHHHhccCCeEeecccc
Confidence            44567899999999999999999999999999999999887543      4566778889999988875 9999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      |+.  ..++|.||||+.||. ..++...+.+++..++.|+..|+.||.|||++||||||||.+|||||.+|++||+|||+
T Consensus       438 fQT--~~~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGl  514 (694)
T KOG0694|consen  438 FQT--KEHLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGL  514 (694)
T ss_pred             ccc--CCeEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccc
Confidence            987  569999999999998 44455567899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCH
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNP  352 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~  352 (410)
                      ++........+.++||||.|+|||++.+..| +.++|.|||||+|||||.|..||.+++..+..+.|+...+.+|..+|.
T Consensus       515 cKe~m~~g~~TsTfCGTpey~aPEil~e~~Y-t~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~  593 (694)
T KOG0694|consen  515 CKEGMGQGDRTSTFCGTPEFLAPEVLTEQSY-TRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSK  593 (694)
T ss_pred             ccccCCCCCccccccCChhhcChhhhccCcc-cchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccH
Confidence            9987656667889999999999999988777 788999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhcccCCCCCCC-----HHHHhhCCcccC
Q 015257          353 ELRNLLEGLLCKDPTRRLT-----LNDVAKHTWVLG  383 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~  383 (410)
                      ++.+++.++|.+||.+|+.     +.+|.+||||..
T Consensus       594 ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~  629 (694)
T KOG0694|consen  594 EAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS  629 (694)
T ss_pred             HHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence            9999999999999999994     589999999976

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-53  Score=399.03  Aligned_cols=260  Identities=30%  Similarity=0.453  Sum_probs=223.1

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVI  193 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~  193 (410)
                      .+.++|.++++||.|.||.||+|+...+|+.||||.+++...+       -+.. .-++|+..|++|+ |||||++.+++
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-------~ee~-~nLREvksL~kln~hpniikL~Evi   78 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-------WEEC-MNLREVKSLRKLNPHPNIIKLKEVI   78 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-------HHHH-HHHHHHHHHHhcCCCCcchhhHHHh
Confidence            3567899999999999999999999999999999998764321       1111 2358999999999 99999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .+... ++|+|||||+..+.+-+-.++..+++..++.|+.||+.||+|+|.+|+.|||+||+|||+..+..+||+|||+|
T Consensus        79 ~d~~~-~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLA  157 (538)
T KOG0661|consen   79 RDNDR-ILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLA  157 (538)
T ss_pred             hccCc-eEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccc
Confidence            98543 99999999987655544445678999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN-----------  342 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~-----------  342 (410)
                      +.... ....+.++.|.+|+|||++....+++.++|||++|||++|+.+-++.|.|.+..+...+|..-           
T Consensus       158 Rev~S-kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  158 REVRS-KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             ccccc-CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            97654 345667788999999999998888888999999999999999999999999888877766430           


Q ss_pred             --------CCCCCC-----------CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          343 --------SLVFPD-----------AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       343 --------~~~~p~-----------~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                              .+.+|.           ..++++.+||.+||.+||.+||||.|+|+||||+..
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG  297 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence                    122232           367899999999999999999999999999999875

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.2e-52  Score=365.89  Aligned_cols=265  Identities=27%  Similarity=0.463  Sum_probs=224.8

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      .+|..++.||+|.||.||+|++..+|+.||||.+......       ........+||..|+.++|+||+.++++|..  
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-------dGi~~talREIK~Lqel~h~nIi~LiD~F~~--   72 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-------DGINRTALREIKLLQELKHPNIIELIDVFPH--   72 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-------cCccHHHHHHHHHHHHccCcchhhhhhhccC--
Confidence            4688899999999999999999999999999998755321       1112357899999999999999999999976  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      .+.+.||+|||+..+-.-.-.+...++...++.|+.++++||+|||++.|+||||||.|+|++++|.+||+|||+|+.+.
T Consensus        73 ~~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~  152 (318)
T KOG0659|consen   73 KSNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFG  152 (318)
T ss_pred             CCceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccC
Confidence            56899999999865433333445589999999999999999999999999999999999999999999999999999988


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CC------
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-----VF------  346 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-----~~------  346 (410)
                      ..+......+-|.+|+|||.+.+...++..+||||.|||+.||+.|.+-|.|.+..++...|...-.     .+      
T Consensus       153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence            7766666667799999999999988888889999999999999999999999988888777754210     01      


Q ss_pred             ---------C--------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCchh
Q 015257          347 ---------P--------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQY  391 (410)
Q Consensus       347 ---------p--------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~  391 (410)
                               |        ...+.++.+|+.+||..||.+|+|+.|+|+|+||...+.|.+.+
T Consensus       233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~  294 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPS  294 (318)
T ss_pred             ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChh
Confidence                     1        13467889999999999999999999999999999876655443

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-53  Score=372.84  Aligned_cols=260  Identities=30%  Similarity=0.556  Sum_probs=233.2

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ..+.+.|.+-+.||+|.|+.||.+.+..+|+.||+|+++...+..       ...+.+.+|+.|.+.|+|||||++.+.+
T Consensus         7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-------~~~e~l~rEarIC~~LqHP~IvrL~~ti   79 (355)
T KOG0033|consen    7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-------RDFQKLEREARICRKLQHPNIVRLHDSI   79 (355)
T ss_pred             cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc-------ccHHHHHHHHHHHHhcCCCcEeehhhhh
Confidence            456678999999999999999999999999999999987664432       2556899999999999999999999988


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC---CcEEEeec
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDF  270 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~---~~~kl~Df  270 (410)
                      .+  ....|||+|+|.|+.+..-+......+|..+-.+++||+++|.|.|.+||||||+||.|+|+-+.   .-+||+||
T Consensus        80 ~~--~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~F  157 (355)
T KOG0033|consen   80 QE--ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADF  157 (355)
T ss_pred             cc--cceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeeccc
Confidence            76  56899999999999887766666678999999999999999999999999999999999999654   35999999


Q ss_pred             cccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--
Q 015257          271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD--  348 (410)
Q Consensus       271 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--  348 (410)
                      |+|..+. +........|||.|||||++....+ ++.+|||+-|||||-||.|++||.+++....+++|..+.+.+|.  
T Consensus       158 GvAi~l~-~g~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~  235 (355)
T KOG0033|consen  158 GLAIEVN-DGEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPE  235 (355)
T ss_pred             ceEEEeC-CccccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcc
Confidence            9999877 4456677889999999999988777 67799999999999999999999999999999999999887764  


Q ss_pred             --CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          349 --AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       349 --~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                        .+++++++|+.+||..||++|.|+.|+|+|||+.+.
T Consensus       236 w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  236 WDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             cCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence              789999999999999999999999999999999764

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-50  Score=385.02  Aligned_cols=255  Identities=31%  Similarity=0.547  Sum_probs=227.3

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||+|+||.||++.+..+|+.||+|++......      .......+.+|+.+++.++||||+++++++.+  
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--   72 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI------RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--   72 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh------hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--
Confidence            3689999999999999999999999999999998653211      12344578899999999999999999998876  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+++||||+++++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus        73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~  152 (291)
T cd05612          73 QRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR  152 (291)
T ss_pred             CCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence            46899999999999999988888889999999999999999999999999999999999999999999999999998654


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNL  357 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~l  357 (410)
                      ..   .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+......+..+..+...+|..+++.+++|
T Consensus       153 ~~---~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  228 (291)
T cd05612         153 DR---TWTLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDL  228 (291)
T ss_pred             CC---cccccCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHH
Confidence            32   234579999999999877665 67799999999999999999999998888888899988888999999999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHhhCCcccCC
Q 015257          358 LEGLLCKDPTRRLT-----LNDVAKHTWVLGD  384 (410)
Q Consensus       358 i~~~L~~dp~~Rpt-----~~ell~h~~~~~~  384 (410)
                      |.+||+.||.+||+     ++++++||||...
T Consensus       229 i~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  260 (291)
T cd05612         229 IKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV  260 (291)
T ss_pred             HHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence            99999999999995     9999999999753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.8e-52  Score=360.35  Aligned_cols=260  Identities=31%  Similarity=0.535  Sum_probs=236.4

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      +-..++|.+.+.||+|-||.||+++.+.++..||+|++.+..+.+      .....++.+|++|-..|+||||++++++|
T Consensus        18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~------~~v~~qlrREiEIqs~L~hpnilrlY~~f   91 (281)
T KOG0580|consen   18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK------TQVEHQLRREIEIQSHLRHPNILRLYGYF   91 (281)
T ss_pred             ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH------hcchhhhhheeEeecccCCccHHhhhhhe
Confidence            345678999999999999999999999999999999998775432      23445799999999999999999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFG--QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      .+  ....|+++||.+.|.+...+.  ....+++..+..|+.|++.||.|+|..+||||||||+|+|++.+|.+||+|||
T Consensus        92 hd--~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfG  169 (281)
T KOG0580|consen   92 HD--SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFG  169 (281)
T ss_pred             ec--cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCC
Confidence            98  568999999999988887777  56689999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCC
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN  351 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~  351 (410)
                      .+...+  .....+.|||..|.+||...+..+ +..+|+|++|++.||++.|.+||......+.+.+|.+-.+.+|..++
T Consensus       170 wsV~~p--~~kR~tlcgt~dyl~pEmv~~~~h-d~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is  246 (281)
T KOG0580|consen  170 WSVHAP--SNKRKTLCGTLDYLPPEMVEGRGH-DKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTIS  246 (281)
T ss_pred             ceeecC--CCCceeeecccccCCHhhcCCCCc-cchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccC
Confidence            997644  445678899999999998877766 67799999999999999999999999988999999999999999999


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       352 ~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      .++++||.+||.++|.+|.+..|++.|||+...
T Consensus       247 ~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  247 GGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             hhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            999999999999999999999999999999754

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-51  Score=381.99  Aligned_cols=258  Identities=33%  Similarity=0.630  Sum_probs=238.0

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ....+|.+.+.||+|.||.|.+|.....|+.||||.+.++...      ++..+-.+++||+||..|+||||+.++++|.
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIk------deqDlvhIRREIeIMSsLNHPhII~IyEVFE  123 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIK------DEQDLVHIRREIEIMSSLNHPHIIQIYEVFE  123 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcc------cHHHHHHHHHHHHHHhhcCCCceeehhhhhc
Confidence            3446899999999999999999999999999999999876432      4667778999999999999999999999997


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      .  .+.++|||||..+|.|.+++...+.|+|.+++.+++||+.|+.|.|.++++|||||.+|||+|.++++||+|||++.
T Consensus       124 N--kdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSN  201 (668)
T KOG0611|consen  124 N--KDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSN  201 (668)
T ss_pred             C--CceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhh
Confidence            5  66899999999999999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPEL  354 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l  354 (410)
                      .+... ....++||+|.|.+||++.+..|.++.+|.|||||+||.|+.|.+||.+.+...+..+|..+.+.-|. -+.++
T Consensus       202 ly~~~-kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA  279 (668)
T KOG0611|consen  202 LYADK-KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDA  279 (668)
T ss_pred             hhccc-cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchH
Confidence            77654 46789999999999999999999999999999999999999999999999999999999999876554 45678


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhhCCccc
Q 015257          355 RNLLEGLLCKDPTRRLTLNDVAKHTWVL  382 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~ell~h~~~~  382 (410)
                      ..||..||-+||.+|.|+.+|..|=|+.
T Consensus       280 ~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  280 SGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             HHHHHHHHhcCcccchhHHHHhhhheee
Confidence            8999999999999999999999998884

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.1e-50  Score=391.06  Aligned_cols=252  Identities=31%  Similarity=0.553  Sum_probs=223.7

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYM  203 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l  203 (410)
                      +.||+|+||.||++++..+|+.||||++.+....      .......+.+|+.+++.++||||+++++++..  ...+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~l   72 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII------AKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCF   72 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEE
Confidence            4699999999999999999999999998754221      23345678899999999999999999999986  458999


Q ss_pred             EEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCcccc
Q 015257          204 VLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVL  283 (410)
Q Consensus       204 v~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  283 (410)
                      ||||+++++|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus        73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  152 (323)
T cd05571          73 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM  152 (323)
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcc
Confidence            99999999998888888889999999999999999999999999999999999999999999999999997643333344


Q ss_pred             ccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcc
Q 015257          284 RRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC  363 (410)
Q Consensus       284 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L~  363 (410)
                      ...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~  231 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLK  231 (323)
T ss_pred             cceecCccccChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcc
Confidence            45679999999999877665 56799999999999999999999988888888888888888999999999999999999


Q ss_pred             cCCCCCC-----CHHHHhhCCcccCC
Q 015257          364 KDPTRRL-----TLNDVAKHTWVLGD  384 (410)
Q Consensus       364 ~dp~~Rp-----t~~ell~h~~~~~~  384 (410)
                      .||++||     ++.++++||||.+.
T Consensus       232 ~dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         232 KDPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             CCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            9999999     89999999999763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-50  Score=390.68  Aligned_cols=256  Identities=33%  Similarity=0.568  Sum_probs=229.7

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+.+.||+|+||.||++++..+++.||||++......      .......+.+|+.+++.++||||+++++++.+
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   89 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL------KMKQVQHVAQEKSILMELSHPFIVNMMCSFQD   89 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh------hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence            357899999999999999999999999999999998754321      22345678999999999999999999999986


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                        ...+|+||||+.+++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        90 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  167 (329)
T PTZ00263         90 --ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK  167 (329)
T ss_pred             --CCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence              468999999999999998888888899999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELR  355 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~  355 (410)
                      .....   ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+......+..+..+...+|..++..++
T Consensus       168 ~~~~~---~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  243 (329)
T PTZ00263        168 VPDRT---FTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRAR  243 (329)
T ss_pred             cCCCc---ceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHH
Confidence            54322   34579999999999877665 677999999999999999999999988888888898888889999999999


Q ss_pred             HHHHHhcccCCCCCCC-----HHHHhhCCcccC
Q 015257          356 NLLEGLLCKDPTRRLT-----LNDVAKHTWVLG  383 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt-----~~ell~h~~~~~  383 (410)
                      +||.+||+.||.+||+     +++++.||||.+
T Consensus       244 ~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        244 DLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             HHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            9999999999999997     799999999976

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-50  Score=378.68  Aligned_cols=259  Identities=27%  Similarity=0.401  Sum_probs=224.4

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .+.|.+...||.|..++||+|+....++.||||+++.+.        ..+.++.+++|+..|+.++||||++++..|.. 
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEk--------c~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv-   95 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEK--------CNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV-   95 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhh--------hhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe-
Confidence            357999999999999999999999999999999987542        44558899999999999999999999999987 


Q ss_pred             CCCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                       +..+|+||.||.+|++.++++.  ...++|..+..+++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+.
T Consensus        96 -~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen   96 -DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSA  174 (516)
T ss_pred             -cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeee
Confidence             4589999999999999988764  3569999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCcc----ccccCCCccccccccc-ccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-
Q 015257          275 VFEDDND----VLRRSPGTPVFTAPEC-CLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD-  348 (410)
Q Consensus       275 ~~~~~~~----~~~~~~gt~~y~aPE~-~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~-  348 (410)
                      .+.....    ...++.|||.|||||+ .+....|+.++||||||++..||.+|..||......+++..-+++.++.+. 
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t  254 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT  254 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc
Confidence            5433221    1256789999999999 555566678899999999999999999999988777766666666554221 


Q ss_pred             ---------CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          349 ---------AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       349 ---------~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                               .++..++.+|..||++||++|||++++|+|+||+...
T Consensus       255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence                     4677899999999999999999999999999998753

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-51  Score=392.35  Aligned_cols=253  Identities=30%  Similarity=0.521  Sum_probs=225.4

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      ...|....+||+|+.|.||.|+...+++.||||++.....         ...+-+.+|+.+|+..+|+|||.+++.|.. 
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---------~~keLilnEi~Vm~~~~H~NiVnfl~Sylv-  341 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---------PKKELLLNEILVMRDLHHPNIVNFLDSYLV-  341 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---------CchhhhHHHHHHHHhccchHHHHHHHHhcc-
Confidence            3468888999999999999999999999999999976532         233468899999999999999999997775 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       .+.+++|||||+||+|.+.+... .++|.++..+.++++.||+|||.+||||||||.+|||+..+|.+||+|||++..+
T Consensus       342 -~deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi  419 (550)
T KOG0578|consen  342 -GDELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQI  419 (550)
T ss_pred             -cceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecc
Confidence             46899999999999999887655 5999999999999999999999999999999999999999999999999999887


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCCCCCHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDAMNPE  353 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~~~~  353 (410)
                      ........+..|||.|||||++....| ++++||||||++++||+-|.+||..++.......|..+   .+..|+.+|+.
T Consensus       420 ~~~~~KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~  498 (550)
T KOG0578|consen  420 SEEQSKRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPE  498 (550)
T ss_pred             ccccCccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHH
Confidence            766666778899999999999887777 56699999999999999999999987777666666553   34567899999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhCCccc
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKHTWVL  382 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h~~~~  382 (410)
                      +++|+.+||+.|+.+|+++.+||+||||+
T Consensus       499 ~kdFL~~cL~~dv~~RasA~eLL~HpFl~  527 (550)
T KOG0578|consen  499 LKDFLDRCLVVDVEQRASAKELLEHPFLK  527 (550)
T ss_pred             HHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence            99999999999999999999999999994

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-50  Score=371.41  Aligned_cols=261  Identities=28%  Similarity=0.468  Sum_probs=223.7

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC-
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP-  196 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  196 (410)
                      ..|..++.||.|+||.|..+.++.+|+.||||.+..       ...+....++..+|+.+|+.++|+||+.+.+++..+ 
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-------~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~   94 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-------PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS   94 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-------hhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence            456668999999999999999999999999998752       234566778899999999999999999999998752 


Q ss_pred             --CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          197 --NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       197 --~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                        .-..+|+|+|+| +..|...++.+..+++..++.++.||++||+|+|+.+|+||||||+|+|++.+..+||+|||+|+
T Consensus        95 ~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen   95 RDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             ccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecccccee
Confidence              345799999999 45677778888789999999999999999999999999999999999999999999999999999


Q ss_pred             cccC--CccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Q 015257          275 VFED--DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----------  341 (410)
Q Consensus       275 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~-----------  341 (410)
                      ....  ....++...-|.+|.|||++.....++++.||||+|||+.||++|++.|.|.+..++...|..           
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            8653  234556777899999999998888889999999999999999999999998876665554432           


Q ss_pred             ------------CCCCCC--------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          342 ------------NSLVFP--------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       342 ------------~~~~~p--------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                                  .....|        +..++.+.+|+.+||..||.+|+|++|+|+||||...-.
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd  318 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD  318 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence                        111111        267899999999999999999999999999999987633

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-50  Score=383.45  Aligned_cols=250  Identities=34%  Similarity=0.581  Sum_probs=223.1

Q ss_pred             ecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEEEE
Q 015257          126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVL  205 (410)
Q Consensus       126 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~  205 (410)
                      ||+|+||.||++++..+++.||+|++......      .......+.+|+.+++.++||||+++++++.+  ...+++||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~   72 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV------SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVL   72 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEE
Confidence            79999999999999999999999998654211      23445678899999999999999999999986  45899999


Q ss_pred             eecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCcccccc
Q 015257          206 EYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR  285 (410)
Q Consensus       206 e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  285 (410)
                      ||+++++|...+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus        73 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  152 (312)
T cd05585          73 AFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT  152 (312)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccc
Confidence            99999999988888888999999999999999999999999999999999999999999999999999865444444456


Q ss_pred             CCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcccC
Q 015257          286 SPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKD  365 (410)
Q Consensus       286 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L~~d  365 (410)
                      ..||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+......+|..+++++.+||.+||+.|
T Consensus       153 ~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  231 (312)
T cd05585         153 FCGTPEYLAPELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRD  231 (312)
T ss_pred             ccCCcccCCHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCC
Confidence            679999999999877665 6679999999999999999999999888888888988888899999999999999999999


Q ss_pred             CCCCC---CHHHHhhCCcccCC
Q 015257          366 PTRRL---TLNDVAKHTWVLGD  384 (410)
Q Consensus       366 p~~Rp---t~~ell~h~~~~~~  384 (410)
                      |.+||   ++.+++.||||.+.
T Consensus       232 p~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         232 PTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHHcCCCCCHHHHHcCCCcCCC
Confidence            99997   58999999999874

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-49  Score=384.40  Aligned_cols=252  Identities=31%  Similarity=0.563  Sum_probs=223.1

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYM  203 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l  203 (410)
                      +.||+|+||.||++++..+|+.||||++.+...      ........+.+|+.+++.++||||+++++++..  ...+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l   72 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI------IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCF   72 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEE
Confidence            469999999999999999999999999875421      123455678899999999999999999999986  468999


Q ss_pred             EEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCcccc
Q 015257          204 VLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVL  283 (410)
Q Consensus       204 v~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  283 (410)
                      ||||++++++...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus        73 v~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  152 (328)
T cd05593          73 VMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM  152 (328)
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccccc
Confidence            99999999998888777789999999999999999999999999999999999999999999999999997644333344


Q ss_pred             ccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcc
Q 015257          284 RRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC  363 (410)
Q Consensus       284 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L~  363 (410)
                      ...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~  231 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLI  231 (328)
T ss_pred             ccccCCcCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcC
Confidence            55679999999999877665 66799999999999999999999988887888888888888999999999999999999


Q ss_pred             cCCCCCC-----CHHHHhhCCcccCC
Q 015257          364 KDPTRRL-----TLNDVAKHTWVLGD  384 (410)
Q Consensus       364 ~dp~~Rp-----t~~ell~h~~~~~~  384 (410)
                      .||.+|+     ++.++++||||.+.
T Consensus       232 ~dP~~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         232 KDPNKRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             CCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            9999997     89999999999763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.3e-50  Score=372.26  Aligned_cols=261  Identities=28%  Similarity=0.468  Sum_probs=231.1

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      --.+.|++++.||.|.-|+||+|+...++..+|+|++.+..+..      ...+.++..|-+||+.++||.++.||..|+
T Consensus        74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~------rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe  147 (459)
T KOG0610|consen   74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS------RKKLKRAQTEREILSLLDHPFLPTLYASFE  147 (459)
T ss_pred             cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh------hhHHHHHHHHHHHHHhcCCCccchhhheee
Confidence            34568999999999999999999999999999999999876542      456678899999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      .  .+..++|||||+||.|....+++  ..+++..++.|+..|+-||+|||-.|||+|||||+||||.++|++.|+||.+
T Consensus       148 t--~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDL  225 (459)
T KOG0610|consen  148 T--DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDL  225 (459)
T ss_pred             c--cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccc
Confidence            6  56899999999999998876654  4799999999999999999999999999999999999999999999999997


Q ss_pred             cccccC---------------------------------C-c----------------------cccccCCCcccccccc
Q 015257          273 SQVFED---------------------------------D-N----------------------DVLRRSPGTPVFTAPE  296 (410)
Q Consensus       273 a~~~~~---------------------------------~-~----------------------~~~~~~~gt~~y~aPE  296 (410)
                      +.....                                 . .                      .....++||-.|+|||
T Consensus       226 S~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE  305 (459)
T KOG0610|consen  226 SLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE  305 (459)
T ss_pred             cccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce
Confidence            632100                                 0 0                      1122356999999999


Q ss_pred             cccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHhcccCCCCCCC---
Q 015257          297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD--AMNPELRNLLEGLLCKDPTRRLT---  371 (410)
Q Consensus       297 ~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~l~~li~~~L~~dp~~Rpt---  371 (410)
                      ++.+..+ +.++|.|+|||+|||||+|..||.+.+..+.+.+|+...+.||.  .++..+++||.++|.+||++|..   
T Consensus       306 vI~G~GH-gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~r  384 (459)
T KOG0610|consen  306 VIRGEGH-GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKR  384 (459)
T ss_pred             eeecCCC-CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhcccc
Confidence            9998877 66799999999999999999999999999999999999999986  57899999999999999999998   


Q ss_pred             -HHHHhhCCcccCC
Q 015257          372 -LNDVAKHTWVLGD  384 (410)
Q Consensus       372 -~~ell~h~~~~~~  384 (410)
                       +.||.+||||.+-
T Consensus       385 GA~eIK~HpFF~gV  398 (459)
T KOG0610|consen  385 GAAEIKRHPFFEGV  398 (459)
T ss_pred             chHHhhcCccccCC
Confidence             9999999999874

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2e-49  Score=382.22  Aligned_cols=252  Identities=32%  Similarity=0.563  Sum_probs=222.9

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYM  203 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l  203 (410)
                      +.||+|+||.||++++..+|..||+|++.....      ........+.+|+.+++.++||||+++++++..  ...+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~l   72 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI------IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCF   72 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh------hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEE
Confidence            469999999999999999999999999875421      123345677889999999999999999999986  458999


Q ss_pred             EEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCcccc
Q 015257          204 VLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVL  283 (410)
Q Consensus       204 v~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  283 (410)
                      ||||+++++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus        73 v~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  152 (323)
T cd05595          73 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  152 (323)
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcc
Confidence            99999999998888777789999999999999999999999999999999999999999999999999987643333334


Q ss_pred             ccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcc
Q 015257          284 RRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC  363 (410)
Q Consensus       284 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L~  363 (410)
                      ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~  231 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK  231 (323)
T ss_pred             ccccCCcCcCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcc
Confidence            45679999999999877665 66799999999999999999999988888888888888888999999999999999999


Q ss_pred             cCCCCCC-----CHHHHhhCCcccCC
Q 015257          364 KDPTRRL-----TLNDVAKHTWVLGD  384 (410)
Q Consensus       364 ~dp~~Rp-----t~~ell~h~~~~~~  384 (410)
                      .||.+||     ++.++++||||.+.
T Consensus       232 ~dP~~R~~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         232 KDPKQRLGGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             CCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence            9999998     99999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2e-49  Score=384.70  Aligned_cols=257  Identities=30%  Similarity=0.508  Sum_probs=227.1

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCC-ceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDG-KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ..++|.+++.||+|+||.||+|....++ ..||+|++.+....      .......+.+|+.+++.++||||+++++++.
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~  101 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII------KQKQVDHVFSERKILNYINHPFCVNLYGSFK  101 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh------hhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence            4568999999999999999999876654 78999998654321      2334567889999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      +  ...+++||||+++++|...+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       102 ~--~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~  179 (340)
T PTZ00426        102 D--ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK  179 (340)
T ss_pred             e--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence            6  45899999999999999998888889999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPEL  354 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l  354 (410)
                      .....   .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..+...+|..+++.+
T Consensus       180 ~~~~~---~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~  255 (340)
T PTZ00426        180 VVDTR---TYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNC  255 (340)
T ss_pred             ecCCC---cceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHH
Confidence            65432   235679999999999877655 56799999999999999999999998888888888888888899999999


Q ss_pred             HHHHHHhcccCCCCCC-----CHHHHhhCCcccCC
Q 015257          355 RNLLEGLLCKDPTRRL-----TLNDVAKHTWVLGD  384 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~  384 (410)
                      .++|.+||+.||.+|+     |++++++||||.+.
T Consensus       256 ~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        256 KHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             HHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            9999999999999995     99999999999763

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.7e-49  Score=373.48  Aligned_cols=253  Identities=27%  Similarity=0.463  Sum_probs=209.3

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||.|+||.||++++..+++.||+|++.....        ......+.+|+.+++.++||||+++++++..  
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--   74 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--------EGAPCTAIREVSLLKNLKHANIVTLHDIIHT--   74 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--------CCcchhHHHHHHHHHhCCCCCEeeEEEEEcC--
Confidence            579999999999999999999999999999999864321        1122457789999999999999999999976  


Q ss_pred             CCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ....++||||+++ .+...+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        75 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~  153 (288)
T cd07871          75 ERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAK  153 (288)
T ss_pred             CCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeec
Confidence            4589999999987 45554433 446899999999999999999999999999999999999999999999999999765


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS-------------  343 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-------------  343 (410)
                      ...........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....             
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07871         154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS  233 (288)
T ss_pred             cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence            4433334455689999999988765545778999999999999999999998877665544433210             


Q ss_pred             ------CCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          344 ------LVFP-----------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       344 ------~~~p-----------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                            ..+|           ..+++++++||.+||+.||.+|||++|+++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                  0011           2467889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.6e-49  Score=376.16  Aligned_cols=257  Identities=27%  Similarity=0.411  Sum_probs=208.9

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||+|+||.||++++..+++.||||++.....        ......+.+|+.+++.++||||+++++++.+  
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--   74 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--------EGTPFTAIREASLLKGLKHANIVLLHDIIHT--   74 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--------cccchhHHHHHHHHhhCCCCCcCeEEEEEec--
Confidence            579999999999999999999999999999999864321        1122356789999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ....++||||++++++.......+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          75 KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             CCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            45899999999876554444445678999999999999999999999999999999999999999999999999997654


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhC--CC---C------
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL-QDTYDKIVNN--SL---V------  345 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~i~~~--~~---~------  345 (410)
                      ..........||+.|+|||++.+....+.++|||||||++|+|++|..||.+... .+....+...  ..   .      
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence            4333444567899999999987655557789999999999999999999987532 2233222110  00   0      


Q ss_pred             ------------CC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          346 ------------FP---------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       346 ------------~p---------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                                  .|         ..+++.+.+||.+||+.||++|||+.|+++||||.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence                        00         0245678999999999999999999999999999765

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-50  Score=358.01  Aligned_cols=264  Identities=25%  Similarity=0.433  Sum_probs=232.1

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVI  193 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  193 (410)
                      .+...|.-.+.||+|..++|..+.++.+|..+|+|++.-........ ......+.-.+|+.||+++ .||+|+++.+++
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e-~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGE-TPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCc-cHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            45567888899999999999999999999999999987554332211 1334555677899999998 699999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      +.  ...+++|+|.|+.|.|.+++.+.-.++|...+.|++|+++|+.|||.++|+||||||+|||++++-++||+|||+|
T Consensus        93 es--~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa  170 (411)
T KOG0599|consen   93 ES--DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFA  170 (411)
T ss_pred             cC--cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEecccee
Confidence            86  4589999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCccccccccccc-----CCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCL-----GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP-  347 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-  347 (410)
                      +.++.+. ..+..||||+|+|||.+.     +...+++.+|+|++|||+|.||.|.+||......-++..|..+.+.|. 
T Consensus       171 ~~l~~Ge-kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s  249 (411)
T KOG0599|consen  171 CQLEPGE-KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS  249 (411)
T ss_pred             eccCCch-hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC
Confidence            9877654 567889999999999863     344457889999999999999999999988777778889999988765 


Q ss_pred             ---CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCccc
Q 015257          348 ---DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL  382 (410)
Q Consensus       348 ---~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~  382 (410)
                         ..++...++||.+||++||.+|.|++|+|.||||+
T Consensus       250 peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~  287 (411)
T KOG0599|consen  250 PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI  287 (411)
T ss_pred             cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence               37889999999999999999999999999999994

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.9e-49  Score=383.80  Aligned_cols=257  Identities=26%  Similarity=0.499  Sum_probs=218.9

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|++++.||+|+||+||++++..+++.||||++.+....      .......+.+|+.++..++||||+++++.+.+  
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--   72 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML------EKEQVGHIRAERDILVEADSLWVVKMFYSFQD--   72 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH------HhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence            3689999999999999999999999999999998754221      23345678899999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+|+||||++|++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          73 KLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             CCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            45899999999999999998888889999999999999999999999999999999999999999999999999987543


Q ss_pred             CCc-----------------------------------cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh
Q 015257          278 DDN-----------------------------------DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII  322 (410)
Q Consensus       278 ~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  322 (410)
                      ...                                   ......+||+.|+|||++.+..+ +.++|||||||++|+|++
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~ell~  231 (363)
T cd05628         153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLI  231 (363)
T ss_pred             ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCC-CCchhhhhhHHHHHHHHh
Confidence            210                                   01124579999999999877665 567999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHhcccCCC---CCCCHHHHhhCCcccCC
Q 015257          323 GQYPFLGETLQDTYDKIVNN--SLVFPD--AMNPELRNLLEGLLCKDPT---RRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       323 G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~l~~li~~~L~~dp~---~Rpt~~ell~h~~~~~~  384 (410)
                      |..||.+.+..+.+..+...  ...+|.  .+++++++||.+|++ +|.   .||+++||++||||.+.
T Consensus       232 G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         232 GYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             CCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence            99999998888888777763  344554  478999999999776 444   46899999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-49  Score=380.63  Aligned_cols=259  Identities=36%  Similarity=0.612  Sum_probs=232.1

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVI  193 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~  193 (410)
                      .....|.+.+.||+|.||.||+++.+.+|+.+|+|++.+.....      ....+.+.+|+.+|+.+. |||||.++++|
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~------~~~~~~v~~Ev~il~~l~~hpniv~l~~~~  105 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG------KEDREDVRREVAILQQLSGHPNIVQLKDAF  105 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc------cccHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            34457999999999999999999999999999999998765432      224567899999999998 99999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC----CcEEEee
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS----GTVKIGD  269 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~----~~~kl~D  269 (410)
                      .++  ..+++|||++.||.|.+.+... .++|..+..++.||+.|++|||+.||+||||||+|+|+...    +.+|++|
T Consensus       106 e~~--~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~D  182 (382)
T KOG0032|consen  106 EDP--DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLID  182 (382)
T ss_pred             EcC--CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEee
Confidence            974  5899999999999999888766 49999999999999999999999999999999999999654    4799999


Q ss_pred             ccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--
Q 015257          270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP--  347 (410)
Q Consensus       270 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--  347 (410)
                      ||+|..... .......+|||.|+|||++....+ +..+||||+||++|.|++|.+||.+.+.......+..+.+.|+  
T Consensus       183 FGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y-~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~  260 (382)
T KOG0032|consen  183 FGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPY-GDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSE  260 (382)
T ss_pred             CCCceEccC-CceEeeecCCccccCchhhcCCCC-CcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCC
Confidence            999998766 567788999999999998887666 6679999999999999999999999998888889999887665  


Q ss_pred             --CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          348 --DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       348 --~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                        +.++..++++|..||..||.+|+|+.++|+|||+.+.
T Consensus       261 ~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  261 PWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             CccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence              3679999999999999999999999999999999975

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.1e-49  Score=378.41  Aligned_cols=252  Identities=30%  Similarity=0.518  Sum_probs=221.7

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEEcCCCCEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNSDHFY  202 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~  202 (410)
                      +.||+|+||.||+++++.+++.||||++.+....      .......+..|..++..+ +||||+++++++.+  ...+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~   72 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL------QDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLF   72 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh------hccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEE
Confidence            4699999999999999999999999998754221      223445677888888876 69999999999986  45899


Q ss_pred             EEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc
Q 015257          203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV  282 (410)
Q Consensus       203 lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  282 (410)
                      +||||+++++|...+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        73 iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~  152 (320)
T cd05590          73 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT  152 (320)
T ss_pred             EEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc
Confidence            99999999999888887788999999999999999999999999999999999999999999999999998764333334


Q ss_pred             cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Q 015257          283 LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLL  362 (410)
Q Consensus       283 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L  362 (410)
                      .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+......+|..+++++.+||.+||
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L  231 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFM  231 (320)
T ss_pred             ccccccCccccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHc
Confidence            455679999999999876655 5679999999999999999999999988888889988888888899999999999999


Q ss_pred             ccCCCCCCCH------HHHhhCCcccCC
Q 015257          363 CKDPTRRLTL------NDVAKHTWVLGD  384 (410)
Q Consensus       363 ~~dp~~Rpt~------~ell~h~~~~~~  384 (410)
                      +.||.+||++      ++++.||||.+.
T Consensus       232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         232 TKNPTMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             ccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence            9999999998      999999999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-50  Score=379.07  Aligned_cols=264  Identities=32%  Similarity=0.571  Sum_probs=240.4

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      .=|.+.+.||+|.|+.|.+|++..+|+.||||++.+..+.       .-....+.+|+..|+..+|||||++|++...  
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-------~~st~hlfqEVRCMKLVQHpNiVRLYEViDT--   88 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-------TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT--   88 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc-------hhhhhHHHHHHHHHHHhcCcCeeeeeehhcc--
Confidence            3488889999999999999999999999999999876543       2344578999999999999999999999976  


Q ss_pred             CCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEc-CCCcEEEeecccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA-PSGTVKIGDFSVSQV  275 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~-~~~~~kl~DfG~a~~  275 (410)
                      ...+|||+|+-.+|.+.+++.+ ...+.|..+++|+.||+.|+.|.|+..++||||||+||++- .-|.|||.|||++..
T Consensus        89 QTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNk  168 (864)
T KOG4717|consen   89 QTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNK  168 (864)
T ss_pred             cceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeecccccc
Confidence            4579999999999999998765 45899999999999999999999999999999999997664 568999999999988


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELR  355 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~  355 (410)
                      +..+ ...++.||+..|.|||++.+..|..+++||||||||||.|++|++||...+..+.+-.|+.-++..|..++.+.+
T Consensus       169 f~PG-~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCr  247 (864)
T KOG4717|consen  169 FQPG-KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECR  247 (864)
T ss_pred             CCCc-chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHH
Confidence            7654 456789999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCchh
Q 015257          356 NLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQY  391 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~  391 (410)
                      +||..||..||++|.|.++|..|+|++....+..+.
T Consensus       248 dLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~  283 (864)
T KOG4717|consen  248 DLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTA  283 (864)
T ss_pred             HHHHHHHhcCchhhccHHHHhccccccCCCCCcccc
Confidence            999999999999999999999999999887777664

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3e-49  Score=381.32  Aligned_cols=252  Identities=31%  Similarity=0.562  Sum_probs=222.4

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYM  203 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l  203 (410)
                      +.||+|+||.||++++..+|+.||+|++.+....      .......+.+|+.+++.++||||+++++++..  ...+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~------~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~l   72 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV------AKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCF   72 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEE
Confidence            4699999999999999999999999998754221      23345577889999999999999999999886  458999


Q ss_pred             EEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc
Q 015257          204 VLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV  282 (410)
Q Consensus       204 v~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  282 (410)
                      ||||+++++|...+.....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++........
T Consensus        73 v~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  152 (325)
T cd05594          73 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT  152 (325)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc
Confidence            99999999998888777789999999999999999999997 79999999999999999999999999998754433334


Q ss_pred             cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Q 015257          283 LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLL  362 (410)
Q Consensus       283 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L  362 (410)
                      .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+......+|..+++++.+||.+||
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L  231 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLL  231 (325)
T ss_pred             cccccCCcccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHh
Confidence            445679999999999877665 5679999999999999999999998888888888888888899999999999999999


Q ss_pred             ccCCCCCC-----CHHHHhhCCcccCC
Q 015257          363 CKDPTRRL-----TLNDVAKHTWVLGD  384 (410)
Q Consensus       363 ~~dp~~Rp-----t~~ell~h~~~~~~  384 (410)
                      +.||++|+     ++.++++||||.+.
T Consensus       232 ~~dP~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         232 KKDPKQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             hcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence            99999997     99999999999863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.7e-49  Score=377.82  Aligned_cols=254  Identities=31%  Similarity=0.529  Sum_probs=222.2

Q ss_pred             eeeecccCceEEEEEEEc---cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCC
Q 015257          123 VRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  199 (410)
                      ++.||+|+||.||+++..   .+++.||||++.......     .......+.+|+.+|+.++||||+++++++..  .+
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~   73 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR-----NQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GG   73 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHh-----hhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CC
Confidence            368999999999999864   478899999987543211     22334567899999999999999999999986  45


Q ss_pred             EEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCC
Q 015257          200 HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD  279 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~  279 (410)
                      .+|+||||+++++|...+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (323)
T cd05584          74 KLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE  153 (323)
T ss_pred             eEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence            89999999999999988888888999999999999999999999999999999999999999999999999998754433


Q ss_pred             ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 015257          280 NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLE  359 (410)
Q Consensus       280 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~  359 (410)
                      ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..+...+|..+++++.+||.
T Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  232 (323)
T cd05584         154 GTVTHTFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLK  232 (323)
T ss_pred             CCcccccCCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            334445679999999999877655 5679999999999999999999999888888888888888889999999999999


Q ss_pred             HhcccCCCCCC-----CHHHHhhCCcccCC
Q 015257          360 GLLCKDPTRRL-----TLNDVAKHTWVLGD  384 (410)
Q Consensus       360 ~~L~~dp~~Rp-----t~~ell~h~~~~~~  384 (410)
                      +||+.||.+||     ++.+++.||||...
T Consensus       233 ~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         233 KLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999999999     89999999999753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.5e-48  Score=376.33  Aligned_cols=257  Identities=30%  Similarity=0.503  Sum_probs=225.1

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCC-CcccceeEEEcCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP-NIVNLIEVIDDPN  197 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~  197 (410)
                      +|.+++.||+|+||.||++++..+++.||||++.+....      .......+..|+.++..+.|+ +|+++++++.+  
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--   72 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII------QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--   72 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--
Confidence            488999999999999999999999999999998754321      233456788899999999765 57788888876  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+|+||||+++++|...+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        73 ~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05587          73 MDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI  152 (324)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence            45899999999999998888777889999999999999999999999999999999999999999999999999987543


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNL  357 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~l  357 (410)
                      .........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+....+....+......+|..+++++.+|
T Consensus       153 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  231 (324)
T cd05587         153 FGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSI  231 (324)
T ss_pred             CCCCceeeecCCccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            33333445679999999999887665 56799999999999999999999998888888888888888899999999999


Q ss_pred             HHHhcccCCCCCCCH-----HHHhhCCcccCC
Q 015257          358 LEGLLCKDPTRRLTL-----NDVAKHTWVLGD  384 (410)
Q Consensus       358 i~~~L~~dp~~Rpt~-----~ell~h~~~~~~  384 (410)
                      +.+||..||.+|++.     .++++||||...
T Consensus       232 i~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         232 CKGLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999999999986     899999999763

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=376.31  Aligned_cols=249  Identities=26%  Similarity=0.416  Sum_probs=212.4

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCce-EEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKH-YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~-vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      +..+.+.||+|+||+||++...  |.. ||||++......       ......|.+|+.+|.+++|||||+++|++.++.
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~-------~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~  112 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFD-------DESRKAFRREASLLSRLRHPNIVQFYGACTSPP  112 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcC-------hHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            4455666999999999876655  666 999998765322       122678999999999999999999999998753


Q ss_pred             CCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-cEeccCCCCcEEEcCCC-cEEEeecccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHN-VVHGDIKPDNLLVAPSG-TVKIGDFSVS  273 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~-iiHrDlkp~NIll~~~~-~~kl~DfG~a  273 (410)
                      . .+.||||||++|+|.+++..  ...++...+..++.||++||.|||+++ ||||||||+|||++.++ ++||+|||++
T Consensus       113 ~-~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  113 G-SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             C-ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence            2 68999999999999999877  678999999999999999999999999 99999999999999998 9999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCC
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGL-TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFPDAM  350 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~  350 (410)
                      +........++...||+.|||||++.+. ..++.++||||||++||||+||..||.+....+....+..  .+..+|..+
T Consensus       192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~  271 (362)
T KOG0192|consen  192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC  271 (362)
T ss_pred             eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence            8765543444557899999999999853 3347789999999999999999999999887666666543  344677889


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          351 NPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ++.+..|+..||..||.+||++.+++.
T Consensus       272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  272 PPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            999999999999999999999998874

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.9e-48  Score=368.56  Aligned_cols=254  Identities=30%  Similarity=0.465  Sum_probs=211.2

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+.+.||+|+||.||++++..+++.||||++.....       .......+.+|+.+++.++||||+++++++..  
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--   71 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-------NEEVKETTLRELKMLRTLKQENIVELKEAFRR--   71 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-------cccchhhHHHHHHHHHhCCCccccchhhhEec--
Confidence            369999999999999999999999999999999865321       12334567899999999999999999999976  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+++||||++++++.........+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  151 (287)
T cd07848          72 RGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS  151 (287)
T ss_pred             CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence            46899999999998777665556679999999999999999999999999999999999999999999999999998754


Q ss_pred             CCc-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Q 015257          278 DDN-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS-------------  343 (410)
Q Consensus       278 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-------------  343 (410)
                      ... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+....+....+....             
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         152 EGSNANYTEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             ccccccccccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence            322 22334568999999999877665 667999999999999999999998766544332222100             


Q ss_pred             ------CCCC-------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          344 ------LVFP-------------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       344 ------~~~p-------------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                            ..+|             ..++.++.+||.+||++||++|||++++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                  0011             2367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.3e-48  Score=375.01  Aligned_cols=255  Identities=33%  Similarity=0.523  Sum_probs=221.2

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHH---HhCCCCCcccceeEEEcC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM---KMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~hpniv~l~~~~~~~  196 (410)
                      |.+++.||+|+||.||++.+..+|+.||||++.+....      .....+.+.+|+.++   +.++||||+++++++.+ 
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-   73 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII------ARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-   73 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-
Confidence            67899999999999999999999999999998754211      123345667776665   56689999999999986 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       ...+|+||||++++++...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        74 -~~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05589          74 -EDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG  151 (324)
T ss_pred             -CCEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence             4689999999999988776654 47999999999999999999999999999999999999999999999999998754


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN  356 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~  356 (410)
                      ...........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+......+|..+++.+.+
T Consensus       152 ~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  230 (324)
T cd05589         152 MGFGDRTSTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAIS  230 (324)
T ss_pred             CCCCCcccccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            333334456779999999998877655 6679999999999999999999999888888888888888889999999999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHhhCCcccCC
Q 015257          357 LLEGLLCKDPTRRL-----TLNDVAKHTWVLGD  384 (410)
Q Consensus       357 li~~~L~~dp~~Rp-----t~~ell~h~~~~~~  384 (410)
                      ||.+||+.||.+||     ++.++++||||.+.
T Consensus       231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            99999999999999     79999999999763

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.5e-48  Score=375.79  Aligned_cols=251  Identities=28%  Similarity=0.497  Sum_probs=221.5

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEEcCCCCEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNSDHFY  202 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~  202 (410)
                      +.||+|+||.||++++..+++.||||++.+....      .......+..|..++..+ +||||+++++++.+  ...+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~   72 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL------QDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLF   72 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh------hhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEE
Confidence            4699999999999999999999999998754221      233445677888888866 79999999999986  45899


Q ss_pred             EEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc
Q 015257          203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV  282 (410)
Q Consensus       203 lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  282 (410)
                      +||||+++++|...+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        73 lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  152 (321)
T cd05591          73 FVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT  152 (321)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc
Confidence            99999999999888877788999999999999999999999999999999999999999999999999999764433334


Q ss_pred             cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Q 015257          283 LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLL  362 (410)
Q Consensus       283 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L  362 (410)
                      .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+......+|..+++++.+||.+||
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L  231 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFM  231 (321)
T ss_pred             ccccccCccccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence            455679999999998877665 5679999999999999999999999988888899988888888899999999999999


Q ss_pred             ccCCCCCC-------CHHHHhhCCcccC
Q 015257          363 CKDPTRRL-------TLNDVAKHTWVLG  383 (410)
Q Consensus       363 ~~dp~~Rp-------t~~ell~h~~~~~  383 (410)
                      +.||.+||       ++.++++||||.+
T Consensus       232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         232 TKNPNKRLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             ccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence            99999999       9999999999966

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.4e-48  Score=367.04  Aligned_cols=255  Identities=24%  Similarity=0.386  Sum_probs=214.9

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  199 (410)
                      |+..+.||+|+||.||++.+..+|+.||+|.+.+....      .......+.+|+.+++.++|+||+++++++.+  ..
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~   73 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK------KRKGEAMALNEKRILEKVNSRFVVSLAYAYET--KD   73 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh------hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CC
Confidence            78899999999999999999999999999998754321      12233457899999999999999999999876  45


Q ss_pred             EEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          200 HFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      .+++||||++++++...+..  ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++....
T Consensus        74 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05631          74 ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIP  153 (285)
T ss_pred             eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence            89999999999988766543  3468999999999999999999999999999999999999999999999999998654


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCCCCCHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ----DTYDKIVNNSLVFPDAMNPE  353 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~----~~~~~i~~~~~~~p~~~~~~  353 (410)
                      ... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......    .....+......++..++++
T Consensus       154 ~~~-~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  231 (285)
T cd05631         154 EGE-TVRGRVGTVGYMAPEVINNEKY-TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSED  231 (285)
T ss_pred             CCC-eecCCCCCCCccCHhhhcCCCC-CcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHH
Confidence            322 2345578999999999987665 56799999999999999999999875432    22333344445677889999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHhhCCcccCC
Q 015257          354 LRNLLEGLLCKDPTRRLT-----LNDVAKHTWVLGD  384 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~~  384 (410)
                      +.+|+.+||+.||.+||+     ++++++||||.+.
T Consensus       232 ~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~  267 (285)
T cd05631         232 AKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI  267 (285)
T ss_pred             HHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence            999999999999999997     8999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-48  Score=381.13  Aligned_cols=257  Identities=35%  Similarity=0.622  Sum_probs=223.4

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||+|+||.||++++..+|+.||||++.+....      .......+.+|+.++..++||||+++++++.+  
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--   72 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI------KRNQIAHVRAERDILADADSPWIVKLYYSFQD--   72 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh------hccHHHHHHHHHHHHHhcCCCCccchhhheec--
Confidence            3699999999999999999999999999999998754321      12345678899999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+++||||+++++|.+.+...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus        73 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  152 (350)
T cd05573          73 EEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMN  152 (350)
T ss_pred             CCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence            46899999999999999988877889999999999999999999999999999999999999999999999999997654


Q ss_pred             CCc-----------------------------cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCC
Q 015257          278 DDN-----------------------------DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL  328 (410)
Q Consensus       278 ~~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~  328 (410)
                      ...                             .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~  231 (350)
T cd05573         153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFY  231 (350)
T ss_pred             ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCC
Confidence            332                             12334569999999999887755 667999999999999999999999


Q ss_pred             CCCHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHhcccCCCCCCC-HHHHhhCCcccCC
Q 015257          329 GETLQDTYDKIVN--NSLVFPD--AMNPELRNLLEGLLCKDPTRRLT-LNDVAKHTWVLGD  384 (410)
Q Consensus       329 ~~~~~~~~~~i~~--~~~~~p~--~~~~~l~~li~~~L~~dp~~Rpt-~~ell~h~~~~~~  384 (410)
                      ..........+..  ....+|.  .+++++.+||.+||. ||.+||+ ++++++||||.+.
T Consensus       232 ~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         232 SDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             CCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            9887777777776  4444554  359999999999997 9999999 9999999999763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-48  Score=375.61  Aligned_cols=255  Identities=27%  Similarity=0.456  Sum_probs=221.2

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||+|+||.||++++..+++.||||++.+....      .......+.+|+.++..++||||+++++++.+  
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--   72 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF------KLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--   72 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh------hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--
Confidence            3699999999999999999999999999999998754321      22345678899999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        73 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~  152 (333)
T cd05600          73 DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV  152 (333)
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence            46899999999999999998888889999999999999999999999999999999999999999999999999997654


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCC------C
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFPD------A  349 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~------~  349 (410)
                      .   ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+....  ...|.      .
T Consensus       153 ~---~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  228 (333)
T cd05600         153 T---YANSVVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFN  228 (333)
T ss_pred             c---ccCCcccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccc
Confidence            3   3345679999999999887755 567999999999999999999999888777766665432  11221      4


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      +++++.+||.+||..+|.+|||+.++++||||.+.
T Consensus       229 ~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         229 LSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             cCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            58999999999999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.3e-48  Score=372.97  Aligned_cols=256  Identities=30%  Similarity=0.507  Sum_probs=224.4

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEEcCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPN  197 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  197 (410)
                      +|.+++.||+|+||.||++++..+++.||||++.+....      .......+..|..++..+ +||+|+++++++.+  
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--   72 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI------QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--   72 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--
Confidence            488999999999999999999999999999998754221      223445667788888777 58899999999876  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+|+||||+++++|...+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        73 ~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~  152 (323)
T cd05616          73 MDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM  152 (323)
T ss_pred             CCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence            45899999999999998888777889999999999999999999999999999999999999999999999999997544


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNL  357 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~l  357 (410)
                      .........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+......+|..++.++.+|
T Consensus       153 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  231 (323)
T cd05616         153 WDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI  231 (323)
T ss_pred             CCCCccccCCCChhhcCHHHhcCCCC-CCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence            33334456679999999999887665 56799999999999999999999998888888888888888999999999999


Q ss_pred             HHHhcccCCCCCCCH-----HHHhhCCcccC
Q 015257          358 LEGLLCKDPTRRLTL-----NDVAKHTWVLG  383 (410)
Q Consensus       358 i~~~L~~dp~~Rpt~-----~ell~h~~~~~  383 (410)
                      +.+||+.||.+|++.     .++++||||..
T Consensus       232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         232 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             HHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence            999999999999984     89999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.6e-48  Score=372.41  Aligned_cols=252  Identities=29%  Similarity=0.500  Sum_probs=218.4

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHh-CCCCCcccceeEEEcCCCCEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM-LQHPNIVNLIEVIDDPNSDHFY  202 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~~~  202 (410)
                      +.||+|+||.||++++..+|+.||+|++.+....      .......+..|..++.. ++||||+++++++.+  ...+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~   72 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL------IDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLF   72 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEE
Confidence            4699999999999999999999999998754221      12234456778888765 489999999999986  46899


Q ss_pred             EEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc
Q 015257          203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV  282 (410)
Q Consensus       203 lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  282 (410)
                      +||||+.++.|...+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++........
T Consensus        73 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  152 (316)
T cd05620          73 FVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR  152 (316)
T ss_pred             EEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCc
Confidence            99999999999888877778999999999999999999999999999999999999999999999999998754333334


Q ss_pred             cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Q 015257          283 LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLL  362 (410)
Q Consensus       283 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L  362 (410)
                      ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+......+|..++.++++||.+||
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  231 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLF  231 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHc
Confidence            456779999999999877665 5679999999999999999999998888888888877777788889999999999999


Q ss_pred             ccCCCCCCCH-HHHhhCCcccCC
Q 015257          363 CKDPTRRLTL-NDVAKHTWVLGD  384 (410)
Q Consensus       363 ~~dp~~Rpt~-~ell~h~~~~~~  384 (410)
                      +.||.+||++ +++++||||...
T Consensus       232 ~~dP~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         232 ERDPTRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             cCCHHHcCCChHHHHcCCCcCCC
Confidence            9999999998 589999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.5e-48  Score=374.56  Aligned_cols=251  Identities=33%  Similarity=0.546  Sum_probs=218.1

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHH-HHHhCCCCCcccceeEEEcCCCCEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL-IMKMLQHPNIVNLIEVIDDPNSDHFY  202 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~~  202 (410)
                      +.||+|+||+||++++..+|+.||||++.+....      .......+..|.. +++.++||||+++++.+.+  ...++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~   72 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL------KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLY   72 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh------hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEE
Confidence            4699999999999999999999999998754321      1222334555554 5688999999999999986  45899


Q ss_pred             EEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc
Q 015257          203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV  282 (410)
Q Consensus       203 lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  282 (410)
                      +||||+++++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        73 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  152 (323)
T cd05575          73 FVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT  152 (323)
T ss_pred             EEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCc
Confidence            99999999999888887788999999999999999999999999999999999999999999999999999764433344


Q ss_pred             cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Q 015257          283 LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLL  362 (410)
Q Consensus       283 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L  362 (410)
                      .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+......++..+++.+.+||.+||
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l  231 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLL  231 (323)
T ss_pred             cccccCChhhcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence            455679999999999877665 6679999999999999999999999888888888888888888889999999999999


Q ss_pred             ccCCCCCCCH----HHHhhCCcccC
Q 015257          363 CKDPTRRLTL----NDVAKHTWVLG  383 (410)
Q Consensus       363 ~~dp~~Rpt~----~ell~h~~~~~  383 (410)
                      +.||.+||++    .++++||||..
T Consensus       232 ~~~p~~R~~~~~~~~~il~~~~~~~  256 (323)
T cd05575         232 QKDRTKRLGAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             hcCHHhCCCCCCCHHHHHcCCCcCC
Confidence            9999999987    69999999965

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-50  Score=376.39  Aligned_cols=255  Identities=25%  Similarity=0.411  Sum_probs=225.9

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      .|..+..||+|+||.||++.+..+++.||||++....        .++..+.+.+|+.+|..++++||.++|+.+..  +
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--------~~deIediqqei~~Ls~~~~~~it~yygsyl~--g   83 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--------AEDEIEDIQQEISVLSQCDSPNITEYYGSYLK--G   83 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhh--------cchhhHHHHHHHHHHHhcCcchHHhhhhheee--c
Confidence            5777899999999999999999999999999987543        45667889999999999999999999998876  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ..++++||||.||++.+.+.....+.|..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||++..+..
T Consensus        84 ~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~  163 (467)
T KOG0201|consen   84 TKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN  163 (467)
T ss_pred             ccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec
Confidence            57999999999999999999888889999999999999999999999999999999999999999999999999988877


Q ss_pred             CccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHH
Q 015257          279 DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFPDAMNPELRNL  357 (410)
Q Consensus       279 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~l~~l  357 (410)
                      ......++.|||.|||||++....| +.++||||||++.+||++|.+|+...........|-+..+ .....+++.+++|
T Consensus       164 ~~~rr~tfvGTPfwMAPEVI~~~~Y-~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEF  242 (467)
T KOG0201|consen  164 TVKRRKTFVGTPFWMAPEVIKQSGY-DTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEF  242 (467)
T ss_pred             hhhccccccccccccchhhhccccc-cchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHH
Confidence            7666688999999999999996565 5569999999999999999999988766444444433332 2334788999999


Q ss_pred             HHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          358 LEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       358 i~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      |..||++||+.||||.++|+|+|++..
T Consensus       243 V~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  243 VEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             HHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence            999999999999999999999999874

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.1e-48  Score=374.42  Aligned_cols=259  Identities=30%  Similarity=0.486  Sum_probs=219.0

Q ss_pred             ceeeeeeecccCceEEEEEEEc---cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEE
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID  194 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  194 (410)
                      +|.+++.||+|+||.||+++..   .+++.||+|++.+....     ......+.+..|+.+++.+ +||||+++++++.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV-----QKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe
Confidence            4889999999999999998874   47899999998754321     1233456788999999999 5999999999987


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      .  ...+++||||++++.+...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        76 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          76 T--EAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             c--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            6  45899999999999999888777889999999999999999999999999999999999999999999999999998


Q ss_pred             cccCC-ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCCCCCC
Q 015257          275 VFEDD-NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE----TLQDTYDKIVNNSLVFPDA  349 (410)
Q Consensus       275 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~  349 (410)
                      ..... ........||+.|+|||++.+....+.++|||||||++|+|++|..||...    ........+......+|..
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd05614         154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSF  233 (332)
T ss_pred             cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence            64332 222335679999999999876554467899999999999999999999643    2334445566666678888


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-----CHHHHhhCCcccCC
Q 015257          350 MNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTWVLGD  384 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~  384 (410)
                      +++.+.+||.+||+.||++||     +++++++||||.+.
T Consensus       234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999999999999999999     88999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-49  Score=357.06  Aligned_cols=259  Identities=32%  Similarity=0.562  Sum_probs=239.9

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|..+++||+|.||.|.+++.+.+|+.||||++++....      ..+....-+.|-.+|+..+||.+..+.-.|+.
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevii------akdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt  239 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVII------AKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT  239 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhhee------ehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence            457899999999999999999999999999999999876432      45566677899999999999999999888876


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                        .+.++.||||.+||.|..++.+...++|..++.|-..|+.||.|||+++||+||||.+|.|+|.+|++||+|||+++.
T Consensus       240 --~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE  317 (516)
T KOG0690|consen  240 --QDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE  317 (516)
T ss_pred             --CceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh
Confidence              568999999999999999999999999999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELR  355 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~  355 (410)
                      .-.....+.++||||.|+|||++....+ +.++|.|.+||++|||++|+.||+..+...+++.|+...+.||..++++++
T Consensus       318 ~I~~g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAk  396 (516)
T KOG0690|consen  318 EIKYGDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAK  396 (516)
T ss_pred             cccccceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHH
Confidence            6556677889999999999999987776 778999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcccCCCCCC-----CHHHHhhCCcccC
Q 015257          356 NLLEGLLCKDPTRRL-----TLNDVAKHTWVLG  383 (410)
Q Consensus       356 ~li~~~L~~dp~~Rp-----t~~ell~h~~~~~  383 (410)
                      .|+..+|.+||++|+     .+.||.+|+||.+
T Consensus       397 tLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~  429 (516)
T KOG0690|consen  397 TLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS  429 (516)
T ss_pred             HHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence            999999999999998     6899999999976

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-48  Score=379.89  Aligned_cols=257  Identities=31%  Similarity=0.591  Sum_probs=219.8

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||+|+||.||++++..+|+.||||++......      .......+.+|+.+++.++||||+++++++.+  
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--   72 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML------EKEQVAHVRAERDILAEADNPWVVKLYYSFQD--   72 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--
Confidence            3699999999999999999999999999999998754221      23345678899999999999999999999987  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+++||||+++++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.+.
T Consensus        73 ~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          73 ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             CCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            46899999999999999988877889999999999999999999999999999999999999999999999999987542


Q ss_pred             CCcc--------------------------------------ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHH
Q 015257          278 DDND--------------------------------------VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYY  319 (410)
Q Consensus       278 ~~~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~e  319 (410)
                      ....                                      .....+||+.|+|||++.+..+ +.++|||||||++|+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~e  231 (364)
T cd05599         153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYE  231 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC-CCeeeeecchhHHHH
Confidence            2110                                      1113469999999999877665 567999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHhCC--CCCCC--CCCHHHHHHHHHhcccCCCCCCC---HHHHhhCCcccCC
Q 015257          320 MIIGQYPFLGETLQDTYDKIVNNS--LVFPD--AMNPELRNLLEGLLCKDPTRRLT---LNDVAKHTWVLGD  384 (410)
Q Consensus       320 lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~~~~l~~li~~~L~~dp~~Rpt---~~ell~h~~~~~~  384 (410)
                      |++|..||......+....+....  ..+|.  .+++++++||.+||. +|.+|++   +.+++.||||.+.
T Consensus       232 l~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         232 MLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             hhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            999999999888777777776543  33443  578999999999997 9999998   9999999999764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4e-48  Score=374.18  Aligned_cols=251  Identities=28%  Similarity=0.470  Sum_probs=215.1

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEEcCCCCEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNSDHFY  202 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~  202 (410)
                      +.||+|+||.||++++..+++.||||++.+....      .......+..|+.++..+ +||||+++++++.+  ...+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~------~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~   72 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN------DDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLF   72 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEE
Confidence            4699999999999999999999999998764321      234456788999999988 79999999999986  45899


Q ss_pred             EEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc
Q 015257          203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV  282 (410)
Q Consensus       203 lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  282 (410)
                      +||||++++.|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        73 lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~  152 (329)
T cd05588          73 FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT  152 (329)
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCc
Confidence            99999999999888877788999999999999999999999999999999999999999999999999998753333334


Q ss_pred             cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHhCCCCCCCCCCHH
Q 015257          283 LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET---------LQDTYDKIVNNSLVFPDAMNPE  353 (410)
Q Consensus       283 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~---------~~~~~~~i~~~~~~~p~~~~~~  353 (410)
                      ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....         .......+......+|..++.+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~  231 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVK  231 (329)
T ss_pred             cccccCCccccCHHHHcCCCC-CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHH
Confidence            456679999999999887665 567999999999999999999995311         1224455666777888999999


Q ss_pred             HHHHHHHhcccCCCCCCC------HHHHhhCCcccC
Q 015257          354 LRNLLEGLLCKDPTRRLT------LNDVAKHTWVLG  383 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt------~~ell~h~~~~~  383 (410)
                      +.+||.+||+.||.+|||      ++++++||||..
T Consensus       232 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             HHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            999999999999999997      799999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.8e-48  Score=371.52  Aligned_cols=252  Identities=31%  Similarity=0.555  Sum_probs=217.6

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHh-CCCCCcccceeEEEcCCCCEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM-LQHPNIVNLIEVIDDPNSDHFY  202 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~~~  202 (410)
                      +.||+|+||.||++++..+++.||||++......      .......+..|..++.. .+||||+++++++..  ...++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~   72 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL------EDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLF   72 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEE
Confidence            4699999999999999999999999998754211      12233455666677664 489999999999976  45899


Q ss_pred             EEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc
Q 015257          203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV  282 (410)
Q Consensus       203 lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  282 (410)
                      +||||++|++|...+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        73 lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  152 (316)
T cd05592          73 FVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK  152 (316)
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCc
Confidence            99999999999888877788999999999999999999999999999999999999999999999999999865433344


Q ss_pred             cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Q 015257          283 LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLL  362 (410)
Q Consensus       283 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L  362 (410)
                      ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+......+|..++.++.+||.+||
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l  231 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLF  231 (316)
T ss_pred             cccccCCccccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence            455679999999999877665 5679999999999999999999999888888888888777788899999999999999


Q ss_pred             ccCCCCCCCH-HHHhhCCcccCC
Q 015257          363 CKDPTRRLTL-NDVAKHTWVLGD  384 (410)
Q Consensus       363 ~~dp~~Rpt~-~ell~h~~~~~~  384 (410)
                      +.||.+||++ .+++.||||...
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         232 ERDPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             cCCHHHcCCChHHHHcCcccCCC
Confidence            9999999986 488899999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.5e-49  Score=364.74  Aligned_cols=256  Identities=29%  Similarity=0.437  Sum_probs=215.1

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      -.|...+++|+|+||.||.+....+++.||||.+-.+..-             -.+|+.+|+.++|||||+++-+|....
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------------knrEl~im~~l~HpNIV~L~~~f~~~~   90 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------------KNRELQIMRKLDHPNIVRLLYFFSSST   90 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------------CcHHHHHHHhcCCcCeeeEEEEEEecC
Confidence            4688899999999999999999999999999998655321             238999999999999999998887643


Q ss_pred             CC---EEEEEEeecCCCCcc---cccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC-CcEEEeec
Q 015257          198 SD---HFYMVLEYVEGKWDN---DGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-GTVKIGDF  270 (410)
Q Consensus       198 ~~---~~~lv~e~~~~~~l~---~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~-~~~kl~Df  270 (410)
                      +.   ++.+|||||+.....   ++...+..++.-.++-|+.||++||.|||+.||+||||||.|+|+|.+ |.+|||||
T Consensus        91 ~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDF  170 (364)
T KOG0658|consen   91 ESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDF  170 (364)
T ss_pred             CCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccC
Confidence            33   567899999865322   222346789999999999999999999999999999999999999987 89999999


Q ss_pred             cccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------
Q 015257          271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------  342 (410)
Q Consensus       271 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--------  342 (410)
                      |.|+.+..+... .....|..|+|||.+.+...++.+.||||.||++.||+-|++-|.|.+..+++..|.+-        
T Consensus       171 GSAK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~  249 (364)
T KOG0658|consen  171 GSAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED  249 (364)
T ss_pred             CcceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999987654433 34455888999999999988888999999999999999999999999888877666541        


Q ss_pred             ---------CCCC------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          343 ---------SLVF------------PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       343 ---------~~~~------------p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                               ...+            ....++++.+|+.++|+.+|.+|.++.|++.||||.....+
T Consensus       250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                     1112            23568999999999999999999999999999999876554

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.5e-48  Score=371.45  Aligned_cols=252  Identities=30%  Similarity=0.508  Sum_probs=221.6

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEEcCCCCEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNSDHFY  202 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~  202 (410)
                      +.||+|+||.||++++..+++.||||++.+....      .......+..|+.++..+ +||||+++++++.+  ...++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~   72 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL------QDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLF   72 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh------hhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEE
Confidence            4699999999999999999999999998754321      223445677899999888 69999999999986  45899


Q ss_pred             EEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc
Q 015257          203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV  282 (410)
Q Consensus       203 lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  282 (410)
                      +||||+++++|...+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        73 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  152 (318)
T cd05570          73 FVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT  152 (318)
T ss_pred             EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc
Confidence            99999999999888887778999999999999999999999999999999999999999999999999998754333333


Q ss_pred             cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Q 015257          283 LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLL  362 (410)
Q Consensus       283 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L  362 (410)
                      ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+......+|..++.++.+||.+||
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l  231 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPY-GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFL  231 (318)
T ss_pred             ccceecCccccCHHHhcCCCC-CcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHc
Confidence            445679999999999877665 5679999999999999999999998888888888888888888899999999999999


Q ss_pred             ccCCCCCCCH-----HHHhhCCcccCC
Q 015257          363 CKDPTRRLTL-----NDVAKHTWVLGD  384 (410)
Q Consensus       363 ~~dp~~Rpt~-----~ell~h~~~~~~  384 (410)
                      +.||.+|||+     .+++.||||...
T Consensus       232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         232 TKNPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             cCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999999     999999999763

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-48  Score=381.53  Aligned_cols=257  Identities=29%  Similarity=0.532  Sum_probs=217.6

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||+|+||.||++.+..+|+.||||++.+....      .......+.+|+.+++.++||||+++++++.+  
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--   72 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF------KKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--   72 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH------HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--
Confidence            3689999999999999999999999999999998654211      23455678899999999999999999999987  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+|+||||++|++|..++.....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+.
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~  152 (377)
T cd05629          73 AQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH  152 (377)
T ss_pred             CCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence            45899999999999999988877889999999999999999999999999999999999999999999999999986321


Q ss_pred             CCc------------c-----------------------------------ccccCCCcccccccccccCCcCCCchhhH
Q 015257          278 DDN------------D-----------------------------------VLRRSPGTPVFTAPECCLGLTYGGKAADT  310 (410)
Q Consensus       278 ~~~------------~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  310 (410)
                      ...            .                                   .....+||+.|+|||++.+..+ +.++||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di  231 (377)
T cd05629         153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDW  231 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceee
Confidence            100            0                                   0012469999999999877665 667999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHhcccCCCCC---CCHHHHhhCCcccC
Q 015257          311 WAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--SLVFPD--AMNPELRNLLEGLLCKDPTRR---LTLNDVAKHTWVLG  383 (410)
Q Consensus       311 wSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~l~~li~~~L~~dp~~R---pt~~ell~h~~~~~  383 (410)
                      |||||++|+|++|..||.+....+.+..+...  .+.+|.  .++.++.+||.+||+ +|.+|   +|+.+++.||||.+
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~  310 (377)
T cd05629         232 WSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG  310 (377)
T ss_pred             EecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            99999999999999999988777777777653  344554  578999999999998 67665   59999999999986


Q ss_pred             C
Q 015257          384 D  384 (410)
Q Consensus       384 ~  384 (410)
                      .
T Consensus       311 ~  311 (377)
T cd05629         311 V  311 (377)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6.9e-48  Score=379.93  Aligned_cols=256  Identities=29%  Similarity=0.501  Sum_probs=215.6

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      .|.+++.||+|+||.||++++..+++.||||++.+....      .......+.+|+.+++.++||||+++++++.+  .
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~------~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~   73 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL------NRNQVAHVKAERDILAEADNEWVVKLYYSFQD--K   73 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--C
Confidence            588999999999999999999999999999998754321      23455678999999999999999999999986  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ..+++||||++|+.|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus        74 ~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~  153 (381)
T cd05626          74 DNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW  153 (381)
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence            58999999999999998888878899999999999999999999999999999999999999999999999999753210


Q ss_pred             C-----------------------------------------------ccccccCCCcccccccccccCCcCCCchhhHH
Q 015257          279 D-----------------------------------------------NDVLRRSPGTPVFTAPECCLGLTYGGKAADTW  311 (410)
Q Consensus       279 ~-----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  311 (410)
                      .                                               .......+||+.|+|||++.+..+ +.++|||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~Diw  232 (381)
T cd05626         154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWW  232 (381)
T ss_pred             ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC-CCcccee
Confidence            0                                               001124579999999999877665 5679999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHhcc--cCCCCCCCHHHHhhCCcccC
Q 015257          312 AVGVTLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFPD--AMNPELRNLLEGLLC--KDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       312 SlG~il~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~l~~li~~~L~--~dp~~Rpt~~ell~h~~~~~  383 (410)
                      ||||++|+|++|..||...+..+....+..  ....+|.  .+++++++||.+||+  .+|..|+++.+++.||||.+
T Consensus       233 SlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~  310 (381)
T cd05626         233 SVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE  310 (381)
T ss_pred             ehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence            999999999999999988776666656554  2334443  589999999999665  45556999999999999976

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.2e-47  Score=367.33  Aligned_cols=265  Identities=26%  Similarity=0.445  Sum_probs=215.2

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||+|+||.||++++..+++.||+|++.....        ......+.+|+.+++.++||||+++++++..  
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--   75 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--------EGAPCTAIREVSLLKDLKHANIVTLHDIVHT--   75 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--------CCcchhHHHHHHHHHhCCCCCcceEEEEEee--
Confidence            579999999999999999999999999999999864321        1122356789999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ....++||||+++............+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        76 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  155 (309)
T cd07872          76 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (309)
T ss_pred             CCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence            45899999999875443333344568999999999999999999999999999999999999999999999999997654


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------------
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---------------  342 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~---------------  342 (410)
                      ..........+|+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+...               
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence            43333345568999999998876555577899999999999999999999887665544333210               


Q ss_pred             ----CCCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC---CCCchhh
Q 015257          343 ----SLVFP-----------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN---GPIPQYL  392 (410)
Q Consensus       343 ----~~~~p-----------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~---~~~~~~~  392 (410)
                          ...+|           ..+++++++||.+||+.||.+|||+.|+++||||+...   .++|+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~  303 (309)
T cd07872         236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSLPESI  303 (309)
T ss_pred             hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccccccCCcce
Confidence                00111           24688999999999999999999999999999999764   3466654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.6e-48  Score=372.21  Aligned_cols=252  Identities=29%  Similarity=0.471  Sum_probs=214.6

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEEcCCCCEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNSDHFY  202 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~  202 (410)
                      +.||+|+||.||++++..+++.||+|++.+....      .......+.+|+.++..+ +||||+++++++.+  ...++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~   72 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN------DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLF   72 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc------chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEE
Confidence            4699999999999999999999999998764221      234456688899988776 89999999999986  45899


Q ss_pred             EEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc
Q 015257          203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV  282 (410)
Q Consensus       203 lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  282 (410)
                      +||||+++++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        73 lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~  152 (329)
T cd05618          73 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT  152 (329)
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc
Confidence            99999999999888877778999999999999999999999999999999999999999999999999999754333333


Q ss_pred             cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhCCCCCCCCCCHH
Q 015257          283 LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE---------TLQDTYDKIVNNSLVFPDAMNPE  353 (410)
Q Consensus       283 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~~~~  353 (410)
                      .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...         ........+......+|..++..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~  231 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK  231 (329)
T ss_pred             cccccCCccccCHHHHcCCCC-CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHH
Confidence            445679999999999877665 56799999999999999999999521         11223455666777889999999


Q ss_pred             HHHHHHHhcccCCCCCCC------HHHHhhCCcccCC
Q 015257          354 LRNLLEGLLCKDPTRRLT------LNDVAKHTWVLGD  384 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt------~~ell~h~~~~~~  384 (410)
                      +.+||.+||+.||.+|||      +.++++||||.+.
T Consensus       232 ~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         232 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            999999999999999998      5899999999763

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.1e-47  Score=369.17  Aligned_cols=252  Identities=28%  Similarity=0.489  Sum_probs=217.7

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHh-CCCCCcccceeEEEcCCCCEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM-LQHPNIVNLIEVIDDPNSDHFY  202 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~~~  202 (410)
                      +.||+|+||.||++++..+++.||||++......      ..........|..++.. ++||||+++++++.+  ...++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~   72 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL------MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLF   72 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------hcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEE
Confidence            4699999999999999999999999998764321      12233456677778775 599999999999986  45899


Q ss_pred             EEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc
Q 015257          203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV  282 (410)
Q Consensus       203 lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  282 (410)
                      +||||+++++|...+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        73 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  152 (316)
T cd05619          73 FVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK  152 (316)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc
Confidence            99999999999988877778999999999999999999999999999999999999999999999999998754333333


Q ss_pred             cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Q 015257          283 LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLL  362 (410)
Q Consensus       283 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L  362 (410)
                      .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+......+|..++.++.+||.+||
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l  231 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLF  231 (316)
T ss_pred             eeeecCCccccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHh
Confidence            445679999999999877665 5679999999999999999999998888888877777777788889999999999999


Q ss_pred             ccCCCCCCCHH-HHhhCCcccCC
Q 015257          363 CKDPTRRLTLN-DVAKHTWVLGD  384 (410)
Q Consensus       363 ~~dp~~Rpt~~-ell~h~~~~~~  384 (410)
                      +.||.+||++. +++.||||...
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         232 VREPERRLGVKGDIRQHPFFREI  254 (316)
T ss_pred             ccCHhhcCCChHHHHcCcccCCC
Confidence            99999999996 99999999774

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1e-47  Score=377.14  Aligned_cols=260  Identities=30%  Similarity=0.505  Sum_probs=221.8

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||++++..+++.||+|++.+....      .......+.+|+.+++.++||||+++++++.+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~  114 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI------KRSDSAFFWEERDIMAHANSEWIVQLHYAFQD  114 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            356899999999999999999999999999999998653221      12233457889999999999999999999986


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                        ...+++||||++|++|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus       115 --~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         115 --DKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             --CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence              4589999999999999887754 4689999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCcc-ccccCCCcccccccccccCCc---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCC-
Q 015257          276 FEDDND-VLRRSPGTPVFTAPECCLGLT---YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFPD-  348 (410)
Q Consensus       276 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~-  348 (410)
                      ...... ......||+.|+|||++.+..   ..+.++|||||||++|+|++|..||.+......+..+....  ..+|. 
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  271 (370)
T cd05596         192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD  271 (370)
T ss_pred             ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCc
Confidence            543321 234567999999999886532   23678999999999999999999999988888888887643  45565 


Q ss_pred             -CCCHHHHHHHHHhcccCCCC--CCCHHHHhhCCcccCC
Q 015257          349 -AMNPELRNLLEGLLCKDPTR--RLTLNDVAKHTWVLGD  384 (410)
Q Consensus       349 -~~~~~l~~li~~~L~~dp~~--Rpt~~ell~h~~~~~~  384 (410)
                       .++.++.+||.+||+.+|.+  |+|++++++||||++.
T Consensus       272 ~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             CCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence             57999999999999999987  9999999999999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.9e-47  Score=368.50  Aligned_cols=257  Identities=30%  Similarity=0.507  Sum_probs=223.7

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEEEcCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDPN  197 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~  197 (410)
                      +|...+.||+|+||.||+|+++.+|+.||||++.+....      .......+..|+.++..+. |++|+++++++.+  
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--   72 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI------QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--   72 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhccCCCchhheeeEEec--
Confidence            367889999999999999999999999999998754221      2234456778899998886 5677788888876  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+|+||||++|++|...+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        73 ~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~  152 (323)
T cd05615          73 VDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM  152 (323)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence            45899999999999999888877889999999999999999999999999999999999999999999999999997644


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNL  357 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~l  357 (410)
                      ..........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+......+|..+++++.+|
T Consensus       153 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  231 (323)
T cd05615         153 VDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSI  231 (323)
T ss_pred             CCCccccCccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence            33333445679999999999877665 56799999999999999999999998888888888888888899999999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHhhCCcccCC
Q 015257          358 LEGLLCKDPTRRLT-----LNDVAKHTWVLGD  384 (410)
Q Consensus       358 i~~~L~~dp~~Rpt-----~~ell~h~~~~~~  384 (410)
                      +.+||+.||.+|++     ..++++||||..-
T Consensus       232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         232 CKGLMTKHPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             HHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence            99999999999997     5799999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1e-47  Score=378.87  Aligned_cols=256  Identities=30%  Similarity=0.515  Sum_probs=216.6

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      .|.+++.||+|+||.||++++..+++.||||++.+....      .......+.+|+.+++.++|||||++++.+.+  .
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~------~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~   73 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL------LRNQVAHVKAERDILAEADNEWVVRLYYSFQD--K   73 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh------hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--C
Confidence            588999999999999999999999999999998754211      23455678999999999999999999999986  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ..+|+||||+++++|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus        74 ~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~  153 (382)
T cd05625          74 DNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (382)
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence            68999999999999988887777899999999999999999999999999999999999999999999999999753210


Q ss_pred             C-----------------------------------------------ccccccCCCcccccccccccCCcCCCchhhHH
Q 015257          279 D-----------------------------------------------NDVLRRSPGTPVFTAPECCLGLTYGGKAADTW  311 (410)
Q Consensus       279 ~-----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  311 (410)
                      .                                               .......+||+.|+|||++.+..+ +.++|||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~Diw  232 (382)
T cd05625         154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWW  232 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC-CCeeeEE
Confidence            0                                               001123569999999999877665 5679999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCC--CCCCHHHHHHHHHhcccCCCCCCC---HHHHhhCCcccCC
Q 015257          312 AVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--SLVFP--DAMNPELRNLLEGLLCKDPTRRLT---LNDVAKHTWVLGD  384 (410)
Q Consensus       312 SlG~il~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~~~~l~~li~~~L~~dp~~Rpt---~~ell~h~~~~~~  384 (410)
                      ||||++|+|++|..||.+.+..+....+...  ...+|  ..+++++.+||.+|+ .+|.+|++   +.+++.||||.+.
T Consensus       233 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         233 SVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             echHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            9999999999999999988777666666543  23344  368999999999976 59999997   9999999999763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4e-48  Score=372.34  Aligned_cols=252  Identities=27%  Similarity=0.476  Sum_probs=220.8

Q ss_pred             eeeecccCceEEEEEEEc---cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCC
Q 015257          123 VRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  199 (410)
                      ++.||+|+||.||++++.   .+|+.||+|++......       ......+.+|+.++++++||||+++++++.+  ..
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~   71 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-------VRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EG   71 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-------hhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CC
Confidence            367999999999998874   47899999998754321       1233467789999999999999999999986  45


Q ss_pred             EEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCC
Q 015257          200 HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD  279 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~  279 (410)
                      .+|+||||+++++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        72 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  151 (318)
T cd05582          72 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  151 (318)
T ss_pred             EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence            89999999999999888877778999999999999999999999999999999999999999999999999999865444


Q ss_pred             ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 015257          280 NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLE  359 (410)
Q Consensus       280 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~  359 (410)
                      ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||......+....+......+|..+++.+.+||.
T Consensus       152 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  230 (318)
T cd05582         152 EKKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR  230 (318)
T ss_pred             CCceecccCChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            334455679999999998876555 5679999999999999999999999888888888888888889999999999999


Q ss_pred             HhcccCCCCCCC-----HHHHhhCCcccCC
Q 015257          360 GLLCKDPTRRLT-----LNDVAKHTWVLGD  384 (410)
Q Consensus       360 ~~L~~dp~~Rpt-----~~ell~h~~~~~~  384 (410)
                      +||+.||.+|||     +.+++.||||...
T Consensus       231 ~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         231 ALFKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             HHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            999999999999     7889999999753

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.2e-48  Score=355.35  Aligned_cols=268  Identities=29%  Similarity=0.485  Sum_probs=222.6

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCC-cccceeEEEc
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN-IVNLIEVIDD  195 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~  195 (410)
                      ...|..+++||+|+||+||+|+.+.+|+.||+|++......       +-.-....+|+.+|+.++|+| ||.+++++..
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-------EG~P~taiREisllk~L~~~~~iv~L~dv~~~   82 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-------EGVPSTAIREISLLKRLSHANHIVRLHDVIHT   82 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-------cCCCchhhHHHHHHHHhCCCcceEEEEeeeee
Confidence            45688889999999999999999999999999998754321       112235679999999999999 9999999986


Q ss_pred             CC----CCEEEEEEeecCCCCcccccCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEE
Q 015257          196 PN----SDHFYMVLEYVEGKWDNDGFGQP----GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKI  267 (410)
Q Consensus       196 ~~----~~~~~lv~e~~~~~~l~~~~~~~----~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl  267 (410)
                      .+    ...+++|+||+... +..++...    ..++...++.+++||+.||+|||+++|+||||||.||||+++|.+||
T Consensus        83 ~~~~~~~~~l~lvfe~~d~D-L~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKl  161 (323)
T KOG0594|consen   83 SNNHRGIGKLYLVFEFLDRD-LKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKL  161 (323)
T ss_pred             cccccccceEEEEEEeeccc-HHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEee
Confidence            33    13799999999754 33333221    46788999999999999999999999999999999999999999999


Q ss_pred             eeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----
Q 015257          268 GDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN-----  342 (410)
Q Consensus       268 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~-----  342 (410)
                      +|||+|+...-+....+...+|..|+|||++.+...++..+||||+|||++||++++..|.+....++...|..-     
T Consensus       162 aDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~  241 (323)
T KOG0594|consen  162 ADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN  241 (323)
T ss_pred             eccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence            999999987766666778889999999999999977888899999999999999999999998888877777541     


Q ss_pred             -------------CCCCCC------------CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCchhh
Q 015257          343 -------------SLVFPD------------AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL  392 (410)
Q Consensus       343 -------------~~~~p~------------~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~~  392 (410)
                                   ...|+.            ..+++..+|+.+||+.+|.+|.|++.+|.||||.....+.+...
T Consensus       242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~~~  316 (323)
T KOG0594|consen  242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQLL  316 (323)
T ss_pred             ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhhhh
Confidence                         111111            12357899999999999999999999999999988766655543

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.3e-47  Score=369.52  Aligned_cols=260  Identities=27%  Similarity=0.415  Sum_probs=208.9

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC-
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN-  197 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-  197 (410)
                      +|.+.+.||+|+||.||++++..+|..||||++.....       .......+.+|+.+++.++||||+++++++.... 
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   73 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-------HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR   73 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-------cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCC
Confidence            58899999999999999999999999999998764211       1223456889999999999999999999886532 


Q ss_pred             --CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          198 --SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       198 --~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                        ...+|+||||+++ .+...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        74 ~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          74 REFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             CCCceEEEEEecCCC-CHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence              2368999999975 5666676677899999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCc---cccccCCCcccccccccccCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------
Q 015257          276 FEDDN---DVLRRSPGTPVFTAPECCLGL-TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN----------  341 (410)
Q Consensus       276 ~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~----------  341 (410)
                      .....   .......||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.+.+.......+..          
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            43221   122345799999999987652 3336789999999999999999999987654332211110          


Q ss_pred             ----------------CCC--CC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          342 ----------------NSL--VF---PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       342 ----------------~~~--~~---p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                                      ...  .+   ...+++.+.+||.+||+.||++|||++++++||||.+...
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                            000  00   0246788999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=8.6e-48  Score=378.55  Aligned_cols=256  Identities=30%  Similarity=0.504  Sum_probs=216.3

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|++++.||+|+||.||++++..+++.||||++.+....      .......+.+|+.+|+.++||||+++++.+.+  .
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~   73 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL------MRNQAAHVKAERDILAEADNEWVVKLYYSFQD--K   73 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH------hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--C
Confidence            699999999999999999999999999999998654221      12334578899999999999999999999986  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      +.+++||||+++++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+..
T Consensus        74 ~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          74 DNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            68999999999999999988888899999999999999999999999999999999999999999999999999753210


Q ss_pred             C-------------------------------------------ccccccCCCcccccccccccCCcCCCchhhHHHHHH
Q 015257          279 D-------------------------------------------NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGV  315 (410)
Q Consensus       279 ~-------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~  315 (410)
                      .                                           .......+||+.|+|||++.+..+ +.++|||||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGv  232 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGV  232 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC-Ccceeeeeccc
Confidence            0                                           001123579999999999877665 56799999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCC--CCCCHHHHHHHHHhcccCCCCCC---CHHHHhhCCcccCC
Q 015257          316 TLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFP--DAMNPELRNLLEGLLCKDPTRRL---TLNDVAKHTWVLGD  384 (410)
Q Consensus       316 il~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~~~~l~~li~~~L~~dp~~Rp---t~~ell~h~~~~~~  384 (410)
                      ++|+|++|..||.+....+....+....  ..+|  ..+++++.+||.+|+ .+|.+|+   |+.++++||||.+.
T Consensus       233 ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         233 ILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             eeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            9999999999999887776666665432  2333  368899999999976 5999999   99999999999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.9e-47  Score=382.94  Aligned_cols=254  Identities=25%  Similarity=0.352  Sum_probs=206.6

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      ..+|.+.+.||+|+||.||++.+..+++.||||++....             ....+|+.+|+.++|||||++++++...
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------------~~~~~Ei~il~~l~h~niv~l~~~~~~~  131 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------------QYKNRELLIMKNLNHINIIFLKDYYYTE  131 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------------chHHHHHHHHHhcCCCCCcceeeeEeec
Confidence            357999999999999999999999999999999875321             1235799999999999999999876432


Q ss_pred             ------CCCEEEEEEeecCCCCcc---cccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC-cEE
Q 015257          197 ------NSDHFYMVLEYVEGKWDN---DGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVK  266 (410)
Q Consensus       197 ------~~~~~~lv~e~~~~~~l~---~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~-~~k  266 (410)
                            ....+++||||++++...   ........+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus       132 ~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vk  211 (440)
T PTZ00036        132 CFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLK  211 (440)
T ss_pred             ccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCcee
Confidence                  123577999999975422   2223456799999999999999999999999999999999999999765 699


Q ss_pred             EeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----
Q 015257          267 IGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN----  342 (410)
Q Consensus       267 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~----  342 (410)
                      |+|||+|+...... ......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+....+...    
T Consensus       212 L~DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p  290 (440)
T PTZ00036        212 LCDFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP  290 (440)
T ss_pred             eeccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99999998654332 2234578999999999877655577899999999999999999999987766555444321    


Q ss_pred             -------------CC------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          343 -------------SL------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       343 -------------~~------------~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                                   ..            .+|...++++++||.+||++||.+|||+.|+++||||...
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence                         01            1344578899999999999999999999999999999764

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.5e-47  Score=360.20  Aligned_cols=250  Identities=29%  Similarity=0.465  Sum_probs=211.8

Q ss_pred             ecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEEEE
Q 015257          126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVL  205 (410)
Q Consensus       126 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~  205 (410)
                      ||+|+||+||++.+..+|+.||+|.+......      .......+..|+.+++.++||||+++++++..  ...+++||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~   72 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK------KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVM   72 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh------hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEE
Confidence            79999999999999999999999998654221      12334567889999999999999999998876  45799999


Q ss_pred             eecCCCCccccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCcc
Q 015257          206 EYVEGKWDNDGF----GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND  281 (410)
Q Consensus       206 e~~~~~~l~~~~----~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  281 (410)
                      ||+++++|...+    .....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus        73 e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  152 (280)
T cd05608          73 TIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS  152 (280)
T ss_pred             eCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence            999999887654    2345799999999999999999999999999999999999999999999999999986654444


Q ss_pred             ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCCCCCCHHHHHH
Q 015257          282 VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL----QDTYDKIVNNSLVFPDAMNPELRNL  357 (410)
Q Consensus       282 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~~~~l~~l  357 (410)
                      ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....    ......+......+|..+++.+.+|
T Consensus       153 ~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  231 (280)
T cd05608         153 KTKGYAGTPGFMAPELLQGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSF  231 (280)
T ss_pred             cccccCCCcCccCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHH
Confidence            4445679999999999887665 5679999999999999999999976432    2334445555566778899999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHhhCCcccCC
Q 015257          358 LEGLLCKDPTRRL-----TLNDVAKHTWVLGD  384 (410)
Q Consensus       358 i~~~L~~dp~~Rp-----t~~ell~h~~~~~~  384 (410)
                      +.+||+.||.+||     |++++++||||++.
T Consensus       232 i~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         232 CEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             HHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence            9999999999999     88999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.6e-47  Score=375.41  Aligned_cols=255  Identities=20%  Similarity=0.279  Sum_probs=206.8

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      .+|.+++.||+|+||.||+|.+..+++.||||....               ..+.+|+.+++.++|||||++++++..  
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------------~~~~~E~~il~~l~HpnIv~~~~~~~~--  154 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------------GGTATEAHILRAINHPSIIQLKGTFTY--  154 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------------hhhHHHHHHHHhCCCCCCCCEeEEEEE--
Confidence            579999999999999999999999999999996421               246789999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ....++|||++.+ .+...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus       155 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        155 NKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV  233 (391)
T ss_pred             CCeeEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence            4578999999975 455566666679999999999999999999999999999999999999999999999999997543


Q ss_pred             CC-ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHH---------
Q 015257          278 DD-NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-------LQDTYDKIV---------  340 (410)
Q Consensus       278 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-------~~~~~~~i~---------  340 (410)
                      .. ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||....       .......+.         
T Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~  312 (391)
T PHA03212        234 DINANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE  312 (391)
T ss_pred             cccccccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence            22 223345679999999999877655 677999999999999999998875321       011111111         


Q ss_pred             -----------------hCCCCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCchh
Q 015257          341 -----------------NNSLVFP---------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQY  391 (410)
Q Consensus       341 -----------------~~~~~~p---------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~  391 (410)
                                       ......|         ..++.++.+||.+||+.||.+|||+.|+|+||||+....|.|..
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~  389 (391)
T PHA03212        313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYPNP  389 (391)
T ss_pred             cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCCCCC
Confidence                             0000001         12466899999999999999999999999999999887776654

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.2e-47  Score=375.41  Aligned_cols=257  Identities=28%  Similarity=0.529  Sum_probs=219.5

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||+|+||.||++.+..+++.||||++......      .......+.+|+.++..++||||+++++.+.+  
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--   72 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML------EKEQVAHIRAERDILVEADGAWVVKMFYSFQD--   72 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh------hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--
Confidence            3689999999999999999999999999999998754221      23455678899999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+++||||++|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||+++...
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          73 KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             CCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            46899999999999999988888889999999999999999999999999999999999999999999999999987542


Q ss_pred             CCc-----------------------------------cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh
Q 015257          278 DDN-----------------------------------DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII  322 (410)
Q Consensus       278 ~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  322 (410)
                      ...                                   ......+||+.|+|||++.+..+ +.++|||||||++|+|++
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyel~t  231 (360)
T cd05627         153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLI  231 (360)
T ss_pred             cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC-CCcceeccccceeeeccc
Confidence            110                                   01123579999999999877665 567999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHhcccCCCCCC---CHHHHhhCCcccCC
Q 015257          323 GQYPFLGETLQDTYDKIVNN--SLVFPD--AMNPELRNLLEGLLCKDPTRRL---TLNDVAKHTWVLGD  384 (410)
Q Consensus       323 G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~l~~li~~~L~~dp~~Rp---t~~ell~h~~~~~~  384 (410)
                      |..||.+.........+...  .+.+|.  .+++++++||.+|+ .||.+|+   ++.++++||||.+.
T Consensus       232 G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         232 GYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence            99999998888777777653  334554  47899999999977 5999998   58999999999873

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1e-46  Score=364.66  Aligned_cols=259  Identities=24%  Similarity=0.422  Sum_probs=216.8

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|++++.||+|+||.||++++..+|..||+|++....        .......+.+|+.+|+.++||||+++++++.+  
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--   74 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--   74 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--
Confidence            68999999999999999999999999999999986431        23445679999999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ...+++||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  154 (331)
T cd06649          75 DGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (331)
T ss_pred             CCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence            458999999999999999888777899999999999999999999986 6999999999999999999999999999765


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----------------
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKI-----------------  339 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i-----------------  339 (410)
                      ...  ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......+....+                 
T Consensus       155 ~~~--~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (331)
T cd06649         155 IDS--MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP  231 (331)
T ss_pred             ccc--ccccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCc
Confidence            432  2345578999999999877655 66799999999999999999999765543322111                 


Q ss_pred             -----------------------------HhCC-CCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCC
Q 015257          340 -----------------------------VNNS-LVFP-DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI  388 (410)
Q Consensus       340 -----------------------------~~~~-~~~p-~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~  388 (410)
                                                   .... ...+ ..+++++++||.+||+.||++|||+.++++||||+.....-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~  311 (331)
T cd06649         232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVEE  311 (331)
T ss_pred             ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccccc
Confidence                                         1111 1111 24688999999999999999999999999999998765543


Q ss_pred             c
Q 015257          389 P  389 (410)
Q Consensus       389 ~  389 (410)
                      .
T Consensus       312 ~  312 (331)
T cd06649         312 V  312 (331)
T ss_pred             c
Confidence            3

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.4e-47  Score=369.79  Aligned_cols=256  Identities=29%  Similarity=0.510  Sum_probs=211.9

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|..++.||+|+||.||++++..+|+.||||++....        .......+.+|+.+++.++|+||+++++++.+
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  143 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--------EDTVRRQICREIEILRDVNHPNVVKCHDMFDH  143 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--------cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc
Confidence            3467889999999999999999999999999999985431        23445678999999999999999999999976


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                        .+.+++||||+.+++|...    ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       144 --~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~  217 (353)
T PLN00034        144 --NGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI  217 (353)
T ss_pred             --CCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccccccee
Confidence              4689999999999887643    3456888899999999999999999999999999999999999999999999987


Q ss_pred             ccCCccccccCCCcccccccccccCC----cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH-hCCCCCC
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGL----TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQD---TYDKIV-NNSLVFP  347 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---~~~~i~-~~~~~~p  347 (410)
                      ............||+.|+|||++...    .+.+.++|||||||++|+|++|+.||......+   ....+. ......+
T Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
T PLN00034        218 LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAP  297 (353)
T ss_pred             cccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCC
Confidence            65443334456799999999987432    233457999999999999999999997433222   222222 2233456


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      ..++.++++||.+||+.||.+|||+.|+++||||.+..
T Consensus       298 ~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        298 ATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            68899999999999999999999999999999998864

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.8e-47  Score=368.88  Aligned_cols=251  Identities=32%  Similarity=0.547  Sum_probs=216.1

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHH-HHHHhCCCCCcccceeEEEcCCCCEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV-LIMKMLQHPNIVNLIEVIDDPNSDHFY  202 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~l~~~~~~~~~~~~~  202 (410)
                      +.||+|+||.||++++..+++.||+|++.+....      .......+..|. .+++.++||||+++++++.+  .+.+|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~   72 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL------KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLY   72 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH------hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEE
Confidence            4699999999999999999999999998754221      111223344444 45788999999999999986  46899


Q ss_pred             EEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc
Q 015257          203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV  282 (410)
Q Consensus       203 lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  282 (410)
                      +||||++++.+...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        73 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~  152 (325)
T cd05602          73 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT  152 (325)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC
Confidence            99999999999988888788999999999999999999999999999999999999999999999999999764433334


Q ss_pred             cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Q 015257          283 LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLL  362 (410)
Q Consensus       283 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L  362 (410)
                      ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+.+..+......++..+++.+.++|.+||
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l  231 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLL  231 (325)
T ss_pred             cccccCCccccCHHHHcCCCC-CCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHc
Confidence            456679999999999877665 5679999999999999999999999888888888888877788889999999999999


Q ss_pred             ccCCCCCCCHH----HHhhCCcccC
Q 015257          363 CKDPTRRLTLN----DVAKHTWVLG  383 (410)
Q Consensus       363 ~~dp~~Rpt~~----ell~h~~~~~  383 (410)
                      +.||.+||++.    ++++|+||..
T Consensus       232 ~~~p~~R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         232 QKDRTKRLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             ccCHHHCCCCCCCHHHHhcCcccCC
Confidence            99999999876    8999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.8e-47  Score=368.20  Aligned_cols=251  Identities=31%  Similarity=0.532  Sum_probs=216.8

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHH-HHHHhCCCCCcccceeEEEcCCCCEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV-LIMKMLQHPNIVNLIEVIDDPNSDHFY  202 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~l~~~~~~~~~~~~~  202 (410)
                      +.||+|+||.||++++..+|+.||+|++.+....      .......+..|. .+++.++||||+++++++.+  ...++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~   72 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL------KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLY   72 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH------HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEE
Confidence            4699999999999999999999999998754321      122234455555 46889999999999999876  45899


Q ss_pred             EEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc
Q 015257          203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV  282 (410)
Q Consensus       203 lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  282 (410)
                      +||||++++++...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++........
T Consensus        73 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  152 (321)
T cd05603          73 FVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET  152 (321)
T ss_pred             EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCc
Confidence            99999999999888877778999999999999999999999999999999999999999999999999998754333334


Q ss_pred             cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Q 015257          283 LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLL  362 (410)
Q Consensus       283 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L  362 (410)
                      .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|...+..+.++|.+||
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l  231 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLL  231 (321)
T ss_pred             cccccCCcccCCHHHhcCCCC-CCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHc
Confidence            455679999999999877655 5679999999999999999999999888888888888888888899999999999999


Q ss_pred             ccCCCCCCCH----HHHhhCCcccC
Q 015257          363 CKDPTRRLTL----NDVAKHTWVLG  383 (410)
Q Consensus       363 ~~dp~~Rpt~----~ell~h~~~~~  383 (410)
                      +.||.+||++    .++++|+||..
T Consensus       232 ~~~p~~R~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         232 HKDQRRRLGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             cCCHhhcCCCCCCHHHHhCCCCcCC
Confidence            9999999975    59999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.4e-47  Score=369.79  Aligned_cols=252  Identities=32%  Similarity=0.514  Sum_probs=217.5

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHH-HHHhCCCCCcccceeEEEcCCCCEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL-IMKMLQHPNIVNLIEVIDDPNSDHFY  202 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~~  202 (410)
                      +.||+|+||.||++++..+|+.||||++.+....      .......+..|.. +++.++||||+++++++..  ...+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~   72 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL------NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLY   72 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEE
Confidence            4699999999999999999999999998654211      1223345555554 5788999999999999986  46899


Q ss_pred             EEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc
Q 015257          203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV  282 (410)
Q Consensus       203 lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  282 (410)
                      +||||++++.+...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus        73 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  152 (325)
T cd05604          73 FVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT  152 (325)
T ss_pred             EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC
Confidence            99999999999888887788999999999999999999999999999999999999999999999999998754333334


Q ss_pred             cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Q 015257          283 LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLL  362 (410)
Q Consensus       283 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L  362 (410)
                      .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+......++...+..+.++|.+||
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll  231 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPY-DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELL  231 (325)
T ss_pred             cccccCChhhCCHHHHcCCCC-CCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHh
Confidence            455679999999999877665 5679999999999999999999999888888888888877777889999999999999


Q ss_pred             ccCCCCCCCH----HHHhhCCcccCC
Q 015257          363 CKDPTRRLTL----NDVAKHTWVLGD  384 (410)
Q Consensus       363 ~~dp~~Rpt~----~ell~h~~~~~~  384 (410)
                      +.||.+||++    .++++||||.+.
T Consensus       232 ~~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         232 EKDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             ccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence            9999999977    599999999763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7.5e-47  Score=371.36  Aligned_cols=264  Identities=25%  Similarity=0.401  Sum_probs=215.3

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC-
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN-  197 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-  197 (410)
                      +|++.+.||+|+||.||++.+..+|+.||||++....       ........+.+|+.+++.++||||+++++++..+. 
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   73 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-------QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI   73 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-------cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc
Confidence            4778999999999999999999999999999875321       12234567889999999999999999999987642 


Q ss_pred             --CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          198 --SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       198 --~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                        ...+|+||||+.+ .+...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        74 ~~~~~~~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          74 DPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             cccceEEEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceee
Confidence              1268999999985 4555566667899999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCc-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------
Q 015257          276 FEDDN-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-------------  341 (410)
Q Consensus       276 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~-------------  341 (410)
                      ..... .......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+..             
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            54322 2333456899999999988766557789999999999999999999988766554443321             


Q ss_pred             ----------CCC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCch
Q 015257          342 ----------NSL---------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ  390 (410)
Q Consensus       342 ----------~~~---------~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~  390 (410)
                                ...         .+....++++.+||.+||+.||.+|||+.++++||||.+.......
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~  300 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHT  300 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcchhcc
Confidence                      111         1223568899999999999999999999999999999986544443

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-47  Score=371.24  Aligned_cols=251  Identities=28%  Similarity=0.454  Sum_probs=215.7

Q ss_pred             ecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC---CCCCcccceeEEEcCCCCEEE
Q 015257          126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML---QHPNIVNLIEVIDDPNSDHFY  202 (410)
Q Consensus       126 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~~~~  202 (410)
                      ||+|+||.||++++..+|+.||||++.+....      ..........|..++..+   +||||+++++++.+  ...+|
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~   72 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV------AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLY   72 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh------hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEE
Confidence            79999999999999999999999998654221      122334455677777655   69999999999986  45899


Q ss_pred             EEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc
Q 015257          203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV  282 (410)
Q Consensus       203 lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  282 (410)
                      +||||++++.|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        73 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~  152 (330)
T cd05586          73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT  152 (330)
T ss_pred             EEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence            99999999999888887888999999999999999999999999999999999999999999999999999764443344


Q ss_pred             cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHh
Q 015257          283 LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD-AMNPELRNLLEGL  361 (410)
Q Consensus       283 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~-~~~~~l~~li~~~  361 (410)
                      ....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+....+.+..+..+...+|. .+++++.+||.+|
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~  232 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGL  232 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHH
Confidence            456779999999999876554567899999999999999999999998888888888877777765 5799999999999


Q ss_pred             cccCCCCCC----CHHHHhhCCcccCC
Q 015257          362 LCKDPTRRL----TLNDVAKHTWVLGD  384 (410)
Q Consensus       362 L~~dp~~Rp----t~~ell~h~~~~~~  384 (410)
                      |+.||.+||    ++.++++||||.+.
T Consensus       233 L~~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         233 LNRNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             cCCCHHHCCCCCCCHHHHhcCccccCC
Confidence            999999998    79999999999763

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-48  Score=372.64  Aligned_cols=259  Identities=25%  Similarity=0.473  Sum_probs=234.9

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .+.|..++++|+|+||.+++++++.++..||+|.+......       ........+|+.++++++|||||.+.+.|.+.
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t-------~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~   75 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT-------EPERRSAIQEMDLLSKLLHPNIVEYKDSFEED   75 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC-------chhhHHHHHHHHHHHhccCCCeeeeccchhcC
Confidence            35799999999999999999999999999999998765432       23344788999999999999999999999873


Q ss_pred             CCCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                       +..++|||+||+||++.+.+...  ..++|..+..++.||+.||.|||++.|+|||||+.|||++.++.|||+|||+|+
T Consensus        76 -~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK  154 (426)
T KOG0589|consen   76 -GQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAK  154 (426)
T ss_pred             -CceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhh
Confidence             34599999999999999888654  368999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHH
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS-LVFPDAMNPE  353 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~  353 (410)
                      .+........+..|||.|+.||++.+..++ .++|||||||++|||++-+++|...+......+|.... .+.|..++.+
T Consensus       155 ~l~~~~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~e  233 (426)
T KOG0589|consen  155 ILNPEDSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSE  233 (426)
T ss_pred             hcCCchhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHH
Confidence            988777677889999999999999998884 55999999999999999999999999999999999887 4688899999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      ++.||..||..+|..||++.++|.+|.++..
T Consensus       234 l~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  234 LRSLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             HHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence            9999999999999999999999999998743

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.8e-47  Score=369.71  Aligned_cols=258  Identities=29%  Similarity=0.486  Sum_probs=219.9

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+.+.||+|+||.||++++..+|+.||||++......      .......+.+|+.+++.++||||+++++++.+  
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--   72 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL------AQETVSFFEEERDILSISNSPWIPQLQYAFQD--   72 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--
Confidence            3689999999999999999999999999999998754221      23345678899999999999999999999886  


Q ss_pred             CCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ...+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus        73 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~  152 (330)
T cd05601          73 KDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL  152 (330)
T ss_pred             CCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence            45899999999999999888665 67999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCcc-ccccCCCcccccccccccC-----CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCC
Q 015257          277 EDDND-VLRRSPGTPVFTAPECCLG-----LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFPD  348 (410)
Q Consensus       277 ~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~  348 (410)
                      ..... ......||+.|+|||++..     ....+.++|||||||++|+|++|..||........+..+....  ..+|.
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  232 (330)
T cd05601         153 TANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPE  232 (330)
T ss_pred             CCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCC
Confidence            44322 2234568999999998863     2233567999999999999999999999887777777776543  33443


Q ss_pred             --CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          349 --AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       349 --~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                        .+++++.+||.+||+ +|.+|||+++++.||||...
T Consensus       233 ~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         233 DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence              578999999999998 99999999999999999863

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.3e-47  Score=372.52  Aligned_cols=259  Identities=29%  Similarity=0.521  Sum_probs=219.3

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|++++.||+|+||.||++++..+++.||+|++.+....      .......+.+|+.+++.++||||+++++++.+ 
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-  114 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI------KRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-  114 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-
Confidence            46899999999999999999999999999999998653211      12234567899999999999999999999986 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       ...+|+||||+++++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus       115 -~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         115 -DKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             -CCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence             46899999999999998877544 6899999999999999999999999999999999999999999999999999865


Q ss_pred             cCCcc-ccccCCCcccccccccccCCc---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCC--
Q 015257          277 EDDND-VLRRSPGTPVFTAPECCLGLT---YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFPD--  348 (410)
Q Consensus       277 ~~~~~-~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--  348 (410)
                      ..... ......||+.|+|||++.+..   ..+.++|||||||++|+|++|..||.+.+....+..+....  +.+|.  
T Consensus       193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  272 (370)
T cd05621         193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV  272 (370)
T ss_pred             ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcc
Confidence            43222 234567999999999986542   23678999999999999999999999888877777777643  44555  


Q ss_pred             CCCHHHHHHHHHhcccCCCC--CCCHHHHhhCCcccCC
Q 015257          349 AMNPELRNLLEGLLCKDPTR--RLTLNDVAKHTWVLGD  384 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~--Rpt~~ell~h~~~~~~  384 (410)
                      .++..+++|+..||..++.+  |+|+.++++||||+..
T Consensus       273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             cCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            56999999999999865543  8999999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.4e-47  Score=365.98  Aligned_cols=252  Identities=29%  Similarity=0.477  Sum_probs=215.2

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEEcCCCCEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNSDHFY  202 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~  202 (410)
                      +.||+|+||.||++++..+++.||+|++.+....      .......+.+|+.++.++ +||||+.+++++.+  ...++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~   72 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH------DDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLF   72 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEE
Confidence            4699999999999999999999999998754221      234456788999999888 69999999999986  45899


Q ss_pred             EEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc
Q 015257          203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV  282 (410)
Q Consensus       203 lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  282 (410)
                      +||||+++++|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        73 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  152 (327)
T cd05617          73 LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT  152 (327)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc
Confidence            99999999999888877778999999999999999999999999999999999999999999999999999754333334


Q ss_pred             cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhCCCCCCCCCCHHHH
Q 015257          283 LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE-------TLQDTYDKIVNNSLVFPDAMNPELR  355 (410)
Q Consensus       283 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~-------~~~~~~~~i~~~~~~~p~~~~~~l~  355 (410)
                      ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...       ........+......+|..++..+.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~  231 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKAS  231 (327)
T ss_pred             eecccCCcccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            456779999999999877665 66799999999999999999999531       1223445556666778889999999


Q ss_pred             HHHHHhcccCCCCCCC------HHHHhhCCcccCC
Q 015257          356 NLLEGLLCKDPTRRLT------LNDVAKHTWVLGD  384 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt------~~ell~h~~~~~~  384 (410)
                      ++|.+||+.||.+|++      +.+++.||||.+.
T Consensus       232 ~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         232 HVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence            9999999999999998      5799999999764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.8e-46  Score=356.54  Aligned_cols=259  Identities=27%  Similarity=0.444  Sum_probs=211.8

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+++.||.|+||.||++++..+++.||+|.+.....        ......+.+|+.+++.++||||+++++++.. 
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-   75 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--------EGAPCTAIREVSLLKDLKHANIVTLHDIIHT-   75 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--------cCchhHHHHHHHHHHhcCCCCcceEEEEEec-
Confidence            4679999999999999999999999999999998864321        1123356789999999999999999999986 


Q ss_pred             CCCEEEEEEeecCCCCccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                       ...+++||||+++. +...+ .....+++..++.++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++..
T Consensus        76 -~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  153 (301)
T cd07873          76 -EKSLTLVFEYLDKD-LKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA  153 (301)
T ss_pred             -CCeEEEEEeccccC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence             45899999999864 44444 3345789999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN-------------  342 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~-------------  342 (410)
                      ............+++.|+|||++.+....+.++|||||||++|+|++|++||...+..+....+...             
T Consensus       154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (301)
T cd07873         154 KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL  233 (301)
T ss_pred             cCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence            5443333344567899999998876555567899999999999999999999887665544333210             


Q ss_pred             ------CCCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          343 ------SLVFP-----------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       343 ------~~~~p-----------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                            ...+|           ..+++.+++||.+||+.||.+|||++++++||||+...+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence                  00111           246888999999999999999999999999999987654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.8e-46  Score=355.52  Aligned_cols=253  Identities=28%  Similarity=0.438  Sum_probs=202.5

Q ss_pred             ceeeeeeecccCceEEEEEEEcc-CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC---CCCCcccceeEEE
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSL-DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML---QHPNIVNLIEVID  194 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~  194 (410)
                      +|.+++.||+|+||.||++++.. +|+.||||++.....       .......+.+|+.+++.+   +||||+++++++.
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~   74 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-------EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT   74 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-------CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence            69999999999999999999865 578899998864321       111223455677777665   6999999999885


Q ss_pred             cC---CCCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEee
Q 015257          195 DP---NSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGD  269 (410)
Q Consensus       195 ~~---~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~D  269 (410)
                      ..   ....+++||||+++ .+..++..  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        75 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~D  153 (290)
T cd07862          75 VSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD  153 (290)
T ss_pred             cccCCCCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEcc
Confidence            31   24578999999986 44444432  34589999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----
Q 015257          270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-----  344 (410)
Q Consensus       270 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-----  344 (410)
                      ||+++..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+....+....+.....     
T Consensus       154 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~  231 (290)
T cd07862         154 FGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  231 (290)
T ss_pred             ccceEeccCC-cccccccccccccChHHHhCCCC-CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence            9999865433 23345678999999999876655 5679999999999999999999998776666555543110     


Q ss_pred             C----------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          345 V----------------------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       345 ~----------------------~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      .                      +...+++.+.+|+.+||+.||++|||+.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            0                      112467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.3e-46  Score=365.04  Aligned_cols=257  Identities=24%  Similarity=0.450  Sum_probs=207.2

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|++++.||+|+||.||++.+..+|+.||||++.....       .......+.+|+.+++.++||||+++++++..
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   91 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-------NQTHAKRAYRELVLLKCVNHKNIISLLNVFTP   91 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-------chhHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence            45789999999999999999999999999999999864321       23345678899999999999999999999865


Q ss_pred             CC----CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          196 PN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       196 ~~----~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      ..    ...+|+||||+++++.... .  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~l~~~~-~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          92 QKSLEEFQDVYLVMELMDANLCQVI-H--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             CCCccccceeEEEEeCCCcCHHHHH-h--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCC
Confidence            32    1358999999987644432 2  348899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN----------  341 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~----------  341 (410)
                      +++..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+.+..+..          
T Consensus       169 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         169 LARTACTN-FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             CccccccC-ccCCCCcccCCCCCchhccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            99754332 23345578999999999877665 5669999999999999999999987654433322211          


Q ss_pred             ------------CCCCC--------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          342 ------------NSLVF--------------------PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       342 ------------~~~~~--------------------p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                                  ....+                    +...++++++||.+||+.||++|||+.|++.||||...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  321 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW  321 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence                        11100                    11246789999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.4e-46  Score=367.46  Aligned_cols=259  Identities=32%  Similarity=0.537  Sum_probs=218.8

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+++.||+|+||.||++++..+++.||+|++.+....      .......+.+|+.+++.++||||+++++++.+ 
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~------~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-  114 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI------KRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-  114 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh------hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-
Confidence            46899999999999999999999999999999998653211      12334567899999999999999999999986 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       ...+++||||++|++|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       115 -~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~  192 (371)
T cd05622         115 -DRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (371)
T ss_pred             -CCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence             46899999999999998877543 5899999999999999999999999999999999999999999999999999865


Q ss_pred             cCCc-cccccCCCcccccccccccCCc---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCC--
Q 015257          277 EDDN-DVLRRSPGTPVFTAPECCLGLT---YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFPD--  348 (410)
Q Consensus       277 ~~~~-~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--  348 (410)
                      .... .......||+.|+|||++....   ..+.++|||||||++|+|++|..||...+....+..+....  ..+|.  
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  272 (371)
T cd05622         193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN  272 (371)
T ss_pred             CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcC
Confidence            4322 2234567999999999986532   24678999999999999999999999988887888877643  34554  


Q ss_pred             CCCHHHHHHHHHhcccCCCC--CCCHHHHhhCCcccCC
Q 015257          349 AMNPELRNLLEGLLCKDPTR--RLTLNDVAKHTWVLGD  384 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~--Rpt~~ell~h~~~~~~  384 (410)
                      .++..+++||.+||..++.+  |+++.++++||||.+.
T Consensus       273 ~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         273 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            68999999999999844443  7899999999999774

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.1e-46  Score=378.05  Aligned_cols=262  Identities=26%  Similarity=0.411  Sum_probs=223.9

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+.+.||+|+||+||++++..+|+.||||++.....       .......+.+|+.++..++|+||+++++.+.
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-------~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~  101 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-------SEADKNRAQAEVCCLLNCDFFSIVKCHEDFA  101 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-------CHHHHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence            445689999999999999999999999999999999865422       2345567889999999999999999988765


Q ss_pred             cCCC------CEEEEEEeecCCCCcccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCc
Q 015257          195 DPNS------DHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT  264 (410)
Q Consensus       195 ~~~~------~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~  264 (410)
                      ....      ..+++||||+++++|.+.+..    ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.
T Consensus       102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL  181 (496)
T ss_pred             cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC
Confidence            3211      247899999999998876643    347899999999999999999999999999999999999999999


Q ss_pred             EEEeeccccccccCC--ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q 015257          265 VKIGDFSVSQVFEDD--NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN  342 (410)
Q Consensus       265 ~kl~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~  342 (410)
                      +||+|||+++.....  .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+..+
T Consensus       182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~  260 (496)
T PTZ00283        182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG  260 (496)
T ss_pred             EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence            999999999865432  223345679999999999877665 67799999999999999999999998888877777765


Q ss_pred             CC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          343 SL-VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       343 ~~-~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      .. .+|..+++++.+|+.+||+.||.+|||+.+++.|||++..
T Consensus       261 ~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        261 RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            54 4678899999999999999999999999999999998653

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-46  Score=360.51  Aligned_cols=259  Identities=29%  Similarity=0.508  Sum_probs=216.1

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||+|+||.||++++..+++.||+|++.+....      .......+.+|+.++..++||||+++++++.+  
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--   72 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML------KRAETACFREERDVLVNGDRRWITNLHYAFQD--   72 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh------hhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--
Confidence            4699999999999999999999999999999998753211      22344568899999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ...+|+||||++|+.|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        73 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  152 (331)
T cd05597          73 ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL  152 (331)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence            4689999999999999888765 457999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCcc-ccccCCCcccccccccccC----CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCC--
Q 015257          277 EDDND-VLRRSPGTPVFTAPECCLG----LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFP--  347 (410)
Q Consensus       277 ~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p--  347 (410)
                      ..... ......||+.|+|||++..    ....+.++|||||||++|+|++|+.||......+.+..+....  ..+|  
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  232 (331)
T cd05597         153 LADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPD  232 (331)
T ss_pred             CCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCc
Confidence            43322 2223469999999998863    2333567999999999999999999999888777777776532  2333  


Q ss_pred             -CCCCHHHHHHHHHhcccCCCC--CCCHHHHhhCCcccCC
Q 015257          348 -DAMNPELRNLLEGLLCKDPTR--RLTLNDVAKHTWVLGD  384 (410)
Q Consensus       348 -~~~~~~l~~li~~~L~~dp~~--Rpt~~ell~h~~~~~~  384 (410)
                       ..+++++++||.+||+.++.+  |+++.++++||||.+.
T Consensus       233 ~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         233 VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence             247899999999999765443  8899999999999763

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-46  Score=352.48  Aligned_cols=256  Identities=25%  Similarity=0.397  Sum_probs=214.6

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      .|++++.||+|+||.||++.+..+++.||+|++......      .......+.+|+.+++.++||||+++++.+..  .
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~   72 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK------KRKGEAMALNEKQILEKVNSRFVVSLAYAYET--K   72 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh------hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--C
Confidence            378899999999999999999999999999998654321      12233457789999999999999999999876  4


Q ss_pred             CEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ..+++||||+++++|...+..  ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||+++..
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05605          73 DALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEI  152 (285)
T ss_pred             CeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence            589999999999988876543  346899999999999999999999999999999999999999999999999999865


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCCCCCH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDT----YDKIVNNSLVFPDAMNP  352 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~----~~~i~~~~~~~p~~~~~  352 (410)
                      .... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+......    ...+......++..+++
T Consensus       153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
T cd05605         153 PEGE-TIRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSE  230 (285)
T ss_pred             CCCC-ccccccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCH
Confidence            4332 2234578999999999876655 5669999999999999999999987654332    23333444566778999


Q ss_pred             HHHHHHHHhcccCCCCCC-----CHHHHhhCCcccCC
Q 015257          353 ELRNLLEGLLCKDPTRRL-----TLNDVAKHTWVLGD  384 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~  384 (410)
                      .+.+||.+||..||.+||     ++.++++||||...
T Consensus       231 ~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         231 AARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             HHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            999999999999999999     99999999999763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-47  Score=370.33  Aligned_cols=262  Identities=34%  Similarity=0.571  Sum_probs=243.2

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      .+..|.+.+.||+|.|+.|.++++..++..||||++++..+       +......+.+|+++|+.++|||||+++.+...
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l-------n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t  126 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL-------NPSKRQKLGREVDIMKSLNHPNIVKLFSVIET  126 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc-------ChHHHHHHHHHHHHHHhcCCcceeeeeeeeee
Confidence            34579999999999999999999999999999999987643       33444568999999999999999999999986


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                        ...+|+||||+.++.+.+++...+.+.+..++.++.|+++|++|+|+++|+|||||++||||+.+-++||+|||++..
T Consensus       127 --~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~  204 (596)
T KOG0586|consen  127 --EATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTF  204 (596)
T ss_pred             --cceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeecccccee
Confidence              568999999999999999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELR  355 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~  355 (410)
                      +. ......++||++.|.|||++.+..+.++.+|+||+|++||.|+.|.+||.+.+.....++.+.+++.+|..++-+..
T Consensus       205 ~~-~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce  283 (596)
T KOG0586|consen  205 FD-YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCE  283 (596)
T ss_pred             ec-ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhH
Confidence            76 44567889999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          356 NLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                      +||.++|..+|.+|++.+++.+|.|+-.....
T Consensus       284 ~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  284 DLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             HHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            99999999999999999999999999766444

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=9.9e-46  Score=358.05  Aligned_cols=264  Identities=25%  Similarity=0.443  Sum_probs=216.8

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|++.+.||+|+||.||++.+..++..+|+|++....        .......+.+|+.+++.++||||+++++++.+  
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--   74 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--   74 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--------CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--
Confidence            57999999999999999999999999999999876431        23345678999999999999999999999987  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ...+++||||+++++|.+++...+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          75 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence            458999999999999999888777899999999999999999999975 7999999999999999999999999999755


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------------
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYD-------------------  337 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~-------------------  337 (410)
                      ...  ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......+...                   
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (333)
T cd06650         155 IDS--MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP  231 (333)
T ss_pred             hhh--ccccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCccc
Confidence            332  2234568999999999876554 667999999999999999999997654322211                   


Q ss_pred             -------------------------HHHhCC-CCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCch
Q 015257          338 -------------------------KIVNNS-LVFP-DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ  390 (410)
Q Consensus       338 -------------------------~i~~~~-~~~p-~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~  390 (410)
                                               .+.... ..++ ..++.++++||.+||+.||.+|||+.|++.||||+........
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~~~  311 (333)
T cd06650         232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEAEEVD  311 (333)
T ss_pred             CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCcccccc
Confidence                                     111111 1111 1367889999999999999999999999999999877544433


Q ss_pred             hhhh
Q 015257          391 YLCW  394 (410)
Q Consensus       391 ~~~~  394 (410)
                      ...|
T Consensus       312 ~~~~  315 (333)
T cd06650         312 FAGW  315 (333)
T ss_pred             HHHH
Confidence            3333

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-46  Score=361.94  Aligned_cols=260  Identities=23%  Similarity=0.415  Sum_probs=210.4

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||++.+..+++.||||++.....       .......+.+|+.+++.++||||+++++++..
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-------SLIHARRTYRELRLLKHMKHENVIGLLDVFTP   85 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-------hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcc
Confidence            45689999999999999999999999999999998764311       12334567799999999999999999998764


Q ss_pred             CC----CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          196 PN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       196 ~~----~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      ..    ...+|++|+++ ++++...+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          86 ATSIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cccccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCc
Confidence            21    24579999998 455555544 4579999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--------  343 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--------  343 (410)
                      +++.....   .....||+.|+|||++.+....+.++|||||||++|+|++|..||.+....+....+....        
T Consensus       164 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07878         164 LARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL  240 (343)
T ss_pred             cceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99865432   3455789999999998775555778999999999999999999998766554443332210        


Q ss_pred             ---------------CCCC--------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          344 ---------------LVFP--------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       344 ---------------~~~p--------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                                     ...+        ...++.+.+||.+||+.||.+|||+.|++.||||.....+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~  307 (343)
T cd07878         241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP  307 (343)
T ss_pred             HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence                           0011        2356778999999999999999999999999999876443

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.5e-45  Score=349.72  Aligned_cols=255  Identities=35%  Similarity=0.637  Sum_probs=226.2

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+.+.||+|+||.||++.+..+++.||+|++......      .......+.+|+.+++.++||||+++++++.+  
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   72 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV------KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--   72 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--
Confidence            3689999999999999999999999999999998654221      22345678899999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+++||||+++++|.+.+.....+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.+||+|||++....
T Consensus        73 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~  152 (290)
T cd05580          73 DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK  152 (290)
T ss_pred             CCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence            46899999999999999988888889999999999999999999999999999999999999999999999999998765


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNL  357 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~l  357 (410)
                      ..   .....|++.|+|||.+.+... +.++||||||+++|+|++|..||...........+..+...+|..++..++++
T Consensus       153 ~~---~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  228 (290)
T cd05580         153 GR---TYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDL  228 (290)
T ss_pred             CC---CCCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHH
Confidence            43   334568999999998876654 56799999999999999999999888777777778888888888999999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHhhCCcccCC
Q 015257          358 LEGLLCKDPTRRL-----TLNDVAKHTWVLGD  384 (410)
Q Consensus       358 i~~~L~~dp~~Rp-----t~~ell~h~~~~~~  384 (410)
                      |.+||..||.+|+     +++++++||||...
T Consensus       229 i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  260 (290)
T cd05580         229 IRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI  260 (290)
T ss_pred             HHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence            9999999999999     99999999999664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=8.6e-46  Score=361.52  Aligned_cols=257  Identities=24%  Similarity=0.453  Sum_probs=207.8

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||++.+..+++.||||++....       ........+.+|+.+++.++||||+++++++..
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   87 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-------QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP   87 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-------cChHHHHHHHHHHHHHHHhCCCchhceeeeeec
Confidence            4578999999999999999999999999999999886431       123445678899999999999999999998864


Q ss_pred             CC----CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          196 PN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       196 ~~----~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      ..    ...+++||||++++.... +.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        88 ~~~~~~~~~~~lv~e~~~~~l~~~-~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          88 QKSLEEFQDVYLVMELMDANLCQV-IQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cccccccceeEEEhhhhcccHHHH-Hh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCc
Confidence            32    246899999998764433 22  358899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---------  342 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~---------  342 (410)
                      +++..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+....+.+..+...         
T Consensus       165 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         165 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             ccccCCCc-cccCCccccCCccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99864332 23345678999999999877665 56799999999999999999999887654433322110         


Q ss_pred             -------------C-----CC---------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          343 -------------S-----LV---------------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       343 -------------~-----~~---------------~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                                   .     ..               .+...+.++++||.+||+.||++|||+.|+++||||...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                         0     00               111235678999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.2e-46  Score=348.41  Aligned_cols=253  Identities=32%  Similarity=0.591  Sum_probs=211.2

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  199 (410)
                      |++++.||+|+||+||++++..+++.||+|++......       ........+|+.+++.++||||+++++++.+  ..
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~   71 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-------EEEREENIREIKILRRLRHPNIVQILDVFQD--DN   71 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-------HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SS
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-------ccccchhhhhhhccccccccccccccccccc--cc
Confidence            78999999999999999999999999999998765321       1222234569999999999999999999987  56


Q ss_pred             EEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCC
Q 015257          200 HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD  279 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~  279 (410)
                      ..++||||++++++.+++.....+++..+..++.||+.||.+||+.||+|+||||+||+++.++.++|+|||.+......
T Consensus        72 ~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~  151 (260)
T PF00069_consen   72 YLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN  151 (260)
T ss_dssp             EEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            89999999999988888876778999999999999999999999999999999999999999999999999999764333


Q ss_pred             ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCCC----CCCCCCH
Q 015257          280 NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQD---TYDKIVNNSLV----FPDAMNP  352 (410)
Q Consensus       280 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---~~~~i~~~~~~----~p~~~~~  352 (410)
                      ........+|+.|+|||++......+.++||||||+++|+|++|..||......+   ...........    .....+.
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (260)
T PF00069_consen  152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSE  231 (260)
T ss_dssp             TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHH
Confidence            4455567789999999998733344778999999999999999999998873333   33333332211    1122348


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      .+.++|.+||+.||++|||+.++++||||
T Consensus       232 ~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  232 ELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            99999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.1e-45  Score=362.09  Aligned_cols=257  Identities=25%  Similarity=0.445  Sum_probs=208.8

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||++.+..+++.||||++....       ........+.+|+.+++.++||||+++++++..
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~   94 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-------QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP   94 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-------cCchhHHHHHHHHHHHHhcCCCCccccceeecc
Confidence            4578999999999999999999999999999999886432       123344678899999999999999999998764


Q ss_pred             CC----CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          196 PN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       196 ~~----~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      ..    ...+|+||||++++... .+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        95 ~~~~~~~~~~~lv~e~~~~~l~~-~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875          95 QKSLEEFQDVYIVMELMDANLCQ-VIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             cccccccCeEEEEEeCCCCCHHH-HHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCC
Confidence            21    24689999999875433 332  347899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--------  343 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--------  343 (410)
                      +++..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+.+..+....        
T Consensus       172 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         172 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             CccccCCC-CcccCCcccCCcCCHHHHhCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            99865332 23345578999999999877665 567999999999999999999998877665554443210        


Q ss_pred             --------------CC--------------C------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          344 --------------LV--------------F------PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       344 --------------~~--------------~------p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                                    ..              +      ....+.++++||.+||+.||.+|||+.++|+||||...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence                          00              0      01134678999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.5e-45  Score=340.19  Aligned_cols=254  Identities=28%  Similarity=0.535  Sum_probs=218.7

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|++++.||+|++|.||++++..+++.||+|.+.....       .......+.+|+.+++.++|||++++++.+... .
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~   72 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-------SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-D   72 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-------CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-C
Confidence            48899999999999999999999999999999864321       233456788999999999999999999987642 3


Q ss_pred             CEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ..+++||||++++++.+.+..  ...+++.+++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus        73 ~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~  152 (257)
T cd08223          73 GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL  152 (257)
T ss_pred             CEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEe
Confidence            478999999999988877654  346899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFPDAMNPELR  355 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~l~  355 (410)
                      ...........|++.|+|||++.+... +.++||||||+++|+|++|..||...+.......+..+.. ..+..+++++.
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (257)
T cd08223         153 ENQCDMASTLIGTPYYMSPELFSNKPY-NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELG  231 (257)
T ss_pred             cccCCccccccCCcCccChhHhcCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHH
Confidence            554444455678999999998877665 5679999999999999999999988777766666666554 45667899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          356 NLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      +++.+||+.||.+|||+.++++||||
T Consensus       232 ~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         232 ELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHHhccCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.7e-45  Score=372.80  Aligned_cols=254  Identities=25%  Similarity=0.402  Sum_probs=219.0

Q ss_pred             cceeeeeeecccCceEEEEEEEccC-CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLD-GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      ..|.+.+.||+|+||.||+|....+ ++.||+|.+...         .......+.+|+.+|+.++|||||++++++.. 
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---------~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-  136 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---------DERQAAYARSELHCLAACDHFGIVKHFDDFKS-  136 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---------CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-
Confidence            4599999999999999999998877 788999975322         23344567889999999999999999999986 


Q ss_pred             CCCEEEEEEeecCCCCcccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                       .+.+||||||++|++|.+.+.    ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus       137 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgl  215 (478)
T PTZ00267        137 -DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGF  215 (478)
T ss_pred             -CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcC
Confidence             468999999999999876543    345789999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCC
Q 015257          273 SQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFPDA  349 (410)
Q Consensus       273 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~  349 (410)
                      ++......  ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....+....+..+.. .+|..
T Consensus       216 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  294 (478)
T PTZ00267        216 SKQYSDSVSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCP  294 (478)
T ss_pred             ceecCCccccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            98754332  22345679999999998877655 6779999999999999999999998888777777776554 46678


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                      +++++.+||.+||..||++|||+.+++.|+|+..
T Consensus       295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        295 VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            8999999999999999999999999999999864

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-46  Score=360.74  Aligned_cols=245  Identities=26%  Similarity=0.418  Sum_probs=210.7

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      +.+..++.||+|-||+|+++.... ...||+|.+....++          .+.|.+|+++|++|+|+|||++++++... 
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~----------~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-  273 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMS----------PEAFLREAQIMKKLRHEKLVKLYGVCTKQ-  273 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccC----------hhHHHHHHHHHHhCcccCeEEEEEEEecC-
Confidence            356778899999999999887763 237999998754322          24688999999999999999999999863 


Q ss_pred             CCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                       +.+|||||||+.|+|.+++..  ...+.......++.|||.|++||+++++|||||-..||||+.++.+||+|||+|+.
T Consensus       274 -~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~  352 (468)
T KOG0197|consen  274 -EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARL  352 (468)
T ss_pred             -CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccc
Confidence             479999999999999999886  45789999999999999999999999999999999999999999999999999996


Q ss_pred             ccCCcccccc-CCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCCH
Q 015257          276 FEDDNDVLRR-SPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMNP  352 (410)
Q Consensus       276 ~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~  352 (410)
                      ..++...... ..-...|.|||++....++ .+||||||||+||||+| |+.||.+.+..+..+.+..+. ++-|+.+|+
T Consensus       353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~  431 (468)
T KOG0197|consen  353 IGDDEYTASEGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPD  431 (468)
T ss_pred             cCCCceeecCCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCH
Confidence            5544432222 2224569999999888884 55999999999999998 999999999999999888764 577889999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHh
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVA  376 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell  376 (410)
                      ++.+|+..||+.+|++|||++.+.
T Consensus       432 ~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  432 EVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             HHHHHHHHHhhCCcccCCCHHHHH
Confidence            999999999999999999998664

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-45  Score=341.77  Aligned_cols=257  Identities=28%  Similarity=0.505  Sum_probs=217.5

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      +.|.+.+.||+|++|.||++.+..+++.||+|.+.......    ........+.+|+.+++.++||||+++++++.+  
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--   75 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSP----ETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--   75 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccch----hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--
Confidence            46889999999999999999999999999999986542211    112344678899999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+++||||++++++.+.+.....+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||+++...
T Consensus        76 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          76 DETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             CCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            45899999999999998888777789999999999999999999999999999999999999999999999999987654


Q ss_pred             CCcccc---ccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCH
Q 015257          278 DDNDVL---RRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--SLVFPDAMNP  352 (410)
Q Consensus       278 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~  352 (410)
                      ......   ....|++.|+|||++.+... +.++||||||+++|+|++|+.||...........+...  ...+|..++.
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSP  234 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCH
Confidence            322111   23567889999999877664 67799999999999999999999876655544444433  3456778999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      .+.++|.+||..+|.+|||+.++++||||
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         235 DARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=9e-46  Score=358.19  Aligned_cols=259  Identities=27%  Similarity=0.486  Sum_probs=216.9

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||+|+||.||+++...+++.||+|++.+....      .......+.+|+.++..++|++|+++++++.+  
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--   72 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML------KRAETACFREERDVLVNGDNQWITTLHYAFQD--   72 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH------HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--
Confidence            3689999999999999999999999999999998653211      12234468899999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ...+++||||+++++|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        73 ~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~  152 (332)
T cd05623          73 ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL  152 (332)
T ss_pred             CCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheec
Confidence            4589999999999999988865 457899999999999999999999999999999999999999999999999998764


Q ss_pred             cCCc-cccccCCCcccccccccccC----CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCC-
Q 015257          277 EDDN-DVLRRSPGTPVFTAPECCLG----LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFPD-  348 (410)
Q Consensus       277 ~~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~-  348 (410)
                      .... .......||+.|+|||++..    ....+.++|||||||++|+|++|+.||......+....+....  ..+|. 
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  232 (332)
T cd05623         153 MEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQ  232 (332)
T ss_pred             ccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCc
Confidence            3322 22234579999999998863    2333667999999999999999999999988888877776643  23443 


Q ss_pred             --CCCHHHHHHHHHhcccCCCC--CCCHHHHhhCCcccCC
Q 015257          349 --AMNPELRNLLEGLLCKDPTR--RLTLNDVAKHTWVLGD  384 (410)
Q Consensus       349 --~~~~~l~~li~~~L~~dp~~--Rpt~~ell~h~~~~~~  384 (410)
                        .+++++++||.+||+.++.+  |++++++++||||.+-
T Consensus       233 ~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         233 VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence              57999999999999765544  7899999999999863

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1e-45  Score=373.82  Aligned_cols=260  Identities=20%  Similarity=0.314  Sum_probs=203.9

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCC------CCcccce
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH------PNIVNLI  190 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~l~  190 (410)
                      .++|.+++.||+|+||.||++.+..+++.||||++...          ......+..|+.+++.++|      +++++++
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~----------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~  197 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV----------PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQ  197 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc----------hhhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence            46899999999999999999999999999999998532          1122345667777777755      4588888


Q ss_pred             eEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCcEEEcCCC------
Q 015257          191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSG------  263 (410)
Q Consensus       191 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIll~~~~------  263 (410)
                      +++... ..++++|||++. +.+.+++...+.+++..++.++.||+.||.|||+ .|||||||||+|||++.++      
T Consensus       198 ~~~~~~-~~~~~iv~~~~g-~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        198 RYFQNE-TGHMCIVMPKYG-PCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             EEEEcC-CceEEEEEeccC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccc
Confidence            988764 468999999985 4555666666789999999999999999999998 5999999999999998765      


Q ss_pred             ----------cEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 015257          264 ----------TVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ  333 (410)
Q Consensus       264 ----------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~  333 (410)
                                .+||+|||.+.....   .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+....
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             cccccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                      499999998864322   2345679999999999987766 66799999999999999999999877655


Q ss_pred             HHHHHHHhCCCCCC------------------------------------------CCCCHHHHHHHHHhcccCCCCCCC
Q 015257          334 DTYDKIVNNSLVFP------------------------------------------DAMNPELRNLLEGLLCKDPTRRLT  371 (410)
Q Consensus       334 ~~~~~i~~~~~~~p------------------------------------------~~~~~~l~~li~~~L~~dp~~Rpt  371 (410)
                      +....+......+|                                          ...++.+.+||.+||++||.+|||
T Consensus       352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence            44333222110000                                          012456789999999999999999


Q ss_pred             HHHHhhCCcccCC---CCCCchhh
Q 015257          372 LNDVAKHTWVLGD---NGPIPQYL  392 (410)
Q Consensus       372 ~~ell~h~~~~~~---~~~~~~~~  392 (410)
                      ++|+|+||||...   ....|.|.
T Consensus       432 a~e~L~Hp~~~~~~~~~~~~~~~~  455 (467)
T PTZ00284        432 ARQMTTHPYVLKYYPECRQHPNYP  455 (467)
T ss_pred             HHHHhcCccccccCCccccCCCCC
Confidence            9999999999874   22445554

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.4e-45  Score=345.69  Aligned_cols=253  Identities=27%  Similarity=0.460  Sum_probs=205.8

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|.+++.||+|++|.||++++..++..||||++.....       .......+.+|+.+++.++||||+++++++.+  .
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~   71 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-------EEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--E   71 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-------cCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--C
Confidence            48899999999999999999999999999998754321       12233567899999999999999999999986  4


Q ss_pred             CEEEEEEeecCCCCcccccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFG---QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      ..+++||||+++ .+...+.   ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..
T Consensus        72 ~~~~~v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  150 (285)
T cd07861          72 SRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARA  150 (285)
T ss_pred             CeEEEEEecCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceee
Confidence            589999999985 3444332   235689999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS------------  343 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~------------  343 (410)
                      ............+++.|+|||++.+....+.++|||||||++|+|++|+.||.+....+....+....            
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
T cd07861         151 FGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT  230 (285)
T ss_pred             cCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence            54433333445678999999988765544678999999999999999999998765443332221100            


Q ss_pred             -----------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          344 -----------------LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       344 -----------------~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                                       ......+++++.+||.+||+.||.+|||+.+|+.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                             00123478999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.6e-45  Score=350.18  Aligned_cols=266  Identities=27%  Similarity=0.427  Sum_probs=216.7

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+.+.||+|+||.||++.+..+|+.||+|++.....       .......+.+|+.++++++|+||+++++++.+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-------RDGIPISSLREITLLLNLRHPNIVELKEVVVG   77 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-------CCCCcchhhHHHHHHHhCCCCCCcceEEEEec
Confidence            45689999999999999999999999999999999864321       11112245689999999999999999999986


Q ss_pred             CCCCEEEEEEeecCCCCcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      .....+++||||+.+. +...+. ....+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.
T Consensus        78 ~~~~~~~lv~e~~~~~-l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~  156 (309)
T cd07845          78 KHLDSIFLVMEYCEQD-LASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLAR  156 (309)
T ss_pred             CCCCeEEEEEecCCCC-HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceee
Confidence            5556789999999864 443333 24678999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN------------  342 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~------------  342 (410)
                      .............+++.|+|||++.+....+.++|||||||++|+|++|..||...+..+....+...            
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             ecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence            76543333334456888999998876555577899999999999999999999887776666555431            


Q ss_pred             -------CCCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCc
Q 015257          343 -------SLVFP-----------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIP  389 (410)
Q Consensus       343 -------~~~~p-----------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~  389 (410)
                             ....+           ...++++.+||.+||+.||.+|||+.+++.||||.+...|..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~  301 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCE  301 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCC
Confidence                   01111           125788999999999999999999999999999998777654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-47  Score=368.60  Aligned_cols=258  Identities=23%  Similarity=0.341  Sum_probs=224.9

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      +.|.++..||.|+||.||+|..+.++-.-|-|++...         +.+.++.++-||.||..++||+||++++.|..  
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---------seEELEDylVEIeILa~CdHP~ivkLl~ayy~--  100 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---------SEEELEDYLVEIEILAECDHPVIVKLLSAYYF--  100 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---------chhHHhhhhhhhhhhhcCCChHHHHHHHHHhc--
Confidence            4588999999999999999999999999999987533         56788899999999999999999999986654  


Q ss_pred             CCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      .+.++|+.|||+||-....+.. ...|++.++..+.+|++.||.|||+++|||||||..|||+..+|.++|+|||.+...
T Consensus       101 enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn  180 (1187)
T KOG0579|consen  101 ENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN  180 (1187)
T ss_pred             cCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccc
Confidence            3579999999999988776654 457999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCccccccCCCcccccccccccC----CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCCC
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLG----LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV---FPDA  349 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~  349 (410)
                      .........+.|||+|||||++.-    ...|+.++||||||++|.||..+.+|....+....+-+|.+..++   -|..
T Consensus       181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~  260 (1187)
T KOG0579|consen  181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSH  260 (1187)
T ss_pred             hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcch
Confidence            544445567899999999998742    233466899999999999999999999988888888787775532   4667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      .+..+.+++++||.+||..||+++++|+||||+....
T Consensus       261 Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S  297 (1187)
T KOG0579|consen  261 WSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS  297 (1187)
T ss_pred             hhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence            8899999999999999999999999999999986543

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.3e-45  Score=348.45  Aligned_cols=254  Identities=25%  Similarity=0.457  Sum_probs=205.5

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|.+++.||+|+||.||++++..+|+.||+|.+.....       .......+.+|+.+++.++||||+++++++.+  .
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~   71 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-------DEGVPSSALREICLLKELKHKNIVRLYDVLHS--D   71 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-------cccCccchhHHHHHHHhcCCCCeeeHHHHhcc--C
Confidence            48889999999999999999999999999999864321       11223457789999999999999999999976  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ..+++|+||++++++.......+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||+++....
T Consensus        72 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  151 (284)
T cd07839          72 KKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI  151 (284)
T ss_pred             CceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence            58999999998754443334456799999999999999999999999999999999999999999999999999986544


Q ss_pred             CccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhC---------------
Q 015257          279 DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF-LGETLQDTYDKIVNN---------------  342 (410)
Q Consensus       279 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf-~~~~~~~~~~~i~~~---------------  342 (410)
                      .........+++.|+|||++.+....+.++|||||||++|+|++|..|| .+.+....+..+...               
T Consensus       152 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         152 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence            3333344567899999999877665577899999999999999998885 444444333333210               


Q ss_pred             --CC---C---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          343 --SL---V---------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       343 --~~---~---------~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                        ..   .         ....+++++.+||.+||+.||.+|||+++++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence              00   0         012467899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.4e-45  Score=356.77  Aligned_cols=259  Identities=27%  Similarity=0.504  Sum_probs=217.1

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||+|+||.||++++..+++.||+|++.+....      .......+.+|+.++..++|+||+++++++.+  
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--   72 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML------KRAETACFREERNVLVNGDCQWITTLHYAFQD--   72 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH------hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--
Confidence            4799999999999999999999999999999998653211      12334568899999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ....|+||||++|++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        73 ~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~  152 (331)
T cd05624          73 ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM  152 (331)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence            4689999999999999988866 467899999999999999999999999999999999999999999999999999765


Q ss_pred             cCCcc-ccccCCCcccccccccccCC----cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCC-
Q 015257          277 EDDND-VLRRSPGTPVFTAPECCLGL----TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFPD-  348 (410)
Q Consensus       277 ~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~-  348 (410)
                      ..... ......||+.|+|||++.+.    ...+.++|||||||+||+|++|+.||......+....+....  ..+|. 
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  232 (331)
T cd05624         153 NQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSH  232 (331)
T ss_pred             cCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCc
Confidence            43322 22345699999999988652    223567999999999999999999999888777777776543  33443 


Q ss_pred             --CCCHHHHHHHHHhcccCCCC--CCCHHHHhhCCcccCC
Q 015257          349 --AMNPELRNLLEGLLCKDPTR--RLTLNDVAKHTWVLGD  384 (410)
Q Consensus       349 --~~~~~l~~li~~~L~~dp~~--Rpt~~ell~h~~~~~~  384 (410)
                        .+++++++||.+||+.++++  |++++++++||||.+.
T Consensus       233 ~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         233 ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence              46899999999999976654  5799999999999763

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-47  Score=340.41  Aligned_cols=254  Identities=29%  Similarity=0.504  Sum_probs=219.3

Q ss_pred             ccccceeee-eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHH-HhCCCCCcccceeE
Q 015257          115 KMINEYVHV-RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM-KMLQHPNIVNLIEV  192 (410)
Q Consensus       115 ~~~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~  192 (410)
                      ...++|.+- .+||-|--|.|..+.++.+|+.+|+|++.-.              ...++|+++. ..-.|||||.++++
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------------~KARrEVeLHw~~s~h~~iV~IidV  123 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------------PKARREVELHWMASGHPHIVSIIDV  123 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------------HHHHhHhhhhhhhcCCCceEEeehh
Confidence            345677764 5799999999999999999999999987422              3567888874 45579999999998


Q ss_pred             EEcC--CCCEEEEEEeecCCCCcccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC---CcE
Q 015257          193 IDDP--NSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS---GTV  265 (410)
Q Consensus       193 ~~~~--~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~---~~~  265 (410)
                      |...  ..+.+.+|||.|+||.|...+...+  .++|.++..|+.||..||.|||+.+|+||||||+|+|...+   ..+
T Consensus       124 yeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~l  203 (400)
T KOG0604|consen  124 YENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPL  203 (400)
T ss_pred             hhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcce
Confidence            8652  4578999999999999999988766  59999999999999999999999999999999999999754   469


Q ss_pred             EEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHh
Q 015257          266 KIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL----QDTYDKIVN  341 (410)
Q Consensus       266 kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~----~~~~~~i~~  341 (410)
                      ||+|||+|+.... ...+.+.|-||.|.|||++....+ ++..|+||+||++|.||+|++||+....    ..+..+|..
T Consensus       204 KLtDfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKy-dkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~  281 (400)
T KOG0604|consen  204 KLTDFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT  281 (400)
T ss_pred             EecccccccccCC-CccccCCcccccccCHHHhCchhc-CCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc
Confidence            9999999986544 345667888999999998876664 8889999999999999999999976542    347788999


Q ss_pred             CCCCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          342 NSLVFPD----AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       342 ~~~~~p~----~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      +.+.||.    .+|.+.+++|..+|..+|++|.|+.+++.|||+.+.
T Consensus       282 gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  282 GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence            9999986    588999999999999999999999999999999765

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.2e-45  Score=349.69  Aligned_cols=247  Identities=28%  Similarity=0.456  Sum_probs=192.7

Q ss_pred             eeeecccCceEEEEEEEc--cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCE
Q 015257          123 VRKIGAGSYGKVVLYRSS--LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH  200 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  200 (410)
                      .++||+|+||.||+|++.  .+++.||+|.+....           ....+.+|+.+|+.++||||+++++++.......
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   74 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----------ISMSACREIALLRELKHPNVISLQKVFLSHADRK   74 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----------CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcE
Confidence            468999999999999965  367899999875432           1134678999999999999999999997665678


Q ss_pred             EEEEEeecCCCCccccc---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEE----cCCCcEEE
Q 015257          201 FYMVLEYVEGKWDNDGF---------GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV----APSGTVKI  267 (410)
Q Consensus       201 ~~lv~e~~~~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll----~~~~~~kl  267 (410)
                      +++||||+++.. ...+         .....+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||
T Consensus        75 ~~lv~e~~~~~l-~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl  153 (317)
T cd07868          75 VWLLFDYAEHDL-WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI  153 (317)
T ss_pred             EEEEEeccCCCH-HHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEE
Confidence            999999998643 2222         122358999999999999999999999999999999999999    45678999


Q ss_pred             eeccccccccCCc---cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHH
Q 015257          268 GDFSVSQVFEDDN---DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL---------QDT  335 (410)
Q Consensus       268 ~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~---------~~~  335 (410)
                      +|||+++......   .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.....         ...
T Consensus       154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~  233 (317)
T cd07868         154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  233 (317)
T ss_pred             eecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHH
Confidence            9999998654322   1233567899999999988766557789999999999999999999964321         111


Q ss_pred             HHHHHhC----------------------------CCC----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          336 YDKIVNN----------------------------SLV----------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       336 ~~~i~~~----------------------------~~~----------~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ...+...                            ...          .....+.++.+||.+||+.||.+|||++|+|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         234 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             HHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1111110                            000          00123567899999999999999999999999


Q ss_pred             CCcc
Q 015257          378 HTWV  381 (410)
Q Consensus       378 h~~~  381 (410)
                      ||||
T Consensus       314 hp~f  317 (317)
T cd07868         314 DPYF  317 (317)
T ss_pred             CCCC
Confidence            9998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7e-45  Score=343.51  Aligned_cols=255  Identities=30%  Similarity=0.500  Sum_probs=212.0

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|++.+.||+|+||.||++.+..+|+.||+|++.....       .....+.+.+|+.+++.++||||+++++++..  
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--   71 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-------DPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--   71 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-------CccccHHHHHHHHHHHhCCCCCEeeeeeEEee--
Confidence            468999999999999999999999999999998864321       11223457899999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+++||||++++++.........+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus        72 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (286)
T cd07847          72 KRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILT  151 (286)
T ss_pred             CCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecC
Confidence            45899999999999888877766789999999999999999999999999999999999999999999999999998765


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--------------  343 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--------------  343 (410)
                      ..........++..|+|||++.+....+.++||||||+++|+|++|..||.+....+....+....              
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence            443333345678899999988765444677999999999999999999998766544433322100              


Q ss_pred             -----CCCC------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          344 -----LVFP------------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       344 -----~~~p------------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                           ...|            +.++..+.+|+.+||+.||++|||+.+++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence                 0011            2457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.3e-45  Score=383.84  Aligned_cols=267  Identities=25%  Similarity=0.406  Sum_probs=219.6

Q ss_pred             ccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       113 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      +....++|.+++.||+|+||.||++++..++..||+|++.....       .......+..|+.+|+.|+|||||+++++
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-------~e~~~~~~~~EI~IL~~L~HPNIVrl~d~   80 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-------KEREKSQLVIEVNVMRELKHKNIVRYIDR   80 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-------CHHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence            45567899999999999999999999999999999999865422       23445678999999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhC-------CcEeccCCCCcEEEcC
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGH-------NVVHGDIKPDNLLVAP  261 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~-------~iiHrDlkp~NIll~~  261 (410)
                      |.+.....+||||||+++++|...+..    ...+++..++.|+.||+.||.|||+.       +||||||||+||||+.
T Consensus        81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s  160 (1021)
T PTZ00266         81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST  160 (1021)
T ss_pred             EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence            876556789999999999998877653    35799999999999999999999984       4999999999999964


Q ss_pred             C-----------------CcEEEeeccccccccCCccccccCCCcccccccccccCC-cCCCchhhHHHHHHHHHHHHhC
Q 015257          262 S-----------------GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL-TYGGKAADTWAVGVTLYYMIIG  323 (410)
Q Consensus       262 ~-----------------~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~elltG  323 (410)
                      +                 +.+||+|||++...... .......||+.|+|||++.+. ...+.++||||||||||+|++|
T Consensus       161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG  239 (1021)
T PTZ00266        161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG  239 (1021)
T ss_pred             CccccccccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence            2                 35899999999865432 233456799999999988643 2336779999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          324 QYPFLGETLQDTYDKIVNNSLVFP-DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       324 ~~Pf~~~~~~~~~~~i~~~~~~~p-~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                      ..||............+.....+| ...+.++.+||..||..+|.+|||+.|+|.|+|+.....+
T Consensus       240 k~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p  304 (1021)
T PTZ00266        240 KTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP  304 (1021)
T ss_pred             CCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence            999977654444333333333333 4578999999999999999999999999999999866544

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.2e-45  Score=346.50  Aligned_cols=253  Identities=28%  Similarity=0.461  Sum_probs=201.5

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC---CCCCcccceeEEEc
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML---QHPNIVNLIEVIDD  195 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~  195 (410)
                      +|.+++.||+|+||.||++++..+|+.||+|.+......       ......+.+|+.+++.+   +||||+++++++..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~   73 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-------DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCAT   73 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-------CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeecc
Confidence            488999999999999999999999999999988653211       11112345666666655   79999999998864


Q ss_pred             C---CCCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeec
Q 015257          196 P---NSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       196 ~---~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                      .   ....+++||||+++. +...+..  ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus        74 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~df  152 (288)
T cd07863          74 SRTDRETKVTLVFEHVDQD-LRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADF  152 (288)
T ss_pred             ccCCCCceEEEEEcccccC-HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcc
Confidence            2   235689999999864 4444433  235899999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------
Q 015257          271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS-------  343 (410)
Q Consensus       271 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-------  343 (410)
                      |+++..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+....+...++....       
T Consensus       153 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07863         153 GLARIYSCQ-MALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD  230 (288)
T ss_pred             CccccccCc-ccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            999865432 22334568999999999876655 667999999999999999999998876655554443210       


Q ss_pred             ----C----------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          344 ----L----------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       344 ----~----------------~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                          .                .....++..+.+||.+||+.||.+|||+.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                0                0112467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.3e-45  Score=354.93  Aligned_cols=250  Identities=20%  Similarity=0.375  Sum_probs=202.3

Q ss_pred             cceeeeeeecccCceEEEEEEEc-----cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCccccee
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIE  191 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~  191 (410)
                      ++|++.+.||+|+||.||++.+.     .+++.||||++....        .......+.+|+.++..+ +||||+++++
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~niv~~~~   78 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--------TASEHKALMSELKILIHIGNHLNVVNLLG   78 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--------chHHHHHHHHHHHHHHHhccCcceeeEEe
Confidence            57999999999999999999752     356789999875321        233456789999999999 8999999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCCC---------------------------------------------------
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQP---------------------------------------------------  220 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---------------------------------------------------  220 (410)
                      ++..+ ...+++||||+++++|.+++...                                                   
T Consensus        79 ~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (338)
T cd05102          79 ACTKP-NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGST  157 (338)
T ss_pred             EecCC-CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccc
Confidence            88764 35789999999999887665421                                                   


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCcc--ccccCC
Q 015257          221 -----------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSP  287 (410)
Q Consensus       221 -----------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~  287 (410)
                                 ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......  ......
T Consensus       158 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~  237 (338)
T cd05102         158 NPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR  237 (338)
T ss_pred             ccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCC
Confidence                       2477888999999999999999999999999999999999999999999999986533221  112334


Q ss_pred             CcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHhC-CCCCCCCCCHHHHHHHHHhccc
Q 015257          288 GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTY-DKIVNN-SLVFPDAMNPELRNLLEGLLCK  364 (410)
Q Consensus       288 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~-~~i~~~-~~~~p~~~~~~l~~li~~~L~~  364 (410)
                      +++.|+|||++.+..+ +.++|||||||+||||++ |..||.+....... ..+..+ ....|..+++++.+|+.+||+.
T Consensus       238 ~~~~y~aPE~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  316 (338)
T cd05102         238 LPLKWMAPESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQG  316 (338)
T ss_pred             CCccccCcHHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccC
Confidence            5678999999877665 567999999999999997 99999876543333 333333 2345678899999999999999


Q ss_pred             CCCCCCCHHHHhh
Q 015257          365 DPTRRLTLNDVAK  377 (410)
Q Consensus       365 dp~~Rpt~~ell~  377 (410)
                      ||.+|||+.++++
T Consensus       317 dp~~RPs~~el~~  329 (338)
T cd05102         317 DPKERPTFSALVE  329 (338)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.9e-45  Score=355.03  Aligned_cols=247  Identities=20%  Similarity=0.279  Sum_probs=195.9

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      .+|.+++.||+|+||.||+++...+++.||+|+....               ....|+.+++.++||||+++++++..  
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------------~~~~E~~~l~~l~h~~iv~~~~~~~~--  128 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------------TTLIEAMLLQNVNHPSVIRMKDTLVS--  128 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------------ccHHHHHHHHhCCCCCCcChhheEEe--
Confidence            3699999999999999999999999999999974321               23468999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ....++|||++.+.++.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       129 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        129 GAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             CCeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            45789999999875544444455679999999999999999999999999999999999999999999999999997533


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHH---------HHHHHHHhC----C
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF-LGETLQ---------DTYDKIVNN----S  343 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf-~~~~~~---------~~~~~i~~~----~  343 (410)
                      .. .......||+.|+|||++.+..+ +.++|||||||++|+|+++..|+ ......         .....+...    .
T Consensus       209 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  286 (357)
T PHA03209        209 VA-PAFLGLAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP  286 (357)
T ss_pred             cC-cccccccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence            22 22335669999999999887665 56799999999999999855444 321110         011111110    0


Q ss_pred             CCCC------------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          344 LVFP------------------------------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       344 ~~~p------------------------------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                      ..+|                              ..++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        287 EEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             hhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence            0111                              134567788999999999999999999999999975

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.4e-44  Score=335.77  Aligned_cols=253  Identities=26%  Similarity=0.430  Sum_probs=219.2

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|.+.+.||+|++|.||++....+++.||+|.+.....       .......+.+|+.+++.++||||+++++++.+  .
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~   71 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-------NRREREEAIDEARVLAKLDSSYIIRYYESFLD--K   71 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-------CHHHHHHHHHHHHHHHhcCCCCeehheeeecc--C
Confidence            47889999999999999999999999999998864322       23455678899999999999999999999876  4


Q ss_pred             CEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ...++||||++++++.+++...  ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++..
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~  151 (256)
T cd08529          72 GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL  151 (256)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceec
Confidence            6899999999999988877553  57899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFPDAMNPELR  355 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~l~  355 (410)
                      ...........|++.|+|||++.+... +.++||||||+++|+|++|..||...........+..+.. .++..++.++.
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (256)
T cd08529         152 SDNTNFANTIVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLA  230 (256)
T ss_pred             cCccchhhccccCccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHH
Confidence            554444445678999999998877665 5679999999999999999999988877666666666543 35557889999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          356 NLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      +++.+||+.+|++||++.++++|||+
T Consensus       231 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         231 QLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHHHccCCcccCcCHHHHhhCCCC
Confidence            99999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.3e-44  Score=346.42  Aligned_cols=257  Identities=25%  Similarity=0.428  Sum_probs=213.5

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+....        .......+.+|+++++.++||||+++++++.+  
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--   70 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--------KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--   70 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--
Confidence            36899999999999999999999999999999875321        23445678899999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      .+.+++||||+++++|..++.....+++..+..++.||+.||.|||+ .+++|+||||+|||++.++.++|+|||++...
T Consensus        71 ~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (308)
T cd06615          71 DGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  150 (308)
T ss_pred             CCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccc
Confidence            46899999999999999998877889999999999999999999997 59999999999999999999999999998754


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------------  342 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--------------  342 (410)
                      ...  ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||...........+...              
T Consensus       151 ~~~--~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (308)
T cd06615         151 IDS--MANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS  227 (308)
T ss_pred             ccc--ccccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccccc
Confidence            332  2345678999999998876554 56799999999999999999999765433322211110              


Q ss_pred             -----------------------CCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          343 -----------------------SLVFP-DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       343 -----------------------~~~~p-~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                                             ....| ..++.++++|+.+||..||++|||+.++++||||.+...+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  296 (308)
T cd06615         228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE  296 (308)
T ss_pred             CCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence                                   01111 1367889999999999999999999999999999876444

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-45  Score=344.72  Aligned_cols=256  Identities=27%  Similarity=0.390  Sum_probs=219.0

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||.|+||.||++.+..++..+|+|++...         .......+.+|+.+++.++||||+++++++..  
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   73 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---------SEEELEDFMVEIDILSECKHPNIVGLYEAYFY--   73 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---------CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--
Confidence            5699999999999999999999889999999997532         33455678899999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ...+++||||++++++..++.. ...+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++...
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~  153 (280)
T cd06611          74 ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKN  153 (280)
T ss_pred             CCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhh
Confidence            4589999999999999888765 357999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCccccccCCCcccccccccccCC----cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCCC
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGL----TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL---VFPDA  349 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~  349 (410)
                      ...........||+.|+|||.+...    ...+.++||||||+++|+|++|..||...........+.....   ..|..
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (280)
T cd06611         154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSK  233 (280)
T ss_pred             cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCccc
Confidence            4433333455689999999987532    2235579999999999999999999988776666666655432   34567


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      ++.++.++|.+||+.+|.+|||+.++++||||...
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         234 WSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            89999999999999999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6e-45  Score=343.39  Aligned_cols=249  Identities=24%  Similarity=0.416  Sum_probs=204.7

Q ss_pred             ecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEEEE
Q 015257          126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVL  205 (410)
Q Consensus       126 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~  205 (410)
                      ||+|+||.||+++...+|+.||+|++.......      ......+..|+++++.++||||+++++++..  ...+++||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~------~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~   72 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK------KSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVM   72 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc------chhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEE
Confidence            799999999999999999999999986543211      1222345679999999999999999999876  45899999


Q ss_pred             eecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCcccc
Q 015257          206 EYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVL  283 (410)
Q Consensus       206 e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  283 (410)
                      ||++|+++...+...  ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++....... ..
T Consensus        73 e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~  151 (277)
T cd05607          73 SLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TI  151 (277)
T ss_pred             ecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-ee
Confidence            999999887766433  358899999999999999999999999999999999999999999999999987654332 23


Q ss_pred             ccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCC-CCCCHHHHHHH
Q 015257          284 RRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL----QDTYDKIVNNSLVFP-DAMNPELRNLL  358 (410)
Q Consensus       284 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p-~~~~~~l~~li  358 (410)
                      ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....    .+....+......++ ..+++++.+||
T Consensus       152 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  230 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDIC  230 (277)
T ss_pred             eccCCCCCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHH
Confidence            34568999999999877764 6679999999999999999999976432    223333444343333 46899999999


Q ss_pred             HHhcccCCCCCCCH----HHHhhCCcccCC
Q 015257          359 EGLLCKDPTRRLTL----NDVAKHTWVLGD  384 (410)
Q Consensus       359 ~~~L~~dp~~Rpt~----~ell~h~~~~~~  384 (410)
                      .+||+.||.+||++    .+++.||||.+.
T Consensus       231 ~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         231 RLFLAKKPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             HHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence            99999999999999    678899999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-44  Score=339.17  Aligned_cols=260  Identities=31%  Similarity=0.492  Sum_probs=216.7

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|.+...||.|+||.||++.+..+++.||+|.+.................+.+.+|+.+++.++||||+++++++.+  .
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~   78 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--A   78 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Confidence            36778899999999999999998999999998865432211111122345678899999999999999999999876  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ...++||||++++++..++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++....
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06628          79 DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA  158 (267)
T ss_pred             CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence            57899999999999998888778899999999999999999999999999999999999999999999999999886642


Q ss_pred             Ccc------ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCCCC
Q 015257          279 DND------VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN-SLVFPDAMN  351 (410)
Q Consensus       279 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~  351 (410)
                      ...      ......|++.|+|||.+.+... +.++||||||+++|+|++|..||...........+... ...+|..++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNIS  237 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccC
Confidence            211      1123457889999998876655 56799999999999999999999876655544444443 335667889


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       352 ~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      ..+.++|.+||+.||.+||++.++++||||
T Consensus       238 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         238 SEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6e-45  Score=340.88  Aligned_cols=252  Identities=26%  Similarity=0.402  Sum_probs=210.0

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+.+.||+|+||.||++++..+++.||+|++....         ......+.+|+.+++.++||||+++++.+.+  
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--   77 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---------GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--   77 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---------hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--
Confidence            47999999999999999999999999999999975431         1233467889999999999999999999876  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+++||||+++++|.+.+...+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645          78 RDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             CCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence            46899999999999999988877889999999999999999999999999999999999999999999999999987654


Q ss_pred             CCccccccCCCcccccccccccC--CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----CCC
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLG--LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP-----DAM  350 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~  350 (410)
                      ..........|++.|+|||++..  ....+.++|||||||++|+|++|..||...........+.......+     ..+
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd06645         158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW  237 (267)
T ss_pred             CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCC
Confidence            33333345578999999998742  22235679999999999999999999976543333323222222111     246


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhhCCc
Q 015257          351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTW  380 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt~~ell~h~~  380 (410)
                      +..+.++|.+||+.+|.+|||++++++|||
T Consensus       238 ~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             CHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=8.4e-45  Score=343.16  Aligned_cols=255  Identities=32%  Similarity=0.512  Sum_probs=212.9

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||+|+||.||++.+..+++.||+|++.....       .....+.+.+|+.+++.++||||+++++++.+  
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   71 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED-------DKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--   71 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC-------cchhhHHHHHHHHHHHhcCCcchhhHHHhccc--
Confidence            368999999999999999999998999999998754321       12234568899999999999999999999975  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ....++||||++++.+.........+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~  151 (286)
T cd07846          72 KKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA  151 (286)
T ss_pred             CCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence            46899999999999888777666679999999999999999999999999999999999999999999999999998765


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------------
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---------------  342 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~---------------  342 (410)
                      ..........++..|+|||++.+....+.++||||||+++|+|++|.+||......+....+...               
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence            44444445668899999998876554467899999999999999999999876654433332210               


Q ss_pred             ----CCCC------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          343 ----SLVF------------PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       343 ----~~~~------------p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                          ....            +..++..+.+|+.+||..+|.+|||+.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                0001            23567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.1e-44  Score=341.96  Aligned_cols=259  Identities=25%  Similarity=0.357  Sum_probs=217.1

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      +.|++++.||.|+||.||++++..++..||+|.+...         .......+.+|+.+++.++||||+++++.+..  
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   80 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---------SEEELEDYMVEIEILATCNHPYIVKLLGAFYW--   80 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---------CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--
Confidence            5699999999999999999999999999999997542         34456778899999999999999999999876  


Q ss_pred             CCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ...+++||||++++++...+.+ ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++...
T Consensus        81 ~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  160 (292)
T cd06644          81 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN  160 (292)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceec
Confidence            4589999999999988776543 457899999999999999999999999999999999999999999999999998764


Q ss_pred             cCCccccccCCCcccccccccccCC----cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCCC
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGL----TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL---VFPDA  349 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~  349 (410)
                      ...........+++.|+|||++.+.    ...+.++|||||||++|+|++|..||...........+.....   ..+..
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T cd06644         161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK  240 (292)
T ss_pred             cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcc
Confidence            4333333445688999999987532    2225679999999999999999999987766555555544322   23457


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                      ++.++.++|.+||..||.+||++.++++||||..-...
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         241 WSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence            78999999999999999999999999999999765443

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-46  Score=335.56  Aligned_cols=258  Identities=32%  Similarity=0.523  Sum_probs=220.6

Q ss_pred             cccceee-eeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEE
Q 015257          116 MINEYVH-VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVI  193 (410)
Q Consensus       116 ~~~~y~~-~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~  193 (410)
                      +.+-|++ .+.||+|+||.|--+....+|..||||++.+..         .-...++.+|++++...+ |+||++++++|
T Consensus        75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---------gHsR~RvfREVe~f~~Cqgh~nilqLiefF  145 (463)
T KOG0607|consen   75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---------GHSRSRVFREVETFYQCQGHKNILQLIEFF  145 (463)
T ss_pred             HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---------chHHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence            3344554 367999999999999999999999999997641         234467899999999985 99999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC---cEEEeec
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---TVKIGDF  270 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~---~~kl~Df  270 (410)
                      ++  ...+|||||-|.||.+..++.+...++|.++.++..+|+.||.+||.+||.||||||+|||-....   -||||||
T Consensus       146 Ed--d~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDf  223 (463)
T KOG0607|consen  146 ED--DTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDF  223 (463)
T ss_pred             cc--cceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecc
Confidence            87  468999999999999999999999999999999999999999999999999999999999997655   3899999


Q ss_pred             cccccccCC-------ccccccCCCccccccccccc----CCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------
Q 015257          271 SVSQVFEDD-------NDVLRRSPGTPVFTAPECCL----GLTYGGKAADTWAVGVTLYYMIIGQYPFLGET--------  331 (410)
Q Consensus       271 G~a~~~~~~-------~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~--------  331 (410)
                      .++.-....       .....+.+|+..|||||+..    ...+++++.|.||||||||.||+|++||.+.-        
T Consensus       224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr  303 (463)
T KOG0607|consen  224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR  303 (463)
T ss_pred             ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence            987532211       12234667899999999752    34556889999999999999999999996532        


Q ss_pred             -------HHHHHHHHHhCCCCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          332 -------LQDTYDKIVNNSLVFPD----AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       332 -------~~~~~~~i~~~~~~~p~----~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                             ...+++.|..+.+.||+    .+|.+.++|+..+|..|+.+|.++.+++.|||++..
T Consensus       304 Ge~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~  367 (463)
T KOG0607|consen  304 GEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC  367 (463)
T ss_pred             CCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence                   44578899999999997    689999999999999999999999999999999864

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.4e-44  Score=335.21  Aligned_cols=255  Identities=27%  Similarity=0.493  Sum_probs=220.7

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|.+++.||.|+||.||++.+..+|..||+|++.....       .....+.+..|+.+++.++||||+++++++.....
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-------TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN   73 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-------CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC
Confidence            48889999999999999999999999999998864321       23455678899999999999999999998876556


Q ss_pred             CEEEEEEeecCCCCcccccCC----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCcEeccCCCCcEEEcCCCcEEEee
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLH-----GHNVVHGDIKPDNLLVAPSGTVKIGD  269 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH-----~~~iiHrDlkp~NIll~~~~~~kl~D  269 (410)
                      ..++++|||++++++...+..    ...+++..++.++.||+.||.|||     +.+|+|+||+|+||+++.++.+||+|
T Consensus        74 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d  153 (265)
T cd08217          74 QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGD  153 (265)
T ss_pred             CEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEec
Confidence            688999999999988877643    457899999999999999999999     89999999999999999999999999


Q ss_pred             ccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCC
Q 015257          270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFPD  348 (410)
Q Consensus       270 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~  348 (410)
                      ||++..............|++.|+|||.+.+... +.++|+||||+++|+|++|..||...........+..... .+|.
T Consensus       154 ~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (265)
T cd08217         154 FGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPY  232 (265)
T ss_pred             ccccccccCCcccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCcc
Confidence            9999876654433445678999999999877654 5679999999999999999999988876666666665544 4667


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      .++..+.+++.+||..+|.+|||+.+|++|||+
T Consensus       233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            889999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.9e-45  Score=361.57  Aligned_cols=249  Identities=27%  Similarity=0.449  Sum_probs=209.9

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-C-----CCcccceeE
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-H-----PNIVNLIEV  192 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~l~~~  192 (410)
                      +|.+++.||+|+||.|.+|.+..+++.||||+++..          .....+...|+.+|..|+ |     -|+|+++++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~  256 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----------KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY  256 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence            799999999999999999999999999999998753          456678889999999997 4     399999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC--cEEEe
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG--TVKIG  268 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~--~~kl~  268 (410)
                      |..  ..+++||+|.+.. .|.++++.+  .+++...++.++.||+.||..||+.||||+||||+||||...+  .|||+
T Consensus       257 F~f--r~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVI  333 (586)
T KOG0667|consen  257 FYF--RNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVI  333 (586)
T ss_pred             ccc--ccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEE
Confidence            987  5699999999964 466666654  4689999999999999999999999999999999999997654  69999


Q ss_pred             eccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------
Q 015257          269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN------  342 (410)
Q Consensus       269 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~------  342 (410)
                      |||.|......  +. +.+-+..|+|||++.+.++ +.+.||||||||++||++|.+.|.|.+..+++..|..-      
T Consensus       334 DFGSSc~~~q~--vy-tYiQSRfYRAPEVILGlpY-~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~  409 (586)
T KOG0667|consen  334 DFGSSCFESQR--VY-TYIQSRFYRAPEVILGLPY-DTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP  409 (586)
T ss_pred             ecccccccCCc--ce-eeeeccccccchhhccCCC-CCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence            99999875443  22 6677888999999999998 55699999999999999999999998888777665430      


Q ss_pred             --------------C--------------------------------CCCC-C----------CCCHHHHHHHHHhcccC
Q 015257          343 --------------S--------------------------------LVFP-D----------AMNPELRNLLEGLLCKD  365 (410)
Q Consensus       343 --------------~--------------------------------~~~p-~----------~~~~~l~~li~~~L~~d  365 (410)
                                    .                                ...| .          .-...+.++|++||++|
T Consensus       410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d  489 (586)
T KOG0667|consen  410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD  489 (586)
T ss_pred             HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence                          0                                0011 0          11245789999999999


Q ss_pred             CCCCCCHHHHhhCCcccCC
Q 015257          366 PTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       366 p~~Rpt~~ell~h~~~~~~  384 (410)
                      |.+|+|+.++|+||||.+.
T Consensus       490 P~~R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  490 PAERITPAQALNHPFLTGT  508 (586)
T ss_pred             chhcCCHHHHhcCcccccc
Confidence            9999999999999999954

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=9.7e-45  Score=343.47  Aligned_cols=255  Identities=27%  Similarity=0.445  Sum_probs=211.2

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  199 (410)
                      |++.+.||+|+||.||++.+..+++.||+|.+......      .......+.+|+.+++.++|++|+.+++.+.+  ..
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~   73 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK------KRKGESMALNEKQILEKVNSRFVVSLAYAYET--KD   73 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc------chHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CC
Confidence            67889999999999999999999999999998654221      22334567789999999999999999999876  45


Q ss_pred             EEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          200 HFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      .+++||||+++++|.+.+..  ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus        74 ~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05630          74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  153 (285)
T ss_pred             EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence            89999999999998877643  2368999999999999999999999999999999999999999999999999987654


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh-CCCCCCCCCCHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ---DTYDKIVN-NSLVFPDAMNPE  353 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~---~~~~~i~~-~~~~~p~~~~~~  353 (410)
                      ... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......   .....+.. ....++..++++
T Consensus       154 ~~~-~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
T cd05630         154 EGQ-TIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPD  231 (285)
T ss_pred             CCc-cccCCCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHH
Confidence            322 2234578999999999877665 56799999999999999999999764321   12222221 223456788999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHhhCCcccCC
Q 015257          354 LRNLLEGLLCKDPTRRLT-----LNDVAKHTWVLGD  384 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~~  384 (410)
                      +.+|+.+||+.||.+|||     +.|+++||||.+.
T Consensus       232 ~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         232 ARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            999999999999999999     9999999999763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.1e-44  Score=340.24  Aligned_cols=255  Identities=25%  Similarity=0.376  Sum_probs=215.2

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      .|++++.||.|+||.||++.+..++..+|+|.+...         .......+.+|+.+++.++||||+++++++..  .
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~   74 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---------SEEELEDYMVEIDILASCDHPNIVKLLDAFYY--E   74 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---------CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--C
Confidence            378889999999999999999999999999987532         23455678899999999999999999999876  4


Q ss_pred             CEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...++||||++++++...+.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus        75 ~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  154 (282)
T cd06643          75 NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT  154 (282)
T ss_pred             CEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccc
Confidence            589999999999988776543 4579999999999999999999999999999999999999999999999999997654


Q ss_pred             CCccccccCCCcccccccccccCC----cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCCCCCC
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGL----TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS---LVFPDAM  350 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~  350 (410)
                      ..........||+.|+|||++...    ...+.++|||||||++|+|++|.+||...+.......+....   ...|..+
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd06643         155 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW  234 (282)
T ss_pred             ccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCcccc
Confidence            433333455689999999987421    222567999999999999999999998877666555554432   2345678


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      +.++.+||.+||+.||.+|||+.++++||||...
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         235 SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            8999999999999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.2e-44  Score=334.86  Aligned_cols=253  Identities=30%  Similarity=0.580  Sum_probs=218.8

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|++++.||+|+||.||++++..+|+.||+|.+.....       .......+.+|+.+++.++||||+++++++.+  .
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~   71 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-------SPKEREESRKEVAVLSNMKHPNIVQYQESFEE--N   71 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-------ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--C
Confidence            48899999999999999999999999999999864321       22344678999999999999999999999876  4


Q ss_pred             CEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ...++||||+.++++...+...  ..+++..+..++.|++.||.|||+++++|+||+|+|||++.++.++|+|||++...
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~  151 (256)
T cd08218          72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL  151 (256)
T ss_pred             CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence            6899999999998888776543  35799999999999999999999999999999999999999999999999999876


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFPDAMNPELR  355 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~l~  355 (410)
                      ...........|++.|+|||++.+... +.++|+|||||++|+|++|..||......+....+..+.. ..+..++.++.
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (256)
T cd08218         152 NSTVELARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLR  230 (256)
T ss_pred             CcchhhhhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHH
Confidence            544333345568899999999877655 5679999999999999999999988877777777766554 46678899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          356 NLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      ++|.+||+.+|.+||++.++++||||
T Consensus       231 ~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         231 NLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.4e-44  Score=336.89  Aligned_cols=258  Identities=28%  Similarity=0.497  Sum_probs=214.7

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      .|...+.||+|+||.||++.+..++..||+|.+......    .........+.+|+.+++.++||||+++++++.+...
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   78 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPES----PETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE   78 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCC----chhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC
Confidence            588899999999999999999999999999987644211    1123455678999999999999999999999876555


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ..++++|||+++++|.+.+.....+++..++.++.||+.||+|||+.+|+||||+|+||+++.++.++|+|||+++....
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence            68999999999999988887777899999999999999999999999999999999999999999999999999875432


Q ss_pred             C---ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHH
Q 015257          279 D---NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--SLVFPDAMNPE  353 (410)
Q Consensus       279 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~  353 (410)
                      .   ........++..|+|||++.+... +.++|||||||++|+|++|..||...........+...  ...+|..+++.
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEH  237 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHH
Confidence            1   111223458889999998876554 56799999999999999999999876554444433332  23456678899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhCCccc
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKHTWVL  382 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h~~~~  382 (410)
                      +++++ +||..+|++|||++||++||||+
T Consensus       238 ~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         238 ARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            99999 67778999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1e-44  Score=339.33  Aligned_cols=252  Identities=24%  Similarity=0.376  Sum_probs=209.1

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+.+.||+|+||.||++++..+++.||+|++....         ......+.+|+.+++.++||||+++++++..  
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---------~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~--   77 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---------GDDFSLIQQEIFMVKECKHCNIVAYFGSYLS--   77 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---------cchHHHHHHHHHHHHhcCCCCeeeeeEEEEe--
Confidence            57999999999999999999999999999999985431         1233467899999999999999999999876  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+++||||+++++|.+.+.....+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....
T Consensus        78 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          78 REKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            45899999999999999888777789999999999999999999999999999999999999999999999999998654


Q ss_pred             CCccccccCCCcccccccccccC--CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----CCCCC
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLG--LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV-----FPDAM  350 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~  350 (410)
                      ..........|++.|+|||.+..  ....+.++|||||||++|+|++|..||...........+......     .+..+
T Consensus       158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd06646         158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKW  237 (267)
T ss_pred             ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCcccccc
Confidence            33323334568899999998743  222356799999999999999999999655433332222222221     12356


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhhCCc
Q 015257          351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTW  380 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt~~ell~h~~  380 (410)
                      +..+.+||.+||+.||.+|||++++++|+|
T Consensus       238 ~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         238 SSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            889999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-44  Score=338.70  Aligned_cols=258  Identities=24%  Similarity=0.391  Sum_probs=220.2

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+.+.||.|+||.||++++..+++.||+|++....        .......+.+|+.+++.++||||+++++++.+  
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   70 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--------AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--   70 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--------cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--
Confidence            36888999999999999999999999999999985431        22344578899999999999999999999886  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+++|+||++++++.+.+... .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+++...
T Consensus        71 ~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  149 (274)
T cd06609          71 GSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT  149 (274)
T ss_pred             CCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeec
Confidence            46899999999999998887755 78999999999999999999999999999999999999999999999999998766


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCC-CCHHHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFPDA-MNPELR  355 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~-~~~~l~  355 (410)
                      ..........|++.|+|||++.+... +.++||||||+++|+|++|..||...........+..... ..+.. +++++.
T Consensus       150 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (274)
T cd06609         150 STMSKRNTFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFK  228 (274)
T ss_pred             ccccccccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHH
Confidence            54334445678999999999877664 6779999999999999999999987665555444444332 33444 789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          356 NLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                      +++.+||..+|.+|||++++++||||++....
T Consensus       229 ~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         229 DFVSLCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             HHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence            99999999999999999999999999886554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-46  Score=382.54  Aligned_cols=259  Identities=33%  Similarity=0.527  Sum_probs=230.6

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+++.||+|+||.|.+++.+.+++.||+|++++..+.+      .....-|..|-.+|.--+.+=||.++-+|+| 
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK------r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD-  146 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK------RAETACFREERDIMVFGNSEWIVQLHYAFQD-  146 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh------chhHHHHHHHhHHHHcCCcHHHHHHHHHhcC-
Confidence            468999999999999999999999999999999998765433      1233468899999999999999999999998 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       ..++|+|||||+||.+..++.+..++|+.+++.|+..|+.||.-||+.|+|||||||+|||||..|++||+|||.+-.+
T Consensus       147 -~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm  225 (1317)
T KOG0612|consen  147 -ERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM  225 (1317)
T ss_pred             -ccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhc
Confidence             4699999999999999999988889999999999999999999999999999999999999999999999999988766


Q ss_pred             c-CCccccccCCCcccccccccccCC----cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCC--
Q 015257          277 E-DDNDVLRRSPGTPVFTAPECCLGL----TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--SLVFP--  347 (410)
Q Consensus       277 ~-~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p--  347 (410)
                      . ++.-.....+|||.|++||++...    ..+++.+|.||+||++|||++|..||+..+..+.+.+|..-  .+.||  
T Consensus       226 ~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~  305 (1317)
T KOG0612|consen  226 DADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDE  305 (1317)
T ss_pred             CCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcc
Confidence            6 444455677899999999998532    34577899999999999999999999999999999999875  67888  


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCC---HHHHhhCCcccCC
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLT---LNDVAKHTWVLGD  384 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt---~~ell~h~~~~~~  384 (410)
                      ..+|.++++||.++|+. |..|..   ++++-.||||.+.
T Consensus       306 ~~VSeeakdLI~~ll~~-~e~RLgrngiedik~HpFF~g~  344 (1317)
T KOG0612|consen  306 TDVSEEAKDLIEALLCD-REVRLGRNGIEDIKNHPFFEGI  344 (1317)
T ss_pred             cccCHHHHHHHHHHhcC-hhhhcccccHHHHHhCccccCC
Confidence            47899999999999865 778887   9999999999875

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.9e-44  Score=340.09  Aligned_cols=256  Identities=27%  Similarity=0.431  Sum_probs=214.0

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  199 (410)
                      |+..+.||+|+||+||++.+..+++.||+|.+......      .......+.+|+.+++.++|+||+.+++++..  ..
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~   73 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK------KRKGESMALNEKQILEKVNSQFVVNLAYAYET--KD   73 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh------hhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CC
Confidence            77889999999999999999999999999998654221      12233457789999999999999999998876  45


Q ss_pred             EEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          200 HFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ..++||||++++++...+..  ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05632          74 ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIP  153 (285)
T ss_pred             EEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence            89999999999988776643  3469999999999999999999999999999999999999999999999999997654


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCCCCCHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTY----DKIVNNSLVFPDAMNPE  353 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~----~~i~~~~~~~p~~~~~~  353 (410)
                      ... ......|++.|+|||++.+..+ +.++|+||||+++|+|++|..||.........    ..+......++..++++
T Consensus       154 ~~~-~~~~~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
T cd05632         154 EGE-SIRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEE  231 (285)
T ss_pred             CCC-cccCCCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHH
Confidence            322 2234578999999999877655 56799999999999999999999876544322    33333444567788999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHhhCCcccCCC
Q 015257          354 LRNLLEGLLCKDPTRRLT-----LNDVAKHTWVLGDN  385 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~~~  385 (410)
                      +.+|+.+||+.||.+|||     +.+++.|+||....
T Consensus       232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         232 AKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             HHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence            999999999999999999     89999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.9e-44  Score=341.19  Aligned_cols=254  Identities=28%  Similarity=0.484  Sum_probs=216.7

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      .+|.+++.||.|+||.||++.+..+|+.||+|.+....         ....+.+.+|+.+++.++||||+++++++.+  
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--   87 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---------QPKKELIINEILVMKELKNPNIVNFLDSFLV--   87 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---------CchHHHHHHHHHHHHhcCCCceeeeeeeEec--
Confidence            46999999999999999999999999999999885431         1234568899999999999999999999976  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+++|+||++++++...+.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus        88 ~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~  166 (296)
T cd06655          88 GDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT  166 (296)
T ss_pred             CceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence            4589999999999999887754 368999999999999999999999999999999999999999999999999987654


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCCCCCCCHHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS---LVFPDAMNPEL  354 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~~~~l  354 (410)
                      ..........|++.|+|||.+.+... +.++|||||||++|+|++|..||...........+....   ...|..+++.+
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (296)
T cd06655         167 PEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIF  245 (296)
T ss_pred             cccccCCCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHH
Confidence            43333344568999999998876655 567999999999999999999998876655444443322   23456789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      .+||.+||..||.+|||+.++++||||...
T Consensus       246 ~~li~~~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         246 RDFLNRCLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             HHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence            999999999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=6.2e-44  Score=336.67  Aligned_cols=262  Identities=22%  Similarity=0.375  Sum_probs=213.4

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|++++.||+|+||.||++.+..+++.||+|++....        .......+.+|+.++++++||||+++++++..  .
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~   71 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--------TVELQKQIMSELEILYKCDSPYIIGFYGAFFV--E   71 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--------ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--C
Confidence            5788999999999999999999999999999875431        23345678899999999999999999999987  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ...++||||++++++...    ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++.....
T Consensus        72 ~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          72 NRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             CEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            578999999999887543    3578999999999999999999999999999999999999999999999999976543


Q ss_pred             CccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC-CCC-CCC
Q 015257          279 DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL-------QDTYDKIVNNS-LVF-PDA  349 (410)
Q Consensus       279 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-------~~~~~~i~~~~-~~~-p~~  349 (410)
                      .  ......||+.|+|||++.+... +.++||||||+++|+|++|..||.....       ......+.... ... ...
T Consensus       148 ~--~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (279)
T cd06619         148 S--IAKTYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQ  224 (279)
T ss_pred             c--cccCCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCc
Confidence            2  2334578999999999877655 5679999999999999999999965321       12222222222 122 235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCchh-hhhhhc
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQY-LCWCKR  397 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~-~~~~~~  397 (410)
                      +++++.+++.+||+.||.+||++++++.||||+......-.. =+|..+
T Consensus       225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~~~~~~~~~~  273 (279)
T cd06619         225 FSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEVVSMWVCR  273 (279)
T ss_pred             CCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCccHHHHHHHHHH
Confidence            788999999999999999999999999999998775554444 345443

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.7e-44  Score=341.03  Aligned_cols=264  Identities=26%  Similarity=0.443  Sum_probs=217.2

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|.+.+.||+|+||.||++.+..+|+.||||.+.......    ........+..|+.+++.++|+||+++++++.+  .
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~   74 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE----AKDGINFTALREIKLLQELKHPNIIGLLDVFGH--K   74 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccc----ccchhhHHHHHHHHHHhhcCCCCChhhhheeec--C
Confidence            4788999999999999999999999999999987543211    012233467789999999999999999999987  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...++||||+ ++++..++.... .+++..++.++.||+.||.|||++||+|+||+|+|||++.++.++|+|||+++...
T Consensus        75 ~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          75 SNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             CEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            6899999999 778888877665 79999999999999999999999999999999999999999999999999998765


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--------------  343 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--------------  343 (410)
                      ..........+++.|+|||.+.+....+.++|||||||++|+|++|.+||.+....+....+....              
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         154 SPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             CCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence            544344445678889999988665555678999999999999999988887766544443332210              


Q ss_pred             ---------CC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCc
Q 015257          344 ---------LV-----FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIP  389 (410)
Q Consensus       344 ---------~~-----~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~  389 (410)
                               ..     .....+..+.++|.+||..||++|||+.+++.||||.+...+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~  293 (298)
T cd07841         234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP  293 (298)
T ss_pred             cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence                     00     01234678999999999999999999999999999999877765

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6.7e-44  Score=331.55  Aligned_cols=253  Identities=30%  Similarity=0.537  Sum_probs=219.9

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|+.++.||.|+||.||++++..+++.+++|.+.....       .......+.+|+.++++++|+||+++++++.+  .
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~   71 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-------SEKERRDALNEIVILSLLQHPNIIAYYNHFMD--D   71 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-------chhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--C
Confidence            48899999999999999999999999999999864321       23455678899999999999999999999987  4


Q ss_pred             CEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ..++++|||++++++.+.+...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++...
T Consensus        72 ~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~  151 (256)
T cd08221          72 NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL  151 (256)
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence            6899999999999998887654  46899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCCCCHHHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV-FPDAMNPELR  355 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~~~~l~  355 (410)
                      ...........|++.|+|||.+.+... +.++||||||+++|+|++|..||......+....+..+... .+..++.++.
T Consensus       152 ~~~~~~~~~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (256)
T cd08221         152 GSEYSMAETVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELI  230 (256)
T ss_pred             ccccccccccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHH
Confidence            544433445678999999998876654 56799999999999999999999888777777777665443 4456889999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          356 NLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      +++.+||+.+|.+|||+.++++|||+
T Consensus       231 ~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         231 SLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHHHcccCcccCCCHHHHhhCcCC
Confidence            99999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-44  Score=343.51  Aligned_cols=259  Identities=29%  Similarity=0.516  Sum_probs=221.1

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+.+.||+|+||.||++.+..+++.||+|.+......      .......+..|+.+++.++||||+++++.+.+  
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--   72 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI------KRNKVKRVLTEQEILATLDHPFLPTLYASFQT--   72 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc------hHHHHHHHHHHHHHHHhCCCCCchhheeeeec--
Confidence            3689999999999999999999999999999998754221      12355678999999999999999999999876  


Q ss_pred             CCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      ....++||||+.+++|.+++...  ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus        73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  152 (316)
T cd05574          73 ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQ  152 (316)
T ss_pred             CCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhc
Confidence            56899999999999998877643  5789999999999999999999999999999999999999999999999999865


Q ss_pred             ccCCcc-----------------------------ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCC
Q 015257          276 FEDDND-----------------------------VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYP  326 (410)
Q Consensus       276 ~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~P  326 (410)
                      ......                             ......||..|+|||++.+... +.++||||||+++|+|++|..|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCC
Confidence            422111                             1123468899999999876655 6679999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcccCCCCCCC----HHHHhhCCcccCCC
Q 015257          327 FLGETLQDTYDKIVNNSLVFPDA--MNPELRNLLEGLLCKDPTRRLT----LNDVAKHTWVLGDN  385 (410)
Q Consensus       327 f~~~~~~~~~~~i~~~~~~~p~~--~~~~l~~li~~~L~~dp~~Rpt----~~ell~h~~~~~~~  385 (410)
                      |.+......+..+......++..  ++..+.++|.+||+.||.+|||    +.+++.||||++..
T Consensus       232 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         232 FKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             CCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence            98888777777777666555544  6899999999999999999999    99999999998753

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.3e-44  Score=337.71  Aligned_cols=254  Identities=25%  Similarity=0.374  Sum_probs=209.7

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEEcC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDP  196 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  196 (410)
                      +.|.+.+.||+|+||.||++....+++.||+|++....          .....+.+|+.+++.+ +||||+++++++...
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   75 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----------DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   75 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence            56888999999999999999999999999999975431          1234678999999998 799999999988753


Q ss_pred             C----CCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeec
Q 015257          197 N----SDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       197 ~----~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                      .    ...+++||||++++++..++...  ..+++..+..++.||+.||.|||+++|+|+||||+||+++.++.++|+||
T Consensus        76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccC
Confidence            2    24689999999999888877653  46899999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCccccccCCCcccccccccccCC----cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--
Q 015257          271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLGL----TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL--  344 (410)
Q Consensus       271 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~--  344 (410)
                      |++..............|++.|+|||++...    ...+.++|||||||++|+|++|..||...........+.....  
T Consensus       156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (272)
T cd06637         156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR  235 (272)
T ss_pred             CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCC
Confidence            9998654433334456789999999988532    2235679999999999999999999976654444433333221  


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          345 VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       345 ~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      ..+..++.++.+|+.+||..||.+|||+.++++||||
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            1234678999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.6e-44  Score=341.38  Aligned_cols=255  Identities=27%  Similarity=0.456  Sum_probs=215.6

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      ..+|.+++.||+|+||.||++.+..+++.||+|.+....         ......+.+|+.+++.++||||+++++.+.. 
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~---------~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-   88 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---------QPKKELIINEILVMRENKNPNIVNYLDSYLV-   88 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC---------cchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-
Confidence            358999999999999999999999999999999886432         1233568899999999999999999999876 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       ....++||||++++++.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus        89 -~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~  166 (296)
T cd06654          89 -GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (296)
T ss_pred             -CCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence             4589999999999999887754 46899999999999999999999999999999999999999999999999998765


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCCCCCCCHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS---LVFPDAMNPE  353 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~~~~  353 (410)
                      ...........|++.|+|||.+.+... +.++|||||||++|+|++|+.||...........+....   ...+..+++.
T Consensus       167 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (296)
T cd06654         167 TPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI  245 (296)
T ss_pred             cccccccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHH
Confidence            443333344568999999998876554 567999999999999999999998776554433333222   2345578899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      +.+|+.+||..||.+|||+.++++||||...
T Consensus       246 l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             HHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence            9999999999999999999999999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-44  Score=333.10  Aligned_cols=251  Identities=27%  Similarity=0.441  Sum_probs=213.9

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+.+.||.|+||.||++.+..+++.+|+|++....         ......+.+|+.+++.++||||+++++++.+  
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--   71 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---------GDDFEIIQQEISMLKECRHPNIVAYFGSYLR--   71 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---------hhhHHHHHHHHHHHHhCCCCChhceEEEEEe--
Confidence            57999999999999999999999899999999986431         2245688999999999999999999999876  


Q ss_pred             CCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ...++++|||++++.+.+++... ..+++..++.++.|++.||.|||+++|+|+||+|+||+++.++.++|+|||++...
T Consensus        72 ~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  151 (262)
T cd06613          72 RDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQL  151 (262)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhh
Confidence            45899999999999999887665 68999999999999999999999999999999999999999999999999999765


Q ss_pred             cCCccccccCCCcccccccccccCC---cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CCCC
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGL---TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-----VFPD  348 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-----~~p~  348 (410)
                      ...........++..|+|||.+.+.   .. +.++||||||+++|+|++|..||...........+....+     ..+.
T Consensus       152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (262)
T cd06613         152 TATIAKRKSFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKE  230 (262)
T ss_pred             hhhhhccccccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchh
Confidence            5433333455688999999988655   34 5679999999999999999999988765554444443322     1233


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCc
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW  380 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~  380 (410)
                      .++.++.+++.+||+.+|.+|||+.+++.|+|
T Consensus       231 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             hhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            56788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.6e-44  Score=339.27  Aligned_cols=243  Identities=18%  Similarity=0.241  Sum_probs=207.3

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc--CCCCEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD--PNSDHF  201 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~~  201 (410)
                      ..||+|++|.||+++.  +|+.||||++.....      ......+.+.+|+.+|++++|||||++++++.+  .....+
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~------~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~   97 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK------GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL   97 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEecccccc------ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCce
Confidence            5799999999998876  689999999865321      123445778899999999999999999999876  444578


Q ss_pred             EEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCcEEEcCCCcEEEeeccccccccCCc
Q 015257          202 YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN  280 (410)
Q Consensus       202 ~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~  280 (410)
                      ++||||+++++|.+.+.....+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus        98 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988         98 SLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             EEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            9999999999999998888889999999999999999999998 499999999999999999999999999998654321


Q ss_pred             cccccCCCcccccccccccCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHH
Q 015257          281 DVLRRSPGTPVFTAPECCLGL-TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--SLVFPDAMNPELRNL  357 (410)
Q Consensus       281 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~l~~l  357 (410)
                         ....||+.|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+....+...  ...+|..+++++.+|
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l  254 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCI  254 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHH
Confidence               235688999999988652 23367899999999999999999999988877777777544  345566789999999


Q ss_pred             HHHhcccCCCCCCCHHHHhh
Q 015257          358 LEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       358 i~~~L~~dp~~Rpt~~ell~  377 (410)
                      +.+||+.||.+|||++++++
T Consensus       255 i~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        255 VEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHhcCCcccCcCHHHHHH
Confidence            99999999999999999986

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8e-44  Score=337.74  Aligned_cols=257  Identities=25%  Similarity=0.391  Sum_probs=213.3

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID  194 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  194 (410)
                      ..++|.+.+.||+|+||.||++....+++.+|+|++...          ......+.+|+.+++++ +|||++++++++.
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~----------~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI----------SDVDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc----------ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            457899999999999999999999999999999987532          12234677899999998 8999999999987


Q ss_pred             cCC---CCEEEEEEeecCCCCcccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEE
Q 015257          195 DPN---SDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKI  267 (410)
Q Consensus       195 ~~~---~~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl  267 (410)
                      ..+   ...+++||||++++++.+.+.    ....+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl  169 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKL  169 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEE
Confidence            532   247899999999998877653    3457899999999999999999999999999999999999999999999


Q ss_pred             eeccccccccCCccccccCCCcccccccccccCCcC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Q 015257          268 GDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTY----GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS  343 (410)
Q Consensus       268 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~  343 (410)
                      +|||++..............|++.|+|||++.....    .+.++|||||||++|+|++|+.||...........+....
T Consensus       170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~  249 (291)
T cd06639         170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP  249 (291)
T ss_pred             eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence            999998865543333344568999999998754331    2567999999999999999999998776555555554432


Q ss_pred             ---CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCccc
Q 015257          344 ---LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL  382 (410)
Q Consensus       344 ---~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~  382 (410)
                         ...+...+..+.+||.+||+.+|.+||++.+++.||||+
T Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence               223556778999999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.5e-44  Score=333.22  Aligned_cols=259  Identities=28%  Similarity=0.483  Sum_probs=215.2

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      .+|.+.+.||+|+||.||++.+..+|..||||.+......    .........+.+|+.+++.++||||+++++++.++.
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~----~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   77 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPES----PETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM   77 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCC----cccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC
Confidence            4689999999999999999999999999999987543211    112345678899999999999999999999987755


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+++||||+++++|.+.+.....+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||+++...
T Consensus        78 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          78 ERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             CceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            56789999999999999888776778999999999999999999999999999999999999999999999999987543


Q ss_pred             CCc---cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCH
Q 015257          278 DDN---DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFPDAMNP  352 (410)
Q Consensus       278 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~  352 (410)
                      ...   .......|+..|+|||++.+... +.++|||||||++|+|++|+.||...........+....  ...|..++.
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD  236 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCH
Confidence            211   12233458899999998876554 667999999999999999999998765544444443332  235667788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhhCCccc
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWVL  382 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell~h~~~~  382 (410)
                      .+.++|.+||. +|++|||++++++|||+.
T Consensus       237 ~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         237 HCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            99999999995 999999999999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-44  Score=358.67  Aligned_cols=249  Identities=20%  Similarity=0.267  Sum_probs=198.3

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      ...|.+.+.||+|+||.||++.+..+++.||||....               ..+.+|+.+|++++|||||++++++.. 
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------------~~~~~E~~iL~~L~HpnIv~l~~~~~~-  231 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------------ASSVHEARLLRRLSHPAVLALLDVRVV-  231 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------------cCHHHHHHHHHHCCCCCCCcEEEEEEE-
Confidence            4579999999999999999999999999999996321               235689999999999999999999876 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       .+..++|||++.+.++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       232 -~~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~  310 (461)
T PHA03211        232 -GGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA  310 (461)
T ss_pred             -CCEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceec
Confidence             4578999999976444333333457999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC--
Q 015257          277 EDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET--------LQDTYDKIVNNSL--  344 (410)
Q Consensus       277 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~--------~~~~~~~i~~~~~--  344 (410)
                      .....  ......||+.|+|||++.+..+ +.++|||||||+||||++|..|+....        ..+....+.....  
T Consensus       311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~  389 (461)
T PHA03211        311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV  389 (461)
T ss_pred             ccccccccccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc
Confidence            43221  2234579999999999887665 667999999999999999876543211        1122222211110  


Q ss_pred             -CCC-------------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          345 -VFP-------------------------------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       345 -~~p-------------------------------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                       .++                               ..++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       390 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        390 DEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             ccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence             011                               034568899999999999999999999999999975

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.2e-44  Score=346.59  Aligned_cols=255  Identities=18%  Similarity=0.281  Sum_probs=203.1

Q ss_pred             eeeeeccc--CceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCC
Q 015257          122 HVRKIGAG--SYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       122 ~~~~lG~G--~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  199 (410)
                      ++++||+|  +||+||++..+.+|+.||||++.....       .......+.+|+.+++.++||||+++++++..  ..
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~   72 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-------TNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DN   72 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-------cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CC
Confidence            46789999  789999999999999999999864321       23345578889999999999999999999987  45


Q ss_pred             EEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          200 HFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      .+++||||++++++.+++..  ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.++++||+.+....
T Consensus        73 ~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~  152 (327)
T cd08227          73 ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  152 (327)
T ss_pred             EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccc
Confidence            89999999999999887754  3468999999999999999999999999999999999999999999999998654322


Q ss_pred             CCcc-------ccccCCCcccccccccccCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----
Q 015257          278 DDND-------VLRRSPGTPVFTAPECCLGL-TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV----  345 (410)
Q Consensus       278 ~~~~-------~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~----  345 (410)
                      ....       ......++..|+|||++.+. ..++.++|||||||++|+|++|..||..............+...    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (327)
T cd08227         153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  232 (327)
T ss_pred             cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccc
Confidence            1110       11223467789999998653 23467899999999999999999999765443333222221110    


Q ss_pred             ------------------------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          346 ------------------------------------------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       346 ------------------------------------------~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                                                                ....+++++.+||.+||+.||.+|||++++++||||+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence                                                      11235678999999999999999999999999999976


Q ss_pred             CC
Q 015257          384 DN  385 (410)
Q Consensus       384 ~~  385 (410)
                      ..
T Consensus       313 ~~  314 (327)
T cd08227         313 IK  314 (327)
T ss_pred             cc
Confidence            43

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.9e-44  Score=337.75  Aligned_cols=253  Identities=29%  Similarity=0.504  Sum_probs=206.1

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|++++.||.|++|.||++++..+|+.||||.+.....       .......+.+|+.++++++||||+++++++.+  .
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~   71 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-------TEGVPSTAIREISLLKELNHPNIVKLLDVIHT--E   71 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-------ccccchHHHHHHHHHHhcCCCCCcchhhhccc--C
Confidence            38899999999999999999999999999998764321       12233468899999999999999999999876  4


Q ss_pred             CEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ...++||||+++ .+..++..  ...+++..+..++.||+.||+|||+.+++|+||+|+||+++.++.+||+|||++...
T Consensus        72 ~~~~~v~e~~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~  150 (284)
T cd07860          72 NKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF  150 (284)
T ss_pred             CcEEEEeecccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence            589999999975 45544432  356899999999999999999999999999999999999999999999999998765


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS-------------  343 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-------------  343 (410)
                      ...........+++.|+|||++.+....+.++||||||+++|+|+||..||.+.+..+...++....             
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07860         151 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  230 (284)
T ss_pred             ccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH
Confidence            4433333444578899999988765555678999999999999999999998766544333322100             


Q ss_pred             -----CC-----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          344 -----LV-----------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       344 -----~~-----------~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                           ..           ....++++++++|.+||+.||.+|||+.++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                 00           123467899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.8e-44  Score=341.43  Aligned_cols=256  Identities=27%  Similarity=0.456  Sum_probs=215.1

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      ..+|.+++.||+|+||.||++.+..+++.||+|.+....         ....+.+.+|+.+++.++||||+++++++.. 
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-   87 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---------QPKKELIINEILVMRENKNPNIVNYLDSYLV-   87 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---------cchHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            368999999999999999999999999999999885432         1233568899999999999999999999986 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       ...+++||||++++++..++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus        88 -~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~  165 (297)
T cd06656          88 -GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (297)
T ss_pred             -CCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence             4589999999999999887754 46899999999999999999999999999999999999999999999999998765


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCCCCCHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDAMNPE  353 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~~~~  353 (410)
                      ...........+++.|+|||.+.+... +.++|||||||++|+|++|..||...........+...   ....|..++..
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (297)
T cd06656         166 TPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAV  244 (297)
T ss_pred             cCCccCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHH
Confidence            444333344568999999998876555 57799999999999999999999776543332222221   12345678899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      +.+|+.+||..||.+|||+.++++||||....
T Consensus       245 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         245 FRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence            99999999999999999999999999997653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-44  Score=354.41  Aligned_cols=251  Identities=22%  Similarity=0.344  Sum_probs=202.1

Q ss_pred             cccceeeeeeecccCceEEEEEEEc--cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSS--LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ...+|.+++.||+|+||.||++...  .++..||+|.+...              ....+|+.+|+.++|||||++++++
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------------~~~~~E~~il~~l~h~~iv~~~~~~  155 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------------KTPGREIDILKTISHRAIINLIHAY  155 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------------ccHHHHHHHHHhcCCCCccceeeeE
Confidence            3457999999999999999998754  35688999987532              1345899999999999999999998


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      ..  ...+++|||++.+. +..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus       156 ~~--~~~~~lv~e~~~~~-l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a  232 (392)
T PHA03207        156 RW--KSTVCMVMPKYKCD-LFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA  232 (392)
T ss_pred             ee--CCEEEEEehhcCCC-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccc
Confidence            76  45899999999754 5555566678999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh----CC-
Q 015257          274 QVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ---DTYDKIVN----NS-  343 (410)
Q Consensus       274 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~---~~~~~i~~----~~-  343 (410)
                      +.......  ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....   ..+..+..    .. 
T Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~  311 (392)
T PHA03207        233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPL  311 (392)
T ss_pred             cccCcccccccccccccccCccCHhHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcc
Confidence            76543321  2234679999999999877665 56799999999999999999999764321   11111111    00 


Q ss_pred             ------------------------CCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          344 ------------------------LVFP-----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       344 ------------------------~~~p-----~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                                              ...|     ..++.++.+||.+||..||.+|||+.++|.||||...
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        312 EFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             ccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence                                    1111     1346788999999999999999999999999999764

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.5e-44  Score=337.88  Aligned_cols=265  Identities=25%  Similarity=0.443  Sum_probs=218.8

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|++++.||+|+||.||++++..+|..||+|.+...        ........+.+|+.++++++||||+++++.+..  
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--   70 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--------LDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--   70 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--------cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--
Confidence            3688999999999999999999999999999987532        123445678899999999999999999998876  


Q ss_pred             CCEEEEEEeecCCCCcccccCCC---CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQP---GAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~---~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      ...+++||||++++.+..++...   ..+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.++|+|||++
T Consensus        71 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  150 (286)
T cd06622          71 EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS  150 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence            46899999999999887776553   378999999999999999999996 59999999999999999999999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCCcC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhC-CC
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTY-----GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYD---KIVNN-SL  344 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~---~i~~~-~~  344 (410)
                      ......  ......|++.|+|||.+.+...     .+.++|||||||++|+|++|..||..........   .+... ..
T Consensus       151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd06622         151 GNLVAS--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP  228 (286)
T ss_pred             ccccCC--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCC
Confidence            765332  2234568889999998754322     2567999999999999999999997655444332   23332 23


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCchhhhh
Q 015257          345 VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCW  394 (410)
Q Consensus       345 ~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~~~~  394 (410)
                      .+|..+++++.+||.+||+.+|.+||++.+++.||||.....+..+-..|
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~~~~~~~~  278 (286)
T cd06622         229 TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEW  278 (286)
T ss_pred             CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCCccchHHH
Confidence            56677899999999999999999999999999999998876665544445

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-44  Score=335.09  Aligned_cols=256  Identities=26%  Similarity=0.391  Sum_probs=213.3

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID  194 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  194 (410)
                      ..++|.+.+.||.|+||.||++.+..+++.+|+|++...          ......+.+|+.+++++ +||||+++++++.
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~----------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   73 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII----------EDEEEEIKEEYNILRKYSNHPNIATFYGAFI   73 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC----------chhHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence            347899999999999999999999989999999987643          12345788999999999 7999999999987


Q ss_pred             cCC----CCEEEEEEeecCCCCcccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEE
Q 015257          195 DPN----SDHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVK  266 (410)
Q Consensus       195 ~~~----~~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~k  266 (410)
                      +..    ...+++||||++++++.+.+..    ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~  153 (275)
T cd06608          74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVK  153 (275)
T ss_pred             ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEE
Confidence            632    4578999999999988876643    35789999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCccccccCCCcccccccccccCC----cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q 015257          267 IGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL----TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN  342 (410)
Q Consensus       267 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~  342 (410)
                      |+|||++..............|++.|+|||++...    ...+.++||||||+++|+|++|..||...........+...
T Consensus       154 l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  233 (275)
T cd06608         154 LVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN  233 (275)
T ss_pred             ECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc
Confidence            99999987654443344456689999999987542    22355799999999999999999999876555555555443


Q ss_pred             CC---CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          343 SL---VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       343 ~~---~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      ..   ..+..++.++.+||.+||..||.+|||+.++++|||+
T Consensus       234 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         234 PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            22   2233477899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6.7e-44  Score=336.14  Aligned_cols=252  Identities=29%  Similarity=0.460  Sum_probs=203.4

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEEEcCCC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDPNS  198 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~  198 (410)
                      |.+++.||+|+||.||++.+..+++.||+|++.....       .... ....+|+.++.++. ||||+++++++.+...
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-------~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   72 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-------SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKT   72 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-------Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCC
Confidence            6789999999999999999999999999998764321       1111 23457888888885 9999999999987544


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      +.+++||||++++.+.........+++..++.++.||+.||+|||+.|++||||+|+||+++. +.+||+|||+++....
T Consensus        73 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          73 GRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             CcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            689999999987544443333457899999999999999999999999999999999999999 9999999999986543


Q ss_pred             CccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------------
Q 015257          279 DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN----------------  342 (410)
Q Consensus       279 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~----------------  342 (410)
                      .. ......+++.|+|||++......+.++|||||||++|+|++|..||.+.+..+....+...                
T Consensus       152 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         152 KP-PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             CC-CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence            32 2234567899999998765555567899999999999999999999887655544333220                


Q ss_pred             --CCCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          343 --SLVFP-----------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       343 --~~~~p-----------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                        ...+|           ..++.++.+||.+||.+||.+|||++++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence              11111           2467899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1e-43  Score=339.65  Aligned_cols=258  Identities=32%  Similarity=0.580  Sum_probs=218.7

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||+|+||.||++.+..+++.||+|.+......      .......+.+|+.+++.++||||+++++.+..  
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--   72 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI------LRNQIQQVFVERDILTFAENPFVVSMFCSFET--   72 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhh------hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--
Confidence            3689999999999999999999999999999987654211      12344578899999999999999999999876  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+++||||++|+++..++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++...
T Consensus        73 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~  152 (305)
T cd05609          73 KRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL  152 (305)
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence            45899999999999999988877889999999999999999999999999999999999999999999999999986421


Q ss_pred             CCc---------------cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q 015257          278 DDN---------------DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN  342 (410)
Q Consensus       278 ~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~  342 (410)
                      ...               .......|+..|+|||.+..... +.++|||||||++|+|++|..||.+....+....+...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~  231 (305)
T cd05609         153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD  231 (305)
T ss_pred             cCccccccccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            100               01112457889999998876555 66799999999999999999999988877777777666


Q ss_pred             CCCCCC---CCCHHHHHHHHHhcccCCCCCCC---HHHHhhCCcccCC
Q 015257          343 SLVFPD---AMNPELRNLLEGLLCKDPTRRLT---LNDVAKHTWVLGD  384 (410)
Q Consensus       343 ~~~~p~---~~~~~l~~li~~~L~~dp~~Rpt---~~ell~h~~~~~~  384 (410)
                      ....|.   .++.++.++|.+||+.||.+||+   +.++++||||...
T Consensus       232 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         232 DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             ccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence            544443   57899999999999999999997   7999999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.9e-44  Score=343.24  Aligned_cols=248  Identities=28%  Similarity=0.441  Sum_probs=191.6

Q ss_pred             eeeecccCceEEEEEEEcc--CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCE
Q 015257          123 VRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH  200 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  200 (410)
                      ..+||+|+||.||+++...  ++..||+|.+....           ....+.+|+.+++.++||||+++++++.......
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   74 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----------ISMSACREIALLRELKHPNVIALQKVFLSHSDRK   74 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCe
Confidence            3679999999999999654  66899999875431           1235778999999999999999999987655678


Q ss_pred             EEEEEeecCCCCccccc--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEE----cCCCcEEEe
Q 015257          201 FYMVLEYVEGKWDNDGF--------GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV----APSGTVKIG  268 (410)
Q Consensus       201 ~~lv~e~~~~~~l~~~~--------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll----~~~~~~kl~  268 (410)
                      +++||||++++.+....        .....+++..++.++.||+.||.|||+.||+||||||+|||+    +.++.+||+
T Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~  154 (317)
T cd07867          75 VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA  154 (317)
T ss_pred             EEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEe
Confidence            99999999875332211        122358999999999999999999999999999999999999    456789999


Q ss_pred             eccccccccCCcc---ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHH
Q 015257          269 DFSVSQVFEDDND---VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ---------DTY  336 (410)
Q Consensus       269 DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~---------~~~  336 (410)
                      |||+++.......   ......||+.|+|||++.+....+.++|||||||++|+|+||.+||......         ...
T Consensus       155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~  234 (317)
T cd07867         155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL  234 (317)
T ss_pred             eccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHH
Confidence            9999986543221   2234568999999999877555577899999999999999999999643210         011


Q ss_pred             HHHHh----------------------------CCC----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          337 DKIVN----------------------------NSL----------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       337 ~~i~~----------------------------~~~----------~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..+..                            ...          ......+..+.+||.+||+.||.+|||+.|+|+|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             HHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence            11100                            000          0011235678899999999999999999999999


Q ss_pred             Ccc
Q 015257          379 TWV  381 (410)
Q Consensus       379 ~~~  381 (410)
                      |||
T Consensus       315 p~f  317 (317)
T cd07867         315 PYF  317 (317)
T ss_pred             CCC
Confidence            998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5e-44  Score=336.85  Aligned_cols=257  Identities=25%  Similarity=0.425  Sum_probs=218.0

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      .|..++.||.|+||.||++.+..++..||||++....        .......+.+|+.+++.+.||||+++++++.+  .
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~   74 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--G   74 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--------cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--C
Confidence            5778899999999999999999999999999876431        23455688999999999999999999999986  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ..+++||||++++++.+++.. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 ~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06640          75 TKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             CEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence            689999999999999887764 5689999999999999999999999999999999999999999999999999976654


Q ss_pred             CccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 015257          279 DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNL  357 (410)
Q Consensus       279 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~l~~l  357 (410)
                      .........++..|+|||++.+... +.++|+|||||++|+|++|..||...........+... ...++..++..+.++
T Consensus       154 ~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  232 (277)
T cd06640         154 TQIKRNTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEF  232 (277)
T ss_pred             CccccccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHH
Confidence            3333334568889999998876554 66799999999999999999999877655554444333 223455678899999


Q ss_pred             HHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          358 LEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       358 i~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                      +.+||+.+|.+||++.+++.|+||......
T Consensus       233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06640         233 IDACLNKDPSFRPTAKELLKHKFIVKNAKK  262 (277)
T ss_pred             HHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence            999999999999999999999999876555

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1e-43  Score=337.05  Aligned_cols=254  Identities=27%  Similarity=0.437  Sum_probs=202.6

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||+|+||.||++.+..+|+.||+|++.....        ......+.+|+.+++.++|+||+++++++.+  
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--   74 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--------EGVPFTAIREASLLKGLKHANIVLLHDIIHT--   74 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--------CCCcHHHHHHHHHHHhcCCCCEeEEEEEEec--
Confidence            579999999999999999999999999999999854321        1122356789999999999999999999876  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ....++||||+.+..+.........+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||+++...
T Consensus        75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          75 KETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             CCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence            45899999999865555444445678899999999999999999999999999999999999999999999999997654


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhC--------------
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ-DTYDKIVNN--------------  342 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~i~~~--------------  342 (410)
                      ..........+++.|+|||++.+....+.++|||||||++|+|++|..||...... +....+...              
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            33333344557899999998876543466799999999999999999999764422 222211110              


Q ss_pred             C---------CCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          343 S---------LVFP---------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       343 ~---------~~~p---------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      .         ...+         ...++.+.+++.+||..||++|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            0         0000         0135688999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-45  Score=342.42  Aligned_cols=258  Identities=29%  Similarity=0.457  Sum_probs=228.1

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .+.|..-+.||+||||.||-++.+.+|+.||.|.+.+..+++      .....-.++|-.||.+++.+.||.+--+|+. 
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk------r~ge~maLnEk~iL~kV~s~FiVslaYAfeT-  256 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK------RKGETMALNEKQILEKVSSPFIVSLAYAFET-  256 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH------hhhhHHhhHHHHHHHHhccCcEEEEeeeecC-
Confidence            456888999999999999999999999999999998776543      2233457899999999999999999888876 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                       .+.+++||..|+||.|.-++.+.+  .+++..++.|+.+|+-||++||..+||+|||||+|||+|+.|++.|+|+|+|.
T Consensus       257 -kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAv  335 (591)
T KOG0986|consen  257 -KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAV  335 (591)
T ss_pred             -CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEE
Confidence             568999999999999999988765  89999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCCCCC
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET----LQDTYDKIVNNSLVFPDAM  350 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~  350 (410)
                      .+..+.....+ .||.+|||||++.+..| +.+.|.|||||+||||+.|+.||....    ..+.-+.+......+|+.+
T Consensus       336 ei~~g~~~~~r-vGT~GYMAPEvl~ne~Y-~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kF  413 (591)
T KOG0986|consen  336 EIPEGKPIRGR-VGTVGYMAPEVLQNEVY-DFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKF  413 (591)
T ss_pred             ecCCCCccccc-cCcccccCHHHHcCCcc-cCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccccc
Confidence            88776655444 89999999999998885 777999999999999999999996532    2345566777778899999


Q ss_pred             CHHHHHHHHHhcccCCCCCC-----CHHHHhhCCcccCC
Q 015257          351 NPELRNLLEGLLCKDPTRRL-----TLNDVAKHTWVLGD  384 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~  384 (410)
                      |+++++|...+|++||.+|+     ++.++-+||||++-
T Consensus       414 S~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l  452 (591)
T KOG0986|consen  414 SEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL  452 (591)
T ss_pred             CHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence            99999999999999999998     67899999999873

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=360.52  Aligned_cols=249  Identities=29%  Similarity=0.435  Sum_probs=219.9

Q ss_pred             eecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEEE
Q 015257          125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMV  204 (410)
Q Consensus       125 ~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv  204 (410)
                      +||+|.||+||.+++..+...+|||.+...         .....+-+.+||.+.+.|+|.|||+++|.+.+  ++++-|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---------dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIF  650 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---------DSREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIF  650 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc---------cchhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEE
Confidence            699999999999999999999999987533         33455678999999999999999999999865  5699999


Q ss_pred             EeecCCCCcccccCCC-CCC--CHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEc-CCCcEEEeeccccccccCCc
Q 015257          205 LEYVEGKWDNDGFGQP-GAI--GESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA-PSGTVKIGDFSVSQVFEDDN  280 (410)
Q Consensus       205 ~e~~~~~~l~~~~~~~-~~l--~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~  280 (410)
                      ||-++||+|..++... +++  .|.++-.|..||++||.|||++.|+|||||-+|||++ ..|.+||+|||-++.+..-+
T Consensus       651 MEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin  730 (1226)
T KOG4279|consen  651 MEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN  730 (1226)
T ss_pred             eecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence            9999999999988765 566  8899999999999999999999999999999999996 46899999999999988888


Q ss_pred             cccccCCCccccccccccc-CCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhCCCCCCCCCCHHHHH
Q 015257          281 DVLRRSPGTPVFTAPECCL-GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTY---DKIVNNSLVFPDAMNPELRN  356 (410)
Q Consensus       281 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~---~~i~~~~~~~p~~~~~~l~~  356 (410)
                      ....++.||..|||||++. +...+++++|||||||++.||.||++||......+..   -.+.+..+++|..++.++++
T Consensus       731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~  810 (1226)
T KOG4279|consen  731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKN  810 (1226)
T ss_pred             ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHH
Confidence            8889999999999999985 4456689999999999999999999999775444322   22344566789999999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          357 LLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       357 li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      +|.+|+.+||.+||++.++|..||++..
T Consensus       811 FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  811 FILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHHHHcCCCcccCccHHHhccCcccccC
Confidence            9999999999999999999999999977

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9.8e-44  Score=332.31  Aligned_cols=256  Identities=26%  Similarity=0.455  Sum_probs=213.0

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|++.+.||.|+||.||++... +|+.+|||.+......   ..........+.+|+.+++.++|+||+++++++.+  .
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~---~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSN---VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--D   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccc---hhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--C
Confidence            4788899999999999999764 7889999987643211   11123445678999999999999999999999986  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ..+++||||++++.|.+.+.....+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++.++|+|||++.....
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            68999999999999999887777899999999999999999999999999999999999999999999999999875421


Q ss_pred             C------ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCCC
Q 015257          279 D------NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDA  349 (410)
Q Consensus       279 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~  349 (410)
                      .      ........|++.|+|||++.+..+ +.++||||||+++|+|++|..||...........+...   ...++..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDS  233 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCC
Confidence            1      112234568999999998876655 56799999999999999999999876544433333322   2246677


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      ++.++.++|.+||+.+|.+|||+.+++.||||
T Consensus       234 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         234 FSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            89999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.4e-44  Score=333.36  Aligned_cols=253  Identities=29%  Similarity=0.517  Sum_probs=218.0

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|++.+.||.|+||.||++.+..+++.||+|++.+....      .....+.+.+|+.++++++||||+++++++.+  .
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~   72 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV------EKGSVRNVLNERRILQELNHPFLVNLWYSFQD--E   72 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc------chhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--C
Confidence            488999999999999999999999999999998754221      22456789999999999999999999999876  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ..+++||||+.|++|...+.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        73 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~  152 (258)
T cd05578          73 ENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP  152 (258)
T ss_pred             CeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence            68999999999999998887777899999999999999999999999999999999999999999999999999876544


Q ss_pred             CccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCCCCCHHHH
Q 015257          279 DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL---QDTYDKIVNNSLVFPDAMNPELR  355 (410)
Q Consensus       279 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p~~~~~~l~  355 (410)
                      .. ......|+..|+|||++.+... +.++|+||||+++|+|++|..||.....   .............+|..++.++.
T Consensus       153 ~~-~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (258)
T cd05578         153 DT-LTTSTSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAI  230 (258)
T ss_pred             Cc-cccccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHH
Confidence            32 2334568889999998876654 6679999999999999999999987663   33333333355567788999999


Q ss_pred             HHHHHhcccCCCCCCCH--HHHhhCCcc
Q 015257          356 NLLEGLLCKDPTRRLTL--NDVAKHTWV  381 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt~--~ell~h~~~  381 (410)
                      ++|.+||..||.+||++  +++++||||
T Consensus       231 ~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         231 DAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            99999999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.8e-44  Score=339.04  Aligned_cols=257  Identities=30%  Similarity=0.436  Sum_probs=210.9

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+.+.||.|+||.||++.+..+++.+|+|.+......       ......+.+|+.++++++||||+++++++...
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   76 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-------EGFPITSLREINILLKLQHPNIVTVKEVVVGS   76 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEec
Confidence            35799999999999999999999999999999998644211       22234567899999999999999999998875


Q ss_pred             CCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      .....++||||+++ .+...+.. ...+++..++.++.||+.||+|||+.|++|+||||+|||++.++.++|+|||++..
T Consensus        77 ~~~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~  155 (293)
T cd07843          77 NLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLARE  155 (293)
T ss_pred             CCCcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceee
Confidence            44789999999986 55555443 34689999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN-------------  342 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~-------------  342 (410)
                      ............+++.|+|||.+.+....+.++||||||+++|+|++|..||......+...++...             
T Consensus       156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         156 YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             ccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence            6554333344567889999998876554467799999999999999999999877655544433221             


Q ss_pred             ------------------CCCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          343 ------------------SLVFPDA-MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       343 ------------------~~~~p~~-~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                                        ...++.. +++.+.+||.+||+.||++|||+.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                              0112333 68889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-44  Score=336.10  Aligned_cols=255  Identities=31%  Similarity=0.524  Sum_probs=213.6

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|++.+.||+|+||.||++.+..+++.||||++.....       .......+.+|+.+++.++|+||+++++++.+  
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--   71 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-------DEDVKKTALREVKVLRQLRHENIVNLKEAFRR--   71 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-------cccchhHHHHHHHHHHhcCCCCeeehhheEEE--
Confidence            369999999999999999999999999999998864321       23344678999999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ....++||||++++.+.........+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||++....
T Consensus        72 ~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~  151 (288)
T cd07833          72 KGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALR  151 (288)
T ss_pred             CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence            46899999999998877766666779999999999999999999999999999999999999999999999999998765


Q ss_pred             CCcc-ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Q 015257          278 DDND-VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------------  342 (410)
Q Consensus       278 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--------------  342 (410)
                      .... ......++..|+|||++.+....+.++||||||+++|+|++|..||.+....+....+...              
T Consensus       152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence            4432 3345668899999999887744577899999999999999999999876554433222110              


Q ss_pred             -----C-------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          343 -----S-------------LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       343 -----~-------------~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                           .             ..++..+++++.+||.+||..+|.+|||++++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                 0             01233458899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.1e-43  Score=331.45  Aligned_cols=249  Identities=30%  Similarity=0.558  Sum_probs=215.5

Q ss_pred             ecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEEEE
Q 015257          126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVL  205 (410)
Q Consensus       126 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~  205 (410)
                      ||.|+||.||++++..+++.||+|++.+....      .....+.+.+|+.+++.++||||+++++++.+  ...+++||
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~   72 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV------ETGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLM   72 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcch------hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEE
Confidence            79999999999999989999999998754321      23345679999999999999999999999876  45799999


Q ss_pred             eecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCcccccc
Q 015257          206 EYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR  285 (410)
Q Consensus       206 e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  285 (410)
                      ||+++++|.+.+.+...+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||+++...... ....
T Consensus        73 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~  151 (262)
T cd05572          73 EYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWT  151 (262)
T ss_pred             ecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccc
Confidence            999999999988877789999999999999999999999999999999999999999999999999998765432 2234


Q ss_pred             CCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHH--hCCCCCCCCCCHHHHHHHHHh
Q 015257          286 SPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET--LQDTYDKIV--NNSLVFPDAMNPELRNLLEGL  361 (410)
Q Consensus       286 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~--~~~~~~~i~--~~~~~~p~~~~~~l~~li~~~  361 (410)
                      ..|++.|+|||.+.+... +.++|+||||+++|+|++|..||....  .......+.  .....+|...++++.++|.+|
T Consensus       152 ~~~~~~~~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  230 (262)
T cd05572         152 FCGTPEYVAPEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQL  230 (262)
T ss_pred             ccCCcCccChhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHH
Confidence            568999999998776554 567999999999999999999998766  555666666  345667778899999999999


Q ss_pred             cccCCCCCCC-----HHHHhhCCcccCC
Q 015257          362 LCKDPTRRLT-----LNDVAKHTWVLGD  384 (410)
Q Consensus       362 L~~dp~~Rpt-----~~ell~h~~~~~~  384 (410)
                      |+.||.+||+     +.|+++||||.+.
T Consensus       231 l~~~p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         231 LRRNPEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             ccCChhhCcCCcccCHHHHhcChhhhCC
Confidence            9999999999     9999999999753

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-43  Score=336.46  Aligned_cols=254  Identities=29%  Similarity=0.477  Sum_probs=202.1

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+.+.||+|++|.||++.+..+++.||||.+......        .....+.+|+.+++.++||||+++++++.+ 
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   74 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--------GAPFTAIREASLLKDLKHANIVTLHDIIHT-   74 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--------CCchhHHHHHHHHhhCCCcceeeEEEEEec-
Confidence            36799999999999999999999989999999998643211        112346689999999999999999999986 


Q ss_pred             CCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                       ....++||||+++ .+...+.. ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.
T Consensus        75 -~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  152 (291)
T cd07844          75 -KKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARA  152 (291)
T ss_pred             -CCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccc
Confidence             4689999999986 55555443 45789999999999999999999999999999999999999999999999999875


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCC-----------
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKIVNNS-----------  343 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~i~~~~-----------  343 (410)
                      ............+++.|+|||++.+....+.++||||||+++|+|++|..||.... ..+....+....           
T Consensus       153 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07844         153 KSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV  232 (291)
T ss_pred             cCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhh
Confidence            43222222233468889999988765444677999999999999999999997654 222222221100           


Q ss_pred             --------CCC-----------CCCCC--HHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          344 --------LVF-----------PDAMN--PELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       344 --------~~~-----------p~~~~--~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                              ..+           ...++  .++.+++.+||+.+|.+|||+.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                    000           01233  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.3e-43  Score=331.05  Aligned_cols=254  Identities=27%  Similarity=0.446  Sum_probs=214.6

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+.+.||.|+||.||++....++..+|+|++....        .......+.+|+.+++.++|+||+++++.+..  
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--   70 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK--------CQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV--   70 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCC--------cchHHHHHHHHHHHHHhcCCCCEEEEEEEEee--
Confidence            36899999999999999999998899999999875432        12255678999999999999999999998876  


Q ss_pred             CCEEEEEEeecCCCCcccccCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQP---GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~---~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      ...+++|||+++++++.+.+...   ..+++..++.++.||+.||+|||++||+||||+|+||+++.++.++|+|||++.
T Consensus        71 ~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~  150 (267)
T cd06610          71 GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSA  150 (267)
T ss_pred             CCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHH
Confidence            45899999999999988887553   468999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCccc----cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCC--
Q 015257          275 VFEDDNDV----LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFP--  347 (410)
Q Consensus       275 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p--  347 (410)
                      ........    .....|++.|+|||++......+.++|+|||||++|+|++|..||................. .++  
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  230 (267)
T cd06610         151 SLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETG  230 (267)
T ss_pred             HhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCc
Confidence            66543322    23446899999999987664446789999999999999999999987766555555544322 122  


Q ss_pred             ---CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          348 ---DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       348 ---~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                         ..+++.+.+++.+||+.||.+|||+.+|++||||
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence               2567899999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.3e-43  Score=333.10  Aligned_cols=254  Identities=27%  Similarity=0.500  Sum_probs=210.4

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|.+.+.||.|+||.||++.+..+|+.||+|++.....       .......+.+|+.+++.++||||+++++++.+  .
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~   71 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-------EGGIPNQALREIKALQACQHPYVVKLLDVFPH--G   71 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-------cchhhHHHHHHHHHHHhCCCCCCcceeeEEec--C
Confidence            48899999999999999999999999999999865421       12334678899999999999999999999986  4


Q ss_pred             CEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ..+++||||+ ++++...+.. ...+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus        72 ~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~  150 (286)
T cd07832          72 SGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFS  150 (286)
T ss_pred             CeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence            6899999999 8888776643 4579999999999999999999999999999999999999999999999999998654


Q ss_pred             CCc-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Q 015257          278 DDN-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------------  342 (410)
Q Consensus       278 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--------------  342 (410)
                      ... .......|+..|+|||++.+....+.++||||||+++|+|++|.+||.+......+..+...              
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence            432 12334568999999998876555577899999999999999999888776654444333321              


Q ss_pred             -----CCCC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCccc
Q 015257          343 -----SLVF-----------PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL  382 (410)
Q Consensus       343 -----~~~~-----------p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~  382 (410)
                           ...+           ....+..+.+||.+||..||.+|||+++++.||||.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                 0011           124568899999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.1e-43  Score=329.61  Aligned_cols=250  Identities=27%  Similarity=0.433  Sum_probs=213.5

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+.+.||+|+||.||++....+++.||+|.+...           ...+.+.+|+.+++.++||||+++++.+.+  
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-----------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--   69 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-----------EDLQEIIKEISILKQCDSPYIVKYYGSYFK--   69 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-----------HHHHHHHHHHHHHHhCCCCcEeeeeeeeec--
Confidence            5799999999999999999999988999999987532           125689999999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ...+++++||++++++.+.+.. ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus        70 ~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~  149 (256)
T cd06612          70 NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL  149 (256)
T ss_pred             CCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhc
Confidence            4689999999999999888754 457899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCCCCCHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDAMNPE  353 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~~~~  353 (410)
                      ...........|+..|+|||++.+... +.++||||||+++|+|++|..||...........+...   ....+..++.+
T Consensus       150 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (256)
T cd06612         150 TDTMAKRNTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPE  228 (256)
T ss_pred             ccCccccccccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHH
Confidence            544333344568899999998877655 66799999999999999999999876555444333222   12334567889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      +.++|.+||+.||.+|||+.++++||||
T Consensus       229 ~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         229 FNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.1e-43  Score=333.81  Aligned_cols=257  Identities=27%  Similarity=0.408  Sum_probs=210.1

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVI  193 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  193 (410)
                      ...++|.+++.||+|+||.||++++..+++.+|+|++...          ......+.+|+.+++.+ +||||+++++++
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~----------~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   84 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI----------HDIDEEIEAEYNILKALSDHPNVVKFYGMY   84 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc----------cchHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence            3457899999999999999999999999999999986532          11224677899999999 699999999987


Q ss_pred             Ec---CCCCEEEEEEeecCCCCccccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEE
Q 015257          194 DD---PNSDHFYMVLEYVEGKWDNDGF----GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVK  266 (410)
Q Consensus       194 ~~---~~~~~~~lv~e~~~~~~l~~~~----~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~k  266 (410)
                      ..   ..+..+++||||+++++|.+.+    .....+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEE
Confidence            53   2346799999999999887654    2345789999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCccccccCCCcccccccccccCC----cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q 015257          267 IGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL----TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN  342 (410)
Q Consensus       267 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~  342 (410)
                      |+|||+++.............|++.|+|||++...    ...+.++|||||||++|+|++|..||...........+...
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~  244 (286)
T cd06638         165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN  244 (286)
T ss_pred             EccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence            99999998654433333445689999999987532    22366799999999999999999999876554443333222


Q ss_pred             C---CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          343 S---LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       343 ~---~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      .   ...|..++.++.+||.+||+.||.+|||+.++++|+||
T Consensus       245 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            1   12345578899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2e-43  Score=337.43  Aligned_cols=260  Identities=26%  Similarity=0.437  Sum_probs=204.6

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+++.||+|+||.||++++..+++.||||.+.....       .......+.+|+.++++++||||+++++++.
T Consensus         9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   81 (310)
T cd07865           9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-------KEGFPITALREIKILQLLKHENVVNLIEICR   81 (310)
T ss_pred             chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-------cCCchhHHHHHHHHHHhCCCCCccceEEEEe
Confidence            345689999999999999999999999999999998754321       1122234668999999999999999999887


Q ss_pred             cCC------CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEe
Q 015257          195 DPN------SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIG  268 (410)
Q Consensus       195 ~~~------~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~  268 (410)
                      ...      ....++||||+++............+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~  161 (310)
T cd07865          82 TKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLA  161 (310)
T ss_pred             cccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEEC
Confidence            532      24679999999875433333334478999999999999999999999999999999999999999999999


Q ss_pred             eccccccccCCcc----ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--C
Q 015257          269 DFSVSQVFEDDND----VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--N  342 (410)
Q Consensus       269 DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~--~  342 (410)
                      |||++........    ......++..|+|||++.+....+.++||||||+++|+|++|..||.+.........+..  +
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T cd07865         162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG  241 (310)
T ss_pred             cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999976543221    122345788899999886655446779999999999999999999987665443322221  0


Q ss_pred             C-----------------CCCCC-------------CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          343 S-----------------LVFPD-------------AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       343 ~-----------------~~~p~-------------~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      .                 ..+|.             ..++.+.+||.+||..||.+|||++++++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            0                 01111             235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.9e-43  Score=327.07  Aligned_cols=256  Identities=30%  Similarity=0.459  Sum_probs=216.3

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|+..+.||+|+||.||++....+++.||+|.+......    ....+....+.+|+.+++.++||||+++++++.+  .
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~   74 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDG----QTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--E   74 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccc----ccchHHHHHHHHHHHHHHhcCCCCchheeeeEec--C
Confidence            367788999999999999999989999999998643211    1134456789999999999999999999999876  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ..+++||||++++++..++.....+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++.....
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          75 DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             CeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            58999999999999998887777799999999999999999999999999999999999999999999999999876543


Q ss_pred             CccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHH
Q 015257          279 DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFPDAMNPELRN  356 (410)
Q Consensus       279 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~l~~  356 (410)
                      .. ......|++.|+|||.+......+.++|+||||+++|+|++|..||...........+..  ....+|..+++.+.+
T Consensus       155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (258)
T cd06632         155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD  233 (258)
T ss_pred             cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHH
Confidence            33 234566899999999886655346779999999999999999999977654444434333  223466788999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          357 LLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       357 li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      ++.+||+.+|.+|||+.+++.|||+
T Consensus       234 li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         234 FILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHHhhcCcccCcCHHHHhcCCCC
Confidence            9999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=354.98  Aligned_cols=271  Identities=26%  Similarity=0.394  Sum_probs=224.5

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      -|.-++.||.|+||.||.|++..+.+.||||.+...+.      .+.+....+..|+.+|+++.|||+|.+.++|..  .
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK------Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr--e   98 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK------QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR--E   98 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeecccccc------ccHHHHHHHHHHHHHHHhccCCCcccccceeec--c
Confidence            36778999999999999999999999999999876542      245677789999999999999999999999986  3


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ...++|||||-|.--+-+-....++-+..+..|..+.+.||+|||+.+.||||||..|||++..|.|||+|||.|.....
T Consensus        99 ~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P  178 (948)
T KOG0577|consen   99 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP  178 (948)
T ss_pred             chHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence            47899999998753322223356799999999999999999999999999999999999999999999999999976543


Q ss_pred             CccccccCCCcccccccccccC--CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCC-CCCCHHH
Q 015257          279 DNDVLRRSPGTPVFTAPECCLG--LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFP-DAMNPEL  354 (410)
Q Consensus       279 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p-~~~~~~l  354 (410)
                          ...++|||.|||||++..  ...++-++||||||++..||.-.++|+...+....+..|..+.. ..+ ...+..+
T Consensus       179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F  254 (948)
T KOG0577|consen  179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYF  254 (948)
T ss_pred             ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHH
Confidence                456889999999999752  23334569999999999999999999888777776666666543 333 3678899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhhCCcccCC-CCCCchhhhhhhccccc
Q 015257          355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGD-NGPIPQYLCWCKRDRLR  401 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~ell~h~~~~~~-~~~~~~~~~~~~~~~~~  401 (410)
                      .+|+..||++-|.+|||.+++|+|+|+... +..+--.|-+++++++.
T Consensus       255 ~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~dLIqRTKdaVr  302 (948)
T KOG0577|consen  255 RNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVIMDLIQRTKDAVR  302 (948)
T ss_pred             HHHHHHHHhhCcccCCcHHHHhhcchhccCCCchHHHHHHHHHHHHHH
Confidence            999999999999999999999999999865 33444555566555543

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=8.3e-44  Score=338.30  Aligned_cols=257  Identities=26%  Similarity=0.453  Sum_probs=214.0

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      +.|.....||+|+||.||++.+..++..||||.+...         .....+.+.+|+.+++.++||||+++++.+..  
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--   90 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---------KQQRRELLFNEVVIMRDYHHENVVDMYNSYLV--   90 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---------hHHHHHHHHHHHHHHHhCCCCcHHHHHHheec--
Confidence            3455567899999999999999999999999987532         23345678899999999999999999998876  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ....++||||++++++..++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus        91 ~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (292)
T cd06658          91 GDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS  169 (292)
T ss_pred             CCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence            4589999999999998887644 468999999999999999999999999999999999999999999999999987654


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCCCCCHHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDAMNPEL  354 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~~~~l  354 (410)
                      ..........|++.|+|||.+.+... +.++||||||+++|+|++|..||...........+...   ....+..++..+
T Consensus       170 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (292)
T cd06658         170 KEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVL  248 (292)
T ss_pred             cccccCceeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHH
Confidence            43333344568999999998876555 56799999999999999999999877665554444332   122233578899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                      .+++.+||..||.+|||++++++||||.....|
T Consensus       249 ~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         249 RGFLDLMLVREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             HHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence            999999999999999999999999999865443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.8e-44  Score=332.51  Aligned_cols=258  Identities=25%  Similarity=0.471  Sum_probs=212.6

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|+..+.||+|+||.||++++..+++.||+|++.......   .........+.+|+.+++.++||||+++++++.+  .
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS---SEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--D   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCc---hhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--C
Confidence            3778899999999999999999999999999986432110   1122356789999999999999999999999976  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC-cEEEeecccccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSVSQVFE  277 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~-~~kl~DfG~a~~~~  277 (410)
                      ..+++||||+++++|.+.+...+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||.+....
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            58999999999999998887777899999999999999999999999999999999999998776 59999999987654


Q ss_pred             CCcc----ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----hCCCCCCC
Q 015257          278 DDND----VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV-----NNSLVFPD  348 (410)
Q Consensus       278 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~-----~~~~~~p~  348 (410)
                      ....    ......||..|+|||.+.+..+ +.++||||||+++|+|++|..||...........+.     .....+|.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE  234 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCch
Confidence            3211    1123457889999998876554 567999999999999999999997544332222221     12344667


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCccc
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL  382 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~  382 (410)
                      .+++++.+++.+||..+|.+|||+.++++||||+
T Consensus       235 ~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         235 HLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             hhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            7899999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.7e-43  Score=333.90  Aligned_cols=250  Identities=29%  Similarity=0.450  Sum_probs=202.4

Q ss_pred             eecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHH---HHhCCCCCcccceeEEEcCCCCEE
Q 015257          125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI---MKMLQHPNIVNLIEVIDDPNSDHF  201 (410)
Q Consensus       125 ~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~---l~~l~hpniv~l~~~~~~~~~~~~  201 (410)
                      .||+|+||.||++.+..+++.||+|.+.+.....      ......+.+|..+   +...+||||+.+++++..  .+..
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~   72 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM------KQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKL   72 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEcccccc------chHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeE
Confidence            4899999999999999999999999986543211      1111223444443   344579999999999876  4579


Q ss_pred             EEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCcc
Q 015257          202 YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND  281 (410)
Q Consensus       202 ~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  281 (410)
                      ++||||+++++|...+...+.+++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++....... 
T Consensus        73 ~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-  151 (279)
T cd05633          73 CFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-  151 (279)
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence            9999999999998888777789999999999999999999999999999999999999999999999999987543322 


Q ss_pred             ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCCCCCHHHHHHH
Q 015257          282 VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL---QDTYDKIVNNSLVFPDAMNPELRNLL  358 (410)
Q Consensus       282 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p~~~~~~l~~li  358 (410)
                       .....||+.|+|||.+.+....+.++|||||||++|+|++|..||.....   .............+|..+++++.++|
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  230 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLL  230 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHH
Confidence             23456899999999886544446779999999999999999999965322   22222223334456778999999999


Q ss_pred             HHhcccCCCCCC-----CHHHHhhCCcccCC
Q 015257          359 EGLLCKDPTRRL-----TLNDVAKHTWVLGD  384 (410)
Q Consensus       359 ~~~L~~dp~~Rp-----t~~ell~h~~~~~~  384 (410)
                      .+||..||++||     |+.++++||||++.
T Consensus       231 ~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~  261 (279)
T cd05633         231 EGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI  261 (279)
T ss_pred             HHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence            999999999999     69999999999884

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.5e-43  Score=327.65  Aligned_cols=249  Identities=26%  Similarity=0.512  Sum_probs=214.5

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|.+.+.||.|+||.||++.+..+++.||+|.+....        .....+.+.+|+.+++.++||||+++++.+.+  .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~   70 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--------SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--D   70 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--------chHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--C
Confidence            4889999999999999999999999999999875331        22345678899999999999999999999976  4


Q ss_pred             CEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ..+++||||++++.+...+..  ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+...
T Consensus        71 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  150 (255)
T cd08219          71 GHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL  150 (255)
T ss_pred             CEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceee
Confidence            689999999999888776543  346899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFPDAMNPELR  355 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~l~  355 (410)
                      ...........|++.|+|||++.+... +.++|+||||+++|+|++|..||...+.......+..+.. ..|..++..+.
T Consensus       151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (255)
T cd08219         151 TSPGAYACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELR  229 (255)
T ss_pred             cccccccccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHH
Confidence            554444445678999999998876654 6679999999999999999999998877777666666544 46677899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhhC
Q 015257          356 NLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +||.+||+.||.+|||+.+++.-
T Consensus       230 ~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         230 SLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHhCCcccCCCHHHHhhc
Confidence            99999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.7e-43  Score=326.23  Aligned_cols=252  Identities=27%  Similarity=0.491  Sum_probs=215.7

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|++++.||+|+||.||++.+..+++.+|||.+.....       .......+.+|+.+++.++||||+++++.+..  .
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~   71 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-------TKDERLAAQNECQVLKLLSHPNIIEYYENFLE--D   71 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-------ccHHHHHHHHHHHHHhhCCCCchhheeeeEec--C
Confidence            48899999999999999999999999999999865422       23445688999999999999999999998875  4


Q ss_pred             CEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC-cEEEeecccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSVSQV  275 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~-~~kl~DfG~a~~  275 (410)
                      ..+++||||++++++.+.+...  ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++ .++|+|||++..
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~  151 (256)
T cd08220          72 KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI  151 (256)
T ss_pred             CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCcee
Confidence            6899999999999988887653  3589999999999999999999999999999999999998654 689999999986


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHH
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS-LVFPDAMNPEL  354 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~l  354 (410)
                      ..... ......|++.|+|||.+.+... +.++||||||+++|+|++|..||...+.......+.... ..++..+++++
T Consensus       152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  229 (256)
T cd08220         152 LSSKS-KAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDL  229 (256)
T ss_pred             cCCCc-cccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHH
Confidence            64432 2234568899999998876554 567999999999999999999998887776666665543 34667789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          355 RNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      .+++.+||..||.+|||+.+++.||||
T Consensus       230 ~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         230 RQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2e-43  Score=335.45  Aligned_cols=257  Identities=28%  Similarity=0.410  Sum_probs=205.2

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEEEcC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDP  196 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~  196 (410)
                      ++|.+.+.||+|+||.||++.+..+|+.||||.+.....       .......+.+|+.+++.+. ||||+++++++...
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-------~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   73 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-------EEGIPPTALREISLLQMLSESIYIVRLLDVEHVE   73 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-------ccCCchHHHHHHHHHHHccCCCCccceeeeEeec
Confidence            368999999999999999999999999999998754321       1123346788999999995 69999999988753


Q ss_pred             C---CCEEEEEEeecCCCCcccccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC-CCcEEE
Q 015257          197 N---SDHFYMVLEYVEGKWDNDGFGQ-----PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKI  267 (410)
Q Consensus       197 ~---~~~~~lv~e~~~~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~-~~~~kl  267 (410)
                      .   ....|+||||+++. +...+..     ...+++..++.++.||+.||.|||++||+||||+|+||+++. ++.+||
T Consensus        74 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl  152 (295)
T cd07837          74 EKNGKPSLYLVFEYLDSD-LKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKI  152 (295)
T ss_pred             CCCCCceEEEEeeccCcC-HHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEE
Confidence            2   12489999999974 4444322     245899999999999999999999999999999999999998 889999


Q ss_pred             eeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---
Q 015257          268 GDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL---  344 (410)
Q Consensus       268 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---  344 (410)
                      +|||+++.............+++.|+|||++.+....+.++||||||+++|+|++|..||.+.+.......+.....   
T Consensus       153 ~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  232 (295)
T cd07837         153 ADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT  232 (295)
T ss_pred             eecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99999986543333333445788999999887655456789999999999999999999988765554443332100   


Q ss_pred             --C------------C-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCccc
Q 015257          345 --V------------F-----------PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL  382 (410)
Q Consensus       345 --~------------~-----------p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~  382 (410)
                        .            +           ...++.++.+||.+||.+||.+|||+.+++.||||.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence              0            0           124788899999999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-45  Score=318.89  Aligned_cols=253  Identities=24%  Similarity=0.340  Sum_probs=205.5

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|++.+.||+|||+.||++++..++..||+|.+...         +.+..+..++|++..++++|||+++++++....
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---------~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~   90 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---------SQEDIEEALREIDNHRKFNSPNVLRLVDHQLRE   90 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeecc---------chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence            35899999999999999999999999999999987543         356778899999999999999999998755431


Q ss_pred             ---CCCEEEEEEeecCCCCcccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeccCCCCcEEEcCCCcEEE
Q 015257          197 ---NSDHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGHN--VVHGDIKPDNLLVAPSGTVKI  267 (410)
Q Consensus       197 ---~~~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NIll~~~~~~kl  267 (410)
                         .....||+++|...|++.+.+..    ...++|.++..|+.+|++||++||+..  ++||||||.|||++..+.++|
T Consensus        91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl  170 (302)
T KOG2345|consen   91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL  170 (302)
T ss_pred             hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence               34578999999998888776543    347999999999999999999999998  999999999999999999999


Q ss_pred             eeccccccccCC---ccc------cccCCCcccccccccccCCcCC--CchhhHHHHHHHHHHHHhCCCCCCCCCHH--H
Q 015257          268 GDFSVSQVFEDD---NDV------LRRSPGTPVFTAPECCLGLTYG--GKAADTWAVGVTLYYMIIGQYPFLGETLQ--D  334 (410)
Q Consensus       268 ~DfG~a~~~~~~---~~~------~~~~~gt~~y~aPE~~~~~~~~--~~~~DiwSlG~il~elltG~~Pf~~~~~~--~  334 (410)
                      .|||.++...-.   +..      ......|..|+|||.+.-..+.  +.++|||||||+||+|++|..||...-.+  .
T Consensus       171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS  250 (302)
T KOG2345|consen  171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS  250 (302)
T ss_pred             EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence            999988754311   000      0111248889999977533322  56799999999999999999999653211  1


Q ss_pred             HHHHHHhCCCCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          335 TYDKIVNNSLVFPD--AMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       335 ~~~~i~~~~~~~p~--~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..-.+.++.+.+|.  .+|..+..||++||++||.+||++.+++.+
T Consensus       251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            22344555666774  589999999999999999999999999875

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-44  Score=346.84  Aligned_cols=258  Identities=24%  Similarity=0.438  Sum_probs=206.7

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEEEcC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDP  196 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~  196 (410)
                      ..|+++++||+||.+.||+++.... +.||+|.+...       ......+.-+.+|+..|.+|+ |.+||++++|-.. 
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~-------~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-  431 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLL-------EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-  431 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHh-------hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-
Confidence            4699999999999999999987644 45666655432       225567788999999999995 9999999998765 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                       .+.+||||||-+ -.|..++.+.. .++...++.|+.||+.|+.++|+.||||.||||.|+|+- .|.+||+|||+|..
T Consensus       432 -d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  432 -DGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANA  508 (677)
T ss_pred             -CceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcc
Confidence             579999999854 34666666554 344468999999999999999999999999999999998 79999999999998


Q ss_pred             ccCCcc--ccccCCCcccccccccccCCcCC----------CchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhC
Q 015257          276 FEDDND--VLRRSPGTPVFTAPECCLGLTYG----------GKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKIVNN  342 (410)
Q Consensus       276 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~----------~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~i~~~  342 (410)
                      ...+..  ....-+||+.||+||.+......          ++++||||||||||+|++|++||.... ...-...|...
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P  588 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDP  588 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCC
Confidence            765432  33456899999999988532221          457999999999999999999996643 33344455544


Q ss_pred             --CCCCCCCCCHH-HHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          343 --SLVFPDAMNPE-LRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       343 --~~~~p~~~~~~-l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                        .++||..-++. +.++++.||..||++|||+.+||+|||++...-|
T Consensus       589 ~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~  636 (677)
T KOG0596|consen  589 NHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIP  636 (677)
T ss_pred             CccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccccc
Confidence              34777765555 9999999999999999999999999999875443

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.9e-43  Score=333.50  Aligned_cols=250  Identities=26%  Similarity=0.368  Sum_probs=210.6

Q ss_pred             cceeeeeeecccCceEEEEEEEccCC-----ceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDG-----KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      ++|++++.||+|+||.||++.....+     ..||+|.+....        .......+.+|+.+++.++||||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--------~~~~~~~~~~ei~~l~~l~h~~i~~~~~~   76 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--------EPKVQQEFRQEAELMSDLQHPNIVCLLGV   76 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--------CHHHHHHHHHHHHHHHhcCCcccceEEEE
Confidence            47899999999999999999876544     679999875321        23455678999999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDN  256 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N  256 (410)
                      +.+  ....+++|||+++++|.+++...                ..+++..++.++.||+.||.|||++|++||||||+|
T Consensus        77 ~~~--~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~N  154 (283)
T cd05048          77 CTK--EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARN  154 (283)
T ss_pred             EcC--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccce
Confidence            876  45789999999998887766432                458889999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 015257          257 LLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQ  333 (410)
Q Consensus       257 Ill~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~  333 (410)
                      ||++.++.++|+|||+++......  .......+++.|+|||.+.+... +.++|||||||++|+|++ |..||.+....
T Consensus       155 il~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~  233 (283)
T cd05048         155 CLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQ  233 (283)
T ss_pred             EEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999999999997643222  22334457888999998876665 667999999999999998 99999988877


Q ss_pred             HHHHHHHhCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          334 DTYDKIVNNSL-VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       334 ~~~~~i~~~~~-~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +....+..... ..|..+++++.+|+.+||+.||.+|||+.+|+++
T Consensus       234 ~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         234 EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            77777765543 4567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-43  Score=343.96  Aligned_cols=268  Identities=24%  Similarity=0.417  Sum_probs=214.8

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+++.||+|+||.||++++..+++.||||.+.....       .......+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~   76 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-------NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPP   76 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-------ccchhHHHHHHHHHHHhcCCCCccchHHheecc
Confidence            3579999999999999999999999999999998764311       122345677899999999999999999988653


Q ss_pred             C---CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          197 N---SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       197 ~---~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .   ...+++||||+.+ .+...+...+.+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||++
T Consensus        77 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          77 HREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             cccccCcEEEEEeCCCC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            2   1458999999975 56666666678999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN------------  341 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~------------  341 (410)
                      +.............++..|+|||.+......+.++|||||||++|+|++|..||.+.+.......+..            
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            86654333344556889999999886544456789999999999999999999977654332221110            


Q ss_pred             -----------CC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCchhh
Q 015257          342 -----------NS--------LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL  392 (410)
Q Consensus       342 -----------~~--------~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~~  392 (410)
                                 ..        ....+.+++++.+||.+||+.+|.+|||++++++||||.....+.....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~  305 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPV  305 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCcc
Confidence                       00        0012357889999999999999999999999999999987655444433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.4e-43  Score=330.87  Aligned_cols=253  Identities=26%  Similarity=0.479  Sum_probs=214.0

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|...+.||+|+||.||++.+..+++.+|+|.+....        .......+.+|+.+++.++||||+++++++..  .
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~   71 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--------NEAIQKQILRELDILHKCNSPYIVGFYGAFYN--N   71 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--------ChHHHHHHHHHHHHHHHCCCCchhhhheeeec--C
Confidence            5788899999999999999999999999999876432        23455678899999999999999999999876  4


Q ss_pred             CEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ..+++|+||+++++|.+.+... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+...
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~  151 (265)
T cd06605          72 GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL  151 (265)
T ss_pred             CEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhh
Confidence            6899999999999998888665 789999999999999999999999 99999999999999999999999999998765


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCC-CCCCCC-
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE-----TLQDTYDKIVNNS-LVFPDA-  349 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~-----~~~~~~~~i~~~~-~~~p~~-  349 (410)
                      .....  ....++..|+|||.+.+... +.++||||||+++|+|++|..||...     ...+....+.... ...+.. 
T Consensus       152 ~~~~~--~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (265)
T cd06605         152 VNSLA--KTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGK  228 (265)
T ss_pred             HHHHh--hcccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhh
Confidence            43221  12668899999998877654 67799999999999999999999654     2333444444432 234444 


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      +++++.++|.+||..||.+|||+.+++.||||+..
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         229 FSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             cCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            88999999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2e-43  Score=333.35  Aligned_cols=255  Identities=25%  Similarity=0.363  Sum_probs=208.8

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEEc
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDD  195 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~  195 (410)
                      .+.|++.+.||.|+||.||++++..+++.+|+|++...          ......+..|+.+++.+ +||||+++++++..
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----------EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----------hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            35799999999999999999999999999999987532          22345688899999998 79999999998854


Q ss_pred             C----CCCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEee
Q 015257          196 P----NSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGD  269 (410)
Q Consensus       196 ~----~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~D  269 (410)
                      .    ....++++|||++++++.+++..  ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~d  164 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVD  164 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEee
Confidence            2    24578999999999988877754  34588999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCccccccCCCcccccccccccC----CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-
Q 015257          270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCLG----LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-  344 (410)
Q Consensus       270 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-  344 (410)
                      ||++..............|++.|+|||.+..    ....+.++|||||||++|+|++|..||...........+..... 
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  244 (282)
T cd06636         165 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP  244 (282)
T ss_pred             CcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCC
Confidence            9998765433333345668999999998753    12235679999999999999999999977654443333333221 


Q ss_pred             C-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          345 V-FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       345 ~-~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      . .+..++.++.+||.+||..||.+|||+.++++||||
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            1 223578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.2e-43  Score=331.78  Aligned_cols=253  Identities=29%  Similarity=0.433  Sum_probs=205.8

Q ss_pred             eecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEEE
Q 015257          125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMV  204 (410)
Q Consensus       125 ~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv  204 (410)
                      .||+|+||.||++++..+++.||+|++.+.....   .............+..++...||+|+.+++++.+  ...+++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM---KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeecccccc---chhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEE
Confidence            4899999999999999999999999987543211   0011111112223345556789999999999986  4589999


Q ss_pred             EeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccccc
Q 015257          205 LEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR  284 (410)
Q Consensus       205 ~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  284 (410)
                      |||++|++|...+...+.+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++......  ...
T Consensus        76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~  153 (278)
T cd05606          76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPH  153 (278)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCc
Confidence            999999999888877778999999999999999999999999999999999999999999999999998755332  223


Q ss_pred             cCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q 015257          285 RSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE---TLQDTYDKIVNNSLVFPDAMNPELRNLLEGL  361 (410)
Q Consensus       285 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~  361 (410)
                      ...|+..|+|||++.+....+.++||||+|+++|+|++|..||...   ........+......+|..+++++.+++.+|
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  233 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL  233 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHH
Confidence            4578999999999875543467799999999999999999999765   3333334444445667778899999999999


Q ss_pred             cccCCCCCC-----CHHHHhhCCcccCC
Q 015257          362 LCKDPTRRL-----TLNDVAKHTWVLGD  384 (410)
Q Consensus       362 L~~dp~~Rp-----t~~ell~h~~~~~~  384 (410)
                      |..+|.+||     ++.++++||||.+.
T Consensus       234 l~~~p~~R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         234 LQRDVNRRLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             hhcCHHhccCCCCCCHHHHHhCccccCC
Confidence            999999999     99999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.7e-43  Score=330.91  Aligned_cols=256  Identities=26%  Similarity=0.431  Sum_probs=216.6

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      -|.+++.||+|+||.||++.+..++..||||++....        .......+.+|+.+++.++||||+++++++.+  .
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~   74 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--D   74 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--------chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--C
Confidence            3778899999999999999998899999999875321        23345678899999999999999999999986  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ...++||||++++++...+.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 ~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          75 TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            589999999999988877654 4689999999999999999999999999999999999999999999999999876544


Q ss_pred             CccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 015257          279 DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS-LVFPDAMNPELRNL  357 (410)
Q Consensus       279 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~l~~l  357 (410)
                      .........|+..|+|||.+.+... +.++|+|||||++|+|++|..||...........+.... ..++..++.++.++
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (277)
T cd06641         154 TQIKRNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEF  232 (277)
T ss_pred             chhhhccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHH
Confidence            3333334568899999998876554 567999999999999999999998766655555554433 23556788999999


Q ss_pred             HHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          358 LEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       358 i~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      +.+||+.+|.+||++.++++||||.....
T Consensus       233 i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~  261 (277)
T cd06641         233 VEACLNKEPSFRPTAKELLKHKFIVRFAK  261 (277)
T ss_pred             HHHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence            99999999999999999999999988643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.9e-43  Score=328.92  Aligned_cols=249  Identities=20%  Similarity=0.285  Sum_probs=207.4

Q ss_pred             cceeeeeeecccCceEEEEEEEc---cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ++|++.+.||+|+||.||++...   ..+..||+|.+....        .......+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   76 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--------SDKQRRGFLAEALTLGQFDHSNIVRLEGVIT   76 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--------CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe
Confidence            57999999999999999998765   346789999876431        2334567889999999999999999999987


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .  ...+++||||++++++.+++.. ...+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+
T Consensus        77 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~  154 (266)
T cd05064          77 R--GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRL  154 (266)
T ss_pred             c--CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccc
Confidence            6  4579999999999999887765 357899999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCcc-ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCC
Q 015257          274 QVFEDDND-VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAM  350 (410)
Q Consensus       274 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~  350 (410)
                      ........ ......++..|+|||.+.+..+ +.++|||||||++|++++ |..||......+....+..+. .+.|..+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  233 (266)
T cd05064         155 QEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNC  233 (266)
T ss_pred             ccccccchhcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCC
Confidence            65322211 1112335678999998877655 567999999999999875 999998887777766665543 3556788


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          351 NPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      +..+.+++.+||+.+|.+|||++++++
T Consensus       234 ~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         234 PNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             CHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=337.35  Aligned_cols=260  Identities=27%  Similarity=0.420  Sum_probs=221.5

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      -|.++++||+|+||.||+|.++.+|..+|||.+.-           ...+.++..|+.|+++++.|++|++||.+..  .
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-----------~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK--~  100 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-----------DTDLQEIIKEISIMQQCKSKYVVKYYGSYFK--H  100 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-----------cchHHHHHHHHHHHHHcCCchhhhhhhhhcc--C
Confidence            37789999999999999999999999999998642           3466789999999999999999999986654  3


Q ss_pred             CEEEEEEeecCCCCcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ..++||||||+.|+..+.+. ++.+|+|.++..+++.-+.||+|||...-||||||..|||++-+|..||+|||.|..+.
T Consensus       101 sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT  180 (502)
T KOG0574|consen  101 SDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT  180 (502)
T ss_pred             CceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh
Confidence            46999999999999988774 45689999999999999999999999999999999999999999999999999998877


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCCCCCCCHHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS---LVFPDAMNPEL  354 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~~~~l  354 (410)
                      +.-....+..|||.|||||++....|.+. +||||||++..||.-|++||..-........|-..+   +.-|+..|.++
T Consensus       181 DTMAKRNTVIGTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F  259 (502)
T KOG0574|consen  181 DTMAKRNTVIGTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEF  259 (502)
T ss_pred             hhHHhhCccccCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHH
Confidence            76666678899999999999988777555 999999999999999999997754433222222222   12345778999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhhCCcccCCCC-CCchhh
Q 015257          355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG-PIPQYL  392 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~-~~~~~~  392 (410)
                      -+++++||.+.|++|.|+.++++|||+++.+. .+...|
T Consensus       260 ~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~~~  298 (502)
T KOG0574|consen  260 NDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIMQLM  298 (502)
T ss_pred             HHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHHHHH
Confidence            99999999999999999999999999998754 333333

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-43  Score=332.17  Aligned_cols=257  Identities=27%  Similarity=0.478  Sum_probs=215.8

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC---CCCcccceeEEEc
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ---HPNIVNLIEVIDD  195 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~  195 (410)
                      .|..++.||+|+||.||++.+..+++.||+|.+....        .......+.+|+.+++.++   |||++++++++.+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~   73 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--------PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK   73 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--------CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee
Confidence            4778899999999999999999999999999875431        2334567889999999997   9999999999876


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                        ....++||||+++++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..
T Consensus        74 --~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06917          74 --GPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAAL  150 (277)
T ss_pred             --CCEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceee
Confidence              4589999999999999887755 4789999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCC-CCCHH
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS-LVFPD-AMNPE  353 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~-~~~~~  353 (410)
                      ............|+..|+|||.+.+....+.++|+|||||++|+|++|..||...........+.... ..++. .++.+
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (277)
T cd06917         151 LNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKL  230 (277)
T ss_pred             cCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHH
Confidence            65544334455789999999988765545678999999999999999999998776555443332222 12333 37889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      +.+++.+||+.||.+|||+.+++.|+||+....
T Consensus       231 ~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~  263 (277)
T cd06917         231 LREFVAACLDEEPKERLSAEELLKSKWIKAHSK  263 (277)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence            999999999999999999999999999987654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3e-43  Score=332.24  Aligned_cols=252  Identities=28%  Similarity=0.474  Sum_probs=206.3

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|++++.||.|++|.||++++..+|..||||++.....        ......+.+|+.+++.++||||+++++++.+  .
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~   70 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--------EGTPSTAIREISLMKELKHENIVRLHDVIHT--E   70 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--------ccchHHHHHHHHHHHhhcCCCEeeeeeeEee--C
Confidence            48899999999999999999999999999999864321        1223467789999999999999999999987  4


Q ss_pred             CEEEEEEeecCCCCcccccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQ---PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      ...++||||+++ .+.+++..   ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++..
T Consensus        71 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~  149 (284)
T cd07836          71 NKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARA  149 (284)
T ss_pred             CcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhh
Confidence            578999999997 44444432   24689999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS------------  343 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~------------  343 (410)
                      ............+|+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....            
T Consensus       150 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07836         150 FGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS  229 (284)
T ss_pred             hcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence            54433333345578899999988765555678999999999999999999998876555444432210            


Q ss_pred             ------CCC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          344 ------LVF-----------PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       344 ------~~~-----------p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                            ..+           .+..++.+.+++.+||+.||.+||++.++++||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                  001           12457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.6e-44  Score=335.91  Aligned_cols=255  Identities=26%  Similarity=0.419  Sum_probs=214.3

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      .|..++.||+|+||.||++.+..++..||+|.+....        .......+.+|+.+++.++||||+++++++..  .
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~   74 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AEDEIEDIQQEITVLSQCDSPYITRYYGSYLK--G   74 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--------chHHHHHHHHHHHHHHcCCCCccHhhhccccc--C
Confidence            4778899999999999999999899999999875331        23345678999999999999999999999876  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ...++||||++++++.+.+.. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          75 TKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             CceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence            579999999999998877654 5789999999999999999999999999999999999999999999999999976654


Q ss_pred             CccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 015257          279 DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS-LVFPDAMNPELRNL  357 (410)
Q Consensus       279 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~l~~l  357 (410)
                      .........|+..|+|||++.+... +.++|||||||++|+|++|..||...........+.... ..++..++.++.++
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  232 (277)
T cd06642         154 TQIKRNTFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEF  232 (277)
T ss_pred             cchhhhcccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHH
Confidence            4333334568899999999877654 567999999999999999999997655444443333332 23445678899999


Q ss_pred             HHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          358 LEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       358 i~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      |.+||..+|.+|||+.++++||||....
T Consensus       233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         233 VEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             HHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence            9999999999999999999999997654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.3e-43  Score=335.82  Aligned_cols=249  Identities=28%  Similarity=0.374  Sum_probs=200.0

Q ss_pred             cceeeeeeecccCceEEEEEEEcc----------------CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSL----------------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML  181 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  181 (410)
                      ++|++.+.||+|+||.||++....                ++..||+|++....        .......+.+|+.++.++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l   76 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--------NKNARNDFLKEVKILSRL   76 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--------CHHHHHHHHHHHHHHhhc
Confidence            479999999999999999997532                34579999875431        234556799999999999


Q ss_pred             CCCCcccceeEEEcCCCCEEEEEEeecCCCCcccccCCC-------------------CCCCHHHHHHHHHHHHHHHHHH
Q 015257          182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP-------------------GAIGESMARKYLRDIVSGLMYL  242 (410)
Q Consensus       182 ~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-------------------~~l~~~~~~~i~~qi~~gL~yL  242 (410)
                      +||||+++++++.+  ....++||||+++++|.+++...                   ..+++..+..++.||+.||.||
T Consensus        77 ~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l  154 (304)
T cd05096          77 KDPNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL  154 (304)
T ss_pred             CCCCeeEEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            99999999999986  35789999999998887665321                   2467888999999999999999


Q ss_pred             HhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHH
Q 015257          243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYM  320 (410)
Q Consensus       243 H~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el  320 (410)
                      |+.||+||||||+|||++.++.+||+|||+++......  .......+++.|+|||++....+ +.++||||||+++|+|
T Consensus       155 H~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el  233 (304)
T cd05096         155 SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEI  233 (304)
T ss_pred             HHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHH
Confidence            99999999999999999999999999999997653322  12234456788999998876665 6679999999999999


Q ss_pred             Hh--CCCCCCCCCHHHHHHHHHh---C-----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          321 II--GQYPFLGETLQDTYDKIVN---N-----SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       321 lt--G~~Pf~~~~~~~~~~~i~~---~-----~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ++  +..||......+....+..   .     ....|..+++.+.+|+.+||+.||.+|||+.+|.+
T Consensus       234 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         234 LMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             HHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            86  6678877655544333221   1     12345678899999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.3e-43  Score=331.78  Aligned_cols=255  Identities=31%  Similarity=0.560  Sum_probs=222.5

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEEEcC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDP  196 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~  196 (410)
                      ++|.+.+.||+|+||.||++....+|..||+|++.+....      .......+.+|+.+++.+. ||||+++++++.+ 
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-   73 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI------KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-   73 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc------chHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-
Confidence            3699999999999999999999999999999998754221      2234467889999999998 9999999999876 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       ....++||||++++++.+.+...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        74 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~  152 (280)
T cd05581          74 -EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVL  152 (280)
T ss_pred             -CceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence             4589999999999999988888778999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCc--------------------cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015257          277 EDDN--------------------DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTY  336 (410)
Q Consensus       277 ~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~  336 (410)
                      ....                    .......|+..|+|||++..... +.++||||||++++++++|..||.........
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~  231 (280)
T cd05581         153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF  231 (280)
T ss_pred             CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence            4322                    12223457889999998776554 66799999999999999999999887766677


Q ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhhCCcc
Q 015257          337 DKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTL----NDVAKHTWV  381 (410)
Q Consensus       337 ~~i~~~~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~----~ell~h~~~  381 (410)
                      ..+......+|..+++.+.+||.+||+.+|.+|||+    .++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         232 QKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            777777778888999999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.6e-43  Score=342.79  Aligned_cols=257  Identities=26%  Similarity=0.476  Sum_probs=206.1

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||++.+..+|+.||||++....       ........+.+|+.+++.++||||+++++++..
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-------QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTP   86 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-------cChhHHHHHHHHHHHHHhcCCCCCcceeeeecc
Confidence            3468999999999999999999999999999999875321       123344567789999999999999999998864


Q ss_pred             CC----CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          196 PN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       196 ~~----~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      ..    ....|+||||+.+. +...+...  +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        87 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          87 QKSLEEFQDVYLVMELMDAN-LCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CCCccccCcEEEEEeccCCC-HHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCc
Confidence            32    23579999999764 44444332  8999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--------  343 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--------  343 (410)
                      +++...... ......+|+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+....+..+....        
T Consensus       164 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         164 LARTAGTSF-MMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             cceeCCCCC-CCCCCcccccccCHHHHhCCCC-CCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            998654322 2334568899999999877665 567999999999999999999998766544443332100        


Q ss_pred             --------------C--------------CC-------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          344 --------------L--------------VF-------PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       344 --------------~--------------~~-------p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                                    .              .+       +...++.+.+||.+||+.||++|||+.|+|.||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~  317 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW  317 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence                          0              00       11245678999999999999999999999999998743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.7e-43  Score=328.40  Aligned_cols=261  Identities=26%  Similarity=0.429  Sum_probs=212.5

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeeccccccccc-CCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      +|.+.+.||.|+||.||++....+|+.||+|.+.......... .......+.+.+|+.+++.++||||+++++++..  
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   79 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT--   79 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence            5888999999999999999999899999999886432211100 0012234578899999999999999999999876  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ....++||||++++++...+...+.+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||+++...
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  159 (272)
T cd06629          80 EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD  159 (272)
T ss_pred             CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence            45799999999999999888877889999999999999999999999999999999999999999999999999997654


Q ss_pred             CCc--cccccCCCcccccccccccCCc-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCC----
Q 015257          278 DDN--DVLRRSPGTPVFTAPECCLGLT-YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--SLVFPD----  348 (410)
Q Consensus       278 ~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~----  348 (410)
                      ...  .......|+..|+|||.+.... ..+.++|+||||+++|++++|..||...........+...  ...++.    
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM  239 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccc
Confidence            321  1223456889999999886554 2366799999999999999999999766554443333222  222333    


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      .++.++.++|.+||.++|.+|||++++++||||
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         240 NLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            468899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-43  Score=325.65  Aligned_cols=258  Identities=28%  Similarity=0.496  Sum_probs=217.3

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      .+|.+.+.||+|+||.||++.+..++..||+|.+......    .........+.+|+.+++.++||||+++++++.+..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~   77 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDS----QETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE   77 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCccc----chhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC
Confidence            3689999999999999999999999999999987543211    112345568899999999999999999999988765


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+++||||++++++.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++...
T Consensus        78 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          78 EKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            66899999999999998888776779999999999999999999999999999999999999999999999999997643


Q ss_pred             CC---ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCH
Q 015257          278 DD---NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFPDAMNP  352 (410)
Q Consensus       278 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~  352 (410)
                      ..   ........|+..|+|||++.+... +.++|+|||||++|+|++|..||..........++....  ..+|..+++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~  236 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD  236 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCH
Confidence            21   111234568999999998877554 567999999999999999999998776555555554432  346888999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      .+.+++.+||. +|..|||+.+++.|||+
T Consensus       237 ~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         237 ACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            99999999999 57999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.7e-43  Score=333.68  Aligned_cols=257  Identities=28%  Similarity=0.454  Sum_probs=207.1

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+.+.||+|++|.||++.+..+|+.||+|.+.....       .......+.+|+.+++.++||||+++++++.+  
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   72 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-------DEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--   72 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-------cccchHHHHHHHHHHHhccCCCEeeEEEEEec--
Confidence            579999999999999999999999999999998754321       12234567899999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC-CCcEEEeeccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDFSVSQ  274 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~-~~~~kl~DfG~a~  274 (410)
                      ....++||||+++. +...+...  ..+++..++.++.||+.||+|||+++++|+||+|+||+++. ++.+||+|||++.
T Consensus        73 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~  151 (294)
T PLN00009         73 EKRLYLVFEYLDLD-LKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR  151 (294)
T ss_pred             CCeEEEEEeccccc-HHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEccccccc
Confidence            45899999999764 44444332  23688899999999999999999999999999999999985 4579999999997


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---C--------
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---S--------  343 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~---~--------  343 (410)
                      .............+++.|+|||++.+....+.++||||||+++|+|++|..||......+....+...   .        
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (294)
T PLN00009        152 AFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV  231 (294)
T ss_pred             ccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence            65443333344567899999998876554567899999999999999999999876655544433210   0        


Q ss_pred             ----------CC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          344 ----------LV--------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       344 ----------~~--------~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                                ..        ....+++++.+++.+||+.+|.+||++.++++||||.+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence                      00        123568889999999999999999999999999999764

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7.1e-43  Score=327.18  Aligned_cols=251  Identities=27%  Similarity=0.413  Sum_probs=206.4

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  199 (410)
                      ......||+|+||.||++++..++..||+|.+...         .....+.+.+|+.+++.++|+||+++++++..  ..
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~   78 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---------DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NG   78 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---------CHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CC
Confidence            33456899999999999999989999999987543         23345678999999999999999999999876  45


Q ss_pred             EEEEEEeecCCCCcccccCCC-CCC--CHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC-CCcEEEeecccccc
Q 015257          200 HFYMVLEYVEGKWDNDGFGQP-GAI--GESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDFSVSQV  275 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~~-~~l--~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~-~~~~kl~DfG~a~~  275 (410)
                      ..++||||+++++|.+.+... ..+  ++..+..++.||+.||+|||+.||+||||||+||+++. ++.++|+|||++..
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          79 FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            899999999999998877653 445  88889999999999999999999999999999999976 67999999999876


Q ss_pred             ccCCccccccCCCcccccccccccCCc-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH-HHHhCCCCCCCCCC
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLT-YGGKAADTWAVGVTLYYMIIGQYPFLGETLQD--TYD-KIVNNSLVFPDAMN  351 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~-~i~~~~~~~p~~~~  351 (410)
                      ............|++.|+|||++.+.. ..+.++||||||+++|+|++|..||.......  ... ........+|..++
T Consensus       159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd06624         159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLS  238 (268)
T ss_pred             cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccC
Confidence            544333334456899999999876543 23667999999999999999999997543221  111 12223345677889


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       352 ~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      +++.+|+.+||+.+|.+|||+.+++.||||
T Consensus       239 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         239 AEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            999999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.8e-43  Score=347.40  Aligned_cols=251  Identities=22%  Similarity=0.352  Sum_probs=202.6

Q ss_pred             ccceeeeeeecccCceEEEEEEEccC-----CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccce
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLD-----GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLI  190 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  190 (410)
                      .++|.+.+.||+|+||.||++++...     +..||||++....        .......+.+|+.+++.+ +|||||+++
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~il~~l~~h~nIv~~~  108 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--------HTDEREALMSELKILSHLGQHKNIVNLL  108 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--------CHHHHHHHHHHHHHHHhhccCCceeeEe
Confidence            45799999999999999999986543     3579999886432        233456788999999999 899999999


Q ss_pred             eEEEcCCCCEEEEEEeecCCCCcccccCC---------------------------------------------------
Q 015257          191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQ---------------------------------------------------  219 (410)
Q Consensus       191 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---------------------------------------------------  219 (410)
                      +++.+  ...+++||||+++++|.+++..                                                   
T Consensus       109 ~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (374)
T cd05106         109 GACTH--GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRP  186 (374)
T ss_pred             eEecC--CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCC
Confidence            99986  4579999999999887765432                                                   


Q ss_pred             -------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCc
Q 015257          220 -------------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN  280 (410)
Q Consensus       220 -------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~  280 (410)
                                         ..++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~  266 (374)
T cd05106         187 VSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS  266 (374)
T ss_pred             ccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCc
Confidence                               1247888999999999999999999999999999999999999999999999997654332


Q ss_pred             c--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHH
Q 015257          281 D--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN--SLVFPDAMNPELR  355 (410)
Q Consensus       281 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~l~  355 (410)
                      .  ......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...........+...  ....|..+++++.
T Consensus       267 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  345 (374)
T cd05106         267 NYVVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIY  345 (374)
T ss_pred             ceeeccCCCCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHH
Confidence            1  1122335678999999876655 667999999999999997 99999876544433344333  2345567789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhhC
Q 015257          356 NLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +++.+||+.||.+|||+.++++.
T Consensus       346 ~li~~cl~~dp~~RPs~~~l~~~  368 (374)
T cd05106         346 SIMKMCWNLEPTERPTFSQISQL  368 (374)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-43  Score=330.29  Aligned_cols=252  Identities=27%  Similarity=0.486  Sum_probs=205.5

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  199 (410)
                      |.+++.||.|++|.||++.+..+|..||+|++.....       .......+.+|+.+++.++||||+++++++.+  ..
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~   71 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-------DEGVPSTAIREISLLKELNHPNIVRLLDVVHS--EN   71 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-------cccchhHHHHHHHHHHhcCCCCccCHhheecc--CC
Confidence            5678999999999999999999999999999864421       12233467789999999999999999999976  46


Q ss_pred             EEEEEEeecCCCCcccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          200 HFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ..++||||+++ .+...+....  .+++..+..++.||+.||+|||+++++||||+|+||+++.++.++|+|||++....
T Consensus        72 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~  150 (283)
T cd07835          72 KLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFG  150 (283)
T ss_pred             eEEEEEeccCc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence            89999999964 5666655444  68999999999999999999999999999999999999999999999999997654


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--------------  343 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--------------  343 (410)
                      ..........+++.|+|||++.+....+.++||||||+++|+|++|..||...+.......+....              
T Consensus       151 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         151 VPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             CCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc
Confidence            333333344568899999988765444677999999999999999999998766544332222110              


Q ss_pred             ---------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          344 ---------------LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       344 ---------------~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                                     ......++..+.++|.+||+.||.+|||+.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                           01123567899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.5e-43  Score=341.34  Aligned_cols=268  Identities=27%  Similarity=0.439  Sum_probs=216.4

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC-
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP-  196 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  196 (410)
                      ++|.+.+.||.|+||.||++.+..+|+.||+|++.....       .......+.+|+.+|+.++||||+++++++... 
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   77 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-------VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG   77 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-------cccchHHHHHHHHHHHhcCCCCccCHHHhccccC
Confidence            579999999999999999999999999999998864321       123445678899999999999999999987643 


Q ss_pred             -CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          197 -NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       197 -~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                       ....+++||||+.+ .+...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus        78 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          78 ADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             CCCceEEEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence             23578999999975 6777776667799999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCc----cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------
Q 015257          276 FEDDN----DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN----------  341 (410)
Q Consensus       276 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~----------  341 (410)
                      .....    .......|+..|+|||++.+....+.++|||||||++|+|++|+.||.+.........+..          
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            53322    1123456899999999886644457789999999999999999999977654332221111          


Q ss_pred             -------------C---CCCC-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCchhhh
Q 015257          342 -------------N---SLVF-----PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLC  393 (410)
Q Consensus       342 -------------~---~~~~-----p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~~~  393 (410)
                                   .   ....     ....++++.++|.+||+.+|.+|||+++++.||||.+...+..+-.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~  309 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTC  309 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccC
Confidence                         0   0011     13468899999999999999999999999999999887776665554

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6.5e-43  Score=324.72  Aligned_cols=253  Identities=26%  Similarity=0.540  Sum_probs=214.7

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|.+.+.||+|+||.||++....+|..+|+|.+.....       .......+.+|+.+++.++||||+++++.+.+  .
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~   71 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-------PVKEKEASKKEVILLAKMKHPNIVTFFASFQE--N   71 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-------cchhhHHHHHHHHHHHhCCCCChhhhhheecc--C
Confidence            48889999999999999999999999999999865422       11234567899999999999999999999876  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC-cEEEeecccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSVSQV  275 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~-~~kl~DfG~a~~  275 (410)
                      ...++|+||++++++.+.+....  .+++..+..++.||+.||.|||+.+++|+||||+||+++.++ .++|+|||.+..
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~  151 (257)
T cd08225          72 GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ  151 (257)
T ss_pred             CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchh
Confidence            58999999999998888765432  579999999999999999999999999999999999999886 469999999987


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHH
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFPDAMNPEL  354 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~l  354 (410)
                      ............|++.|+|||++.+... +.++|+||||+++|+|++|..||...+..+....+..... ..+..++.++
T Consensus       152 ~~~~~~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (257)
T cd08225         152 LNDSMELAYTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDL  230 (257)
T ss_pred             ccCCcccccccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHH
Confidence            6554434445568999999998876554 5679999999999999999999988776666665555443 3455778999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          355 RNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      .++|.+||..+|++|||+.++++||||
T Consensus       231 ~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         231 RSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-43  Score=338.69  Aligned_cols=260  Identities=27%  Similarity=0.436  Sum_probs=206.8

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+.+.||+|+||.||++.+..+|+.||||++....        .......+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   75 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--------HQTFCQRTLREIKILRRFKHENIIGILDIIRPP   75 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--------cchhHHHHHHHHHHHHhCCCCCcCchhheeecc
Confidence            368999999999999999999999999999999875321        223445678899999999999999999987653


Q ss_pred             C---CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          197 N---SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       197 ~---~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .   ...+++|+||+++. +...+ ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus        76 ~~~~~~~~~lv~e~~~~~-l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          76 SFESFNDVYIVQELMETD-LYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             cccccceEEEEehhcccC-HHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccce
Confidence            2   24689999999863 44444 3457999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCcc---ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------
Q 015257          274 QVFEDDND---VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN---------  341 (410)
Q Consensus       274 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~---------  341 (410)
                      ........   ......||+.|+|||.+.+....+.++|||||||++|+|++|+.||.+.........+..         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED  233 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            76533221   223356899999999876544446789999999999999999999977654332221110         


Q ss_pred             ------C-----------CCC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          342 ------N-----------SLV-----FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       342 ------~-----------~~~-----~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                            .           ...     ..+..++++.+||.+||+.||.+|||+.++++||||.....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence                  0           000     01245788999999999999999999999999999976543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.5e-43  Score=332.30  Aligned_cols=256  Identities=26%  Similarity=0.445  Sum_probs=214.8

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|++++.||+|+||+||++.+..+|+.||+|++....        .......+.+|+.+++.++||||+++++++... 
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   75 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--------KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-   75 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--------cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-
Confidence            57899999999999999999999999999999875421        233456789999999999999999999999873 


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       ..+++||||++++++...+...+.+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++...
T Consensus        76 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~  154 (284)
T cd06620          76 -NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL  154 (284)
T ss_pred             -CEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence             6899999999999998888777789999999999999999999997 58999999999999999999999999998754


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhCC-C
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL-----------QDTYDKIVNNS-L  344 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-----------~~~~~~i~~~~-~  344 (410)
                      ...  ......|+..|+|||++.+... +.++|||||||++|+|++|..||.....           .+....+.... .
T Consensus       155 ~~~--~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd06620         155 INS--IADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP  231 (284)
T ss_pred             hhh--ccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC
Confidence            322  1234568999999998876654 5679999999999999999999976443           12333443332 2


Q ss_pred             CCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          345 VFPD-AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       345 ~~p~-~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      .++. .++.++.+|+.+||+.||.+|||+.++++|+||.....
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~  274 (284)
T cd06620         232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR  274 (284)
T ss_pred             CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            2333 37889999999999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.3e-43  Score=334.99  Aligned_cols=253  Identities=26%  Similarity=0.478  Sum_probs=212.5

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  199 (410)
                      |.....||+|+||.||++.+..+++.||+|++....         ......+.+|+.+++.++||||+++++++..  ..
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~   91 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---------QQRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GE   91 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---------cchHHHHHHHHHHHHhCCCCchhhhhhheee--CC
Confidence            445668999999999999999999999999985431         1233568899999999999999999998876  46


Q ss_pred             EEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCC
Q 015257          200 HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD  279 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~  279 (410)
                      ..++||||++++++...+.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus        92 ~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~  170 (297)
T cd06659          92 ELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD  170 (297)
T ss_pred             eEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence            89999999999988876644 56899999999999999999999999999999999999999999999999998765443


Q ss_pred             ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCCCCCHHHHH
Q 015257          280 NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL---VFPDAMNPELRN  356 (410)
Q Consensus       280 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~~~~l~~  356 (410)
                      ........|++.|+|||++.+... +.++|||||||++|+|++|+.||...........+.....   ..+..++..+.+
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  249 (297)
T cd06659         171 VPKRKSLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRD  249 (297)
T ss_pred             cccccceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHH
Confidence            333345668999999998876654 6679999999999999999999987766555554443322   233467889999


Q ss_pred             HHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          357 LLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       357 li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      +|.+||+.+|.+||+++++++||||.+..
T Consensus       250 ~i~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         250 FLERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             HHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence            99999999999999999999999998763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.3e-42  Score=324.02  Aligned_cols=254  Identities=28%  Similarity=0.522  Sum_probs=213.2

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|.+.+.||+|+||.||++....+++.||+|.+.....       .......+.+|+.+++.++|+||+++++++..  .
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~   71 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-------DPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--R   71 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-------chHHHHHHHHHHHHHHhCCCCChhheeeeEec--C
Confidence            48889999999999999999998999999999865421       23466789999999999999999999998875  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ..+++|+||++++++.+.+.....+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.....
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~  151 (264)
T cd06626          72 EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN  151 (264)
T ss_pred             CEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence            68999999999999999888777799999999999999999999999999999999999999999999999999887654


Q ss_pred             Ccccc----ccCCCcccccccccccCCc--CCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhC-CCCCCCC-
Q 015257          279 DNDVL----RRSPGTPVFTAPECCLGLT--YGGKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKIVNN-SLVFPDA-  349 (410)
Q Consensus       279 ~~~~~----~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~i~~~-~~~~p~~-  349 (410)
                      .....    ....+++.|+|||++.+..  ..+.++||||||+++|++++|..||.... .......+... ...+|.. 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  231 (264)
T cd06626         152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSL  231 (264)
T ss_pred             CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCccc
Confidence            33221    2356788999999987654  23667999999999999999999997653 22222223222 2344544 


Q ss_pred             -CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          350 -MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       350 -~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                       +++.+.++|.+||+.+|.+|||+.+++.|||+
T Consensus       232 ~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         232 QLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence             48999999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7.1e-43  Score=333.76  Aligned_cols=259  Identities=27%  Similarity=0.434  Sum_probs=206.8

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+.+.||+|+||.||++.+..+++.||||++......       ......+.+|+.+++.++||||+++++++.+
T Consensus         6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (311)
T cd07866           6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-------DGFPITALREIKILKKLKHPNVVPLIDMAVE   78 (311)
T ss_pred             ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-------CCcchhHHHHHHHHHhcCCCCccchhhheec
Confidence            357899999999999999999999999999999998653211       1112356789999999999999999998765


Q ss_pred             CC------CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEee
Q 015257          196 PN------SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGD  269 (410)
Q Consensus       196 ~~------~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~D  269 (410)
                      ..      ...+++||||+.+............+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|
T Consensus        79 ~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~d  158 (311)
T cd07866          79 RPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIAD  158 (311)
T ss_pred             ccccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECc
Confidence            32      236899999998755444444456799999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCccc-----------cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015257          270 FSVSQVFEDDNDV-----------LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDK  338 (410)
Q Consensus       270 fG~a~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~  338 (410)
                      ||+++........           .....|++.|+|||.+.+....+.++|||||||++|+|++|++||.+.+.......
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~  238 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL  238 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999765432211           12235688899999886654446779999999999999999999988776655544


Q ss_pred             HHhCCC-----------------------CCC-------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          339 IVNNSL-----------------------VFP-------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       339 i~~~~~-----------------------~~p-------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      +.....                       ..+       ..+++.+.++|.+||+.||.+|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            432100                       000       1345678899999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=8.8e-43  Score=324.93  Aligned_cols=256  Identities=31%  Similarity=0.541  Sum_probs=219.7

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|++.+.||.|++|.||++.+..+++.||||++....        .......+.+|+.++..++||||+++++++..  
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--   70 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG--------DEEFRKQLLRELKTLRSCESPYVVKCYGAFYK--   70 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCc--------chHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--
Confidence            36889999999999999999999999999999876432        11445689999999999999999999999976  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ...+++||||+++++|.+.+.....+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++...
T Consensus        71 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~  150 (264)
T cd06623          71 EGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL  150 (264)
T ss_pred             CCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceec
Confidence            46899999999999999988877889999999999999999999999 99999999999999999999999999999876


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCC-CCCCCC-CC
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE---TLQDTYDKIVNNS-LVFPDA-MN  351 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~---~~~~~~~~i~~~~-~~~p~~-~~  351 (410)
                      ...........++..|+|||.+.+... +.++|+||||+++|+|++|..||...   ...+....+.... ...+.. ++
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (264)
T cd06623         151 ENTLDQCNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFS  229 (264)
T ss_pred             ccCCCcccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCC
Confidence            544433335568899999998876644 66799999999999999999999776   4444455554433 234555 88


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       352 ~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      ..+.++|.+||..+|++|||+.++++||||+..
T Consensus       230 ~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         230 PEFRDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            999999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=9.9e-43  Score=333.07  Aligned_cols=257  Identities=26%  Similarity=0.400  Sum_probs=211.4

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      ...|...+.||+|+||.||+++...+|+.||+|++.....      ........+.+|+.+++.++||||+++++++.+ 
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-   86 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK------QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-   86 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc------CcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-
Confidence            3569999999999999999999999999999998754321      123445678899999999999999999999986 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       ....++||||+.|..+.........+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++...
T Consensus        87 -~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~  165 (307)
T cd06607          87 -EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV  165 (307)
T ss_pred             -CCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceec
Confidence             4578999999987544443334557999999999999999999999999999999999999999999999999998764


Q ss_pred             cCCccccccCCCcccccccccccC--CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCC-CCCCCH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLG--LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS-LVF-PDAMNP  352 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~-p~~~~~  352 (410)
                      ...    ....|++.|+|||++.+  ....+.++||||||+++|+|++|..||...........+.... ... +..++.
T Consensus       166 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (307)
T cd06607         166 SPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSD  241 (307)
T ss_pred             CCC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCH
Confidence            332    24567889999998742  2223567999999999999999999998876655544444332 222 235788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      .+.++|.+||..||.+||++.+++.||||....
T Consensus       242 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         242 YFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            999999999999999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.3e-42  Score=328.89  Aligned_cols=255  Identities=27%  Similarity=0.467  Sum_probs=215.9

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      .|...+.||+|++|.||++.+..+++.+|+|++...         .....+.+.+|+.+++.++||||+++++++..  .
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---------~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~   88 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---------KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--G   88 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---------chhHHHHHHHHHHHHHHcCCCChheEEEEEEc--C
Confidence            466678999999999999999989999999987532         12334568899999999999999999999876  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ...++|+||+++++|.+.+.. ..+++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus        89 ~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~  167 (285)
T cd06648          89 DELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             CeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence            578999999999999888776 5789999999999999999999999999999999999999999999999998876544


Q ss_pred             CccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCCCCCHHHH
Q 015257          279 DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV---FPDAMNPELR  355 (410)
Q Consensus       279 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~~~~l~  355 (410)
                      .........|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+......   .+..++..+.
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  246 (285)
T cd06648         168 EVPRRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLR  246 (285)
T ss_pred             CCcccccccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHH
Confidence            3333344568999999998876654 56799999999999999999999887766666666554322   2334789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          356 NLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      +++.+||..+|.+|||+.++++||||.....
T Consensus       247 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         247 SFLDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             HHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence            9999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.8e-43  Score=327.16  Aligned_cols=249  Identities=33%  Similarity=0.601  Sum_probs=215.9

Q ss_pred             ecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEEEE
Q 015257          126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVL  205 (410)
Q Consensus       126 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~  205 (410)
                      ||.|+||.||++.+..+|+.||+|++......      .......+.+|+.+++.++||||+++++.+..  ....++||
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~   72 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMI------RKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVM   72 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhh------hhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEE
Confidence            68999999999999989999999998654221      23456788999999999999999999998875  56899999


Q ss_pred             eecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCcc----
Q 015257          206 EYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND----  281 (410)
Q Consensus       206 e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~----  281 (410)
                      ||++++++...+...+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........    
T Consensus        73 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  152 (265)
T cd05579          73 EYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN  152 (265)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence            9999999988887767899999999999999999999999999999999999999999999999999876433311    


Q ss_pred             ----ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCC--CHHHH
Q 015257          282 ----VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAM--NPELR  355 (410)
Q Consensus       282 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~--~~~l~  355 (410)
                          ......+++.|+|||.+..... +.++||||||+++|+|++|..||...........+..+...+|...  +..+.
T Consensus       153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (265)
T cd05579         153 DDEKEDKRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAI  231 (265)
T ss_pred             cccccccCcccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHH
Confidence                2234457889999998876654 6679999999999999999999998888888877777777677665  99999


Q ss_pred             HHHHHhcccCCCCCCCH---HHHhhCCcccC
Q 015257          356 NLLEGLLCKDPTRRLTL---NDVAKHTWVLG  383 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt~---~ell~h~~~~~  383 (410)
                      +++.+||+.+|.+|||+   .++++||||.+
T Consensus       232 ~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         232 DLISKLLVPDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             HHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence            99999999999999999   99999999964

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-43  Score=341.53  Aligned_cols=251  Identities=25%  Similarity=0.337  Sum_probs=198.5

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..+.|...+.||+|+||.||++.... |..||||++.....        .. ..+|.+|+.++.+++|||+|+++|||.+
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~--------~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e  142 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSG--------QG-EREFLNEVEILSRLRHPNLVKLLGYCLE  142 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCC--------cc-hhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence            34678888999999999999887664 48999997654321        11 3569999999999999999999999987


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcEeccCCCCcEEEcCCCcEEEeec
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGH---NVVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                      .+. +.+||+|||++|+|.+++....  .++|..+.+|+.++|.||+|||+.   .||||||||+|||||.++.+||+||
T Consensus       143 ~~~-~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF  221 (361)
T KOG1187|consen  143 GGE-HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF  221 (361)
T ss_pred             CCc-eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence            432 6999999999999999887755  899999999999999999999985   3999999999999999999999999


Q ss_pred             cccccccC-CccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCC
Q 015257          271 SVSQVFED-DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE------TLQDTYDKIVNNS  343 (410)
Q Consensus       271 G~a~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~------~~~~~~~~i~~~~  343 (410)
                      |+|+..+. .........||.+|+|||++..... +.++|||||||+|+||+||+.|....      ...++....+...
T Consensus       222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~  300 (361)
T KOG1187|consen  222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG  300 (361)
T ss_pred             cCcccCCccccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence            99977654 3322222279999999999887655 56699999999999999999887642      2334433333221


Q ss_pred             -C------CCC-CCCC--HH---HHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          344 -L------VFP-DAMN--PE---LRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       344 -~------~~p-~~~~--~~---l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                       .      .+. ..++  ..   +..+...|++.+|.+||++.||++.
T Consensus       301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~  348 (361)
T KOG1187|consen  301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE  348 (361)
T ss_pred             chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence             1      111 2233  22   5567889999999999999998654

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-42  Score=328.83  Aligned_cols=259  Identities=29%  Similarity=0.468  Sum_probs=211.8

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|...+.||.|++|.||++.+..+++.||+|.+....        .......+.+|+++++.++||||+++++++.+..
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   72 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--------NPDLQKQILRELEINKSCKSPYIVKYYGAFLDES   72 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--------chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC
Confidence            36889999999999999999999999999999876431        2245567899999999999999999999987655


Q ss_pred             CCEEEEEEeecCCCCcccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      ...+++||||+++++|.+.+.    ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~  152 (287)
T cd06621          73 SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS  152 (287)
T ss_pred             CCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccc
Confidence            668999999999988876542    3456899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCC-CCC
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-----LQDTYDKIVNNSL-VFP  347 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-----~~~~~~~i~~~~~-~~p  347 (410)
                      .......  .....++..|+|||.+.+..+ +.++||||||+++|+|++|..||....     ..+....+..... .++
T Consensus       153 ~~~~~~~--~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd06621         153 GELVNSL--AGTFTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK  229 (287)
T ss_pred             ccccccc--cccccCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhc
Confidence            7543322  224557889999998876655 567999999999999999999997652     2333333333221 111


Q ss_pred             ------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          348 ------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       348 ------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                            ...++.+.++|.+||..||.+|||+.|+++||||+....+
T Consensus       230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~  275 (287)
T cd06621         230 DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK  275 (287)
T ss_pred             cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence                  1346789999999999999999999999999999766443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.1e-43  Score=330.64  Aligned_cols=249  Identities=29%  Similarity=0.477  Sum_probs=207.8

Q ss_pred             ecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEEEE
Q 015257          126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVL  205 (410)
Q Consensus       126 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~  205 (410)
                      ||+|+||+||++.+..+|+.||+|.+......      .......+..|+.+++.++||||+++++++..  .+.+|+||
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~   72 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK------KRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVM   72 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh------hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEE
Confidence            69999999999999999999999998654221      12233456789999999999999999999876  45899999


Q ss_pred             eecCCCCcccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCcccc
Q 015257          206 EYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVL  283 (410)
Q Consensus       206 e~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  283 (410)
                      ||+++++|...+....  .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... ...
T Consensus        73 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~  151 (277)
T cd05577          73 TLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKI  151 (277)
T ss_pred             ecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-Ccc
Confidence            9999999988776544  7899999999999999999999999999999999999999999999999998765432 222


Q ss_pred             ccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 015257          284 RRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL----QDTYDKIVNNSLVFPDAMNPELRNLLE  359 (410)
Q Consensus       284 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~~~~l~~li~  359 (410)
                      ....++..|+|||++.+..+ +.++||||||+++|+|++|+.||.....    ......+......+|..+++.+.++|.
T Consensus       152 ~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  230 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCE  230 (277)
T ss_pred             ccccCCCCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHH
Confidence            34567889999999876664 6679999999999999999999976543    223333333445567788999999999


Q ss_pred             HhcccCCCCCC-----CHHHHhhCCcccCC
Q 015257          360 GLLCKDPTRRL-----TLNDVAKHTWVLGD  384 (410)
Q Consensus       360 ~~L~~dp~~Rp-----t~~ell~h~~~~~~  384 (410)
                      +||+.||.+||     ++.+++.||||...
T Consensus       231 ~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~  260 (277)
T cd05577         231 ALLQKDPEKRLGCRGGSADEVREHPLFKDL  260 (277)
T ss_pred             HHccCChhHccCCCcccHHHHHhChhhhcC
Confidence            99999999999     88899999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.2e-44  Score=324.11  Aligned_cols=264  Identities=30%  Similarity=0.480  Sum_probs=208.6

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCC----ceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCccccee
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDG----KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE  191 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  191 (410)
                      ....|..++.||+|.||.||+|..+.++    +.||||.++...-   .    .-......+|+.+++.++|||+|.+..
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd---~----tGiS~SAcREiaL~REl~h~nvi~Lv~   94 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD---G----TGISMSACREIALLRELKHPNVISLVK   94 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC---C----CCcCHHHHHHHHHHHHhcCCcchhHHH
Confidence            4467999999999999999999665532    3799999875421   0    011235679999999999999999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC----C
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDG----FGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS----G  263 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~----~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~----~  263 (410)
                      +|..- ...+++++||.+..++.-+    -.....++...++.|+.||+.|+.|||++.|+||||||.|||+..+    |
T Consensus        95 Vfl~~-d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG  173 (438)
T KOG0666|consen   95 VFLSH-DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERG  173 (438)
T ss_pred             HHhcc-CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccC
Confidence            98863 5789999999987654421    1223478999999999999999999999999999999999999988    8


Q ss_pred             cEEEeeccccccccCCcccc---ccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------
Q 015257          264 TVKIGDFSVSQVFEDDNDVL---RRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET---------  331 (410)
Q Consensus       264 ~~kl~DfG~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~---------  331 (410)
                      .|||+|||+++.+.+.-..+   ...+-|.+|+|||.+.+...++++.|||+.|||+.|||+..+.|.+..         
T Consensus       174 ~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pf  253 (438)
T KOG0666|consen  174 RVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPF  253 (438)
T ss_pred             eeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCc
Confidence            99999999999876653322   234568899999999999999999999999999999999988885532         


Q ss_pred             HHHHHHHHHhC--C---------CCCCC--------------------------CCCHHHHHHHHHhcccCCCCCCCHHH
Q 015257          332 LQDTYDKIVNN--S---------LVFPD--------------------------AMNPELRNLLEGLLCKDPTRRLTLND  374 (410)
Q Consensus       332 ~~~~~~~i~~~--~---------~~~p~--------------------------~~~~~l~~li~~~L~~dp~~Rpt~~e  374 (410)
                      ..+...+|..-  .         ..+|+                          .-++...+|+.+||..||.+|.|+++
T Consensus       254 q~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~q  333 (438)
T KOG0666|consen  254 QHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQ  333 (438)
T ss_pred             hHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHH
Confidence            12233444321  0         01111                          12455889999999999999999999


Q ss_pred             HhhCCcccCCCCC
Q 015257          375 VAKHTWVLGDNGP  387 (410)
Q Consensus       375 ll~h~~~~~~~~~  387 (410)
                      +|+|+||.....|
T Consensus       334 Aleh~yF~~d~lp  346 (438)
T KOG0666|consen  334 ALEHPYFTEDPLP  346 (438)
T ss_pred             HhcccccccCCCC
Confidence            9999999988554

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-43  Score=334.94  Aligned_cols=257  Identities=30%  Similarity=0.466  Sum_probs=203.4

Q ss_pred             ceeeeeeecccCceEEEEEEEcc--CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      +|.+.+.||+|+||.||++.+..  +++.||+|.+.....      ........+.+|+.+++.++||||+++++++.+.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE------QYTGISQSACREIALLRELKHENVVSLVEVFLEH   74 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc------cccCccHHHHHHHHHHHhcCCCCccceEEEEeCC
Confidence            48899999999999999999988  899999999875321      1122335678899999999999999999999886


Q ss_pred             CCCEEEEEEeecCCCCcccc---cC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC----CCcEEEe
Q 015257          197 NSDHFYMVLEYVEGKWDNDG---FG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP----SGTVKIG  268 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~---~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~----~~~~kl~  268 (410)
                      ....+++||||+++.++...   .. ....+++..++.++.||+.||.|||+.+|+||||||+|||++.    ++.+||+
T Consensus        75 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~  154 (316)
T cd07842          75 ADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG  154 (316)
T ss_pred             CCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence            55789999999987543322   11 2237899999999999999999999999999999999999999    8999999


Q ss_pred             eccccccccCCcc---ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HH
Q 015257          269 DFSVSQVFEDDND---VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQD---------TY  336 (410)
Q Consensus       269 DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---------~~  336 (410)
                      |||++........   ......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.....         ..
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
T cd07842         155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL  234 (316)
T ss_pred             CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence            9999986543322   22345678999999988765545678999999999999999999997543221         00


Q ss_pred             HHHH--------------------------hCCCCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCC
Q 015257          337 DKIV--------------------------NNSLVFP-----------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT  379 (410)
Q Consensus       337 ~~i~--------------------------~~~~~~p-----------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~  379 (410)
                      ..+.                          .....++           ...+.++.+++.+||+.||++|||+.+++.||
T Consensus       235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~  314 (316)
T cd07842         235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHP  314 (316)
T ss_pred             HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCC
Confidence            0000                          0001111           14667899999999999999999999999999


Q ss_pred             cc
Q 015257          380 WV  381 (410)
Q Consensus       380 ~~  381 (410)
                      ||
T Consensus       315 ~f  316 (316)
T cd07842         315 YF  316 (316)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-44  Score=334.70  Aligned_cols=258  Identities=30%  Similarity=0.506  Sum_probs=231.5

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEEEc
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDD  195 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~  195 (410)
                      ..+|..+.+||+|+||.|.++..+.+.++||||+++++...+      .+.++--+.|-.+|.... -|.+++++..|+.
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQ------dDDvectm~EKrvLAL~~kppFL~qlHScFQT  421 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQ------DDDVECTMVEKRVLALPGKPPFLVQLHSCFQT  421 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeee------cCcccceehhhhheecCCCCchHHHHHHHhhh
Confidence            457999999999999999999999999999999998875432      223344557777877774 6788899999986


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      .  +.+|.||||+.||.|--.+++-+.+-|..+..|+..|+-||-+||++|||+||||.+|||++.+|++||+|||+++.
T Consensus       422 m--DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  422 M--DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             h--hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc
Confidence            3  57999999999999999999999999999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELR  355 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~  355 (410)
                      ---+.....++||||.|+|||++...++ ++++|.||+||+|||||.|++||.+++..+....|......+|..+|.++.
T Consensus       500 ni~~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv  578 (683)
T KOG0696|consen  500 NIFDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAV  578 (683)
T ss_pred             cccCCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHH
Confidence            5555667789999999999998877666 788999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcccCCCCCCCH-----HHHhhCCcccC
Q 015257          356 NLLEGLLCKDPTRRLTL-----NDVAKHTWVLG  383 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt~-----~ell~h~~~~~  383 (410)
                      ++.+..|.+.|.+|+..     .+|-.||||..
T Consensus       579 ~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~  611 (683)
T KOG0696|consen  579 AICKGLLTKHPGKRLGCGPEGERDIREHPFFRR  611 (683)
T ss_pred             HHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence            99999999999999843     78999999964

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.6e-42  Score=324.00  Aligned_cols=248  Identities=23%  Similarity=0.383  Sum_probs=210.1

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      .+|.+.+.||+|+||.||++....+++.||+|++...          ......+.+|+.+++.++||||+++++++..  
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   73 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--   73 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----------chHHHHHHHHHHHHHhCCCCChhheEEEEcC--
Confidence            4688999999999999999999989999999987532          2234578899999999999999999999876  


Q ss_pred             CCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      ...+++||||++++++.+.+..  ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++..
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~  153 (263)
T cd05052          74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL  153 (263)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence            4578999999999998887754  34689999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCccc-cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCCCH
Q 015257          276 FEDDNDV-LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNP  352 (410)
Q Consensus       276 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~  352 (410)
                      ....... .....+++.|+|||.+.+... +.++|||||||++|+|++ |..||.+....+....+... ....|..+++
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (263)
T cd05052         154 MTGDTYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPP  232 (263)
T ss_pred             cccceeeccCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH
Confidence            5443221 112234667999998876665 567999999999999998 99999888777776666554 3456778899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ++.+++.+||+.||++|||+.++++.
T Consensus       233 ~~~~li~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         233 KVYELMRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHHHH
Confidence            99999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-45  Score=348.73  Aligned_cols=251  Identities=24%  Similarity=0.373  Sum_probs=214.0

Q ss_pred             ccccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccce
Q 015257          111 ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLI  190 (410)
Q Consensus       111 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  190 (410)
                      +....-++....++-||+|+.|.||+.+..  ++.||||.++.                .-..+|+.|++|+||||+.+.
T Consensus       117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e----------------lkETdIKHLRkLkH~NII~Fk  178 (904)
T KOG4721|consen  117 ELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE----------------LKETDIKHLRKLKHPNIITFK  178 (904)
T ss_pred             hhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhh----------------hhhhhHHHHHhccCcceeeEe
Confidence            334455566667889999999999887765  78999997642                123688999999999999999


Q ss_pred             eEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeec
Q 015257          191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       191 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                      |+|..  ...++||||||..|-|...++....++......+..+|+.|+.|||.+.|||||||.-||||..+..|||+||
T Consensus       179 GVCtq--sPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDF  256 (904)
T KOG4721|consen  179 GVCTQ--SPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDF  256 (904)
T ss_pred             eeecC--CceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccc
Confidence            99986  4589999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCC
Q 015257          271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--SLVFPD  348 (410)
Q Consensus       271 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~  348 (410)
                      |-++...+. .....++||..|||||++.+... +.++|||||||||||||||..||.......+.-.+-.+  .++.|.
T Consensus       257 GTS~e~~~~-STkMSFaGTVaWMAPEvIrnePc-sEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPs  334 (904)
T KOG4721|consen  257 GTSKELSDK-STKMSFAGTVAWMAPEVIRNEPC-SEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPS  334 (904)
T ss_pred             cchHhhhhh-hhhhhhhhhHhhhCHHHhhcCCc-ccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcc
Confidence            999877665 44557899999999999998877 56699999999999999999999775443322222222  356788


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                      .++..++-||+.||+-.|..||++.+++.|-=+.+
T Consensus       335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            99999999999999999999999999999955443

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.9e-43  Score=345.27  Aligned_cols=251  Identities=22%  Similarity=0.364  Sum_probs=201.9

Q ss_pred             ccceeeeeeecccCceEEEEEEE-----ccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccce
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRS-----SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLI  190 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  190 (410)
                      .++|.+.+.||+|+||.||+++.     ..++..||||++....        .......+.+|+.+|+.+ +||||++++
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~~Ei~il~~l~~HpnIv~l~  105 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--------HLTEREALMSELKVLSYLGNHINIVNLL  105 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--------CcHHHHHHHHHHHHHHHhcCCcceeeee
Confidence            34799999999999999999874     3456789999885431        123345788999999999 899999999


Q ss_pred             eEEEcCCCCEEEEEEeecCCCCcccccCCC--------------------------------------------------
Q 015257          191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQP--------------------------------------------------  220 (410)
Q Consensus       191 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--------------------------------------------------  220 (410)
                      +++.+  ....++||||+++++|.+++...                                                  
T Consensus       106 ~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  183 (375)
T cd05104         106 GACTV--GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKA  183 (375)
T ss_pred             eeecc--CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccc
Confidence            99976  45789999999998876655321                                                  


Q ss_pred             -------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          221 -------------------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       221 -------------------------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                                               ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~  263 (375)
T cd05104         184 DKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARD  263 (375)
T ss_pred             ccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCcccee
Confidence                                     2478889999999999999999999999999999999999999999999999986


Q ss_pred             ccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC--CCCCCCC
Q 015257          276 FEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS--LVFPDAM  350 (410)
Q Consensus       276 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~  350 (410)
                      ......  ......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||..........+.....  ...|...
T Consensus       264 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (375)
T cd05104         264 IRNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECA  342 (375)
T ss_pred             ccCcccccccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCC
Confidence            543321  1122335667999999877665 667999999999999998 899998765444333333332  2345667


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          351 NPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +.++.+|+.+||+.||++|||+.+|++.
T Consensus       343 ~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         343 PSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            8999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.2e-42  Score=327.84  Aligned_cols=259  Identities=22%  Similarity=0.371  Sum_probs=203.5

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHH-HHhCCCCCcccceeEEEcC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI-MKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~  196 (410)
                      ++|.+++.||+|+||.||++.+..+|+.||||++.....        ......+..|+.+ ++.++||||+++++++.. 
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-   71 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--------SQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-   71 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--------cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-
Confidence            368999999999999999999999999999998864321        1222345556554 677899999999999976 


Q ss_pred             CCCEEEEEEeecCCCC---cccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          197 NSDHFYMVLEYVEGKW---DNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~---l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                       ...+++||||+++..   +.........+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||+
T Consensus        72 -~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~  150 (283)
T cd06617          72 -EGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGI  150 (283)
T ss_pred             -CCcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence             457999999998642   222223345799999999999999999999997 999999999999999999999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCC---cCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhC-CCCCC
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGL---TYGGKAADTWAVGVTLYYMIIGQYPFLGE-TLQDTYDKIVNN-SLVFP  347 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlG~il~elltG~~Pf~~~-~~~~~~~~i~~~-~~~~p  347 (410)
                      +....... ......|+..|+|||.+.+.   ...+.++|+|||||++|+|++|..||... ...+....+... ...+|
T Consensus       151 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd06617         151 SGYLVDSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP  229 (283)
T ss_pred             cccccccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCC
Confidence            98654321 22334688899999987542   22356799999999999999999999653 222333333332 23333


Q ss_pred             -CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          348 -DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       348 -~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                       ..++.++.++|.+||..+|.+|||+.++++||||......
T Consensus       230 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence             3578999999999999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.8e-44  Score=348.87  Aligned_cols=256  Identities=24%  Similarity=0.429  Sum_probs=223.4

Q ss_pred             eeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCE
Q 015257          121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH  200 (410)
Q Consensus       121 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  200 (410)
                      +....||+|+|-+||+|.+..+|..||--.++...+.+     ....+++|..|+.+|+.|+|||||+++..|.+...+.
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q-----~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~  117 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQ-----SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT  117 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhc-----ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence            34568999999999999999999999987776554433     5667789999999999999999999999999987788


Q ss_pred             EEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcEeccCCCCcEEEcCC-CcEEEeecccccccc
Q 015257          201 FYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH--NVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFE  277 (410)
Q Consensus       201 ~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~--~iiHrDlkp~NIll~~~-~~~kl~DfG~a~~~~  277 (410)
                      +.+|+|.|..|+|..+.++.+.+....++.|++||+.||.|||++  .|||||||.+||+|+.+ |.|||+|+|+|....
T Consensus       118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            999999999999999999999999999999999999999999988  59999999999999864 899999999998765


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCC--CCCCCCHHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE-TLQDTYDKIVNNSLV--FPDAMNPEL  354 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~-~~~~~~~~i~~~~~~--~p~~~~~~l  354 (410)
                      ..  ......|||.|||||.+. ..| ...+||||||++++||+|+..||..- +..+.+.++..+..+  +...-++++
T Consensus       198 ~s--~aksvIGTPEFMAPEmYE-E~Y-nE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPev  273 (632)
T KOG0584|consen  198 KS--HAKSVIGTPEFMAPEMYE-ENY-NELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEV  273 (632)
T ss_pred             cc--ccceeccCccccChHHHh-hhc-chhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHH
Confidence            43  334588999999999775 334 67799999999999999999999884 556778888887653  334457999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      +++|.+||.. .++|||+.|||+||||.....
T Consensus       274 r~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g  304 (632)
T KOG0584|consen  274 REFIEKCLAT-KSERLSAKELLKDPFFDEDGG  304 (632)
T ss_pred             HHHHHHHhcC-chhccCHHHHhhChhhccccc
Confidence            9999999999 999999999999999998633

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=8.2e-43  Score=338.07  Aligned_cols=262  Identities=28%  Similarity=0.460  Sum_probs=212.0

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID  194 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  194 (410)
                      ..++|.+.+.||+|+||.||++.+..+|+.+|||.+.....       .......+.+|+.+++.+ +||||+++++++.
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~   77 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-------NATDAQRTFREIMFLQELGDHPNIVKLLNVIK   77 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-------cchhhhhhhHHHHHHHHhcCCCCccceeeeec
Confidence            45689999999999999999999998999999998754211       223345677899999999 9999999999987


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      ..+...+++||||+++ .+...+... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus        78 ~~~~~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          78 AENDKDIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             cCCCceEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            6555678999999985 566655544 78899999999999999999999999999999999999999999999999997


Q ss_pred             cccCCc-----cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------
Q 015257          275 VFEDDN-----DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS------  343 (410)
Q Consensus       275 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~------  343 (410)
                      ......     .......||+.|+|||++.+....+.++||||||+++|+|++|+.||.+....+....+....      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            654322     123345689999999988665545678999999999999999999997765444333221110      


Q ss_pred             ---------------------C----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          344 ---------------------L----VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       344 ---------------------~----~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                                           .    .....++.++.++|.+||+.||.+|||+.++++|||+.+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence                                 0    011236889999999999999999999999999999977643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.2e-42  Score=331.11  Aligned_cols=260  Identities=25%  Similarity=0.414  Sum_probs=209.2

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+.+.||+|+||.||++.+..+|+.||||++.....       .......+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~   76 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-------KEGFPITAIREIKILRQLNHRNIVNLKEIVT   76 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-------ccCchHHHHHHHHHHHhCCCCCeeeeeheec
Confidence            455789999999999999999999999999999999864321       1122346778999999999999999999887


Q ss_pred             cCC--------CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEE
Q 015257          195 DPN--------SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVK  266 (410)
Q Consensus       195 ~~~--------~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~k  266 (410)
                      +..        ...+++|+||++++.+.........+++..++.++.||+.||+|||+.||+|+||||+||+++.++.+|
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          77 DKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             CcchhhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEE
Confidence            633        237999999999855444443445789999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCcc-ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---
Q 015257          267 IGDFSVSQVFEDDND-VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---  342 (410)
Q Consensus       267 l~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~---  342 (410)
                      |+|||++........ ......+++.|+|||.+.+....+.++|||||||++|+|++|+.||......+....+...   
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            999999986544332 2223346788999998865544467899999999999999999999876655544333321   


Q ss_pred             CC---------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          343 SL---------------------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       343 ~~---------------------------~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      ..                           .....++..+.+++.+||+.||.+|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            00                           0112468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=344.88  Aligned_cols=253  Identities=29%  Similarity=0.570  Sum_probs=220.8

Q ss_pred             eee--eeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          120 YVH--VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       120 y~~--~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      |++  -+.||+|-||+||-++++.+|+.||||++.+..+..       .....+++|+.||+.++||.||.+.-.|+.+ 
T Consensus       564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-------kqesqlR~EVaILq~l~HPGiV~le~M~ET~-  635 (888)
T KOG4236|consen  564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-------KQESQLRNEVAILQNLHHPGIVNLECMFETP-  635 (888)
T ss_pred             HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCC-------chHHHHHHHHHHHHhcCCCCeeEEEEeecCC-
Confidence            544  368999999999999999999999999998764432       2336899999999999999999999999874 


Q ss_pred             CCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC---cEEEeecccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---TVKIGDFSVS  273 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~---~~kl~DfG~a  273 (410)
                       +.++.|||-+.|..|.-++.+ .+++++...+.++.||+-||.|||.++|+|+||||+|||+.+..   .+||||||+|
T Consensus       636 -ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfA  714 (888)
T KOG4236|consen  636 -ERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFA  714 (888)
T ss_pred             -ceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccce
Confidence             579999999999888877654 57899999999999999999999999999999999999998654   6999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----C
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD----A  349 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~  349 (410)
                      +..++.+ ..+...|||.|+|||++....+ .++.|+||+|||+|.-|+|..||...  ++..++|.+..+.+|.    .
T Consensus       715 RiIgEks-FRrsVVGTPAYLaPEVLrnkGy-NrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~e  790 (888)
T KOG4236|consen  715 RIIGEKS-FRRSVVGTPAYLAPEVLRNKGY-NRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSE  790 (888)
T ss_pred             eecchhh-hhhhhcCCccccCHHHHhhccc-cccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhh
Confidence            9887654 4467789999999999988877 56799999999999999999999764  3556677777777664    6


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      +++++.+||+.+|++.-.+|.|++..+.|||+++.+
T Consensus       791 is~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  791 ISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             cCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence            899999999999999999999999999999999864

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.7e-42  Score=319.93  Aligned_cols=253  Identities=33%  Similarity=0.608  Sum_probs=219.1

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|.+.+.||+|+||.||++.+..++..||+|++.....       .......+.+|+++++.++|||++++++.+..  .
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~   71 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-------SEKEREDALNEVKILKKLNHPNIIKYYESFEE--K   71 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-------ChHHHHHHHHHHHHHHhcCCCChhheEEEEec--C
Confidence            48899999999999999999999999999999864321       23455678899999999999999999999876  3


Q ss_pred             CEEEEEEeecCCCCcccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      ...++|+||++++++...+..    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~  151 (258)
T cd08215          72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISK  151 (258)
T ss_pred             CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCcccee
Confidence            689999999999988877654    3679999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHH
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS-LVFPDAMNPE  353 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~  353 (410)
                      .............|++.|+|||.+.+... +.++|+||||+++++|++|..||......+......... ...|..++..
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (258)
T cd08215         152 VLSSTVDLAKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSE  230 (258)
T ss_pred             ecccCcceecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHH
Confidence            76554434445678999999998776654 567999999999999999999998877666666655543 3456688999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      +.+++.+||..+|.+|||+.++++||||
T Consensus       231 ~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         231 LRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.2e-42  Score=327.41  Aligned_cols=249  Identities=28%  Similarity=0.428  Sum_probs=209.5

Q ss_pred             cceeeeeeecccCceEEEEEEEc-----cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      ++|.+.+.||+|+||.||++...     .+++.||||++....        ..+....+.+|+.+++.++||||++++++
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   76 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--------SNDARKDFEREAELLTNFQHENIVKFYGV   76 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--------CHHHHHHHHHHHHHHHhcCCCCchheeeE
Confidence            46889999999999999999874     346789999875321        23355789999999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEE
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP--------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLL  258 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~--------------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIl  258 (410)
                      +..  ....++||||+++++|.+++...              ..+++..+..++.||+.||.|||++|++||||||+|||
T Consensus        77 ~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nil  154 (280)
T cd05049          77 CTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCL  154 (280)
T ss_pred             Eec--CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEE
Confidence            986  35799999999999888776432              35789999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 015257          259 VAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDT  335 (410)
Q Consensus       259 l~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~  335 (410)
                      ++.++.++|+|||+++......  .......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||......+.
T Consensus       155 i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~  233 (280)
T cd05049         155 VGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV  233 (280)
T ss_pred             EcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            9999999999999997543221  12233446788999998877665 667999999999999998 9999988877777


Q ss_pred             HHHHHhCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          336 YDKIVNNSL-VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       336 ~~~i~~~~~-~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ...+..+.. .++..++..+.+++.+||+.||.+|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         234 IECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            777776654 345678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.1e-42  Score=330.69  Aligned_cols=264  Identities=26%  Similarity=0.450  Sum_probs=219.0

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+++.||+|+||.||++.+..++..||+|.+....         ....+.+.+|+.+++.++||||+++++++.. 
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-   87 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---------QPKKELIINEILVMRENKHPNIVNYLDSYLV-   87 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---------chHHHHHHHHHHHHhhcCCCCeeehhheeee-
Confidence            368999999999999999999998889999999875321         2234578899999999999999999999986 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       ....|+|+||++++++.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        88 -~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~  165 (293)
T cd06647          88 -GDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (293)
T ss_pred             -CCcEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence             45799999999999998877643 5889999999999999999999999999999999999999999999999998765


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CC--CCCCCCCHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN-SL--VFPDAMNPE  353 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~-~~--~~p~~~~~~  353 (410)
                      ...........|++.|+|||.+..... +.++||||||+++|++++|..||...+.......+... ..  ..+..++..
T Consensus       166 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (293)
T cd06647         166 TPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI  244 (293)
T ss_pred             cccccccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHH
Confidence            544333344568899999998876554 56799999999999999999999876554433332222 21  223457889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhCCcccCCC--CCCchhhh
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN--GPIPQYLC  393 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~--~~~~~~~~  393 (410)
                      +.+++.+||..+|.+||++.+++.|+||....  ..+|.-+.
T Consensus       245 l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~~~~  286 (293)
T cd06647         245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTPLIA  286 (293)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccccchHH
Confidence            99999999999999999999999999999876  56665544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.1e-42  Score=327.70  Aligned_cols=248  Identities=26%  Similarity=0.414  Sum_probs=208.1

Q ss_pred             cceeeeeeecccCceEEEEEEEc-----cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      ++|.+.+.||+|+||.||++...     .++..+|+|.+...         .......+.+|+.++++++||||++++++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   75 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---------SDNARKDFHREAELLTNLQHEHIVKFYGV   75 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---------CHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            46899999999999999999853     34567999987532         23455678999999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEE
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP-------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV  259 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~-------------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll  259 (410)
                      +..  ...+++||||+++++|.+++...             ..+++..++.++.||+.||+|||+.|++||||||+|||+
T Consensus        76 ~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili  153 (288)
T cd05093          76 CVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV  153 (288)
T ss_pred             Eec--CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE
Confidence            986  45799999999999887766432             248999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 015257          260 APSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTY  336 (410)
Q Consensus       260 ~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~  336 (410)
                      +.++.++|+|||+++......  .......+++.|+|||++.+... +.++|||||||++|+|++ |..||......+..
T Consensus       154 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~  232 (288)
T cd05093         154 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI  232 (288)
T ss_pred             ccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999999997653322  12233446788999998876555 667999999999999998 99999888777777


Q ss_pred             HHHHhCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          337 DKIVNNSL-VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       337 ~~i~~~~~-~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ..+..+.. ..+..+++++.+|+.+||+.||.+|||+.+++.
T Consensus       233 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         233 ECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            77777653 456678999999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=357.83  Aligned_cols=261  Identities=26%  Similarity=0.420  Sum_probs=212.8

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeE-EEc
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEV-IDD  195 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~-~~~  195 (410)
                      .++++.+.|.+|||+.||+|.+...|..||+|++..         .++..++.+.+||.+|+.|. |+|||.+++. ...
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---------~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~  107 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---------NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN  107 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---------CCHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence            367889999999999999999998889999998642         26788899999999999997 9999999983 221


Q ss_pred             ---CC-CCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeccCCCCcEEEcCCCcEEE
Q 015257          196 ---PN-SDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHN--VVHGDIKPDNLLVAPSGTVKI  267 (410)
Q Consensus       196 ---~~-~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NIll~~~~~~kl  267 (410)
                         .+ ...++|+||||.|+.|-+++..  ...|+|.++.+|+.|+++||++||...  |||||||-+||||+.+|..||
T Consensus       108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL  187 (738)
T KOG1989|consen  108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL  187 (738)
T ss_pred             ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence               12 2578999999998888877763  346999999999999999999999887  999999999999999999999


Q ss_pred             eeccccccccCCc-cc--------cccCCCccccccccccc---CCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 015257          268 GDFSVSQVFEDDN-DV--------LRRSPGTPVFTAPECCL---GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDT  335 (410)
Q Consensus       268 ~DfG~a~~~~~~~-~~--------~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~  335 (410)
                      ||||.|...-..- ..        -....-|+.|+|||.+.   +... +.++|||+|||+||-||+...||.+...   
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~---  263 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGK---  263 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcc---
Confidence            9999886421111 00        00112599999999874   3333 5679999999999999999999987532   


Q ss_pred             HHHHHhCCCCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC-CCCCCchhh
Q 015257          336 YDKIVNNSLVFPD--AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG-DNGPIPQYL  392 (410)
Q Consensus       336 ~~~i~~~~~~~p~--~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~-~~~~~~~~~  392 (410)
                       -+|+.+.+.||.  .++..+++||..||+.||.+||++.|++++-+-.. ...|++...
T Consensus       264 -laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~  322 (738)
T KOG1989|consen  264 -LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY  322 (738)
T ss_pred             -eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence             367888888886  78999999999999999999999999998766543 344444433

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.6e-42  Score=335.72  Aligned_cols=267  Identities=25%  Similarity=0.358  Sum_probs=211.0

Q ss_pred             ccceee-eeeecccCceEEEEEEEccCCceEEEEeeecccccccccC-----CChHHHHHHHHHHHHHHhCCCCCcccce
Q 015257          117 INEYVH-VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVA-----PSETAMTDVRREVLIMKMLQHPNIVNLI  190 (410)
Q Consensus       117 ~~~y~~-~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hpniv~l~  190 (410)
                      .++|.. .+.||.|+||.||++.+..+++.||||++...........     ........+.+|+.+++.++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            356765 4679999999999999999999999999865432210000     0001122577999999999999999999


Q ss_pred             eEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeec
Q 015257          191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       191 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                      +++..  ....++||||+++ .+...+.....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+||
T Consensus        87 ~~~~~--~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df  163 (335)
T PTZ00024         87 DVYVE--GDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF  163 (335)
T ss_pred             EEEec--CCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence            99876  4589999999985 56666666678999999999999999999999999999999999999999999999999


Q ss_pred             cccccccC--------------CccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015257          271 SVSQVFED--------------DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTY  336 (410)
Q Consensus       271 G~a~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~  336 (410)
                      |+++....              .........+++.|+|||++.+....+.++|||||||++|+|++|..||...+..+..
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~  243 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL  243 (335)
T ss_pred             cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99876541              1111223346888999999876555577899999999999999999999887766555


Q ss_pred             HHHHhCC---C--CC-----------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          337 DKIVNNS---L--VF-----------------------PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       337 ~~i~~~~---~--~~-----------------------p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      ..+....   .  .+                       ....+.++.++|.+||+.+|.+|||+++++.||||++...
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~  321 (335)
T PTZ00024        244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL  321 (335)
T ss_pred             HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence            4443210   0  00                       1235788999999999999999999999999999987644

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-42  Score=318.27  Aligned_cols=253  Identities=32%  Similarity=0.530  Sum_probs=219.1

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|.+.+.||+|++|.||++++..+++.||+|.+.....       .......+.+|++++++++|||++++++++.+  .
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~   71 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-------KEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--S   71 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-------CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--C
Confidence            47889999999999999999998999999999865432       23456789999999999999999999999876  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ...++||||+++++|.+.+.....+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  151 (254)
T cd06627          72 DSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLND  151 (254)
T ss_pred             CEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence            68999999999999998887778899999999999999999999999999999999999999999999999999987655


Q ss_pred             CccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hCCCCCCCCCCHHHHHH
Q 015257          279 DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV-NNSLVFPDAMNPELRNL  357 (410)
Q Consensus       279 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~-~~~~~~p~~~~~~l~~l  357 (410)
                      .........++..|+|||.+.+.. .+.++||||||+++|+|++|..||...........+. .....+|..++..+.++
T Consensus       152 ~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (254)
T cd06627         152 VSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDF  230 (254)
T ss_pred             CcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHH
Confidence            444334566899999999887655 4677999999999999999999997765444333333 34445777889999999


Q ss_pred             HHHhcccCCCCCCCHHHHhhCCcc
Q 015257          358 LEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       358 i~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      +.+||..+|++|||+.+++.||||
T Consensus       231 i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         231 LMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHHHhCChhhCcCHHHHhcCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.7e-42  Score=322.78  Aligned_cols=252  Identities=26%  Similarity=0.441  Sum_probs=207.9

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+.+.||+|+||.||+++...+++.||||.+.....      ........+.+|+.+++.++||||+++++++.+  
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   73 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM------MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--   73 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc------CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--
Confidence            579999999999999999999999999999998754321      133455678899999999999999999999886  


Q ss_pred             CCEEEEEEeecCCCCcccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .+..++||||++++++...+.    ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++
T Consensus        74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~  153 (267)
T cd08228          74 DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccc
Confidence            458899999999988876553    3446899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCC-CC-CCC
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL--QDTYDKIVNNSL-VF-PDA  349 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~--~~~~~~i~~~~~-~~-p~~  349 (410)
                      ..............|++.|+|||.+.+... +.++|+||||+++|+|++|..||.....  ......+..... +. +..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd08228         154 RFFSSKTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEH  232 (267)
T ss_pred             eeccchhHHHhcCCCCccccChhhhccCCC-CchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhh
Confidence            876544333345568899999998876655 5679999999999999999999966432  333344333221 12 235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ++..+.+++.+||+.+|.+|||+.++++.
T Consensus       233 ~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         233 YSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             cCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            77899999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-42  Score=323.06  Aligned_cols=248  Identities=31%  Similarity=0.577  Sum_probs=206.8

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHH-HHhCCCCCcccceeEEEcCCCCEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI-MKMLQHPNIVNLIEVIDDPNSDHFY  202 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~~~  202 (410)
                      +.||.|+||.||+|.+..+|+.||||++.+....      .......+..|..+ ....+||||+++++++..  ...+|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~   73 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI------AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLY   73 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh------HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEE
Confidence            5799999999999999999999999998643211      11222334455444 455689999999999976  46899


Q ss_pred             EEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc
Q 015257          203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV  282 (410)
Q Consensus       203 lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  282 (410)
                      +||||+++++|..++...+.+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||+++....    
T Consensus        74 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----  149 (260)
T cd05611          74 LVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----  149 (260)
T ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence            9999999999999888777899999999999999999999999999999999999999999999999999875433    


Q ss_pred             cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHH
Q 015257          283 LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAMNPELRNLL  358 (410)
Q Consensus       283 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~l~~li  358 (410)
                      .....|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+....+..+......++    ..+++.+.+++
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  228 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLI  228 (260)
T ss_pred             cccCCCCcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHH
Confidence            234458889999999877653 6779999999999999999999988877777776665544333    35789999999


Q ss_pred             HHhcccCCCCCC---CHHHHhhCCcccCC
Q 015257          359 EGLLCKDPTRRL---TLNDVAKHTWVLGD  384 (410)
Q Consensus       359 ~~~L~~dp~~Rp---t~~ell~h~~~~~~  384 (410)
                      .+||+.||++||   ++.|++.||||.+.
T Consensus       229 ~~~l~~~p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         229 NRLLCMDPAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             HHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence            999999999999   55899999999653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2e-42  Score=332.44  Aligned_cols=249  Identities=20%  Similarity=0.333  Sum_probs=205.2

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCce----EEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKH----YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      .+|++++.||+|+||.||++....++..    ||||++....        .......+.+|+.+++.++||||+++++++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~niv~~~g~~   78 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--------SPKANKEILDEAYVMASVDNPHVCRLLGIC   78 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            4699999999999999999987665554    8999875321        234456788999999999999999999998


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      ..   ...++|+||++++++.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        79 ~~---~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~  155 (316)
T cd05108          79 LT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGL  155 (316)
T ss_pred             cC---CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccc
Confidence            75   2478999999999988877653 4689999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccc--cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCC
Q 015257          273 SQVFEDDNDV--LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPD  348 (410)
Q Consensus       273 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~  348 (410)
                      ++........  .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+..+ ....|.
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
T cd05108         156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP  234 (316)
T ss_pred             cccccCCCcceeccCCccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCC
Confidence            9876533221  122334678999998876655 567999999999999997 99999887665544333332 234566


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .++.++.+++.+||..||.+|||+.+++.+
T Consensus       235 ~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         235 ICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            788999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.2e-42  Score=335.91  Aligned_cols=260  Identities=28%  Similarity=0.450  Sum_probs=206.6

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      ..+|.+.+.||.|+||.||++.+..+|+.||+|.+....         ....+.+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---------~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~   74 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---------PQSVKHALREIKIIRRLDHDNIVKVYEVLGPS   74 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---------CchHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence            368999999999999999999999999999999875432         23446788999999999999999999877643


Q ss_pred             CC------------CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC-CC
Q 015257          197 NS------------DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SG  263 (410)
Q Consensus       197 ~~------------~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~-~~  263 (410)
                      ..            ...++||||+++ ++...+. ...+++..++.++.||+.||.|||+.||+||||||+||+++. ++
T Consensus        75 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~  152 (342)
T cd07854          75 GSDLTEDVGSLTELNSVYIVQEYMET-DLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL  152 (342)
T ss_pred             ccccccccccccccceEEEEeecccc-cHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc
Confidence            21            357999999985 5555443 346899999999999999999999999999999999999975 55


Q ss_pred             cEEEeeccccccccCCcc---ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015257          264 TVKIGDFSVSQVFEDDND---VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV  340 (410)
Q Consensus       264 ~~kl~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~  340 (410)
                      .++|+|||+++.......   ......|+..|+|||.+......+.++|||||||++|+|++|..||...........+.
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            789999999976432211   11233578899999987665555678999999999999999999998765444333332


Q ss_pred             hCC-------------------------C-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          341 NNS-------------------------L-----VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       341 ~~~-------------------------~-----~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                      ...                         .     .+...++.++.+||.+||+.||.+|||+.+++.||||+....|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~  309 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP  309 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence            210                         0     0123577889999999999999999999999999999855433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.9e-42  Score=317.97  Aligned_cols=255  Identities=33%  Similarity=0.528  Sum_probs=217.7

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|...+.||+|++|.||++.+..+++.|++|++.....       .......+.+|+.++++++||||+++++.+.+...
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-------SEEELEALEREIRILSSLQHPNIVRYYGSERDEEK   73 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC
Confidence            47888999999999999999999999999999865422       13456789999999999999999999999987433


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ..+++|+||++++++.+.+.....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        74 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          74 NTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             CeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            68999999999999998887777899999999999999999999999999999999999999999999999999987655


Q ss_pred             Ccc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHh--CCCCCCCCCCHH
Q 015257          279 DND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKIVN--NSLVFPDAMNPE  353 (410)
Q Consensus       279 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~i~~--~~~~~p~~~~~~  353 (410)
                      ...  ......++..|+|||.+.+... +.++||||||+++|+|++|..||.... .......+..  ....+|...+..
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEE  232 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHH
Confidence            432  1345568899999998876654 667999999999999999999998765 2223333332  334567788999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      +.++|.+||+.||.+||++.+++.||||
T Consensus       233 l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         233 AKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.6e-42  Score=325.22  Aligned_cols=246  Identities=23%  Similarity=0.416  Sum_probs=201.0

Q ss_pred             ccceeeeeee--cccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEE
Q 015257          117 INEYVHVRKI--GAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVI  193 (410)
Q Consensus       117 ~~~y~~~~~l--G~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  193 (410)
                      .++|.+.+.+  |+|+||.||++.++.++..+|+|.+......            .  .|+.....+ +||||+++++.+
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~------------~--~e~~~~~~~~~h~~iv~~~~~~   78 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN------------A--IEPMVHQLMKDNPNFIKLYYSV   78 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc------------h--hhHHHHHHhhcCCCEEEEEEEE
Confidence            3456666665  9999999999999999999999998653211            0  122222222 799999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC-cEEEeeccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSV  272 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~-~~kl~DfG~  272 (410)
                      ..  ...+++||||+++++|.+++.....+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||+
T Consensus        79 ~~--~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~  156 (267)
T PHA03390         79 TT--LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL  156 (267)
T ss_pred             ec--CCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence            87  358999999999999999887777899999999999999999999999999999999999999998 999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCC
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQD----TYDKIVNNSLVFPD  348 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~----~~~~i~~~~~~~p~  348 (410)
                      ++.....    ....|++.|+|||++.+..+ +.++||||||+++|+|++|..||.......    .+..........+.
T Consensus       157 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (267)
T PHA03390        157 CKIIGTP----SCYDGTLDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIK  231 (267)
T ss_pred             ceecCCC----ccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCccc
Confidence            8765432    23458899999999877665 567999999999999999999997543322    12222233445666


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCC-HHHHhhCCcccC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLT-LNDVAKHTWVLG  383 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt-~~ell~h~~~~~  383 (410)
                      .+++.+.+||.+||+.||.+||+ ++++++||||..
T Consensus       232 ~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        232 NVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             ccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            79999999999999999999996 699999999963

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-42  Score=334.09  Aligned_cols=258  Identities=25%  Similarity=0.412  Sum_probs=210.1

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||++.+..+|..||||++....       ........+.+|+.+++.++||||+++++++..
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-------QSELFAKRAYRELRLLKHMKHENVIGLLDVFTP   85 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHHHHHHhcCCCCccceeeeecC
Confidence            4568999999999999999999999999999999875421       123344568899999999999999999998875


Q ss_pred             CCC----CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          196 PNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       196 ~~~----~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      ...    ..+++||||+ ++++...+. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||
T Consensus        86 ~~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          86 DLSLDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             CccccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence            321    2569999999 556666554 3578999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-------  344 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-------  344 (410)
                      ++......   .....+++.|+|||.+.+....+.++|+||||+++|+|++|..||.+.........+.....       
T Consensus       164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07880         164 LARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV  240 (343)
T ss_pred             cccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            99765332   23446788999999887644446789999999999999999999987765544433322110       


Q ss_pred             ------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          345 ------------------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       345 ------------------------~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                                              .+...+++++.++|.+||+.||.+|||+.+++.||||....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence                                    01235678899999999999999999999999999998753

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.7e-42  Score=319.27  Aligned_cols=243  Identities=26%  Similarity=0.367  Sum_probs=201.4

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYM  203 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l  203 (410)
                      +.||+|+||.||++.+..+++.||+|.+...        ...+....+.+|+.+++.++||||+++++++..  ....++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l   70 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET--------LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYI   70 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc--------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEE
Confidence            3699999999999999999999999986432        134455678999999999999999999999876  457899


Q ss_pred             EEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc
Q 015257          204 VLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV  282 (410)
Q Consensus       204 v~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  282 (410)
                      ||||++++++.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        71 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          71 VMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             EEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccccc
Confidence            99999999998887553 46899999999999999999999999999999999999999999999999998754432111


Q ss_pred             cc--cCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCCCHHHHHHH
Q 015257          283 LR--RSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNLL  358 (410)
Q Consensus       283 ~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~l~~li  358 (410)
                      ..  ...++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+... ....|..++..+.+|+
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  229 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLM  229 (252)
T ss_pred             ccCCCCCCceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHH
Confidence            11  1122456999998877665 567999999999999997 99999776665555554443 3456778899999999


Q ss_pred             HHhcccCCCCCCCHHHHhh
Q 015257          359 EGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       359 ~~~L~~dp~~Rpt~~ell~  377 (410)
                      .+||+.+|.+|||+.++++
T Consensus       230 ~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         230 ERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.2e-42  Score=325.44  Aligned_cols=250  Identities=22%  Similarity=0.351  Sum_probs=206.4

Q ss_pred             cceeeeeeecccCceEEEEEEEc----cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSS----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ++|++.+.||+|+||.||++...    .++..||+|.+...        ........+.+|+.+++.++||||+++++++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   76 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--------NNPQQWGEFQQEASLMAELHHPNIVCLLGVV   76 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--------CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE
Confidence            56889999999999999999853    35678999987532        1234456788999999999999999999998


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQ-----------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDN  256 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~-----------------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N  256 (410)
                      ..  ....++||||++++++.+++..                 ...+++..+..++.||+.||+|||++||+||||||+|
T Consensus        77 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~n  154 (283)
T cd05090          77 TQ--EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARN  154 (283)
T ss_pred             ec--CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccce
Confidence            76  4578999999999888776532                 1247888999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 015257          257 LLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQ  333 (410)
Q Consensus       257 Ill~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~  333 (410)
                      ||++.++.+||+|||+++......  .......++..|+|||++.+... +.++||||||+++|+|++ |..||.+....
T Consensus       155 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~  233 (283)
T cd05090         155 ILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ  233 (283)
T ss_pred             EEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999999999997653321  22233446778999998876655 667999999999999998 99999887766


Q ss_pred             HHHHHHHhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          334 DTYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       334 ~~~~~i~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .....+.... ...+..+++.+.+++.+||+.||.+||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         234 EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            6555555443 34667889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.3e-42  Score=336.74  Aligned_cols=251  Identities=20%  Similarity=0.372  Sum_probs=202.3

Q ss_pred             cceeeeeeecccCceEEEEEEEcc-----CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCccccee
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIE  191 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~  191 (410)
                      ++|++++.||.|+||.||++....     +++.||+|++....        .......+..|+.++.++ +||||+++++
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~~~~E~~~~~~l~~h~niv~~~~   78 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--------TASEYKALMTELKILIHIGHHLNVVNLLG   78 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--------CHHHHHHHHHHHHHHHhhccCcchhheee
Confidence            579999999999999999997433     45789999875321        233456788999999999 8999999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCC----------------------------------------------------
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQ----------------------------------------------------  219 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~----------------------------------------------------  219 (410)
                      ++... ...++++|||++++++.+.+..                                                    
T Consensus        79 ~~~~~-~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (337)
T cd05054          79 ACTKP-GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVE  157 (337)
T ss_pred             eEecC-CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcc
Confidence            88754 4578999999999888765532                                                    


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCcc--ccccCCC
Q 015257          220 ---------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPG  288 (410)
Q Consensus       220 ---------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~g  288 (410)
                               ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.+.....  ......+
T Consensus       158 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~  237 (337)
T cd05054         158 EDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  237 (337)
T ss_pred             cchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCC
Confidence                     12678999999999999999999999999999999999999999999999999986533221  1223445


Q ss_pred             cccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH-hC-CCCCCCCCCHHHHHHHHHhcccC
Q 015257          289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIV-NN-SLVFPDAMNPELRNLLEGLLCKD  365 (410)
Q Consensus       289 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~-~~-~~~~p~~~~~~l~~li~~~L~~d  365 (410)
                      +..|+|||++.+..+ +.++|||||||+||+|++ |..||.+....+...... .+ ....|...++++.+++.+||+.+
T Consensus       238 ~~~y~aPE~~~~~~~-~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~  316 (337)
T cd05054         238 PLKWMAPESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNN  316 (337)
T ss_pred             CccccCcHHhcCCCC-CccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCC
Confidence            678999998877666 566999999999999998 999998754433332332 22 23456678899999999999999


Q ss_pred             CCCCCCHHHHhhC
Q 015257          366 PTRRLTLNDVAKH  378 (410)
Q Consensus       366 p~~Rpt~~ell~h  378 (410)
                      |.+|||+.++++|
T Consensus       317 p~~RPs~~ell~~  329 (337)
T cd05054         317 PEDRPTFSELVEI  329 (337)
T ss_pred             hhhCcCHHHHHHH
Confidence            9999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-42  Score=335.19  Aligned_cols=261  Identities=28%  Similarity=0.461  Sum_probs=216.4

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC-
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN-  197 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-  197 (410)
                      +|.+.+.||.|+||.||++++..+++.||||.+.....       .....+.+.+|+.+++.++||||+++++++.... 
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-------DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSP   73 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-------cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc
Confidence            48899999999999999999998999999998864311       1334467889999999999999999999887642 


Q ss_pred             --CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          198 --SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       198 --~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                        ...+|+||||+++ .+...+.....+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++..
T Consensus        74 ~~~~~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          74 EDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             ccccceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence              2478999999985 5666666667899999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCc---cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------
Q 015257          276 FEDDN---DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV-------  345 (410)
Q Consensus       276 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-------  345 (410)
                      .....   .......+|+.|+|||++.+....+.++||||||+++|+|++|..||.+.+..+....+......       
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence            65443   12344567899999999887745577899999999999999999999887766555444331100       


Q ss_pred             ------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          346 ------------------------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       346 ------------------------~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                                              ....+++++.+||.+||+.+|.+|||+.+++.||||.+...+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                                    112367889999999999999999999999999999876554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-42  Score=318.15  Aligned_cols=247  Identities=36%  Similarity=0.659  Sum_probs=218.3

Q ss_pred             ecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEEEE
Q 015257          126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVL  205 (410)
Q Consensus       126 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~  205 (410)
                      ||.|+||.||++.+..+++.||+|++......      .......+..|+.+++.++||||+++++.+..  ....++||
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~   72 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII------KRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVL   72 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhc------chHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEE
Confidence            79999999999999989999999998754321      23456688999999999999999999998875  56899999


Q ss_pred             eecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCcccccc
Q 015257          206 EYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR  285 (410)
Q Consensus       206 e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  285 (410)
                      ||++++++.+.+.....+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++............
T Consensus        73 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~  152 (250)
T cd05123          73 EYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT  152 (250)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccC
Confidence            99999999988887778999999999999999999999999999999999999999999999999999876544333445


Q ss_pred             CCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcccC
Q 015257          286 SPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKD  365 (410)
Q Consensus       286 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L~~d  365 (410)
                      ..++..|+|||.+.+... +.++|+||||+++|+|++|..||...........+......+|...+..+.+++.+||..|
T Consensus       153 ~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~  231 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKD  231 (250)
T ss_pred             CcCCccccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCC
Confidence            668899999998876554 5679999999999999999999988777777777777778888899999999999999999


Q ss_pred             CCCCCCH---HHHhhCCcc
Q 015257          366 PTRRLTL---NDVAKHTWV  381 (410)
Q Consensus       366 p~~Rpt~---~ell~h~~~  381 (410)
                      |.+|||+   .++++||||
T Consensus       232 p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         232 PTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HhhCCCcccHHHHHhCCCC
Confidence            9999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.1e-42  Score=322.37  Aligned_cols=247  Identities=23%  Similarity=0.375  Sum_probs=211.1

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      .+|.+++.||.|+||.||++.... +..+|+|++....         ......+..|+.+++.++||||+++++++.+  
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--   73 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---------LLKQQDFQKEVQALKRLRHKHLISLFAVCSV--   73 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---------hhhHHHHHHHHHHHhcCCCcchhheeeeEec--
Confidence            469999999999999999999987 8899999876432         2234578899999999999999999999876  


Q ss_pred             CCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      ...+++||||+++++|.+++..  ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~  153 (261)
T cd05148          74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARL  153 (261)
T ss_pred             CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhh
Confidence            4578999999999999888765  34689999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCCCHH
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPE  353 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~  353 (410)
                      ............+++.|+|||.+..... +.++||||||+++|+|++ |..||.+....+....+... ....+..+++.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (261)
T cd05148         154 IKEDVYLSSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQE  232 (261)
T ss_pred             cCCccccccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHH
Confidence            6544333334456778999998876554 567999999999999998 89999888777777666654 33456788999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhh
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      +.+++.+||+.||.+|||+.++++
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         233 IYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.9e-42  Score=325.22  Aligned_cols=256  Identities=21%  Similarity=0.281  Sum_probs=209.5

Q ss_pred             ccceeeeeeecccCceEEEEEEEcc-----CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCccccee
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE  191 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  191 (410)
                      .++|.+.+.||+|+||.||++..+.     .+..||+|.+....        .......+.+|+.+++.++||||+++++
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~   76 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--------SLRERIEFLNEASVMKGFTCHHVVRLLG   76 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--------CHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence            3579999999999999999987652     35589999875321        2223346788999999999999999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQP----------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP  261 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~  261 (410)
                      ++.+.  ...++||||+++++|.+++...          ..++...+..++.||+.||.|||+++|+||||||+|||++.
T Consensus        77 ~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~  154 (288)
T cd05061          77 VVSKG--QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH  154 (288)
T ss_pred             EEcCC--CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcC
Confidence            98763  4789999999999988877431          23567788999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 015257          262 SGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDK  338 (410)
Q Consensus       262 ~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~  338 (410)
                      ++.++|+|||+++.......  ......++..|+|||.+.+... +.++|||||||++|+|++ |..||.+....+....
T Consensus       155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~  233 (288)
T cd05061         155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF  233 (288)
T ss_pred             CCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999986543221  1122345678999998876655 667999999999999998 7899988777776666


Q ss_pred             HHhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh------CCcccC
Q 015257          339 IVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK------HTWVLG  383 (410)
Q Consensus       339 i~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~------h~~~~~  383 (410)
                      +..+. ...+...++.+.+++.+||+.||++|||+.++++      ||||.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         234 VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            65543 3466778899999999999999999999999987      899875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-42  Score=354.04  Aligned_cols=270  Identities=19%  Similarity=0.309  Sum_probs=196.0

Q ss_pred             cccccceeeeeeecccCceEEEEEEEcc-CCceEEEEeeeccccc--------ccccCCChHHHHHHHHHHHHHHhCCCC
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSL-DGKHYAIKAFHKSHLS--------KLRVAPSETAMTDVRREVLIMKMLQHP  184 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~~vaiK~~~~~~~~--------~~~~~~~~~~~~~~~~E~~~l~~l~hp  184 (410)
                      ..+.++|++++.||+|+||+||++..+. ++...++|.+......        .............+.+|+.+|+.++||
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence            4556789999999999999999987654 3333333322111000        000111233455788999999999999


Q ss_pred             CcccceeEEEcCCCCEEEEEEeecCCCCcccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEc
Q 015257          185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA  260 (410)
Q Consensus       185 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~  260 (410)
                      |||++++++.+  ....|+|++++.+..+.....    .........++.++.||+.||.|||++||+||||||+|||++
T Consensus       224 nIv~l~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        224 NILKIEEILRS--EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcCcEeEEEEE--CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence            99999999987  457899999987654332221    122345677889999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCcc-ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCC-CCCCC--HHHHH
Q 015257          261 PSGTVKIGDFSVSQVFEDDND-VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYP-FLGET--LQDTY  336 (410)
Q Consensus       261 ~~~~~kl~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~P-f~~~~--~~~~~  336 (410)
                      .++.+||+|||+++.+..... ......||+.|+|||++.+..+ +.++|||||||++|||++|..+ |....  .....
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            999999999999987654322 2334679999999999887665 6679999999999999998754 43221  11111


Q ss_pred             HHHHhC----CCCCC----------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          337 DKIVNN----SLVFP----------------------------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       337 ~~i~~~----~~~~p----------------------------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      ..++..    ...+|                            ..++.++.++|.+||+.||.+|||+.|+|.||||...
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            111110    00011                            1345678889999999999999999999999999876


Q ss_pred             CC
Q 015257          385 NG  386 (410)
Q Consensus       385 ~~  386 (410)
                      ..
T Consensus       461 ~~  462 (501)
T PHA03210        461 EE  462 (501)
T ss_pred             Cc
Confidence            44

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.5e-42  Score=319.90  Aligned_cols=243  Identities=22%  Similarity=0.362  Sum_probs=203.6

Q ss_pred             eecccCceEEEEEEE--ccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEE
Q 015257          125 KIGAGSYGKVVLYRS--SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFY  202 (410)
Q Consensus       125 ~lG~G~fg~Vy~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~  202 (410)
                      .||+|+||.||++..  ..++..+|+|++....       ......+.+.+|+.+++.++||||+++++++..   ...+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   71 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-------NDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWM   71 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-------CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcE
Confidence            589999999999854  4578899999875331       123456788999999999999999999998853   4679


Q ss_pred             EEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc
Q 015257          203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV  282 (410)
Q Consensus       203 lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  282 (410)
                      +||||++++++.+++.....+++..+..++.||+.||+|||++||+||||||.|||++.++.+||+|||+++........
T Consensus        72 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~  151 (257)
T cd05116          72 LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY  151 (257)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence            99999999999988877778999999999999999999999999999999999999999999999999999865433221


Q ss_pred             ---cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 015257          283 ---LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMNPELRNL  357 (410)
Q Consensus       283 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~l~~l  357 (410)
                         .....+++.|+|||.+..... +.++|||||||++|||++ |..||...........+..+. ...|..+++++.+|
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  230 (257)
T cd05116         152 YKAKTHGKWPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDL  230 (257)
T ss_pred             eeecCCCCCCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence               122234578999998865554 567999999999999998 999998877777666666543 35677899999999


Q ss_pred             HHHhcccCCCCCCCHHHHhhC
Q 015257          358 LEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       358 i~~~L~~dp~~Rpt~~ell~h  378 (410)
                      |.+||+.||.+||++++|.+.
T Consensus       231 i~~~~~~~p~~Rp~~~~i~~~  251 (257)
T cd05116         231 MKLCWTYGVDERPGFAVVELR  251 (257)
T ss_pred             HHHHhccCchhCcCHHHHHHH
Confidence            999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.9e-42  Score=318.76  Aligned_cols=246  Identities=24%  Similarity=0.404  Sum_probs=206.2

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+.+.||+|+||.||++... ++..+|+|.+....          .....+.+|+.+++.++||||+++++++.+  
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   70 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA----------MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ--   70 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC----------ccHHHHHHHHHHHHHCCCCCceeEEEEEcc--
Confidence            46889999999999999999875 45679999865321          123468899999999999999999999876  


Q ss_pred             CCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ....++||||++++++.+.+.. .+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++..
T Consensus        71 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~  150 (256)
T cd05114          71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV  150 (256)
T ss_pred             CCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCcccc
Confidence            4579999999999998887754 356899999999999999999999999999999999999999999999999998765


Q ss_pred             cCCccc-cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHH
Q 015257          277 EDDNDV-LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMNPE  353 (410)
Q Consensus       277 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~  353 (410)
                      ...... .....++..|+|||++.+..+ +.++||||||+++|+|++ |+.||...+..+....+..+. ...|...+..
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  229 (256)
T cd05114         151 LDDEYTSSSGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMT  229 (256)
T ss_pred             CCCceeccCCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence            432221 122335667999998876554 567999999999999999 999998888777777776654 3456678899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhh
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      +.+|+.+||+.+|.+|||++++++
T Consensus       230 ~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         230 VYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.4e-42  Score=323.49  Aligned_cols=251  Identities=20%  Similarity=0.279  Sum_probs=205.9

Q ss_pred             ccceeeeeeecccCceEEEEEEEcc-----CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCccccee
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE  191 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  191 (410)
                      .++|++.+.||+|+||.||++....     ++..||||++....        .......+.+|+.+++.++||||+++++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~iv~~~~   76 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--------SMRERIEFLNEASVMKEFNCHHVVRLLG   76 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--------CHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence            3579999999999999999988642     45789999874321        2234456889999999999999999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQP----------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP  261 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~  261 (410)
                      ++.+  ....++||||+++++|.+++...          ..+++..+..++.|++.||.|||+.|++||||||+|||++.
T Consensus        77 ~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~  154 (277)
T cd05062          77 VVSQ--GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE  154 (277)
T ss_pred             EEcC--CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcC
Confidence            9875  45789999999999888776432          23577889999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCccc--cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 015257          262 SGTVKIGDFSVSQVFEDDNDV--LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDK  338 (410)
Q Consensus       262 ~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~  338 (410)
                      ++.++|+|||+++........  .....+++.|+|||++.+... +.++|||||||++|+|++ |..||.+.........
T Consensus       155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~  233 (277)
T cd05062         155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF  233 (277)
T ss_pred             CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            999999999998754332211  112345778999999876655 667999999999999999 7899988877776666


Q ss_pred             HHhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          339 IVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       339 i~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +.... ..++..++..+.+++.+||+.||.+|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         234 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            55544 35667889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-42  Score=334.91  Aligned_cols=262  Identities=24%  Similarity=0.424  Sum_probs=213.0

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+.+.||+|+||.||++++..++..||||++....       ........+.+|+.+++.++||||+++++++.
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   84 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-------QSAIHAKRTYRELRLLKHMDHENVIGLLDVFT   84 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-------chhhHHHHHHHHHHHHHhccCCCHHHHHHHhh
Confidence            34568999999999999999999999999999999875421       12234456788999999999999999998776


Q ss_pred             cCC----CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeec
Q 015257          195 DPN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       195 ~~~----~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                      ...    ...+++|+||++ +++.+.+.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+||
T Consensus        85 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~df  162 (343)
T cd07851          85 PASSLEDFQDVYLVTHLMG-ADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF  162 (343)
T ss_pred             ccccccccccEEEEEecCC-CCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccc
Confidence            432    135899999995 466665554 46999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----
Q 015257          271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV-----  345 (410)
Q Consensus       271 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-----  345 (410)
                      |++......   .....+|+.|+|||.+.+....+.++||||||+++|+|++|+.||.+......+..+......     
T Consensus       163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         163 GLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             ccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            999765432   334567889999998866444567899999999999999999999877666555444331100     


Q ss_pred             --------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCC
Q 015257          346 --------------------------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI  388 (410)
Q Consensus       346 --------------------------~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~  388 (410)
                                                ....+++.+.+||.+||+.||.+|||+.+|+.||||.....+-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~  308 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE  308 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence                                      0124588999999999999999999999999999998765543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-42  Score=322.70  Aligned_cols=254  Identities=30%  Similarity=0.523  Sum_probs=207.6

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  199 (410)
                      |.+++.||+|+||.||++....+|+.+|+|++....       ........+.+|+.+++.++|||++++++++.+....
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   73 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-------EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKG   73 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-------ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCC
Confidence            678999999999999999999999999999987542       1123335678999999999999999999999874346


Q ss_pred             EEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          200 HFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ..++||||+++ ++...+... ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        74 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~  152 (287)
T cd07840          74 SIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTK  152 (287)
T ss_pred             cEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence            89999999986 455555443 5799999999999999999999999999999999999999999999999999986654


Q ss_pred             Ccc-ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------------
Q 015257          279 DND-VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-------------  344 (410)
Q Consensus       279 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-------------  344 (410)
                      ... ......++..|+|||.+.+....+.++||||||+++|+|++|+.||...+.......+.....             
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            321 123345688899999877655456789999999999999999999988776555444432100             


Q ss_pred             ----------C--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          345 ----------V--------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       345 ----------~--------~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                                .        +...+++.+.+++.+||..+|.+|||++++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                      0        011138889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-44  Score=340.66  Aligned_cols=258  Identities=28%  Similarity=0.487  Sum_probs=235.3

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      ..++.++..||-||||.|-+++.......+|+|++++...-      ...+.+.+..|-.||..++.|.||++|..|.+ 
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIV------dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd-  491 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIV------DTKQQEHVFSERNIMMECRSDFIVRLYRTFRD-  491 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhcc------chhHHHHHHhHHHHHHhcCchHHHHHHHHhcc-
Confidence            45677888999999999999998876667999999876543      34567789999999999999999999999987 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       .+++||+||-|-||.+...+...+.+.+.+++.++..+++|++|||.+|||+|||||+|.|++.+|.+||.|||+|+..
T Consensus       492 -~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki  570 (732)
T KOG0614|consen  492 -SKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI  570 (732)
T ss_pred             -chhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh
Confidence             6799999999999999999999999999999999999999999999999999999999999999999999999999987


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFPDAMNPEL  354 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~l  354 (410)
                      ..+. .+.++||||.|.|||++.+..+ +.++|.||||+++||||+|.+||.+.+....+..|+++-  +.||..++..+
T Consensus       571 ~~g~-KTwTFcGTpEYVAPEIILnKGH-D~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a  648 (732)
T KOG0614|consen  571 GSGR-KTWTFCGTPEYVAPEIILNKGH-DRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTA  648 (732)
T ss_pred             ccCC-ceeeecCCcccccchhhhccCc-chhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhH
Confidence            7654 4458899999999999988776 678999999999999999999999999999999999874  57999999999


Q ss_pred             HHHHHHhcccCCCCCCC-----HHHHhhCCcccCC
Q 015257          355 RNLLEGLLCKDPTRRLT-----LNDVAKHTWVLGD  384 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~~  384 (410)
                      .+||+++...+|.+|+.     +.++-+|.||.+.
T Consensus       649 ~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf  683 (732)
T KOG0614|consen  649 TDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF  683 (732)
T ss_pred             HHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence            99999999999999995     8999999999763

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-43  Score=310.60  Aligned_cols=273  Identities=24%  Similarity=0.382  Sum_probs=219.8

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID  194 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  194 (410)
                      .+++.+.+..||+|++|.|++++.+.+|...|||.+...        .+.+..++++..+.++... +.|+||+++|+|.
T Consensus        90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--------~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi  161 (391)
T KOG0983|consen   90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--------GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI  161 (391)
T ss_pred             ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--------CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence            356778889999999999999999999999999988654        3566778888888886655 4999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      ..  ..++|.||.|.--....+..-.++++|..+-++...++.||.||-+ +||||||+||+|||+|..|++||||||++
T Consensus       162 ~n--~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIs  239 (391)
T KOG0983|consen  162 TN--TDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGIS  239 (391)
T ss_pred             eC--chHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccc
Confidence            63  4588999998642222222234569999999999999999999996 48999999999999999999999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCC--cCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCC-CC--
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGL--TYGGKAADTWAVGVTLYYMIIGQYPFLGE-TLQDTYDKIVNNSLV-FP--  347 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~elltG~~Pf~~~-~~~~~~~~i~~~~~~-~p--  347 (410)
                      ..+.+. ...+...|.+.|||||.+.-.  ..+.-++||||||++|+||.||..||.+. ...+.+-++++...+ .|  
T Consensus       240 GrlvdS-kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~  318 (391)
T KOG0983|consen  240 GRLVDS-KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGH  318 (391)
T ss_pred             ceeecc-cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcc
Confidence            876654 344566799999999988543  33356799999999999999999999884 445677777775442 22  


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC---CCCchhhhhhhccc
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN---GPIPQYLCWCKRDR  399 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~---~~~~~~~~~~~~~~  399 (410)
                      ..+|+++.+|+..||.+|+.+||...++|+|||+....   ..+++.+.-...++
T Consensus       319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF~dV~~~~  373 (391)
T KOG0983|consen  319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASWFKDVMAKT  373 (391)
T ss_pred             cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHHHHHHHhcc
Confidence            25899999999999999999999999999999998763   34555555444444

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.8e-42  Score=324.82  Aligned_cols=260  Identities=27%  Similarity=0.475  Sum_probs=215.5

Q ss_pred             ceeeeeeecccCceEEEEEEEc---cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEE
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID  194 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  194 (410)
                      .|++.+.||.|+||.||+++..   .+|+.||+|++......     ......+.+.+|+.+++.+ +||||+++++.+.
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~-----~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIV-----QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhh-----hcchHHHHHHHHHHHHHhcccCCChhceeeEee
Confidence            3788999999999999999875   47899999998643211     1223445788999999999 5999999999987


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      .  ...+++||||++++++.+.+.....+++..+..++.||+.||.|||+.|++||||+|+|||++.++.+||+|||++.
T Consensus        76 ~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          76 T--DTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             c--CCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            6  45889999999999999888777789999999999999999999999999999999999999999999999999997


Q ss_pred             cccCCc-cccccCCCcccccccccccCCc-CCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCCC
Q 015257          275 VFEDDN-DVLRRSPGTPVFTAPECCLGLT-YGGKAADTWAVGVTLYYMIIGQYPFLGET----LQDTYDKIVNNSLVFPD  348 (410)
Q Consensus       275 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~  348 (410)
                      ...... .......|+..|+|||.+.... ..+.++||||||+++|+|++|..||....    .......+......+|.
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (290)
T cd05613         154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ  233 (290)
T ss_pred             ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCc
Confidence            654322 2223456899999999886532 23567999999999999999999996432    23344455555566778


Q ss_pred             CCCHHHHHHHHHhcccCCCCCC-----CHHHHhhCCcccCCC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTWVLGDN  385 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~~  385 (410)
                      .+++.+.+++.+||..||.+||     ++.+++.||||+...
T Consensus       234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            8999999999999999999997     899999999998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1e-41  Score=318.97  Aligned_cols=250  Identities=26%  Similarity=0.382  Sum_probs=208.9

Q ss_pred             cceeeeeeecccCceEEEEEEEccC---CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ++|.+.+.||+|+||.||++....+   ...||||.+....        .......+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   75 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--------SDKQRLDFLTEASIMGQFDHPNIIRLEGVVT   75 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--------ChHHHHHHHHHHHHHHhCCCCCcceEeEEEe
Confidence            4689999999999999999988654   4579999875321        2344567889999999999999999999987


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .  ....++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++
T Consensus        76 ~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~  153 (266)
T cd05033          76 K--SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS  153 (266)
T ss_pred             c--CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchh
Confidence            6  4578999999999999888755 347899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccc--cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCC
Q 015257          274 QVFEDDNDV--LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDA  349 (410)
Q Consensus       274 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~  349 (410)
                      +........  .....+++.|+|||.+.+... +.++||||||+++|+|++ |..||......+....+.... ...+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  232 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMD  232 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            876422221  122334678999998876655 567999999999999998 999998777777666666542 345667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ++..+.+|+.+||+.+|++||++.+++++
T Consensus       233 ~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         233 CPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            89999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-42  Score=317.36  Aligned_cols=244  Identities=27%  Similarity=0.420  Sum_probs=210.5

Q ss_pred             eeecccCceEEEEEEEccC---CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCE
Q 015257          124 RKIGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH  200 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  200 (410)
                      +.||+|+||.||++.....   +..||+|++....        .......+.+|+.+++.++|+||+++++++..  ...
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~   70 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--------SEEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEP   70 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeecccc--------chhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCc
Confidence            4699999999999999866   8899999986432        12246788999999999999999999999986  568


Q ss_pred             EEEEEeecCCCCcccccCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          201 FYMVLEYVEGKWDNDGFGQP---------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       201 ~~lv~e~~~~~~l~~~~~~~---------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      +++||||++++++.+.+...         ..+++..++.++.||+.||+|||++||+|+||+|+||+++.++.++|+|||
T Consensus        71 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg  150 (262)
T cd00192          71 LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFG  150 (262)
T ss_pred             eEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccc
Confidence            99999999999999888764         789999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCC
Q 015257          272 VSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFP  347 (410)
Q Consensus       272 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p  347 (410)
                      .+.......  .......+++.|+|||.+..... +.++||||||+++|+|++ |..||......+....+..+ ....|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  229 (262)
T cd00192         151 LSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKP  229 (262)
T ss_pred             cccccccccccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            998765432  22334557889999998876644 677999999999999999 69999988777777777654 34567


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..+++++.+++.+||+.||.+|||+.+++++
T Consensus       230 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         230 EYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             ccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            7889999999999999999999999999975

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4e-42  Score=321.58  Aligned_cols=251  Identities=28%  Similarity=0.448  Sum_probs=207.1

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+.+.||+|+||.||++....+++.||||.+.....      ........+.+|+.+++.++||||+++++++.+  
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--   73 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL------MDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--   73 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh------hhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--
Confidence            468899999999999999999999999999998764321      123445678899999999999999999999886  


Q ss_pred             CCEEEEEEeecCCCCcccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      ....+++|||++++++.+++.    ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++
T Consensus        74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~  153 (267)
T cd08229          74 DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             CCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhh
Confidence            458999999999998887654    2456899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCC-CC-CCC
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL--QDTYDKIVNNSL-VF-PDA  349 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~--~~~~~~i~~~~~-~~-p~~  349 (410)
                      ..............|++.|+|||++.+... +.++||||||+++|+|++|..||.+...  ......+..... .. +..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd08229         154 RFFSSKTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH  232 (267)
T ss_pred             hccccCCcccccccCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCccc
Confidence            876544333345578999999998876655 5679999999999999999999976433  233333333221 12 235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      +++.+.+++.+||..||.+|||+.+|++
T Consensus       233 ~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         233 YSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            7889999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7.3e-42  Score=322.12  Aligned_cols=251  Identities=23%  Similarity=0.313  Sum_probs=207.1

Q ss_pred             ccceeeeeeecccCceEEEEEEEcc-----CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCccccee
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE  191 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  191 (410)
                      .++|.+.+.||+|+||.||++....     ++..||+|.+....        .......+.+|+.+++.++|+||+++++
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~   76 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--------SEQDESDFLMEALIMSKFNHQNIVRLIG   76 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--------CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            3579999999999999999999987     67889999764321        2334457889999999999999999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC-
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQP-------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-  263 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~-  263 (410)
                      ++.+  ....++||||++|++|.+++...       ..+++..+..++.||+.||+|||+++++||||||+|||++.++ 
T Consensus        77 ~~~~--~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~  154 (277)
T cd05036          77 VSFE--RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGP  154 (277)
T ss_pred             EEcc--CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCC
Confidence            8876  34679999999999988876543       2589999999999999999999999999999999999998765 


Q ss_pred             --cEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 015257          264 --TVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDK  338 (410)
Q Consensus       264 --~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~  338 (410)
                        .+||+|||+++.......  ......++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~  233 (277)
T cd05036         155 GRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF  233 (277)
T ss_pred             CcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence              599999999986532211  1112233567999999877665 667999999999999997 9999998877766655


Q ss_pred             HHhC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          339 IVNN-SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       339 i~~~-~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +... ...+|..++..+.+++.+||+.+|++|||+.+|++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         234 VTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            5443 345677889999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.1e-41  Score=319.62  Aligned_cols=250  Identities=22%  Similarity=0.330  Sum_probs=204.1

Q ss_pred             eeeeeecccCceEEEEEEEccCCc--eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC-
Q 015257          121 VHVRKIGAGSYGKVVLYRSSLDGK--HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN-  197 (410)
Q Consensus       121 ~~~~~lG~G~fg~Vy~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-  197 (410)
                      .+.+.||+|+||.||++....++.  .+|+|.+....       ........+.+|+.+++.++||||+++++++.... 
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-------CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVE   74 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCc
Confidence            457889999999999999877665  69999875431       13445678899999999999999999999775321 


Q ss_pred             ---CCEEEEEEeecCCCCcccccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEe
Q 015257          198 ---SDHFYMVLEYVEGKWDNDGFG------QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIG  268 (410)
Q Consensus       198 ---~~~~~lv~e~~~~~~l~~~~~------~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~  268 (410)
                         ....+++|||+.++.+...+.      ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+
T Consensus        75 ~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~  154 (272)
T cd05075          75 SEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVA  154 (272)
T ss_pred             ccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEEC
Confidence               235789999999988776542      23458999999999999999999999999999999999999999999999


Q ss_pred             eccccccccCCccc--cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCC-
Q 015257          269 DFSVSQVFEDDNDV--LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSL-  344 (410)
Q Consensus       269 DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~-  344 (410)
                      |||+++........  .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+....+....+..+.. 
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~  233 (272)
T cd05075         155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL  233 (272)
T ss_pred             CCCcccccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99999875433211  122345778999998876655 667999999999999999 8999988777777776666543 


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          345 VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       345 ~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..+..++..+.++|.+||+.||.+|||+.+++++
T Consensus       234 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         234 KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            4567788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.5e-42  Score=358.47  Aligned_cols=251  Identities=25%  Similarity=0.375  Sum_probs=201.5

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.++++||+|+||.||++.+..+|+.||||++....      ........++.+|+.+++.++||||+++++++.+  
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l------~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--   73 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL------SENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--   73 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc------ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--
Confidence            57999999999999999999999999999999986432      1123455679999999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEE
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ-----------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVK  266 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~-----------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~k  266 (410)
                      .+..++||||++|++|.+.+..           ...++...+..++.||+.||+|||++||+||||||+|||++.++.++
T Consensus        74 ~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         74 GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             CCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEE
Confidence            4589999999999988876532           12456677889999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCc------------------cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCC
Q 015257          267 IGDFSVSQVFEDDN------------------DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL  328 (410)
Q Consensus       267 l~DfG~a~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~  328 (410)
                      |+|||+++......                  .......||+.|+|||++.+... +.++|||||||++|+|++|..||.
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~  232 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYR  232 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCC
Confidence            99999997652110                  11123469999999999877665 677999999999999999999998


Q ss_pred             CCCHHHHHHHH-HhCCCCC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          329 GETLQDTYDKI-VNNSLVF--PDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       329 ~~~~~~~~~~i-~~~~~~~--p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ........... .......  ...+++.+.+++.+||..||++||+..+.+.
T Consensus       233 ~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        233 RKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             CcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            75544332221 1111111  1367899999999999999999987655553

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.2e-42  Score=332.63  Aligned_cols=261  Identities=25%  Similarity=0.407  Sum_probs=208.5

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+.+.||+|+||.||++.+..+|+.||+|++.....       .......+.+|+.++++++||||+++++++..
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-------hhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            34789999999999999999999999999999998864311       12234567889999999999999999998864


Q ss_pred             CC----CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          196 PN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       196 ~~----~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      ..    ....+++++++ ++++...+.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg  165 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG  165 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccc
Confidence            21    23578899987 4556655543 468999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--------  343 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--------  343 (410)
                      +++....   ......||+.|+|||++.+....+.++|||||||++|+|++|..||...........+....        
T Consensus       166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (345)
T cd07877         166 LARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  242 (345)
T ss_pred             ccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9876432   22345688999999988764444678999999999999999999997765444333222110        


Q ss_pred             ---------------CCCC--------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCC
Q 015257          344 ---------------LVFP--------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI  388 (410)
Q Consensus       344 ---------------~~~p--------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~  388 (410)
                                     ...|        ...++++.+||.+||+.||.+|||+.+++.||||++...|.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~  310 (345)
T cd07877         243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  310 (345)
T ss_pred             hhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence                           0011        13578899999999999999999999999999999765544

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-42  Score=323.71  Aligned_cols=253  Identities=29%  Similarity=0.491  Sum_probs=207.3

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  199 (410)
                      |.+++.||.|++|.||++.+..+|+.+|+|.+.....       .......+.+|+.+++.++||||+++++++.+  ..
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~   71 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-------SEGIPKTALREIKLLKELNHPNIIKLLDVFRH--KG   71 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-------cchhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CC
Confidence            5678899999999999999998999999998764421       12344578899999999999999999999876  46


Q ss_pred             EEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCC
Q 015257          200 HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD  279 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~  279 (410)
                      .+++||||+++............+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||.+......
T Consensus        72 ~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~  151 (283)
T cd05118          72 DLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSP  151 (283)
T ss_pred             CEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence            89999999987443333333468999999999999999999999999999999999999999999999999999876554


Q ss_pred             ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------------
Q 015257          280 NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS----------------  343 (410)
Q Consensus       280 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~----------------  343 (410)
                      ........++..|+|||.+.+....+.++||||||+++|+|++|+.||...+..+....+....                
T Consensus       152 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         152 VRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             cccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence            3233345678889999988776445778999999999999999999998776655444332210                


Q ss_pred             ---CCC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          344 ---LVF-----------PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       344 ---~~~-----------p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                         ..+           ...++.++.++|.+||.+||.+||++.+++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence               001           12367889999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.9e-42  Score=325.58  Aligned_cols=254  Identities=28%  Similarity=0.446  Sum_probs=212.2

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  199 (410)
                      |.....||+|+||.||++....+|+.||||.+...         .......+.+|+.+++.++||||+++++.+..  ..
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~   90 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---------KQQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GD   90 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---------chhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CC
Confidence            33457899999999999999999999999986432         22345578899999999999999999999986  46


Q ss_pred             EEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCC
Q 015257          200 HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD  279 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~  279 (410)
                      ..++||||++++++.+.+.. ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~  169 (292)
T cd06657          91 ELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  169 (292)
T ss_pred             EEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence            89999999999988876643 46899999999999999999999999999999999999999999999999998765443


Q ss_pred             ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCCCCCCCHHHHH
Q 015257          280 NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS---LVFPDAMNPELRN  356 (410)
Q Consensus       280 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~~~~l~~  356 (410)
                      ........|++.|+|||.+.+... +.++|+||||+++|+|++|..||.+.........+....   ......+++.+.+
T Consensus       170 ~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  248 (292)
T cd06657         170 VPRRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKG  248 (292)
T ss_pred             cccccccccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHH
Confidence            333344568999999998866554 567999999999999999999998776555444443322   2233467899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          357 LLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       357 li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      ++.+||+.||.+||++.+++.||||.....
T Consensus       249 li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         249 FLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             HHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence            999999999999999999999999988774

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.1e-42  Score=332.27  Aligned_cols=259  Identities=25%  Similarity=0.441  Sum_probs=208.0

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+.+.||+|+||.||++.+..+|+.||||++.....       .......+.+|+.+++.++||||+++++++...
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~   86 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-------SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSA   86 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-------cccchhHHHHHHHHHHhcCCCCccchhheeccc
Confidence            4689999999999999999999998999999998864321       122345678999999999999999999988653


Q ss_pred             C----CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          197 N----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       197 ~----~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      .    ...+++|+||+.. .+....  ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+
T Consensus        87 ~~~~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          87 VSGDEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             ccCCCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            2    2357999999975 343332  23689999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS---------  343 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~---------  343 (410)
                      ++.....   .....+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+....         
T Consensus       164 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         164 ARHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CcCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            8764322   2344678899999988764444678999999999999999999998876554443333210         


Q ss_pred             --------------CCCC--------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCC
Q 015257          344 --------------LVFP--------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI  388 (410)
Q Consensus       344 --------------~~~p--------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~  388 (410)
                                    ..++        ...++.+.+||.+||+.||.+|||+.+++.||||.+....-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~  307 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD  307 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence                          0011        24678899999999999999999999999999998875433

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-43  Score=292.49  Aligned_cols=258  Identities=25%  Similarity=0.443  Sum_probs=218.0

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|.-.++||+|.||+||+++...+++.||+|.+..+.-       .+-.-....+||-+|+.++|.|||+++++...  .
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-------degvpssalreicllkelkhknivrl~dvlhs--d   73 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-------DEGVPSSALREICLLKELKHKNIVRLHDVLHS--D   73 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-------CCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--C
Confidence            46667899999999999999999999999999875431       22233467899999999999999999999875  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      +.+-+|+|||....-.-+-.-++.++...++.++.|+++||.+.|++++.|||+||.|.||+.+|.+|++|||+|+.++-
T Consensus        74 kkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi  153 (292)
T KOG0662|consen   74 KKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI  153 (292)
T ss_pred             ceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence            67999999998654333334467899999999999999999999999999999999999999999999999999998876


Q ss_pred             CccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCC-----C-------
Q 015257          279 DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSL-----V-------  345 (410)
Q Consensus       279 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~-----~-------  345 (410)
                      +-.......-|..|.+|.++.+...++.+.|+||.|||+.|+.. |++.|.+.+..++..+|...-.     .       
T Consensus       154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence            65555556679999999999999999889999999999999995 8888999988888887765210     0       


Q ss_pred             --------CCC---------CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          346 --------FPD---------AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       346 --------~p~---------~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                              +|.         .++..-++|++++|.-+|.+|.+++++++||||.+..
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence                    111         2345568999999999999999999999999998754

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.2e-41  Score=316.18  Aligned_cols=251  Identities=27%  Similarity=0.462  Sum_probs=208.5

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+.+.||+|+||.||++....+|+.||+|.+......      .......+.+|+.+++.++|+||+++++++.+  
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--   73 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM------DAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--   73 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc------chhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--
Confidence            5799999999999999999999999999999988643211      23345678999999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      ....++||||+++++|...+.    ....+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++
T Consensus        74 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~  153 (267)
T cd08224          74 NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             CCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEecccee
Confidence            457899999999998877653    2456899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCC-CCCC-C
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET--LQDTYDKIVNNSL-VFPD-A  349 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~--~~~~~~~i~~~~~-~~p~-~  349 (410)
                      ..............|++.|+|||.+.+..+ +.++|||||||++|+|++|..||....  ..+....+..+.. ..|. .
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd08224         154 RFFSSKTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADH  232 (267)
T ss_pred             eeccCCCcccceecCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhh
Confidence            765543333344568899999998876655 567999999999999999999996543  2334444444332 2343 6


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ++..+.++|.+||..+|++|||+.+|++
T Consensus       233 ~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         233 YSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            7889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.6e-42  Score=327.38  Aligned_cols=250  Identities=24%  Similarity=0.366  Sum_probs=203.6

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCce--EEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEE
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKH--YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVI  193 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  193 (410)
                      .++|.+.+.||+|+||.||+|.+..++..  +|+|.+...        ........+.+|+.++.++ +||||+++++++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--------~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~   77 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--------ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC   77 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--------CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence            45799999999999999999998877764  466665321        1334556788999999999 899999999998


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcE
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNL  257 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NI  257 (410)
                      .+  ....|+||||+++++|.+++...                ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus        78 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Ni  155 (303)
T cd05088          78 EH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI  155 (303)
T ss_pred             CC--CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheE
Confidence            76  45799999999998887766432                2578999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 015257          258 LVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTY  336 (410)
Q Consensus       258 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~  336 (410)
                      |++.++.+||+|||+++...... ......++..|+|||++.+... +.++|||||||++|+|+| |..||.+....+..
T Consensus       156 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  233 (303)
T cd05088         156 LVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY  233 (303)
T ss_pred             EecCCCcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHH
Confidence            99999999999999986432111 1111224667999998866554 667999999999999998 99999887776666


Q ss_pred             HHHHhC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          337 DKIVNN-SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       337 ~~i~~~-~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..+... ....+..+++++.+|+.+||+.+|.+|||+.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         234 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            655443 234556788999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-42  Score=318.26  Aligned_cols=247  Identities=21%  Similarity=0.370  Sum_probs=205.0

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      .+|.+.+.||+|+||.||+++.. ++..+|+|++.....          ....+.+|+.+++.++||||+++++++.+  
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--   70 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----------SEDDFIEEAKVMMKLSHPNLVQLYGVCTK--   70 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----------CHHHHHHHHHHHHhCCCCCEEEEEEEEcC--
Confidence            35888999999999999999876 466899998754321          12457789999999999999999999876  


Q ss_pred             CCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ....++||||++++++.+++.. ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        71 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~  150 (256)
T cd05059          71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV  150 (256)
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceec
Confidence            4578999999999998887754 347899999999999999999999999999999999999999999999999999765


Q ss_pred             cCCccc-cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCCCHH
Q 015257          277 EDDNDV-LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPE  353 (410)
Q Consensus       277 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~  353 (410)
                      ...... .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||......+....+... ....|..++.+
T Consensus       151 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd05059         151 LDDQYTSSQGTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTE  229 (256)
T ss_pred             ccccccccCCCCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHH
Confidence            432211 112223457999998876655 567999999999999998 89999887776666666554 33556778999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +.+++.+||+.+|.+|||+.++++.
T Consensus       230 ~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         230 VYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-41  Score=318.58  Aligned_cols=251  Identities=24%  Similarity=0.339  Sum_probs=205.7

Q ss_pred             eeeeeeecccCceEEEEEEEccC---CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      |.+.+.||+|+||.||++....+   +..||||.+....       ........+.+|+.+++.++||||+++++++...
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   73 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-------HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEA   73 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-------CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccC
Confidence            56788999999999999987653   4789999876432       1234567899999999999999999999987653


Q ss_pred             CC----CEEEEEEeecCCCCcccccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEE
Q 015257          197 NS----DHFYMVLEYVEGKWDNDGFGQ------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVK  266 (410)
Q Consensus       197 ~~----~~~~lv~e~~~~~~l~~~~~~------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~k  266 (410)
                      ..    ...++||||++++++...+..      ...+++..+..++.|++.||.|||+.+|+||||||+||++++++.+|
T Consensus        74 ~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~k  153 (273)
T cd05035          74 SSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVC  153 (273)
T ss_pred             CccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEE
Confidence            21    347999999999988766522      23689999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCccc--cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Q 015257          267 IGDFSVSQVFEDDNDV--LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS  343 (410)
Q Consensus       267 l~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~  343 (410)
                      |+|||+++........  .....++..|+|||.+.+... +.++|||||||++|||++ |..||.+....+....+..+.
T Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  232 (273)
T cd05035         154 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN  232 (273)
T ss_pred             ECCccceeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999865433211  112234678999998866554 667999999999999999 999998877777776666543


Q ss_pred             -CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          344 -LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       344 -~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                       ...|..+++++.+++.+||+.||.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             45677899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.1e-42  Score=323.95  Aligned_cols=250  Identities=22%  Similarity=0.333  Sum_probs=208.1

Q ss_pred             cceeeeeeecccCceEEEEEEEcc-----CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      .+|.+++.||+|+||.||++....     .+..||||++....        .......+.+|+.++..++||||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~   76 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--------EGPLREEFKHEAMMRSRLQHPNIVCLLGV   76 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--------CHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence            458889999999999999998754     35789999876321        23345678899999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQ----------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDN  256 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~----------------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N  256 (410)
                      +.+.  ...++++||+.++.+..++..                ...+++..+..++.|++.||.|||+.||+||||||+|
T Consensus        77 ~~~~--~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~N  154 (283)
T cd05091          77 VTKE--QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRN  154 (283)
T ss_pred             EcCC--CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhh
Confidence            9763  468999999998877766531                2358889999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 015257          257 LLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQ  333 (410)
Q Consensus       257 Ill~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~  333 (410)
                      ||++.++.+||+|||+++......  .......+++.|+|||.+.+... +.++|||||||++|||++ |..||.+....
T Consensus       155 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~  233 (283)
T cd05091         155 VLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ  233 (283)
T ss_pred             eEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999999999988654322  12233446788999998876655 567999999999999998 89999888887


Q ss_pred             HHHHHHHhCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          334 DTYDKIVNNSL-VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       334 ~~~~~i~~~~~-~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +....+..... .+|..++..+.+|+.+||+.+|.+||++++++..
T Consensus       234 ~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         234 DVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            77777776654 4577899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-41  Score=321.62  Aligned_cols=250  Identities=22%  Similarity=0.386  Sum_probs=199.2

Q ss_pred             cce-eeeeeecccCceEEEEEE----EccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          118 NEY-VHVRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       118 ~~y-~~~~~lG~G~fg~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      ++| .+++.||+|+||+||++.    ...++..||+|++....        .......+.+|+.+|+.++||||++++++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   74 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--------GQQNTSGWKKEINILKTLYHENIVKYKGC   74 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--------ChHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            345 889999999999998865    33468899999875431        12344578899999999999999999998


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      +.......+++||||++++++.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus        75 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~  153 (283)
T cd05080          75 CSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGL  153 (283)
T ss_pred             EecCCCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccc
Confidence            8765556789999999999998877653 599999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccc---cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HH------------
Q 015257          273 SQVFEDDNDV---LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ--DT------------  335 (410)
Q Consensus       273 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~------------  335 (410)
                      ++........   .....++..|+|||++.+... +.++||||||+++|+|++|..||......  +.            
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05080         154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR  232 (283)
T ss_pred             ccccCCcchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhh
Confidence            9865443221   122345667999998876555 56799999999999999999998543211  00            


Q ss_pred             HHHHHh--CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          336 YDKIVN--NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       336 ~~~i~~--~~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ......  ...+.|..++.++.+++.+||+.||++|||+++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            011111  112345678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2e-41  Score=319.41  Aligned_cols=248  Identities=21%  Similarity=0.317  Sum_probs=205.6

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCc----eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGK----HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ++|++++.||+|+||.||+++...+|.    .||+|++....        .......+.+|+.+++.++||||+++++++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   78 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--------SPKANKEILDEAYVMAGVGSPYVCRLLGIC   78 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--------CHHHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence            579999999999999999999877666    48999875331        234456788999999999999999999998


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      ..   ...+++|||++++.+.+.+.. .+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus        79 ~~---~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~  155 (279)
T cd05109          79 LT---STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGL  155 (279)
T ss_pred             cC---CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCc
Confidence            75   347899999999998888765 45789999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccc--cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCC
Q 015257          273 SQVFEDDNDV--LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPD  348 (410)
Q Consensus       273 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~  348 (410)
                      ++........  .....+++.|+|||.+.+..+ +.++|||||||++|||++ |..||...........+... ....+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~  234 (279)
T cd05109         156 ARLLDIDETEYHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPP  234 (279)
T ss_pred             eeecccccceeecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCc
Confidence            9876432221  122334678999998876655 567999999999999998 99999877665555544443 234556


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      .++.++.+++.+||+.||.+|||+.+++.
T Consensus       235 ~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         235 ICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            78999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.6e-41  Score=326.23  Aligned_cols=268  Identities=26%  Similarity=0.379  Sum_probs=216.1

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      .|...+.||+|+||.||++++..++..||+|++.....      ........+.+|+.+++.++|||++++++++.+  .
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~   97 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK------QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--E   97 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC------CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--C
Confidence            47788999999999999999999999999998864321      123445678899999999999999999999986  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ...++||||++|..+.........+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus        98 ~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635          98 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP  177 (317)
T ss_pred             CeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence            57899999998754433333456789999999999999999999999999999999999999999999999999875433


Q ss_pred             CccccccCCCcccccccccccC--CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCCCCHHH
Q 015257          279 DNDVLRRSPGTPVFTAPECCLG--LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--FPDAMNPEL  354 (410)
Q Consensus       279 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~~~~l  354 (410)
                      .    ....|++.|+|||++..  ....+.++|||||||++|+|++|..||...........+......  .+..+++.+
T Consensus       178 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  253 (317)
T cd06635         178 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYF  253 (317)
T ss_pred             c----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHH
Confidence            2    24568899999998742  222366799999999999999999999887666666666554332  234678899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhhCCcccCCCC-CCchhhhhhhcc
Q 015257          355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG-PIPQYLCWCKRD  398 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~-~~~~~~~~~~~~  398 (410)
                      .+|+.+||+.+|.+||++.++++|+|+..... ..+..+-....+
T Consensus       254 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~~~~~~~~~~~  298 (317)
T cd06635         254 RNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDLIQRTKD  298 (317)
T ss_pred             HHHHHHHccCCcccCcCHHHHHhChhhhccCcccchhhHHHHHHH
Confidence            99999999999999999999999999976543 333334333333

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.6e-41  Score=328.47  Aligned_cols=267  Identities=27%  Similarity=0.420  Sum_probs=211.4

Q ss_pred             ceeeeeeecccCceEEEEEEEccC--CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEEc
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLD--GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDD  195 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~  195 (410)
                      +|.+.+.||+|+||.||++.+..+  +..||||++....       ........+.+|+.+++.+ +||||+++++.+..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   73 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-------SKKILAKRALRELKLLRHFRGHKNITCLYDMDIV   73 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-------ccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence            488899999999999999999887  8999999875321       1122345678899999999 59999999986543


Q ss_pred             C--CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          196 P--NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       196 ~--~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .  ....+++++||+++ .|...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus        74 ~~~~~~~~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          74 FPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             ccccCCcEEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            2  23468899999975 56666666678999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCcc----ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------
Q 015257          274 QVFEDDND----VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN-------  342 (410)
Q Consensus       274 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~-------  342 (410)
                      +.......    ......||+.|+|||++.+....+.++|||||||++|+|++|..||...........+...       
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            76543211    1234568999999998766544467899999999999999999999776543332221110       


Q ss_pred             ---------------------CCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCchhhh
Q 015257          343 ---------------------SLVF---PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLC  393 (410)
Q Consensus       343 ---------------------~~~~---p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~~~  393 (410)
                                           ...+   ....+..+.+|+.+||+.||.+|||+.+++.||||....+|..+-.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~  307 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVC  307 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccc
Confidence                                 0011   12357899999999999999999999999999999888776555555

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.3e-41  Score=317.14  Aligned_cols=247  Identities=23%  Similarity=0.374  Sum_probs=205.8

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|+++++||+|+||.||++... ++..||+|.+...          ....+.+.+|+.+++.++||||+++++++.+ 
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   72 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG----------TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK-   72 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC----------chhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence            357999999999999999999865 5677999986532          1234678899999999999999999998876 


Q ss_pred             CCCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                       ....++||||++++++.+.+..  ...+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||+++
T Consensus        73 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~  151 (261)
T cd05072          73 -EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR  151 (261)
T ss_pred             -CCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccce
Confidence             4578999999999988887754  3468899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCcc-ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCC
Q 015257          275 VFEDDND-VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMN  351 (410)
Q Consensus       275 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~  351 (410)
                      ....... ......++..|+|||++..... +.++|||||||++|+|++ |..||...........+.... .+.+..++
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (261)
T cd05072         152 VIEDNEYTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCP  230 (261)
T ss_pred             ecCCCceeccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            7544322 1223345678999998876655 567999999999999998 999998877777666665442 23445688


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          352 PELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       352 ~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      .++.+++.+||..+|++|||++++.+
T Consensus       231 ~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         231 DELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.5e-41  Score=326.60  Aligned_cols=264  Identities=26%  Similarity=0.452  Sum_probs=212.8

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||.|+||.||++.+..+|+.||||++.+...       .......+..|+.+++.++||||+++++++..
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   80 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-------TPVLAKRTYRELKLLKHLRHENIISLSDIFIS   80 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-------ccchhHHHHHHHHHHHhcCCCCeeeEeeeEec
Confidence            45689999999999999999999999999999998764321       12234567899999999999999999999875


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      . ...+++||||+++ ++...+. ...+++..+..++.||+.||.|||+.+|+||||+|+|||++.++.++|+|||++..
T Consensus        81 ~-~~~~~lv~e~~~~-~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          81 P-LEDIYFVTELLGT-DLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             C-CCcEEEEeehhcc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence            3 3478999999964 5555544 34688999999999999999999999999999999999999999999999999875


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--------------  341 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~--------------  341 (410)
                      ...   ......+++.|+|||++.+....+.++||||||+++|+|++|..||...........+..              
T Consensus       158 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd07856         158 QDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC  234 (328)
T ss_pred             cCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            432   223446788999999886645457789999999999999999999977654322211110              


Q ss_pred             ----------C--CCCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCchhh
Q 015257          342 ----------N--SLVFP-----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL  392 (410)
Q Consensus       342 ----------~--~~~~p-----~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~~  392 (410)
                                .  ....|     ..+++.+.++|.+||+.+|.+|||+.+++.||||.....|..+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~  302 (328)
T cd07856         235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPV  302 (328)
T ss_pred             chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccC
Confidence                      0  00111     246789999999999999999999999999999998888877655

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-41  Score=319.11  Aligned_cols=251  Identities=22%  Similarity=0.306  Sum_probs=207.8

Q ss_pred             ccceeeeeeecccCceEEEEEEEccC-----CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCccccee
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLD-----GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE  191 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  191 (410)
                      .++|.+.+.||+|+||.||++.....     +..||+|.+....        .......+.+|+.+++.++||||+++++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--------~~~~~~~~~~e~~~l~~~~~~~i~~~~~   76 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--------SMRERIEFLNEASVMKEFNCHHVVRLLG   76 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--------CHHHHHHHHHHHHHHHhCCCCceeEEEE
Confidence            35799999999999999999987643     4789999875321        2234457889999999999999999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQ----------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP  261 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~----------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~  261 (410)
                      ++..  ....++||||+++++|..++..          ...+++..+..++.||+.||.|||+.+|+||||||+|||++.
T Consensus        77 ~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~  154 (277)
T cd05032          77 VVST--GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE  154 (277)
T ss_pred             EEcC--CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcC
Confidence            9876  4579999999999888877643          224788899999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 015257          262 SGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDK  338 (410)
Q Consensus       262 ~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~  338 (410)
                      ++.+||+|||+++.......  ......+|..|+|||.+.+... +.++|||||||++|+|++ |..||.+....+....
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  233 (277)
T cd05032         155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF  233 (277)
T ss_pred             CCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHH
Confidence            99999999999976543221  2223446788999998876554 667999999999999998 9999988777666665


Q ss_pred             HHhC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          339 IVNN-SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       339 i~~~-~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +... ...+|..++.++.+++.+||+.+|++|||+.+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~  274 (277)
T cd05032         234 VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS  274 (277)
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            5544 345677889999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.8e-41  Score=322.80  Aligned_cols=249  Identities=24%  Similarity=0.364  Sum_probs=204.1

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCc--eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGK--HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID  194 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  194 (410)
                      ++|.+.+.||+|+||.||++....++.  .+|+|.+...        ........+.+|+.++.++ +||||+++++++.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--------~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~   73 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--------ASENDHRDFAGELEVLCKLGHHPNIINLLGACE   73 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--------CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc
Confidence            578999999999999999999877665  4688876421        1233456788999999999 7999999999987


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEE
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLL  258 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIl  258 (410)
                      +  ....++||||+++++|.+++...                ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus        74 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil  151 (297)
T cd05089          74 N--RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVL  151 (297)
T ss_pred             c--CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEE
Confidence            6  45789999999998887776432                25889999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 015257          259 VAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYD  337 (410)
Q Consensus       259 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~  337 (410)
                      ++.++.+||+|||++....... .......+..|+|||++.+..+ +.++|||||||++|+|++ |..||......+...
T Consensus       152 l~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~  229 (297)
T cd05089         152 VGENLASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE  229 (297)
T ss_pred             ECCCCeEEECCcCCCcccccee-ccCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999999986432211 1111223456999998876655 667999999999999997 999999888777777


Q ss_pred             HHHhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          338 KIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       338 ~i~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .+..+. ...|..++..+.+|+.+||..+|.+|||++++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         230 KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            766543 34566789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.7e-41  Score=323.24  Aligned_cols=254  Identities=25%  Similarity=0.378  Sum_probs=208.7

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  199 (410)
                      |...+.||+|+||.||++++..+|..||+|++.....      ........+.+|+.+++.++|||++++++++.+  ..
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~   94 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK------QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EH   94 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc------CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CC
Confidence            6667889999999999999999999999999864321      123445678899999999999999999999987  45


Q ss_pred             EEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCC
Q 015257          200 HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD  279 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~  279 (410)
                      ..|+||||+.+..+.........+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..... 
T Consensus        95 ~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-  173 (313)
T cd06633          95 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-  173 (313)
T ss_pred             EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence            7999999998654443334456789999999999999999999999999999999999999999999999999864322 


Q ss_pred             ccccccCCCcccccccccccC--CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCCCCHHHH
Q 015257          280 NDVLRRSPGTPVFTAPECCLG--LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--FPDAMNPELR  355 (410)
Q Consensus       280 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~~~~l~  355 (410)
                         .....|+..|+|||++..  ....+.++|||||||++|+|++|..||...........+......  ....++..+.
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  250 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFR  250 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHH
Confidence               234568899999998743  233366799999999999999999999887665555555443221  2235778899


Q ss_pred             HHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          356 NLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      +|+.+||+.+|.+||++.+++.||||....
T Consensus       251 ~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         251 GFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            999999999999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.6e-41  Score=315.04  Aligned_cols=251  Identities=27%  Similarity=0.474  Sum_probs=215.2

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|.+.+.||+|+||.||++++..+++.+|+|.+.....       .......+.+|+.+++.++||||+++++++.+  .
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~   71 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-------SQKEREDAVNEIRILASVNHPNIISYKEAFLD--G   71 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-------cHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--C
Confidence            48899999999999999999999999999999865321       22344577889999999999999999998876  4


Q ss_pred             CEEEEEEeecCCCCcccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      ...++||||++++++...+..    ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~  151 (256)
T cd08530          72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISK  151 (256)
T ss_pred             CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchh
Confidence            689999999999988876644    3568999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHH
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFPDAMNPE  353 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~  353 (410)
                      .....  ......+++.|+|||.+.+... +.++|+||||+++|+|++|+.||...+.......+..... ..+..++.+
T Consensus       152 ~~~~~--~~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (256)
T cd08530         152 VLKKN--MAKTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQD  228 (256)
T ss_pred             hhccC--CcccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHH
Confidence            76544  2334568899999999876654 5679999999999999999999998877666666555443 355678899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      +.+++.+||..+|.+|||+.++++||++
T Consensus       229 ~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         229 LQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.5e-41  Score=316.33  Aligned_cols=247  Identities=21%  Similarity=0.337  Sum_probs=205.6

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||+|+||.||++.... +..+|||.+.....          ....+.+|+.+++.++||||+++++++.+  
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   70 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----------SEDEFIEEAKVMMKLSHEKLVQLYGVCTK--   70 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----------cHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence            468999999999999999997653 44699998754321          23468899999999999999999999876  


Q ss_pred             CCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ...+++||||++++++.+.+... ..+++..++.++.||+.||.|||+.|++|+||||+|||++.++.+||+|||.++..
T Consensus        71 ~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~  150 (256)
T cd05113          71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV  150 (256)
T ss_pred             CCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceec
Confidence            34689999999999888877553 46899999999999999999999999999999999999999999999999998765


Q ss_pred             cCCccc-cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHH
Q 015257          277 EDDNDV-LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSL-VFPDAMNPE  353 (410)
Q Consensus       277 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~  353 (410)
                      ...... .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||......+....+..+.. ..+...+..
T Consensus       151 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd05113         151 LDDEYTSSVGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEK  229 (256)
T ss_pred             CCCceeecCCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHH
Confidence            433211 112335677999998876554 567999999999999998 9999988777777777766543 345678899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +.+++.+||+.||.+|||+.+++.+
T Consensus       230 ~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         230 VYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHHh
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-43  Score=338.69  Aligned_cols=252  Identities=21%  Similarity=0.319  Sum_probs=206.6

Q ss_pred             ccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       113 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      .....++..+...||+|.||+||+++.-.   .||||+++...       ...+.++.|++|+.+|++-+|.||+-+.|+
T Consensus       387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~-------pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~  456 (678)
T KOG0193|consen  387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDD-------PTPEQLQAFKNEVAVLKKTRHENILLFMGA  456 (678)
T ss_pred             cccCHHHhhccceeccccccceeeccccc---ceEEEEEecCC-------CCHHHHHHHHHHHHHHhhcchhhheeeehh
Confidence            34455677888999999999998877653   49999997653       245688999999999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      +..+.   +.||..||+|.+|..++.-. ..|.....+.|+.||+.||.|||.++|||||||..|||+.+++.|||+|||
T Consensus       457 ~~~p~---~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFG  533 (678)
T KOG0193|consen  457 CMNPP---LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFG  533 (678)
T ss_pred             hcCCc---eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEeccc
Confidence            98643   59999999999999888653 578899999999999999999999999999999999999999999999999


Q ss_pred             cccccc--CCccccccCCCcccccccccccCC--cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---
Q 015257          272 VSQVFE--DDNDVLRRSPGTPVFTAPECCLGL--TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL---  344 (410)
Q Consensus       272 ~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---  344 (410)
                      ++....  ..........|...|||||++...  ..+++.+||||||+++|||++|..||......+..-.+-.+.+   
T Consensus       534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd  613 (678)
T KOG0193|consen  534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD  613 (678)
T ss_pred             ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc
Confidence            986422  223344556688899999998533  2337889999999999999999999985544443333323321   


Q ss_pred             --CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          345 --VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       345 --~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                        ..-...+.++++|+..||..++++||++.+||.
T Consensus       614 ~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  614 LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence              122356779999999999999999999999987

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.2e-41  Score=321.26  Aligned_cols=249  Identities=27%  Similarity=0.427  Sum_probs=206.7

Q ss_pred             cceeeeeeecccCceEEEEEEEc-----cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      .+|.+.+.||+|+||.||+++..     .++..+|+|.+...         .......+.+|+.+++.++||||++++++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   75 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---------TLAARKDFQREAELLTNLQHEHIVKFYGV   75 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---------cHHHHHHHHHHHHHHhcCCCCCcceEEEE
Confidence            46889999999999999999854     24567899986532         22344578899999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDN  256 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N  256 (410)
                      +..  ....++||||++++++.+++...                +.+++..++.++.||+.||+|||++||+||||||+|
T Consensus        76 ~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N  153 (291)
T cd05094          76 CGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRN  153 (291)
T ss_pred             Ecc--CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcce
Confidence            976  45799999999999888776432                348999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 015257          257 LLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQ  333 (410)
Q Consensus       257 Ill~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~  333 (410)
                      ||++.++.++|+|||+++......  .......+++.|+|||++.+... +.++||||||+++|+|++ |..||......
T Consensus       154 il~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~  232 (291)
T cd05094         154 CLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNT  232 (291)
T ss_pred             EEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999997654322  12234456788999998876655 567999999999999998 99999887777


Q ss_pred             HHHHHHHhCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          334 DTYDKIVNNSL-VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       334 ~~~~~i~~~~~-~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +..+.+..+.. ..+...+..+.+++.+||+.||.+|||+.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~  278 (291)
T cd05094         233 EVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI  278 (291)
T ss_pred             HHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            76666665544 3456678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3e-41  Score=311.40  Aligned_cols=249  Identities=29%  Similarity=0.473  Sum_probs=211.3

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|...+.||+|++|.||++.+..+++.+++|++....         ......+.+|+.+++.++||||+++++++..  .
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~   69 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES---------KEKKEKIINEIQILKKCKHPNIVKYYGSYLK--K   69 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccc---------hhHHHHHHHHHHHHHhCCCCCEeEEEEEEec--C
Confidence            4788999999999999999999899999999986432         1355688999999999999999999999876  3


Q ss_pred             CEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...++++||++++++.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        70 ~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  149 (253)
T cd05122          70 DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS  149 (253)
T ss_pred             CeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccc
Confidence            5799999999999988887665 579999999999999999999999999999999999999999999999999997765


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCC--CCCHHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN-SLVFPD--AMNPEL  354 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~--~~~~~l  354 (410)
                      .... .....|+..|+|||.+.+... +.++||||||+++|+|++|..||...+.......+... ....+.  .++..+
T Consensus       150 ~~~~-~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (253)
T cd05122         150 DTKA-RNTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEF  227 (253)
T ss_pred             cccc-ccceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHH
Confidence            4332 345668899999998876654 66799999999999999999999877554444333322 222333  348999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhhCCc
Q 015257          355 RNLLEGLLCKDPTRRLTLNDVAKHTW  380 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~ell~h~~  380 (410)
                      .++|.+||+.||++|||+.++++|||
T Consensus       228 ~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         228 KDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHHHHHccCChhhCCCHHHHhcCCC
Confidence            99999999999999999999999999

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-44  Score=371.15  Aligned_cols=262  Identities=27%  Similarity=0.437  Sum_probs=223.3

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      -+|+....||.|.||.||-+.+..+|+..|+|.+.....       .......+.+|..+|..++|||+|+++|+-.+  
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~-------~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH-- 1305 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDS-------DHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH-- 1305 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCcc-------ccccCcchHHHHHHHHhccCccccccCceeec--
Confidence            467778899999999999999999999999998764322       13445578899999999999999999998776  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...++|.||||.+|+|.+.+...+..+|...+.|..|++.|+.|||+.|||||||||+||+|+.+|.+|++|||.|....
T Consensus      1306 Rekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEec
Confidence            45799999999999999999988889999999999999999999999999999999999999999999999999998765


Q ss_pred             CCc----cccccCCCcccccccccccCCcC--CCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHh-CCCCCCCC
Q 015257          278 DDN----DVLRRSPGTPVFTAPECCLGLTY--GGKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKIVN-NSLVFPDA  349 (410)
Q Consensus       278 ~~~----~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~i~~-~~~~~p~~  349 (410)
                      ...    .......|||.|||||++.+...  ...+.||||||||+.||+||+.||...+ .......+-. ..+.+|+.
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ 1465 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER 1465 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh
Confidence            442    12345679999999999976542  2558999999999999999999997643 2333333433 45678999


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCC
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI  388 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~  388 (410)
                      ++++.+++|..||+.||++|.++.|+++|.|........
T Consensus      1466 ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~ 1504 (1509)
T KOG4645|consen 1466 LSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDED 1504 (1509)
T ss_pred             hhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccccc
Confidence            999999999999999999999999999999988765443

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.3e-41  Score=321.70  Aligned_cols=255  Identities=30%  Similarity=0.498  Sum_probs=217.4

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..+.|.+.+.||+|++|.||++.+..++..||+|++....          .....+.+|+.+++.++|+||+++++.+..
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   86 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK----------QNKELIINEILIMKDCKHPNIVDYYDSYLV   86 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCc----------hhHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence            4456889999999999999999999889999999986431          144678899999999999999999999987


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                        ....++|+||+++++|.+.+.... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.
T Consensus        87 --~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~  164 (286)
T cd06614          87 --GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAA  164 (286)
T ss_pred             --CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhh
Confidence              368999999999999999887766 89999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-C--CCCCCC
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-V--FPDAMN  351 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~--~p~~~~  351 (410)
                      .............+++.|+|||++.+... +.++||||||+++|+|++|..||...........+..... .  .+..++
T Consensus       165 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (286)
T cd06614         165 QLTKEKSKRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWS  243 (286)
T ss_pred             hhccchhhhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCC
Confidence            65443333344567889999998876655 5679999999999999999999988766555544443322 2  223478


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       352 ~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                      ..+.++|.+||+.+|.+|||+.++++|+||..
T Consensus       244 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         244 PEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence            99999999999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=7e-42  Score=323.79  Aligned_cols=257  Identities=21%  Similarity=0.356  Sum_probs=203.9

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEEEcC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDP  196 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~  196 (410)
                      ++|...+.||+|+||.||++.+..+++.||+|.+....        .......+.+|+.++.++. ||||+++++++.. 
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-   74 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV--------DEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-   74 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhcc--------ChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-
Confidence            35667889999999999999999999999999876432        1234567889999999996 9999999998876 


Q ss_pred             CCCEEEEEEeecCCCC--ccccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          197 NSDHFYMVLEYVEGKW--DNDGF--GQPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~--l~~~~--~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                       ....+++|||+++..  +...+  .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||
T Consensus        75 -~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  153 (288)
T cd06616          75 -EGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFG  153 (288)
T ss_pred             -CCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecc
Confidence             357899999987532  11111  2245799999999999999999999975 99999999999999999999999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCC--cCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCC-CCC-
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGL--TYGGKAADTWAVGVTLYYMIIGQYPFLGETL-QDTYDKIVNNS-LVF-  346 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~i~~~~-~~~-  346 (410)
                      +++...... ......|++.|+|||++.+.  ...+.++|||||||++|+|++|..||..... .+....+.... ... 
T Consensus       154 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd06616         154 ISGQLVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS  232 (288)
T ss_pred             hhHHhccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCC
Confidence            997654322 22344688999999998765  2446789999999999999999999976542 12222222221 112 


Q ss_pred             ---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          347 ---PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       347 ---p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                         +..++.++.+||.+||+.||.+|||+.++++||||....
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence               234789999999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.6e-41  Score=322.42  Aligned_cols=249  Identities=27%  Similarity=0.342  Sum_probs=204.8

Q ss_pred             cceeeeeeecccCceEEEEEEEccCC----------------ceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDG----------------KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML  181 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  181 (410)
                      .+|++++.||+|+||.||++.+...+                ..||+|.+....        .....+.+.+|+.+++.+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~~~~e~~~l~~l   76 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--------SDNAREDFLKEVKILSRL   76 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--------CHHHHHHHHHHHHHHHhc
Confidence            57999999999999999998876533                568999875432        234567889999999999


Q ss_pred             CCCCcccceeEEEcCCCCEEEEEEeecCCCCcccccCCCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcEec
Q 015257          182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG-----------AIGESMARKYLRDIVSGLMYLHGHNVVHG  250 (410)
Q Consensus       182 ~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-----------~l~~~~~~~i~~qi~~gL~yLH~~~iiHr  250 (410)
                      +||||+++++++..  ...+++||||++++++..++....           .+++..++.++.|++.||.|||+.||+||
T Consensus        77 ~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~  154 (296)
T cd05051          77 SDPNIARLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHR  154 (296)
T ss_pred             CCCCEeEEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Confidence            99999999999976  357999999999998887765544           68999999999999999999999999999


Q ss_pred             cCCCCcEEEcCCCcEEEeeccccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh--CCCC
Q 015257          251 DIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII--GQYP  326 (410)
Q Consensus       251 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt--G~~P  326 (410)
                      ||||+||+++.++.++|+|||+++......  .......+++.|+|||++.+... +.++|||||||++|+|++  |..|
T Consensus       155 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p  233 (296)
T cd05051         155 DLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQP  233 (296)
T ss_pred             ccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCC
Confidence            999999999999999999999987643322  22334456788999998876554 677999999999999998  7889


Q ss_pred             CCCCCHHHHHHHHHhC--------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          327 FLGETLQDTYDKIVNN--------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       327 f~~~~~~~~~~~i~~~--------~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      |......+....+...        ....+..++.++.+|+.+||+.||.+|||+.+|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         234 YEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             CCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            9776665555444322        12334567899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-41  Score=314.04  Aligned_cols=246  Identities=24%  Similarity=0.363  Sum_probs=204.5

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|++.+.||+|++|.||++... +++.||+|.+....          .....+.+|+.++++++||||+++++++..  
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   72 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT----------MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL--   72 (261)
T ss_pred             hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc----------ccHHHHHHHHHHHHHCCCCCccceeEEEec--
Confidence            46999999999999999999865 45789999876432          123568899999999999999999999876  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      ...+++||||++++++.+++....  .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++.
T Consensus        73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  152 (261)
T cd05068          73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARV  152 (261)
T ss_pred             CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEE
Confidence            457899999999999988876543  689999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCccc-cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCCCH
Q 015257          276 FEDDNDV-LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNP  352 (410)
Q Consensus       276 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~  352 (410)
                      ....... .....++..|+|||++.+... +.++||||||+++|+|++ |+.||.+.........+... ....+..++.
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (261)
T cd05068         153 IKEDIYEAREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPK  231 (261)
T ss_pred             ccCCcccccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence            6532111 111223457999998876555 567999999999999999 99999887777666666544 2345667889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      .+.+++.+||+.+|.+||++.++++
T Consensus       232 ~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         232 ELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHHHhhcCcccCCCHHHHHH
Confidence            9999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.2e-41  Score=323.79  Aligned_cols=251  Identities=21%  Similarity=0.381  Sum_probs=206.4

Q ss_pred             ccceeeeeeecccCceEEEEEEEcc-------CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCccc
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSL-------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVN  188 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  188 (410)
                      .++|.+.+.||+|+||.||++++..       ++..+|+|.+....        .......+.+|+.+++.+ +||||++
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~e~~~l~~l~~h~~i~~   88 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--------TEKDLSDLISEMEMMKMIGKHKNIIN   88 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--------ChHHHHHHHHHHHHHHHhcCCCCEee
Confidence            3679999999999999999998643       23579999876431        233456788999999999 7999999


Q ss_pred             ceeEEEcCCCCEEEEEEeecCCCCcccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccC
Q 015257          189 LIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDI  252 (410)
Q Consensus       189 l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl  252 (410)
                      +++++..  ....++||||+++++|.+++...                ..+++..+..++.||+.||+|||++|++||||
T Consensus        89 ~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dl  166 (307)
T cd05098          89 LLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDL  166 (307)
T ss_pred             EEEEEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence            9999976  45789999999999888776542                24888999999999999999999999999999


Q ss_pred             CCCcEEEcCCCcEEEeeccccccccCCccc--cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 015257          253 KPDNLLVAPSGTVKIGDFSVSQVFEDDNDV--LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLG  329 (410)
Q Consensus       253 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~  329 (410)
                      ||+|||++.++.+||+|||+++........  .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+
T Consensus       167 kp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~  245 (307)
T cd05098         167 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPG  245 (307)
T ss_pred             cHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence            999999999999999999998765432211  112234568999998876555 667999999999999998 8999988


Q ss_pred             CCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          330 ETLQDTYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       330 ~~~~~~~~~i~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ....+....+.... ..+|..++.++.+|+.+||..+|.+|||+.+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         246 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             CCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            77766666655543 35677889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.4e-41  Score=335.99  Aligned_cols=250  Identities=23%  Similarity=0.354  Sum_probs=201.1

Q ss_pred             ccceeeeeeecccCceEEEEEEEcc-----CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccce
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLI  190 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~  190 (410)
                      .++|++.+.||+|+||.||++.+..     .+..||||++....        .....+.+.+|+.+|+.+. |||||+++
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~~Ei~~l~~l~~HpnIv~l~  107 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--------RSSEKQALMSELKIMTHLGPHLNIVNLL  107 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--------ChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence            4579999999999999999998643     23579999885431        2334467899999999996 99999999


Q ss_pred             eEEEcCCCCEEEEEEeecCCCCcccccCC---------------------------------------------------
Q 015257          191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQ---------------------------------------------------  219 (410)
Q Consensus       191 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---------------------------------------------------  219 (410)
                      +++.+  ...++||||||++++|.+++..                                                   
T Consensus       108 ~~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (400)
T cd05105         108 GACTK--SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT  185 (400)
T ss_pred             EEEcc--CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence            99976  4579999999999887655422                                                   


Q ss_pred             ---------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCC
Q 015257          220 ---------------------------------------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKP  254 (410)
Q Consensus       220 ---------------------------------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp  254 (410)
                                                                   ...+++..+..++.||+.||.|||+.+|+||||||
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp  265 (400)
T cd05105         186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAA  265 (400)
T ss_pred             cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence                                                         12478888899999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 015257          255 DNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGET  331 (410)
Q Consensus       255 ~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~  331 (410)
                      +|||++.++.+||+|||+++.......  ......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||....
T Consensus       266 ~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~  344 (400)
T cd05105         266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMI  344 (400)
T ss_pred             HhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence            999999999999999999986543221  1223346788999998877655 667999999999999997 999998754


Q ss_pred             HHHHH-HHHHhC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          332 LQDTY-DKIVNN-SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       332 ~~~~~-~~i~~~-~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ..... ..+..+ ....+..++.++.+++.+||+.||++|||+.+|.+
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         345 VDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             hhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            43333 333333 23456678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.8e-42  Score=319.96  Aligned_cols=246  Identities=26%  Similarity=0.468  Sum_probs=201.4

Q ss_pred             eeeeeecccCceEEEEEEEc----cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          121 VHVRKIGAGSYGKVVLYRSS----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       121 ~~~~~lG~G~fg~Vy~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .+.+.||.|+||.||++...    ..+..|+||.+...        ...+....+.+|+..+++++||||+++++++.. 
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--------~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-   72 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--------SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-   72 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--------SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--------cccccceeeeecccccccccccccccccccccc-
Confidence            35789999999999999988    35678999998432        134457789999999999999999999999985 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                       ....++||||+++++|.+++...  ..+++..+..++.||+.||.|||+++++|+||+++|||++.++.+||+|||++.
T Consensus        73 -~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~  151 (259)
T PF07714_consen   73 -NEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSR  151 (259)
T ss_dssp             -SSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGE
T ss_pred             -ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence             34599999999999999887765  689999999999999999999999999999999999999999999999999998


Q ss_pred             cccCC--ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCC-CCCCCC
Q 015257          275 VFEDD--NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSL-VFPDAM  350 (410)
Q Consensus       275 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~  350 (410)
                      .....  ........+...|+|||.+..... +.++||||||+++|||++ |..||......+....+..+.. .+|..+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  230 (259)
T PF07714_consen  152 PISEKSKYKNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNC  230 (259)
T ss_dssp             ETTTSSSEEESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTS
T ss_pred             ccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccch
Confidence            76222  112223446778999998876664 778999999999999999 7899988888877777765543 466789


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          351 NPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      +..+.++|..||..||.+|||+.++++
T Consensus       231 ~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  231 PKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             BHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            999999999999999999999999985

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.6e-41  Score=316.47  Aligned_cols=255  Identities=23%  Similarity=0.476  Sum_probs=211.3

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|.+.+.||+|+||.||++++...+..+++|+++......    ........+..|+.+++.++||||+++++++.+  .
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~   74 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGE----LNPNETVQANQEAQLLSKLDHPAIVKFHASFLE--R   74 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccc----cCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--C
Confidence            4889999999999999999998887778888765432211    112233457789999999999999999998876  3


Q ss_pred             CEEEEEEeecCCCCcccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      ...++||||++++++...+.    ....+++..++.++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||+++
T Consensus        75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~-~~~~~l~d~g~~~  153 (260)
T cd08222          75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK-NNLLKIGDFGVSR  153 (260)
T ss_pred             CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee-cCCEeecccCcee
Confidence            47899999999988876653    345799999999999999999999999999999999999997 4679999999998


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHH
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS-LVFPDAMNPE  353 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~  353 (410)
                      .............|++.|+|||.+.+... +.++|+||||+++|+|++|..||...........+..+. ..++..++.+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (260)
T cd08222         154 LLMGSCDLATTFTGTPYYMSPEALKHQGY-DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQ  232 (260)
T ss_pred             ecCCCcccccCCCCCcCccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHH
Confidence            76554444445668999999998866554 556999999999999999999998777666666655543 3456678999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      +.++|.+||..||.+||++.++++||||
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         233 LNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-41  Score=314.00  Aligned_cols=242  Identities=23%  Similarity=0.364  Sum_probs=202.5

Q ss_pred             eeecccCceEEEEEEEccCC---ceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCE
Q 015257          124 RKIGAGSYGKVVLYRSSLDG---KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH  200 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  200 (410)
                      +.||+|+||.||+++....+   ..||+|.+.....        ......+.+|+.+++.+.||||+++++++..   ..
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~   69 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI--------AAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EP   69 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccc--------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---Cc
Confidence            46999999999999876544   7899998764421        1345678899999999999999999998763   46


Q ss_pred             EEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCc
Q 015257          201 FYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN  280 (410)
Q Consensus       201 ~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~  280 (410)
                      +++||||++++++.+.+.....+++..+..++.|++.||+|||+.+++|+||||+|||++.++.+||+|||+++......
T Consensus        70 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~  149 (257)
T cd05060          70 LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS  149 (257)
T ss_pred             eEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence            89999999999999988877789999999999999999999999999999999999999999999999999998664433


Q ss_pred             ccccc---CCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHH
Q 015257          281 DVLRR---SPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMNPELR  355 (410)
Q Consensus       281 ~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~l~  355 (410)
                      .....   ..++..|+|||.+.+... +.++||||||+++|+|++ |..||......+....+.... ...|..+++.+.
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  228 (257)
T cd05060         150 DYYRATTAGRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIY  228 (257)
T ss_pred             cccccccCccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence            22211   123467999998876655 567999999999999998 999998877766666655543 356678899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhh
Q 015257          356 NLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ++|.+||+.+|.+|||+.++++
T Consensus       229 ~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         229 SIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999985

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.2e-41  Score=314.42  Aligned_cols=242  Identities=24%  Similarity=0.370  Sum_probs=199.9

Q ss_pred             eecccCceEEEEEEEc--cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEE
Q 015257          125 KIGAGSYGKVVLYRSS--LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFY  202 (410)
Q Consensus       125 ~lG~G~fg~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~  202 (410)
                      .||+|+||.||++...  ..+..||+|++....        .....+.+.+|+.++++++||||+++++++..   ...+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~   70 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--------EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALM   70 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--------ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeE
Confidence            4899999999998765  345679999875431        23445679999999999999999999998853   4689


Q ss_pred             EEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCcc
Q 015257          203 MVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND  281 (410)
Q Consensus       203 lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  281 (410)
                      +||||+++++|.+.+.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.......
T Consensus        71 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          71 LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS  150 (257)
T ss_pred             EEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence            99999999999887754 45789999999999999999999999999999999999999999999999999976543322


Q ss_pred             cc---ccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHH
Q 015257          282 VL---RRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMNPELRN  356 (410)
Q Consensus       282 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~l~~  356 (410)
                      ..   ....+++.|+|||++.+... +.++|||||||++|++++ |..||......+....+..+. ..+|...++++.+
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  229 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYA  229 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence            11   11223578999998876554 667999999999999996 999998877777666655543 4567788999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhhC
Q 015257          357 LLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       357 li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ++.+||..||++||++.+|++.
T Consensus       230 li~~c~~~~~~~Rp~~~~i~~~  251 (257)
T cd05115         230 LMKDCWIYKWEDRPNFAKVEER  251 (257)
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.7e-41  Score=318.82  Aligned_cols=248  Identities=27%  Similarity=0.437  Sum_probs=205.5

Q ss_pred             cceeeeeeecccCceEEEEEEEc-----cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      .+|+..++||+|+||.||++...     .++..+|+|.+...         .......+.+|+.+++.++||||++++++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   75 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---------SESARQDFQREAELLTVLQHQHIVRFYGV   75 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---------CHHHHHHHHHHHHHHhcCCCCCCceEEEE
Confidence            46888999999999999998743     35678999986532         23455689999999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcE
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP---------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNL  257 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NI  257 (410)
                      +.+  ....++||||++++++.+++...               ..+++..+..++.||+.||+|||+.|++||||||+||
T Consensus        76 ~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~ni  153 (280)
T cd05092          76 CTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNC  153 (280)
T ss_pred             Eec--CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhE
Confidence            876  45789999999999888766443               2488999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 015257          258 LVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQD  334 (410)
Q Consensus       258 ll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~  334 (410)
                      |++.++.+||+|||+++......  .......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||......+
T Consensus       154 l~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~  232 (280)
T cd05092         154 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTE  232 (280)
T ss_pred             EEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHH
Confidence            99999999999999997543321  11223345778999998876655 667999999999999998 999998777666


Q ss_pred             HHHHHHhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          335 TYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       335 ~~~~i~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ....+..+. ...|..+++.+.+|+.+||+.||.+||++.+|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         233 AIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            666665543 3556788999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.1e-41  Score=315.74  Aligned_cols=245  Identities=23%  Similarity=0.392  Sum_probs=204.3

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|++++.||+|+||.||++... ++..+|+|.+.....          ....+.+|+.++++++||||+++++++..  
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----------~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--   72 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----------SPESFLEEAQIMKKLRHDKLVQLYAVVSE--   72 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----------CHHHHHHHHHHHHhcCCCceEEEEeEECC--
Confidence            57999999999999999999766 566799998764321          12468899999999999999999998753  


Q ss_pred             CCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                       ...++||||++++++.+.+..  ...+++..++.++.|++.||.|||+++|+||||||+||+++.++.++|+|||++..
T Consensus        73 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~  151 (260)
T cd05070          73 -EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARL  151 (260)
T ss_pred             -CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeee
Confidence             357899999999998887754  34589999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCcc-ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCCCH
Q 015257          276 FEDDND-VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNP  352 (410)
Q Consensus       276 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~  352 (410)
                      ...... ......++..|+|||.+.+... +.++||||||+++|+|++ |..||.+.+..+....+... ....+...+.
T Consensus       152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (260)
T cd05070         152 IEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPI  230 (260)
T ss_pred             ccCcccccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence            543321 1122335667999998866554 567999999999999999 99999888777777666554 3445677899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      .+.+|+.+||+++|.+|||++++++
T Consensus       231 ~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         231 SLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.4e-41  Score=320.97  Aligned_cols=251  Identities=22%  Similarity=0.391  Sum_probs=207.5

Q ss_pred             ccceeeeeeecccCceEEEEEEEccC-----CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccce
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLD-----GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLI  190 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  190 (410)
                      .++|.+.+.||+|+||.||++.....     ...+|+|.+....        .......+.+|+.+++.+ +||||++++
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~~i~~~~   82 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--------TEKDLSDLVSEMEMMKMIGKHKNIINLL   82 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--------CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            45799999999999999999987643     3789999875421        233445788999999999 899999999


Q ss_pred             eEEEcCCCCEEEEEEeecCCCCcccccC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCC
Q 015257          191 EVIDDPNSDHFYMVLEYVEGKWDNDGFG----------------QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKP  254 (410)
Q Consensus       191 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~----------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp  254 (410)
                      +++..  ...++++|||++++++..++.                ....+++..+..++.||+.||.|||+.+|+||||||
T Consensus        83 ~~~~~--~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp  160 (293)
T cd05053          83 GVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAA  160 (293)
T ss_pred             EEEcC--CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccce
Confidence            99876  457999999999988877663                234689999999999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 015257          255 DNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGET  331 (410)
Q Consensus       255 ~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~  331 (410)
                      +|||++.++.+||+|||+++.......  ......++..|+|||++.+..+ +.++|||||||++|+|++ |..||....
T Consensus       161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~  239 (293)
T cd05053         161 RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIP  239 (293)
T ss_pred             eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCC
Confidence            999999999999999999986543221  1122234677999998876655 567999999999999997 999998887


Q ss_pred             HHHHHHHHHhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          332 LQDTYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       332 ~~~~~~~i~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..+....+..+. ...|...+..+.+|+.+||..||.+|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         240 VEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            777666665543 34566788999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.8e-41  Score=317.76  Aligned_cols=249  Identities=22%  Similarity=0.337  Sum_probs=203.9

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCce----EEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKH----YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ++|++++.||+|+||.||++....+|..    +|+|.+...        .......++..|+.+++.++||||+++++++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~   78 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--------SGRQTFQEITDHMLAMGSLDHAYIVRLLGIC   78 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--------cchHHHHHHHHHHHHHhcCCCCCcceEEEEE
Confidence            4788999999999999999998877764    566654321        1234456788899999999999999999987


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      ..   ...++++||++++++.+.+.. .+.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+
T Consensus        79 ~~---~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~  155 (279)
T cd05111          79 PG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGV  155 (279)
T ss_pred             CC---CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcc
Confidence            53   357899999999999888764 45789999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCC
Q 015257          273 SQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPD  348 (410)
Q Consensus       273 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~  348 (410)
                      ++......  .......++..|+|||++.+..+ +.++||||||+++|||++ |..||.+.........+..+. ...+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~  234 (279)
T cd05111         156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQ  234 (279)
T ss_pred             ceeccCCCcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCC
Confidence            98654322  12234456778999998876655 667999999999999998 999998876655544444433 23455


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .++.++.+++.+||..||.+|||+.++++.
T Consensus       235 ~~~~~~~~li~~c~~~~p~~Rps~~el~~~  264 (279)
T cd05111         235 ICTIDVYMVMVKCWMIDENVRPTFKELANE  264 (279)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            678899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.9e-41  Score=314.79  Aligned_cols=246  Identities=24%  Similarity=0.376  Sum_probs=204.7

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .+.|+++++||+|+||.||++... +++.||+|.+....          .....+.+|+.+++.++||||+++++++.. 
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~----------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   72 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS----------MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ-   72 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC----------CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc-
Confidence            357999999999999999999865 57889999876432          123468899999999999999999998753 


Q ss_pred             CCCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                        ..+++||||+.++.+.+.+..  ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.
T Consensus        73 --~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  150 (260)
T cd05067          73 --EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR  150 (260)
T ss_pred             --CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCccee
Confidence              468999999999988887654  3468999999999999999999999999999999999999999999999999997


Q ss_pred             cccCCc-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCC
Q 015257          275 VFEDDN-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMN  351 (410)
Q Consensus       275 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~  351 (410)
                      ...... .......++..|+|||++.+... +.++||||||+++|+|++ |+.||.+.+..+....+.... ...+...+
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (260)
T cd05067         151 LIEDNEYTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCP  229 (260)
T ss_pred             ecCCCCcccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Confidence            654222 12223345778999998876655 567999999999999999 999998877766666554442 34566788


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          352 PELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       352 ~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      .++.+++.+||..+|++|||+++++.
T Consensus       230 ~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         230 EELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHH
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.5e-41  Score=313.54  Aligned_cols=242  Identities=24%  Similarity=0.418  Sum_probs=203.0

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      .+|.+.+.||+|+||.||++...  |..||+|.+...           .....+.+|+.+++.++|+|++++++++... 
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-   71 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-   71 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-
Confidence            47899999999999999998664  788999987432           1235688999999999999999999976543 


Q ss_pred             CCEEEEEEeecCCCCcccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      ....++||||++++++.+.+....  .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  151 (256)
T cd05082          72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  151 (256)
T ss_pred             CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCcccee
Confidence            357899999999999888775533  488999999999999999999999999999999999999999999999999875


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHH
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMNPE  353 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~  353 (410)
                      .....   ....++..|+|||++.+... +.++|||||||++|+|++ |..||......+....+..+. ...++.+++.
T Consensus       152 ~~~~~---~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (256)
T cd05082         152 ASSTQ---DTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPV  227 (256)
T ss_pred             ccccC---CCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHH
Confidence            43322   23345667999998876655 567999999999999997 999998877777666665542 3456778999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhh
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      +.+++.+||+.+|.+|||+.++++
T Consensus       228 ~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         228 VYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHHH
Confidence            999999999999999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.9e-41  Score=323.21  Aligned_cols=255  Identities=27%  Similarity=0.402  Sum_probs=208.7

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      +.|...+.||.|+||.||++++..++..+|+|.+.....      ........+.+|+.+++.++|+|++++++++..  
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   86 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK------QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--   86 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc------cChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--
Confidence            458888999999999999999999999999998764311      123345578899999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ....++||||+.+..+.........+++..+..++.|++.||.|||+.+++||||+|+|||++.++.++|+|||++....
T Consensus        87 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  166 (308)
T cd06634          87 EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (308)
T ss_pred             CCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence            45789999999864433333345568999999999999999999999999999999999999999999999999987643


Q ss_pred             CCccccccCCCcccccccccccC--CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCCCCHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLG--LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--FPDAMNPE  353 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~~~~  353 (410)
                      ..    ....|++.|+|||.+.+  ....+.++|||||||++|+|++|..||...........+......  .+..++..
T Consensus       167 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (308)
T cd06634         167 PA----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY  242 (308)
T ss_pred             Cc----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHH
Confidence            32    24568899999998753  222356799999999999999999999876655544444443322  23468899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      +.+||.+||..+|.+||++.++++|||+...
T Consensus       243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            9999999999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.3e-41  Score=328.79  Aligned_cols=251  Identities=20%  Similarity=0.374  Sum_probs=201.0

Q ss_pred             cceeeeeeecccCceEEEEEEE-----ccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCccccee
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRS-----SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIE  191 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~  191 (410)
                      ++|++.+.||+|+||.||+|.+     ..+++.||||++....        .......+.+|+.++..+ +||||+++++
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~niv~~~~   78 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--------THSEHRALMSELKILIHIGHHLNVVNLLG   78 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--------ChHHHHHHHHHHHHHHhccCCccHhhhcc
Confidence            5799999999999999999984     3467899999885431        233456788999999999 6899999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCCC---------------------------------------------------
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQP---------------------------------------------------  220 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---------------------------------------------------  220 (410)
                      ++... ...+++||||+++++|.+++...                                                   
T Consensus        79 ~~~~~-~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (343)
T cd05103          79 ACTKP-GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKS  157 (343)
T ss_pred             eeecC-CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCc
Confidence            88754 35789999999998887665321                                                   


Q ss_pred             ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCcc--c
Q 015257          221 ----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--V  282 (410)
Q Consensus       221 ----------------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~  282 (410)
                                      ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........  .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  237 (343)
T cd05103         158 LSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR  237 (343)
T ss_pred             cccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhh
Confidence                            2367888899999999999999999999999999999999999999999999976533221  1


Q ss_pred             cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH-HHHHHhC-CCCCCCCCCHHHHHHHH
Q 015257          283 LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDT-YDKIVNN-SLVFPDAMNPELRNLLE  359 (410)
Q Consensus       283 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~-~~~i~~~-~~~~p~~~~~~l~~li~  359 (410)
                      .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||........ ...+..+ ....|..+++++.+++.
T Consensus       238 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (343)
T cd05103         238 KGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML  316 (343)
T ss_pred             cCCCCCCcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence            122345677999998876655 567999999999999997 9999977543332 2223222 23456678899999999


Q ss_pred             HhcccCCCCCCCHHHHhhC
Q 015257          360 GLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       360 ~~L~~dp~~Rpt~~ell~h  378 (410)
                      .||+.||.+|||+.+|++|
T Consensus       317 ~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         317 DCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHccCChhhCcCHHHHHHH
Confidence            9999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.1e-41  Score=320.68  Aligned_cols=250  Identities=22%  Similarity=0.356  Sum_probs=204.9

Q ss_pred             ccceeeeeeecccCceEEEEEEEc-----cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccce
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLI  190 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  190 (410)
                      .++|.+.+.||+|+||.||++...     .++..||||.+....        .....+.+.+|+.+++++ +||||++++
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~~iv~~~  105 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--------HSSEREALMSELKIMSHLGNHENIVNLL  105 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--------ChHHHHHHHHHHHHHHhccCCCCcceEE
Confidence            357999999999999999999752     345689999875431        233456789999999999 799999999


Q ss_pred             eEEEcCCCCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEe
Q 015257          191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIG  268 (410)
Q Consensus       191 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~  268 (410)
                      +++..  ....++||||+++++|..++...  ..+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+
T Consensus       106 ~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~  183 (302)
T cd05055         106 GACTI--GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKIC  183 (302)
T ss_pred             EEEec--CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEEC
Confidence            99876  45799999999999988877543  248999999999999999999999999999999999999999999999


Q ss_pred             eccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCC-
Q 015257          269 DFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSL-  344 (410)
Q Consensus       269 DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~-  344 (410)
                      |||+++.......  ......+++.|+|||.+.+... +.++|||||||++|+|++ |..||................. 
T Consensus       184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~  262 (302)
T cd05055         184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR  262 (302)
T ss_pred             CCcccccccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc
Confidence            9999986543321  1223346788999998877665 667999999999999998 9999987765554444444322 


Q ss_pred             -CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          345 -VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       345 -~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                       ..+...++++.+|+.+||..+|.+|||+.++++
T Consensus       263 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         263 MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence             344567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.1e-41  Score=313.90  Aligned_cols=245  Identities=23%  Similarity=0.361  Sum_probs=203.3

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+.++||+|+||.||++++..+ ..||+|++.....          ..+.+.+|+.+++.++||||+++++++.+  
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----------~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--   72 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--   72 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----------CHHHHHHHHHHHHhCCCCCcceEEEEECC--
Confidence            5799999999999999999988755 4599998864321          12468899999999999999999998753  


Q ss_pred             CCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                       ...++||||++++++.+++..  ...+++..+..++.|++.||+|||+.+|+||||||+||+++.++.++|+|||.++.
T Consensus        73 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~  151 (262)
T cd05071          73 -EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL  151 (262)
T ss_pred             -CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceee
Confidence             357999999999998888764  23578999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCcc-ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCCH
Q 015257          276 FEDDND-VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMNP  352 (410)
Q Consensus       276 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~  352 (410)
                      ...... ......++..|+|||+..+..+ +.++||||||+++|+|++ |..||.+.........+.... ...+..++.
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (262)
T cd05071         152 IEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE  230 (262)
T ss_pred             ccccccccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCH
Confidence            543322 1123346678999998876655 667999999999999999 899998877666666665442 344567899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      .+.+|+.+||+.||.+|||+.++++
T Consensus       231 ~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         231 SLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2e-41  Score=327.23  Aligned_cols=253  Identities=19%  Similarity=0.301  Sum_probs=199.6

Q ss_pred             eeeccc--CceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEE
Q 015257          124 RKIGAG--SYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHF  201 (410)
Q Consensus       124 ~~lG~G--~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  201 (410)
                      ..||+|  +||+||++++..+|+.||||++.....       .....+.+.+|+.+++.++||||+++++++..  ....
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~   74 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-------TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWL   74 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCce
Confidence            456666  999999999999999999999764321       23445788999999999999999999999987  4578


Q ss_pred             EEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCC
Q 015257          202 YMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD  279 (410)
Q Consensus       202 ~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~  279 (410)
                      ++||||+.++++.+.+.+.  ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.++++||+.+......
T Consensus        75 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~  154 (328)
T cd08226          75 WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRN  154 (328)
T ss_pred             EEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhcc
Confidence            9999999998888776653  35899999999999999999999999999999999999999999999999865332211


Q ss_pred             ccc-------cccCCCcccccccccccCCc-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------
Q 015257          280 NDV-------LRRSPGTPVFTAPECCLGLT-YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-------  344 (410)
Q Consensus       280 ~~~-------~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-------  344 (410)
                      ...       .....++..|+|||++.+.. ..+.++|||||||++|+|++|..||...........+.....       
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd08226         155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT  234 (328)
T ss_pred             CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence            100       01123456799999986642 236789999999999999999999987654443333222111       


Q ss_pred             ----------------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          345 ----------------------------------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       345 ----------------------------------------~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                                                              ..+..+++.+.+||.+||+.||.+|||++++++||||...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                                                    0112356789999999999999999999999999999754


Q ss_pred             C
Q 015257          385 N  385 (410)
Q Consensus       385 ~  385 (410)
                      .
T Consensus       315 ~  315 (328)
T cd08226         315 K  315 (328)
T ss_pred             H
Confidence            3

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.9e-41  Score=352.04  Aligned_cols=150  Identities=33%  Similarity=0.582  Sum_probs=135.2

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      +++|.+++.||+|+||.||++.+..+++.||||++.....      ........+.+|+.+++.++||||+++++++.. 
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-   75 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM------INKNMVHQVQAERDALALSKSPFIVHLYYSLQS-   75 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc------cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-
Confidence            4689999999999999999999999999999999865422      133455678999999999999999999998876 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                       ...+||||||+.|+.|..++...+.+++..++.++.||+.||.|||..+|+||||||+|||++.++.+||+|||+++
T Consensus        76 -~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          76 -ANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             -CCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence             45899999999999999888777789999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.6e-41  Score=313.80  Aligned_cols=249  Identities=28%  Similarity=0.393  Sum_probs=205.8

Q ss_pred             cceeeeeeecccCceEEEEEEEccCC---ceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDG---KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      .+|++.+.||+|+||.||++....++   ..+|+|.+....        .......+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   75 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--------TEKQRRDFLSEASIMGQFDHPNIIHLEGVVT   75 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            46899999999999999999886544   379999875421        2334567899999999999999999999987


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .  ....++||||+++++|.+++... ..+++..+..++.||+.||.|||+++++||||||+|||++.++.++|+|||++
T Consensus        76 ~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd05066          76 K--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLS  153 (267)
T ss_pred             c--CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcc
Confidence            6  45789999999999988887654 46899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccc---cCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCC
Q 015257          274 QVFEDDNDVLR---RSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPD  348 (410)
Q Consensus       274 ~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~  348 (410)
                      ...........   ...++..|+|||.+.+... +.++|+||||+++|++++ |..||......+....+.... .+.+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPM  232 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCC
Confidence            87644322111   1223567999998876555 667999999999999886 999998877666666665542 23445


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      .+++.+.+++.+||+.+|.+|||+.++++
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         233 DCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            67899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.2e-41  Score=317.98  Aligned_cols=259  Identities=29%  Similarity=0.476  Sum_probs=212.1

Q ss_pred             ceeeeeeecccCceEEEEEEEc---cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEE
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID  194 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  194 (410)
                      +|.+.+.||+|+||.||+++..   .+++.||||++.+....     ........+.+|+.++..+ +||||+++++.+.
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~-----~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV-----QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH-----hhhhHHHHHHHHHHHHHhccCCcchhhhheeee
Confidence            3788999999999999998864   36789999998643211     1223445788999999999 5999999999887


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      .  ....++||||++++++...+.....+++..++.++.|++.||.|||+.+++||||+|.||+++.++.++|+|||+++
T Consensus        76 ~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          76 T--DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             c--CCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            6  45789999999999998887777789999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCcc-ccccCCCcccccccccccCCc-CCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCCC
Q 015257          275 VFEDDND-VLRRSPGTPVFTAPECCLGLT-YGGKAADTWAVGVTLYYMIIGQYPFLGET----LQDTYDKIVNNSLVFPD  348 (410)
Q Consensus       275 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~  348 (410)
                      ....... ......|++.|+|||.+.+.. ..+.++||||||+++|+|++|..||....    .......+.......|.
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd05583         154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK  233 (288)
T ss_pred             ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCc
Confidence            6543321 122345889999999876543 23567999999999999999999996432    22334445555566778


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCC---HHHHhhCCcccCC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLT---LNDVAKHTWVLGD  384 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt---~~ell~h~~~~~~  384 (410)
                      .++..+.++|.+||+.||++|||   +.++++||||+.-
T Consensus       234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            89999999999999999999998   5677999999764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.1e-41  Score=318.17  Aligned_cols=251  Identities=24%  Similarity=0.401  Sum_probs=201.2

Q ss_pred             ceeeeeeecccCceEEEEEEE----ccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          119 EYVHVRKIGAGSYGKVVLYRS----SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      -|++++.||+|+||.||+++.    ..++..||+|.+....        .......+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   76 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--------GGNHIADLKKEIEILRNLYHENIVKYKGICT   76 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--------cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence            378899999999999999974    4578899999875331        2344567899999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      +......++||||++|++|..++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++
T Consensus        77 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          77 EDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             cCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccc
Confidence            75456789999999999999887554 46899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCcc---ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------------H-HHH
Q 015257          274 QVFEDDND---VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET--------------L-QDT  335 (410)
Q Consensus       274 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~--------------~-~~~  335 (410)
                      +.......   ......++..|+|||++.+..+ +.++|||||||++|+|+++..|+....              . ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL  235 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence            86543221   2224456778999998876554 567999999999999999876642210              1 111


Q ss_pred             HHHHHhC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          336 YDKIVNN-SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       336 ~~~i~~~-~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ...+..+ ..+.+..++..+.+|+.+||+.||.+|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            1111111 233456789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-41  Score=310.92  Aligned_cols=243  Identities=26%  Similarity=0.440  Sum_probs=206.3

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|++.+.||.|+||.||++...  |+.||||.+....          ...+++.+|+.+++.++|+||+++++++.+  
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--   71 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS----------TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ--   71 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccch----------hHHHHHHHHHHHHHhcCCcceeeeEEEEcC--
Confidence            47889999999999999998765  8899999875431          145678999999999999999999999876  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      ....++||||++++.+.+.+....  .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.++.
T Consensus        72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~  151 (256)
T cd05039          72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE  151 (256)
T ss_pred             CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccc
Confidence            457899999999999988876554  689999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCCCHH
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPE  353 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~  353 (410)
                      ......   ...++..|+|||++.+... +.++||||||+++|+|++ |..||......+....+... ....|..+++.
T Consensus       152 ~~~~~~---~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (256)
T cd05039         152 ASQGQD---SGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPE  227 (256)
T ss_pred             cccccc---cCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHH
Confidence            533221   2334567999998876655 567999999999999997 99999888777666555544 33456778999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +.++|.+||..+|.+|||+.++++.
T Consensus       228 ~~~li~~~l~~~p~~Rp~~~~l~~~  252 (256)
T cd05039         228 VYKVMKDCWELDPAKRPTFKQLREQ  252 (256)
T ss_pred             HHHHHHHHhccChhhCcCHHHHHHH
Confidence            9999999999999999999999863

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8e-41  Score=311.98  Aligned_cols=245  Identities=23%  Similarity=0.361  Sum_probs=203.0

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+.+.||+|+||.||++....+ ..+|+|.+....          .....+.+|+.+++.++|||++++++++..  
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~----------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   72 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT----------MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE--   72 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC----------ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC--
Confidence            4689999999999999999987654 469999875421          123567899999999999999999998753  


Q ss_pred             CCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                       ...++||||++++++.+++...  ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus        73 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~  151 (260)
T cd05069          73 -EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARL  151 (260)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceE
Confidence             4578999999998888877543  3578999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCcc-ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCCCH
Q 015257          276 FEDDND-VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNP  352 (410)
Q Consensus       276 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~  352 (410)
                      ...... ......++..|+|||...+... +.++||||||+++|+|++ |..||.+....+....+... ....+..++.
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (260)
T cd05069         152 IEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPE  230 (260)
T ss_pred             ccCCcccccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCH
Confidence            543321 1123345678999998876554 677999999999999999 99999887777666666554 2345667899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      .+.+++.+||.+||.+||+++++++
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         231 SLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-41  Score=318.67  Aligned_cols=252  Identities=30%  Similarity=0.523  Sum_probs=207.9

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  199 (410)
                      |...+.||+|++|.||+++...+++.||+|++.....       .......+..|+.+++.++||||+++++++.+  ..
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~   71 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-------EEGIPSTALREISLLKELKHPNIVKLLDVIHT--ER   71 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-------cccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CC
Confidence            5678899999999999999999999999999875421       12334567789999999999999999999876  36


Q ss_pred             EEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          200 HFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ..++||||+++ ++.+.+... ..+++..++.++.|++.||.|||++||+||||+|+||+++.++.++|+|||+++....
T Consensus        72 ~~~~v~e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          72 KLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             ceEEEecCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            89999999985 677766654 5799999999999999999999999999999999999999999999999999987654


Q ss_pred             CccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------------
Q 015257          279 DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN----------------  342 (410)
Q Consensus       279 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~----------------  342 (410)
                      .........++..|+|||.+.+....+.++||||||+++|+|++|..||...........+...                
T Consensus       151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence            4333344456788999998876644567799999999999999999999887655544433220                


Q ss_pred             --CCCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          343 --SLVFP-----------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       343 --~~~~p-----------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                        ...++           ..++..+.++|.+||..||.+||++++++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence              00011           1347789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6.6e-41  Score=319.92  Aligned_cols=251  Identities=20%  Similarity=0.382  Sum_probs=207.4

Q ss_pred             ccceeeeeeecccCceEEEEEEEc-------cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCccc
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSS-------LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVN  188 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  188 (410)
                      .++|.+.+.||+|+||.||+++..       .++..||+|.+....        .......+.+|+.+++.+ +||||++
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~~i~~   85 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--------TEKDLSDLVSEMEMMKMIGKHKNIIN   85 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--------chHHHHHHHHHHHHHHhhccCCCchh
Confidence            467999999999999999999753       235579999875321        234456789999999999 8999999


Q ss_pred             ceeEEEcCCCCEEEEEEeecCCCCcccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccC
Q 015257          189 LIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDI  252 (410)
Q Consensus       189 l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl  252 (410)
                      +++++..  ....++||||+++++|..++...                ..+++..+..++.||+.||.|||++||+||||
T Consensus        86 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dl  163 (304)
T cd05101          86 LLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDL  163 (304)
T ss_pred             eeEEEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccc
Confidence            9999986  45789999999998888766432                34788889999999999999999999999999


Q ss_pred             CCCcEEEcCCCcEEEeeccccccccCCccc--cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 015257          253 KPDNLLVAPSGTVKIGDFSVSQVFEDDNDV--LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLG  329 (410)
Q Consensus       253 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~  329 (410)
                      ||+|||++.++.+||+|||+++........  .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+
T Consensus       164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~  242 (304)
T cd05101         164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPG  242 (304)
T ss_pred             ccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCccc
Confidence            999999999999999999999866432221  222345678999998877655 567999999999999998 8899988


Q ss_pred             CCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          330 ETLQDTYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       330 ~~~~~~~~~i~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ....+....+..+. ...|..++.++.+|+.+||..+|.+|||+.++++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         243 IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             CCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            88777777665543 24566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.8e-41  Score=317.59  Aligned_cols=248  Identities=22%  Similarity=0.383  Sum_probs=202.3

Q ss_pred             ceeeeeeecccCceEEEEEEEcc-----CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      +|++.+.||+|+||.||++....     ....+|+|.+....        .......+.+|+.+++.++||||+++++.+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   72 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--------SSSELRDLLSEFNLLKQVNHPHVIKLYGAC   72 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--------CHHHHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence            47888999999999999998753     23568888875321        233456788999999999999999999998


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCC------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEe
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQ------------------------PGAIGESMARKYLRDIVSGLMYLHGHNVVH  249 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~------------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiH  249 (410)
                      ..  ....++||||+.++++.+++..                        ...+++..+..++.|++.||.|||+.+|+|
T Consensus        73 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH  150 (290)
T cd05045          73 SQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVH  150 (290)
T ss_pred             ec--CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeeh
Confidence            76  4568999999999888766432                        135788999999999999999999999999


Q ss_pred             ccCCCCcEEEcCCCcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCC
Q 015257          250 GDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYP  326 (410)
Q Consensus       250 rDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~P  326 (410)
                      |||||+|||++.++.+||+|||+++.......  ......++..|+|||++.+... +.++||||||+++|+|++ |..|
T Consensus       151 ~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p  229 (290)
T cd05045         151 RDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNP  229 (290)
T ss_pred             hhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCC
Confidence            99999999999999999999999976533221  1123345678999998866554 677999999999999998 9999


Q ss_pred             CCCCCHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          327 FLGETLQDTYDKIVNN-SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       327 f~~~~~~~~~~~i~~~-~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      |.+......+..+... ....|..++.++.+++.+||+.+|.+||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         230 YPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            9887776666555443 23456778999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.8e-41  Score=321.05  Aligned_cols=251  Identities=21%  Similarity=0.376  Sum_probs=205.8

Q ss_pred             ccceeeeeeecccCceEEEEEEEcc-------CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCccc
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSL-------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVN  188 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  188 (410)
                      .++|.+.+.||+|+||.||++++..       ....+|+|.+....        .......+.+|+.+++.+ +||||++
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~~iv~   82 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--------TDKDLADLISEMELMKLIGKHKNIIN   82 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--------ChHHHHHHHHHHHHHHhccCCCCeee
Confidence            3579999999999999999998632       34579999875321        234456788999999999 6999999


Q ss_pred             ceeEEEcCCCCEEEEEEeecCCCCcccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccC
Q 015257          189 LIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDI  252 (410)
Q Consensus       189 l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl  252 (410)
                      +++++.+  ...+++||||+++++|..++...                ..+++..+..++.||+.||.|||++||+||||
T Consensus        83 ~~~~~~~--~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dl  160 (314)
T cd05099          83 LLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDL  160 (314)
T ss_pred             EEEEEcc--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccc
Confidence            9999876  45789999999999887766432                35889999999999999999999999999999


Q ss_pred             CCCcEEEcCCCcEEEeeccccccccCCccc--cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 015257          253 KPDNLLVAPSGTVKIGDFSVSQVFEDDNDV--LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLG  329 (410)
Q Consensus       253 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~  329 (410)
                      ||+|||++.++.+||+|||+++........  .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+
T Consensus       161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~  239 (314)
T cd05099         161 AARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPG  239 (314)
T ss_pred             cceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999865432211  112234567999998876555 567999999999999999 8999988


Q ss_pred             CCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          330 ETLQDTYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       330 ~~~~~~~~~i~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ....+....+.... ...|..++.++.+|+.+||..||.+|||+.++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~  289 (314)
T cd05099         240 IPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA  289 (314)
T ss_pred             CCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            87777776666553 34567788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.9e-41  Score=316.36  Aligned_cols=251  Identities=25%  Similarity=0.409  Sum_probs=200.2

Q ss_pred             cceeeeeeecccCceEEEEEEE----ccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRS----SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      .+|++++.||+|+||.||++..    ..++..||+|.+...         .......+.+|+.+++.++||||+++++++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   74 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---------TAEHLRDFEREIEILKSLQHDNIVKYKGVC   74 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---------CHHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence            4689999999999999999873    457889999987543         234556789999999999999999999988


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      ...+...+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          75 YSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             ccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcc
Confidence            665556789999999999999887543 4689999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccc---cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------------H
Q 015257          273 SQVFEDDNDV---LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ---------------D  334 (410)
Q Consensus       273 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~---------------~  334 (410)
                      ++........   .....++..|+|||++.+..+ +.++|||||||++|||++|..|+......               .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVY  233 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchH
Confidence            9876443221   111223456999998876554 67799999999999999987765332110               0


Q ss_pred             HHHHHHhC--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          335 TYDKIVNN--SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       335 ~~~~i~~~--~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ....+...  ....+..++.++.+|+.+||..+|.+|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05081         234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ  279 (284)
T ss_pred             HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            01111222  223456788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.7e-42  Score=356.31  Aligned_cols=258  Identities=27%  Similarity=0.489  Sum_probs=207.3

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ....+|+.+..||+||||.||+|+++.+|+.||||++...        .+......+.+|+..|.+|+|||||+++..|.
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~--------~s~~~~skI~rEVk~LArLnHpNVVRYysAWV  547 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLK--------ASDKLYSKILREVKLLARLNHPNVVRYYSAWV  547 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCc--------hHHHHHHHHHHHHHHHhhcCCcceeeeehhhh
Confidence            3567899999999999999999999999999999987543        24456678999999999999999999986551


Q ss_pred             cC------------------------------------------------------------------------------
Q 015257          195 DP------------------------------------------------------------------------------  196 (410)
Q Consensus       195 ~~------------------------------------------------------------------------------  196 (410)
                      +.                                                                              
T Consensus       548 Es~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg  627 (1351)
T KOG1035|consen  548 ESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDG  627 (1351)
T ss_pred             ccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccc
Confidence            00                                                                              


Q ss_pred             ---------C----------------------C--------CEEEEEEeecCCCCcccccCCCCCC-CHHHHHHHHHHHH
Q 015257          197 ---------N----------------------S--------DHFYMVLEYVEGKWDNDGFGQPGAI-GESMARKYLRDIV  236 (410)
Q Consensus       197 ---------~----------------------~--------~~~~lv~e~~~~~~l~~~~~~~~~l-~~~~~~~i~~qi~  236 (410)
                               +                      .        -.+||.||||+..++.+.+..+... ....+|++++||+
T Consensus       628 ~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIl  707 (1351)
T KOG1035|consen  628 RNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREIL  707 (1351)
T ss_pred             cccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHH
Confidence                     0                      0        2579999999998888888777654 4678899999999


Q ss_pred             HHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc-----------------C-CccccccCCCcccccccccc
Q 015257          237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE-----------------D-DNDVLRRSPGTPVFTAPECC  298 (410)
Q Consensus       237 ~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~-----------------~-~~~~~~~~~gt~~y~aPE~~  298 (410)
                      .||.|+|++|||||||||.||++++++.|||+|||+|+...                 . .....+..+||..|+|||++
T Consensus       708 EGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll  787 (1351)
T KOG1035|consen  708 EGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL  787 (1351)
T ss_pred             HHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence            99999999999999999999999999999999999997621                 0 11134556799999999988


Q ss_pred             cCCc--CCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHhcccCCCCCCC
Q 015257          299 LGLT--YGGKAADTWAVGVTLYYMIIGQYPFLGE-TLQDTYDKIVNNSLVFPD----AMNPELRNLLEGLLCKDPTRRLT  371 (410)
Q Consensus       299 ~~~~--~~~~~~DiwSlG~il~elltG~~Pf~~~-~~~~~~~~i~~~~~~~p~----~~~~~l~~li~~~L~~dp~~Rpt  371 (410)
                      .+..  .++.++|+||||+|++||+.   ||.-. .-......+..+.+++|.    ..-+.-..+|.+||+.||++|||
T Consensus       788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPt  864 (1351)
T KOG1035|consen  788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPT  864 (1351)
T ss_pred             cccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCC
Confidence            7665  45778999999999999995   56432 222345555566665552    22345678999999999999999


Q ss_pred             HHHHhhCCcccC
Q 015257          372 LNDVAKHTWVLG  383 (410)
Q Consensus       372 ~~ell~h~~~~~  383 (410)
                      |.|+|++.||.-
T Consensus       865 A~eLL~s~llpp  876 (1351)
T KOG1035|consen  865 ATELLNSELLPP  876 (1351)
T ss_pred             HHHHhhccCCCc
Confidence            999999999973

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.2e-42  Score=347.21  Aligned_cols=248  Identities=28%  Similarity=0.446  Sum_probs=212.7

Q ss_pred             cceeeeeeecccCceEEEEEEEcc-----CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      .+-+..+.||+|+||+||+++...     +-..||||.++...        +.....+|++|++++..|+|||||+++|+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--------~~~~~~dF~REaeLla~l~H~nIVrLlGV  557 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--------ENQARQDFRREAELLAELQHPNIVRLLGV  557 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--------cHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence            456677899999999999998653     34679999886442        44577899999999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEE
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQ--------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLL  258 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~--------------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIl  258 (410)
                      |.+  ++.++||+|||..|+|..++..              ..+|+..+...|+.|||.||.||-++.++||||-..|+|
T Consensus       558 C~~--~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL  635 (774)
T KOG1026|consen  558 CRE--GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL  635 (774)
T ss_pred             Ecc--CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence            987  5689999999999988877642              223888999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCC-ccccc-cCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 015257          259 VAPSGTVKIGDFSVSQVFEDD-NDVLR-RSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDT  335 (410)
Q Consensus       259 l~~~~~~kl~DfG~a~~~~~~-~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~  335 (410)
                      |.++..|||+|||+++..-.. ..... ...-...|||||.+....+++ +||||||||+|||+++ |..||.+...++.
T Consensus       636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTt-eSDVWs~GVvLWEIFsyG~QPy~glSn~EV  714 (774)
T KOG1026|consen  636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTT-ESDVWSFGVVLWEIFSYGKQPYYGLSNQEV  714 (774)
T ss_pred             eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccc-hhhhhhhhhhhhhhhccccCcccccchHHH
Confidence            999999999999999864322 22211 233356799999999888854 5999999999999996 9999999999999


Q ss_pred             HHHHHhCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 015257          336 YDKIVNNSL-VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVA  376 (410)
Q Consensus       336 ~~~i~~~~~-~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell  376 (410)
                      .+.|..+.. +-|+.++.++++|+..||+.+|++||+++||-
T Consensus       715 Ie~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  715 IECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             HHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            999988875 67889999999999999999999999999984

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.8e-41  Score=316.17  Aligned_cols=239  Identities=21%  Similarity=0.265  Sum_probs=195.5

Q ss_pred             eeecccCceEEEEEEEccCCc-------eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          124 RKIGAGSYGKVVLYRSSLDGK-------HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      +.||+|+||.||++.....+.       .+|+|.+...         .....+.+.+|+.+++.++||||+++++++.. 
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-   70 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---------HRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-   70 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch---------hHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-
Confidence            369999999999998865443       4888876432         23345678899999999999999999999986 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCc--------EEE
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT--------VKI  267 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~--------~kl  267 (410)
                       ....++||||+++++|..++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.        +++
T Consensus        71 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l  149 (258)
T cd05078          71 -GDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL  149 (258)
T ss_pred             -CCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEe
Confidence             34689999999999998887654 46899999999999999999999999999999999999987765        699


Q ss_pred             eeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhCCCCC
Q 015257          268 GDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIG-QYPFLGETLQDTYDKIVNNSLVF  346 (410)
Q Consensus       268 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG-~~Pf~~~~~~~~~~~i~~~~~~~  346 (410)
                      +|||++......    ....+++.|+|||++.+....+.++||||||+++|+|++| ..||........ ..+......+
T Consensus       150 ~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~  224 (258)
T cd05078         150 SDPGISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRHQL  224 (258)
T ss_pred             cccccccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccccC
Confidence            999998654332    2345788999999987755456779999999999999998 466655444333 3344455667


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          347 PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       347 p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      |...+.++.+|+.+||+.||.+|||++++++.
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         225 PAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             CCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            87888999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.2e-40  Score=312.32  Aligned_cols=250  Identities=28%  Similarity=0.394  Sum_probs=206.7

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCc---eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGK---HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ..|.+.+.||+|+||.||++....+++   .||||++...        ........+..|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~   75 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--------YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT   75 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--------CCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC
Confidence            468899999999999999999887665   6999987532        13445578999999999999999999999987


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      +  ...+++||||++++++..++.. .+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++
T Consensus        76 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~  153 (269)
T cd05065          76 K--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS  153 (269)
T ss_pred             C--CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccc
Confidence            5  4578999999999998887764 456899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCccc--cccCC---CcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCC
Q 015257          274 QVFEDDNDV--LRRSP---GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVF  346 (410)
Q Consensus       274 ~~~~~~~~~--~~~~~---gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~  346 (410)
                      .........  .....   .+..|+|||++.+..+ +.++|||||||++||+++ |..||......+....+... ..+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  232 (269)
T cd05065         154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP  232 (269)
T ss_pred             cccccCccccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence            765432211  11111   2457999998876665 567999999999999886 99999887776666666443 2345


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          347 PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       347 p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +..++..+.+++.+||+.+|.+||++.+++..
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  264 (269)
T cd05065         233 PMDCPTALHQLMLDCWQKDRNARPKFGQIVST  264 (269)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            56788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=310.15  Aligned_cols=247  Identities=25%  Similarity=0.368  Sum_probs=206.7

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+.+.||+|+||.||++... ++..||||.+....          .....+.+|+.+++.++||||+++++++.. 
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   72 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT----------MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-   72 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc----------cCHHHHHHHHHHHhhCCCCCEeeeeeeeec-
Confidence            357999999999999999999875 45789999876432          123568899999999999999999999875 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                       ....++||||++++++.+.+...  ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++
T Consensus        73 -~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~  151 (261)
T cd05034          73 -EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR  151 (261)
T ss_pred             -CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccce
Confidence             35789999999999988887654  368999999999999999999999999999999999999999999999999997


Q ss_pred             cccCCcc-ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCCC
Q 015257          275 VFEDDND-VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMN  351 (410)
Q Consensus       275 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~  351 (410)
                      ....... ......++..|+|||.+.+... +.++||||||+++|+|++ |+.||.+.........+... ....|...+
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (261)
T cd05034         152 LIEDDEYTAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCP  230 (261)
T ss_pred             eccchhhhhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            6543211 1122234567999998876554 667999999999999998 99999887777777766654 234566788


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          352 PELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       352 ~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      .++.+++.+||+.+|.+||+++++++
T Consensus       231 ~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         231 EELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHHH
Confidence            99999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-41  Score=318.07  Aligned_cols=249  Identities=26%  Similarity=0.318  Sum_probs=199.6

Q ss_pred             cceeeeeeecccCceEEEEEEEccC--------------CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLD--------------GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH  183 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~--------------~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  183 (410)
                      ++|++.+.||+|+||.||++.+...              ...||+|.+....        .......+.+|+++++.++|
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~ei~~l~~l~h   76 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--------TKTARNDFLKEIKIMSRLKN   76 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--------CHHHHHHHHHHHHHHHhCCC
Confidence            4799999999999999999987543              2358999875431        23445678999999999999


Q ss_pred             CCcccceeEEEcCCCCEEEEEEeecCCCCcccccCCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecc
Q 015257          184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGD  251 (410)
Q Consensus       184 pniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~------------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD  251 (410)
                      |||+++++++..  ....++||||++++++.+++...            ..+++..+..++.|++.||.|||++|++|||
T Consensus        77 ~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~d  154 (295)
T cd05097          77 PNIIRLLGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRD  154 (295)
T ss_pred             CCcCeEEEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccc
Confidence            999999999976  45789999999999887765332            2468889999999999999999999999999


Q ss_pred             CCCCcEEEcCCCcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh--CCCCC
Q 015257          252 IKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII--GQYPF  327 (410)
Q Consensus       252 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt--G~~Pf  327 (410)
                      |||+|||++.++.+||+|||++........  ......+++.|+|||++.+..+ +.++|||||||++|+|++  |..||
T Consensus       155 lkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~  233 (295)
T cd05097         155 LATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPY  233 (295)
T ss_pred             cChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCC
Confidence            999999999999999999999976433221  1223345778999998876665 677999999999999988  67888


Q ss_pred             CCCCHHHHHHHHHh-----C---CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          328 LGETLQDTYDKIVN-----N---SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       328 ~~~~~~~~~~~i~~-----~---~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ......+....+..     .   ....+..+++.+.+|+.+||..||.+|||+++|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         234 SLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             cccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            77665554433321     1   12234567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=9.1e-41  Score=317.77  Aligned_cols=259  Identities=24%  Similarity=0.408  Sum_probs=204.8

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID  194 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  194 (410)
                      ..++|.+.+.||+|+||.||++.+..+++.||||.+....        .......+..|+.++... .||||+++++++.
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~   84 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--------NKEENKRILMDLDVVLKSHDCPYIVKCYGYFI   84 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC--------ChHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence            3467999999999999999999999889999999986432        122334566677766666 4999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      +  ...+++||||+++. +..... ....+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||+
T Consensus        85 ~--~~~~~~v~e~~~~~-l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~  161 (296)
T cd06618          85 T--DSDVFICMELMSTC-LDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGI  161 (296)
T ss_pred             c--CCeEEEEeeccCcC-HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECcccc
Confidence            6  45799999998753 333332 24578999999999999999999997 5999999999999999999999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCc---CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC-CCC
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLT---YGGKAADTWAVGVTLYYMIIGQYPFLGETL-QDTYDKIVNNSL-VFP  347 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~i~~~~~-~~p  347 (410)
                      +........ .....+++.|+|||.+.+..   ..+.++||||||+++|+|++|+.||..... .+....+..... .++
T Consensus       162 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  240 (296)
T cd06618         162 SGRLVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP  240 (296)
T ss_pred             chhccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCC
Confidence            876543322 23345788999999886543   235679999999999999999999976322 334444444332 233


Q ss_pred             --CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          348 --DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       348 --~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                        ..++.++.+|+.+||..||.+|||+.+++.||||.....
T Consensus       241 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         241 PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence              247899999999999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.6e-41  Score=316.15  Aligned_cols=249  Identities=25%  Similarity=0.376  Sum_probs=205.5

Q ss_pred             cceeeeeeecccCceEEEEEEEcc-----CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      ++|.+++.||+|+||.||++.+..     ++..||+|++....        .......+.+|+.+++.++||||++++++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~ei~~l~~l~h~~iv~~~~~   76 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--------SADMQADFQREAALMAEFDHPNIVKLLGV   76 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--------CHHHHHHHHHHHHHHHhcCCCchheEEEE
Confidence            579999999999999999998753     67889999875331        23445678999999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEec
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP----------------------GAIGESMARKYLRDIVSGLMYLHGHNVVHG  250 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr  250 (410)
                      +.+  ....++||||+++++|..++...                      ..+++..++.++.||+.||.|||+++++||
T Consensus        77 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~  154 (288)
T cd05050          77 CAV--GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHR  154 (288)
T ss_pred             EcC--CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            876  45789999999998877665421                      247888999999999999999999999999


Q ss_pred             cCCCCcEEEcCCCcEEEeeccccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCC
Q 015257          251 DIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPF  327 (410)
Q Consensus       251 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf  327 (410)
                      ||||+|||++.++.++|+|||++.......  .......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||
T Consensus       155 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~  233 (288)
T cd05050         155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPY  233 (288)
T ss_pred             cccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999987543221  11222334667999998876655 567999999999999997 88999


Q ss_pred             CCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          328 LGETLQDTYDKIVNNSL-VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       328 ~~~~~~~~~~~i~~~~~-~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      .+....+....+..+.. ..|..++.++.+|+.+||+.||.+|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         234 YGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            88777777666665543 346678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=332.91  Aligned_cols=249  Identities=26%  Similarity=0.390  Sum_probs=211.3

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCc---e-EEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGK---H-YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~---~-vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      +-.+.++||+|+||.||+++.+..+.   . ||||......      ....+.+.++.+|+++|+.++|||||++||+..
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~------~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS------ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc------cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            34455899999999999998776422   3 8999876421      124678889999999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      +  ...++||||+|+||+|.+++...+ .++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+|||++
T Consensus       232 ~--~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs  309 (474)
T KOG0194|consen  232 L--EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS  309 (474)
T ss_pred             C--CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence            7  457999999999999999998877 5999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccc-cCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC--CCCCCC
Q 015257          274 QVFEDDNDVLR-RSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS--LVFPDA  349 (410)
Q Consensus       274 ~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~  349 (410)
                      +.... ..... ...-...|+|||.+....+ +.++|||||||++||+.+ |..||.+....+....|..+.  ..+|..
T Consensus       310 ~~~~~-~~~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~  387 (474)
T KOG0194|consen  310 RAGSQ-YVMKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSK  387 (474)
T ss_pred             cCCcc-eeeccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCC
Confidence            86541 11111 1223567999999988855 677999999999999998 899999999999988885543  356778


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      .+.++..++.+||..||++|||+.++.+
T Consensus       388 ~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  388 TPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             CHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            8899999999999999999999998875

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.4e-41  Score=321.77  Aligned_cols=246  Identities=18%  Similarity=0.275  Sum_probs=194.7

Q ss_pred             CceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEEEEeecC
Q 015257          130 SYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE  209 (410)
Q Consensus       130 ~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~  209 (410)
                      ++|.||++++..+++.||||++....       ........+.+|+.+++.++||||+++++++.+  ...++++|||++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~-------~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~~~   82 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDS-------CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMA   82 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccc-------cchhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEeccC
Confidence            45666778888899999999986532       133456789999999999999999999999986  457999999999


Q ss_pred             CCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCcc------
Q 015257          210 GKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND------  281 (410)
Q Consensus       210 ~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~------  281 (410)
                      ++++.+++..  ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||.+........      
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence            9998887764  34689999999999999999999999999999999999999999999999998865432211      


Q ss_pred             -ccccCCCcccccccccccCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------------
Q 015257          282 -VLRRSPGTPVFTAPECCLGL-TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL---------------  344 (410)
Q Consensus       282 -~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---------------  344 (410)
                       ......++..|+|||++... ...+.++|||||||++|+|++|..||..............+..               
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS  242 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence             12234467789999988653 2236679999999999999999999987544332221111110               


Q ss_pred             -------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          345 -------------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       345 -------------------~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                                         ..+..++.++.+|+.+||+.||++|||++++++||||...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~  301 (314)
T cd08216         243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC  301 (314)
T ss_pred             cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence                               0011234678899999999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.2e-40  Score=313.06  Aligned_cols=250  Identities=22%  Similarity=0.381  Sum_probs=207.6

Q ss_pred             cceeeeeeecccCceEEEEEEEcc-----CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      ++|.+++.||+|+||.||+++.+.     +.+.||+|.+...        ........+.+|+.++++++||||++++++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   76 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--------KDENLQSEFRRELDMFRKLSHKNVVRLLGL   76 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc--------cchHHHHHHHHHHHHHHhcCCcceeeeEEE
Confidence            468999999999999999999754     3467999976432        123356789999999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCCC---------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPG---------AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG  263 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---------~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~  263 (410)
                      +.+  ....++||||+++++|.+++....         .+++..+..++.||+.||+|||+.+|+||||||+|||++.++
T Consensus        77 ~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~  154 (275)
T cd05046          77 CRE--AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR  154 (275)
T ss_pred             ECC--CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC
Confidence            876  457899999999999988876544         689999999999999999999999999999999999999999


Q ss_pred             cEEEeeccccccccCCc-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015257          264 TVKIGDFSVSQVFEDDN-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVN  341 (410)
Q Consensus       264 ~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~  341 (410)
                      .++|+|||++....... .......+++.|+|||.+.+... +.++||||||+++|+|++ |..||...........+..
T Consensus       155 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~  233 (275)
T cd05046         155 EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA  233 (275)
T ss_pred             cEEEcccccccccCcccccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc
Confidence            99999999987543221 12233346778999998876654 567999999999999998 8899987766666666655


Q ss_pred             CCC--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          342 NSL--VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       342 ~~~--~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +..  ..+..++..+.+++.+||+.||.+|||+.+++.+
T Consensus       234 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         234 GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            443  3456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.2e-40  Score=317.06  Aligned_cols=249  Identities=25%  Similarity=0.339  Sum_probs=198.8

Q ss_pred             cceeeeeeecccCceEEEEEEEcc----------------CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSL----------------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML  181 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  181 (410)
                      ++|++.+.||+|+||.||++....                ++..+|+|++....        .......+.+|+.+++.+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--------~~~~~~~~~~E~~~l~~l   76 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--------NKNARNDFLKEIKIMSRL   76 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--------CHHHHHHHHHHHHHHHhC
Confidence            469999999999999999986432                34579999875321        234456789999999999


Q ss_pred             CCCCcccceeEEEcCCCCEEEEEEeecCCCCcccccCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEec
Q 015257          182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP-----------GAIGESMARKYLRDIVSGLMYLHGHNVVHG  250 (410)
Q Consensus       182 ~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr  250 (410)
                      +||||+++++++..  ....++||||++++++..++...           ..+++..+..++.||+.||+|||+.||+||
T Consensus        77 ~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~  154 (296)
T cd05095          77 KDPNIIRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHR  154 (296)
T ss_pred             CCCCcceEEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            99999999999976  45789999999998887765432           246778999999999999999999999999


Q ss_pred             cCCCCcEEEcCCCcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh--CCCC
Q 015257          251 DIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII--GQYP  326 (410)
Q Consensus       251 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt--G~~P  326 (410)
                      ||||+|||++.++.++|+|||+++.......  ...+..+++.|+|||+..+..+ +.++|||||||++|+|++  |..|
T Consensus       155 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p  233 (296)
T cd05095         155 DLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQP  233 (296)
T ss_pred             cCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999976533221  1222344678999998776665 667999999999999998  7789


Q ss_pred             CCCCCHHHHHHHHHh--------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          327 FLGETLQDTYDKIVN--------NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       327 f~~~~~~~~~~~i~~--------~~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      |......+.......        .....|..+++.+.+|+.+||+.||.+|||+.+|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         234 YSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            977665554332211        112345567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=314.19  Aligned_cols=250  Identities=30%  Similarity=0.439  Sum_probs=201.6

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEEEcCCC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDPNS  198 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~  198 (410)
                      |.+.+.||+|++|.||+++...+++.||||.+.....        ........+|+..+++++ ||||+++++++.+  .
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~   70 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--------SWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--N   70 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--------chhHHHHHHHHHHHHhccCCCCchhHHHHhhc--C
Confidence            6788999999999999999998999999998764321        111223457899999999 9999999999876  5


Q ss_pred             CEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ...++||||+ ++.+.+.+...  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        71 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~  149 (283)
T cd07830          71 DELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREI  149 (283)
T ss_pred             CcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceec
Confidence            6899999999 55566555443  37899999999999999999999999999999999999999999999999999765


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS-------------  343 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-------------  343 (410)
                      .... ......++..|+|||++......+.++|+||||+++++|++|..||......+....+....             
T Consensus       150 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07830         150 RSRP-PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK  228 (283)
T ss_pred             cCCC-CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence            4322 22345688899999988655545678999999999999999999998766554443322100             


Q ss_pred             ------CC-----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          344 ------LV-----------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       344 ------~~-----------~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                            ..           .....+..+.++|.+||+.||.+|||+.|++.||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                  00           011236789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1e-40  Score=329.88  Aligned_cols=252  Identities=20%  Similarity=0.325  Sum_probs=203.2

Q ss_pred             cccceeeeeeecccCceEEEEEEEc-----cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNL  189 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l  189 (410)
                      ..++|.+.+.||+|+||.||+++..     ..++.||||++....        .......+.+|+.+|..+. |||||++
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~~E~~~l~~l~~H~niv~~  106 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--------RSSEKQALMSELKIMSHLGPHLNIVNL  106 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--------ChhHHHHHHHHHHHHHhcCCCCCeEEE
Confidence            3457889999999999999999854     345689999986431        2233457889999999997 9999999


Q ss_pred             eeEEEcCCCCEEEEEEeecCCCCcccccCCC-------------------------------------------------
Q 015257          190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP-------------------------------------------------  220 (410)
Q Consensus       190 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-------------------------------------------------  220 (410)
                      ++++..  ...+++||||+++++|.+++...                                                 
T Consensus       107 ~~~~~~--~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (401)
T cd05107         107 LGACTK--GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKD  184 (401)
T ss_pred             EEEEcc--CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCc
Confidence            999986  35799999999998887655321                                                 


Q ss_pred             -------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecc
Q 015257          221 -------------------------------------------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGD  251 (410)
Q Consensus       221 -------------------------------------------------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD  251 (410)
                                                                       ..+++..+..++.||+.||.|||+.+|+|||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrd  264 (401)
T cd05107         185 ESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRD  264 (401)
T ss_pred             cccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCccc
Confidence                                                             2367778899999999999999999999999


Q ss_pred             CCCCcEEEcCCCcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 015257          252 IKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFL  328 (410)
Q Consensus       252 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~  328 (410)
                      |||+|||++.++.+||+|||+++.......  ......+++.|+|||.+.+..+ +.++||||||+++|||++ |..||.
T Consensus       265 lkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~  343 (401)
T cd05107         265 LAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYP  343 (401)
T ss_pred             CCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCC
Confidence            999999999999999999999986533221  1223456788999998876655 667999999999999998 899997


Q ss_pred             CCCHHHHHHHHHh-C-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          329 GETLQDTYDKIVN-N-SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       329 ~~~~~~~~~~i~~-~-~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .....+....... + ....|..++.++.+|+.+||+.+|.+||++++|++.
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         344 ELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            7655554433333 3 234567789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-42  Score=333.97  Aligned_cols=244  Identities=29%  Similarity=0.475  Sum_probs=206.6

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHH-HhCCCCCcccceeEEE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM-KMLQHPNIVNLIEVID  194 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~  194 (410)
                      +.++|.....+|.|+|+.|..+.+..+++.+++|++.+..             ....+|+.++ ..-+||||+++.+++.
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------------~~~~~e~~~~~~~~~h~niv~~~~v~~  386 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------------DDNQDEIPISLLVRDHPNIVKSHDVYE  386 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc-------------cccccccchhhhhcCCCcceeecceec
Confidence            5678888889999999999999999999999999987541             1223566554 4447999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEE-cCCCcEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV-APSGTVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll-~~~~~~kl~DfG~a  273 (410)
                      +  ..+.|+|||.+.|+.+.+.+.....+. ..+..|+.+|+.||.|||++|++||||||+|||+ +..|+++|+|||.+
T Consensus       387 ~--~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a  463 (612)
T KOG0603|consen  387 D--GKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFW  463 (612)
T ss_pred             C--CceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechh
Confidence            7  578999999999998888877766555 7888899999999999999999999999999999 68899999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCCCCCCH
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ-DTYDKIVNNSLVFPDAMNP  352 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p~~~~~  352 (410)
                      +.....   ..+.+-|..|.|||++....+ +.++|+||||++||+||+|+.||...... +....+..+.  +...+|.
T Consensus       464 ~~~~~~---~~tp~~t~~y~APEvl~~~~y-t~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~--~s~~vS~  537 (612)
T KOG0603|consen  464 SELERS---CDTPALTLQYVAPEVLAIQEY-TEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK--FSECVSD  537 (612)
T ss_pred             hhCchh---hcccchhhcccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc--cccccCH
Confidence            876554   344566889999998885554 78899999999999999999999765444 4444444433  4488999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      .+++||.+||++||.+||++.++..||||
T Consensus       538 ~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  538 EAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHHHHHHhccCChhhCcChhhhccCcch
Confidence            99999999999999999999999999999

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-40  Score=311.33  Aligned_cols=239  Identities=21%  Similarity=0.299  Sum_probs=191.7

Q ss_pred             eeecccCceEEEEEEEccC------------CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCccccee
Q 015257          124 RKIGAGSYGKVVLYRSSLD------------GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE  191 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~------------~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  191 (410)
                      +.||+|+||.||+++....            ...+|+|++...         .......+.+|+.+++.++||||+++++
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---------~~~~~~~~~~~~~~l~~l~hp~iv~~~~   71 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---------HRDISLAFFETASMMRQVSHKHIVLLYG   71 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---------hhhHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            3689999999999985322            235888876432         2334457889999999999999999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCc------
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT------  264 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~------  264 (410)
                      ++..  ....++||||++++.+..++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.      
T Consensus        72 ~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~  149 (262)
T cd05077          72 VCVR--DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGP  149 (262)
T ss_pred             EEec--CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCc
Confidence            9886  3467999999999988777654 456899999999999999999999999999999999999987664      


Q ss_pred             -EEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhC
Q 015257          265 -VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN  342 (410)
Q Consensus       265 -~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell-tG~~Pf~~~~~~~~~~~i~~~  342 (410)
                       ++++|||++......    ....++..|+|||++......+.++|||||||++|+|+ +|..||......+. ..+...
T Consensus       150 ~~~l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~  224 (262)
T cd05077         150 FIKLSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYEG  224 (262)
T ss_pred             eeEeCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHhc
Confidence             899999998754322    23457888999998875554577899999999999998 58899877554433 233344


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          343 SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       343 ~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ........+.++.+||.+||+.||.+||++.+|+++
T Consensus       225 ~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         225 QCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            444445567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.6e-40  Score=309.66  Aligned_cols=249  Identities=25%  Similarity=0.380  Sum_probs=205.6

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCc---eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGK---HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ++|...+.||+|+||.||++....++.   .+|+|.+....        .......+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   76 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--------TEKQRQDFLSEASIMGQFSHHNIIRLEGVVT   76 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--------CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc
Confidence            468889999999999999999876554   79999875321        2334567889999999999999999999997


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      +  .+..++||||+++++|..++.. .+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++
T Consensus        77 ~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~  154 (268)
T cd05063          77 K--FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLS  154 (268)
T ss_pred             c--CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccc
Confidence            6  4578999999999999888754 357899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCcccc---ccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCC
Q 015257          274 QVFEDDNDVL---RRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPD  348 (410)
Q Consensus       274 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~  348 (410)
                      ..........   .....++.|+|||++.+..+ +.++|||||||++|+|++ |..||......+....+.... .+.+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  233 (268)
T cd05063         155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPM  233 (268)
T ss_pred             eecccccccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCC
Confidence            7654322111   11223457999998876655 667999999999999997 999998877766666665432 23445


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      .++.++.+++.+||+.+|.+||++.+|++
T Consensus       234 ~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         234 DCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            67899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.3e-40  Score=305.59  Aligned_cols=243  Identities=24%  Similarity=0.364  Sum_probs=200.5

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYM  203 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l  203 (410)
                      +.||+|+||.||++... ++..+|+|.+....        .......+.+|+.+++.++||||+++++++..  ....++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l   69 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--------PQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYI   69 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--------CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEE
Confidence            36899999999999865 68899999875431        23344578899999999999999999999876  457899


Q ss_pred             EEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc
Q 015257          204 VLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV  282 (410)
Q Consensus       204 v~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  282 (410)
                      ||||++++++.+.+.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus        70 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          70 VMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccc
Confidence            9999999998887654 346899999999999999999999999999999999999999999999999998754332111


Q ss_pred             -cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCCCHHHHHHHH
Q 015257          283 -LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNLLE  359 (410)
Q Consensus       283 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~l~~li~  359 (410)
                       .....+++.|+|||++.+... +.++||||||+++|++++ |..||.+.........+... ....+..++..+.+++.
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  228 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQ  228 (250)
T ss_pred             cCCCCCCcccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence             112234567999998876655 567999999999999998 99999887776666655544 23566778999999999


Q ss_pred             HhcccCCCCCCCHHHHhhC
Q 015257          360 GLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       360 ~~L~~dp~~Rpt~~ell~h  378 (410)
                      +||..+|.+|||+.++++.
T Consensus       229 ~~l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         229 RCWDYKPENRPKFSELQKE  247 (250)
T ss_pred             HHcccCcccCCCHHHHHHH
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-40  Score=311.36  Aligned_cols=248  Identities=22%  Similarity=0.353  Sum_probs=207.5

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCc----eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGK----HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      .+|++++.||+|+||.||++....+|+    .+|+|.+....        .......+.+|+.+++.++||||+++++++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   78 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--------SPKANKEILDEAYVMASVDHPHVVRLLGIC   78 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--------CHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            478999999999999999999876665    58999765431        234556788999999999999999999998


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      ..   ...++||||++++++.+.+.. ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+
T Consensus        79 ~~---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~  155 (279)
T cd05057          79 LS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGL  155 (279)
T ss_pred             ec---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcc
Confidence            75   478999999999998888765 34689999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccccc--cCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCC
Q 015257          273 SQVFEDDNDVLR--RSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPD  348 (410)
Q Consensus       273 a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~  348 (410)
                      ++..........  ...++..|+|||.+....+ +.++||||||+++|++++ |..||.+....+....+..+. ...|.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  234 (279)
T cd05057         156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP  234 (279)
T ss_pred             cccccCcccceecCCCcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCC
Confidence            986543322111  2223567999998865554 567999999999999998 999999887777666666543 45666


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ..+..+.+++.+||..||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         235 ICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            78899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.8e-40  Score=307.23  Aligned_cols=247  Identities=23%  Similarity=0.378  Sum_probs=205.6

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      .+|++.+.||+|+||.||++... ++..+|+|.+.....          ....+.+|+.+++.++||||+++++++..  
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--   70 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----------SEEDFIEEAQVMMKLSHPKLVQLYGVCTE--   70 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----------CHHHHHHHHHHHHhCCCCCeeeEEEEEcc--
Confidence            46889999999999999999875 467899998754321          12467899999999999999999999876  


Q ss_pred             CCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ....++||||+++++|.+++.. .+.+++..++.++.|++.||+|||+.+++|+||||+||+++.++.++|+|||+++..
T Consensus        71 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  150 (256)
T cd05112          71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFV  150 (256)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeec
Confidence            4578999999999998887754 356899999999999999999999999999999999999999999999999998765


Q ss_pred             cCCcc-ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHH
Q 015257          277 EDDND-VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMNPE  353 (410)
Q Consensus       277 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~  353 (410)
                      ..... ......++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+. ...|...+..
T Consensus       151 ~~~~~~~~~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd05112         151 LDDQYTSSTGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQS  229 (256)
T ss_pred             ccCcccccCCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence            43221 1122335678999998876554 567999999999999998 999998877777776665543 3345668899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +.+|+.+||+.+|++|||+.+++++
T Consensus       230 ~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         230 VYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHHHHcccChhhCCCHHHHHHh
Confidence            9999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-40  Score=313.99  Aligned_cols=238  Identities=22%  Similarity=0.307  Sum_probs=191.9

Q ss_pred             eecccCceEEEEEEEccC------------------------CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHh
Q 015257          125 KIGAGSYGKVVLYRSSLD------------------------GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM  180 (410)
Q Consensus       125 ~lG~G~fg~Vy~~~~~~~------------------------~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  180 (410)
                      .||+|+||.||++....+                        ...||+|++...         .......+.+|+.+++.
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---------~~~~~~~~~~~~~~~~~   72 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---------HRDIALAFFETASLMSQ   72 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---------HHHHHHHHHHHHHHHhc
Confidence            599999999999874321                        235888877532         22344578889999999


Q ss_pred             CCCCCcccceeEEEcCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEE
Q 015257          181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV  259 (410)
Q Consensus       181 l~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll  259 (410)
                      ++||||+++++++.+  ....++||||++++++...+.. .+.+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus        73 l~h~niv~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill  150 (274)
T cd05076          73 VSHIHLAFVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILL  150 (274)
T ss_pred             CCCCCeeeEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEE
Confidence            999999999999986  4578999999999998887754 4578999999999999999999999999999999999999


Q ss_pred             cCCC-------cEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHH-hCCCCCCCCC
Q 015257          260 APSG-------TVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGET  331 (410)
Q Consensus       260 ~~~~-------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell-tG~~Pf~~~~  331 (410)
                      +..+       .+|++|||++......    ....+++.|+|||.+.+....+.++||||||+++|+|+ +|..||....
T Consensus       151 ~~~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  226 (274)
T cd05076         151 ARLGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT  226 (274)
T ss_pred             eccCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence            8654       4899999988643322    12346788999998876554577899999999999985 6999998765


Q ss_pred             HHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       332 ~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..+.. ........+|...++.+.++|.+||+.+|.+|||+.+++++
T Consensus       227 ~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         227 PSEKE-RFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             hHHHH-HHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            54432 23334445666778899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.6e-40  Score=311.75  Aligned_cols=251  Identities=20%  Similarity=0.255  Sum_probs=206.7

Q ss_pred             ccceeeeeeecccCceEEEEEEEcc----CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSL----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      .++|.+.+.||+|+||.||++.+..    .+..||+|.+...        ........+.+|+.+++.++||||++++++
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~   76 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--------ASEIQVTLLLQESCLLYGLSHQNILPILHV   76 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--------CCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            3579999999999999999999876    3578999986532        134456778999999999999999999998


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP--------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT  264 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~--------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~  264 (410)
                      +... ....++++||++++++..++...        ..+++..++.++.||+.||+|||+++++||||||+||+++.++.
T Consensus        77 ~~~~-~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~  155 (280)
T cd05043          77 CIED-GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ  155 (280)
T ss_pred             EecC-CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc
Confidence            7753 35789999999988888776432        45899999999999999999999999999999999999999999


Q ss_pred             EEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015257          265 VKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVN  341 (410)
Q Consensus       265 ~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~  341 (410)
                      +||+|||+++.+.....  ......++..|+|||++.+..+ +.++||||||+++|++++ |..||......+....+..
T Consensus       156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  234 (280)
T cd05043         156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD  234 (280)
T ss_pred             EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc
Confidence            99999999986543221  1123345677999998876655 667999999999999998 9999988776666555544


Q ss_pred             CC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          342 NS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       342 ~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      +. ...+..+++++.+++.+||..||++|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         235 GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            32 2344567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.3e-40  Score=307.31  Aligned_cols=246  Identities=26%  Similarity=0.414  Sum_probs=207.4

Q ss_pred             eeeeeecccCceEEEEEEEccCC----ceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          121 VHVRKIGAGSYGKVVLYRSSLDG----KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       121 ~~~~~lG~G~fg~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .+.+.||.|+||.||+++....+    ..||+|++....        .......+..|+.+++.++||||+++++++.+ 
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-   72 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--------DEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-   72 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--------ChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-
Confidence            46789999999999999998766    899999875432        22255688999999999999999999999986 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGA--IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~--l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                       .+..+++|||++++++.+.+.....  +++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||+++
T Consensus        73 -~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~  151 (258)
T smart00219       73 -EEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR  151 (258)
T ss_pred             -CCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCce
Confidence             3589999999999999888765443  9999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccc-cCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCC-CCCCCCC
Q 015257          275 VFEDDNDVLR-RSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSL-VFPDAMN  351 (410)
Q Consensus       275 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~  351 (410)
                      .......... ...+++.|+|||.+.+... +.++||||||+++|+|++ |..||......+....+..... ..+..++
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (258)
T smart00219      152 DLYDDDYYKKKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCP  230 (258)
T ss_pred             ecccccccccccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCC
Confidence            6554321111 2336789999998855444 677999999999999998 8999988777777766665443 4566789


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          352 PELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       352 ~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      .++.+++.+||..||.+|||+.++++
T Consensus       231 ~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      231 PEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            99999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-40  Score=314.03  Aligned_cols=252  Identities=29%  Similarity=0.480  Sum_probs=201.5

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC---CCCCcccceeEEEcC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML---QHPNIVNLIEVIDDP  196 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~  196 (410)
                      |.+.+.||+|+||.||++++..+++.||+|.+.....       .......+.+|+.+++.+   +||||+++++++.+.
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   73 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-------EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGP   73 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-------cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeec
Confidence            6788999999999999999998899999999864321       112223566777777666   599999999998864


Q ss_pred             CC---CEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          197 NS---DHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       197 ~~---~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      ..   ..++++|||+++ .+.+++...  ..+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||
T Consensus        74 ~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg  152 (287)
T cd07838          74 RTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFG  152 (287)
T ss_pred             cCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccC
Confidence            21   248999999986 455544432  358999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----C-
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-----V-  345 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-----~-  345 (410)
                      ++....... ......+++.|+|||++.+... +.++|||||||++|+|++|.+||.+....+...++.....     . 
T Consensus       153 ~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07838         153 LARIYSFEM-ALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW  230 (287)
T ss_pred             cceeccCCc-ccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhc
Confidence            997754332 2233457889999999877665 5569999999999999999999988877666655543110     0 


Q ss_pred             ----------CC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          346 ----------FP-----------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       346 ----------~p-----------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                                ++           ..+++.+.++|.+||+.||.+||++.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                      00           1345778899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2e-40  Score=311.15  Aligned_cols=242  Identities=25%  Similarity=0.376  Sum_probs=196.7

Q ss_pred             eeecccCceEEEEEEEccCCc--eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEEcCCCCE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGK--HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNSDH  200 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~  200 (410)
                      +.||+|+||.||+++...++.  .+|+|.+....        .......+.+|+.++.++ +||||+++++++..  ...
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~   70 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--------SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY   70 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--------CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCC
Confidence            368999999999999987775  46888765321        234456788999999999 89999999999976  457


Q ss_pred             EEEEEeecCCCCcccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCc
Q 015257          201 FYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT  264 (410)
Q Consensus       201 ~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~  264 (410)
                      .++||||+++++|.+++...                ..+++..++.++.|++.||+|||+.|++||||||+|||++.++.
T Consensus        71 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~  150 (270)
T cd05047          71 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV  150 (270)
T ss_pred             ceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe
Confidence            89999999999887776432                24789999999999999999999999999999999999999999


Q ss_pred             EEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-
Q 015257          265 VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-  342 (410)
Q Consensus       265 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-  342 (410)
                      +||+|||++....... .......+..|+|||++....+ +.++|||||||++|+|++ |..||.+....+....+..+ 
T Consensus       151 ~kl~dfgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~  228 (270)
T cd05047         151 AKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  228 (270)
T ss_pred             EEECCCCCccccchhh-hccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC
Confidence            9999999986322111 1111223567999998866554 677999999999999997 99999887776666666554 


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          343 SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       343 ~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ....+..++.++.+|+.+||..||.+|||+.+++.
T Consensus       229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         229 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            23456678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.6e-40  Score=320.22  Aligned_cols=252  Identities=20%  Similarity=0.358  Sum_probs=206.7

Q ss_pred             cceeeeeeecccCceEEEEEEEccC-------CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccc
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLD-------GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNL  189 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  189 (410)
                      .+|.+.+.||+|+||.||++.+...       +..||+|.+...        ........+.+|+.+++++ +||||+++
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--------ATDKDLSDLVSEMEMMKMIGKHKNIINL   83 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--------cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence            4699999999999999999986432       236899987532        1234556889999999999 79999999


Q ss_pred             eeEEEcCCCCEEEEEEeecCCCCcccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCC
Q 015257          190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIK  253 (410)
Q Consensus       190 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk  253 (410)
                      ++++.+  ...++++|||+++++|.+++...                ..+++..+..++.||+.||.|||++||+|||||
T Consensus        84 ~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlk  161 (334)
T cd05100          84 LGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLA  161 (334)
T ss_pred             eEEEcc--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence            999976  45789999999999888776432                247788899999999999999999999999999


Q ss_pred             CCcEEEcCCCcEEEeeccccccccCCccc--cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 015257          254 PDNLLVAPSGTVKIGDFSVSQVFEDDNDV--LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGE  330 (410)
Q Consensus       254 p~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~  330 (410)
                      |+|||++.++.+||+|||+++........  .....++..|+|||++.+..+ +.++||||||+++|+|++ |..||.+.
T Consensus       162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~  240 (334)
T cd05100         162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGI  240 (334)
T ss_pred             cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc-CchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999765432211  122234567999998877665 567999999999999998 89999888


Q ss_pred             CHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCc
Q 015257          331 TLQDTYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW  380 (410)
Q Consensus       331 ~~~~~~~~i~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~  380 (410)
                      ...+....+.... ...|..++.++.+|+.+||+.+|.+|||+.+++++-.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~  291 (334)
T cd05100         241 PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD  291 (334)
T ss_pred             CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence            8777776665543 3456678899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.9e-40  Score=307.25  Aligned_cols=242  Identities=29%  Similarity=0.430  Sum_probs=202.1

Q ss_pred             eeecccCceEEEEEEEcc-CCc--eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCE
Q 015257          124 RKIGAGSYGKVVLYRSSL-DGK--HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH  200 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  200 (410)
                      +.||+|++|.||++.+.. .++  .||||.+.....        ....+.+.+|+.++++++||||+++++++.+   ..
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~   69 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--------SDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HP   69 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc--------HHHHHHHHHHHHHHhhcCCCCccceeEEEcC---Ce
Confidence            468999999999999865 333  699998765421        1566789999999999999999999999875   57


Q ss_pred             EEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          201 FYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       201 ~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      +++||||++++++...+...  ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++.+||+|||+++....
T Consensus        70 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          70 LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             EEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccc
Confidence            89999999999988877654  3689999999999999999999999999999999999999999999999999987644


Q ss_pred             Ccc---ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC--CCCCCCCCCH
Q 015257          279 DND---VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN--SLVFPDAMNP  352 (410)
Q Consensus       279 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~  352 (410)
                      ...   ......++..|+|||++.+... +.++|||||||++|+|++ |..||...+..+....+...  ....+..++.
T Consensus       150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (257)
T cd05040         150 NEDHYVMEEHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQ  228 (257)
T ss_pred             cccceecccCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCH
Confidence            221   1123456788999998876655 567999999999999998 99999887777766665532  2335567889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      .+.+++.+||+.+|++|||+.++++
T Consensus       229 ~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         229 DIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHHHHCCCCcccCCCHHHHHH
Confidence            9999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.2e-40  Score=308.71  Aligned_cols=249  Identities=26%  Similarity=0.394  Sum_probs=205.9

Q ss_pred             cceeeeeeecccCceEEEEEEEccC---CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ++|.+.+.||+|+||.||++.....   ...||||......        .....+.+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   77 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--------SPSVREKFLQEAYIMRQFDHPHIVKLIGVIT   77 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--------CHHHHHHHHHHHHHHHhCCCCchhceeEEEc
Confidence            4688999999999999999987543   3468999865321        2345568899999999999999999999987


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      +   ...++||||++++++.+++... ..+++..++.++.||+.||+|||+.|++|+||||+|||++.++.++|+|||++
T Consensus        78 ~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~  154 (270)
T cd05056          78 E---NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS  154 (270)
T ss_pred             C---CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCcee
Confidence            5   3578999999999998887653 35899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccc-cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCC
Q 015257          274 QVFEDDNDV-LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAM  350 (410)
Q Consensus       274 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  350 (410)
                      +........ .....+++.|+|||.+....+ +.++||||||+++|++++ |..||.+....+....+..+ ....|..+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  233 (270)
T cd05056         155 RYLEDESYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNC  233 (270)
T ss_pred             eecccccceecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence            865443211 112234567999998766554 567999999999999996 99999888776666666554 34567788


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          351 NPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +..+.+++.+||..+|.+|||+.+++..
T Consensus       234 ~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         234 PPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.4e-40  Score=306.93  Aligned_cols=245  Identities=20%  Similarity=0.276  Sum_probs=197.6

Q ss_pred             eeecccCceEEEEEEEcc---CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCE
Q 015257          124 RKIGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH  200 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  200 (410)
                      +.||+|+||.||++....   .+..+|||.+...        ........+.+|+.+++.++||||+++++++... ...
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~   71 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--------TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGS   71 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc--------CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCC
Confidence            468999999999998653   3467999986432        1234456788999999999999999999987643 345


Q ss_pred             EEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCC
Q 015257          201 FYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD  279 (410)
Q Consensus       201 ~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~  279 (410)
                      .++||||+.++++.+++... ..+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||+++.....
T Consensus        72 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~  151 (262)
T cd05058          72 PLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDK  151 (262)
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCC
Confidence            78999999999998887653 45678888899999999999999999999999999999999999999999999765332


Q ss_pred             cc----ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHH
Q 015257          280 ND----VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMNPE  353 (410)
Q Consensus       280 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~  353 (410)
                      ..    ......+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||......+....+..+. ...+..+++.
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDP  230 (262)
T ss_pred             cceeecccccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHH
Confidence            11    1123345778999998876655 567999999999999999 577787777666666555543 3445667899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +.+++.+||..+|++||++.++++.
T Consensus       231 ~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         231 LYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.4e-40  Score=314.28  Aligned_cols=249  Identities=24%  Similarity=0.387  Sum_probs=202.7

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCc----eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGK----HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ++|+..+.||+|+||.||++.+..+|.    .+|+|.+....        .......+.+|+.+++.++||||+++++++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~~~~l~h~niv~~~~~~   78 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--------GPKANVEFMDEALIMASMDHPHLVRLLGVC   78 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--------CHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence            468899999999999999999887776    46888764321        223344688999999999999999999998


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      ..+   ..++++||++++.+.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        79 ~~~---~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~  155 (303)
T cd05110          79 LSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGL  155 (303)
T ss_pred             cCC---CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccc
Confidence            752   467999999999888877654 3689999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCC
Q 015257          273 SQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPD  348 (410)
Q Consensus       273 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~  348 (410)
                      ++.......  ......++..|+|||++.+... +.++||||||+++|+|++ |..||.+.........+..+. ...+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd05110         156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPP  234 (303)
T ss_pred             cccccCcccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Confidence            986543322  1223345678999998876555 667999999999999997 999998766555444443332 34456


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .++..+.+++.+||..+|.+||+++++++.
T Consensus       235 ~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         235 ICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-40  Score=304.34  Aligned_cols=243  Identities=25%  Similarity=0.349  Sum_probs=201.4

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYM  203 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l  203 (410)
                      ++||.|+||.||++.+.. ++.||+|.+....        .......+.+|+.+++.++||||+++++++.+  ....++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~   69 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTL--------PPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYI   69 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccC--------CHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEE
Confidence            469999999999999887 9999999875432        12345678999999999999999999999876  457899


Q ss_pred             EEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc
Q 015257          204 VLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV  282 (410)
Q Consensus       204 v~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  282 (410)
                      ||||++++.+.+.+.. ...+++..+..++.|++.||.|||+++++||||+|+|||++.++.++|+|||+++........
T Consensus        70 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          70 VMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce
Confidence            9999999988887754 346899999999999999999999999999999999999999999999999999765422211


Q ss_pred             c--ccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCCCHHHHHHH
Q 015257          283 L--RRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNLL  358 (410)
Q Consensus       283 ~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~l~~li  358 (410)
                      .  ....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+... ....|..++.++.+++
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  228 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLM  228 (251)
T ss_pred             eccccCcceeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHH
Confidence            1  11223567999998876654 667999999999999999 89999887766655555443 3345678899999999


Q ss_pred             HHhcccCCCCCCCHHHHhhC
Q 015257          359 EGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       359 ~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .+||+.+|.+|||+.++++.
T Consensus       229 ~~~l~~~p~~Rp~~~ell~~  248 (251)
T cd05041         229 LQCWAYDPENRPSFSEIYNE  248 (251)
T ss_pred             HHHhccChhhCcCHHHHHHH
Confidence            99999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5.6e-40  Score=307.68  Aligned_cols=244  Identities=19%  Similarity=0.284  Sum_probs=190.7

Q ss_pred             eeecccCceEEEEEEEcc--CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEE
Q 015257          124 RKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHF  201 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  201 (410)
                      +.||+|+||.||++....  ....+|+|.+...        ........+.+|+.+++.++||||+++++.+.+  ...+
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~   70 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS--------ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPY   70 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCcc--------CChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCce
Confidence            369999999999986432  4457888876432        123445678899999999999999999999876  4579


Q ss_pred             EEEEeecCCCCcccccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          202 YMVLEYVEGKWDNDGFGQP-----GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       202 ~lv~e~~~~~~l~~~~~~~-----~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ++||||+++++|.+++...     ...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        71 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  150 (269)
T cd05042          71 LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQ  150 (269)
T ss_pred             EEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEecccccccc
Confidence            9999999999998877543     23467888999999999999999999999999999999999999999999998754


Q ss_pred             cCCcc--ccccCCCcccccccccccC------CcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCC-
Q 015257          277 EDDND--VLRRSPGTPVFTAPECCLG------LTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLV-  345 (410)
Q Consensus       277 ~~~~~--~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~-  345 (410)
                      .....  ......+++.|+|||++..      ....+.++|||||||++|+|++ |..||......+....+... ... 
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~  230 (269)
T cd05042         151 YPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL  230 (269)
T ss_pred             ccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC
Confidence            32211  1123345677999998743      2233668999999999999999 88899877665555444332 222 


Q ss_pred             ----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          346 ----FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       346 ----~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                          .+..+++.+..++..|| .||.+|||+++|++-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~  266 (269)
T cd05042         231 PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL  266 (269)
T ss_pred             CCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence                23467889999999998 599999999999863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-41  Score=304.34  Aligned_cols=259  Identities=28%  Similarity=0.488  Sum_probs=225.2

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID  194 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  194 (410)
                      ..++|.++++||+|+|+.|.+++.+.+.+.||+|++++..+.      ..+.+.-...|-.+...- +||.+|.++..|+
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~n------ddedidwvqtek~vfe~asn~pflvglhscfq  321 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVN------DDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ  321 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcC------CcccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence            346899999999999999999999999999999999876543      223333445666665544 7999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      .  ...++.|.||++||.|-.++++...++|+.++.|...|..||.|||++|||+||||.+|||++..|++||.|+|+.+
T Consensus       322 t--esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmck  399 (593)
T KOG0695|consen  322 T--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK  399 (593)
T ss_pred             c--cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhh
Confidence            6  34799999999999999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCC-------CCCHHH-HHHHHHhCCCCC
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL-------GETLQD-TYDKIVNNSLVF  346 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~-------~~~~~~-~~~~i~~~~~~~  346 (410)
                      ..-.+.....++||||.|.|||++.+..+ +.++|.|+|||+++||+.|+.||.       ..+..+ .++-|+...+.+
T Consensus       400 e~l~~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri  478 (593)
T KOG0695|consen  400 EGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI  478 (593)
T ss_pred             cCCCCCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc
Confidence            76666778889999999999999988877 678999999999999999999993       223333 345566667889


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCC------CHHHHhhCCcccC
Q 015257          347 PDAMNPELRNLLEGLLCKDPTRRL------TLNDVAKHTWVLG  383 (410)
Q Consensus       347 p~~~~~~l~~li~~~L~~dp~~Rp------t~~ell~h~~~~~  383 (410)
                      |..+|-.+..+++..|++||++|.      .++++..|+||..
T Consensus       479 prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~  521 (593)
T KOG0695|consen  479 PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS  521 (593)
T ss_pred             cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence            999999999999999999999987      5799999999963

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.1e-39  Score=304.25  Aligned_cols=246  Identities=22%  Similarity=0.354  Sum_probs=203.6

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+.+.||+|+||.||++... .+..+|+|.+...          ......+.+|+.+++.++|+||+++++++.+ 
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-   72 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-   72 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence            357999999999999999999754 4567999986532          2234578899999999999999999999875 


Q ss_pred             CCCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                        ...+++|||++++++.+++..  ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||.+.
T Consensus        73 --~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~  150 (260)
T cd05073          73 --EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR  150 (260)
T ss_pred             --CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCccee
Confidence              468999999999988887754  3457888999999999999999999999999999999999999999999999997


Q ss_pred             cccCCcc-ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCC
Q 015257          275 VFEDDND-VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMN  351 (410)
Q Consensus       275 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~  351 (410)
                      ....... ......++..|+|||++..... +.++|+|||||++|++++ |..||.+....+....+..+. ...+...+
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (260)
T cd05073         151 VIEDNEYTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP  229 (260)
T ss_pred             eccCCCcccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCC
Confidence            6543221 1122345677999998876554 567999999999999998 999998877766666655543 23456788


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          352 PELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       352 ~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      .++.+++.+||+++|++||++.++++
T Consensus       230 ~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         230 EELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHHcccCcccCcCHHHHHH
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.7e-40  Score=305.95  Aligned_cols=229  Identities=26%  Similarity=0.362  Sum_probs=190.3

Q ss_pred             cCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEEEEeec
Q 015257          129 GSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV  208 (410)
Q Consensus       129 G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~  208 (410)
                      |.||.||++++..+++.||+|.+....              ...+|...+....||||+++++++.+  ....++||||+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~   67 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHA   67 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecC
Confidence            899999999999999999999986431              12345555566679999999999886  46899999999


Q ss_pred             CCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccccccCCC
Q 015257          209 EGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG  288 (410)
Q Consensus       209 ~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  288 (410)
                      +|++|.+.+.....+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+......   .....+
T Consensus        68 ~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~  144 (237)
T cd05576          68 EGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAV  144 (237)
T ss_pred             CCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCc
Confidence            99999888877777999999999999999999999999999999999999999999999999988655432   223446


Q ss_pred             cccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcccCCCC
Q 015257          289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTR  368 (410)
Q Consensus       289 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L~~dp~~  368 (410)
                      +..|+|||.+.+... +.++||||+|+++|+|++|..|+.......    .......+|..+++.+++||.+||+.||++
T Consensus       145 ~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  219 (237)
T cd05576         145 ENMYCAPEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTE  219 (237)
T ss_pred             CccccCCcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHH
Confidence            778999998866555 567999999999999999998875432110    011223467788999999999999999999


Q ss_pred             CCCH-----HHHhhCCcc
Q 015257          369 RLTL-----NDVAKHTWV  381 (410)
Q Consensus       369 Rpt~-----~ell~h~~~  381 (410)
                      |||+     +++++||||
T Consensus       220 R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         220 RLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             hcCCCccchHHHHcCCCC
Confidence            9986     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.6e-40  Score=304.19  Aligned_cols=241  Identities=22%  Similarity=0.379  Sum_probs=201.3

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+.+.||+|+||.||++.  .+++.||+|.+...           .....+.+|+.+++.++||||+++++++..  
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~-----------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--   70 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD-----------VTAQAFLEETAVMTKLHHKNLVRLLGVILH--   70 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc-----------chHHHHHHHHHHHHhCCCCCcCeEEEEEcC--
Confidence            579999999999999998775  46889999987432           123578899999999999999999999865  


Q ss_pred             CCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                       ...++||||++++++...+...  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..
T Consensus        71 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~  149 (254)
T cd05083          71 -NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV  149 (254)
T ss_pred             -CCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCcccee
Confidence             2479999999999988877543  3589999999999999999999999999999999999999999999999999875


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHH
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMNPE  353 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~  353 (410)
                      ....   ......+..|+|||.+.+... +.++|+||||+++|+|++ |..||......+....+..+. ...+..++..
T Consensus       150 ~~~~---~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (254)
T cd05083         150 GSMG---VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPAD  225 (254)
T ss_pred             cccc---CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHH
Confidence            4322   122334567999998876555 567999999999999997 999998887777666665543 2345678899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +.+++.+||+.+|.+|||+++++..
T Consensus       226 ~~~li~~~l~~~p~~Rp~~~~l~~~  250 (254)
T cd05083         226 VYVLMTSCWETEPKKRPSFHKLREK  250 (254)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-42  Score=302.53  Aligned_cols=268  Identities=28%  Similarity=0.456  Sum_probs=214.6

Q ss_pred             ccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       113 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      .......|..+.+||+|.||+||+|+.+.+|+.||+|++-.....       +-.-....+|+.+|..|+|+|++.++++
T Consensus        12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK-------eGfpitalreikiL~~lkHenv~nliEi   84 (376)
T KOG0669|consen   12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK-------EGFPITALREIKILQLLKHENVVNLIEI   84 (376)
T ss_pred             ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc-------cCCcHHHHHHHHHHHHhcchhHHHHHHH
Confidence            344556788899999999999999999999999999986543211       1122346799999999999999999987


Q ss_pred             EEcC------CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEE
Q 015257          193 IDDP------NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVK  266 (410)
Q Consensus       193 ~~~~------~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~k  266 (410)
                      |...      ....+|+||.+|+..+..-+-.....++..++++++.+++.||.|+|...|+|||+||+|+||+.+|.+|
T Consensus        85 c~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilk  164 (376)
T KOG0669|consen   85 CRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILK  164 (376)
T ss_pred             HhhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEE
Confidence            7531      2346999999998653332222336799999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCcc----ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-
Q 015257          267 IGDFSVSQVFEDDND----VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-  341 (410)
Q Consensus       267 l~DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~-  341 (410)
                      |+|||+++.+.....    ..+..+-|..|++||.+.+...++++.|||..|||+.||.+|.+-+.+.+.++....|.. 
T Consensus       165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L  244 (376)
T KOG0669|consen  165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL  244 (376)
T ss_pred             eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence            999999987643221    223344589999999999998889999999999999999999999998887776655532 


Q ss_pred             -CCC---CCC-----------------C-------------CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          342 -NSL---VFP-----------------D-------------AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       342 -~~~---~~p-----------------~-------------~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                       +..   .+|                 .             .-++++.+|+.++|..||.+|+++++++.|.||...+.|
T Consensus       245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence             111   011                 1             124578899999999999999999999999999887666

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=319.21  Aligned_cols=268  Identities=27%  Similarity=0.448  Sum_probs=223.5

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ..+.++|-++.+||+|||+.||+|.+....+.||+|+-....  .++....++..+...+|..|.+.|+||.||++|++|
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK--~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf  536 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNK--NWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF  536 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhcc--chhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence            345678999999999999999999999999999999865442  233334567778899999999999999999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcEeccCCCCcEEEcCC---CcEEEe
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH--NVVHGDIKPDNLLVAPS---GTVKIG  268 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~--~iiHrDlkp~NIll~~~---~~~kl~  268 (410)
                      .-. .+.++-|+|||+|..|..++++...++|.+++.|+.||+.||.||.+.  .|||.||||.|||+...   |.+||.
T Consensus       537 slD-tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  537 SLD-TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             eec-cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence            753 568999999999999999999999999999999999999999999976  59999999999999653   679999


Q ss_pred             eccccccccCCcc-------ccccCCCcccccccccccCC---cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHH-
Q 015257          269 DFSVSQVFEDDND-------VLRRSPGTPVFTAPECCLGL---TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ-DTY-  336 (410)
Q Consensus       269 DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~-  336 (410)
                      |||+++.+.+++.       ......||.+|++||++.-.   +.-+.++||||+|||+|.+++|+.||.....+ +.+ 
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq  695 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ  695 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence            9999998876542       33456799999999998543   22255799999999999999999999764322 222 


Q ss_pred             -HHHHh-CCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          337 -DKIVN-NSLVFP--DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       337 -~~i~~-~~~~~p--~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                       .-|++ ....||  +.++++++++|.+||++...+|..+.++..||+|.-.
T Consensus       696 eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  696 ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence             22333 234555  4789999999999999999999999999999999653

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7e-40  Score=304.70  Aligned_cols=236  Identities=22%  Similarity=0.273  Sum_probs=191.3

Q ss_pred             eeecccCceEEEEEEEccCC----------ceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDG----------KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      +.||+|+||.||++....++          ..+++|++...          ......+.+|+.+++.++||||+++++++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   70 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD----------HRDSLAFFETASLMSQLSHKHLVKLYGVC   70 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccc----------hhhHHHHHHHHHHHHcCCCcchhheeeEE
Confidence            46999999999999998766          34777765432          11156788999999999999999999988


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC-------cE
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-------TV  265 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~-------~~  265 (410)
                      ..   ...++||||+++++|..++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++       .+
T Consensus        71 ~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~  147 (259)
T cd05037          71 VR---DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFI  147 (259)
T ss_pred             ec---CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeE
Confidence            76   35799999999999998887655 789999999999999999999999999999999999999888       79


Q ss_pred             EEeeccccccccCCccccccCCCcccccccccccCC-cCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Q 015257          266 KIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL-TYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS  343 (410)
Q Consensus       266 kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~  343 (410)
                      ||+|||++.....    .....++..|+|||++.+. ...+.++||||||+++|+|++ |..||............. ..
T Consensus       148 kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~  222 (259)
T cd05037         148 KLSDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQ  222 (259)
T ss_pred             EeCCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cC
Confidence            9999999986543    1234467789999998765 344678999999999999999 588887665333322222 22


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          344 LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       344 ~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ...+......+.+++.+||..+|.+|||+.++++
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         223 HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            2334444589999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.1e-39  Score=305.75  Aligned_cols=243  Identities=21%  Similarity=0.289  Sum_probs=189.8

Q ss_pred             eeecccCceEEEEEEEc--cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEE
Q 015257          124 RKIGAGSYGKVVLYRSS--LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHF  201 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  201 (410)
                      +.||+|+||.||++...  .++..+|+|.+....        .......+.+|+.+++.++||||+++++++.+  ...+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~   70 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--------SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPY   70 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCc
Confidence            36899999999999754  356789999875331        22334578899999999999999999999876  3468


Q ss_pred             EEEEeecCCCCcccccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          202 YMVLEYVEGKWDNDGFGQP-----GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       202 ~lv~e~~~~~~l~~~~~~~-----~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ++||||+++++|.+++...     ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||+++..
T Consensus        71 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~  150 (269)
T cd05087          71 LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNK  150 (269)
T ss_pred             EEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccc
Confidence            9999999999988776432     24577788899999999999999999999999999999999999999999999754


Q ss_pred             cCCcc--ccccCCCcccccccccccCCc------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh-CCCCC
Q 015257          277 EDDND--VLRRSPGTPVFTAPECCLGLT------YGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVN-NSLVF  346 (410)
Q Consensus       277 ~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~-~~~~~  346 (410)
                      .....  ......|++.|+|||++....      ..+.++||||||+++|+|++ |..||......+....... ....+
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  230 (269)
T cd05087         151 YKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL  230 (269)
T ss_pred             cCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCC
Confidence            33221  122345788899999875422      12567999999999999996 9999987665554332222 22222


Q ss_pred             C-----CCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          347 P-----DAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       347 p-----~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      +     ...++.+.+++..|+ .+|.+|||+++|+.
T Consensus       231 ~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         231 PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            2     246788999999999 68999999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.9e-39  Score=304.02  Aligned_cols=256  Identities=26%  Similarity=0.456  Sum_probs=208.7

Q ss_pred             ceeeeeeecccCceEEEEEEEcc-CCceEEEEeeeccccccccc-CCChHHHHHHHHHHHHHHh-CCCCCcccceeEEEc
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSL-DGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREVLIMKM-LQHPNIVNLIEVIDD  195 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~  195 (410)
                      .|.+.+.||+|+||.||++.+.. .++.+|+|.+.......... .........+.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            37788999999999999999987 78899999886543221110 1123455667789988865 799999999999876


Q ss_pred             CCCCEEEEEEeecCCCCccccc----CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCcEEEcCCCcEEEeec
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGF----GQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~----~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                        ....++||||++++++.+.+    .....+++..++.++.|++.||.|||+ .+++|+||+|+|||++.++.++|+||
T Consensus        81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence              46899999999998887665    234578999999999999999999996 78999999999999999999999999


Q ss_pred             cccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCC-
Q 015257          271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV-FPD-  348 (410)
Q Consensus       271 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~-  348 (410)
                      |++....... ......|+..|+|||.+.+... +.++||||||+++|+|++|..||...........+...... .+. 
T Consensus       159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd08528         159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG  236 (269)
T ss_pred             cceeeccccc-ccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence            9998654433 3345668999999999877655 66799999999999999999999887766666666554432 222 


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .+++.+.++|.+||+.||.+|||+.|+..+
T Consensus       237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            678999999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=343.95  Aligned_cols=249  Identities=24%  Similarity=0.361  Sum_probs=211.6

Q ss_pred             cceeeeeeecccCceEEEEEEEcc-CCc----eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSL-DGK----HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~-~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      ..-...+.||+|+||.||.+.-.. .|.    .||||.+.+.        .+......|.+|..+|+.++|||||+++|+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--------~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv  763 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--------SSEQEVSDFLKEALLMSKFDHPNIVSLIGV  763 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--------CCHHHHHHHHHHHHHHhcCCCcceeeEEEe
Confidence            345678899999999999988665 343    4899987543        246677899999999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcE
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP-------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTV  265 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~-------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~  265 (410)
                      +.+  ....+|++|||.||.|..++.+.       ..++......++.|||+|+.||+++++|||||...|+||+....|
T Consensus       764 ~l~--~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~V  841 (1025)
T KOG1095|consen  764 CLD--SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVV  841 (1025)
T ss_pred             ecC--CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcE
Confidence            987  45789999999999999888764       368899999999999999999999999999999999999999999


Q ss_pred             EEeeccccccccCCcc-ccccC-CCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH-HHHh
Q 015257          266 KIGDFSVSQVFEDDND-VLRRS-PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYD-KIVN  341 (410)
Q Consensus       266 kl~DfG~a~~~~~~~~-~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~-~i~~  341 (410)
                      ||+|||+|+....... ..... .-...|||||.+....+++ ++|||||||+|||++| |..||......+... -...
T Consensus       842 KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFts-kSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g  920 (1025)
T KOG1095|consen  842 KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTS-KSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG  920 (1025)
T ss_pred             EEcccchhHhhhhchheeccCccccceecCCHHHHhhccccc-ccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC
Confidence            9999999995433222 11111 1235699999999877754 5999999999999998 999999988888776 4455


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          342 NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       342 ~~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      +++..|..++..+.+||..||+.+|++||++..|++
T Consensus       921 gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  921 GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            677889999999999999999999999999999997

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7.6e-40  Score=306.51  Aligned_cols=244  Identities=23%  Similarity=0.375  Sum_probs=199.0

Q ss_pred             eeecccCceEEEEEEEccCC------ceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          124 RKIGAGSYGKVVLYRSSLDG------KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      +.||+|+||.||+++.....      ..+|||.+....        .......+.+|+.+++.++||||+++++++.+  
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   70 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--------TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--   70 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc--------chhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--
Confidence            36999999999999876433      689999875321        12345678899999999999999999999876  


Q ss_pred             CCEEEEEEeecCCCCcccccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC-----cE
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ-------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-----TV  265 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~-----~~  265 (410)
                      ....++||||++++++.+++..       ...+++..+..++.||+.||.|||+.+++|+||||+||+++.++     .+
T Consensus        71 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~  150 (269)
T cd05044          71 NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVV  150 (269)
T ss_pred             CCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcce
Confidence            4578999999999988877642       23478899999999999999999999999999999999999887     89


Q ss_pred             EEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC
Q 015257          266 KIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN  342 (410)
Q Consensus       266 kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~  342 (410)
                      +|+|||+++.......  ......++..|+|||++.+... +.++|||||||++|+|++ |..||......+....+..+
T Consensus       151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  229 (269)
T cd05044         151 KIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG  229 (269)
T ss_pred             EECCcccccccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC
Confidence            9999999875433211  1123345778999998877665 677999999999999998 99999887766665555443


Q ss_pred             -CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          343 -SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       343 -~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                       ....+..++..+.++|.+||..+|.+||++.++++.
T Consensus       230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  266 (269)
T cd05044         230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEI  266 (269)
T ss_pred             CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence             345667889999999999999999999999999763

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.8e-39  Score=304.68  Aligned_cols=251  Identities=22%  Similarity=0.328  Sum_probs=202.2

Q ss_pred             eeeeeeecccCceEEEEEEEcc---CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      |.+.+.||+|+||.||++....   ++..||||++....       ......+.+.+|+.+++.++||||+++++++...
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   73 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-------FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRS   73 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-------CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            5678899999999999998653   57899999886432       1234556788999999999999999999988653


Q ss_pred             CC----CEEEEEEeecCCCCcccccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEE
Q 015257          197 NS----DHFYMVLEYVEGKWDNDGFGQ------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVK  266 (410)
Q Consensus       197 ~~----~~~~lv~e~~~~~~l~~~~~~------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~k  266 (410)
                      ..    ...++++||+.++.+..++..      ...+++..++.++.||+.||+|||+.||+||||||+||+++.++.+|
T Consensus        74 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~k  153 (273)
T cd05074          74 RAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVC  153 (273)
T ss_pred             CCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEE
Confidence            21    235789999998887655421      22578999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Q 015257          267 IGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS  343 (410)
Q Consensus       267 l~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~  343 (410)
                      |+|||+++.......  ......+++.|++||.+.+... +.++|||||||++|+|++ |..||.+....+....+....
T Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  232 (273)
T cd05074         154 VADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN  232 (273)
T ss_pred             ECcccccccccCCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999986543221  1123345678999998876655 567999999999999999 899998877776666665543


Q ss_pred             -CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          344 -LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       344 -~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                       ...+...+..+.+++.+||..+|.+|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         233 RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             34556788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-39  Score=306.30  Aligned_cols=252  Identities=25%  Similarity=0.431  Sum_probs=202.8

Q ss_pred             cceeeeeeecccCceEEEEEEEcc----CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSL----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ..|.+.+.||+|+||.||++....    ++..||||++....        .......+.+|+.+++.+.||||+++++++
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~--------~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~   75 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG--------EEQHRSDFEREIEILRTLDHENIVKYKGVC   75 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEecccc--------chHHHHHHHHHHHHHHhCCCCChheEEeee
Confidence            357888999999999999998653    47899999986432        113456899999999999999999999998


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      ........++||||++++++.+++.... .+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||+
T Consensus        76 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~  155 (284)
T cd05038          76 EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGL  155 (284)
T ss_pred             ecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccc
Confidence            8765668999999999999888876543 689999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccc---cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------------HH
Q 015257          273 SQVFEDDNDV---LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ--------------DT  335 (410)
Q Consensus       273 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--------------~~  335 (410)
                      +.........   .....++..|+|||.+.+... +.++||||||+++|+|++|..|+......              ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05038         156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR  234 (284)
T ss_pred             ccccccCCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence            9876532211   112234566999998876654 56799999999999999999998653211              11


Q ss_pred             HHHHHhCC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          336 YDKIVNNS--LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       336 ~~~i~~~~--~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ........  ...+..++.++.+|+.+||+.+|.+|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05038         235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI  279 (284)
T ss_pred             HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            11222222  23455778999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.8e-39  Score=300.98  Aligned_cols=242  Identities=21%  Similarity=0.314  Sum_probs=189.5

Q ss_pred             eecccCceEEEEEEEccC--CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEE
Q 015257          125 KIGAGSYGKVVLYRSSLD--GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFY  202 (410)
Q Consensus       125 ~lG~G~fg~Vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~  202 (410)
                      .||+|+||.||++.....  ...+++|.+....        .......+.+|+.+++.++||||+++++.+.+  ....+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~   71 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--------SSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYL   71 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--------ChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccE
Confidence            599999999999875432  3346666654321        23345689999999999999999999999986  45789


Q ss_pred             EEEeecCCCCcccccCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          203 MVLEYVEGKWDNDGFGQP----GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       203 lv~e~~~~~~l~~~~~~~----~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      +||||+++++|..++...    ..+++..++.++.||+.||+|||+.+++||||||+|||++.++.++|+|||++.....
T Consensus        72 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~  151 (268)
T cd05086          72 LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK  151 (268)
T ss_pred             EEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCc
Confidence            999999999988776542    3467778889999999999999999999999999999999999999999999864322


Q ss_pred             Cc--cccccCCCcccccccccccCCc------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC------
Q 015257          279 DN--DVLRRSPGTPVFTAPECCLGLT------YGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS------  343 (410)
Q Consensus       279 ~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~------  343 (410)
                      ..  .......+++.|+|||++....      ..+.++|||||||++|+|++ |..||......+....+....      
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  231 (268)
T cd05086         152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFK  231 (268)
T ss_pred             chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCC
Confidence            11  1223456788999999874321      12567999999999999997 577888777666666554432      


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          344 LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       344 ~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ..++..+++.+.+++..|| .+|.+|||+.+|++
T Consensus       232 ~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         232 PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            1234467899999999999 67999999999976

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.7e-39  Score=306.63  Aligned_cols=255  Identities=16%  Similarity=0.204  Sum_probs=187.6

Q ss_pred             ccceeeeeeecccCceEEEEEEEccC---CceEEEEeeecccccccccCCChHH-----HHHHHHHHHHHHhCCCCCccc
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHLSKLRVAPSETA-----MTDVRREVLIMKMLQHPNIVN  188 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~  188 (410)
                      .++|.+.+.||+|+||.||++....+   +..+|+|+.......   .......     ......+...+..+.|+||++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~---~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENET---IVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCc---hhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            35899999999999999999998877   677888864322110   0000000     011223444566778999999


Q ss_pred             ceeEEEcCCC--CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEE
Q 015257          189 LIEVIDDPNS--DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVK  266 (410)
Q Consensus       189 l~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~k  266 (410)
                      +++.+.....  ...++++|++... +.+.+......++..+..++.||+.||.|||+.+|+||||||+|||++.++.++
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~  166 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLVEN-TKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY  166 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhccC-HHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEE
Confidence            9987654321  2457788876543 333333334568889999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCc-------cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-H----
Q 015257          267 IGDFSVSQVFEDDN-------DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ-D----  334 (410)
Q Consensus       267 l~DfG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~----  334 (410)
                      |+|||+|+......       .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.... .    
T Consensus       167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            99999998653221       11123469999999998877665 67899999999999999999999876321 1    


Q ss_pred             ----HHHHHHhCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          335 ----TYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       335 ----~~~~i~~~~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                          ...++..+...+ ..+++.+.+++..|+..+|.+||++.++++
T Consensus       246 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        246 AKCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             hHHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                223333333333 456899999999999999999999999975

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=327.67  Aligned_cols=202  Identities=30%  Similarity=0.467  Sum_probs=175.6

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC--
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN--  197 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--  197 (410)
                      |..-+.||+||||.||+++++.+|+.||||.+.+..        .....+.+.+|+++|++++|||||+++++-.+..  
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--------~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~   86 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--------SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLG   86 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhc--------ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence            566788999999999999999999999999987653        2335578899999999999999999998765543  


Q ss_pred             --CCEEEEEEeecCCCCcccccCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC--C--cEEEe
Q 015257          198 --SDHFYMVLEYVEGKWDNDGFGQP---GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS--G--TVKIG  268 (410)
Q Consensus       198 --~~~~~lv~e~~~~~~l~~~~~~~---~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~--~--~~kl~  268 (410)
                        ...-++|||||.||+|...+.+.   ..|+|.+.+.++..++.||.|||++||+||||||.||++...  |  ..||+
T Consensus        87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLt  166 (732)
T KOG4250|consen   87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLT  166 (732)
T ss_pred             cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeee
Confidence              45678999999999999888764   479999999999999999999999999999999999998543  3  47999


Q ss_pred             eccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015257          269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE  330 (410)
Q Consensus       269 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~  330 (410)
                      |||.|+.+.+++ ......||+.|++||.+...++++..+|.|||||++|+++||..||...
T Consensus       167 DfG~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  167 DFGAARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             cccccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            999999887765 7778899999999998875455566799999999999999999999654

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-40  Score=303.71  Aligned_cols=256  Identities=24%  Similarity=0.409  Sum_probs=204.4

Q ss_pred             ccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCC--C----Cc
Q 015257          113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH--P----NI  186 (410)
Q Consensus       113 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p----ni  186 (410)
                      +..+.++|.++..+|+|.||.|..+.+..++..||||+++.-          ....+..+-|+++|.++.+  |    -+
T Consensus        84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----------~kYreAa~iEi~vLqki~~~DP~g~~rc  153 (415)
T KOG0671|consen   84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----------DKYREAALIEIEVLQKINESDPNGKFRC  153 (415)
T ss_pred             ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----------HHHhhHHHHHHHHHHHHHhcCCCCceEE
Confidence            455678999999999999999999999999999999998642          3455678899999999943  2    35


Q ss_pred             ccceeEEEcCCCCEEEEEEeecCCCCcccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC---
Q 015257          187 VNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP---  261 (410)
Q Consensus       187 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~---  261 (410)
                      |.+.++|+-  .++.+||+|.++ .++.+++..+.  +++...++.+..|++++|+|||+.+++|-||||+|||+.+   
T Consensus       154 v~m~~wFdy--rghiCivfellG-~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~  230 (415)
T KOG0671|consen  154 VQMRDWFDY--RGHICIVFELLG-LSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEY  230 (415)
T ss_pred             Eeeehhhhc--cCceEEEEeccC-hhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccce
Confidence            677777865  568999999984 46677776654  7899999999999999999999999999999999999853   


Q ss_pred             -----------------CCcEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCC
Q 015257          262 -----------------SGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQ  324 (410)
Q Consensus       262 -----------------~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~  324 (410)
                                       +..++|+|||.|+......   ...+.|..|.|||++.+..+. .++||||+||||+||.+|.
T Consensus       231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~  306 (415)
T KOG0671|consen  231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGE  306 (415)
T ss_pred             EEEeccCCccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccc
Confidence                             2358999999998643322   455678899999999999984 4599999999999999999


Q ss_pred             CCCCCCCHHH---HHHHHHhC------------------CCCCCCC-------------------------CCHHHHHHH
Q 015257          325 YPFLGETLQD---TYDKIVNN------------------SLVFPDA-------------------------MNPELRNLL  358 (410)
Q Consensus       325 ~Pf~~~~~~~---~~~~i~~~------------------~~~~p~~-------------------------~~~~l~~li  358 (410)
                      ..|......+   +.+.|+..                  .+.+|..                         --.+|.+||
T Consensus       307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl  386 (415)
T KOG0671|consen  307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL  386 (415)
T ss_pred             eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence            9998765444   33444331                  1111211                         013588999


Q ss_pred             HHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          359 EGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       359 ~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      .+||..||++|+|+.|+|.||||....
T Consensus       387 ~~mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  387 RRMLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             HHHHccCccccccHHHHhcCHHhhcCC
Confidence            999999999999999999999997653

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-39  Score=315.85  Aligned_cols=256  Identities=30%  Similarity=0.524  Sum_probs=215.0

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      .-|..++.||-|+||+|-++....+..+||+|.+.+....      ..+.....+.|-.||..-+.+-||+||-.|++  
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl------~rnQvaHVKAERDILAEADn~WVVrLyySFQD--  700 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVL------MRNQVAHVKAERDILAEADNEWVVRLYYSFQD--  700 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHH------hhhhhhhhhhhhhhHhhcCCcceEEEEEEecc--
Confidence            3588899999999999999999999999999999876543      34566788999999999999999999999997  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc-
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF-  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~-  276 (410)
                      .+++|+||+|++||.+-.++.+.+.|+|..++.|+..+.-|+++.|..|+|||||||+|||||.+|++||.|||++.-+ 
T Consensus       701 kdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  701 KDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             CCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccce
Confidence            5789999999999999998888999999999999999999999999999999999999999999999999999987422 


Q ss_pred             --------cCCcc---------------------------------ccccCCCcccccccccccCCcCCCchhhHHHHHH
Q 015257          277 --------EDDND---------------------------------VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGV  315 (410)
Q Consensus       277 --------~~~~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~  315 (410)
                              ..+++                                 .....+||+.|+|||++....+ +..+|.||.||
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~-~q~cdwws~gv  859 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY-TQLCDWWSVGV  859 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc-cccchhhHhhH
Confidence                    11110                                 0112359999999999987766 45699999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCC--CCCCHHHHHHHHHhcccCCCCCC---CHHHHhhCCcccC
Q 015257          316 TLYYMIIGQYPFLGETLQDTYDKIVNN--SLVFP--DAMNPELRNLLEGLLCKDPTRRL---TLNDVAKHTWVLG  383 (410)
Q Consensus       316 il~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~~~~l~~li~~~L~~dp~~Rp---t~~ell~h~~~~~  383 (410)
                      |||||+.|++||...+..+...++++.  .+.||  ..+++++.+||.++. -+++.|+   .+++|..||||++
T Consensus       860 il~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg  933 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG  933 (1034)
T ss_pred             HHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence            999999999999887766655555443  23344  478999999998765 4577777   5678999999976

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=294.52  Aligned_cols=262  Identities=22%  Similarity=0.323  Sum_probs=211.7

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHH-HHhCCCCCcccceeEEEc
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI-MKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~  195 (410)
                      .++.+.+..||.|+||+|++..++.+|+..|||.+....        .+..+++++.|.+. ++.-+.||||+++|+...
T Consensus        63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n--------~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~  134 (361)
T KOG1006|consen   63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN--------IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS  134 (361)
T ss_pred             cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc--------chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence            345667889999999999999999999999999886432        34566788888877 555579999999998775


Q ss_pred             CCCCEEEEEEeecCCCCccccc-----CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCcEEEcCCCcEEEee
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGF-----GQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGD  269 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIll~~~~~~kl~D  269 (410)
                        .+-.+|.||+|.-. +..+.     .+...++|..+-.|..-.++||.||-+ ..|||||+||+|||++..|.+||||
T Consensus       135 --EGdcWiCMELMd~S-lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCD  211 (361)
T KOG1006|consen  135 --EGDCWICMELMDIS-LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCD  211 (361)
T ss_pred             --CCceeeeHHHHhhh-HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeec
Confidence              35689999999743 22221     235579999999999999999999985 4899999999999999999999999


Q ss_pred             ccccccccCCccccccCCCcccccccccccCCcC-CCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCC--
Q 015257          270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTY-GGKAADTWAVGVTLYYMIIGQYPFLGE-TLQDTYDKIVNNSLV--  345 (410)
Q Consensus       270 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwSlG~il~elltG~~Pf~~~-~~~~~~~~i~~~~~~--  345 (410)
                      ||++..+.+. ...+...|...|||||.+..... +.-++||||||++|||+.||..|+.+- +..++...+..+.++  
T Consensus       212 FGIcGqLv~S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l  290 (361)
T KOG1006|consen  212 FGICGQLVDS-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPIL  290 (361)
T ss_pred             ccchHhHHHH-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCee
Confidence            9998766543 23345568888999999865433 467899999999999999999999764 334555566665543  


Q ss_pred             -CCC---CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCch
Q 015257          346 -FPD---AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ  390 (410)
Q Consensus       346 -~p~---~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~  390 (410)
                       ++.   .++..+..+|..||-+|-+.||...+++++||+......-|+
T Consensus       291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~~  339 (361)
T KOG1006|consen  291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGPD  339 (361)
T ss_pred             cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCCc
Confidence             222   478999999999999999999999999999999887766665

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=323.80  Aligned_cols=249  Identities=30%  Similarity=0.419  Sum_probs=217.6

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCc---eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGK---HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ...+.+.||.|.||+|+..+.+..|+   .||||.++..        ..+.+...|+.|+.||.+++||||++|.|+...
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--------ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk  701 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--------YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK  701 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccC--------ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence            35677899999999999999887664   6999988643        345667789999999999999999999999976


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                        .+.+.||.|||++|+|+.++..+ +.++.-+...+++.|+.|++||-+.|++||||-..|||++.+..+|++|||+++
T Consensus       702 --s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSR  779 (996)
T KOG0196|consen  702 --SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSR  779 (996)
T ss_pred             --CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccccee
Confidence              56899999999999999988664 679999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCC-C--cccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCC
Q 015257          275 VFEDDNDVLRRSP-G--TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDA  349 (410)
Q Consensus       275 ~~~~~~~~~~~~~-g--t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~  349 (410)
                      .++++.....+.. |  ...|.|||.+...++ +.++||||+|++|||.++ |..||-..+.++....|..+. ++.|..
T Consensus       780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmD  858 (996)
T KOG0196|consen  780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMD  858 (996)
T ss_pred             ecccCCCccccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCC
Confidence            8877653333332 2  356999999988777 567999999999999885 999999999999998887764 566779


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ++..|..|+..||++|-.+||++.||+.+
T Consensus       859 CP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  859 CPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             CcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            99999999999999999999999999875

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.7e-39  Score=281.34  Aligned_cols=252  Identities=24%  Similarity=0.449  Sum_probs=208.9

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEEE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVID  194 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~  194 (410)
                      .+++|++++++|+|.+++||.+....+.+.++||++++-            ..+.+.+|+.||..|. ||||++++++..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------------kkkKIkREikIL~nL~gg~NIi~L~DiV~  103 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------------KKKKIKREIKILQNLRGGPNIIKLLDIVK  103 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------------HHHHHHHHHHHHHhccCCCCeeehhhhhc
Confidence            357899999999999999999999999999999998654            2357889999999997 999999999999


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC-cEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~-~~kl~DfG~a  273 (410)
                      ++.++...+|+||+++.....+.   ..++...++.++.+++.||.|.|+.||+|||+||.|++|+... .++|+|||+|
T Consensus       104 Dp~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLA  180 (338)
T KOG0668|consen  104 DPESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLA  180 (338)
T ss_pred             CccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchH
Confidence            99889999999999876554432   3578889999999999999999999999999999999999764 6999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhC----------
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL-GETLQDTYDKIVNN----------  342 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~-~~~~~~~~~~i~~~----------  342 (410)
                      .++..... ......+..|--||.+...+.+..+.|+|||||+|..|+..+.||. |.+..+++-+|.+-          
T Consensus       181 EFYHp~~e-YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  181 EFYHPGKE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             hhcCCCce-eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence            87654322 2223346678999999998888889999999999999999998873 44544444333220          


Q ss_pred             ---CCCCC------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          343 ---SLVFP------------------------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       343 ---~~~~p------------------------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                         .+..+                        ...++++.+|+.++|..|-.+|||+.|++.||||..
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~  327 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP  327 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence               00000                        135799999999999999999999999999999963

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.4e-38  Score=326.18  Aligned_cols=257  Identities=17%  Similarity=0.211  Sum_probs=178.3

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccC----CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccce
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLD----GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLI  190 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  190 (410)
                      ...++|.+.+.||+|+||.||++.+..+    +..||||++....           ..+....|  .+....+.++..++
T Consensus       129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----------~~e~~~~e--~l~~~~~~~~~~~~  195 (566)
T PLN03225        129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----------AVEIWMNE--RVRRACPNSCADFV  195 (566)
T ss_pred             CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----------hhHHHHHH--HHHhhchhhHHHHH
Confidence            3567899999999999999999999988    9999999865321           01111111  12222233333333


Q ss_pred             eEEE----cCCCCEEEEEEeecCCCCcccccCCCC--------------------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 015257          191 EVID----DPNSDHFYMVLEYVEGKWDNDGFGQPG--------------------AIGESMARKYLRDIVSGLMYLHGHN  246 (410)
Q Consensus       191 ~~~~----~~~~~~~~lv~e~~~~~~l~~~~~~~~--------------------~l~~~~~~~i~~qi~~gL~yLH~~~  246 (410)
                      ..+.    ......+++||||+++++|.+++....                    ...+..+..++.||+.||.|||+++
T Consensus       196 ~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g  275 (566)
T PLN03225        196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG  275 (566)
T ss_pred             HhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC
Confidence            2211    123467999999999998877664321                    1123456789999999999999999


Q ss_pred             cEeccCCCCcEEEcC-CCcEEEeeccccccccCC-ccccccCCCcccccccccccCCcC---------------------
Q 015257          247 VVHGDIKPDNLLVAP-SGTVKIGDFSVSQVFEDD-NDVLRRSPGTPVFTAPECCLGLTY---------------------  303 (410)
Q Consensus       247 iiHrDlkp~NIll~~-~~~~kl~DfG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~---------------------  303 (410)
                      |+||||||+|||++. ++.+||+|||+|+..... ........||+.|+|||.+.....                     
T Consensus       276 IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~  355 (566)
T PLN03225        276 IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN  355 (566)
T ss_pred             EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence            999999999999986 579999999999865432 233456778999999996642221                     


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------CC--------CCCCCCCCHHHHHHHHHh
Q 015257          304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--------------NS--------LVFPDAMNPELRNLLEGL  361 (410)
Q Consensus       304 ~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~--------------~~--------~~~p~~~~~~l~~li~~~  361 (410)
                      .+.++|||||||+||||+++..|+...  ...+..++.              ..        +...+..+....+||.+|
T Consensus       356 ~~~k~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m  433 (566)
T PLN03225        356 LPDRFDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM  433 (566)
T ss_pred             CCCCcccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence            123469999999999999987765432  111111111              00        001112234456899999


Q ss_pred             cccCCCCCCCHHHHhhCCcccCCCC
Q 015257          362 LCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       362 L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      |+.||.+|||+.++|+||||++...
T Consensus       434 L~~dP~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        434 MRFKGRQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             ccCCcccCCCHHHHhCCcCcCCCCc
Confidence            9999999999999999999987644

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=319.79  Aligned_cols=258  Identities=26%  Similarity=0.380  Sum_probs=221.1

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEEc-
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDD-  195 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-  195 (410)
                      +.|++...||.|.+|.||+++++.+++..|+|+....          .+.-+++..|.+||+.+ +|||++.++++|.- 
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~----------~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT----------EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC----------ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            5689999999999999999999999999999997654          33345788899999888 69999999998753 


Q ss_pred             --CCCCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          196 --PNSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       196 --~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                        ..+++++||||||.||+..++++.  ...+.|..+..|++.++.||.+||.+.+||||||-.|||++.+|.|||+|||
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFG  168 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFG  168 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeee
Confidence              246799999999999998888765  4578999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCc----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLT----YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL---  344 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---  344 (410)
                      ++..+........++.|||.|||||++.-..    .++..+|+||||++..||.-|.+|+........+-.|..++.   
T Consensus       169 vSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkL  248 (953)
T KOG0587|consen  169 VSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL  248 (953)
T ss_pred             eeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccc
Confidence            9988777767777899999999999985322    224569999999999999999999988766665555554432   


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          345 VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       345 ~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      .-|...+.++.++|..||.+|-.+||++.++|+|||+..+.
T Consensus       249 krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~  289 (953)
T KOG0587|consen  249 KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP  289 (953)
T ss_pred             cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence            23456788999999999999999999999999999999443

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=4.6e-37  Score=281.41  Aligned_cols=240  Identities=40%  Similarity=0.715  Sum_probs=204.3

Q ss_pred             CceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEEEEeecC
Q 015257          130 SYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE  209 (410)
Q Consensus       130 ~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~  209 (410)
                      +||.||++....+|+.+|+|++......        .....+.+|+..+++++|+||+++++.+..  ....+++|||++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~--------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~   70 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIK--------KKRERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCD   70 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccc--------cHHHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCC
Confidence            6899999999989999999998654211        115789999999999999999999999876  358999999999


Q ss_pred             CCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccccccCCCc
Q 015257          210 GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT  289 (410)
Q Consensus       210 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  289 (410)
                      ++++...+.....+++..++.++.+++.+|.|||+.+++|+||+|.||+++.++.++|+|||.+....... ......++
T Consensus        71 ~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~  149 (244)
T smart00220       71 GGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGT  149 (244)
T ss_pred             CCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCC
Confidence            98888887766668999999999999999999999999999999999999999999999999998765432 33456688


Q ss_pred             ccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCCC---CCHHHHHHHHHhcccC
Q 015257          290 PVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG-ETLQDTYDKIVNNSLVFPDA---MNPELRNLLEGLLCKD  365 (410)
Q Consensus       290 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~-~~~~~~~~~i~~~~~~~p~~---~~~~l~~li~~~L~~d  365 (410)
                      +.|+|||.+.+... +.++||||||++++++++|..||.. .........+.......+..   ++.++.+++.+||..+
T Consensus       150 ~~~~~pE~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  228 (244)
T smart00220      150 PEYMAPEVLLGKGY-GKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKD  228 (244)
T ss_pred             cCCCCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCC
Confidence            99999998876555 5589999999999999999999977 55555555555554443333   8899999999999999


Q ss_pred             CCCCCCHHHHhhCCcc
Q 015257          366 PTRRLTLNDVAKHTWV  381 (410)
Q Consensus       366 p~~Rpt~~ell~h~~~  381 (410)
                      |++||++.++++||||
T Consensus       229 p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      229 PEKRLTAEEALQHPFF  244 (244)
T ss_pred             chhccCHHHHhhCCCC
Confidence            9999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-38  Score=306.14  Aligned_cols=271  Identities=24%  Similarity=0.339  Sum_probs=216.1

Q ss_pred             eeeecccCceEEEEEEEcc--CCc--eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          123 VRKIGAGSYGKVVLYRSSL--DGK--HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~--~~~--~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      .++||.|-||.||.+.-..  .|+  -||||..+.+.        ..+..+.|+.|..+|+.++|||||+++|++.+   
T Consensus       394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--------t~d~tekflqEa~iMrnfdHphIikLIGv~~e---  462 (974)
T KOG4257|consen  394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--------TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE---  462 (974)
T ss_pred             HHhhcCCcccceeeeEecccccCcceeeeeehhccCC--------ChhhHHHHHHHHHHHHhCCCcchhheeeeeec---
Confidence            3579999999999877543  233  58899876542        23346789999999999999999999999986   


Q ss_pred             CEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+||||+++.|.|..+++.+ ..++......|+.||+.||+|||+..++||||-..|||+.+...|||+|||+++.+.
T Consensus       463 ~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  463 QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            4689999999999999888765 478999999999999999999999999999999999999999999999999999877


Q ss_pred             CCcc-ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCCCHHH
Q 015257          278 DDND-VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPEL  354 (410)
Q Consensus       278 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~l  354 (410)
                      +... ...+..-..-|||||-+.-..+ +.++|||-|||++||++. |..||.+....+..-.+-++ +++.|+.+++.+
T Consensus       543 d~~yYkaS~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~L  621 (974)
T KOG4257|consen  543 DDAYYKASRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPAL  621 (974)
T ss_pred             ccchhhccccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHH
Confidence            6532 2222223456999998876666 567999999999999985 99999998888876666655 468899999999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhh--CCcccCCCCCCchhhhhhhccccccccc
Q 015257          355 RNLLEGLLCKDPTRRLTLNDVAK--HTWVLGDNGPIPQYLCWCKRDRLRRDNT  405 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~ell~--h~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (410)
                      ..|+.+||.++|.+||.+.++..  |.-++...-.-.|-+.+-.+.+...|+.
T Consensus       622 YslmskcWayeP~kRPrftei~~~lsdv~qeek~~~~Eq~r~~R~~a~~~~~~  674 (974)
T KOG4257|consen  622 YSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINSSEQLRRQRKVASMIWQN  674 (974)
T ss_pred             HHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhhHHHHHhhhcccceeecc
Confidence            99999999999999999887763  2333333333444444444444444433

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=295.16  Aligned_cols=270  Identities=23%  Similarity=0.376  Sum_probs=205.0

Q ss_pred             cccccc-cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-----C--
Q 015257          112 NGTKMI-NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-----H--  183 (410)
Q Consensus       112 ~~~~~~-~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h--  183 (410)
                      +|..+. .+|.++++||.|.|++||+|.++.+.+.||+|+++..          +-..+....||.+|++++     |  
T Consensus        71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----------qhYtEaAlDEIklL~~v~~~Dp~~~~  140 (590)
T KOG1290|consen   71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----------QHYTEAALDEIKLLQQVREGDPNDPG  140 (590)
T ss_pred             ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----------hHHHHHHHHHHHHHHHHHhcCCCCCC
Confidence            345555 7899999999999999999999999999999998642          334567889999999984     2  


Q ss_pred             -CCcccceeEEEc--CCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCcEE
Q 015257          184 -PNIVNLIEVIDD--PNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLL  258 (410)
Q Consensus       184 -pniv~l~~~~~~--~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIl  258 (410)
                       .+||+|++.|..  +++.+++||+|+++..+|..+.... ..++...++.|++||+.||.|||.. ||||-||||+|||
T Consensus       141 ~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvL  220 (590)
T KOG1290|consen  141 KKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVL  220 (590)
T ss_pred             CceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceee
Confidence             489999998875  5778999999999776666555443 5799999999999999999999965 9999999999999


Q ss_pred             EcCC----------------------------------------------------------------------------
Q 015257          259 VAPS----------------------------------------------------------------------------  262 (410)
Q Consensus       259 l~~~----------------------------------------------------------------------------  262 (410)
                      +..+                                                                            
T Consensus       221 l~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~  300 (590)
T KOG1290|consen  221 LCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQ  300 (590)
T ss_pred             eeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccc
Confidence            8400                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 015257          263 --------------------------------------------------------------------------------  262 (410)
Q Consensus       263 --------------------------------------------------------------------------------  262 (410)
                                                                                                      
T Consensus       301 ~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v  380 (590)
T KOG1290|consen  301 ESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLV  380 (590)
T ss_pred             cccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccccccc
Confidence                                                                                            


Q ss_pred             ----------CcEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC-
Q 015257          263 ----------GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-  331 (410)
Q Consensus       263 ----------~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-  331 (410)
                                -.+||+|||-|....   ..++....|..|+|||++.+..|. ..+||||++|++|||+||...|.... 
T Consensus       381 ~p~~~~~~~di~vKIaDlGNACW~~---khFT~DIQTRQYRapEVllGsgY~-~~ADiWS~AC~~FELaTGDyLFePhsG  456 (590)
T KOG1290|consen  381 NPDIPLPECDIRVKIADLGNACWVH---KHFTEDIQTRQYRAPEVLLGSGYS-TSADIWSTACMAFELATGDYLFEPHSG  456 (590)
T ss_pred             CCCCCCCccceeEEEeeccchhhhh---hhhchhhhhhhccCcceeecCCCC-CchhHHHHHHHHHHhhcCceeecCCCC
Confidence                      014555555554321   122333457789999999999884 45999999999999999998774321 


Q ss_pred             -----HHHHHHHHH------------------------------------------hCCCCCCCCCCHHHHHHHHHhccc
Q 015257          332 -----LQDTYDKIV------------------------------------------NNSLVFPDAMNPELRNLLEGLLCK  364 (410)
Q Consensus       332 -----~~~~~~~i~------------------------------------------~~~~~~p~~~~~~l~~li~~~L~~  364 (410)
                           ..+....|+                                          ..++.|+..-..++.+||.-||+.
T Consensus       457 ~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef  536 (590)
T KOG1290|consen  457 ENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEF  536 (590)
T ss_pred             CCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhc
Confidence                 111111111                                          112222333346788999999999


Q ss_pred             CCCCCCCHHHHhhCCcccCCCCCCchhhhhhh
Q 015257          365 DPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCK  396 (410)
Q Consensus       365 dp~~Rpt~~ell~h~~~~~~~~~~~~~~~~~~  396 (410)
                      +|.+||||.++|+|||+.....| +.+++...
T Consensus       537 ~PeKR~tA~~cl~hPwLn~~~~~-~~~~~~~~  567 (590)
T KOG1290|consen  537 DPEKRPTAAQCLKHPWLNPVAGP-PPSDSPQN  567 (590)
T ss_pred             CccccccHHHHhcCccccCCCCC-ccccCCcc
Confidence            99999999999999999988887 55555443

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=287.20  Aligned_cols=268  Identities=25%  Similarity=0.437  Sum_probs=217.6

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC-
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS-  198 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-  198 (410)
                      .+--+.||-|+||.||.+.+..+|+.||+|.+..-       ..+-...+++.+|+.+|..++|.|++..+++.+-++- 
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-------fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d  127 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-------FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS  127 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchH-------HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence            34467899999999999999999999999986432       2234456788999999999999999999988765432 


Q ss_pred             --CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          199 --DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       199 --~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                        ..+|.+.|.|. ..|...+.....++...++-+++||++||+|||+.+|.||||||.|.|++++..+||||||+|+..
T Consensus       128 fFqEiYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  128 FFQELYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEeccccccccc
Confidence              24678889886 457778888889999999999999999999999999999999999999999999999999999976


Q ss_pred             cCC-ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Q 015257          277 EDD-NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--------------  341 (410)
Q Consensus       277 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~--------------  341 (410)
                      +.+ ...++...-|..|.|||++.+...++.++||||+|||+.|||..+..|...+..+.++.|..              
T Consensus       207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence            543 34455556688999999999999889999999999999999999999987776666555432              


Q ss_pred             ---------CCCCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCchhhhhh
Q 015257          342 ---------NSLVFP-----------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWC  395 (410)
Q Consensus       342 ---------~~~~~p-----------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~~~~~  395 (410)
                               +...-|           ..-..+...++..+|..||.+|.+..+.+.|+++-......=.-+|.|
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r~~sCmC~~  360 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLRFHSCMCSC  360 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccceeeeeeeEee
Confidence                     111111           123356778999999999999999999999999977654444444433

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=300.62  Aligned_cols=246  Identities=24%  Similarity=0.373  Sum_probs=210.0

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      .+..+..+||-|-||.||....+.-.-.||||.++.+.          -.+++|+.|+.+|+.++|||+|+++++|..  
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----------MeveEFLkEAAvMKeikHpNLVqLLGVCT~--  334 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH--  334 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----------hhHHHHHHHHHHHHhhcCccHHHHhhhhcc--
Confidence            34566789999999999999998888899999986543          356789999999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      ...+|||.|||..|.|.+++...  ..++.-....++.||..|++||..+++|||||-..|.|+..+..|||+|||++++
T Consensus       335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhh
Confidence            45799999999999988888653  3466677778889999999999999999999999999999999999999999999


Q ss_pred             ccCCccccc-cCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCCH
Q 015257          276 FEDDNDVLR-RSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMNP  352 (410)
Q Consensus       276 ~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~  352 (410)
                      +..+..... ...-..-|.|||-+.-..+ +.++|||+|||+|||+.| |..||.+.+..+.+..+-++. +.-|+.+++
T Consensus       415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPp  493 (1157)
T KOG4278|consen  415 MTGDTYTAHAGAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPP  493 (1157)
T ss_pred             hcCCceecccCccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCH
Confidence            876543322 1122456999998876666 456999999999999997 999999999888887776653 457899999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHh
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVA  376 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell  376 (410)
                      ....|+..||+++|.+||+++|+-
T Consensus       494 kVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  494 KVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             HHHHHHHHHhcCCcccCccHHHHH
Confidence            999999999999999999998874

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-38  Score=301.41  Aligned_cols=249  Identities=27%  Similarity=0.337  Sum_probs=205.1

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      +...++++||+|-||.|.++.... +.+||||.++...        .......|..|+++|.+|+|||||.++++|..  
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--------~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~--  606 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--------TKNARNDFLKEIKILSRLKHPNIVELLGVCVQ--  606 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--------chhHHHHHHHHHHHHhccCCCCeeEEEeeeec--
Confidence            457788999999999999988653 6899999886542        44556789999999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGA--IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~--l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      .+.++||+|||+.|.|..++.....  +.-.....++.||+.||+||.+.+++||||.+.|+|++.++++||+|||+++.
T Consensus       607 DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~  686 (807)
T KOG1094|consen  607 DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRN  686 (807)
T ss_pred             CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccc
Confidence            4579999999999999998876632  33445567999999999999999999999999999999999999999999985


Q ss_pred             ccCC-c-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHh---C-----C
Q 015257          276 FEDD-N-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMI--IGQYPFLGETLQDTYDKIVN---N-----S  343 (410)
Q Consensus       276 ~~~~-~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell--tG~~Pf~~~~~~~~~~~i~~---~-----~  343 (410)
                      +-.+ . ..-.+..-...|||||.+...+. +.++|||+||+++||++  +...||...+..+..+..-.   .     -
T Consensus       687 lysg~yy~vqgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~  765 (807)
T KOG1094|consen  687 LYSGDYYRVQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV  765 (807)
T ss_pred             cccCCceeeecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee
Confidence            4332 2 22234445678999999988888 55699999999999987  47889988776665544322   1     2


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          344 LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       344 ~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +..|..++..+..|+..||..|..+|||++++..|
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~  800 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLF  800 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence            34577899999999999999999999999999654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-36  Score=303.89  Aligned_cols=267  Identities=19%  Similarity=0.250  Sum_probs=189.1

Q ss_pred             cccceeeeeeecccCceEEEEEEEc----------------cCCceEEEEeeecccccccccCC-----ChHHHHHHHHH
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSS----------------LDGKHYAIKAFHKSHLSKLRVAP-----SETAMTDVRRE  174 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~----------------~~~~~vaiK~~~~~~~~~~~~~~-----~~~~~~~~~~E  174 (410)
                      ..++|.+.++||+|+||.||++...                ..++.||||.+............     .....+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4578999999999999999998642                24567999998643210000000     00011234567


Q ss_pred             HHHHHhCCCCCc-----ccceeEEEcC------CCCEEEEEEeecCCCCcccccCCC-----------------------
Q 015257          175 VLIMKMLQHPNI-----VNLIEVIDDP------NSDHFYMVLEYVEGKWDNDGFGQP-----------------------  220 (410)
Q Consensus       175 ~~~l~~l~hpni-----v~l~~~~~~~------~~~~~~lv~e~~~~~~l~~~~~~~-----------------------  220 (410)
                      +.++.+++|.++     ++++++|...      .....++||||+++++|.+++...                       
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            788888877654     6677776531      134689999999998887665421                       


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCcc-ccccCCCcccccccccc
Q 015257          221 -GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND-VLRRSPGTPVFTAPECC  298 (410)
Q Consensus       221 -~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~  298 (410)
                       ..+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++........ ......+|+.|+|||.+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence             1345678899999999999999999999999999999999999999999999976433221 11122358899999987


Q ss_pred             cCCcC--------------------C-CchhhHHHHHHHHHHHHhCCC-CCCCCCHH-----------HHHHHHHhCCCC
Q 015257          299 LGLTY--------------------G-GKAADTWAVGVTLYYMIIGQY-PFLGETLQ-----------DTYDKIVNNSLV  345 (410)
Q Consensus       299 ~~~~~--------------------~-~~~~DiwSlG~il~elltG~~-Pf~~~~~~-----------~~~~~i~~~~~~  345 (410)
                      .....                    . ....||||+||++|+|++|.. ||......           ..+..+......
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~  462 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD  462 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence            53221                    0 124799999999999999875 77542211           112222223333


Q ss_pred             CC--CCCCHHHHHHHHHhcccCC---CCCCCHHHHhhCCccc
Q 015257          346 FP--DAMNPELRNLLEGLLCKDP---TRRLTLNDVAKHTWVL  382 (410)
Q Consensus       346 ~p--~~~~~~l~~li~~~L~~dp---~~Rpt~~ell~h~~~~  382 (410)
                      ++  +..++..++|+.+||..+|   .+|+|++|+|+||||.
T Consensus       463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            33  4678999999999999866   6899999999999995

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=306.15  Aligned_cols=254  Identities=25%  Similarity=0.376  Sum_probs=215.2

Q ss_pred             cceeeeeeecccCceEEEEEEEcc-CCc--eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSL-DGK--HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ++..+.++||+|+||.|+.+..+. +|+  .||||++....+        ...+..|++|+.+|.+|+|||+|+|||+..
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l--------~~~mddflrEas~M~~L~H~hliRLyGvVl  181 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL--------NAIMDDFLREASHMLKLQHPHLIRLYGVVL  181 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc--------chhHHHHHHHHHHHHhccCcceeEEeeeec
Confidence            456667899999999999888765 443  689999865432        236789999999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      +   ..+.||||++++|+|.+.+..  ...|.......|+.||+.||.||.++++|||||-..|+|+-....|||+|||+
T Consensus       182 ~---qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGL  258 (1039)
T KOG0199|consen  182 D---QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGL  258 (1039)
T ss_pred             c---chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccc
Confidence            6   458899999999999888765  45788899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCcccc--c-cCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCC
Q 015257          273 SQVFEDDNDVL--R-RSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFP  347 (410)
Q Consensus       273 a~~~~~~~~~~--~-~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p  347 (410)
                      .+.+......+  . ...-...|+|||.+...++ +.++|||+|||+||||+| |..||.+....+.++.|-.+ .++-|
T Consensus       259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kF-ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRP  337 (1039)
T KOG0199|consen  259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKF-SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRP  337 (1039)
T ss_pred             eeccCCCCcceEecCCCcCcccccCHhHhccccc-cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCC
Confidence            99876654332  1 1123445999999988888 567999999999999997 89999999988888887654 45778


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                      ..++.+++++++.||..+|.+|||+.+|.+.-++..
T Consensus       338 k~csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  338 KYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             CCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            899999999999999999999999999976555443

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=279.84  Aligned_cols=260  Identities=28%  Similarity=0.500  Sum_probs=209.9

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC-
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP-  196 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  196 (410)
                      .+|.-++.+|.|.- .|..|.+...++.||+|.+...       ..+.....+..+|...+..+.|+||++++.+|.-. 
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-------f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~   88 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-------FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK   88 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-------cccCccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence            57888999999999 7777888899999999987544       12344556788999999999999999999988632 


Q ss_pred             ---CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          197 ---NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       197 ---~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                         .-..+|+|||+|....-....   -.++-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+|
T Consensus        89 ~l~~~~e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   89 TLEEFQEVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             cHHHHHhHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhh
Confidence               124689999999865332222   24677889999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS----------  343 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~----------  343 (410)
                      +..... ..++....|..|.|||++.+..+ ...+||||+||++.||++|+.-|.+....+.+.++....          
T Consensus       166 r~e~~~-~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  166 RTEDTD-FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             cccCcc-cccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            864433 46677788999999999988875 556999999999999999999999888777766554310          


Q ss_pred             -----------------CC----CCC-----------CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCccc---C---CC
Q 015257          344 -----------------LV----FPD-----------AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL---G---DN  385 (410)
Q Consensus       344 -----------------~~----~p~-----------~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~---~---~~  385 (410)
                                       ..    ||+           .-...+++|+.+||..||++|.|++++|.|||+.   .   -+
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~  323 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVE  323 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccccccc
Confidence                             11    121           1124588999999999999999999999999997   2   24


Q ss_pred             CCCch
Q 015257          386 GPIPQ  390 (410)
Q Consensus       386 ~~~~~  390 (410)
                      .|.|+
T Consensus       324 ap~pe  328 (369)
T KOG0665|consen  324 APPPE  328 (369)
T ss_pred             CCCCc
Confidence            56666

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.3e-37  Score=294.97  Aligned_cols=255  Identities=28%  Similarity=0.459  Sum_probs=206.3

Q ss_pred             ccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCC------CCc
Q 015257          113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH------PNI  186 (410)
Q Consensus       113 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------pni  186 (410)
                      +..+-.+|.+....|+|-|++|..|++..-|..||||++...          +.-.+.=+.|+.||++|+.      -|+
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN----------E~M~KtGl~EleiLkKL~~AD~Edk~Hc  496 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN----------EVMHKTGLKELEILKKLNDADPEDKFHC  496 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc----------hHHhhhhhHHHHHHHHhhccCchhhhHH
Confidence            555667899999999999999999999998999999998653          3334556799999999963      488


Q ss_pred             ccceeEEEcCCCCEEEEEEeecCCCCccccc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC-
Q 015257          187 VNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-  262 (410)
Q Consensus       187 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~-  262 (410)
                      ++++..|..  ..+++||+|-+... |.+.+   ..+-.|....++.|+.|+.-||..|-..||+|.||||+|||++.. 
T Consensus       497 lrl~r~F~h--knHLClVFE~LslN-LRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  497 LRLFRHFKH--KNHLCLVFEPLSLN-LREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESK  573 (752)
T ss_pred             HHHHHHhhh--cceeEEEehhhhch-HHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCc
Confidence            999987765  56999999987643 22333   344578889999999999999999999999999999999999976 


Q ss_pred             CcEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q 015257          263 GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN  342 (410)
Q Consensus       263 ~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~  342 (410)
                      ..+||||||.|.......  .+.+.-+..|.|||++.+..| ....|+||+||+||||.||+..|+|.+..+++.-...-
T Consensus       574 ~iLKLCDfGSA~~~~ene--itPYLVSRFYRaPEIiLG~~y-d~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~  650 (752)
T KOG0670|consen  574 NILKLCDFGSASFASENE--ITPYLVSRFYRAPEIILGLPY-DYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL  650 (752)
T ss_pred             ceeeeccCcccccccccc--ccHHHHHHhccCcceeecCcc-cCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence            468999999997655432  222233556999999999988 55699999999999999999999999888877655433


Q ss_pred             CCCCCCC-----------------------------------------------------CC-------HHHHHHHHHhc
Q 015257          343 SLVFPDA-----------------------------------------------------MN-------PELRNLLEGLL  362 (410)
Q Consensus       343 ~~~~p~~-----------------------------------------------------~~-------~~l~~li~~~L  362 (410)
                      ..+||..                                                     ++       .++++||.+||
T Consensus       651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml  730 (752)
T KOG0670|consen  651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML  730 (752)
T ss_pred             cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence            2223310                                                     11       35889999999


Q ss_pred             ccCCCCCCCHHHHhhCCcccC
Q 015257          363 CKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       363 ~~dp~~Rpt~~ell~h~~~~~  383 (410)
                      ..||++|.|.+|+|+||||++
T Consensus       731 ~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  731 ILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             ccChhhcCCHHHHhcCCcccC
Confidence            999999999999999999986

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7.3e-36  Score=327.25  Aligned_cols=237  Identities=24%  Similarity=0.312  Sum_probs=185.1

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ..|...+.||+|+||.||+++...+|..||||.+.....             ....|+.++++++|||||++++++.+. 
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~l~~l~HpnIv~~~~~~~~~-  755 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------------IPSSEIADMGKLQHPNIVKLIGLCRSE-  755 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------------ccHHHHHHHhhCCCCCcceEEEEEEcC-
Confidence            456677899999999999999998999999998753210             112568899999999999999999873 


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH---GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                       ...++||||++++++.+++.   .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+++. ||.+.
T Consensus       756 -~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~  830 (968)
T PLN00113        756 -KGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG  830 (968)
T ss_pred             -CCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence             46899999999999998875   3889999999999999999999   6699999999999999998888876 66654


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHh--------
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-----LQDTYDKIVN--------  341 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-----~~~~~~~i~~--------  341 (410)
                      .....    ....||+.|+|||++.+..+ +.++|||||||++|||+||+.||....     ..++......        
T Consensus       831 ~~~~~----~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  905 (968)
T PLN00113        831 LLCTD----TKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWI  905 (968)
T ss_pred             ccccC----CCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhee
Confidence            33221    23367899999999877665 567999999999999999999985421     1122211111        


Q ss_pred             -CCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          342 -NSL----VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       342 -~~~----~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                       ...    ..+.....++.+++.+||+.||++|||+.|+++.
T Consensus       906 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence             000    0111112356789999999999999999999876

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-36  Score=295.28  Aligned_cols=256  Identities=26%  Similarity=0.427  Sum_probs=219.1

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|..+..+|+|.+|.||+++++.++++.|+|+++...         .+...-+.+|+-+++..+|||||.+++-+.. 
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---------~dd~~~iqqei~~~~dc~h~nivay~gsylr-   83 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---------GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-   83 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccC---------CccccccccceeeeecCCCcChHHHHhhhhh-
Confidence            368999999999999999999999999999999997652         2233457799999999999999999998765 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       ...++|.||||+||++++...-.+++++.++....+..++||+|||++|=+|||||-.|||+++.|.+|++|||.+..+
T Consensus        84 -~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqi  162 (829)
T KOG0576|consen   84 -RDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQI  162 (829)
T ss_pred             -hcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhh
Confidence             4579999999999999999999999999999999999999999999999999999999999999999999999998776


Q ss_pred             cCCccccccCCCccccccccccc---CCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----C
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCL---GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP-----D  348 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~  348 (410)
                      ...-.....+.|||.|||||+..   ...+ ...+|||++|++..|+---++|-.............+..+..|     .
T Consensus       163 tati~KrksfiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~  241 (829)
T KOG0576|consen  163 TATIAKRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKT  241 (829)
T ss_pred             hhhhhhhhcccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCc
Confidence            66555667889999999999863   2233 4569999999999999888888766555555444444433333     3


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      ..++.+-+|++.+|.++|++|||++-+|.|||+...
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            567889999999999999999999999999999764

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-36  Score=300.61  Aligned_cols=245  Identities=26%  Similarity=0.419  Sum_probs=191.4

Q ss_pred             eeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEEcCCCC
Q 015257          121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       121 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~  199 (410)
                      .-.+.+|.|+-|+|. ++....|+.||||.+-.            +....+.+||..|+.- +|||||++++.-.+  ..
T Consensus       512 ~~~eilG~Gs~Gt~V-f~G~ye~R~VAVKrll~------------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d--~q  576 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVV-FRGVYEGREVAVKRLLE------------EFFDFAQREIQLLQESDEHPNVIRYYCSEQD--RQ  576 (903)
T ss_pred             ccHHHcccCCCCcEE-EEEeeCCceehHHHHhh------------HhHHHHHHHHHHHHhccCCCceEEEEeeccC--Cc
Confidence            334678999999863 55667899999998742            3445678999999988 59999999987665  67


Q ss_pred             EEEEEEeecCCCCcccccCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC---C--CcEEEeec
Q 015257          200 HFYMVLEYVEGKWDNDGFGQPG----AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP---S--GTVKIGDF  270 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~~~----~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~---~--~~~kl~Df  270 (410)
                      .+||..|.|.. +|++++....    ....-..+.++.|++.||++||+.+||||||||.||||+.   +  ..++|+||
T Consensus       577 F~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDf  655 (903)
T KOG1027|consen  577 FLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDF  655 (903)
T ss_pred             eEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccc
Confidence            99999999975 4566655531    1111345788899999999999999999999999999986   3  46899999


Q ss_pred             cccccccCCccc---cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhCCCCC
Q 015257          271 SVSQVFEDDNDV---LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIG-QYPFLGETLQDTYDKIVNNSLVF  346 (410)
Q Consensus       271 G~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG-~~Pf~~~~~~~~~~~i~~~~~~~  346 (410)
                      |+++.+..+...   ..+..||.+|+|||++..... +.++|||||||++|+.++| ..||......+  -.|+.+....
T Consensus       656 glsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L  732 (903)
T KOG1027|consen  656 GLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTL  732 (903)
T ss_pred             ccccccCCCcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccce
Confidence            999988765433   335679999999999877665 5579999999999999985 89996643332  3466655432


Q ss_pred             C---CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          347 P---DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       347 p---~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      -   ..-..++.+||.+||.++|..||+|.+||.||+|...
T Consensus       733 ~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  733 VHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             eeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            2   1122289999999999999999999999999999765

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6e-35  Score=291.05  Aligned_cols=246  Identities=24%  Similarity=0.340  Sum_probs=208.5

Q ss_pred             eeeeeeecccCceEEEEEEEccCCc----eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGK----HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      .+..++||+|+||+||+......|+    +||||++....        ......+++.|+-+|.+++|||++++++++..
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--------~~~~s~e~LdeAl~masldHpnl~RLLgvc~~  769 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--------SPKASIELLDEALRMASLDHPNLLRLLGVCML  769 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--------CchhhHHHHHHHHHHhcCCCchHHHHhhhccc
Confidence            4456799999999999988766554    67888765432        34456789999999999999999999999986


Q ss_pred             CCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      .   .+.||++||++|.|.+++.. +..+.......|..||++||.|||++.++||||-..|||+..-..+||.|||+|+
T Consensus       770 s---~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~  846 (1177)
T KOG1025|consen  770 S---TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAK  846 (1177)
T ss_pred             c---hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhh
Confidence            3   48899999999999998765 4578899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCC--cccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCC
Q 015257          275 VFEDDNDVLRRSPG--TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAM  350 (410)
Q Consensus       275 ~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  350 (410)
                      .+..+........|  .+-|||-|.+....+ +.++|||||||++|||+| |..|+.+....+.-+.+..+ ++.-|+.+
T Consensus       847 ll~~d~~ey~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiC  925 (1177)
T KOG1025|consen  847 LLAPDEKEYSAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPIC  925 (1177)
T ss_pred             ccCcccccccccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCc
Confidence            87765544433333  455999998877776 677999999999999997 99999998877776666554 46778899


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          351 NPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      +-++..++.+||..|+..||+++++..
T Consensus       926 tiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  926 TIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             cHHHHHHHHHHhccCcccCccHHHHHH
Confidence            999999999999999999999988764

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=291.41  Aligned_cols=248  Identities=23%  Similarity=0.392  Sum_probs=203.3

Q ss_pred             ceeeeeeecccCceEEEEEEEcc---C----CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccce
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSL---D----GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLI  190 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~---~----~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  190 (410)
                      +..+.+.||+|+||.|+++....   .    ...||||.+....        .....+.+..|+++|+.+ .||||+.++
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~--------~~~~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA--------SSSEKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEeccccc--------CcHHHHHHHHHHHHHHHhcCCcchhhhe
Confidence            34556699999999999987542   1    4579999876432        235667899999999999 599999999


Q ss_pred             eEEEcCCCCEEEEEEeecCCCCcccccCCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCC
Q 015257          191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG----------------AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKP  254 (410)
Q Consensus       191 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp  254 (410)
                      +++..  .+.+++|+||+..|.|..++....                .++..+...++.||+.|++||++.+++||||-.
T Consensus       369 G~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAa  446 (609)
T KOG0200|consen  369 GACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAA  446 (609)
T ss_pred             eeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhh
Confidence            99987  568999999999988877765543                488999999999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEeeccccccccCCcc-ccccCCC--cccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 015257          255 DNLLVAPSGTVKIGDFSVSQVFEDDND-VLRRSPG--TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGE  330 (410)
Q Consensus       255 ~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~  330 (410)
                      .|||+..+..+||+|||+|+....... ......|  ...|||||.+....+ +.++||||||++|||++| |..||.+.
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            999999999999999999996544322 2222333  234999999988666 556899999999999997 89999885


Q ss_pred             C-HHHHHHHHHhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          331 T-LQDTYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       331 ~-~~~~~~~i~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      . ..+.++.+..+. ...|..+++++.++++.||+.+|.+||++.++.+
T Consensus       526 ~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  526 PPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            5 556666555554 4788899999999999999999999999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-35  Score=282.52  Aligned_cols=208  Identities=28%  Similarity=0.466  Sum_probs=179.8

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC---CCCcccceeEE
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ---HPNIVNLIEVI  193 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~  193 (410)
                      +.+|..++.+|.|+||.|++|.++.+...|+||.+.+.....-..- ....+-.+-.||+||..++   |+||++++++|
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWv-rDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWV-RDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhh-cccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            4569999999999999999999999999999999887643110000 0011223558999999998   99999999999


Q ss_pred             EcCCCCEEEEEEeecC-CCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          194 DDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~-~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      ++  .+++||+||-.. |-.|.+++.....++|.+++.|++||+.|+++||++||||||||-+||.++.+|.+||+|||.
T Consensus       639 Ed--dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  639 ED--DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             ec--CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence            87  569999999874 667899999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG  329 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~  329 (410)
                      |....  +.....+.||..|.|||++.+..|-++.-|||+||++||.+++...||+.
T Consensus       717 aa~~k--sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAYTK--SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhhc--CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            87543  34566788999999999999999989999999999999999999999864

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-34  Score=245.48  Aligned_cols=214  Identities=23%  Similarity=0.389  Sum_probs=173.2

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHh-CCCCCcccceeEEEcCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM-LQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~  197 (410)
                      ....+..||+|++|.|-++++..+|...|+|.+...        .+...++++++|+++..+ ..+|.+|.++|.+.+  
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t--------vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--  116 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT--------VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--  116 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh--------cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--
Confidence            344567899999999999999999999999987543        245667788899988554 479999999997765  


Q ss_pred             CCEEEEEEeecCCCC---cccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          198 SDHFYMVLEYVEGKW---DNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~---l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .+.++|.||.|.-..   ....+...+.++|..+-+++..++.||.|||++ .+||||+||+|||++.+|+|||||||++
T Consensus       117 egdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIs  196 (282)
T KOG0984|consen  117 EGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGIS  196 (282)
T ss_pred             cccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccc
Confidence            457999999997532   123345677899999999999999999999976 8999999999999999999999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCC---cCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGL---TYGGKAADTWAVGVTLYYMIIGQYPFLG-ETLQDTYDKIVNNS  343 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlG~il~elltG~~Pf~~-~~~~~~~~~i~~~~  343 (410)
                      ..+.+.-. .+-..|.-.|+|||.+...   ..++-++||||||+++.||.+++.||.. .+..+++.++...+
T Consensus       197 G~L~dSiA-kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep  269 (282)
T KOG0984|consen  197 GYLVDSIA-KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP  269 (282)
T ss_pred             eeehhhhH-HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence            87665322 2224577889999988532   2346679999999999999999999965 45667777777654

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=267.13  Aligned_cols=244  Identities=24%  Similarity=0.292  Sum_probs=188.5

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC--CCCCcccceeEEE
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML--QHPNIVNLIEVID  194 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~~~~  194 (410)
                      ......+.+||+|.||.||+++..  ++.||||++..            .....+.+|-+|++..  +|+||++++++-.
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~------------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ek  274 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE------------QEKQSFQNEKNIYSLPGMKHENILQFIGAEK  274 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc--CceeEEEecCH------------HHHHHHHhHHHHHhccCccchhHHHhhchhc
Confidence            345677889999999999877654  69999999853            3455788888887765  7999999998765


Q ss_pred             cCC--CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcEeccCCCCcEEEcCCC
Q 015257          195 DPN--SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH---------NVVHGDIKPDNLLVAPSG  263 (410)
Q Consensus       195 ~~~--~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~---------~iiHrDlkp~NIll~~~~  263 (410)
                      ...  ...++||++|.+.|+|.+++..+ .+++....+++..|++||+|||+.         +|+|||||..||||..|+
T Consensus       275 r~t~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl  353 (534)
T KOG3653|consen  275 RGTADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL  353 (534)
T ss_pred             cCCccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence            421  34789999999999999998876 689999999999999999999962         599999999999999999


Q ss_pred             cEEEeeccccccccCCc--cccccCCCcccccccccccCCcCC-----CchhhHHHHHHHHHHHHhCCC-----------
Q 015257          264 TVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYG-----GKAADTWAVGVTLYYMIIGQY-----------  325 (410)
Q Consensus       264 ~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwSlG~il~elltG~~-----------  325 (410)
                      +..|+|||+|..+..+.  .....-+||..|||||++.+...-     -++.||||+|.|||||++...           
T Consensus       354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq  433 (534)
T KOG3653|consen  354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ  433 (534)
T ss_pred             cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence            99999999998765432  223346799999999998654221     257999999999999997532           


Q ss_pred             -CCC-----CCCHHHHHHHHHh--CCCCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHH
Q 015257          326 -PFL-----GETLQDTYDKIVN--NSLVFPD-----AMNPELRNLLEGLLCKDPTRRLTLNDV  375 (410)
Q Consensus       326 -Pf~-----~~~~~~~~~~i~~--~~~~~p~-----~~~~~l~~li~~~L~~dp~~Rpt~~el  375 (410)
                       ||.     ..+..++......  .++.+|.     ..-.-+.+.+..||..||.-|+|+.=+
T Consensus       434 lpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  434 LPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             CchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence             332     1223334333333  2334553     223567899999999999999998533

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.9e-34  Score=270.10  Aligned_cols=255  Identities=27%  Similarity=0.423  Sum_probs=198.8

Q ss_pred             cccceeeeeeecccCceEEEEEEEcc---CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCccccee
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIE  191 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~  191 (410)
                      ..+.|..+.+||+|.|++||++.+..   .++.||+|.+...           +...++.+|+++|..+ .+.||+++.+
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-----------s~p~ri~~El~~L~~~gG~~ni~~~~~  102 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-----------SSPSRILNELEMLYRLGGSDNIIKLNG  102 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-----------cCchHHHHHHHHHHHhccchhhhcchh
Confidence            34578999999999999999999887   7889999987543           2234688999999998 5999999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC-CcEEEeec
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-GTVKIGDF  270 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~-~~~kl~Df  270 (410)
                      ++..  .+++.+||||++.....+++.   .++...++.|++.++.||+++|.+|||||||||+|+|.+.. +.-.|+||
T Consensus       103 ~~rn--nd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDF  177 (418)
T KOG1167|consen  103 CFRN--NDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDF  177 (418)
T ss_pred             hhcc--CCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEec
Confidence            9975  578999999999876666544   36688999999999999999999999999999999999864 67899999


Q ss_pred             cccccccCC-------c-------c----------c--------------------cccCCCcccccccccccCCcCCCc
Q 015257          271 SVSQVFEDD-------N-------D----------V--------------------LRRSPGTPVFTAPECCLGLTYGGK  306 (410)
Q Consensus       271 G~a~~~~~~-------~-------~----------~--------------------~~~~~gt~~y~aPE~~~~~~~~~~  306 (410)
                      |+|......       .       .          .                    .....||++|.|||++......+.
T Consensus       178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt  257 (418)
T KOG1167|consen  178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT  257 (418)
T ss_pred             hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence            998621000       0       0          0                    001239999999999988877788


Q ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHH----------------------------------------HH-----H
Q 015257          307 AADTWAVGVTLYYMIIGQYPFLGETL-QDTYD----------------------------------------KI-----V  340 (410)
Q Consensus       307 ~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~----------------------------------------~i-----~  340 (410)
                      ++||||.|||++.++++..||..... .+...                                        .+     .
T Consensus       258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~  337 (418)
T KOG1167|consen  258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY  337 (418)
T ss_pred             ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence            89999999999999999999833210 00000                                        00     0


Q ss_pred             hCCC------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          341 NNSL------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       341 ~~~~------~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      ....      ...+..+..+.+|+.+||+.||.+|.|++++|+||||.....
T Consensus       338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence            0000      011234568899999999999999999999999999986544

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-32  Score=259.28  Aligned_cols=244  Identities=25%  Similarity=0.357  Sum_probs=185.0

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHh--CCCCCcccceeEEEc
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM--LQHPNIVNLIEVIDD  195 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~  195 (410)
                      .+..+++.||+|.||+||+++.  .|+.||||++....            -..+.+|.+|++.  |+|+||+.+++.-..
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------------E~SWfrEtEIYqTvmLRHENILgFIaaD~~  276 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------------ERSWFRETEIYQTVMLRHENILGFIAADNK  276 (513)
T ss_pred             heeEEEEEecCccccceeeccc--cCCceEEEEecccc------------hhhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence            4578899999999999966654  58999999986431            2356777777754  599999999965332


Q ss_pred             --CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-----C---CcEeccCCCCcEEEcCCCcE
Q 015257          196 --PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-----H---NVVHGDIKPDNLLVAPSGTV  265 (410)
Q Consensus       196 --~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-----~---~iiHrDlkp~NIll~~~~~~  265 (410)
                        ....+++||.+|.+.|+|.|++.. ..++.....+++..++.||++||.     +   .|+|||||..|||+.++|..
T Consensus       277 ~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C  355 (513)
T KOG2052|consen  277 DNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  355 (513)
T ss_pred             CCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence              234689999999999999999988 578999999999999999999994     2   49999999999999999999


Q ss_pred             EEeeccccccccCCcc----ccccCCCcccccccccccCCcC----C-CchhhHHHHHHHHHHHHh-----C-----CCC
Q 015257          266 KIGDFSVSQVFEDDND----VLRRSPGTPVFTAPECCLGLTY----G-GKAADTWAVGVTLYYMII-----G-----QYP  326 (410)
Q Consensus       266 kl~DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~----~-~~~~DiwSlG~il~ellt-----G-----~~P  326 (410)
                      .|+|+|+|........    ..+..+||-.|||||++...-.    . -+.+||||||.|+||++.     |     .+|
T Consensus       356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P  435 (513)
T KOG2052|consen  356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP  435 (513)
T ss_pred             EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence            9999999976554322    2345679999999998753211    1 246999999999999984     2     468


Q ss_pred             CCCC-----CHHHHHHHHHhC--CCCCCCCC--C---HHHHHHHHHhcccCCCCCCCHHHHh
Q 015257          327 FLGE-----TLQDTYDKIVNN--SLVFPDAM--N---PELRNLLEGLLCKDPTRRLTLNDVA  376 (410)
Q Consensus       327 f~~~-----~~~~~~~~i~~~--~~~~p~~~--~---~~l~~li~~~L~~dp~~Rpt~~ell  376 (410)
                      |.+.     ...++.+-+.-.  ++.+|...  .   ..+..|++.||..||.-|.|+--+-
T Consensus       436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             cccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence            8653     233333222222  23344322  2   3466789999999999999886554

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1e-31  Score=239.78  Aligned_cols=213  Identities=38%  Similarity=0.722  Sum_probs=184.3

Q ss_pred             ecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEEEE
Q 015257          126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVL  205 (410)
Q Consensus       126 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~  205 (410)
                      ||+|++|.||++....+++.+++|++.....        ......+.+|+..++.+.|++|+++++++...  ...+++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~   70 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS--------SSLLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVM   70 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccc--------hhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEE
Confidence            6899999999999988899999999865421        11346789999999999999999999999863  6899999


Q ss_pred             eecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC-CCcEEEeeccccccccCCcccc
Q 015257          206 EYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDFSVSQVFEDDNDVL  283 (410)
Q Consensus       206 e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~-~~~~kl~DfG~a~~~~~~~~~~  283 (410)
                      ||++++.+..++... ..+++..++.++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+..........
T Consensus        71 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~  150 (215)
T cd00180          71 EYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL  150 (215)
T ss_pred             ecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchh
Confidence            999988888887665 57899999999999999999999999999999999999999 8999999999998665443223


Q ss_pred             ccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcc
Q 015257          284 RRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC  363 (410)
Q Consensus       284 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L~  363 (410)
                      ....+...|++||.+......+.+.|+|+||+++++|                               ..+.+++.+||+
T Consensus       151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~  199 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQ  199 (215)
T ss_pred             hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhh
Confidence            4455788899999887653446779999999999998                               678999999999


Q ss_pred             cCCCCCCCHHHHhhCC
Q 015257          364 KDPTRRLTLNDVAKHT  379 (410)
Q Consensus       364 ~dp~~Rpt~~ell~h~  379 (410)
                      .||.+||++.++++|+
T Consensus       200 ~~p~~R~~~~~l~~~~  215 (215)
T cd00180         200 KDPEKRPSAKEILEHL  215 (215)
T ss_pred             CCcccCcCHHHHhhCC
Confidence            9999999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.9e-30  Score=235.29  Aligned_cols=214  Identities=37%  Similarity=0.619  Sum_probs=178.2

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  199 (410)
                      |.+.+.||+|++|.||++....+++.+|+|.+......        .....+.+|+..++.++|+|++++++++..  ..
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~   70 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--------KQREEFLREIRILKKLKHPNIVKLYGVFED--PE   70 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--------HHHHHHHHHHHHHHhCCCCChhhheeeeec--CC
Confidence            56788999999999999999988999999998654211        245688899999999999999999999876  35


Q ss_pred             EEEEEEeecCCCCcccccCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          200 HFYMVLEYVEGKWDNDGFGQPGA-IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~~~~-l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ..++++||++++++...+..... +++..+..++.|++.+|.+||+.+++|+||+|.||+++.++.++|+|||++.....
T Consensus        71 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~  150 (225)
T smart00221       71 PLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHR  150 (225)
T ss_pred             ceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence            78999999999888888776655 89999999999999999999999999999999999999999999999999987654


Q ss_pred             Cc-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHH-HHHHHHHhCC
Q 015257          279 DN-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG-ETLQ-DTYDKIVNNS  343 (410)
Q Consensus       279 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~-~~~~-~~~~~i~~~~  343 (410)
                      .. .......++..|++||.+.+....+.++|+||||+++++|++|+.||.. .... ...+.+..+.
T Consensus       151 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      151 DLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             cccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            32 1223456788899999873322335579999999999999999999977 3443 5666666665

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=236.26  Aligned_cols=252  Identities=22%  Similarity=0.435  Sum_probs=195.5

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVI  193 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  193 (410)
                      .+.+.|.+.+.||+|.||.+.++.++.+...+++|.+...          ...+..|.+|...--.| .|.||+.-|++-
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p----------~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va   90 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP----------QTTQADFVREFHYSFFLSPHQHIIDTYEVA   90 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc----------hhhHHHHHHHhccceeeccchhhhHHHHHH
Confidence            4567899999999999999999999999999999987653          34567888888764444 599999988644


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC-C-CcEEEeecc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-S-GTVKIGDFS  271 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~-~-~~~kl~DfG  271 (410)
                      ... .+.++.++||++.|+|...+.. ..+.|...+.++.|+++|+.|+|+.+++|||||.+||||-. + .+|||||||
T Consensus        91 Fqt-~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG  168 (378)
T KOG1345|consen   91 FQT-SDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFG  168 (378)
T ss_pred             hhc-CceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecc
Confidence            332 4588999999999998887765 46889999999999999999999999999999999999853 2 479999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCC
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTY----GGKAADTWAVGVTLYYMIIGQYPFLGETLQD----TYDKIVNNS  343 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwSlG~il~elltG~~Pf~~~~~~~----~~~~i~~~~  343 (410)
                      +.+..+..   .....-+..|.|||.+.....    ..+.+|||.||+++|.+|||.+||......+    .+.+..+..
T Consensus       169 ~t~k~g~t---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk  245 (378)
T KOG1345|consen  169 LTRKVGTT---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK  245 (378)
T ss_pred             cccccCce---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc
Confidence            98764332   122234667999997654321    1467999999999999999999997543222    122222222


Q ss_pred             -CCCC---CCCCHHHHHHHHHhcccCCCCC---CCHHHHhhCCcc
Q 015257          344 -LVFP---DAMNPELRNLLEGLLCKDPTRR---LTLNDVAKHTWV  381 (410)
Q Consensus       344 -~~~p---~~~~~~l~~li~~~L~~dp~~R---pt~~ell~h~~~  381 (410)
                       ...|   ..+++.+..+.++-|..+|++|   .++....+..|.
T Consensus       246 ~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  246 NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             CccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence             2334   3578899999999999999999   566666777776

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=1.6e-31  Score=286.35  Aligned_cols=202  Identities=16%  Similarity=0.151  Sum_probs=146.9

Q ss_pred             HhCCC-CCcccceeEEEcC-----CCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecc
Q 015257          179 KMLQH-PNIVNLIEVIDDP-----NSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGD  251 (410)
Q Consensus       179 ~~l~h-pniv~l~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD  251 (410)
                      +.++| +||+++++.|...     ....++.+|||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+|||
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD  105 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDV-SLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN  105 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccCCc-cHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence            34556 5888888877321     12467888998855 67777754 45699999999999999999999999999999


Q ss_pred             CCCCcEEEcCC-------------------CcEEEeeccccccccCCc----------------cccccCCCcccccccc
Q 015257          252 IKPDNLLVAPS-------------------GTVKIGDFSVSQVFEDDN----------------DVLRRSPGTPVFTAPE  296 (410)
Q Consensus       252 lkp~NIll~~~-------------------~~~kl~DfG~a~~~~~~~----------------~~~~~~~gt~~y~aPE  296 (410)
                      |||+||||+..                   +.+||+|||+++......                .......||+.|+|||
T Consensus       106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE  185 (793)
T PLN00181        106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE  185 (793)
T ss_pred             CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence            99999999653                   456666666665321100                0011245899999999


Q ss_pred             cccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 015257          297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFPDAMNPELRNLLEGLLCKDPTRRLTLNDV  375 (410)
Q Consensus       297 ~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~l~~li~~~L~~dp~~Rpt~~el  375 (410)
                      ++.+..+ +.++|||||||+||||++|.+|+....  .....+..... ..+....+...+++.+||++||.+|||+.|+
T Consensus       186 ~~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ei  262 (793)
T PLN00181        186 EDNGSSS-NCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSEL  262 (793)
T ss_pred             hhccCCC-CchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence            9887776 677999999999999999998875422  11122211111 1111234567889999999999999999999


Q ss_pred             hhCCcccCC
Q 015257          376 AKHTWVLGD  384 (410)
Q Consensus       376 l~h~~~~~~  384 (410)
                      ++||||...
T Consensus       263 l~h~~~~~~  271 (793)
T PLN00181        263 LQSEFINEP  271 (793)
T ss_pred             hhchhhhhh
Confidence            999999864

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=3.6e-29  Score=232.06  Aligned_cols=250  Identities=16%  Similarity=0.206  Sum_probs=203.2

Q ss_pred             cceeeeeeecccCceEEEEEEEcc-----CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      ++++....+-+|.||.||.+....     +.+.|-+|.++...        ++-+...++.|..++..+.|||+.++.++
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--------S~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--------SQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--------cHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            457777789999999999986553     23557777765432        45567789999999999999999999998


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccC-----C---CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFG-----Q---PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT  264 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~-----~---~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~  264 (410)
                      ..+. ....+.++.+++-+.|..++.     .   .+.++..+...++.|++.|++|||..||||.||-..|.+|++...
T Consensus       356 ~ie~-~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  356 SIED-YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             Eeec-cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee
Confidence            8764 456788899998777777665     1   235677778889999999999999999999999999999999999


Q ss_pred             EEEeeccccccccC-CccccccCC-CcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015257          265 VKIGDFSVSQVFED-DNDVLRRSP-GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVN  341 (410)
Q Consensus       265 ~kl~DfG~a~~~~~-~~~~~~~~~-gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~  341 (410)
                      |||+|=.+++.+-. +.+...... ....||+||.+.+..+ +.++|||||||+||||+| |+.|+..-+..++..-+..
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~y-ssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd  513 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHY-SSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD  513 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhh-cchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence            99999999986532 222222111 2345999999988777 667999999999999997 9999999888888776666


Q ss_pred             CC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          342 NS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       342 ~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      +. +.-|-.++.++..++.-||...|++||+++|+..
T Consensus       514 GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  514 GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            54 4567799999999999999999999999999874

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=4.3e-29  Score=219.00  Aligned_cols=158  Identities=21%  Similarity=0.250  Sum_probs=125.7

Q ss_pred             CcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccccccCCCcc
Q 015257          212 WDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP  290 (410)
Q Consensus       212 ~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  290 (410)
                      +|.+.+.. ...+++..++.++.||+.||.|||+++      ||+|||++.++.+|+  ||+++......     ..||+
T Consensus         2 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~g~~   68 (176)
T smart00750        2 SLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SRVDP   68 (176)
T ss_pred             cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-----CCCcc
Confidence            45555554 446999999999999999999999998      999999999999999  99998654422     25899


Q ss_pred             cccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCC-------CCCCCH--HHHHHHHH
Q 015257          291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL-QDTYDKIVNNSLVF-------PDAMNP--ELRNLLEG  360 (410)
Q Consensus       291 ~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~i~~~~~~~-------p~~~~~--~l~~li~~  360 (410)
                      .|+|||++.+..+ +.++|||||||++|+|++|..||..... ......+.......       +..++.  ++.++|.+
T Consensus        69 ~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  147 (176)
T smart00750       69 YFMAPEVIQGQSY-TEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV  147 (176)
T ss_pred             cccChHHhcCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence            9999999987766 5679999999999999999999976433 23333333322211       122333  69999999


Q ss_pred             hcccCCCCCCCHHHHhhCCcccC
Q 015257          361 LLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       361 ~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                      ||..||.+|||+.++++|+|+..
T Consensus       148 cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      148 CASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHhcccccccCHHHHHHHHHHHH
Confidence            99999999999999999999863

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=9.8e-30  Score=260.49  Aligned_cols=263  Identities=25%  Similarity=0.435  Sum_probs=207.3

Q ss_pred             cce-eeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          118 NEY-VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       118 ~~y-~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      +.| ...+.+|.|++|.|+.+......+.++.|.+... ..  ...........+..|+-+-..+.|||++..+..+.+.
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~--~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~  393 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK--PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI  393 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcc-cC--CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc
Confidence            445 4578899999999988888887777887765422 10  1112233334477888889999999999888776653


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                        ...+-+||||++ .|..++...+.++...+..++.|++.||+|+|+.||.|||+||+|+++..+|.+||+|||.+...
T Consensus       394 --~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf  470 (601)
T KOG0590|consen  394 --DGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVF  470 (601)
T ss_pred             --ccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceee
Confidence              233444999999 88888888778999999999999999999999999999999999999999999999999998765


Q ss_pred             cCC--c--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-------HHhCC
Q 015257          277 EDD--N--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTY--DK-------IVNNS  343 (410)
Q Consensus       277 ~~~--~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~--~~-------i~~~~  343 (410)
                      ..+  .  ......+|+..|+|||++.+..+.....||||.|+++..|.+|+.||.-....+..  ..       +..+.
T Consensus       471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~  550 (601)
T KOG0590|consen  471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP  550 (601)
T ss_pred             ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh
Confidence            322  2  45567789999999999999998888999999999999999999999765444321  11       11111


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          344 LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       344 ~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      ..+-..++...+.+|.+||++||.+|.|+++|++.+||+.-..
T Consensus       551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence            1122356778899999999999999999999999999987644

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=3.4e-26  Score=217.00  Aligned_cols=254  Identities=36%  Similarity=0.598  Sum_probs=206.8

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCC-CcccceeEEEcCCC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP-NIVNLIEVIDDPNS  198 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~  198 (410)
                      |.+...||.|+||.||++.+.   ..+|+|.+......      .......+.+|+.++..+.|+ +|+++.+++..  .
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~   70 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLES------KSKEVERFLREIQILASLNHPPNIVKLYDFFQD--E   70 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhcc------chhHHHHHHHHHHHHHHccCCcceeeEEEEEec--C
Confidence            778899999999999999988   78999998765322      113567899999999999988 79999999965  3


Q ss_pred             CEEEEEEeecCCCCcccccCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC-cEEEeeccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPG---AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSVSQ  274 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~---~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~-~~kl~DfG~a~  274 (410)
                      ...+++++++.++.+...+....   .+++..+..++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.++
T Consensus        71 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          71 GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             CEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            45899999999998886666554   799999999999999999999999999999999999999988 79999999998


Q ss_pred             cccCCcc------ccccCCCcccccccccccCC--cCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhC
Q 015257          275 VFEDDND------VLRRSPGTPVFTAPECCLGL--TYGGKAADTWAVGVTLYYMIIGQYPFLGETL----QDTYDKIVNN  342 (410)
Q Consensus       275 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~elltG~~Pf~~~~~----~~~~~~i~~~  342 (410)
                      .......      ......||..|+|||.+.+.  .......|+||+|++++++++|..||.....    ......+...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  230 (384)
T COG0515         151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL  230 (384)
T ss_pred             ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc
Confidence            6544332      34567899999999988774  4456789999999999999999999877653    4444444444


Q ss_pred             CCC-CCCCCC--------HHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          343 SLV-FPDAMN--------PELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       343 ~~~-~p~~~~--------~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      ... ......        ..+.+++..++..+|..|.+..+...++|....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             CCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            332 222111        478999999999999999999999998776554

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-28  Score=241.01  Aligned_cols=240  Identities=28%  Similarity=0.481  Sum_probs=207.7

Q ss_pred             eecccCceEEEEEEE---ccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEEEcCCCCE
Q 015257          125 KIGAGSYGKVVLYRS---SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDPNSDH  200 (410)
Q Consensus       125 ~lG~G~fg~Vy~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~  200 (410)
                      .+|.|+||.|++++.   ...|..||+|+..+......     ...  ....|-.++...+ ||.+|++...++.  ...
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~-----~~~--~t~~er~il~~~~~~~f~v~lhyafqt--~~k   71 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVR-----DRT--HTKQERIILAFVHNTPFLVKLHYAFQT--DGK   71 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccc-----ccc--ccccHHHHHhhccCCCceeeeeeeecc--ccc
Confidence            379999999998764   34688999999877654221     111  4557778888887 9999999999986  457


Q ss_pred             EEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCc
Q 015257          201 FYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN  280 (410)
Q Consensus       201 ~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~  280 (410)
                      +++++++..|+.+...+.....+.+.....+...++-+++++|+.+|+|||+|++||+++.+|++++.|||+++......
T Consensus        72 l~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~  151 (612)
T KOG0603|consen   72 LYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK  151 (612)
T ss_pred             hhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence            89999999999999999988899999999999999999999999999999999999999999999999999998765433


Q ss_pred             cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 015257          281 DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEG  360 (410)
Q Consensus       281 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~  360 (410)
                      ..    |||..|||||++.+   +..++|.||||+++++|+||..||.+    +....|....+.+|..++..+++++..
T Consensus       152 ~~----cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~  220 (612)
T KOG0603|consen  152 IA----CGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQ  220 (612)
T ss_pred             hc----ccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHH
Confidence            22    89999999999872   25679999999999999999999987    677888898999999999999999999


Q ss_pred             hcccCCCCCCC-----HHHHhhCCcccCC
Q 015257          361 LLCKDPTRRLT-----LNDVAKHTWVLGD  384 (410)
Q Consensus       361 ~L~~dp~~Rpt-----~~ell~h~~~~~~  384 (410)
                      ++..+|..|.-     +.++++|+||+.-
T Consensus       221 l~~r~p~nrLg~~~~~~~eik~h~f~~~i  249 (612)
T KOG0603|consen  221 LFKRNPENRLGAGPDGVDEIKQHEFFQSI  249 (612)
T ss_pred             HHhhCHHHHhccCcchhHHHhccchheee
Confidence            99999999984     4799999999764

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.7e-26  Score=222.84  Aligned_cols=170  Identities=19%  Similarity=0.210  Sum_probs=130.5

Q ss_pred             ccccceeeeeeecccCceEEEEEEEcc-CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSL-DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      .+.++|.+.+.||+|+||+||+|.+.. +++.+|||++.....    ..........+.+|+.+|+.++|+|++..+..+
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~----~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVP----WWSKPLARHLAAREIRALKTVRGIGVVPQLLAT   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccc----ccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence            455789999999999999999999876 778889998642210    001223456799999999999999998633221


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccC-CCCcEEEcCCCcEEEeeccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDI-KPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl-kp~NIll~~~~~~kl~DfG~  272 (410)
                           +..||||||++|++|... ..   ..   ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+
T Consensus        91 -----~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         91 -----GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             -----CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence                 247999999999888632 11   11   1467899999999999999999999 99999999999999999999


Q ss_pred             cccccCCccc--------cccCCCcccccccccccC
Q 015257          273 SQVFEDDNDV--------LRRSPGTPVFTAPECCLG  300 (410)
Q Consensus       273 a~~~~~~~~~--------~~~~~gt~~y~aPE~~~~  300 (410)
                      |+........        ..+..+++.|+|||.+..
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9866443211        134568888999998753

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.1e-25  Score=214.67  Aligned_cols=248  Identities=23%  Similarity=0.317  Sum_probs=186.9

Q ss_pred             ceeeeeeecccCceEEEEEEEccCC-ceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCC----CCcccceeEE
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDG-KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH----PNIVNLIEVI  193 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~l~~~~  193 (410)
                      +|.+.+.||+|+||.||++.+..++ ..+|+|+........         ...+..|+.++..+..    +++..+++..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---------~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G   89 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---------PSVLKIEIQVLKKLEKKNGPSHFPKLLDHG   89 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---------CccchhHHHHHHHHhhhcCCCCCCEEEEec
Confidence            7999999999999999999988764 679999865432111         1156788888888873    5888888877


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccC-C-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC-----CcEE
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFG-Q-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-----GTVK  266 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~-~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~-----~~~k  266 (410)
                      . .....-+|||+.++. +|.++.. . .+.++..++..++.|++.+|++||+.|++||||||+|+++...     ..+.
T Consensus        90 ~-~~~~~~~iVM~l~G~-sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~  167 (322)
T KOG1164|consen   90 R-STEDFNFIVMSLLGP-SLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLY  167 (322)
T ss_pred             c-CCCceeEEEEeccCc-cHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEE
Confidence            4 224578999999854 4555442 2 4689999999999999999999999999999999999999865     3599


Q ss_pred             Eeeccccc--cccCCcc----c----cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015257          267 IGDFSVSQ--VFEDDND----V----LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTY  336 (410)
Q Consensus       267 l~DfG~a~--~~~~~~~----~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~  336 (410)
                      |.|||+++  .......    .    ...+.||..|+++.++.+... +++.|+||++.++.+++.|..||.........
T Consensus       168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~  246 (322)
T KOG1164|consen  168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLK  246 (322)
T ss_pred             EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence            99999998  4322211    1    123459999999998888776 67799999999999999999999765532222


Q ss_pred             HHH---HhCCCC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          337 DKI---VNNSLV--FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       337 ~~i---~~~~~~--~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..+   ......  +....+.++..++..+-..+...+|....+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  247 SKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            222   222111  234456778888887777889999988777654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=7.8e-26  Score=197.99  Aligned_cols=240  Identities=24%  Similarity=0.324  Sum_probs=186.6

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCC-CCcccceeEEEc
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH-PNIVNLIEVIDD  195 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~  195 (410)
                      ..+|.++++||+|+||.+|++....+|+.||||+-...           ....++..|..+++.|++ ..|..+..+..+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-----------a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e   82 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-----------AKHPQLLYESKVYRILQGGVGIPHIRHYGTE   82 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-----------CCCcchhHHHHHHHHhccCCCCchhhhhccc
Confidence            46899999999999999999999999999999974432           122367899999999975 466666666654


Q ss_pred             CCCCEEEEEEeecCCCCccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC---CcEEEeecc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDFS  271 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~---~~~kl~DfG  271 (410)
                        ..+-.+||+.+... |.++. .....++..++.-++-||+.-++|+|.+++|||||||+|+|..-+   ..+.++|||
T Consensus        83 --~~ynvlVMdLLGPs-LEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG  159 (341)
T KOG1163|consen   83 --KDYNVLVMDLLGPS-LEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFG  159 (341)
T ss_pred             --cccceeeeeccCcc-HHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEecc
Confidence              45778999998654 44443 345679999999999999999999999999999999999999754   468999999


Q ss_pred             ccccccCCcc-------ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHh
Q 015257          272 VSQVFEDDND-------VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET---LQDTYDKIVN  341 (410)
Q Consensus       272 ~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~---~~~~~~~i~~  341 (410)
                      +|+.+-+...       ..+...||..|.+-....+... +...|+-|+|.+|..+.-|..||.+..   ..+-+++|..
T Consensus       160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E  238 (341)
T KOG1163|consen  160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE  238 (341)
T ss_pred             chhhhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH
Confidence            9987654321       1234569999999876665544 667999999999999999999998854   4456677777


Q ss_pred             CCCCCC-----CCCCHHHHHHHHHhcccCCCCCCC
Q 015257          342 NSLVFP-----DAMNPELRNLLEGLLCKDPTRRLT  371 (410)
Q Consensus       342 ~~~~~p-----~~~~~~l~~li~~~L~~dp~~Rpt  371 (410)
                      .+...|     ..+|.++...+.-|-..-=.+-|.
T Consensus       239 kK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd  273 (341)
T KOG1163|consen  239 KKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD  273 (341)
T ss_pred             hhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence            666555     367888888888776554444453

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.92  E-value=2.4e-25  Score=228.87  Aligned_cols=219  Identities=32%  Similarity=0.558  Sum_probs=173.0

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      -.+|..++.|-.|++|.||+++++.+.+.+|+|+- +..+              +.+-  ++..-..|.+|         
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~l--------------ilRn--ilt~a~npfvv---------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNL--------------ILRN--ILTFAGNPFVV---------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccc-ccch--------------hhhc--cccccCCccee---------
Confidence            45799999999999999999999999999999643 2211              0010  22222333333         


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                                    +.-...++..+.++...        +.+++|||+.||+|||+||+|.+|..-|++|+.|||+++..
T Consensus       136 --------------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  136 --------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKG  193 (1205)
T ss_pred             --------------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhh
Confidence                          22223344444555433        78999999999999999999999999999999999998653


Q ss_pred             cCC---------------ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015257          277 EDD---------------NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN  341 (410)
Q Consensus       277 ~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~  341 (410)
                      ...               .-.....+|||.|.|||++....| ++.+|.|++|+|+|+.+-|..||.+++.++++..++.
T Consensus       194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis  272 (1205)
T KOG0606|consen  194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS  272 (1205)
T ss_pred             hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence            110               012245689999999999987776 6779999999999999999999999999999999999


Q ss_pred             CCCCCCC---CCCHHHHHHHHHhcccCCCCCC---CHHHHhhCCcccCC
Q 015257          342 NSLVFPD---AMNPELRNLLEGLLCKDPTRRL---TLNDVAKHTWVLGD  384 (410)
Q Consensus       342 ~~~~~p~---~~~~~l~~li~~~L~~dp~~Rp---t~~ell~h~~~~~~  384 (410)
                      ..+.+|+   .+++++++++..+|+.+|..|.   .+-+|.+|+||+..
T Consensus       273 d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L  321 (1205)
T KOG0606|consen  273 DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL  321 (1205)
T ss_pred             hhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence            8888886   5789999999999999999997   67889999999865

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=1.5e-24  Score=192.45  Aligned_cols=148  Identities=22%  Similarity=0.196  Sum_probs=113.2

Q ss_pred             eeeecccCceEEEEEEEccCCceEEEEeeeccccccccc---------------CCCh--HHHHHHHHHHHHHHhCCCCC
Q 015257          123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV---------------APSE--TAMTDVRREVLIMKMLQHPN  185 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~---------------~~~~--~~~~~~~~E~~~l~~l~hpn  185 (410)
                      ...||+|+||.||+|.+. +|+.||||++..........               ....  -.......|+.++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999987 89999999997653211000               0000  01123456999999999888


Q ss_pred             cccceeEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeccCCCCcEEEcCCCc
Q 015257          186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL-HGHNVVHGDIKPDNLLVAPSGT  264 (410)
Q Consensus       186 iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yL-H~~~iiHrDlkp~NIll~~~~~  264 (410)
                      +.....+...    ..+|||||++|+.+.........+++..+..++.||+.+|.|| |+.||+||||||+|||++ ++.
T Consensus        81 v~~p~~~~~~----~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          81 IPCPEPILLK----SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             CCCCcEEEec----CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence            7554433222    2389999999876665444456799999999999999999999 799999999999999998 588


Q ss_pred             EEEeeccccccc
Q 015257          265 VKIGDFSVSQVF  276 (410)
Q Consensus       265 ~kl~DfG~a~~~  276 (410)
                      ++|+|||+|...
T Consensus       156 v~LiDFG~a~~~  167 (190)
T cd05147         156 LYIIDVSQSVEH  167 (190)
T ss_pred             EEEEEccccccC
Confidence            999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=1.8e-24  Score=194.89  Aligned_cols=177  Identities=20%  Similarity=0.241  Sum_probs=133.6

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHH------HHHHHHHHHhCCCCCccc
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD------VRREVLIMKMLQHPNIVN  188 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~------~~~E~~~l~~l~hpniv~  188 (410)
                      .+.++|++++.||.|+||.||++..  ++..+|||++......      .......      +.+|+..+.++.||+|..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~------~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~   99 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKR------TERFLKSFVKGDYYENLIVQTDRVRSEGLAS   99 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCc------hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence            3456899999999999999998655  4678999998754321      2222233      689999999999999999


Q ss_pred             ceeEEEcCC------CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC
Q 015257          189 LIEVIDDPN------SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS  262 (410)
Q Consensus       189 l~~~~~~~~------~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~  262 (410)
                      +.+++.+..      ....+|||||++|.++.+..    .+++    ..+.+|+.+|..+|+.|++|||++|+||+++.+
T Consensus       100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~  171 (232)
T PRK10359        100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKN  171 (232)
T ss_pred             ceEeeeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCC
Confidence            998866532      23579999999998887652    2333    345699999999999999999999999999998


Q ss_pred             CcEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHH
Q 015257          263 GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMI  321 (410)
Q Consensus       263 ~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell  321 (410)
                      | ++|+|||............            .++....+. .++|+||||+++..+.
T Consensus       172 g-i~liDfg~~~~~~e~~a~d------------~~vler~y~-~~~di~~lg~~~~~~~  216 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKAKD------------RIDLERHYG-IKNEIKDLGYYLLIYK  216 (232)
T ss_pred             C-EEEEECCCcccccchhhHH------------HHHHHhHhc-ccccccceeEeehHHH
Confidence            8 9999999887553322111            022333343 5699999999987654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=1.7e-23  Score=186.21  Aligned_cols=150  Identities=21%  Similarity=0.233  Sum_probs=115.7

Q ss_pred             eeeecccCceEEEEEEEccCCceEEEEeeecccccccc-----------------cCCChHHHHHHHHHHHHHHhCCCCC
Q 015257          123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR-----------------VAPSETAMTDVRREVLIMKMLQHPN  185 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-----------------~~~~~~~~~~~~~E~~~l~~l~hpn  185 (410)
                      .+.||+|+||.||++.+. +|+.||||++.........                 ..........+..|+..+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            578999999999999987 8999999999865311000                 0000111233568999999999999


Q ss_pred             cccceeEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCcEEEcCCCc
Q 015257          186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGT  264 (410)
Q Consensus       186 iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIll~~~~~  264 (410)
                      +.....+...    ..+|||||++|+.+.........+++..+..++.|++.+|.+||+ .||+||||||+|||++ ++.
T Consensus        81 i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~  155 (190)
T cd05145          81 VPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence            8655554432    238999999987544333334568889999999999999999999 9999999999999999 899


Q ss_pred             EEEeeccccccccC
Q 015257          265 VKIGDFSVSQVFED  278 (410)
Q Consensus       265 ~kl~DfG~a~~~~~  278 (410)
                      ++|+|||++.....
T Consensus       156 ~~liDFG~a~~~~~  169 (190)
T cd05145         156 PYIIDVSQAVELDH  169 (190)
T ss_pred             EEEEEcccceecCC
Confidence            99999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=3.1e-23  Score=189.38  Aligned_cols=209  Identities=23%  Similarity=0.378  Sum_probs=168.0

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEEEcC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDP  196 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~  196 (410)
                      -.|++.++||.|+||..++.+...++++||||.-..           ....-+++.|...++.|. .++|...+-+-.+ 
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-----------kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqe-   95 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-----------KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQE-   95 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccc-----------cCCcchHHHHHHHHHHHcCCCCCCceeeeccc-
Confidence            369999999999999999999999999999996322           222346889999999985 6788887766554 


Q ss_pred             CCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC-----cEEEeec
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-----TVKIGDF  270 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~-----~~kl~Df  270 (410)
                       +.+-.||||+++. +|.++... ...++..++..++.||+.-++|+|++.+|+|||||+|+||..-+     .+-|+||
T Consensus        96 -G~~NiLVidLLGP-SLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF  173 (449)
T KOG1165|consen   96 -GKYNILVIDLLGP-SLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDF  173 (449)
T ss_pred             -cchhhhhhhhhCc-CHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEec
Confidence             6677899999854 45555443 45799999999999999999999999999999999999998644     5889999


Q ss_pred             cccccccCCccc-------cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHH
Q 015257          271 SVSQVFEDDNDV-------LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE---TLQDTYDKIV  340 (410)
Q Consensus       271 G~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~---~~~~~~~~i~  340 (410)
                      |+|+.+.+....       .....||..||+=....+... +++.|+=|||-++.+.|-|..||.+.   +..+-+++|-
T Consensus       174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG  252 (449)
T KOG1165|consen  174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG  252 (449)
T ss_pred             cchhhhcCccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence            999987654321       234569999999887777665 67799999999999999999999874   3445566654


Q ss_pred             h
Q 015257          341 N  341 (410)
Q Consensus       341 ~  341 (410)
                      .
T Consensus       253 e  253 (449)
T KOG1165|consen  253 E  253 (449)
T ss_pred             c
Confidence            3

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1.8e-22  Score=178.33  Aligned_cols=190  Identities=18%  Similarity=0.189  Sum_probs=139.9

Q ss_pred             eeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEEEcCCCC
Q 015257          121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       121 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~  199 (410)
                      .+...|++|+||+||++..  .+.+++.+.+......     ........+.+|+++|++|. |++|++++++.      
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~-----~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------   71 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWW-----LRGVAWWLARREALALRQLDGLPRTPRLLHWD------   71 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhh-----hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------
Confidence            3567899999999997665  5788888776533211     01112235789999999995 57899998851      


Q ss_pred             EEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccC-CCCcEEEcCCCcEEEeeccccccccC
Q 015257          200 HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDI-KPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl-kp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ..+++|||+.|.+|......      . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|.....
T Consensus        72 ~~~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274         72 GRHLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             CEEEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence            36999999999887643221      1 2357889999999999999999999 79999999999999999999985443


Q ss_pred             Cccc----c---------ccCCCcccccccccccCCcCCC-chhhHHHHHHHHHHHHhCCCCCCCC
Q 015257          279 DNDV----L---------RRSPGTPVFTAPECCLGLTYGG-KAADTWAVGVTLYYMIIGQYPFLGE  330 (410)
Q Consensus       279 ~~~~----~---------~~~~gt~~y~aPE~~~~~~~~~-~~~DiwSlG~il~elltG~~Pf~~~  330 (410)
                      ....    .         .-...++.|++|+...-....+ ...+.++.|.-+|.++|+..|+.+.
T Consensus       145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            2211    0         0112688899998654332212 4679999999999999999887543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=2.8e-23  Score=192.65  Aligned_cols=237  Identities=23%  Similarity=0.340  Sum_probs=148.1

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCC----------CCccc
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH----------PNIVN  188 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------pniv~  188 (410)
                      .+...+.||.|+++.||.+.+..+|+.+|||++....      .......+++++|.-....+.+          -.++.
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~------~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~   86 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA------DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLV   86 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS------TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B--
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc------ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEe
Confidence            4667889999999999999999999999999986543      2234566778777766555432          23333


Q ss_pred             ceeEEEcCC----------CC-----EEEEEEeecCCCCccccc---CCCC----CCCHHHHHHHHHHHHHHHHHHHhCC
Q 015257          189 LIEVIDDPN----------SD-----HFYMVLEYVEGKWDNDGF---GQPG----AIGESMARKYLRDIVSGLMYLHGHN  246 (410)
Q Consensus       189 l~~~~~~~~----------~~-----~~~lv~e~~~~~~l~~~~---~~~~----~l~~~~~~~i~~qi~~gL~yLH~~~  246 (410)
                      .++....+.          ..     +.+++|+-+.+. |...+   ....    .+.-.....+..|+++.+++||..|
T Consensus        87 P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~d-L~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G  165 (288)
T PF14531_consen   87 PLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGD-LQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG  165 (288)
T ss_dssp             -SEEEEETTS-SEEEECETTEEEEEESEEEEEE--SEE-HHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeEEEEEcCCCcceecCCCCccceeehhhhccchhhhc-HHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc
Confidence            333332111          11     235677766543 23221   1111    1222233455589999999999999


Q ss_pred             cEeccCCCCcEEEcCCCcEEEeeccccccccCCccccccCCCcccccccccccCC-------cCCCchhhHHHHHHHHHH
Q 015257          247 VVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL-------TYGGKAADTWAVGVTLYY  319 (410)
Q Consensus       247 iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwSlG~il~e  319 (410)
                      ++|+||+|+|+|++.+|.+.|+||+...........   ...+..|.+||.....       ...+.+.|.|+||+++|.
T Consensus       166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~  242 (288)
T PF14531_consen  166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS  242 (288)
T ss_dssp             EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred             eEecccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence            999999999999999999999999987654332211   2345779999965332       223678999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 015257          320 MIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRR  369 (410)
Q Consensus       320 lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L~~dp~~R  369 (410)
                      |.+|..||..............   .-. .++..++.||..+|+.||.+|
T Consensus       243 lWC~~lPf~~~~~~~~~~~~f~---~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  243 LWCGRLPFGLSSPEADPEWDFS---RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHSS-STCCCGGGSTSGGGGT---TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHccCCCCCCCccccccccch---hcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999976533221111111   122 788999999999999999987

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=1.2e-23  Score=216.68  Aligned_cols=268  Identities=20%  Similarity=0.262  Sum_probs=191.7

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      +|...+.||++.|=.|.++++.  ...|+||++-+..-     ..+-....+..+|++ ...++|||.+.+.-+...  .
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~--eG~vVvKVFvk~~p-----~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~   93 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR--EGLVVVKVFVKQDP-----TISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--D   93 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC--CceEEEEEEeccCC-----CCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--h
Confidence            6788899999999999666665  33599999876531     112233344455666 677799999998876543  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc--c
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV--F  276 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~--~  276 (410)
                      +..|||-+|+.. .|.|++..+..+...+.+.|+.|++.||.-.|..||+|||||.+||||++-+-+.|+||..-+-  +
T Consensus        94 kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL  172 (1431)
T KOG1240|consen   94 KAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYL  172 (1431)
T ss_pred             HHHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccC
Confidence            567888888864 4778888888888899999999999999999999999999999999999999999999986542  2


Q ss_pred             cCCccc-----cccCCCcccccccccccCCc----------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 015257          277 EDDNDV-----LRRSPGTPVFTAPECCLGLT----------YGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIV  340 (410)
Q Consensus       277 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~----------~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~  340 (410)
                      ++++..     ..+...-.+|+|||.+....          .-+++.||||+||+++||++ |++||.-.    ++-+..
T Consensus       173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr  248 (1431)
T KOG1240|consen  173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYR  248 (1431)
T ss_pred             CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHh
Confidence            222211     11222234599999885421          12568999999999999998 78888421    111222


Q ss_pred             hCCCCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHhhC---------------Cccc---CCCCCCchhhhhhhc
Q 015257          341 NNSLVFP-----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKH---------------TWVL---GDNGPIPQYLCWCKR  397 (410)
Q Consensus       341 ~~~~~~p-----~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h---------------~~~~---~~~~~~~~~~~~~~~  397 (410)
                      .+.-..|     ..-+..+++||..|++.||++|.++++.|+.               +|+.   .....+|...|.|..
T Consensus       249 ~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yFy~FL~~Y~~~~~~~~~~~p~~~~~~~g  328 (1431)
T KOG1240|consen  249 SGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYFYSFLYDYLDRFVPLTTSTPISDNTCTG  328 (1431)
T ss_pred             ccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhhccccHHHHHHHHHHHHHhcCCccccCccccccccC
Confidence            2211111     1234578999999999999999999999986               2222   224556777777776


Q ss_pred             cccc
Q 015257          398 DRLR  401 (410)
Q Consensus       398 ~~~~  401 (410)
                      .+.+
T Consensus       329 s~i~  332 (1431)
T KOG1240|consen  329 STIE  332 (1431)
T ss_pred             cccc
Confidence            6554

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.5e-22  Score=180.24  Aligned_cols=241  Identities=17%  Similarity=0.299  Sum_probs=187.6

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      .+..++.+|.+...|+.|+.+.  .|..+++|++.-....       ......|..|.-.|+.+.||||+.+++.|..+ 
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t-------~risrdfneefp~lrifshpnilpvlgacnsp-  259 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVT-------ARISRDFNEEFPALRIFSHPNILPVLGACNSP-  259 (448)
T ss_pred             hhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcc-------hhhcchhhhhCcceeeecCCchhhhhhhccCC-
Confidence            3455667889999999966554  4667888887644321       12234688899999999999999999999875 


Q ss_pred             CCEEEEEEeecCCCCcccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--cEeccCCCCcEEEcCCCcEEEe--ecc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHN--VVHGDIKPDNLLVAPSGTVKIG--DFS  271 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NIll~~~~~~kl~--DfG  271 (410)
                       .++.++..||+.++|...+....  ..+..++.+++.+|++|++|||+..  |.---|....+++|++-+.+|+  |--
T Consensus       260 -pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~k  338 (448)
T KOG0195|consen  260 -PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTK  338 (448)
T ss_pred             -CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccce
Confidence             47999999999999988876654  4678899999999999999999874  4445688889999998877764  222


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCC--CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCC
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYG--GKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFP  347 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p  347 (410)
                      ++-  ..     ......|.|++||.++..+..  -.++|+|||+++||||.|...||......+.-.+|.-  -+..+|
T Consensus       339 fsf--qe-----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip  411 (448)
T KOG0195|consen  339 FSF--QE-----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP  411 (448)
T ss_pred             eee--ec-----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC
Confidence            221  11     112247889999998765432  4589999999999999999999988777765555433  345789


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVA  376 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell  376 (410)
                      +.+++.+..|++-|+..||.+||.++.++
T Consensus       412 pgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  412 PGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             CCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            99999999999999999999999998764

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=2.1e-21  Score=174.17  Aligned_cols=136  Identities=18%  Similarity=0.218  Sum_probs=106.6

Q ss_pred             eeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-----CCCCcccceeEEEcCC
Q 015257          123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-----QHPNIVNLIEVIDDPN  197 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~~~~~~~~  197 (410)
                      ...||+|+||.||.  +..++.. +||++....         ....+.+.+|+.+++.+     .||||+++++++.+..
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---------~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~   74 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---------DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC   74 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccc---------cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC
Confidence            57899999999995  6666665 699875432         12345789999999999     5799999999998753


Q ss_pred             C-CEEE-EEEee--cCCCCcccccCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCcEeccCCCCcEEEcCC----CcEEEe
Q 015257          198 S-DHFY-MVLEY--VEGKWDNDGFGQPGAIGESMARKYLRDIVSGL-MYLHGHNVVHGDIKPDNLLVAPS----GTVKIG  268 (410)
Q Consensus       198 ~-~~~~-lv~e~--~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL-~yLH~~~iiHrDlkp~NIll~~~----~~~kl~  268 (410)
                      + +.++ +||||  +.+++|.+.+.+. .+++.  ..++.|++.++ +|||+++|+||||||+|||++..    +.++|+
T Consensus        75 g~g~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         75 GTGYVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             CCeEEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence            2 3434 78999  4478999988664 46666  35688888888 99999999999999999999743    379999


Q ss_pred             ecccc
Q 015257          269 DFSVS  273 (410)
Q Consensus       269 DfG~a  273 (410)
                      ||+.+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            95444

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.6e-21  Score=182.00  Aligned_cols=216  Identities=22%  Similarity=0.290  Sum_probs=148.0

Q ss_pred             CCCCcccceeEEEcC-------------------------CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHH
Q 015257          182 QHPNIVNLIEVIDDP-------------------------NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV  236 (410)
Q Consensus       182 ~hpniv~l~~~~~~~-------------------------~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~  236 (410)
                      +|||||.+.++|.+.                         +...+|+||..++.. |..++- ....+.....-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~t-Lr~yl~-~~~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQT-LREYLW-TRHRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhh-HHHHHh-cCCCchHHHHHHHHHHH
Confidence            499999998876431                         235789999887653 333322 23466777888999999


Q ss_pred             HHHHHHHhCCcEeccCCCCcEEEc--CCC--cEEEeeccccccccCC------ccccccCCCcccccccccccCCcC---
Q 015257          237 SGLMYLHGHNVVHGDIKPDNLLVA--PSG--TVKIGDFSVSQVFEDD------NDVLRRSPGTPVFTAPECCLGLTY---  303 (410)
Q Consensus       237 ~gL~yLH~~~iiHrDlkp~NIll~--~~~--~~kl~DfG~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~---  303 (410)
                      +|+.|||.+||.|||+|.+|||+.  +++  .+.|+|||++-.-...      ....-..-|.-.-||||+....+.   
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            999999999999999999999984  344  4789999976321110      011112336667899998754321   


Q ss_pred             --CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHh-CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH---h
Q 015257          304 --GGKAADTWAVGVTLYYMIIGQYPFLGETLQDT-YDKIVN-NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDV---A  376 (410)
Q Consensus       304 --~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-~~~i~~-~~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~el---l  376 (410)
                        +-.++|.|+.|.+.||++....||++...... ...... .-...|+.+++.+++|+..+|+.||++|++.+-.   |
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence              12369999999999999999999987432211 111222 2345788999999999999999999999986433   3


Q ss_pred             ------hCCcccCC-CCCCchhhhhhhccc
Q 015257          377 ------KHTWVLGD-NGPIPQYLCWCKRDR  399 (410)
Q Consensus       377 ------~h~~~~~~-~~~~~~~~~~~~~~~  399 (410)
                            .|.|++.. ..+.++-+-|-...+
T Consensus       512 ~LsLw~~~~~vka~~~~~~~~~~~wLL~~s  541 (598)
T KOG4158|consen  512 NLSLWRMGEDVKAMMEKCGISQMTWLLAGS  541 (598)
T ss_pred             HHHHhcCchHHHHhcccccHHHHHHHHHhh
Confidence                  24455443 334555555544433

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=6.5e-21  Score=174.92  Aligned_cols=153  Identities=22%  Similarity=0.166  Sum_probs=115.6

Q ss_pred             eeeeeeecccCceEEEEEE-EccCCceEEEEeeeccccccccc---------------CCChHHHHHHHHHHHHHHhCCC
Q 015257          120 YVHVRKIGAGSYGKVVLYR-SSLDGKHYAIKAFHKSHLSKLRV---------------APSETAMTDVRREVLIMKMLQH  183 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~-~~~~~~~vaiK~~~~~~~~~~~~---------------~~~~~~~~~~~~E~~~l~~l~h  183 (410)
                      |.+.+.||+|+||.||+|. +..+|+.||||++..........               .........+..|+.+++++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            7788999999999999998 66789999999987543210000               0001122346789999999976


Q ss_pred             CCcccceeEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cEeccCCCCcEEEcCC
Q 015257          184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHN-VVHGDIKPDNLLVAPS  262 (410)
Q Consensus       184 pniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-iiHrDlkp~NIll~~~  262 (410)
                      . .+.+..++...   ..++||||++|.++.........+....+..++.||+.+|.+||+.| |+||||||+||+++ +
T Consensus       110 ~-~i~~p~~~~~~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~  184 (237)
T smart00090      110 A-GVPVPKPIAWR---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D  184 (237)
T ss_pred             c-CCCCCeeeEec---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C
Confidence            3 33333333221   24899999999887765544556677778899999999999999999 99999999999999 8


Q ss_pred             CcEEEeecccccccc
Q 015257          263 GTVKIGDFSVSQVFE  277 (410)
Q Consensus       263 ~~~kl~DfG~a~~~~  277 (410)
                      +.++|+|||.+....
T Consensus       185 ~~i~LiDFg~a~~~~  199 (237)
T smart00090      185 GKVVIIDVSQSVELD  199 (237)
T ss_pred             CCEEEEEChhhhccC
Confidence            899999999987543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=1.8e-22  Score=207.07  Aligned_cols=258  Identities=29%  Similarity=0.491  Sum_probs=210.0

Q ss_pred             ccceeeeeeecccCceEEEEEEEcc-CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEEE
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSL-DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVID  194 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~  194 (410)
                      ...|.+.+.||+|+|+.|-++.... ....+|+|.+....       ......++...|..+-+.+. |+|++.+++...
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-------~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~   91 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-------KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS   91 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-------CccchhhhcCccccccccccccccccccCCccC
Confidence            3468889999999999998777654 44567777665432       24455667778888888887 999999999887


Q ss_pred             cCCCCEEEEEEeecCCCCccccc-CCCC-CCCHHHHHHHHHHHHHHHHHHH-hCCcEeccCCCCcEEEcCCC-cEEEeec
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGF-GQPG-AIGESMARKYLRDIVSGLMYLH-GHNVVHGDIKPDNLLVAPSG-TVKIGDF  270 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~-~~~~-~l~~~~~~~i~~qi~~gL~yLH-~~~iiHrDlkp~NIll~~~~-~~kl~Df  270 (410)
                      ++  ...+++++|..|+.+...+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ .++++||
T Consensus        92 ~~--~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df  169 (601)
T KOG0590|consen   92 SP--RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADF  169 (601)
T ss_pred             CC--cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCc
Confidence            64  5789999999999998888 5544 7888889999999999999999 99999999999999999999 9999999


Q ss_pred             cccccccC-C--ccccccCCC-cccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhC---
Q 015257          271 SVSQVFED-D--NDVLRRSPG-TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTY-DKIVNN---  342 (410)
Q Consensus       271 G~a~~~~~-~--~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-~~i~~~---  342 (410)
                      |+|..+.. .  .......+| ++.|+|||...+..+..+..|+||.|+++..+++|..|+......+.. ......   
T Consensus       170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~  249 (601)
T KOG0590|consen  170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR  249 (601)
T ss_pred             hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc
Confidence            99987655 2  233445678 999999999888777778899999999999999999999665433322 111111   


Q ss_pred             -CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          343 -SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       343 -~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                       .......++....+++.++|..+|..|.+.+++..+||+..
T Consensus       250 ~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  250 FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence             13344678889999999999999999999999999999998

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=2.4e-20  Score=195.55  Aligned_cols=192  Identities=23%  Similarity=0.286  Sum_probs=152.9

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC---CCCcccceeEE
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ---HPNIVNLIEVI  193 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~  193 (410)
                      .+.|.|-+.||+|+||+||+|.... |+.||+|+-.........            -=.+++.+|+   -+.|+.+...+
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfY------------I~~q~~~RLk~~~~~~~~~~~~a~  763 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFY------------ICLQVMERLKPQMLPSIMHISSAH  763 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeee------------ehHHHHHhhchhhhcchHHHHHHH
Confidence            3579999999999999999999886 999999986554332221            1123334443   23455555444


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC-------CCcEE
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-------SGTVK  266 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~-------~~~~k  266 (410)
                      .-  .+..++|+||.+.|+|.+++...+.++|..+..+..||++.|+.||..+|||+||||+|+||..       ..-++
T Consensus       764 ~~--~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  764 VF--QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             cc--CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceE
Confidence            33  2356899999999999999998899999999999999999999999999999999999999953       23589


Q ss_pred             Eeecccccccc--CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCC
Q 015257          267 IGDFSVSQVFE--DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQ  324 (410)
Q Consensus       267 l~DfG~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~  324 (410)
                      |+|||.+-.+.  .+.......++|-.+-.+|...+..+ +..+|.|.|+.+++.||.|+
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpW-tYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPW-TYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCC-chhhhhHHHHHHHHHHHHHH
Confidence            99999986542  22345667788999999998888888 67899999999999999985

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=3.2e-19  Score=161.13  Aligned_cols=143  Identities=22%  Similarity=0.306  Sum_probs=112.5

Q ss_pred             eeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEE
Q 015257          123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFY  202 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~  202 (410)
                      ++.||+|++|.||++..  .|..++||+......... ..........+.+|+.++..+.|++|+....++.+.  ...+
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~   75 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHP-ELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP--ENFI   75 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcCh-HHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC--CCCE
Confidence            35799999999999986  677899997653221100 000111234678999999999999998777776553  4578


Q ss_pred             EEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       203 lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      +||||++|.++.+.+....   . ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||.+..
T Consensus        76 lv~e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         76 IVMEYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999999887765432   2 7788999999999999999999999999999999 88999999999875

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=8.7e-21  Score=183.64  Aligned_cols=176  Identities=24%  Similarity=0.393  Sum_probs=138.2

Q ss_pred             CEEEEEEeecCCCCcccccCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPG---AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~---~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      .++||.|++|....|.+++..+.   ..+......++.|++.|++|   +|.+|||+||.||++..+..+||.|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            46899999999999999986543   46778899999999999999   9999999999999999999999999999876


Q ss_pred             ccCCc------cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCC--C
Q 015257          276 FEDDN------DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLV--F  346 (410)
Q Consensus       276 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~--~  346 (410)
                      .....      ...+...||..||+||++.+..+ +.++||||||++|+||++ -..+|...   .....+..+.++  +
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y-~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~g~ip~~~  481 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY-SEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRDGIIPPEF  481 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhhh-hhhcchhhHHHHHHHHHHHhccHHHHH---HhhhhhhcCCCChHH
Confidence            55433      13345679999999999998887 677999999999999997 22333211   122233333322  1


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCccc
Q 015257          347 PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL  382 (410)
Q Consensus       347 p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~  382 (410)
                      ... .++-..|+.+||...|.+||++.+..-|+|.+
T Consensus       482 ~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  482 LQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             hhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence            112 34557899999999999999999988888864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=5.1e-19  Score=158.37  Aligned_cols=146  Identities=21%  Similarity=0.226  Sum_probs=109.1

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCC-------------ChHHHHHHHHHHHHHHhCCCCC-
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAP-------------SETAMTDVRREVLIMKMLQHPN-  185 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~-------------~~~~~~~~~~E~~~l~~l~hpn-  185 (410)
                      |.+.+.||+|+||.||++... +|+.||||++............             .......+..|+.++..+.|++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            777899999999999999875 7999999997653211000000             0011124678999999998874 


Q ss_pred             -cccceeEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCc
Q 015257          186 -IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT  264 (410)
Q Consensus       186 -iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~  264 (410)
                       ++..++.      ...++||||++|.++......      .....++.+++.++.++|+.||+||||||+||+++.++.
T Consensus        96 ~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~  163 (198)
T cd05144          96 PVPKPIDW------NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK  163 (198)
T ss_pred             CCCceeec------CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence             3333331      235899999999887654321      345678899999999999999999999999999999999


Q ss_pred             EEEeeccccccccC
Q 015257          265 VKIGDFSVSQVFED  278 (410)
Q Consensus       265 ~kl~DfG~a~~~~~  278 (410)
                      ++|+|||++.....
T Consensus       164 ~~liDfg~~~~~~~  177 (198)
T cd05144         164 IYIIDWPQMVSTDH  177 (198)
T ss_pred             EEEEECCccccCCC
Confidence            99999999965443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=7.6e-19  Score=173.06  Aligned_cols=198  Identities=23%  Similarity=0.364  Sum_probs=154.4

Q ss_pred             HHhCCCCCcccceeEEEcCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCc-EeccCCCC
Q 015257          178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNV-VHGDIKPD  255 (410)
Q Consensus       178 l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~i-iHrDlkp~  255 (410)
                      |+.+.|.|+.+++|.+.+.  ..+++|.+||..|++.+.+.. ...+++.....++++|+.||.|||...| .|+.+++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence            4568999999999999874  689999999999999998877 4578888899999999999999998877 99999999


Q ss_pred             cEEEcCCCcEEEeeccccccccCCc--cccccCCCcccccccccccCCcC------CCchhhHHHHHHHHHHHHhCCCCC
Q 015257          256 NLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTY------GGKAADTWAVGVTLYYMIIGQYPF  327 (410)
Q Consensus       256 NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwSlG~il~elltG~~Pf  327 (410)
                      |.+++....+||+|||+........  .......-..-|.|||.+.....      .+.+.||||||++++|+++...||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            9999999999999999987664310  00111112345999998765311      356799999999999999999999


Q ss_pred             CCCC----HHHHHHHHHh-CCCCC-CC-----CCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          328 LGET----LQDTYDKIVN-NSLVF-PD-----AMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       328 ~~~~----~~~~~~~i~~-~~~~~-p~-----~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ....    ..+....+.+ +...+ |.     ..++++..++..||..+|.+||+++++-.
T Consensus       159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            6632    2234444444 22211 21     34567999999999999999999988753

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=1.4e-18  Score=155.53  Aligned_cols=138  Identities=22%  Similarity=0.283  Sum_probs=105.2

Q ss_pred             eecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEEE
Q 015257          125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMV  204 (410)
Q Consensus       125 ~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv  204 (410)
                      .||+|+||.||++.  .+|..+++|+........ ..........++.+|+.++..+.|+++....-++.+.  ...++|
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv   75 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRH-PELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP--DNKTIV   75 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcC-chHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC--CCCEEE
Confidence            48999999999998  467889999865321100 0000112345788999999999998766555444432  346899


Q ss_pred             EeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          205 LEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       205 ~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      |||++|+++.+.+.....       .++.|++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus        76 ~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        76 MEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999988776543221       7889999999999999999999999999999 89999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=4.9e-18  Score=174.39  Aligned_cols=144  Identities=19%  Similarity=0.233  Sum_probs=109.5

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      .|...+.||+|+||.||++...  +..+++|+........ .........+++.+|+.+++.++|++++....++.+.  
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--  408 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRH-PELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP--  408 (535)
T ss_pred             ccCccceeccCCcEEEEEEeec--CccceeEEEecccccc-hhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--
Confidence            3456789999999999997764  4445555433211100 0001112345788999999999999998877766653  


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ...++||||++|+++.+.+.        ....++.|++.+|.|||+.|++||||||+|||+ .++.++|+|||+++..
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            35689999999998877653        457789999999999999999999999999999 5889999999999753

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.75  E-value=1.1e-17  Score=148.17  Aligned_cols=146  Identities=21%  Similarity=0.217  Sum_probs=100.0

Q ss_pred             eeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCC---------------hHHHHHHHHHHHHHHhCCCCC--
Q 015257          123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPS---------------ETAMTDVRREVLIMKMLQHPN--  185 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~---------------~~~~~~~~~E~~~l~~l~hpn--  185 (410)
                      .+.||+|+||.||++.+. +|+.||||++.............               .........|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999887 89999999986542111000000               000011245666676665543  


Q ss_pred             cccceeEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCcEEEcCCCc
Q 015257          186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGT  264 (410)
Q Consensus       186 iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIll~~~~~  264 (410)
                      +.+++++      ...++||||++++.+........... ..+..++.+++.++.++|. .||+|+||||+||+++ ++.
T Consensus        81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CCceEec------CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence            3344432      13589999999854332111111111 6678899999999999999 9999999999999999 999


Q ss_pred             EEEeecccccccc
Q 015257          265 VKIGDFSVSQVFE  277 (410)
Q Consensus       265 ~kl~DfG~a~~~~  277 (410)
                      ++|+|||.+....
T Consensus       153 ~~liDfg~a~~~~  165 (187)
T cd05119         153 VYIIDVPQAVEID  165 (187)
T ss_pred             EEEEECccccccc
Confidence            9999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.73  E-value=3.5e-17  Score=150.47  Aligned_cols=145  Identities=19%  Similarity=0.284  Sum_probs=106.2

Q ss_pred             eeec-ccCceEEEEEEEccCCceEEEEeeecccc-ccc---ccCCChHHHHHHHHHHHHHHhCCCCCc--ccceeEEEcC
Q 015257          124 RKIG-AGSYGKVVLYRSSLDGKHYAIKAFHKSHL-SKL---RVAPSETAMTDVRREVLIMKMLQHPNI--VNLIEVIDDP  196 (410)
Q Consensus       124 ~~lG-~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-~~~---~~~~~~~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~~  196 (410)
                      ..|| .||.|+||.+...  +..++||.+....+ .++   ...........+.+|+.++..+.|++|  +..+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4577 8888888877664  78899999864322 010   001112344578899999999999885  6667664432


Q ss_pred             CCC--EEEEEEeecCC-CCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          197 NSD--HFYMVLEYVEG-KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       197 ~~~--~~~lv~e~~~~-~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      ...  ..++|||+++| .++.+.+.. ..+++..    +.||+.+|.+||+.||+||||||.|||++.++.++|+|||.+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence            221  23599999997 577666544 3455543    578999999999999999999999999999999999999998


Q ss_pred             cc
Q 015257          274 QV  275 (410)
Q Consensus       274 ~~  275 (410)
                      ..
T Consensus       190 ~~  191 (239)
T PRK01723        190 EL  191 (239)
T ss_pred             cc
Confidence            75

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.68  E-value=9.2e-18  Score=173.54  Aligned_cols=278  Identities=23%  Similarity=0.309  Sum_probs=215.7

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...+.+.+.+-+-+|+++.++.+.-..+|...++|+........      ....+..+.+-.++-...+|-++...--+ 
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~------~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-  873 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIR------TNDYESIRSKSNILITPRSPAVVRSFPSF-  873 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhc------cccccccCCccCccccCCCCceecccCCC-
Confidence            35677888899999999999999988888888888765432111      11122333343444334456665444332 


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                       +.....++|++|.+++.+...+...+..++.-++.++..+..+++|||...+.|+|++|.|+|...+|..++.|||...
T Consensus       874 -~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  874 -PCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLS  952 (1205)
T ss_pred             -CCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccc
Confidence             2345789999999999888888888888888899999999999999999999999999999999999999999998322


Q ss_pred             cccC------C-------------------------ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhC
Q 015257          275 VFED------D-------------------------NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIG  323 (410)
Q Consensus       275 ~~~~------~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG  323 (410)
                      ....      .                         ........||+.|.+||...+... ...+|.|++|+++++.++|
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcC
Confidence            1100      0                         001223458999999999888776 5569999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhCCCCCCC---CCCHHHHHHHHHhcccCCCCCCCHH---HHhhCCcccCC-CCCCchhhhhhh
Q 015257          324 QYPFLGETLQDTYDKIVNNSLVFPD---AMNPELRNLLEGLLCKDPTRRLTLN---DVAKHTWVLGD-NGPIPQYLCWCK  396 (410)
Q Consensus       324 ~~Pf~~~~~~~~~~~i~~~~~~~p~---~~~~~l~~li~~~L~~dp~~Rpt~~---ell~h~~~~~~-~~~~~~~~~~~~  396 (410)
                      .+||.....++.++.|.+....+|.   ..++.+.+++..+|..+|.+|..+.   ++-.|+||++. ++.+.--.||..
T Consensus      1032 ~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~~~~~ 1111 (1205)
T KOG0606|consen 1032 IPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQKAEFV 1111 (1205)
T ss_pred             CCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccccccCccC
Confidence            9999999999999999988877664   6889999999999999999999998   99999999964 566666666665


Q ss_pred             ccccc
Q 015257          397 RDRLR  401 (410)
Q Consensus       397 ~~~~~  401 (410)
                      .....
T Consensus      1112 p~~~s 1116 (1205)
T KOG0606|consen 1112 PQPES 1116 (1205)
T ss_pred             CCCCC
Confidence            55544

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=6.2e-16  Score=130.90  Aligned_cols=132  Identities=21%  Similarity=0.346  Sum_probs=109.7

Q ss_pred             eeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCC--CCcccceeEEEcCCCC
Q 015257          122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH--PNIVNLIEVIDDPNSD  199 (410)
Q Consensus       122 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~  199 (410)
                      +++.||+|.++.||++....  ..+++|.+....        .   ...+.+|+.+++.+.|  .++++++.+...  .+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~--------~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~   66 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSRE--------K---GADREREVAILQLLARKGLPVPKVLASGES--DG   66 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCC--------c---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CC
Confidence            46789999999999998753  789999875431        0   3468899999999987  488888887765  35


Q ss_pred             EEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          200 HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH---NVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      ..+++|||++|..+...       +......++.+++.+|++||..   +++|+|++|+||+++..+.++++|||.+..
T Consensus        67 ~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          67 WSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            78999999998766644       5667778899999999999985   699999999999999889999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=5e-17  Score=160.39  Aligned_cols=254  Identities=23%  Similarity=0.302  Sum_probs=189.8

Q ss_pred             cceeeeeeecc--cCceEEEEEEE--ccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeE
Q 015257          118 NEYVHVRKIGA--GSYGKVVLYRS--SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEV  192 (410)
Q Consensus       118 ~~y~~~~~lG~--G~fg~Vy~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~  192 (410)
                      ..+.+...+|.  |.+|.||....  ..++..+|+|.-+....       .......=.+|+...+.+ .|+|.++.+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-------~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~  186 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-------PPLDSKRKLREFLSHHKIDSHENPVRDSPA  186 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-------CccccccccchhhcccccCccccccccCcc
Confidence            45777889999  99999999998  88999999997432211       001111223566666666 49999998888


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCcEeccCCCCcEEEcCC-CcEEE
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS----GLMYLHGHNVVHGDIKPDNLLVAPS-GTVKI  267 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~----gL~yLH~~~iiHrDlkp~NIll~~~-~~~kl  267 (410)
                      |.+  ++..++-+|++...+..........+++..++..+.+...    ||..+|+.+++|-|+||.||++..+ ...++
T Consensus       187 ~e~--~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  187 WEG--SGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             ccc--CCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeec
Confidence            876  6789999999985444433334445899999999999999    9999999999999999999999999 88999


Q ss_pred             eeccccccccCCcc-----ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q 015257          268 GDFSVSQVFEDDND-----VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN  342 (410)
Q Consensus       268 ~DfG~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~  342 (410)
                      +|||+...+.....     ...+..|...|++||...+..  +.+.||||||.++.+..+|..+....... .|..+...
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~~r~~  341 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNS-SWSQLRQG  341 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCC-Cccccccc
Confidence            99999887665432     223446788899999876654  57799999999999999886655332111 11112111


Q ss_pred             C--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          343 S--LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       343 ~--~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                      .  ..+-...+.++..++..|++.+|..|++++.++.|+++..
T Consensus       342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            1  1223355677788999999999999999999999999863

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.54  E-value=2.5e-14  Score=142.72  Aligned_cols=151  Identities=20%  Similarity=0.236  Sum_probs=100.9

Q ss_pred             eeeecccCceEEEEEEEccCCceEEEEeeeccccccccc----------------C-----CCh----HHHH------HH
Q 015257          123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV----------------A-----PSE----TAMT------DV  171 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~----------------~-----~~~----~~~~------~~  171 (410)
                      .+.||+|++|.||+|+.. +|+.||||+..+.....+..                .     ...    +...      .+
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            468999999999999875 79999999986542111000                0     000    0011      24


Q ss_pred             HHHHHHHHhCC----CCCcccceeEEEcCCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHH-HHHHHHhC
Q 015257          172 RREVLIMKMLQ----HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVS-GLMYLHGH  245 (410)
Q Consensus       172 ~~E~~~l~~l~----hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~-gL~yLH~~  245 (410)
                      .+|...+.++.    |.+-+.+-.++.+- ....+|||||++|..+.+..... ...   ....++.+++. .+..+|..
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC
Confidence            55666666553    33333433444332 23469999999999887754321 112   23446666665 47889999


Q ss_pred             CcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       246 ~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      |++|+|++|.||+++.+|.++++|||++..+..
T Consensus       277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            999999999999999999999999999976643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.52  E-value=2.3e-13  Score=120.19  Aligned_cols=148  Identities=17%  Similarity=0.128  Sum_probs=104.2

Q ss_pred             eeeecccCceEEEEEEEcc------CCceEEEEeeeccccc--cc--------ccC--C-ChHHHHH----HHHHHHHHH
Q 015257          123 VRKIGAGSYGKVVLYRSSL------DGKHYAIKAFHKSHLS--KL--------RVA--P-SETAMTD----VRREVLIMK  179 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~------~~~~vaiK~~~~~~~~--~~--------~~~--~-~~~~~~~----~~~E~~~l~  179 (410)
                      ...||.|--+.||.+....      .+..+|||+.......  +.        +..  . ..+....    ..+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999998654      3579999998644211  00        000  0 0112222    348999999


Q ss_pred             hCCC--CCcccceeEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeccCCCCc
Q 015257          180 MLQH--PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL-HGHNVVHGDIKPDN  256 (410)
Q Consensus       180 ~l~h--pniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yL-H~~~iiHrDlkp~N  256 (410)
                      ++..  -++.+++.+.      .-+|||||+++..+.........+++..+..++.|++.+|..| |..||+|+||++.|
T Consensus        82 rl~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N  155 (197)
T cd05146          82 RMQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN  155 (197)
T ss_pred             HHHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            9964  3555666542      2489999998754322222223456667778889999999999 89999999999999


Q ss_pred             EEEcCCCcEEEeecccccccc
Q 015257          257 LLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       257 Ill~~~~~~kl~DfG~a~~~~  277 (410)
                      ||++ ++.+.|+|||.+....
T Consensus       156 IL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         156 MLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEEE-CCcEEEEECCCceeCC
Confidence            9997 5789999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=1.6e-15  Score=139.13  Aligned_cols=262  Identities=19%  Similarity=0.224  Sum_probs=168.0

Q ss_pred             EEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC---CCCEEEEEEeecCC
Q 015257          134 VVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP---NSDHFYMVLEYVEG  210 (410)
Q Consensus       134 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---~~~~~~lv~e~~~~  210 (410)
                      ||++-++..|..|+--.+.....+.     -...-+..+.-+.-|-.+.|.|||+++.||.+.   +.....++.|||..
T Consensus        82 v~lamd~e~g~evvwneVq~~~rK~-----~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymss  156 (458)
T KOG1266|consen   82 VYLAMDTEEGVEVVWNEVQFSERKN-----PKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSS  156 (458)
T ss_pred             HHHHhhhccCchhhHHHHHHHHhcC-----hhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccc
Confidence            5666666666655544333221111     011112233344556677899999999999763   23457889999999


Q ss_pred             CCcccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhC--CcEeccCCCCcEEEcCCCcEEEeecccccccc----CCc
Q 015257          211 KWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGH--NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE----DDN  280 (410)
Q Consensus       211 ~~l~~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~--~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~----~~~  280 (410)
                      +++..++++    ...+.....++++.||+.||.|||+.  .|+|+++..+-|++..+|.+||.----.....    ...
T Consensus       157 gs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~  236 (458)
T KOG1266|consen  157 GSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTRE  236 (458)
T ss_pred             hhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhH
Confidence            888877654    34688888899999999999999986  59999999999999999999985221111000    000


Q ss_pred             cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 015257          281 DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYP-FLGETLQDTYDKIVNNSLVFPDAMNPELRNLLE  359 (410)
Q Consensus       281 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~P-f~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~  359 (410)
                      .......+-++|.|||.=..... +.++|||+||....+|..|..- -.+......-..+....+..   -+..-++++.
T Consensus       237 ~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~l---en~lqr~~i~  312 (458)
T KOG1266|consen  237 AEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGL---ENGLQRGSIT  312 (458)
T ss_pred             hhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeec---cCccccCcCc
Confidence            11122346788999996444333 4469999999999999887643 22222222222222211111   1222356899


Q ss_pred             HhcccCCCCCCCHHHHhhCCcccC-CCCCCchhhhhhhcccccccc
Q 015257          360 GLLCKDPTRRLTLNDVAKHTWVLG-DNGPIPQYLCWCKRDRLRRDN  404 (410)
Q Consensus       360 ~~L~~dp~~Rpt~~ell~h~~~~~-~~~~~~~~~~~~~~~~~~~~~  404 (410)
                      +||+..|..||++++++.||-+.. ...++.-.-|-...+..++|=
T Consensus       313 kcl~~eP~~rp~ar~llfHpllfeVhslkll~ahclv~~~~~~~m~  358 (458)
T KOG1266|consen  313 KCLEGEPNGRPDARLLLFHPLLFEVHSLKLLMAHCLVLEDQMHRML  358 (458)
T ss_pred             ccccCCCCCCcchhhhhcCceeeecchHHHHhhHheeccHHhhhhc
Confidence            999999999999999999998764 344444455555544454443

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.51  E-value=4.7e-14  Score=142.56  Aligned_cols=155  Identities=17%  Similarity=0.269  Sum_probs=102.2

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccc----------------------cCC---ChHHHH
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR----------------------VAP---SETAMT  169 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~----------------------~~~---~~~~~~  169 (410)
                      ..+.+|.. +.||+|++|.||.|+.+.+|+.||||++.+.....+.                      ...   -.+..+
T Consensus       117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~  195 (537)
T PRK04750        117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK  195 (537)
T ss_pred             HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence            34456776 8999999999999999888999999999765311100                      000   001222


Q ss_pred             H------HHHHHHHHHhCC----CCCcccceeEEEcCCCCEEEEEEeecCCCCcccc--cCCCC----CCCHHHHHHHHH
Q 015257          170 D------VRREVLIMKMLQ----HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG--FGQPG----AIGESMARKYLR  233 (410)
Q Consensus       170 ~------~~~E~~~l~~l~----hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~--~~~~~----~l~~~~~~~i~~  233 (410)
                      .      +.+|+..+.++.    +.+.+.+-.++.+- ....+|||||+.|+.+.+.  +...+    .+.+..+..++.
T Consensus       196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~  274 (537)
T PRK04750        196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT  274 (537)
T ss_pred             HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence            2      334444444442    44444444555442 3457899999999887653  22222    244445555555


Q ss_pred             HHHHHHHHHHhCCcEeccCCCCcEEEcCCC----cEEEeeccccccccC
Q 015257          234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSG----TVKIGDFSVSQVFED  278 (410)
Q Consensus       234 qi~~gL~yLH~~~iiHrDlkp~NIll~~~~----~~kl~DfG~a~~~~~  278 (410)
                      ||+       ..|++|+|++|.||+++.+|    .++++|||++..+..
T Consensus       275 Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 QVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            554       58999999999999999988    999999999876543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.50  E-value=1.6e-13  Score=119.24  Aligned_cols=128  Identities=18%  Similarity=0.230  Sum_probs=96.0

Q ss_pred             eeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcc-cceeEEEcCCCCEE
Q 015257          123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIV-NLIEVIDDPNSDHF  201 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~~  201 (410)
                      ++.|+.|.++.||++...  +..|++|+.....          .....+..|+.+++.+.+.+++ +++.+. .   ...
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~----------~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-~---~~~   66 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGT----------ELLINRENEAENSKLAAEAGIGPKLYYFD-P---ETG   66 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCc----------ccccCHHHHHHHHHHHHHhCCCCceEEEe-C---CCC
Confidence            678999999999988864  7889999864321          0112457899999988766655 444433 2   134


Q ss_pred             EEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----EeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          202 YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNV-----VHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       202 ~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i-----iHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      ++||||++|..+...        ......++.+++.+|+.||..++     +|+|++|.||+++ ++.++++|||.+..
T Consensus        67 ~lv~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          67 VLITEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             eEEEEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            799999999876543        11123467899999999999885     9999999999999 77899999999863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.47  E-value=2.7e-14  Score=141.18  Aligned_cols=255  Identities=20%  Similarity=0.176  Sum_probs=185.5

Q ss_pred             ccccceeeeeeecccCceEEEEEEEc-cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSS-LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEV  192 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~  192 (410)
                      ....+|..+..||.|.|+.|+.+... .++..|++|.+.+.....       ..-..-..|+.+...+ .|.+++.+...
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~-------~~di~sl~ev~l~~~l~~~~~~~g~~~~  334 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF-------ASDIFSLGEVILEAILGSHLPSVGKNSS  334 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccch-------HhhhcchhhhhHhhHhhcccccCCCCCC
Confidence            34467899999999999999887755 578899999876543211       1112234566666555 58999998877


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC-CcEEEeecc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-GTVKIGDFS  271 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~-~~~kl~DfG  271 (410)
                      |..  ..+.||-.|||.+++......-...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||
T Consensus       335 W~~--~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~  412 (524)
T KOG0601|consen  335 WSQ--LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFG  412 (524)
T ss_pred             ccc--cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccc
Confidence            765  34678999999988877766555568888999999999999999999999999999999999976 788999999


Q ss_pred             ccccccCCccccccCCCccccc-ccccccCCcCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhCCCCCCCC
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFT-APECCLGLTYGGKAADTWAVGVTLYYMIIGQYP-FLGETLQDTYDKIVNNSLVFPDA  349 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DiwSlG~il~elltG~~P-f~~~~~~~~~~~i~~~~~~~p~~  349 (410)
                      .+..+.-...   ....+-.+. .+|++........+.|++|||..+.+.++|..- ..+    ..+..+..+.......
T Consensus       413 ~~t~~~~~~~---~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~----~~~~~i~~~~~p~~~~  485 (524)
T KOG0601|consen  413 CWTRLAFSSG---VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG----VQSLTIRSGDTPNLPG  485 (524)
T ss_pred             cccccceecc---cccccccccccchhhccccccccccccccccccccccccCcccCccc----ccceeeecccccCCCc
Confidence            9864221111   112223344 355554444445669999999999999998643 222    2233444454444444


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      ...++..+.+.++..++..||++.++..|+=|....
T Consensus       486 ~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~  521 (524)
T KOG0601|consen  486 LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDS  521 (524)
T ss_pred             hHHhhhhhhhhhcCCccccchhhhhhcccchhhhhc
Confidence            458888999999999999999999999987765443

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.36  E-value=8.1e-12  Score=125.04  Aligned_cols=167  Identities=23%  Similarity=0.357  Sum_probs=122.7

Q ss_pred             EEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEEEEeecCCCCccccc
Q 015257          138 RSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF  217 (410)
Q Consensus       138 ~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~  217 (410)
                      ..+.++.++.|..++...         ......+.+-+..|+.++||||+++++.+..  .+.+|||+|.+..  +...+
T Consensus        32 t~k~~~~~vsVF~~~~~~---------~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV~P--l~~~l   98 (690)
T KOG1243|consen   32 TRKADGGPVSVFVYKRSN---------GEVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERVRP--LETVL   98 (690)
T ss_pred             ceeccCCceEEEEEeCCC---------chhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeecccc--HHHHH
Confidence            445578888888775431         1344567788999999999999999999876  4589999998743  12112


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccccccCCCcccccccc
Q 015257          218 GQPGAIGESMARKYLRDIVSGLMYLH-GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE  296 (410)
Q Consensus       218 ~~~~~l~~~~~~~i~~qi~~gL~yLH-~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE  296 (410)
                      .+   ++...+...+.||+.||.+|| +.+++|++|.-+.|+++..|..||++|-++..............--..|..|+
T Consensus        99 k~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~  175 (690)
T KOG1243|consen   99 KE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPE  175 (690)
T ss_pred             HH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChh
Confidence            21   336667778899999999998 56799999999999999999999999998865443332111122223467777


Q ss_pred             cccCCcCCCchhhHHHHHHHHHHHHhC
Q 015257          297 CCLGLTYGGKAADTWAVGVTLYYMIIG  323 (410)
Q Consensus       297 ~~~~~~~~~~~~DiwSlG~il~elltG  323 (410)
                      .+....   -..|.|-|||++++++.|
T Consensus       176 ~~~~s~---~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  176 EIDPSE---WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             hcCccc---cchhhhhHHHHHHHHhCc
Confidence            543322   247999999999999998

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.29  E-value=4.5e-11  Score=108.27  Aligned_cols=143  Identities=22%  Similarity=0.395  Sum_probs=108.3

Q ss_pred             eeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCC--cccceeEEEcCC-CC
Q 015257          123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN--IVNLIEVIDDPN-SD  199 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~-~~  199 (410)
                      ++.||.|..+.||++... +|+.|++|+......        ......+..|+.+++.+.+.+  +.+++.+..... .+
T Consensus         3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~--------~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~   73 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGAL--------LPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG   73 (223)
T ss_pred             ceecCCCccceEEEEEec-CCcceEEEeCCCccc--------CcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence            467999999999998864 368899998654321        012346789999999997644  566776654321 12


Q ss_pred             EEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 015257          200 HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-----------------------------------  244 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-----------------------------------  244 (410)
                      ..++||||++|..+...+.. ..+++.....++.+++.+|..||+                                   
T Consensus        74 ~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (223)
T cd05154          74 TPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTD  152 (223)
T ss_pred             CceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccc
Confidence            56899999999887776543 457888888889999999999984                                   


Q ss_pred             ---------------------CCcEeccCCCCcEEEcC--CCcEEEeecccccc
Q 015257          245 ---------------------HNVVHGDIKPDNLLVAP--SGTVKIGDFSVSQV  275 (410)
Q Consensus       245 ---------------------~~iiHrDlkp~NIll~~--~~~~kl~DfG~a~~  275 (410)
                                           ..++|+|+.|.|||++.  ++.+.|+||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         153 EPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             ccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                 23699999999999998  56789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.29  E-value=1.2e-10  Score=113.57  Aligned_cols=214  Identities=19%  Similarity=0.222  Sum_probs=155.1

Q ss_pred             CceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC--CCCEEEEEEee
Q 015257          130 SYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP--NSDHFYMVLEY  207 (410)
Q Consensus       130 ~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~~~lv~e~  207 (410)
                      --.+.|++....+|..|++|+++.......         .....-+++++++.|+|||++.++|...  ..-.+++|++|
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---------nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDY  358 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---------NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDY  358 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCc---------ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEec
Confidence            346789999999999999999865432211         0122457789999999999999988731  23478999999


Q ss_pred             cCCC-Ccccc---------------cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          208 VEGK-WDNDG---------------FGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       208 ~~~~-~l~~~---------------~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      .++. +|.+.               ..++...+|..+|.|+.|+..||.++|+.|+..+-|.|.+||++.+-+++|+..|
T Consensus       359 yP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~  438 (655)
T KOG3741|consen  359 YPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCG  438 (655)
T ss_pred             CCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEeccc
Confidence            9863 33322               1233467899999999999999999999999999999999999988789998888


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHH-HHHHHhCCCCCCCC
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG-ETLQDT-YDKIVNNSLVFPDA  349 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~-~~~~~~-~~~i~~~~~~~p~~  349 (410)
                      +......+.            .+|  +..    -.+-|.=-||.+++.|.||..--.. ...... ...       +-..
T Consensus       439 i~Dvl~~d~------------~~~--le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~-------I~~~  493 (655)
T KOG3741|consen  439 IMDVLQEDP------------TEP--LES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR-------ITTT  493 (655)
T ss_pred             ceeeecCCC------------Ccc--hhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH-------hhhh
Confidence            776554332            011  222    2357999999999999999643211 111111 122       2346


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ++.+++++|.-+...++.+ -++.+++.+
T Consensus       494 yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  494 YSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             hhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            7889999999999888886 777777754

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=4.3e-11  Score=102.63  Aligned_cols=139  Identities=22%  Similarity=0.287  Sum_probs=98.0

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYM  203 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l  203 (410)
                      ..+++|+-+.+|.+..  -|..+++|.=.+... ..+.-...-...+-.+|+.++.++.--.|...+=+..++  ....|
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~Y-R~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~--~~~~I   76 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRY-RHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP--DNGLI   76 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCccc-CChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC--CCCEE
Confidence            3578999999987633  355677775322210 100001122334567899999998766665555445453  35689


Q ss_pred             EEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          204 VLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       204 v~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      +|||++|..+.+.+...       ...++..+=.-+.-||..||+|+||.++||++..+ .+.++|||++..
T Consensus        77 ~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~  140 (204)
T COG3642          77 VMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF  140 (204)
T ss_pred             EEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence            99999999888776655       24566777788899999999999999999999844 499999999974

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.19  E-value=6.2e-12  Score=126.31  Aligned_cols=159  Identities=25%  Similarity=0.386  Sum_probs=117.3

Q ss_pred             HHHHHHHHHHHhC-CcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc-c--------ccCCCcccccccccccCCc
Q 015257          233 RDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV-L--------RRSPGTPVFTAPECCLGLT  302 (410)
Q Consensus       233 ~qi~~gL~yLH~~-~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~--------~~~~gt~~y~aPE~~~~~~  302 (410)
                      .+++.||.|+|.. ++||+.|.|++|.++.+|.+||+.|+++......... .        .-..-...|.|||++....
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            3455999999965 7999999999999999999999999987654432211 0        0111345699999887744


Q ss_pred             CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh-----CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 015257          303 YGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVN-----NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVA  376 (410)
Q Consensus       303 ~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~-----~~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell  376 (410)
                       .+.++|+|||||++|.+.. |+.-+........+ .+..     +...++..+++++++=+.++|..++..||++..++
T Consensus       186 -~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  186 -NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             -ccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence             4677999999999999984 55544333222221 1111     22345568899999999999999999999999999


Q ss_pred             hCCcccCCCCCCchhhh
Q 015257          377 KHTWVLGDNGPIPQYLC  393 (410)
Q Consensus       377 ~h~~~~~~~~~~~~~~~  393 (410)
                      ..|||++...+...+|.
T Consensus       264 ~~~ff~D~~~~aLrfLD  280 (700)
T KOG2137|consen  264 SIPFFSDPGLKALRFLD  280 (700)
T ss_pred             cccccCCchhhhhhhcc
Confidence            99999997665555543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.17  E-value=2.4e-10  Score=100.62  Aligned_cols=134  Identities=22%  Similarity=0.244  Sum_probs=83.2

Q ss_pred             EEEEEEccCCceEEEEeeeccccc--c--------cc-------cCCChHHHHHHHHHHHHHHhCCCC--CcccceeEEE
Q 015257          134 VVLYRSSLDGKHYAIKAFHKSHLS--K--------LR-------VAPSETAMTDVRREVLIMKMLQHP--NIVNLIEVID  194 (410)
Q Consensus       134 Vy~~~~~~~~~~vaiK~~~~~~~~--~--------~~-------~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~  194 (410)
                      ||.+... +|..+|||+......+  .        .+       ............+|...|.++..-  ++.+++.+-.
T Consensus         2 Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~   80 (188)
T PF01163_consen    2 VYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR   80 (188)
T ss_dssp             EEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred             EEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence            7777764 5779999997654210  0        00       111122334678999999999876  4556665431


Q ss_pred             cCCCCEEEEEEeecC--CCCcccccCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          195 DPNSDHFYMVLEYVE--GKWDNDGFGQPGAIGESMARKYLRDIVSGLMY-LHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~--~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~y-LH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                            -+|||||++  |..+..+....  ++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|||
T Consensus        81 ------~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~  151 (188)
T PF01163_consen   81 ------NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFG  151 (188)
T ss_dssp             ------TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred             ------CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecC
Confidence                  279999998  54444322211  2234566778888886555 679999999999999999966 99999999


Q ss_pred             cccccc
Q 015257          272 VSQVFE  277 (410)
Q Consensus       272 ~a~~~~  277 (410)
                      .+....
T Consensus       152 qav~~~  157 (188)
T PF01163_consen  152 QAVDSS  157 (188)
T ss_dssp             TEEETT
T ss_pred             cceecC
Confidence            886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.13  E-value=3.8e-10  Score=96.49  Aligned_cols=147  Identities=18%  Similarity=0.249  Sum_probs=103.1

Q ss_pred             eeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCC--ChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCC
Q 015257          122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAP--SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       122 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  199 (410)
                      .+..|-+|+-+.|+.+.  ..|+.+.||.-...   +.+.+.  ..-...+..+|+..|.++.--.|.-..-++.+...+
T Consensus        11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K---~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~   85 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSK---RYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGG   85 (229)
T ss_pred             cceeeeccceeeEeeec--cCCceeEEeecccc---cccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCC
Confidence            57789999999886554  56898899863221   111111  122335678999999999766666555556554433


Q ss_pred             EEEEEEeecCC-CCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCc---EEEeecccc
Q 015257          200 HFYMVLEYVEG-KWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT---VKIGDFSVS  273 (410)
Q Consensus       200 ~~~lv~e~~~~-~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~---~kl~DfG~a  273 (410)
                        .|+|||++| ..+.+++...  ......-...++.+|-..+.-||.++|||+||..+||++.++|.   +.++|||++
T Consensus        86 --~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls  163 (229)
T KOG3087|consen   86 --QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS  163 (229)
T ss_pred             --eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence              688999988 3444444322  12223333688899999999999999999999999999987763   589999998


Q ss_pred             cc
Q 015257          274 QV  275 (410)
Q Consensus       274 ~~  275 (410)
                      ..
T Consensus       164 ~~  165 (229)
T KOG3087|consen  164 SV  165 (229)
T ss_pred             hc
Confidence            64

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.01  E-value=3.6e-09  Score=96.16  Aligned_cols=145  Identities=21%  Similarity=0.221  Sum_probs=103.4

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCC-----------C--hHHHHHHHHHHHHHHhCCCC--
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAP-----------S--ETAMTDVRREVLIMKMLQHP--  184 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~-----------~--~~~~~~~~~E~~~l~~l~hp--  184 (410)
                      +.+...||-|--|.||.+.+. .|.++|||.-.....+-.+...           +  ......+.+|.++|..|.-.  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            345578999999999999877 6889999974332211111111           1  12334578999999999755  


Q ss_pred             CcccceeEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCc
Q 015257          185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT  264 (410)
Q Consensus       185 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~  264 (410)
                      .+.+.+++-      .-.+||||++|-.|...-     +.......++..|+.-+.-+-..||||+|+++-|||++.+|.
T Consensus       172 ~VP~P~~~n------RHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~  240 (304)
T COG0478         172 KVPKPIAWN------RHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD  240 (304)
T ss_pred             CCCCccccc------cceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence            677777642      358999999997665432     133445556666666666666899999999999999999999


Q ss_pred             EEEeeccccccc
Q 015257          265 VKIGDFSVSQVF  276 (410)
Q Consensus       265 ~kl~DfG~a~~~  276 (410)
                      +.++||-.+...
T Consensus       241 ~~vIDwPQ~v~~  252 (304)
T COG0478         241 IVVIDWPQAVPI  252 (304)
T ss_pred             EEEEeCcccccC
Confidence            999999887543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.00  E-value=4e-09  Score=98.31  Aligned_cols=136  Identities=13%  Similarity=0.165  Sum_probs=92.3

Q ss_pred             ccCCceEEEEeeeccccccc-c-cCCChHHHHHHHHHHHHHHhCCCCCcc--cceeEEEcCC---CCEEEEEEeecCCC-
Q 015257          140 SLDGKHYAIKAFHKSHLSKL-R-VAPSETAMTDVRREVLIMKMLQHPNIV--NLIEVIDDPN---SDHFYMVLEYVEGK-  211 (410)
Q Consensus       140 ~~~~~~vaiK~~~~~~~~~~-~-~~~~~~~~~~~~~E~~~l~~l~hpniv--~l~~~~~~~~---~~~~~lv~e~~~~~-  211 (410)
                      ...|+.|.||.......... + ...-......+.+|...+..|..-+|.  .++.+.....   ...-++|||++++. 
T Consensus        42 ~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~  121 (268)
T PRK15123         42 ELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTI  121 (268)
T ss_pred             EECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCc
Confidence            34677899997643321100 0 000001112477899888888544443  4445543211   23578999999985 


Q ss_pred             CcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC-------CCcEEEeecccccc
Q 015257          212 WDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-------SGTVKIGDFSVSQV  275 (410)
Q Consensus       212 ~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~-------~~~~kl~DfG~a~~  275 (410)
                      ++.+++..  ....++.....++.+++..+.-||..||+|+|+++.|||++.       ++.+.|+||+.+..
T Consensus       122 sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        122 SLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             cHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            66666542  234567788899999999999999999999999999999985       46799999998853

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.98  E-value=1.3e-08  Score=97.34  Aligned_cols=236  Identities=18%  Similarity=0.243  Sum_probs=150.7

Q ss_pred             eeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHH-HhCCCCCccc----ceeEEEcCC
Q 015257          123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM-KMLQHPNIVN----LIEVIDDPN  197 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~----l~~~~~~~~  197 (410)
                      .+.||+|+-+.+|-.-...+   .+-|+++....         ....   +-+..| +.-.||-+-.    -......++
T Consensus        16 gr~LgqGgea~ly~l~e~~d---~VAKIYh~Ppp---------a~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~   80 (637)
T COG4248          16 GRPLGQGGEADLYTLGEVRD---QVAKIYHAPPP---------AAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGR   80 (637)
T ss_pred             CccccCCccceeeecchhhc---hhheeecCCCc---------hHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCC
Confidence            57899999999976543322   35677764321         1111   112223 3335664322    111112222


Q ss_pred             -CCEEEEEEeecCCCC-ccccc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEee
Q 015257          198 -SDHFYMVLEYVEGKW-DNDGF------GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGD  269 (410)
Q Consensus       198 -~~~~~lv~e~~~~~~-l~~~~------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~D  269 (410)
                       +.-.-++|+.++|.. ...++      ..-....|....+.++.++.+.+.||..|..-+|+.++|+|+++++.|.|.|
T Consensus        81 ~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVd  160 (637)
T COG4248          81 RGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVD  160 (637)
T ss_pred             ccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEc
Confidence             233678888887742 11211      1223467889999999999999999999999999999999999999999998


Q ss_pred             ccccccccCCccccccCCCcccccccccccCCc----CCCchhhHHHHHHHHHHHHhC-CCCCCCCCHH----HHHH-HH
Q 015257          270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT----YGGKAADTWAVGVTLYYMIIG-QYPFLGETLQ----DTYD-KI  339 (410)
Q Consensus       270 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlG~il~elltG-~~Pf~~~~~~----~~~~-~i  339 (410)
                      -..-... ..........|.+.|.+||.-.-..    ..+...|-|.||++++++|.| +.||.+-...    ..++ .|
T Consensus       161 sDsfqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I  239 (637)
T COG4248         161 SDSFQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI  239 (637)
T ss_pred             ccceeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence            7655443 2233445567999999999533111    114468999999999999986 9999763211    1111 22


Q ss_pred             HhCC-----------CCCC-----CCCCHHHHHHHHHhccc--CCCCCCCHHH
Q 015257          340 VNNS-----------LVFP-----DAMNPELRNLLEGLLCK--DPTRRLTLND  374 (410)
Q Consensus       340 ~~~~-----------~~~p-----~~~~~~l~~li~~~L~~--dp~~Rpt~~e  374 (410)
                      ..+.           .+.|     ..+++++..|..+|+..  ++.-|||++.
T Consensus       240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            2221           1111     24678999999999864  4678999854

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.93  E-value=3.2e-08  Score=89.14  Aligned_cols=146  Identities=22%  Similarity=0.247  Sum_probs=101.6

Q ss_pred             eeeecccCceEEEEEEEccCCceEEEEeeecccccccc----------cC---CCh-HHH-HHHHHHHHHHHhCC--CCC
Q 015257          123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR----------VA---PSE-TAM-TDVRREVLIMKMLQ--HPN  185 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~----------~~---~~~-~~~-~~~~~E~~~l~~l~--hpn  185 (410)
                      ...|.+|--+.||+|.. .++..+|||++........+          ..   .+. ... .=...|+..|+++.  +-.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            44788899999998876 46889999998765321110          00   010 111 11357888888885  445


Q ss_pred             cccceeEEEcCCCCEEEEEEeecCCC-CcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCcEEEcCCC
Q 015257          186 IVNLIEVIDDPNSDHFYMVLEYVEGK-WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSG  263 (410)
Q Consensus       186 iv~l~~~~~~~~~~~~~lv~e~~~~~-~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIll~~~~  263 (410)
                      +.+.+.+..      -.|||||++.. .-...+..- ++...++..+..++++.+.-|-. .++||+||+.=|||+. ++
T Consensus       132 vP~Pi~~~~------nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~  203 (268)
T COG1718         132 VPEPIAFRN------NVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG  203 (268)
T ss_pred             CCCceeecC------CeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC
Confidence            566666653      37999999754 222223322 33344788888999999988876 8999999999999999 99


Q ss_pred             cEEEeecccccccc
Q 015257          264 TVKIGDFSVSQVFE  277 (410)
Q Consensus       264 ~~kl~DfG~a~~~~  277 (410)
                      .+.|+|||.|....
T Consensus       204 ~p~iID~~QaV~~~  217 (268)
T COG1718         204 EPYIIDVSQAVTID  217 (268)
T ss_pred             eEEEEECccccccC
Confidence            99999999987544

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.87  E-value=1.8e-08  Score=90.69  Aligned_cols=132  Identities=23%  Similarity=0.304  Sum_probs=93.9

Q ss_pred             cCCceEEEEeeecccccc-cccCCChHHHHHHHHHHHHHHhCCCCCc--ccceeEEEcCC--CCEEEEEEeecCCC-Ccc
Q 015257          141 LDGKHYAIKAFHKSHLSK-LRVAPSETAMTDVRREVLIMKMLQHPNI--VNLIEVIDDPN--SDHFYMVLEYVEGK-WDN  214 (410)
Q Consensus       141 ~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~~~--~~~~~lv~e~~~~~-~l~  214 (410)
                      ..++.|-+|.+....... ...   .-......+|...+..|..-.|  .+.+.+.....  ....++|+|++++. ++.
T Consensus        30 ~~~~~y~~k~~~~~~~~~~~~~---~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~  106 (206)
T PF06293_consen   30 LVGRRYYRKRLWNKLRRDRLRF---PLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLR  106 (206)
T ss_pred             ccceEEEECCeechhccchhhh---cccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHH
Confidence            356677777654322111 000   0123467788888887754433  45555554321  13568999999874 677


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC---cEEEeecccccc
Q 015257          215 DGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---TVKIGDFSVSQV  275 (410)
Q Consensus       215 ~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~---~~kl~DfG~a~~  275 (410)
                      +.+.....++......++.+++..+.-||+.||+|+|+++.|||++.++   .+.++||+.++.
T Consensus       107 ~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  107 DLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            7776644477788889999999999999999999999999999999887   899999998865

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.81  E-value=8.4e-08  Score=85.57  Aligned_cols=148  Identities=21%  Similarity=0.261  Sum_probs=92.0

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeeccccccccc---CCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV---APSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ..+|.+++.+-......|  +.-..+|+.+++|..........+.   ....+...++...+..+....-..+..++-+.
T Consensus        30 ~~~~~~~kv~k~~~r~~V--alIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYV--ALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEE--EEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            457888999988888888  5556678999999865432110000   00001112222223333332333333333222


Q ss_pred             EcC---CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeec
Q 015257          194 DDP---NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       194 ~~~---~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                      ...   -....+|||||++|..+.+...    +++    .+...|+.++.-||+.|+.|+|+.|.|++++. +.++++||
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~i~iID~  178 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NGIRIIDT  178 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-CcEEEEEC
Confidence            211   1235678999999987766532    333    24466778899999999999999999999994 55999999


Q ss_pred             ccccc
Q 015257          271 SVSQV  275 (410)
Q Consensus       271 G~a~~  275 (410)
                      +..+.
T Consensus       179 ~~k~~  183 (229)
T PF06176_consen  179 QGKRM  183 (229)
T ss_pred             ccccc
Confidence            87653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.72  E-value=2e-07  Score=82.88  Aligned_cols=145  Identities=17%  Similarity=0.231  Sum_probs=101.5

Q ss_pred             ecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCC--cccce--eEEEcCCCCEE
Q 015257          126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN--IVNLI--EVIDDPNSDHF  201 (410)
Q Consensus       126 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~--~~~~~~~~~~~  201 (410)
                      -|+||-+.|+....  .|..|=+|............+   .....|.+|+..+..|..-+  +.+++  +.-..+....-
T Consensus        26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P---~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA  100 (216)
T PRK09902         26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYP---FGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRA  100 (216)
T ss_pred             cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCC---CCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEE
Confidence            46688888976543  355788898653322222211   13346889999988886433  33444  11122333457


Q ss_pred             EEEEeecCC-CCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCc--EEEeecccccc
Q 015257          202 YMVLEYVEG-KWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT--VKIGDFSVSQV  275 (410)
Q Consensus       202 ~lv~e~~~~-~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~--~kl~DfG~a~~  275 (410)
                      +||+|-++| .+|.+.+...  .+.++.....++.+++..+.-||+.|+.|+|+-+.|||++.+|.  ++++||.-++.
T Consensus       101 ~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        101 LLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            899998875 4566555442  35677888899999999999999999999999999999987777  99999987754

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.68  E-value=5.7e-09  Score=104.32  Aligned_cols=255  Identities=19%  Similarity=0.137  Sum_probs=176.5

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCC-cccceeEEEcCCC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN-IVNLIEVIDDPNS  198 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~  198 (410)
                      |....-+++|+++.+++.+...+...+ .+.+...              ....-++++|.+++||| .+..++-++  ..
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------------l~~rl~~eLLdK~n~P~~~v~~~~d~~--~E  306 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------------LSRRLAIELLDKVNNPNPVVRYLEDYD--GE  306 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------------hhhHHHHHHHHHccCCCCcccccccCC--cc
Confidence            455667899999999988877665554 6665322              34567889999999999 455554443  35


Q ss_pred             CEEEEEEeecCCC--CcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          199 DHFYMVLEYVEGK--WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       199 ~~~~lv~e~~~~~--~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ...+++|+++.++  .........-.+.+-+...+.+.-+++++|||+..=+|+|    ||+.. ++..+..||+....+
T Consensus       307 ~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L  381 (829)
T KOG0576|consen  307 DYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQL  381 (829)
T ss_pred             cccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCccc
Confidence            6889999999876  2222222222344445556667777899999988778999    77776 588999999998766


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCC-----C
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAM-----N  351 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~-----~  351 (410)
                      .... ..++..+|+.++|||+.....+ ....|+|++|+--.++.-|.+|-...-  .....+ ......|...     +
T Consensus       382 ~~~~-~~~t~~~~~~~~~pev~~~~~~-~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~-g~~p~s~~L~~~~aw~  456 (829)
T KOG0576|consen  382 TRTM-KPRTAIGTPEPLAPEVIQENTI-DGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMI-GNGPNSPMLTDKSAWS  456 (829)
T ss_pred             Cccc-ccccCCCCCCCCCchhhccccc-ccCCCccCCCcchhhcCCCCCCCCCCc--cccCCC-CCCCCccccchhhhcC
Confidence            5543 4566789999999998877766 345899999987777777776653310  000000 0000011111     1


Q ss_pred             HHHH-HHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCchhhhhhhccccc
Q 015257          352 PELR-NLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLR  401 (410)
Q Consensus       352 ~~l~-~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~~~~~~~~~~~  401 (410)
                      +... ++...|+..-|..|+....++.|.+|-+.+..+.-.-.|..+.|.+
T Consensus       457 ~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i~~aaswIhp~t~d  507 (829)
T KOG0576|consen  457 PVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLRIHCAASWIHPSTRD  507 (829)
T ss_pred             cccccCCcccccCCCCCCCcchhhHHHHHHhccCcccceecccccCcchhh
Confidence            1111 3677899999999999999999999999999998888888777654

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.67  E-value=6.3e-08  Score=97.43  Aligned_cols=179  Identities=21%  Similarity=0.203  Sum_probs=103.9

Q ss_pred             cCCccccccccccccccccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeeccccccc---------------c
Q 015257           96 QFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKL---------------R  160 (410)
Q Consensus        96 ~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~---------------~  160 (410)
                      .+|..+..+..+.+....-+.+-....-+.||..+.|.||+|+.+. |+.||||+.++.-...+               .
T Consensus       139 p~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k  217 (538)
T KOG1235|consen  139 PFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQK  217 (538)
T ss_pred             CCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHH
Confidence            3444445555555444433333233334789999999999999886 99999999776521100               0


Q ss_pred             cCCC-------hHHHHH------HHHHHHH----HHhCCCCC---cccceeEEEcCCCCEEEEEEeecCCCCcccccC-C
Q 015257          161 VAPS-------ETAMTD------VRREVLI----MKMLQHPN---IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-Q  219 (410)
Q Consensus       161 ~~~~-------~~~~~~------~~~E~~~----l~~l~hpn---iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~  219 (410)
                      ..+.       .+..+.      |.+|.+.    .+.+.|-+   -|.+=.++.+- ....+|+||||+|..+.+.-. .
T Consensus       218 ~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~-st~RVLtME~~~G~~i~Dl~~i~  296 (538)
T KOG1235|consen  218 FFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL-STKRVLTMEYVDGIKINDLDAID  296 (538)
T ss_pred             hCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc-CcceEEEEEecCCccCCCHHHHH
Confidence            0000       011111      2333333    33344555   22233444442 346899999999987766522 1


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC----CCcEEEeeccccccccC
Q 015257          220 PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP----SGTVKIGDFSVSQVFED  278 (410)
Q Consensus       220 ~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~----~~~~kl~DfG~a~~~~~  278 (410)
                      ...++...+..-+.++..  .-+=..|++|.|-.|.||++..    ++.+.+.|||+......
T Consensus       297 ~~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  297 KRGISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HcCCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            223444443333322222  1122468999999999999994    56899999999876544

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.59  E-value=5.9e-07  Score=81.70  Aligned_cols=140  Identities=21%  Similarity=0.375  Sum_probs=81.5

Q ss_pred             eeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCC--cccceeEEEcC-CCC
Q 015257          123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN--IVNLIEVIDDP-NSD  199 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~-~~~  199 (410)
                      ++.|+.|..+.||++....  ..+++|....           ......+.+|..+++.+....  +.+++...... ...
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~-----------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~   68 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRP-----------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNG   68 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESS-----------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETS
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCC-----------CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccc
Confidence            5789999999999888764  5899998532           134567889999988886443  45666543322 234


Q ss_pred             EEEEEEeecCCCCcccc----------------cC-------CCCCCCHHH---H---HHH---------------HHHH
Q 015257          200 HFYMVLEYVEGKWDNDG----------------FG-------QPGAIGESM---A---RKY---------------LRDI  235 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~----------------~~-------~~~~l~~~~---~---~~i---------------~~qi  235 (410)
                      ..+++|++++|..+...                +.       ....+....   .   ...               ...+
T Consensus        69 ~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (239)
T PF01636_consen   69 FPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEEL  148 (239)
T ss_dssp             EEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHH
T ss_pred             cceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHH
Confidence            57999999998765550                00       001111100   0   000               0111


Q ss_pred             HH-HHHHHHh-------CCcEeccCCCCcEEEc-CCCcEEEeecccccc
Q 015257          236 VS-GLMYLHG-------HNVVHGDIKPDNLLVA-PSGTVKIGDFSVSQV  275 (410)
Q Consensus       236 ~~-gL~yLH~-------~~iiHrDlkp~NIll~-~~~~~kl~DfG~a~~  275 (410)
                      .. .+..+++       ..++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  149 EERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            11 2333331       3599999999999999 566678999998753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.58  E-value=8.1e-07  Score=81.02  Aligned_cols=130  Identities=16%  Similarity=0.221  Sum_probs=82.0

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCc--ccceeEEEcCCCCEE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNI--VNLIEVIDDPNSDHF  201 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~~~~~~~  201 (410)
                      ..||+|..+.||+.    .|..+++|......           ....+.+|.++++.+..-.+  .+.+.+..+  .+..
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~   69 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----------DKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRL   69 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----------CHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCee
Confidence            57899999999873    25568899764321           22356889999999865444  566666654  3457


Q ss_pred             EEEEeecCCCC-cccccCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 015257          202 YMVLEYVEGKW-DNDGFGQPGAIGESMARKYLRDIVSGLMYLHG------------------------------------  244 (410)
Q Consensus       202 ~lv~e~~~~~~-l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~------------------------------------  244 (410)
                      .+|||+++|.. +.....    .+......++.+++..+.-||+                                    
T Consensus        70 glv~e~i~G~~~~~~~~~----~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~  145 (226)
T TIGR02172        70 GLIYELIVGKRSFSRIIS----DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAF  145 (226)
T ss_pred             eeeeeecCCccchhhhhc----CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHH
Confidence            88999999963 111110    0111111112222222222221                                    


Q ss_pred             -------CCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          245 -------HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       245 -------~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                             ..++|+|+.|.||+++.++ +.|+||+.+..
T Consensus       146 l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       146 IKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             HHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence                   2468999999999999888 99999998853

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.55  E-value=5.8e-07  Score=95.74  Aligned_cols=210  Identities=18%  Similarity=0.160  Sum_probs=144.9

Q ss_pred             HHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCC--EEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 015257          166 TAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD--HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH  243 (410)
Q Consensus       166 ~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH  243 (410)
                      ........|...+..+.|+|++.++.+-......  .+.+..+++.+..+...+..-+.++..+.+.+..+++.||.|+|
T Consensus       224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence            3445566788889999999999999887653211  12334567788788888888888999999999999999999999


Q ss_pred             hCCcEeccCCCC---cEEEcCCCcEEEe--eccccccccCCccccccCCCcccccccccccCCcCC-CchhhHHHHHHHH
Q 015257          244 GHNVVHGDIKPD---NLLVAPSGTVKIG--DFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYG-GKAADTWAVGVTL  317 (410)
Q Consensus       244 ~~~iiHrDlkp~---NIll~~~~~~kl~--DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~DiwSlG~il  317 (410)
                      +....|.-|..+   +.-.+..+.+.++  ||+.++...+.... ....-+..+.|||........ ....|+|.+|..+
T Consensus       304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             HhccceeEEecccccccccCccceeecchhhhcccccCCCcccc-hhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence            986555544444   3344455667777  99988766554322 222235567788865443321 2347999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          318 YYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       318 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      ..+..|..+-....   ....+      .+........+++.+|+..++++|+++.+++.|+|..-..
T Consensus       383 ~~~~~~~~i~~~~~---~~~~~------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~  441 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSA---VPVSL------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT  441 (1351)
T ss_pred             hhhhhcCccccccc---chhhh------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence            99988765422111   11111      1111222678889999999999999999999999997653

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.54  E-value=3.3e-07  Score=92.62  Aligned_cols=150  Identities=19%  Similarity=0.181  Sum_probs=93.7

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccc----------------cC-----CCh----HHHH------HHH
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR----------------VA-----PSE----TAMT------DVR  172 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~----------------~~-----~~~----~~~~------~~~  172 (410)
                      ..|+.++-|.||.|+... |+.||||+..+.....+.                ..     .-.    +..+      .+.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            689999999999999875 999999998766321100                00     001    1111      244


Q ss_pred             HHHHHHHhCC----CCCcccceeEEEcCCCCEEEEEEeecCCCCccccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 015257          173 REVLIMKMLQ----HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVSGLMYLHGHN  246 (410)
Q Consensus       173 ~E~~~l~~l~----hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~l~~~~~~~i~~qi~~gL~yLH~~~  246 (410)
                      +|...+.+++    ...-+.+=.++.+- ....+|+|||++|..+.+..  .. ..++...+.....++  -+..+=..|
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dg  285 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhc-cCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcC
Confidence            5666666553    22223333444432 24579999999998777663  22 334432222221111  122222379


Q ss_pred             cEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          247 VVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       247 iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ++|.|..|.||+++.+|.+.+.|||+...+..
T Consensus       286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            99999999999999999999999998866543

>PLN02876 acyl-CoA dehydrogenase

Probab=98.43  E-value=4.9e-06  Score=90.04  Aligned_cols=84  Identities=21%  Similarity=0.398  Sum_probs=57.3

Q ss_pred             eeeeecccCceEEEEEEEccCC--ceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCc--ccceeEEEcC
Q 015257          122 HVRKIGAGSYGKVVLYRSSLDG--KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNI--VNLIEVIDDP  196 (410)
Q Consensus       122 ~~~~lG~G~fg~Vy~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpni--v~l~~~~~~~  196 (410)
                      .++.|+.|.+..+|++.....+  ..+++|+......        ......+.+|+.+|+.+. |+++  .+++.++.++
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~--------~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~  113 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL--------LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA  113 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc--------CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC
Confidence            3688999999999998765432  4678886432210        112246789999999996 6665  6777777653


Q ss_pred             C-CCEEEEEEeecCCCCc
Q 015257          197 N-SDHFYMVLEYVEGKWD  213 (410)
Q Consensus       197 ~-~~~~~lv~e~~~~~~l  213 (410)
                      . .+..|+||||++|..+
T Consensus       114 ~v~G~~flVME~v~G~~~  131 (822)
T PLN02876        114 SVIGTAFYIMEYLEGRIF  131 (822)
T ss_pred             CcCCCceEEEEecCCccc
Confidence            1 2357899999998653

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.30  E-value=6.7e-06  Score=75.49  Aligned_cols=76  Identities=12%  Similarity=0.164  Sum_probs=46.3

Q ss_pred             eeeecccCce-EEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCC---CcccceeEEEcCCC
Q 015257          123 VRKIGAGSYG-KVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP---NIVNLIEVIDDPNS  198 (410)
Q Consensus       123 ~~~lG~G~fg-~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~~~~~  198 (410)
                      ++.|+.|+.. .||++     +..+++|....           ......+.+|..++..+...   -+.++++....++.
T Consensus         2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~-----------~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~   65 (235)
T cd05155           2 IEPVDSGGTDNATFRL-----GDDMSVRLPSA-----------AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEG   65 (235)
T ss_pred             ceeccCCCcccceEEc-----CCceEEEcCCc-----------cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccC
Confidence            4568877777 48875     23578886432           11234788999999888632   23344443322211


Q ss_pred             -CEEEEEEeecCCCCcc
Q 015257          199 -DHFYMVLEYVEGKWDN  214 (410)
Q Consensus       199 -~~~~lv~e~~~~~~l~  214 (410)
                       ...+++|++++|..+.
T Consensus        66 ~~~~~~l~~~i~G~~l~   82 (235)
T cd05155          66 YPWPWSVYRWLEGETAT   82 (235)
T ss_pred             CCcceEEEEeecCCCCC
Confidence             2458899999996654

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.30  E-value=1.3e-05  Score=70.82  Aligned_cols=136  Identities=21%  Similarity=0.229  Sum_probs=92.8

Q ss_pred             cceeeeeeecccCc-eEEEEEEEccCCceEEEEeeecccccccc-----cCCC-------hHHHHHHHHHHHHHHhCC--
Q 015257          118 NEYVHVRKIGAGSY-GKVVLYRSSLDGKHYAIKAFHKSHLSKLR-----VAPS-------ETAMTDVRREVLIMKMLQ--  182 (410)
Q Consensus       118 ~~y~~~~~lG~G~f-g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-----~~~~-------~~~~~~~~~E~~~l~~l~--  182 (410)
                      .+++.++.||.|.- |.||+++..  |+.||+|++.........     ....       .....-|..|.....+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            57889999999999 999877654  889999993322111100     0000       123345778888877664  


Q ss_pred             -CCCc--ccceeEEEcC----------------CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 015257          183 -HPNI--VNLIEVIDDP----------------NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH  243 (410)
Q Consensus       183 -hpni--v~l~~~~~~~----------------~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH  243 (410)
                       +.++  |+++|+..-.                ......||.||++...         .+.    ..-+.+|++-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence             5566  8999987422                1124578888876542         222    234567888899999


Q ss_pred             hCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       244 ~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      ..||+-+|+++.|..     .-||+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc-----CCEEEecccC
Confidence            999999999999976     3489999864

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.20  E-value=1.3e-07  Score=102.42  Aligned_cols=268  Identities=13%  Similarity=-0.013  Sum_probs=170.9

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  199 (410)
                      +++.--+|-|.++.--..+.+.++  +-+|+.+...+...    .+...+-...|.+-++...|++++....-.......
T Consensus      1231 ~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~L----sePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1231 SEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENL----SEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred             hheeeecccceeeccchHhhhhce--eEEEeehhhhHHHH----hhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence            444444555555433222222222  45555543332221    122333445666667778999998887666555566


Q ss_pred             EEEEEEeecCCCCcccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhC-C----cEeccCCCCcEEEcCCCcEEEeec
Q 015257          200 HFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGH-N----VVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~-~----iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                      ..+++++|+.+|.+...+.+    ...+.+..+.....+.+.+..-.|.+ +    .+|+++|+.|.+|..+..+|++++
T Consensus      1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred             HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence            78999999998877766543    33455555555555557777776654 1    689999999999999999999999


Q ss_pred             cccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCC
Q 015257          271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFPD  348 (410)
Q Consensus       271 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~  348 (410)
                      |+.+.............+++.|++|++...-.+ +.++|+|+.|+.+|+..-|..+|...... ....++.+.  ..++.
T Consensus      1385 gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~-t~rsdilr~s~~ly~rs~~n~~fi~flq~-~Lkgiidn~tf~sIe~ 1462 (2724)
T KOG1826|consen 1385 GLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKF-TKRSDILRRSLSLYLRSDGNAYFIFFLQP-ALKGIIDNHTFFSIEK 1462 (2724)
T ss_pred             ccccccCchHhhhhhhhCCHHHHHHHHHHHHhh-hhHHHHHHHHHHHHHHhcccHHHHHHHHH-HHcCcccccccccccc
Confidence            999955555555666778999999998776666 44599999999999999888777432111 111222211  12333


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC--CCchhhhhh
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG--PIPQYLCWC  395 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~--~~~~~~~~~  395 (410)
                      ..|.++-.....+|-..-..||.-..++.-+.+-....  +-+-++.|+
T Consensus      1463 l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~~~~d~~k~i~~~a~ 1511 (2724)
T KOG1826|consen 1463 LKPGDANVEALHRLLWKYMERPGQYISLSRDHFAVGLRDICKMIYLLAY 1511 (2724)
T ss_pred             cCCCcccHHHHHHHHHHhhhcchhhhhcccccccccccCcchhHHHHHh
Confidence            44445555555556666677898888888887765533  334444444

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.16  E-value=1.6e-05  Score=73.35  Aligned_cols=136  Identities=15%  Similarity=0.126  Sum_probs=79.4

Q ss_pred             eeecccCc-eEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEEEcCCCCEE
Q 015257          124 RKIGAGSY-GKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDPNSDHF  201 (410)
Q Consensus       124 ~~lG~G~f-g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~  201 (410)
                      ..|-.|.. +.||++...  +..+.||+.....            ...+.+|+.+++.+. +--+.+++++....  +.-
T Consensus         4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~   67 (244)
T cd05150           4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------------TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRA   67 (244)
T ss_pred             eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------------ccchHHHHHHHHHHHhcCCCCeEEEEEecC--Ccc
Confidence            34555555 788877543  4678999754221            235678999988884 33345667766542  457


Q ss_pred             EEEEeecCCCCcccccC-------------------C----CCCCCHH--HHH-HH---HH----------------HHH
Q 015257          202 YMVLEYVEGKWDNDGFG-------------------Q----PGAIGES--MAR-KY---LR----------------DIV  236 (410)
Q Consensus       202 ~lv~e~~~~~~l~~~~~-------------------~----~~~l~~~--~~~-~i---~~----------------qi~  236 (410)
                      ++|||+++|..+.....                   .    ...+...  ... ..   +.                .+.
T Consensus        68 ~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (244)
T cd05150          68 WLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAE  147 (244)
T ss_pred             EEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHH
Confidence            89999999875543210                   0    0011100  000 00   00                011


Q ss_pred             HHHHHHH-------hCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          237 SGLMYLH-------GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       237 ~gL~yLH-------~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      ..+..|-       ...++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       148 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         148 ELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            1112221       12489999999999999877788999998753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.12  E-value=1.3e-05  Score=68.77  Aligned_cols=130  Identities=18%  Similarity=0.243  Sum_probs=90.1

Q ss_pred             eeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCE
Q 015257          121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH  200 (410)
Q Consensus       121 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  200 (410)
                      ...+.||+|.+|.||++...  |..+|+|+-..+           +....+..|+++|..+.-.++.+=+-.+..     
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d-----------s~r~~l~kEakiLeil~g~~~~p~vy~yg~-----   86 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD-----------SPRRNLEKEAKILEILAGEGVTPEVYFYGE-----   86 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecCC-----------cchhhHHHHHHHHHHhhhcCCCceEEEech-----
Confidence            45678999999999987765  668999975433           334578999999999987777543333321     


Q ss_pred             EEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCC-CCcEEEcCCCcEEEeecccccc
Q 015257          201 FYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIK-PDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       201 ~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk-p~NIll~~~~~~kl~DfG~a~~  275 (410)
                      -++.|||+.|..|.......   +    ++-+..++..---|-..||-|..|. |..++|..++.+.|+||..|+.
T Consensus        87 ~~i~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          87 DFIRMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            24569999986665432211   1    2333455566444666799999987 5555555566999999999974

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.11  E-value=1.8e-05  Score=69.86  Aligned_cols=98  Identities=22%  Similarity=0.172  Sum_probs=79.1

Q ss_pred             HHHHHHHHhCCC-CCcccceeEEEcCCCCEEEEEEeecCCCCcccc---cCCCCCCCHHHHHHHHHHHHHHHHHHHh---
Q 015257          172 RREVLIMKMLQH-PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG---FGQPGAIGESMARKYLRDIVSGLMYLHG---  244 (410)
Q Consensus       172 ~~E~~~l~~l~h-pniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~---~~~~~~l~~~~~~~i~~qi~~gL~yLH~---  244 (410)
                      ..|.-+++.+.+ +++.+++|+|-      .++|.||.+.+.+...   +.+-...+|..+.+++.++++.+.+|+.   
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~   80 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL   80 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence            368889999987 69999999983      2678899986655321   2222356899999999999999999997   


Q ss_pred             CCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       245 ~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      ..+.-.|++|+|+-++.+|.+|++|...+-.
T Consensus        81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             CcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            3467799999999999999999999997654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK10593 hypothetical protein; Provisional

Probab=98.07  E-value=9.6e-05  Score=70.33  Aligned_cols=80  Identities=14%  Similarity=0.085  Sum_probs=55.4

Q ss_pred             eeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCC---CCcccceeEEEcC-
Q 015257          121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH---PNIVNLIEVIDDP-  196 (410)
Q Consensus       121 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~l~~~~~~~-  196 (410)
                      ..++.||.|..+.||.+...  +..+.+|..+..           .....+..|...|+.+.-   ..+.++++++.+. 
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~-----------~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~   83 (297)
T PRK10593         17 SRVECISEQPYAALWALYDS--QGNPMPLMARSF-----------STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ   83 (297)
T ss_pred             heeeecCCccceeEEEEEcC--CCCEEEEEeccc-----------ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC
Confidence            34678999999999887543  235777874321           012468899999998853   3567888777542 


Q ss_pred             CCCEEEEEEeecCCCCc
Q 015257          197 NSDHFYMVLEYVEGKWD  213 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l  213 (410)
                      ..+..+||||+++|..+
T Consensus        84 ~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         84 SPGPDVLLLERLRGVSV  100 (297)
T ss_pred             cCCCeEEEEeccCCEec
Confidence            23458999999998644

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.03  E-value=8.5e-05  Score=67.98  Aligned_cols=75  Identities=16%  Similarity=0.302  Sum_probs=48.0

Q ss_pred             eeeecccCceEEEEEEEcc-CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcc-cceeEEEcCCCCE
Q 015257          123 VRKIGAGSYGKVVLYRSSL-DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIV-NLIEVIDDPNSDH  200 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~  200 (410)
                      ++.|..|-...||++.... .++.|++|+......          ..-...+|+.+++.+...+++ +++..+.   .  
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----------~~~d~~~E~~~~~~l~~~gl~P~v~~~~~---~--   67 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----------LIIDRERELRIHKLLSKHGLAPKLYATFQ---N--   67 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----------ceecHHHHHHHHHHHHhCCCCCeEEEEeC---C--
Confidence            5678888889999886543 357899997643211          111234788888888644443 4444332   1  


Q ss_pred             EEEEEeecCCCCc
Q 015257          201 FYMVLEYVEGKWD  213 (410)
Q Consensus       201 ~~lv~e~~~~~~l  213 (410)
                       .+||||++|..+
T Consensus        68 -~~l~e~i~G~~l   79 (235)
T cd05157          68 -GLIYEFIPGRTL   79 (235)
T ss_pred             -cEEEEeeCCCcC
Confidence             379999998654

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.00  E-value=5.5e-05  Score=70.34  Aligned_cols=133  Identities=17%  Similarity=0.209  Sum_probs=75.8

Q ss_pred             eecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcc-cceeEEEcCCCCEEEE
Q 015257          125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIV-NLIEVIDDPNSDHFYM  203 (410)
Q Consensus       125 ~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~~~l  203 (410)
                      .+..|-.+.+|++.  .++..+++|.......         ...-...+|..+++.+....++ +++...  .    -++
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---------~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~----~~~   65 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK---------ALGVDRQREYQILQALSALGLAPKPILVN--E----HWL   65 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccc---------cccCcHHHHHHHHHHHHhcCCCCceEEEe--C----CEE
Confidence            35567778888776  4577899997532210         0001246788898888654443 344332  1    268


Q ss_pred             EEeecCCCCccccc-----------------CC----CCCCCH-HHHHHHHHHH---------HHHHHHHHh--------
Q 015257          204 VLEYVEGKWDNDGF-----------------GQ----PGAIGE-SMARKYLRDI---------VSGLMYLHG--------  244 (410)
Q Consensus       204 v~e~~~~~~l~~~~-----------------~~----~~~l~~-~~~~~i~~qi---------~~gL~yLH~--------  244 (410)
                      ||||++|..+....                 ..    ..+++. ..+..+..++         ...+..+-.        
T Consensus        66 v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (256)
T TIGR02721        66 LVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLP  145 (256)
T ss_pred             EEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCC
Confidence            99999986543210                 00    001111 1112222111         111222211        


Q ss_pred             CCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       245 ~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      ..++|+|+.|.||+++.++ +.|+||..|..
T Consensus       146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            2489999999999999877 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.92  E-value=0.00019  Score=68.45  Aligned_cols=148  Identities=22%  Similarity=0.191  Sum_probs=103.4

Q ss_pred             eeeecccCceEEEEEEEccCCceEEEEeeeccccccc---------------ccCCCh-HHHH-HHHHHHHHHHhCCCCC
Q 015257          123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKL---------------RVAPSE-TAMT-DVRREVLIMKMLQHPN  185 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~---------------~~~~~~-~~~~-~~~~E~~~l~~l~hpn  185 (410)
                      -.+|..|--+.||.|... +|..+|||+++...+.-.               .+..+. .-.+ =+..|+..|++++...
T Consensus       149 nGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             ccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            357889999999987755 688899999876543110               001111 1111 2457888899998877


Q ss_pred             cccceeEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcEeccCCCCcEEEcCCCc
Q 015257          186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH-GHNVVHGDIKPDNLLVAPSGT  264 (410)
Q Consensus       186 iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH-~~~iiHrDlkp~NIll~~~~~  264 (410)
                      |.-.--+...    .-+|||+|++......-......++...+..+-.|++.-+.-|- ..++||.||+--|+|+. +|.
T Consensus       228 IP~PePIlLk----~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~  302 (520)
T KOG2270|consen  228 IPCPEPILLK----NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGK  302 (520)
T ss_pred             CCCCCceeee----cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCE
Confidence            6544434432    35899999985433333333456788888888888888888775 45899999999999998 889


Q ss_pred             EEEeeccccccc
Q 015257          265 VKIGDFSVSQVF  276 (410)
Q Consensus       265 ~kl~DfG~a~~~  276 (410)
                      +.|+|.+.+...
T Consensus       303 lyiIDVSQSVE~  314 (520)
T KOG2270|consen  303 LYIIDVSQSVEH  314 (520)
T ss_pred             EEEEEccccccC
Confidence            999999988643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.92  E-value=7.7e-05  Score=70.84  Aligned_cols=139  Identities=16%  Similarity=0.216  Sum_probs=82.2

Q ss_pred             eeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCC--cccceeE-----EE
Q 015257          122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN--IVNLIEV-----ID  194 (410)
Q Consensus       122 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~-----~~  194 (410)
                      -++.|..|....+|++..  ++..+++|+....            ....+..|+.++..+.+.+  +.+++..     +.
T Consensus        18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~   83 (296)
T cd05153          18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEKV------------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLS   83 (296)
T ss_pred             heecccCccccceEEEEe--CCCcEEEEEcCCC------------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEee
Confidence            367788888889998754  3457999986421            1235667888877775433  3444331     11


Q ss_pred             cCCCCEEEEEEeecCCCCcccc------------------cCC-CC------CCCHHHH--H--------HHHHHHHHHH
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDG------------------FGQ-PG------AIGESMA--R--------KYLRDIVSGL  239 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~------------------~~~-~~------~l~~~~~--~--------~i~~qi~~gL  239 (410)
                      . -.+..++|++|++|..+...                  ... ..      ...+...  .        .....+..++
T Consensus        84 ~-~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  162 (296)
T cd05153          84 E-LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADEL  162 (296)
T ss_pred             e-eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHH
Confidence            1 12356899999998654320                  000 00      0000000  0        0111123344


Q ss_pred             HHHHh-------CCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          240 MYLHG-------HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       240 ~yLH~-------~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      .++..       .+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         163 ARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             HHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            45443       4699999999999999877778999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.91  E-value=0.00017  Score=70.92  Aligned_cols=80  Identities=19%  Similarity=0.184  Sum_probs=53.4

Q ss_pred             eeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCC--hHHHHHHHHHHHHHHhCC---CCCcccceeEEEcCC
Q 015257          123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPS--ETAMTDVRREVLIMKMLQ---HPNIVNLIEVIDDPN  197 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~  197 (410)
                      .+.||.|.+..||.+.....++.++||.-....    +....  .-..++...|...|+.+.   -.++.+++.+-    
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~----r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D----  102 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYV----RVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD----  102 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCccc----ccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC----
Confidence            578999999999999986433689999853211    11001  123456778888888763   23566677663    


Q ss_pred             CCEEEEEEeecCC
Q 015257          198 SDHFYMVLEYVEG  210 (410)
Q Consensus       198 ~~~~~lv~e~~~~  210 (410)
                      ....++||||+++
T Consensus       103 ~~~~~lVME~L~~  115 (401)
T PRK09550        103 EELAVTVMEDLSD  115 (401)
T ss_pred             CCCCEEEEecCCC
Confidence            2357899999976

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.80  E-value=0.00022  Score=68.23  Aligned_cols=141  Identities=15%  Similarity=0.214  Sum_probs=80.8

Q ss_pred             eeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCC--cccceeEEE----
Q 015257          121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN--IVNLIEVID----  194 (410)
Q Consensus       121 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~----  194 (410)
                      ..++.++.|.-..||++...  +..+++|+.....           ....+..|+.++..|....  +.+++....    
T Consensus        25 ~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~-----------~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~   91 (307)
T TIGR00938        25 LSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV-----------KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQL   91 (307)
T ss_pred             eeccccCCccccceEEEEeC--CCcEEEEEecCCC-----------CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCee
Confidence            34677888888899987643  4468899764321           1124556677777664322  334433111    


Q ss_pred             cCCCCEEEEEEeecCCCCcccc--------------cC---CC--C------CCC-HHH--HH----------HHHHHHH
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDG--------------FG---QP--G------AIG-ESM--AR----------KYLRDIV  236 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~--------------~~---~~--~------~l~-~~~--~~----------~i~~qi~  236 (410)
                      ....+..+++|+|++|......              +.   ..  .      .++ +..  ..          .....+.
T Consensus        92 ~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~  171 (307)
T TIGR00938        92 STLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELD  171 (307)
T ss_pred             hhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHH
Confidence            0113467899999998543210              00   00  0      000 000  00          0011233


Q ss_pred             HHHHHHHh-------CCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          237 SGLMYLHG-------HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       237 ~gL~yLH~-------~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      ..+++|..       .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       172 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       172 KELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            34555542       579999999999999988877899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.79  E-value=0.00025  Score=68.17  Aligned_cols=31  Identities=26%  Similarity=0.314  Sum_probs=26.3

Q ss_pred             CCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       245 ~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      .++||+|+.|.|||++.+...-|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            3799999999999999665568999998753

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.75  E-value=0.00043  Score=61.57  Aligned_cols=141  Identities=18%  Similarity=0.227  Sum_probs=90.7

Q ss_pred             eeeecccCceEEEEEEEccCCceEEEEeeeccccccccc-------CCChHHHHHHHHHHHHHHhCC------CCCcccc
Q 015257          123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-------APSETAMTDVRREVLIMKMLQ------HPNIVNL  189 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~-------~~~~~~~~~~~~E~~~l~~l~------hpniv~l  189 (410)
                      ...||+|+.=.||  .+.. .....||+...........       ........+..+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy--~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCY--QHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEE--ECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            4579999999995  4443 3457899987664100000       001123456778887777776      7889999


Q ss_pred             eeEEEcCCCCEEEEEEeecCC--C----CcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC
Q 015257          190 IEVIDDPNSDHFYMVLEYVEG--K----WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG  263 (410)
Q Consensus       190 ~~~~~~~~~~~~~lv~e~~~~--~----~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~  263 (410)
                      +|+.+..  ....+|+|.+..  |    +|.+++.. +.+++    .+...+-+-..||-+..|+.+|++|.||++....
T Consensus        83 ~G~veT~--~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~  155 (199)
T PF10707_consen   83 YGFVETN--LGLGLVVELIRDADGNISPTLEDYLKE-GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRD  155 (199)
T ss_pred             eEEEecC--CceEEEEEEEECCCCCcCccHHHHHHc-CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence            9999863  457899998743  2    34444432 34555    2333344556788899999999999999997543


Q ss_pred             ----cEEEee-cccc
Q 015257          264 ----TVKIGD-FSVS  273 (410)
Q Consensus       264 ----~~kl~D-fG~a  273 (410)
                          .+.|+| ||..
T Consensus       156 ~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  156 SGEFRLVLIDGLGEK  170 (199)
T ss_pred             CCceEEEEEeCCCCc
Confidence                466665 3543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.65  E-value=7e-05  Score=70.26  Aligned_cols=142  Identities=18%  Similarity=0.207  Sum_probs=93.1

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCCh---------HH----HHHHHHHHHHHHhCCC--C
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE---------TA----MTDVRREVLIMKMLQH--P  184 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~---------~~----~~~~~~E~~~l~~l~h--p  184 (410)
                      +.+.++||-|--+-||++-+. .|+++++|.-.....+-.......         ..    .-...+|+..|+.|.-  -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            556789999999999987665 688899996433221110000011         11    1135689999999853  2


Q ss_pred             CcccceeEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCc
Q 015257          185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT  264 (410)
Q Consensus       185 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~  264 (410)
                      -+.+.+++.      .-++|||++.|-.+...-.-   ..   +..+...+..-+.-|-.+|+||+|+.--||++..++.
T Consensus       173 pVPkpiD~~------RH~Vvmelv~g~Pl~~v~~v---~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~  240 (465)
T KOG2268|consen  173 PVPKPIDHN------RHCVVMELVDGYPLRQVRHV---ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK  240 (465)
T ss_pred             CCCCccccc------ceeeHHHhhcccceeeeeec---CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence            344555543      34789999988765543211   11   2233344445556677899999999999999999999


Q ss_pred             EEEeeccccc
Q 015257          265 VKIGDFSVSQ  274 (410)
Q Consensus       265 ~kl~DfG~a~  274 (410)
                      ++++||-...
T Consensus       241 i~vIDFPQmv  250 (465)
T KOG2268|consen  241 IVVIDFPQMV  250 (465)
T ss_pred             EEEeechHhh
Confidence            9999998543

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.58  E-value=0.00059  Score=64.99  Aligned_cols=75  Identities=17%  Similarity=0.251  Sum_probs=47.8

Q ss_pred             eeeecccCceEEEEEEEcc------CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcc-cceeEEEc
Q 015257          123 VRKIGAGSYGKVVLYRSSL------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIV-NLIEVIDD  195 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~  195 (410)
                      ++.|..|-...||++....      .++.|++|+.....          .......+|..++..+....+. +++.++..
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----------~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~   72 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----------ELLIDRERELVVFARLSERNLGPKLYGIFPN   72 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----------cceechHHHHHHHHHHHhCCCCCceEEEeCC
Confidence            4567777778898887543      25789999864321          1122456888888888644443 45555431


Q ss_pred             CCCCEEEEEEeecCCCCc
Q 015257          196 PNSDHFYMVLEYVEGKWD  213 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l  213 (410)
                            .+|+||++|..+
T Consensus        73 ------~~v~e~i~G~~l   84 (302)
T cd05156          73 ------GRIEEFIPSRTL   84 (302)
T ss_pred             ------CchhheeCCCcC
Confidence                  358999988654

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.52  E-value=0.002  Score=60.67  Aligned_cols=30  Identities=27%  Similarity=0.596  Sum_probs=25.3

Q ss_pred             CcEeccCCCCcEEEcCCCc-EEEeecccccc
Q 015257          246 NVVHGDIKPDNLLVAPSGT-VKIGDFSVSQV  275 (410)
Q Consensus       246 ~iiHrDlkp~NIll~~~~~-~kl~DfG~a~~  275 (410)
                      .++|+|+.|.|||++.++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            3799999999999997565 56999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.51  E-value=0.00061  Score=65.81  Aligned_cols=78  Identities=14%  Similarity=0.132  Sum_probs=49.5

Q ss_pred             eecccCceEEEEEEEccCCceEEEEeeeccccccccc-C-CChHHHHHHHHHHHHHHhCC--CCC-cccceeEEEcCCCC
Q 015257          125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-A-PSETAMTDVRREVLIMKMLQ--HPN-IVNLIEVIDDPNSD  199 (410)
Q Consensus       125 ~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~-~-~~~~~~~~~~~E~~~l~~l~--hpn-iv~l~~~~~~~~~~  199 (410)
                      .||.|....||++.+...++.++||.-....    +. + .-.-..++...|...|+...  -|. +.+++.+-    ..
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~v----Rv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D----~e   73 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYV----RVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD----TE   73 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHH----hhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc----cc
Confidence            5799999999999975434689999854321    11 1 11233456667888887763  343 44454432    23


Q ss_pred             EEEEEEeecCC
Q 015257          200 HFYMVLEYVEG  210 (410)
Q Consensus       200 ~~~lv~e~~~~  210 (410)
                      ...+|||+++.
T Consensus        74 ~~~~vMEdL~~   84 (370)
T TIGR01767        74 MAVTVMEDLSH   84 (370)
T ss_pred             cceehHhhCcc
Confidence            56799999864

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.47  E-value=0.00033  Score=69.47  Aligned_cols=162  Identities=17%  Similarity=0.202  Sum_probs=101.6

Q ss_pred             HHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcE
Q 015257          169 TDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVV  248 (410)
Q Consensus       169 ~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii  248 (410)
                      ..+.-...+++.+.|+|...++++-.... ....+|||+++. ++.+...... +-..             .++ .+++.
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~-~r~IVV~e~~~~-Sled~~~~~~-l~~~-------------s~~-~~~~~   89 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKH-ERVIVVMEHYTM-SLEDILKTGN-LKDE-------------SLL-AHGVL   89 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCcc-ceEEEEehhhcc-chHHHHHhcc-cchh-------------hhc-ccccc
Confidence            35667788999999999999999876533 458999999864 3444333221 1110             011 12222


Q ss_pred             eccCCCCcEEEcCCCcEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCC
Q 015257          249 HGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL  328 (410)
Q Consensus       249 HrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~  328 (410)
                      |            -+..+++| -++.    .            |  |-      ...+++||||+|.++.++..|...+.
T Consensus        90 ~------------~~~~~~td-~~~t----~------------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~  132 (725)
T KOG1093|consen   90 H------------LNIIYITD-HFLT----K------------Y--PS------PIGPKSDVWSLGFIILELYLGISLEA  132 (725)
T ss_pred             e------------ehhhhccc-cccc----c------------C--CC------CCCcchhhhhHHHHHHHHHHhhHHHH
Confidence            2            12233344 1110    0            0  10      00247999999999999999988776


Q ss_pred             CCCHHHHHHHHHhCCCC------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          329 GETLQDTYDKIVNNSLV------------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       329 ~~~~~~~~~~i~~~~~~------------~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      .....+....+.+-...            +--.++..+..+.++|+-..|..||...++.+++-|..-
T Consensus       133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            66555555544432110            111356677889999999999999999999999988653

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.46  E-value=0.0026  Score=60.58  Aligned_cols=140  Identities=21%  Similarity=0.341  Sum_probs=87.7

Q ss_pred             eeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCc--ccceeEEEcCCCC
Q 015257          122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNI--VNLIEVIDDPNSD  199 (410)
Q Consensus       122 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~~~~~  199 (410)
                      +++.+-.|.--.+|.+..+  ++.+++. ....       ...........+|..+++.+.---+  ...++.+.+..-+
T Consensus        29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~-------~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g   98 (321)
T COG3173          29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPPR-------GDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLG   98 (321)
T ss_pred             eeeeccCCcccceEEEecC--CceEEEe-cCCc-------cccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCC
Confidence            4445534444445544444  7788888 2210       1122344566788888888754222  2334555442223


Q ss_pred             EEEEEEeecCCCCcccccCCCCCCCHHHHHHHHH-HHHHHHHHHHh----------------------------------
Q 015257          200 HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR-DIVSGLMYLHG----------------------------------  244 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~-qi~~gL~yLH~----------------------------------  244 (410)
                      ..+.||+|+.|........     +......++. .+++.|.-||+                                  
T Consensus        99 ~pf~v~~~veGe~~~~~~~-----~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~  173 (321)
T COG3173          99 TPFYVMEWVEGEVVWSALP-----PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKEL  173 (321)
T ss_pred             CceEEEEEecceeccCcCC-----cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhc
Confidence            6799999999864333222     1111133444 77888888886                                  


Q ss_pred             ------------------------CCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          245 ------------------------HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       245 ------------------------~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                                              ..++|+|+.+.||+++.++-+=|.||+++...
T Consensus       174 ~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         174 GGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             cCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                                    35899999999999999988999999999753

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.20  E-value=0.0088  Score=58.93  Aligned_cols=79  Identities=13%  Similarity=0.131  Sum_probs=51.9

Q ss_pred             eeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCC--hHHHHHHHHHHHHHHhCC---CCCcccceeEEEcC
Q 015257          122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPS--ETAMTDVRREVLIMKMLQ---HPNIVNLIEVIDDP  196 (410)
Q Consensus       122 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~  196 (410)
                      ..+.||.|....||++.+.  +..|+||.-.....    ....  .-...+...|...|+.+.   ..++.+++.++.+ 
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r----~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded-  108 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIR----CIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT-  108 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCcccc----CCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC-
Confidence            4788999999999998863  45699997543211    0000  012344556677776664   2467778887753 


Q ss_pred             CCCEEEEEEeecCC
Q 015257          197 NSDHFYMVLEYVEG  210 (410)
Q Consensus       197 ~~~~~~lv~e~~~~  210 (410)
                         ..+++||++++
T Consensus       109 ---~~vlvME~L~~  119 (418)
T PLN02756        109 ---MALIGMRYLEP  119 (418)
T ss_pred             ---CCEEEEeecCC
Confidence               46889999977

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.10  E-value=0.0081  Score=57.30  Aligned_cols=29  Identities=24%  Similarity=0.343  Sum_probs=25.6

Q ss_pred             CCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       245 ~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.08  E-value=0.0018  Score=63.34  Aligned_cols=80  Identities=15%  Similarity=0.184  Sum_probs=53.3

Q ss_pred             eeeecccCceEEEEEEEccCCceEEEEeeecccccccccCC-ChHHHHHHHHHHHHHHhCC--CCC-cccceeEEEcCCC
Q 015257          123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAP-SETAMTDVRREVLIMKMLQ--HPN-IVNLIEVIDDPNS  198 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~--hpn-iv~l~~~~~~~~~  198 (410)
                      ++.||.|.-..||++.+...++.++||.-....    +... -.-..++..-|...|+...  -|. +.+++.+-    .
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~v----Rv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D----~  105 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTA----RISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD----S  105 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhh----ccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC----c
Confidence            678999999999999985445679999854332    1111 1334567778888888764  454 44455442    2


Q ss_pred             CEEEEEEeecCC
Q 015257          199 DHFYMVLEYVEG  210 (410)
Q Consensus       199 ~~~~lv~e~~~~  210 (410)
                      ....+|||+++.
T Consensus       106 e~~~~vMEdL~~  117 (409)
T PRK12396        106 VMNCCVMEDLSD  117 (409)
T ss_pred             HHhhHHHHhCcc
Confidence            356899999864

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.07  E-value=0.005  Score=58.93  Aligned_cols=30  Identities=17%  Similarity=0.247  Sum_probs=27.6

Q ss_pred             CcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       246 ~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      +++|+|+.+.|||++.++.+-|+||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            699999999999999999999999998864

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02236 choline kinase

Probab=97.06  E-value=0.0078  Score=58.51  Aligned_cols=140  Identities=14%  Similarity=0.231  Sum_probs=81.8

Q ss_pred             eeeeeeecccCceEEEEEEEcc----CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcc-cceeEEE
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSL----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIV-NLIEVID  194 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~  194 (410)
                      ...+..|-.|-.-.+|++....    .++.|++|+......         ... .-.+|..+++.+..-++- ++++.+.
T Consensus        38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~---------~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~  107 (344)
T PLN02236         38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE---------LFF-DRDDEIRTFECMSRHGQGPRLLGRFP  107 (344)
T ss_pred             cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC---------eee-chHHHHHHHHHHHHcCCCCceEEEEC
Confidence            3445677668888999886432    346899998654311         111 235788888888655554 5556553


Q ss_pred             cCCCCEEEEEEeecCCCCcccc-----------------cCC---CC---CCCHHHHHHHHHHH----------------
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDG-----------------FGQ---PG---AIGESMARKYLRDI----------------  235 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~-----------------~~~---~~---~l~~~~~~~i~~qi----------------  235 (410)
                      .  +    .|.+|+++..+...                 +..   ..   ......+..++.++                
T Consensus       108 ~--g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~  181 (344)
T PLN02236        108 N--G----RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDS  181 (344)
T ss_pred             C--c----eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHH
Confidence            2  2    58999987654311                 000   00   11122233332221                


Q ss_pred             -HHHHHHH----H----hCCcEeccCCCCcEEEcC-CCcEEEeecccccc
Q 015257          236 -VSGLMYL----H----GHNVVHGDIKPDNLLVAP-SGTVKIGDFSVSQV  275 (410)
Q Consensus       236 -~~gL~yL----H----~~~iiHrDlkp~NIll~~-~~~~kl~DfG~a~~  275 (410)
                       ...+..|    .    ...++|+|+++.|||++. ++.+.|+||..|..
T Consensus       182 l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        182 LEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             1112222    1    225899999999999986 46899999998864

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.97  E-value=0.0061  Score=57.54  Aligned_cols=75  Identities=19%  Similarity=0.247  Sum_probs=45.4

Q ss_pred             eeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC---CCCcccceeEEEcCC
Q 015257          121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ---HPNIVNLIEVIDDPN  197 (410)
Q Consensus       121 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~  197 (410)
                      ...+.|+.|....+|.+.  .+++.|.||+-...            ....+..|..-|+.|.   --.+.+++.+.... 
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~-   84 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD-   84 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S-
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChh------------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec-
Confidence            346789999999998776  66888999986422            2235788998888884   33466777776553 


Q ss_pred             CCEEEEEEeecCCC
Q 015257          198 SDHFYMVLEYVEGK  211 (410)
Q Consensus       198 ~~~~~lv~e~~~~~  211 (410)
                       +.-++||||++.+
T Consensus        85 -~~~fLlle~l~~~   97 (288)
T PF03881_consen   85 -DDAFLLLEFLEMG   97 (288)
T ss_dssp             -SCCEEEEE-----
T ss_pred             -CCceEEEEeecCC
Confidence             2348999999765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.75  E-value=0.0052  Score=55.23  Aligned_cols=30  Identities=33%  Similarity=0.609  Sum_probs=21.5

Q ss_pred             CcEeccCCCCcEEE-cCCCcEEEeecccccc
Q 015257          246 NVVHGDIKPDNLLV-APSGTVKIGDFSVSQV  275 (410)
Q Consensus       246 ~iiHrDlkp~NIll-~~~~~~kl~DfG~a~~  275 (410)
                      .++|.|+.|.|||+ ..++.++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            47999999999999 7889999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.46  E-value=0.04  Score=53.26  Aligned_cols=138  Identities=17%  Similarity=0.217  Sum_probs=79.2

Q ss_pred             eeeeecccCceEEEEEEEccC---CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcc-cceeEEEcCC
Q 015257          122 HVRKIGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIV-NLIEVIDDPN  197 (410)
Q Consensus       122 ~~~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~  197 (410)
                      .++.|..|=...+|++.....   +..|++|+......          ..-.-.+|..+++.+..-++- ++++++.  +
T Consensus        18 ~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~----------~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~   85 (330)
T PLN02421         18 SVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD----------YVIDRERELQAIKYLSAAGFGAKLLGVFG--N   85 (330)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC----------eEechHHHHHHHHHHHhcCCCCceeEEeC--C
Confidence            356666677788888764432   34789997653211          111235788888888765554 5565552  2


Q ss_pred             CCEEEEEEeecCCCCcccc-----------------cCC-C----C-CCCHHHHHHHHHHH-------------------
Q 015257          198 SDHFYMVLEYVEGKWDNDG-----------------FGQ-P----G-AIGESMARKYLRDI-------------------  235 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~-----------------~~~-~----~-~l~~~~~~~i~~qi-------------------  235 (410)
                       +   +|.+|++|..+...                 +.. .    . .-....+..++.++                   
T Consensus        86 -G---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~  161 (330)
T PLN02421         86 -G---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISF  161 (330)
T ss_pred             -c---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCH
Confidence             2   58999987654210                 000 0    0 11122233332222                   


Q ss_pred             ---HHHHHHH----HhC----CcEeccCCCCcEEEcC-CCcEEEeecccccc
Q 015257          236 ---VSGLMYL----HGH----NVVHGDIKPDNLLVAP-SGTVKIGDFSVSQV  275 (410)
Q Consensus       236 ---~~gL~yL----H~~----~iiHrDlkp~NIll~~-~~~~kl~DfG~a~~  275 (410)
                         ..-+..+    ...    -++|.|+-+.|||++. ++.++++||..|..
T Consensus       162 ~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        162 EELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence               1112111    111    2799999999999975 47899999998864

>PRK06148 hypothetical protein; Provisional

Probab=96.35  E-value=0.096  Score=58.26  Aligned_cols=31  Identities=26%  Similarity=0.396  Sum_probs=26.1

Q ss_pred             CCcEeccCCCCcEEEcCCC--cEE-Eeecccccc
Q 015257          245 HNVVHGDIKPDNLLVAPSG--TVK-IGDFSVSQV  275 (410)
Q Consensus       245 ~~iiHrDlkp~NIll~~~~--~~k-l~DfG~a~~  275 (410)
                      .++||.|+.+.|||++.++  .+. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4799999999999999875  555 999997753

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=96.24  E-value=0.054  Score=51.26  Aligned_cols=29  Identities=31%  Similarity=0.557  Sum_probs=24.7

Q ss_pred             cEeccCCCCcEEEcCC--C---cEEEeecccccc
Q 015257          247 VVHGDIKPDNLLVAPS--G---TVKIGDFSVSQV  275 (410)
Q Consensus       247 iiHrDlkp~NIll~~~--~---~~kl~DfG~a~~  275 (410)
                      ++|||++++|||+..+  |   .+++.||.+++.
T Consensus       217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~  250 (294)
T PF02958_consen  217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY  250 (294)
T ss_pred             EEcCccCHHhEeEccccccccccceeeccccccC
Confidence            8999999999999765  3   589999998763

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.14  E-value=0.083  Score=50.86  Aligned_cols=135  Identities=16%  Similarity=0.256  Sum_probs=78.4

Q ss_pred             eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC---CCCccc---cee----EE
Q 015257          124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ---HPNIVN---LIE----VI  193 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~---l~~----~~  193 (410)
                      ..|.+ .-..||++...  +..+++|+....           ....++..|...|..|.   .+-.+.   +-|    ..
T Consensus        32 ~~l~s-~eN~~f~~~~~--~g~~iLki~~~~-----------~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~   97 (331)
T COG2334          32 RGLNS-EENSNFRVQTE--DGRYILKIYRPG-----------WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEAL   97 (331)
T ss_pred             ccccc-ccCceEEEEec--CCCeEEEEecCC-----------CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhc
Confidence            34555 55678777655  334599987653           12245667777777774   222222   112    22


Q ss_pred             EcCCCCEEEEEEeecCCCCccc-ccC-----------------------CCC---CCCHH----H---------HHHHHH
Q 015257          194 DDPNSDHFYMVLEYVEGKWDND-GFG-----------------------QPG---AIGES----M---------ARKYLR  233 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~-~~~-----------------------~~~---~l~~~----~---------~~~i~~  233 (410)
                      ..+  ...+-|++|++|..+.. ...                       ...   ...+.    .         ......
T Consensus        98 ~~~--~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a  175 (331)
T COG2334          98 SGG--PRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRA  175 (331)
T ss_pred             cCC--ceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHH
Confidence            221  37788999999977662 100                       000   11121    0         011233


Q ss_pred             HHHHHHHHHHh--------CC--cEeccCCCCcEEEcCCCc-EEEeeccccc
Q 015257          234 DIVSGLMYLHG--------HN--VVHGDIKPDNLLVAPSGT-VKIGDFSVSQ  274 (410)
Q Consensus       234 qi~~gL~yLH~--------~~--iiHrDlkp~NIll~~~~~-~kl~DfG~a~  274 (410)
                      ++...+..+.+        .+  +||+|+.|.||+++.+.. +.++||+-+.
T Consensus       176 ~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         176 ALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             HHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            44455555553        23  999999999999998875 8999999875

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.05  E-value=0.034  Score=53.45  Aligned_cols=112  Identities=15%  Similarity=0.213  Sum_probs=72.4

Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      .-+.|++|++-.+. +..    -.....+++..++.+-+..+.-|... ..-|||+...||||+ +|+|.|+||-+++.-
T Consensus       298 ~~y~yl~~kdhgt~-is~----ik~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         298 TLYLYLHFKDHGTP-ISI----IKADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             ceEEEEEEecCCce-eee----eecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            34667777775432 221    12235677888888887777777654 689999999999999 999999999999964


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCC
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQY  325 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~  325 (410)
                      ..+.......     .--|-.+.|..  +.+-+||-+   |--|+.|..
T Consensus       372 ~~q~~isy~r-----ldhp~lF~G~d--d~QFeIYrl---Mr~l~~g~w  410 (488)
T COG5072         372 YSQGIISYNR-----LDHPDLFNGVD--DYQFEIYRL---MRRLLKGRW  410 (488)
T ss_pred             cCCceeeccc-----cCchhhhcCcc--ceeeeHHHH---HHHHhcCcH
Confidence            4433332222     22343344333  455788874   445555543

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.84  E-value=0.012  Score=51.61  Aligned_cols=28  Identities=25%  Similarity=0.436  Sum_probs=25.0

Q ss_pred             cEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          247 VVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       247 iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      .+|+|+.|.||++..+| ++|+||+.|..
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            59999999999998777 89999998864

>PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat

Probab=95.83  E-value=0.02  Score=56.99  Aligned_cols=31  Identities=26%  Similarity=0.322  Sum_probs=24.7

Q ss_pred             cEeccCCCCcEEEcCCCc-----EEEeecccccccc
Q 015257          247 VVHGDIKPDNLLVAPSGT-----VKIGDFSVSQVFE  277 (410)
Q Consensus       247 iiHrDlkp~NIll~~~~~-----~kl~DfG~a~~~~  277 (410)
                      ++|+||..+|||++.++.     ..|+||-.+....
T Consensus       270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~G~  305 (414)
T PF07914_consen  270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHRGS  305 (414)
T ss_pred             eecCCccHHheeeecCCchhHHHHHHHHHHHhhcCc
Confidence            699999999999998543     5688998776543

In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO).

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.80  E-value=0.1  Score=50.30  Aligned_cols=29  Identities=24%  Similarity=0.360  Sum_probs=24.4

Q ss_pred             CCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       245 ~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      .++||+|+.+.|||++ + .+.|+||+.+..
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            3689999999999995 4 578999998753

>PTZ00296 choline kinase; Provisional

Probab=94.89  E-value=0.31  Score=49.01  Aligned_cols=75  Identities=13%  Similarity=0.146  Sum_probs=47.6

Q ss_pred             eeeeecccCceEEEEEEEcc--------CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcc-cceeE
Q 015257          122 HVRKIGAGSYGKVVLYRSSL--------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIV-NLIEV  192 (410)
Q Consensus       122 ~~~~lG~G~fg~Vy~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~  192 (410)
                      .++.|..|=.-.+|++....        .++.|.+++.....          +..-.-.+|..+++.+..-+|- ++++.
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t----------e~lIdR~~E~~v~~~ls~~gi~P~l~~~  178 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV----------DELYNPISEFEVYKTMSKYRIAPQLLNT  178 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc----------cceeCHHHHHHHHHHHHHCCCCCceEEE
Confidence            57778888888888887542        25678898764321          1111335678888777655554 45565


Q ss_pred             EEcCCCCEEEEEEeecCCCC
Q 015257          193 IDDPNSDHFYMVLEYVEGKW  212 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~  212 (410)
                      +.   +   +.|.||++|..
T Consensus       179 f~---g---g~I~efi~g~~  192 (442)
T PTZ00296        179 FS---G---GRIEEWLYGDP  192 (442)
T ss_pred             eC---C---CEEEEeeCCcc
Confidence            53   1   45789998863

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	410
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-47
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-42
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-41
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-41
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-40
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-40
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-40
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-40
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-39
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-39
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-39
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-39
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-38
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-38
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-38
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-38
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-38
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-37
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-36
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-36
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-36
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-35
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-35
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-34
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-34
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-33
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-33
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-33
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-33
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-33
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-33
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-33
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-33
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-33
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-33
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-33
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-33
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-33
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-33
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-33
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-33
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-33
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-33
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-33
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-33
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-33
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-33
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-33
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-33
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-33
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-33
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-33
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-33
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-33
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-33
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-33
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-33
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-33
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-33
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-33
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-33
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-33
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-33
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-33
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-33
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-32
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-32
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-32
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-32
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-32
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-32
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-32
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-32
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-32
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-32
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-32
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-32
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-32
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-32
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-32
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-32
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-32
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-32
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-32
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-32
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-32
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-32
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-32
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-32
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-32
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-32
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-32
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-32
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-32
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-32
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-32
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-32
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-32
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-32
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-32
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-32
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-32
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-32
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-32
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-32
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-32
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-32
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		9e-32
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-31
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-31
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-31
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-31
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-31
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-31
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-31
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-31
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-30
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-30
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-30
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-30
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-30
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-30
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-30
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-30
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-30
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-30
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-30
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-30
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-30
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-30
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-30
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-30
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-30
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-30
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-30
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-30
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-30
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-30
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-30
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-30
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-30
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-30
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-30
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		8e-30
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-30
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-30
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		9e-30
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-29
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-29
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-29
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-29
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-29
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-29
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-29
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-29
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-29
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-29
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-29
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-29
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-28
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-28
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-28
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-28
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-28
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-28
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-28
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-28
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-28
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-28
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-28
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-28
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-28
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-28
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-28
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-28
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-28
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-28
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-28
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-28
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-28
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-28
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-28
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-28
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-28
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-28
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-28
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-28
3soa_A	444	Full-Length Human Camkii Length = 444		4e-28
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-28
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-28
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-28
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-28
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-28
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-28
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-28
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-28
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		9e-28
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-27
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-27
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-27
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-27
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-27
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-27
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-27
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-27
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-27
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-27
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-27
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-27
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-27
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-26
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-26
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-26
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-26
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-26
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-25
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-25
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-25
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-25
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-25
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-25
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-25
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-25
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-25
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-25
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-25
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-25
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-25
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-25
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-25
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-25
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-25
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-25
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-25
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-25
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-25
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-25
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-25
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-25
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-25
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-25
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-25
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-25
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-25
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-25
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-25
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-25
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-25
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-25
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-25
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-25
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-25
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-25
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-25
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-25
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-25
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-25
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-25
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-25
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-25
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-25
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-25
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-25
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-24
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-24
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-24
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-24
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-24
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-24
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-24
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-24
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-24
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-24
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-24
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-24
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-24
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-24
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-24
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-24
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-24
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-23
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-23
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-23
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-23
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-23
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-23
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-23
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-23
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-23
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-23
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-23
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-23
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-23
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-23
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-23
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-23
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-23
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-23
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-23
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-23
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-23
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-22
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-22
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-22
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-22
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-22
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-22
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-22
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-22
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-22
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-22
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-22
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-22
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-22
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-22
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-22
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-21
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-21
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-21
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-21
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-21
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-21
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-21
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-21
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-21
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-21
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-21
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-21
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-21
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-21
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-21
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-21
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-21
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-21
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-21
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-21
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-21
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-20
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-20
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-20
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-20
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-20
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-20
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-20
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		7e-20
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-19
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-19
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-19
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-19
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-19
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-19
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-19
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-19
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-19
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-19
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-19
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-19
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-19
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-19
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-19
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-19
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-19
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-19
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-19
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-19
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-19
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-19
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-19
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-19
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-19
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-19
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-19
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-19
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-19
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-19
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-19
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-19
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-19
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-19
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-19
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-18
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-18
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-18
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-18
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-18
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-18
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-18
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-18
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-18
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-18
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-18
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-18
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-18
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-18
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-18
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-18
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-18
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-18
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-17
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-17
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-17
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-17
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-17
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-17
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-17
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-17
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-17
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-17
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-17
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-17
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-17
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-17
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-17
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-17
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-17
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		7e-17
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-16
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-16
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-16
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-16
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-16
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-16
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-16
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-16
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-16
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-16
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-16
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-16
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-16
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-16
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-16
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-16
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-16
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-16
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-16
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-16
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-16
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-16
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-16
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-16
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-16
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-16
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-16
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-16
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-16
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-16
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-16
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-16
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-16
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-16
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-16
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		7e-16
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-16
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-16
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-16
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		9e-16
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-16
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		9e-16
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-15
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-15
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-15
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-15
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-15
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-15
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-15
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-15
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-15
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-15
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-15
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-15
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-15
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-15
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-15
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-15
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-15
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-15
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-15
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-15
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-15
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-15
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-15
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-15
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-15
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-15
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-15
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-15
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-15
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-15
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		7e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-15
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-15
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		8e-15
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		8e-15
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		8e-15
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-15
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-15
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		9e-15
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		9e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-15
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-14
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-14
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-14
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-14
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-14
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-14
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-14
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-14
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		8e-14
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		9e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-13
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-13
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-13
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-13
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-13
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-13
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-13
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-13
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-13
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-13
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-13
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-13
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-13
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-13
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-13
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-13
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-13
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-13
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-13
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-13
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-13
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-13
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-13
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-13
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-13
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-13
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-13
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-13
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-13
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-13
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-13
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-13
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-13
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-13
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-13
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-13
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-13
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-13
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-13
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-13
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-13
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-13
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-13
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-13
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-13
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-13
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-13
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-13
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-13
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-13
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-13
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-13
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-13
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-13
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-12
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-12
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-12
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-12
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-12
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-12
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-12
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-12
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-12
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-12
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-12
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-12
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-12
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-12
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-12
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-12
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-12
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-11
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-10
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		3e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-10
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		4e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-10
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-10
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		7e-10
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		7e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-10
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-09
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-09
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-09
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-09
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-09
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-09
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-09
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-09
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-09
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-09
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-09
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-09
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-09
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-09
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-09
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-09
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-09
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		4e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-09
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		5e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-09
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		5e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-08
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-08
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-08
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-08
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-08
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		5e-08
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		5e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-08
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		6e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		7e-08
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-08
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		7e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-08
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		7e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-08
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		7e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-08
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		8e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		8e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-08
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		8e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-08
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		9e-08
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		9e-08
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		9e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-07
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-07
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-07
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-07
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		4e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-07
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		4e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-07
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-07
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-07
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-07

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  185 bits (469), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 107/288 (37%), Positives = 155/288 (53%), Gaps = 26/288 (9%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR---------------- 160
           +N+Y    +IG GSYG V L  +  D  +YA+K   K  L +                  
Sbjct: 12  LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 161 --VAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGF 217
             + P    +  V +E+ I+K L HPN+V L+EV+DDPN DH YMV E V +G       
Sbjct: 72  GCIQP-RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT 130
Query: 218 GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277
            +P  + E  AR Y +D++ G+ YLH   ++H DIKP NLLV   G +KI DF VS  F+
Sbjct: 131 LKP--LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 278 DDNDVLRRSPGTPVFTAPECCLGL--TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDT 335
             + +L  + GTP F APE        + GKA D WA+GVTLY  + GQ PF+ E +   
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248
Query: 336 YDKIVNNSLVFPDA--MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           + KI + +L FPD   +  +L++L+  +L K+P  R+ + ++  H WV
Sbjct: 249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 94/288 (32%), Positives = 153/288 (53%), Gaps = 12/288 (4%)
Query: 105 LIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPS 164
           +   +  +G   I  Y+    +G G++GKV + +  L G   A+K  ++  +  L V   
Sbjct: 3   MAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDV--- 59
Query: 165 ETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIG 224
              +  +RRE+  +K+ +HP+I+ L +VI  P+    +MV+EYV G    D   + G + 
Sbjct: 60  ---VGKIRREIQNLKLFRHPHIIKLYQVISTPSD--IFMVMEYVSGGELFDYICKNGRLD 114
Query: 225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR 284
           E  +R+  + I+SG+ Y H H VVH D+KP+N+L+      KI DF +S +  D  + LR
Sbjct: 115 EKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLR 173
Query: 285 RSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL 344
            S G+P + APE   G  Y G   D W+ GV LY ++ G  PF  + +   + KI +   
Sbjct: 174 XSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF 233
Query: 345 VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL 392
             P  +NP + +LL+ +L  DP +R T+ D+ +H W   D   +P+YL
Sbjct: 234 YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD---LPKYL 278

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  165 bits (417), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 95/282 (33%), Positives = 145/282 (51%), Gaps = 12/282 (4%)
Query: 111 ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD 170
            +G   I  YV    +G G++GKV +    L G   A+K  ++  +  L V      +  
Sbjct: 4   HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDV------VGK 57
Query: 171 VRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARK 230
           ++RE+  +K+ +HP+I+ L +VI  P    F+MV+EYV G    D   + G + E  AR+
Sbjct: 58  IKREIQNLKLFRHPHIIKLYQVISTPTD--FFMVMEYVSGGELFDYICKHGRVEEMEARR 115
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
             + I+S + Y H H VVH D+KP+N+L+      KI DF +S +   D + LR S G+P
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSCGSP 174
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAM 350
            + APE   G  Y G   D W+ GV LY ++ G  PF  E +   + KI       P+ +
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYL 234
Query: 351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL 392
           N  +  LL  +L  DP +R T+ D+ +H W   D   +P YL
Sbjct: 235 NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD---LPSYL 273

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  164 bits (416), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 95/282 (33%), Positives = 145/282 (51%), Gaps = 12/282 (4%)
Query: 111 ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD 170
            +G   I  YV    +G G++GKV +    L G   A+K  ++  +  L V      +  
Sbjct: 4   HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDV------VGK 57
Query: 171 VRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARK 230
           ++RE+  +K+ +HP+I+ L +VI  P    F+MV+EYV G    D   + G + E  AR+
Sbjct: 58  IKREIQNLKLFRHPHIIKLYQVISTPTD--FFMVMEYVSGGELFDYICKHGRVEEMEARR 115
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
             + I+S + Y H H VVH D+KP+N+L+      KI DF +S +  D  + LR S G+P
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRDSCGSP 174
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAM 350
            + APE   G  Y G   D W+ GV LY ++ G  PF  E +   + KI       P+ +
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYL 234
Query: 351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL 392
           N  +  LL  +L  DP +R T+ D+ +H W   D   +P YL
Sbjct: 235 NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD---LPSYL 273

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 94/265 (35%), Positives = 138/265 (52%), Gaps = 10/265 (3%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I  Y  ++ IG G++ KV L R  L GK  A+K   K+ L+        +++  + REV 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLN-------SSSLQKLFREVR 65
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           IMK+L HPNIV L EVI+   +   Y+V+EY  G    D     G + E  AR   R IV
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKT--LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV 123
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S + Y H   +VH D+K +NLL+     +KI DF  S  F   N  L    G+P + APE
Sbjct: 124 SAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPE 182
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
              G  Y G   D W++GV LY ++ G  PF G+ L++  ++++      P  M+ +  N
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCEN 242
Query: 357 LLEGLLCKDPTRRLTLNDVAKHTWV 381
           LL+  L  +P++R TL  + K  W+
Sbjct: 243 LLKKFLILNPSKRGTLEQIMKDRWM 267

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 94/265 (35%), Positives = 138/265 (52%), Gaps = 10/265 (3%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I  Y  ++ IG G++ KV L R  L GK  A+K   K+ L+        +++  + REV 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLN-------SSSLQKLFREVR 65
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           IMK+L HPNIV L EVI+   +   Y+V+EY  G    D     G + E  AR   R IV
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKT--LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV 123
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S + Y H   +VH D+K +NLL+     +KI DF  S  F   N  L    G+P + APE
Sbjct: 124 SAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPE 182
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
              G  Y G   D W++GV LY ++ G  PF G+ L++  ++++      P  M+ +  N
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCEN 242
Query: 357 LLEGLLCKDPTRRLTLNDVAKHTWV 381
           LL+  L  +P++R TL  + K  W+
Sbjct: 243 LLKKFLILNPSKRGTLEQIMKDRWM 267

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  161 bits (407), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 93/265 (35%), Positives = 138/265 (52%), Gaps = 10/265 (3%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I  Y  ++ IG G++ KV L R  L GK  A++   K+ L+        +++  + REV 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLN-------SSSLQKLFREVR 65
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           IMK+L HPNIV L EVI+   +   Y+V+EY  G    D     G + E  AR   R IV
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKT--LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV 123
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S + Y H   +VH D+K +NLL+     +KI DF  S  F   N  L    G+P + APE
Sbjct: 124 SAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDEFCGSPPYAAPE 182
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
              G  Y G   D W++GV LY ++ G  PF G+ L++  ++++      P  M+ +  N
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCEN 242
Query: 357 LLEGLLCKDPTRRLTLNDVAKHTWV 381
           LL+  L  +P++R TL  + K  W+
Sbjct: 243 LLKKFLILNPSKRGTLEQIMKDRWM 267

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  161 bits (407), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 94/265 (35%), Positives = 137/265 (51%), Gaps = 10/265 (3%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I  Y  ++ IG G++ KV L R  L GK  A+K   K+ L+        +++  + REV 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLN-------SSSLQKLFREVR 65
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           IMK+L HPNIV L EVI+   +   Y+V+EY  G    D     G + E  AR   R IV
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKT--LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV 123
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S + Y H   +VH D+K +NLL+     +KI DF  S  F   N  L    G P + APE
Sbjct: 124 SAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDAFCGAPPYAAPE 182
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
              G  Y G   D W++GV LY ++ G  PF G+ L++  ++++      P  M+ +  N
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCEN 242
Query: 357 LLEGLLCKDPTRRLTLNDVAKHTWV 381
           LL+  L  +P++R TL  + K  W+
Sbjct: 243 LLKKFLILNPSKRGTLEQIMKDRWM 267

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 93/265 (35%), Positives = 138/265 (52%), Gaps = 10/265 (3%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I  Y  ++ IG G++ KV L R  L GK  A++   K+ L+        +++  + REV 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLN-------SSSLQKLFREVR 65
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           IMK+L HPNIV L EVI+   +   Y+V+EY  G    D     G + E  AR   R IV
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKT--LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV 123
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S + Y H   +VH D+K +NLL+     +KI DF  S  F   N  L    G+P + APE
Sbjct: 124 SAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPE 182
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
              G  Y G   D W++GV LY ++ G  PF G+ L++  ++++      P  M+ +  N
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCEN 242
Query: 357 LLEGLLCKDPTRRLTLNDVAKHTWV 381
           LL+  L  +P++R TL  + K  W+
Sbjct: 243 LLKKFLILNPSKRGTLEQIMKDRWM 267

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 94/265 (35%), Positives = 138/265 (52%), Gaps = 10/265 (3%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I  Y  ++ IG G++ KV L R  L GK  A+K   K+ L+        +++  + REV 
Sbjct: 6   IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLN-------SSSLQKLFREVR 58
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           IMK+L HPNIV L EVI+   +   Y+V+EY  G    D     G + E  AR   R IV
Sbjct: 59  IMKVLNHPNIVKLFEVIETEKT--LYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIV 116
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S + Y H   +VH D+K +NLL+     +KI DF  S  F   N  L    G+P + APE
Sbjct: 117 SAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPE 175
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
              G  Y G   D W++GV LY ++ G  PF G+ L++  ++++      P  M+ +  N
Sbjct: 176 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCEN 235
Query: 357 LLEGLLCKDPTRRLTLNDVAKHTWV 381
           LL+  L  +P++R TL  + K  W+
Sbjct: 236 LLKKFLILNPSKRGTLEQIMKDRWM 260

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 93/265 (35%), Positives = 136/265 (51%), Gaps = 10/265 (3%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I  Y  ++ IG G++ KV L R  L G+  AIK   K+ L+        T++  + REV 
Sbjct: 11  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP-------TSLQKLFREVR 63
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           IMK+L HPNIV L EVI+   +   Y+++EY  G    D     G + E  AR   R IV
Sbjct: 64  IMKILNHPNIVKLFEVIETEKT--LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV 121
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S + Y H   +VH D+K +NLL+     +KI DF  S  F      L    G+P + APE
Sbjct: 122 SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDTFCGSPPYAAPE 180
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
              G  Y G   D W++GV LY ++ G  PF G+ L++  ++++      P  M+ +  N
Sbjct: 181 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCEN 240
Query: 357 LLEGLLCKDPTRRLTLNDVAKHTWV 381
           LL+  L  +P +R TL  + K  W+
Sbjct: 241 LLKRFLVLNPIKRGTLEQIMKDRWI 265

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 93/265 (35%), Positives = 135/265 (50%), Gaps = 10/265 (3%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I  Y  ++ IG G++ KV L R  L G+  AIK   K+ L+        T++  + REV 
Sbjct: 14  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP-------TSLQKLFREVR 66
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           IMK+L HPNIV L EVI+   +   Y+++EY  G    D     G + E  AR   R IV
Sbjct: 67  IMKILNHPNIVKLFEVIETEKT--LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV 124
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S + Y H   +VH D+K +NLL+     +KI DF  S  F      L    G P + APE
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDAFCGAPPYAAPE 183
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
              G  Y G   D W++GV LY ++ G  PF G+ L++  ++++      P  M+ +  N
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCEN 243
Query: 357 LLEGLLCKDPTRRLTLNDVAKHTWV 381
           LL+  L  +P +R TL  + K  W+
Sbjct: 244 LLKRFLVLNPIKRGTLEQIMKDRWI 268

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 90/276 (32%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I  Y+    +G GS+GKV L       +  A+K   +  L K     S+  M  V RE+ 
Sbjct: 8   IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK-----SDMHMR-VEREIS 61
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
            +K+L+HP+I+ L +VI  P      MV+EY  G+   D   +   + E   R++ + I+
Sbjct: 62  YLKLLRHPHIIKLYDVITTPTD--IVMVIEYAGGEL-FDYIVEKKRMTEDEGRRFFQQII 118
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
             + Y H H +VH D+KP+NLL+  +  VKI DF +S +  D N  L+ S G+P + APE
Sbjct: 119 CAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPE 177
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
              G  Y G   D W+ G+ LY M++G+ PF  E + + + K+ +   V PD ++P  ++
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQS 237
Query: 357 LLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL 392
           L+  ++  DP +R+T+ ++ +  W    N  +P YL
Sbjct: 238 LIRRMIVADPMQRITIQEIRRDPWF---NVNLPDYL 270

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 90/276 (32%), Positives = 145/276 (52%), Gaps = 13/276 (4%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I  Y  V+ +G GS+GKV L   +  G+  A+K  +K  L+K            + RE+ 
Sbjct: 13  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK------SDMQGRIEREIS 66
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
            +++L+HP+I+ L +VI   + D   MV+EY  G    D   Q   + E  AR++ + I+
Sbjct: 67  YLRLLRHPHIIKLYDVIK--SKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQII 123
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S + Y H H +VH D+KP+NLL+     VKI DF +S +  D N  L+ S G+P + APE
Sbjct: 124 SAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPE 182
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
              G  Y G   D W+ GV LY M+  + PF  E++   +  I N     P  ++P    
Sbjct: 183 VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAG 242
Query: 357 LLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL 392
           L++ +L  +P  R++++++ +  W   D   +P+YL
Sbjct: 243 LIKRMLIVNPLNRISIHEIMQDDWFKVD---LPEYL 275

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 90/276 (32%), Positives = 145/276 (52%), Gaps = 13/276 (4%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I  Y  V+ +G GS+GKV L   +  G+  A+K  +K  L+K            + RE+ 
Sbjct: 12  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK------SDMQGRIEREIS 65
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
            +++L+HP+I+ L +VI   + D   MV+EY  G    D   Q   + E  AR++ + I+
Sbjct: 66  YLRLLRHPHIIKLYDVIK--SKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQII 122
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S + Y H H +VH D+KP+NLL+     VKI DF +S +  D N  L+ S G+P + APE
Sbjct: 123 SAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPE 181
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
              G  Y G   D W+ GV LY M+  + PF  E++   +  I N     P  ++P    
Sbjct: 182 VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAG 241
Query: 357 LLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL 392
           L++ +L  +P  R++++++ +  W   D   +P+YL
Sbjct: 242 LIKRMLIVNPLNRISIHEIMQDDWFKVD---LPEYL 274

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 90/276 (32%), Positives = 145/276 (52%), Gaps = 13/276 (4%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I  Y  V+ +G GS+GKV L   +  G+  A+K  +K  L+K            + RE+ 
Sbjct: 3   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK------SDMQGRIEREIS 56
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
            +++L+HP+I+ L +VI   + D   MV+EY  G    D   Q   + E  AR++ + I+
Sbjct: 57  YLRLLRHPHIIKLYDVIK--SKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQII 113
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S + Y H H +VH D+KP+NLL+     VKI DF +S +  D N  L+ S G+P + APE
Sbjct: 114 SAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPE 172
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
              G  Y G   D W+ GV LY M+  + PF  E++   +  I N     P  ++P    
Sbjct: 173 VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAG 232
Query: 357 LLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL 392
           L++ +L  +P  R++++++ +  W   D   +P+YL
Sbjct: 233 LIKRMLIVNPLNRISIHEIMQDDWFKVD---LPEYL 265

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 90/276 (32%), Positives = 145/276 (52%), Gaps = 13/276 (4%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I  Y  V+ +G GS+GKV L   +  G+  A+K  +K  L+K            + RE+ 
Sbjct: 7   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK------SDMQGRIEREIS 60
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
            +++L+HP+I+ L +VI   + D   MV+EY  G    D   Q   + E  AR++ + I+
Sbjct: 61  YLRLLRHPHIIKLYDVIK--SKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQII 117
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S + Y H H +VH D+KP+NLL+     VKI DF +S +  D N  L+ S G+P + APE
Sbjct: 118 SAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPE 176
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
              G  Y G   D W+ GV LY M+  + PF  E++   +  I N     P  ++P    
Sbjct: 177 VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAG 236
Query: 357 LLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL 392
           L++ +L  +P  R++++++ +  W   D   +P+YL
Sbjct: 237 LIKRMLIVNPLNRISIHEIMQDDWFKVD---LPEYL 269

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 132/264 (50%), Gaps = 10/264 (3%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I  Y  ++ IG G++ KV L R  L GK  A+K   K+ L+        +++  + REV 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLN-------SSSLQKLFREVR 65
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           I K+L HPNIV L EVI+   +   Y+V EY  G    D     G   E  AR   R IV
Sbjct: 66  IXKVLNHPNIVKLFEVIETEKT--LYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIV 123
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S + Y H   +VH D+K +NLL+     +KI DF  S  F   N  L    G P + APE
Sbjct: 124 SAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK-LDAFCGAPPYAAPE 182
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
              G  Y G   D W++GV LY ++ G  PF G+ L++  ++++      P   + +  N
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTDCEN 242
Query: 357 LLEGLLCKDPTRRLTLNDVAKHTW 380
           LL+  L  +P++R TL  + K  W
Sbjct: 243 LLKKFLILNPSKRGTLEQIXKDRW 266

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 91/278 (32%), Positives = 142/278 (51%), Gaps = 9/278 (3%)
Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
            K+I +Y+    +G GSYGKV   +  LD +    +A       KLR  P+  A  +V++
Sbjct: 1   AKLIGKYLMGDLLGEGSYGKV---KEVLDSETLCRRAVKILKKKKLRRIPNGEA--NVKK 55
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEY-VEGKWDNDGFGQPGAIGESMARKYL 232
           E+ +++ L+H N++ L++V+ +      YMV+EY V G  +              A  Y 
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED--DNDVLRRSPGTP 290
             ++ GL YLH   +VH DIKP NLL+   GT+KI    V++       +D  R S G+P
Sbjct: 116 CQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 291 VFTAPECCLGL-TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA 349
            F  PE   GL T+ G   D W+ GVTLY +  G YPF G+ +   ++ I   S   P  
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGD 235
Query: 350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
             P L +LL+G+L  +P +R ++  + +H+W    + P
Sbjct: 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 138/277 (49%), Gaps = 29/277 (10%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + Y  V+ IGAG++G   L R     +  A+K   +           E    +V+RE++ 
Sbjct: 19  DRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERG----------EKIDENVKREIIN 68
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
            + L+HPNIV   EVI  P   H  +V+EY  G    +     G   E  AR + + ++S
Sbjct: 69  HRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 238 GLMYLHGHNVVHGDIKPDNLLV--APSGTVKIGDFSVSQVFEDDNDVLRRSP----GTPV 291
           G+ Y H   V H D+K +N L+  +P+  +KI DF  S+       VL   P    GTP 
Sbjct: 127 GVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA-----SVLHSQPKSAVGTPA 181
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG----ETLQDTYDKIVNNSLVFP 347
           + APE  L   Y GK AD W+ GVTLY M++G YPF      +  + T  +I+N     P
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIP 241
Query: 348 D--AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL 382
           D   ++PE R+L+  +   DP +R+++ ++  H W L
Sbjct: 242 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 278

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  148 bits (373), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 139/277 (50%), Gaps = 29/277 (10%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + Y  V+ IG+G++G   L R     +  A+K   +           E    +V+RE++ 
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG----------EKIAANVKREIIN 68
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
            + L+HPNIV   EVI  P   H  +V+EY  G    +     G   E  AR + + ++S
Sbjct: 69  HRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 238 GLMYLHGHNVVHGDIKPDNLLV--APSGTVKIGDFSVSQVFEDDNDVLRRSP----GTPV 291
           G+ Y H   V H D+K +N L+  +P+  +KI DF  S+     + VL   P    GTP 
Sbjct: 127 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPA 181
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG----ETLQDTYDKIVNNSLVFP 347
           + APE  L   Y GK AD W+ GVTLY M++G YPF      +  + T  +I+N     P
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIP 241
Query: 348 D--AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL 382
           D   ++PE R+L+  +   DP +R+++ ++  H W L
Sbjct: 242 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 278

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 94/265 (35%), Positives = 137/265 (51%), Gaps = 10/265 (3%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I  Y   + IG G++ KV L R  L G+  A+K   K+ L+        T++  + REV 
Sbjct: 14  IGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNP-------TSLQKLFREVR 66
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           IMK+L HPNIV L EVI+   +   Y+V+EY  G    D     G + E  AR   R IV
Sbjct: 67  IMKILNHPNIVKLFEVIETEKT--LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV 124
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S + Y H   +VH D+K +NLL+     +KI DF  S  F   N  L    G+P + APE
Sbjct: 125 SAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK-LDTFCGSPPYAAPE 183
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
              G  Y G   D W++GV LY ++ G  PF G+ L++  ++++      P  M+ +  N
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCEN 243
Query: 357 LLEGLLCKDPTRRLTLNDVAKHTWV 381
           LL+ LL  +P +R +L  + K  W+
Sbjct: 244 LLKKLLVLNPIKRGSLEQIMKDRWM 268

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 139/277 (50%), Gaps = 29/277 (10%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + Y  V+ IG+G++G   L R     +  A+K   +           E    +V+RE++ 
Sbjct: 18  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG----------EKIDENVKREIIN 67
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
            + L+HPNIV   EVI  P   H  +V+EY  G    +     G   E  AR + + ++S
Sbjct: 68  HRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 125
Query: 238 GLMYLHGHNVVHGDIKPDNLLV--APSGTVKIGDFSVSQVFEDDNDVLRRSP----GTPV 291
           G+ Y H   V H D+K +N L+  +P+  +KI DF  S+     + VL   P    GTP 
Sbjct: 126 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPA 180
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG----ETLQDTYDKIVNNSLVFP 347
           + APE  L   Y GK AD W+ GVTLY M++G YPF      +  + T  +I+N     P
Sbjct: 181 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIP 240
Query: 348 D--AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL 382
           D   ++PE R+L+  +   DP +R+++ ++  H W L
Sbjct: 241 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 277

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 89/277 (32%), Positives = 138/277 (49%), Gaps = 29/277 (10%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + Y  V+ IG+G++G   L R     +  A+K   +           E    +V+RE++ 
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG----------EKIDENVKREIIN 68
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
            + L+HPNIV   EVI  P   H  +V+EY  G    +     G   E  AR + + ++S
Sbjct: 69  HRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 238 GLMYLHGHNVVHGDIKPDNLLV--APSGTVKIGDFSVSQVFEDDNDVLRRSP----GTPV 291
           G+ Y H   V H D+K +N L+  +P+  +KI  F  S+     + VL   P    GTP 
Sbjct: 127 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK-----SSVLHSQPKSTVGTPA 181
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG----ETLQDTYDKIVNNSLVFP 347
           + APE  L   Y GK AD W+ GVTLY M++G YPF      +  + T  +I+N     P
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIP 241
Query: 348 D--AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL 382
           D   ++PE R+L+  +   DP +R+++ ++  H W L
Sbjct: 242 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 278

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 89/277 (32%), Positives = 138/277 (49%), Gaps = 29/277 (10%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + Y  V+ IG+G++G   L R     +  A+K   +           E    +V+RE++ 
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG----------EKIDENVKREIIN 68
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
            + L+HPNIV   EVI  P   H  +V+EY  G    +     G   E  AR + + ++S
Sbjct: 69  HRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 238 GLMYLHGHNVVHGDIKPDNLLV--APSGTVKIGDFSVSQVFEDDNDVLRRSP----GTPV 291
           G+ Y H   V H D+K +N L+  +P+  +KI  F  S+     + VL   P    GTP 
Sbjct: 127 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK-----SSVLHSQPKDTVGTPA 181
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG----ETLQDTYDKIVNNSLVFP 347
           + APE  L   Y GK AD W+ GVTLY M++G YPF      +  + T  +I+N     P
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIP 241
Query: 348 D--AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL 382
           D   ++PE R+L+  +   DP +R+++ ++  H W L
Sbjct: 242 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 278

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 91/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ IG GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +K+ DF 
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSED--ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---AGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 91/294 (30%), Positives = 143/294 (48%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  +R +G GS+G+V+L +    G HYA+K  
Sbjct: 16  VKEFLAKAKEDFLKKWESPAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKIL 75
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I + +  P +V L     D  + + YMVLEY  G 
Sbjct: 76  DKQKVVKLKQI--EHTLNEKR----IQQAVNFPFLVKLEFSFKD--NSNLYMVLEYAPGG 127
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +K+ DF 
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFG 187
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 188 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 243
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 244 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 297

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 135/273 (49%), Gaps = 16/273 (5%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPS----ETAMTDVRREV 175
           Y  VRK+G+G+YG+V+L +        AIK   KS   K R +      E    ++  E+
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++K L HPNI+ L +V +D    +FY+V E+ EG    +         E  A   ++ I
Sbjct: 98  SLLKSLDHPNIIKLFDVFEDKK--YFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGT---VKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
           +SG+ YLH HN+VH DIKP+N+L+    +   +KI DF +S  F  D   LR   GT  +
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRDRLGTAYY 214
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----D 348
            APE  L   Y  K  D W+ GV +Y ++ G  PF G+  QD   K+      F      
Sbjct: 215 IAPE-VLKKKYNEK-CDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWK 272
Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            ++ E + L++ +L  D  +R T  +     W+
Sbjct: 273 NISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSED--ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXLX---GTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSED--ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYQMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 140/269 (52%), Gaps = 23/269 (8%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           ++G+G +  V   R    GK YA K   K  LS  R   S     ++ REV I++ ++HP
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSRE---EIEREVNILREIRHP 68
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           NI+ L ++ +  N     ++LE V G    D   +  ++ E  A ++L+ I+ G+ YLH 
Sbjct: 69  NIITLHDIFE--NKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 245 HNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC-- 298
             + H D+KP+N+++     P+  +K+ DF ++   E  N+  +   GTP F APE    
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAPEIVNY 185
Query: 299 --LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD---AMNPE 353
             LGL      AD W++GV  Y ++ G  PFLGET Q+T   I   +  F +   +   E
Sbjct: 186 EPLGL-----EADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240
Query: 354 L-RNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           L ++ +  LL KDP RR+T+    +H+W+
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 143/294 (48%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSED--ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 36  VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 95
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+       +     E  I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 96  DKQKVVKLK------QIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG 147
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 148 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 207
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 208 FAKRVKGATWTL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 263
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 264 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 317

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSED--ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLK--QIEHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSED--ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 16  VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 75
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 76  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG 127
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 188 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 243
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 244 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 297

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSED--ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSED--ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 2   VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 61
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 62  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG 113
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 114 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFG 173
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 174 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 229
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 230 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 283

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 143/294 (48%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSED--ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+       +     E  I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLK------QIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLPNGVNDIKNHKW 296

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSED--ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSED--ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADE 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 88/274 (32%), Positives = 139/274 (50%), Gaps = 14/274 (5%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +N++ +++ +G G++GKV+L R    G++YA+K   K  +    +A  E A T     VL
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI----IAKDEVAHTVTESRVL 59
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
             +  +HP +  L         D    V+EY  G        +     E  AR Y  +IV
Sbjct: 60  --QNTRHPFLTALKYAFQ--THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S L YLH  +VV+ DIK +NL++   G +KI DF + +    D   ++   GTP + APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
                 YG +A D W +GV +Y M+ G+ PF  +  +  ++ I+   + FP  ++PE ++
Sbjct: 176 VLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 234
Query: 357 LLEGLLCKDPTRRL-----TLNDVAKHTWVLGDN 385
           LL GLL KDP +RL        +V +H + L  N
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 88/274 (32%), Positives = 139/274 (50%), Gaps = 14/274 (5%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +N++ +++ +G G++GKV+L R    G++YA+K   K  +    +A  E A T     VL
Sbjct: 7   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI----IAKDEVAHTVTESRVL 62
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
             +  +HP +  L         D    V+EY  G        +     E  AR Y  +IV
Sbjct: 63  --QNTRHPFLTALKYAFQ--THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 118
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S L YLH  +VV+ DIK +NL++   G +KI DF + +    D   ++   GTP + APE
Sbjct: 119 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 178
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
                 YG +A D W +GV +Y M+ G+ PF  +  +  ++ I+   + FP  ++PE ++
Sbjct: 179 VLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 237
Query: 357 LLEGLLCKDPTRRL-----TLNDVAKHTWVLGDN 385
           LL GLL KDP +RL        +V +H + L  N
Sbjct: 238 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 271

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 88/274 (32%), Positives = 139/274 (50%), Gaps = 14/274 (5%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +N++ +++ +G G++GKV+L R    G++YA+K   K  +    +A  E A T     VL
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI----IAKDEVAHTVTESRVL 59
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
             +  +HP +  L         D    V+EY  G        +     E  AR Y  +IV
Sbjct: 60  --QNTRHPFLTALKYAFQ--THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S L YLH  +VV+ DIK +NL++   G +KI DF + +    D   ++   GTP + APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
                 YG +A D W +GV +Y M+ G+ PF  +  +  ++ I+   + FP  ++PE ++
Sbjct: 176 VLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 234
Query: 357 LLEGLLCKDPTRRL-----TLNDVAKHTWVLGDN 385
           LL GLL KDP +RL        +V +H + L  N
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 88/274 (32%), Positives = 139/274 (50%), Gaps = 14/274 (5%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +N++ +++ +G G++GKV+L R    G++YA+K   K  +    +A  E A T     VL
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI----IAKDEVAHTVTESRVL 59
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
             +  +HP +  L         D    V+EY  G        +     E  AR Y  +IV
Sbjct: 60  --QNTRHPFLTALKYAFQ--THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S L YLH  +VV+ DIK +NL++   G +KI DF + +    D   ++   GTP + APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
                 YG +A D W +GV +Y M+ G+ PF  +  +  ++ I+   + FP  ++PE ++
Sbjct: 176 VLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 234
Query: 357 LLEGLLCKDPTRRL-----TLNDVAKHTWVLGDN 385
           LL GLL KDP +RL        +V +H + L  N
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 88/274 (32%), Positives = 139/274 (50%), Gaps = 14/274 (5%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +N++ +++ +G G++GKV+L R    G++YA+K   K  +    +A  E A T     VL
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI----IAKDEVAHTVTESRVL 59
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
             +  +HP +  L         D    V+EY  G        +     E  AR Y  +IV
Sbjct: 60  --QNTRHPFLTALKYAFQ--THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S L YLH  +VV+ DIK +NL++   G +KI DF + +    D   ++   GTP + APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
                 YG +A D W +GV +Y M+ G+ PF  +  +  ++ I+   + FP  ++PE ++
Sbjct: 176 VLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 234
Query: 357 LLEGLLCKDPTRRL-----TLNDVAKHTWVLGDN 385
           LL GLL KDP +RL        +V +H + L  N
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 147/297 (49%), Gaps = 25/297 (8%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ IG GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EY+ G 
Sbjct: 75  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYMPG- 125
Query: 212 WDNDGFGQPGAIG---ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIG 268
              D F     IG   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +K+ 
Sbjct: 126 --GDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVA 183
Query: 269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL 328
           DF  ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF 
Sbjct: 184 DFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFF 239
Query: 329 GETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
            +     Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 240 ADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 88/274 (32%), Positives = 139/274 (50%), Gaps = 14/274 (5%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +N++ +++ +G G++GKV+L R    G++YA+K   K  +    +A  E A T     VL
Sbjct: 9   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI----IAKDEVAHTVTESRVL 64
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
             +  +HP +  L         D    V+EY  G        +     E  AR Y  +IV
Sbjct: 65  --QNTRHPFLTALKYAFQ--THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 120
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S L YLH  +VV+ DIK +NL++   G +KI DF + +    D   ++   GTP + APE
Sbjct: 121 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 180
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
                 YG +A D W +GV +Y M+ G+ PF  +  +  ++ I+   + FP  ++PE ++
Sbjct: 181 VLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 239
Query: 357 LLEGLLCKDPTRRL-----TLNDVAKHTWVLGDN 385
           LL GLL KDP +RL        +V +H + L  N
Sbjct: 240 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 273

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 88/274 (32%), Positives = 139/274 (50%), Gaps = 14/274 (5%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +N++ +++ +G G++GKV+L R    G++YA+K   K  +    +A  E A T     VL
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI----IAKDEVAHTVTESRVL 59
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
             +  +HP +  L         D    V+EY  G        +     E  AR Y  +IV
Sbjct: 60  --QNTRHPFLTALKYAFQ--THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S L YLH  +VV+ DIK +NL++   G +KI DF + +    D   ++   GTP + APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
                 YG +A D W +GV +Y M+ G+ PF  +  +  ++ I+   + FP  ++PE ++
Sbjct: 176 VLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 234
Query: 357 LLEGLLCKDPTRRL-----TLNDVAKHTWVLGDN 385
           LL GLL KDP +RL        +V +H + L  N
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSED--ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSED--ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 10  VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 69
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 70  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG 121
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 122 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 181
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 182 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 237
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 238 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 291

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 147/297 (49%), Gaps = 25/297 (8%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ IG GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EY+ G 
Sbjct: 75  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYMPG- 125
Query: 212 WDNDGFGQPGAIG---ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIG 268
              D F     IG   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +K+ 
Sbjct: 126 --GDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVA 183
Query: 269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL 328
           DF  ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF 
Sbjct: 184 DFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFF 239
Query: 329 GETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
            +     Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 240 ADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSED--ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 141/277 (50%), Gaps = 29/277 (10%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + Y  V+ IG+G++G   L R  L  +  A+K   +        A  E    +V+RE++ 
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG------AAIDE----NVQREIIN 69
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
            + L+HPNIV   EVI  P   H  +++EY  G    +     G   E  AR + + ++S
Sbjct: 70  HRSLRHPNIVRFKEVILTPT--HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS 127
Query: 238 GLMYLHGHNVVHGDIKPDNLLV--APSGTVKIGDFSVSQVFEDDNDVLRRSP----GTPV 291
           G+ Y H   + H D+K +N L+  +P+  +KI DF  S+     + VL   P    GTP 
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPA 182
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG-ETLQD---TYDKIVNNSLVFP 347
           + APE  L   Y GK AD W+ GVTLY M++G YPF   E  +D   T  +I++     P
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP 242
Query: 348 D--AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL 382
           D   ++PE  +L+  +   DP  R+++ ++  H+W L
Sbjct: 243 DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFL 279

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 143/294 (48%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSED--ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 36  VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 95
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+       +     E  I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 96  DKQKVVKLK------QIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG 147
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 148 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 207
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 208 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 263
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 264 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 317

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 16  VKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL 75
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 76  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGG 127
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 188 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 243
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 244 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 297

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 16  VKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL 75
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 76  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGG 127
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 188 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 243
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 244 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIXNHKW 297

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 135/269 (50%), Gaps = 23/269 (8%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           ++G+G +  V   R    G  YA K   K      R   S     D+ REV I+K +QHP
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQHP 74
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           N++ L EV +  N     ++LE V G    D   +  ++ E  A ++L+ I++G+ YLH 
Sbjct: 75  NVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 245 HNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC-- 298
             + H D+KP+N+++     P   +KI DF ++   +  N+  +   GTP F APE    
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPAFVAPEIVNY 191
Query: 299 --LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA----MNP 352
             LGL      AD W++GV  Y ++ G  PFLG+T Q+T   +   +  F D      + 
Sbjct: 192 EPLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
             ++ +  LL KDP +R+T+ D  +H W+
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSED--ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLK--QIEHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 16  VKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL 75
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 76  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGG 127
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 188 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 243
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 244 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 297

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 36  VKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL 95
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 96  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGG 147
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 148 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 207
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 208 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 263
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 264 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 317

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 8   VKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL 67
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 68  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGG 119
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 120 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 179
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 180 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 235
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 236 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 289

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 1   VKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL 60
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 61  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGG 112
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 113 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 172
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 173 FAKRVKGRTWTL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 228
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 229 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKW 282

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 16  VKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL 75
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 76  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGG 127
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 188 FAKRVKGRTWTL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 243
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 244 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 297

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKW 296

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  137 bits (346), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 142/272 (52%), Gaps = 25/272 (9%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y  V+K+G+G+YG+V+L R  +     AIK   K+ +S        ++ + +  EV ++K
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-------SSNSKLLEEVAVLK 91
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
           +L HPNI+ L +  +D    ++Y+V+E  +G    D         E  A   ++ ++SG+
Sbjct: 92  LLDHPNIMKLYDFFEDKR--NYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGV 149
Query: 240 MYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
            YLH HN+VH D+KP+NLL+        +KI DF +S VFE+   +  R  GT  + APE
Sbjct: 150 TYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER-LGTAYYIAPE 208
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
             L   Y  K  D W++GV L+ ++ G  PF G+T Q+   K+      F    +PE +N
Sbjct: 209 -VLRKKYDEK-CDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD---SPEWKN 263
Query: 357 LLEG-------LLCKDPTRRLTLNDVAKHTWV 381
           + EG       +L  D  RR++     +H W+
Sbjct: 264 VSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKW 296

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 16  VKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL 75
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 76  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGG 127
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 188 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 243
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 244 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 297

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 89/272 (32%), Positives = 143/272 (52%), Gaps = 18/272 (6%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + Y  V+K+G+G+YG+V+L +  L G   AIK   KS ++      +  A+ D   EV +
Sbjct: 4   DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVT---TTSNSGALLD---EVAV 57
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +K L HPNI+ L E  +D    ++Y+V+E   G    D         E  A   ++ ++S
Sbjct: 58  LKQLDHPNIMKLYEFFEDKR--NYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS 115
Query: 238 GLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           G  YLH HN+VH D+KP+NLL+   +    +KI DF +S  FE    +  R  GT  + A
Sbjct: 116 GTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER-LGTAYYIA 174
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF--PD--AM 350
           PE  L   Y  K  D W+ GV LY ++ G  PF G+T Q+   ++      F  PD   +
Sbjct: 175 PE-VLRKKYDEK-CDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQV 232
Query: 351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL 382
           + E + L++ +L  +P++R++  +   H W++
Sbjct: 233 SDEAKQLVKLMLTYEPSKRISAEEALNHPWIV 264

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 8   VKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL 67
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 68  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGG 119
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 120 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 179
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 180 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 235
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 236 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 289

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 135/269 (50%), Gaps = 23/269 (8%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           ++G+G +  V   R    G  YA K   K      R   S     D+ REV I+K +QHP
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQHP 74
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           N++ L EV +  N     ++LE V G    D   +  ++ E  A ++L+ I++G+ YLH 
Sbjct: 75  NVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 245 HNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC-- 298
             + H D+KP+N+++     P   +KI DF ++   +  N+  +   GTP F APE    
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 299 --LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA----MNP 352
             LGL      AD W++GV  Y ++ G  PFLG+T Q+T   +   +  F D      + 
Sbjct: 192 EPLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
             ++ +  LL KDP +R+T+ D  +H W+
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 86/272 (31%), Positives = 138/272 (50%), Gaps = 17/272 (6%)
Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           T  ++++  ++ +G GS+G+V+L +    G H+A+K   K  + KL+    E  + + R 
Sbjct: 37  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQI--EHTLNEKR- 93
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
              I++ +  P +V L     D  + + YMV+EYV G        + G   E  AR Y  
Sbjct: 94  ---ILQAVNFPFLVKLEYSFKD--NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
            IV    YLH  ++++ D+KP+NLL+   G +++ DF  ++  +     L    GTP + 
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYL 205
Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPE 353
           APE  L   Y  KA D WA+GV +Y M  G  PF  +     Y+KIV+  + FP   + +
Sbjct: 206 APEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSD 264
Query: 354 LRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
           L++LL  LL  D T+R       +ND+  H W
Sbjct: 265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 144/294 (48%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 16  VKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL 75
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EY  G 
Sbjct: 76  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYAPGG 127
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NL++   G +K+ DF 
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 187
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 188 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 243
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 244 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 297

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 143/294 (48%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSED--ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+       +     E  I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLK------QIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NL++   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  +   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEYLAPEIIISKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 86/272 (31%), Positives = 138/272 (50%), Gaps = 17/272 (6%)
Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           T  ++++  ++ +G GS+G+V+L +    G H+A+K   K  + KL+    E  + + R 
Sbjct: 37  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQI--EHTLNEKR- 93
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
              I++ +  P +V L     D  + + YMV+EYV G        + G   E  AR Y  
Sbjct: 94  ---ILQAVNFPFLVKLEYSFKD--NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
            IV    YLH  ++++ D+KP+NLL+   G +++ DF  ++  +     L    GTP + 
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYL 205
Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPE 353
           APE  L   Y  KA D WA+GV +Y M  G  PF  +     Y+KIV+  + FP   + +
Sbjct: 206 APEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSD 264
Query: 354 LRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
           L++LL  LL  D T+R       +ND+  H W
Sbjct: 265 LKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKW 296

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 135/269 (50%), Gaps = 23/269 (8%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           ++G+G +  V   R    G  YA K   K      R   S     D+ REV I+K +QHP
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQHP 74
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           N++ L EV +  N     ++LE V G    D   +  ++ E  A ++L+ I++G+ YLH 
Sbjct: 75  NVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 245 HNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC-- 298
             + H D+KP+N+++     P   +KI DF ++   +  N+  +   GTP F APE    
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 299 --LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA----MNP 352
             LGL      AD W++GV  Y ++ G  PFLG+T Q+T   +   +  F D      + 
Sbjct: 192 EPLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
             ++ +  LL KDP +R+T+ D  +H W+
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 86/272 (31%), Positives = 138/272 (50%), Gaps = 17/272 (6%)
Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           T  ++++  ++ +G GS+G+V+L +    G H+A+K   K  + KL+    E  + + R 
Sbjct: 37  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQI--EHTLNEKR- 93
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
              I++ +  P +V L     D  + + YMV+EYV G        + G   E  AR Y  
Sbjct: 94  ---ILQAVNFPFLVKLEYSFKD--NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
            IV    YLH  ++++ D+KP+NLL+   G +++ DF  ++  +     L    GTP + 
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYL 205
Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPE 353
           APE  L   Y  KA D WA+GV +Y M  G  PF  +     Y+KIV+  + FP   + +
Sbjct: 206 APEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSD 264
Query: 354 LRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
           L++LL  LL  D T+R       +ND+  H W
Sbjct: 265 LKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKW 296

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 16  VKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL 75
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 76  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGG 127
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 128 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 188 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 243
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 244 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 297

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 139/269 (51%), Gaps = 23/269 (8%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           ++G+G +  V   R    GK YA K   K  LS  R   S     ++ REV I++ ++HP
Sbjct: 19  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSRE---EIEREVNILREIRHP 75
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           NI+ L ++ +  N     ++LE V G    D   +  ++ E  A ++L+ I+ G+ YLH 
Sbjct: 76  NIITLHDIFE--NKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 133
Query: 245 HNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC-- 298
             + H D+KP+N+++     P+  +K+ DF ++   E  N+  +   GTP F APE    
Sbjct: 134 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAPEIVNY 192
Query: 299 --LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD---AMNPE 353
             LGL      AD W++GV  Y ++ G  PFLGET Q+T   I   +  F +   +   E
Sbjct: 193 EPLGL-----EADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 247
Query: 354 L-RNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           L ++ +  LL KDP RR+ +    +H+W+
Sbjct: 248 LAKDFIRRLLVKDPKRRMXIAQSLEHSWI 276

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EY  G 
Sbjct: 75  DKQKVVKLK--EIEHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYAPGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NL++   G +K+ DF 
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
           +++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 LAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 144/294 (48%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSED--ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP   APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 142/294 (48%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSED--ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+       +     E  I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLK------QIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + AP   L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEYLAPAIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 135/270 (50%), Gaps = 23/270 (8%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
            ++G+G +  V   R    G  YA K   K      R   S     D+ REV I+K +QH
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQH 73
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PN++ L EV +  N     ++LE V G    D   +  ++ E  A ++L+ I++G+ YLH
Sbjct: 74  PNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 244 GHNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC- 298
              + H D+KP+N+++     P   +KI DF ++   +  N+  +   GTP F APE   
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVN 190
Query: 299 ---LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA----MN 351
              LGL      AD W++GV  Y ++ G  PFLG+T Q+T   +   +  F D      +
Sbjct: 191 YEPLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
              ++ +  LL KDP +R+T+ D  +H W+
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 135/269 (50%), Gaps = 23/269 (8%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           ++G+G +  V   R    G  YA K   K      R   S     D+ REV I+K +QHP
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQHP 74
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           N++ L EV +  N     ++LE V G    D   +  ++ E  A ++L+ I++G+ YLH 
Sbjct: 75  NVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 245 HNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC-- 298
             + H D+KP+N+++     P   +KI DF ++   +  N+  +   GTP F APE    
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 299 --LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA----MNP 352
             LGL      AD W++GV  Y ++ G  PFLG+T Q+T   +   +  F D      + 
Sbjct: 192 EPLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
             ++ +  LL KDP +R+T+ D  +H W+
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 89/272 (32%), Positives = 142/272 (52%), Gaps = 18/272 (6%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + Y  V+K+G+G+YG+V+L +  L G   AIK   KS ++      +  A+ D   EV +
Sbjct: 21  DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVT---TTSNSGALLD---EVAV 74
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +K L HPNI+ L E  +D    ++Y+V+E   G    D         E  A   ++ ++S
Sbjct: 75  LKQLDHPNIMKLYEFFEDKR--NYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS 132
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           G  YLH HN+VH D+KP+NLL+        +KI DF +S  FE    +  R  GT  + A
Sbjct: 133 GTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL-GTAYYIA 191
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF--PD--AM 350
           PE  L   Y  K  D W+ GV LY ++ G  PF G+T Q+   ++      F  PD   +
Sbjct: 192 PE-VLRKKYDEK-CDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQV 249
Query: 351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL 382
           + E + L++ +L  +P++R++  +   H W++
Sbjct: 250 SDEAKQLVKLMLTYEPSKRISAEEALNHPWIV 281

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 86/272 (31%), Positives = 137/272 (50%), Gaps = 17/272 (6%)
Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           T  ++++  ++ +G GS+G+V+L +    G HYA+K   K  + KL+    E  + + R 
Sbjct: 37  TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKR- 93
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
              I++ +  P +V L     D  + + YMV+EY  G        + G   E  AR Y  
Sbjct: 94  ---ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
            IV    YLH  ++++ D+KP+NL++   G +K+ DF  ++  +     L    GTP + 
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYL 205
Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPE 353
           APE  L   Y  KA D WA+GV +Y M  G  PF  +     Y+KIV+  + FP   + +
Sbjct: 206 APEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSD 264
Query: 354 LRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
           L++LL  LL  D T+R       +ND+  H W
Sbjct: 265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 142/294 (48%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSED--ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+       +     E  I++ +  P +V L     D  + + YMV+EYV G 
Sbjct: 75  DKQKVVKLK------QIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+        +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKAFGNLKNGVNDIKNHKW 296

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 135/270 (50%), Gaps = 23/270 (8%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
            ++G+G +  V   R    G  YA K   K      R   S     D+ REV I+K +QH
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQH 73
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PN++ L EV +  N     ++LE V G    D   +  ++ E  A ++L+ I++G+ YLH
Sbjct: 74  PNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 244 GHNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC- 298
              + H D+KP+N+++     P   +KI DF ++   +  N+  +   GTP F APE   
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVN 190
Query: 299 ---LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA----MN 351
              LGL      AD W++GV  Y ++ G  PFLG+T Q+T   +   +  F D      +
Sbjct: 191 YEPLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
              ++ +  LL KDP +R+T+ D  +H W+
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 135/270 (50%), Gaps = 23/270 (8%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
            ++G+G +  V   R    G  YA K   K      R   S     D+ REV I+K +QH
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQH 73
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PN++ L EV +  N     ++LE V G    D   +  ++ E  A ++L+ I++G+ YLH
Sbjct: 74  PNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 244 GHNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC- 298
              + H D+KP+N+++     P   +KI DF ++   +  N+  +   GTP F APE   
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVN 190
Query: 299 ---LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA----MN 351
              LGL      AD W++GV  Y ++ G  PFLG+T Q+T   +   +  F D      +
Sbjct: 191 YEPLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
              ++ +  LL KDP +R+T+ D  +H W+
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 135/270 (50%), Gaps = 23/270 (8%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
            ++G+G +  V   R    G  YA K   K      R   S     D+ REV I+K +QH
Sbjct: 17  EELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQH 73
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PN++ L EV +  N     ++LE V G    D   +  ++ E  A ++L+ I++G+ YLH
Sbjct: 74  PNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 244 GHNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC- 298
              + H D+KP+N+++     P   +KI DF ++   +  N+  +   GTP F APE   
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVN 190
Query: 299 ---LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA----MN 351
              LGL      AD W++GV  Y ++ G  PFLG+T Q+T   +   +  F D      +
Sbjct: 191 YEPLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
              ++ +  LL KDP +R+T+ D  +H W+
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 135/270 (50%), Gaps = 23/270 (8%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
            ++G+G +  V   R    G  YA K   K      R   S     D+ REV I+K +QH
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQH 73
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PN++ L EV +  N     ++LE V G    D   +  ++ E  A ++L+ I++G+ YLH
Sbjct: 74  PNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 244 GHNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC- 298
              + H D+KP+N+++     P   +KI DF ++   +  N+  +   GTP F APE   
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVN 190
Query: 299 ---LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA----MN 351
              LGL      AD W++GV  Y ++ G  PFLG+T Q+T   +   +  F D      +
Sbjct: 191 YEPLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
              ++ +  LL KDP +R+T+ D  +H W+
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 135/270 (50%), Gaps = 23/270 (8%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
            ++G+G +  V   R    G  YA K   K      R   S     D+ REV I+K +QH
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQH 72
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PN++ L EV +  N     ++LE V G    D   +  ++ E  A ++L+ I++G+ YLH
Sbjct: 73  PNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 244 GHNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC- 298
              + H D+KP+N+++     P   +KI DF ++   +  N+  +   GTP F APE   
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVN 189
Query: 299 ---LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA----MN 351
              LGL      AD W++GV  Y ++ G  PFLG+T Q+T   +   +  F D      +
Sbjct: 190 YEPLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244
Query: 352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
              ++ +  LL KDP +R+T+ D  +H W+
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 135/269 (50%), Gaps = 23/269 (8%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           ++G+G +  V   R    G  YA K   K      R   S     D+ REV I+K +QHP
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQHP 74
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           N++ L EV +  N     ++LE V G    D   +  ++ E  A ++L+ I++G+ YLH 
Sbjct: 75  NVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 245 HNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC-- 298
             + H D+KP+N+++     P   +KI DF ++   +  N+  +   GTP F APE    
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 299 --LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA----MNP 352
             LGL      AD W++GV  Y ++ G  PFLG+T Q+T   +   +  F D      + 
Sbjct: 192 EPLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
             ++ +  LL KDP +R+T+ D  +H W+
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 135/270 (50%), Gaps = 23/270 (8%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
            ++G+G +  V   R    G  YA K   K      R   S     D+ REV I+K +QH
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQH 72
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PN++ L EV +  N     ++LE V G    D   +  ++ E  A ++L+ I++G+ YLH
Sbjct: 73  PNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 244 GHNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC- 298
              + H D+KP+N+++     P   +KI DF ++   +  N+  +   GTP F APE   
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVN 189
Query: 299 ---LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA----MN 351
              LGL      AD W++GV  Y ++ G  PFLG+T Q+T   +   +  F D      +
Sbjct: 190 YEPLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244
Query: 352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
              ++ +  LL KDP +R+T+ D  +H W+
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 144/294 (48%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EY  G 
Sbjct: 75  DKQKVVKLKQI--EHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYAPGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NL++   G +K+ DF 
Sbjct: 127 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 132/268 (49%), Gaps = 19/268 (7%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G++ +VVL      GK +A+K   K  L        +   + +  E+ +++ ++H N
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCIPKKAL--------KGKESSIENEIAVLRKIKHEN 81
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           IV L ++ + PN  H Y+V++ V G    D   + G   E  A   +R ++  + YLH  
Sbjct: 82  IVALEDIYESPN--HLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRM 139
Query: 246 NVVHGDIKPDNLLVAPS---GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
            +VH D+KP+NLL         + I DF +S++ E   DV+  + GTP + APE      
Sbjct: 140 GIVHRDLKPENLLYYSQDEESKIMISDFGLSKM-EGKGDVMSTACGTPGYVAPEVLAQKP 198
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAMNPELRNLL 358
           Y  KA D W++GV  Y ++ G  PF  E     +++I+     F     D ++   ++ +
Sbjct: 199 Y-SKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFI 257
Query: 359 EGLLCKDPTRRLTLNDVAKHTWVLGDNG 386
             L+ KDP +R T    A+H W+ GD  
Sbjct: 258 RNLMEKDPNKRYTCEQAARHPWIAGDTA 285

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 145/294 (49%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+    E  + + R    I++ +  P +V L     D  + + YMV+EY  G 
Sbjct: 75  DKQKVVKLK--EIEHTLNEKR----ILQAVNFPFLVKLEFSFKD--NSNLYMVMEYAPGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NL++   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
           +++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 LAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 135/270 (50%), Gaps = 23/270 (8%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
            ++G+G +  V   R    G  YA K   K      R   S     D+ REV I+K +QH
Sbjct: 17  EELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQH 73
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PN++ L EV +  N     ++LE V G    D   +  ++ E  A ++L+ I++G+ YLH
Sbjct: 74  PNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 244 GHNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC- 298
              + H D+KP+N+++     P   +KI DF ++   +  N+  +   GTP F APE   
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVN 190
Query: 299 ---LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA----MN 351
              LGL      AD W++GV  Y ++ G  PFLG+T Q+T   +   +  F D      +
Sbjct: 191 YEPLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
              ++ +  LL KDP +R+T+ D  +H W+
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 142/294 (48%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 15  VKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL 74
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+       +     E  I++ +  P +V L     D  + + YMV+EY  G 
Sbjct: 75  DKQKVVKLK------QIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYAPGG 126
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NL++   G +++ DF 
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFG 186
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 187 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 138/269 (51%), Gaps = 23/269 (8%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           ++G+G +  V   R    GK YA K   K  L   R   S     ++ REV I++ ++HP
Sbjct: 33  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSRE---EIEREVNILREIRHP 89
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           NI+ L ++ +  N     ++LE V G    D   +  ++ E  A ++L+ I+ G+ YLH 
Sbjct: 90  NIITLHDIFE--NKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 147
Query: 245 HNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC-- 298
             + H D+KP+N+++     P+  +K+ DF ++   E  N+  +   GTP F APE    
Sbjct: 148 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAPEIVNY 206
Query: 299 --LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD---AMNPE 353
             LGL      AD W++GV  Y ++ G  PFLGET Q+T   I   +  F +   +   E
Sbjct: 207 EPLGL-----EADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 261
Query: 354 L-RNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           L ++ +  LL KDP RR+ +    +H+W+
Sbjct: 262 LAKDFIRRLLVKDPKRRMXIAQSLEHSWI 290

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 141/294 (47%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 16  VKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL 75
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+       +     E  I++ +  P +  L     D  + + YMV+EY  G 
Sbjct: 76  DKQKVVKLK------QIEHTLNEKRILQAVNFPFLTKLEFSFKD--NSNLYMVMEYAPGG 127
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NL++   G +K+ DF 
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 187
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 188 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 243
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 244 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 297

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 134/272 (49%), Gaps = 17/272 (6%)
Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           T  ++++  ++ +G GS+G+V+L +    G HYA+K   K  + KL+       +     
Sbjct: 38  TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK------QIEHTLN 91
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
           E  I++ +  P +  L     D  + + YMV+EY  G        + G   E  AR Y  
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKD--NSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
            IV    YLH  ++++ D+KP+NL++   G +K+ DF  ++  +     L    GTP + 
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYL 206
Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPE 353
           APE  L   Y  KA D WA+GV +Y M  G  PF  +     Y+KIV+  + FP   + +
Sbjct: 207 APEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSD 265
Query: 354 LRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
           L++LL  LL  D T+R       +ND+  H W
Sbjct: 266 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 297

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 131/255 (51%), Gaps = 10/255 (3%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +NE+ +++ +G G++GKV+L +    G++YA+K   K  +    VA  E A T     VL
Sbjct: 150 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI----VAKDEVAHTLTENRVL 205
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
             +  +HP +  L         D    V+EY  G        +     E  AR Y  +IV
Sbjct: 206 --QNSRHPFLTALKYSFQ--THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 261
Query: 237 SGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           S L YLH   NVV+ D+K +NL++   G +KI DF + +    D   ++   GTP + AP
Sbjct: 262 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAP 321
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELR 355
           E      YG +A D W +GV +Y M+ G+ PF  +  +  ++ I+   + FP  + PE +
Sbjct: 322 EVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAK 380
Query: 356 NLLEGLLCKDPTRRL 370
           +LL GLL KDP +RL
Sbjct: 381 SLLSGLLKKDPKQRL 395

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  134 bits (338), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 131/255 (51%), Gaps = 10/255 (3%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +NE+ +++ +G G++GKV+L +    G++YA+K   K  +    VA  E A T     VL
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI----VAKDEVAHTLTENRVL 202
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
             +  +HP +  L         D    V+EY  G        +     E  AR Y  +IV
Sbjct: 203 --QNSRHPFLTALKYSFQ--THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 258
Query: 237 SGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           S L YLH   NVV+ D+K +NL++   G +KI DF + +    D   ++   GTP + AP
Sbjct: 259 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAP 318
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELR 355
           E      YG +A D W +GV +Y M+ G+ PF  +  +  ++ I+   + FP  + PE +
Sbjct: 319 EVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAK 377
Query: 356 NLLEGLLCKDPTRRL 370
           +LL GLL KDP +RL
Sbjct: 378 SLLSGLLKKDPKQRL 392

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 141/294 (47%), Gaps = 19/294 (6%)
Query: 94  CRQFPVKESNKLIRSEDE--NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
            ++F  K     ++  +     T  ++++  ++ +G GS+G+V+L +    G HYA+K  
Sbjct: 16  VKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL 75
Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK 211
            K  + KL+       +     E  I++ +  P +  L     D  + + YMV+EY  G 
Sbjct: 76  DKQKVVKLK------QIEHTLNEKRILQAVNFPFLTKLEFSFKD--NSNLYMVMEYAPGG 127
Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
                  + G   E  AR Y   IV    YLH  ++++ D+KP+NL++   G +K+ DF 
Sbjct: 128 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 187
Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            ++  +     L    GTP + APE  L   Y  KA D WA+GV +Y M  G  PF  + 
Sbjct: 188 FAKRVKGRTWXL---CGTPEYLAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQ 243
Query: 332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
               Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 244 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 297

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 138/269 (51%), Gaps = 17/269 (6%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           + ++  +R +G GS+G+V L RS  +G++YA+K   K  + +L+       +     E L
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK------QVEHTNDERL 58
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           ++ ++ HP I+ +     D  +   +M+++Y+EG        +       +A+ Y  ++ 
Sbjct: 59  MLSIVTHPFIIRMWGTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC 116
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
             L YLH  ++++ D+KP+N+L+  +G +KI DF  ++   D   V     GTP + APE
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYXLCGTPDYIAPE 173
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
                 Y  K+ D W+ G+ +Y M+ G  PF       TY+KI+N  L FP   N ++++
Sbjct: 174 VVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 232
Query: 357 LLEGLLCKDPTRRL-----TLNDVAKHTW 380
           LL  L+ +D ++RL        DV  H W
Sbjct: 233 LLSRLITRDLSQRLGNLQNGTEDVKNHPW 261

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 131/255 (51%), Gaps = 10/255 (3%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +NE+ +++ +G G++GKV+L +    G++YA+K   K  +    VA  E A T     VL
Sbjct: 8   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI----VAKDEVAHTLTENRVL 63
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
             +  +HP +  L         D    V+EY  G        +     E  AR Y  +IV
Sbjct: 64  --QNSRHPFLTALKYSFQ--THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 119
Query: 237 SGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           S L YLH   NVV+ D+K +NL++   G +KI DF + +    D   ++   GTP + AP
Sbjct: 120 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAP 179
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELR 355
           E      YG +A D W +GV +Y M+ G+ PF  +  +  ++ I+   + FP  + PE +
Sbjct: 180 EVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAK 238
Query: 356 NLLEGLLCKDPTRRL 370
           +LL GLL KDP +RL
Sbjct: 239 SLLSGLLKKDPKQRL 253

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 132/255 (51%), Gaps = 10/255 (3%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +NE+ +++ +G G++GKV+L +    G++YA+K   K    ++ VA  E A T     VL
Sbjct: 7   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK----EVIVAKDEVAHTLTENRVL 62
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
             +  +HP +  L         D    V+EY  G        +     E  AR Y  +IV
Sbjct: 63  --QNSRHPFLTALKYSFQ--THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 118
Query: 237 SGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           S L YLH   NVV+ D+K +NL++   G +KI DF + +    D   ++   GTP + AP
Sbjct: 119 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAP 178
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELR 355
           E      YG +A D W +GV +Y M+ G+ PF  +  +  ++ I+   + FP  + PE +
Sbjct: 179 EVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAK 237
Query: 356 NLLEGLLCKDPTRRL 370
           +LL GLL KDP +RL
Sbjct: 238 SLLSGLLKKDPKQRL 252

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 131/255 (51%), Gaps = 10/255 (3%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +NE+ +++ +G G++GKV+L +    G++YA+K   K  +    VA  E A T     VL
Sbjct: 9   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI----VAKDEVAHTLTENRVL 64
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
             +  +HP +  L         D    V+EY  G        +     E  AR Y  +IV
Sbjct: 65  --QNSRHPFLTALKYSFQ--THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 120
Query: 237 SGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           S L YLH   NVV+ D+K +NL++   G +KI DF + +    D   ++   GTP + AP
Sbjct: 121 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAP 180
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELR 355
           E      YG +A D W +GV +Y M+ G+ PF  +  +  ++ I+   + FP  + PE +
Sbjct: 181 EVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAK 239
Query: 356 NLLEGLLCKDPTRRL 370
           +LL GLL KDP +RL
Sbjct: 240 SLLSGLLKKDPKQRL 254

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 143/273 (52%), Gaps = 23/273 (8%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           + +YV ++KIG GS+GK +L +S+ DG+ Y IK  + S +S            + RREV 
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-------SKEREESRREVA 75
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF----GQPGAI-GESMARKY 231
           ++  ++HPNIV   E  ++  S   Y+V++Y EG    D F     Q G +  E     +
Sbjct: 76  VLANMKHPNIVQYRESFEENGS--LYIVMDYCEG---GDLFKRINAQKGVLFQEDQILDW 130
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
              I   L ++H   ++H DIK  N+ +   GTV++GDF +++V     ++ R   GTP 
Sbjct: 131 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY 190
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA-- 349
           + +PE C    Y  K +D WA+G  LY +   ++ F   ++++   KI++ S  FP    
Sbjct: 191 YLSPEICENKPYNNK-SDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS--FPPVSL 247
Query: 350 -MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
             + +LR+L+  L  ++P  R ++N + +  ++
Sbjct: 248 HYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 134/270 (49%), Gaps = 23/270 (8%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
            ++G+G +  V   R    G  YA K   K      R   S     D+ REV I+K +QH
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQH 73
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PN++ L EV +  N     ++ E V G    D   +  ++ E  A ++L+ I++G+ YLH
Sbjct: 74  PNVITLHEVYE--NKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 244 GHNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC- 298
              + H D+KP+N+++     P   +KI DF ++   +  N+  +   GTP F APE   
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVN 190
Query: 299 ---LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA----MN 351
              LGL      AD W++GV  Y ++ G  PFLG+T Q+T   +   +  F D      +
Sbjct: 191 YEPLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
              ++ +  LL KDP +R+T+ D  +H W+
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 125/265 (47%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 93
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 94  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 151
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDF--SVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  SV       +D+     GT  +  PE   G 
Sbjct: 152 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDYLPPEMIEGR 207
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 208 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 266
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 267 LKHNPSQRPMLREVLEHPWITANSS 291

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 139/272 (51%), Gaps = 25/272 (9%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           ++  RK+G+G++G V L      G    IK  +K          S+  M  +  E+ ++K
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--------SQVPMEQIEAEIEVLK 75
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY----LRDI 235
            L HPNI+ + EV +D ++   Y+V+E  EG    +      A G++++  Y    ++ +
Sbjct: 76  SLDHPNIIKIFEVFEDYHN--MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 236 VSGLMYLHGHNVVHGDIKPDNLL---VAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
           ++ L Y H  +VVH D+KP+N+L    +P   +KI DF ++++F+ D      + GT ++
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-TNAAGTALY 192
Query: 293 TAPECC-LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN---NSLVFPD 348
            APE     +T+     D W+ GV +Y+++ G  PF G +L++   K      N  V   
Sbjct: 193 MAPEVFKRDVTF---KCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR 249
Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
            + P+  +LL+ +L KDP RR +   V  H W
Sbjct: 250 PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEW 281

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 14  RPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 67
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  S   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 68  PNILRLYGYFHD--STRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  S          RR+   GT  +  PE   G 
Sbjct: 126 SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRAALCGTLDYLPPEMIEGR 181
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T QDTY +I      FPD +    R+L+  L
Sbjct: 182 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARDLISRL 240
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 241 LKHNPSQRPMLREVLEHPWITANSS 265

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 72
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 73  PNILRLYGYFHD--ATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCH 130
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  S          RR+   GT  +  PE   G 
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGR 186
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 187 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 245
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 246 LKHNPSQRPMLREVLEHPWITANSS 270

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 68
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 69  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDF--SVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  SV        D+     GT  +  PE   G 
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGR 182
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 183 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 241
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 242 LKHNPSQRPMLREVLEHPWITANSS 266

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 123/264 (46%), Gaps = 13/264 (4%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 68
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 69  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
              V+H DIKP+NLL+  +G +KI DF  S        D L    GT  +  PE   G  
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTL---CGTLDYLPPEMIEGRM 183
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLL 362
           +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  LL
Sbjct: 184 HDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 242
Query: 363 CKDPTRRLTLNDVAKHTWVLGDNG 386
             +P++R  L +V +H W+  ++ 
Sbjct: 243 KHNPSQRPMLREVLEHPWITANSS 266

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 31  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 84
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 85  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 142
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  S          RR+   GT  +  PE   G 
Sbjct: 143 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGR 198
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 199 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 257
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 258 LKHNPSQRPMLREVLEHPWITANSS 282

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 93
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 94  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 151
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  S          RR+   GT  +  PE   G 
Sbjct: 152 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGR 207
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 208 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 266
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 267 LKHNPSQRPMLREVLEHPWITANSS 291

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 67
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 68  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDF--SVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  SV        D+     GT  +  PE   G 
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGR 181
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 182 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 240
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 241 LKHNPSQRPMLREVLEHPWITANSS 265

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 72
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 73  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 130
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDF--SVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  SV        D+     GT  +  PE   G 
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGR 186
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 187 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 245
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 246 LKHNPSQRPMLREVLEHPWITANSS 270

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 122/263 (46%), Gaps = 11/263 (4%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 72
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 73  PNILRLYGYFHD--ATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCH 130
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTY 303
              V+H DIKP+NLL+  +G +KI DF  S      +       GT  +  PE   G  +
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLXGTLDYLPPEMIEGRMH 188
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  LL 
Sbjct: 189 DEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 247
Query: 364 KDPTRRLTLNDVAKHTWVLGDNG 386
            +P++R  L +V +H W+  ++ 
Sbjct: 248 HNPSQRPMLREVLEHPWITANSS 270

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 136/271 (50%), Gaps = 19/271 (7%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+G+V+  +  +  + YA+K  +K+       +      + + REV ++K L HPN
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKA-------SAKNKDTSTILREVELLKKLDHPN 82
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           I+ L E+++D +S  FY+V E   G    D   +     E  A + ++ + SG+ Y+H H
Sbjct: 83  IMKLFEILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 246 NVVHGDIKPDNLLVAPSGT---VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
           N+VH D+KP+N+L+        +KI DF +S  F+  N  ++   GT  + APE   G T
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYIAPEVLRG-T 198
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAMNPELRNLL 358
           Y  K  D W+ GV LY ++ G  PF G+   D   ++      F       ++ + ++L+
Sbjct: 199 YDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI 257
Query: 359 EGLLCKDPTRRLTLNDVAKHTWVLGDNGPIP 389
             +L   P+ R+T     +H W+   +   P
Sbjct: 258 RKMLTFHPSLRITATQCLEHPWIQKYSSETP 288

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 67
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 68  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDF--SVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  SV        D+     GT  +  PE   G 
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGR 181
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 182 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 240
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 241 LKHNPSQRPMLREVLEHPWITANSS 265

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 70
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 71  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  S          RR+   GT  +  PE   G 
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGR 184
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 185 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 243
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 244 LKHNPSQRPMLREVLEHPWITANSS 268

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 72
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 73  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 130
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  S          RR+   GT  +  PE   G 
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEXIEGR 186
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 187 XHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 245
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 246 LKHNPSQRPXLREVLEHPWITANSS 270

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 72
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 73  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 130
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  S          RR+   GT  +  PE   G 
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGR 186
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 187 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 245
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 246 LKHNPSQRPMLREVLEHPWITANSS 270

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 125/265 (47%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 70
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 71  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDF--SVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  SV       +D+     GT  +  PE   G 
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDYLPPEMIEGR 184
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 185 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 243
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 244 LKHNPSQRPMLREVLEHPWITANSS 268

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 70
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 71  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  S          RR+   GT  +  PE   G 
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRAALCGTLDYLPPEMIEGR 184
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 185 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 243
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 244 LKHNPSQRPMLREVLEHPWITANSS 268

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 67
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 68  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  S          RR+   GT  +  PE   G 
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTELCGTLDYLPPEMIEGR 181
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 182 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 240
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 241 LKHNPSQRPMLREVLEHPWITANSS 265

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 67
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 68  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  S          RR+   GT  +  PE   G 
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGR 181
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 182 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 240
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 241 LKHNPSQRPMLREVLEHPWITANSS 265

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 68
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 69  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS--PGTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  S          RR+   GT  +  PE   G 
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSS----RRTTLSGTLDYLPPEMIEGR 182
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 183 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 241
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 242 LKHNPSQRPMLREVLEHPWITANSS 266

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 134/263 (50%), Gaps = 19/263 (7%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+G+V+  +  +  + YA+K  +K+       +      + + REV ++K L HPN
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKA-------SAKNKDTSTILREVELLKKLDHPN 82
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           I+ L E+++D +S  FY+V E   G    D   +     E  A + ++ + SG+ Y+H H
Sbjct: 83  IMKLFEILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 246 NVVHGDIKPDNLLVAPSGT---VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
           N+VH D+KP+N+L+        +KI DF +S  F+  N  ++   GT  + APE   G T
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYIAPEVLRG-T 198
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAMNPELRNLL 358
           Y  K  D W+ GV LY ++ G  PF G+   D   ++      F       ++ + ++L+
Sbjct: 199 YDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI 257
Query: 359 EGLLCKDPTRRLTLNDVAKHTWV 381
             +L   P+ R+T     +H W+
Sbjct: 258 RKMLTFHPSLRITATQCLEHPWI 280

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 70
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 71  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  S          RR+   GT  +  PE   G 
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGR 184
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 185 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 243
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 244 LKHNPSQRPMLREVLEHPWITANSS 268

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 134/263 (50%), Gaps = 19/263 (7%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+G+V+  +  +  + YA+K  +K+       +      + + REV ++K L HPN
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKA-------SAKNKDTSTILREVELLKKLDHPN 82
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           I+ L E+++D +S  FY+V E   G    D   +     E  A + ++ + SG+ Y+H H
Sbjct: 83  IMKLFEILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 246 NVVHGDIKPDNLLVAPSGT---VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
           N+VH D+KP+N+L+        +KI DF +S  F+  N  ++   GT  + APE   G T
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYIAPEVLRG-T 198
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAMNPELRNLL 358
           Y  K  D W+ GV LY ++ G  PF G+   D   ++      F       ++ + ++L+
Sbjct: 199 YDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI 257
Query: 359 EGLLCKDPTRRLTLNDVAKHTWV 381
             +L   P+ R+T     +H W+
Sbjct: 258 RKMLTFHPSLRITATQCLEHPWI 280

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 67
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 68  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  S          RR+   GT  +  PE   G 
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRAALCGTLDYLPPEMIEGR 181
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 182 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 240
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 241 LKHNPSQRPMLREVLEHPWITANSS 265

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 123/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 69
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 70  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 127
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  S          RR    GT  +  PE   G 
Sbjct: 128 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGTLDYLPPEMIEGR 183
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 184 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 242
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 243 LKHNPSQRPMLREVLEHPWITANSS 267

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 13  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 66
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 67  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 124
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  S          RR+   GT  +  PE   G 
Sbjct: 125 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGR 180
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 181 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 239
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 240 LKHNPSQRPMLREVLEHPWITANSS 264

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 18  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 71
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 72  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 129
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  S          RR+   GT  +  PE   G 
Sbjct: 130 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGR 185
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 186 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 244
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 245 LKHNPSQRPMLREVLEHPWITANSS 269

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 67
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 68  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  S          RR+   GT  +  PE   G 
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTXLCGTLDYLPPEMIEGR 181
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 182 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 240
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 241 LKHNPSQRPMLREVLEHPWITANSS 265

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 69
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 70  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 127
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI +F  S          RR+   GT  +  PE   G 
Sbjct: 128 SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGR 183
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 184 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 242
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 243 LKHNPSQRPMLREVLEHPWITANSS 267

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 123/264 (46%), Gaps = 13/264 (4%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE------HQLRREVEIQSHLRH 71
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 72  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCH 129
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
              V+H DIKP+NLL+  +G +KI DF  S        D L    GT  +  PE   G  
Sbjct: 130 SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTL---CGTLDYLPPEMIEGRM 186
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLL 362
           +  K  D W++GV  Y  ++G  PF   T Q+TY +I      FPD +    R+L+  LL
Sbjct: 187 HDEKV-DLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISRLL 245
Query: 363 CKDPTRRLTLNDVAKHTWVLGDNG 386
             + ++RLTL +V +H W+  ++ 
Sbjct: 246 KHNASQRLTLAEVLEHPWIKANSS 269

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  127 bits (320), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 122/263 (46%), Gaps = 11/263 (4%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 70
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 71  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTY 303
              V+H DIKP+NLL+  +G +KI DF  S      +       GT  +  PE   G  +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIEGRMH 186
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  LL 
Sbjct: 187 DEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 245
Query: 364 KDPTRRLTLNDVAKHTWVLGDNG 386
            +P++R  L +V +H W+  ++ 
Sbjct: 246 HNPSQRPMLREVLEHPWITANSS 268

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  127 bits (320), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 128/254 (50%), Gaps = 8/254 (3%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I+ +  +R +G GS+GKV+L R    G  YA+K   K  +  L+    E  MT+ R   +
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI--LQDDDVECTMTEKR---I 76
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           +     HP +  L      P  D  + V+E+V G        +     E+ AR Y  +I+
Sbjct: 77  LSLARNHPFLTQLFCCFQTP--DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEII 134
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S LM+LH   +++ D+K DN+L+   G  K+ DF + +    +        GTP + APE
Sbjct: 135 SALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
               + YG  A D WA+GV LY M+ G  PF  E   D ++ I+N+ +V+P  ++ +   
Sbjct: 195 ILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATG 253
Query: 357 LLEGLLCKDPTRRL 370
           +L+  + K+PT RL
Sbjct: 254 ILKSFMTKNPTMRL 267

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 11  RPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 64
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 65  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 122
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  S          RR+   GT  +  PE   G 
Sbjct: 123 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGR 178
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 179 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 237
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 238 LKHNPSQRPMLREVLEHPWITANSS 262

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 123/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 67
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 68  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  S          RR    GT  +  PE   G 
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGTLDYLPPEMIEGR 181
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 182 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 240
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 241 LKHNPSQRPMLREVLEHPWITANSS 265

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 142/280 (50%), Gaps = 21/280 (7%)
Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           T +   ++ +  +G+G++ +V L +  L GK +A+K   KS   +          + +  
Sbjct: 5   TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---------DSSLEN 55
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
           E+ ++K ++H NIV L ++ +  ++ H+Y+V++ V G    D   + G   E  A   ++
Sbjct: 56  EIAVLKKIKHENIVTLEDIYE--STTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ 113
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLL-VAP--SGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
            ++S + YLH + +VH D+KP+NLL + P  +  + I DF +S++  + N ++  + GTP
Sbjct: 114 QVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTACGTP 171
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP--- 347
            + APE      Y  KA D W++GV  Y ++ G  PF  ET    ++KI      F    
Sbjct: 172 GYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPF 230
Query: 348 -DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG 386
            D ++   ++ +  LL KDP  R T      H W+ G+  
Sbjct: 231 WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA 270

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 134/269 (49%), Gaps = 23/269 (8%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           ++G+G +  V   R    G  YA K   K    + R +       ++ REV I++ + HP
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKR---QSRASRRGVCREEIEREVSILRQVLHP 75
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           NI+ L +V +  N     ++LE V G    D   Q  ++ E  A  +++ I+ G+ YLH 
Sbjct: 76  NIITLHDVYE--NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 245 HNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC-- 298
             + H D+KP+N+++     P   +K+ DF ++   ED  +  +   GTP F APE    
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEIVNY 192
Query: 299 --LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD---AMNPE 353
             LGL      AD W++GV  Y ++ G  PFLG+T Q+T   I   S  F +   +   E
Sbjct: 193 EPLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247
Query: 354 L-RNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           L ++ +  LL K+  +RLT+ +  +H W+
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSHLRH 70
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 71  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI +F  S          RR+   GT  +  PE   G 
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGR 184
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 185 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 243
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  +P++R  L +V +H W+  ++ 
Sbjct: 244 LKHNPSQRPMLREVLEHPWITANSS 268

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 84/265 (31%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   K+ L K  V         +RREV I   L+H
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE------HQLRREVEIQSHLRH 71
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D  +   Y++LEY           +     E     Y+ ++ + L Y H
Sbjct: 72  PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCH 129
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+  +G +KI DF  S          RR+   GT  +  PE   G 
Sbjct: 130 SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGR 185
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W++GV  Y  ++G  PF   T Q+TY +I      FPD +    R+L+  L
Sbjct: 186 MHDEKV-DLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISRL 244
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDNG 386
           L  + ++RLTL +V +H W+  ++ 
Sbjct: 245 LKHNASQRLTLAEVLEHPWIKANSS 269

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 131/271 (48%), Gaps = 18/271 (6%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + Y   R +G GS+G+V+L +  + G+  A+K   K      R    +T    + REV +
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK------RQVKQKTDKESLLREVQL 79
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +K L HPNI+ L E  +D    +FY+V E   G    D         E  A + +R ++S
Sbjct: 80  LKQLDHPNIMKLYEFFEDKG--YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 238 GLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           G+ Y+H + +VH D+KP+NLL+   +    ++I DF +S  FE     ++   GT  + A
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKIGTAYYIA 196
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAM 350
           PE   G TY  K  D W+ GV LY ++ G  PF G    D   K+      F       +
Sbjct: 197 PEVLHG-TYDEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254
Query: 351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           +   ++L+  +L   P+ R++  D   H W+
Sbjct: 255 SESAKDLIRKMLTYVPSMRISARDALDHEWI 285

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 131/271 (48%), Gaps = 18/271 (6%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + Y   R +G GS+G+V+L +  + G+  A+K   K      R    +T    + REV +
Sbjct: 50  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK------RQVKQKTDKESLLREVQL 103
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +K L HPNI+ L E  +D    +FY+V E   G    D         E  A + +R ++S
Sbjct: 104 LKQLDHPNIMKLYEFFEDKG--YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 161
Query: 238 GLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           G+ Y+H + +VH D+KP+NLL+   +    ++I DF +S  FE     ++   GT  + A
Sbjct: 162 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKIGTAYYIA 220
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAM 350
           PE   G TY  K  D W+ GV LY ++ G  PF G    D   K+      F       +
Sbjct: 221 PEVLHG-TYDEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 278
Query: 351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           +   ++L+  +L   P+ R++  D   H W+
Sbjct: 279 SESAKDLIRKMLTYVPSMRISARDALDHEWI 309

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 131/271 (48%), Gaps = 18/271 (6%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + Y   R +G GS+G+V+L +  + G+  A+K   K      R    +T    + REV +
Sbjct: 49  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK------RQVKQKTDKESLLREVQL 102
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +K L HPNI+ L E  +D    +FY+V E   G    D         E  A + +R ++S
Sbjct: 103 LKQLDHPNIMKLYEFFEDKG--YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 160
Query: 238 GLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           G+ Y+H + +VH D+KP+NLL+   +    ++I DF +S  FE     ++   GT  + A
Sbjct: 161 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKIGTAYYIA 219
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAM 350
           PE   G TY  K  D W+ GV LY ++ G  PF G    D   K+      F       +
Sbjct: 220 PEVLHG-TYDEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 277
Query: 351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           +   ++L+  +L   P+ R++  D   H W+
Sbjct: 278 SESAKDLIRKMLTYVPSMRISARDALDHEWI 308

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 131/271 (48%), Gaps = 18/271 (6%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + Y   R +G GS+G+V+L +  + G+  A+K   K      R    +T    + REV +
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK------RQVKQKTDKESLLREVQL 85
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +K L HPNI+ L E  +D    +FY+V E   G    D         E  A + +R ++S
Sbjct: 86  LKQLDHPNIMKLYEFFEDKG--YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 143
Query: 238 GLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           G+ Y+H + +VH D+KP+NLL+   +    ++I DF +S  FE     ++   GT  + A
Sbjct: 144 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKIGTAYYIA 202
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAM 350
           PE   G TY  K  D W+ GV LY ++ G  PF G    D   K+      F       +
Sbjct: 203 PEVLHG-TYDEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 260
Query: 351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           +   ++L+  +L   P+ R++  D   H W+
Sbjct: 261 SESAKDLIRKMLTYVPSMRISARDALDHEWI 291

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 85/271 (31%), Positives = 127/271 (46%), Gaps = 15/271 (5%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I+++  VR +G G +G V L R   +    A+K   KS L K      E     +RRE+ 
Sbjct: 13  IDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK------EGVEHQLRREIE 66
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           I   L+HPNI+ +     D      Y++LE+           + G   E  +  ++ ++ 
Sbjct: 67  IQSHLRHPNILRMYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELA 124
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTA 294
             L Y H   V+H DIKP+NLL+   G +KI DF  S         LRR    GT  +  
Sbjct: 125 DALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV----HAPSLRRRXMCGTLDYLP 180
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPEL 354
           PE   G T+  K  D W  GV  Y  ++G  PF   +  +T+ +IVN  L FP  ++   
Sbjct: 181 PEMIEGKTHDEKV-DLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGS 239
Query: 355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN 385
           ++L+  LL   P +RL L  V +H WV  ++
Sbjct: 240 KDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 84/257 (32%), Positives = 124/257 (48%), Gaps = 8/257 (3%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +++  ++ IG GS+GKV+L R   +   YA+K   K  + K +    E       R VL 
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK----EEKHIMSERNVL- 92
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +K ++HP +V L        +D  Y VL+Y+ G        +     E  AR Y  +I S
Sbjct: 93  LKNVKHPFLVGLHFSFQ--TADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIAS 150
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPEC 297
            L YLH  N+V+ D+KP+N+L+   G + + DF + +   + N       GTP + APE 
Sbjct: 151 ALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210
Query: 298 CLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNL 357
                Y  +  D W +G  LY M+ G  PF      + YD I+N  L     +    R+L
Sbjct: 211 LHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHL 269
Query: 358 LEGLLCKDPTRRLTLND 374
           LEGLL KD T+RL   D
Sbjct: 270 LEGLLQKDRTKRLGAKD 286

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 119/247 (48%), Gaps = 11/247 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+  VVL R     + YAIK   K H+ K      E  +  V RE  +M  L HP 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPF 93
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
            V L     D   +  Y  L Y +         + G+  E+  R Y  +IVS L YLHG 
Sbjct: 94  FVKLYFTFQD--DEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLTY 303
            ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  + +PE  L    
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEKS 210
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K++D WA+G  +Y ++ G  PF        + KI+     FP+   P+ R+L+E LL 
Sbjct: 211 ASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 270
Query: 364 KDPTRRL 370
            D T+RL
Sbjct: 271 LDATKRL 277

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 119/247 (48%), Gaps = 11/247 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+  VVL R     + YAIK   K H+ K      E  +  V RE  +M  L HP 
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPF 70
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
            V L     D   +  Y  L Y +         + G+  E+  R Y  +IVS L YLHG 
Sbjct: 71  FVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLTY 303
            ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  + +PE  L    
Sbjct: 129 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 187
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K++D WA+G  +Y ++ G  PF        + KI+     FP+   P+ R+L+E LL 
Sbjct: 188 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 247
Query: 364 KDPTRRL 370
            D T+RL
Sbjct: 248 LDATKRL 254

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 119/247 (48%), Gaps = 11/247 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+  VVL R     + YAIK   K H+ K      E  +  V RE  +M  L HP 
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPF 69
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
            V L     D   +  Y  L Y +         + G+  E+  R Y  +IVS L YLHG 
Sbjct: 70  FVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLTY 303
            ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  + +PE  L    
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 186
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K++D WA+G  +Y ++ G  PF        + KI+     FP+   P+ R+L+E LL 
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 246
Query: 364 KDPTRRL 370
            D T+RL
Sbjct: 247 LDATKRL 253

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 119/247 (48%), Gaps = 11/247 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+  VVL R     + YAIK   K H+ K      E  +  V RE  +M  L HP 
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPF 68
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
            V L     D   +  Y  L Y +         + G+  E+  R Y  +IVS L YLHG 
Sbjct: 69  FVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLTY 303
            ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  + +PE  L    
Sbjct: 127 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 185
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K++D WA+G  +Y ++ G  PF        + KI+     FP+   P+ R+L+E LL 
Sbjct: 186 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 245
Query: 364 KDPTRRL 370
            D T+RL
Sbjct: 246 LDATKRL 252

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 119/247 (48%), Gaps = 11/247 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+  VVL R     + YAIK   K H+ K      E  +  V RE  +M  L HP 
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPF 71
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
            V L     D   +  Y  L Y +         + G+  E+  R Y  +IVS L YLHG 
Sbjct: 72  FVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLTY 303
            ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  + +PE  L    
Sbjct: 130 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 188
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K++D WA+G  +Y ++ G  PF        + KI+     FP+   P+ R+L+E LL 
Sbjct: 189 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 248
Query: 364 KDPTRRL 370
            D T+RL
Sbjct: 249 LDATKRL 255

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 119/247 (48%), Gaps = 11/247 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+  VVL R     + YAIK   K H+ K      E  +  V RE  +M  L HP 
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPF 90
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
            V L     D   +  Y  L Y +         + G+  E+  R Y  +IVS L YLHG 
Sbjct: 91  FVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLTY 303
            ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  + +PE  L    
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEKS 207
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K++D WA+G  +Y ++ G  PF        + KI+     FP+   P+ R+L+E LL 
Sbjct: 208 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 267
Query: 364 KDPTRRL 370
            D T+RL
Sbjct: 268 LDATKRL 274

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 131/254 (51%), Gaps = 23/254 (9%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           + +Y ++  +G GSYG V+  R+   G+  AIK F +S   K+     + AM    RE+ 
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM---VKKIAM----REIK 76
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           ++K L+H N+VNL+EV        +Y+V E+V+    +D    P  +   + +KYL  I+
Sbjct: 77  LLKQLRHENLVNLLEVC--KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQII 134
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           +G+ + H HN++H DIKP+N+LV+ SG VK+ DF  ++      +V      T  + APE
Sbjct: 135 NGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPE 194
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET--------------LQDTYDKIVNN 342
             +G    GKA D WA+G  +  M +G+  F G++              L   + ++ N 
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254
Query: 343 SLVFPDAMNPELRN 356
           + VF     PE++ 
Sbjct: 255 NPVFAGVRLPEIKE 268

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 80/247 (32%), Positives = 119/247 (48%), Gaps = 11/247 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+  VVL R     + YAIK   K H+ K      E  +  V RE  +M  L HP 
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPF 96
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
            V L     D   +  Y  L Y +         + G+  E+  R Y  +IVS L YLHG 
Sbjct: 97  FVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLTY 303
            ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  + +PE  L    
Sbjct: 155 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 213
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K++D WA+G  +Y ++ G  PF        + KI+     FP A  P+ R+L+E LL 
Sbjct: 214 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARDLVEKLLV 273
Query: 364 KDPTRRL 370
            D T+RL
Sbjct: 274 LDATKRL 280

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 119/247 (48%), Gaps = 11/247 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+  VVL R     + YAIK   K H+ K      E  +  V RE  +M  L HP 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPF 91
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
            V L     D   +  Y  L Y +         + G+  E+  R Y  +IVS L YLHG 
Sbjct: 92  FVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLTY 303
            ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  + +PE  L    
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE-LLTEKS 208
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K++D WA+G  +Y ++ G  PF        + KI+     FP+   P+ R+L+E LL 
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 268
Query: 364 KDPTRRL 370
            D T+RL
Sbjct: 269 LDATKRL 275

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 119/247 (48%), Gaps = 11/247 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+  VVL R     + YAIK   K H+ K      E  +  V RE  +M  L HP 
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPF 90
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
            V L     D   +  Y  L Y +         + G+  E+  R Y  +IVS L YLHG 
Sbjct: 91  FVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLTY 303
            ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  + +PE  L    
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 207
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K++D WA+G  +Y ++ G  PF        + KI+     FP+   P+ R+L+E LL 
Sbjct: 208 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 267
Query: 364 KDPTRRL 370
            D T+RL
Sbjct: 268 LDATKRL 274

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 119/247 (48%), Gaps = 11/247 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+  VVL R     + YAIK   K H+ K      E  +  V RE  +M  L HP 
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPF 94
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
            V L     D   +  Y  L Y +         + G+  E+  R Y  +IVS L YLHG 
Sbjct: 95  FVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLTY 303
            ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  + +PE  L    
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEKS 211
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K++D WA+G  +Y ++ G  PF        + KI+     FP+   P+ R+L+E LL 
Sbjct: 212 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 271
Query: 364 KDPTRRL 370
            D T+RL
Sbjct: 272 LDATKRL 278

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 119/247 (48%), Gaps = 11/247 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+  VVL R     + YAIK   K H+ K      E  +  V RE  +M  L HP 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPF 93
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
            V L     D   +  Y  L Y +         + G+  E+  R Y  +IVS L YLHG 
Sbjct: 94  FVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLTY 303
            ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  + +PE  L    
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 210
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K++D WA+G  +Y ++ G  PF        + KI+     FP+   P+ R+L+E LL 
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 270
Query: 364 KDPTRRL 370
            D T+RL
Sbjct: 271 LDATKRL 277

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 134/269 (49%), Gaps = 23/269 (8%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           ++G+G +  V   R    G  YA K   K    + R +    +  ++ REV I++ + H 
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKR---QSRASRRGVSREEIEREVSILRQVLHH 75
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           N++ L +V +  N     ++LE V G    D   Q  ++ E  A  +++ I+ G+ YLH 
Sbjct: 76  NVITLHDVYE--NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 245 HNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC-- 298
             + H D+KP+N+++     P   +K+ DF ++   ED  +  +   GTP F APE    
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEIVNY 192
Query: 299 --LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAM---NPE 353
             LGL      AD W++GV  Y ++ G  PFLG+T Q+T   I + S  F +       E
Sbjct: 193 EPLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247
Query: 354 L-RNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           L ++ +  LL K+  +RLT+ +  +H W+
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 119/247 (48%), Gaps = 11/247 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+  VVL R     + YAIK   K H+ K      E  +  V RE  +M  L HP 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPF 91
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
            V L     D   +  Y  L Y +         + G+  E+  R Y  +IVS L YLHG 
Sbjct: 92  FVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLTY 303
            ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  + +PE  L    
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 208
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K++D WA+G  +Y ++ G  PF        + KI+     FP+   P+ R+L+E LL 
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 268
Query: 364 KDPTRRL 370
            D T+RL
Sbjct: 269 LDATKRL 275

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 119/247 (48%), Gaps = 11/247 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+  VVL R     + YAIK   K H+ K      E  +  V RE  +M  L HP 
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPF 75
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
            V L     D   +  Y  L Y +         + G+  E+  R Y  +IVS L YLHG 
Sbjct: 76  FVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLTY 303
            ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  + +PE  L    
Sbjct: 134 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 192
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K++D WA+G  +Y ++ G  PF        + KI+     FP+   P+ R+L+E LL 
Sbjct: 193 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 252
Query: 364 KDPTRRL 370
            D T+RL
Sbjct: 253 LDATKRL 259

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 119/247 (48%), Gaps = 11/247 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+  VVL R     + YAIK   K H+ K      E  +  V RE  +M  L HP 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPF 91
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
            V L     D   +  Y  L Y +         + G+  E+  R Y  +IVS L YLHG 
Sbjct: 92  FVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLTY 303
            ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  + +PE  L    
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 208
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K++D WA+G  +Y ++ G  PF        + KI+     FP+   P+ R+L+E LL 
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 268
Query: 364 KDPTRRL 370
            D T+RL
Sbjct: 269 LDATKRL 275

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 134/269 (49%), Gaps = 23/269 (8%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           ++G+G +  V   R    G  YA K   K    + R +    +  ++ REV I++ + H 
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKR---QSRASRRGVSREEIEREVSILRQVLHH 75
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           N++ L +V +  N     ++LE V G    D   Q  ++ E  A  +++ I+ G+ YLH 
Sbjct: 76  NVITLHDVYE--NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 245 HNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC-- 298
             + H D+KP+N+++     P   +K+ DF ++   ED  +  +   GTP F APE    
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEIVNY 192
Query: 299 --LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAM---NPE 353
             LGL      AD W++GV  Y ++ G  PFLG+T Q+T   I + S  F +       E
Sbjct: 193 EPLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247
Query: 354 L-RNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           L ++ +  LL K+  +RLT+ +  +H W+
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 119/247 (48%), Gaps = 11/247 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+  VVL R     + YAIK   K H+ K      E  +  V RE  +M  L HP 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPF 93
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
            V L     D   +  Y  L Y +         + G+  E+  R Y  +IVS L YLHG 
Sbjct: 94  FVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLTY 303
            ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  + +PE  L    
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 210
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K++D WA+G  +Y ++ G  PF        + KI+     FP+   P+ R+L+E LL 
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 270
Query: 364 KDPTRRL 370
            D T+RL
Sbjct: 271 LDATKRL 277

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 119/247 (48%), Gaps = 11/247 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+  VVL R     + YAIK   K H+ K      E  +  V RE  +M  L HP 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPF 93
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
            V L     D   +  Y  L Y +         + G+  E+  R Y  +IVS L YLHG 
Sbjct: 94  FVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLTY 303
            ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  + +PE  L    
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 210
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K++D WA+G  +Y ++ G  PF        + KI+     FP+   P+ R+L+E LL 
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 270
Query: 364 KDPTRRL 370
            D T+RL
Sbjct: 271 LDATKRL 277

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 134/269 (49%), Gaps = 23/269 (8%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           ++G+G +  V   R    G  YA K   K    + R +    +  ++ REV I++ + H 
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKR---QSRASRRGVSREEIEREVSILRQVLHH 75
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           N++ L +V +  N     ++LE V G    D   Q  ++ E  A  +++ I+ G+ YLH 
Sbjct: 76  NVITLHDVYE--NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 245 HNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC-- 298
             + H D+KP+N+++     P   +K+ DF ++   ED  +  +   GTP F APE    
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEIVNY 192
Query: 299 --LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD---AMNPE 353
             LGL      AD W++GV  Y ++ G  PFLG+T Q+T   I   S  F +   +   E
Sbjct: 193 EPLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247
Query: 354 L-RNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           L ++ +  LL K+  +RLT+ +  +H W+
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 119/247 (48%), Gaps = 11/247 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+  VVL R     + YAIK   K H+ K      E  +  V RE  +M  L HP 
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPF 94
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
            V L     D   +  Y  L Y +         + G+  E+  R Y  +IVS L YLHG 
Sbjct: 95  FVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLTY 303
            ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  + +PE  L    
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 211
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K++D WA+G  +Y ++ G  PF        + KI+     FP+   P+ R+L+E LL 
Sbjct: 212 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 271
Query: 364 KDPTRRL 370
            D T+RL
Sbjct: 272 LDATKRL 278

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 134/269 (49%), Gaps = 23/269 (8%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           ++G+G +  V   R    G  YA K   K    + R +    +  ++ REV I++ + H 
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKR---QSRASRRGVSREEIEREVSILRQVLHH 75
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           N++ L +V +  N     ++LE V G    D   Q  ++ E  A  +++ I+ G+ YLH 
Sbjct: 76  NVITLHDVYE--NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 245 HNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC-- 298
             + H D+KP+N+++     P   +K+ DF ++   ED  +  +   GTP F APE    
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEIVNY 192
Query: 299 --LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD---AMNPE 353
             LGL      AD W++GV  Y ++ G  PFLG+T Q+T   I   S  F +   +   E
Sbjct: 193 EPLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247
Query: 354 L-RNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           L ++ +  LL K+  +RLT+ +  +H W+
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 122/264 (46%), Gaps = 15/264 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R   +    A+K   KS L K      E     +RRE+ I   L+H
Sbjct: 21  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK------EGVEHQLRREIEIQSHLRH 74
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ +     D      Y++LE+           + G   E  +  ++ ++   L Y H
Sbjct: 75  PNILRMYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH 132
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
              V+H DIKP+NLL+   G +KI DF  S         LRR    GT  +  PE   G 
Sbjct: 133 ERKVIHRDIKPENLLMGYKGELKIADFGWSV----HAPSLRRRXMCGTLDYLPPEMIEGK 188
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
           T+  K  D W  GV  Y  ++G  PF   +  +T+ +IVN  L FP  ++   ++L+  L
Sbjct: 189 THDEKV-DLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKL 247
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDN 385
           L   P +RL L  V +H WV  ++
Sbjct: 248 LRYHPPQRLPLKGVMEHPWVKANS 271

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 119/247 (48%), Gaps = 11/247 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+  VVL R     + YAIK   K H+ K      E  +  V RE  +M  L HP 
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPF 98
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
            V L     D   +  Y  L Y +         + G+  E+  R Y  +IVS L YLHG 
Sbjct: 99  FVKLYFCFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLTY 303
            ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  + +PE  L    
Sbjct: 157 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 215
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K++D WA+G  +Y ++ G  PF        + KI+     FP+   P+ R+L+E LL 
Sbjct: 216 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 275
Query: 364 KDPTRRL 370
            D T+RL
Sbjct: 276 LDATKRL 282

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 134/269 (49%), Gaps = 23/269 (8%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           ++G+G +  V   R    G  YA K   K    + R +    +  ++ REV I++ + H 
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKR---QSRASRRGVSREEIEREVSILRQVLHH 75
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           N++ L +V +  N     ++LE V G    D   Q  ++ E  A  +++ I+ G+ YLH 
Sbjct: 76  NVITLHDVYE--NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 245 HNVVHGDIKPDNLLV----APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC-- 298
             + H D+KP+N+++     P   +K+ DF ++   ED  +  +   GTP F APE    
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEIVNY 192
Query: 299 --LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAM---NPE 353
             LGL      AD W++GV  Y ++ G  PFLG+T Q+T   I + S  F +       E
Sbjct: 193 EPLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247
Query: 354 L-RNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           L ++ +  LL K+  +RLT+ +  +H W+
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 119/247 (48%), Gaps = 11/247 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+  VVL R     + YAIK   K H+ K      E  +  V RE  +M  L HP 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPF 93
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
            V L     D   +  Y  L Y +         + G+  E+  R Y  +IVS L YLHG 
Sbjct: 94  FVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLTY 303
            ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  + +PE  L    
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 210
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K++D WA+G  +Y ++ G  PF        + KI+     FP+   P+ R+L+E LL 
Sbjct: 211 AXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLV 270
Query: 364 KDPTRRL 370
            D T+RL
Sbjct: 271 LDATKRL 277

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 129/275 (46%), Gaps = 17/275 (6%)
Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           T+   EY    ++G G++  V      L G+ YA    +   LS             + R
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-------RDHQKLER 59
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
           E  I ++L+HPNIV L + I +    H Y++ + V G    +         E+ A   ++
Sbjct: 60  EARICRLLKHPNIVRLHDSISE--EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ 117
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
            I+  +++ H   VVH ++KP+NLL+A       VK+ DF ++   E +        GTP
Sbjct: 118 QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP--- 347
            + +PE      YG K  D WA GV LY +++G  PF  E     Y +I   +  FP   
Sbjct: 178 GYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE 236
Query: 348 -DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            D + PE ++L+  +L  +P++R+T  +  KH W+
Sbjct: 237 WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 119/247 (48%), Gaps = 11/247 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+  VVL R     + YAIK   K H+ K      E  +  V RE  +M  L HP 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPF 93
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
            V L     D   +  Y  L Y +         + G+  E+  R Y  +IVS L YLHG 
Sbjct: 94  FVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLTY 303
            ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  + +PE  L    
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 210
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K++D WA+G  +Y ++ G  PF        + KI+     FP+   P+ R+L+E LL 
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLV 270
Query: 364 KDPTRRL 370
            D T+RL
Sbjct: 271 LDATKRL 277

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 125/273 (45%), Gaps = 17/273 (6%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           M +EY     IG G++  V        G  YA K  +   LS             + RE 
Sbjct: 2   MTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSA-------RDHQKLEREA 54
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            I ++L+H NIV L + I +      Y+V + V G    +         E+ A   ++ I
Sbjct: 55  RICRLLKHSNIVRLHDSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI 112
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
           +  +++ H   VVH D+KP+NLL+A       VK+ DF ++   + D        GTP +
Sbjct: 113 LEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGY 172
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----D 348
            +PE      YG K  D WA GV LY +++G  PF  E     Y +I   +  FP    D
Sbjct: 173 LSPEVLRKEAYG-KPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWD 231
Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            + PE +NL+  +L  +P +R+T ++  KH WV
Sbjct: 232 TVTPEAKNLINQMLTINPAKRITAHEALKHPWV 264

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 127/271 (46%), Gaps = 18/271 (6%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + Y   R +G GS+G+V+L +  + G+  A+K   K      R    +T    + REV +
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK------RQVKQKTDKESLLREVQL 79
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +K L HPNI  L E  +D    +FY+V E   G    D         E  A + +R ++S
Sbjct: 80  LKQLDHPNIXKLYEFFEDKG--YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 238 GLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           G+ Y H + +VH D+KP+NLL+   +    ++I DF +S  FE      +   GT  + A
Sbjct: 138 GITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKX-KDKIGTAYYIA 196
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAM 350
           PE   G TY  K  D W+ GV LY ++ G  PF G    D   K+      F       +
Sbjct: 197 PEVLHG-TYDEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254
Query: 351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           +   ++L+   L   P+ R++  D   H W+
Sbjct: 255 SESAKDLIRKXLTYVPSXRISARDALDHEWI 285

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 128/275 (46%), Gaps = 17/275 (6%)
Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           T+  ++Y    ++G G++  V         + YA K  +   LS             + R
Sbjct: 27  TRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSA-------RDHQKLER 79
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
           E  I ++L+HPNIV L + I +      Y+V + V G    +         E+ A   + 
Sbjct: 80  EARICRLLKHPNIVRLHDSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCIH 137
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
            I+  + ++H H++VH D+KP+NLL+A       VK+ DF ++   + +        GTP
Sbjct: 138 QILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTP 197
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP--- 347
            + +PE      YG K  D WA GV LY +++G  PF  E     Y +I   +  FP   
Sbjct: 198 GYLSPEVLRKDPYG-KPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPE 256
Query: 348 -DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            D + PE +NL+  +L  +P +R+T +   KH WV
Sbjct: 257 WDTVTPEAKNLINQMLTINPAKRITADQALKHPWV 291

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 78/247 (31%), Positives = 118/247 (47%), Gaps = 11/247 (4%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+   VL R     + YAIK   K H+ K      E  +  V RE  +M  L HP 
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPF 91
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
            V L     D   +  Y  L Y +         + G+  E+  R Y  +IVS L YLHG 
Sbjct: 92  FVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGLTY 303
            ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  + +PE  L    
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 208
Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
             K++D WA+G  +Y ++ G  PF        + KI+     FP+   P+ R+L+E LL 
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 268
Query: 364 KDPTRRL 370
            D T+RL
Sbjct: 269 LDATKRL 275

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 127/269 (47%), Gaps = 17/269 (6%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y    ++G G++  V      L G+ YA K  +   LS             + RE  I +
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSA-------RDHQKLEREARICR 76
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
           +L+HPNIV L + I +    H Y++ + V G    +         E+ A   ++ I+  +
Sbjct: 77  LLKHPNIVRLHDSISEEG--HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV 134
Query: 240 MYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           ++ H   VVH D+KP+NLL+A       VK+ DF ++   E +        GTP + +PE
Sbjct: 135 LHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE 194
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAMNP 352
                 YG K  D WA GV LY +++G  PF  E     Y +I   +  FP    D + P
Sbjct: 195 VLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 253
Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           E ++L+  +L  +P++R+T  +  KH W+
Sbjct: 254 EAKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  121 bits (303), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 128/268 (47%), Gaps = 19/268 (7%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G++ +V+L       K  AIK   K  L        E     +  E+ ++  ++HPN
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--------EGKEGSMENEIAVLHKIKHPN 77
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           IV L ++ +  +  H Y++++ V G    D   + G   E  A + +  ++  + YLH  
Sbjct: 78  IVALDDIYE--SGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 135
Query: 246 NVVHGDIKPDNLL---VAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
            +VH D+KP+NLL   +     + I DF +S++ ED   VL  + GTP + APE      
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAMNPELRNLL 358
           Y  KA D W++GV  Y ++ G  PF  E     +++I+     F     D ++   ++ +
Sbjct: 195 Y-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 253
Query: 359 EGLLCKDPTRRLTLNDVAKHTWVLGDNG 386
             L+ KDP +R T     +H W+ GD  
Sbjct: 254 RHLMEKDPEKRFTCEQALQHPWIAGDTA 281

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  121 bits (303), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 128/268 (47%), Gaps = 19/268 (7%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G++ +V+L       K  AIK   K  L        E     +  E+ ++  ++HPN
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEAL--------EGKEGSMENEIAVLHKIKHPN 77
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           IV L ++ +  +  H Y++++ V G    D   + G   E  A + +  ++  + YLH  
Sbjct: 78  IVALDDIYE--SGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 135
Query: 246 NVVHGDIKPDNLL---VAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
            +VH D+KP+NLL   +     + I DF +S++ ED   VL  + GTP + APE      
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAMNPELRNLL 358
           Y  KA D W++GV  Y ++ G  PF  E     +++I+     F     D ++   ++ +
Sbjct: 195 Y-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 253
Query: 359 EGLLCKDPTRRLTLNDVAKHTWVLGDNG 386
             L+ KDP +R T     +H W+ GD  
Sbjct: 254 RHLMEKDPEKRFTCEQALQHPWIAGDTA 281

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 128/268 (47%), Gaps = 19/268 (7%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G++ +V+L       K  AIK   K  L        E     +  E+ ++  ++HPN
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEAL--------EGKEGSMENEIAVLHKIKHPN 77
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           IV L ++ +  +  H Y++++ V G    D   + G   E  A + +  ++  + YLH  
Sbjct: 78  IVALDDIYE--SGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 135
Query: 246 NVVHGDIKPDNLL---VAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
            +VH D+KP+NLL   +     + I DF +S++ ED   VL  + GTP + APE      
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAMNPELRNLL 358
           Y  KA D W++GV  Y ++ G  PF  E     +++I+     F     D ++   ++ +
Sbjct: 195 Y-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 253
Query: 359 EGLLCKDPTRRLTLNDVAKHTWVLGDNG 386
             L+ KDP +R T     +H W+ GD  
Sbjct: 254 RHLMEKDPEKRFTCEQALQHPWIAGDTA 281

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 128/268 (47%), Gaps = 19/268 (7%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G++ +V+L       K  AIK   K  L        E     +  E+ ++  ++HPN
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEAL--------EGKEGSMENEIAVLHKIKHPN 77
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           IV L ++ +  +  H Y++++ V G    D   + G   E  A + +  ++  + YLH  
Sbjct: 78  IVALDDIYE--SGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 135
Query: 246 NVVHGDIKPDNLL---VAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
            +VH D+KP+NLL   +     + I DF +S++ ED   VL  + GTP + APE      
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAMNPELRNLL 358
           Y  KA D W++GV  Y ++ G  PF  E     +++I+     F     D ++   ++ +
Sbjct: 195 Y-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 253
Query: 359 EGLLCKDPTRRLTLNDVAKHTWVLGDNG 386
             L+ KDP +R T     +H W+ GD  
Sbjct: 254 RHLMEKDPEKRFTCEQALQHPWIAGDTA 281

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 85/260 (32%), Positives = 130/260 (50%), Gaps = 27/260 (10%)
Query: 135 VLYRSSLDG--KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV 192
           ++YR    G  K YA+K   K+   K+           VR E+ ++  L HPNI+ L E+
Sbjct: 68  IVYRCKQKGTQKPYALKVLKKTVDKKI-----------VRTEIGVLLRLSHPNIIKLKEI 116
Query: 193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDI 252
            + P      +VLE V G    D   + G   E  A   ++ I+  + YLH + +VH D+
Sbjct: 117 FETPT--EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDL 174
Query: 253 KPDNLLV---APSGTVKIGDFSVSQVFEDDNDVLRRSP-GTPVFTAPECCLGLTYGGKAA 308
           KP+NLL    AP   +KI DF +S++ E  + VL ++  GTP + APE   G  YG +  
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTPGYCAPEILRGCAYGPE-V 231
Query: 309 DTWAVGVTLYYMIIGQYPFLGETL-QDTYDKIVNNSLVFP----DAMNPELRNLLEGLLC 363
           D W+VG+  Y ++ G  PF  E   Q  + +I+N    F     D ++   ++L+  L+ 
Sbjct: 232 DMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIV 291
Query: 364 KDPTRRLTLNDVAKHTWVLG 383
            DP +RLT     +H WV G
Sbjct: 292 LDPKKRLTTFQALQHPWVTG 311

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 134/275 (48%), Gaps = 35/275 (12%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IG G++  V    +   G+ +A+K      ++K   +P   +  D++RE  I  ML+HP+
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVD---VAKFTSSPG-LSTEDLKREASICHMLKHPH 87
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMARKYLRDIVS 237
           IV L+E     +    YMV E+++G        K  + GF       E++A  Y+R I+ 
Sbjct: 88  IVELLETYS--SDGMLYMVFEFMDGADLCFEIVKRADAGF----VYSEAVASHYMRQILE 141
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAP---SGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
            L Y H +N++H D+KP+N+L+A    S  VK+GDF V+    +   V     GTP F A
Sbjct: 142 ALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMA 201
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNP-- 352
           PE      Y GK  D W  GV L+ ++ G  PF G T +  ++ I+         MNP  
Sbjct: 202 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKY----KMNPRQ 255
Query: 353 ------ELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
                   ++L+  +L  DP  R+T+ +   H W+
Sbjct: 256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 89/276 (32%), Positives = 134/276 (48%), Gaps = 19/276 (6%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +Y  V+ IG G++G+V L R     K YA+K   K  +    +  S++A     R+  IM
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM----IKRSDSAFFWEERD--IM 123
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
                P +V L     D    + YMV+EY+ G  D         + E  AR Y  ++V  
Sbjct: 124 AFANSPWVVQLFYAFQDDR--YLYMVMEYMPGG-DLVNLMSNYDVPEKWARFYTAEVVLA 180
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV-LRRSPGTPVFTAPEC 297
           L  +H    +H D+KPDN+L+  SG +K+ DF        +  V    + GTP + +PE 
Sbjct: 181 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240
Query: 298 CL---GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFPD--AM 350
                G  Y G+  D W+VGV LY M++G  PF  ++L  TY KI+N  NSL FPD   +
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 300
Query: 351 NPELRNLLEGLLCKDPTR--RLTLNDVAKHTWVLGD 384
           + E +NL+   L     R  R  + ++ +H +   D
Sbjct: 301 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 89/276 (32%), Positives = 134/276 (48%), Gaps = 19/276 (6%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +Y  V+ IG G++G+V L R     K YA+K   K  +    +  S++A     R+  IM
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM----IKRSDSAFFWEERD--IM 128
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
                P +V L     D    + YMV+EY+ G  D         + E  AR Y  ++V  
Sbjct: 129 AFANSPWVVQLFYAFQDDR--YLYMVMEYMPGG-DLVNLMSNYDVPEKWARFYTAEVVLA 185
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV-LRRSPGTPVFTAPEC 297
           L  +H    +H D+KPDN+L+  SG +K+ DF        +  V    + GTP + +PE 
Sbjct: 186 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 245
Query: 298 CL---GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFPD--AM 350
                G  Y G+  D W+VGV LY M++G  PF  ++L  TY KI+N  NSL FPD   +
Sbjct: 246 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 305
Query: 351 NPELRNLLEGLLCKDPTR--RLTLNDVAKHTWVLGD 384
           + E +NL+   L     R  R  + ++ +H +   D
Sbjct: 306 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 341

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 128/273 (46%), Gaps = 17/273 (6%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           M +EY    ++G G++  V        G+ YA K  +   LS             + RE 
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSA-------RDHQKLEREA 54
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            I ++L+HPNIV L + I +      Y+V + V G    +         E+ A   ++ I
Sbjct: 55  RICRLLKHPNIVRLHDSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI 112
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
           +  + + H + +VH D+KP+NLL+A       VK+ DF ++   + D        GTP +
Sbjct: 113 LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGY 172
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----D 348
            +PE      YG K  D WA GV LY +++G  PF  E     Y +I   +  FP    D
Sbjct: 173 LSPEVLRKDPYG-KPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWD 231
Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            + PE ++L+  +L  +P +R+T ++  KH W+
Sbjct: 232 TVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 134/277 (48%), Gaps = 19/277 (6%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +Y  V+ IG G++G+V L R     K YA+K   K  + K     S++A     R+  IM
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK----RSDSAFFWEERD--IM 128
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
                P +V L     D    + YMV+EY+ G  D         + E  AR Y  ++V  
Sbjct: 129 AFANSPWVVQLFYAFQDDR--YLYMVMEYMPGG-DLVNLMSNYDVPEKWARFYTAEVVLA 185
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV-LRRSPGTPVFTAPEC 297
           L  +H    +H D+KPDN+L+  SG +K+ DF        +  V    + GTP + +PE 
Sbjct: 186 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 245
Query: 298 CL---GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFPD--AM 350
                G  Y G+  D W+VGV LY M++G  PF  ++L  TY KI+N  NSL FPD   +
Sbjct: 246 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 305
Query: 351 NPELRNLLEGLLCKDPTR--RLTLNDVAKHTWVLGDN 385
           + E +NL+   L     R  R  + ++ +H +   D 
Sbjct: 306 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 342

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 128/273 (46%), Gaps = 17/273 (6%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           M +EY    ++G G++  V        G+ YA K  +   LS             + RE 
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSA-------RDHQKLEREA 54
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            I ++L+HPNIV L + I +      Y+V + V G    +         E+ A   ++ I
Sbjct: 55  RICRLLKHPNIVRLHDSISE--EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI 112
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
           +  + + H + +VH D+KP+NLL+A       VK+ DF ++   + D        GTP +
Sbjct: 113 LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGY 172
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----D 348
            +PE      YG K  D WA GV LY +++G  PF  E     Y +I   +  FP    D
Sbjct: 173 LSPEVLRKDPYG-KPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWD 231
Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            + PE ++L+  +L  +P +R+T ++  KH W+
Sbjct: 232 TVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 87/310 (28%), Positives = 143/310 (46%), Gaps = 24/310 (7%)
Query: 98  PVKESNKLIRSEDENGTK---MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKS 154
           P +++   I   D NG +    + ++  +  +G GS+GKV+L       + YA+K   K 
Sbjct: 318 PEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD 377
Query: 155 HLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDN 214
               + +   +   T V + VL +   + P +  L         D  Y V+EYV G    
Sbjct: 378 ----VVIQDDDVECTMVEKRVLALPG-KPPFLTQLHSCFQ--TMDRLYFVMEYVNGGDLM 430
Query: 215 DGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
               Q G   E  A  Y  +I  GL +L    +++ D+K DN+++   G +KI DF + +
Sbjct: 431 YHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490
Query: 275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQD 334
               D    +   GTP + APE      YG K+ D WA GV LY M+ GQ PF GE   +
Sbjct: 491 ENIWDGVTTKXFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549
Query: 335 TYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLN-----DVAKHTWVLGDNGPIP 389
            +  I+ +++ +P +M+ E   + +GL+ K P +RL        D+ +H +         
Sbjct: 550 LFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF-------- 601
Query: 390 QYLCWCKRDR 399
           +Y+ W K +R
Sbjct: 602 RYIDWEKLER 611

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 135/257 (52%), Gaps = 10/257 (3%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+  V    S   G   AIK   K  + K  +      +  V+ EV I   L+HP+
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGM------VQRVQNEVKIHCQLKHPS 72
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           I+ L    +D  S++ Y+VLE    G+ +     +     E+ AR ++  I++G++YLH 
Sbjct: 73  ILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYG 304
           H ++H D+   NLL+  +  +KI DF ++   +  ++      GTP + +PE      +G
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHG 190
Query: 305 GKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCK 364
            ++ D W++G   Y ++IG+ PF  +T+++T +K+V      P  ++ E ++L+  LL +
Sbjct: 191 LES-DVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRR 249
Query: 365 DPTRRLTLNDVAKHTWV 381
           +P  RL+L+ V  H ++
Sbjct: 250 NPADRLSLSSVLDHPFM 266

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 131/272 (48%), Gaps = 22/272 (8%)
Query: 117 INEYVHVRK-IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           IN+Y  +   IG GS+G+V +          A K   K  +  +            ++E+
Sbjct: 24  INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV---------DRFKQEI 74
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            IMK L HPNI+ L E  +D N+D  Y+V+E   G    +         ES A + ++D+
Sbjct: 75  EIMKSLDHPNIIRLYETFED-NTD-IYLVMELCTGGELFERVVHKRVFRESDAARIMKDV 132
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
           +S + Y H  NV H D+KP+N L    +P   +K+ DF ++  F+    ++R   GTP +
Sbjct: 133 LSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKVGTPYY 191
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA--- 349
            +P+   GL   G   D W+ GV +Y ++ G  PF   T  +   KI   +  FP+    
Sbjct: 192 VSPQVLEGLY--GPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWL 249
Query: 350 -MNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
            ++P+  +L+  LL K P +R+T     +H W
Sbjct: 250 NVSPQAESLIRRLLTKSPKQRITSLQALEHEW 281

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 131/272 (48%), Gaps = 22/272 (8%)
Query: 117 INEYVHVRK-IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           IN+Y  +   IG GS+G+V +          A K   K  +  +            ++E+
Sbjct: 7   INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV---------DRFKQEI 57
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            IMK L HPNI+ L E  +D N+D  Y+V+E   G    +         ES A + ++D+
Sbjct: 58  EIMKSLDHPNIIRLYETFED-NTD-IYLVMELCTGGELFERVVHKRVFRESDAARIMKDV 115
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
           +S + Y H  NV H D+KP+N L    +P   +K+ DF ++  F+    ++R   GTP +
Sbjct: 116 LSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKVGTPYY 174
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA--- 349
            +P+   GL   G   D W+ GV +Y ++ G  PF   T  +   KI   +  FP+    
Sbjct: 175 VSPQVLEGLY--GPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWL 232
Query: 350 -MNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
            ++P+  +L+  LL K P +R+T     +H W
Sbjct: 233 NVSPQAESLIRRLLTKSPKQRITSLQALEHEW 264

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 121/245 (49%), Gaps = 8/245 (3%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+GKV+L       + YAIK   K     + +   +   T V + VL + + + P 
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKD----VVIQDDDVECTMVEKRVLAL-LDKPPF 81
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           +  L         D  Y V+EYV G        Q G   E  A  Y  +I  GL +LH  
Sbjct: 82  LTQLHSCFQ--TVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKR 139
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
            +++ D+K DN+++   G +KI DF + +    D    R   GTP + APE      YG 
Sbjct: 140 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYG- 198
Query: 306 KAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKD 365
           K+ D WA GV LY M+ GQ PF GE   + +  I+ +++ +P +++ E  ++ +GL+ K 
Sbjct: 199 KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKH 258
Query: 366 PTRRL 370
           P +RL
Sbjct: 259 PAKRL 263

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 120/264 (45%), Gaps = 15/264 (5%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V L R        A+K   KS + K      E     +RRE+ I   L H
Sbjct: 29  RPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEK------EGVEHQLRREIEIQAHLHH 82
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L     D      Y++LEY           +     E      + ++   LMY H
Sbjct: 83  PNILRLYNYFYD--RRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCH 140
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCLGL 301
           G  V+H DIKP+NLL+   G +KI DF  S         LRR    GT  +  PE   G 
Sbjct: 141 GKKVIHRDIKPENLLLGLKGELKIADFGWSV----HAPSLRRKTMCGTLDYLPPEMIEGR 196
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            +  K  D W +GV  Y +++G  PF   +  +TY +IV   L FP ++    ++L+  L
Sbjct: 197 MHNEKV-DLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKL 255
Query: 362 LCKDPTRRLTLNDVAKHTWVLGDN 385
           L  +P+ RL L  V+ H WV  ++
Sbjct: 256 LRHNPSERLPLAQVSAHPWVRANS 279

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 138/298 (46%), Gaps = 24/298 (8%)
Query: 110 DENGTK---MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSET 166
           D NG +    + ++  +  +G GS+GKV+L       + YA+K   K     + +   + 
Sbjct: 9   DNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD----VVIQDDDV 64
Query: 167 AMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGES 226
             T V + VL +   + P +  L         D  Y V+EYV G        Q G   E 
Sbjct: 65  ECTMVEKRVLALPG-KPPFLTQLHSCFQ--TMDRLYFVMEYVNGGDLMYHIQQVGRFKEP 121
Query: 227 MARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS 286
            A  Y  +I  GL +L    +++ D+K DN+++   G +KI DF + +    D    +  
Sbjct: 122 HAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXF 181
Query: 287 PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF 346
            GTP + APE      YG K+ D WA GV LY M+ GQ PF GE   + +  I+ +++ +
Sbjct: 182 CGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 240
Query: 347 PDAMNPELRNLLEGLLCKDPTRRLTLN-----DVAKHTWVLGDNGPIPQYLCWCKRDR 399
           P +M+ E   + +GL+ K P +RL        D+ +H +         +Y+ W K +R
Sbjct: 241 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF--------RYIDWEKLER 290

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 125/251 (49%), Gaps = 11/251 (4%)
Query: 123 VRKIGAGSYGKVVLYRS---SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +R +G G YGKV   R    +  GK +A+K   K+ + +      +TA T   R +L  +
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR---NAKDTAHTKAERNIL--E 76
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
            ++HP IV+LI           Y++LEY+ G        + G   E  A  YL +I   L
Sbjct: 77  EVKHPFIVDLIYAFQ--TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL 134
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
            +LH   +++ D+KP+N+++   G VK+ DF + +    D  V     GT  + APE  +
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILM 194
Query: 300 GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLE 359
              +  +A D W++G  +Y M+ G  PF GE  + T DKI+   L  P  +  E R+LL+
Sbjct: 195 RSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 253
Query: 360 GLLCKDPTRRL 370
            LL ++   RL
Sbjct: 254 KLLKRNAASRL 264

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 125/251 (49%), Gaps = 11/251 (4%)
Query: 123 VRKIGAGSYGKVVLYRS---SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +R +G G YGKV   R    +  GK +A+K   K+ + +      +TA T   R +L  +
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR---NAKDTAHTKAERNIL--E 76
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
            ++HP IV+LI           Y++LEY+ G        + G   E  A  YL +I   L
Sbjct: 77  EVKHPFIVDLIYAFQ--TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL 134
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
            +LH   +++ D+KP+N+++   G VK+ DF + +    D  V     GT  + APE  +
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 300 GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLE 359
              +  +A D W++G  +Y M+ G  PF GE  + T DKI+   L  P  +  E R+LL+
Sbjct: 195 RSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 253
Query: 360 GLLCKDPTRRL 370
            LL ++   RL
Sbjct: 254 KLLKRNAASRL 264

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 146/287 (50%), Gaps = 20/287 (6%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           + ++G+G++G  V++R          KA  +  ++K    P       V+ E+ IM  L 
Sbjct: 56  LEELGSGAFG--VVHRC-------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 106
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMY 241
           HP ++NL +  +D       ++LE++ G    D    +   + E+    Y+R    GL +
Sbjct: 107 HPKLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 164
Query: 242 LHGHNVVHGDIKPDNLL--VAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
           +H H++VH DIKP+N++     + +VKI DF ++     D ++++ +  T  F APE  +
Sbjct: 165 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEI-V 222
Query: 300 GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD----AMNPELR 355
                G   D WA+GV  Y ++ G  PF GE   +T   +      F +    +++PE +
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282
Query: 356 NLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLRR 402
           + ++ LL K+P +RLT++D  +H W+ GD+  +   +   + +++R+
Sbjct: 283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQ 329

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 9/263 (3%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I +++  + +G GS+GKV L       + +AIKA  K     + +   +   T V + VL
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKD----VVLMDDDVECTMVEKRVL 71
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
            +   +HP + ++         ++ + V+EY+ G               S A  Y  +I+
Sbjct: 72  SLAW-EHPFLTHMFCTFQ--TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 128
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
            GL +LH   +V+ D+K DN+L+   G +KI DF + +     +       GTP + APE
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPE 188
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
             LG  Y   + D W+ GV LY M+IGQ PF G+  ++ +  I  ++  +P  +  E ++
Sbjct: 189 ILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 247
Query: 357 LLEGLLCKDPTRRLTLN-DVAKH 378
           LL  L  ++P +RL +  D+ +H
Sbjct: 248 LLVKLFVREPEKRLGVRGDIRQH 270

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 94/382 (24%), Positives = 168/382 (43%), Gaps = 22/382 (5%)
Query: 10  RDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGXXXXXXXXXNSYNGEATNTADGD 69
           RD  C  CF     K     R  +  ++RI R+             +S NG   NT    
Sbjct: 34  RDKSCEYCFDEPLLKRTDKYRTYSKKHFRIFREVGPKNSYIAYIEDHSGNGTFVNTELVG 93
Query: 70  GGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAG 129
            G+ +     SE           +     V + +   ++       + +EY+  + +G+G
Sbjct: 94  KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKA-------LRDEYIMSKTLGSG 146
Query: 130 SYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNL 189
           + G+V L       K  AI+   K   +      ++ A+ +V  E+ I+K L HP I+ +
Sbjct: 147 ACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL-NVETEIEILKKLNHPCIIKI 205
Query: 190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVH 249
               D   ++ +Y+VLE +EG    D       + E+  + Y   ++  + YLH + ++H
Sbjct: 206 KNFFD---AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 262
Query: 250 GDIKPDNLLVAPSGT---VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG- 305
            D+KP+N+L++       +KI DF  S++   +  ++R   GTP + APE  + +   G 
Sbjct: 263 RDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYLAPEVLVSVGTAGY 321
Query: 306 -KAADTWAVGVTLYYMIIGQYPFLGETLQDTY-DKIVNNSLVFPDAMNPELR----NLLE 359
            +A D W++GV L+  + G  PF     Q +  D+I +    F   +  E+     +L++
Sbjct: 322 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVK 381
Query: 360 GLLCKDPTRRLTLNDVAKHTWV 381
            LL  DP  R T  +  +H W+
Sbjct: 382 KLLVVDPKARFTTEEALRHPWL 403

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 94/382 (24%), Positives = 168/382 (43%), Gaps = 22/382 (5%)
Query: 10  RDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGXXXXXXXXXNSYNGEATNTADGD 69
           RD  C  CF     K     R  +  ++RI R+             +S NG   NT    
Sbjct: 48  RDKSCEYCFDEPLLKRTDKYRTYSKKHFRIFREVGPKNSYIAYIEDHSGNGTFVNTELVG 107
Query: 70  GGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAG 129
            G+ +     SE           +     V + +   ++       + +EY+  + +G+G
Sbjct: 108 KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKA-------LRDEYIMSKTLGSG 160
Query: 130 SYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNL 189
           + G+V L       K  AI+   K   +      ++ A+ +V  E+ I+K L HP I+ +
Sbjct: 161 ACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL-NVETEIEILKKLNHPCIIKI 219
Query: 190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVH 249
               D   ++ +Y+VLE +EG    D       + E+  + Y   ++  + YLH + ++H
Sbjct: 220 KNFFD---AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 276
Query: 250 GDIKPDNLLVAPSGT---VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG- 305
            D+KP+N+L++       +KI DF  S++   +  ++R   GTP + APE  + +   G 
Sbjct: 277 RDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYLAPEVLVSVGTAGY 335
Query: 306 -KAADTWAVGVTLYYMIIGQYPFLGETLQDTY-DKIVNNSLVFPDAMNPELR----NLLE 359
            +A D W++GV L+  + G  PF     Q +  D+I +    F   +  E+     +L++
Sbjct: 336 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVK 395
Query: 360 GLLCKDPTRRLTLNDVAKHTWV 381
            LL  DP  R T  +  +H W+
Sbjct: 396 KLLVVDPKARFTTEEALRHPWL 417

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 136/274 (49%), Gaps = 15/274 (5%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +EY+  + +G+G+ G+V L       K  AIK   K   +      ++ A+ +V  E+ I
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL-NVETEIEI 68
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +K L HP I+ +    D   ++ +Y+VLE +EG    D       + E+  + Y   ++ 
Sbjct: 69  LKKLNHPCIIKIKNFFD---AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGT---VKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
            + YLH + ++H D+KP+N+L++       +KI DF  S++   +  ++R   GTP + A
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYLA 184
Query: 295 PECCLGLTYGG--KAADTWAVGVTLYYMIIGQYPFLGETLQDTY-DKIVNNSLVFPDAMN 351
           PE  + +   G  +A D W++GV L+  + G  PF     Q +  D+I +    F   + 
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244
Query: 352 PELR----NLLEGLLCKDPTRRLTLNDVAKHTWV 381
            E+     +L++ LL  DP  R T  +  +H W+
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 136/274 (49%), Gaps = 15/274 (5%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +EY+  + +G+G+ G+V L       K  AIK   K   +      ++ A+ +V  E+ I
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL-NVETEIEI 68
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +K L HP I+ +    D   ++ +Y+VLE +EG    D       + E+  + Y   ++ 
Sbjct: 69  LKKLNHPCIIKIKNFFD---AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGT---VKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
            + YLH + ++H D+KP+N+L++       +KI DF  S++   +  ++R   GTP + A
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYLA 184
Query: 295 PECCLGLTYGG--KAADTWAVGVTLYYMIIGQYPFLGETLQDTY-DKIVNNSLVFPDAMN 351
           PE  + +   G  +A D W++GV L+  + G  PF     Q +  D+I +    F   + 
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244
Query: 352 PELR----NLLEGLLCKDPTRRLTLNDVAKHTWV 381
            E+     +L++ LL  DP  R T  +  +H W+
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 136/274 (49%), Gaps = 15/274 (5%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +EY+  + +G+G+ G+V L       K  AIK   K   +      ++ A+ +V  E+ I
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL-NVETEIEI 67
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +K L HP I+ +    D   ++ +Y+VLE +EG    D       + E+  + Y   ++ 
Sbjct: 68  LKKLNHPCIIKIKNFFD---AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 124
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGT---VKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
            + YLH + ++H D+KP+N+L++       +KI DF  S++   +  ++R   GTP + A
Sbjct: 125 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYLA 183
Query: 295 PECCLGLTYGG--KAADTWAVGVTLYYMIIGQYPFLGETLQDTY-DKIVNNSLVFPDAMN 351
           PE  + +   G  +A D W++GV L+  + G  PF     Q +  D+I +    F   + 
Sbjct: 184 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 243
Query: 352 PELR----NLLEGLLCKDPTRRLTLNDVAKHTWV 381
            E+     +L++ LL  DP  R T  +  +H W+
Sbjct: 244 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 136/274 (49%), Gaps = 15/274 (5%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +EY+  + +G+G+ G+V L       K  AIK   K   +      ++ A+ +V  E+ I
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL-NVETEIEI 68
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +K L HP I+ +    D   ++ +Y+VLE +EG    D       + E+  + Y   ++ 
Sbjct: 69  LKKLNHPCIIKIKNFFD---AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGT---VKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
            + YLH + ++H D+KP+N+L++       +KI DF  S++   +  ++R   GTP + A
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYLA 184
Query: 295 PECCLGLTYGG--KAADTWAVGVTLYYMIIGQYPFLGETLQDTY-DKIVNNSLVFPDAMN 351
           PE  + +   G  +A D W++GV L+  + G  PF     Q +  D+I +    F   + 
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244
Query: 352 PELR----NLLEGLLCKDPTRRLTLNDVAKHTWV 381
            E+     +L++ LL  DP  R T  +  +H W+
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 136/274 (49%), Gaps = 15/274 (5%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +EY+  + +G+G+ G+V L       K  AIK   K   +      ++ A+ +V  E+ I
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL-NVETEIEI 74
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +K L HP I+ +    D   ++ +Y+VLE +EG    D       + E+  + Y   ++ 
Sbjct: 75  LKKLNHPCIIKIKNFFD---AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 131
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGT---VKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
            + YLH + ++H D+KP+N+L++       +KI DF  S++   +  ++R   GTP + A
Sbjct: 132 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYLA 190
Query: 295 PECCLGLTYGG--KAADTWAVGVTLYYMIIGQYPFLGETLQDTY-DKIVNNSLVFPDAMN 351
           PE  + +   G  +A D W++GV L+  + G  PF     Q +  D+I +    F   + 
Sbjct: 191 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 250
Query: 352 PELR----NLLEGLLCKDPTRRLTLNDVAKHTWV 381
            E+     +L++ LL  DP  R T  +  +H W+
Sbjct: 251 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 130/275 (47%), Gaps = 35/275 (12%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IG G +  V    +   G+ +A+K      ++K   +P   +  D++RE  I  ML+HP+
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVD---VAKFTSSPG-LSTEDLKREASICHMLKHPH 89
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMARKYLRDIVS 237
           IV L+E     +    YMV E+++G        K  + GF       E++A  Y+R I+ 
Sbjct: 90  IVELLETYS--SDGMLYMVFEFMDGADLCFEIVKRADAGF----VYSEAVASHYMRQILE 143
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAP---SGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
            L Y H +N++H D+KP  +L+A    S  VK+G F V+    +   V     GTP F A
Sbjct: 144 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 203
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNP-- 352
           PE      Y GK  D W  GV L+ ++ G  PF G T +  ++ I+         MNP  
Sbjct: 204 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKY----KMNPRQ 257
Query: 353 ------ELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
                   ++L+  +L  DP  R+T+ +   H W+
Sbjct: 258 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 292

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 87/311 (27%), Positives = 137/311 (44%), Gaps = 45/311 (14%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDV 171
           G   +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +  
Sbjct: 1   GPGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTA 52
Query: 172 RREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMA 228
            RE+ ++K L HPNIV L++VI   N    Y+V E+V+   D   F    A   I   + 
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENK--LYLVFEHVDQ--DLKKFMDASALTGIPLPLI 108
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           + YL  ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            
Sbjct: 109 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NS 343
           T  + APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + 
Sbjct: 169 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 228
Query: 344 LVFPDAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHT 379
           +V+P   +                    P L    R+LL  +L  DP +R++      H 
Sbjct: 229 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 288
Query: 380 WVLGDNGPIPQ 390
           +      P+P 
Sbjct: 289 FFQDVTKPVPH 299

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 130/275 (47%), Gaps = 35/275 (12%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IG G +  V    +   G+ +A+K      ++K   +P   +  D++RE  I  ML+HP+
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVD---VAKFTSSPG-LSTEDLKREASICHMLKHPH 87
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMARKYLRDIVS 237
           IV L+E     +    YMV E+++G        K  + GF       E++A  Y+R I+ 
Sbjct: 88  IVELLETYS--SDGMLYMVFEFMDGADLCFEIVKRADAGF----VYSEAVASHYMRQILE 141
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAP---SGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
            L Y H +N++H D+KP  +L+A    S  VK+G F V+    +   V     GTP F A
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 201
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNP-- 352
           PE      Y GK  D W  GV L+ ++ G  PF G T +  ++ I+         MNP  
Sbjct: 202 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKY----KMNPRQ 255
Query: 353 ------ELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
                   ++L+  +L  DP  R+T+ +   H W+
Sbjct: 256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 78/252 (30%), Positives = 126/252 (50%), Gaps = 13/252 (5%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G + K      +   + +A K   KS L K    P +     +  E+ I + L H +
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK----PHQREKMSM--EISIHRSLAHQH 82
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           +V      +D  +D  ++VLE    +   +   +  A+ E  AR YLR IV G  YLH +
Sbjct: 83  VVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 140
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
            V+H D+K  NL +     VKIGDF ++   E D +  +   GTP + APE    L+  G
Sbjct: 141 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEV---LSKKG 197
Query: 306 KA--ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
            +   D W++G  +Y +++G+ PF    L++TY +I  N    P  +NP   +L++ +L 
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 257
Query: 364 KDPTRRLTLNDV 375
            DPT R T+N++
Sbjct: 258 TDPTARPTINEL 269

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 128/263 (48%), Gaps = 9/263 (3%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I ++   + +G GS+GKV L       + +AIKA  K     + +   +   T V + VL
Sbjct: 17  IEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKD----VVLMDDDVECTMVEKRVL 72
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
            +   +HP + ++         ++ + V+EY+ G               S A  Y  +I+
Sbjct: 73  SLAW-EHPFLTHMFCTFQ--TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 129
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
            GL +LH   +V+ D+K DN+L+   G +KI DF + +     +       GTP + APE
Sbjct: 130 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPE 189
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
             LG  Y   + D W+ GV LY M+IGQ PF G+  ++ +  I  ++  +P  +  E ++
Sbjct: 190 ILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 248
Query: 357 LLEGLLCKDPTRRLTLN-DVAKH 378
           LL  L  ++P +RL +  D+ +H
Sbjct: 249 LLVKLFVREPEKRLGVRGDIRQH 271

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 78/252 (30%), Positives = 126/252 (50%), Gaps = 13/252 (5%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G + K      +   + +A K   KS L K    P +     +  E+ I + L H +
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK----PHQREKMSM--EISIHRSLAHQH 78
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           +V      +D  +D  ++VLE    +   +   +  A+ E  AR YLR IV G  YLH +
Sbjct: 79  VVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
            V+H D+K  NL +     VKIGDF ++   E D +  +   GTP + APE    L+  G
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEV---LSKKG 193
Query: 306 KA--ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
            +   D W++G  +Y +++G+ PF    L++TY +I  N    P  +NP   +L++ +L 
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 253
Query: 364 KDPTRRLTLNDV 375
            DPT R T+N++
Sbjct: 254 TDPTARPTINEL 265

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 132/269 (49%), Gaps = 15/269 (5%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G + K      +   + +A K   KS L K    P +     +  E+ I + L H +
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK----PHQREKMSM--EISIHRSLAHQH 76
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           +V      +D  +D  ++VLE    +   +   +  A+ E  AR YLR IV G  YLH +
Sbjct: 77  VVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
            V+H D+K  NL +     VKIGDF ++   E D +  +   GTP + APE    L+  G
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV---LSKKG 191
Query: 306 KA--ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
            +   D W++G  +Y +++G+ PF    L++TY +I  N    P  +NP   +L++ +L 
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 251
Query: 364 KDPTRRLTLNDVAKHTWVLGDNGPIPQYL 392
            DPT R T+N++    +    +G IP  L
Sbjct: 252 TDPTARPTINELLNDEFF--TSGYIPARL 278

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 136/307 (44%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 54
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 55  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 110
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP+NLL+   G +K+ DF +++ F            T  +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 170
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 230
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 231 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 291 VTKPVPH 297

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 78/252 (30%), Positives = 126/252 (50%), Gaps = 13/252 (5%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G + K      +   + +A K   KS L K    P +     +  E+ I + L H +
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK----PHQREKMSM--EISIHRSLAHQH 78
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           +V      +D  +D  ++VLE    +   +   +  A+ E  AR YLR IV G  YLH +
Sbjct: 79  VVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
            V+H D+K  NL +     VKIGDF ++   E D +  +   GTP + APE    L+  G
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEV---LSKKG 193
Query: 306 KA--ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
            +   D W++G  +Y +++G+ PF    L++TY +I  N    P  +NP   +L++ +L 
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 253
Query: 364 KDPTRRLTLNDV 375
            DPT R T+N++
Sbjct: 254 TDPTARPTINEL 265

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 52
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E+V    D   F    A   I   + + YL
Sbjct: 53  SLLKELNHPNIVKLLDVIHTENK--LYLVFEHVHQ--DLKTFMDASALTGIPLPLIKSYL 108
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 289 VTKPVPH 295

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 135/279 (48%), Gaps = 20/279 (7%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           +++ Y    ++G G++G V        G ++A         +K  + P E+    VR+E+
Sbjct: 49  VLDHYDIHEELGTGAFGVVHRVTERATGNNFA---------AKFVMTPHESDKETVRKEI 99
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRD 234
             M +L+HP +VNL +  +D N     M+ E++ G    +    +   + E  A +Y+R 
Sbjct: 100 QTMSVLRHPTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 157
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAP--SGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
           +  GL ++H +N VH D+KP+N++     S  +K+ DF ++    D    ++ + GT  F
Sbjct: 158 VCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEF 216
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA--- 349
            APE   G    G   D W+VGV  Y ++ G  PF GE   +T   + +      D+   
Sbjct: 217 AAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS 275
Query: 350 -MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
            ++ + ++ +  LL  DP  R+T++   +H W+   N P
Sbjct: 276 GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 314

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 86/311 (27%), Positives = 136/311 (43%), Gaps = 45/311 (14%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDV 171
           G   +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +  
Sbjct: 1   GPGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTA 52
Query: 172 RREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMA 228
            RE+ ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + 
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLI 108
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           + YL  ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            
Sbjct: 109 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NS 343
           T  + APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + 
Sbjct: 169 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 228
Query: 344 LVFPDAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHT 379
           +V+P   +                    P L    R+LL  +L  DP +R++      H 
Sbjct: 229 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 288
Query: 380 WVLGDNGPIPQ 390
           +      P+P 
Sbjct: 289 FFQDVTKPVPH 299

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 136/307 (44%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 55
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 56  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 111
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP+NLL+   G +K+ DF +++ F            T  +
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 171
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 231
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 232 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 292 VTKPVPH 298

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 78/252 (30%), Positives = 126/252 (50%), Gaps = 13/252 (5%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G + K      +   + +A K   KS L K    P +     +  E+ I + L H +
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK----PHQREKMSM--EISIHRSLAHQH 100
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           +V      +D  +D  ++VLE    +   +   +  A+ E  AR YLR IV G  YLH +
Sbjct: 101 VVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 158
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
            V+H D+K  NL +     VKIGDF ++   E D +  +   GTP + APE    L+  G
Sbjct: 159 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV---LSKKG 215
Query: 306 KA--ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
            +   D W++G  +Y +++G+ PF    L++TY +I  N    P  +NP   +L++ +L 
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 275
Query: 364 KDPTRRLTLNDV 375
            DPT R T+N++
Sbjct: 276 TDPTARPTINEL 287

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 136/307 (44%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 54
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 55  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLS--MDLKKFMDASALTGIPLPLIKSYL 110
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP+NLL+   G +K+ DF +++ F            T  +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 170
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 230
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 231 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 291 VTKPVPH 297

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 136/307 (44%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 56
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 57  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLS--MDLKKFMDASALTGIPLPLIKSYL 112
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP+NLL+   G +K+ DF +++ F            T  +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 232
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 233 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 293 VTKPVPH 299

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 136/307 (44%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 53
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKDFMDASALTGIPLPLIKSYL 109
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP+NLL+   G +K+ DF +++ F            T  +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 229
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 290 VTKPVPH 296

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 86/311 (27%), Positives = 136/311 (43%), Gaps = 45/311 (14%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDV 171
           G   +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +  
Sbjct: 1   GPGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTA 52
Query: 172 RREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMA 228
            RE+ ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + 
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKTFMDASALTGIPLPLI 108
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           + YL  ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            
Sbjct: 109 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NS 343
           T  + APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + 
Sbjct: 169 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 228
Query: 344 LVFPDAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHT 379
           +V+P   +                    P L    R+LL  +L  DP +R++      H 
Sbjct: 229 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 288
Query: 380 WVLGDNGPIPQ 390
           +      P+P 
Sbjct: 289 FFQDVTKPVPH 299

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 136/309 (44%), Gaps = 45/309 (14%)
Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRR 173
           + +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   R
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIR 58
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARK 230
           E+ ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + 
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKS 114
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
           YL  ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T 
Sbjct: 115 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL 174
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLV 345
            + APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V
Sbjct: 175 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 234
Query: 346 FPDAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           +P   +                    P L    R+LL  +L  DP +R++      H + 
Sbjct: 235 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294
Query: 382 LGDNGPIPQ 390
                P+P 
Sbjct: 295 QDVTKPVPH 303

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 54
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 55  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 110
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 170
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 230
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 231 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 291 VTKPVPH 297

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 78/252 (30%), Positives = 126/252 (50%), Gaps = 13/252 (5%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G + K      +   + +A K   KS L K    P +     +  E+ I + L H +
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK----PHQREKMSM--EISIHRSLAHQH 102
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH 245
           +V      +D  +D  ++VLE    +   +   +  A+ E  AR YLR IV G  YLH +
Sbjct: 103 VVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG 305
            V+H D+K  NL +     VKIGDF ++   E D +  +   GTP + APE    L+  G
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV---LSKKG 217
Query: 306 KA--ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLC 363
            +   D W++G  +Y +++G+ PF    L++TY +I  N    P  +NP   +L++ +L 
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 277
Query: 364 KDPTRRLTLNDV 375
            DPT R T+N++
Sbjct: 278 TDPTARPTINEL 289

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 135/279 (48%), Gaps = 20/279 (7%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           +++ Y    ++G G++G V        G ++A         +K  + P E+    VR+E+
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFA---------AKFVMTPHESDKETVRKEI 205
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRD 234
             M +L+HP +VNL +  +D N     M+ E++ G    +    +   + E  A +Y+R 
Sbjct: 206 QTMSVLRHPTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 263
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAP--SGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
           +  GL ++H +N VH D+KP+N++     S  +K+ DF ++    D    ++ + GT  F
Sbjct: 264 VCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEF 322
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA--- 349
            APE   G    G   D W+VGV  Y ++ G  PF GE   +T   + +      D+   
Sbjct: 323 AAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS 381
Query: 350 -MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
            ++ + ++ +  LL  DP  R+T++   +H W+   N P
Sbjct: 382 GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 53
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 109
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 170 RAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 229
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 290 VTKPVPH 296

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 136/309 (44%), Gaps = 45/309 (14%)
Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRR 173
           + +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   R
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIR 58
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARK 230
           E+ ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + 
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKS 114
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
           YL  ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T 
Sbjct: 115 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL 174
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLV 345
            + APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V
Sbjct: 175 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 234
Query: 346 FPDAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           +P   +                    P L    R+LL  +L  DP +R++      H + 
Sbjct: 235 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294
Query: 382 LGDNGPIPQ 390
                P+P 
Sbjct: 295 QDVTKPVPH 303

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 56
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 57  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 112
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 232
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 233 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 293 VTKPVPH 299

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 55
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 56  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 111
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 171
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 231
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 232 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 292 VTKPVPH 298

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 53
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 109
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 229
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 290 VTKPVPH 296

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 53
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 109
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 229
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 290 VTKPVPH 296

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 52
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 53  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 108
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 168
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 289 VTKPVPH 295

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 54
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 55  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 110
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 170
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 230
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 231 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 291 VTKPVPH 297

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 88/320 (27%), Positives = 140/320 (43%), Gaps = 49/320 (15%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 57
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 58  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 113
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 114 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 173
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 233
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 234 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293
Query: 384 DNGPIPQYLCWCKRDRLRRD 403
              P+P      + +R  RD
Sbjct: 294 VTKPVPH----LRLERPHRD 309

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 53
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 109
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 229
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 290 VTKPVPH 296

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 53
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 109
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 229
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 290 VTKPVPH 296

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 52
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 53  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 108
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 289 VTKPVPH 295

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 53
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 109
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 229
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 290 VTKPVPH 296

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 52
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 53  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 108
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 168
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 289 VTKPVPH 295

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 133/301 (44%), Gaps = 45/301 (14%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREVLIMKML 181
           V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+ ++K L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREISLLKEL 58
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYLRDIVSG 238
            HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL  ++ G
Sbjct: 59  NHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L + H H V+H D+KP NLL+   G +K+ DF +++ F            T  + APE  
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFPDAMN-- 351
           LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P   +  
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 352 ------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIP 389
                             P L    R+LL  +L  DP +R++      H +      P+P
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
Query: 390 Q 390
Sbjct: 295 H 295

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 55
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 56  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 111
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 171
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 231
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 232 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 292 VTKPVPH 298

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 54
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 55  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 110
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 170
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 230
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 231 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 291 VTKPVPH 297

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 53
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 109
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 110 FQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 229
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 290 VTKPVPH 296

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 57
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 58  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 113
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 114 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 173
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 233
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 234 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 294 VTKPVPH 300

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 56
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 57  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLS--MDLKDFMDASALTGIPLPLIKSYL 112
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 232
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 233 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 293 VTKPVPH 299

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 55
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 56  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLS--MDLKDFMDASALTGIPLPLIKSYL 111
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 171
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 231
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 232 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 292 VTKPVPH 298

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/257 (31%), Positives = 127/257 (49%), Gaps = 17/257 (6%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +Y  V+ IG G++G+V L R     K YA+K   K  + K     S++A     R+  IM
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIK----RSDSAFFWEERD--IM 129
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
                P +V L     D    + YMV+EY+ G  D         + E  A+ Y  ++V  
Sbjct: 130 AFANSPWVVQLFCAFQD--DKYLYMVMEYMPGG-DLVNLMSNYDVPEKWAKFYTAEVVLA 186
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV-LRRSPGTPVFTAPEC 297
           L  +H   ++H D+KPDN+L+   G +K+ DF      ++   V    + GTP + +PE 
Sbjct: 187 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEV 246
Query: 298 CL---GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFPDAMNP 352
                G  Y G+  D W+VGV L+ M++G  PF  ++L  TY KI++  NSL FP+  + 
Sbjct: 247 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPE--DA 304
Query: 353 ELRNLLEGLLCKDPTRR 369
           E+    + L+C   T R
Sbjct: 305 EISKHAKNLICAFLTDR 321

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 130/276 (47%), Gaps = 13/276 (4%)
Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           + +  Y+  R +G G + K          + +A K   KS L  L+    E   T    E
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSML--LKPHQKEKMST----E 76
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           + I K L +P++V      +D   D  Y+VLE    +   +   +  A+ E  AR ++R 
Sbjct: 77  IAIHKSLDNPHVVGFHGFFED--DDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 134
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
            + G+ YLH + V+H D+K  NL +     VKIGDF ++   E D +  +   GTP + A
Sbjct: 135 TIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIA 194
Query: 295 PE--CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNP 352
           PE  C  G ++     D W++G  LY +++G+ PF    L++TY +I  N    P  +NP
Sbjct: 195 PEVLCKKGHSF---EVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINP 251
Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI 388
               L+  +L  DPT R ++ ++    +      P+
Sbjct: 252 VASALIRRMLHADPTLRPSVAELLTDEFFTSGYAPM 287

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 133/277 (48%), Gaps = 15/277 (5%)
Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKH-YAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           + +  Y+  R +G G + K     + +D K  +A K   KS L  L+    E   T    
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEI-TDMDTKEVFAGKVVPKSML--LKPHQKEKMST---- 91
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
           E+ I K L +P++V      +D   D  Y+VLE    +   +   +  A+ E  AR ++R
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFED--DDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR 149
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
             + G+ YLH + V+H D+K  NL +     VKIGDF ++   E D +  +   GTP + 
Sbjct: 150 QTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYI 209
Query: 294 APE--CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
           APE  C  G ++     D W++G  LY +++G+ PF    L++TY +I  N    P  +N
Sbjct: 210 APEVLCKKGHSF---EVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHIN 266
Query: 352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI 388
           P    L+  +L  DPT R ++ ++    +      P+
Sbjct: 267 PVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAPM 303

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 134/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A        L K+R+   +E   +   RE+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVA--------LXKIRLDTETEGVPSTAIREI 53
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 109
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 229
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 290 VTKPVPH 296

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 134/307 (43%), Gaps = 45/307 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A        L K+R+   +E   +   RE+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVA--------LXKIRLDTETEGVPSTAIREI 52
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 53  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 108
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              +                    P L    R+LL  +L  DP +R++      H +   
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 384 DNGPIPQ 390
              P+P 
Sbjct: 289 VTKPVPH 295

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 133/277 (48%), Gaps = 15/277 (5%)
Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKH-YAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           + +  Y+  R +G G + K     + +D K  +A K   KS L  L+    E   T    
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEI-TDMDTKEVFAGKVVPKSML--LKPHQKEKMST---- 91
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
           E+ I K L +P++V      +D   D  Y+VLE    +   +   +  A+ E  AR ++R
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFED--DDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR 149
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
             + G+ YLH + V+H D+K  NL +     VKIGDF ++   E D +  +   GTP + 
Sbjct: 150 QTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYI 209
Query: 294 APE--CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
           APE  C  G ++     D W++G  LY +++G+ PF    L++TY +I  N    P  +N
Sbjct: 210 APEVLCKKGHSF---EVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHIN 266
Query: 352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI 388
           P    L+  +L  DPT R ++ ++    +      P+
Sbjct: 267 PVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAPM 303

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 136/304 (44%), Gaps = 31/304 (10%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
            TK  + Y    ++G G++  V        G  +A K  +   LS             + 
Sbjct: 24  STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-------RDFQKLE 76
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           RE  I + LQHPNIV L + I + +    Y+V + V G    +         E+ A   +
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEES--FHYLVFDLVTGGELFEDIVAREFYSEADASHCI 134
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDFSVSQVFEDDNDVLRRSPGT 289
           + I+  + Y H + +VH ++KP+NLL+A       VK+ DF ++ +  +D++      GT
Sbjct: 135 QQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGT 193
Query: 290 PVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP-- 347
           P + +PE      Y  K  D WA GV LY +++G  PF  E     Y +I   +  +P  
Sbjct: 194 PGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP 252
Query: 348 --DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLRRDNT 405
             D + PE ++L++ +L  +P +R+T +   K  W+             C R+R+     
Sbjct: 253 EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI-------------CNRERVASAIH 299
Query: 406 TQDS 409
            QD+
Sbjct: 300 RQDT 303

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 133/277 (48%), Gaps = 15/277 (5%)
Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKH-YAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           + +  Y+  R +G G + K     + +D K  +A K   KS L  L+    E   T    
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEI-TDMDTKEVFAGKVVPKSML--LKPHQKEKMST---- 91
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
           E+ I K L +P++V      +D   D  Y+VLE    +   +   +  A+ E  AR ++R
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFED--DDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR 149
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
             + G+ YLH + V+H D+K  NL +     VKIGDF ++   E D +  +   GTP + 
Sbjct: 150 QTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYI 209
Query: 294 APE--CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
           APE  C  G ++     D W++G  LY +++G+ PF    L++TY +I  N    P  +N
Sbjct: 210 APEVLCKKGHSF---EVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHIN 266
Query: 352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI 388
           P    L+  +L  DPT R ++ ++    +      P+
Sbjct: 267 PVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAPM 303

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 135/303 (44%), Gaps = 31/303 (10%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
            TK  + Y    ++G G++  V        G  +A K  +   LS             + 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-------RDFQKLE 53
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           RE  I + LQHPNIV L + I + +    Y+V + V G    +         E+ A   +
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEES--FHYLVFDLVTGGELFEDIVAREFYSEADASHCI 111
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDFSVSQVFEDDNDVLRRSPGT 289
           + I+  + Y H + +VH ++KP+NLL+A       VK+ DF ++ +  +D++      GT
Sbjct: 112 QQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGT 170
Query: 290 PVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP-- 347
           P + +PE      Y  K  D WA GV LY +++G  PF  E     Y +I   +  +P  
Sbjct: 171 PGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP 229
Query: 348 --DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLRRDNT 405
             D + PE ++L++ +L  +P +R+T +   K  W+             C R+R+     
Sbjct: 230 EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI-------------CNRERVASAIH 276
Query: 406 TQD 408
            QD
Sbjct: 277 RQD 279

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 136/302 (45%), Gaps = 31/302 (10%)
Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           TK  + Y    ++G G++  V        G  +A K  +   LS             + R
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-------RDFQKLER 53
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
           E  I + LQHPNIV L + I +  S H Y+V + V G    +         E+ A   ++
Sbjct: 54  EARICRKLQHPNIVRLHDSIQE-ESFH-YLVFDLVTGGELFEDIVAREFYSEADASHCIQ 111
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
            I+  + Y H + +VH ++KP+NLL+A       VK+ DF ++ +  +D++      GTP
Sbjct: 112 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTP 170
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP--- 347
            + +PE      Y  K  D WA GV LY +++G  PF  E     Y +I   +  +P   
Sbjct: 171 GYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 229
Query: 348 -DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLRRDNTT 406
            D + PE ++L++ +L  +P +R+T +   K  W+             C R+R+      
Sbjct: 230 WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI-------------CNRERVASAIHR 276
Query: 407 QD 408
           QD
Sbjct: 277 QD 278

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 129/276 (46%), Gaps = 18/276 (6%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
            TK  + Y    ++G G++  V        G  +A K  +   LS             + 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-------RDFQKLE 53
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           RE  I + LQHPNIV L + I +  S H Y+V + V G    +         E+ A   +
Sbjct: 54  REARICRKLQHPNIVRLHDSIQE-ESFH-YLVFDLVTGGELFEDIVAREFYSEADASHCI 111
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDFSVSQVFEDDNDVLRRSPGT 289
           + I+  + Y H + +VH ++KP+NLL+A       VK+ DF ++ +  +D++      GT
Sbjct: 112 QQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGT 170
Query: 290 PVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP-- 347
           P + +PE      Y  K  D WA GV LY +++G  PF  E     Y +I   +  +P  
Sbjct: 171 PGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP 229
Query: 348 --DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
             D + PE ++L++ +L  +P +R+T +   K  W+
Sbjct: 230 EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 87/284 (30%), Positives = 141/284 (49%), Gaps = 37/284 (13%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           ++ IG G++G+V + +     + YA+K  +K  + K     +ETA     R+VL+    Q
Sbjct: 95  IKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLK----RAETACFREERDVLVNGDCQ 150
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMARKYLRD 234
              I  L     D N  H Y+V++Y  G        K+++        + E MAR Y+ +
Sbjct: 151 W--ITALHYAFQDEN--HLYLVMDYYVGGDLLTLLSKFED-------KLPEDMARFYIGE 199
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR-SPGTPVFT 293
           +V  +  +H  + VH DIKPDN+L+  +G +++ DF       DD  V    + GTP + 
Sbjct: 200 MVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYI 259
Query: 294 APECCLGLTYG----GKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFP 347
           +PE    +  G    G   D W++GV +Y M+ G+ PF  E+L +TY KI+N+     FP
Sbjct: 260 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 319
Query: 348 DA---MNPELRNLLEGLLCKDPTRRLTLN---DVAKHTWVLGDN 385
                ++ E ++L++ L+C    RRL  N   D  KH +  G N
Sbjct: 320 SHVTDVSEEAKDLIQRLICS-RERRLGQNGIEDFKKHAFFEGLN 362

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 138/277 (49%), Gaps = 23/277 (8%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           ++ IG G++G+V + +     + YA+K  +K  + K     +ETA     R+VL+    Q
Sbjct: 79  IKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLK----RAETACFREERDVLVNGDCQ 134
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEY-VEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
              I  L     D N  H Y+V++Y V G            + E MAR Y+ ++V  +  
Sbjct: 135 W--ITALHYAFQDEN--HLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDS 190
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR-SPGTPVFTAPECCLG 300
           +H  + VH DIKPDN+L+  +G +++ DF       DD  V    + GTP + +PE    
Sbjct: 191 IHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQA 250
Query: 301 LTYG----GKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFPDA---MN 351
           +  G    G   D W++GV +Y M+ G+ PF  E+L +TY KI+N+     FP     ++
Sbjct: 251 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVS 310
Query: 352 PELRNLLEGLLCKDPTRRLTLN---DVAKHTWVLGDN 385
            E ++L++ L+C    RRL  N   D  KH +  G N
Sbjct: 311 EEAKDLIQRLICS-RERRLGQNGIEDFKKHAFFEGLN 346

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 132/297 (44%), Gaps = 45/297 (15%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
           +  +  V KIG G+YG V   R+ L G+  A+K        K+R+   +E   +   RE+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK--------KIRLDTETEGVPSTAIREI 53
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYL 232
            ++K L HPNIV L++VI   N    Y+V E++    D   F    A   I   + + YL
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYL 109
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFP 347
            APE  LG  Y   A D W++G     M+  +  F G++  D   +I       + +V+P
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 229
Query: 348 DAMN--------------------PEL----RNLLEGLLCKDPTRRLTLNDVAKHTW 380
              +                    P L    R+LL  +L  DP +R++      H +
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 89/309 (28%), Positives = 139/309 (44%), Gaps = 61/309 (19%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR-VAPSETAMTDVRREVLIMKMLQHP 184
           IG GSYG V   R +++ +  AI+A    + +K+R + P +  +  ++ EV +MK L HP
Sbjct: 34  IGQGSYGVV---RVAIENQTRAIRAIKIMNKNKIRQINPKD--VERIKTEVRLMKKLHHP 88
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGK--------WDNDGFGQ----------------- 219
           NI  L EV +D    +  +V+E   G         + +D  G+                 
Sbjct: 89  NIARLYEVYED--EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 220 ----PGAIG-----------ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA--PS 262
                G+I            E +    +R I S L YLH   + H DIKP+N L +   S
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 263 GTVKIGDFSVSQVFEDDNDV----LRRSPGTPVFTAPEC--CLGLTYGGKAADTWAVGVT 316
             +K+ DF +S+ F   N+     +    GTP F APE       +YG K  D W+ GV 
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC-DAWSAGVL 265
Query: 317 LYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAMNPELRNLLEGLLCKDPTRRLTL 372
           L+ +++G  PF G    DT  +++N  L F     + ++P  R+LL  LL ++   R   
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325
Query: 373 NDVAKHTWV 381
               +H W+
Sbjct: 326 MRALQHPWI 334

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 131/273 (47%), Gaps = 15/273 (5%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
               + ++  V+ +G G+YG+V L  + +  +  A+K              +     +++
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--------AVDCPENIK 52
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +E+ I KML H N+V       + N    Y+ LEY  G    D       + E  A+++ 
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTP 290
             +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT 
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFP- 347
            + APE      +  +  D W+ G+ L  M+ G+ P+    ++ Q+  D     + + P 
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             ++     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 139/281 (49%), Gaps = 21/281 (7%)
Query: 110 DENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMT 169
           DEN     + +  +R IG GS+GKV + + +   K YA+K  +K    +         + 
Sbjct: 7   DENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE------RNEVR 60
Query: 170 DVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR 229
           +V +E+ IM+ L+HP +VNL     D   +  +MV++ + G        Q     E   +
Sbjct: 61  NVFKELQIMQGLEHPFLVNLWYSFQD--EEDMFMVVDLLLGGDLRYHLQQNVHFKEETVK 118
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
            ++ ++V  L YL    ++H D+KPDN+L+   G V I DF+++ +   +  +   + GT
Sbjct: 119 LFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA-GT 177
Query: 290 PVFTAPECCLGLTYGGK--AADTWAVGVTLYYMIIGQYPF------LGETLQDTYDKIVN 341
             + APE        G   A D W++GVT Y ++ G+ P+        + +  T++  V 
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV- 236
Query: 342 NSLVFPDAMNPELRNLLEGLLCKDPTRRLT-LNDVAKHTWV 381
             + +P A + E+ +LL+ LL  +P +R + L+DV    ++
Sbjct: 237 --VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 131/273 (47%), Gaps = 15/273 (5%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
               + ++  V+ +G G+YG+V L  + +  +  A+K              +     +++
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--------AVDCPENIK 52
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +E+ I KML H N+V       + N    Y+ LEY  G    D       + E  A+++ 
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTP 290
             +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT 
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFP- 347
            + APE      +  +  D W+ G+ L  M+ G+ P+    ++ Q+  D     + + P 
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPW 230
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             ++     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 131/273 (47%), Gaps = 15/273 (5%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
               + ++  V+ +G G+YG+V L  + +  +  A+K              +     +++
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--------AVDCPENIK 52
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +E+ I KML H N+V       + N    Y+ LEY  G    D       + E  A+++ 
Sbjct: 53  KEIXINKMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTP 290
             +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT 
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFP- 347
            + APE      +  +  D W+ G+ L  M+ G+ P+    ++ Q+  D     + + P 
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             ++     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 131/273 (47%), Gaps = 15/273 (5%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
               + ++  V+ +G G+YG+V L  + +  +  A+K              +     +++
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--------AVDCPENIK 53
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +E+ I KML H N+V       + N    Y+ LEY  G    D       + E  A+++ 
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTP 290
             +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT 
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFP- 347
            + APE      +  +  D W+ G+ L  M+ G+ P+    ++ Q+  D     + + P 
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             ++     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 131/273 (47%), Gaps = 15/273 (5%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
               + ++  V+ +G G+YG+V L  + +  +  A+K              +     +++
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--------AVDCPENIK 52
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +E+ I KML H N+V       + N    Y+ LEY  G    D       + E  A+++ 
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTP 290
             +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT 
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFP- 347
            + APE      +  +  D W+ G+ L  M+ G+ P+    ++ Q+  D     + + P 
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             ++     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 133/273 (48%), Gaps = 15/273 (5%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
               + ++  V+ +G G+YG+V L  + +  +  A+K      + +    P      +++
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPE-----NIK 53
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +E+ I KML H N+V       + N    Y+ LEY  G    D       + E  A+++ 
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTP 290
             +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT 
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFP- 347
            + APE      +  +  D W+ G+ L  M+ G+ P+    ++ Q+  D     + + P 
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             ++     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 133/273 (48%), Gaps = 15/273 (5%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
               + ++  V+ +G G+YG+V L  + +  +  A+K      + +    P      +++
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPE-----NIK 52
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +E+ I KML H N+V       + N    Y+ LEY  G    D       + E  A+++ 
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTP 290
             +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT 
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFP- 347
            + APE      +  +  D W+ G+ L  M+ G+ P+    ++ Q+  D     + + P 
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             ++     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 131/273 (47%), Gaps = 15/273 (5%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
               + ++  V+ +G G+YG+V L  + +  +  A+K              +     +++
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--------AVDCPENIK 52
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +E+ I KML H N+V       + N    Y+ LEY  G    D       + E  A+++ 
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTP 290
             +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT 
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFP- 347
            + APE      +  +  D W+ G+ L  M+ G+ P+    ++ Q+  D     + + P 
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             ++     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 131/273 (47%), Gaps = 15/273 (5%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
               + ++  V+ +G G+YG+V L  + +  +  A+K              +     +++
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--------AVDCPENIK 52
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +E+ I KML H N+V       + N    Y+ LEY  G    D       + E  A+++ 
Sbjct: 53  KEIXINKMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTP 290
             +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT 
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFP- 347
            + APE      +  +  D W+ G+ L  M+ G+ P+    ++ Q+  D     + + P 
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             ++     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 131/273 (47%), Gaps = 15/273 (5%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
               + ++  V+ +G G+YG+V L  + +  +  A+K              +     +++
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--------AVDCPENIK 52
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +E+ I KML H N+V       + N    Y+ LEY  G    D       + E  A+++ 
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTP 290
             +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT 
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFP- 347
            + APE      +  +  D W+ G+ L  M+ G+ P+    ++ Q+  D     + + P 
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             ++     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 131/273 (47%), Gaps = 15/273 (5%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
               + ++  V+ +G G+YG+V L  + +  +  A+K              +     +++
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--------AVDCPENIK 52
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +E+ I KML H N+V       + N    Y+ LEY  G    D       + E  A+++ 
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTP 290
             +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT 
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFP- 347
            + APE      +  +  D W+ G+ L  M+ G+ P+    ++ Q+  D     + + P 
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             ++     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 131/270 (48%), Gaps = 15/270 (5%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
            + ++  V+ +G G+YG+V L  + +  +  A+K              +     ++++E+
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--------AVDCPENIKKEI 54
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            I KML H N+V       + N    Y+ LEY  G    D       + E  A+++   +
Sbjct: 55  CINKMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 112
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFT 293
           ++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT  + 
Sbjct: 113 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFP-DAM 350
           APE      +  +  D W+ G+ L  M+ G+ P+    ++ Q+  D     + + P   +
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
           +     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 233 DSAPLALLHKILVENPSARITIPDIKKDRW 262

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 131/273 (47%), Gaps = 15/273 (5%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
               + ++  V+ +G G+YG+V L  + +  +  A+K              +     +++
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--------AVDCPENIK 52
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +E+ I KML H N+V       + N    Y+ LEY  G    D       + E  A+++ 
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTP 290
             +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT 
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFP- 347
            + APE      +  +  D W+ G+ L  M+ G+ P+    ++ Q+  D     + + P 
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             ++     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 131/273 (47%), Gaps = 15/273 (5%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
               + ++  V+ +G G+YG+V L  + +  +  A+K              +     +++
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--------AVDCPENIK 52
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +E+ I KML H N+V       + N    Y+ LEY  G    D       + E  A+++ 
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTP 290
             +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT 
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFP- 347
            + APE      +  +  D W+ G+ L  M+ G+ P+    ++ Q+  D     + + P 
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             ++     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 131/273 (47%), Gaps = 15/273 (5%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
               + ++  V+ +G G+YG+V L  + +  +  A+K              +     +++
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--------AVDCPENIK 53
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +E+ I KML H N+V       + N    Y+ LEY  G    D       + E  A+++ 
Sbjct: 54  KEIXINKMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTP 290
             +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT 
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 171
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFP- 347
            + APE      +  +  D W+ G+ L  M+ G+ P+    ++ Q+  D     + + P 
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             ++     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 131/273 (47%), Gaps = 15/273 (5%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
               + ++  V+ +G G+YG+V L  + +  +  A+K              +     +++
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--------AVDCPENIK 53
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +E+ I KML H N+V       + N    Y+ LEY  G    D       + E  A+++ 
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTP 290
             +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT 
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFP- 347
            + APE      +  +  D W+ G+ L  M+ G+ P+    ++ Q+  D     + + P 
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             ++     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 131/273 (47%), Gaps = 15/273 (5%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
               + ++  V+ +G G+YG+V L  + +  +  A+K              +     +++
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--------AVDCPENIK 53
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +E+ I KML H N+V       + N    Y+ LEY  G    D       + E  A+++ 
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTP 290
             +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT 
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFP- 347
            + APE      +  +  D W+ G+ L  M+ G+ P+    ++ Q+  D     + + P 
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             ++     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 131/273 (47%), Gaps = 15/273 (5%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
               + ++  V+ +G G+YG+V L  + +  +  A+K              +     +++
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--------AVDCPENIK 53
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +E+ I KML H N+V       + N    Y+ LEY  G    D       + E  A+++ 
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTP 290
             +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT 
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFP- 347
            + APE      +  +  D W+ G+ L  M+ G+ P+    ++ Q+  D     + + P 
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             ++     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 131/273 (47%), Gaps = 15/273 (5%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
               + ++  V+ +G G+YG+V L  + +  +  A+K              +     +++
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--------AVDCPENIK 53
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +E+ I KML H N+V       + N    Y+ LEY  G    D       + E  A+++ 
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTP 290
             +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT 
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFP- 347
            + APE      +  +  D W+ G+ L  M+ G+ P+    ++ Q+  D     + + P 
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             ++     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 128/258 (49%), Gaps = 12/258 (4%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +N++   R IG G +G+V   R +  GK YA+K   K    ++++   ET   + R  + 
Sbjct: 187 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK---RIKMKQGETLALNERIMLS 243
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           ++     P IV +      P  D    +L+ + G   +    Q G   E+  R Y  +I+
Sbjct: 244 LVSTGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 301
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
            GL ++H   VV+ D+KP N+L+   G V+I D  ++  F         S GT  + APE
Sbjct: 302 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPE 359
Query: 297 CCL-GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYD---KIVNNSLVFPDAMNP 352
               G+ Y   +AD +++G  L+ ++ G  PF     +D ++     +  ++  PD+ +P
Sbjct: 360 VLQKGVAYDS-SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 418
Query: 353 ELRNLLEGLLCKDPTRRL 370
           ELR+LLEGLL +D  RRL
Sbjct: 419 ELRSLLEGLLQRDVNRRL 436

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 128/258 (49%), Gaps = 12/258 (4%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +N++   R IG G +G+V   R +  GK YA+K   K    ++++   ET   + R  + 
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK---RIKMKQGETLALNERIMLS 244
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           ++     P IV +      P  D    +L+ + G   +    Q G   E+  R Y  +I+
Sbjct: 245 LVSTGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
            GL ++H   VV+ D+KP N+L+   G V+I D  ++  F         S GT  + APE
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPE 360
Query: 297 CCL-GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYD---KIVNNSLVFPDAMNP 352
               G+ Y   +AD +++G  L+ ++ G  PF     +D ++     +  ++  PD+ +P
Sbjct: 361 VLQKGVAYDS-SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 419
Query: 353 ELRNLLEGLLCKDPTRRL 370
           ELR+LLEGLL +D  RRL
Sbjct: 420 ELRSLLEGLLQRDVNRRL 437

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 128/258 (49%), Gaps = 12/258 (4%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +N++   R IG G +G+V   R +  GK YA+K   K    ++++   ET   + R  + 
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK---RIKMKQGETLALNERIMLS 244
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           ++     P IV +      P  D    +L+ + G   +    Q G   E+  R Y  +I+
Sbjct: 245 LVSTGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
            GL ++H   VV+ D+KP N+L+   G V+I D  ++  F         S GT  + APE
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPE 360
Query: 297 CCL-GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYD---KIVNNSLVFPDAMNP 352
               G+ Y   +AD +++G  L+ ++ G  PF     +D ++     +  ++  PD+ +P
Sbjct: 361 VLQKGVAYDS-SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 419
Query: 353 ELRNLLEGLLCKDPTRRL 370
           ELR+LLEGLL +D  RRL
Sbjct: 420 ELRSLLEGLLQRDVNRRL 437

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 128/258 (49%), Gaps = 12/258 (4%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +N++   R IG G +G+V   R +  GK YA+K   K    ++++   ET   + R  + 
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK---RIKMKQGETLALNERIMLS 244
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           ++     P IV +      P  D    +L+ + G   +    Q G   E+  R Y  +I+
Sbjct: 245 LVSTGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
            GL ++H   VV+ D+KP N+L+   G V+I D  ++  F         S GT  + APE
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPE 360
Query: 297 CCL-GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYD---KIVNNSLVFPDAMNP 352
               G+ Y   +AD +++G  L+ ++ G  PF     +D ++     +  ++  PD+ +P
Sbjct: 361 VLQKGVAYDS-SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 419
Query: 353 ELRNLLEGLLCKDPTRRL 370
           ELR+LLEGLL +D  RRL
Sbjct: 420 ELRSLLEGLLQRDVNRRL 437

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 129/296 (43%), Gaps = 40/296 (13%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           M+ +Y  + KIG GSYG V   R+   G+  AIK F       L             RE+
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-------LESEDDPVIKKIALREI 53
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++K L+HPN+VNL+EV       H  +V EY +    ++       + E + +      
Sbjct: 54  RMLKQLKHPNLVNLLEVFRRKRRLH--LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT 111
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           +  + + H HN +H D+KP+N+L+     +K+ DF  +++    +D       T  + +P
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSP 171
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIG-----------QYPFLGETLQDT---YDKIVN 341
           E  +G T  G   D WA+G     ++ G           Q   + +TL D    + ++ +
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231
Query: 342 NSLVF-------PDAMNP-ELR---------NLLEGLLCKDPTRRLTLNDVAKHTW 380
            +  F       P+ M P EL+          LL+G L  DPT RLT   +  H +
Sbjct: 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 130/273 (47%), Gaps = 15/273 (5%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
               + ++  V+ +G G+YG+V L  + +  +  A+K              +     +++
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--------AVDCPENIK 53
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +E+ I  ML H N+V       + N    Y+ LEY  G    D       + E  A+++ 
Sbjct: 54  KEICINAMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTP 290
             +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT 
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFP- 347
            + APE      +  +  D W+ G+ L  M+ G+ P+    ++ Q+  D     + + P 
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             ++     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 126/267 (47%), Gaps = 25/267 (9%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR----VAPSETAMTDVRREV 175
           ++  R +G G +G+V   +    GK YA K  +K  L K +        +  +  V    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSD----HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++          +L  V+   N      H Y V E      DN GF +P AI       Y
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDE------DNPGFQEPRAI------FY 294
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
              IVSGL +LH  N+++ D+KP+N+L+   G V+I D  ++   +      +   GTP 
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQ--DTYDKIVNNSLVFP 347
           F APE  LG  Y   + D +A+GVTLY MI  + PF   GE ++  +   +++  ++ +P
Sbjct: 355 FMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLND 374
           D  +P  ++  E LL KDP +RL   D
Sbjct: 414 DKFSPASKDFCEALLQKDPEKRLGFRD 440

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 126/267 (47%), Gaps = 25/267 (9%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR----VAPSETAMTDVRREV 175
           ++  R +G G +G+V   +    GK YA K  +K  L K +        +  +  V    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSD----HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++          +L  V+   N      H Y V E      DN GF +P AI       Y
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDE------DNPGFQEPRAI------FY 294
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
              IVSGL +LH  N+++ D+KP+N+L+   G V+I D  ++   +      +   GTP 
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQ--DTYDKIVNNSLVFP 347
           F APE  LG  Y   + D +A+GVTLY MI  + PF   GE ++  +   +++  ++ +P
Sbjct: 355 FMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLND 374
           D  +P  ++  E LL KDP +RL   D
Sbjct: 414 DKFSPASKDFCEALLQKDPEKRLGFRD 440

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 126/267 (47%), Gaps = 25/267 (9%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR----VAPSETAMTDVRREV 175
           ++  R +G G +G+V   +    GK YA K  +K  L K +        +  +  V    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSD----HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++          +L  V+   N      H Y V E      DN GF +P AI       Y
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDE------DNPGFQEPRAI------FY 294
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
              IVSGL +LH  N+++ D+KP+N+L+   G V+I D  ++   +      +   GTP 
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQ--DTYDKIVNNSLVFP 347
           F APE  LG  Y   + D +A+GVTLY MI  + PF   GE ++  +   +++  ++ +P
Sbjct: 355 FMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLND 374
           D  +P  ++  E LL KDP +RL   D
Sbjct: 414 DKFSPASKDFCEALLQKDPEKRLGFRD 440

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 126/267 (47%), Gaps = 25/267 (9%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR----VAPSETAMTDVRREV 175
           ++  R +G G +G+V   +    GK YA K  +K  L K +        +  +  V    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSD----HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++          +L  V+   N      H Y V E      DN GF +P AI       Y
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDE------DNPGFQEPRAI------FY 294
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
              IVSGL +LH  N+++ D+KP+N+L+   G V+I D  ++   +      +   GTP 
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQ--DTYDKIVNNSLVFP 347
           F APE  LG  Y   + D +A+GVTLY MI  + PF   GE ++  +   +++  ++ +P
Sbjct: 355 FMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLND 374
           D  +P  ++  E LL KDP +RL   D
Sbjct: 414 DKFSPASKDFCEALLQKDPEKRLGFRD 440

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 74/225 (32%), Positives = 113/225 (50%), Gaps = 23/225 (10%)
Query: 115 KMINE-YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR- 172
           K+INE Y  V K+G G    V L   ++     AIKA        + + P E   T  R 
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKA--------IFIPPREKEETLKRF 58
Query: 173 -REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
            REV     L H NIV++I+V  D   D +Y+V+EY+EG   ++     G +    A  +
Sbjct: 59  EREVHNSSQLSHQNIVSMIDV--DEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINF 116
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED-----DNDVLRRS 286
              I+ G+ + H   +VH DIKP N+L+  + T+KI DF +++   +      N VL   
Sbjct: 117 TNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL--- 173
Query: 287 PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
            GT  + +PE   G     +  D +++G+ LY M++G+ PF GET
Sbjct: 174 -GTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGET 216

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 130/273 (47%), Gaps = 15/273 (5%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
               + ++  V+ +G G+ G+V L  + +  +  A+K              +     +++
Sbjct: 1   AVPFVEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKR--------AVDCPENIK 52
Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +E+ I KML H N+V       + N    Y+ LEY  G    D       + E  A+++ 
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTP 290
             +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT 
Sbjct: 111 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFP- 347
            + APE      +  +  D W+ G+ L  M+ G+ P+    ++ Q+  D     + + P 
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             ++     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 129/292 (44%), Gaps = 45/292 (15%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HP 184
           +G G+Y KV    S  +GK YA+K   K          +  + + V REV  +   Q + 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQ---------AGHSRSRVFREVETLYQCQGNK 71
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           NI+ LIE  +D     FY+V E ++G        +     E  A + +RD+ + L +LH 
Sbjct: 72  NILELIEFFEDDT--RFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHT 129
Query: 245 HNVVHGDIKPDNLLV-APS--GTVKIGDFSVSQVFEDDNDV-------LRRSPGTPVFTA 294
             + H D+KP+N+L  +P     VKI DF +    + +N         L    G+  + A
Sbjct: 130 KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMA 189
Query: 295 PECCLGL----TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDT--------------- 335
           PE         T+  K  D W++GV LY M+ G  PF+G    D                
Sbjct: 190 PEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 249
Query: 336 YDKIVNNSLVFPDA----MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
           ++ I      FPD     ++ E ++L+  LL +D  +RL+   V +H WV G
Sbjct: 250 FESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 83/321 (25%), Positives = 144/321 (44%), Gaps = 48/321 (14%)
Query: 103 NKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR-- 160
           NK ++ +D    K IN+Y  +R +  G + K++L     D K YA+K + KS L K R  
Sbjct: 20  NKYVKEKD----KYINDYRIIRTLNQGKFNKIIL--CEKDNKFYALKKYEKSLLEKKRDF 73
Query: 161 ------VAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG---- 210
                     ++   D + E+ I+  +++   +    +I   N D  Y++ EY+E     
Sbjct: 74  TKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII--TNYDEVYIIYEYMENDSIL 131
Query: 211 KWDNDGF----GQPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTV 265
           K+D   F         I   + +  ++ +++   Y+H   N+ H D+KP N+L+  +G V
Sbjct: 132 KFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRV 191
Query: 266 KIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG-LTYGGKAADTWAVGVTLYYMIIGQ 324
           K+ DF  S+   D    ++ S GT  F  PE      +Y G   D W++G+ LY M    
Sbjct: 192 KLSDFGESEYMVDKK--IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
Query: 325 YPF-LGETLQDTYDKIVNNSLVFP-------------------DAMNPELRNLLEGLLCK 364
            PF L  +L + ++ I   ++ +P                   + ++ E  + L+  L K
Sbjct: 250 VPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK 309
Query: 365 DPTRRLTLNDVAKHTWVLGDN 385
           +P  R+T  D  KH W+   N
Sbjct: 310 NPAERITSEDALKHEWLADTN 330

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 130/279 (46%), Gaps = 27/279 (9%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           +++ YV   KIG GS G V L R    G+  A+K      +  LR       + +   EV
Sbjct: 46  LLDSYV---KIGEGSTGIVCLAREKHSGRQVAVK------MMDLRKQQRRELLFN---EV 93
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
           +IM+  QH N+V + +       +  ++++E+++G    D   Q     E +A      +
Sbjct: 94  VIMRDYQHFNVVEMYK--SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIA-TVCEAV 150
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           +  L YLH   V+H DIK D++L+   G VK+ DF        D    +   GTP + AP
Sbjct: 151 LQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAP 210
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-------LQDTYDKIVNNSLVFPD 348
           E      Y  +  D W++G+ +  M+ G+ P+  ++       L+D+    + NS     
Sbjct: 211 EVISRSLYATE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS----H 265
Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
            ++P LR+ LE +L +DP  R T  ++  H ++L    P
Sbjct: 266 KVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLP 304

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 136/273 (49%), Gaps = 22/273 (8%)
Query: 118 NEYVHVRKIGAGSYGKVVLYR--SSLDGKH-YAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           +++  ++ +G GS+GKV L +  S  D +  YA+K   K+ L K+R    +   T + R+
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL-KVR----DRVRTKMERD 78
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +L+   + HP IV L            Y++L+++ G        +     E   + YL +
Sbjct: 79  ILVE--VNHPFIVKLHYAFQ--TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 134
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           +   L +LH   +++ D+KP+N+L+   G +K+ DF +S+   D         GT  + A
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194
Query: 295 PECC--LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNP 352
           PE     G T   ++AD W+ GV ++ M+ G  PF G+  ++T   I+   L  P  ++P
Sbjct: 195 PEVVNRRGHT---QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSP 251
Query: 353 ELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
           E ++LL  L  ++P  RL      + ++ +H++
Sbjct: 252 EAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 133/287 (46%), Gaps = 31/287 (10%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           KIG GS G V +      GK  A+K         LR       + +   EV+IM+  QH 
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKM------DLRKQQRRELLFN---EVVIMRDYQHE 208
Query: 185 NIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
           N+V +       NS    D  ++V+E++EG    D         E +A   L  ++  L 
Sbjct: 209 NVVEMY------NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCL-AVLQALS 261
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV-SQVFEDDNDVLRRSP--GTPVFTAPEC 297
            LH   V+H DIK D++L+   G VK+ DF   +QV     +V RR    GTP + APE 
Sbjct: 262 VLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPEL 318
Query: 298 CLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDAMNPEL 354
              L YG +  D W++G+ +  M+ G+ P+  E        I +N    L     ++P L
Sbjct: 319 ISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSL 377
Query: 355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLR 401
           +  L+ LL +DP +R T  ++ KH + L   GP    +   +++R R
Sbjct: 378 KGFLDRLLVRDPAQRATAAELLKHPF-LAKAGPPASIVPLMRQNRTR 423

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 136/273 (49%), Gaps = 22/273 (8%)
Query: 118 NEYVHVRKIGAGSYGKVVLYR--SSLDGKH-YAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           +++  ++ +G GS+GKV L +  S  D +  YA+K   K+ L K+R    +   T + R+
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL-KVR----DRVRTKMERD 79
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +L+   + HP IV L            Y++L+++ G        +     E   + YL +
Sbjct: 80  ILVE--VNHPFIVKLHYAFQ--TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 135
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           +   L +LH   +++ D+KP+N+L+   G +K+ DF +S+   D         GT  + A
Sbjct: 136 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 195
Query: 295 PECC--LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNP 352
           PE     G T   ++AD W+ GV ++ M+ G  PF G+  ++T   I+   L  P  ++P
Sbjct: 196 PEVVNRRGHT---QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSP 252
Query: 353 ELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
           E ++LL  L  ++P  RL      + ++ +H++
Sbjct: 253 EAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 285

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 136/273 (49%), Gaps = 22/273 (8%)
Query: 118 NEYVHVRKIGAGSYGKVVLYR--SSLDGKH-YAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           +++  ++ +G GS+GKV L +  S  D +  YA+K   K+ L K+R    +   T + R+
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL-KVR----DRVRTKMERD 78
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +L+   + HP IV L            Y++L+++ G        +     E   + YL +
Sbjct: 79  ILVE--VNHPFIVKLHYAFQ--TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 134
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           +   L +LH   +++ D+KP+N+L+   G +K+ DF +S+   D         GT  + A
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194
Query: 295 PECC--LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNP 352
           PE     G T   ++AD W+ GV ++ M+ G  PF G+  ++T   I+   L  P  ++P
Sbjct: 195 PEVVNRRGHT---QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSP 251
Query: 353 ELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
           E ++LL  L  ++P  RL      + ++ +H++
Sbjct: 252 EAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 133/287 (46%), Gaps = 31/287 (10%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           KIG GS G V +      GK  A+K         LR       + +   EV+IM+  QH 
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKM------DLRKQQRRELLFN---EVVIMRDYQHE 86
Query: 185 NIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
           N+V +       NS    D  ++V+E++EG    D         E +A   L  ++  L 
Sbjct: 87  NVVEMY------NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCL-AVLQALS 139
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV-SQVFEDDNDVLRRSP--GTPVFTAPEC 297
            LH   V+H DIK D++L+   G VK+ DF   +QV     +V RR    GTP + APE 
Sbjct: 140 VLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPEL 196
Query: 298 CLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDAMNPEL 354
              L YG +  D W++G+ +  M+ G+ P+  E        I +N    L     ++P L
Sbjct: 197 ISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSL 255
Query: 355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLR 401
           +  L+ LL +DP +R T  ++ KH + L   GP    +   +++R R
Sbjct: 256 KGFLDRLLVRDPAQRATAAELLKHPF-LAKAGPPASIVPLMRQNRTR 301

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 128/296 (43%), Gaps = 42/296 (14%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRRE 174
           ++ +Y  + K+G G+YG V   + S  G+  A+K        ++R+ A  E   +   RE
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALK--------RIRLDAEDEGIPSTAIRE 69
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           + ++K L HPNIV+LI+VI         +V E++E             + +S  + YL  
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERC--LTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           ++ G+ + H H ++H D+KP NLL+   G +K+ DF +++ F            T  + A
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFPDA 349
           P+  +G      + D W++G     MI G+  F G T  D   KI +     N   +P  
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247
Query: 350 MNPELR-------------------------NLLEGLLCKDPTRRLTLNDVAKHTW 380
               L                          +LL  +LC DP +R++  D   H +
Sbjct: 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 88/287 (30%), Positives = 134/287 (46%), Gaps = 31/287 (10%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           KIG GS G V +      GK  A+K   K  L K      +     +  EV+IM+  QH 
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVK---KMDLRK------QQRRELLFNEVVIMRDYQHE 88
Query: 185 NIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
           N+V +       NS    D  ++V+E++EG    D         E +A   L  ++  L 
Sbjct: 89  NVVEMY------NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCL-AVLQALS 141
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV-SQVFEDDNDVLRRSP--GTPVFTAPEC 297
            LH   V+H DIK D++L+   G VK+ DF   +QV     +V RR    GTP + APE 
Sbjct: 142 VLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPEL 198
Query: 298 CLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDAMNPEL 354
              L YG +  D W++G+ +  M+ G+ P+  E        I +N    L     ++P L
Sbjct: 199 ISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSL 257
Query: 355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLR 401
           +  L+ LL +DP +R T  ++ KH + L   GP    +   +++R R
Sbjct: 258 KGFLDRLLVRDPAQRATAAELLKHPF-LAKAGPPASIVPLMRQNRTR 303

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 128/296 (43%), Gaps = 42/296 (14%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRRE 174
           ++ +Y  + K+G G+YG V   + S  G+  A+K        ++R+ A  E   +   RE
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALK--------RIRLDAEDEGIPSTAIRE 69
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           + ++K L HPNIV+LI+VI         +V E++E             + +S  + YL  
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERC--LTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           ++ G+ + H H ++H D+KP NLL+   G +K+ DF +++ F            T  + A
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFPDA 349
           P+  +G      + D W++G     MI G+  F G T  D   KI +     N   +P  
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247
Query: 350 MNPELR-------------------------NLLEGLLCKDPTRRLTLNDVAKHTW 380
               L                          +LL  +LC DP +R++  D   H +
Sbjct: 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 88/287 (30%), Positives = 134/287 (46%), Gaps = 31/287 (10%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           KIG GS G V +      GK  A+K   K  L K      +     +  EV+IM+  QH 
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVK---KMDLRK------QQRRELLFNEVVIMRDYQHE 131
Query: 185 NIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
           N+V +       NS    D  ++V+E++EG    D         E +A   L  ++  L 
Sbjct: 132 NVVEMY------NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCL-AVLQALS 184
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV-SQVFEDDNDVLRRSP--GTPVFTAPEC 297
            LH   V+H DIK D++L+   G VK+ DF   +QV     +V RR    GTP + APE 
Sbjct: 185 VLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPEL 241
Query: 298 CLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDAMNPEL 354
              L YG +  D W++G+ +  M+ G+ P+  E        I +N    L     ++P L
Sbjct: 242 ISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSL 300
Query: 355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLR 401
           +  L+ LL +DP +R T  ++ KH + L   GP    +   +++R R
Sbjct: 301 KGFLDRLLVRDPAQRATAAELLKHPF-LAKAGPPASIVPLMRQNRTR 346

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 128/265 (48%), Gaps = 11/265 (4%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            +Y  +  +G+G++G V         K   +K   K  + +      +  +  V  E+ I
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLE-DCWIEDPKLGKVTLEIAI 82
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIV 236
           +  ++H NI+ ++++ +  N   F +V+E      D   F  +   + E +A    R +V
Sbjct: 83  LSRVEHANIIKVLDIFE--NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S + YL   +++H DIK +N+++A   T+K+ DF  S  + +   +     GT  + APE
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG-SAAYLERGKLFYTFCGTIEYCAPE 199
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
             +G  Y G   + W++GVTLY ++  + PF    L++T +  ++     P  ++ EL +
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENPFC--ELEETVEAAIHP----PYLVSKELMS 253
Query: 357 LLEGLLCKDPTRRLTLNDVAKHTWV 381
           L+ GLL   P RR TL  +    WV
Sbjct: 254 LVSGLLQPVPERRTTLEKLVTDPWV 278

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 129/271 (47%), Gaps = 27/271 (9%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           +++G G +  V    S   G+ YA K   K           +    ++  E+ ++++ + 
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRR-------RGQDCRAEILHEIAVLELAKS 87
Query: 184 -PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-----PGAIGESMARKYLRDIVS 237
            P ++NL EV +  N+    ++LEY  G    + F          + E+   + ++ I+ 
Sbjct: 88  CPRVINLHEVYE--NTSEIILILEYAAG---GEIFSLCLPELAEMVSENDVIRLIKQILE 142
Query: 238 GLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           G+ YLH +N+VH D+KP N+L++   P G +KI DF +S+      + LR   GTP + A
Sbjct: 143 GVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYLA 201
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPEL 354
           PE  L       A D W +G+  Y ++    PF+GE  Q+TY  I   ++ + +     +
Sbjct: 202 PE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV 260
Query: 355 RNL----LEGLLCKDPTRRLTLNDVAKHTWV 381
             L    ++ LL K+P +R T      H+W+
Sbjct: 261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 133/287 (46%), Gaps = 31/287 (10%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           KIG GS G V +      GK  A+K         LR       + +   EV+IM+  QH 
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKM------DLRKQQRRELLFN---EVVIMRDYQHE 77
Query: 185 NIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
           N+V +       NS    D  ++V+E++EG    D         E +A   L  ++  L 
Sbjct: 78  NVVEMY------NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCL-AVLQALS 130
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV-SQVFEDDNDVLRRSP--GTPVFTAPEC 297
            LH   V+H DIK D++L+   G VK+ DF   +QV     +V RR    GTP + APE 
Sbjct: 131 VLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPEL 187
Query: 298 CLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDAMNPEL 354
              L YG +  D W++G+ +  M+ G+ P+  E        I +N    L     ++P L
Sbjct: 188 ISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSL 246
Query: 355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLR 401
           +  L+ LL +DP +R T  ++ KH + L   GP    +   +++R R
Sbjct: 247 KGFLDRLLVRDPAQRATAAELLKHPF-LAKAGPPASIVPLMRQNRTR 292

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 133/287 (46%), Gaps = 31/287 (10%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           KIG GS G V +      GK  A+K         LR       + +   EV+IM+  QH 
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKM------DLRKQQRRELLFN---EVVIMRDYQHE 81
Query: 185 NIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
           N+V +       NS    D  ++V+E++EG    D         E +A   L  ++  L 
Sbjct: 82  NVVEMY------NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCL-AVLQALS 134
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV-SQVFEDDNDVLRRSP--GTPVFTAPEC 297
            LH   V+H DIK D++L+   G VK+ DF   +QV     +V RR    GTP + APE 
Sbjct: 135 VLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPEL 191
Query: 298 CLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDAMNPEL 354
              L YG +  D W++G+ +  M+ G+ P+  E        I +N    L     ++P L
Sbjct: 192 ISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSL 250
Query: 355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLR 401
           +  L+ LL +DP +R T  ++ KH + L   GP    +   +++R R
Sbjct: 251 KGFLDRLLVRDPAQRATAAELLKHPF-LAKAGPPASIVPLMRQNRTR 296

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 124/269 (46%), Gaps = 22/269 (8%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +Y    KIG G+ G V        G+  AI+  +      L+  P +  + +   E+L+M
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN------LQQQPKKELIIN---EILVM 71
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           +  ++PNIVN ++       D  ++V+EY+ G    D   +   + E       R+ +  
Sbjct: 72  RENKNPNIVNYLD--SYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 128
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L +LH + V+H DIK DN+L+   G+VK+ DF        +        GTP + APE  
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVV 188
Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKIVNNSLVFPDAMNPE---- 353
               YG K  D W++G+    MI G+ P+L E  L+  Y    N +   P+  NPE    
Sbjct: 189 TRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT---PELQNPEKLSA 244
Query: 354 -LRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
             R+ L   L  D  +R +  ++ +H ++
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 124/269 (46%), Gaps = 22/269 (8%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +Y    KIG G+ G V        G+  AI+  +      L+  P +  + +   E+L+M
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN------LQQQPKKELIIN---EILVM 72
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           +  ++PNIVN ++       D  ++V+EY+ G    D   +   + E       R+ +  
Sbjct: 73  RENKNPNIVNYLD--SYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 129
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L +LH + V+H DIK DN+L+   G+VK+ DF        +        GTP + APE  
Sbjct: 130 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV 189
Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKIVNNSLVFPDAMNPE---- 353
               YG K  D W++G+    MI G+ P+L E  L+  Y    N +   P+  NPE    
Sbjct: 190 TRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT---PELQNPEKLSA 245
Query: 354 -LRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
             R+ L   L  D  +R +  ++ +H ++
Sbjct: 246 IFRDFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 138/281 (49%), Gaps = 35/281 (12%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           ++ IG G++G+V + +     K +A+K  +K  + K     +ETA     R+VL+     
Sbjct: 79  LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK----RAETACFREERDVLVNG--D 132
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMARKYLRD 234
              I  L     D N+   Y+V++Y  G        K+++        + E MAR YL +
Sbjct: 133 SKWITTLHYAFQDDNN--LYLVMDYYVGGDLLTLLSKFED-------RLPEEMARFYLAE 183
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF-SVSQVFEDDNDVLRRSPGTPVFT 293
           +V  +  +H  + VH DIKPDN+L+  +G +++ DF S  ++ ED       + GTP + 
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 294 APECCLGLTYG----GKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFP 347
           +PE    +  G    G   D W++GV +Y M+ G+ PF  E+L +TY KI+N+     FP
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303
Query: 348 DA---MNPELRNLLEGLLCKDPTR--RLTLNDVAKHTWVLG 383
                ++   ++L+  L+C    R  +  + D  KH +  G
Sbjct: 304 TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 121/273 (44%), Gaps = 26/273 (9%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           YV    IG GSY +            YA+K   KS     +  PSE          ++++
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKS-----KRDPSEEIE-------ILLR 76
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
             QHPNI+ L +V DD    H Y+V E + G    D   +     E  A   L  I   +
Sbjct: 77  YGQHPNIITLKDVYDD--GKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTV 134
Query: 240 MYLHGHNVVHGDIKPDNLL-VAPSGT---VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
            YLH   VVH D+KP N+L V  SG    ++I DF  ++    +N +L     T  F AP
Sbjct: 135 EYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAP 194
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL---GETLQDTYDKIVNNSLVFP----D 348
           E      Y  +  D W++G+ LY M+ G  PF     +T ++   +I +          +
Sbjct: 195 EVLKRQGY-DEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWN 253
Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            ++   ++L+  +L  DP +RLT   V +H WV
Sbjct: 254 TVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 124/269 (46%), Gaps = 22/269 (8%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +Y    KIG G+ G V        G+  AI+  +      L+  P +  + +   E+L+M
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN------LQQQPKKELIIN---EILVM 71
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           +  ++PNIVN ++       D  ++V+EY+ G    D   +   + E       R+ +  
Sbjct: 72  RENKNPNIVNYLD--SYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 128
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L +LH + V+H DIK DN+L+   G+VK+ DF        +        GTP + APE  
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV 188
Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKIVNNSLVFPDAMNPE---- 353
               YG K  D W++G+    MI G+ P+L E  L+  Y    N +   P+  NPE    
Sbjct: 189 TRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT---PELQNPEKLSA 244
Query: 354 -LRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
             R+ L   L  D  +R +  ++ +H ++
Sbjct: 245 IFRDFLNRCLEMDVEKRGSAKELLQHQFL 273

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 121/273 (44%), Gaps = 26/273 (9%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           YV    IG GSY +            YA+K   KS     +  PSE          ++++
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKS-----KRDPSEEIE-------ILLR 76
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
             QHPNI+ L +V DD    H Y+V E + G    D   +     E  A   L  I   +
Sbjct: 77  YGQHPNIITLKDVYDD--GKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTV 134
Query: 240 MYLHGHNVVHGDIKPDNLL-VAPSGT---VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
            YLH   VVH D+KP N+L V  SG    ++I DF  ++    +N +L     T  F AP
Sbjct: 135 EYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAP 194
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL---GETLQDTYDKIVNNSLVFP----D 348
           E      Y  +  D W++G+ LY M+ G  PF     +T ++   +I +          +
Sbjct: 195 EVLKRQGY-DEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWN 253
Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            ++   ++L+  +L  DP +RLT   V +H WV
Sbjct: 254 TVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 124/269 (46%), Gaps = 22/269 (8%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +Y    KIG G+ G V        G+  AI+  +      L+  P +  + +   E+L+M
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN------LQQQPKKELIIN---EILVM 71
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           +  ++PNIVN ++       D  ++V+EY+ G    D   +   + E       R+ +  
Sbjct: 72  RENKNPNIVNYLD--SYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 128
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L +LH + V+H DIK DN+L+   G+VK+ DF        +        GTP + APE  
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKIVNNSLVFPDAMNPE---- 353
               YG K  D W++G+    MI G+ P+L E  L+  Y    N +   P+  NPE    
Sbjct: 189 TRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT---PELQNPEKLSA 244
Query: 354 -LRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
             R+ L   L  D  +R +  ++ +H ++
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 127/266 (47%), Gaps = 20/266 (7%)
Query: 127 GAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPS--ETAMTDVRREVLIMKMLQ-H 183
           G  S  +  ++R++  G  +A+K      ++  R++P   E      RRE  I++ +  H
Sbjct: 105 GVSSVVRRCVHRAT--GHEFAVKIME---VTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           P+I+ LI+  +  +S   ++V + +      D   +  A+ E   R  +R ++  + +LH
Sbjct: 160 PHIITLIDSYE--SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH 217
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE---CCLG 300
            +N+VH D+KP+N+L+  +  +++ DF  S   E   + LR   GTP + APE   C + 
Sbjct: 218 ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-PGEKLRELCGTPGYLAPEILKCSMD 276
Query: 301 LTYG--GKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAMNPEL 354
            T+   GK  D WA GV L+ ++ G  PF           I+     F     D  +  +
Sbjct: 277 ETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTV 336
Query: 355 RNLLEGLLCKDPTRRLTLNDVAKHTW 380
           ++L+  LL  DP  RLT     +H +
Sbjct: 337 KDLISRLLQVDPEARLTAEQALQHPF 362

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 121/251 (48%), Gaps = 13/251 (5%)
Query: 123 VRKIGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           ++ +G GS+GKV L R       G  YA+K   K+ L K+R    +   T + R++L   
Sbjct: 33  LKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATL-KVR----DRVRTKMERDIL--A 85
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
            + HP +V L            Y++L+++ G        +     E   + YL ++  GL
Sbjct: 86  DVNHPFVVKLHYAFQ--TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGL 143
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
            +LH   +++ D+KP+N+L+   G +K+ DF +S+   D         GT  + APE   
Sbjct: 144 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVN 203
Query: 300 GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLE 359
              +   +AD W+ GV ++ M+ G  PF G+  ++T   I+   L  P  ++ E ++LL 
Sbjct: 204 RQGH-SHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQSLLR 262
Query: 360 GLLCKDPTRRL 370
            L  ++P  RL
Sbjct: 263 ALFKRNPANRL 273

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 124/269 (46%), Gaps = 22/269 (8%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +Y    KIG G+ G V        G+  AI+  +      L+  P +  + +   E+L+M
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN------LQQQPKKELIIN---EILVM 72
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           +  ++PNIVN ++       D  ++V+EY+ G    D   +   + E       R+ +  
Sbjct: 73  RENKNPNIVNYLD--SYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 129
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L +LH + V+H +IK DN+L+   G+VK+ DF        +        GTP + APE  
Sbjct: 130 LEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 189
Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKIVNNSLVFPDAMNPE---- 353
               YG K  D W++G+    MI G+ P+L E  L+  Y    N +   P+  NPE    
Sbjct: 190 TRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT---PELQNPEKLSA 245
Query: 354 -LRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
             R+ L   L  D  +R +  ++ +H ++
Sbjct: 246 IFRDFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 130/263 (49%), Gaps = 15/263 (5%)
Query: 117 INEYVHVRKIGAGSYGKVVLYR--SSLD-GKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           I  +  ++ +G G+YGKV L R  S  D GK YA+K   K+ + +       T  T   R
Sbjct: 53  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ---KAKTTEHTRTER 109
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
           +VL   + Q P +V L          H  ++L+Y+ G        Q     E   + Y+ 
Sbjct: 110 QVL-EHIRQSPFLVTLHYAFQTETKLH--LILDYINGGELFTHLSQRERFTEHEVQIYVG 166
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF-EDDNDVLRRSPGTPVF 292
           +IV  L +LH   +++ DIK +N+L+  +G V + DF +S+ F  D+ +      GT  +
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 293 TAPECCLGLTYG-GKAADTWAVGVTLYYMIIGQYPFL--GE--TLQDTYDKIVNNSLVFP 347
            AP+   G   G  KA D W++GV +Y ++ G  PF   GE  +  +   +I+ +   +P
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 286
Query: 348 DAMNPELRNLLEGLLCKDPTRRL 370
             M+   ++L++ LL KDP +RL
Sbjct: 287 QEMSALAKDLIQRLLMKDPKKRL 309

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 141/302 (46%), Gaps = 31/302 (10%)
Query: 103 NKLIRSEDENGTKMINEYVHVRKIGAGSYG--KVVLYRSSLDGKHYAIKAFHKSHLSKLR 160
           + +++    N  +  + Y     IG GSY   K  +++++     +A+K   KS     +
Sbjct: 7   HSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKAT--NMEFAVKIIDKS-----K 59
Query: 161 VAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP 220
             P+E          ++++  QHPNI+ L +V DD    + Y+V E ++G    D   + 
Sbjct: 60  RDPTEEIE-------ILLRYGQHPNIITLKDVYDD--GKYVYVVTELMKGGELLDKILRQ 110
Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLL-VAPSG---TVKIGDFSVSQVF 276
               E  A   L  I   + YLH   VVH D+KP N+L V  SG   +++I DF  ++  
Sbjct: 111 KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170
Query: 277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG---ETLQ 333
             +N +L     T  F APE      Y   A D W++GV LY M+ G  PF     +T +
Sbjct: 171 RAENGLLMTPCYTANFVAPEVLERQGYDA-ACDIWSLGVLLYTMLTGYTPFANGPDDTPE 229
Query: 334 DTYDKIVNNSLVFP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIP 389
           +   +I +          ++++   ++L+  +L  DP +RLT   V +H W++  +  +P
Sbjct: 230 EILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD-QLP 288
Query: 390 QY 391
           QY
Sbjct: 289 QY 290

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/320 (24%), Positives = 133/320 (41%), Gaps = 38/320 (11%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y  +  +G G +  V   R     +  AIK     H S+ +   + TA+    RE+ +++
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL----REIKLLQ 67
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
            L HPNI+ L++     +  +  +V +++E   +         +  S  + Y+   + GL
Sbjct: 68  ELSHPNIIGLLDAFG--HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
            YLH H ++H D+KP+NLL+  +G +K+ DF +++ F   N        T  + APE   
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLF 185
Query: 300 GLTYGGKAADTWAVGVTLYYMIIGQYPFLG------------ETLQDTYDKIVNNSLVFP 347
           G    G   D WAVG  L  +++ + PFL             ETL    ++   +    P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244
Query: 348 D-----------------AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
           D                 A   +L +L++GL   +P  R+T     K  +     GP P 
Sbjct: 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 304
Query: 391 YLCWCKRDRLRRDNTTQDSN 410
             C   R     +   + SN
Sbjct: 305 --CQLPRPNCPVETLKEQSN 322

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 114/233 (48%), Gaps = 18/233 (7%)
Query: 164 SETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA 222
           S+    + ++E+  +K+ + HPNIV L EV  D    H ++V+E + G    +   +   
Sbjct: 45  SKRMEANTQKEITALKLCEGHPNIVKLHEVFHD--QLHTFLVMELLNGGELFERIKKKKH 102
Query: 223 IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---TVKIGDFSVSQVFEDD 279
             E+ A   +R +VS + ++H   VVH D+KP+NLL         +KI DF  +++   D
Sbjct: 103 FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162
Query: 280 NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE-------TL 332
           N  L+    T  + APE  L      ++ D W++GV LY M+ GQ PF          + 
Sbjct: 163 NQPLKTPCFTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSA 221
Query: 333 QDTYDKIVNNSLVFP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            +   KI      F       ++ E ++L++GLL  DP +RL ++ +  + W+
Sbjct: 222 VEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWL 274

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 124/275 (45%), Gaps = 18/275 (6%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            +Y  +  IG GSYG+    R   DGK    K      +++     +E  M  +  EV +
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-----AEKQM--LVSEVNL 58
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMARKYLR 233
           ++ L+HPNIV   + I D  +   Y+V+EY EG         G  +   + E    + + 
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 234 DIVSGLMYLH-----GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
            +   L   H     GH V+H D+KP N+ +     VK+GDF ++++   D D  +   G
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVG 178
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFP 347
           TP + +PE    ++Y  K +D W++G  LY +     PF   + ++   KI        P
Sbjct: 179 TPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 237
Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL 382
              + EL  ++  +L      R ++ ++ ++  +L
Sbjct: 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 127/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 72
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE +E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 73  SGVIRLLDWFERPDS--FVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 130
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 131 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 188
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 242
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 243 LALRPSDRPTFEEIQNHPWM 262

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 71
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 72  SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 129
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 130 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 187
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 188 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 241
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 242 LALRPSDRPTFEEIQNHPWM 261

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 117/270 (43%), Gaps = 18/270 (6%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R+IG GS+G V   R   + +  AIK    S         S     D+ +EV  ++ L+
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG------KQSNEKWQDIIKEVRFLQKLR 73
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           HPN +         ++   ++V+EY  G   +        + E          + GL YL
Sbjct: 74  HPNTIQYRGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL- 301
           H HN++H D+K  N+L++  G VK+GDF  + +    N  +    GTP + APE  L + 
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV----GTPYWMAPEVILAMD 187
Query: 302 --TYGGKAADTWAVGVTLYYMIIGQYPFLG-ETLQDTYDKIVNNSLVFPDAMNPE-LRNL 357
              Y GK  D W++G+T   +   + P      +   Y    N S         E  RN 
Sbjct: 188 EGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246
Query: 358 LEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
           ++  L K P  R T   + KH +VL +  P
Sbjct: 247 VDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 68
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 69  SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 127 HNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 184
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSXECQHLIRWC 238
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 239 LALRPSDRPTFEEIQNHPWM 258

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 72
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 73  SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 130
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 131 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 188
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 242
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 243 LALRPSDRPTFEEIQNHPWM 262

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 73
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 74  SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 131
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 189
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 243
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 244 LALRPSDRPTFEEIQNHPWM 263

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 68
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 69  SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 184
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 238
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 239 LALRPSDRPTFEEIQNHPWM 258

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 88
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 89  SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 146
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 147 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 204
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 258
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 259 LALRPSDRPTFEEIQNHPWM 278

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 73
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 74  SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 131
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 189
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 243
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 244 LALRPSDRPTFEEIQNHPWM 263

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 87
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 88  SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 145
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 146 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 203
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 204 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 257
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 258 LALRPSDRPTFEEIQNHPWM 277

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 73
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 74  SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 131
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 189
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 243
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 244 LALRPSDRPTFEEIQNHPWM 263

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 68
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 69  SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 184
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIGGQVFFRQRVSSECQHLIRWC 238
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 239 LALRPSDRPTFEEIQNHPWM 258

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 117/270 (43%), Gaps = 18/270 (6%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R+IG GS+G V   R   + +  AIK    S         S     D+ +EV  ++ L+
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG------KQSNEKWQDIIKEVRFLQKLR 112
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           HPN +         ++   ++V+EY  G   +        + E          + GL YL
Sbjct: 113 HPNTIQYRGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL- 301
           H HN++H D+K  N+L++  G VK+GDF  + +    N  +    GTP + APE  L + 
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV----GTPYWMAPEVILAMD 226
Query: 302 --TYGGKAADTWAVGVTLYYMIIGQYPFLG-ETLQDTYDKIVNNSLVFPDAMNPE-LRNL 357
              Y GK  D W++G+T   +   + P      +   Y    N S         E  RN 
Sbjct: 227 EGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 285
Query: 358 LEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
           ++  L K P  R T   + KH +VL +  P
Sbjct: 286 VDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 107
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 108 SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 165
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 166 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 223
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 224 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 277
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 278 LALRPSDRPTFEEIQNHPWM 297

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 115
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 116 SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 173
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 174 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 231
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 285
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 286 LALRPSDRPTFEEIQNHPWM 305

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 87
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 88  SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 145
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 146 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 203
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 204 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSXECQHLIRWC 257
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 258 LALRPSDRPTFEEIQNHPWM 277

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 88
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 89  SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 146
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 147 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 204
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSXECQHLIRWC 258
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 259 LALRPSDRPTFEEIQNHPWM 278

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 100
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 101 SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 158
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 216
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 270
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 271 LALRPSDRPTFEEIQNHPWM 290

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 100
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 101 SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 158
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 216
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIGGQVFFRQRVSSECQHLIRWC 270
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 271 LALRPSDRPTFEEIQNHPWM 290

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 101
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 102 SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 159
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 217
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIGGQVFFRQRVSSECQHLIRWC 271
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 272 LALRPSDRPTFEEIQNHPWM 291

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 100
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 101 SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 158
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 216
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIGGQVFFRQRVSSECQHLIRWC 270
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 271 LALRPSDRPTFEEIQNHPWM 290

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 101
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 102 SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 159
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 217
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIGGQVFFRQRVSSECQHLIRWC 271
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 272 LALRPSDRPTFEEIQNHPWM 291

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 95
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 96  SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 153
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 154 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 211
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 212 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSXECQHLIRWC 265
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 266 LALRPSDRPTFEEIQNHPWM 285

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 111/233 (47%), Gaps = 19/233 (8%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAM-TDVRREVL 176
            +Y  V +IG G+YGKV   R   +G  +         L ++RV   E  M     REV 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVA-------LKRVRVQTGEEGMPLSTIREVA 63
Query: 177 IMKMLQ---HPNIVNLIEVIDDPNSDH---FYMVLEYVEGKWDN--DGFGQPGAIGESMA 228
           +++ L+   HPN+V L +V     +D      +V E+V+       D   +PG   E++ 
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI- 122
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           +  +  ++ GL +LH H VVH D+KP N+LV  SG +K+ DF +++++      L     
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTSVVV 181
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN 341
           T  + APE  L  +Y     D W+VG     M   +  F G +  D   KI++
Sbjct: 182 TLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 101
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 102 SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 159
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 217
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIGGQVFFRQRVSXECQHLIRWC 271
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 272 LALRPSDRPTFEEIQNHPWM 291

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 111/233 (47%), Gaps = 19/233 (8%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAM-TDVRREVL 176
            +Y  V +IG G+YGKV   R   +G  +         L ++RV   E  M     REV 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVA-------LKRVRVQTGEEGMPLSTIREVA 63
Query: 177 IMKMLQ---HPNIVNLIEVIDDPNSDH---FYMVLEYVEGKWDN--DGFGQPGAIGESMA 228
           +++ L+   HPN+V L +V     +D      +V E+V+       D   +PG   E++ 
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI- 122
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           +  +  ++ GL +LH H VVH D+KP N+LV  SG +K+ DF +++++      L     
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTSVVV 181
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN 341
           T  + APE  L  +Y     D W+VG     M   +  F G +  D   KI++
Sbjct: 182 TLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 101
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 102 SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 159
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 217
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIGGQVFFRQRVSXECQHLIRWC 271
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 272 LALRPSDRPTFEEIQNHPWM 291

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 100
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 101 SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 158
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 216
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIGGQVFFRQRVSXECQHLIRWC 270
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 271 LALRPSDRPTFEEIQNHPWM 290

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 115
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 116 SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 173
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 174 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 231
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSXECQHLIRWC 285
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 286 LALRPSDRPTFEEIQNHPWM 305

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 120
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 121 SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 178
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 179 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 236
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 237 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSXECQHLIRWC 290
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P+ R T  ++  H W+
Sbjct: 291 LALRPSDRPTFEEIQNHPWM 310

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 125/260 (48%), Gaps = 17/260 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--H 183
           +G+G +G V       D    AIK   K  +S     P+ T    V  EV+++K +    
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGF 88
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYL 242
             ++ L++  + P+S  F ++LE  E   D  D   + GA+ E +AR +   ++  + + 
Sbjct: 89  SGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 146
Query: 243 HGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   V+H DIK +N+L+  + G +K+ DF    + +D   V     GT V++ PE     
Sbjct: 147 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 204
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGL 361
            Y G++A  W++G+ LY M+ G  PF      +  ++I+   + F   ++ E ++L+   
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSXECQHLIRWC 258
Query: 362 LCKDPTRRLTLNDVAKHTWV 381
           L   P  R T  ++  H W+
Sbjct: 259 LALRPXDRPTFEEIQNHPWM 278

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 111/233 (47%), Gaps = 19/233 (8%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAM-TDVRREVL 176
            +Y  V +IG G+YGKV   R   +G  +         L ++RV   E  M     REV 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVA-------LKRVRVQTGEEGMPLSTIREVA 63
Query: 177 IMKMLQ---HPNIVNLIEVIDDPNSDH---FYMVLEYVEGKWDN--DGFGQPGAIGESMA 228
           +++ L+   HPN+V L +V     +D      +V E+V+       D   +PG   E++ 
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI- 122
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           +  +  ++ GL +LH H VVH D+KP N+LV  SG +K+ DF +++++      L     
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTSVVV 181
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN 341
           T  + APE  L  +Y     D W+VG     M   +  F G +  D   KI++
Sbjct: 182 TLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 123/274 (44%), Gaps = 18/274 (6%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +Y  +  IG GSYG+    R   DGK    K      +++     +E  M  +  EV ++
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-----AEKQM--LVSEVNLL 59
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMARKYLRD 234
           + L+HPNIV   + I D  +   Y+V+EY EG         G  +   + E    + +  
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 235 IVSGLMYLH-----GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
           +   L   H     GH V+H D+KP N+ +     VK+GDF ++++   D    +   GT
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT 179
Query: 290 PVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFPD 348
           P + +PE    ++Y  K +D W++G  LY +     PF   + ++   KI        P 
Sbjct: 180 PYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 238
Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL 382
             + EL  ++  +L      R ++ ++ ++  +L
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 123/274 (44%), Gaps = 18/274 (6%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +Y  +  IG GSYG+    R   DGK    K      +++     +E  M  +  EV ++
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-----AEKQM--LVSEVNLL 59
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMARKYLRD 234
           + L+HPNIV   + I D  +   Y+V+EY EG         G  +   + E    + +  
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 235 IVSGLMYLH-----GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
           +   L   H     GH V+H D+KP N+ +     VK+GDF ++++   D    +   GT
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGT 179
Query: 290 PVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFPD 348
           P + +PE    ++Y  K +D W++G  LY +     PF   + ++   KI        P 
Sbjct: 180 PYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 238
Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL 382
             + EL  ++  +L      R ++ ++ ++  +L
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 138/302 (45%), Gaps = 31/302 (10%)
Query: 103 NKLIRSEDENGTKMINEYVHVRKIGAGSYG--KVVLYRSSLDGKHYAIKAFHKSHLSKLR 160
           + +++    N  +  + Y     IG GSY   K  +++++     +A+K   KS     +
Sbjct: 7   HSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKAT--NXEFAVKIIDKS-----K 59
Query: 161 VAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP 220
             P+E          ++++  QHPNI+ L +V DD    + Y+V E  +G    D   + 
Sbjct: 60  RDPTEEIE-------ILLRYGQHPNIITLKDVYDD--GKYVYVVTELXKGGELLDKILRQ 110
Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLL-VAPSG---TVKIGDFSVSQVF 276
               E  A   L  I   + YLH   VVH D+KP N+L V  SG   +++I DF  ++  
Sbjct: 111 KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170
Query: 277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG---ETLQ 333
             +N +L     T  F APE      Y   A D W++GV LY  + G  PF     +T +
Sbjct: 171 RAENGLLXTPCYTANFVAPEVLERQGYDA-ACDIWSLGVLLYTXLTGYTPFANGPDDTPE 229
Query: 334 DTYDKIVNNSLVFP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIP 389
           +   +I +          ++++   ++L+   L  DP +RLT   V +H W++  +  +P
Sbjct: 230 EILARIGSGKFSLSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHWD-QLP 288
Query: 390 QY 391
           QY
Sbjct: 289 QY 290

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 123/264 (46%), Gaps = 19/264 (7%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           + ++  +R IG GSY KV+L R     + YA+K   K       +   +  +  V+ E  
Sbjct: 19  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKE------LVNDDEDIDWVQTEKH 72
Query: 177 IMKMLQ-HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
           + +    HP +V L            + V+EYV G        +   + E  AR Y  +I
Sbjct: 73  VFEQASNHPFLVGLHSCFQ--TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 130
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
              L YLH   +++ D+K DN+L+   G +K+ D+ + +      D      GTP + AP
Sbjct: 131 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 190
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGET---LQDTYDK----IVNNSLVF 346
           E   G  YG  + D WA+GV ++ M+ G+ PF  +G +    Q+T D     I+   +  
Sbjct: 191 EILRGEDYGF-SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 249
Query: 347 PDAMNPELRNLLEGLLCKDPTRRL 370
           P +M+ +  ++L+  L KDP  RL
Sbjct: 250 PRSMSVKAASVLKSFLNKDPKERL 273

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 129/275 (46%), Gaps = 23/275 (8%)
Query: 117 INEYVHVRK---IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           +N +  V K   +G G +G+V     +  G   A K      +             +V+ 
Sbjct: 85  VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---------KEEVKN 135
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYL 232
           E+ +M  L H N++ L +  +  N     +V+EYV+G    D    +   + E     ++
Sbjct: 136 EISVMNQLDHANLIQLYDAFESKND--IVLVMEYVDGGELFDRIIDESYNLTELDTILFM 193
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVA--PSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
           + I  G+ ++H   ++H D+KP+N+L     +  +KI DF +++ ++   + L+ + GTP
Sbjct: 194 KQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP-REKLKVNFGTP 252
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA- 349
            F APE  +   +     D W+VGV  Y ++ G  PFLG+   +T + I+       D  
Sbjct: 253 EFLAPEV-VNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE 311
Query: 350 ---MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
              ++ E +  +  LL K+ + R++ ++  KH W+
Sbjct: 312 FQDISEEAKEFISKLLIKEKSWRISASEALKHPWL 346

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 114/265 (43%), Gaps = 20/265 (7%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           +KIG G + +V      LDG   A+K      L   +      A  D  +E+ ++K L H
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK------ARADCIKEIDLLKQLNH 91
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMARKYLRDIVSGL 239
           PN++       + N     +VLE  +     +       Q   I E    KY   + S L
Sbjct: 92  PNVIKYYASFIEDNE--LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
            ++H   V+H DIKP N+ +  +G VK+GD  + + F           GTP + +PE   
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 300 GLTYGGKAADTWAVGVTLYYMIIGQYPFLGE--TLQDTYDKI--VNNSLVFPDAMNPELR 355
              Y  K +D W++G  LY M   Q PF G+   L     KI   +   +  D  + ELR
Sbjct: 210 ENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 268
Query: 356 NLLEGLLCKDPTRRLTLN---DVAK 377
            L+   +  DP +R  +    DVAK
Sbjct: 269 QLVNMCINPDPEKRPDVTYVYDVAK 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 118/258 (45%), Gaps = 19/258 (7%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           KIGAGS+G V  +R+   G   A+K   +      RV        +  REV IMK L+HP
Sbjct: 44  KIGAGSFGTV--HRAEWHGSDVAVKILMEQDFHAERV-------NEFLREVAIMKRLRHP 94
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR---DIVSGLMY 241
           NIV  +  +  P   +  +V EY+          + GA  +   R+ L    D+  G+ Y
Sbjct: 95  NIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 242 LHGHN--VVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
           LH  N  +VH D+K  NLLV    TVK+ DF +S++        + + GTP + APE  L
Sbjct: 153 LHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPE-VL 211
Query: 300 GLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFPDAMNPELRNL 357
                 + +D ++ GV L+ +   Q P+  L               L  P  +NP++  +
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAI 271
Query: 358 LEGLLCKDPTRRLTLNDV 375
           +EG    +P +R +   +
Sbjct: 272 IEGCWTNEPWKRPSFATI 289

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 116/241 (48%), Gaps = 22/241 (9%)
Query: 153 KSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG-- 210
           K++++K  V    T    V++E+ I+ + +H NI++L E  +  + +   M+ E++ G  
Sbjct: 31  KTYMAKF-VKVKGTDQVLVKKEISILNIARHRNILHLHESFE--SMEELVMIFEFISGLD 87
Query: 211 ---KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP--SGTV 265
              + +   F     + E     Y+  +   L +LH HN+ H DI+P+N++     S T+
Sbjct: 88  IFERINTSAF----ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTI 143
Query: 266 KIGDF-SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQ 324
           KI +F    Q+   DN   R     P + APE          A D W++G  +Y ++ G 
Sbjct: 144 KIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGI 200
Query: 325 YPFLGETLQDTYDKIVNNSLVFPD----AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
            PFL ET Q   + I+N    F +     ++ E  + ++ LL K+   R+T ++  +H W
Sbjct: 201 NPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260
Query: 381 V 381
           +
Sbjct: 261 L 261

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 119/263 (45%), Gaps = 22/263 (8%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           KIG GS G V +      GK  A+K         LR       + +   EV+IM+   H 
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKM------DLRKQQRRELLFN---EVVIMRDYHHD 102
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           N+V++         D  ++V+E++EG    D         E +A   L  ++  L YLH 
Sbjct: 103 NVVDMYS--SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCL-SVLRALSYLHN 159
Query: 245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYG 304
             V+H DIK D++L+   G +K+ DF        +    +   GTP + APE    L YG
Sbjct: 160 QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYG 219
Query: 305 GKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP------DAMNPELRNLL 358
            +  D W++G+ +  MI G+ P+  E       +I ++    P        ++  LR  L
Sbjct: 220 TE-VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDS---LPPRVKDLHKVSSVLRGFL 275
Query: 359 EGLLCKDPTRRLTLNDVAKHTWV 381
           + +L ++P++R T  ++  H ++
Sbjct: 276 DLMLVREPSQRATAQELLGHPFL 298

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 126/284 (44%), Gaps = 29/284 (10%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +++  ++ IG G++ +V + +    G+ YA+K  +K  + K      E +     R+VL+
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR----GEVSCFREERDVLV 116
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGE----SMARKYLR 233
                   I  L     D N  + Y+V+EY  G    D        GE     MAR YL 
Sbjct: 117 NG--DRRWITQLHFAFQDEN--YLYLVMEYYVG---GDLLTLLSKFGERIPAEMARFYLA 169
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR-SPGTPVF 292
           +IV  +  +H    VH DIKPDN+L+   G +++ DF        D  V    + GTP +
Sbjct: 170 EIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDY 229
Query: 293 TAPECCLGLTYGGKA------ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---- 342
            +PE    +  G          D WA+GV  Y M  GQ PF  ++  +TY KIV+     
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289
Query: 343 SLVFPDAMNP-ELRNLLEGLLCKDPTR--RLTLNDVAKHTWVLG 383
           SL   D   P E R+ ++ LLC   TR  R    D   H +  G
Sbjct: 290 SLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFG 333

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 137/313 (43%), Gaps = 50/313 (15%)
Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
           G+   + Y  V +IG G+YG V   R    G   A+K+     +           ++ VR
Sbjct: 4   GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGGGGGGGLPISTVR 60
Query: 173 REVLIMKM--LQHPNIVNLIEVIDDPNSDH---FYMVLEYVEGKWDN--DGFGQPGAIGE 225
              L+ ++   +HPN+V L++V     +D      +V E+V+       D    PG   E
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120
Query: 226 SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR 285
           ++ +  +R  + GL +LH + +VH D+KP+N+LV   GTVK+ DF +++++     +   
Sbjct: 121 TI-KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--- 176
Query: 286 SPGTPV-----FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV 340
              TPV     + APE  L  TY     D W+VG     M   +  F G +  D   KI 
Sbjct: 177 ---TPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 232
Query: 341 -------------NNSL---VFP-------DAMNPELR----NLLEGLLCKDPTRRLTLN 373
                        + SL    FP        ++ PE+      LL  +L  +P +R++  
Sbjct: 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 292
Query: 374 DVAKHTWVLGDNG 386
              +H+++  D G
Sbjct: 293 RALQHSYLHKDEG 305

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 119/264 (45%), Gaps = 19/264 (7%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           + ++  +R IG GSY KV+L R     + YA+K   K       +   +  +  V+ E  
Sbjct: 4   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKK------ELVNDDEDIDWVQTEKH 57
Query: 177 IMKMLQ-HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
           + +    HP +V L            + V+EYV G        +   + E  AR Y  +I
Sbjct: 58  VFEQASNHPFLVGLHSCFQ--TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 115
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
              L YLH   +++ D+K DN+L+   G +K+ D+ + +      D      GTP + AP
Sbjct: 116 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 175
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDK---------IVNNSLVF 346
           E   G  YG  + D WA+GV ++ M+ G+ PF      D  D+         I+   +  
Sbjct: 176 EILRGEDYGF-SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 234
Query: 347 PDAMNPELRNLLEGLLCKDPTRRL 370
           P +++ +  ++L+  L KDP  RL
Sbjct: 235 PRSLSVKAASVLKSFLNKDPKERL 258

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 119/264 (45%), Gaps = 19/264 (7%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           + ++  +R IG GSY KV+L R     + YA+K   K       +   +  +  V+ E  
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKE------LVNDDEDIDWVQTEKH 61
Query: 177 IMKMLQ-HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
           + +    HP +V L            + V+EYV G        +   + E  AR Y  +I
Sbjct: 62  VFEQASNHPFLVGLHSCFQ--TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 119
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
              L YLH   +++ D+K DN+L+   G +K+ D+ + +      D      GTP + AP
Sbjct: 120 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 179
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDK---------IVNNSLVF 346
           E   G  YG  + D WA+GV ++ M+ G+ PF      D  D+         I+   +  
Sbjct: 180 EILRGEDYGF-SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 238
Query: 347 PDAMNPELRNLLEGLLCKDPTRRL 370
           P +++ +  ++L+  L KDP  RL
Sbjct: 239 PRSLSVKAASVLKSFLNKDPKERL 262

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 118/258 (45%), Gaps = 19/258 (7%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           KIGAGS+G V  +R+   G   A+K   +      RV        +  REV IMK L+HP
Sbjct: 44  KIGAGSFGTV--HRAEWHGSDVAVKILMEQDFHAERV-------NEFLREVAIMKRLRHP 94
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR---DIVSGLMY 241
           NIV  +  +  P   +  +V EY+          + GA  +   R+ L    D+  G+ Y
Sbjct: 95  NIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 242 LHGHN--VVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
           LH  N  +VH ++K  NLLV    TVK+ DF +S++        + + GTP + APE  L
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE-VL 211
Query: 300 GLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNSLVFPDAMNPELRNL 357
                 + +D ++ GV L+ +   Q P+  L               L  P  +NP++  +
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAI 271
Query: 358 LEGLLCKDPTRRLTLNDV 375
           +EG    +P +R +   +
Sbjct: 272 IEGCWTNEPWKRPSFATI 289

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 119/264 (45%), Gaps = 19/264 (7%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           + ++  +R IG GSY KV+L R     + YA++   K       +   +  +  V+ E  
Sbjct: 51  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKK------ELVNDDEDIDWVQTEKH 104
Query: 177 IMKMLQ-HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
           + +    HP +V L            + V+EYV G        +   + E  AR Y  +I
Sbjct: 105 VFEQASNHPFLVGLHSCFQ--TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 162
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
              L YLH   +++ D+K DN+L+   G +K+ D+ + +      D      GTP + AP
Sbjct: 163 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 222
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDK---------IVNNSLVF 346
           E   G  YG  + D WA+GV ++ M+ G+ PF      D  D+         I+   +  
Sbjct: 223 EILRGEDYGF-SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 281
Query: 347 PDAMNPELRNLLEGLLCKDPTRRL 370
           P +++ +  ++L+  L KDP  RL
Sbjct: 282 PRSLSVKAASVLKSFLNKDPKERL 305

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 122/265 (46%), Gaps = 15/265 (5%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +  + KIG GS+G+V     +   K  AIK         + +  +E  + D+++E+ ++ 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI--------IDLEEAEDEIEDIQQEITVLS 75
Query: 180 MLQHPNIVNLI-EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
               P +       + D      ++++EY+ G    D   +PG + E+     LR+I+ G
Sbjct: 76  QCDSPYVTKYYGSYLKDTK---LWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKG 131
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L YLH    +H DIK  N+L++  G VK+ DF V+    D         GTP + APE  
Sbjct: 132 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI 191
Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLG-ETLQDTYDKIVNNSLVFPDAMNPELRNL 357
               Y  K AD W++G+T   +  G+ P      ++  +    NN        +  L+  
Sbjct: 192 KQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEF 250
Query: 358 LEGLLCKDPTRRLTLNDVAKHTWVL 382
           +E  L K+P+ R T  ++ KH ++L
Sbjct: 251 VEACLNKEPSFRPTAKELLKHKFIL 275

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 118/239 (49%), Gaps = 17/239 (7%)
Query: 147 AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--HPNIVNLIEVIDDPNSDHFYMV 204
           AIK   K  +S     P+ T    V  EV+++K +      ++ L++  + P+S  F ++
Sbjct: 80  AIKHVEKDRISDWGELPNGTR---VPMEVVLLKKVSSGFSGVIRLLDWFERPDS--FVLI 134
Query: 205 LEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS- 262
           LE  E   D  D   + GA+ E +AR +   ++  + + H   V+H DIK +N+L+  + 
Sbjct: 135 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR 194
Query: 263 GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII 322
           G +K+ DF    + +D   V     GT V++ PE      Y G++A  W++G+ LY M+ 
Sbjct: 195 GELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 252
Query: 323 GQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           G  PF      +  ++I+   + F   ++ E ++L+   L   P+ R T  ++  H W+
Sbjct: 253 GDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 184 PNIVNLIEVIDDPNSDH----FYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVS 237
           P+IV +++V +  N  H      +++E +EG        + G  A  E  A + +RDI +
Sbjct: 82  PHIVCILDVYE--NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
            + +LH HN+ H D+KP+NLL         +K+ DF  ++  E   + L+    TP + A
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVA 197
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYD----KIVNNSLVFPDA- 349
           PE  LG     K+ D W++GV +Y ++ G  PF   T Q        +I      FP+  
Sbjct: 198 PE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256
Query: 350 ---MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
              ++ + + L+  LL  DPT RLT+     H W+
Sbjct: 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 184 PNIVNLIEVIDDPNSDH----FYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVS 237
           P+IV +++V +  N  H      +++E +EG        + G  A  E  A + +RDI +
Sbjct: 63  PHIVCILDVYE--NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 120
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
            + +LH HN+ H D+KP+NLL         +K+ DF  ++  E   + L+    TP + A
Sbjct: 121 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVA 178
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYD----KIVNNSLVFPDA- 349
           PE  LG     K+ D W++GV +Y ++ G  PF   T Q        +I      FP+  
Sbjct: 179 PE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 237
Query: 350 ---MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
              ++ + + L+  LL  DPT RLT+     H W+
Sbjct: 238 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 272

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 136/305 (44%), Gaps = 47/305 (15%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAM-TDVRREVL 176
           + Y  V +IG G+YG V   R    G   A+K+        +RV   E  +     REV 
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKS--------VRVPNGEEGLPISTVREVA 55
Query: 177 IMKMLQ---HPNIVNLIEVIDDPNSDH---FYMVLEYVEGKWDN--DGFGQPGAIGESMA 228
           +++ L+   HPN+V L++V     +D      +V E+V+       D    PG   E++ 
Sbjct: 56  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI- 114
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           +  +R  + GL +LH + +VH D+KP+N+LV   GTVK+ DF +++++      L     
Sbjct: 115 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALAPVVV 173
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV-------- 340
           T  + APE  L  TY     D W+VG     M   +  F G +  D   KI         
Sbjct: 174 TLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 232
Query: 341 -----NNSL---VFP-------DAMNPELR----NLLEGLLCKDPTRRLTLNDVAKHTWV 381
                + SL    FP        ++ PE+      LL  +L  +P +R++     +H+++
Sbjct: 233 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292
Query: 382 LGDNG 386
             D G
Sbjct: 293 HKDEG 297

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 122/265 (46%), Gaps = 15/265 (5%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +  + KIG GS+G+V     +   K  AIK         + +  +E  + D+++E+ ++ 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI--------IDLEEAEDEIEDIQQEITVLS 60
Query: 180 MLQHPNIVNLI-EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
               P +       + D      ++++EY+ G    D   +PG + E+     LR+I+ G
Sbjct: 61  QCDSPYVTKYYGSYLKDTK---LWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKG 116
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L YLH    +H DIK  N+L++  G VK+ DF V+    D         GTP + APE  
Sbjct: 117 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI 176
Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLG-ETLQDTYDKIVNNSLVFPDAMNPELRNL 357
               Y  K AD W++G+T   +  G+ P      ++  +    NN        +  L+  
Sbjct: 177 KQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEF 235
Query: 358 LEGLLCKDPTRRLTLNDVAKHTWVL 382
           +E  L K+P+ R T  ++ KH ++L
Sbjct: 236 VEACLNKEPSFRPTAKELLKHKFIL 260

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 122/265 (46%), Gaps = 15/265 (5%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +  + KIG GS+G+V     +   K  AIK         + +  +E  + D+++E+ ++ 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI--------IDLEEAEDEIEDIQQEITVLS 60
Query: 180 MLQHPNIVNLI-EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
               P +       + D      ++++EY+ G    D   +PG + E+     LR+I+ G
Sbjct: 61  QCDSPYVTKYYGSYLKDTK---LWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKG 116
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L YLH    +H DIK  N+L++  G VK+ DF V+    D         GTP + APE  
Sbjct: 117 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 176
Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLG-ETLQDTYDKIVNNSLVFPDAMNPELRNL 357
               Y  K AD W++G+T   +  G+ P      ++  +    NN        +  L+  
Sbjct: 177 KQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEF 235
Query: 358 LEGLLCKDPTRRLTLNDVAKHTWVL 382
           +E  L K+P+ R T  ++ KH ++L
Sbjct: 236 VEACLNKEPSFRPTAKELLKHKFIL 260

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 84/310 (27%), Positives = 137/310 (44%), Gaps = 57/310 (18%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAM-TDVRREVL 176
           + Y  V +IG G+YG V   R    G   A+K+        +RV   E  +     REV 
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKS--------VRVPNGEEGLPISTVREVA 55
Query: 177 IMKMLQ---HPNIVNLIEVIDDPNSDH---FYMVLEYVEGKWDN--DGFGQPGAIGESMA 228
           +++ L+   HPN+V L++V     +D      +V E+V+       D    PG   E++ 
Sbjct: 56  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI- 114
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           +  +R  + GL +LH + +VH D+KP+N+LV   GTVK+ DF +++++     +      
Sbjct: 115 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALF----- 169
Query: 289 TPV-----FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--- 340
            PV     + APE  L  TY     D W+VG     M   +  F G +  D   KI    
Sbjct: 170 -PVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 227
Query: 341 ----------NNSL---VFP-------DAMNPELR----NLLEGLLCKDPTRRLTLNDVA 376
                     + SL    FP        ++ PE+      LL  +L  +P +R++     
Sbjct: 228 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 287
Query: 377 KHTWVLGDNG 386
           +H+++  D G
Sbjct: 288 QHSYLHKDEG 297

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 136/305 (44%), Gaps = 47/305 (15%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAM-TDVRREVL 176
           + Y  V +IG G+YG V   R    G   A+K+        +RV   E  +     REV 
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKS--------VRVPNGEEGLPISTVREVA 55
Query: 177 IMKMLQ---HPNIVNLIEVIDDPNSDH---FYMVLEYVEGKWDN--DGFGQPGAIGESMA 228
           +++ L+   HPN+V L++V     +D      +V E+V+       D    PG   E++ 
Sbjct: 56  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI- 114
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           +  +R  + GL +LH + +VH D+KP+N+LV   GTVK+ DF +++++      L     
Sbjct: 115 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALDPVVV 173
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV-------- 340
           T  + APE  L  TY     D W+VG     M   +  F G +  D   KI         
Sbjct: 174 TLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 232
Query: 341 -----NNSL---VFP-------DAMNPELR----NLLEGLLCKDPTRRLTLNDVAKHTWV 381
                + SL    FP        ++ PE+      LL  +L  +P +R++     +H+++
Sbjct: 233 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292
Query: 382 LGDNG 386
             D G
Sbjct: 293 HKDEG 297

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 122/265 (46%), Gaps = 15/265 (5%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +  + KIG GS+G+V     +   K  AIK         + +  +E  + D+++E+ ++ 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI--------IDLEEAEDEIEDIQQEITVLS 80
Query: 180 MLQHPNIVNLI-EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
               P +       + D      ++++EY+ G    D   +PG + E+     LR+I+ G
Sbjct: 81  QCDSPYVTKYYGSYLKDTK---LWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKG 136
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L YLH    +H DIK  N+L++  G VK+ DF V+    D         GTP + APE  
Sbjct: 137 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 196
Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLG-ETLQDTYDKIVNNSLVFPDAMNPELRNL 357
               Y  K AD W++G+T   +  G+ P      ++  +    NN        +  L+  
Sbjct: 197 KQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEF 255
Query: 358 LEGLLCKDPTRRLTLNDVAKHTWVL 382
           +E  L K+P+ R T  ++ KH ++L
Sbjct: 256 VEACLNKEPSFRPTAKELLKHKFIL 280

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 10/218 (4%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +  Y+ + K+G G+Y  V   +S L     A+K        ++R+   E A     REV 
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALK--------EIRLEHEEGAPCTAIREVS 52
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           ++K L+H NIV L ++I    S    +V EY++             I     + +L  ++
Sbjct: 53  LLKDLKHANIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLL 110
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
            GL Y H   V+H D+KP NLL+   G +K+ DF +++              T  +  P+
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPD 170
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQD 334
             LG T      D W VG   Y M  G+  F G T+++
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/302 (23%), Positives = 130/302 (43%), Gaps = 49/302 (16%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +++  + K+G G+Y  V    +   G + A+K        ++++   E   +   RE+ +
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALK--------EVKLDSEEGTPSTAIREISL 56
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK----WDNDGFGQ-PGAIGESMARKYL 232
           MK L+H NIV L +VI   N     +V E+++       D+   G  P  +  ++ + + 
Sbjct: 57  MKELKHENIVRLYDVIHTENK--LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ GL + H + ++H D+KP NLL+   G +K+GDF +++ F    +       T  +
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWY 174
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG----ETLQDTYDKI-VNNSLVFP 347
            AP+  +G      + D W+ G  L  MI G+  F G    E L+  +D +   N  ++P
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234
Query: 348 -----------------------------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
                                        + ++  L + L GLL  +P  RL+      H
Sbjct: 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294
Query: 379 TW 380
            W
Sbjct: 295 PW 296

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 112/252 (44%), Gaps = 27/252 (10%)
Query: 153 KSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKW 212
           K  + ++ +   +T+M ++ +E+  M    HPNIV+          D  ++V++ + G  
Sbjct: 42  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF--VVKDELWLVMKLLSGGS 99
Query: 213 DND--------GFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT 264
             D        G  + G + ES     LR+++ GL YLH +  +H D+K  N+L+   G+
Sbjct: 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS 159
Query: 265 VKIGDFSVSQVFEDDNDVLRRS-----PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYY 319
           V+I DF VS       D+ R        GTP + APE    +      AD W+ G+T   
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
Query: 320 MIIGQYPF--------LGETLQD---TYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTR 368
           +  G  P+        L  TLQ+   + +  V +  +         R ++   L KDP +
Sbjct: 220 LATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEML-KKYGKSFRKMISLCLQKDPEK 278
Query: 369 RLTLNDVAKHTW 380
           R T  ++ +H +
Sbjct: 279 RPTAAELLRHKF 290

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 112/252 (44%), Gaps = 27/252 (10%)
Query: 153 KSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKW 212
           K  + ++ +   +T+M ++ +E+  M    HPNIV+          D  ++V++ + G  
Sbjct: 37  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF--VVKDELWLVMKLLSGGS 94
Query: 213 DND--------GFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT 264
             D        G  + G + ES     LR+++ GL YLH +  +H D+K  N+L+   G+
Sbjct: 95  VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS 154
Query: 265 VKIGDFSVSQVFEDDNDVLRRS-----PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYY 319
           V+I DF VS       D+ R        GTP + APE    +      AD W+ G+T   
Sbjct: 155 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 214
Query: 320 MIIGQYPF--------LGETLQD---TYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTR 368
           +  G  P+        L  TLQ+   + +  V +  +         R ++   L KDP +
Sbjct: 215 LATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEML-KKYGKSFRKMISLCLQKDPEK 273
Query: 369 RLTLNDVAKHTW 380
           R T  ++ +H +
Sbjct: 274 RPTAAELLRHKF 285

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 133/292 (45%), Gaps = 34/292 (11%)
Query: 116 MINEY-VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           +I++Y V  + +G G  GKV+   +    + +A+K                      RRE
Sbjct: 13  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARRE 58
Query: 175 V-LIMKMLQHPNIVNLIEVIDDPNSDH--FYMVLEYVEGKWDNDGFGQPG--AIGESMAR 229
           V L  +  Q P+IV +++V ++  +      +V+E ++G          G  A  E  A 
Sbjct: 59  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 118
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRS 286
           + ++ I   + YLH  N+ H D+KP+NLL     P+  +K+ DF  ++     N  L   
Sbjct: 119 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTP 177
Query: 287 PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG----ETLQDTYDKIVNN 342
             TP + APE  LG     K+ D W++GV +Y ++ G  PF              +I   
Sbjct: 178 CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 236
Query: 343 SLVFPDA----MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
              FP+     ++ E++ L+  LL  +PT+R+T+ +   H W++  +  +PQ
Sbjct: 237 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM-QSTKVPQ 287

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 136/292 (46%), Gaps = 34/292 (11%)
Query: 116 MINEY-VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           +I++Y V  + +G G  GKV+   +    + +A+K         L+  P        RRE
Sbjct: 19  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM--------LQDCPK------ARRE 64
Query: 175 V-LIMKMLQHPNIVNLIEVIDDPNSDH--FYMVLEYVEGKWDNDGFGQPG--AIGESMAR 229
           V L  +  Q P+IV +++V ++  +      +V+E ++G          G  A  E  A 
Sbjct: 65  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 124
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRS 286
           + ++ I   + YLH  N+ H D+KP+NLL     P+  +K+ DF  ++     N  L   
Sbjct: 125 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTP 183
Query: 287 PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG----ETLQDTYDKIVNN 342
             TP + APE  LG     K+ D W++GV +Y ++ G  PF              +I   
Sbjct: 184 CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 242
Query: 343 SLVFPDA----MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
              FP+     ++ E++ L+  LL  +PT+R+T+ +   H W++  +  +PQ
Sbjct: 243 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM-QSTKVPQ 293

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 133/292 (45%), Gaps = 34/292 (11%)
Query: 116 MINEY-VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           +I++Y V  + +G G  GKV+   +    + +A+K                      RRE
Sbjct: 13  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARRE 58
Query: 175 V-LIMKMLQHPNIVNLIEVIDDPNSDH--FYMVLEYVEGKWDNDGFGQPG--AIGESMAR 229
           V L  +  Q P+IV +++V ++  +      +V+E ++G          G  A  E  A 
Sbjct: 59  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 118
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRS 286
           + ++ I   + YLH  N+ H D+KP+NLL     P+  +K+ DF  ++     N  L   
Sbjct: 119 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTEP 177
Query: 287 PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG----ETLQDTYDKIVNN 342
             TP + APE  LG     K+ D W++GV +Y ++ G  PF              +I   
Sbjct: 178 CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 236
Query: 343 SLVFPDA----MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
              FP+     ++ E++ L+  LL  +PT+R+T+ +   H W++  +  +PQ
Sbjct: 237 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM-QSTKVPQ 287

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 133/292 (45%), Gaps = 34/292 (11%)
Query: 116 MINEY-VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           +I++Y V  + +G G  GKV+   +    + +A+K                      RRE
Sbjct: 21  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARRE 66
Query: 175 V-LIMKMLQHPNIVNLIEVIDDPNSDH--FYMVLEYVEGKWDNDGFGQPG--AIGESMAR 229
           V L  +  Q P+IV +++V ++  +      +V+E ++G          G  A  E  A 
Sbjct: 67  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 126
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRS 286
           + ++ I   + YLH  N+ H D+KP+NLL     P+  +K+ DF  ++     N  L   
Sbjct: 127 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTP 185
Query: 287 PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG----ETLQDTYDKIVNN 342
             TP + APE  LG     K+ D W++GV +Y ++ G  PF              +I   
Sbjct: 186 CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 244
Query: 343 SLVFPDA----MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
              FP+     ++ E++ L+  LL  +PT+R+T+ +   H W++  +  +PQ
Sbjct: 245 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM-QSTKVPQ 295

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 133/292 (45%), Gaps = 34/292 (11%)
Query: 116 MINEY-VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           +I++Y V  + +G G  GKV+   +    + +A+K                      RRE
Sbjct: 20  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARRE 65
Query: 175 V-LIMKMLQHPNIVNLIEVIDDPNSDH--FYMVLEYVEGKWDNDGFGQPG--AIGESMAR 229
           V L  +  Q P+IV +++V ++  +      +V+E ++G          G  A  E  A 
Sbjct: 66  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 125
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRS 286
           + ++ I   + YLH  N+ H D+KP+NLL     P+  +K+ DF  ++     N  L   
Sbjct: 126 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTP 184
Query: 287 PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG----ETLQDTYDKIVNN 342
             TP + APE  LG     K+ D W++GV +Y ++ G  PF              +I   
Sbjct: 185 CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 243
Query: 343 SLVFPDA----MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
              FP+     ++ E++ L+  LL  +PT+R+T+ +   H W++  +  +PQ
Sbjct: 244 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM-QSTKVPQ 294

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 136/292 (46%), Gaps = 34/292 (11%)
Query: 116 MINEY-VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           +I++Y V  + +G G  GKV+   +    + +A+K         L+  P        RRE
Sbjct: 15  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM--------LQDCPK------ARRE 60
Query: 175 V-LIMKMLQHPNIVNLIEVIDDPNSDH--FYMVLEYVEGKWDNDGFGQPG--AIGESMAR 229
           V L  +  Q P+IV +++V ++  +      +V+E ++G          G  A  E  A 
Sbjct: 61  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 120
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRS 286
           + ++ I   + YLH  N+ H D+KP+NLL     P+  +K+ DF  ++     N  L   
Sbjct: 121 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTP 179
Query: 287 PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG----ETLQDTYDKIVNN 342
             TP + APE  LG     K+ D W++GV +Y ++ G  PF              +I   
Sbjct: 180 CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 238
Query: 343 SLVFPDA----MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
              FP+     ++ E++ L+  LL  +PT+R+T+ +   H W++  +  +PQ
Sbjct: 239 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM-QSTKVPQ 289

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 136/292 (46%), Gaps = 34/292 (11%)
Query: 116 MINEY-VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           +I++Y V  + +G G  GKV+   +    + +A+K         L+  P        RRE
Sbjct: 59  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM--------LQDCPK------ARRE 104
Query: 175 V-LIMKMLQHPNIVNLIEVIDDPNSDH--FYMVLEYVEGKWDNDGFGQPG--AIGESMAR 229
           V L  +  Q P+IV +++V ++  +      +V+E ++G          G  A  E  A 
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 164
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRS 286
           + ++ I   + YLH  N+ H D+KP+NLL     P+  +K+ DF  ++     N  L   
Sbjct: 165 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTP 223
Query: 287 PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG----ETLQDTYDKIVNN 342
             TP + APE  LG     K+ D W++GV +Y ++ G  PF              +I   
Sbjct: 224 CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 282
Query: 343 SLVFPDA----MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
              FP+     ++ E++ L+  LL  +PT+R+T+ +   H W++  +  +PQ
Sbjct: 283 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM-QSTKVPQ 333

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 133/292 (45%), Gaps = 34/292 (11%)
Query: 116 MINEY-VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           +I++Y V  + +G G  GKV+   +    + +A+K                      RRE
Sbjct: 14  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARRE 59
Query: 175 V-LIMKMLQHPNIVNLIEVIDDPNSDH--FYMVLEYVEGKWDNDGFGQPG--AIGESMAR 229
           V L  +  Q P+IV +++V ++  +      +V+E ++G          G  A  E  A 
Sbjct: 60  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 119
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRS 286
           + ++ I   + YLH  N+ H D+KP+NLL     P+  +K+ DF  ++     N  L   
Sbjct: 120 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTP 178
Query: 287 PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG----ETLQDTYDKIVNN 342
             TP + APE  LG     K+ D W++GV +Y ++ G  PF              +I   
Sbjct: 179 CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 237
Query: 343 SLVFPDA----MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
              FP+     ++ E++ L+  LL  +PT+R+T+ +   H W++  +  +PQ
Sbjct: 238 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM-QSTKVPQ 288

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 133/292 (45%), Gaps = 34/292 (11%)
Query: 116 MINEY-VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           +I++Y V  + +G G  GKV+   +    + +A+K                      RRE
Sbjct: 29  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARRE 74
Query: 175 V-LIMKMLQHPNIVNLIEVIDDPNSDH--FYMVLEYVEGKWDNDGFGQPG--AIGESMAR 229
           V L  +  Q P+IV +++V ++  +      +V+E ++G          G  A  E  A 
Sbjct: 75  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 134
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRS 286
           + ++ I   + YLH  N+ H D+KP+NLL     P+  +K+ DF  ++     N  L   
Sbjct: 135 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTP 193
Query: 287 PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG----ETLQDTYDKIVNN 342
             TP + APE  LG     K+ D W++GV +Y ++ G  PF              +I   
Sbjct: 194 CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 252
Query: 343 SLVFPDA----MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
              FP+     ++ E++ L+  LL  +PT+R+T+ +   H W++  +  +PQ
Sbjct: 253 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM-QSTKVPQ 303

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 136/292 (46%), Gaps = 34/292 (11%)
Query: 116 MINEY-VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           +I++Y V  + +G G  GKV+   +    + +A+K         L+  P        RRE
Sbjct: 15  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM--------LQDCPK------ARRE 60
Query: 175 V-LIMKMLQHPNIVNLIEVIDDPNSDH--FYMVLEYVEGKWDNDGFGQPG--AIGESMAR 229
           V L  +  Q P+IV +++V ++  +      +V+E ++G          G  A  E  A 
Sbjct: 61  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 120
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRS 286
           + ++ I   + YLH  N+ H D+KP+NLL     P+  +K+ DF  ++     N  L   
Sbjct: 121 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTP 179
Query: 287 PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG----ETLQDTYDKIVNN 342
             TP + APE  LG     K+ D W++GV +Y ++ G  PF              +I   
Sbjct: 180 CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 238
Query: 343 SLVFPDA----MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
              FP+     ++ E++ L+  LL  +PT+R+T+ +   H W++  +  +PQ
Sbjct: 239 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM-QSTKVPQ 289

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 136/292 (46%), Gaps = 34/292 (11%)
Query: 116 MINEY-VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           +I++Y V  + +G G  GKV+   +    + +A+K         L+  P        RRE
Sbjct: 65  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM--------LQDCPK------ARRE 110
Query: 175 V-LIMKMLQHPNIVNLIEVIDDPNSDH--FYMVLEYVEGKWDNDGFGQPG--AIGESMAR 229
           V L  +  Q P+IV +++V ++  +      +V+E ++G          G  A  E  A 
Sbjct: 111 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 170
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRS 286
           + ++ I   + YLH  N+ H D+KP+NLL     P+  +K+ DF  ++     N  L   
Sbjct: 171 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTP 229
Query: 287 PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG----ETLQDTYDKIVNN 342
             TP + APE  LG     K+ D W++GV +Y ++ G  PF              +I   
Sbjct: 230 CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 288
Query: 343 SLVFPD----AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
              FP+     ++ E++ L+  LL  +PT+R+T+ +   H W++  +  +PQ
Sbjct: 289 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM-QSTKVPQ 339

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 121/286 (42%), Gaps = 51/286 (17%)
Query: 110 DENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMT 169
           DENG +++        +G G+YG V           YA +       +++R+A  E    
Sbjct: 22  DENGDRVV--------LGKGTYGIV-----------YAGRDLS----NQVRIAIKEIPER 58
Query: 170 DVR------REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG---------KWDN 214
           D R       E+ + K L+H NIV  +    +      +M  E V G         KW  
Sbjct: 59  DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM--EQVPGGSLSALLRSKWG- 115
Query: 215 DGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDFSVS 273
                P    E     Y + I+ GL YLH + +VH DIK DN+L+   SG +KI DF  S
Sbjct: 116 -----PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTS 170
Query: 274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYG-GKAADTWAVGVTLYYMIIGQYPF--LGE 330
           +     N       GT  + APE       G GKAAD W++G T+  M  G+ PF  LGE
Sbjct: 171 KRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230
Query: 331 TLQDTYD-KIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDV 375
                +   +       P++M+ E +  +      DP +R   ND+
Sbjct: 231 PQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDL 276

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 82/335 (24%), Positives = 135/335 (40%), Gaps = 78/335 (23%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++ +Y  V+K+G G+YG V        G+  A+K    +         + T      RE+
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-------QNSTDAQRTFREI 59
Query: 176 LIMKMLQ-HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +I+  L  H NIVNL+ V+   N    Y+V +Y+E   D     +   +     +  +  
Sbjct: 60  MILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET--DLHAVIRANILEPVHKQYVVYQ 117
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV------------------- 275
           ++  + YLH   ++H D+KP N+L+     VK+ DF +S+                    
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 276 --FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG---- 329
             F+DD  +L     T  + APE  LG T   K  D W++G  L  ++ G+  F G    
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237
Query: 330 ------------------ETLQDTYDKIVNNSL------------------------VFP 347
                             E++Q  + K +  SL                        + P
Sbjct: 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINP 297
Query: 348 DA-MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            A  N E  +LL+ LL  +P +R++ ND  KH +V
Sbjct: 298 KADCNEEALDLLDKLLQFNPNKRISANDALKHPFV 332

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 140/289 (48%), Gaps = 31/289 (10%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM- 178
           Y  +++IG+G   KV    +    + YAIK  +      L  A ++T +   R E+  + 
Sbjct: 11  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVN------LEEADNQT-LDSYRNEIAYLN 62
Query: 179 KMLQHPNIVNLIEVIDDPNSDHF-YMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIV 236
           K+ QH +   +I + D   +D + YMV+E   G  D N    +  +I     + Y ++++
Sbjct: 63  KLQQHSD--KIIRLYDYEITDQYIYMVMEC--GNIDLNSWLKKKKSIDPWERKSYWKNML 118
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSP-GTPVFTA 294
             +  +H H +VH D+KP N L+   G +K+ DF ++ Q+  D   V++ S  GT  +  
Sbjct: 119 EAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 295 PECCLGLTYGGK----------AADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV---N 341
           PE    ++   +           +D W++G  LYYM  G+ PF     Q +    +   N
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 237
Query: 342 NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
           + + FPD    +L+++L+  L +DP +R+++ ++  H +V     P+ Q
Sbjct: 238 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 286

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 140/289 (48%), Gaps = 31/289 (10%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM- 178
           Y  +++IG+G   KV    +    + YAIK  +      L  A ++T +   R E+  + 
Sbjct: 58  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVN------LEEADNQT-LDSYRNEIAYLN 109
Query: 179 KMLQHPNIVNLIEVIDDPNSDHF-YMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIV 236
           K+ QH +   +I + D   +D + YMV+E   G  D N    +  +I     + Y ++++
Sbjct: 110 KLQQHSD--KIIRLYDYEITDQYIYMVMEC--GNIDLNSWLKKKKSIDPWERKSYWKNML 165
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSP-GTPVFTA 294
             +  +H H +VH D+KP N L+   G +K+ DF ++ Q+  D   V++ S  GT  +  
Sbjct: 166 EAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 224
Query: 295 PECCLGLTYGGK----------AADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV---N 341
           PE    ++   +           +D W++G  LYYM  G+ PF     Q +    +   N
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284
Query: 342 NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
           + + FPD    +L+++L+  L +DP +R+++ ++  H +V     P+ Q
Sbjct: 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 333

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 130/300 (43%), Gaps = 43/300 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLD-GKHYAIKAFHKSHLSKLRVAPSETAM-TDVRRE 174
           + +Y  + KIG G+YG  V+Y++  + G+ +A+K        K+R+   +  + +   RE
Sbjct: 1   MEKYHGLEKIGEGTYG--VVYKAQNNYGETFALK--------KIRLEKEDEGIPSTTIRE 50
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           + I+K L+H NIV L +VI         +V E+++           G +    A+ +L  
Sbjct: 51  ISILKELKHSNIVKLYDVIH--TKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           +++G+ Y H   V+H D+KP NLL+   G +KI DF +++ F            T  + A
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRA 168
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFPDA 349
           P+  +G        D W+VG     M+ G   F G +  D   +I       NS  +P+ 
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 350 M-----NPELR-------------------NLLEGLLCKDPTRRLTLNDVAKHTWVLGDN 385
                 +P                      +LL  +L  DP +R+T     +H +   +N
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 130/300 (43%), Gaps = 43/300 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLD-GKHYAIKAFHKSHLSKLRVAPSETAM-TDVRRE 174
           + +Y  + KIG G+YG  V+Y++  + G+ +A+K        K+R+   +  + +   RE
Sbjct: 1   MEKYHGLEKIGEGTYG--VVYKAQNNYGETFALK--------KIRLEKEDEGIPSTTIRE 50
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           + I+K L+H NIV L +VI         +V E+++           G +    A+ +L  
Sbjct: 51  ISILKELKHSNIVKLYDVIH--TKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           +++G+ Y H   V+H D+KP NLL+   G +KI DF +++ F            T  + A
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRA 168
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFPDA 349
           P+  +G        D W+VG     M+ G   F G +  D   +I       NS  +P+ 
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 350 M-----NPELR-------------------NLLEGLLCKDPTRRLTLNDVAKHTWVLGDN 385
                 +P                      +LL  +L  DP +R+T     +H +   +N
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 140/289 (48%), Gaps = 31/289 (10%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM- 178
           Y  +++IG+G   KV    +    + YAIK  +      L  A ++T +   R E+  + 
Sbjct: 58  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVN------LEEADNQT-LDSYRNEIAYLN 109
Query: 179 KMLQHPNIVNLIEVIDDPNSDHF-YMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIV 236
           K+ QH +   +I + D   +D + YMV+E   G  D N    +  +I     + Y ++++
Sbjct: 110 KLQQHSD--KIIRLYDYEITDQYIYMVMEC--GNIDLNSWLKKKKSIDPWERKSYWKNML 165
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSP-GTPVFTA 294
             +  +H H +VH D+KP N L+   G +K+ DF ++ Q+  D   V++ S  GT  +  
Sbjct: 166 EAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 224
Query: 295 PECCLGLTYGGK----------AADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV---N 341
           PE    ++   +           +D W++G  LYYM  G+ PF     Q +    +   N
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284
Query: 342 NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
           + + FPD    +L+++L+  L +DP +R+++ ++  H +V     P+ Q
Sbjct: 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 333

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 121/286 (42%), Gaps = 51/286 (17%)
Query: 110 DENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMT 169
           DENG +++        +G G+YG V           YA +       +++R+A  E    
Sbjct: 8   DENGDRVV--------LGKGTYGIV-----------YAGRDLS----NQVRIAIKEIPER 44
Query: 170 DVR------REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG---------KWDN 214
           D R       E+ + K L+H NIV  +    +      +M  E V G         KW  
Sbjct: 45  DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM--EQVPGGSLSALLRSKWG- 101
Query: 215 DGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV-APSGTVKIGDFSVS 273
                P    E     Y + I+ GL YLH + +VH DIK DN+L+   SG +KI DF  S
Sbjct: 102 -----PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTS 156
Query: 274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYG-GKAADTWAVGVTLYYMIIGQYPF--LGE 330
           +     N       GT  + APE       G GKAAD W++G T+  M  G+ PF  LGE
Sbjct: 157 KRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 216
Query: 331 TLQDTYD-KIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDV 375
                +   +       P++M+ E +  +      DP +R   ND+
Sbjct: 217 PQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDL 262

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 130/300 (43%), Gaps = 43/300 (14%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLD-GKHYAIKAFHKSHLSKLRVAPSETAM-TDVRRE 174
           + +Y  + KIG G+YG  V+Y++  + G+ +A+K        K+R+   +  + +   RE
Sbjct: 1   MEKYHGLEKIGEGTYG--VVYKAQNNYGETFALK--------KIRLEKEDEGIPSTTIRE 50
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           + I+K L+H NIV L +VI         +V E+++           G +    A+ +L  
Sbjct: 51  ISILKELKHSNIVKLYDVIH--TKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           +++G+ Y H   V+H D+KP NLL+   G +KI DF +++ F            T  + A
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----NSLVFPDA 349
           P+  +G        D W+VG     M+ G   F G +  D   +I       NS  +P+ 
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 350 M-----NPELR-------------------NLLEGLLCKDPTRRLTLNDVAKHTWVLGDN 385
                 +P                      +LL  +L  DP +R+T     +H +   +N
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/312 (23%), Positives = 138/312 (44%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G VV    ++  ++ AIK          R   ++T      RE+
Sbjct: 22  VLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYREL 74
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK++ H NI+ L+ V     S       Y+V+E ++         Q     E M+   
Sbjct: 75  VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQ--VIQMELDHERMSY-L 131
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 132 LYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-AGTSFMMTPYVVTRY 190
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VGV +  MI G   F G    D ++K++           
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD + P           + R+LL  +L  D ++R
Sbjct: 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 370 LTLNDVAKHTWV 381
           +++++  +H ++
Sbjct: 310 ISVDEALQHPYI 321

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 140/289 (48%), Gaps = 31/289 (10%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM- 178
           Y  +++IG+G   KV    +    + YAIK  +      L  A ++T +   R E+  + 
Sbjct: 30  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVN------LEEADNQT-LDSYRNEIAYLN 81
Query: 179 KMLQHPNIVNLIEVIDDPNSDHF-YMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIV 236
           K+ QH +   +I + D   +D + YMV+E   G  D N    +  +I     + Y ++++
Sbjct: 82  KLQQHSD--KIIRLYDYEITDQYIYMVMEC--GNIDLNSWLKKKKSIDPWERKSYWKNML 137
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSP-GTPVFTA 294
             +  +H H +VH D+KP N L+   G +K+ DF ++ Q+  D   V++ S  GT  +  
Sbjct: 138 EAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196
Query: 295 PECCLGLTYGGK----------AADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV---N 341
           PE    ++   +           +D W++G  LYYM  G+ PF     Q +    +   N
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256
Query: 342 NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
           + + FPD    +L+++L+  L +DP +R+++ ++  H +V     P+ Q
Sbjct: 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 305

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 140/289 (48%), Gaps = 31/289 (10%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM- 178
           Y  +++IG+G   KV    +    + YAIK  +      L  A ++T +   R E+  + 
Sbjct: 14  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVN------LEEADNQT-LDSYRNEIAYLN 65
Query: 179 KMLQHPNIVNLIEVIDDPNSDHF-YMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIV 236
           K+ QH +   +I + D   +D + YMV+E   G  D N    +  +I     + Y ++++
Sbjct: 66  KLQQHSD--KIIRLYDYEITDQYIYMVMEC--GNIDLNSWLKKKKSIDPWERKSYWKNML 121
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSP-GTPVFTA 294
             +  +H H +VH D+KP N L+   G +K+ DF ++ Q+  D   V++ S  GT  +  
Sbjct: 122 EAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 180
Query: 295 PECCLGLTYGGK----------AADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV---N 341
           PE    ++   +           +D W++G  LYYM  G+ PF     Q +    +   N
Sbjct: 181 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 240
Query: 342 NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
           + + FPD    +L+++L+  L +DP +R+++ ++  H +V     P+ Q
Sbjct: 241 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 289

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 140/289 (48%), Gaps = 31/289 (10%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM- 178
           Y  +++IG+G   KV    +    + YAIK  +      L  A ++T +   R E+  + 
Sbjct: 10  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVN------LEEADNQT-LDSYRNEIAYLN 61
Query: 179 KMLQHPNIVNLIEVIDDPNSDHF-YMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIV 236
           K+ QH +   +I + D   +D + YMV+E   G  D N    +  +I     + Y ++++
Sbjct: 62  KLQQHSD--KIIRLYDYEITDQYIYMVMEC--GNIDLNSWLKKKKSIDPWERKSYWKNML 117
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSP-GTPVFTA 294
             +  +H H +VH D+KP N L+   G +K+ DF ++ Q+  D   V++ S  GT  +  
Sbjct: 118 EAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 176
Query: 295 PECCLGLTYGGK----------AADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV---N 341
           PE    ++   +           +D W++G  LYYM  G+ PF     Q +    +   N
Sbjct: 177 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 236
Query: 342 NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
           + + FPD    +L+++L+  L +DP +R+++ ++  H +V     P+ Q
Sbjct: 237 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 285

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 115/255 (45%), Gaps = 29/255 (11%)
Query: 144 KHYAIK--------AFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVID 194
           K YA+K        +F    + +LR A          +EV I++ +  HPNI+ L +  +
Sbjct: 30  KEYAVKIIDVTGGGSFSAEEVQELREA--------TLKEVDILRKVSGHPNIIQLKDTYE 81
Query: 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKP 254
              +  F++V + ++     D   +   + E   RK +R ++  +  LH  N+VH D+KP
Sbjct: 82  --TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKP 139
Query: 255 DNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP---ECCLGLTYG--GKAAD 309
           +N+L+     +K+ DF  S    D  + LR   GTP + AP   EC +   +   GK  D
Sbjct: 140 ENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVD 198
Query: 310 TWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAMNPELRNLLEGLLCKD 365
            W+ GV +Y ++ G  PF           I++ +  F     D  +  +++L+   L   
Sbjct: 199 MWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQ 258
Query: 366 PTRRLTLNDVAKHTW 380
           P +R T  +   H +
Sbjct: 259 PQKRYTAEEALAHPF 273

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 122/274 (44%), Gaps = 16/274 (5%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G   +V L R   D +  A+K        +  +A   +     RRE      L HP 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVL------RADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 186 IVNLIEV--IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           IV + +    + P     Y+V+EYV+G    D     G +    A + + D    L + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP---GTPVFTAPECCLG 300
            + ++H D+KP N+L++ +  VK+ DF +++   D  + + ++    GT  + +PE   G
Sbjct: 134 QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARG 193
Query: 301 LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA----MNPELRN 356
            +   + +D +++G  LY ++ G+ PF G++      + V    + P A    ++ +L  
Sbjct: 194 DSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDA 252
Query: 357 LLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
           ++   L K+P  R       +   V   NG  P+
Sbjct: 253 VVLKALAKNPENRYQTAAEMRADLVRVHNGEPPE 286

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 122/274 (44%), Gaps = 16/274 (5%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G   +V L R   D +  A+K        +  +A   +     RRE      L HP 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVL------RADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 186 IVNLIEV--IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           IV + +    + P     Y+V+EYV+G    D     G +    A + + D    L + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP---GTPVFTAPECCLG 300
            + ++H D+KP N++++ +  VK+ DF +++   D  + + ++    GT  + +PE   G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 301 LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA----MNPELRN 356
            +   + +D +++G  LY ++ G+ PF G++      + V    + P A    ++ +L  
Sbjct: 194 DSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSARHEGLSADLDA 252
Query: 357 LLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
           ++   L K+P  R       +   V   NG  P+
Sbjct: 253 VVLKALAKNPENRYQTAAEMRADLVRVHNGEPPE 286

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 115/255 (45%), Gaps = 29/255 (11%)
Query: 144 KHYAIK--------AFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVID 194
           K YA+K        +F    + +LR A          +EV I++ +  HPNI+ L +  +
Sbjct: 43  KEYAVKIIDVTGGGSFSAEEVQELREA--------TLKEVDILRKVSGHPNIIQLKDTYE 94
Query: 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKP 254
              +  F++V + ++     D   +   + E   RK +R ++  +  LH  N+VH D+KP
Sbjct: 95  --TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKP 152
Query: 255 DNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP---ECCLGLTYG--GKAAD 309
           +N+L+     +K+ DF  S    D  + LR   GTP + AP   EC +   +   GK  D
Sbjct: 153 ENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVD 211
Query: 310 TWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAMNPELRNLLEGLLCKD 365
            W+ GV +Y ++ G  PF           I++ +  F     D  +  +++L+   L   
Sbjct: 212 MWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQ 271
Query: 366 PTRRLTLNDVAKHTW 380
           P +R T  +   H +
Sbjct: 272 PQKRYTAEEALAHPF 286

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 140/289 (48%), Gaps = 31/289 (10%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM- 178
           Y  +++IG+G   KV    +    + YAIK  +      L  A ++T +   R E+  + 
Sbjct: 30  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVN------LEEADNQT-LDSYRNEIAYLN 81
Query: 179 KMLQHPNIVNLIEVIDDPNSDHF-YMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIV 236
           K+ QH +   +I + D   +D + YMV+E   G  D N    +  +I     + Y ++++
Sbjct: 82  KLQQHSD--KIIRLYDYEITDQYIYMVMEC--GNIDLNSWLKKKKSIDPWERKSYWKNML 137
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSP-GTPVFTA 294
             +  +H H +VH D+KP N L+   G +K+ DF ++ Q+  D   V++ S  GT  +  
Sbjct: 138 EAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMP 196
Query: 295 PECCLGLTYGGK----------AADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV---N 341
           PE    ++   +           +D W++G  LYYM  G+ PF     Q +    +   N
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256
Query: 342 NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
           + + FPD    +L+++L+  L +DP +R+++ ++  H +V     P+ Q
Sbjct: 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 305

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 115/255 (45%), Gaps = 29/255 (11%)
Query: 144 KHYAIK--------AFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVID 194
           K YA+K        +F    + +LR A          +EV I++ +  HPNI+ L +  +
Sbjct: 43  KEYAVKIIDVTGGGSFSAEEVQELREA--------TLKEVDILRKVSGHPNIIQLKDTYE 94
Query: 195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKP 254
              +  F++V + ++     D   +   + E   RK +R ++  +  LH  N+VH D+KP
Sbjct: 95  --TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKP 152
Query: 255 DNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP---ECCLGLTYG--GKAAD 309
           +N+L+     +K+ DF  S    D  + LR   GTP + AP   EC +   +   GK  D
Sbjct: 153 ENILLDDDMNIKLTDFGFSCQL-DPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVD 211
Query: 310 TWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAMNPELRNLLEGLLCKD 365
            W+ GV +Y ++ G  PF           I++ +  F     D  +  +++L+   L   
Sbjct: 212 MWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQ 271
Query: 366 PTRRLTLNDVAKHTW 380
           P +R T  +   H +
Sbjct: 272 PQKRYTAEEALAHPF 286

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 104/233 (44%), Gaps = 14/233 (6%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R IGAG +G+V   R  L GK     A     +  L+V  +E    D   E  IM    H
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVA-----IKTLKVGYTEKQRRDFLGEASIMGQFDH 82
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           PNI++L  V+    S    +V EY+E G  D       G          LR I +G+ YL
Sbjct: 83  PNIIHLEGVVT--KSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYL 140
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV---FTAPECCL 299
                VH D+   N+L+  +   K+ DF +S+V EDD +    + G  +   +TAPE  +
Sbjct: 141 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AI 199
Query: 300 GLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
                  A+D W+ G+ ++ ++  G+ P+   T QD   K V      P  M+
Sbjct: 200 AFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVI-KAVEEGYRLPSPMD 251

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 116/257 (45%), Gaps = 18/257 (7%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETA--MTDVRREV 175
             +  + ++G GSYG+V   RS  DG+ YA+K      +S  R  P + A  + +V    
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK----RSMSPFR-GPKDRARKLAEVGSH- 110
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
              K+ QHP  V L +  ++      Y+  E               ++ E+    YLRD 
Sbjct: 111 --EKVGQHPCCVRLEQAWEE--GGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDT 166
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           +  L +LH   +VH D+KP N+ + P G  K+GDF +  V            G P + AP
Sbjct: 167 LLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLL-VELGTAGAGEVQEGDPRYMAP 225
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIG-QYPFLGETLQDTYDKIVNNSLVFPDAMNPEL 354
           E   G +Y G AAD +++G+T+  +    + P  GE  Q      +     F   ++ EL
Sbjct: 226 ELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPE--FTAGLSSEL 281
Query: 355 RNLLEGLLCKDPTRRLT 371
           R++L  +L  DP  R T
Sbjct: 282 RSVLVMMLEPDPKLRAT 298

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 131/305 (42%), Gaps = 26/305 (8%)
Query: 89  LNGLICRQFPVKESNKLIRSEDENGTKMINEYVHV-RKIGAGSYGKVVLYRSSLDGKHYA 147
           L  +  R  P ++  KL   ++++ TK   E   V  K+G GSYG V             
Sbjct: 2   LETVQLRNPPRRQLKKL---DEDSLTKQPEEVFDVLEKLGEGSYGSVY------------ 46
Query: 148 IKAFHKS--HLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVL 205
            KA HK    +  ++  P E+ + ++ +E+ IM+    P++V         N+D  ++V+
Sbjct: 47  -KAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFK-NTD-LWIVM 103
Query: 206 EYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT 264
           EY      +D    +   + E      L+  + GL YLH    +H DIK  N+L+   G 
Sbjct: 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH 163
Query: 265 VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQ 324
            K+ DF V+    D         GTP + APE    + Y    AD W++G+T   M  G+
Sbjct: 164 AKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNC-VADIWSLGITAIEMAEGK 222
Query: 325 YPFLG-ETLQDTYDKIVNNSLVF--PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            P+     ++  +    N    F  P+  +    + ++  L K P +R T   + +H +V
Sbjct: 223 PPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282
Query: 382 LGDNG 386
               G
Sbjct: 283 RSAKG 287

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 116/261 (44%), Gaps = 17/261 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--- 182
           +G G +G V       D    AIK   ++ +  L  +P   ++T      L+ K+     
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRV--LGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMY 241
           HP ++ L++  +    + F +VLE      D  D   + G +GE  +R +   +V+ + +
Sbjct: 97  HPGVIRLLDWFE--TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQH 154
Query: 242 LHGHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG 300
            H   VVH DIK +N+L+    G  K+ DF    +  D+        GT V++ PE    
Sbjct: 155 CHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--YTDFDGTRVYSPPEWISR 212
Query: 301 LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEG 360
             Y    A  W++G+ LY M+ G  PF      +   +I+   L FP  ++P+   L+  
Sbjct: 213 HQYHALPATVWSLGILLYDMVCGDIPF------ERDQEILEAELHFPAHVSPDCCALIRR 266
Query: 361 LLCKDPTRRLTLNDVAKHTWV 381
            L   P+ R +L ++    W+
Sbjct: 267 CLAPKPSSRPSLEEILLDPWM 287

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 122/274 (44%), Gaps = 16/274 (5%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G   +V L R   D +  A+K        +  +A   +     RRE      L HP 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVL------RADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 186 IVNLIEV--IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           IV + +    + P     Y+V+EYV+G    D     G +    A + + D    L + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP---GTPVFTAPECCLG 300
            + ++H D+KP N++++ +  VK+ DF +++   D  + + ++    GT  + +PE   G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 301 LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA----MNPELRN 356
            +   + +D +++G  LY ++ G+ PF G++      + V    + P A    ++ +L  
Sbjct: 194 DSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDA 252
Query: 357 LLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
           ++   L K+P  R       +   V   NG  P+
Sbjct: 253 VVLKALAKNPENRYQTAAEMRADLVRVHNGEPPE 286

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 133/302 (44%), Gaps = 53/302 (17%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +L+    AIK          +++P E  T      RE+ I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIK----------KISPFEHQTYCQRTLREIKI 78
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKTQHLSNDHICYFLYQ 136
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 196
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF---------------LGETLQDTY 336
           + APE  L      K+ D W+VG  L  M+  +  F               LG   Q+  
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256
Query: 337 DKIVN----NSL-------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
           + I+N    N L             +FP+A +  L +LL+ +L  +P +R+ +     H 
Sbjct: 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKAL-DLLDKMLTFNPHKRIEVEQALAHP 315
Query: 380 WV 381
           ++
Sbjct: 316 YL 317

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 133/302 (44%), Gaps = 53/302 (17%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +L+    AIK          +++P E  T      RE+ I
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIK----------KISPFEHQTYCQRTLREIKI 79
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 80  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKTQHLSNDHICYFLYQ 137
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 138 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 197
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF---------------LGETLQDTY 336
           + APE  L      K+ D W+VG  L  M+  +  F               LG   Q+  
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 257
Query: 337 DKIVN----NSL-------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
           + I+N    N L             +FP+A +  L +LL+ +L  +P +R+ +     H 
Sbjct: 258 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKAL-DLLDKMLTFNPHKRIEVEQALAHP 316
Query: 380 WV 381
           ++
Sbjct: 317 YL 318

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 139/289 (48%), Gaps = 31/289 (10%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM- 178
           Y  +++IG+G   KV    +    + YAIK  +      L  A ++T +   R E+  + 
Sbjct: 58  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVN------LEEADNQT-LDSYRNEIAYLN 109
Query: 179 KMLQHPNIVNLIEVIDDPNSDHF-YMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIV 236
           K+ QH +   +I + D   +D + YMV+E   G  D N    +  +I     + Y ++++
Sbjct: 110 KLQQHSD--KIIRLYDYEITDQYIYMVMEC--GNIDLNSWLKKKKSIDPWERKSYWKNML 165
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSP-GTPVFTA 294
             +  +H H +VH D+KP N L+   G +K+ DF ++ Q+  D   V++ S  G   +  
Sbjct: 166 EAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224
Query: 295 PECCLGLTYGGK----------AADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV---N 341
           PE    ++   +           +D W++G  LYYM  G+ PF     Q +    +   N
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284
Query: 342 NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
           + + FPD    +L+++L+  L +DP +R+++ ++  H +V     P+ Q
Sbjct: 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 333

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/312 (23%), Positives = 137/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYREL 74
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK++ H NI+ L+ V     S       Y+V+E ++         Q     E M+   
Sbjct: 75  VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQ--VIQMELDHERMSY-L 131
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 132 LYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-AGTSFMMTPYVVTRY 190
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VGV +  MI G   F G    D ++K++           
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD + P           + R+LL  +L  D ++R
Sbjct: 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 370 LTLNDVAKHTWV 381
           +++++  +H ++
Sbjct: 310 ISVDEALQHPYI 321

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 83/322 (25%), Positives = 134/322 (41%), Gaps = 57/322 (17%)
Query: 102 SNKLIRS-----EDENGT--KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKS 154
           S  LIR      +D N T  ++   YV    +G+G+YG V        G+  AIK     
Sbjct: 19  SMSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-- 76
Query: 155 HLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH----FYMVLEYVEG 210
                R   SE       RE+L++K +QH N++ L++V    +S      FY+V+ +++ 
Sbjct: 77  -----RPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT 131
Query: 211 KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270
                  G      E   +  +  ++ GL Y+H   VVH D+KP NL V     +KI DF
Sbjct: 132 DLQKI-MGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDF 188
Query: 271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG- 329
            +++  + +   +     T  + APE  L   +  +  D W+VG  +  M+ G+  F G 
Sbjct: 189 GLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245
Query: 330 ------------------ETLQDTYDKIVNNSL-------------VFPDAMNPELRNLL 358
                             E +Q   DK   + +             +FP A +P+  +LL
Sbjct: 246 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRA-SPQAADLL 304
Query: 359 EGLLCKDPTRRLTLNDVAKHTW 380
           E +L  D  +RLT      H +
Sbjct: 305 EKMLELDVDKRLTAAQALTHPF 326

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 20/229 (8%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +L+    AIK          +++P E  T      RE+ I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIK----------KISPFEHQTYCQRTLREIKI 78
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKTQHLSNDHICYFLYQ 136
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV 340
           + APE  L      K+ D W+VG  L  M+  +  F G+   D  + I+
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 133/302 (44%), Gaps = 53/302 (17%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +L+    AIK          +++P E  T      RE+ I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIK----------KISPFEHQTYXQRTLREIKI 78
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKTQHLSNDHICYFLYQ 136
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF---------------LGETLQDTY 336
           + APE  L      K+ D W+VG  L  M+  +  F               LG   Q+  
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256
Query: 337 DKIVN----NSL-------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
           + I+N    N L             +FP+A +  L +LL+ +L  +P +R+ +     H 
Sbjct: 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKAL-DLLDKMLTFNPHKRIEVEQALAHP 315
Query: 380 WV 381
           ++
Sbjct: 316 YL 317

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 20/229 (8%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +L+    AIK          +++P E  T      RE+ I
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIK----------KISPFEHQTYCQRTLREIKI 79
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 80  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKTQHLSNDHICYFLYQ 137
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 138 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 197
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV 340
           + APE  L      K+ D W+VG  L  M+  +  F G+   D  + I+
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 246

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 20/229 (8%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +L+    AIK          +++P E  T      RE+ I
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIK----------KISPFEHQTYCQRTLREIKI 80
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 81  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKTQHLSNDHICYFLYQ 138
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 139 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 198
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV 340
           + APE  L      K+ D W+VG  L  M+  +  F G+   D  + I+
Sbjct: 199 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 247

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 20/229 (8%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +L+    AIK          +++P E  T      RE+ I
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIK----------KISPFEHQTYCQRTLREIKI 71
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 72  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKTQHLSNDHICYFLYQ 129
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 130 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 189
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV 340
           + APE  L      K+ D W+VG  L  M+  +  F G+   D  + I+
Sbjct: 190 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 238

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 20/229 (8%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +L+    AIK          +++P E  T      RE+ I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIK----------KISPFEHQTYCQRTLREIKI 78
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKTQHLSNDHICYFLYQ 136
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV 340
           + APE  L      K+ D W+VG  L  M+  +  F G+   D  + I+
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 20/229 (8%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +L+    AIK          +++P E  T      RE+ I
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIK----------KISPFEHQTYCQRTLREIKI 72
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 73  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKTQHLSNDHICYFLYQ 130
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 131 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV 340
           + APE  L      K+ D W+VG  L  M+  +  F G+   D  + I+
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 239

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 20/229 (8%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +L+    AIK          +++P E  T      RE+ I
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIK----------KISPFEHQTYCQRTLREIKI 72
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 73  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKTQHLSNDHICYFLYQ 130
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 131 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV 340
           + APE  L      K+ D W+VG  L  M+  +  F G+   D  + I+
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 239

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/312 (22%), Positives = 137/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYREL 74
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI++L+ V     +       Y+V+E ++         Q     E M+   
Sbjct: 75  VLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQ--VIQMELDHERMSY-L 131
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVVTRY 190
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  M+  +  F G    D ++K++           
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 249
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD++ P           + R+LL  +L  DP +R
Sbjct: 250 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 309
Query: 370 LTLNDVAKHTWV 381
           ++++D  +H ++
Sbjct: 310 ISVDDALQHPYI 321

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 133/302 (44%), Gaps = 53/302 (17%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +L+    AIK          +++P E  T      RE+ I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIK----------KISPFEHQTYCQRTLREIKI 78
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKCQHLSNDHICYFLYQ 136
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF---------------LGETLQDTY 336
           + APE  L      K+ D W+VG  L  M+  +  F               LG   Q+  
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256
Query: 337 DKIVN----NSL-------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
           + I+N    N L             +FP+A +  L +LL+ +L  +P +R+ +     H 
Sbjct: 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKAL-DLLDKMLTFNPHKRIEVEQALAHP 315
Query: 380 WV 381
           ++
Sbjct: 316 YL 317

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/312 (22%), Positives = 137/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYREL 74
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI++L+ V     +       Y+V+E ++         Q     E M+   
Sbjct: 75  VLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQ--VIQMELDHERMSY-L 131
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 132 LYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVVTRY 190
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  M+  +  F G    D ++K++           
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 249
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD++ P           + R+LL  +L  DP +R
Sbjct: 250 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 309
Query: 370 LTLNDVAKHTWV 381
           ++++D  +H ++
Sbjct: 310 ISVDDALQHPYI 321

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 133/302 (44%), Gaps = 53/302 (17%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +++    AIK          +++P E  T      RE+ I
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIK----------KISPFEHQTYCQRTLREIKI 74
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 75  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKTQHLSNDHICYFLYQ 132
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF---------------LGETLQDTY 336
           + APE  L      K+ D W+VG  L  M+  +  F               LG   Q+  
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 252
Query: 337 DKIVN----NSL-------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
           + I+N    N L             +FP+A +  L +LL+ +L  +P +R+ +     H 
Sbjct: 253 NXIINLKARNYLLSLPHKNKVPWNRLFPNADSKAL-DLLDKMLTFNPHKRIEVEQALAHP 311
Query: 380 WV 381
           ++
Sbjct: 312 YL 313

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 106/228 (46%), Gaps = 10/228 (4%)
Query: 172 RREVLIMKMLQHPNIVNLIEV--IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR 229
           RRE      L HP IV + +    + P     Y+V+EYV+G    D     G +    A 
Sbjct: 60  RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP-- 287
           + + D    L + H + ++H D+KP N++++ +  VK+ DF +++   D  + + ++   
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 288 -GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF 346
            GT  + +PE   G +   + +D +++G  LY ++ G+ PF G++      + V    + 
Sbjct: 180 IGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238
Query: 347 PDA----MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
           P A    ++ +L  ++   L K+P  R       +   V   NG  P+
Sbjct: 239 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPE 286

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/309 (25%), Positives = 129/309 (41%), Gaps = 54/309 (17%)
Query: 109 EDENGT--KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSET 166
           +D N T  ++   YV    +G+G+YG V        G+  AIK          R   SE 
Sbjct: 13  QDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEI 65
Query: 167 AMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH----FYMVLEYVEGKWDND-GFGQPG 221
                 RE+L++K +QH N++ L++V    +S      FY+V+ +++       G     
Sbjct: 66  FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL---- 121
Query: 222 AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281
              E   +  +  ++ GL Y+H   VVH D+KP NL V     +KI DF +++  + +  
Sbjct: 122 KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 179
Query: 282 VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG------------ 329
            +     T  + APE  L   +  +  D W+VG  +  M+ G+  F G            
Sbjct: 180 -MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 238
Query: 330 -------ETLQDTYDKIVNNSL-------------VFPDAMNPELRNLLEGLLCKDPTRR 369
                  E +Q   DK   + +             +FP A +P+  +LLE +L  D  +R
Sbjct: 239 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRA-SPQAADLLEKMLELDVDKR 297
Query: 370 LTLNDVAKH 378
           LT      H
Sbjct: 298 LTAAQALTH 306

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 131/292 (44%), Gaps = 34/292 (11%)
Query: 116 MINEY-VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           +I++Y V  + +G G  GKV+   +    + +A+K         L+  P        RRE
Sbjct: 59  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKX--------LQDCPK------ARRE 104
Query: 175 V-LIMKMLQHPNIVNLIEVIDDPNSDH--FYMVLEYVEGKWDNDGFGQPG--AIGESMAR 229
           V L  +  Q P+IV +++V ++  +      +V E ++G          G  A  E  A 
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREAS 164
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRS 286
           +  + I   + YLH  N+ H D+KP+NLL     P+  +K+ DF  ++     N  L   
Sbjct: 165 EIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTP 223
Query: 287 PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE----TLQDTYDKIVNN 342
             TP + APE  LG     K+ D W++GV  Y ++ G  PF              +I   
Sbjct: 224 CYTPYYVAPE-VLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXG 282
Query: 343 SLVFPDA----MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
              FP+     ++ E++ L+  LL  +PT+R T+ +   H W+   +  +PQ
Sbjct: 283 QYEFPNPEWSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWI-XQSTKVPQ 333

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 133/302 (44%), Gaps = 53/302 (17%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +++    AIK          +++P E  T      RE+ I
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIK----------KISPFEHQTYCQRTLREIKI 74
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 75  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKTQHLSNDHICYFLYQ 132
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF---------------LGETLQDTY 336
           + APE  L      K+ D W+VG  L  M+  +  F               LG   Q+  
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 252
Query: 337 DKIVN----NSL-------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
           + I+N    N L             +FP+A +  L +LL+ +L  +P +R+ +     H 
Sbjct: 253 NXIINLKARNYLLSLPHKNKVPWNRLFPNADSKAL-DLLDKMLTFNPHKRIEVEQALAHP 311
Query: 380 WV 381
           ++
Sbjct: 312 YL 313

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 127/284 (44%), Gaps = 46/284 (16%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +++  +  +G G++G+VV  R++LD ++YAIK          ++  +E  ++ +  EV++
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIK----------KIRHTEEKLSTILSEVML 55
Query: 178 MKMLQHPNIV----------NLIEVIDD-PNSDHFYMVLEYVEGKWDNDGFGQPGAIGES 226
           +  L H  +V          N ++ +         ++ +EY E +   D         + 
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQR 115
Query: 227 MAR-KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV------------- 272
               +  R I+  L Y+H   ++H D+KP N+ +  S  VKIGDF +             
Sbjct: 116 DEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 273 -SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF-LGE 330
            SQ     +D L  + GT ++ A E   G  +  +  D +++G+  + MI   YPF  G 
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGM 232
Query: 331 TLQDTYDKIVNNSLVFP-----DAMNPELRNLLEGLLCKDPTRR 369
              +   K+ + S+ FP     + M  E + ++  L+  DP +R
Sbjct: 233 ERVNILKKLRSVSIEFPPDFDDNKMKVE-KKIIRLLIDHDPNKR 275

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/312 (22%), Positives = 137/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYREL 74
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI++L+ V     +       Y+V+E ++         Q     E M+   
Sbjct: 75  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQ--VIQMELDHERMSY-L 131
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 132 LYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVVTRY 190
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  M+  +  F G    D ++K++           
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 249
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD++ P           + R+LL  +L  DP +R
Sbjct: 250 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 309
Query: 370 LTLNDVAKHTWV 381
           ++++D  +H ++
Sbjct: 310 ISVDDALQHPYI 321

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 70/312 (22%), Positives = 137/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYREL 112
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI++L+ V     +       Y+V+E ++         Q     E M+   
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ--VIQMELDHERMSY-L 169
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRY 228
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  M+  +  F G    D ++K++           
Sbjct: 229 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD++ P           + R+LL  +L  DP +R
Sbjct: 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 347
Query: 370 LTLNDVAKHTWV 381
           ++++D  +H ++
Sbjct: 348 ISVDDALQHPYI 359

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 107/229 (46%), Gaps = 20/229 (8%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +++    AIK          +++P E  T      RE+ I
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIK----------KISPFEHQTYCQRTLREIKI 76
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 77  LLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKTQHLSNDHICYFLYQ 134
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV 340
           + APE  L      K+ D W+VG  L  M+  +  F G+   D  + I+
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 70/312 (22%), Positives = 137/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYREL 74
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI++L+ V     +       Y+V+E ++         Q     E M+   
Sbjct: 75  VLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ--VIQMELDHERMSY-L 131
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVVTRY 190
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  M+  +  F G    D ++K++           
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 249
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD++ P           + R+LL  +L  DP +R
Sbjct: 250 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 309
Query: 370 LTLNDVAKHTWV 381
           ++++D  +H ++
Sbjct: 310 ISVDDALQHPYI 321

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 70/312 (22%), Positives = 137/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYREL 67
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI++L+ V     +       Y+V+E ++         Q     E M+   
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQ--VIQMELDHERMSY-L 124
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 125 LYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVVTRY 183
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  M+  +  F G    D ++K++           
Sbjct: 184 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD++ P           + R+LL  +L  DP +R
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302
Query: 370 LTLNDVAKHTWV 381
           ++++D  +H ++
Sbjct: 303 ISVDDALQHPYI 314

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 131/287 (45%), Gaps = 24/287 (8%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           + ++G G++GKV  Y++    K  ++ A  K   +K     SE  + D   E+ I+    
Sbjct: 42  IGELGDGAFGKV--YKAQ--NKETSVLAAAKVIDTK-----SEEELEDYMVEIDILASCD 92
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEG-KWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
           HPNIV L++     N  + ++++E+  G   D         + ES  +   +  +  L Y
Sbjct: 93  HPNIVKLLDAFYYEN--NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNY 150
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCL 299
           LH + ++H D+K  N+L    G +K+ DF VS   ++   + RR    GTP + APE  +
Sbjct: 151 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVM 208
Query: 300 GLTYGGK----AADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDAMNP 352
             T   +     AD W++G+TL  M   + P           KI  +   +L  P   + 
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 268
Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD-NGPIPQYLCWCKRD 398
             ++ L+  L K+   R T + + +H +V  D N PI + +   K +
Sbjct: 269 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKAE 315

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 116/260 (44%), Gaps = 18/260 (6%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           N +   R +G G +G+V   +    GK YA K   K  +                 E  I
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK------KRKGEAMALNEKQI 237
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG---KWDNDGFGQPGAIGESMARKYLRD 234
           ++ +    +V+L    +    D   +VL  + G   K+     GQ G   E+ A  Y  +
Sbjct: 238 LEKVNSRFVVSLAYAYE--TKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVFYAAE 294
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           I  GL  LH   +V+ D+KP+N+L+   G ++I D  ++ V   +   ++   GT  + A
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMA 353
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL---GETLQDTYDKIVNN-SLVFPDAM 350
           PE      Y   + D WA+G  LY MI GQ PF     +  ++  +++V      + +  
Sbjct: 354 PEVVKNERYTF-SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERF 412
Query: 351 NPELRNLLEGLLCKDPTRRL 370
           +P+ R+L   LLCKDP  RL
Sbjct: 413 SPQARSLCSQLLCKDPAERL 432

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 129/292 (44%), Gaps = 17/292 (5%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +++  + ++GAG+ G V        G   A K  H      L + P+      + RE+ +
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPA--IRNQIIRELQV 60
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +     P IV         +     + +E+++G   +    + G I E +  K    ++ 
Sbjct: 61  LHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 118
Query: 238 GLMYL-HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           GL YL   H ++H D+KP N+LV   G +K+ DF VS    D  ++     GT  + +PE
Sbjct: 119 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--EMANEFVGTRSYMSPE 176
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV-FPDAM-NPEL 354
              G  Y  + +D W++G++L  M +G+YP     + +  D IVN      P A+ + E 
Sbjct: 177 RLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEF 235
Query: 355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCW-CKRDRLRRDNT 405
           ++ +   L K+P  R  L  +  H ++   +     +  W C    L + +T
Sbjct: 236 QDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPST 287

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 131/287 (45%), Gaps = 24/287 (8%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           + ++G G++GKV  Y++    K  ++ A  K   +K     SE  + D   E+ I+    
Sbjct: 42  IGELGDGAFGKV--YKAQ--NKETSVLAAAKVIDTK-----SEEELEDYMVEIDILASCD 92
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEG-KWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
           HPNIV L++     N  + ++++E+  G   D         + ES  +   +  +  L Y
Sbjct: 93  HPNIVKLLDAFYYEN--NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNY 150
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCL 299
           LH + ++H D+K  N+L    G +K+ DF VS   ++   + RR    GTP + APE  +
Sbjct: 151 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDSFIGTPYWMAPEVVM 208
Query: 300 GLTYGGK----AADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDAMNP 352
             T   +     AD W++G+TL  M   + P           KI  +   +L  P   + 
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 268
Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD-NGPIPQYLCWCKRD 398
             ++ L+  L K+   R T + + +H +V  D N PI + +   K +
Sbjct: 269 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKAE 315

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 107/229 (46%), Gaps = 20/229 (8%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +L+    AI+          +++P E  T      RE+ I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIR----------KISPFEHQTYCQRTLREIKI 78
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKTQHLSNDHICYFLYQ 136
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV 340
           + APE  L      K+ D W+VG  L  M+  +  F G+   D  + I+
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 105/228 (46%), Gaps = 10/228 (4%)
Query: 172 RREVLIMKMLQHPNIVNLIEV--IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR 229
           RRE      L HP IV +      + P     Y+V+EYV+G    D     G +    A 
Sbjct: 60  RREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP-- 287
           + + D    L + H + ++H D+KP N++++ +  VK+ DF +++   D  + + ++   
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 288 -GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF 346
            GT  + +PE   G +   + +D +++G  LY ++ G+ PF G++      + V    + 
Sbjct: 180 IGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238
Query: 347 PDA----MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
           P A    ++ +L  ++   L K+P  R       +   V   NG  P+
Sbjct: 239 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPE 286

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 116/260 (44%), Gaps = 18/260 (6%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           N +   R +G G +G+V   +    GK YA K   K  +                 E  I
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK------KRKGEAMALNEKQI 237
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG---KWDNDGFGQPGAIGESMARKYLRD 234
           ++ +    +V+L    +    D   +VL  + G   K+     GQ G   E+ A  Y  +
Sbjct: 238 LEKVNSRFVVSLAYAYE--TKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVFYAAE 294
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           I  GL  LH   +V+ D+KP+N+L+   G ++I D  ++ V   +   ++   GT  + A
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMA 353
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL---GETLQDTYDKIVNN-SLVFPDAM 350
           PE      Y   + D WA+G  LY MI GQ PF     +  ++  +++V      + +  
Sbjct: 354 PEVVKNERYTF-SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERF 412
Query: 351 NPELRNLLEGLLCKDPTRRL 370
           +P+ R+L   LLCKDP  RL
Sbjct: 413 SPQARSLCSQLLCKDPAERL 432

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 133/302 (44%), Gaps = 53/302 (17%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +++    AIK          +++P E  T      RE+ I
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIK----------KISPFEHQTYCQRTLREIKI 76
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 77  LLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKTQHLSNDHICYFLYQ 134
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF---------------LGETLQDTY 336
           + APE  L      K+ D W+VG  L  M+  +  F               LG   Q+  
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 254
Query: 337 DKIVN----NSL-------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
           + I+N    N L             +FP+A +  L +LL+ +L  +P +R+ +     H 
Sbjct: 255 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKAL-DLLDKMLTFNPHKRIEVEQALAHP 313
Query: 380 WV 381
           ++
Sbjct: 314 YL 315

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 133/302 (44%), Gaps = 53/302 (17%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +++    AIK          +++P E  T      RE+ I
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIK----------KISPFEHQTYCQRTLREIKI 76
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 77  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKTQHLSNDHICYFLYQ 134
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF---------------LGETLQDTY 336
           + APE  L      K+ D W+VG  L  M+  +  F               LG   Q+  
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 254
Query: 337 DKIVN----NSL-------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
           + I+N    N L             +FP+A +  L +LL+ +L  +P +R+ +     H 
Sbjct: 255 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKAL-DLLDKMLTFNPHKRIEVEQALAHP 313
Query: 380 WV 381
           ++
Sbjct: 314 YL 315

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/312 (22%), Positives = 137/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYREL 75
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI++L+ V     +       Y+V+E ++         Q     E M+   
Sbjct: 76  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ--VIQMELDHERMSY-L 132
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRY 191
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  M+  +  F G    D ++K++           
Sbjct: 192 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 250
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD++ P           + R+LL  +L  DP +R
Sbjct: 251 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 310
Query: 370 LTLNDVAKHTWV 381
           ++++D  +H ++
Sbjct: 311 ISVDDALQHPYI 322

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/312 (22%), Positives = 137/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYREL 74
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI++L+ V     +       Y+V+E ++         Q     E M+   
Sbjct: 75  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ--VIQMELDHERMSY-L 131
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRY 190
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  M+  +  F G    D ++K++           
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 249
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD++ P           + R+LL  +L  DP +R
Sbjct: 250 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 309
Query: 370 LTLNDVAKHTWV 381
           ++++D  +H ++
Sbjct: 310 ISVDDALQHPYI 321

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/312 (22%), Positives = 137/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYREL 112
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI++L+ V     +       Y+V+E ++         Q     E M+   
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ--VIQMELDHERMSY-L 169
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRY 228
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  M+  +  F G    D ++K++           
Sbjct: 229 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD++ P           + R+LL  +L  DP +R
Sbjct: 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 347
Query: 370 LTLNDVAKHTWV 381
           ++++D  +H ++
Sbjct: 348 ISVDDALQHPYI 359

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 131/287 (45%), Gaps = 24/287 (8%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           + ++G G++GKV  Y++    K  ++ A  K   +K     SE  + D   E+ I+    
Sbjct: 42  IGELGDGAFGKV--YKAQ--NKETSVLAAAKVIDTK-----SEEELEDYMVEIDILASCD 92
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEG-KWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
           HPNIV L++     N  + ++++E+  G   D         + ES  +   +  +  L Y
Sbjct: 93  HPNIVKLLDAFYYEN--NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNY 150
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCL 299
           LH + ++H D+K  N+L    G +K+ DF VS   ++   + RR    GTP + APE  +
Sbjct: 151 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDXFIGTPYWMAPEVVM 208
Query: 300 GLTYGGK----AADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDAMNP 352
             T   +     AD W++G+TL  M   + P           KI  +   +L  P   + 
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 268
Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD-NGPIPQYLCWCKRD 398
             ++ L+  L K+   R T + + +H +V  D N PI + +   K +
Sbjct: 269 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKAE 315

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 107/229 (46%), Gaps = 20/229 (8%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +++    AIK          +++P E  T      RE+ I
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIK----------KISPFEHQTYCQRTLREIKI 74
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 75  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKTQHLSNDHICYFLYQ 132
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV 340
           + APE  L      K+ D W+VG  L  M+  +  F G+   D  + I+
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/312 (22%), Positives = 136/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYREL 74
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK++ H NI+ L+ V     S       Y+V+E ++         Q     E M+   
Sbjct: 75  VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQ--VIQMELDHERMSY-L 131
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-AGTSFMMTPYVVTRY 190
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  MI G   F G    D ++K++           
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD + P           + R+LL  +L  D ++R
Sbjct: 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 370 LTLNDVAKHTWV 381
           +++++  +H ++
Sbjct: 310 ISVDEALQHPYI 321

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 107/229 (46%), Gaps = 20/229 (8%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +++    AIK          +++P E  T      RE+ I
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIK----------KISPFEHQTYCQRTLREIKI 74
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 75  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKTQHLSNDHICYFLYQ 132
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV 340
           + APE  L      K+ D W+VG  L  M+  +  F G+   D  + I+
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/312 (22%), Positives = 137/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 21  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYREL 73
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI++L+ V     +       Y+V+E ++         Q     E M+   
Sbjct: 74  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ--VIQMELDHERMSY-L 130
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 131 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRY 189
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  M+  +  F G    D ++K++           
Sbjct: 190 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 248
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD++ P           + R+LL  +L  DP +R
Sbjct: 249 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 308
Query: 370 LTLNDVAKHTWV 381
           ++++D  +H ++
Sbjct: 309 ISVDDALQHPYI 320

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/312 (22%), Positives = 137/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYREL 74
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI++L+ V     +       Y+V+E ++         Q     E M+   
Sbjct: 75  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ--VIQMELDHERMSY-L 131
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRY 190
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  M+  +  F G    D ++K++           
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 249
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD++ P           + R+LL  +L  DP +R
Sbjct: 250 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 309
Query: 370 LTLNDVAKHTWV 381
           ++++D  +H ++
Sbjct: 310 ISVDDALQHPYI 321

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 3/186 (1%)
Query: 197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDN 256
            S   ++++EY+ G    D   +PG + E+     LR+I+ GL YLH    +H DIK  N
Sbjct: 88  KSTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERKIHRDIKAAN 146
Query: 257 LLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVT 316
           +L++  G VK+ DF V+    D         GTP + APE      Y  K AD W++G+T
Sbjct: 147 VLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFK-ADIWSLGIT 205
Query: 317 LYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPE-LRNLLEGLLCKDPTRRLTLNDV 375
              +  G+ P            I  NS    +  + +  +  +E  L KDP  R T  ++
Sbjct: 206 AIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLNKDPRFRPTAKEL 265
Query: 376 AKHTWV 381
            KH ++
Sbjct: 266 LKHKFI 271

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/312 (22%), Positives = 137/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYREL 75
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI++L+ V     +       Y+V+E ++         Q     E M+   
Sbjct: 76  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ--VIQMELDHERMSY-L 132
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRY 191
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  M+  +  F G    D ++K++           
Sbjct: 192 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 250
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD++ P           + R+LL  +L  DP +R
Sbjct: 251 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 310
Query: 370 LTLNDVAKHTWV 381
           ++++D  +H ++
Sbjct: 311 ISVDDALQHPYI 322

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 133/302 (44%), Gaps = 53/302 (17%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +++    AIK          +++P E  T      RE+ I
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIK----------KISPFEHQTYCQRTLREIKI 82
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 83  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKTQHLSNDHICYFLYQ 140
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 141 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 200
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF---------------LGETLQDTY 336
           + APE  L      K+ D W+VG  L  M+  +  F               LG   Q+  
Sbjct: 201 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 260
Query: 337 DKIVN----NSL-------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
           + I+N    N L             +FP+A +  L +LL+ +L  +P +R+ +     H 
Sbjct: 261 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKAL-DLLDKMLTFNPHKRIEVEQALAHP 319
Query: 380 WV 381
           ++
Sbjct: 320 YL 321

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 133/302 (44%), Gaps = 53/302 (17%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +++    AIK          +++P E  T      RE+ I
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIK----------KISPFEHQTYCQRTLREIKI 74
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 75  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKTQHLSNDHICYFLYQ 132
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF---------------LGETLQDTY 336
           + APE  L      K+ D W+VG  L  M+  +  F               LG   Q+  
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 252
Query: 337 DKIVN----NSL-------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
           + I+N    N L             +FP+A +  L +LL+ +L  +P +R+ +     H 
Sbjct: 253 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKAL-DLLDKMLTFNPHKRIEVEQALAHP 311
Query: 380 WV 381
           ++
Sbjct: 312 YL 313

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R +G G +GKV L R   +G +   +   KS    L+       + D+++E+ I++ L 
Sbjct: 14  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS----LKPESGGNHIADLKKEIEILRNLY 69
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
           H NIV    +  +   +   +++E++  G            I      KY   I  G+ Y
Sbjct: 70  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 129
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVF-TAPECC 298
           L     VH D+   N+LV     VKIGDF +++  E D +   ++    +PVF  APEC 
Sbjct: 130 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 299 LGLTYGGKAADTWAVGVTLYYMI 321
           +   +   A+D W+ GVTL+ ++
Sbjct: 190 MQSKF-YIASDVWSFGVTLHELL 211

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R +G G +GKV L R   +G +   +   KS    L+       + D+++E+ I++ L 
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS----LKPESGGNHIADLKKEIEILRNLY 81
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
           H NIV    +  +   +   +++E++  G            I      KY   I  G+ Y
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 141
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVF-TAPECC 298
           L     VH D+   N+LV     VKIGDF +++  E D +   ++    +PVF  APEC 
Sbjct: 142 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 299 LGLTYGGKAADTWAVGVTLYYMI 321
           +   +   A+D W+ GVTL+ ++
Sbjct: 202 MQSKF-YIASDVWSFGVTLHELL 223

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/312 (22%), Positives = 137/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYREL 67
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI++L+ V     +       Y+V+E ++         Q     E M+   
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ--VIQMELDHERMSY-L 124
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRY 183
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  M+  +  F G    D ++K++           
Sbjct: 184 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD++ P           + R+LL  +L  DP +R
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302
Query: 370 LTLNDVAKHTWV 381
           ++++D  +H ++
Sbjct: 303 ISVDDALQHPYI 314

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/308 (25%), Positives = 134/308 (43%), Gaps = 49/308 (15%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y  ++ +G+G+YG V    S++DG+  A  A  K +    R   SE       RE+ ++K
Sbjct: 27  YRDLQPVGSGAYGAVC---SAVDGRTGAKVAIKKLY----RPFQSELFAKRAYRELRLLK 79
Query: 180 MLQHPNIVNLIEVI--DDPNSDH--FYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V   D+   D   FY+V+ ++    D     +   +GE   +  +  +
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT--DLGKLMKHEKLGEDRIQFLVYQM 137
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H   ++H D+KP NL V     +KI DF +++  + +   +     T  + AP
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MXGXVVTRWYRAP 194
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP-------- 347
           E  L      +  D W+VG  +  MI G+  F G    D   +I+  +   P        
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254
Query: 348 --DAMN-----PELR----------------NLLEGLLCKDPTRRLTLNDVAKHTWV--L 382
             +A N     PEL                 NLLE +L  D  +R+T  +   H +   L
Sbjct: 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314
Query: 383 GDNGPIPQ 390
            D    PQ
Sbjct: 315 HDTEDEPQ 322

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/312 (22%), Positives = 137/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 16  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYREL 68
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI++L+ V     +       Y+V+E ++         Q     E M+   
Sbjct: 69  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ--VIQMELDHERMSY-L 125
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 126 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRY 184
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  M+  +  F G    D ++K++           
Sbjct: 185 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 243
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD++ P           + R+LL  +L  DP +R
Sbjct: 244 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 303
Query: 370 LTLNDVAKHTWV 381
           ++++D  +H ++
Sbjct: 304 ISVDDALQHPYI 315

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/312 (22%), Positives = 136/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYREL 74
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK++ H NI+ L+ V     S       Y+V+E ++         Q     E M+   
Sbjct: 75  VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQ--VIQMELDHERMSY-L 131
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 132 LYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-AGTSFMMTPYVVTRY 190
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  MI G   F G    D ++K++           
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD + P           + R+LL  +L  D ++R
Sbjct: 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 370 LTLNDVAKHTWV 381
           +++++  +H ++
Sbjct: 310 ISVDEALQHPYI 321

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 124/289 (42%), Gaps = 38/289 (13%)
Query: 125 KIGAGSYGKVVLYRS-----SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           ++G G++GKV L          D    A+KA  ++         SE+A  D +RE  ++ 
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---------SESARQDFQREAELLT 75
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ----------------PGAI 223
           MLQH +IV    V  +       MV EY+    D + F +                PG +
Sbjct: 76  MLQHQHIVRFFGVCTEGRP--LLMVFEYMRHG-DLNRFLRSHGPDAKLLAGGEDVAPGPL 132
Query: 224 GESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDV 282
           G          + +G++YL G + VH D+   N LV     VKIGDF +S+ ++  D   
Sbjct: 133 GLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 192
Query: 283 LRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIV 340
           +      P+ +  PE  L   +  + +D W+ GV L+ +   G+ P+   +  +  D I 
Sbjct: 193 VGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 251
Query: 341 NN-SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI 388
               L  P A  PE+  ++ G   ++P +R ++ DV      L    P+
Sbjct: 252 QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 300

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/312 (22%), Positives = 137/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 16  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYREL 68
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI++L+ V     +       Y+V+E ++         Q     E M+   
Sbjct: 69  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ--VIQMELDHERMSY-L 125
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 126 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRY 184
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  M+  +  F G    D ++K++           
Sbjct: 185 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 243
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD++ P           + R+LL  +L  DP +R
Sbjct: 244 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 303
Query: 370 LTLNDVAKHTWV 381
           ++++D  +H ++
Sbjct: 304 ISVDDALQHPYI 315

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 105/233 (45%), Gaps = 14/233 (6%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R IGAG +G+V   R  L GK     A     +  L+V  +E    D   E  IM    H
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVA-----IKTLKVGYTEKQRRDFLCEASIMGQFDH 103
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           PN+V+L  V+         +V+E++E G  D       G          LR I +G+ YL
Sbjct: 104 PNVVHLEGVVT--RGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYL 161
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG--TPV-FTAPECCL 299
                VH D+   N+LV  +   K+ DF +S+V EDD + +  + G   PV +TAPE   
Sbjct: 162 ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQ 221
Query: 300 GLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
              +   A+D W+ G+ ++  M  G+ P+   + QD   K +      P  M+
Sbjct: 222 YRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-KAIEEGYRLPAPMD 272

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 107/229 (46%), Gaps = 20/229 (8%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +++    AIK          +++P E  T      RE+ I
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIK----------KISPFEHQTYCQRTLREIKI 94
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V + +E   D     +   +       +L  
Sbjct: 95  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--DLYKLLKTQHLSNDHICYFLYQ 152
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 153 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV 340
           + APE  L      K+ D W+VG  L  M+  +  F G+   D  + I+
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 261

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 124/289 (42%), Gaps = 38/289 (13%)
Query: 125 KIGAGSYGKVVLYRS-----SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           ++G G++GKV L          D    A+KA  ++         SE+A  D +RE  ++ 
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---------SESARQDFQREAELLT 69
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ----------------PGAI 223
           MLQH +IV    V  +       MV EY+    D + F +                PG +
Sbjct: 70  MLQHQHIVRFFGVCTEGRP--LLMVFEYMRHG-DLNRFLRSHGPDAKLLAGGEDVAPGPL 126
Query: 224 GESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDV 282
           G          + +G++YL G + VH D+   N LV     VKIGDF +S+ ++  D   
Sbjct: 127 GLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 186
Query: 283 LRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIV 340
           +      P+ +  PE  L   +  + +D W+ GV L+ +   G+ P+   +  +  D I 
Sbjct: 187 VGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 245
Query: 341 NN-SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI 388
               L  P A  PE+  ++ G   ++P +R ++ DV      L    P+
Sbjct: 246 QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 294

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 100/207 (48%), Gaps = 10/207 (4%)
Query: 172 RREVLIMKMLQHPNIVNLIEV--IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR 229
           RRE      L HP IV + +    + P     Y+V+EYV+G    D     G +    A 
Sbjct: 77  RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 136
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP-- 287
           + + D    L + H + ++H D+KP N++++ +  VK+ DF +++   D  + + ++   
Sbjct: 137 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 196
Query: 288 -GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF 346
            GT  + +PE   G +   + +D +++G  LY ++ G+ PF G++      + V    + 
Sbjct: 197 IGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 255
Query: 347 PDA----MNPELRNLLEGLLCKDPTRR 369
           P A    ++ +L  ++   L K+P  R
Sbjct: 256 PSARHEGLSADLDAVVLKALAKNPENR 282

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/312 (22%), Positives = 135/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYREL 74
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI+ L+ V     S       Y+V+E ++         Q     E M+   
Sbjct: 75  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQ--VIQMELDHERMSY-L 131
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-AGTSFMMTPYVVTRY 190
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  MI G   F G    D ++K++           
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD + P           + R+LL  +L  D ++R
Sbjct: 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 370 LTLNDVAKHTWV 381
           +++++  +H ++
Sbjct: 310 ISVDEALQHPYI 321

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 124/289 (42%), Gaps = 38/289 (13%)
Query: 125 KIGAGSYGKVVLYR-----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           ++G G++GKV L          D    A+KA  ++         SE+A  D +RE  ++ 
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---------SESARQDFQREAELLT 98
Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ----------------PGAI 223
           MLQH +IV    V  +       MV EY+    D + F +                PG +
Sbjct: 99  MLQHQHIVRFFGVCTEGRP--LLMVFEYMRHG-DLNRFLRSHGPDAKLLAGGEDVAPGPL 155
Query: 224 GESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDV 282
           G          + +G++YL G + VH D+   N LV     VKIGDF +S+ ++  D   
Sbjct: 156 GLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 215
Query: 283 LRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIV 340
           +      P+ +  PE  L   +  + +D W+ GV L+ +   G+ P+   +  +  D I 
Sbjct: 216 VGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274
Query: 341 NN-SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI 388
               L  P A  PE+  ++ G   ++P +R ++ DV      L    P+
Sbjct: 275 QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/316 (22%), Positives = 137/316 (43%), Gaps = 66/316 (20%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYREL 74
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI+ L+ V     S       Y+V+E ++         Q     E M+   
Sbjct: 75  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ--VIQMELDHERMSY-L 131
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV----FEDDNDVLRRSP 287
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     F  + +V+ R  
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTR-- 189
Query: 288 GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN----- 342
               + APE  LG+ Y  +  D W+VG  +  M+  +  F G    D ++K++       
Sbjct: 190 ---YYRAPEVILGMGY-KENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 343 --------------------------SLVFPDAMNP-----------ELRNLLEGLLCKD 365
                                       +FPD + P           + R+LL  +L  D
Sbjct: 246 PAFMKKLQPTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 366 PTRRLTLNDVAKHTWV 381
            ++R+++++  +H ++
Sbjct: 306 ASKRISVDEALQHPYI 321

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/316 (22%), Positives = 137/316 (43%), Gaps = 66/316 (20%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYREL 74
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI+ L+ V     S       Y+V+E ++         Q     E M+   
Sbjct: 75  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ--VIQMELDHERMSY-L 131
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV----FEDDNDVLRRSP 287
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     F  + +V+ R  
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTR-- 189
Query: 288 GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN----- 342
               + APE  LG+ Y  +  D W+VG  +  M+  +  F G    D ++K++       
Sbjct: 190 ---YYRAPEVILGMGY-KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 343 --------------------------SLVFPDAMNP-----------ELRNLLEGLLCKD 365
                                       +FPD + P           + R+LL  +L  D
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 366 PTRRLTLNDVAKHTWV 381
            ++R+++++  +H ++
Sbjct: 306 ASKRISVDEALQHPYI 321

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 126/284 (44%), Gaps = 46/284 (16%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +++  +  +G G++G+VV  R++LD ++YAIK          ++  +E  ++ +  EV++
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIK----------KIRHTEEKLSTILSEVML 55
Query: 178 MKMLQHPNIV----------NLIEVIDD-PNSDHFYMVLEYVEGKWDNDGFGQPGAIGES 226
           +  L H  +V          N ++ +         ++ +EY E     D         + 
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 227 MAR-KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV------------- 272
               +  R I+  L Y+H   ++H D+KP N+ +  S  VKIGDF +             
Sbjct: 116 DEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 273 -SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF-LGE 330
            SQ     +D L  + GT ++ A E   G  +  +  D +++G+  + MI   YPF  G 
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGM 232
Query: 331 TLQDTYDKIVNNSLVFP-----DAMNPELRNLLEGLLCKDPTRR 369
              +   K+ + S+ FP     + M  E + ++  L+  DP +R
Sbjct: 233 ERVNILKKLRSVSIEFPPDFDDNKMKVE-KKIIRLLIDHDPNKR 275

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 122/270 (45%), Gaps = 21/270 (7%)
Query: 100 KESNKLIRSEDENGT-KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSK 158
           K  N+    E  + T  ++  Y  ++ IG+G+ G V     ++ G + A+K         
Sbjct: 5   KVDNQFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS------ 58
Query: 159 LRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDN 214
            R   ++T      RE++++K + H NI++L+ V     +       Y+V+E ++    N
Sbjct: 59  -RPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA---N 114
Query: 215 DGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
                   +        L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++
Sbjct: 115 LCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQD 334
                N ++     T  + APE  LG+ Y     D W+VG  +  ++ G   F G    D
Sbjct: 175 T-ACTNFMMTPYVVTRYYRAPEVILGMGYAAN-VDIWSVGCIMGELVKGCVIFQGTDHID 232
Query: 335 TYDKIVNN----SLVFPDAMNPELRNLLEG 360
            ++K++      S  F  A+ P +RN +E 
Sbjct: 233 QWNKVIEQLGTPSAEFMAALQPTVRNYVEN 262

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/316 (23%), Positives = 136/316 (43%), Gaps = 66/316 (20%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYREL 74
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI+ L+ V     S       Y+V+E ++         Q     E M+   
Sbjct: 75  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ--VIQMELDHERMSY-L 131
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV----FEDDNDVLRRSP 287
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     F    +V+ R  
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTR-- 189
Query: 288 GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN----- 342
               + APE  LG+ Y  +  D W+VG  +  MI G   F G    D ++K++       
Sbjct: 190 ---YYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
Query: 343 --------------------------SLVFPDAMNP-----------ELRNLLEGLLCKD 365
                                       +FPD + P           + R+LL  +L  D
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVID 305
Query: 366 PTRRLTLNDVAKHTWV 381
            ++R+++++  +H ++
Sbjct: 306 ASKRISVDEALQHPYI 321

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/312 (22%), Positives = 135/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYREL 74
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI+ L+ V     S       Y+V+E ++         Q     E M+   
Sbjct: 75  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQ--VIQMELDHERMSY-L 131
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRY 190
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  MI G   F G    D ++K++           
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD + P           + R+LL  +L  D ++R
Sbjct: 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 370 LTLNDVAKHTWV 381
           +++++  +H ++
Sbjct: 310 ISVDEALQHPYI 321

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 123 VRKIGAGSYGKVVLY----RSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +R +G G +GKV LY     +   G+  A+KA  +    +LR        +  +RE+ I+
Sbjct: 13  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLR--------SGWQREIEIL 64
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           + L H +IV      +D       +V+EYV      D   +   +G +    + + I  G
Sbjct: 65  RTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPR-HCVGLAQLLLFAQQICEG 123
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPG-TPVF-TAP 295
           + YLH  + +H  +   N+L+     VKIGDF +++   + ++  R R  G +PVF  AP
Sbjct: 124 MAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 183
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMI 321
           EC     +   A+D W+ GVTLY ++
Sbjct: 184 ECLKECKF-YYASDVWSFGVTLYELL 208

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 123 VRKIGAGSYGKVVLY----RSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +R +G G +GKV LY     +   G+  A+KA  +    +LR        +  +RE+ I+
Sbjct: 14  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLR--------SGWQREIEIL 65
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           + L H +IV      +D       +V+EYV      D   +   +G +    + + I  G
Sbjct: 66  RTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPR-HCVGLAQLLLFAQQICEG 124
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPG-TPVF-TAP 295
           + YLH  + +H  +   N+L+     VKIGDF +++   + ++  R R  G +PVF  AP
Sbjct: 125 MAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 184
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMI 321
           EC     +   A+D W+ GVTLY ++
Sbjct: 185 ECLKECKF-YYASDVWSFGVTLYELL 209

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 76/315 (24%), Positives = 133/315 (42%), Gaps = 53/315 (16%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +++Y  + KIG G++G+V   R    G+  A+K   K  +   +     TA+    RE+ 
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITAL----REIK 69
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDH------FYMVLEYVEGKWDNDGFGQPGAIGESMA-- 228
           I+++L+H N+VNLIE+     S +       Y+V ++ E   D  G      +  +++  
Sbjct: 70  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH--DLAGLLSNVLVKFTLSEI 127
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE-DDNDVLRRSP 287
           ++ ++ +++GL Y+H + ++H D+K  N+L+   G +K+ DF +++ F    N    R  
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 288 GTPV---FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--- 341
              V   +  PE  LG    G   D W  G  +  M        G T Q     I     
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 247
Query: 342 --NSLVFPDAMNPELR---------------------------NLLEGLLCKDPTRRLTL 372
                V+P+  N EL                            +L++ LL  DP +R+  
Sbjct: 248 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 307
Query: 373 NDVAKHTWVLGDNGP 387
           +D   H +   D  P
Sbjct: 308 DDALNHDFFWSDPMP 322

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 117/252 (46%), Gaps = 20/252 (7%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y  ++ IG+G+ G V     ++ G + A+K          R   ++T      RE+
Sbjct: 20  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-------RPFQNQTHAKRAYREL 72
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           +++K + H NI++L+ V     +       Y+V+E ++         +   +        
Sbjct: 73  VLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHME---LDHERMSYL 129
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     N ++     T  
Sbjct: 130 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-ASTNFMMTPYVVTRY 188
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN----SLVFP 347
           + APE  LG+ Y  +  D W+VG  +  ++ G   F G    D ++K++      S  F 
Sbjct: 189 YRAPEVILGMGY-KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 247
Query: 348 DAMNPELRNLLE 359
            A+ P +RN +E
Sbjct: 248 AALQPTVRNYVE 259

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 16/237 (6%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I+ Y  + K+G G+YG+V     ++  +  AIK     H         E       REV 
Sbjct: 33  IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-------EEEGVPGTAIREVS 85
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           ++K LQH NI+ L  VI   ++   +++ EY E          P  +   + + +L  ++
Sbjct: 86  LLKELQHRNIIELKSVIH--HNHRLHLIFEYAENDLKKYMDKNPD-VSMRVIKSFLYQLI 142
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSG-----TVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           +G+ + H    +H D+KP NLL++ S       +KIGDF +++ F            T  
Sbjct: 143 NGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW 202
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD 348
           +  PE  LG  +   + D W++      M++    F G++  D   KI    L  PD
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIF-EVLGLPD 258

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 125/295 (42%), Gaps = 51/295 (17%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HP 184
           +G G++ +V    + +  + YA+K   K         P     + V REV ++   Q H 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQ--------PGHI-RSRVFREVEMLYQCQGHR 71
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           N++ LIE  +    D FY+V E + G        +     E  A   ++D+ S L +LH 
Sbjct: 72  NVLELIEFFE--EEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 245 HNVVHGDIKPDNLL------VAPSGTVKIGDFSVSQVFEDDNDV-------LRRSPGTPV 291
             + H D+KP+N+L      V+P   VKI DF +    + + D        L    G+  
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSP---VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 292 FTAPECCLGLTYGG----KAADTWAVGVTLYYMIIGQYPFLGETLQDT------------ 335
           + APE     +       K  D W++GV LY ++ G  PF+G    D             
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246
Query: 336 ---YDKIVNNSLVFPDA----MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              ++ I      FPD     ++   ++L+  LL +D  +RL+   V +H WV G
Sbjct: 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 20/229 (8%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y ++  IG G+YG V     +++    AIK          +++P E  T      RE+ I
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIK----------KISPFEHQTYCQRTLREIKI 94
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V   +    D     +   +       +L  
Sbjct: 95  LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGA--DLYKLLKTQHLSNDHICYFLYQ 152
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 153 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV 340
           + APE  L      K+ D W+VG  L  M+  +  F G+   D  + I+
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 261

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 125/295 (42%), Gaps = 51/295 (17%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HP 184
           +G G++ +V    + +  + YA+K   K         P     + V REV ++   Q H 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQ--------PGHI-RSRVFREVEMLYQCQGHR 71
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           N++ LIE  +    D FY+V E + G        +     E  A   ++D+ S L +LH 
Sbjct: 72  NVLELIEFFE--EEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 245 HNVVHGDIKPDNLL------VAPSGTVKIGDFSVSQVFEDDNDV-------LRRSPGTPV 291
             + H D+KP+N+L      V+P   VKI DF +    + + D        L    G+  
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSP---VKICDFGLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 292 FTAPECCLGLTYGG----KAADTWAVGVTLYYMIIGQYPFLGETLQDT------------ 335
           + APE     +       K  D W++GV LY ++ G  PF+G    D             
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246
Query: 336 ---YDKIVNNSLVFPDA----MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
              ++ I      FPD     ++   ++L+  LL +D  +RL+   V +H WV G
Sbjct: 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/312 (22%), Positives = 135/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYREL 75
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI+ L+ V     S       Y+V+E ++         Q     E M+   
Sbjct: 76  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ--VIQMELDHERMSY-L 132
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRY 191
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  MI G   F G    D ++K++           
Sbjct: 192 YRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD + P           + R+LL  +L  D ++R
Sbjct: 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 310
Query: 370 LTLNDVAKHTWV 381
           +++++  +H ++
Sbjct: 311 ISVDEALQHPYI 322

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 76/315 (24%), Positives = 133/315 (42%), Gaps = 53/315 (16%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +++Y  + KIG G++G+V   R    G+  A+K   K  +   +     TA+    RE+ 
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITAL----REIK 69
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDH------FYMVLEYVEGKWDNDGFGQPGAIGESMA-- 228
           I+++L+H N+VNLIE+     S +       Y+V ++ E   D  G      +  +++  
Sbjct: 70  ILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH--DLAGLLSNVLVKFTLSEI 127
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE-DDNDVLRRSP 287
           ++ ++ +++GL Y+H + ++H D+K  N+L+   G +K+ DF +++ F    N    R  
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 288 GTPV---FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--- 341
              V   +  PE  LG    G   D W  G  +  M        G T Q     I     
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 247
Query: 342 --NSLVFPDAMNPELR---------------------------NLLEGLLCKDPTRRLTL 372
                V+P+  N EL                            +L++ LL  DP +R+  
Sbjct: 248 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 307
Query: 373 NDVAKHTWVLGDNGP 387
           +D   H +   D  P
Sbjct: 308 DDALNHDFFWSDPMP 322

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/312 (22%), Positives = 135/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYREL 74
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI+ L+ V     S       Y+V+E ++         Q     E M+   
Sbjct: 75  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ--VIQMELDHERMSY-L 131
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRY 190
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  MI G   F G    D ++K++           
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD + P           + R+LL  +L  D ++R
Sbjct: 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 370 LTLNDVAKHTWV 381
           +++++  +H ++
Sbjct: 310 ISVDEALQHPYI 321

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 76/315 (24%), Positives = 133/315 (42%), Gaps = 53/315 (16%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +++Y  + KIG G++G+V   R    G+  A+K   K  +   +     TA+    RE+ 
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITAL----REIK 68
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDH------FYMVLEYVEGKWDNDGFGQPGAIGESMA-- 228
           I+++L+H N+VNLIE+     S +       Y+V ++ E   D  G      +  +++  
Sbjct: 69  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH--DLAGLLSNVLVKFTLSEI 126
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE-DDNDVLRRSP 287
           ++ ++ +++GL Y+H + ++H D+K  N+L+   G +K+ DF +++ F    N    R  
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 186
Query: 288 GTPV---FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--- 341
              V   +  PE  LG    G   D W  G  +  M        G T Q     I     
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246
Query: 342 --NSLVFPDAMNPELR---------------------------NLLEGLLCKDPTRRLTL 372
                V+P+  N EL                            +L++ LL  DP +R+  
Sbjct: 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 306
Query: 373 NDVAKHTWVLGDNGP 387
           +D   H +   D  P
Sbjct: 307 DDALNHDFFWSDPMP 321

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 76/315 (24%), Positives = 133/315 (42%), Gaps = 53/315 (16%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +++Y  + KIG G++G+V   R    G+  A+K   K  +   +     TA+    RE+ 
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITAL----REIK 69
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDH------FYMVLEYVEGKWDNDGFGQPGAIGESMA-- 228
           I+++L+H N+VNLIE+     S +       Y+V ++ E   D  G      +  +++  
Sbjct: 70  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH--DLAGLLSNVLVKFTLSEI 127
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE-DDNDVLRRSP 287
           ++ ++ +++GL Y+H + ++H D+K  N+L+   G +K+ DF +++ F    N    R  
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 288 GTPV---FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--- 341
              V   +  PE  LG    G   D W  G  +  M        G T Q     I     
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 247
Query: 342 --NSLVFPDAMNPELR---------------------------NLLEGLLCKDPTRRLTL 372
                V+P+  N EL                            +L++ LL  DP +R+  
Sbjct: 248 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 307
Query: 373 NDVAKHTWVLGDNGP 387
           +D   H +   D  P
Sbjct: 308 DDALNHDFFWSDPMP 322

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 71/312 (22%), Positives = 135/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 24  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYREL 76
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI+ L+ V     S       Y+V+E ++         Q     E M+   
Sbjct: 77  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ--VIQMELDHERMSY-L 133
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 134 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMVPFVVTRY 192
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  MI G   F G    D ++K++           
Sbjct: 193 YRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 251
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD + P           + R+LL  +L  D ++R
Sbjct: 252 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 311
Query: 370 LTLNDVAKHTWV 381
           +++++  +H ++
Sbjct: 312 ISVDEALQHPYI 323

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 71/312 (22%), Positives = 135/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYREL 74
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI+ L+ V     S       Y+V+E ++         Q     E M+   
Sbjct: 75  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ--VIQMELDHERMSY-L 131
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRY 190
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  MI G   F G    D ++K++           
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD + P           + R+LL  +L  D ++R
Sbjct: 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 370 LTLNDVAKHTWV 381
           +++++  +H ++
Sbjct: 310 ISVDEALQHPYI 321

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 123 VRKIGAGSYGKVVLY----RSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +R +G G +GKV LY     +   G+  A+KA        L+        +  ++E+ I+
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA--------LKADAGPQHRSGWKQEIDIL 87
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           + L H +I+      +D  +    +V+EYV      D   +  +IG +    + + I  G
Sbjct: 88  RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEG 146
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPG-TPVF-TAP 295
           + YLH  + +H D+   N+L+     VKIGDF +++   + ++  R R  G +PVF  AP
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAP 206
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMI 321
           EC     +   A+D W+ GVTLY ++
Sbjct: 207 ECLKEYKF-YYASDVWSFGVTLYELL 231

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 123/289 (42%), Gaps = 37/289 (12%)
Query: 124 RKIGAGSYGKVVL-----YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           R++G G++GKV L        + D    A+KA            P+  A  D +RE  ++
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD---------PTLAARKDFQREAELL 71
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-------------GQP----G 221
             LQH +IV    V  D   D   MV EY++   D + F             GQP    G
Sbjct: 72  TNLQHEHIVKFYGVCGD--GDPLIMVFEYMKHG-DLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 222 AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDN 280
            +G S        I SG++YL   + VH D+   N LV  +  VKIGDF +S+ V+  D 
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188
Query: 281 DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKI 339
             +      P+   P   +        +D W+ GV L+ +   G+ P+   +  +  + I
Sbjct: 189 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 248
Query: 340 VNNSLV-FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
               ++  P     E+ +++ G   ++P +RL + ++ K    LG   P
Sbjct: 249 TQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKATP 297

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 115/274 (41%), Gaps = 54/274 (19%)
Query: 160 RVAPSETAMTDVR------REVLIMKMLQHPNIVNLIEVI--------DDPNS----DHF 201
           RVA  +  +TD +      RE+ I++ L H NIV + E++        DD  S    +  
Sbjct: 38  RVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSV 97
Query: 202 YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP 261
           Y+V EY+E    N    + G + E  AR ++  ++ GL Y+H  NV+H D+KP NL +  
Sbjct: 98  YIVQEYMETDLAN--VLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT 155
Query: 262 SGTV-KIGDFSVSQVFE---DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTL 317
              V KIGDF ++++ +        L     T  + +P   L      KA D WA G   
Sbjct: 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF 215
Query: 318 YYMIIGQYPFLG----ETLQDTYDKI------------------VNNSLVFPD------- 348
             M+ G+  F G    E +Q   + I                  + N +  P        
Sbjct: 216 AEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLL 275
Query: 349 -AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
             ++ E  + LE +L   P  RLT  +   H ++
Sbjct: 276 PGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/312 (22%), Positives = 135/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 27  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYREL 79
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI+ L+ V     S       Y+V+E ++         Q     E M+   
Sbjct: 80  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ--VIQMELDHERMSY-L 136
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 137 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRY 195
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  M+  +  F G    D ++K++           
Sbjct: 196 YRAPEVILGMGY-KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFM 254
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD + P           + R+LL  +L  D ++R
Sbjct: 255 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 314
Query: 370 LTLNDVAKHTWV 381
           +++++  +H ++
Sbjct: 315 ISVDEALQHPYI 326

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 19/223 (8%)
Query: 108 SEDENGTKMINEYVH-VRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVA 162
           SED + T+    ++  ++++G G++G V + R        G+  A+K    S        
Sbjct: 2   SEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-------- 53
Query: 163 PSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPG 221
            +E  + D  RE+ I+K LQH NIV    V       +  +++EY+  G   +       
Sbjct: 54  -TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE 112
Query: 222 AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281
            I      +Y   I  G+ YL     +H D+   N+LV     VKIGDF +++V   D +
Sbjct: 113 RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 172
Query: 282 VLR-RSPG-TPVF-TAPECCLGLTYGGKAADTWAVGVTLYYMI 321
             + + PG +P+F  APE  L  +    A+D W+ GV LY + 
Sbjct: 173 XXKVKEPGESPIFWYAPE-SLTESKFSVASDVWSFGVVLYELF 214

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/312 (22%), Positives = 135/312 (43%), Gaps = 58/312 (18%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++  Y +++ IG+G+ G V     ++  ++ AIK          R   ++T      RE+
Sbjct: 16  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYREL 68
Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI+ L+ V     S       Y+V+E ++         Q     E M+   
Sbjct: 69  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ--VIQMELDHERMSY-L 125
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  
Sbjct: 126 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRY 184
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE  LG+ Y  +  D W+VG  +  M+  +  F G    D ++K++           
Sbjct: 185 YRAPEVILGMGY-KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFM 243
Query: 343 ----------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRR 369
                                   +FPD + P           + R+LL  +L  D ++R
Sbjct: 244 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 303
Query: 370 LTLNDVAKHTWV 381
           +++++  +H ++
Sbjct: 304 ISVDEALQHPYI 315

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/294 (22%), Positives = 119/294 (40%), Gaps = 39/294 (13%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           + +Y  + KIG G+YG V     + + + + I A  +  L        E   +   RE+ 
Sbjct: 1   MQKYEKLEKIGEGTYGTVF---KAKNRETHEIVALKRVRLDD----DDEGVPSSALREIC 53
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           ++K L+H NIV L +V+   +     +V E+ +           G +   + + +L  ++
Sbjct: 54  LLKELKHKNIVRLHDVLH--SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLL 111
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
            GL + H  NV+H D+KP NLL+  +G +K+ DF +++ F            T  +  P+
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPD 171
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYP-FLGETLQDTYDKIVN-----------NSL 344
              G      + D W+ G     +     P F G  + D   +I             +  
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231
Query: 345 VFPD------------------AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             PD                   +N   R+LL+ LL  +P +R++  +  +H +
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 102/233 (43%), Gaps = 14/233 (6%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           + +GAG +G+V   R  L  K     A     +  L+V  +E    D   E  IM    H
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVA-----IKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L  V+    S    +V EY+E G  D+                 LR I SG+ YL
Sbjct: 106 PNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV---FTAPECCL 299
                VH D+   N+L+  +   K+ DF +S+V EDD +    + G  +   +T+PE   
Sbjct: 164 SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 300 GLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
              +   A+D W+ G+ L+  M  G+ P+   + QD   K V+     P  M+
Sbjct: 224 YRKFTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-KAVDEGYRLPPPMD 274

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 128/282 (45%), Gaps = 54/282 (19%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV-LIMKMLQHP 184
           +G G+ G +V YR   D +  A+K          R+ P   +  D  REV L+ +  +HP
Sbjct: 32  LGHGAEGTIV-YRGMFDNRDVAVK----------RILPECFSFAD--REVQLLRESDEHP 78
Query: 185 NIVNLIEVIDDPNSDHFYMVL------EYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           N++       D    +  + L      EYVE K     F   G    ++    L+   SG
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELCAATLQEYVEQK----DFAHLGLEPITL----LQQTTSG 130
Query: 239 LMYLHGHNVVHGDIKPDNLLVA---PSGTVK--IGDFSVSQVFE-DDNDVLRRS--PGTP 290
           L +LH  N+VH D+KP N+L++     G +K  I DF + +      +   RRS  PGT 
Sbjct: 131 LAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 291 VFTAPE-----CCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSL 344
            + APE     C    TY     D ++ G   YY+I  G +PF G++LQ   + ++    
Sbjct: 191 GWIAPEMLSEDCKENPTY---TVDIFSAGCVFYYVISEGSHPF-GKSLQRQANILLGACS 246
Query: 345 VFPDAMNPE------LRNLLEGLLCKDPTRRLTLNDVAKHTW 380
           +  D ++PE       R L+E ++  DP +R +   V KH +
Sbjct: 247 L--DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 102/233 (43%), Gaps = 14/233 (6%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           + +GAG +G+V   R  L  K     A     +  L+V  +E    D   E  IM    H
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVA-----IKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L  V+    S    +V EY+E G  D+                 LR I SG+ YL
Sbjct: 106 PNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV---FTAPECCL 299
                VH D+   N+L+  +   K+ DF +S+V EDD +    + G  +   +T+PE   
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 300 GLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
              +   A+D W+ G+ L+  M  G+ P+   + QD   K V+     P  M+
Sbjct: 224 YRKFTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-KAVDEGYRLPPPMD 274

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 102/233 (43%), Gaps = 14/233 (6%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           + +GAG +G+V   R  L  K     A     +  L+V  +E    D   E  IM    H
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVA-----IKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L  V+    S    +V EY+E G  D+                 LR I SG+ YL
Sbjct: 106 PNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV---FTAPECCL 299
                VH D+   N+L+  +   K+ DF +S+V EDD +    + G  +   +T+PE   
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 300 GLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
              +   A+D W+ G+ L+  M  G+ P+   + QD   K V+     P  M+
Sbjct: 224 YRKFTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-KAVDEGYRLPPPMD 274

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 102/233 (43%), Gaps = 14/233 (6%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           + +GAG +G+V   R  L  K     A     +  L+V  +E    D   E  IM    H
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVA-----IKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L  V+    S    +V EY+E G  D+                 LR I SG+ YL
Sbjct: 106 PNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV---FTAPECCL 299
                VH D+   N+L+  +   K+ DF +S+V EDD +    + G  +   +T+PE   
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 300 GLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
              +   A+D W+ G+ L+  M  G+ P+   + QD   K V+     P  M+
Sbjct: 224 YRKFTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-KAVDEGYRLPPPMD 274

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 102/233 (43%), Gaps = 14/233 (6%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           + +GAG +G+V   R  L  K     A     +  L+V  +E    D   E  IM    H
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVA-----IKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L  V+    S    +V EY+E G  D+                 LR I SG+ YL
Sbjct: 106 PNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV---FTAPECCL 299
                VH D+   N+L+  +   K+ DF +S+V EDD +    + G  +   +T+PE   
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 300 GLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
              +   A+D W+ G+ L+  M  G+ P+   + QD   K V+     P  M+
Sbjct: 224 YRKFTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-KAVDEGYRLPPPMD 274

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 102/233 (43%), Gaps = 14/233 (6%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           + +GAG +G+V   R  L  K     A     +  L+V  +E    D   E  IM    H
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVA-----IKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L  V+    S    +V EY+E G  D+                 LR I SG+ YL
Sbjct: 104 PNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 161
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV---FTAPECCL 299
                VH D+   N+L+  +   K+ DF +S+V EDD +    + G  +   +T+PE   
Sbjct: 162 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 221
Query: 300 GLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
              +   A+D W+ G+ L+  M  G+ P+   + QD   K V+     P  M+
Sbjct: 222 YRKFTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-KAVDEGYRLPPPMD 272

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 5/203 (2%)
Query: 201 FYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA 260
            ++++EY+ G    D   + G   E      L++I+ GL YLH    +H DIK  N+L++
Sbjct: 96  LWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS 154
Query: 261 PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYM 320
             G VK+ DF V+    D         GTP + APE      Y  K AD W++G+T   +
Sbjct: 155 EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK-ADIWSLGITAIEL 213
Query: 321 IIGQYPFLG-ETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
             G+ P      ++  +    NN            +  ++  L KDP+ R T  ++ KH 
Sbjct: 214 AKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDPSFRPTAKELLKHK 273
Query: 380 WVLGDNGPIPQYLCWCKRDRLRR 402
           +++  N     YL     DR +R
Sbjct: 274 FIV-KNSKKTSYLTEL-IDRFKR 294

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 102/233 (43%), Gaps = 14/233 (6%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           + +GAG +G+V   R  L  K     A     +  L+V  +E    D   E  IM    H
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVA-----IKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L  V+    S    +V EY+E G  D+                 LR I SG+ YL
Sbjct: 77  PNIIRLEGVV--TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 134
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV---FTAPECCL 299
                VH D+   N+L+  +   K+ DF +S+V EDD +    + G  +   +T+PE   
Sbjct: 135 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 194
Query: 300 GLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
              +   A+D W+ G+ L+  M  G+ P+   + QD   K V+     P  M+
Sbjct: 195 YRKFTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-KAVDEGYRLPPPMD 245

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 102/233 (43%), Gaps = 14/233 (6%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           + +GAG +G+V   R  L  K     A     +  L+V  +E    D   E  IM    H
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVA-----IKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L  V+    S    +V EY+E G  D+                 LR I SG+ YL
Sbjct: 94  PNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 151
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV---FTAPECCL 299
                VH D+   N+L+  +   K+ DF +S+V EDD +    + G  +   +T+PE   
Sbjct: 152 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 211
Query: 300 GLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
              +   A+D W+ G+ L+  M  G+ P+   + QD   K V+     P  M+
Sbjct: 212 YRKFTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-KAVDEGYRLPPPMD 262

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 101/228 (44%), Gaps = 20/228 (8%)
Query: 121 VHVRKI-GAGSYGKVVLYRSSLDGKH---YAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +H+ KI G+G  G+V   R  + G+     AIKA    +  + R         D   E  
Sbjct: 51  IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--------RDFLSEAS 102
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDI 235
           IM    HPNI+ L  V+         +V EY+E G  D       G          LR +
Sbjct: 103 IMGQFDHPNIIRLEGVVT--RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV---F 292
            +G+ YL     VH D+   N+LV  +   K+ DF +S+V EDD D    + G  +   +
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRW 220
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKI 339
           TAPE     T+   A+D W+ GV ++ ++  G+ P+   T +D    +
Sbjct: 221 TAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 19/222 (8%)
Query: 109 EDENGTKMINEYVH-VRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAP 163
           ED + T+    ++  ++++G G++G V + R        G+  A+K    S         
Sbjct: 3   EDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--------- 53
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGA 222
           +E  + D  RE+ I+K LQH NIV    V       +  +++EY+  G   +        
Sbjct: 54  TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER 113
Query: 223 IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
           I      +Y   I  G+ YL     +H D+   N+LV     VKIGDF +++V   D + 
Sbjct: 114 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 173
Query: 283 LR-RSPG-TPVF-TAPECCLGLTYGGKAADTWAVGVTLYYMI 321
            + + PG +P+F  APE  L  +    A+D W+ GV LY + 
Sbjct: 174 XKVKEPGESPIFWYAPE-SLTESKFSVASDVWSFGVVLYELF 214

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 116/256 (45%), Gaps = 20/256 (7%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           V ++GAG +G+V +   +   K  A+K+  +  +S                E  +MK LQ
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSP----------DAFLAEANLMKQLQ 72
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLM 240
           H  +V L  V+     +  Y++ EY+E     D    P  I  ++ +       I  G+ 
Sbjct: 73  HQRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 129
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECCL 299
           ++   N +H D++  N+LV+ + + KI DF ++++ ED+    R     P+ +TAPE   
Sbjct: 130 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 189
Query: 300 GLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNL 357
             T+  K +D W+ G+ L  ++  G+ P+ G T  +    +     +V PD    EL  L
Sbjct: 190 YGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 248
Query: 358 LEGLLCKDPTRRLTLN 373
           +     + P  R T +
Sbjct: 249 MRLCWKERPEDRPTFD 264

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 116/256 (45%), Gaps = 20/256 (7%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           V ++GAG +G+V +   +   K  A+K+  +  +S                E  +MK LQ
Sbjct: 26  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSP----------DAFLAEANLMKQLQ 74
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLM 240
           H  +V L  V+     +  Y++ EY+E     D    P  I  ++ +       I  G+ 
Sbjct: 75  HQRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 131
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECCL 299
           ++   N +H D++  N+LV+ + + KI DF ++++ ED+    R     P+ +TAPE   
Sbjct: 132 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 191
Query: 300 GLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNL 357
             T+  K +D W+ G+ L  ++  G+ P+ G T  +    +     +V PD    EL  L
Sbjct: 192 YGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 250
Query: 358 LEGLLCKDPTRRLTLN 373
           +     + P  R T +
Sbjct: 251 MRLCWKERPEDRPTFD 266

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 120/267 (44%), Gaps = 36/267 (13%)
Query: 89  LNGLICRQFPVKESNKLIR---SEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKH 145
           LNG+  +  P+ + NK+I+   S+ + G +    Y + + IG GS+G VV     ++   
Sbjct: 10  LNGV--KLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFG-VVFQAKLVESDE 66
Query: 146 YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI----DDPNSDHF 201
            AIK   +    K              RE+ IM++++HPN+V+L        D  +    
Sbjct: 67  VAIKKVLQDKRFK-------------NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113
Query: 202 YMVLEYVEG---KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLL 258
            +VLEYV     +           +   + + Y+  ++  L Y+H   + H DIKP NLL
Sbjct: 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLL 173
Query: 259 V-APSGTVKIGDFSVSQVF----EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAV 313
           +  PSG +K+ DF  +++      + + +  R      + APE   G T      D W+ 
Sbjct: 174 LDPPSGVLKLIDFGSAKILIAGEPNVSXICSR-----YYRAPELIFGATNYTTNIDIWST 228
Query: 314 GVTLYYMIIGQYPFLGETLQDTYDKIV 340
           G  +  ++ GQ  F GE+  D   +I+
Sbjct: 229 GCVMAELMQGQPLFPGESGIDQLVEII 255

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 117/260 (45%), Gaps = 32/260 (12%)
Query: 125 KIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           K+G G +G+V  +  + +G    AIK             P   +     +E  +MK L+H
Sbjct: 25  KLGQGCFGEV--WMGTWNGTTRVAIKTLK----------PGTMSPEAFLQEAQVMKKLRH 72
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD----IVSGL 239
             +V L  V+ +   +  Y+V+EY+      D     G +G+ +    L D    I SG+
Sbjct: 73  EKLVQLYAVVSE---EPIYIVIEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGM 127
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            Y+   N VH D++  N+LV  +   K+ DF ++++ ED+    R+    P+ +TAPE  
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAA 187
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNL 357
           L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++      +     PE    
Sbjct: 188 LYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPES 243
Query: 358 LEGLLC----KDPTRRLTLN 373
           L  L+C    KDP  R T  
Sbjct: 244 LHDLMCQCWRKDPEERPTFE 263

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 116/256 (45%), Gaps = 20/256 (7%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           V ++GAG +G+V +   +   K  A+K+  +  +S                E  +MK LQ
Sbjct: 20  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSP----------DAFLAEANLMKQLQ 68
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLM 240
           H  +V L  V+     +  Y++ EY+E     D    P  I  ++ +       I  G+ 
Sbjct: 69  HQRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 125
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECCL 299
           ++   N +H D++  N+LV+ + + KI DF ++++ ED+    R     P+ +TAPE   
Sbjct: 126 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 185
Query: 300 GLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNL 357
             T+  K +D W+ G+ L  ++  G+ P+ G T  +    +     +V PD    EL  L
Sbjct: 186 YGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 244
Query: 358 LEGLLCKDPTRRLTLN 373
           +     + P  R T +
Sbjct: 245 MRLCWKERPEDRPTFD 260

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 114/258 (44%), Gaps = 35/258 (13%)
Query: 97  FPVKESNKLIRSEDENGTKMINEYVHVRK-IGAGSYGKVVLYRSSLDGKH---YAIKAFH 152
           F  ++ N+ +R   E   ++    + + K IG G +G+V   R  + GK     AIK   
Sbjct: 10  FTFEDPNQAVR---EFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLK 66
Query: 153 KSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GK 211
             +  K R         D   E  IM    HPNI++L  V+         ++ EY+E G 
Sbjct: 67  AGYTDKQR--------RDFLSEASIMGQFDHPNIIHLEGVVT--KCKPVMIITEYMENGS 116
Query: 212 WD-----NDG-FGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTV 265
            D     NDG F     +G       LR I SG+ YL   + VH D+   N+LV  +   
Sbjct: 117 LDAFLRKNDGRFTVIQLVG------MLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVC 170
Query: 266 KIGDFSVSQVFEDDNDVLRRSPGTPV---FTAPECCLGLTYGGKAADTWAVGVTLY-YMI 321
           K+ DF +S+V EDD +    + G  +   +TAPE      +   A+D W+ G+ ++  M 
Sbjct: 171 KVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTS-ASDVWSYGIVMWEVMS 229
Query: 322 IGQYPFLGETLQDTYDKI 339
            G+ P+   + QD    I
Sbjct: 230 YGERPYWDMSNQDVIKAI 247

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 116/256 (45%), Gaps = 20/256 (7%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           V ++GAG +G+V +   +   K  A+K+  +  +S                E  +MK LQ
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSP----------DAFLAEANLMKQLQ 66
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLM 240
           H  +V L  V+     +  Y++ EY+E     D    P  I  ++ +       I  G+ 
Sbjct: 67  HQRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECCL 299
           ++   N +H D++  N+LV+ + + KI DF ++++ ED+    R     P+ +TAPE   
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 183
Query: 300 GLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNL 357
             T+  K +D W+ G+ L  ++  G+ P+ G T  +    +     +V PD    EL  L
Sbjct: 184 YGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242
Query: 358 LEGLLCKDPTRRLTLN 373
           +     + P  R T +
Sbjct: 243 MRLCWKERPEDRPTFD 258

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 116/256 (45%), Gaps = 20/256 (7%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           V ++GAG +G+V +   +   K  A+K+  +  +S                E  +MK LQ
Sbjct: 19  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSP----------DAFLAEANLMKQLQ 67
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLM 240
           H  +V L  V+     +  Y++ EY+E     D    P  I  ++ +       I  G+ 
Sbjct: 68  HQRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 124
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECCL 299
           ++   N +H D++  N+LV+ + + KI DF ++++ ED+    R     P+ +TAPE   
Sbjct: 125 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 184
Query: 300 GLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNL 357
             T+  K +D W+ G+ L  ++  G+ P+ G T  +    +     +V PD    EL  L
Sbjct: 185 YGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 243
Query: 358 LEGLLCKDPTRRLTLN 373
           +     + P  R T +
Sbjct: 244 MRLCWKERPEDRPTFD 259

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 116/256 (45%), Gaps = 20/256 (7%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           V ++GAG +G+V +   +   K  A+K+  +  +S                E  +MK LQ
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSP----------DAFLAEANLMKQLQ 66
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLM 240
           H  +V L  V+     +  Y++ EY+E     D    P  I  ++ +       I  G+ 
Sbjct: 67  HQRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECCL 299
           ++   N +H D++  N+LV+ + + KI DF ++++ ED+    R     P+ +TAPE   
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 183
Query: 300 GLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNL 357
             T+  K +D W+ G+ L  ++  G+ P+ G T  +    +     +V PD    EL  L
Sbjct: 184 YGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242
Query: 358 LEGLLCKDPTRRLTLN 373
           +     + P  R T +
Sbjct: 243 MRLCWKERPEDRPTFD 258

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 123 VRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           ++++G G++G V + R        G+  A+K    S         +E  + D  RE+ I+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---------TEEHLRDFEREIEIL 65
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVS 237
           K LQH NIV    V       +  +++EY+  G   +        I      +Y   I  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPG-TPVF-TA 294
           G+ YL     +H D+   N+LV     VKIGDF +++V   D +  + + PG +P+F  A
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMI 321
           PE  L  +    A+D W+ GV LY + 
Sbjct: 186 PE-SLTESKFSVASDVWSFGVVLYELF 211

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 117/260 (45%), Gaps = 32/260 (12%)
Query: 125 KIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           K+G G +G+V  +  + +G    AIK             P   +     +E  +MK L+H
Sbjct: 25  KLGQGCFGEV--WMGTWNGTTRVAIKTLK----------PGTMSPEAFLQEAQVMKKLRH 72
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD----IVSGL 239
             +V L  V+ +   +  Y+V+EY+      D     G +G+ +    L D    I SG+
Sbjct: 73  EKLVQLYAVVSE---EPIYIVMEYMSKGCLLDFLK--GEMGKYLRLPQLVDMAAQIASGM 127
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            Y+   N VH D++  N+LV  +   K+ DF ++++ ED+    R+    P+ +TAPE  
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 187
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNL 357
           L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++      +     PE    
Sbjct: 188 LYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPES 243
Query: 358 LEGLLC----KDPTRRLTLN 373
           L  L+C    KDP  R T  
Sbjct: 244 LHDLMCQCWRKDPEERPTFE 263

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 116/256 (45%), Gaps = 20/256 (7%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           V ++GAG +G+V +   +   K  A+K+  +  +S                E  +MK LQ
Sbjct: 27  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSP----------DAFLAEANLMKQLQ 75
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLM 240
           H  +V L  V+     +  Y++ EY+E     D    P  I  ++ +       I  G+ 
Sbjct: 76  HQRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 132
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECCL 299
           ++   N +H D++  N+LV+ + + KI DF ++++ ED+    R     P+ +TAPE   
Sbjct: 133 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 192
Query: 300 GLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNL 357
             T+  K +D W+ G+ L  ++  G+ P+ G T  +    +     +V PD    EL  L
Sbjct: 193 YGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 251
Query: 358 LEGLLCKDPTRRLTLN 373
           +     + P  R T +
Sbjct: 252 MRLCWKERPEDRPTFD 267

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 101/228 (44%), Gaps = 20/228 (8%)
Query: 121 VHVRKI-GAGSYGKVVLYRSSLDGKH---YAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +H+ KI G+G  G+V   R  + G+     AIKA    +  + R         D   E  
Sbjct: 51  IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--------RDFLSEAS 102
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDI 235
           IM    HPNI+ L  V+         +V EY+E G  D       G          LR +
Sbjct: 103 IMGQFDHPNIIRLEGVVT--RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV---F 292
            +G+ YL     VH D+   N+LV  +   K+ DF +S+V EDD D    + G  +   +
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKI 339
           TAPE     T+   A+D W+ GV ++ ++  G+ P+   T +D    +
Sbjct: 221 TAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 102/233 (43%), Gaps = 14/233 (6%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           + +GAG +G+V   R  L  K     A     +  L+V  +E    D   E  IM    H
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVA-----IKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L  V+    S    +V EY+E G  D+                 LR I SG+ YL
Sbjct: 106 PNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV---FTAPECCL 299
                VH D+   N+L+  +   K+ DF +++V EDD +    + G  +   +T+PE   
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 300 GLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
              +   A+D W+ G+ L+  M  G+ P+   + QD   K V+     P  M+
Sbjct: 224 YRKFTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-KAVDEGYRLPPPMD 274

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 123 VRKIGAGSYGKVVLY----RSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +R +G G +GKV LY     +   G+  A+KA       K    P     +  ++E+ I+
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL------KADCGPQHR--SGWKQEIDIL 70
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           + L H +I+      +D       +V+EYV      D   +  +IG +    + + I  G
Sbjct: 71  RTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEG 129
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPG-TPVF-TAP 295
           + YLH  + +H ++   N+L+     VKIGDF +++   + ++  R R  G +PVF  AP
Sbjct: 130 MAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 189
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMI 321
           EC     +   A+D W+ GVTLY ++
Sbjct: 190 ECLKEYKF-YYASDVWSFGVTLYELL 214

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 109 EDENGTKMINEYVH-VRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAP 163
           ED + T+    ++  +R++G G++G V + R        G+  A+K    S         
Sbjct: 3   EDRDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--------- 53
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGA 222
           +E  + D  RE+ I+K LQH NIV    V       +  +++E++  G            
Sbjct: 54  TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER 113
Query: 223 IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
           I      +Y   I  G+ YL     +H D+   N+LV     VKIGDF +++V   D + 
Sbjct: 114 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 173
Query: 283 LR-RSPG-TPVF-TAPECCLGLTYGGKAADTWAVGVTLYYMI 321
            + + PG +P+F  APE  L  +    A+D W+ GV LY + 
Sbjct: 174 XKVKEPGESPIFWYAPE-SLTESKFSVASDVWSFGVVLYELF 214

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           ++G G +G V+ +     G+  AIK   +       ++P       +  E+ IMK L HP
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQE------LSPKNRERWCL--EIQIMKKLNHP 73
Query: 185 NIVNLIEVID-----DPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMARKYLRDI 235
           N+V+  EV D      PN D   + +EY EG    K+ N  F     + E   R  L DI
Sbjct: 74  NVVSAREVPDGLQKLAPN-DLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDI 131
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTV---KIGDFSVSQVFEDDNDVLRRSPGTPVF 292
            S L YLH + ++H D+KP+N+++ P       KI D   ++   D  ++     GT  +
Sbjct: 132 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTEFVGTLQY 190
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL 328
            APE      Y     D W+ G   +  I G  PFL
Sbjct: 191 LAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFL 225

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 26/226 (11%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR---E 174
           +EY  +  IG G+YG V   R  L G+  AIK          ++  +   +T+ +R   E
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIK----------KIPNAFDVVTNAKRTLRE 103
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDH-----FYMVLEYVEGKWDND-GFGQPGAIGESMA 228
           + I+K  +H NI+ + +++  P   +      Y+VL+ +E          QP  +     
Sbjct: 104 LKILKHFKHDNIIAIKDILR-PTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTL--EHV 160
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF----EDDNDVLR 284
           R +L  ++ GL Y+H   V+H D+KP NLLV  +  +KIGDF +++       +    + 
Sbjct: 161 RYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMT 220
Query: 285 RSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE 330
               T  + APE  L L    +A D W+VG     M+  +  F G+
Sbjct: 221 EYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 19/222 (8%)
Query: 109 EDENGTKMINEYVH-VRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAP 163
           ED + T+    ++  ++++G G++G V + R        G+  A+K    S         
Sbjct: 5   EDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--------- 55
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGA 222
           +E  + D  RE+ I+K LQH NIV    V       +  +++EY+  G   +        
Sbjct: 56  TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 115
Query: 223 IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
           I      +Y   I  G+ YL     +H D+   N+LV     VKIGDF +++V   D + 
Sbjct: 116 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 175
Query: 283 LR-RSPG-TPVF-TAPECCLGLTYGGKAADTWAVGVTLYYMI 321
            + + PG +P+F  APE  L  +    A+D W+ GV LY + 
Sbjct: 176 XKVKEPGESPIFWYAPE-SLTESKFSVASDVWSFGVVLYELF 216

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           ++G G +G V+ +     G+  AIK   +       ++P       +  E+ IMK L HP
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQE------LSPKNRERWCL--EIQIMKKLNHP 72
Query: 185 NIVNLIEVID-----DPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMARKYLRDI 235
           N+V+  EV D      PN D   + +EY EG    K+ N  F     + E   R  L DI
Sbjct: 73  NVVSAREVPDGLQKLAPN-DLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDI 130
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTV---KIGDFSVSQVFEDDNDVLRRSPGTPVF 292
            S L YLH + ++H D+KP+N+++ P       KI D   ++   D  ++     GT  +
Sbjct: 131 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTEFVGTLQY 189
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL 328
            APE      Y     D W+ G   +  I G  PFL
Sbjct: 190 LAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFL 224

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 19/222 (8%)
Query: 109 EDENGTKMINEYVH-VRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAP 163
           ED + T+    ++  ++++G G++G V + R        G+  A+K    S         
Sbjct: 4   EDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--------- 54
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGA 222
           +E  + D  RE+ I+K LQH NIV    V       +  +++EY+  G   +        
Sbjct: 55  TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 114
Query: 223 IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
           I      +Y   I  G+ YL     +H D+   N+LV     VKIGDF +++V   D + 
Sbjct: 115 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 174
Query: 283 LR-RSPG-TPVF-TAPECCLGLTYGGKAADTWAVGVTLYYMI 321
            + + PG +P+F  APE  L  +    A+D W+ GV LY + 
Sbjct: 175 XKVKEPGESPIFWYAPE-SLTESKFSVASDVWSFGVVLYELF 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 19/222 (8%)
Query: 109 EDENGTKMINEYVH-VRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAP 163
           ED + T+    ++  ++++G G++G V + R        G+  A+K    S         
Sbjct: 7   EDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--------- 57
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGA 222
           +E  + D  RE+ I+K LQH NIV    V       +  +++EY+  G   +        
Sbjct: 58  TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 117
Query: 223 IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
           I      +Y   I  G+ YL     +H D+   N+LV     VKIGDF +++V   D + 
Sbjct: 118 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 177
Query: 283 LR-RSPG-TPVF-TAPECCLGLTYGGKAADTWAVGVTLYYMI 321
            + + PG +P+F  APE  L  +    A+D W+ GV LY + 
Sbjct: 178 XKVKEPGESPIFWYAPE-SLTESKFSVASDVWSFGVVLYELF 218

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 19/222 (8%)
Query: 109 EDENGTKMINEYVH-VRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAP 163
           ED + T+    ++  ++++G G++G V + R        G+  A+K    S         
Sbjct: 6   EDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--------- 56
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGA 222
           +E  + D  RE+ I+K LQH NIV    V       +  +++EY+  G   +        
Sbjct: 57  TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 116
Query: 223 IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
           I      +Y   I  G+ YL     +H D+   N+LV     VKIGDF +++V   D + 
Sbjct: 117 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 176
Query: 283 LR-RSPG-TPVF-TAPECCLGLTYGGKAADTWAVGVTLYYMI 321
            + + PG +P+F  APE  L  +    A+D W+ GV LY + 
Sbjct: 177 XKVKEPGESPIFWYAPE-SLTESKFSVASDVWSFGVVLYELF 217

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 116/256 (45%), Gaps = 20/256 (7%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           V ++GAG +G+V +   +   K  A+K+  +  +S                E  +MK LQ
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSP----------DAFLAEANLMKQLQ 72
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLM 240
           H  +V L  V+     +  Y++ EY+E     D    P  I  ++ +       I  G+ 
Sbjct: 73  HQRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 129
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECCL 299
           ++   N +H D++  N+LV+ + + KI DF ++++ ED+    R     P+ +TAPE   
Sbjct: 130 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 189
Query: 300 GLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNL 357
             T+  K +D W+ G+ L  ++  G+ P+ G T  +    +     +V PD    EL  L
Sbjct: 190 YGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 248
Query: 358 LEGLLCKDPTRRLTLN 373
           +     + P  R T +
Sbjct: 249 MRLCWKERPEDRPTFD 264

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 123 VRKIGAGSYGKVVLY----RSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +R +G G +GKV LY     +   G+  A+KA       K    P     +  ++E+ I+
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL------KADCGPQHR--SGWKQEIDIL 70
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           + L H +I+      +D       +V+EYV      D   +  +IG +    + + I  G
Sbjct: 71  RTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEG 129
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPG-TPVF-TAP 295
           + YLH  + +H ++   N+L+     VKIGDF +++   + ++  R R  G +PVF  AP
Sbjct: 130 MAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 189
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMI 321
           EC     +   A+D W+ GVTLY ++
Sbjct: 190 ECLKEYKF-YYASDVWSFGVTLYELL 214

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 19/222 (8%)
Query: 109 EDENGTKMINEYVH-VRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAP 163
           ED + T+    ++  ++++G G++G V + R        G+  A+K    S         
Sbjct: 31  EDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--------- 81
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGA 222
           +E  + D  RE+ I+K LQH NIV    V       +  +++EY+  G   +        
Sbjct: 82  TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 141
Query: 223 IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
           I      +Y   I  G+ YL     +H D+   N+LV     VKIGDF +++V   D + 
Sbjct: 142 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 201
Query: 283 LR-RSPG-TPVF-TAPECCLGLTYGGKAADTWAVGVTLYYMI 321
            + + PG +P+F  APE  L  +    A+D W+ GV LY + 
Sbjct: 202 XKVKEPGESPIFWYAPE-SLTESKFSVASDVWSFGVVLYELF 242

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 116/256 (45%), Gaps = 20/256 (7%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           V ++GAG +G+V +   +   K  A+K+  +  +S                E  +MK LQ
Sbjct: 23  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSP----------DAFLAEANLMKQLQ 71
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLM 240
           H  +V L  V+     +  Y++ EY+E     D    P  I  ++ +       I  G+ 
Sbjct: 72  HQRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 128
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECCL 299
           ++   N +H D++  N+LV+ + + KI DF ++++ ED+    R     P+ +TAPE   
Sbjct: 129 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 188
Query: 300 GLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNL 357
             T+  K +D W+ G+ L  ++  G+ P+ G T  +    +     +V PD    EL  L
Sbjct: 189 YGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 247
Query: 358 LEGLLCKDPTRRLTLN 373
           +     + P  R T +
Sbjct: 248 MRLCWKERPEDRPTFD 263

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 116/256 (45%), Gaps = 20/256 (7%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           V ++GAG +G+V +   +   K  A+K+  +  +S                E  +MK LQ
Sbjct: 28  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSP----------DAFLAEANLMKQLQ 76
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLM 240
           H  +V L  V+     +  Y++ EY+E     D    P  I  ++ +       I  G+ 
Sbjct: 77  HQRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 133
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECCL 299
           ++   N +H D++  N+LV+ + + KI DF ++++ ED+    R     P+ +TAPE   
Sbjct: 134 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 193
Query: 300 GLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNL 357
             T+  K +D W+ G+ L  ++  G+ P+ G T  +    +     +V PD    EL  L
Sbjct: 194 YGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 252
Query: 358 LEGLLCKDPTRRLTLN 373
           +     + P  R T +
Sbjct: 253 MRLCWKERPEDRPTFD 268

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 117/260 (45%), Gaps = 32/260 (12%)
Query: 125 KIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           K+G G +G+V  +  + +G    AIK             P   +     +E  +MK L+H
Sbjct: 25  KLGQGCFGEV--WMGTWNGTTRVAIKTLK----------PGTMSPEAFLQEAQVMKKLRH 72
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD----IVSGL 239
             +V L  V+ +   +  Y+V+EY+      D     G +G+ +    L D    I SG+
Sbjct: 73  EKLVQLYAVVSE---EPIYIVIEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGM 127
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            Y+   N VH D++  N+LV  +   K+ DF ++++ ED+    R+    P+ +TAPE  
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 187
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNL 357
           L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++      +     PE    
Sbjct: 188 LYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPES 243
Query: 358 LEGLLC----KDPTRRLTLN 373
           L  L+C    KDP  R T  
Sbjct: 244 LHDLMCQCWRKDPEERPTFE 263

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 123 VRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           ++++G G++G V + R        G+  A+K    S         +E  + D  RE+ I+
Sbjct: 14  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---------TEEHLRDFEREIEIL 64
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVS 237
           K LQH NIV    V       +  +++EY+  G   +        I      +Y   I  
Sbjct: 65  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 124
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPG-TPVF-TA 294
           G+ YL     +H D+   N+LV     VKIGDF +++V   D +  + + PG +P+F  A
Sbjct: 125 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 184
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMI 321
           PE  L  +    A+D W+ GV LY + 
Sbjct: 185 PE-SLTESKFSVASDVWSFGVVLYELF 210

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 101/228 (44%), Gaps = 31/228 (13%)
Query: 126 IGAGSYGKVVLYRSSLDGKH---YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           IG G +G+V   R  + GK     AIK     +  K R         D   E  IM    
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR--------RDFLSEASIMGQFD 73
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWD-----NDG-FGQPGAIGESMARKYLRDI 235
           HPNI++L  V+         ++ EY+E G  D     NDG F     +G       LR I
Sbjct: 74  HPNIIHLEGVVT--KCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVG------MLRGI 125
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV---F 292
            SG+ YL   + VH D+   N+LV  +   K+ DF +S+V EDD +    + G  +   +
Sbjct: 126 GSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW 185
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKI 339
           TAPE  +       A+D W+ G+ ++  M  G+ P+   + QD    I
Sbjct: 186 TAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 232

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 116/256 (45%), Gaps = 20/256 (7%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           V ++GAG +G+V +   +   K  A+K+  +  +S                E  +MK LQ
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSP----------DAFLAEANLMKQLQ 66
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLM 240
           H  +V L  V+     +  Y++ EY+E     D    P  I  ++ +       I  G+ 
Sbjct: 67  HQRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECCL 299
           ++   N +H D++  N+LV+ + + KI DF ++++ ED+    R     P+ +TAPE   
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 300 GLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNL 357
             T+  K +D W+ G+ L  ++  G+ P+ G T  +    +     +V PD    EL  L
Sbjct: 184 YGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242
Query: 358 LEGLLCKDPTRRLTLN 373
           +     + P  R T +
Sbjct: 243 MRLCWKERPEDRPTFD 258

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 123 VRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           ++++G G++G V + R        G+  A+K    S         +E  + D  RE+ I+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---------TEEHLRDFEREIEIL 65
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVS 237
           K LQH NIV    V       +  +++EY+  G   +        I      +Y   I  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPG-TPVF-TA 294
           G+ YL     +H D+   N+LV     VKIGDF +++V   D +  + + PG +P+F  A
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMI 321
           PE  L  +    A+D W+ GV LY + 
Sbjct: 186 PE-SLTESKFSVASDVWSFGVVLYELF 211

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 121/275 (44%), Gaps = 28/275 (10%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +++  + ++GAG+ G V        G   A K  H      L + P+      + RE+ +
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPA--IRNQIIRELQV 76
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +     P IV         +     + +E+++G   +    + G I E +  K    ++ 
Sbjct: 77  LHECNSPYIVGFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 134
Query: 238 GLMYL-HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           GL YL   H ++H D+KP N+LV   G +K+ DF VS    D   +     GT  + +PE
Sbjct: 135 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPE 192
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET----LQDTYDKIVNN------SLVF 346
              G  Y  + +D W++G++L  M +G+YP    +    + +  D IVN       S VF
Sbjct: 193 RLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVF 251
Query: 347 PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
               + E ++ +   L K+P  R  L  +  H ++
Sbjct: 252 ----SLEFQDFVNKCLIKNPAERADLKQLMVHAFI 282

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 101/233 (43%), Gaps = 14/233 (6%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           + +GAG +G+V   R  L  K     A     +  L+V  +E    D   E  IM    H
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVA-----IKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L  V+    S    +V EY+E G  D+                 LR I SG+ YL
Sbjct: 106 PNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV---FTAPECCL 299
                VH D+   N+L+  +   K+ DF + +V EDD +    + G  +   +T+PE   
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 300 GLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
              +   A+D W+ G+ L+  M  G+ P+   + QD   K V+     P  M+
Sbjct: 224 YRKFTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-KAVDEGYRLPPPMD 274

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 26/226 (11%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR---E 174
           +EY  +  IG G+YG V   R  L G+  AIK          ++  +   +T+ +R   E
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIK----------KIPNAFDVVTNAKRTLRE 104
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDH-----FYMVLEYVEGKWDND-GFGQPGAIGESMA 228
           + I+K  +H NI+ + +++  P   +      Y+VL+ +E          QP  +     
Sbjct: 105 LKILKHFKHDNIIAIKDILR-PTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTL--EHV 161
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF----EDDNDVLR 284
           R +L  ++ GL Y+H   V+H D+KP NLLV  +  +KIGDF +++       +    + 
Sbjct: 162 RYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMT 221
Query: 285 RSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE 330
               T  + APE  L L    +A D W+VG     M+  +  F G+
Sbjct: 222 EYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 267

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 123 VRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           ++++G G++G V + R        G+  A+K    S         +E  + D  RE+ I+
Sbjct: 13  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---------TEEHLRDFEREIEIL 63
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVS 237
           K LQH NIV    V       +  +++EY+  G   +        I      +Y   I  
Sbjct: 64  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 123
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPG-TPVF-TA 294
           G+ YL     +H D+   N+LV     VKIGDF +++V   D +  + + PG +P+F  A
Sbjct: 124 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 183
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMI 321
           PE  L  +    A+D W+ GV LY + 
Sbjct: 184 PE-SLTESKFSVASDVWSFGVVLYELF 209

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 101/228 (44%), Gaps = 31/228 (13%)
Query: 126 IGAGSYGKVVLYRSSLDGKH---YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           IG G +G+V   R  + GK     AIK     +  K R         D   E  IM    
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR--------RDFLSEASIMGQFD 67
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWD-----NDG-FGQPGAIGESMARKYLRDI 235
           HPNI++L  V+         ++ EY+E G  D     NDG F     +G       LR I
Sbjct: 68  HPNIIHLEGVVT--KCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVG------MLRGI 119
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV---F 292
            SG+ YL   + VH D+   N+LV  +   K+ DF +S+V EDD +    + G  +   +
Sbjct: 120 GSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW 179
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKI 339
           TAPE  +       A+D W+ G+ ++  M  G+ P+   + QD    I
Sbjct: 180 TAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 226

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 116/256 (45%), Gaps = 20/256 (7%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           V ++GAG +G+V +   +   K  A+K+  +  +S                E  +MK LQ
Sbjct: 13  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSP----------DAFLAEANLMKQLQ 61
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLM 240
           H  +V L  V+     +  Y++ EY+E     D    P  I  ++ +       I  G+ 
Sbjct: 62  HQRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 118
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECCL 299
           ++   N +H D++  N+LV+ + + KI DF ++++ ED+    R     P+ +TAPE   
Sbjct: 119 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 178
Query: 300 GLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNL 357
             T+  K +D W+ G+ L  ++  G+ P+ G T  +    +     +V PD    EL  L
Sbjct: 179 YGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 237
Query: 358 LEGLLCKDPTRRLTLN 373
           +     + P  R T +
Sbjct: 238 MRLCWKERPEDRPTFD 253

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 131/302 (43%), Gaps = 53/302 (17%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE--TAMTDVRREVLI 177
           Y  ++ IG G+YG V      +     AIK          +++P E  T      RE+ I
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIK----------KISPFEHQTYCQRTLREIQI 94
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H N++ + +++     +     Y+V + +E   D     +   +       +L  
Sbjct: 95  LLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMET--DLYKLLKSQQLSNDHICYFLYQ 152
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF ++++ + ++D    L     T  
Sbjct: 153 ILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRW 212
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF---------------LGETLQDTY 336
           + APE  L      K+ D W+VG  L  M+  +  F               LG   Q+  
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 272
Query: 337 DKIVN-------NSL----------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
           + I+N        SL          +FP + +  L +LL+ +L  +P +R+T+ +   H 
Sbjct: 273 NCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKAL-DLLDRMLTFNPNKRITVEEALAHP 331
Query: 380 WV 381
           ++
Sbjct: 332 YL 333

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 123 VRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           ++++G G++G V + R        G+  A+K    S         +E  + D  RE+ I+
Sbjct: 33  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---------TEEHLRDFEREIEIL 83
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVS 237
           K LQH NIV    V       +  +++EY+  G   +        I      +Y   I  
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPG-TPVF-TA 294
           G+ YL     +H D+   N+LV     VKIGDF +++V   D +  + + PG +P+F  A
Sbjct: 144 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 203
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMI 321
           PE  L  +    A+D W+ GV LY + 
Sbjct: 204 PE-SLTESKFSVASDVWSFGVVLYELF 229

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 123 VRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           ++++G G++G V + R        G+  A+K    S         +E  + D  RE+ I+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---------TEEHLRDFEREIEIL 65
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVS 237
           K LQH NIV    V       +  +++EY+  G   +        I      +Y   I  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPG-TPVF-TA 294
           G+ YL     +H D+   N+LV     VKIGDF +++V   D +  + + PG +P+F  A
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMI 321
           PE  L  +    A+D W+ GV LY + 
Sbjct: 186 PE-SLTESKFSVASDVWSFGVVLYELF 211

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 10/211 (4%)
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAI 223
           S++      +E L M+   HP+IV LI VI +   +  ++++E      +   F Q    
Sbjct: 51  SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLG-ELRSFLQVRKF 106
Query: 224 GESMARK--YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281
              +A    Y   + + L YL     VH DI   N+LV+ +  VK+GDF +S+  ED   
Sbjct: 107 SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTX 166
Query: 282 VLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKI 339
                   P+ + APE  +       A+D W  GV ++ +++ G  PF G    D   +I
Sbjct: 167 XKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225
Query: 340 VNNS-LVFPDAMNPELRNLLEGLLCKDPTRR 369
            N   L  P    P L +L+      DP+RR
Sbjct: 226 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 256

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 123 VRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           ++++G G++G V + R        G+  A+K    S         +E  + D  RE+ I+
Sbjct: 33  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---------TEEHLRDFEREIEIL 83
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVS 237
           K LQH NIV    V       +  +++EY+  G   +        I      +Y   I  
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPG-TPVF-TA 294
           G+ YL     +H D+   N+LV     VKIGDF +++V   D +  + + PG +P+F  A
Sbjct: 144 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 203
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMI 321
           PE  L  +    A+D W+ GV LY + 
Sbjct: 204 PE-SLTESKFSVASDVWSFGVVLYELF 229

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 116/260 (44%), Gaps = 32/260 (12%)
Query: 125 KIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           K+G G +G+V  +  + +G    AIK             P   +     +E  +MK L+H
Sbjct: 25  KLGQGCFGEV--WMGTWNGTTRVAIKTLK----------PGTMSPEAFLQEAQVMKKLRH 72
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD----IVSGL 239
             +V L  V+ +   +  Y+V EY+      D     G +G+ +    L D    I SG+
Sbjct: 73  EKLVQLYAVVSE---EPIYIVTEYMSKGCLLDFLK--GEMGKYLRLPQLVDMAAQIASGM 127
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            Y+   N VH D++  N+LV  +   K+ DF ++++ ED+    R+    P+ +TAPE  
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 187
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNL 357
           L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++      +     PE    
Sbjct: 188 LYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPES 243
Query: 358 LEGLLC----KDPTRRLTLN 373
           L  L+C    KDP  R T  
Sbjct: 244 LHDLMCQCWRKDPEERPTFE 263

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 91/385 (23%), Positives = 149/385 (38%), Gaps = 98/385 (25%)
Query: 97  FPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKV--VLYRSSLDGKHYAIKAFHKS 154
           F VK S++  R ED      + EY    K+G G+YG V     +   D K YA+K    +
Sbjct: 7   FKVKLSSERERVED------LFEYEGC-KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT 59
Query: 155 HLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK-WD 213
            +S               RE+ +++ L+HPN+++L +V         +++ +Y E   W 
Sbjct: 60  GIS-----------MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWH 108
Query: 214 NDGF-------GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV----APS 262
              F        +P  +   M +  L  I+ G+ YLH + V+H D+KP N+LV       
Sbjct: 109 IIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 168
Query: 263 GTVKIGDFSVSQVFEDDNDVLRRSPGTPV-----------FTAPECCLGLTYGGKAADTW 311
           G VKI D   +++F         SP  P+           + APE  LG  +  KA D W
Sbjct: 169 GRVKIADMGFARLFN--------SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 220
Query: 312 AVGVTLYYMIIGQYPF---------LGETLQDTYDKIVN------------------NSL 344
           A+G     ++  +  F               D  D+I N                  +S 
Sbjct: 221 AIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHST 280
Query: 345 VFPD------------------AMNPELR--NLLEGLLCKDPTRRLTLNDVAKHTWVLGD 384
           +  D                   + P+ +  +LL+ LL  DP +R+T     +  + L D
Sbjct: 281 LMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED 340
Query: 385 NGPIPQYLCWCKRDRLRRDNTTQDS 409
             P       C+    +R+  T++ 
Sbjct: 341 PLPTSDVFAGCQIPYPKREFLTEEE 365

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/294 (21%), Positives = 119/294 (40%), Gaps = 39/294 (13%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           + +Y  + KIG G+YG V     + + + + I A  +  L        E   +   RE+ 
Sbjct: 1   MQKYEKLEKIGEGTYGTVF---KAKNRETHEIVALKRVRLDD----DDEGVPSSALREIC 53
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           ++K L+H NIV L +V+   +     +V E+ +           G +   + + +L  ++
Sbjct: 54  LLKELKHKNIVRLHDVLH--SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLL 111
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
            GL + H  NV+H D+KP NLL+  +G +K+ +F +++ F            T  +  P+
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYP-FLGETLQDTYDKIVN-----------NSL 344
              G      + D W+ G     +     P F G  + D   +I             +  
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231
Query: 345 VFPD------------------AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
             PD                   +N   R+LL+ LL  +P +R++  +  +H +
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 101/233 (43%), Gaps = 14/233 (6%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           + +GAG +G+V   R  L  K     A     +  L+V  +E    D   E  IM    H
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVA-----IKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L  V+    S    +V E +E G  D+                 LR I SG+ YL
Sbjct: 106 PNIIRLEGVVT--KSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV---FTAPECCL 299
                VH D+   N+L+  +   K+ DF +S+V EDD +    + G  +   +T+PE   
Sbjct: 164 SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 300 GLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
              +   A+D W+ G+ L+  M  G+ P+   + QD   K V+     P  M+
Sbjct: 224 YRKFTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-KAVDEGYRLPPPMD 274

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 10/211 (4%)
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAI 223
           S++      +E L M+   HP+IV LI VI +   +  ++++E      +   F Q    
Sbjct: 51  SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLG-ELRSFLQVRKF 106
Query: 224 GESMARK--YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281
              +A    Y   + + L YL     VH DI   N+LV+ +  VK+GDF +S+  ED   
Sbjct: 107 SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTY 166
Query: 282 VLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKI 339
                   P+ + APE  +       A+D W  GV ++ +++ G  PF G    D   +I
Sbjct: 167 YKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225
Query: 340 VNNS-LVFPDAMNPELRNLLEGLLCKDPTRR 369
            N   L  P    P L +L+      DP+RR
Sbjct: 226 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 256

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 116/260 (44%), Gaps = 32/260 (12%)
Query: 125 KIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           K+G G +G+V  +  + +G    AIK             P   +     +E  +MK L+H
Sbjct: 25  KLGQGCFGEV--WMGTWNGTTRVAIKTLK----------PGTMSPEAFLQEAQVMKKLRH 72
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD----IVSGL 239
             +V L  V+ +   +  Y+V EY+      D     G +G+ +    L D    I SG+
Sbjct: 73  EKLVQLYAVVSE---EPIYIVCEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGM 127
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            Y+   N VH D++  N+LV  +   K+ DF ++++ ED+    R+    P+ +TAPE  
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 187
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNL 357
           L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++      +     PE    
Sbjct: 188 LYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPES 243
Query: 358 LEGLLC----KDPTRRLTLN 373
           L  L+C    KDP  R T  
Sbjct: 244 LHDLMCQCWRKDPEERPTFE 263

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 116/260 (44%), Gaps = 32/260 (12%)
Query: 125 KIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           K+G G +G+V  +  + +G    AIK             P   +     +E  +MK L+H
Sbjct: 14  KLGQGCFGEV--WMGTWNGTTRVAIKTLK----------PGTMSPEAFLQEAQVMKKLRH 61
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD----IVSGL 239
             +V L  V+ +   +  Y+V EY+      D     G +G+ +    L D    I SG+
Sbjct: 62  EKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGM 116
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            Y+   N VH D++  N+LV  +   K+ DF ++++ ED+    R+    P+ +TAPE  
Sbjct: 117 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 176
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNL 357
           L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++      +     PE    
Sbjct: 177 LYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPES 232
Query: 358 LEGLLC----KDPTRRLTLN 373
           L  L+C    KDP  R T  
Sbjct: 233 LHDLMCQCWRKDPEERPTFE 252

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 116/260 (44%), Gaps = 32/260 (12%)
Query: 125 KIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           K+G G +G+V  +  + +G    AIK             P   +     +E  +MK L+H
Sbjct: 16  KLGQGCFGEV--WMGTWNGTTRVAIKTLK----------PGTMSPEAFLQEAQVMKKLRH 63
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD----IVSGL 239
             +V L  V+ +   +  Y+V EY+      D     G +G+ +    L D    I SG+
Sbjct: 64  EKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGM 118
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            Y+   N VH D++  N+LV  +   K+ DF ++++ ED+    R+    P+ +TAPE  
Sbjct: 119 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 178
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNL 357
           L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++      +     PE    
Sbjct: 179 LYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPES 234
Query: 358 LEGLLC----KDPTRRLTLN 373
           L  L+C    KDP  R T  
Sbjct: 235 LHDLMCQCWRKDPEERPTFE 254

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 116/260 (44%), Gaps = 32/260 (12%)
Query: 125 KIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           K+G G +G+V  +  + +G    AIK             P   +     +E  +MK L+H
Sbjct: 25  KLGQGCFGEV--WMGTWNGTTRVAIKTLK----------PGTMSPEAFLQEAQVMKKLRH 72
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD----IVSGL 239
             +V L  V+ +   +  Y+V EY+      D     G +G+ +    L D    I SG+
Sbjct: 73  EKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGM 127
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            Y+   N VH D++  N+LV  +   K+ DF ++++ ED+    R+    P+ +TAPE  
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 187
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNL 357
           L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++      +     PE    
Sbjct: 188 LYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPES 243
Query: 358 LEGLLC----KDPTRRLTLN 373
           L  L+C    KDP  R T  
Sbjct: 244 LHDLMCQCWRKDPEERPTFE 263

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/283 (22%), Positives = 120/283 (42%), Gaps = 44/283 (15%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +++  +  +G G++G+VV  R++LD ++YAIK          ++  +E  ++ +  EV +
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIK----------KIRHTEEKLSTILSEVXL 55
Query: 178 MKMLQHPNIV----------NLIE-VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGES 226
           +  L H  +V          N ++           ++  EY E +   D         + 
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQR 115
Query: 227 MAR-KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV------------- 272
               +  R I+  L Y+H   ++H ++KP N+ +  S  VKIGDF +             
Sbjct: 116 DEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 273 -SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF-LGE 330
            SQ     +D L  + GT  + A E   G  +  +  D +++G+  +  I   YPF  G 
Sbjct: 176 DSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---YPFSTGX 232
Query: 331 TLQDTYDKIVNNSLVFP----DAMNPELRNLLEGLLCKDPTRR 369
              +   K+ + S+ FP    D      + ++  L+  DP +R
Sbjct: 233 ERVNILKKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKR 275

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G+   V   R    G  +AIK F  +++S LR  P +  M    RE  ++K L H N
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVF--NNISFLR--PVDVQM----REFEVLKKLNHKN 68
Query: 186 IVNLIEVIDDPNSDHFYMVLE-------YVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           IV L  + ++  + H  +++E       Y   +  ++ +G P    ES     LRD+V G
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP----ESEFLIVLRDVVGG 124
Query: 239 LMYLHGHNVVHGDIKPDNLL--VAPSG--TVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           + +L  + +VH +IKP N++  +   G    K+ DF  ++  EDD   +    GT  +  
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYLH 183
Query: 295 PECCLGLTYG-------GKAADTWAVGVTLYYMIIGQYPF 327
           P+               G   D W++GVT Y+   G  PF
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 101/233 (43%), Gaps = 14/233 (6%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           + +GAG +G+V   R  L  K     A     +  L+V  +E    D   E  IM    H
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVA-----IKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L  V+    S    +V E +E G  D+                 LR I SG+ YL
Sbjct: 106 PNIIRLEGVVT--KSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV---FTAPECCL 299
                VH D+   N+L+  +   K+ DF +S+V EDD +    + G  +   +T+PE   
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 300 GLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
              +   A+D W+ G+ L+  M  G+ P+   + QD   K V+     P  M+
Sbjct: 224 YRKFTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-KAVDEGYRLPPPMD 274

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G+   V   R    G  +AIK F  +++S LR  P +  M    RE  ++K L H N
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVF--NNISFLR--PVDVQM----REFEVLKKLNHKN 68
Query: 186 IVNLIEVIDDPNSDHFYMVLE-------YVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           IV L  + ++  + H  +++E       Y   +  ++ +G P    ES     LRD+V G
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP----ESEFLIVLRDVVGG 124
Query: 239 LMYLHGHNVVHGDIKPDNLL--VAPSG--TVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           + +L  + +VH +IKP N++  +   G    K+ DF  ++  EDD   +    GT  +  
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLY-GTEEYLH 183
Query: 295 PECCLGLTYG-------GKAADTWAVGVTLYYMIIGQYPF 327
           P+               G   D W++GVT Y+   G  PF
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 32/224 (14%)
Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
           V+++GAG +G+V +  Y +S      A+K             P   ++     E  +MK 
Sbjct: 18  VKRLGAGQFGEVWMGYYNNS---TKVAVKTLK----------PGTMSVQAFLEEANLMKT 64
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL---RDIVS 237
           LQH  +V L  V+     +  Y++ EY+  K     F +    G+ +  K +     I  
Sbjct: 65  LQHDKLVRLYAVVT--REEPIYIITEYM-AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 121
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPE 296
           G+ Y+   N +H D++  N+LV+ S   KI DF +++V ED+    R     P+ +TAPE
Sbjct: 122 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 181
Query: 297 C----CLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDT 335
                C  +      +D W+ G+ LY ++  G+ P+ G T  D 
Sbjct: 182 AINFGCFTIK-----SDVWSFGILLYEIVTYGKIPYPGRTNADV 220

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 116/260 (44%), Gaps = 32/260 (12%)
Query: 125 KIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           K+G G +G+V  +  + +G    AIK     ++S               +E  +MK L+H
Sbjct: 192 KLGQGCFGEV--WMGTWNGTTRVAIKTLKPGNMSP----------EAFLQEAQVMKKLRH 239
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD----IVSGL 239
             +V L  V+ +   +  Y+V EY+      D     G +G+ +    L D    I SG+
Sbjct: 240 EKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGM 294
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            Y+   N VH D++  N+LV  +   K+ DF + ++ ED+    R+    P+ +TAPE  
Sbjct: 295 AYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAA 354
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNL 357
           L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++      +     PE    
Sbjct: 355 LYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPES 410
Query: 358 LEGLLC----KDPTRRLTLN 373
           L  L+C    KDP  R T  
Sbjct: 411 LHDLMCQCWRKDPEERPTFE 430

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 101/233 (43%), Gaps = 14/233 (6%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           + +GAG +G+V   R  L  K     A     +  L+V  +E    D   E  IM    H
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVA-----IKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L  V+    S    +V E +E G  D+                 LR I SG+ YL
Sbjct: 77  PNIIRLEGVV--TKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 134
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV---FTAPECCL 299
                VH D+   N+L+  +   K+ DF +S+V EDD +    + G  +   +T+PE   
Sbjct: 135 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 194
Query: 300 GLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
              +   A+D W+ G+ L+  M  G+ P+   + QD   K V+     P  M+
Sbjct: 195 YRKFTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-KAVDEGYRLPPPMD 245

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 111/261 (42%), Gaps = 23/261 (8%)
Query: 126 IGAGSYGKVV--LYRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           IGAG +G+V   + ++S   K    AIK     +  K RV        D   E  IM   
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--------DFLGEAGIMGQF 103
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLM 240
            H NI+ L  VI         ++ EY+E G  D     + G          LR I +G+ 
Sbjct: 104 SHHNIIRLEGVIS--KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 161
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV---FTAPEC 297
           YL   N VH D+   N+LV  +   K+ DF +S+V EDD +    + G  +   +TAPE 
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 298 CLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN--PEL 354
                +   A+D W+ G+ ++  M  G+ P+  E       K +N+    P  M+    +
Sbjct: 222 ISYRKFTS-ASDVWSFGIVMWEVMTYGERPYW-ELSNHEVMKAINDGFRLPTPMDCPSAI 279
Query: 355 RNLLEGLLCKDPTRRLTLNDV 375
             L+     ++  RR    D+
Sbjct: 280 YQLMMQCWQQERARRPKFADI 300

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 26/219 (11%)
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAI 223
           S++      +E L M+   HP+IV LI VI +   +  ++++E           G+  + 
Sbjct: 56  SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCT-------LGELRSF 105
Query: 224 GESMARKYLRDIVS----------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
            +   RKY  D+ S           L YL     VH DI   N+LV+ +  VK+GDF +S
Sbjct: 106 LQ--VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
Query: 274 QVFEDDNDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGET 331
           +  ED           P+ + APE  +       A+D W  GV ++ +++ G  PF G  
Sbjct: 164 RYMEDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222
Query: 332 LQDTYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRR 369
             D   +I N   L  P    P L +L+      DP+RR
Sbjct: 223 NNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 261

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 10/211 (4%)
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAI 223
           S++      +E L M+   HP+IV LI VI +   +  ++++E      +   F Q    
Sbjct: 431 SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLG-ELRSFLQVRKF 486
Query: 224 GESMARK--YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281
              +A    Y   + + L YL     VH DI   N+LV+ +  VK+GDF +S+  ED   
Sbjct: 487 SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTY 546
Query: 282 VLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKI 339
                   P+ + APE  +       A+D W  GV ++ +++ G  PF G    D   +I
Sbjct: 547 YKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
Query: 340 VNNS-LVFPDAMNPELRNLLEGLLCKDPTRR 369
            N   L  P    P L +L+      DP+RR
Sbjct: 606 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 636

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 26/219 (11%)
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAI 223
           S++      +E L M+   HP+IV LI VI +   +  ++++E           G+  + 
Sbjct: 54  SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCT-------LGELRSF 103
Query: 224 GESMARKYLRDIVS----------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
            +   RKY  D+ S           L YL     VH DI   N+LV+ +  VK+GDF +S
Sbjct: 104 LQ--VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 161
Query: 274 QVFEDDNDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGET 331
           +  ED           P+ + APE  +       A+D W  GV ++ +++ G  PF G  
Sbjct: 162 RYMEDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 220
Query: 332 LQDTYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRR 369
             D   +I N   L  P    P L +L+      DP+RR
Sbjct: 221 NNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 259

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 26/219 (11%)
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAI 223
           S++      +E L M+   HP+IV LI VI +   +  ++++E           G+  + 
Sbjct: 51  SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWIIMELC-------TLGELRSF 100
Query: 224 GESMARKYLRDIVS----------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
            +   RKY  D+ S           L YL     VH DI   N+LV+ +  VK+GDF +S
Sbjct: 101 LQ--VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 158
Query: 274 QVFEDDNDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGET 331
           +  ED           P+ + APE  +       A+D W  GV ++ +++ G  PF G  
Sbjct: 159 RYMEDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 217
Query: 332 LQDTYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRR 369
             D   +I N   L  P    P L +L+      DP+RR
Sbjct: 218 NNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 256

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 26/219 (11%)
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAI 223
           S++      +E L M+   HP+IV LI VI +   +  ++++E           G+  + 
Sbjct: 53  SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWIIMELC-------TLGELRSF 102
Query: 224 GESMARKYLRDIVS----------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
            +   RKY  D+ S           L YL     VH DI   N+LV+ +  VK+GDF +S
Sbjct: 103 LQ--VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 160
Query: 274 QVFEDDNDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGET 331
           +  ED           P+ + APE  +       A+D W  GV ++ +++ G  PF G  
Sbjct: 161 RYMEDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 219
Query: 332 LQDTYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRR 369
             D   +I N   L  P    P L +L+      DP+RR
Sbjct: 220 NNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 258

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 97/221 (43%), Gaps = 15/221 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IGAG +G+V      L GK     A     +  L+   +E    D   E  IM    HPN
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVA-----IKTLKSGYTEKQRRDFLSEASIMGQFDHPN 95
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           +++L  V+    S    ++ E++E G  D+      G          LR I +G+ YL  
Sbjct: 96  VIHLEGVVT--KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD 153
Query: 245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG----TPV-FTAPECCL 299
            N VH D+   N+LV  +   K+ DF +S+  EDD      +       P+ +TAPE   
Sbjct: 154 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 213
Query: 300 GLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKI 339
              +   A+D W+ G+ ++  M  G+ P+   T QD  + I
Sbjct: 214 YRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 253

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 26/219 (11%)
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAI 223
           S++      +E L M+   HP+IV LI VI +   +  ++++E           G+  + 
Sbjct: 51  SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWIIMELC-------TLGELRSF 100
Query: 224 GESMARKYLRDIVS----------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
            +   RKY  D+ S           L YL     VH DI   N+LV+ +  VK+GDF +S
Sbjct: 101 LQ--VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 158
Query: 274 QVFEDDNDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGET 331
           +  ED           P+ + APE  +       A+D W  GV ++ +++ G  PF G  
Sbjct: 159 RYMEDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 217
Query: 332 LQDTYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRR 369
             D   +I N   L  P    P L +L+      DP+RR
Sbjct: 218 NNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 256

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 122/279 (43%), Gaps = 43/279 (15%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           ++  +  IG+G +G+V   +  +DGK Y IK          RV  +        REV  +
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIK----------RVKYNNEK---AEREVKAL 58
Query: 179 KMLQHPNIVNLIEVID----DPNSDH----------FYMVLEYVEG----KWDNDGFGQP 220
             L H NIV+     D    DP +             ++ +E+ +     +W     G+ 
Sbjct: 59  AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN 280
             + + +A +    I  G+ Y+H   +++ D+KP N+ +  +  VKIGDF +    ++D 
Sbjct: 119 --LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176
Query: 281 DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPF-LGETLQDTYDK 338
               RS GT  + +PE      Y GK  D +A+G+ L  ++ +    F   +   D  D 
Sbjct: 177 K-RXRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG 234
Query: 339 IVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
           I++      D  + + + LL+ LL K P  R   +++ +
Sbjct: 235 IIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 26/219 (11%)
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAI 223
           S++      +E L M+   HP+IV LI VI +   +  ++++E           G+  + 
Sbjct: 48  SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWIIMELC-------TLGELRSF 97
Query: 224 GESMARKYLRDIVS----------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
            +   RKY  D+ S           L YL     VH DI   N+LV+ +  VK+GDF +S
Sbjct: 98  LQ--VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 155
Query: 274 QVFEDDNDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGET 331
           +  ED           P+ + APE  +       A+D W  GV ++ +++ G  PF G  
Sbjct: 156 RYMEDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214
Query: 332 LQDTYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRR 369
             D   +I N   L  P    P L +L+      DP+RR
Sbjct: 215 NNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 253

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 26/219 (11%)
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAI 223
           S++      +E L M+   HP+IV LI VI +   +  ++++E           G+  + 
Sbjct: 79  SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCT-------LGELRSF 128
Query: 224 GESMARKYLRDIVS----------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
            +   RKY  D+ S           L YL     VH DI   N+LV+ +  VK+GDF +S
Sbjct: 129 LQ--VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 186
Query: 274 QVFEDDNDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGET 331
           +  ED           P+ + APE  +       A+D W  GV ++ +++ G  PF G  
Sbjct: 187 RYMEDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 245
Query: 332 LQDTYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRR 369
             D   +I N   L  P    P L +L+      DP+RR
Sbjct: 246 NNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 284

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/335 (21%), Positives = 136/335 (40%), Gaps = 51/335 (15%)
Query: 91  GLICRQFPVKESNKLIRSEDENGT--KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAI 148
           GL+ R   + +       ++ N T  ++   Y ++  +G+G+YG V     +  G   A+
Sbjct: 13  GLVPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAV 72
Query: 149 KAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS----DHFYMV 204
           K   +   S +    +        RE+ ++K ++H N++ L++V     S    +  Y+V
Sbjct: 73  KKLSRPFQSIIHAKRT-------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 125
Query: 205 LEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT 264
              +    +N    Q   + +   +  +  I+ GL Y+H  +++H D+KP NL V     
Sbjct: 126 THLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 183
Query: 265 VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQ 324
           +KI DF +++  +D+   +     T  + APE  L   +  +  D W+VG  +  ++ G+
Sbjct: 184 LKILDFGLARHTDDE---MXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
Query: 325 YPFLGETLQDTYDKIV--------------------------------NNSLVFPDAMNP 352
             F G    D    I+                                N + VF  A NP
Sbjct: 241 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGA-NP 299
Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
              +LLE +L  D  +R+T      H +    + P
Sbjct: 300 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 334

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 123 VRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           ++++G G++G V + R        G+  A+K    S         +E  + D  RE+ I+
Sbjct: 16  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---------TEEHLRDFEREIEIL 66
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVS 237
           K LQH NIV    V       +  +++EY+  G   +        I      +Y   I  
Sbjct: 67  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 126
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPG-TPVF-TA 294
           G+ YL     +H ++   N+LV     VKIGDF +++V   D +  + + PG +P+F  A
Sbjct: 127 GMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 186
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMI 321
           PE  L  +    A+D W+ GV LY + 
Sbjct: 187 PE-SLTESKFSVASDVWSFGVVLYELF 212

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 116/260 (44%), Gaps = 32/260 (12%)
Query: 125 KIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           K+G G +G+V  +  + +G    AIK             P   +     +E  +MK ++H
Sbjct: 25  KLGQGCFGEV--WMGTWNGTTRVAIKTLK----------PGTMSPEAFLQEAQVMKKIRH 72
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD----IVSGL 239
             +V L  V+ +   +  Y+V EY+      D     G +G+ +    L D    I SG+
Sbjct: 73  EKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGM 127
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            Y+   N VH D++  N+LV  +   K+ DF ++++ ED+    R+    P+ +TAPE  
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 187
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNL 357
           L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++      +     PE    
Sbjct: 188 LYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPES 243
Query: 358 LEGLLC----KDPTRRLTLN 373
           L  L+C    KDP  R T  
Sbjct: 244 LHDLMCQCWRKDPEERPTFE 263

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 116/256 (45%), Gaps = 20/256 (7%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           V ++GAG +G+V +   +   K  A+K+  +  +S                E  +MK LQ
Sbjct: 14  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSP----------DAFLAEANLMKQLQ 62
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLM 240
           H  +V L  V+     +  Y++ EY+E     D    P  I  ++ +       I  G+ 
Sbjct: 63  HQRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 119
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECCL 299
           ++   N +H +++  N+LV+ + + KI DF ++++ ED+    R     P+ +TAPE   
Sbjct: 120 FIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 179
Query: 300 GLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNL 357
             T+  K +D W+ G+ L  ++  G+ P+ G T  +    +     +V PD    EL  L
Sbjct: 180 YGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 238
Query: 358 LEGLLCKDPTRRLTLN 373
           +     + P  R T +
Sbjct: 239 MRLCWKERPEDRPTFD 254

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 114/256 (44%), Gaps = 20/256 (7%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           V ++GAG  G+V +   +   K  A+K+  +  +S                E  +MK LQ
Sbjct: 18  VERLGAGQAGEVWMGYYNGHTK-VAVKSLKQGSMSP----------DAFLAEANLMKQLQ 66
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLM 240
           H  +V L  V+     +  Y++ EY+E     D    P  I  ++ +       I  G+ 
Sbjct: 67  HQRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECCL 299
           ++   N +H D++  N+LV+ + + KI DF ++++ ED     R     P+ +TAPE   
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAIN 183
Query: 300 GLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNL 357
             T+  K +D W+ G+ L  ++  G+ P+ G T  +    +     +V PD    EL  L
Sbjct: 184 YGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242
Query: 358 LEGLLCKDPTRRLTLN 373
           +     + P  R T +
Sbjct: 243 MRLCWKERPEDRPTFD 258

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   K   S +    +        RE+ ++K
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRT-------YRELRLLK 88
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 146
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 147 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 203
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 263
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 264 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 322
Query: 384 DNGP 387
            + P
Sbjct: 323 YHDP 326

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 115/260 (44%), Gaps = 32/260 (12%)
Query: 125 KIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           K+G G +G+V  +  + +G    AIK             P   +     +E  +MK L+H
Sbjct: 25  KLGQGCFGEV--WMGTWNGTTRVAIKTLK----------PGTMSPEAFLQEAQVMKKLRH 72
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD----IVSGL 239
             +V L  V+ +   +  Y+V EY+      D     G +G+ +    L D    I SG+
Sbjct: 73  EKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGM 127
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            Y+   N VH D+   N+LV  +   K+ DF ++++ ED+    R+    P+ +TAPE  
Sbjct: 128 AYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 187
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNL 357
           L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++      +     PE    
Sbjct: 188 LYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPES 243
Query: 358 LEGLLC----KDPTRRLTLN 373
           L  L+C    KDP  R T  
Sbjct: 244 LHDLMCQCWRKDPEERPTFE 263

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 94/217 (43%), Gaps = 22/217 (10%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKH-----YAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + K+G GS+G  V+ R   D         A+K      LS+        AM D  REV  
Sbjct: 13  LEKLGDGSFG--VVRRGEWDAPSGKTVSVAVKCLKPDVLSQ------PEAMDDFIREVNA 64
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIV 236
           M  L H N++ L  V+  P      MV E    G   +      G        +Y   + 
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF--EDDNDVLRRSPGTP-VFT 293
            G+ YL     +H D+   NLL+A    VKIGDF + +     DD+ V++     P  + 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 181
Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLG 329
           APE     T+   A+DTW  GVTL+ M   GQ P++G
Sbjct: 182 APESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIG 217

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 10/211 (4%)
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAI 223
           S++      +E L M+   HP+IV LI VI +   +  ++++E      +   F Q    
Sbjct: 431 SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLG-ELRSFLQVRKF 486
Query: 224 GESMARK--YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281
              +A    Y   + + L YL     VH DI   N+LV+ +  VK+GDF +S+  ED   
Sbjct: 487 SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546
Query: 282 VLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKI 339
                   P+ + APE  +       A+D W  GV ++ +++ G  PF G    D   +I
Sbjct: 547 YKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
Query: 340 VNNS-LVFPDAMNPELRNLLEGLLCKDPTRR 369
            N   L  P    P L +L+      DP+RR
Sbjct: 606 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 636

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 117/265 (44%), Gaps = 42/265 (15%)
Query: 125 KIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           K+G G +G+V  +  + +G    AIK             P   +     +E  +MK L+H
Sbjct: 22  KLGQGCFGEV--WMGTWNGTTRVAIKTLK----------PGTMSPEAFLQEAQVMKKLRH 69
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR---------D 234
             +V L  V+ +   +  Y+V EY+     N G       GE+   KYLR          
Sbjct: 70  EKLVQLYAVVSE---EPIYIVTEYM-----NKGSLLDFLKGET--GKYLRLPQLVDMSAQ 119
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FT 293
           I SG+ Y+   N VH D++  N+LV  +   K+ DF ++++ ED+    R+    P+ +T
Sbjct: 120 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWT 179
Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLVFPDAMNP 352
           APE  L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++      +     P
Sbjct: 180 APEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPP 235
Query: 353 ELRNLLEGLLC----KDPTRRLTLN 373
           E    L  L+C    K+P  R T  
Sbjct: 236 ECPESLHDLMCQCWRKEPEERPTFE 260

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 117/265 (44%), Gaps = 42/265 (15%)
Query: 125 KIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           K+G G +G+V  +  + +G    AIK             P   +     +E  +MK L+H
Sbjct: 22  KLGQGCFGEV--WMGTWNGTTRVAIKTLK----------PGTMSPEAFLQEAQVMKKLRH 69
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR---------D 234
             +V L  V+ +   +  Y+V EY+     N G       GE+   KYLR          
Sbjct: 70  EKLVQLYAVVSE---EPIYIVTEYM-----NKGSLLDFLKGET--GKYLRLPQLVDMSAQ 119
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FT 293
           I SG+ Y+   N VH D++  N+LV  +   K+ DF ++++ ED+    R+    P+ +T
Sbjct: 120 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 179
Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLVFPDAMNP 352
           APE  L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++      +     P
Sbjct: 180 APEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPP 235
Query: 353 ELRNLLEGLLC----KDPTRRLTLN 373
           E    L  L+C    K+P  R T  
Sbjct: 236 ECPESLHDLMCQCWRKEPEERPTFE 260

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 94/217 (43%), Gaps = 22/217 (10%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKH-----YAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + K+G GS+G  V+ R   D         A+K      LS+        AM D  REV  
Sbjct: 23  LEKLGDGSFG--VVRRGEWDAPSGKTVSVAVKCLKPDVLSQ------PEAMDDFIREVNA 74
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIV 236
           M  L H N++ L  V+  P      MV E    G   +      G        +Y   + 
Sbjct: 75  MHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF--EDDNDVLRRSPGTP-VFT 293
            G+ YL     +H D+   NLL+A    VKIGDF + +     DD+ V++     P  + 
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 191
Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLG 329
           APE     T+   A+DTW  GVTL+ M   GQ P++G
Sbjct: 192 APESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIG 227

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 119/266 (44%), Gaps = 44/266 (16%)
Query: 125 KIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           K+G G +G+V  +  + +G    AIK           + P   +     +E  +MK L+H
Sbjct: 191 KLGQGCFGEV--WMGTWNGTTRVAIKT----------LKPGTMSPEAFLQEAQVMKKLRH 238
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGFGQPGAIGESMARKYLR--------- 233
             +V L  V+ +   +  Y+V EY+ +G   +   G+ G        KYLR         
Sbjct: 239 EKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETG--------KYLRLPQLVDMAA 287
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-F 292
            I SG+ Y+   N VH D++  N+LV  +   K+ DF ++++ ED+    R+    P+ +
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
           TAPE  L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++      +     
Sbjct: 348 TAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCP 403
Query: 352 PELRNLLEGLLC----KDPTRRLTLN 373
           PE    L  L+C    K+P  R T  
Sbjct: 404 PECPESLHDLMCQCWRKEPEERPTFE 429

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/335 (21%), Positives = 136/335 (40%), Gaps = 51/335 (15%)
Query: 91  GLICRQFPVKESNKLIRSEDENGT--KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAI 148
           GL+ R   + +       ++ N T  ++   Y ++  +G+G+YG V     +  G   A+
Sbjct: 13  GLVPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAV 72
Query: 149 KAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS----DHFYMV 204
           K   +   S +    +        RE+ ++K ++H N++ L++V     S    +  Y+V
Sbjct: 73  KKLSRPFQSIIHAKRT-------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 125
Query: 205 LEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT 264
              +    +N    Q   + +   +  +  I+ GL Y+H  +++H D+KP NL V     
Sbjct: 126 THLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 183
Query: 265 VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQ 324
           +KI DF +++  +D+   +     T  + APE  L   +  +  D W+VG  +  ++ G+
Sbjct: 184 LKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
Query: 325 YPFLGETLQDTYDKIV--------------------------------NNSLVFPDAMNP 352
             F G    D    I+                                N + VF  A NP
Sbjct: 241 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGA-NP 299
Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
              +LLE +L  D  +R+T      H +    + P
Sbjct: 300 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 334

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/335 (21%), Positives = 136/335 (40%), Gaps = 51/335 (15%)
Query: 91  GLICRQFPVKESNKLIRSEDENGT--KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAI 148
           GL+ R   + +       ++ N T  ++   Y ++  +G+G+YG V     +  G   A+
Sbjct: 12  GLVPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAV 71
Query: 149 KAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS----DHFYMV 204
           K   +   S +    +        RE+ ++K ++H N++ L++V     S    +  Y+V
Sbjct: 72  KKLSRPFQSIIHAKRT-------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 124
Query: 205 LEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT 264
              +    +N    Q   + +   +  +  I+ GL Y+H  +++H D+KP NL V     
Sbjct: 125 THLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 182
Query: 265 VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQ 324
           +KI DF +++  +D+   +     T  + APE  L   +  +  D W+VG  +  ++ G+
Sbjct: 183 LKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239
Query: 325 YPFLGETLQDTYDKIV--------------------------------NNSLVFPDAMNP 352
             F G    D    I+                                N + VF  A NP
Sbjct: 240 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGA-NP 298
Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
              +LLE +L  D  +R+T      H +    + P
Sbjct: 299 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 333

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 119/266 (44%), Gaps = 44/266 (16%)
Query: 125 KIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           K+G G +G+V  +  + +G    AIK           + P   +     +E  +MK L+H
Sbjct: 191 KLGQGCFGEV--WMGTWNGTTRVAIKT----------LKPGTMSPEAFLQEAQVMKKLRH 238
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGFGQPGAIGESMARKYLR--------- 233
             +V L  V+ +   +  Y+V EY+ +G   +   G+ G        KYLR         
Sbjct: 239 EKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETG--------KYLRLPQLVDMAA 287
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-F 292
            I SG+ Y+   N VH D++  N+LV  +   K+ DF ++++ ED+    R+    P+ +
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
           TAPE  L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++      +     
Sbjct: 348 TAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCP 403
Query: 352 PELRNLLEGLLC----KDPTRRLTLN 373
           PE    L  L+C    K+P  R T  
Sbjct: 404 PECPESLHDLMCQCWRKEPEERPTFE 429

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 72
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    +   + +   +  +  I
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCAKLTDDHVQFLIYQI 130
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 187
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 248 SESARNYIQSLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 384 DNGP 387
            + P
Sbjct: 307 YHDP 310

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/323 (22%), Positives = 132/323 (40%), Gaps = 55/323 (17%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 76
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 134
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 191
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 384 ----DNGPI--PQYLCWCKRDRL 400
               D+ P+  PQ   +  RD L
Sbjct: 311 YHDPDDEPVADPQDQSFESRDLL 333

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  IG+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 29  YQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 81
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 139
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 140 LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE---MTGYVATRWYRAP 196
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 256
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315
Query: 384 DNGP 387
            + P
Sbjct: 316 YHDP 319

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 120/286 (41%), Gaps = 36/286 (12%)
Query: 119 EYVHVRK-------------IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE 165
           EY HVR+             +G G++GKV   ++   G   A K              SE
Sbjct: 7   EYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---------SE 57
Query: 166 TAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG-KWDNDGFGQPGAIG 224
             + D   E+ I+    HP IV L+      +    ++++E+  G   D         + 
Sbjct: 58  EELEDYIVEIEILATCDHPYIVKLLGAYY--HDGKLWIMIEFCPGGAVDAIMLELDRGLT 115
Query: 225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR 284
           E   +   R ++  L +LH   ++H D+K  N+L+   G +++ DF VS   ++   + +
Sbjct: 116 EPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQK 173
Query: 285 RSP--GTPVFTAPECCLGLTYGGKA----ADTWAVGVTLYYMIIGQYPFLGETLQDTYDK 338
           R    GTP + APE  +  T         AD W++G+TL  M   + P           K
Sbjct: 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 233
Query: 339 IVNN---SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           I  +   +L+ P   + E R+ L+  L K+P  R +   + +H +V
Sbjct: 234 IAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFV 279

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 118/266 (44%), Gaps = 44/266 (16%)
Query: 125 KIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           K+G G +G+V  +  + +G    AIK             P   +     +E  +MK L+H
Sbjct: 18  KLGQGCFGEV--WMGTWNGTTRVAIKTLK----------PGTMSPEAFLQEAQVMKKLRH 65
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGFGQPGAIGESMARKYLR--------- 233
             +V L  V+ +   +  Y+V EY+ +G   +   G+ G        KYLR         
Sbjct: 66  EKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETG--------KYLRLPQLVDMAA 114
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-F 292
            I SG+ Y+   N VH D++  N+LV  +   K+ DF ++++ ED+    R+    P+ +
Sbjct: 115 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 174
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
           TAPE  L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++      +     
Sbjct: 175 TAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCP 230
Query: 352 PELRNLLEGLLC----KDPTRRLTLN 373
           PE    L  L+C    K+P  R T  
Sbjct: 231 PECPESLHDLMCQCWRKEPEERPTFE 256

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 116/267 (43%), Gaps = 34/267 (12%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE---TAMTDVRREVLIMKMLQ 182
           IG G +GKV  YR+   G   A+KA         R  P E     + +VR+E  +  ML+
Sbjct: 15  IGIGGFGKV--YRAFWIGDEVAVKA--------ARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 183 HPNIVNLIEV-IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
           HPNI+ L  V + +PN     +V+E+  G   N        I   +   +   I  G+ Y
Sbjct: 65  HPNIIALRGVCLKEPN---LCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNY 120
Query: 242 LHGHNVV---HGDIKPDNLLVA--------PSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
           LH   +V   H D+K  N+L+          +  +KI DF +++ +     +   + G  
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM--SAAGAY 178
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG-ETLQDTYDKIVNN-SLVFPD 348
            + APE      +  K +D W+ GV L+ ++ G+ PF G + L   Y   +N  +L  P 
Sbjct: 179 AWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237
Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDV 375
                   L+E     DP  R +  ++
Sbjct: 238 TCPEPFAKLMEDCWNPDPHSRPSFTNI 264

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 94/217 (43%), Gaps = 22/217 (10%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKH-----YAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + K+G GS+G  V+ R   D         A+K      LS+        AM D  REV  
Sbjct: 17  LEKLGDGSFG--VVRRGEWDAPSGKTVSVAVKCLKPDVLSQ------PEAMDDFIREVNA 68
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIV 236
           M  L H N++ L  V+  P      MV E    G   +      G        +Y   + 
Sbjct: 69  MHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 125
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF--EDDNDVLRRSPGTP-VFT 293
            G+ YL     +H D+   NLL+A    VKIGDF + +     DD+ V++     P  + 
Sbjct: 126 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLG 329
           APE     T+   A+DTW  GVTL+ M   GQ P++G
Sbjct: 186 APESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIG 221

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 82
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 140
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 141 LRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE---MTGYVATRWYRAP 197
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 258 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 316
Query: 384 DNGP 387
            + P
Sbjct: 317 YHDP 320

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/335 (21%), Positives = 136/335 (40%), Gaps = 51/335 (15%)
Query: 91  GLICRQFPVKESNKLIRSEDENGT--KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAI 148
           GL+ R   + +       ++ N T  ++   Y ++  +G+G+YG V     +  G   A+
Sbjct: 13  GLVPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAV 72
Query: 149 KAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS----DHFYMV 204
           K   +   S +    +        RE+ ++K ++H N++ L++V     S    +  Y+V
Sbjct: 73  KKLSRPFQSIIHAKRT-------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 125
Query: 205 LEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT 264
              +    +N    Q   + +   +  +  I+ GL Y+H  +++H D+KP NL V     
Sbjct: 126 THLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 183
Query: 265 VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQ 324
           +KI DF +++  +D+   +     T  + APE  L   +  +  D W+VG  +  ++ G+
Sbjct: 184 LKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
Query: 325 YPFLGETLQDTYDKIV--------------------------------NNSLVFPDAMNP 352
             F G    D    I+                                N + VF  A NP
Sbjct: 241 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA-NP 299
Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
              +LLE +L  D  +R+T      H +    + P
Sbjct: 300 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 334

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 119/266 (44%), Gaps = 44/266 (16%)
Query: 125 KIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           K+G G +G+V  +  + +G    AIK           + P   +     +E  +MK L+H
Sbjct: 274 KLGQGCFGEV--WMGTWNGTTRVAIKT----------LKPGTMSPEAFLQEAQVMKKLRH 321
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGFGQPGAIGESMARKYLR--------- 233
             +V L  V+ +   +  Y+V EY+ +G   +   G+ G        KYLR         
Sbjct: 322 EKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETG--------KYLRLPQLVDMAA 370
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-F 292
            I SG+ Y+   N VH D++  N+LV  +   K+ DF ++++ ED+    R+    P+ +
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
           TAPE  L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++      +     
Sbjct: 431 TAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCP 486
Query: 352 PELRNLLEGLLC----KDPTRRLTLN 373
           PE    L  L+C    K+P  R T  
Sbjct: 487 PECPESLHDLMCQCWRKEPEERPTFE 512

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 78
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 136
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 137 LRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE---MTGYVATRWYRAP 193
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312
Query: 384 DNGP 387
            + P
Sbjct: 313 YHDP 316

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 123/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 76
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQ--KLTDDHVQFLIYQI 134
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF + +  +D+   +     T  + AP
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE---MTGYVATRWYRAP 191
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 384 DNGP 387
            + P
Sbjct: 311 YHDP 314

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 94/217 (43%), Gaps = 22/217 (10%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKH-----YAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + K+G GS+G  V+ R   D         A+K      LS+        AM D  REV  
Sbjct: 17  LEKLGDGSFG--VVRRGEWDAPSGKTVSVAVKCLKPDVLSQ------PEAMDDFIREVNA 68
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIV 236
           M  L H N++ L  V+  P      MV E    G   +      G        +Y   + 
Sbjct: 69  MHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 125
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF--EDDNDVLRRSPGTP-VFT 293
            G+ YL     +H D+   NLL+A    VKIGDF + +     DD+ V++     P  + 
Sbjct: 126 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLG 329
           APE     T+   A+DTW  GVTL+ M   GQ P++G
Sbjct: 186 APESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIG 221

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/335 (21%), Positives = 136/335 (40%), Gaps = 51/335 (15%)
Query: 91  GLICRQFPVKESNKLIRSEDENGT--KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAI 148
           GL+ R   + +       ++ N T  ++   Y ++  +G+G+YG V     +  G   A+
Sbjct: 12  GLVPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAV 71
Query: 149 KAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS----DHFYMV 204
           K   +   S +    +        RE+ ++K ++H N++ L++V     S    +  Y+V
Sbjct: 72  KKLSRPFQSIIHAKRT-------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 124
Query: 205 LEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT 264
              +    +N    Q   + +   +  +  I+ GL Y+H  +++H D+KP NL V     
Sbjct: 125 THLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 182
Query: 265 VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQ 324
           +KI DF +++  +D+   +     T  + APE  L   +  +  D W+VG  +  ++ G+
Sbjct: 183 LKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239
Query: 325 YPFLGETLQDTYDKIV--------------------------------NNSLVFPDAMNP 352
             F G    D    I+                                N + VF  A NP
Sbjct: 240 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA-NP 298
Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
              +LLE +L  D  +R+T      H +    + P
Sbjct: 299 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 333

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 76
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 134
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 191
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 252 SESARNYIQSLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 384 DNGP 387
            + P
Sbjct: 311 YHDP 314

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 76
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 134
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGXVATRWYRAP 191
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 384 DNGP 387
            + P
Sbjct: 311 YHDP 314

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 82
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 140
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 141 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 197
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 258 SESARNYIQSLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 316
Query: 384 DNGP 387
            + P
Sbjct: 317 YHDP 320

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 76
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    +   + +   +  +  I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKXQKLTDDHVQFLIYQI 134
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE---MTGYVATRWYRAP 191
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 384 DNGP 387
            + P
Sbjct: 311 YHDP 314

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 72
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 130
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 187
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 248 SESARNYIQSLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 384 DNGP 387
            + P
Sbjct: 307 YHDP 310

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 76
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 134
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MAGFVATRWYRAP 191
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 384 DNGP 387
            + P
Sbjct: 311 YHDP 314

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 94/217 (43%), Gaps = 22/217 (10%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKH-----YAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + K+G GS+G  V+ R   D         A+K      LS+        AM D  REV  
Sbjct: 13  LEKLGDGSFG--VVRRGEWDAPSGKTVSVAVKCLKPDVLSQ------PEAMDDFIREVNA 64
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIV 236
           M  L H N++ L  V+  P      MV E    G   +      G        +Y   + 
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF--EDDNDVLRRSPGTP-VFT 293
            G+ YL     +H D+   NLL+A    VKIGDF + +     DD+ V++     P  + 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLG 329
           APE     T+   A+DTW  GVTL+ M   GQ P++G
Sbjct: 182 APESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIG 217

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 94/217 (43%), Gaps = 22/217 (10%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKH-----YAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + K+G GS+G  V+ R   D         A+K      LS+        AM D  REV  
Sbjct: 23  LEKLGDGSFG--VVRRGEWDAPSGKTVSVAVKCLKPDVLSQ------PEAMDDFIREVNA 74
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIV 236
           M  L H N++ L  V+  P      MV E    G   +      G        +Y   + 
Sbjct: 75  MHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF--EDDNDVLRRSPGTP-VFT 293
            G+ YL     +H D+   NLL+A    VKIGDF + +     DD+ V++     P  + 
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLG 329
           APE     T+   A+DTW  GVTL+ M   GQ P++G
Sbjct: 192 APESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIG 227

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 88
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 146
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 147 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 203
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 263
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 264 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 322
Query: 384 DNGP 387
            + P
Sbjct: 323 YHDP 326

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 94/217 (43%), Gaps = 22/217 (10%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKH-----YAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + K+G GS+G  V+ R   D         A+K      LS+        AM D  REV  
Sbjct: 13  LEKLGDGSFG--VVRRGEWDAPSGKTVSVAVKCLKPDVLSQ------PEAMDDFIREVNA 64
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIV 236
           M  L H N++ L  V+  P      MV E    G   +      G        +Y   + 
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF--EDDNDVLRRSPGTP-VFT 293
            G+ YL     +H D+   NLL+A    VKIGDF + +     DD+ V++     P  + 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLG 329
           APE     T+   A+DTW  GVTL+ M   GQ P++G
Sbjct: 182 APESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIG 217

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 88
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 146
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 147 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 203
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 263
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 264 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 322
Query: 384 DNGP 387
            + P
Sbjct: 323 YHDP 326

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 76
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    +   + +   +  +  I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKXQKLTDDHVQFLIYQI 134
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 191
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 384 DNGP 387
            + P
Sbjct: 311 YHDP 314

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 76
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 134
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MAGFVATRWYRAP 191
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 252 SESARNYIQSLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 384 DNGP 387
            + P
Sbjct: 311 YHDP 314

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 87
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 88  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 145
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 146 LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE---MTGYVATRWYRAP 202
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 262
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 263 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 321
Query: 384 DNGP 387
            + P
Sbjct: 322 YHDP 325

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 119/277 (42%), Gaps = 26/277 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +++  + ++GAG+ G V        G   A K  H      L + P+      + RE+ +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPA--IRNQIIRELQV 57
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +     P IV         +     + +E+++G   +    + G I E +  K    ++ 
Sbjct: 58  LHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 115
Query: 238 GLMYL-HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           GL YL   H ++H D+KP N+LV   G +K+ DF VS    D   +     GT  + +PE
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPE 173
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE----------TLQDTYDKIVNNSLV- 345
              G  Y  + +D W++G++L  M +G+YP               + +  D IVN     
Sbjct: 174 RLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPK 232
Query: 346 FPDAM-NPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            P  + + E ++ +   L K+P  R  L  +  H ++
Sbjct: 233 LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 269

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 34  YQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 86
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 87  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 144
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 145 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 201
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 202 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 261
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 262 SESARNYIQSLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 320
Query: 384 DNGP 387
            + P
Sbjct: 321 YHDP 324

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 76
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 134
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 191
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 384 DNGP 387
            + P
Sbjct: 311 YHDP 314

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 76
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 134
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE---MTGYVATRWYRAP 191
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 384 DNGP 387
            + P
Sbjct: 311 YHDP 314

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 76
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 134
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 191
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 384 DNGP 387
            + P
Sbjct: 311 YHDP 314

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 72
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 130
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MAGFVATRWYRAP 187
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 248 SESARNYIQSLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 384 DNGP 387
            + P
Sbjct: 307 YHDP 310

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 87
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 88  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 145
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 146 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 202
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 262
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 263 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 321
Query: 384 DNGP 387
            + P
Sbjct: 322 YHDP 325

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 81
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 139
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 140 LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE---MTGYVATRWYRAP 196
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 256
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315
Query: 384 DNGP 387
            + P
Sbjct: 316 YHDP 319

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 76
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 134
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 191
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 384 DNGP 387
            + P
Sbjct: 311 YHDP 314

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 78
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 136
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 137 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 193
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312
Query: 384 DNGP 387
            + P
Sbjct: 313 YHDP 316

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 81
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 139
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 140 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 196
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 256
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315
Query: 384 DNGP 387
            + P
Sbjct: 316 YHDP 319

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 23  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 75
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 76  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 133
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 134 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 190
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 191 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 250
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 251 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 309
Query: 384 DNGP 387
            + P
Sbjct: 310 YHDP 313

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 76
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 134
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 191
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 384 DNGP 387
            + P
Sbjct: 311 YHDP 314

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 76
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 134
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 191
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 192 EIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 384 DNGP 387
            + P
Sbjct: 311 YHDP 314

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 99
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    +   + +   +  +  I
Sbjct: 100 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLTDDHVQFLIYQI 157
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 158 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MXGYVATRWYRAP 214
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 274
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 275 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 333
Query: 384 DNGP 387
            + P
Sbjct: 334 YHDP 337

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 32/224 (14%)
Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
           V+K+GAG +G+V +  Y +S      A+K             P   ++     E  +MK 
Sbjct: 17  VKKLGAGQFGEVWMGYYNNS---TKVAVKTLK----------PGTMSVQAFLEEANLMKT 63
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL---RDIVS 237
           LQH  +V L  V+     +  Y++ E++  K     F +    G+ +  K +     I  
Sbjct: 64  LQHDKLVRLYAVVT--KEEPIYIITEFM-AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 120
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPE 296
           G+ Y+   N +H D++  N+LV+ S   KI DF +++V ED+    R     P+ +TAPE
Sbjct: 121 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 180
Query: 297 C----CLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDT 335
                C  +      ++ W+ G+ LY ++  G+ P+ G T  D 
Sbjct: 181 AINFGCFTIK-----SNVWSFGILLYEIVTYGKIPYPGRTNADV 219

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 119/266 (44%), Gaps = 44/266 (16%)
Query: 125 KIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           K+G G +G+V  +  + +G    AIK           + P   +     +E  +MK L+H
Sbjct: 191 KLGQGCFGEV--WMGTWNGTTRVAIKT----------LKPGTMSPEAFLQEAQVMKKLRH 238
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGFGQPGAIGESMARKYLR--------- 233
             +V L  V+ +   +  Y+V EY+ +G   +   G+ G        KYLR         
Sbjct: 239 EKLVQLYAVVSE---EPIYIVGEYMSKGSLLDFLKGETG--------KYLRLPQLVDMAA 287
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-F 292
            I SG+ Y+   N VH D++  N+LV  +   K+ DF ++++ ED+    R+    P+ +
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
           TAPE  L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++      +     
Sbjct: 348 TAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCP 403
Query: 352 PELRNLLEGLLC----KDPTRRLTLN 373
           PE    L  L+C    K+P  R T  
Sbjct: 404 PECPESLHDLMCQCWRKEPEERPTFE 429

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 78
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 136
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 137 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 193
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312
Query: 384 DNGP 387
            + P
Sbjct: 313 YHDP 316

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 82
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 140
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 141 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 197
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 258 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 316
Query: 384 DNGP 387
            + P
Sbjct: 317 YHDP 320

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 99
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 100 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 157
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 158 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 214
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 274
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 275 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 333
Query: 384 DNGP 387
            + P
Sbjct: 334 YHDP 337

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 72
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 130
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 187
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 384 DNGP 387
            + P
Sbjct: 307 YHDP 310

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 78
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 136
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 137 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 193
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312
Query: 384 DNGP 387
            + P
Sbjct: 313 YHDP 316

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 22  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 74
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 75  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 132
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 133 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 189
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 249
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 250 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 308
Query: 384 DNGP 387
            + P
Sbjct: 309 YHDP 312

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 76
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 134
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 191
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 384 DNGP 387
            + P
Sbjct: 311 YHDP 314

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 83
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 141
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 198
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 384 DNGP 387
            + P
Sbjct: 318 YHDP 321

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 76
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 134
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 191
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 384 DNGP 387
            + P
Sbjct: 311 YHDP 314

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 108/234 (46%), Gaps = 28/234 (11%)
Query: 120 YVHVRK-IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           YV + + IGAG +G+V   R    GK  +  A     +  L+   +E    +   E  IM
Sbjct: 15  YVKIEEVIGAGEFGEVCRGRLKAPGKKESCVA-----IKTLKGGYTERQRREFLSEASIM 69
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWD-----NDG-FGQPGAIGESMARKY 231
              +HPNI+ L  V+   NS    ++ E++E G  D     NDG F     +G       
Sbjct: 70  GQFEHPNIIRLEGVVT--NSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVG------M 121
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGT 289
           LR I SG+ YL   + VH D+   N+LV  +   K+ DF +S+  E+++       S G 
Sbjct: 122 LRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGG 181
Query: 290 PV---FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKI 339
            +   +TAPE  +       A+D W+ G+ ++  M  G+ P+   + QD  + I
Sbjct: 182 KIPIRWTAPE-AIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAI 234

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 106/234 (45%), Gaps = 28/234 (11%)
Query: 120 YVHVRK-IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           YV + + IGAG +G+V   R    GK  +  A     +  L+   +E    +   E  IM
Sbjct: 17  YVKIEEVIGAGEFGEVCRGRLKAPGKKESCVA-----IKTLKGGYTERQRREFLSEASIM 71
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWD-----NDG-FGQPGAIGESMARKY 231
              +HPNI+ L  V+   NS    ++ E++E G  D     NDG F     +G       
Sbjct: 72  GQFEHPNIIRLEGVVT--NSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVG------M 123
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE----DDNDVLRRSP 287
           LR I SG+ YL   + VH D+   N+LV  +   K+ DF +S+  E    D  +      
Sbjct: 124 LRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGG 183
Query: 288 GTPV-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKI 339
             P+ +TAPE  +       A+D W+ G+ ++  M  G+ P+   + QD  + I
Sbjct: 184 KIPIRWTAPE-AIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAI 236

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 73
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 131
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 132 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 188
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 248
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 249 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 307
Query: 384 DNGP 387
            + P
Sbjct: 308 YHDP 311

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 73
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 131
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 132 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 188
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 248
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 249 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 307
Query: 384 DNGP 387
            + P
Sbjct: 308 YHDP 311

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 81
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 139
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 140 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 196
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 256
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315
Query: 384 DNGP 387
            + P
Sbjct: 316 YHDP 319

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 127/283 (44%), Gaps = 42/283 (14%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD----VRR 173
           NE  + ++IG G +G V   R   D    AIK+        L  +  ET M +     +R
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSL------ILGDSEGETEMIEKFQEFQR 72
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYL 232
           EV IM  L HPNIV L  ++ +P      MV+E+V  G   +    +   I  S+  + +
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPR----MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128
Query: 233 RDIVSGLMYLHGHN--VVHGDIKPDNLLV------APSGTVKIGDFSVSQVFEDDNDVLR 284
            DI  G+ Y+   N  +VH D++  N+ +      AP    K+ DFS+SQ        L 
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPV-CAKVADFSLSQQSVHSVSGLL 187
Query: 285 RSPGTPVFTAPECCLG--LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN 342
              G   + APE       +Y  K ADT++  + LY ++ G+ PF     + +Y KI   
Sbjct: 188 ---GNFQWMAPETIGAEEESYTEK-ADTYSFAMILYTILTGEGPF----DEYSYGKIKFI 239
Query: 343 SLV--------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
           +++         P+   P LRN++E     DP +R   + + K
Sbjct: 240 NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 125/292 (42%), Gaps = 56/292 (19%)
Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           ++  +  IG+G +G+V   +  +DGK Y I+          RV  +        REV  +
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIR----------RVKYNNEK---AEREVKAL 59
Query: 179 KMLQHPNIVNL----------IEVIDDP--NSDH---------------FYMVLEYVEG- 210
             L H NIV+            E  DD   +SD+                ++ +E+ +  
Sbjct: 60  AKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKG 119
Query: 211 ---KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKI 267
              +W     G+   + + +A +    I  G+ Y+H   ++H D+KP N+ +  +  VKI
Sbjct: 120 TLEQWIEKRRGEK--LDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKI 177
Query: 268 GDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYP 326
           GDF +    ++D     RS GT  + +PE      Y GK  D +A+G+ L  ++ +    
Sbjct: 178 GDFGLVTSLKNDGKRT-RSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTA 235
Query: 327 F-LGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
           F   +   D  D I++      D  + + + LL+ LL K P  R   +++ +
Sbjct: 236 FETSKFFTDLRDGIIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEILR 281

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 82
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 140
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 141 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 197
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 258 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 316
Query: 384 DNGP 387
            + P
Sbjct: 317 YHDP 320

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 15/221 (6%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IGAG +G+V      L GK     A     +  L+   +E    D   E  IM    HPN
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVA-----IKTLKSGYTEKQRRDFLSEASIMGQFDHPN 69
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           +++L  V+    S    ++ E++E G  D+      G          LR I +G+ YL  
Sbjct: 70  VIHLEGVVT--KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD 127
Query: 245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG----TPV-FTAPECCL 299
            N VH  +   N+LV  +   K+ DF +S+  EDD      +       P+ +TAPE   
Sbjct: 128 MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 300 GLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKI 339
              +   A+D W+ G+ ++  M  G+ P+   T QD  + I
Sbjct: 188 YRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 227

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 116/269 (43%), Gaps = 23/269 (8%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           V ++G G++GKV   ++   G   A K              SE  + D   E+ I+    
Sbjct: 16  VGELGDGAFGKVYKAKNKETGALAAAKVIETK---------SEEELEDYIVEIEILATCD 66
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEG-KWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
           HP IV L+      +    ++++E+  G   D         + E   +   R ++  L +
Sbjct: 67  HPYIVKLLGAYY--HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 124
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPECCL 299
           LH   ++H D+K  N+L+   G +++ DF VS   ++   + +R    GTP + APE  +
Sbjct: 125 LHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVM 182
Query: 300 GLTYGGKA----ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDAMNP 352
             T         AD W++G+TL  M   + P           KI  +   +L+ P   + 
Sbjct: 183 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV 242
Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           E R+ L+  L K+P  R +   + +H +V
Sbjct: 243 EFRDFLKIALDKNPETRPSAAQLLEHPFV 271

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 123/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 83
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 141
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++   D+   +     T  + AP
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRAP 198
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 384 DNGP 387
            + P
Sbjct: 318 YHDP 321

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 123/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 83
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 141
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++   D+   +     T  + AP
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRAP 198
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 384 DNGP 387
            + P
Sbjct: 318 YHDP 321

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 123/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 83
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 141
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++   D+   +     T  + AP
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRAP 198
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 384 DNGP 387
            + P
Sbjct: 318 YHDP 321

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 112/270 (41%), Gaps = 20/270 (7%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHK--SHLSKLRVAPSETAMTDVRR 173
           M + Y   R I +GSYG V     S +G   AIK      S    + +         V R
Sbjct: 20  MQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 174 EVLIMKMLQHPNIVNLIEVI---DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARK 230
           E+ ++    HPNI+ L ++    ++P     Y+V E +          Q   I     + 
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY 138
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
           ++  I+ GL  LH   VVH D+ P N+L+A +  + I DF++++  ED  D  +    T 
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYVTH 196
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------N 341
             + APE  +      K  D W+ G  +  M   +  F G T  +  +KIV         
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256
Query: 342 NSLVFPDAMNPELRNLLEGLLCKDPTRRLT 371
           + ++F    +P  R+ L   L   P R  T
Sbjct: 257 DVVMFS---SPSARDYLRNSLSNVPARAWT 283

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 112/270 (41%), Gaps = 20/270 (7%)
Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHK--SHLSKLRVAPSETAMTDVRR 173
           M + Y   R I +GSYG V     S +G   AIK      S    + +         V R
Sbjct: 20  MQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 174 EVLIMKMLQHPNIVNLIEVI---DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARK 230
           E+ ++    HPNI+ L ++    ++P     Y+V E +          Q   I     + 
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY 138
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
           ++  I+ GL  LH   VVH D+ P N+L+A +  + I DF++++  ED  D  +    T 
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYVTH 196
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------N 341
             + APE  +      K  D W+ G  +  M   +  F G T  +  +KIV         
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256
Query: 342 NSLVFPDAMNPELRNLLEGLLCKDPTRRLT 371
           + ++F    +P  R+ L   L   P R  T
Sbjct: 257 DVVMFS---SPSARDYLRNSLSNVPARAWT 283

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 76
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 134
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI D+ +++  +D+   +     T  + AP
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE---MTGYVATRWYRAP 191
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 384 DNGP 387
            + P
Sbjct: 311 YHDP 314

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 107/239 (44%), Gaps = 39/239 (16%)
Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           + + ++  ++ +G G +G V   ++ +D  +YAIK        ++R+   E A   V RE
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIK--------RIRLPNRELAREKVMRE 53
Query: 175 VLIMKMLQHPNIV---------NLIEVIDDPNSDHFYMVLEYVEGKWDN--DGFGQPGAI 223
           V  +  L+HP IV         N  E +  P+S   Y+ ++    + +N  D       I
Sbjct: 54  VKALAKLEHPGIVRYFNAWLEKNTTEKLQ-PSSPKVYLYIQMQLCRKENLKDWMNGRCTI 112
Query: 224 GE---SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN 280
            E   S+       I   + +LH   ++H D+KP N+       VK+GDF +    + D 
Sbjct: 113 EERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 281 D---VLRRSP---------GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
           +   VL   P         GT ++ +PE   G +Y  K  D +++G+ L+ ++   YPF
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPF 227

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/303 (22%), Positives = 124/303 (40%), Gaps = 47/303 (15%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y  +  +G+G+YG V        G   A+K   +   S +    +        RE+ ++K
Sbjct: 53  YQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRT-------YRELRLLK 105
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 106 HMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 163
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI DF +++  +D+   +     T  + AP
Sbjct: 164 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAP 220
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-------------- 341
           E  L   +     D W+VG  +  ++ G+  F G    +   +I+               
Sbjct: 221 EIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMP 280
Query: 342 --------NSLV------FPDAM---NPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD 384
                   NSL       F D     NP   +LLE +L  D  +R+T ++   H +    
Sbjct: 281 SHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQY 340
Query: 385 NGP 387
           + P
Sbjct: 341 HDP 343

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 117/266 (43%), Gaps = 44/266 (16%)
Query: 125 KIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           K+G G +G+V  +  + +G    AIK             P   +     +E  +MK L+H
Sbjct: 15  KLGQGCFGEV--WMGTWNGTTRVAIKTLK----------PGTMSPEAFLQEAQVMKKLRH 62
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDNDGFGQPGAIGESMARKYLR--------- 233
             +V L  V+ +   +   +V EY+ +G   +   G+ G        KYLR         
Sbjct: 63  EKLVQLYAVVSE---EPIXIVTEYMSKGSLLDFLKGETG--------KYLRLPQLVDMAA 111
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-F 292
            I SG+ Y+   N VH D++  N+LV  +   K+ DF ++++ ED+    R+    P+ +
Sbjct: 112 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 171
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
           TAPE  L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++      +     
Sbjct: 172 TAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCP 227
Query: 352 PELRNLLEGLLC----KDPTRRLTLN 373
           PE    L  L+C    K+P  R T  
Sbjct: 228 PECPESLHDLMCQCWRKEPEERPTFE 253

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 119/277 (42%), Gaps = 33/277 (11%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV-LIMKML 181
           V  +G G+YG+V   R    G+  AIK         + V   E    ++++E+ ++ K  
Sbjct: 29  VELVGNGTYGQVYKGRHVKTGQLAAIKV--------MDVTGDEEE--EIKQEINMLKKYS 78
Query: 182 QHPNIVNLIEVIDDPN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL----R 233
            H NI          N     D  ++V+E+       D        G ++  +++    R
Sbjct: 79  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKGNTLKEEWIAYICR 136
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPV 291
           +I+ GL +LH H V+H DIK  N+L+  +  VK+ DF VS     D  V RR+   GTP 
Sbjct: 137 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPY 194
Query: 292 FTAPECCL-----GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-- 344
           + APE          TY  K +D W++G+T   M  G  P            I  N    
Sbjct: 195 WMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 253
Query: 345 VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           +     + + ++ +E  L K+ ++R     + KH ++
Sbjct: 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 128/292 (43%), Gaps = 55/292 (18%)
Query: 116 MINEY-VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           +I++Y V  + +G G  GKV+   +    + +A+K         L+  P        RRE
Sbjct: 15  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM--------LQDCPK------ARRE 60
Query: 175 V-LIMKMLQHPNIVNLIEVIDDPNSDH--FYMVLEYVEGKWDNDGFGQPG--AIGESMAR 229
           V L  +  Q P+IV +++V ++  +      +V+E ++G          G  A  E  A 
Sbjct: 61  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 120
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRS 286
           + ++ I   + YLH  N+ H D+KP+NLL     P+  +K+ DF  ++            
Sbjct: 121 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE----------- 169
Query: 287 PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG----ETLQDTYDKIVNN 342
                        G  Y  K+ D W++GV +Y ++ G  PF              +I   
Sbjct: 170 -----------TTGEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 217
Query: 343 SLVFPD----AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
              FP+     ++ E++ L+  LL  +PT+R+T+ +   H W++  +  +PQ
Sbjct: 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM-QSTKVPQ 268

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 126/283 (44%), Gaps = 42/283 (14%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD----VRR 173
           NE  + ++IG G +G V   R   D    AIK+        L  +  ET M +     +R
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSL------ILGDSEGETEMIEKFQEFQR 72
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYL 232
           EV IM  L HPNIV L  ++ +P      MV+E+V  G   +    +   I  S+  + +
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPR----MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128
Query: 233 RDIVSGLMYLHGHN--VVHGDIKPDNLLV------APSGTVKIGDFSVSQVFEDDNDVLR 284
            DI  G+ Y+   N  +VH D++  N+ +      AP    K+ DF +SQ        L 
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPV-CAKVADFGLSQQSVHSVSGLL 187
Query: 285 RSPGTPVFTAPECCLG--LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN 342
              G   + APE       +Y  K ADT++  + LY ++ G+ PF     + +Y KI   
Sbjct: 188 ---GNFQWMAPETIGAEEESYTEK-ADTYSFAMILYTILTGEGPF----DEYSYGKIKFI 239
Query: 343 SLV--------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
           +++         P+   P LRN++E     DP +R   + + K
Sbjct: 240 NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +++  + ++GAG+ G V        G   A K  H      L + P+      + RE+ +
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPA--IRNQIIRELQV 84
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +     P IV         +     + +E+++G   +    + G I E +  K    ++ 
Sbjct: 85  LHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 142
Query: 238 GLMYL-HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           GL YL   H ++H D+KP N+LV   G +K+ DF VS    D   +     GT  + +PE
Sbjct: 143 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPE 200
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
              G  Y  + +D W++G++L  M +G+YP 
Sbjct: 201 RLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPI 230

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 126/294 (42%), Gaps = 32/294 (10%)
Query: 90  NGLICRQFPVKESNKLIRSEDE---NGTKM-INEYVHVRKIGAGSYGKVVL--YRSSLDG 143
           +GL  R    K     + ++DE   +G  + + E   ++ IG G +G V+L  YR    G
Sbjct: 161 DGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR----G 216
Query: 144 KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYM 203
              A+K       ++  +A           E  +M  L+H N+V L+ VI +      Y+
Sbjct: 217 NKVAVKCIKNDATAQAFLA-----------EASVMTQLRHSNLVQLLGVIVEEKGG-LYI 264
Query: 204 VLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP 261
           V EY+      D     G   +G     K+  D+   + YL G+N VH D+   N+LV+ 
Sbjct: 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE 324
Query: 262 SGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYM 320
               K+ DF +++      D  +     PV +TAPE      +  K +D W+ G+ L+ +
Sbjct: 325 DNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALREKKFSTK-SDVWSFGILLWEI 379
Query: 321 I-IGQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRNLLEGLLCKDPTRRLTL 372
              G+ P+    L+D   ++     +  PD   P + ++++     D   R T 
Sbjct: 380 YSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTF 433

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 125/283 (44%), Gaps = 42/283 (14%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD----VRR 173
           NE  + ++IG G +G V   R   D    AIK+        L  +  ET M +     +R
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSL------ILGDSEGETEMIEKFQEFQR 72
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYL 232
           EV IM  L HPNIV L  ++ +P      MV+E+V  G   +    +   I  S+  + +
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPR----MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128
Query: 233 RDIVSGLMYLHGHN--VVHGDIKPDNLLV------APSGTVKIGDFSVSQVFEDDNDVLR 284
            DI  G+ Y+   N  +VH D++  N+ +      AP    K+ DF  SQ        L 
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPV-CAKVADFGTSQQSVHSVSGLL 187
Query: 285 RSPGTPVFTAPECCLG--LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN 342
              G   + APE       +Y  K ADT++  + LY ++ G+ PF     + +Y KI   
Sbjct: 188 ---GNFQWMAPETIGAEEESYTEK-ADTYSFAMILYTILTGEGPF----DEYSYGKIKFI 239
Query: 343 SLV--------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
           +++         P+   P LRN++E     DP +R   + + K
Sbjct: 240 NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 38/226 (16%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IG GSYG V      L+ +  AIK         LRV         + RE+ I+  L H +
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKI-------LRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 186 IVNLIEVI---DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           +V +++++   D    D  Y+VLE  +  +    F  P  + E   +  L +++ G+ Y+
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADSDFKK-LFRTPVYLTELHIKTLLYNLLVGVKYV 172
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF---EDDNDVLRRSPG----------- 288
           H   ++H D+KP N LV    +VK+ DF +++     E+ N  L  SP            
Sbjct: 173 HSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
Query: 289 -------------TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMI 321
                        T  + APE  L      +A D W++G     ++
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 27/219 (12%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           ++   H  ++G GS+G+V   +    G   A+K   K  L   RV            E++
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRV-----------EELV 102
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
               L  P IV L   + +    + +M  E +EG        Q G + E  A  YL   +
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNIFM--ELLEGGSLGQLIKQMGCLPEDRALYYLGQAL 160
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGT-VKIGDFSVSQVFEDDNDVLRRS-------PG 288
            GL YLH   ++HGD+K DN+L++  G+   + DF  +   + D   L +S       PG
Sbjct: 161 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG--LGKSLLTGDYIPG 218
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
           T    APE  +G     K  D W+    + +M+ G +P+
Sbjct: 219 TETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPW 256

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +++  + ++GAG+ G V        G   A K  H      L + P+      + RE+ +
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPA--IRNQIIRELQV 119
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +     P IV         +     + +E+++G   +    + G I E +  K    ++ 
Sbjct: 120 LHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 177
Query: 238 GLMYL-HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           GL YL   H ++H D+KP N+LV   G +K+ DF VS    D   +     GT  + +PE
Sbjct: 178 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPE 235
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
              G  Y  + +D W++G++L  M +G+YP 
Sbjct: 236 RLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPI 265

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 27/219 (12%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           ++   H  ++G GS+G+V   +    G   A+K   K  L   RV            E++
Sbjct: 73  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRV-----------EELV 118
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
               L  P IV L   + +    + +M  E +EG        Q G + E  A  YL   +
Sbjct: 119 ACAGLSSPRIVPLYGAVREGPWVNIFM--ELLEGGSLGQLIKQMGCLPEDRALYYLGQAL 176
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGT-VKIGDFSVSQVFEDDNDVLRRS-------PG 288
            GL YLH   ++HGD+K DN+L++  G+   + DF  +   + D   L +S       PG
Sbjct: 177 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG--LGKSLLTGDYIPG 234
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
           T    APE  +G     K  D W+    + +M+ G +P+
Sbjct: 235 TETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPW 272

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 122 HVRKIGAGSYGKVVLYRSSL----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           ++ ++G G++G V L R        G   A+K    S   + R         D +RE+ I
Sbjct: 11  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---------DFQREIQI 61
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA-IGESMARKYLRDIV 236
           +K L    IV    V   P      +V+EY+      D   +  A +  S    Y   I 
Sbjct: 62  LKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 121
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVF-T 293
            G+ YL     VH D+   N+LV     VKI DF ++++   D D  V+R    +P+F  
Sbjct: 122 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWY 181
Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMI 321
           APE  L      + +D W+ GV LY + 
Sbjct: 182 APE-SLSDNIFSRQSDVWSFGVVLYELF 208

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/310 (22%), Positives = 130/310 (41%), Gaps = 61/310 (19%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR--REVLIMKMLQH 183
           +G G+YG V        G+  AIK          ++ P +  +  +R  RE+ I+K  +H
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIK----------KIEPFDKPLFALRTLREIKILKHFKH 68
Query: 184 PNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
            NI+ +   I  P+S    +  Y++ E ++   D         + +   + ++   +  +
Sbjct: 69  ENIITIFN-IQRPDSFENFNEVYIIQELMQT--DLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED---DNDV-------LRRSPGT 289
             LHG NV+H D+KP NLL+  +  +K+ DF ++++ ++   DN         +     T
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVAT 185
Query: 290 PVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------N 341
             + APE  L      +A D W+ G  L  + + +  F G   +     I         +
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245
Query: 342 NSL----------------VFPDA--------MNPELRNLLEGLLCKDPTRRLTLNDVAK 377
           N L                ++P A        +NP+  +LL+ +L  DP +R+T  +  +
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305
Query: 378 HTWVLGDNGP 387
           H ++   + P
Sbjct: 306 HPYLQTYHDP 315

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 100/223 (44%), Gaps = 16/223 (7%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R +G+G+YG V     +   +  A+K   +   S +             RE+ ++K L+
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHA-------RRTYRELRLLKHLK 85
Query: 183 HPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           H N++ L++V     S       Y+V   +    +N    Q  A+ +   +  +  ++ G
Sbjct: 86  HENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQ--ALSDEHVQFLVYQLLRG 143
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L Y+H   ++H D+KP N+ V     ++I DF +++  +++   +     T  + APE  
Sbjct: 144 LKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE---MTGYVATRWYRAPEIM 200
Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN 341
           L   +  +  D W+VG  +  ++ G+  F G    D   +I+ 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIME 243

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/310 (22%), Positives = 131/310 (42%), Gaps = 61/310 (19%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR--REVLIMKMLQH 183
           +G G+YG V        G+  AIK          ++ P +  +  +R  RE+ I+K  +H
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIK----------KIEPFDKPLFALRTLREIKILKHFKH 68
Query: 184 PNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
            NI+ +   I  P+S    +  Y++ E ++   D         + +   + ++   +  +
Sbjct: 69  ENIITIFN-IQRPDSFENFNEVYIIQELMQT--DLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE----DDNDVLRRSPGTPVFT-- 293
             LHG NV+H D+KP NLL+  +  +K+ DF ++++ +    D+++   +  G   F   
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 294 ----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------N 341
               APE  L      +A D W+ G  L  + + +  F G   +     I         +
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245
Query: 342 NSL----------------VFPDA--------MNPELRNLLEGLLCKDPTRRLTLNDVAK 377
           N L                ++P A        +NP+  +LL+ +L  DP +R+T  +  +
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305
Query: 378 HTWVLGDNGP 387
           H ++   + P
Sbjct: 306 HPYLQTYHDP 315

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 27/219 (12%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           ++   H  ++G GS+G+V   +    G   A+K   K  L   RV            E++
Sbjct: 71  VHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRV-----------EELV 116
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
               L  P IV L   + +    + +M  E +EG        Q G + E  A  YL   +
Sbjct: 117 ACAGLSSPRIVPLYGAVREGPWVNIFM--ELLEGGSLGQLIKQMGCLPEDRALYYLGQAL 174
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGT-VKIGDFSVSQVFEDDNDVLRRS-------PG 288
            GL YLH   ++HGD+K DN+L++  G+   + DF  +   + D   L +S       PG
Sbjct: 175 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG--LGKSLLTGDYIPG 232
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
           T    APE  +G     K  D W+    + +M+ G +P+
Sbjct: 233 TETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPW 270

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           ++   H  ++G GS+G+V        G   A+K   K  L   R             E++
Sbjct: 73  VHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVK---KVRLEVFRA-----------EELM 118
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
               L  P IV L   + +    + +M  E +EG        + G + E  A  YL   +
Sbjct: 119 ACAGLTSPRIVPLYGAVREGPWVNIFM--ELLEGGSLGQLVKEQGCLPEDRALYYLGQAL 176
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGT-VKIGDFSVSQVFEDD---NDVLRRS--PGTP 290
            GL YLH   ++HGD+K DN+L++  G+   + DF  +   + D    D+L     PGT 
Sbjct: 177 EGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTE 236
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
              APE  LG +   K  D W+    + +M+ G +P+
Sbjct: 237 THMAPEVVLGRSCDAK-VDVWSSCCMMLHMLNGCHPW 272

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 122 HVRKIGAGSYGKVVLYRSSL----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           ++ ++G G++G V L R        G   A+K    S   + R         D +RE+ I
Sbjct: 15  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---------DFQREIQI 65
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA-IGESMARKYLRDIV 236
           +K L    IV    V   P      +V+EY+      D   +  A +  S    Y   I 
Sbjct: 66  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 125
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVF-T 293
            G+ YL     VH D+   N+LV     VKI DF ++++   D D  V+R    +P+F  
Sbjct: 126 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 185
Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMI 321
           APE  L      + +D W+ GV LY + 
Sbjct: 186 APE-SLSDNIFSRQSDVWSFGVVLYELF 212

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/304 (22%), Positives = 123/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 76
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 134
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI  F +++  +D+   +     T  + AP
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE---MTGYVATRWYRAP 191
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 384 DNGP 387
            + P
Sbjct: 311 YHDP 314

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/310 (22%), Positives = 132/310 (42%), Gaps = 61/310 (19%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR--REVLIMKMLQH 183
           +G G+YG V        G+  AIK          ++ P +  +  +R  RE+ I+K  +H
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIK----------KIEPFDKPLFALRTLREIKILKHFKH 68
Query: 184 PNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
            NI+ +   I  P+S    +  Y++ E ++   D         + +   + ++   +  +
Sbjct: 69  ENIITIFN-IQRPDSFENFNEVYIIQELMQT--DLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE----DDNDVLRRSPG------T 289
             LHG NV+H D+KP NLL+  +  +K+ DF ++++ +    D+++   +  G      T
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVAT 185
Query: 290 PVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------N 341
             + APE  L      +A D W+ G  L  + + +  F G   +     I         +
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245
Query: 342 NSL----------------VFPDA--------MNPELRNLLEGLLCKDPTRRLTLNDVAK 377
           N L                ++P A        +NP+  +LL+ +L  DP +R+T  +  +
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305
Query: 378 HTWVLGDNGP 387
           H ++   + P
Sbjct: 306 HPYLQTYHDP 315

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 114/259 (44%), Gaps = 26/259 (10%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGK-HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           ++++G G +G+V  +  + +G    AIK             P   +      E  IMK L
Sbjct: 14  IKRLGNGQFGEV--WMGTWNGNTKVAIKTLK----------PGTMSPESFLEEAQIMKKL 61
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMARKYLRDIVS 237
           +H  +V L  V+ +   +  Y+V EY+       +  DG G+  A+           + +
Sbjct: 62  KHDKLVQLYAVVSE---EPIYIVTEYMNKGSLLDFLKDGEGR--ALKLPNLVDMAAQVAA 116
Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPE 296
           G+ Y+   N +H D++  N+LV      KI DF ++++ ED+    R+    P+ +TAPE
Sbjct: 117 GMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPE 176
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPEL 354
             L   +  K +D W+ G+ L  ++  G+ P+ G   ++  +++     +  P      L
Sbjct: 177 AALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISL 235
Query: 355 RNLLEGLLCKDPTRRLTLN 373
             L+     KDP  R T  
Sbjct: 236 HELMIHCWKKDPEERPTFE 254

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 122 HVRKIGAGSYGKVVLYRSSL----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           ++ ++G G++G V L R        G   A+K    S   + R         D +RE+ I
Sbjct: 14  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---------DFQREIQI 64
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA-IGESMARKYLRDIV 236
           +K L    IV    V   P      +V+EY+      D   +  A +  S    Y   I 
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 124
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVF-T 293
            G+ YL     VH D+   N+LV     VKI DF ++++   D D  V+R    +P+F  
Sbjct: 125 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 184
Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMI 321
           APE  L      + +D W+ GV LY + 
Sbjct: 185 APE-SLSDNIFSRQSDVWSFGVVLYELF 211

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +++  + ++GAG+ G V        G   A K  H      L + P+      + RE+ +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPA--IRNQIIRELQV 57
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +     P IV         +     + +E+++G   +    + G I E +  K    ++ 
Sbjct: 58  LHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 115
Query: 238 GLMYL-HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           GL YL   H ++H D+KP N+LV   G +K+ DF VS    D   +     GT  + +PE
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPE 173
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
              G  Y  + +D W++G++L  M +G+YP 
Sbjct: 174 RLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPI 203

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 122 HVRKIGAGSYGKVVLYRSSL----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           ++ ++G G++G V L R        G   A+K    S   + R         D +RE+ I
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---------DFQREIQI 77
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA-IGESMARKYLRDIV 236
           +K L    IV    V   P      +V+EY+      D   +  A +  S    Y   I 
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVF-T 293
            G+ YL     VH D+   N+LV     VKI DF ++++   D D  V+R    +P+F  
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMI 321
           APE  L      + +D W+ GV LY + 
Sbjct: 198 APE-SLSDNIFSRQSDVWSFGVVLYELF 224

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +++  + ++GAG+ G V        G   A K  H      L + P+      + RE+ +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPA--IRNQIIRELQV 57
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +     P IV         +     + +E+++G   +    + G I E +  K    ++ 
Sbjct: 58  LHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 115
Query: 238 GLMYL-HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           GL YL   H ++H D+KP N+LV   G +K+ DF VS    D   +     GT  + +PE
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPE 173
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
              G  Y  + +D W++G++L  M +G+YP 
Sbjct: 174 RLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPI 203

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/304 (22%), Positives = 123/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 76
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 134
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI D  +++  +D+   +     T  + AP
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE---MTGYVATRWYRAP 191
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 384 DNGP 387
            + P
Sbjct: 311 YHDP 314

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 108/258 (41%), Gaps = 22/258 (8%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
            K+G G YG+V +          A+K   +  +           + +  +E  +MK ++H
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME----------VEEFLKEAAVMKEIKH 87
Query: 184 PNIVNLIEV--IDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGL 239
           PN+V L+ V  ++ P    FY+V EY+      D   +     +   +       I S +
Sbjct: 88  PNLVQLLGVCTLEPP----FYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAM 143
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ +TAPE  
Sbjct: 144 EYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 203
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRN 356
              T+  K +D WA GV L+ +   G  P+ G  L   YD +     +  P+   P++  
Sbjct: 204 AYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGCPPKVYE 262
Query: 357 LLEGLLCKDPTRRLTLND 374
           L+       P  R +  +
Sbjct: 263 LMRACWKWSPADRPSFAE 280

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +++  + ++GAG+ G V        G   A K  H      L + P+      + RE+ +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPA--IRNQIIRELQV 57
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +     P IV         +     + +E+++G   +    + G I E +  K    ++ 
Sbjct: 58  LHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 115
Query: 238 GLMYL-HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           GL YL   H ++H D+KP N+LV   G +K+ DF VS    D   +     GT  + +PE
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPE 173
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
              G  Y  + +D W++G++L  M +G+YP 
Sbjct: 174 RLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +++  + ++GAG+ G V        G   A K  H      L + P+      + RE+ +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPA--IRNQIIRELQV 57
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +     P IV         +     + +E+++G   +    + G I E +  K    ++ 
Sbjct: 58  LHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 115
Query: 238 GLMYL-HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           GL YL   H ++H D+KP N+LV   G +K+ DF VS    D   +     GT  + +PE
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPE 173
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
              G  Y  + +D W++G++L  M +G+YP 
Sbjct: 174 RLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPI 203

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 101/223 (45%), Gaps = 16/223 (7%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R +G+G+YG V     +   +  A+K   +   S +    +        RE+ ++K L+
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRT-------YRELRLLKHLK 85
Query: 183 HPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           H N++ L++V     S       Y+V   +    +N    Q  A+ +   +  +  ++ G
Sbjct: 86  HENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQ--ALSDEHVQFLVYQLLRG 143
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L Y+H   ++H D+KP N+ V     ++I DF +++  +++   +     T  + APE  
Sbjct: 144 LKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE---MTGYVATRWYRAPEIM 200
Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN 341
           L   +  +  D W+VG  +  ++ G+  F G    D   +I+ 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIME 243

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/304 (22%), Positives = 123/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 76
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 134
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI D  +++  +D+   +     T  + AP
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE---MTGYVATRWYRAP 191
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 384 DNGP 387
            + P
Sbjct: 311 YHDP 314

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 117/263 (44%), Gaps = 30/263 (11%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           ++Y  VRK+G G Y +V    +  + +   +K       +K            ++RE+ I
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNK------------IKREIKI 84
Query: 178 MKMLQH-PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDI 235
           ++ L+  PNI+ L +++ DP S    +V E+V    +N  F Q    + +   R Y+ +I
Sbjct: 85  LENLRGGPNIITLADIVKDPVSRTPALVFEHV----NNTDFKQLYQTLTDYDIRFYMYEI 140
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           +  L Y H   ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  
Sbjct: 141 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKG 199
Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--------F 346
           PE  +       + D W++G  L  MI  + PF      D YD++V  + V        +
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVLGTEDLYDY 257
Query: 347 PDAMNPELRNLLEGLLCKDPTRR 369
            D  N EL      +L +   +R
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKR 280

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 41/226 (18%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           ++ +H   +G G +G+ +       G+   +K           +   E       +EV +
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKEL---------IRFDEETQRTFLKEVKV 60
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY------ 231
           M+ L+HPN++  I V+      +F  + EY++G       G    I +SM  +Y      
Sbjct: 61  MRCLEHPNVLKFIGVLYKDKRLNF--ITEYIKG-------GTLRGIIKSMDSQYPWSQRV 111
Query: 232 --LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN---DVLR-- 284
              +DI SG+ YLH  N++H D+   N LV  +  V + DF ++++  D+    + LR  
Sbjct: 112 SFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 285 RSP---------GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMI 321
           + P         G P + APE   G +Y  K  D ++ G+ L  +I
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEII 216

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 18/220 (8%)
Query: 172 RREVLIMKMLQHPNIVNLIEVIDD--PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR 229
           + E   +K LQHPNIV   +  +          +V E            +       + R
Sbjct: 73  KEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLR 132
Query: 230 KYLRDIVSGLMYLHGHN--VVHGDIKPDNLLVA-PSGTVKIGDFSVSQVFEDDNDVLRRS 286
            + R I+ GL +LH     ++H D+K DN+ +  P+G+VKIGD  ++ +        +  
Sbjct: 133 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKAV 190
Query: 287 PGTPVFTAPECCLGLTYGGK---AADTWAVGVTLYYMIIGQYPFLG-ETLQDTYDKIVN- 341
            GTP F APE      Y  K   + D +A G         +YP+   +     Y ++ + 
Sbjct: 191 IGTPEFXAPE-----XYEEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSG 245
Query: 342 -NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
                F     PE++ ++EG + ++   R ++ D+  H +
Sbjct: 246 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           +K+GAG +G+V +   +   KH        + ++   + P   ++     E  +MK LQH
Sbjct: 21  KKLGAGQFGEVWM---ATYNKH--------TKVAVKTMKPGSMSVEAFLAEANVMKTLQH 69
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLMY 241
             +V L  V+     +  Y++ E++      D         + + +   +   I  G+ +
Sbjct: 70  DKLVKLHAVV---TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 126
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECCLG 300
           +   N +H D++  N+LV+ S   KI DF +++V ED+    R     P+ +TAPE    
Sbjct: 127 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 186
Query: 301 LTYGGKAADTWAVGVTLYYMII-GQYPFLG 329
            ++  K +D W+ G+ L  ++  G+ P+ G
Sbjct: 187 GSFTIK-SDVWSFGILLMEIVTYGRIPYPG 215

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/304 (22%), Positives = 123/304 (40%), Gaps = 49/304 (16%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y ++  +G+G+YG V     +  G   A+K   +   S +    +        RE+ ++K
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------YRELRLLK 76
Query: 180 MLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
            ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  +  I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 134
Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL Y+H  +++H D+KP NL V     +KI D  +++  +D+   +     T  + AP
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE---MTGYVATRWYRAP 191
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--------------- 340
           E  L   +  +  D W+VG  +  ++ G+  F G    D    I+               
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 341 -----------------NNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                            N + VF  A NP   +LLE +L  D  +R+T      H +   
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 384 DNGP 387
            + P
Sbjct: 311 YHDP 314

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 106/233 (45%), Gaps = 24/233 (10%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           ++IG+GS+G V  Y+    G   A+K  + +       AP+   +   + EV +++  +H
Sbjct: 18  QRIGSGSFGTV--YKGKWHGD-VAVKMLNVT-------APTPQQLQAFKNEVGVLRKTRH 67
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS----GL 239
            NI+  +     P      +V ++ EG   +  +    A       K L DI      G+
Sbjct: 68  VNILLFMGYSTKP---QLAIVTQWCEG---SSLYHHLHASETKFEMKKLIDIARQTARGM 121
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE--DDNDVLRRSPGTPVFTAPEC 297
            YLH  +++H D+K +N+ +    TVKIGDF ++ V      +    +  G+ ++ APE 
Sbjct: 122 DYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 181
Query: 298 CLGLTYGGKA--ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD 348
                    +  +D +A G+ LY ++ GQ P+     +D   ++V    + PD
Sbjct: 182 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 234

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 101/223 (45%), Gaps = 16/223 (7%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R +G+G+YG V     +   +  A+K   +   S +    +        RE+ ++K L+
Sbjct: 25  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRT-------YRELRLLKHLK 77
Query: 183 HPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
           H N++ L++V     S       Y+V   +    +N    Q  A+ +   +  +  ++ G
Sbjct: 78  HENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQ--ALSDEHVQFLVYQLLRG 135
Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L Y+H   ++H D+KP N+ V     ++I DF +++  +++   +     T  + APE  
Sbjct: 136 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE---MTGYVATRWYRAPEIM 192
Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN 341
           L   +  +  D W+VG  +  ++ G+  F G    D   +I+ 
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIME 235

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 27/219 (12%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           ++   H  ++G GS+G+V        G   A+K   K  L   R             E++
Sbjct: 92  VHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVK---KVRLEVFRA-----------EELM 137
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
               L  P IV L   + +    + +M  E +EG        + G + E  A  YL   +
Sbjct: 138 ACAGLTSPRIVPLYGAVREGPWVNIFM--ELLEGGSLGQLVKEQGCLPEDRALYYLGQAL 195
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGT-VKIGDFSVSQVFEDDNDVLRRS-------PG 288
            GL YLH   ++HGD+K DN+L++  G+   + DF  +   + D   L +S       PG
Sbjct: 196 EGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDG--LGKSLLTGDYIPG 253
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
           T    APE  LG +   K  D W+    + +M+ G +P+
Sbjct: 254 TETHMAPEVVLGRSCDAK-VDVWSSCCMMLHMLNGCHPW 291

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 119/271 (43%), Gaps = 28/271 (10%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
           + +GAG++GKVV   +   GK  A+       L     A  + A+     E+ IM  L Q
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS---ELKIMSHLGQ 108
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEY-------------VEGKWDNDGFGQPGAIGESMAR 229
           H NIVNL+      +     ++ EY              E   D +  G+P  + + +  
Sbjct: 109 HENIVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKAEADLDKED-GRPLELRDLL-- 163
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLRRSPG 288
            +   +  G+ +L   N +H D+   N+L+      KIGDF +++ +  D N +++ +  
Sbjct: 164 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 223
Query: 289 TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN--SL 344
            PV + APE      Y  + +D W+ G+ L+ +  +G  P+ G  +   + K+V +   +
Sbjct: 224 LPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 282
Query: 345 VFPDAMNPELRNLLEGLLCKDPTRRLTLNDV 375
             P      + ++++     +PT R T   +
Sbjct: 283 AQPAFAPKNIYSIMQACWALEPTHRPTFQQI 313

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           +K+GAG +G+V +   +   KH        + ++   + P   ++     E  +MK LQH
Sbjct: 194 KKLGAGQFGEVWM---ATYNKH--------TKVAVKTMKPGSMSVEAFLAEANVMKTLQH 242
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLMY 241
             +V L  V+     +  Y++ E++      D         + + +   +   I  G+ +
Sbjct: 243 DKLVKLHAVV---TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECCLG 300
           +   N +H D++  N+LV+ S   KI DF +++V ED+    R     P+ +TAPE    
Sbjct: 300 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 359
Query: 301 LTYGGKAADTWAVGVTLYYMII-GQYPFLG 329
            ++  K +D W+ G+ L  ++  G+ P+ G
Sbjct: 360 GSFTIK-SDVWSFGILLMEIVTYGRIPYPG 388

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 119/271 (43%), Gaps = 28/271 (10%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
           + +GAG++GKVV   +   GK  A+       L     A  + A+     E+ IM  L Q
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS---ELKIMSHLGQ 100
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEY-------------VEGKWDNDGFGQPGAIGESMAR 229
           H NIVNL+      +     ++ EY              E   D +  G+P  + + +  
Sbjct: 101 HENIVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKAEADLDKED-GRPLELRDLL-- 155
Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLRRSPG 288
            +   +  G+ +L   N +H D+   N+L+      KIGDF +++ +  D N +++ +  
Sbjct: 156 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 215
Query: 289 TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN--SL 344
            PV + APE      Y  + +D W+ G+ L+ +  +G  P+ G  +   + K+V +   +
Sbjct: 216 LPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 274
Query: 345 VFPDAMNPELRNLLEGLLCKDPTRRLTLNDV 375
             P      + ++++     +PT R T   +
Sbjct: 275 AQPAFAPKNIYSIMQACWALEPTHRPTFQQI 305

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 111/260 (42%), Gaps = 28/260 (10%)
Query: 117 INEYVHVRKIGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           + E   ++ IG G +G V+L  YR    G   A+K       ++  +A           E
Sbjct: 11  MKELKLLQTIGKGEFGDVMLGDYR----GNKVAVKCIKNDATAQAFLA-----------E 55
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYL 232
             +M  L+H N+V L+ VI +      Y+V EY+      D     G   +G     K+ 
Sbjct: 56  ASVMTQLRHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 114
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV- 291
            D+   + YL G+N VH D+   N+LV+     K+ DF +++      D  +     PV 
Sbjct: 115 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVK 170
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN-SLVFPDA 349
           +TAPE      +  K +D W+ G+ L+ +   G+ P+    L+D   ++     +  PD 
Sbjct: 171 WTAPEALREAAFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 229
Query: 350 MNPELRNLLEGLLCKDPTRR 369
             P +  +++     D   R
Sbjct: 230 CPPAVYEVMKNCWHLDAAMR 249

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 114/263 (43%), Gaps = 30/263 (11%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           +IG G++G+V   R   D    A+K+  ++    L+            +E  I+K   HP
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK--------AKFLQEARILKQYSHP 172
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV----SGLM 240
           NIV LI V         Y+V+E V+G    D        G  +  K L  +V    +G+ 
Sbjct: 173 NIVRLIGVCTQKQP--IYIVMELVQG---GDFLTFLRTEGARLRVKTLLQMVGDAAAGME 227
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG---TPV-FTAPE 296
           YL     +H D+   N LV     +KI DF +S+  E+ + V   S G    PV +TAPE
Sbjct: 228 YLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR--EEADGVXAASGGLRQVPVKWTAPE 285
Query: 297 CCLGLTYG--GKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS-LVFPDAMNP 352
               L YG     +D W+ G+ L+    +G  P+   + Q T + +     L  P+    
Sbjct: 286 ---ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPD 342
Query: 353 ELRNLLEGLLCKDPTRRLTLNDV 375
            +  L+E     +P +R + + +
Sbjct: 343 AVFRLMEQCWAYEPGQRPSFSTI 365

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 116/272 (42%), Gaps = 31/272 (11%)
Query: 117 INEYVHVRKIGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           + E   ++ IG G +G V+L  YR    G   A+K       ++  +A           E
Sbjct: 20  MKELKLLQTIGKGEFGDVMLGDYR----GNKVAVKCIKNDATAQAFLA-----------E 64
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYL 232
             +M  L+H N+V L+ VI +      Y+V EY+      D     G   +G     K+ 
Sbjct: 65  ASVMTQLRHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 123
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV- 291
            D+   + YL G+N VH D+   N+LV+     K+ DF +++      D  +     PV 
Sbjct: 124 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVK 179
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN-SLVFPDA 349
           +TAPE      +  K +D W+ G+ L+ +   G+ P+    L+D   ++     +  PD 
Sbjct: 180 WTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 238
Query: 350 MNPELRNLLEGLLCKDPTRR---LTLNDVAKH 378
             P +  +++     D   R   L L +  +H
Sbjct: 239 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 114/263 (43%), Gaps = 30/263 (11%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           +IG G++G+V   R   D    A+K+  ++    L+            +E  I+K   HP
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK--------AKFLQEARILKQYSHP 172
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV----SGLM 240
           NIV LI V         Y+V+E V+G    D        G  +  K L  +V    +G+ 
Sbjct: 173 NIVRLIGVCTQKQP--IYIVMELVQG---GDFLTFLRTEGARLRVKTLLQMVGDAAAGME 227
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG---TPV-FTAPE 296
           YL     +H D+   N LV     +KI DF +S+  E+ + V   S G    PV +TAPE
Sbjct: 228 YLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPE 285
Query: 297 CCLGLTYG--GKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS-LVFPDAMNP 352
               L YG     +D W+ G+ L+    +G  P+   + Q T + +     L  P+    
Sbjct: 286 ---ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPD 342
Query: 353 ELRNLLEGLLCKDPTRRLTLNDV 375
            +  L+E     +P +R + + +
Sbjct: 343 AVFRLMEQCWAYEPGQRPSFSTI 365

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 111/260 (42%), Gaps = 28/260 (10%)
Query: 117 INEYVHVRKIGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           + E   ++ IG G +G V+L  YR    G   A+K       ++  +A           E
Sbjct: 5   MKELKLLQTIGKGEFGDVMLGDYR----GNKVAVKCIKNDATAQAFLA-----------E 49
Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYL 232
             +M  L+H N+V L+ VI +      Y+V EY+      D     G   +G     K+ 
Sbjct: 50  ASVMTQLRHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 108
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV- 291
            D+   + YL G+N VH D+   N+LV+     K+ DF +++      D  +     PV 
Sbjct: 109 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVK 164
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN-SLVFPDA 349
           +TAPE      +  K +D W+ G+ L+ +   G+ P+    L+D   ++     +  PD 
Sbjct: 165 WTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 223
Query: 350 MNPELRNLLEGLLCKDPTRR 369
             P +  +++     D   R
Sbjct: 224 CPPAVYEVMKNCWHLDAAMR 243

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +++  + ++GAG+ G V   +    G   A K  H      L + P+      + RE+ +
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIH------LEIKPA--IRNQIIRELQV 67
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +     P IV         +     + +E+++G   +    +   I E +  K    ++ 
Sbjct: 68  LHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLR 125
Query: 238 GLMYL-HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           GL YL   H ++H D+KP N+LV   G +K+ DF VS    D   +     GT  + APE
Sbjct: 126 GLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMAPE 183
Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
              G  Y  + +D W++G++L  + +G+YP 
Sbjct: 184 RLQGTHYSVQ-SDIWSMGLSLVELAVGRYPI 213

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 117/301 (38%), Gaps = 57/301 (18%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y   + IG GS+G  V+Y++ L   G+  AIK   +    K              RE+ I
Sbjct: 22  YTDTKVIGNGSFG--VVYQAKLCDSGELVAIKKVLQGKAFK-------------NRELQI 66
Query: 178 MKMLQHPNIVNLIEVI----DDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARK 230
           M+ L H NIV L        +  +  +  +VL+YV             A   +     + 
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL 126
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDF-SVSQVFEDDNDVLRRSPG 288
           Y+  +   L Y+H   + H DIKP NLL+ P +  +K+ DF S  Q+   + +V      
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXIC 184
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN------- 341
           +  + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+        
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244
Query: 342 ----------NSLVFPDA------------MNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                         FP                PE   L   LL   PT RLT  +   H+
Sbjct: 245 EQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304
Query: 380 W 380
           +
Sbjct: 305 F 305

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 105/260 (40%), Gaps = 54/260 (20%)
Query: 108 SEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETA 167
           + DE   K ++ +   R  G G++G V L +    G   AIK                  
Sbjct: 13  AADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK----------------KV 56
Query: 168 MTDVR---REVLIMK---MLQHPNIVNLIEVI-----DDPNSDHFYMVLEYVEG------ 210
           + D R   RE+ IM+   +L HPNIV L          D    +  +V+EYV        
Sbjct: 57  IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCC 116
Query: 211 -KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-GTVKIG 268
             +       P  + +    + +R I  G ++L   NV H DIKP N+LV  + GT+K+ 
Sbjct: 117 RNYYRRQVAPPPILIKVFLFQLIRSI--GCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174
Query: 269 DFSVSQVFEDDNDVLRRSPGTP--------VFTAPECCLGLTYGGKAADTWAVGVTLYYM 320
           DF  ++         + SP  P         + APE   G  +   A D W+VG     M
Sbjct: 175 DFGSAK---------KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEM 225
Query: 321 IIGQYPFLGETLQDTYDKIV 340
           ++G+  F G+       +IV
Sbjct: 226 MLGEPIFRGDNSAGQLHEIV 245

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 8/200 (4%)
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLE-YVEGKWDNDGFGQPGAIGESMARKYL 232
           E +IMK L HP+IV LI +I++  +   ++++E Y  G+  +       ++       Y 
Sbjct: 59  EAVIMKNLDHPHIVKLIGIIEEEPT---WIIMELYPYGELGHYLERNKNSLKVLTLVLYS 115
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV- 291
             I   + YL   N VH DI   N+LVA    VK+GDF +S+  ED++         P+ 
Sbjct: 116 LQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK 175
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVN-NSLVFPDA 349
           + +PE  +       A+D W   V ++ ++  G+ PF     +D    +   + L  PD 
Sbjct: 176 WMSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDL 234
Query: 350 MNPELRNLLEGLLCKDPTRR 369
             P L  L+      DP+ R
Sbjct: 235 CPPVLYTLMTRCWDYDPSDR 254

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 126/275 (45%), Gaps = 21/275 (7%)
Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           IN+  ++ ++G+G+ G+V   R    G   A+K   +S   +     ++  + D+    +
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE----ENKRILMDLD---V 76
Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           ++K    P IV         N+D F + +E +    +       G I E +  K    IV
Sbjct: 77  VLKSHDCPYIVQCFGTFIT-NTDVF-IAMELMGTCAEKLKKRMQGPIPERILGKMTVAIV 134
Query: 237 SGLMYL-HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
             L YL   H V+H D+KP N+L+   G +K+ DF +S    DD     RS G   + AP
Sbjct: 135 KALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-AKDRSAGCAAYMAP 193
Query: 296 ECC-----LGLTYGGKAADTWAVGVTLYYMIIGQYPFLG-ETLQDTYDKIVNNS-LVFPD 348
           E           Y  + AD W++G++L  +  GQ+P+   +T  +   K++     + P 
Sbjct: 194 ERIDPPDPTKPDYDIR-ADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG 252
Query: 349 AM--NPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            M  + + ++ ++  L KD  +R   N + +H+++
Sbjct: 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 8/200 (4%)
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLE-YVEGKWDNDGFGQPGAIGESMARKYL 232
           E +IMK L HP+IV LI +I++  +   ++++E Y  G+  +       ++       Y 
Sbjct: 63  EAVIMKNLDHPHIVKLIGIIEEEPT---WIIMELYPYGELGHYLERNKNSLKVLTLVLYS 119
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV- 291
             I   + YL   N VH DI   N+LVA    VK+GDF +S+  ED++         P+ 
Sbjct: 120 LQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK 179
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVN-NSLVFPDA 349
           + +PE  +       A+D W   V ++ ++  G+ PF     +D    +   + L  PD 
Sbjct: 180 WMSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDL 238
Query: 350 MNPELRNLLEGLLCKDPTRR 369
             P L  L+      DP+ R
Sbjct: 239 CPPVLYTLMTRCWDYDPSDR 258

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 8/200 (4%)
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLE-YVEGKWDNDGFGQPGAIGESMARKYL 232
           E +IMK L HP+IV LI +I++  +   ++++E Y  G+  +       ++       Y 
Sbjct: 75  EAVIMKNLDHPHIVKLIGIIEEEPT---WIIMELYPYGELGHYLERNKNSLKVLTLVLYS 131
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV- 291
             I   + YL   N VH DI   N+LVA    VK+GDF +S+  ED++         P+ 
Sbjct: 132 LQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK 191
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVN-NSLVFPDA 349
           + +PE  +       A+D W   V ++ ++  G+ PF     +D    +   + L  PD 
Sbjct: 192 WMSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDL 250
Query: 350 MNPELRNLLEGLLCKDPTRR 369
             P L  L+      DP+ R
Sbjct: 251 CPPVLYTLMTRCWDYDPSDR 270

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 117/270 (43%), Gaps = 22/270 (8%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
           + +GAG++GKVV   +   GK  A+       L     A  + A+     E+ IM  L Q
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS---ELKIMSHLGQ 108
Query: 183 HPNIVNLI-------EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARK----- 230
           H NIVNL+        V+       +  +L ++  K          AI  S A       
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLRRSPGT 289
           +   +  G+ +L   N +H D+   N+L+      KIGDF +++ +  D N +++ +   
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN--SLV 345
           PV + APE      Y  + +D W+ G+ L+ +  +G  P+ G  +   + K+V +   + 
Sbjct: 229 PVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA 287
Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDV 375
            P      + ++++     +PT R T   +
Sbjct: 288 QPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 89/220 (40%), Gaps = 20/220 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E   V+ +G+G++G V       +G+   I    K     L       A  +   E LI
Sbjct: 15  TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKI----LNETTGPKANVEFMDEALI 70
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMV------LEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + HP++V L+ V   P       +      LEYV    DN        IG  +   +
Sbjct: 71  MASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDN--------IGSQLLLNW 122
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+MYL    +VH D+   N+LV     VKI DF ++++ E D        G  P
Sbjct: 123 CVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 182
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           +      C+        +D W+ GVT++  M  G  P+ G
Sbjct: 183 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 222

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 106/233 (45%), Gaps = 24/233 (10%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           ++IG+GS+G V  Y+    G   A+K  + +       AP+   +   + EV +++  +H
Sbjct: 30  QRIGSGSFGTV--YKGKWHGD-VAVKMLNVT-------APTPQQLQAFKNEVGVLRKTRH 79
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS----GL 239
            NI+  +     P      +V ++ EG   +  +    A       K L DI      G+
Sbjct: 80  VNILLFMGYSTKP---QLAIVTQWCEG---SSLYHHLHASETKFEMKKLIDIARQTARGM 133
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS--QVFEDDNDVLRRSPGTPVFTAPEC 297
            YLH  +++H D+K +N+ +    TVKIGDF ++  +     +    +  G+ ++ APE 
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193
Query: 298 CLGLTYGGKA--ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD 348
                    +  +D +A G+ LY ++ GQ P+     +D   ++V    + PD
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 92/228 (40%), Gaps = 20/228 (8%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E   V+ +G+G++G V       +G+   I    K     L       A  +   E LI
Sbjct: 38  TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKI----LNETTGPKANVEFMDEALI 93
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMV------LEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + HP++V L+ V   P       +      LEYV    DN        IG  +   +
Sbjct: 94  MASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDN--------IGSQLLLNW 145
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+MYL    +VH D+   N+LV     VKI DF ++++ E D        G  P
Sbjct: 146 CVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 205
Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYD 337
           +      C+        +D W+ GVT++  M  G  P+ G   ++  D
Sbjct: 206 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD 253

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 106/233 (45%), Gaps = 24/233 (10%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           ++IG+GS+G V  Y+    G   A+K  + +       AP+   +   + EV +++  +H
Sbjct: 30  QRIGSGSFGTV--YKGKWHGD-VAVKMLNVT-------APTPQQLQAFKNEVGVLRKTRH 79
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS----GL 239
            NI+  +     P      +V ++ EG   +  +    A       K L DI      G+
Sbjct: 80  VNILLFMGYSTAP---QLAIVTQWCEG---SSLYHHLHASETKFEMKKLIDIARQTARGM 133
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS--QVFEDDNDVLRRSPGTPVFTAPEC 297
            YLH  +++H D+K +N+ +    TVKIGDF ++  +     +    +  G+ ++ APE 
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193
Query: 298 CLGLTYGGKA--ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD 348
                    +  +D +A G+ LY ++ GQ P+     +D   ++V    + PD
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 117/301 (38%), Gaps = 57/301 (18%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y   + IG GS+G  V+Y++ L   G+  AIK   +    K              RE+ I
Sbjct: 22  YTDTKVIGNGSFG--VVYQAKLCDSGELVAIKKVLQGKAFK-------------NRELQI 66
Query: 178 MKMLQHPNIVNLIEVI----DDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARK 230
           M+ L H NIV L        +  +  +  +VL+YV             A   +     + 
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDF-SVSQVFEDDNDVLRRSPG 288
           Y+  +   L Y+H   + H DIKP NLL+ P +  +K+ DF S  Q+   + +V      
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-- 184
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN------- 341
           +  + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+        
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244
Query: 342 ----------NSLVFPDA------------MNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                         FP                PE   L   LL   PT RLT  +   H+
Sbjct: 245 EQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304
Query: 380 W 380
           +
Sbjct: 305 F 305

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 110/259 (42%), Gaps = 24/259 (9%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 67
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGL 239
           +HPN+V L+ V        FY+++E++      D   +     +   +       I S +
Sbjct: 68  KHPNLVQLLGVCT--REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 125
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ +TAPE  
Sbjct: 126 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE-S 184
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRN 356
           L        +D WA GV L+ +   G  P+ G  L   Y+ +  +  +  P+    ++  
Sbjct: 185 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 244
Query: 357 LLEGLLCKDPTRRLTLNDV 375
           L+      +P+ R +  ++
Sbjct: 245 LMRACWQWNPSDRPSFAEI 263

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 118/301 (39%), Gaps = 57/301 (18%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y   + IG GS+G  V+Y++ L   G+  AIK   +    K              RE+ I
Sbjct: 22  YTDTKVIGNGSFG--VVYQAKLCDSGELVAIKKVLQDKRFK-------------NRELQI 66
Query: 178 MKMLQHPNIVNLIEVI----DDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARK 230
           M+ L H NIV L        +  +  +  +VL+YV             A   +     + 
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDF-SVSQVFEDDNDVLRRSPG 288
           Y+  +   L Y+H   + H DIKP NLL+ P +  +K+ DF S  Q+   + +V      
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXIC 184
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN------ 342
           +  + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+        
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244
Query: 343 -----------------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                                  + VF     PE   L   LL   PT RLT  +   H+
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304
Query: 380 W 380
           +
Sbjct: 305 F 305

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 118/301 (39%), Gaps = 57/301 (18%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y   + IG GS+G  V+Y++ L   G+  AIK   +    K              RE+ I
Sbjct: 22  YTDTKVIGNGSFG--VVYQAKLCDSGELVAIKKVLQDKRFK-------------NRELQI 66
Query: 178 MKMLQHPNIVNLIEVI----DDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARK 230
           M+ L H NIV L        +  +  +  +VL+YV             A   +     + 
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDF-SVSQVFEDDNDVLRRSPG 288
           Y+  +   L Y+H   + H DIKP NLL+ P +  +K+ DF S  Q+   + +V      
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXIC 184
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN------ 342
           +  + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+        
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244
Query: 343 -----------------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                                  + VF     PE   L   LL   PT RLT  +   H+
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304
Query: 380 W 380
           +
Sbjct: 305 F 305

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 101/233 (43%), Gaps = 28/233 (12%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y   + IG GS+G  V+Y++ L   G+  AIK   +    K              RE+ I
Sbjct: 41  YTDTKVIGNGSFG--VVYQAKLCDSGELVAIKKVLQDKRFK-------------NRELQI 85
Query: 178 MKMLQHPNIVNLIEVI----DDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARK 230
           M+ L H NIV L        +  +  +  +VL+YV             A   +     + 
Sbjct: 86  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 145
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDF-SVSQVFEDDNDVLRRSPG 288
           Y+  +   L Y+H   + H DIKP NLL+ P +  +K+ DF S  Q+   + +V      
Sbjct: 146 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXIC 203
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN 341
           +  + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+ 
Sbjct: 204 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 256

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 117/301 (38%), Gaps = 57/301 (18%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y   + IG GS+G  V+Y++ L   G+  AIK   +    K              RE+ I
Sbjct: 56  YTDTKVIGNGSFG--VVYQAKLCDSGELVAIKKVLQDKRFK-------------NRELQI 100
Query: 178 MKMLQHPNIVNLIEVI--DDPNSDHFYM--VLEYVEGKWDNDGFGQPGA---IGESMARK 230
           M+ L H NIV L           D  Y+  VL+YV             A   +     + 
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 160
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDF-SVSQVFEDDNDVLRRSPG 288
           Y+  +   L Y+H   + H DIKP NLL+ P +  +K+ DF S  Q+   + +V      
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXIC 218
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN------ 342
           +  + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+        
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278
Query: 343 -----------------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                                  + VF     PE   L   LL   PT RLT  +   H+
Sbjct: 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338
Query: 380 W 380
           +
Sbjct: 339 F 339

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 101/233 (43%), Gaps = 28/233 (12%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y   + IG GS+G  V+Y++ L   G+  AIK   +    K              RE+ I
Sbjct: 23  YTDTKVIGNGSFG--VVYQAKLCDSGELVAIKKVLQDKRFK-------------NRELQI 67
Query: 178 MKMLQHPNIVNLIEVI----DDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARK 230
           M+ L H NIV L        +  +  +  +VL+YV             A   +     + 
Sbjct: 68  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 127
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDF-SVSQVFEDDNDVLRRSPG 288
           Y+  +   L Y+H   + H DIKP NLL+ P +  +K+ DF S  Q+   + +V      
Sbjct: 128 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXIC 185
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN 341
           +  + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+ 
Sbjct: 186 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 238

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 101/233 (43%), Gaps = 28/233 (12%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y   + IG GS+G  V+Y++ L   G+  AIK   +    K              RE+ I
Sbjct: 30  YTDTKVIGNGSFG--VVYQAKLCDSGELVAIKKVLQDKRFK-------------NRELQI 74
Query: 178 MKMLQHPNIVNLIEVI----DDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARK 230
           M+ L H NIV L        +  +  +  +VL+YV             A   +     + 
Sbjct: 75  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 134
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDF-SVSQVFEDDNDVLRRSPG 288
           Y+  +   L Y+H   + H DIKP NLL+ P +  +K+ DF S  Q+   + +V      
Sbjct: 135 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXIC 192
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN 341
           +  + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+ 
Sbjct: 193 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 245

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 118/301 (39%), Gaps = 57/301 (18%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y   + IG GS+G  V+Y++ L   G+  AIK   +    K              RE+ I
Sbjct: 34  YTDTKVIGNGSFG--VVYQAKLCDSGELVAIKKVLQDKRFK-------------NRELQI 78
Query: 178 MKMLQHPNIVNLIEVI----DDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARK 230
           M+ L H NIV L        +  +  +  +VL+YV             A   +     + 
Sbjct: 79  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 138
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDF-SVSQVFEDDNDVLRRSPG 288
           Y+  +   L Y+H   + H DIKP NLL+ P +  +K+ DF S  Q+   + +V      
Sbjct: 139 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXIC 196
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN------ 342
           +  + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+        
Sbjct: 197 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 256
Query: 343 -----------------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                                  + VF     PE   L   LL   PT RLT  +   H+
Sbjct: 257 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 316
Query: 380 W 380
           +
Sbjct: 317 F 317

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 118/301 (39%), Gaps = 57/301 (18%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y   + IG GS+G  V+Y++ L   G+  AIK   +    K              RE+ I
Sbjct: 34  YTDTKVIGNGSFG--VVYQAKLCDSGELVAIKKVLQDKRFK-------------NRELQI 78
Query: 178 MKMLQHPNIVNLIEVI----DDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARK 230
           M+ L H NIV L        +  +  +  +VL+YV             A   +     + 
Sbjct: 79  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 138
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDF-SVSQVFEDDNDVLRRSPG 288
           Y+  +   L Y+H   + H DIKP NLL+ P +  +K+ DF S  Q+   + +V      
Sbjct: 139 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXIC 196
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN------ 342
           +  + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+        
Sbjct: 197 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 256
Query: 343 -----------------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                                  + VF     PE   L   LL   PT RLT  +   H+
Sbjct: 257 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 316
Query: 380 W 380
           +
Sbjct: 317 F 317

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 118/301 (39%), Gaps = 57/301 (18%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y   + IG GS+G  V+Y++ L   G+  AIK   +    K              RE+ I
Sbjct: 22  YTDTKVIGNGSFG--VVYQAKLCDSGELVAIKKVLQGKAFK-------------NRELQI 66
Query: 178 MKMLQHPNIVNLIEVI----DDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARK 230
           M+ L H NIV L        +  +  +  +VL+YV             A   +     + 
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDF-SVSQVFEDDNDVLRRSPG 288
           Y+  +   L Y+H   + H DIKP NLL+ P +  +K+ DF S  Q+   + +V      
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-- 184
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN------ 342
           +  + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+        
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244
Query: 343 -----------------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                                  + VF     PE   L   LL   PT RLT  +   H+
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304
Query: 380 W 380
           +
Sbjct: 305 F 305

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 118/301 (39%), Gaps = 57/301 (18%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y   + IG GS+G  V+Y++ L   G+  AIK   +    K              RE+ I
Sbjct: 26  YTDTKVIGNGSFG--VVYQAKLCDSGELVAIKKVLQDKRFK-------------NRELQI 70
Query: 178 MKMLQHPNIVNLIEVI----DDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARK 230
           M+ L H NIV L        +  +  +  +VL+YV             A   +     + 
Sbjct: 71  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 130
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDF-SVSQVFEDDNDVLRRSPG 288
           Y+  +   L Y+H   + H DIKP NLL+ P +  +K+ DF S  Q+   + +V      
Sbjct: 131 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXIC 188
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN------ 342
           +  + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+        
Sbjct: 189 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 248
Query: 343 -----------------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                                  + VF     PE   L   LL   PT RLT  +   H+
Sbjct: 249 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 308
Query: 380 W 380
           +
Sbjct: 309 F 309

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 118/301 (39%), Gaps = 57/301 (18%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y   + IG GS+G  V+Y++ L   G+  AIK   +    K              RE+ I
Sbjct: 22  YTDTKVIGNGSFG--VVYQAKLCDSGELVAIKKVLQDKRFK-------------NRELQI 66
Query: 178 MKMLQHPNIVNLIEVI----DDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARK 230
           M+ L H NIV L        +  +  +  +VL+YV             A   +     + 
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDF-SVSQVFEDDNDVLRRSPG 288
           Y+  +   L Y+H   + H DIKP NLL+ P +  +K+ DF S  Q+   + +V      
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXIC 184
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN------ 342
           +  + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+        
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244
Query: 343 -----------------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                                  + VF     PE   L   LL   PT RLT  +   H+
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304
Query: 380 W 380
           +
Sbjct: 305 F 305

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 118/301 (39%), Gaps = 57/301 (18%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y   + IG GS+G  V+Y++ L   G+  AIK   +    K              RE+ I
Sbjct: 35  YTDTKVIGNGSFG--VVYQAKLCDSGELVAIKKVLQDKRFK-------------NRELQI 79
Query: 178 MKMLQHPNIVNLIEVI----DDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARK 230
           M+ L H NIV L        +  +  +  +VL+YV             A   +     + 
Sbjct: 80  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 139
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDF-SVSQVFEDDNDVLRRSPG 288
           Y+  +   L Y+H   + H DIKP NLL+ P +  +K+ DF S  Q+   + +V      
Sbjct: 140 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-- 197
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN------ 342
           +  + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+        
Sbjct: 198 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 257
Query: 343 -----------------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                                  + VF     PE   L   LL   PT RLT  +   H+
Sbjct: 258 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 317
Query: 380 W 380
           +
Sbjct: 318 F 318

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 110/259 (42%), Gaps = 24/259 (9%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 66
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGL 239
           +HPN+V L+ V        FY+++E++      D   +     +   +       I S +
Sbjct: 67  KHPNLVQLLGVCT--REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ +TAPE  
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-S 183
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRN 356
           L        +D WA GV L+ +   G  P+ G  L   Y+ +  +  +  P+    ++  
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 243
Query: 357 LLEGLLCKDPTRRLTLNDV 375
           L+      +P+ R +  ++
Sbjct: 244 LMRACWQWNPSDRPSFAEI 262

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 118/301 (39%), Gaps = 57/301 (18%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y   + IG GS+G  V+Y++ L   G+  AIK   +    K              RE+ I
Sbjct: 50  YTDTKVIGNGSFG--VVYQAKLCDSGELVAIKKVLQDKRFK-------------NRELQI 94
Query: 178 MKMLQHPNIVNLIEVI----DDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARK 230
           M+ L H NIV L        +  +  +  +VL+YV             A   +     + 
Sbjct: 95  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 154
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDF-SVSQVFEDDNDVLRRSPG 288
           Y+  +   L Y+H   + H DIKP NLL+ P +  +K+ DF S  Q+   + +V      
Sbjct: 155 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-- 212
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN------ 342
           +  + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+        
Sbjct: 213 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 272
Query: 343 -----------------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                                  + VF     PE   L   LL   PT RLT  +   H+
Sbjct: 273 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 332
Query: 380 W 380
           +
Sbjct: 333 F 333

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 117/301 (38%), Gaps = 57/301 (18%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y   + IG GS+G  V+Y++ L   G+  AIK   +    K              RE+ I
Sbjct: 56  YTDTKVIGNGSFG--VVYQAKLCDSGELVAIKKVLQDKRFK-------------NRELQI 100
Query: 178 MKMLQHPNIVNLIEVI--DDPNSDHFYM--VLEYVEGKWDNDGFGQPGA---IGESMARK 230
           M+ L H NIV L           D  Y+  VL+YV             A   +     + 
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 160
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDF-SVSQVFEDDNDVLRRSPG 288
           Y+  +   L Y+H   + H DIKP NLL+ P +  +K+ DF S  Q+   + +V      
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-- 218
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN------ 342
           +  + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+        
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278
Query: 343 -----------------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                                  + VF     PE   L   LL   PT RLT  +   H+
Sbjct: 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338
Query: 380 W 380
           +
Sbjct: 339 F 339

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 117/301 (38%), Gaps = 57/301 (18%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y   + IG GS+G  V+Y++ L   G+  AIK   +    K              RE+ I
Sbjct: 58  YTDTKVIGNGSFG--VVYQAKLCDSGELVAIKKVLQDKRFK-------------NRELQI 102
Query: 178 MKMLQHPNIVNLIEVI--DDPNSDHFYM--VLEYVEGKWDNDGFGQPGA---IGESMARK 230
           M+ L H NIV L           D  Y+  VL+YV             A   +     + 
Sbjct: 103 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 162
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDF-SVSQVFEDDNDVLRRSPG 288
           Y+  +   L Y+H   + H DIKP NLL+ P +  +K+ DF S  Q+   + +V      
Sbjct: 163 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-- 220
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN------ 342
           +  + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+        
Sbjct: 221 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 280
Query: 343 -----------------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                                  + VF     PE   L   LL   PT RLT  +   H+
Sbjct: 281 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 340
Query: 380 W 380
           +
Sbjct: 341 F 341

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 110/259 (42%), Gaps = 24/259 (9%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 66
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGL 239
           +HPN+V L+ V        FY+++E++      D   +     +   +       I S +
Sbjct: 67  KHPNLVQLLGVCT--REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ +TAPE  
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-S 183
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRN 356
           L        +D WA GV L+ +   G  P+ G  L   Y+ +  +  +  P+    ++  
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 243
Query: 357 LLEGLLCKDPTRRLTLNDV 375
           L+      +P+ R +  ++
Sbjct: 244 LMRACWQWNPSDRPSFAEI 262

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 118/301 (39%), Gaps = 57/301 (18%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y   + IG GS+G  V+Y++ L   G+  AIK   +    K              RE+ I
Sbjct: 27  YTDTKVIGNGSFG--VVYQAKLCDSGELVAIKKVLQDKRFK-------------NRELQI 71
Query: 178 MKMLQHPNIVNLIEVI----DDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARK 230
           M+ L H NIV L        +  +  +  +VL+YV             A   +     + 
Sbjct: 72  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 131
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDF-SVSQVFEDDNDVLRRSPG 288
           Y+  +   L Y+H   + H DIKP NLL+ P +  +K+ DF S  Q+   + +V      
Sbjct: 132 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-- 189
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN------ 342
           +  + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+        
Sbjct: 190 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 249
Query: 343 -----------------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                                  + VF     PE   L   LL   PT RLT  +   H+
Sbjct: 250 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 309
Query: 380 W 380
           +
Sbjct: 310 F 310

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 118/301 (39%), Gaps = 57/301 (18%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y   + IG GS+G  V+Y++ L   G+  AIK   +    K              RE+ I
Sbjct: 22  YTDTKVIGNGSFG--VVYQAKLCDSGELVAIKKVLQDKRFK-------------NRELQI 66
Query: 178 MKMLQHPNIVNLIEVI----DDPNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARK 230
           M+ L H NIV L        +  +  +  +VL+YV             A   +     + 
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDF-SVSQVFEDDNDVLRRSPG 288
           Y+  +   L Y+H   + H DIKP NLL+ P +  +K+ DF S  Q+   + +V      
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYIC 184
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN------ 342
           +  + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+        
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244
Query: 343 -----------------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                                  + VF     PE   L   LL   PT RLT  +   H+
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304
Query: 380 W 380
           +
Sbjct: 305 F 305

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 110/259 (42%), Gaps = 24/259 (9%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 71
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGL 239
           +HPN+V L+ V        FY+++E++      D   +     +   +       I S +
Sbjct: 72  KHPNLVQLLGVCT--REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 129
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ +TAPE  
Sbjct: 130 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-S 188
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRN 356
           L        +D WA GV L+ +   G  P+ G  L   Y+ +  +  +  P+    ++  
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 248
Query: 357 LLEGLLCKDPTRRLTLNDV 375
           L+      +P+ R +  ++
Sbjct: 249 LMRACWQWNPSDRPSFAEI 267

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 117/301 (38%), Gaps = 57/301 (18%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y   + IG GS+G  V+Y++ L   G+  AIK   +    K              RE+ I
Sbjct: 101 YTDTKVIGNGSFG--VVYQAKLCDSGELVAIKKVLQDKRFK-------------NRELQI 145
Query: 178 MKMLQHPNIVNLIEVI--DDPNSDHFYM--VLEYVEGKWDNDGFGQPGA---IGESMARK 230
           M+ L H NIV L           D  Y+  VL+YV             A   +     + 
Sbjct: 146 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 205
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDF-SVSQVFEDDNDVLRRSPG 288
           Y+  +   L Y+H   + H DIKP NLL+ P +  +K+ DF S  Q+   + +V      
Sbjct: 206 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-- 263
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN------ 342
           +  + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+        
Sbjct: 264 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 323
Query: 343 -----------------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                                  + VF     PE   L   LL   PT RLT  +   H+
Sbjct: 324 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 383
Query: 380 W 380
           +
Sbjct: 384 F 384

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 117/301 (38%), Gaps = 57/301 (18%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y   + IG GS+G  V+Y++ L   G+  AIK   +    K              RE+ I
Sbjct: 60  YTDTKVIGNGSFG--VVYQAKLCDSGELVAIKKVLQDKRFK-------------NRELQI 104
Query: 178 MKMLQHPNIVNLIEVI--DDPNSDHFYM--VLEYVEGKWDNDGFGQPGA---IGESMARK 230
           M+ L H NIV L           D  Y+  VL+YV             A   +     + 
Sbjct: 105 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 164
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDF-SVSQVFEDDNDVLRRSPG 288
           Y+  +   L Y+H   + H DIKP NLL+ P +  +K+ DF S  Q+   + +V      
Sbjct: 165 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-- 222
Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN------ 342
           +  + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+        
Sbjct: 223 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 282
Query: 343 -----------------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                                  + VF     PE   L   LL   PT RLT  +   H+
Sbjct: 283 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 342
Query: 380 W 380
           +
Sbjct: 343 F 343

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 104/233 (44%), Gaps = 24/233 (10%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           ++IG+GS+G V  Y+    G   A+K  + +       AP+   +   + EV +++  +H
Sbjct: 41  QRIGSGSFGTV--YKGKWHGD-VAVKMLNVT-------APTPQQLQAFKNEVGVLRKTRH 90
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV----SGL 239
            NI+  +     P      +V ++ EG   +  +     I        L DI      G+
Sbjct: 91  VNILLFMGYSTKP---QLAIVTQWCEG---SSLYHHLHIIETKFEMIKLIDIARQTAQGM 144
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE--DDNDVLRRSPGTPVFTAPEC 297
            YLH  +++H D+K +N+ +    TVKIGDF ++ V      +    +  G+ ++ APE 
Sbjct: 145 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 204
Query: 298 CLGLTYGGKA--ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD 348
                    +  +D +A G+ LY ++ GQ P+     +D    +V    + PD
Sbjct: 205 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 257

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 116/270 (42%), Gaps = 22/270 (8%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
           + +GAG++GKVV   +   GK  A+       L     A  + A+     E+ IM  L Q
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS---ELKIMSHLGQ 108
Query: 183 HPNIVNLI-------EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARK----- 230
           H NIVNL+        V+       +  +L ++  K          AI  S         
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLH 168
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLRRSPGT 289
           +   +  G+ +L   N +H D+   N+L+      KIGDF +++ +  D N +++ +   
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN--SLV 345
           PV + APE      Y  + +D W+ G+ L+ +  +G  P+ G  +   + K+V +   + 
Sbjct: 229 PVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA 287
Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDV 375
            P      + ++++     +PT R T   +
Sbjct: 288 QPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 104/233 (44%), Gaps = 24/233 (10%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           ++IG+GS+G V  Y+    G   A+K  + +       AP+   +   + EV +++  +H
Sbjct: 42  QRIGSGSFGTV--YKGKWHGD-VAVKMLNVT-------APTPQQLQAFKNEVGVLRKTRH 91
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV----SGL 239
            NI+  +     P      +V ++ EG   +  +     I        L DI      G+
Sbjct: 92  VNILLFMGYSTKP---QLAIVTQWCEG---SSLYHHLHIIETKFEMIKLIDIARQTAQGM 145
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE--DDNDVLRRSPGTPVFTAPEC 297
            YLH  +++H D+K +N+ +    TVKIGDF ++ V      +    +  G+ ++ APE 
Sbjct: 146 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 205
Query: 298 CLGLTYGGKA--ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD 348
                    +  +D +A G+ LY ++ GQ P+     +D    +V    + PD
Sbjct: 206 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 258

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 109/259 (42%), Gaps = 24/259 (9%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 71
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGL 239
           +HPN+V L+ V        FY++ E++      D   +     +   +       I S +
Sbjct: 72  KHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 129
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ +TAPE  
Sbjct: 130 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE-S 188
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRN 356
           L        +D WA GV L+ +   G  P+ G  L   Y+ +  +  +  P+    ++  
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 248
Query: 357 LLEGLLCKDPTRRLTLNDV 375
           L+      +P+ R +  ++
Sbjct: 249 LMRACWQWNPSDRPSFAEI 267

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 109/259 (42%), Gaps = 24/259 (9%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 66
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGL 239
           +HPN+V L+ V        FY++ E++      D   +     +   +       I S +
Sbjct: 67  KHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ +TAPE  
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-S 183
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRN 356
           L        +D WA GV L+ +   G  P+ G  L   Y+ +  +  +  P+    ++  
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 243
Query: 357 LLEGLLCKDPTRRLTLNDV 375
           L+      +P+ R +  ++
Sbjct: 244 LMRACWQWNPSDRPSFAEI 262

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 75/158 (47%), Gaps = 9/158 (5%)
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESM-ARKYLRDIVSGLMYLH 243
           NI+ LI+ + DP S    +V EY+    +N  F Q   I      R Y+ +++  L Y H
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYI----NNTDFKQLYQILTDFDIRFYMYELLKALDYCH 149
Query: 244 GHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
              ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  +   
Sbjct: 150 SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRV-ASRYFKGPELLVDYQ 208
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV 340
               + D W++G  L  MI  + PF     QD YD++V
Sbjct: 209 MYDYSLDMWSLGCMLASMIFRREPFFHG--QDNYDQLV 244

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 109/259 (42%), Gaps = 24/259 (9%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 71
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGL 239
           +HPN+V L+ V        FY++ E++      D   +     +   +       I S +
Sbjct: 72  KHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 129
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ +TAPE  
Sbjct: 130 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-S 188
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRN 356
           L        +D WA GV L+ +   G  P+ G  L   Y+ +  +  +  P+    ++  
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 248
Query: 357 LLEGLLCKDPTRRLTLNDV 375
           L+      +P+ R +  ++
Sbjct: 249 LMRACWQWNPSDRPSFAEI 267

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 104/233 (44%), Gaps = 24/233 (10%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           ++IG+GS+G V  Y+    G   A+K  + +       AP+   +   + EV +++  +H
Sbjct: 16  QRIGSGSFGTV--YKGKWHGD-VAVKMLNVT-------APTPQQLQAFKNEVGVLRKTRH 65
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV----SGL 239
            NI+  +     P      +V ++ EG   +  +     I        L DI      G+
Sbjct: 66  VNILLFMGYSTKPQ---LAIVTQWCEG---SSLYHHLHIIETKFEMIKLIDIARQTAQGM 119
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE--DDNDVLRRSPGTPVFTAPEC 297
            YLH  +++H D+K +N+ +    TVKIGDF ++ V      +    +  G+ ++ APE 
Sbjct: 120 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 179
Query: 298 CLGLTYGGKA--ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD 348
                    +  +D +A G+ LY ++ GQ P+     +D    +V    + PD
Sbjct: 180 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 232

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 109/259 (42%), Gaps = 24/259 (9%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 66
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGL 239
           +HPN+V L+ V        FY++ E++      D   +     +   +       I S +
Sbjct: 67  KHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 124
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ +TAPE  
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-S 183
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRN 356
           L        +D WA GV L+ +   G  P+ G  L   Y+ +  +  +  P+    ++  
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 243
Query: 357 LLEGLLCKDPTRRLTLNDV 375
           L+      +P+ R +  ++
Sbjct: 244 LMRACWQWNPSDRPSFAEI 262

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 109/259 (42%), Gaps = 24/259 (9%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 71
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGL 239
           +HPN+V L+ V        FY++ E++      D   +     +   +       I S +
Sbjct: 72  KHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 129
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ +TAPE  
Sbjct: 130 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-S 188
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRN 356
           L        +D WA GV L+ +   G  P+ G  L   Y+ +  +  +  P+    ++  
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 248
Query: 357 LLEGLLCKDPTRRLTLNDV 375
           L+      +P+ R +  ++
Sbjct: 249 LMRACWQWNPSDRPSFAEI 267

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 109/259 (42%), Gaps = 24/259 (9%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 66
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGL 239
           +HPN+V L+ V        FY++ E++      D   +     +   +       I S +
Sbjct: 67  KHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ +TAPE  
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-S 183
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRN 356
           L        +D WA GV L+ +   G  P+ G  L   Y+ +  +  +  P+    ++  
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 243
Query: 357 LLEGLLCKDPTRRLTLNDV 375
           L+      +P+ R +  ++
Sbjct: 244 LMRACWQWNPSDRPSFAEI 262

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 75/158 (47%), Gaps = 9/158 (5%)
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESM-ARKYLRDIVSGLMYLH 243
           NI+ LI+ + DP S    +V EY+    +N  F Q   I      R Y+ +++  L Y H
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYI----NNTDFKQLYQILTDFDIRFYMYELLKALDYCH 154
Query: 244 GHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
              ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  +   
Sbjct: 155 SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRV-ASRYFKGPELLVDYQ 213
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV 340
               + D W++G  L  MI  + PF     QD YD++V
Sbjct: 214 MYDYSLDMWSLGCMLASMIFRREPFFHG--QDNYDQLV 249

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 104/233 (44%), Gaps = 24/233 (10%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           ++IG+GS+G V  Y+    G   A+K  + +       AP+   +   + EV +++  +H
Sbjct: 19  QRIGSGSFGTV--YKGKWHGD-VAVKMLNVT-------APTPQQLQAFKNEVGVLRKTRH 68
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV----SGL 239
            NI+  +     P      +V ++ EG   +  +     I        L DI      G+
Sbjct: 69  VNILLFMGYSTKPQ---LAIVTQWCEG---SSLYHHLHIIETKFEMIKLIDIARQTAQGM 122
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE--DDNDVLRRSPGTPVFTAPEC 297
            YLH  +++H D+K +N+ +    TVKIGDF ++ V      +    +  G+ ++ APE 
Sbjct: 123 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 182
Query: 298 CLGLTYGGKA--ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD 348
                    +  +D +A G+ LY ++ GQ P+     +D    +V    + PD
Sbjct: 183 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 235

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 109/259 (42%), Gaps = 24/259 (9%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 70
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGL 239
           +HPN+V L+ V        FY++ E++      D   +     +   +       I S +
Sbjct: 71  KHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 128
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ +TAPE  
Sbjct: 129 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-S 187
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRN 356
           L        +D WA GV L+ +   G  P+ G  L   Y+ +  +  +  P+    ++  
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247
Query: 357 LLEGLLCKDPTRRLTLNDV 375
           L+      +P+ R +  ++
Sbjct: 248 LMRACWQWNPSDRPSFAEI 266

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/266 (23%), Positives = 111/266 (41%), Gaps = 38/266 (14%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 68
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV----- 236
           +HPN+V L+ V        FY++ E++        +G          R+ +  +V     
Sbjct: 69  KHPNLVQLLGVCT--REPPFYIITEFM-------TYGNLLDYLRECNRQEVNAVVLLYMA 119
Query: 237 ----SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV- 291
               S + YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ 
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 179
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDA 349
           +TAPE  L        +D WA GV L+ +   G  P+ G  L   Y+ +  +  +  P+ 
Sbjct: 180 WTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 238
Query: 350 MNPELRNLLEGLLCKDPTRRLTLNDV 375
              ++  L+      +P+ R +  ++
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/266 (23%), Positives = 111/266 (41%), Gaps = 38/266 (14%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 71
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV----- 236
           +HPN+V L+ V        FY++ E++        +G          R+ +  +V     
Sbjct: 72  KHPNLVQLLGVCT--REPPFYIITEFM-------TYGNLLDYLRECNRQEVNAVVLLYMA 122
Query: 237 ----SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV- 291
               S + YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ 
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDA 349
           +TAPE  L        +D WA GV L+ +   G  P+ G  L   Y+ +  +  +  P+ 
Sbjct: 183 WTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 241
Query: 350 MNPELRNLLEGLLCKDPTRRLTLNDV 375
              ++  L+      +P+ R +  ++
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/266 (23%), Positives = 111/266 (41%), Gaps = 38/266 (14%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 68
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV----- 236
           +HPN+V L+ V        FY++ E++        +G          R+ +  +V     
Sbjct: 69  KHPNLVQLLGVCT--REPPFYIITEFM-------TYGNLLDYLRECNRQEVNAVVLLYMA 119
Query: 237 ----SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV- 291
               S + YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ 
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 179
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDA 349
           +TAPE  L        +D WA GV L+ +   G  P+ G  L   Y+ +  +  +  P+ 
Sbjct: 180 WTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 238
Query: 350 MNPELRNLLEGLLCKDPTRRLTLNDV 375
              ++  L+      +P+ R +  ++
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/262 (23%), Positives = 117/262 (44%), Gaps = 33/262 (12%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           +IG+GS+G V  Y+    G   A+K           V P+       R EV +++  +H 
Sbjct: 43  RIGSGSFGTV--YKGKWHGD-VAVKILKV-------VDPTPEQFQAFRNEVAVLRKTRHV 92
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY-----LRDIVSGL 239
           NI+  +  +     D+  +V ++ EG        +   + E+  + +      R    G+
Sbjct: 93  NILLFMGYM---TKDNLAIVTQWCEG----SSLYKHLHVQETKFQMFQLIDIARQTAQGM 145
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE--DDNDVLRRSPGTPVFTAPEC 297
            YLH  N++H D+K +N+ +    TVKIGDF ++ V      +  + +  G+ ++ APE 
Sbjct: 146 DYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEV 205
Query: 298 CLGLTYG--GKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELR 355
                       +D ++ G+ LY ++ G+ P+   +  +  D+I+   +V     +P+L 
Sbjct: 206 IRMQDNNPFSFQSDVYSYGIVLYELMTGELPY---SHINNRDQII--FMVGRGYASPDLS 260
Query: 356 NLLEGLLCKDPTRRLTLNDVAK 377
            L +   C    +RL  + V K
Sbjct: 261 KLYKN--CPKAMKRLVADCVKK 280

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 109/259 (42%), Gaps = 24/259 (9%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 66
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGL 239
           +HPN+V L+ V        FY++ E++      D   +     +   +       I S +
Sbjct: 67  KHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 124
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ +TAPE  
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-S 183
Query: 299 LGLTYGGKAADTWAVGVTLYYM-IIGQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRN 356
           L        +D WA GV L+ +   G  P+ G  L   Y+ +  +  +  P+    ++  
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 243
Query: 357 LLEGLLCKDPTRRLTLNDV 375
           L+      +P+ R +  ++
Sbjct: 244 LMRACWQWNPSDRPSFAEI 262

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 104/233 (44%), Gaps = 24/233 (10%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           ++IG+GS+G V  Y+    G   A+K  + +       AP+   +   + EV +++  +H
Sbjct: 19  QRIGSGSFGTV--YKGKWHGD-VAVKMLNVT-------APTPQQLQAFKNEVGVLRKTRH 68
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV----SGL 239
            NI+  +     P      +V ++ EG   +  +     I        L DI      G+
Sbjct: 69  VNILLFMGYSTKP---QLAIVTQWCEG---SSLYHHLHIIETKFEMIKLIDIARQTAQGM 122
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE--DDNDVLRRSPGTPVFTAPEC 297
            YLH  +++H D+K +N+ +    TVKIGDF ++ V      +    +  G+ ++ APE 
Sbjct: 123 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 182
Query: 298 CLGLTYGGKA--ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD 348
                    +  +D +A G+ LY ++ GQ P+     +D    +V    + PD
Sbjct: 183 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 235

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/266 (23%), Positives = 111/266 (41%), Gaps = 38/266 (14%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 33  KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 79
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV----- 236
           +HPN+V L+ V        FY++ E++        +G          R+ +  +V     
Sbjct: 80  KHPNLVQLLGVCT--REPPFYIITEFM-------TYGNLLDYLRECNRQEVNAVVLLYMA 130
Query: 237 ----SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV- 291
               S + YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ 
Sbjct: 131 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 190
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDA 349
           +TAPE  L        +D WA GV L+ +   G  P+ G  L   Y+ +  +  +  P+ 
Sbjct: 191 WTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 249
Query: 350 MNPELRNLLEGLLCKDPTRRLTLNDV 375
              ++  L+      +P+ R +  ++
Sbjct: 250 CPEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 104/233 (44%), Gaps = 24/233 (10%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           ++IG+GS+G V  Y+    G   A+K  + +       AP+   +   + EV +++  +H
Sbjct: 14  QRIGSGSFGTV--YKGKWHGD-VAVKMLNVT-------APTPQQLQAFKNEVGVLRKTRH 63
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV----SGL 239
            NI+  +     P      +V ++ EG   +  +     I        L DI      G+
Sbjct: 64  VNILLFMGYSTKPQ---LAIVTQWCEG---SSLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE--DDNDVLRRSPGTPVFTAPEC 297
            YLH  +++H D+K +N+ +    TVKIGDF ++ V      +    +  G+ ++ APE 
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 298 CLGLTYGGKA--ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD 348
                    +  +D +A G+ LY ++ GQ P+     +D    +V    + PD
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 104/233 (44%), Gaps = 24/233 (10%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           ++IG+GS+G V  Y+    G   A+K  + +       AP+   +   + EV +++  +H
Sbjct: 14  QRIGSGSFGTV--YKGKWHGD-VAVKMLNVT-------APTPQQLQAFKNEVGVLRKTRH 63
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV----SGL 239
            NI+  +     P      +V ++ EG   +  +     I        L DI      G+
Sbjct: 64  VNILLFMGYSTAPQ---LAIVTQWCEG---SSLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE--DDNDVLRRSPGTPVFTAPEC 297
            YLH  +++H D+K +N+ +    TVKIGDF ++ V      +    +  G+ ++ APE 
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 298 CLGLTYGGKA--ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD 348
                    +  +D +A G+ LY ++ GQ P+     +D    +V    + PD
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 125 KIGAGSYGKVV--LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           ++G G++G V   +YR        AIK         L+    +    ++ RE  IM  L 
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKV--------LKQGTEKADTEEMMREAQIMHQLD 68
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEG-KWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
           +P IV LI V     ++   +V+E   G        G+   I  S   + L  +  G+ Y
Sbjct: 69  NPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 125
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF-EDDNDVLRRSPGT-PV-FTAPECC 298
           L   N VH D+   N+L+      KI DF +S+    DD+    RS G  P+ + APEC 
Sbjct: 126 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 299 LGLTYGGKAADTWAVGVTLYYMI-IGQYPF 327
               +  + +D W+ GVT++  +  GQ P+
Sbjct: 186 NFRKFSSR-SDVWSYGVTMWEALSYGQKPY 214

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 118/291 (40%), Gaps = 36/291 (12%)
Query: 124 RKIGAGSYGKVVLYRS-----SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           R++G G++GKV L          D    A+K    +         S+ A  D  RE  ++
Sbjct: 19  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---------SDNARKDFHREAELL 69
Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--------------GQPGAIG 224
             LQH +IV    V  +   D   MV EY++   D + F                P  + 
Sbjct: 70  TNLQHEHIVKFYGVCVE--GDPLIMVFEYMKHG-DLNKFLRAHGPDAVLMAEGNPPTELT 126
Query: 225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVL 283
           +S      + I +G++YL   + VH D+   N LV  +  VKIGDF +S+ V+  D   +
Sbjct: 127 QSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 186
Query: 284 RRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN 342
                 P+   P   +        +D W++GV L+ +   G+ P+   +  +  + I   
Sbjct: 187 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246
Query: 343 SLV-FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL 392
            ++  P     E+  L+ G   ++P  R  +  +  HT +       P YL
Sbjct: 247 RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLAKASPVYL 295

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 110/282 (39%), Gaps = 46/282 (16%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ- 182
           R +  G +  V   +    G+ YA+K    +   K R          + +EV  MK L  
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRA---------IIQEVCFMKKLSG 84
Query: 183 HPNIVNLIEVID------DPNSDHFYMVLEYVEGKWDN--DGFGQPGAIGESMARKYLRD 234
           HPNIV             D     F ++ E  +G+           G +      K    
Sbjct: 85  HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 235 IVSGLMYLHGHN--VVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED-------------- 278
               + ++H     ++H D+K +NLL++  GT+K+ DF  +                   
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 279 DNDVLRRSPGTPVFTAPECC-LGLTYG-GKAADTWAVGVTLYYMIIGQYPFL-GETLQDT 335
           + ++ R +  TP++  PE   L   +  G+  D WA+G  LY +   Q+PF  G  L   
Sbjct: 205 EEEITRNT--TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--- 259
Query: 336 YDKIVNNSLVFP--DAMNPELRNLLEGLLCKDPTRRLTLNDV 375
             +IVN     P  D       +L+  +L  +P  RL++ +V
Sbjct: 260 --RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEV 299

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKA------FHKSHLSKLRVAPSETAMTDVRR 173
           Y  ++ IG GS+G+VV        +H A+K       FH+    ++R+        D   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRIL-EHLRKQDKDN 157
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
            + ++ ML++    N I +  +  S + Y +++    K    GF  P      + RK+  
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIK----KNKFQGFSLP------LVRKFAH 207
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT--VKIGDFSVSQVFEDDNDVLRRSPGTPV 291
            I+  L  LH + ++H D+KP+N+L+   G   +K+ DF  S  +E     +     +  
Sbjct: 208 SILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQR--VYTXIQSRF 264
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL 328
           + APE  LG  Y G   D W++G  L  ++ G YP L
Sbjct: 265 YRAPEVILGARY-GMPIDMWSLGCILAELLTG-YPLL 299

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/281 (22%), Positives = 121/281 (43%), Gaps = 35/281 (12%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
           + +GAG++GKVV   +   GK  A+       L     A  + A+     E+ IM  L Q
Sbjct: 37  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS---ELKIMSHLGQ 93
Query: 183 HPNIVNLI-------------------EVIDDPNSDHFYMVLEYVEGKWDNDGF----GQ 219
           H NIVNL+                   ++++        M+   +    D +G     G+
Sbjct: 94  HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGR 153
Query: 220 PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFED 278
           P  + + +   +   +  G+ +L   N +H D+   N+L+      KIGDF +++ +  D
Sbjct: 154 PLELRDLL--HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 211
Query: 279 DNDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTY 336
            N +++ +   PV + APE      Y  + +D W+ G+ L+ +  +G  P+ G  +   +
Sbjct: 212 SNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILVNSKF 270
Query: 337 DKIVNN--SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDV 375
            K+V +   +  P      + ++++     +PT R T   +
Sbjct: 271 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 311

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 109/259 (42%), Gaps = 24/259 (9%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 67
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGL 239
           +HPN+V L+ V        FY++ E++      D   +     +   +       I S +
Sbjct: 68  KHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 125
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ +TAPE  
Sbjct: 126 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE-S 184
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRN 356
           L        +D WA GV L+ +   G  P+ G  L   Y+ +  +  +  P+    ++  
Sbjct: 185 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 244
Query: 357 LLEGLLCKDPTRRLTLNDV 375
           L+      +P+ R +  ++
Sbjct: 245 LMRACWQWNPSDRPSFAEI 263

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 109/259 (42%), Gaps = 24/259 (9%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 64
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGL 239
           +HPN+V L+ V        FY+++E++      D   +     +   +       I S +
Sbjct: 65  KHPNLVQLLGVCT--REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 122
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ +TAPE  
Sbjct: 123 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE-S 181
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRN 356
           L        +D WA GV L+ +   G  P+ G      Y+ +  +  +  P+    ++  
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYE 241
Query: 357 LLEGLLCKDPTRRLTLNDV 375
           L+      +P+ R +  ++
Sbjct: 242 LMRACWQWNPSDRPSFAEI 260

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 108/261 (41%), Gaps = 62/261 (23%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR---REVLIMKM 180
           + +G GS+G V        GK +A+K                  + D R   RE+ IMK+
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKRFALKK----------------VLQDPRYKNRELDIMKV 56
Query: 181 LQHPNIVNLIE-----------------------------------VIDDPNSDHFY-MV 204
           L H NI+ L++                                   VI +P+ + +  ++
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 205 LEYVEGKWDN--DGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV-A 260
           +EYV          F + G +I  ++   Y+  +   + ++H   + H DIKP NLLV +
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 261 PSGTVKIGDF-SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYY 319
              T+K+ DF S  ++   +  V      +  + APE  LG T    + D W++G     
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAXIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 320 MIIGQYPFLGETLQDTYDKIV 340
           +I+G+  F GET  D   +I+
Sbjct: 235 LILGKPLFSGETSIDQLVRII 255

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKA------FHKSHLSKLRVAPSETAMTDVRR 173
           Y  ++ IG GS+G+VV        +H A+K       FH+    ++R+        D   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRIL-EHLRKQDKDN 157
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
            + ++ ML++    N I +  +  S + Y +++    K    GF  P      + RK+  
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIK----KNKFQGFSLP------LVRKFAH 207
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT--VKIGDFSVSQVFEDDNDVLRRSPGTPV 291
            I+  L  LH + ++H D+KP+N+L+   G   +K+ DF  S  +E     +     +  
Sbjct: 208 SILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQR--VYTXIQSRF 264
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL 328
           + APE  LG  Y G   D W++G  L  ++ G YP L
Sbjct: 265 YRAPEVILGARY-GMPIDMWSLGCILAELLTG-YPLL 299

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 109/259 (42%), Gaps = 24/259 (9%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 68
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGL 239
           +HPN+V L+ V        FY++ E++      D   +     +   +       I S +
Sbjct: 69  KHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 126
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ +TAPE  
Sbjct: 127 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE-S 185
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRN 356
           L        +D WA GV L+ +   G  P+ G  L   Y+ +  +  +  P+    ++  
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 245
Query: 357 LLEGLLCKDPTRRLTLNDV 375
           L+      +P+ R +  ++
Sbjct: 246 LMRACWQWNPSDRPSFAEI 264

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/275 (22%), Positives = 115/275 (41%), Gaps = 30/275 (10%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
           + +GAG++GKVV   +   GK  A+       L     A  + A+     E+ IM  L Q
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS---ELKIMSHLGQ 108
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEY-----------------VEGKWDNDGFGQPGAIGE 225
           H NIVNL+      +     ++ EY                 +E  + N        +  
Sbjct: 109 HENIVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSY-NPSHNPEEQLSS 165
Query: 226 SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLR 284
                +   +  G+ +L   N +H D+   N+L+      KIGDF +++ +  D N +++
Sbjct: 166 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 225
Query: 285 RSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN 342
            +   PV + APE      Y  + +D W+ G+ L+ +  +G  P+ G  +   + K+V +
Sbjct: 226 GNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 284
Query: 343 --SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDV 375
              +  P      + ++++     +PT R T   +
Sbjct: 285 GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 319

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 17/213 (7%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +E   V++IG+G +G V L    L+    AIK   +  +S+           D   E  +
Sbjct: 7   SELTFVQEIGSGQFGLVHL-GYWLNKDKVAIKTIREGAMSE----------EDFIEEAEV 55
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIV 236
           M  L HP +V L  V  +       +V E++E    +D    Q G            D+ 
Sbjct: 56  MMKLSHPKLVQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 113
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAP 295
            G+ YL   +V+H D+   N LV  +  +K+ DF +++   DD          PV + +P
Sbjct: 114 EGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 173
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMII-GQYPF 327
           E      Y  K+ D W+ GV ++ +   G+ P+
Sbjct: 174 EVFSFSRYSSKS-DVWSFGVLMWEVFSEGKIPY 205

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L +++ DP S    +V E+V    +N  F Q    + +   R Y+ +I+  L Y 
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV----NNTDFKQLYQTLTDYDIRFYMYEILKALDYC 147
Query: 243 HGHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   ++H D+KP N+L+      +++ D+ +++ +    +   R   +  F  PE  +  
Sbjct: 148 HSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLVDY 206
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--------FPDAMNPE 353
                + D W++G  L  MI  + PF      D YD++V  + V        + D  N E
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 354 LRNLLEGLLCKDPTRR 369
           L      +L +   +R
Sbjct: 265 LDPRFNDILGRHSRKR 280

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 121/281 (43%), Gaps = 42/281 (14%)
Query: 123 VRKIGAGSYGKVVLYRSSLDG-------KHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           + ++G   +GKV  Y+  L G       +  AIK         LR         + R E 
Sbjct: 31  MEELGEDRFGKV--YKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR--------EEFRHEA 80
Query: 176 LIMKMLQHPNIVNLIEVI--DDPNSD----------HFYMVLEYVE---GKWDNDGFGQP 220
           ++   LQHPN+V L+ V+  D P S           H ++V+       G  D+D   + 
Sbjct: 81  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK- 139
Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV-SQVFEDD 279
            A+        +  I +G+ YL  H+VVH D+   N+LV     VKI D  +  +V+  D
Sbjct: 140 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 199
Query: 280 NDVLRRSPGTPV-FTAPECCLGLTYGGKA--ADTWAVGVTLYYMI-IGQYPFLGETLQDT 335
              L  +   P+ + APE    + YG  +  +D W+ GV L+ +   G  P+ G + QD 
Sbjct: 200 YYKLLGNSLLPIRWMAPE---AIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256
Query: 336 YDKIVNNSLV-FPDAMNPELRNLLEGLLCKDPTRRLTLNDV 375
            + I N  ++  PD     +  L+     + P+RR    D+
Sbjct: 257 VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 297

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 88/217 (40%), Gaps = 36/217 (16%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IG GSYG V L       K+ AIK  +       R+         + RE+ I+  L+   
Sbjct: 36  IGRGSYGYVYLAYDKNANKNVAIKKVN-------RMFEDLIDCKRILREITILNRLKSDY 88
Query: 186 IVNLIEVI---DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           I+ L ++I   D    D  Y+VLE  +       F  P  + E   +  L +++ G  ++
Sbjct: 89  IIRLHDLIIPEDLLKFDELYIVLEIADSDLKK-LFKTPIFLTEQHVKTILYNLLLGEKFI 147
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV-------------------- 282
           H   ++H D+KP N L+    +VKI DF +++    D D+                    
Sbjct: 148 HESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNK 207
Query: 283 -LRRSPGTPVFT----APECCLGLTYGGKAADTWAVG 314
            L++   + V T    APE  L       + D W+ G
Sbjct: 208 NLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTG 244

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 121/281 (43%), Gaps = 42/281 (14%)
Query: 123 VRKIGAGSYGKVVLYRSSLDG-------KHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           + ++G   +GKV  Y+  L G       +  AIK         LR         + R E 
Sbjct: 14  MEELGEDRFGKV--YKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR--------EEFRHEA 63
Query: 176 LIMKMLQHPNIVNLIEVI--DDPNSD----------HFYMVLEYVE---GKWDNDGFGQP 220
           ++   LQHPN+V L+ V+  D P S           H ++V+       G  D+D   + 
Sbjct: 64  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK- 122
Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV-SQVFEDD 279
            A+        +  I +G+ YL  H+VVH D+   N+LV     VKI D  +  +V+  D
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
Query: 280 NDVLRRSPGTPV-FTAPECCLGLTYGGKA--ADTWAVGVTLYYMI-IGQYPFLGETLQDT 335
              L  +   P+ + APE    + YG  +  +D W+ GV L+ +   G  P+ G + QD 
Sbjct: 183 YYKLLGNSLLPIRWMAPE---AIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 239
Query: 336 YDKIVNNSLV-FPDAMNPELRNLLEGLLCKDPTRRLTLNDV 375
            + I N  ++  PD     +  L+     + P+RR    D+
Sbjct: 240 VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 280

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 104/233 (44%), Gaps = 24/233 (10%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           ++IG+GS+G V  Y+    G   A+K  + +       AP+   +   + EV +++  +H
Sbjct: 34  QRIGSGSFGTV--YKGKWHGD-VAVKMLNVT-------APTPQQLQAFKNEVGVLRKTRH 83
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV----SGL 239
            NI+  +     P      +V ++ EG   +  +     I        L DI      G+
Sbjct: 84  VNILLFMGYSTKP---QLAIVTQWCEG---SSLYHHLHIIETKFEMIKLIDIARQTAQGM 137
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS--QVFEDDNDVLRRSPGTPVFTAPEC 297
            YLH  +++H D+K +N+ +    TVKIGDF ++  +     +    +  G+ ++ APE 
Sbjct: 138 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 197
Query: 298 CLGLTYGGKA--ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD 348
                    +  +D +A G+ LY ++ GQ P+     +D    +V    + PD
Sbjct: 198 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 250

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L +++ DP S    +V E+V    +N  F Q    + +   R Y+ +I+  L Y 
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV----NNTDFKQLRQTLTDYDIRFYMYEILKALDYC 147
Query: 243 HGHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  +  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLVDY 206
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--------FPDAMNPE 353
                + D W++G  L  MI  + PF      D YD++V  + V        + D  N E
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 354 LRNLLEGLLCKDPTRR 369
           L      +L +   +R
Sbjct: 265 LDPRFNDILGRHSRKR 280

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/266 (22%), Positives = 112/266 (42%), Gaps = 38/266 (14%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 266 KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 312
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV----- 236
           +HPN+V L+ V        FY++ E++        +G          R+ +  +V     
Sbjct: 313 KHPNLVQLLGVCT--REPPFYIITEFMT-------YGNLLDYLRECNRQEVNAVVLLYMA 363
Query: 237 ----SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV- 291
               S + YL   N +H ++   N LV  +  VK+ DF +S++   D          P+ 
Sbjct: 364 TQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 423
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDA 349
           +TAPE      +  K +D WA GV L+ +   G  P+ G  L   Y+ +  +  +  P+ 
Sbjct: 424 WTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 482
Query: 350 MNPELRNLLEGLLCKDPTRRLTLNDV 375
              ++  L+      +P+ R +  ++
Sbjct: 483 CPEKVYELMRACWQWNPSDRPSFAEI 508

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 17/213 (7%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +E   V++IG+G +G V L    L+    AIK   +  +S+           D   E  +
Sbjct: 10  SELTFVQEIGSGQFGLVHL-GYWLNKDKVAIKTIREGAMSE----------EDFIEEAEV 58
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIV 236
           M  L HP +V L  V  +       +V E++E    +D    Q G            D+ 
Sbjct: 59  MMKLSHPKLVQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 116
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAP 295
            G+ YL    V+H D+   N LV  +  +K+ DF +++   DD          PV + +P
Sbjct: 117 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 176
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMII-GQYPF 327
           E      Y  K+ D W+ GV ++ +   G+ P+
Sbjct: 177 EVFSFSRYSSKS-DVWSFGVLMWEVFSEGKIPY 208

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 104/233 (44%), Gaps = 24/233 (10%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           ++IG+GS+G V  Y+    G   A+K  + +       AP+   +   + EV +++  +H
Sbjct: 42  QRIGSGSFGTV--YKGKWHGD-VAVKMLNVT-------APTPQQLQAFKNEVGVLRKTRH 91
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV----SGL 239
            NI+  +     P      +V ++ EG   +  +     I        L DI      G+
Sbjct: 92  VNILLFMGYSTKP---QLAIVTQWCEG---SSLYHHLHIIETKFEMIKLIDIARQTAQGM 145
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS--QVFEDDNDVLRRSPGTPVFTAPEC 297
            YLH  +++H D+K +N+ +    TVKIGDF ++  +     +    +  G+ ++ APE 
Sbjct: 146 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 205
Query: 298 CLGLTYGGKA--ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD 348
                    +  +D +A G+ LY ++ GQ P+     +D    +V    + PD
Sbjct: 206 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 258

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 17/213 (7%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +E   V++IG+G +G V L    L+    AIK   +  +S+           D   E  +
Sbjct: 5   SELTFVQEIGSGQFGLVHL-GYWLNKDKVAIKTIREGAMSE----------EDFIEEAEV 53
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIV 236
           M  L HP +V L  V  +       +V E++E    +D    Q G            D+ 
Sbjct: 54  MMKLSHPKLVQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 111
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAP 295
            G+ YL    V+H D+   N LV  +  +K+ DF +++   DD          PV + +P
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMII-GQYPF 327
           E      Y  K+ D W+ GV ++ +   G+ P+
Sbjct: 172 EVFSFSRYSSKS-DVWSFGVLMWEVFSEGKIPY 203

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 17/213 (7%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +E   V++IG+G +G V L    L+    AIK   +  +S+           D   E  +
Sbjct: 7   SELTFVQEIGSGQFGLVHL-GYWLNKDKVAIKTIREGAMSE----------EDFIEEAEV 55
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIV 236
           M  L HP +V L  V  +       +V E++E    +D    Q G            D+ 
Sbjct: 56  MMKLSHPKLVQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 113
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAP 295
            G+ YL    V+H D+   N LV  +  +K+ DF +++   DD          PV + +P
Sbjct: 114 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 173
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMII-GQYPF 327
           E      Y  K+ D W+ GV ++ +   G+ P+
Sbjct: 174 EVFSFSRYSSKS-DVWSFGVLMWEVFSEGKIPY 205

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L +++ DP S    +V E+V    +N  F Q    + +   R Y+ +I+  L Y 
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV----NNTDFKQLYQTLTDYDIRFYMYEILKALDYC 147
Query: 243 HGHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  +  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLVDY 206
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--------FPDAMNPE 353
                + D W++G  L  MI  + PF      D YD++V  + V        + D  N E
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 354 LRNLLEGLLCKDPTRR 369
           L      +L +   +R
Sbjct: 265 LDPRFNDILGRHSRKR 280

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L +++ DP S    +V E+V    +N  F Q    + +   R Y+ +I+  L Y 
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV----NNTDFKQLYQTLTDYDIRFYMYEILKALDYC 147
Query: 243 HGHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  +  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLVDY 206
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--------FPDAMNPE 353
                + D W++G  L  MI  + PF      D YD++V  + V        + D  N E
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 354 LRNLLEGLLCKDPTRR 369
           L      +L +   +R
Sbjct: 265 LDPRFNDILGRHSRKR 280

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L +++ DP S    +V E+V    +N  F Q    + +   R Y+ +I+  L Y 
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV----NNTDFKQLYQTLTDYDIRFYMYEILKALDYC 147
Query: 243 HGHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  +  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLVDY 206
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--------FPDAMNPE 353
                + D W++G  L  MI  + PF      D YD++V  + V        + D  N E
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 354 LRNLLEGLLCKDPTRR 369
           L      +L +   +R
Sbjct: 265 LDPRFNDILGRHSRKR 280

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L +++ DP S    +V E+V    +N  F Q    + +   R Y+ +I+  L Y 
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV----NNTDFKQLYQTLTDYDIRFYMYEILKALDYC 147
Query: 243 HGHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  +  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLVDY 206
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--------FPDAMNPE 353
                + D W++G  L  MI  + PF      D YD++V  + V        + D  N E
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 354 LRNLLEGLLCKDPTRR 369
           L      +L +   +R
Sbjct: 265 LDPRFNDILGRHSRKR 280

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/266 (22%), Positives = 112/266 (42%), Gaps = 38/266 (14%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 273
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV----- 236
           +HPN+V L+ V        FY++ E++        +G          R+ +  +V     
Sbjct: 274 KHPNLVQLLGVCT--REPPFYIITEFMT-------YGNLLDYLRECNRQEVSAVVLLYMA 324
Query: 237 ----SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV- 291
               S + YL   N +H ++   N LV  +  VK+ DF +S++   D          P+ 
Sbjct: 325 TQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 384
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDA 349
           +TAPE      +  K +D WA GV L+ +   G  P+ G  L   Y+ +  +  +  P+ 
Sbjct: 385 WTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 443
Query: 350 MNPELRNLLEGLLCKDPTRRLTLNDV 375
              ++  L+      +P+ R +  ++
Sbjct: 444 CPEKVYELMRACWQWNPSDRPSFAEI 469

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L +++ DP S    +V E+V    +N  F Q    + +   R Y+ +I+  L Y 
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV----NNTDFKQLYQTLTDYDIRFYMYEILKALDYC 147
Query: 243 HGHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  +  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLVDY 206
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--------FPDAMNPE 353
                + D W++G  L  MI  + PF      D YD++V  + V        + D  N E
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 354 LRNLLEGLLCKDPTRR 369
           L      +L +   +R
Sbjct: 265 LDPRFNDILGRHSRKR 280

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L +++ DP S    +V E+V    +N  F Q    + +   R Y+ +I+  L Y 
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHV----NNTDFKQLYQTLTDYDIRFYMYEILKALDYC 146
Query: 243 HGHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  +  
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLVDY 205
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--------FPDAMNPE 353
                + D W++G  L  MI  + PF      D YD++V  + V        + D  N E
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263
Query: 354 LRNLLEGLLCKDPTRR 369
           L      +L +   +R
Sbjct: 264 LDPRFNDILGRHSRKR 279

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L +++ DP S    +V E+V    +N  F Q    + +   R Y+ +I+  L Y 
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV----NNTDFKQLYQTLTDYDIRFYMYEILKALDYC 147
Query: 243 HGHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  +  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLVDY 206
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--------FPDAMNPE 353
                + D W++G  L  MI  + PF      D YD++V  + V        + D  N E
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 354 LRNLLEGLLCKDPTRR 369
           L      +L +   +R
Sbjct: 265 LDPRFNDILGRHSRKR 280

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L +++ DP S    +V E+V    +N  F Q    + +   R Y+ +I+  L Y 
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV----NNTDFKQLYQTLTDYDIRFYMYEILKALDYC 147
Query: 243 HGHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  +  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLVDY 206
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--------FPDAMNPE 353
                + D W++G  L  MI  + PF      D YD++V  + V        + D  N E
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 354 LRNLLEGLLCKDPTRR 369
           L      +L +   +R
Sbjct: 265 LDPRFNDILGRHSRKR 280

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L +++ DP S    +V E+V    +N  F Q    + +   R Y+ +I+  L Y 
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHV----NNTDFKQLYQTLTDYDIRFYMYEILKALDYC 146
Query: 243 HGHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  +  
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLVDY 205
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--------FPDAMNPE 353
                + D W++G  L  MI  + PF      D YD++V  + V        + D  N E
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263
Query: 354 LRNLLEGLLCKDPTRR 369
           L      +L +   +R
Sbjct: 264 LDPRFNDILGRHSRKR 279

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y+    IG GSYG V L       K+ AIK  +       R+         + RE+ I+ 
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREITILN 80
Query: 180 MLQHPNIVNLIEVI---DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
            L+   I+ L ++I   D    D  Y+VLE  +       F  P  + E   +  L +++
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKK-LFKTPIFLTEEHIKTILYNLL 139
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV-------------- 282
            G  ++H   ++H D+KP N L+    +VK+ DF +++    + D               
Sbjct: 140 LGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 283 ----LRRSPGTPVFT----APECCLGLTYGGKAADTWAVG 314
               L++   + V T    APE  L      K+ D W+ G
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 111/285 (38%), Gaps = 28/285 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           N   +VR IG G++G+V   R+         + F    +  L+   S     D +RE  +
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAP---GLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 178 MKMLQHPNIVNLIEV--IDDPNSDHF-YMVL----EYVEGKWDND-------------GF 217
           M    +PNIV L+ V  +  P    F YM      E++     +                
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 218 GQPGAIGESMARKYL--RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ- 274
             PG    S A +    R + +G+ YL     VH D+   N LV  +  VKI DF +S+ 
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQ 333
           ++  D      +   P+   P   +        +D WA GV L+ +   G  P+ G   +
Sbjct: 224 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283
Query: 334 DTYDKIVN-NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
           +    + + N L  P+    EL NL+     K P  R +   + +
Sbjct: 284 EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L +++ DP S    +V E+V    +N  F Q    + +   R Y+ +I+  L Y 
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHV----NNTDFKQLYQTLTDYDIRFYMYEILKALDYC 145
Query: 243 HGHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  +  
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLVDY 204
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--------FPDAMNPE 353
                + D W++G  L  MI  + PF      D YD++V  + V        + D  N E
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 354 LRNLLEGLLCKDPTRR 369
           L      +L +   +R
Sbjct: 263 LDPRFNDILGRHSRKR 278

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L +++ DP S    +V E+V    +N  F Q    + +   R Y+ +I+  L Y 
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV----NNTDFKQLYQTLTDYDIRFYMYEILKALDYC 147
Query: 243 HGHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  +  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLVDY 206
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--------FPDAMNPE 353
                + D W++G  L  MI  + PF      D YD++V  + V        + D  N E
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 354 LRNLLEGLLCKDPTRR 369
           L      +L +   +R
Sbjct: 265 LDPRFNDILGRHSRKR 280

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYL 242
           PNI+ L +++ DP S    +V E+V    +N  F Q    + +   R Y+ +I+  L Y 
Sbjct: 97  PNIITLADIVKDPVSRTPALVFEHV----NNTDFKQLYQTLTDYDIRFYMYEILKALDYC 152
Query: 243 HGHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL 301
           H   ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  +  
Sbjct: 153 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLVDY 211
Query: 302 TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--------FPDAMNPE 353
                + D W++G  L  MI  + PF      D YD++V  + V        + D  N E
Sbjct: 212 QMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVLGTEDLYDYIDKYNIE 269
Query: 354 LRNLLEGLLCKDPTRR 369
           L      +L +   +R
Sbjct: 270 LDPRFNDILGRHSRKR 285

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 124/284 (43%), Gaps = 38/284 (13%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           + +G G +GKVV   ++   K  A        + K   +PSE  + D+  E  ++K + H
Sbjct: 29  KTLGEGEFGKVV-KATAFHLKGRAGYTTVAVKMLKENASPSE--LRDLLSEFNVLKQVNH 85
Query: 184 PNIVNLIEVI--DDPNSDHFYMVLEYV----------EGKWDNDGF------------GQ 219
           P+++ L      D P      +++EY           E +    G+              
Sbjct: 86  PHVIKLYGACSQDGP----LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 220 PGAIGESMAR--KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VF 276
           P     +M     +   I  G+ YL   ++VH D+   N+LVA    +KI DF +S+ V+
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 277 EDDNDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQD 334
           E+D+ V R     PV + A E      Y  + +D W+ GV L+ ++ +G  P+ G   + 
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 335 TYDKI-VNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
            ++ +   + +  PD  + E+  L+     ++P +R    D++K
Sbjct: 261 LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 104/233 (44%), Gaps = 24/233 (10%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           ++IG+GS+G V  Y+    G   A+K  + +       AP+   +   + EV +++  +H
Sbjct: 14  QRIGSGSFGTV--YKGKWHGD-VAVKMLNVT-------APTPQQLQAFKNEVGVLRKTRH 63
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV----SGL 239
            NI+  +     P      +V ++ EG   +  +     I        L DI      G+
Sbjct: 64  VNILLFMGYSTKPQ---LAIVTQWCEG---SSLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS--QVFEDDNDVLRRSPGTPVFTAPEC 297
            YLH  +++H D+K +N+ +    TVKIGDF ++  +     +    +  G+ ++ APE 
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 298 CLGLTYGGKA--ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD 348
                    +  +D +A G+ LY ++ GQ P+     +D    +V    + PD
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 108/259 (41%), Gaps = 24/259 (9%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G YG+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 64
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGL 239
           +HPN+V L+ V        FY++ E++      D   +     +   +       I S +
Sbjct: 65  KHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 122
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ +TAPE  
Sbjct: 123 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPE-S 181
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRN 356
           L        +D WA GV L+ +   G  P+ G      Y+ +  +  +  P+    ++  
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYE 241
Query: 357 LLEGLLCKDPTRRLTLNDV 375
           L+      +P+ R +  ++
Sbjct: 242 LMRACWQWNPSDRPSFAEI 260

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 17/213 (7%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +E   V++IG+G +G V L    L+    AIK   +  +S+           D   E  +
Sbjct: 8   SELTFVQEIGSGQFGLVHL-GYWLNKDKVAIKTIREGAMSE----------EDFIEEAEV 56
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIV 236
           M  L HP +V L  V  +       +V E++E    +D    Q G            D+ 
Sbjct: 57  MMKLSHPKLVQLYGVCLEQAP--ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 114
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAP 295
            G+ YL    V+H D+   N LV  +  +K+ DF +++   DD          PV + +P
Sbjct: 115 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 174
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMII-GQYPF 327
           E      Y  K+ D W+ GV ++ +   G+ P+
Sbjct: 175 EVFSFSRYSSKS-DVWSFGVLMWEVFSEGKIPY 206

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 17/213 (7%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +E   V++IG+G +G V L    L+    AIK   +  +S+           D   E  +
Sbjct: 27  SELTFVQEIGSGQFGLVHL-GYWLNKDKVAIKTIKEGSMSE----------DDFIEEAEV 75
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIV 236
           M  L HP +V L  V  +       +V E++E    +D    Q G            D+ 
Sbjct: 76  MMKLSHPKLVQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 133
Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAP 295
            G+ YL    V+H D+   N LV  +  +K+ DF +++   DD          PV + +P
Sbjct: 134 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 193
Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMII-GQYPF 327
           E      Y  K+ D W+ GV ++ +   G+ P+
Sbjct: 194 EVFSFSRYSSKS-DVWSFGVLMWEVFSEGKIPY 225

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKA------FHKSHLSKLRVAPSETAMTDVRR 173
           Y  ++ IG G +G+VV        +H A+K       FH+    ++R+        D   
Sbjct: 99  YEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRIL-EHLRKQDKDN 157
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
            + ++ ML++    N I +  +  S + Y +++    K    GF  P      + RK+  
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIK----KNKFQGFSLP------LVRKFAH 207
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT--VKIGDFSVSQVFEDDNDVLRRSPGTPV 291
            I+  L  LH + ++H D+KP+N+L+   G   +K+ DF  S  +E     +     +  
Sbjct: 208 SILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQR--VYXXIQSRF 264
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL 328
           + APE  LG  Y G   D W++G  L  ++ G YP L
Sbjct: 265 YRAPEVILGARY-GMPIDMWSLGCILAELLTG-YPLL 299

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 125 KIGAGSYGKVV--LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           ++G G++G V   +YR        AIK         L+    +    ++ RE  IM  L 
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKV--------LKQGTEKADTEEMMREAQIMHQLD 394
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEG-KWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
           +P IV LI V     ++   +V+E   G        G+   I  S   + L  +  G+ Y
Sbjct: 395 NPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 451
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF-EDDNDVLRRSPGT-PV-FTAPECC 298
           L   N VH ++   N+L+      KI DF +S+    DD+    RS G  P+ + APEC 
Sbjct: 452 LEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 299 LGLTYGGKAADTWAVGVTLYYMI-IGQYPF 327
               +  + +D W+ GVT++  +  GQ P+
Sbjct: 512 NFRKFSSR-SDVWSYGVTMWEALSYGQKPY 540

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           + +G G +GKVV   ++   K  A        + K   +PSE  + D+  E  ++K + H
Sbjct: 29  KTLGEGEFGKVV-KATAFHLKGRAGYTTVAVKMLKENASPSE--LRDLLSEFNVLKQVNH 85
Query: 184 PNIVNLIEVI--DDPNSDHFYMVLEYV----------EGKWDNDGF------------GQ 219
           P+++ L      D P      +++EY           E +    G+              
Sbjct: 86  PHVIKLYGACSQDGP----LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 220 PGAIGESMAR--KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VF 276
           P     +M     +   I  G+ YL    +VH D+   N+LVA    +KI DF +S+ V+
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 277 EDDNDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQD 334
           E+D+ V R     PV + A E      Y  + +D W+ GV L+ ++ +G  P+ G   + 
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 335 TYDKI-VNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
            ++ +   + +  PD  + E+  L+     ++P +R    D++K
Sbjct: 261 LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 122/301 (40%), Gaps = 47/301 (15%)
Query: 111 ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD 170
           E  ++   E+  + KIG+G +G V      LDG  YAIK       SK  +A S     +
Sbjct: 2   EMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR------SKKPLAGS-VDEQN 54
Query: 171 VRREVLIMKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR 229
             REV    +L QH ++V       +   DH  +  EY  G    D   +   I      
Sbjct: 55  ALREVYAHAVLGQHSHVVRYFSAWAE--DDHMLIQNEYCNGGSLADAISENYRIMSYFKE 112
Query: 230 KYLRDIV----SGLMYLHGHNVVHGDIKPDNLLVA----PSGTVKIGDFSVSQVFEDD-- 279
             L+D++     GL Y+H  ++VH DIKP N+ ++    P+   + GD       EDD  
Sbjct: 113 AELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD-------EDDWA 165
Query: 280 -NDVLRR-----------SP----GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIG 323
            N V+ +           SP    G   F A E           AD +A+ +T+     G
Sbjct: 166 SNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VCAAG 224
Query: 324 QYPFLGETLQDTYDKIVNNSLV-FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL 382
             P       D + +I    L   P  ++ E   LL+ ++  DP RR +   + KH+ +L
Sbjct: 225 AEPLPRNG--DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 282
Query: 383 G 383
Sbjct: 283 S 283

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/259 (22%), Positives = 108/259 (41%), Gaps = 24/259 (9%)
Query: 125 KIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           K+G G +G+V   V  + SL     A+K   +  +           + +  +E  +MK +
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLT---VAVKTLKEDTME----------VEEFLKEAAVMKEI 64
Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGL 239
           +HPN+V L+ V        FY++ E++      D   +     +   +       I S +
Sbjct: 65  KHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 122
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECC 298
            YL   N +H D+   N LV  +  VK+ DF +S++   D          P+ +TAPE  
Sbjct: 123 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE-S 181
Query: 299 LGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELRN 356
           L        +D WA GV L+ +   G  P+ G      Y+ +  +  +  P+    ++  
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYE 241
Query: 357 LLEGLLCKDPTRRLTLNDV 375
           L+      +P+ R +  ++
Sbjct: 242 LMRACWQWNPSDRPSFAEI 260

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 123/285 (43%), Gaps = 40/285 (14%)
Query: 124 RKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           + +G G +GKVV   +  L G+      +    +  L+   S + + D+  E  ++K + 
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGR----AGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN 84
Query: 183 HPNIVNLIEVI--DDPNSDHFYMVLEYV----------EGKWDNDGF------------G 218
           HP+++ L      D P      +++EY           E +    G+             
Sbjct: 85  HPHVIKLYGACSQDGP----LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 219 QPGAIGESMAR--KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-V 275
            P     +M     +   I  G+ YL    +VH D+   N+LVA    +KI DF +S+ V
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 276 FEDDNDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQ 333
           +E+D+ V R     PV + A E      Y  + +D W+ GV L+ ++ +G  P+ G   +
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 334 DTYDKI-VNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
             ++ +   + +  PD  + E+  L+     ++P +R    D++K
Sbjct: 260 RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 121/298 (40%), Gaps = 47/298 (15%)
Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           ++   E+  + KIG+G +G V      LDG  YAIK       SK  +A S     +  R
Sbjct: 3   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR------SKKPLAGS-VDEQNALR 55
Query: 174 EVLIMKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           EV    +L QH ++V       +   DH  +  EY  G    D   +   I        L
Sbjct: 56  EVYAHAVLGQHSHVVRYFSAWAE--DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 113
Query: 233 RDIV----SGLMYLHGHNVVHGDIKPDNLLVA----PSGTVKIGDFSVSQVFEDD---ND 281
           +D++     GL Y+H  ++VH DIKP N+ ++    P+   + GD       EDD   N 
Sbjct: 114 KDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD-------EDDWASNK 166
Query: 282 VLRR-----------SP----GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYP 326
           V+ +           SP    G   F A E           AD +A+ +T+     G  P
Sbjct: 167 VMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VXAAGAEP 225
Query: 327 FLGETLQDTYDKIVNNSLV-FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                  D + +I    L   P  ++ E   LL+ ++  DP RR +   + KH+ +L 
Sbjct: 226 LPRNG--DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 281

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 102/242 (42%), Gaps = 48/242 (19%)
Query: 126 IGAGSYGKVVLYRSSLDG----------KHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           IG G++G+V+  R   DG          K YA K  H+    +L V              
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-------------- 78
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV-EGKW-----------DNDGFGQPGAI 223
            + K+  HPNI+NL+   +  +  + Y+ +EY   G              +  F    + 
Sbjct: 79  -LCKLGHHPNIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 135
Query: 224 GESMARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
             +++ + L     D+  G+ YL     +H D+   N+LV  +   KI DF +S+  E  
Sbjct: 136 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-- 193
Query: 280 NDVLRRSPG-TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYD 337
              ++++ G  PV       L  +     +D W+ GV L+ ++ +G  P+ G T  + Y+
Sbjct: 194 -VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 252
Query: 338 KI 339
           K+
Sbjct: 253 KL 254

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 118/296 (39%), Gaps = 45/296 (15%)
Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           ++   E+  + KIG+G +G V      LDG  YAIK       SK  +A S      +R 
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR------SKKPLAGSVDEQNALRE 60
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
                 + QH ++V       +   DH  +  EY  G    D   +   I        L+
Sbjct: 61  VYAHAVLGQHSHVVRYFSAWAE--DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK 118
Query: 234 DIV----SGLMYLHGHNVVHGDIKPDNLLVA----PSGTVKIGDFSVSQVFEDD---NDV 282
           D++     GL Y+H  ++VH DIKP N+ ++    P+   + GD       EDD   N V
Sbjct: 119 DLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD-------EDDWASNKV 171
Query: 283 LRR-----------SP----GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
           + +           SP    G   F A E           AD +A+ +T+     G  P 
Sbjct: 172 MFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL 230
Query: 328 LGETLQDTYDKIVNNSLV-FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL 382
                 D + +I    L   P  ++ E   LL+ ++  DP RR +   + KH+ +L
Sbjct: 231 PRNG--DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 102/242 (42%), Gaps = 48/242 (19%)
Query: 126 IGAGSYGKVVLYRSSLDG----------KHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           IG G++G+V+  R   DG          K YA K  H+    +L V              
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-------------- 68
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV-EGKW-----------DNDGFGQPGAI 223
            + K+  HPNI+NL+   +  +  + Y+ +EY   G              +  F    + 
Sbjct: 69  -LCKLGHHPNIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 125
Query: 224 GESMARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
             +++ + L     D+  G+ YL     +H D+   N+LV  +   KI DF +S+  E  
Sbjct: 126 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-- 183
Query: 280 NDVLRRSPG-TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYD 337
              ++++ G  PV       L  +     +D W+ GV L+ ++ +G  P+ G T  + Y+
Sbjct: 184 -VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 242
Query: 338 KI 339
           K+
Sbjct: 243 KL 244

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 118/297 (39%), Gaps = 45/297 (15%)
Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           ++   E+  + KIG+G +G V      LDG  YAIK       SK  +A S      +R 
Sbjct: 5   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR------SKKPLAGSVDEQNALRE 58
Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
                 + QH ++V       +   DH  +  EY  G    D   +   I        L+
Sbjct: 59  VYAHAVLGQHSHVVRYFSAWAE--DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK 116
Query: 234 DIV----SGLMYLHGHNVVHGDIKPDNLLVA----PSGTVKIGDFSVSQVFEDD---NDV 282
           D++     GL Y+H  ++VH DIKP N+ ++    P+   + GD       EDD   N V
Sbjct: 117 DLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD-------EDDWASNKV 169
Query: 283 LRR-----------SP----GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
           + +           SP    G   F A E           AD +A+ +T+     G  P 
Sbjct: 170 MFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL 228
Query: 328 LGETLQDTYDKIVNNSLV-FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                 D + +I    L   P  ++ E   LL+ ++  DP RR +   + KH+ +L 
Sbjct: 229 PRNG--DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 283

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 114/264 (43%), Gaps = 35/264 (13%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G++G  V+ ++    K  AIK              SE+       E+  +  + HPN
Sbjct: 16  VGRGAFG--VVCKAKWRAKDVAIKQIE-----------SESERKAFIVELRQLSRVNHPN 62
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGK--WDNDGFGQP-GAIGESMARKYLRDIVSGLMYL 242
           IV L     +P      +V+EY EG   ++     +P      + A  +      G+ YL
Sbjct: 63  IVKLYGACLNP----VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 243 HGHN---VVHGDIKPDNLLVAPSGTV-KIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           H      ++H D+KP NLL+   GTV KI DF  +    D    +  + G+  + APE  
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTNNKGSAAWMAPEVF 175
Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPF---LGETLQDTYDKIVNNSLVFPDAMN--PE 353
            G  Y  K  D ++ G+ L+ +I  + PF    G   +  +   V+N    P   N    
Sbjct: 176 EGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAFRIMW--AVHNGTRPPLIKNLPKP 232
Query: 354 LRNLLEGLLCKDPTRRLTLNDVAK 377
           + +L+     KDP++R ++ ++ K
Sbjct: 233 IESLMTRCWSKDPSQRPSMEEIVK 256

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 21/215 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
            E   ++++G+G +G V L  ++   D    A+K   +  +S+           +  +E 
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYD---VAVKMIKEGSMSE----------DEFFQEA 54
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRD 234
             M  L HP +V    V         Y+V EY+  G   N        +  S   +   D
Sbjct: 55  QTMMKLSHPKLVKFYGVCSKEYP--IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FT 293
           +  G+ +L  H  +H D+   N LV     VK+ DF +++   DD  V       PV ++
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS 172
Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPF 327
           APE      Y  K +D WA G+ ++ +  +G+ P+
Sbjct: 173 APEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPY 206

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 114/264 (43%), Gaps = 35/264 (13%)
Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G++G  V+ ++    K  AIK              SE+       E+  +  + HPN
Sbjct: 17  VGRGAFG--VVCKAKWRAKDVAIKQIE-----------SESERKAFIVELRQLSRVNHPN 63
Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGK--WDNDGFGQP-GAIGESMARKYLRDIVSGLMYL 242
           IV L     +P      +V+EY EG   ++     +P      + A  +      G+ YL
Sbjct: 64  IVKLYGACLNP----VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 243 HGHN---VVHGDIKPDNLLVAPSGTV-KIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           H      ++H D+KP NLL+   GTV KI DF  +    D    +  + G+  + APE  
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTNNKGSAAWMAPEVF 176
Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPF---LGETLQDTYDKIVNNSLVFPDAMN--PE 353
            G  Y  K  D ++ G+ L+ +I  + PF    G   +  +   V+N    P   N    
Sbjct: 177 EGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAFRIMW--AVHNGTRPPLIKNLPKP 233
Query: 354 LRNLLEGLLCKDPTRRLTLNDVAK 377
           + +L+     KDP++R ++ ++ K
Sbjct: 234 IESLMTRCWSKDPSQRPSMEEIVK 257

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD-VRREVLIMKMLQ 182
           +++G+G++G V        G +   K      +  L+   ++ A+ D +  E  +M+ L 
Sbjct: 17  KELGSGNFGTVK------KGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 70
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           +P IV +I + +   ++ + +V+E  E    N    Q   + +    + +  +  G+ YL
Sbjct: 71  NPYIVRMIGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 127
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE-DDNDVLRRSPGT-PV-FTAPECCL 299
              N VH D+   N+L+      KI DF +S+    D+N    ++ G  PV + APEC  
Sbjct: 128 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECIN 187
Query: 300 GLTYGGKAADTWAVGVTLYYMI-IGQYPFLG 329
              +  K +D W+ GV ++     GQ P+ G
Sbjct: 188 YYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG 217

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD-VRREVLIMKMLQ 182
           +++G+G++G V        G +   K      +  L+   ++ A+ D +  E  +M+ L 
Sbjct: 23  KELGSGNFGTVK------KGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 76
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           +P IV +I + +   ++ + +V+E  E    N    Q   + +    + +  +  G+ YL
Sbjct: 77  NPYIVRMIGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 133
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPV-FTAPECCL 299
              N VH D+   N+L+      KI DF +S+    D +  +       PV + APEC  
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 300 GLTYGGKAADTWAVGVTLYYMI-IGQYPFLG 329
              +  K +D W+ GV ++     GQ P+ G
Sbjct: 194 YYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG 223

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 117/264 (44%), Gaps = 28/264 (10%)
Query: 111 ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF--HKSHLSKLRVAPSETAM 168
           +NG K ++ Y     IG GS+G+VV     ++ +  AIK     K+ L++ ++      +
Sbjct: 28  KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLEL 87
Query: 169 T---DVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGE 225
               D   +  I+ + +H    N + ++ +  S + Y +L        N  F     +  
Sbjct: 88  MNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLR-------NTNF---RGVSL 137
Query: 226 SMARKYLRDIVSGLMYLHGH--NVVHGDIKPDNLLVA--PSGTVKIGDFSVSQVFEDDND 281
           ++ RK+ + + + L++L     +++H D+KP+N+L+       +KI DF  S        
Sbjct: 138 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQ 194
Query: 282 VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN 341
            + +   +  + +PE  LG+ Y   A D W++G  L  M  G+  F G    D  +KIV 
Sbjct: 195 RIYQXIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV- 252
Query: 342 NSLVFPDA----MNPELRNLLEGL 361
             L  P A      P+ R   E L
Sbjct: 253 EVLGIPPAHILDQAPKARKFFEKL 276

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD-VRREVLIMKMLQ 182
           +++G+G++G V        G +   K      +  L+   ++ A+ D +  E  +M+ L 
Sbjct: 13  KELGSGNFGTVK------KGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 66
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           +P IV +I + +   ++ + +V+E  E    N    Q   + +    + +  +  G+ YL
Sbjct: 67  NPYIVRMIGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 123
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPV-FTAPECCL 299
              N VH D+   N+L+      KI DF +S+    D +  +       PV + APEC  
Sbjct: 124 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 300 GLTYGGKAADTWAVGVTLYYMI-IGQYPFLG 329
              +  K +D W+ GV ++     GQ P+ G
Sbjct: 184 YYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG 213

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD-VRREVLIMKMLQ 182
           +++G+G++G V        G +   K      +  L+   ++ A+ D +  E  +M+ L 
Sbjct: 17  KELGSGNFGTVK------KGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 70
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           +P IV +I + +   ++ + +V+E  E    N    Q   + +    + +  +  G+ YL
Sbjct: 71  NPYIVRMIGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 127
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPV-FTAPECCL 299
              N VH D+   N+L+      KI DF +S+    D +  +       PV + APEC  
Sbjct: 128 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 187
Query: 300 GLTYGGKAADTWAVGVTLYYMI-IGQYPFLG 329
              +  K +D W+ GV ++     GQ P+ G
Sbjct: 188 YYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG 217

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD-VRREVLIMKMLQ 182
           +++G+G++G V        G +   K      +  L+   ++ A+ D +  E  +M+ L 
Sbjct: 11  KELGSGNFGTVK------KGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 64
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           +P IV +I + +   ++ + +V+E  E    N    Q   + +    + +  +  G+ YL
Sbjct: 65  NPYIVRMIGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 121
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPV-FTAPECCL 299
              N VH D+   N+L+      KI DF +S+    D +  +       PV + APEC  
Sbjct: 122 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 181
Query: 300 GLTYGGKAADTWAVGVTLYYMI-IGQYPFLG 329
              +  K +D W+ GV ++     GQ P+ G
Sbjct: 182 YYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG 211

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD-VRREVLIMKMLQ 182
           +++G+G++G V        G +   K      +  L+   ++ A+ D +  E  +M+ L 
Sbjct: 33  KELGSGNFGTVK------KGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 86
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           +P IV +I + +   ++ + +V+E  E    N    Q   + +    + +  +  G+ YL
Sbjct: 87  NPYIVRMIGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 143
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPV-FTAPECCL 299
              N VH D+   N+L+      KI DF +S+    D +  +       PV + APEC  
Sbjct: 144 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 203
Query: 300 GLTYGGKAADTWAVGVTLYYMI-IGQYPFLG 329
              +  K +D W+ GV ++     GQ P+ G
Sbjct: 204 YYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG 233

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD-VRREVLIMKMLQ 182
           +++G+G++G V        G +   K      +  L+   ++ A+ D +  E  +M+ L 
Sbjct: 33  KELGSGNFGTVK------KGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 86
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           +P IV +I + +   ++ + +V+E  E    N    Q   + +    + +  +  G+ YL
Sbjct: 87  NPYIVRMIGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 143
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPV-FTAPECCL 299
              N VH D+   N+L+      KI DF +S+    D +  +       PV + APEC  
Sbjct: 144 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 203
Query: 300 GLTYGGKAADTWAVGVTLYYMI-IGQYPFLG 329
              +  K +D W+ GV ++     GQ P+ G
Sbjct: 204 YYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG 233

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD-VRREVLIMKMLQ 182
           +++G+G++G V        G +   K      +  L+   ++ A+ D +  E  +M+ L 
Sbjct: 31  KELGSGNFGTVK------KGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 84
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           +P IV +I + +   ++ + +V+E  E    N    Q   + +    + +  +  G+ YL
Sbjct: 85  NPYIVRMIGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 141
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPV-FTAPECCL 299
              N VH D+   N+L+      KI DF +S+    D +  +       PV + APEC  
Sbjct: 142 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 201
Query: 300 GLTYGGKAADTWAVGVTLYYMI-IGQYPFLG 329
              +  K +D W+ GV ++     GQ P+ G
Sbjct: 202 YYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG 231

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 117/264 (44%), Gaps = 28/264 (10%)
Query: 111 ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF--HKSHLSKLRVAPSETAM 168
           +NG K ++ Y     IG GS+G+VV     ++ +  AIK     K+ L++ ++      +
Sbjct: 47  KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLEL 106
Query: 169 T---DVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGE 225
               D   +  I+ + +H    N + ++ +  S + Y +L        N  F     +  
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLR-------NTNF---RGVSL 156
Query: 226 SMARKYLRDIVSGLMYLHGH--NVVHGDIKPDNLLVA--PSGTVKIGDFSVSQVFEDDND 281
           ++ RK+ + + + L++L     +++H D+KP+N+L+       +KI DF  S        
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQ 213
Query: 282 VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN 341
            + +   +  + +PE  LG+ Y   A D W++G  L  M  G+  F G    D  +KIV 
Sbjct: 214 RIYQXIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV- 271
Query: 342 NSLVFPDA----MNPELRNLLEGL 361
             L  P A      P+ R   E L
Sbjct: 272 EVLGIPPAHILDQAPKARKFFEKL 295

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 102/242 (42%), Gaps = 48/242 (19%)
Query: 126 IGAGSYGKVVLYRSSLDG----------KHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           IG G++G+V+  R   DG          K YA K  H+    +L V              
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-------------- 75
Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYV-EGKW-----------DNDGFGQPGAI 223
            + K+  HPNI+NL+   +  +  + Y+ +EY   G              +  F    + 
Sbjct: 76  -LCKLGHHPNIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 132
Query: 224 GESMARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
             +++ + L     D+  G+ YL     +H ++   N+LV  +   KI DF +S+  E  
Sbjct: 133 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQE-- 190
Query: 280 NDVLRRSPG-TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYD 337
              ++++ G  PV       L  +     +D W+ GV L+ ++ +G  P+ G T  + Y+
Sbjct: 191 -VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 249
Query: 338 KI 339
           K+
Sbjct: 250 KL 251

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 117/264 (44%), Gaps = 28/264 (10%)
Query: 111 ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF--HKSHLSKLRVAPSETAM 168
           +NG K ++ Y     IG GS+G+VV     ++ +  AIK     K+ L++ ++      +
Sbjct: 47  KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLEL 106
Query: 169 T---DVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGE 225
               D   +  I+ + +H    N + ++ +  S + Y +L        N  F     +  
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLR-------NTNF---RGVSL 156
Query: 226 SMARKYLRDIVSGLMYLHGH--NVVHGDIKPDNLLVA--PSGTVKIGDFSVSQVFEDDND 281
           ++ RK+ + + + L++L     +++H D+KP+N+L+       +KI DF  S        
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL---GQ 213
Query: 282 VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN 341
            + +   +  + +PE  LG+ Y   A D W++G  L  M  G+  F G    D  +KIV 
Sbjct: 214 RIYQXIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV- 271
Query: 342 NSLVFPDA----MNPELRNLLEGL 361
             L  P A      P+ R   E L
Sbjct: 272 EVLGIPPAHILDQAPKARKFFEKL 295

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 112/282 (39%), Gaps = 24/282 (8%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R +G G +G V    + L  +  +        L    +A S+  + +  RE   MK   H
Sbjct: 29  RMLGKGEFGSV--REAQLKQEDGSFVKVAVKMLKADIIASSD--IEEFLREAACMKEFDH 84
Query: 184 PNIVNLIEVIDDPNSD---HFYMVLEYVEGKWDNDGFGQPGAIGES-------MARKYLR 233
           P++  L+ V     +       MV+       D   F     IGE+          +++ 
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSPGTPVF 292
           DI  G+ YL   N +H D+   N ++A   TV + DF +S +++  D      +   PV 
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIV-NNSLVFPDAM 350
                 L        +D WA GVT++  M  GQ P+ G    + Y+ ++  N L  P   
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPEC 264
Query: 351 NPELRNLLEGLLCKDPTR-------RLTLNDVAKHTWVLGDN 385
             E+ +L+      DP +       R+ L ++  H  VL  +
Sbjct: 265 MEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD-VRREVLIMKMLQ 182
           +++G+G++G V        G +   K      +  L+   ++ A+ D +  E  +M+ L 
Sbjct: 375 KELGSGNFGTVK------KGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 428
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           +P IV +I + +   ++ + +V+E  E    N    Q   + +    + +  +  G+ YL
Sbjct: 429 NPYIVRMIGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 485
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPGT-PV-FTAPECCL 299
              N VH D+   N+L+      KI DF +S+    D +  + ++ G  PV + APEC  
Sbjct: 486 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 545
Query: 300 GLTYGGKAADTWAVGVTLYYMI-IGQYPFLG 329
              +  K +D W+ GV ++     GQ P+ G
Sbjct: 546 YYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG 575

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 183 HPNIV---NLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
           HP+IV   N +E  D       Y+V+EYV G+      GQ   + E++A  YL +I+  L
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA--YLLEILPAL 195
Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
            YLH   +V+ D+KP+N+++       I   +VS++     +      GTP F APE   
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRI-----NSFGYLYGTPGFQAPEIV- 249
Query: 300 GLTYGGKAADTWAVGVTLYYMII 322
             T    A D + VG TL  + +
Sbjct: 250 -RTGPTVATDIYTVGRTLAALTL 271

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD-VRREVLIMKMLQ 182
           +++G+G++G V        G +   K      +  L+   ++ A+ D +  E  +M+ L 
Sbjct: 376 KELGSGNFGTVK------KGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 429
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           +P IV +I + +   ++ + +V+E  E    N    Q   + +    + +  +  G+ YL
Sbjct: 430 NPYIVRMIGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 486
Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPGT-PV-FTAPECCL 299
              N VH D+   N+L+      KI DF +S+    D +  + ++ G  PV + APEC  
Sbjct: 487 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 546
Query: 300 GLTYGGKAADTWAVGVTLYYMI-IGQYPFLG 329
              +  K +D W+ GV ++     GQ P+ G
Sbjct: 547 YYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG 576

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           K+G G +G  V+Y+  ++    A+K      L+ +    +E       +E+ +M   QH 
Sbjct: 38  KMGEGGFG--VVYKGYVNNTTVAVKK-----LAAMVDITTEELKQQFDQEIKVMAKCQHE 90
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF----GQPGAIGESMARKYLRDIVSGLM 240
           N+V L+    D   D   +V  Y+      D      G P  +   M  K  +   +G+ 
Sbjct: 91  NLVELLGFSSD--GDDLCLVYVYMPNGSLLDRLSCLDGTP-PLSWHMRCKIAQGAANGIN 147
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED--DNDVLRRSPGTPVFTAPECC 298
           +LH ++ +H DIK  N+L+  + T KI DF +++  E      +  R  GT  + APE  
Sbjct: 148 FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL 207
Query: 299 LGLTYGGKAADTWAVGVTLYYMIIG 323
            G       +D ++ GV L  +I G
Sbjct: 208 RGEI--TPKSDIYSFGVVLLEIITG 230

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-T 289
           Y   +  G+ +L     +H D+   N+L++    VKI DF +++    D D +R+     
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LV 345
           P+ + APE      Y  + +D W+ GV L+ +  +G  P+ G  + + + + +     + 
Sbjct: 204 PLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 262
Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            PD   PE+   +      +P++R T +++ +H
Sbjct: 263 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-T 289
           Y   +  G+ +L     +H D+   N+L++    VKI DF +++    D D +R+     
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LV 345
           P+ + APE      Y  + +D W+ GV L+ +  +G  P+ G  + + + + +     + 
Sbjct: 209 PLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMR 267
Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            PD   PE+   +      +P++R T +++ +H
Sbjct: 268 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           K+G G +G  V+Y+  ++    A+K      L+ +    +E       +E+ +M   QH 
Sbjct: 38  KMGEGGFG--VVYKGYVNNTTVAVKK-----LAAMVDITTEELKQQFDQEIKVMAKCQHE 90
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF----GQPGAIGESMARKYLRDIVSGLM 240
           N+V L+    D   D   +V  Y+      D      G P  +   M  K  +   +G+ 
Sbjct: 91  NLVELLGFSSD--GDDLCLVYVYMPNGSLLDRLSCLDGTP-PLSWHMRCKIAQGAANGIN 147
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED--DNDVLRRSPGTPVFTAPECC 298
           +LH ++ +H DIK  N+L+  + T KI DF +++  E      +  R  GT  + APE  
Sbjct: 148 FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL 207
Query: 299 LGLTYGGKAADTWAVGVTLYYMIIG 323
            G       +D ++ GV L  +I G
Sbjct: 208 RGEI--TPKSDIYSFGVVLLEIITG 230

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-T 289
           Y   +  G+ +L     +H D+   N+L++    VKI DF +++    D D +R+     
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LV 345
           P+ + APE      Y  + +D W+ GV L+ +  +G  P+ G  + + + + +     + 
Sbjct: 204 PLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 262
Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            PD   PE+   +      +P++R T +++ +H
Sbjct: 263 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 111/275 (40%), Gaps = 39/275 (14%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y+ ++K+G G +  V L     DG  YA+K           +   +    + +RE  + +
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI---------LCHEQQDREEAQREADMHR 81
Query: 180 MLQHPNIVNLIE-VIDDPNSDH-FYMVLEY---------VEGKWDNDGFGQPGAIGESMA 228
           +  HPNI+ L+   + +  + H  +++L +         +E   D   F     + E   
Sbjct: 82  LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-----LTEDQI 136
Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF-SVSQV---FEDDNDVLR 284
              L  I  GL  +H     H D+KP N+L+   G   + D  S++Q     E     L 
Sbjct: 137 LWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALT 196
Query: 285 RSPG-----TPVFTAPECCLGLTYG--GKAADTWAVGVTLYYMIIGQYPF-LGETLQDTY 336
                    T  + APE     ++    +  D W++G  LY M+ G+ P+ +     D+ 
Sbjct: 197 LQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256
Query: 337 DKIVNNSLVFPDA--MNPELRNLLEGLLCKDPTRR 369
              V N L  P +   +  L  LL  ++  DP +R
Sbjct: 257 ALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQR 291

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-T 289
           Y   +  G+ +L     +H D+   N+L++    VKI DF +++    D D +R+     
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LV 345
           P+ + APE      Y  + +D W+ GV L+ +  +G  P+ G  + + + + +     + 
Sbjct: 213 PLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 271
Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            PD   PE+   +      +P++R T +++ +H
Sbjct: 272 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-T 289
           Y   +  G+ +L     +H D+   N+L++    VKI DF +++    D D +R+     
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LV 345
           P+ + APE      Y  + +D W+ GV L+ +  +G  P+ G  + + + + +     + 
Sbjct: 213 PLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 271
Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            PD   PE+   +      +P++R T +++ +H
Sbjct: 272 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-T 289
           Y   +  G+ +L     +H D+   N+L++    VKI DF +++    D D +R+     
Sbjct: 196 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 255
Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LV 345
           P+ + APE      Y  + +D W+ GV L+ +  +G  P+ G  + + + + +     + 
Sbjct: 256 PLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 314
Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            PD   PE+   +      +P++R T +++ +H
Sbjct: 315 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 347

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/311 (22%), Positives = 129/311 (41%), Gaps = 50/311 (16%)
Query: 99  VKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSK 158
           ++ S KL  S +++      +   + +IG G+YG V        G+  A+K        +
Sbjct: 3   IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVK--------R 54
Query: 159 LRVAPSETAMTDVRREV-LIMKMLQHPNIVNL-------------IEVIDDPNSDHFYMV 204
           +R    E     +  ++ ++M+    P IV               +E++   + D FY  
Sbjct: 55  IRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFY-- 111
Query: 205 LEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSG 263
            +YV    D+        I E +  K     V  L +L  +  ++H DIKP N+L+  SG
Sbjct: 112 -KYVYSVLDD-------VIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG 163
Query: 264 TVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE----CCLGLTYGGKAADTWAVGVTLYY 319
            +K+ DF +S     D+    R  G   + APE          Y  + +D W++G+TLY 
Sbjct: 164 NIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDPSASRQGYDVR-SDVWSLGITLYE 221
Query: 320 MIIGQYPFLGETLQDTYDKIVNNSLVFPDAM--------NPELRNLLEGLLCKDPTRRLT 371
           +  G++P+        +D++       P  +        +P   N +   L KD ++R  
Sbjct: 222 LATGRFPY--PKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPK 279
Query: 372 LNDVAKHTWVL 382
             ++ KH ++L
Sbjct: 280 YKELLKHPFIL 290

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-T 289
           Y   +  G+ +L     +H D+   N+L++    VKI DF +++    D D +R+     
Sbjct: 203 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 262
Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LV 345
           P+ + APE      Y  + +D W+ GV L+ +  +G  P+ G  + + + + +     + 
Sbjct: 263 PLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 321
Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            PD   PE+   +      +P++R T +++ +H
Sbjct: 322 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 354

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-T 289
           Y   +  G+ +L     +H D+   N+L++    VKI DF +++    D D +R+     
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LV 345
           P+ + APE      Y  + +D W+ GV L+ +  +G  P+ G  + + + + +     + 
Sbjct: 204 PLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 262
Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            PD   PE+   +      +P++R T +++ +H
Sbjct: 263 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-T 289
           Y   +  G+ +L     +H D+   N+L++    VKI DF +++    D D +R+     
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LV 345
           P+ + APE      Y  + +D W+ GV L+ +  +G  P+ G  + + + + +     + 
Sbjct: 204 PLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 262
Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            PD   PE+   +      +P++R T +++ +H
Sbjct: 263 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-T 289
           Y   +  G+ +L     +H D+   N+L++    VKI DF +++    D D +R+     
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LV 345
           P+ + APE      Y  + +D W+ GV L+ +  +G  P+ G  + + + + +     + 
Sbjct: 258 PLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 316
Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            PD   PE+   +      +P++R T +++ +H
Sbjct: 317 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-T 289
           Y   +  G+ +L     +H D+   N+L++    VKI DF +++    D D +R+     
Sbjct: 153 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LV 345
           P+ + APE      Y  + +D W+ GV L+ +  +G  P+ G  + + + + +     + 
Sbjct: 213 PLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 271
Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            PD   PE+   +      +P++R T +++ +H
Sbjct: 272 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-T 289
           Y   +  G+ +L     +H D+   N+L++    VKI DF +++    D D +R+     
Sbjct: 205 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 264
Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LV 345
           P+ + APE      Y  + +D W+ GV L+ +  +G  P+ G  + + + + +     + 
Sbjct: 265 PLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 323
Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            PD   PE+   +      +P++R T +++ +H
Sbjct: 324 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 356

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           K+G G +G  V+Y+  ++    A+K      L+ +    +E       +E+ +M   QH 
Sbjct: 32  KMGEGGFG--VVYKGYVNNTTVAVKK-----LAAMVDITTEELKQQFDQEIKVMAKCQHE 84
Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF----GQPGAIGESMARKYLRDIVSGLM 240
           N+V L+    D   D   +V  Y+      D      G P  +   M  K  +   +G+ 
Sbjct: 85  NLVELLGFSSD--GDDLCLVYVYMPNGSLLDRLSCLDGTP-PLSWHMRCKIAQGAANGIN 141
Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED--DNDVLRRSPGTPVFTAPECC 298
           +LH ++ +H DIK  N+L+  + T KI DF +++  E      +  R  GT  + APE  
Sbjct: 142 FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL 201
Query: 299 LGLTYGGKAADTWAVGVTLYYMIIG 323
            G       +D ++ GV L  +I G
Sbjct: 202 RGEI--TPKSDIYSFGVVLLEIITG 224

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-T 289
           Y   +  G+ +L     +H D+   N+L++    VKI DF +++    D D +R+     
Sbjct: 155 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 214
Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LV 345
           P+ + APE      Y  + +D W+ GV L+ +  +G  P+ G  + + + + +     + 
Sbjct: 215 PLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 273
Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            PD   PE+   +      +P++R T +++ +H
Sbjct: 274 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 306

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-T 289
           Y   +  G+ +L     +H D+   N+L++    VKI DF +++    D D +R+     
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARL 212
Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LV 345
           P+ + APE      Y  + +D W+ GV L+ +  +G  P+ G  + + + + +     + 
Sbjct: 213 PLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 271
Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            PD   PE+   +      +P++R T +++ +H
Sbjct: 272 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 85/185 (45%), Gaps = 10/185 (5%)
Query: 205 LEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT 264
           L  VE + D+DGF +     E +   Y   +  G+ +L     +H D+   N+L++ +  
Sbjct: 179 LSDVEEEEDSDGFYKEPITMEDLI-SYSFQVARGMEFLSSRKCIHRDLAARNILLSENNV 237
Query: 265 VKIGDFSVSQVFEDDNDVLRRSPG-TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI- 321
           VKI DF +++    + D +R+     P+ + APE      Y  K +D W+ GV L+ +  
Sbjct: 238 VKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTK-SDVWSYGVLLWEIFS 296
Query: 322 IGQYPFLGETLQDTYDKIVNNSLVF--PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
           +G  P+ G  + + +   +   +    P+   PE+  ++     +DP  R    ++ +  
Sbjct: 297 LGGSPYPGVQMDEDFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEK- 355
Query: 380 WVLGD 384
             LGD
Sbjct: 356 --LGD 358

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 102/250 (40%), Gaps = 33/250 (13%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R +G G++G+V  Y   + G          + +  L    SE    D   E LI+    
Sbjct: 36  IRGLGHGAFGEV--YEGQVSGMPNDPSPLQVA-VKTLPEVCSEQDELDFLMEALIISKFN 92
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--------GQPGAIGESMARKYLRD 234
           H NIV  I V     S   +++LE + G  D   F         QP ++         RD
Sbjct: 93  HQNIVRCIGV--SLQSLPRFILLELMAGG-DLKSFLRETRPRPSQPSSLAMLDLLHVARD 149
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSVSQVFEDDNDVLRRS----- 286
           I  G  YL  ++ +H DI   N L+    P    KIGDF ++Q      D+ R S     
Sbjct: 150 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ------DIYRASYYRKG 203
Query: 287 --PGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN 342
                PV +  PE  +   +  K  DTW+ GV L+ +  +G  P+  ++ Q+  + + + 
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 262
Query: 343 SLVFPDAMNP 352
             + P    P
Sbjct: 263 GRMDPPKNCP 272

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 81/173 (46%), Gaps = 8/173 (4%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNIV L++++ D +S    ++ EYV    + D       + +   R Y+ +++  L Y H
Sbjct: 107 PNIVKLLDIVRDQHSKTPSLIFEYVN---NTDFKVLYPTLTDYDIRYYIYELLKALDYCH 163
Query: 244 GHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
              ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  + L 
Sbjct: 164 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDLQ 222
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF-PDAMNPEL 354
               + D W++G     MI  + PF      D +D++V  + V   D +N  L
Sbjct: 223 DYDYSLDMWSLGCMFAGMIFRKEPFFYG--HDNHDQLVKIAKVLGTDGLNAYL 273

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-T 289
           Y   +  G+ +L     +H D+   N+L++    VKI DF +++    D D +R+     
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212
Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LV 345
           P+ + APE      Y  + +D W+ GV L+ +  +G  P+ G  + + + + +     + 
Sbjct: 213 PLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 271
Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            PD   PE+   +      +P++R T +++ +H
Sbjct: 272 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-T 289
           Y   +  G+ +L     +H D+   N+L++    VKI DF +++    D D +R+     
Sbjct: 190 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 249
Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LV 345
           P+ + APE      Y  + +D W+ GV L+ +  +G  P+ G  + + + + +     + 
Sbjct: 250 PLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 308
Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            PD   PE+   +      +P++R T +++ +H
Sbjct: 309 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-T 289
           Y   +  G+ +L     +H D+   N+L++    VKI DF +++    D D +R+     
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LV 345
           P+ + APE      Y  + +D W+ GV L+ +  +G  P+ G  + + + + +     + 
Sbjct: 209 PLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 267
Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            PD   PE+   +      +P++R T +++ +H
Sbjct: 268 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 73
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNW 125
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 126 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 186 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 225

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 30/231 (12%)
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD-----------------HFYMVLE 206
           S+  + +   E   MK   HPN++ L+ V  + +S                  H Y++  
Sbjct: 76  SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS 135
Query: 207 YVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVK 266
            +E          P  I      K++ DI  G+ YL   N +H D+   N ++    TV 
Sbjct: 136 RLETG--------PKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC 187
Query: 267 IGDFSVS-QVFEDDNDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMII-G 323
           + DF +S +++  D     R    PV + A E      Y  K +D WA GVT++ +   G
Sbjct: 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRG 246
Query: 324 QYPFLGETLQDTYDKIVN-NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLN 373
             P+ G    + YD +++ + L  P+    EL  ++      DP  R T +
Sbjct: 247 MTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFS 297

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 81/173 (46%), Gaps = 8/173 (4%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNIV L++++ D +S    ++ EYV    + D       + +   R Y+ +++  L Y H
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVN---NTDFKVLYPTLTDYDIRYYIYELLKALDYCH 143
Query: 244 GHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
              ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  + L 
Sbjct: 144 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDLQ 202
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF-PDAMNPEL 354
               + D W++G     MI  + PF      D +D++V  + V   D +N  L
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYG--HDNHDQLVKIAKVLGTDGLNVYL 253

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 72
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNW 124
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 125 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 185 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 224

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 80
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 81  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNW 132
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 133 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 192
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 193 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 232

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 70
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNW 122
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 183 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/149 (22%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLRRSPGTPV- 291
            +  G+ +L   N +H D+   N+L+      KI DF +++ +  D N V++ +   PV 
Sbjct: 171 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVK 230
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LVFPD 348
           + APE      Y  + +D W+ G+ L+ +  +G  P+ G  +   + K++     ++ P+
Sbjct: 231 WMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE 289
Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
               E+ ++++     DP +R T   + +
Sbjct: 290 HAPAEMYDIMKTCWDADPLKRPTFKQIVQ 318

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/149 (22%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLRRSPGTPV- 291
            +  G+ +L   N +H D+   N+L+      KI DF +++ +  D N V++ +   PV 
Sbjct: 169 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVK 228
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LVFPD 348
           + APE      Y  + +D W+ G+ L+ +  +G  P+ G  +   + K++     ++ P+
Sbjct: 229 WMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE 287
Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
               E+ ++++     DP +R T   + +
Sbjct: 288 HAPAEMYDIMKTCWDADPLKRPTFKQIVQ 316

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 103/250 (41%), Gaps = 33/250 (13%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R +G G++G+V  Y   + G          + +  L    SE    D   E LI+  L 
Sbjct: 36  IRGLGHGAFGEV--YEGQVSGMPNDPSPLQVA-VKTLPEVCSEQDELDFLMEALIISKLN 92
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--------GQPGAIGESMARKYLRD 234
           H NIV  I V     S   +++LE + G  D   F         QP ++         RD
Sbjct: 93  HQNIVRCIGV--SLQSLPRFILLELMAGG-DLKSFLRETRPRPSQPSSLAMLDLLHVARD 149
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSVSQVFEDDNDVLRRS----- 286
           I  G  YL  ++ +H DI   N L+    P    KIGDF +++      D+ R S     
Sbjct: 150 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKG 203
Query: 287 --PGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN 342
                PV +  PE  +   +  K  DTW+ GV L+ +  +G  P+  ++ Q+  + + + 
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 262
Query: 343 SLVFPDAMNP 352
             + P    P
Sbjct: 263 GRMDPPKNCP 272

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 81/173 (46%), Gaps = 8/173 (4%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNIV L++++ D +S    ++ EYV    + D       + +   R Y+ +++  L Y H
Sbjct: 88  PNIVKLLDIVRDQHSKTPSLIFEYVN---NTDFKVLYPTLTDYDIRYYIYELLKALDYCH 144
Query: 244 GHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
              ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  + L 
Sbjct: 145 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDLQ 203
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF-PDAMNPEL 354
               + D W++G     MI  + PF      D +D++V  + V   D +N  L
Sbjct: 204 DYDYSLDMWSLGCMFAGMIFRKEPFFYG--HDNHDQLVKIAKVLGTDGLNVYL 254

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 73
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNW 125
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 126 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 186 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 225

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/149 (22%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLRRSPGTPV- 291
            +  G+ +L   N +H D+   N+L+      KI DF +++ +  D N V++ +   PV 
Sbjct: 176 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVK 235
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LVFPD 348
           + APE      Y  + +D W+ G+ L+ +  +G  P+ G  +   + K++     ++ P+
Sbjct: 236 WMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE 294
Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
               E+ ++++     DP +R T   + +
Sbjct: 295 HAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 71
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 72  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDN--------IGSQYLLNW 123
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 124 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 184 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 223

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 95
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 96  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNW 147
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 148 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 207
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 208 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 247

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 77
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNW 129
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 130 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 190 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 229

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 70
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDN--------IGSQYLLNW 122
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 183 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 70
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNW 122
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 183 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 72
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--------IGSQYLLNW 124
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 125 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 185 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 224

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 81/173 (46%), Gaps = 8/173 (4%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNIV L++++ D +S    ++ EYV    + D       + +   R Y+ +++  L Y H
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVN---NTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 244 GHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
              ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  + L 
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDLQ 201
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF-PDAMNPEL 354
               + D W++G     MI  + PF      D +D++V  + V   D +N  L
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYG--HDNHDQLVKIAKVLGTDGLNVYL 252

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 74
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 75  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--------IGSQYLLNW 126
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 127 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 186
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 187 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 226

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/149 (22%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLRRSPGTPV- 291
            +  G+ +L   N +H D+   N+L+      KI DF +++ +  D N V++ +   PV 
Sbjct: 176 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVK 235
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LVFPD 348
           + APE      Y  + +D W+ G+ L+ +  +G  P+ G  +   + K++     ++ P+
Sbjct: 236 WMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE 294
Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
               E+ ++++     DP +R T   + +
Sbjct: 295 HAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 73
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNW 125
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 126 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 186 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 225

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 81/173 (46%), Gaps = 8/173 (4%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNIV L++++ D +S    ++ EYV    + D       + +   R Y+ +++  L Y H
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVN---NTDFKVLYPTLTDYDIRYYIYELLKALDYCH 143
Query: 244 GHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
              ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  + L 
Sbjct: 144 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDLQ 202
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF-PDAMNPEL 354
               + D W++G     MI  + PF      D +D++V  + V   D +N  L
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYG--HDNHDQLVKIAKVLGTDGLNVYL 253

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 73
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--------IGSQYLLNW 125
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 126 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 186 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 225

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 116/287 (40%), Gaps = 45/287 (15%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 67
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 68  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNW 119
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 120 CVQIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 179
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPF-------------LGETLQ-- 333
           + + A E  L   Y  + +D W+ GVT++  M  G  P+              GE L   
Sbjct: 180 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 238
Query: 334 -----DTYDKIVNNSLVFPDAMNPELRNLLEGL--LCKDPTRRLTLN 373
                D Y  +V   ++  D+  P+ R L+     + +DP R L + 
Sbjct: 239 PICTIDVYMIMVKCWMIDADS-RPKFRELIIEFSKMARDPQRYLVIQ 284

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 81/173 (46%), Gaps = 8/173 (4%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNIV L++++ D +S    ++ EYV    + D       + +   R Y+ +++  L Y H
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVN---NTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 244 GHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
              ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  + L 
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDLQ 201
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF-PDAMNPEL 354
               + D W++G     MI  + PF      D +D++V  + V   D +N  L
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYG--HDNHDQLVKIAKVLGTDGLNVYL 252

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 70
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--------IGSQYLLNW 122
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 183 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 74/168 (44%), Gaps = 12/168 (7%)
Query: 222 AIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD- 279
            I E +  K    IV  L +LH   +V+H D+KP N+L+   G VK+ DF +S    DD 
Sbjct: 105 TIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV 164
Query: 280 -NDVLRRSPGTPVFTAPECC---LGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQ 333
             D+     G   + APE     L        +D W++G+T+  + I ++P+   G   Q
Sbjct: 165 AKDI---DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ 221
Query: 334 DTYDKIVNNSLVFP-DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
                +   S   P D  + E  +     L K+   R T  ++ +H +
Sbjct: 222 QLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 103/250 (41%), Gaps = 33/250 (13%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R +G G++G+V  Y   + G          + +  L    SE    D   E LI+  L 
Sbjct: 50  IRGLGHGAFGEV--YEGQVSGMPNDPSPLQVA-VKTLPEVCSEQDELDFLMEALIISKLN 106
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--------GQPGAIGESMARKYLRD 234
           H NIV  I V     S   +++LE + G  D   F         QP ++         RD
Sbjct: 107 HQNIVRCIGV--SLQSLPRFILLELMAGG-DLKSFLRETRPRPSQPSSLAMLDLLHVARD 163
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSVSQVFEDDNDVLRRS----- 286
           I  G  YL  ++ +H DI   N L+    P    KIGDF +++      D+ R S     
Sbjct: 164 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKG 217
Query: 287 --PGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN 342
                PV +  PE  +   +  K  DTW+ GV L+ +  +G  P+  ++ Q+  + + + 
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 276
Query: 343 SLVFPDAMNP 352
             + P    P
Sbjct: 277 GRMDPPKNCP 286

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 71
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 72  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--------IGSQYLLNW 123
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 124 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 184 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 223

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 76
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 77  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNW 128
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 129 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 188
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 189 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 228

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/149 (22%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDDNDVLRRSPGTPV- 291
            +  G+ +L   N +H D+   N+L+      KI DF +++ +  D N V++ +   PV 
Sbjct: 153 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVK 212
Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LVFPD 348
           + APE      Y  + +D W+ G+ L+ +  +G  P+ G  +   + K++     ++ P+
Sbjct: 213 WMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE 271
Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
               E+ ++++     DP +R T   + +
Sbjct: 272 HAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 81/173 (46%), Gaps = 8/173 (4%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNIV L++++ D +S    ++ EYV    + D       + +   R Y+ +++  L Y H
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVN---NTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 244 GHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
              ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  + L 
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDLQ 201
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF-PDAMNPEL 354
               + D W++G     MI  + PF      D +D++V  + V   D +N  L
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYG--HDNHDQLVKIAKVLGTDGLNVYL 252

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 116/287 (40%), Gaps = 45/287 (15%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 64
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 65  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNW 116
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 117 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPF-------------LGETLQ-- 333
           + + A E  L   Y  + +D W+ GVT++  M  G  P+              GE L   
Sbjct: 177 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 235
Query: 334 -----DTYDKIVNNSLVFPDAMNPELRNLLEGL--LCKDPTRRLTLN 373
                D Y  +V   ++  D+  P+ R L+     + +DP R L + 
Sbjct: 236 PICTIDVYMIMVKCWMIDADS-RPKFRELIIEFSKMARDPQRYLVIQ 281

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 113/243 (46%), Gaps = 44/243 (18%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
           + +G G++G+VV+  +    K    +A   + +  L+   +E  ++D+  E+ +MKM+ +
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 183 HPNIVNLIEVI--DDPNSDHFYMVLEY-----------------VEGKWDNDGFGQPGAI 223
           H NI+NL+     D P     Y+++EY                 +E  +D +   +    
Sbjct: 100 HKNIINLLGACTQDGP----LYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPE---- 151
Query: 224 GESMARKYLRDIVS-------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
            E M     +D+VS       G+ YL     +H D+   N+LV  +  +KI DF +++  
Sbjct: 152 -EQMT---FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 277 EDDNDVLRRSPG-TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQ 333
            + +   + + G  PV + APE      Y  + +D W+ GV ++ +  +G  P+ G  ++
Sbjct: 208 NNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVE 266
Query: 334 DTY 336
           + +
Sbjct: 267 ELF 269

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 81/173 (46%), Gaps = 8/173 (4%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNIV L++++ D +S    ++ EYV    + D       + +   R Y+ +++  L Y H
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVN---NTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 244 GHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
              ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  + L 
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDLQ 201
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF-PDAMNPEL 354
               + D W++G     MI  + PF      D +D++V  + V   D +N  L
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYG--HDNHDQLVKIAKVLGTDGLNVYL 252

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 81/173 (46%), Gaps = 8/173 (4%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNIV L++++ D +S    ++ EYV    + D       + +   R Y+ +++  L Y H
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVN---NTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 244 GHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
              ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  + L 
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDLQ 201
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF-PDAMNPEL 354
               + D W++G     MI  + PF      D +D++V  + V   D +N  L
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYG--HDNHDQLVKIAKVLGTDGLNVYL 252

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 81/173 (46%), Gaps = 8/173 (4%)
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNIV L++++ D +S    ++ EYV    + D       + +   R Y+ +++  L Y H
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVN---NTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 244 GHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
              ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  PE  + L 
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDLQ 201
Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF-PDAMNPEL 354
               + D W++G     MI  + PF      D +D++V  + V   D +N  L
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYG--HDNHDQLVKIAKVLGTDGLNVYL 252

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 50/110 (45%), Gaps = 1/110 (0%)
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
           +D+   + YL     +H D+   N LV   G VK+ DF +S+   DD     R    PV 
Sbjct: 112 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVR 171
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVN 341
            +P   L  +     +D WA GV ++ +  +G+ P+   T  +T + I  
Sbjct: 172 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 221

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIMELREATSPKANKEILDEAYV 104
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 105 MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNW 156
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 157 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 216
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 217 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 256

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 94/210 (44%), Gaps = 29/210 (13%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           +K+GAG +G+V +   +   KH        + ++   + P   ++     E  +MK LQH
Sbjct: 188 KKLGAGQFGEVWM---ATYNKH--------TKVAVKTMKPGSMSVEAFLAEANVMKTLQH 236
Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMAR--KYLRDIVSGLMY 241
             +V L  V+     +  Y++ E++      D         + + +   +   I  G+ +
Sbjct: 237 DKLVKLHAVV---TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 293
Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTAPECCLG 300
           +   N +H D++  N+LV+ S   KI DF +++V              P+ +TAPE    
Sbjct: 294 IEQRNYIHRDLRAANILVSASLVCKIADFGLARV----------GAKFPIKWTAPEAINF 343
Query: 301 LTYGGKAADTWAVGVTLYYMII-GQYPFLG 329
            ++  K +D W+ G+ L  ++  G+ P+ G
Sbjct: 344 GSFTIK-SDVWSFGILLMEIVTYGRIPYPG 372

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 113/243 (46%), Gaps = 44/243 (18%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
           + +G G++G+VV+  +    K    +A   + +  L+   +E  ++D+  E+ +MKM+ +
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 183 HPNIVNLIEVI--DDPNSDHFYMVLEY-----------------VEGKWDNDGFGQPGAI 223
           H NI+NL+     D P     Y+++EY                 +E  +D +   +    
Sbjct: 100 HKNIINLLGACTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE---- 151
Query: 224 GESMARKYLRDIVS-------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
            E M     +D+VS       G+ YL     +H D+   N+LV  +  +KI DF +++  
Sbjct: 152 -EQMT---FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 277 EDDNDVLRRSPG-TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQ 333
            + +   + + G  PV + APE      Y  + +D W+ GV ++ +  +G  P+ G  ++
Sbjct: 208 NNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVE 266
Query: 334 DTY 336
           + +
Sbjct: 267 ELF 269

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 79/177 (44%), Gaps = 9/177 (5%)
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGA 222
           S  A+TD    +L +  L H +IV L+ +   P S    +V +Y+  G   +      GA
Sbjct: 58  SFQAVTD---HMLAIGSLDHAHIVRLLGLC--PGSS-LQLVTQYLPLGSLLDHVRQHRGA 111
Query: 223 IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF-EDDND 281
           +G  +   +   I  G+ YL  H +VH ++   N+L+     V++ DF V+ +   DD  
Sbjct: 112 LGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171
Query: 282 VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYD 337
           +L     TP+       +        +D W+ GVT++  M  G  P+ G  L +  D
Sbjct: 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD 228

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 105/235 (44%), Gaps = 28/235 (11%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
           + +G G++G+VVL  +    K    +   K  +  L+   +E  ++D+  E+ +MKM+ +
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRV-TKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 183 HPNIVNLIEVI--DDPNSDHFYMVLEYVEGKWDND------------GFGQPGAIGESMA 228
           H NI+NL+     D P     Y+++EY       +             F       E ++
Sbjct: 93  HKNIINLLGACTQDGP----LYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLS 148
Query: 229 RKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR 284
            K L      +  G+ YL     +H D+   N+LV     +KI DF +++     +   +
Sbjct: 149 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKK 208
Query: 285 RSPG-TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTY 336
            + G  PV + APE      Y  + +D W+ GV L+ +  +G  P+ G  +++ +
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 79/177 (44%), Gaps = 9/177 (5%)
Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGA 222
           S  A+TD    +L +  L H +IV L+ +   P S    +V +Y+  G   +      GA
Sbjct: 76  SFQAVTD---HMLAIGSLDHAHIVRLLGLC--PGSS-LQLVTQYLPLGSLLDHVRQHRGA 129
Query: 223 IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF-EDDND 281
           +G  +   +   I  G+ YL  H +VH ++   N+L+     V++ DF V+ +   DD  
Sbjct: 130 LGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 189
Query: 282 VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYD 337
           +L     TP+       +        +D W+ GVT++  M  G  P+ G  L +  D
Sbjct: 190 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD 246

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 72
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNW 124
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF  +++   +        G  P
Sbjct: 125 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 185 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 224

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 115/287 (40%), Gaps = 45/287 (15%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 72
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--------IGSQYLLNW 124
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF  +++   +        G  P
Sbjct: 125 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPF-------------LGETLQ-- 333
           + + A E  L   Y  + +D W+ GVT++  M  G  P+              GE L   
Sbjct: 185 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 243
Query: 334 -----DTYDKIVNNSLVFPDAMNPELRNLLEGL--LCKDPTRRLTLN 373
                D Y  +V   ++  D+  P+ R L+     + +DP R L + 
Sbjct: 244 PICTIDVYMIMVKCWMIDADS-RPKFRELIIEFSKMARDPQRYLVIQ 289

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 102/250 (40%), Gaps = 33/250 (13%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R +G G++G+V  Y   + G          + +  L    SE    D   E LI+    
Sbjct: 52  IRGLGHGAFGEV--YEGQVSGMPNDPSPLQVA-VKTLPEVCSEQDELDFLMEALIISKFN 108
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--------GQPGAIGESMARKYLRD 234
           H NIV  I V     S   +++LE + G  D   F         QP ++         RD
Sbjct: 109 HQNIVRCIGV--SLQSLPRFILLELMAGG-DLKSFLRETRPRPSQPSSLAMLDLLHVARD 165
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSVSQVFEDDNDVLRRS----- 286
           I  G  YL  ++ +H DI   N L+    P    KIGDF +++      D+ R S     
Sbjct: 166 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKG 219
Query: 287 --PGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN 342
                PV +  PE  +   +  K  DTW+ GV L+ +  +G  P+  ++ Q+  + + + 
Sbjct: 220 GCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 278
Query: 343 SLVFPDAMNP 352
             + P    P
Sbjct: 279 GRMDPPKNCP 288

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 72
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--------IGSQYLLNW 124
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF  +++   +        G  P
Sbjct: 125 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 185 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 224

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 102/250 (40%), Gaps = 33/250 (13%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R +G G++G+V  Y   + G          + +  L    SE    D   E LI+    
Sbjct: 36  IRGLGHGAFGEV--YEGQVSGMPNDPSPLQVA-VKTLPEVCSEQDELDFLMEALIISKFN 92
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--------GQPGAIGESMARKYLRD 234
           H NIV  I V     S   +++LE + G  D   F         QP ++         RD
Sbjct: 93  HQNIVRCIGV--SLQSLPRFILLELMAGG-DLKSFLRETRPRPSQPSSLAMLDLLHVARD 149
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSVSQVFEDDNDVLRRS----- 286
           I  G  YL  ++ +H DI   N L+    P    KIGDF +++      D+ R S     
Sbjct: 150 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKG 203
Query: 287 --PGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN 342
                PV +  PE  +   +  K  DTW+ GV L+ +  +G  P+  ++ Q+  + + + 
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 262
Query: 343 SLVFPDAMNP 352
             + P    P
Sbjct: 263 GRMDPPKNCP 272

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 115/287 (40%), Gaps = 45/287 (15%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 77
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNW 129
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF  +++   +        G  P
Sbjct: 130 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 189
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPF-------------LGETLQ-- 333
           + + A E  L   Y  + +D W+ GVT++  M  G  P+              GE L   
Sbjct: 190 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 248
Query: 334 -----DTYDKIVNNSLVFPDAMNPELRNLLEGL--LCKDPTRRLTLN 373
                D Y  +V   ++  D+  P+ R L+     + +DP R L + 
Sbjct: 249 PICTIDVYMIMVKCWMIDADS-RPKFRELIIEFSKMARDPQRYLVIQ 294

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 102/250 (40%), Gaps = 33/250 (13%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R +G G++G+V  Y   + G          + +  L    SE    D   E LI+    
Sbjct: 35  IRGLGHGAFGEV--YEGQVSGMPNDPSPLQVA-VKTLPEVCSEQDELDFLMEALIISKFN 91
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--------GQPGAIGESMARKYLRD 234
           H NIV  I V     S   +++LE + G  D   F         QP ++         RD
Sbjct: 92  HQNIVRCIGV--SLQSLPRFILLELMAGG-DLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSVSQVFEDDNDVLRRS----- 286
           I  G  YL  ++ +H DI   N L+    P    KIGDF +++      D+ R S     
Sbjct: 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKG 202
Query: 287 --PGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN 342
                PV +  PE  +   +  K  DTW+ GV L+ +  +G  P+  ++ Q+  + + + 
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261
Query: 343 SLVFPDAMNP 352
             + P    P
Sbjct: 262 GRMDPPKNCP 271

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 102/250 (40%), Gaps = 33/250 (13%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R +G G++G+V  Y   + G          + +  L    SE    D   E LI+    
Sbjct: 27  IRGLGHGAFGEV--YEGQVSGMPNDPSPLQVA-VKTLPEVCSEQDELDFLMEALIISKFN 83
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--------GQPGAIGESMARKYLRD 234
           H NIV  I V     S   +++LE + G  D   F         QP ++         RD
Sbjct: 84  HQNIVRCIGV--SLQSLPRFILLELMAGG-DLKSFLRETRPRPSQPSSLAMLDLLHVARD 140
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSVSQVFEDDNDVLRRS----- 286
           I  G  YL  ++ +H DI   N L+    P    KIGDF +++      D+ R S     
Sbjct: 141 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKG 194
Query: 287 --PGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN 342
                PV +  PE  +   +  K  DTW+ GV L+ +  +G  P+  ++ Q+  + + + 
Sbjct: 195 GCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 253
Query: 343 SLVFPDAMNP 352
             + P    P
Sbjct: 254 GRMDPPKNCP 263

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 102/250 (40%), Gaps = 33/250 (13%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R +G G++G+V  Y   + G          + +  L    SE    D   E LI+    
Sbjct: 62  IRGLGHGAFGEV--YEGQVSGMPNDPSPLQVA-VKTLPEVCSEQDELDFLMEALIISKFN 118
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--------GQPGAIGESMARKYLRD 234
           H NIV  I V     S   +++LE + G  D   F         QP ++         RD
Sbjct: 119 HQNIVRCIGV--SLQSLPRFILLELMAGG-DLKSFLRETRPRPSQPSSLAMLDLLHVARD 175
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRS----- 286
           I  G  YL  ++ +H DI   N L+    P    KIGDF +++      D+ R S     
Sbjct: 176 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKG 229
Query: 287 --PGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN 342
                PV +  PE  +   +  K  DTW+ GV L+ +  +G  P+  ++ Q+  + + + 
Sbjct: 230 GCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 288
Query: 343 SLVFPDAMNP 352
             + P    P
Sbjct: 289 GRMDPPKNCP 298

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 70
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNW 122
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF  +++   +        G  P
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 182
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 183 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 102/250 (40%), Gaps = 33/250 (13%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R +G G++G+V  Y   + G          + +  L    SE    D   E LI+    
Sbjct: 42  IRGLGHGAFGEV--YEGQVSGMPNDPSPLQVA-VKTLPEVCSEQDELDFLMEALIISKFN 98
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--------GQPGAIGESMARKYLRD 234
           H NIV  I V     S   +++LE + G  D   F         QP ++         RD
Sbjct: 99  HQNIVRCIGV--SLQSLPRFILLELMAGG-DLKSFLRETRPRPSQPSSLAMLDLLHVARD 155
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRS----- 286
           I  G  YL  ++ +H DI   N L+    P    KIGDF +++      D+ R S     
Sbjct: 156 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKG 209
Query: 287 --PGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN 342
                PV +  PE  +   +  K  DTW+ GV L+ +  +G  P+  ++ Q+  + + + 
Sbjct: 210 GCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 268
Query: 343 SLVFPDAMNP 352
             + P    P
Sbjct: 269 GRMDPPKNCP 278

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 73/305 (23%), Positives = 126/305 (41%), Gaps = 71/305 (23%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           N  V  + +G GS G VV ++ S  G+  A+K        ++ +   + A+ +++   L+
Sbjct: 33  NLVVSEKILGYGSSGTVV-FQGSFQGRPVAVK--------RMLIDFCDIALMEIK---LL 80
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF-YMVLEY--------VEGKWDNDGFGQPGAIGESMA 228
            +   HPN+   I       +D F Y+ LE         VE K  +D           + 
Sbjct: 81  TESDDHPNV---IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDE-------NLKLQ 130
Query: 229 RKY-----LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-------------TVKIGDF 270
           ++Y     LR I SG+ +LH   ++H D+KP N+LV+ S               + I DF
Sbjct: 131 KEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 190
Query: 271 SVSQVFEDDNDVLRRS----PGTPVFTAPECCLGLTYG--GKAADTWAVGVTLYYMII-G 323
            + +  +      R +     GT  + APE     T     ++ D +++G   YY++  G
Sbjct: 191 GLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKG 250
Query: 324 QYPFLGETLQDTYDKIVN--NSLVFPDAMN--------PELRNLLEGLLCKDPTRRLTLN 373
           ++PF      D Y +  N    +   D M          E  +L+  ++  DP +R T  
Sbjct: 251 KHPF-----GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAM 305
Query: 374 DVAKH 378
            V +H
Sbjct: 306 KVLRH 310

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 115/287 (40%), Gaps = 45/287 (15%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ +G+G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 74
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 75  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--------IGSQYLLNW 126
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF  +++   +        G  P
Sbjct: 127 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 186
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPF-------------LGETLQ-- 333
           + + A E  L   Y  + +D W+ GVT++  M  G  P+              GE L   
Sbjct: 187 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 245
Query: 334 -----DTYDKIVNNSLVFPDAMNPELRNLLEGL--LCKDPTRRLTLN 373
                D Y  +V   ++  D+  P+ R L+     + +DP R L + 
Sbjct: 246 PICTIDVYMIMVKCWMIDADS-RPKFRELIIEFSKMARDPQRYLVIQ 291

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 73/305 (23%), Positives = 126/305 (41%), Gaps = 71/305 (23%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           N  V  + +G GS G VV ++ S  G+  A+K        ++ +   + A+ +++   L+
Sbjct: 33  NLVVSEKILGYGSSGTVV-FQGSFQGRPVAVK--------RMLIDFCDIALMEIK---LL 80
Query: 178 MKMLQHPNIVNLIEVIDDPNSDHF-YMVLEY--------VEGKWDNDGFGQPGAIGESMA 228
            +   HPN+   I       +D F Y+ LE         VE K  +D           + 
Sbjct: 81  TESDDHPNV---IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDE-------NLKLQ 130
Query: 229 RKY-----LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-------------TVKIGDF 270
           ++Y     LR I SG+ +LH   ++H D+KP N+LV+ S               + I DF
Sbjct: 131 KEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 190
Query: 271 SVSQVFEDDNDVLRRS----PGTPVFTAPECCLGLTYG--GKAADTWAVGVTLYYMII-G 323
            + +  +      R +     GT  + APE     T     ++ D +++G   YY++  G
Sbjct: 191 GLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKG 250
Query: 324 QYPFLGETLQDTYDKIVN--NSLVFPDAMN--------PELRNLLEGLLCKDPTRRLTLN 373
           ++PF      D Y +  N    +   D M          E  +L+  ++  DP +R T  
Sbjct: 251 KHPF-----GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAM 305
Query: 374 DVAKH 378
            V +H
Sbjct: 306 KVLRH 310

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 102/250 (40%), Gaps = 33/250 (13%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R +G G++G+V  Y   + G          + +  L    SE    D   E LI+    
Sbjct: 50  IRGLGHGAFGEV--YEGQVSGMPNDPSPLQVA-VKTLPEVYSEQDELDFLMEALIISKFN 106
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--------GQPGAIGESMARKYLRD 234
           H NIV  I V     S   +++LE + G  D   F         QP ++         RD
Sbjct: 107 HQNIVRCIGV--SLQSLPRFILLELMAGG-DLKSFLRETRPRPSQPSSLAMLDLLHVARD 163
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSVSQVFEDDNDVLRRS----- 286
           I  G  YL  ++ +H DI   N L+    P    KIGDF +++      D+ R S     
Sbjct: 164 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKG 217
Query: 287 --PGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN 342
                PV +  PE  +   +  K  DTW+ GV L+ +  +G  P+  ++ Q+  + + + 
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 276
Query: 343 SLVFPDAMNP 352
             + P    P
Sbjct: 277 GRMDPPKNCP 286

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 109/237 (45%), Gaps = 32/237 (13%)
Query: 124 RKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML- 181
           + +G G++G+VVL  +  LD          K  +  L+   +E  ++D+  E+ +MKM+ 
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKD--KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 182 QHPNIVNLIEVI--DDPNSDHFYMVLEYVEGKWDNDGFGQ----PGA---------IGES 226
           +H NI+NL+     D P     Y+++EY   K +   + Q    PG            E 
Sbjct: 77  KHKNIINLLGACTQDGP----LYVIVEYA-SKGNLREYLQARRPPGLEYCYNPSHNPEEQ 131
Query: 227 MARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
           ++ K L      +  G+ YL     +H D+   N+LV     +KI DF +++     +  
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 283 LRRSPG-TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTY 336
            + + G  PV + APE      Y  + +D W+ GV L+ +  +G  P+ G  +++ +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 103/250 (41%), Gaps = 33/250 (13%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R +G G++G+V  Y   + G          + +  L    SE    D   E LI+    
Sbjct: 53  IRGLGHGAFGEV--YEGQVSGMPNDPSPLQVA-VKTLPEVCSEQDELDFLMEALIISKFN 109
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--------GQPGAIGESMARKYLRD 234
           H NIV  I V     S   +++LE + G  D   F         QP ++         RD
Sbjct: 110 HQNIVRCIGV--SLQSLPRFILLELMAGG-DLKSFLRETRPRPSQPSSLAMLDLLHVARD 166
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSVSQVFEDDNDVLR----RSP 287
           I  G  YL  ++ +H DI   N L+    P    KIGDF +++      D+ R    R  
Sbjct: 167 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRAGYYRKG 220
Query: 288 GT---PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN 342
           G    PV +  PE  +   +  K  DTW+ GV L+ +  +G  P+  ++ Q+  + + + 
Sbjct: 221 GCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 279
Query: 343 SLVFPDAMNP 352
             + P    P
Sbjct: 280 GRMDPPKNCP 289

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 12/168 (7%)
Query: 222 AIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD- 279
            I E +  K    IV  L +LH   +V+H D+KP N+L+   G VK  DF +S    DD 
Sbjct: 132 TIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDV 191
Query: 280 -NDVLRRSPGTPVFTAPECC---LGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQ 333
             D+     G   + APE     L        +D W++G+T   + I ++P+   G   Q
Sbjct: 192 AKDI---DAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQ 248
Query: 334 DTYDKIVNNSLVFP-DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
                +   S   P D  + E  +     L K+   R T  ++ +H +
Sbjct: 249 QLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPF 296

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 113/243 (46%), Gaps = 44/243 (18%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
           + +G G++G+VV+  +    K    +A   + +  L+   +E  ++D+  E+ +MKM+ +
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA-VKMLKDDATEEDLSDLVSEMEMMKMIGK 99
Query: 183 HPNIVNLIEVI--DDPNSDHFYMVLEY-----------------VEGKWDNDGFGQPGAI 223
           H NI+NL+     D P     Y+++EY                 +E  +D +   +    
Sbjct: 100 HKNIINLLGACTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE---- 151
Query: 224 GESMARKYLRDIVS-------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
            E M     +D+VS       G+ YL     +H D+   N+LV  +  +KI DF +++  
Sbjct: 152 -EQMT---FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 277 EDDNDVLRRSPG-TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQ 333
            + +   + + G  PV + APE      Y  + +D W+ GV ++ +  +G  P+ G  ++
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVE 266
Query: 334 DTY 336
           + +
Sbjct: 267 ELF 269

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 109/237 (45%), Gaps = 32/237 (13%)
Query: 124 RKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML- 181
           + +G G++G+VVL  +  LD          K  +  L+   +E  ++D+  E+ +MKM+ 
Sbjct: 23  KPLGEGAFGQVVLAEAIGLDKD--KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 80
Query: 182 QHPNIVNLIEVI--DDPNSDHFYMVLEYVEGKWDNDGFGQ----PGA---------IGES 226
           +H NI+NL+     D P     Y+++EY   K +   + Q    PG            E 
Sbjct: 81  KHKNIINLLGACTQDGP----LYVIVEYA-SKGNLREYLQARRPPGLEYSYNPSHNPEEQ 135
Query: 227 MARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
           ++ K L      +  G+ YL     +H D+   N+LV     +KI DF +++     +  
Sbjct: 136 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 195
Query: 283 LRRSPG-TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTY 336
            + + G  PV + APE      Y  + +D W+ GV L+ +  +G  P+ G  +++ +
Sbjct: 196 KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF 251

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 102/250 (40%), Gaps = 33/250 (13%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R +G G++G+V  Y   + G          + +  L    SE    D   E LI+    
Sbjct: 35  IRGLGHGAFGEV--YEGQVSGMPNDPSPLQVA-VKTLPEVCSEQDELDFLMEALIISKFN 91
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--------GQPGAIGESMARKYLRD 234
           H NIV  I V     S   ++++E + G  D   F         QP ++         RD
Sbjct: 92  HQNIVRCIGV--SLQSLPRFILMELMAGG-DLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSVSQVFEDDNDVLRRS----- 286
           I  G  YL  ++ +H DI   N L+    P    KIGDF +++      D+ R S     
Sbjct: 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKG 202
Query: 287 --PGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN 342
                PV +  PE  +   +  K  DTW+ GV L+ +  +G  P+  ++ Q+  + + + 
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261
Query: 343 SLVFPDAMNP 352
             + P    P
Sbjct: 262 GRMDPPKNCP 271

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 50/110 (45%), Gaps = 1/110 (0%)
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
           +D+   + YL     +H D+   N LV   G VK+ DF +S+   DD +        PV 
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVR 186
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVN 341
            +P   L  +     +D WA GV ++ +  +G+ P+   T  +T + I  
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 118/277 (42%), Gaps = 39/277 (14%)
Query: 124 RKIGAGSYGKVV---LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
           + +G+G++GKV+    Y  S  G   +I+   K    K   +  E  M++++   ++ ++
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTG--VSIQVAVKMLKEKADSSEREALMSELK---MMTQL 105
Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYV-EGKWDN------DGFGQPGAIGESMARK--- 230
             H NIVNL+       S   Y++ EY   G   N      + F +     E+  R    
Sbjct: 106 GSHENIVNLLGAC--TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 231 -------------YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VF 276
                        +   +  G+ +L   + VH D+   N+LV     VKI DF +++ + 
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 277 EDDNDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQD 334
            D N V+R +   PV + APE      Y  K +D W+ G+ L+ +  +G  P+ G  +  
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVDA 282
Query: 335 TYDKIVNNSLVF--PDAMNPELRNLLEGLLCKDPTRR 369
            + K++ N      P     E+  +++     D  +R
Sbjct: 283 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 319

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 102/250 (40%), Gaps = 33/250 (13%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R +G G++G+V  Y   + G          + +  L    SE    D   E LI+    
Sbjct: 50  IRGLGHGAFGEV--YEGQVSGMPNDPSPLQVA-VKTLPEVCSEQDELDFLMEALIISKFN 106
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--------GQPGAIGESMARKYLRD 234
           H NIV  I V     S   ++++E + G  D   F         QP ++         RD
Sbjct: 107 HQNIVRCIGV--SLQSLPRFILMELMAGG-DLKSFLRETRPRPSQPSSLAMLDLLHVARD 163
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSVSQVFEDDNDVLRRS----- 286
           I  G  YL  ++ +H DI   N L+    P    KIGDF +++      D+ R S     
Sbjct: 164 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKG 217
Query: 287 --PGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN 342
                PV +  PE  +   +  K  DTW+ GV L+ +  +G  P+  ++ Q+  + + + 
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 276
Query: 343 SLVFPDAMNP 352
             + P    P
Sbjct: 277 GRMDPPKNCP 286

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 109/237 (45%), Gaps = 32/237 (13%)
Query: 124 RKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML- 181
           + +G G++G+VVL  +  LD          K  +  L+   +E  ++D+  E+ +MKM+ 
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDK--PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 182 QHPNIVNLIEVI--DDPNSDHFYMVLEYVEGKWDNDGFGQ----PGA---------IGES 226
           +H NI+NL+     D P     Y+++EY   K +   + Q    PG            E 
Sbjct: 92  KHKNIINLLGACTQDGP----LYVIVEYA-SKGNLREYLQARRPPGLEYSYNPSHNPEEQ 146
Query: 227 MARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
           ++ K L      +  G+ YL     +H D+   N+LV     +KI DF +++     +  
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 206
Query: 283 LRRSPG-TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTY 336
            + + G  PV + APE      Y  + +D W+ GV L+ +  +G  P+ G  +++ +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 103/250 (41%), Gaps = 33/250 (13%)
Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +R +G G++G+V  Y   + G          + +  L    SE    D   E LI+    
Sbjct: 76  IRGLGHGAFGEV--YEGQVSGMPNDPSPLQVA-VKTLPEVCSEQDELDFLMEALIISKFN 132
Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--------GQPGAIGESMARKYLRD 234
           H NIV  I V     S   +++LE + G  D   F         QP ++         RD
Sbjct: 133 HQNIVRCIGV--SLQSLPRFILLELMAGG-DLKSFLRETRPRPSQPSSLAMLDLLHVARD 189
Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFSVSQVFEDDNDVLR----RSP 287
           I  G  YL  ++ +H DI   N L+    P    KIGDF +++      D+ R    R  
Sbjct: 190 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRAGYYRKG 243
Query: 288 GT---PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN 342
           G    PV +  PE  +   +  K  DTW+ GV L+ +  +G  P+  ++ Q+  + + + 
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302
Query: 343 SLVFPDAMNP 352
             + P    P
Sbjct: 303 GRMDPPKNCP 312

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 109/237 (45%), Gaps = 32/237 (13%)
Query: 124 RKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML- 181
           + +G G++G+VVL  +  LD          K  +  L+   +E  ++D+  E+ +MKM+ 
Sbjct: 26  KPLGEGAFGQVVLAEAIGLDKDK--PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 83
Query: 182 QHPNIVNLIEVI--DDPNSDHFYMVLEYVEGKWDNDGFGQ----PGA---------IGES 226
           +H NI+NL+     D P     Y+++EY   K +   + Q    PG            E 
Sbjct: 84  KHKNIINLLGACTQDGP----LYVIVEYA-SKGNLREYLQARRPPGLEYSYNPSHNPEEQ 138
Query: 227 MARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
           ++ K L      +  G+ YL     +H D+   N+LV     +KI DF +++     +  
Sbjct: 139 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 198
Query: 283 LRRSPG-TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTY 336
            + + G  PV + APE      Y  + +D W+ GV L+ +  +G  P+ G  +++ +
Sbjct: 199 KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF 254

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 109/237 (45%), Gaps = 32/237 (13%)
Query: 124 RKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML- 181
           + +G G++G+VVL  +  LD          K  +  L+   +E  ++D+  E+ +MKM+ 
Sbjct: 27  KPLGEGAFGQVVLAEAIGLDKDK--PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 84
Query: 182 QHPNIVNLIEVI--DDPNSDHFYMVLEYVEGKWDNDGFGQ----PGA---------IGES 226
           +H NI+NL+     D P     Y+++EY   K +   + Q    PG            E 
Sbjct: 85  KHKNIINLLGACTQDGP----LYVIVEYA-SKGNLREYLQARRPPGLEYSYNPSHNPEEQ 139
Query: 227 MARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
           ++ K L      +  G+ YL     +H D+   N+LV     +KI DF +++     +  
Sbjct: 140 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 199
Query: 283 LRRSPG-TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTY 336
            + + G  PV + APE      Y  + +D W+ GV L+ +  +G  P+ G  +++ +
Sbjct: 200 KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF 255

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 109/237 (45%), Gaps = 32/237 (13%)
Query: 124 RKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML- 181
           + +G G++G+VVL  +  LD          K  +  L+   +E  ++D+  E+ +MKM+ 
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDK--PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 182 QHPNIVNLIEVI--DDPNSDHFYMVLEYVEGKWDNDGFGQ----PGA---------IGES 226
           +H NI+NL+     D P     Y+++EY   K +   + Q    PG            E 
Sbjct: 92  KHKNIINLLGACTQDGP----LYVIVEYA-SKGNLREYLQAREPPGLEYSYNPSHNPEEQ 146
Query: 227 MARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
           ++ K L      +  G+ YL     +H D+   N+LV     +KI DF +++     +  
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 206
Query: 283 LRRSPG-TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTY 336
            + + G  PV + APE      Y  + +D W+ GV L+ +  +G  P+ G  +++ +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ + +G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 77
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNW 129
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 130 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 190 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 229

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 22/221 (9%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ + +G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 70
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNW 122
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPFLG 329
           + + A E  L   Y  + +D W+ GVT++  M  G  P+ G
Sbjct: 183 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/287 (22%), Positives = 115/287 (40%), Gaps = 45/287 (15%)
Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E+  ++ + +G++G V       +G+   I       + +LR A S  A  ++  E  +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPV----AIKELREATSPKANKEILDEAYV 77
Query: 178 MKMLQHPNIVNLIEVIDDPNSD------HFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           M  + +P++  L+ +              F  +L+YV    DN        IG      +
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--------IGSQYLLNW 129
Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TP 290
              I  G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P
Sbjct: 130 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 291 V-FTAPECCLGLTYGGKAADTWAVGVTLY-YMIIGQYPF-------------LGETLQ-- 333
           + + A E  L   Y  + +D W+ GVT++  M  G  P+              GE L   
Sbjct: 190 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 248
Query: 334 -----DTYDKIVNNSLVFPDAMNPELRNLLEGL--LCKDPTRRLTLN 373
                D Y  +V   ++  D+  P+ R L+     + +DP R L + 
Sbjct: 249 PICTIDVYMIMVKCWMIDADS-RPKFRELIIEFSKMARDPQRYLVIQ 294

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 109/237 (45%), Gaps = 32/237 (13%)
Query: 124 RKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML- 181
           + +G G++G+VVL  +  LD          K  +  L+   +E  ++D+  E+ +MKM+ 
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDK--PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 182 QHPNIVNLIEVI--DDPNSDHFYMVLEYVEGKWDNDGFGQ----PGA---------IGES 226
           +H NI+NL+     D P     Y+++EY   K +   + Q    PG            E 
Sbjct: 92  KHKNIINLLGACTQDGP----LYVIVEYA-SKGNLREYLQARRPPGLEYCYNPSHNPEEQ 146
Query: 227 MARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
           ++ K L      +  G+ YL     +H D+   N+LV     +KI DF +++     +  
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 206
Query: 283 LRRSPG-TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTY 336
            + + G  PV + APE      Y  + +D W+ GV L+ +  +G  P+ G  +++ +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 41/232 (17%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS--------KL--RVAPSETAMT 169
           Y+ VRK+G G +  V L +  ++  H A+K      +         KL  RV  ++    
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 170 DVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-------GKWDNDGFGQPGA 222
           D      I+K+L H N          PN  H  MV E +         K+++ G      
Sbjct: 81  DSMGANHILKLLDHFNHKG-------PNGVHVVMVFEVLGENLLALIKKYEHRG------ 127
Query: 223 IGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLV----APSG--TVKIGDFSVSQV 275
           I     ++  + ++ GL Y+H    ++H DIKP+N+L+    +P     +KI D   +  
Sbjct: 128 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
           +++       S  T  + +PE  LG  +G   AD W+    ++ +I G + F
Sbjct: 188 YDEH---YTNSIQTREYRSPEVLLGAPWGC-GADIWSTACLIFELITGDFLF 235

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 8/166 (4%)
Query: 222 AIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN 280
            I E +  K    IV  L +LH   +V+H D+KP N+L+   G VK+ DF +S  +  D+
Sbjct: 149 TIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG-YLVDS 207
Query: 281 DVLRRSPGTPVFTAPECC---LGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDT 335
                  G   + APE     L        +D W++G+T+  + I ++P+   G   Q  
Sbjct: 208 VAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL 267
Query: 336 YDKIVNNSLVFP-DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
              +   S   P D  + E  +     L K+   R T  ++ +H +
Sbjct: 268 KQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 313

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 41/232 (17%)
Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS--------KL--RVAPSETAMT 169
           Y+ VRK+G G +  V L +  ++  H A+K      +         KL  RV  ++    
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 170 DVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-------GKWDNDGFGQPGA 222
           D      I+K+L H N          PN  H  MV E +         K+++ G      
Sbjct: 81  DSMGANHILKLLDHFNHKG-------PNGVHVVMVFEVLGENLLALIKKYEHRG------ 127
Query: 223 IGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLV----APSG--TVKIGDFSVSQV 275
           I     ++  + ++ GL Y+H    ++H DIKP+N+L+    +P     +KI D   +  
Sbjct: 128 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
           +++       S  T  + +PE  LG  +G   AD W+    ++ +I G + F
Sbjct: 188 YDEH---YTNSIQTREYRSPEVLLGAPWGC-GADIWSTACLIFELITGDFLF 235

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 109/237 (45%), Gaps = 32/237 (13%)
Query: 124 RKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML- 181
           + +G G++G+VVL  +  LD          K  +  L+   +E  ++D+  E+ +MKM+ 
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDK--PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 182 QHPNIVNLIEVI--DDPNSDHFYMVLEYVEGKWDNDGFGQ----PGA---------IGES 226
           +H NI+NL+     D P     Y+++EY   K +   + Q    PG            E 
Sbjct: 133 KHKNIINLLGACTQDGP----LYVIVEYA-SKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 227 MARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
           ++ K L      +  G+ YL     +H D+   N+LV     +KI DF +++     +  
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247
Query: 283 LRRSPG-TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTY 336
            + + G  PV + APE      Y  + +D W+ GV L+ +  +G  P+ G  +++ +
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 112/243 (46%), Gaps = 44/243 (18%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
           + +G G +G+VV+  +    K    +A   + +  L+   +E  ++D+  E+ +MKM+ +
Sbjct: 28  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 86
Query: 183 HPNIVNLIEVI--DDPNSDHFYMVLEY-----------------VEGKWDNDGFGQPGAI 223
           H NI+NL+     D P     Y+++EY                 +E  +D +   +    
Sbjct: 87  HKNIINLLGACTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE---- 138
Query: 224 GESMARKYLRDIVS-------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
            E M     +D+VS       G+ YL     +H D+   N+LV  +  +KI DF +++  
Sbjct: 139 -EQMT---FKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDI 194
Query: 277 EDDNDVLRRSPG-TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQ 333
            + +   + + G  PV + APE      Y  + +D W+ GV ++ +  +G  P+ G  ++
Sbjct: 195 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVE 253
Query: 334 DTY 336
           + +
Sbjct: 254 ELF 256

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 112/243 (46%), Gaps = 44/243 (18%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
           + +G G +G+VV+  +    K    +A   + +  L+   +E  ++D+  E+ +MKM+ +
Sbjct: 33  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 91
Query: 183 HPNIVNLIEVI--DDPNSDHFYMVLEY-----------------VEGKWDNDGFGQPGAI 223
           H NI+NL+     D P     Y+++EY                 +E  +D +   +    
Sbjct: 92  HKNIINLLGACTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE---- 143
Query: 224 GESMARKYLRDIVS-------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
            E M     +D+VS       G+ YL     +H D+   N+LV  +  +KI DF +++  
Sbjct: 144 -EQMT---FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 199
Query: 277 EDDNDVLRRSPG-TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQ 333
            + +   + + G  PV + APE      Y  + +D W+ GV ++ +  +G  P+ G  ++
Sbjct: 200 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVE 258
Query: 334 DTY 336
           + +
Sbjct: 259 ELF 261

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 112/243 (46%), Gaps = 44/243 (18%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
           + +G G +G+VV+  +    K    +A   + +  L+   +E  ++D+  E+ +MKM+ +
Sbjct: 30  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 88
Query: 183 HPNIVNLIEVI--DDPNSDHFYMVLEY-----------------VEGKWDNDGFGQPGAI 223
           H NI+NL+     D P     Y+++EY                 +E  +D +   +    
Sbjct: 89  HKNIINLLGACTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE---- 140
Query: 224 GESMARKYLRDIVS-------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
            E M     +D+VS       G+ YL     +H D+   N+LV  +  +KI DF +++  
Sbjct: 141 -EQMT---FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 196
Query: 277 EDDNDVLRRSPG-TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQ 333
            + +   + + G  PV + APE      Y  + +D W+ GV ++ +  +G  P+ G  ++
Sbjct: 197 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVE 255
Query: 334 DTY 336
           + +
Sbjct: 256 ELF 258

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 112/243 (46%), Gaps = 44/243 (18%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
           + +G G +G+VV+  +    K    +A   + +  L+   +E  ++D+  E+ +MKM+ +
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 183 HPNIVNLIEVI--DDPNSDHFYMVLEY-----------------VEGKWDNDGFGQPGAI 223
           H NI+NL+     D P     Y+++EY                 +E  +D +   +    
Sbjct: 146 HKNIINLLGACTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE---- 197
Query: 224 GESMARKYLRDIVS-------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
            E M     +D+VS       G+ YL     +H D+   N+LV  +  +KI DF +++  
Sbjct: 198 -EQMT---FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 253
Query: 277 EDDNDVLRRSPG-TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQ 333
            + +   + + G  PV + APE      Y  + +D W+ GV ++ +  +G  P+ G  ++
Sbjct: 254 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVE 312
Query: 334 DTY 336
           + +
Sbjct: 313 ELF 315

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 112/243 (46%), Gaps = 44/243 (18%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
           + +G G++G+VV+  +    K    +A   + +  L+   +E  ++D+  E+ +MKM+ +
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 183 HPNIVNLIEVI--DDPNSDHFYMVLEY-----------------VEGKWDNDGFGQPGAI 223
           H NI+NL+     D P     Y+++EY                 +E  +D +   +    
Sbjct: 100 HKNIINLLGACTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE---- 151
Query: 224 GESMARKYLRDIVS-------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
            E M     +D+VS       G+ YL     +H D+   N+LV  +  +KI DF +++  
Sbjct: 152 -EQMT---FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 277 EDDNDVLRRSPG-TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQ 333
            + +     + G  PV + APE      Y  + +D W+ GV ++ +  +G  P+ G  ++
Sbjct: 208 NNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVE 266
Query: 334 DTY 336
           + +
Sbjct: 267 ELF 269

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 113/243 (46%), Gaps = 44/243 (18%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-Q 182
           + +G G++G+VV+  +    K    +A   + +  L+   +E  ++D+  E+ +MKM+ +
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA-VKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 183 HPNIVNLIEVI--DDPNSDHFYMVLEY-----------------VEGKWDNDGFGQPGAI 223
           H NI+NL+     D P     Y+++EY                 +E  +D +   +    
Sbjct: 100 HKNIINLLGACTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE---- 151
Query: 224 GESMARKYLRDIVS-------GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
            E M     +D+VS       G+ YL     +H D+   N+LV  +  ++I DF +++  
Sbjct: 152 -EQMT---FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDI 207
Query: 277 EDDNDVLRRSPG-TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQ 333
            + +   + + G  PV + APE      Y  + +D W+ GV ++ +  +G  P+ G  ++
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVE 266
Query: 334 DTY 336
           + +
Sbjct: 267 ELF 269

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 32/213 (15%)
Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR---REVLIMKM 180
           R IG G +G VV +   +D     I+   KS LS++      T M  V    RE L+M+ 
Sbjct: 27  RVIGKGHFG-VVYHGEYIDQAQNRIQCAIKS-LSRI------TEMQQVEAFLREGLLMRG 78
Query: 181 LQHPNIVNLIEVIDDPNS-DHF---YM----VLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           L HPN++ LI ++  P    H    YM    +L+++     N       + G  +AR   
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVAR--- 135
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD---NDVLRRSPGT 289
                G+ YL     VH D+   N ++  S TVK+ DF +++   D    +    R    
Sbjct: 136 -----GMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL 190
Query: 290 PV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI 321
           PV +TA E      +  K +D W+ GV L+ ++
Sbjct: 191 PVKWTALESLQTYRFTTK-SDVWSFGVLLWELL 222

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 49/110 (44%), Gaps = 1/110 (0%)
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
           +D+   + YL     +H D+   N LV   G VK+ DF +S+   DD          PV 
Sbjct: 111 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 170
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVN 341
            +P   L  +     +D WA GV ++ +  +G+ P+   T  +T + I  
Sbjct: 171 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 220

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 49/110 (44%), Gaps = 1/110 (0%)
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
           +D+   + YL     +H D+   N LV   G VK+ DF +S+   DD          PV 
Sbjct: 107 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 166
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVN 341
            +P   L  +     +D WA GV ++ +  +G+ P+   T  +T + I  
Sbjct: 167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 49/110 (44%), Gaps = 1/110 (0%)
Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
           +D+   + YL     +H D+   N LV   G VK+ DF +S+   DD          PV 
Sbjct: 112 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 171
Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVN 341
            +P   L  +     +D WA GV ++ +  +G+ P+   T  +T + I  
Sbjct: 172 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 221
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	410
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-104
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-80
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-79
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-79
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-78
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-77
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-76
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-75
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-74
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-74
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-74
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-72
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-72
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-72
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-71
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-70
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-69
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-69
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-68
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-68
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-68
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-67
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-67
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-66
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-66
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-65
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-65
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-65
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-65
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-65
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-64
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-64
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-64
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-64
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-64
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-64
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-64
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-64
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-64
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-63
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-63
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-63
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-63
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-63
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-63
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-62
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-62
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-62
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-62
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-62
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-62
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-61
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-61
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-60
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-60
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-60
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-60
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-60
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-60
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-59
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-59
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-58
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-57
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-57
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-57
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-56
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-56
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-56
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-55
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-55
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-55
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-55
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-54
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-54
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-54
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-54
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-54
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-54
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-54
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-54
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-53
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-53
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-53
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-53
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-52
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-52
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-52
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-52
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-51
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-51
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-50
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-49
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-49
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-49
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-49
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-48
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-46
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-44
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-44
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-44
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-43
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-43
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-42
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-42
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-42
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-42
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-41
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-41
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-41
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-41
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-40
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-40
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-40
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-40
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-39
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-39
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-39
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-39
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-39
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-38
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-38
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-38
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-38
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-38
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-38
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-37
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-37
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-37
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-37
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-36
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-36
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-36
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-36
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-35
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-35
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-34
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-34
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-34
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-33
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-33
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-32
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-32
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-31
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-31
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-31
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-30
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-30
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-30
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-30
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-30
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-30
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-29
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-29
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-29
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-29
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-29
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-29
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-29
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-29
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-28
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-28
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-28
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-28
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-28
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-28
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-28
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-28
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-28
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-28
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-28
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-28
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-28
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-28
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-27
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-27
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-27
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-27
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-27
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-27
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	9e-27
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-26
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-26
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-25
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-25
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-25
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-25
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-25
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-25
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-25
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-25
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-24
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-24
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-24
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-24
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-23
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-23
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-23
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-23
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-22
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-22
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-22
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-22
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-22
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-22
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-21
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-21
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-20
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-20
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-20
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-19
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-19
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-18
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-18
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-16
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-13
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-13
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-13
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-12
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-12
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-10
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-09
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	8e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	5e-04

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  309 bits (794), Expect = e-104
 Identities = 107/301 (35%), Positives = 152/301 (50%), Gaps = 34/301 (11%)

Query: 108 SEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAP---- 163
           S        +N+Y    +IG GSYG V L  +  D  +YA+K   K  L +    P    
Sbjct: 3   SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62

Query: 164 -------------SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG 210
                            +  V +E+ I+K L HPN+V L+EV+DDPN DH YMV E V  
Sbjct: 63  PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122

Query: 211 KWDNDGFG------QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT 264
                  G          + E  AR Y +D++ G+ YLH   ++H DIKP NLLV   G 
Sbjct: 123 -------GPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH 175

Query: 265 VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT--YGGKAADTWAVGVTLYYMII 322
           +KI DF VS  F+  + +L  + GTP F APE        + GKA D WA+GVTLY  + 
Sbjct: 176 IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235

Query: 323 GQYPFLGETLQDTYDKIVNNSLVFPD--AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
           GQ PF+ E +   + KI + +L FPD   +  +L++L+  +L K+P  R+ + ++  H W
Sbjct: 236 GQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295

Query: 381 V 381
           V
Sbjct: 296 V 296

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  249 bits (638), Expect = 1e-80
 Identities = 87/289 (30%), Positives = 137/289 (47%), Gaps = 23/289 (7%)

Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           K+I +Y+    +G GSYGKV     S      A+K   K  L ++          +V++E
Sbjct: 2   KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRI-----PNGEANVKKE 56

Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP--------GAIGES 226
           + +++ L+H N++ L++V+ +      YMV+EY          G                
Sbjct: 57  IQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVC-------GMQEMLDSVPEKRFPVC 109

Query: 227 MARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED--DNDVLR 284
            A  Y   ++ GL YLH   +VH DIKP NLL+   GT+KI    V++       +D  R
Sbjct: 110 QAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169

Query: 285 RSPGTPVFTAPECCLGL-TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS 343
            S G+P F  PE   GL T+ G   D W+ GVTLY +  G YPF G+ +   ++ I   S
Sbjct: 170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS 229

Query: 344 LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL 392
              P    P L +LL+G+L  +P +R ++  + +H+W    + P    +
Sbjct: 230 YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV 278

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  247 bits (632), Expect = 3e-79
 Identities = 74/323 (22%), Positives = 136/323 (42%), Gaps = 44/323 (13%)

Query: 101 ESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR 160
            +   +    +   K IN+Y  +R +  G + K++L       K YA+K + KS L K R
Sbjct: 14  SNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKD--NKFYALKKYEKSLLEKKR 71

Query: 161 VAP--------SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG-- 210
                       ++   D + E+ I+  +++   +    +I +   D  Y++ EY+E   
Sbjct: 72  DFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY--DEVYIIYEYMENDS 129

Query: 211 ------KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSG 263
                  +          I   + +  ++ +++   Y+H   N+ H D+KP N+L+  +G
Sbjct: 130 ILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG 189

Query: 264 TVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG-LTYGGKAADTWAVGVTLYYMII 322
            VK+ DF  S+   D    ++ S GT  F  PE      +Y G   D W++G+ LY M  
Sbjct: 190 RVKLSDFGESEYMVDKK--IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247

Query: 323 GQYPFLGE-TLQDTYDKIVNNSLVFPDA-------------------MNPELRNLLEGLL 362
              PF  + +L + ++ I   ++ +P                     ++ E  + L+  L
Sbjct: 248 NVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFL 307

Query: 363 CKDPTRRLTLNDVAKHTWVLGDN 385
            K+P  R+T  D  KH W+   N
Sbjct: 308 RKNPAERITSEDALKHEWLADTN 330

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  244 bits (625), Expect = 8e-79
 Identities = 81/279 (29%), Positives = 131/279 (46%), Gaps = 11/279 (3%)

Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
            +    YV  R +G G + K      +   + +A K   KS L K            +  
Sbjct: 11  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ------REKMSM 64

Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
           E+ I + L H ++V      +D +    ++VLE    +   +   +  A+ E  AR YLR
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDND--FVFVVLELCRRRSLLELHKRRKALTEPEARYYLR 122

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
            IV G  YLH + V+H D+K  NL +     VKIGDF ++   E D +  +   GTP + 
Sbjct: 123 QIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI 182

Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPE 353
           APE      +  +  D W++G  +Y +++G+ PF    L++TY +I  N    P  +NP 
Sbjct: 183 APEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 241

Query: 354 LRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL 392
             +L++ +L  DPT R T+N++    +    +G IP  L
Sbjct: 242 AASLIQKMLQTDPTARPTINELLNDEFFT--SGYIPARL 278

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  244 bits (624), Expect = 3e-78
 Identities = 81/279 (29%), Positives = 131/279 (46%), Gaps = 11/279 (3%)

Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
            +    YV  R +G G + K      +   + +A K   KS L K            +  
Sbjct: 37  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ------REKMSM 90

Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
           E+ I + L H ++V      +D +    ++VLE    +   +   +  A+ E  AR YLR
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDND--FVFVVLELCRRRSLLELHKRRKALTEPEARYYLR 148

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
            IV G  YLH + V+H D+K  NL +     VKIGDF ++   E D +  +   GTP + 
Sbjct: 149 QIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI 208

Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPE 353
           APE      +  +  D W++G  +Y +++G+ PF    L++TY +I  N    P  +NP 
Sbjct: 209 APEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 267

Query: 354 LRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL 392
             +L++ +L  DPT R T+N++    +    +G IP  L
Sbjct: 268 AASLIQKMLQTDPTARPTINELLNDEFFT--SGYIPARL 304

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  241 bits (618), Expect = 3e-77
 Identities = 93/278 (33%), Positives = 136/278 (48%), Gaps = 16/278 (5%)

Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
             I  Y  ++ IG G++ KV L R  L G+  AIK   K+ L+        T++  + RE
Sbjct: 12  PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-------PTSLQKLFRE 64

Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG---QPGAIGESMARKY 231
           V IMK+L HPNIV L EVI+       Y+++EY  G    + F      G + E  AR  
Sbjct: 65  VRIMKILNHPNIVKLFEVIETEK--TLYLIMEYASG---GEVFDYLVAHGRMKEKEARSK 119

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
            R IVS + Y H   +VH D+K +NLL+     +KI DF  S  F      L    G P 
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFCGAPP 178

Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
           + APE   G  Y G   D W++GV LY ++ G  PF G+ L++  ++++      P  M+
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS 238

Query: 352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIP 389
            +  NLL+  L  +P +R TL  + K  W+   +    
Sbjct: 239 TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDE 276

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  235 bits (603), Expect = 8e-76
 Identities = 75/274 (27%), Positives = 138/274 (50%), Gaps = 10/274 (3%)

Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           + I ++     +G GS+  V    S   G   AIK   K  + K  +      +  V+ E
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGM------VQRVQNE 61

Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLR 233
           V I   L+HP+I+ L    +D N  + Y+VLE       N     +     E+ AR ++ 
Sbjct: 62  VKIHCQLKHPSILELYNYFEDSN--YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
            I++G++YLH H ++H D+   NLL+  +  +KI DF ++   +  ++      GTP + 
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYI 179

Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPE 353
           +PE      +G + +D W++G   Y ++IG+ PF  +T+++T +K+V      P  ++ E
Sbjct: 180 SPEIATRSAHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIE 238

Query: 354 LRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
            ++L+  LL ++P  RL+L+ V  H ++  ++  
Sbjct: 239 AKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSST 272

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  234 bits (598), Expect = 5e-75
 Identities = 95/282 (33%), Positives = 143/282 (50%), Gaps = 12/282 (4%)

Query: 111 ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD 170
            +G   I  YV    +G G++GKV +    L G   A+K  ++  +  L V         
Sbjct: 4   HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK------ 57

Query: 171 VRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARK 230
           ++RE+  +K+ +HP+I+ L +VI  P    F+MV+EYV G    D   + G + E  AR+
Sbjct: 58  IKREIQNLKLFRHPHIIKLYQVISTPT--DFFMVMEYVSGGELFDYICKHGRVEEMEARR 115

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
             + I+S + Y H H VVH D+KP+N+L+      KI DF +S +  D    LR S G+P
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSCGSP 174

Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAM 350
            + APE   G  Y G   D W+ GV LY ++ G  PF  E +   + KI       P+ +
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYL 234

Query: 351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL 392
           N  +  LL  +L  DP +R T+ D+ +H W   D   +P YL
Sbjct: 235 NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD---LPSYL 273

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  232 bits (595), Expect = 2e-74
 Identities = 82/282 (29%), Positives = 128/282 (45%), Gaps = 11/282 (3%)

Query: 108 SEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETA 167
           +E       I+++   R +G G +G V L R   +    A+K   KS L K  V      
Sbjct: 4   AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV------ 57

Query: 168 MTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESM 227
              +RRE+ I   L+HPNI+ +     D      Y++LE+           + G   E  
Sbjct: 58  EHQLRREIEIQSHLRHPNILRMYNYFHDRK--RIYLMLEFAPRGELYKELQKHGRFDEQR 115

Query: 228 ARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP 287
           +  ++ ++   L Y H   V+H DIKP+NLL+   G +KI DF  S      +   R   
Sbjct: 116 SATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMC 173

Query: 288 GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP 347
           GT  +  PE   G T+  +  D W  GV  Y  ++G  PF   +  +T+ +IVN  L FP
Sbjct: 174 GTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP 232

Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIP 389
             ++   ++L+  LL   P +RL L  V +H WV  ++  + 
Sbjct: 233 PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVL 274

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  232 bits (593), Expect = 3e-74
 Identities = 82/281 (29%), Positives = 127/281 (45%), Gaps = 15/281 (5%)

Query: 111 ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD 170
           +     + ++   R +G G +G V L R        A+K   K+ L K  V         
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV------EHQ 55

Query: 171 VRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARK 230
           +RREV I   L+HPNI+ L     D      Y++LEY           +     E     
Sbjct: 56  LRREVEIQSHLRHPNILRLYGYFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTAT 113

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--G 288
           Y+ ++ + L Y H   V+H DIKP+NLL+  +G +KI DF  S          RR+   G
Sbjct: 114 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCG 169

Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD 348
           T  +  PE   G  +  +  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD
Sbjct: 170 TLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 228

Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIP 389
            +    R+L+  LL  +P++R  L +V +H W+  ++    
Sbjct: 229 FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 269

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  229 bits (587), Expect = 1e-72
 Identities = 67/268 (25%), Positives = 124/268 (46%), Gaps = 11/268 (4%)

Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           +   +Y  +  +G+G++G V         K   +K   K  + +            V  E
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK-VTLE 79

Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLE-YVEGKWDNDGFGQPGAIGESMARKYLR 233
           + I+  ++H NI+ ++++ ++     F +V+E +  G        +   + E +A    R
Sbjct: 80  IAILSRVEHANIIKVLDIFENQ--GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR 137

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
            +VS + YL   +++H DIK +N+++A   T+K+ DF  +   E    +     GT  + 
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFCGTIEYC 196

Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPE 353
           APE  +G  Y G   + W++GVTLY ++  + PF         ++ V  ++  P  ++ E
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVEAAIHPPYLVSKE 250

Query: 354 LRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           L +L+ GLL   P RR TL  +    WV
Sbjct: 251 LMSLVSGLLQPVPERRTTLEKLVTDPWV 278

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  229 bits (586), Expect = 2e-72
 Identities = 87/287 (30%), Positives = 146/287 (50%), Gaps = 19/287 (6%)

Query: 111 ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD 170
               + I  Y+    +G GS+GKV L       +  A+K   +  L K  +         
Sbjct: 2   AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR------ 55

Query: 171 VRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG---QPGAIGESM 227
           V RE+  +K+L+HP+I+ L +VI  P      MV+EY  G    + F    +   + E  
Sbjct: 56  VEREISYLKLLRHPHIIKLYDVITTPT--DIVMVIEYAGG----ELFDYIVEKKRMTEDE 109

Query: 228 ARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP 287
            R++ + I+  + Y H H +VH D+KP+NLL+  +  VKI DF +S +  D N  L+ S 
Sbjct: 110 GRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTSC 168

Query: 288 GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP 347
           G+P + APE   G  Y G   D W+ G+ LY M++G+ PF  E + + + K+ +   V P
Sbjct: 169 GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP 228

Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCW 394
           D ++P  ++L+  ++  DP +R+T+ ++ +  W   +   +P YL  
Sbjct: 229 DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN---LPDYLRP 272

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  227 bits (581), Expect = 6e-72
 Identities = 72/298 (24%), Positives = 133/298 (44%), Gaps = 17/298 (5%)

Query: 98  PVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS 157
           P  + +    +  +    + ++Y     +G+G +G V       D    AIK   K  +S
Sbjct: 23  PCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 82

Query: 158 KLRVAPSETAMTDVRREVLIMKMLQH--PNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-N 214
                P+ T    V  EV+++K +      ++ L++  + P  D F ++LE  E   D  
Sbjct: 83  DWGELPNGTR---VPMEVVLLKKVSSGFSGVIRLLDWFERP--DSFVLILERPEPVQDLF 137

Query: 215 DGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV-APSGTVKIGDFSVS 273
           D   + GA+ E +AR +   ++  + + H   V+H DIK +N+L+    G +K+ DF   
Sbjct: 138 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197

Query: 274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ 333
            + +D         GT V++ PE      Y G++A  W++G+ LY M+ G  PF      
Sbjct: 198 ALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF------ 249

Query: 334 DTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQY 391
           +  ++I+   + F   ++ E ++L+   L   P+ R T  ++  H W+     P    
Sbjct: 250 EHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETA 307

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  231 bits (591), Expect = 1e-71
 Identities = 94/288 (32%), Positives = 152/288 (52%), Gaps = 12/288 (4%)

Query: 105 LIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPS 164
           +   +  +G   I  Y+    +G G++GKV + +  L G   A+K  ++  +  L V   
Sbjct: 3   MAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDV--- 59

Query: 165 ETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIG 224
              +  +RRE+  +K+ +HP+I+ L +VI  P+    +MV+EYV G    D   + G + 
Sbjct: 60  ---VGKIRREIQNLKLFRHPHIIKLYQVISTPS--DIFMVMEYVSGGELFDYICKNGRLD 114

Query: 225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR 284
           E  +R+  + I+SG+ Y H H VVH D+KP+N+L+      KI DF +S +  D    LR
Sbjct: 115 EKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLR 173

Query: 285 RSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL 344
            S G+P + APE   G  Y G   D W+ GV LY ++ G  PF  + +   + KI +   
Sbjct: 174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF 233

Query: 345 VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL 392
             P  +NP + +LL+ +L  DP +R T+ D+ +H W   D   +P+YL
Sbjct: 234 YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD---LPKYL 278

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  221 bits (565), Expect = 5e-70
 Identities = 68/275 (24%), Positives = 119/275 (43%), Gaps = 18/275 (6%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
             +Y  +  IG GSYG+    R   DGK    K      ++       E     +  EV 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-------EAEKQMLVSEVN 57

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMARKYL 232
           +++ L+HPNIV   + I D  +   Y+V+EY EG         G  +   + E    + +
Sbjct: 58  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117

Query: 233 RDIVSGLMYLH-----GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP 287
             +   L   H     GH V+H D+KP N+ +     VK+GDF ++++   D    +   
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV 177

Query: 288 GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF- 346
           GTP + +PE    ++Y  K +D W++G  LY +     PF   + ++   KI        
Sbjct: 178 GTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 236

Query: 347 PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           P   + EL  ++  +L      R ++ ++ ++  +
Sbjct: 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  221 bits (564), Expect = 2e-69
 Identities = 68/301 (22%), Positives = 120/301 (39%), Gaps = 25/301 (8%)

Query: 98  PVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS 157
           P            ++      EY     +G G +G V       D    AIK   ++ + 
Sbjct: 11  PAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVL 70

Query: 158 KLRVAPSETAMTDVRREVLIMKML----QHPNIVNLIEVIDDPNSDHFYMVLEY-VEGKW 212
                           EV ++  +     HP ++ L++  +    + F +VLE  +  + 
Sbjct: 71  GWSPLSDSVT---CPLEVALLWKVGAGGGHPGVIRLLDWFETQ--EGFMLVLERPLPAQ- 124

Query: 213 DNDGFG---QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV-APSGTVKIG 268
             D F    + G +GE  +R +   +V+ + + H   VVH DIK +N+L+    G  K+ 
Sbjct: 125 --DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI 182

Query: 269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL 328
           DF    +  D+        GT V++ PE      Y    A  W++G+ LY M+ G  PF 
Sbjct: 183 DFGSGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF- 239

Query: 329 GETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI 388
                +   +I+   L FP  ++P+   L+   L   P+ R +L ++    W+      +
Sbjct: 240 -----ERDQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV 294

Query: 389 P 389
           P
Sbjct: 295 P 295

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  220 bits (563), Expect = 6e-69
 Identities = 79/285 (27%), Positives = 144/285 (50%), Gaps = 17/285 (5%)

Query: 102 SNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV 161
           S+ +    +    + + +YV ++KIG GS+GK +L +S+ DG+ Y IK  + S +S    
Sbjct: 8   SSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS---- 63

Query: 162 APSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGF 217
                   + RREV ++  ++HPNIV   E  ++  +   Y+V++Y EG    K  N   
Sbjct: 64  ---SKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLYIVMDYCEGGDLFKRINAQK 118

Query: 218 GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE 277
           G      E     +   I   L ++H   ++H DIK  N+ +   GTV++GDF +++V  
Sbjct: 119 GVL--FQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176

Query: 278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYD 337
              ++ R   GTP + +PE C    Y  K +D WA+G  LY +   ++ F   ++++   
Sbjct: 177 STVELARACIGTPYYLSPEICENKPYNNK-SDIWALGCVLYELCTLKHAFEAGSMKNLVL 235

Query: 338 KIVNNSL-VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           KI++ S        + +LR+L+  L  ++P  R ++N + +  ++
Sbjct: 236 KIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  217 bits (555), Expect = 1e-68
 Identities = 71/284 (25%), Positives = 128/284 (45%), Gaps = 18/284 (6%)

Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
              + ++  V+ +G G+YG+V L  + +  +  A+K                    ++++
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--------PENIKK 54

Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
           E+ I KML H N+V       + N    Y+ LEY  G    D       + E  A+++  
Sbjct: 55  EICINKMLNHENVVKFYGHRREGN--IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH 112

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPV 291
            +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT  
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKIVNNSLVFPD-- 348
           + APE      +  +  D W+ G+ L  M+ G+ P+   +     Y              
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 232

Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL 392
            ++     LL  +L ++P+ R+T+ D+ K  W    N P+ +  
Sbjct: 233 KIDSAPLALLHKILVENPSARITIPDIKKDRWY---NKPLKKGA 273

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  220 bits (562), Expect = 2e-68
 Identities = 86/286 (30%), Positives = 138/286 (48%), Gaps = 24/286 (8%)

Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
              + Y  V+ IG+G++G   L R  L  +  A+K   +       V          +RE
Sbjct: 17  HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV----------QRE 66

Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           ++  + L+HPNIV   EVI  P   H  +++EY  G    +     G   E  AR + + 
Sbjct: 67  IINHRSLRHPNIVRFKEVILTPT--HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQ 124

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLV--APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
           ++SG+ Y H   + H D+K +N L+  +P+  +KI DF  S+     +   + + GTP +
Sbjct: 125 LLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAY 183

Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDK----IVNNSLVFPD 348
            APE  L   Y GK AD W+ GVTLY M++G YPF        Y K    I++     PD
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD 243

Query: 349 A--MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL 392
              ++PE  +L+  +   DP  R+++ ++  H+W L +   +P  L
Sbjct: 244 DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN---LPADL 286

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  218 bits (558), Expect = 3e-68
 Identities = 81/342 (23%), Positives = 133/342 (38%), Gaps = 57/342 (16%)

Query: 100 KESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKL 159
               + +  +  +  ++  +Y     IG GSYG V +   +      AIK  +K+ + ++
Sbjct: 8   SSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQI 67

Query: 160 RVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG--------- 210
               +   +  ++ EV +MK L HPNI  L EV +D    +  +V+E   G         
Sbjct: 68  ----NPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ--YICLVMELCHGGHLLDKLNV 121

Query: 211 -------------------------------KWDNDGFGQPGAIGESMARKYLRDIVSGL 239
                                                        E +    +R I S L
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181

Query: 240 MYLHGHNVVHGDIKPDNLLVA--PSGTVKIGDFSVSQVF----EDDNDVLRRSPGTPVFT 293
            YLH   + H DIKP+N L +   S  +K+ DF +S+ F      +   +    GTP F 
Sbjct: 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFV 241

Query: 294 APECCLGLTYG-GKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----D 348
           APE         G   D W+ GV L+ +++G  PF G    DT  +++N  L F     +
Sbjct: 242 APEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYN 301

Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
            ++P  R+LL  LL ++   R       +H W+   +  I +
Sbjct: 302 VLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYK 343

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  216 bits (551), Expect = 2e-67
 Identities = 72/312 (23%), Positives = 132/312 (42%), Gaps = 35/312 (11%)

Query: 97  FPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHL 156
             +   N   +S    G      Y  +++IG+G   KV    +    + YAIK  +    
Sbjct: 11  VDLGTENLYFQSMSVKG----RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA 65

Query: 157 SKLRVAPSETAMTDVRREVLIMKMLQHPN--IVNLIEVIDDPNSDHFYMVLEYVEGKWD- 213
                      +   R E+  +  LQ  +  I+ L +        + YMV+E      D 
Sbjct: 66  DN-------QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ--YIYMVMECGNI--DL 114

Query: 214 NDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
           N    +  +I     + Y ++++  +  +H H +VH D+KP N L+   G +K+ DF ++
Sbjct: 115 NSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA 173

Query: 274 QVFEDD-NDVLRRSP-GTPVFTAPECCLGLTYG----------GKAADTWAVGVTLYYMI 321
              + D   V++ S  GT  +  PE    ++               +D W++G  LYYM 
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233

Query: 322 IGQYPFLGETLQ-DTYDKIVNNSLV--FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            G+ PF     Q      I++ +    FPD    +L+++L+  L +DP +R+++ ++  H
Sbjct: 234 YGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293

Query: 379 TWVLGDNGPIPQ 390
            +V     P+ Q
Sbjct: 294 PYVQIQTHPVNQ 305

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  216 bits (551), Expect = 2e-67
 Identities = 69/272 (25%), Positives = 124/272 (45%), Gaps = 15/272 (5%)

Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
              + ++  V+ +G G+YG+V L  + +  +  A+K                    ++++
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--------PENIKK 54

Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
           E+ I KML H N+V       + N    Y+ LEY  G    D       + E  A+++  
Sbjct: 55  EICINKMLNHENVVKFYGHRREGN--IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH 112

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPV 291
            +++G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT  
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKIVNNSLVFPD-- 348
           + APE      +  +  D W+ G+ L  M+ G+ P+   +     Y              
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 232

Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
            ++     LL  +L ++P+ R+T+ D+ K  W
Sbjct: 233 KIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  215 bits (549), Expect = 2e-66
 Identities = 74/340 (21%), Positives = 141/340 (41%), Gaps = 31/340 (9%)

Query: 71  GEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGS 130
           G +   +   E    + E   +        + +K   S +E  +     Y  +++IG+G 
Sbjct: 9   GLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGG 68

Query: 131 YGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN--IVN 188
             KV    +    + YAIK  +               +   R E+  +  LQ  +  I+ 
Sbjct: 69  SSKVFQVLNE-KKQIYAIKYVNLEEADN-------QTLDSYRNEIAYLNKLQQHSDKIIR 120

Query: 189 LIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNV 247
           L +        + YMV+E      D N    +  +I     + Y ++++  +  +H H +
Sbjct: 121 LYDYEITDQ--YIYMVMECGNI--DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 176

Query: 248 VHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD-NDVLRRSP-GTPVFTAPECCLGLTYG- 304
           VH D+KP N L+   G +K+ DF ++   + D   V++ S  G   +  PE    ++   
Sbjct: 177 VHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235

Query: 305 ---------GKAADTWAVGVTLYYMIIGQYPFLGETLQ-DTYDKIVNNS--LVFPDAMNP 352
                       +D W++G  LYYM  G+ PF     Q      I++ +  + FPD    
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 295

Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL 392
           +L+++L+  L +DP +R+++ ++  H +V     P+ Q  
Sbjct: 296 DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMA 335

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  213 bits (543), Expect = 5e-66
 Identities = 69/291 (23%), Positives = 127/291 (43%), Gaps = 31/291 (10%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
             Y  +++IG+G   KV    +    + YAIK  +               +   R E+  
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADN-------QTLDSYRNEIAY 60

Query: 178 MKMLQHPN--IVNLIEVIDDPNSDHFYMVLEYVEGKWD-NDGFGQPGAIGESMARKYLRD 234
           +  LQ  +  I+ L +        + YMV+E      D N    +  +I     + Y ++
Sbjct: 61  LNKLQQHSDKIIRLYDYEITDQ--YIYMVMECGNI--DLNSWLKKKKSIDPWERKSYWKN 116

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD-NDVLRRSP-GTPVF 292
           ++  +  +H H +VH D+KP N L+   G +K+ DF ++   + D   V++ S  GT  +
Sbjct: 117 MLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 175

Query: 293 TAPECCLGLTYG----------GKAADTWAVGVTLYYMIIGQYPFLGETLQ-DTYDKIVN 341
             PE    ++               +D W++G  LYYM  G+ PF     Q      I++
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235

Query: 342 NSLV--FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
            +    FPD    +L+++L+  L +DP +R+++ ++  H +V     P+ Q
Sbjct: 236 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 286

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  208 bits (533), Expect = 3e-65
 Identities = 78/280 (27%), Positives = 123/280 (43%), Gaps = 21/280 (7%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y     IG GS+G+V +          A K   K  +  +            ++E+ IMK
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD---------RFKQEIEIMK 61

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
            L HPNI+ L E  +D      Y+V+E   G    +         ES A + ++D++S +
Sbjct: 62  SLDHPNIIRLYETFEDNT--DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAV 119

Query: 240 MYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
            Y H  NV H D+KP+N L     P   +K+ DF ++        ++R   GTP + +P+
Sbjct: 120 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA-ARFKPGKMMRTKVGTPYYVSPQ 178

Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAMNP 352
             L   Y G   D W+ GV +Y ++ G  PF   T  +   KI   +  FP      ++P
Sbjct: 179 -VLEGLY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236

Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL 392
           +  +L+  LL K P +R+T     +H W        P+ L
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  210 bits (536), Expect = 3e-65
 Identities = 62/320 (19%), Positives = 110/320 (34%), Gaps = 64/320 (20%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + ++    +G G+   V   R    G  +AIK F+     +         +    RE  +
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--------PVDVQMREFEV 60

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG--------FGQPGAIGESMAR 229
           +K L H NIV L  + ++  + H  +++E+        G              + ES   
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC-----GSLYTVLEEPSNAYGLPESEFL 115

Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS----GTVKIGDFSVSQVFEDDNDVLRR 285
             LRD+V G+ +L  + +VH +IKP N++           K+ DF  ++   +D++    
Sbjct: 116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVS 174

Query: 286 SPGTPVFTAPE--------CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL----GETLQ 333
             GT  +  P+              Y G   D W++GVT Y+   G  PF         +
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233

Query: 334 DTYDKIVNN-------------------------SLVFPDAMNPELRNLLEGLLCKDPTR 368
           +   KI+                           S      +   L  +L  +L  D  +
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293

Query: 369 RLTLNDVAKHTWVLGDNGPI 388
               +     T  +   G  
Sbjct: 294 CWGFDQFFAETSDILHRGNS 313

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  208 bits (532), Expect = 5e-65
 Identities = 75/287 (26%), Positives = 125/287 (43%), Gaps = 33/287 (11%)

Query: 114 TKMINE-YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
           +   ++ Y    ++G G++  V        G  +A K  +   LS             + 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-------KLE 53

Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGE 225
           RE  I + LQHPNIV L + I +      Y+V + V G       G             E
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEE--SFHYLVFDLVTG-------GELFEDIVAREFYSE 104

Query: 226 SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDV 282
           + A   ++ I+  + Y H + +VH ++KP+NLL+A       VK+ DF ++     D++ 
Sbjct: 105 ADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEA 163

Query: 283 LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN 342
                GTP + +PE      Y  K  D WA GV LY +++G  PF  E     Y +I   
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 222

Query: 343 SLVFP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN 385
           +  +P    D + PE ++L++ +L  +P +R+T +   K  W+    
Sbjct: 223 AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  212 bits (542), Expect = 5e-65
 Identities = 93/393 (23%), Positives = 168/393 (42%), Gaps = 36/393 (9%)

Query: 10  RDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTADGD 69
           RD  C  CF     K     R  +  ++RI R+    +      +D+S NG   N     
Sbjct: 34  RDKSCEYCFDEPLLKRTDKYRTYSKKHFRIFREVGPKNSYIAYIEDHSGNGTFVN----- 88

Query: 70  GGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAG 129
             E+    KR   +    E+   + R       +  +  +      + +EY+  + +G+G
Sbjct: 89  -TELVGKGKRRP-LNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSG 146

Query: 130 SYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNL 189
           + G+V L       K  AI+   K   +    A       +V  E+ I+K L HP I+ +
Sbjct: 147 ACGEVKLAFERKTCKKVAIRIISKRKFAI-GSAREADPALNVETEIEILKKLNHPCIIKI 205

Query: 190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRDIVSGLMYL 242
               D  +   +Y+VLE +EG       G           + E+  + Y   ++  + YL
Sbjct: 206 KNFFDAED---YYIVLELMEG-------GELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 255

Query: 243 HGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
           H + ++H D+KP+N+L++       +KI DF  S++   +  ++R   GTP + APE  +
Sbjct: 256 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYLAPEVLV 314

Query: 300 GLTYG--GKAADTWAVGVTLYYMIIGQYPFLGETLQDT-YDKIVNNSLVFP----DAMNP 352
            +      +A D W++GV L+  + G  PF     Q +  D+I +    F       ++ 
Sbjct: 315 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 374

Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN 385
           +  +L++ LL  DP  R T  +  +H W+  ++
Sbjct: 375 KALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  209 bits (535), Expect = 5e-65
 Identities = 74/284 (26%), Positives = 134/284 (47%), Gaps = 29/284 (10%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           EY+  + +G+G+ G+V L       K  AIK   K   +      ++ A  +V  E+ I+
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPA-LNVETEIEIL 69

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKY 231
           K L HP I+ +    D  +   +Y+VLE +EG       G           + E+  + Y
Sbjct: 70  KKLNHPCIIKIKNFFDAED---YYIVLELMEG-------GELFDKVVGNKRLKEATCKLY 119

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
              ++  + YLH + ++H D+KP+N+L++       +KI DF  S++   +  ++R   G
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCG 178

Query: 289 TPVFTAPECCLGLTYG--GKAADTWAVGVTLYYMIIGQYPFLGETLQDT-YDKIVNNSLV 345
           TP + APE  + +      +A D W++GV L+  + G  PF     Q +  D+I +    
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238

Query: 346 FP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN 385
           F       ++ +  +L++ LL  DP  R T  +  +H W+  ++
Sbjct: 239 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  209 bits (533), Expect = 1e-64
 Identities = 80/283 (28%), Positives = 135/283 (47%), Gaps = 29/283 (10%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y    ++G+G +  V   R    G  YA K   K    + + +    +  D+ REV I+K
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKR---RTKSSRRGVSREDIEREVSILK 69

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYL 232
            +QHPN++ L EV ++       ++LE V G       G       +  ++ E  A ++L
Sbjct: 70  EIQHPNVITLHEVYENKT--DVILILELVAG-------GELFDFLAEKESLTEEEATEFL 120

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVA----PSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           + I++G+ YLH   + H D+KP+N+++     P   +KI DF ++    D  +  +   G
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-HKIDFGNEFKNIFG 179

Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP- 347
           TP F APE        G  AD W++GV  Y ++ G  PFLG+T Q+T   +   +  F  
Sbjct: 180 TPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238

Query: 348 ---DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
                 +   ++ +  LL KDP +R+T+ D  +H W+   +  
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  208 bits (532), Expect = 1e-64
 Identities = 76/302 (25%), Positives = 137/302 (45%), Gaps = 31/302 (10%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y    ++G+G +  V   R    G  YA K   K    + R +    +  ++ REV I++
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKR---QSRASRRGVSREEIEREVSILR 70

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYL 232
            + H N++ L +V ++       ++LE V G       G       Q  ++ E  A  ++
Sbjct: 71  QVLHHNVITLHDVYENRT--DVVLILELVSG-------GELFDFLAQKESLSEEEATSFI 121

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVA----PSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           + I+ G+ YLH   + H D+KP+N+++     P   +K+ DF ++    +D    +   G
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIFG 180

Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP- 347
           TP F APE        G  AD W++GV  Y ++ G  PFLG+T Q+T   I + S  F  
Sbjct: 181 TPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE 239

Query: 348 ---DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV--LGDNGPIPQYLCWCKRDRLRR 402
                 +   ++ +  LL K+  +RLT+ +  +H W+  + +   + +       +  R+
Sbjct: 240 EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRK 299

Query: 403 DN 404
             
Sbjct: 300 QY 301

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  212 bits (541), Expect = 1e-64
 Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 31/281 (11%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           EY    ++G G++  V      L G+ YA    +   LS             + RE  I 
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ-------KLEREARIC 64

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKY 231
           ++L+HPNIV L + I +    H Y++ + V G       G             E+ A   
Sbjct: 65  RLLKHPNIVRLHDSISEE--GHHYLIFDLVTG-------GELFEDIVAREYYSEADASHC 115

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           ++ I+  +++ H   VVH ++KP+NLL+A       VK+ DF ++   E +        G
Sbjct: 116 IQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 175

Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP- 347
           TP + +PE      Y GK  D WA GV LY +++G  PF  E     Y +I   +  FP 
Sbjct: 176 TPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS 234

Query: 348 ---DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN 385
              D + PE ++L+  +L  +P++R+T  +  KH W+   +
Sbjct: 235 PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRS 275

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  207 bits (529), Expect = 1e-64
 Identities = 74/277 (26%), Positives = 127/277 (45%), Gaps = 33/277 (11%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           ++  RK+G+G++G V L      G    IK  +K              M  +  E+ ++K
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--------PMEQIEAEIEVLK 75

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG---------FGQPGAIGESMARK 230
            L HPNI+ + EV +D +  + Y+V+E  EG     G           +  A+ E    +
Sbjct: 76  SLDHPNIIKIFEVFEDYH--NMYIVMETCEG-----GELLERIVSAQARGKALSEGYVAE 128

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSP 287
            ++ +++ L Y H  +VVH D+KP+N+L     P   +KI DF ++      ++    + 
Sbjct: 129 LMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA-ELFKSDEHSTNAA 187

Query: 288 GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF- 346
           GT ++ APE            D W+ GV +Y+++ G  PF G +L++   K       + 
Sbjct: 188 GTALYMAPE-VFKRDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA 245

Query: 347 --PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
                + P+  +LL+ +L KDP RR +   V  H W 
Sbjct: 246 VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  206 bits (527), Expect = 2e-64
 Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 29/281 (10%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y    ++G+G +  V   R    GK YA K   K    +L  +    +  ++ REV I++
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKR---RLSSSRRGVSREEIEREVNILR 63

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYL 232
            ++HPNI+ L ++ ++       ++LE V G       G       +  ++ E  A ++L
Sbjct: 64  EIRHPNIITLHDIFENKT--DVVLILELVSG-------GELFDFLAEKESLTEDEATQFL 114

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVA----PSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           + I+ G+ YLH   + H D+KP+N+++     P+  +K+ DF ++    +  +  +   G
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGNEFKNIFG 173

Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP- 347
           TP F APE        G  AD W++GV  Y ++ G  PFLGET Q+T   I   +  F  
Sbjct: 174 TPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE 232

Query: 348 ---DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN 385
                 +   ++ +  LL KDP RR+T+    +H+W+    
Sbjct: 233 EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  209 bits (533), Expect = 3e-64
 Identities = 77/282 (27%), Positives = 130/282 (46%), Gaps = 29/282 (10%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + Y    ++G+G +  V   R    G  YA K   K    + R +       ++ REV I
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKR---QSRASRRGVCREEIEREVSI 68

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARK 230
           ++ + HPNI+ L +V ++       ++LE V G       G       Q  ++ E  A  
Sbjct: 69  LRQVLHPNIITLHDVYENRT--DVVLILELVSG-------GELFDFLAQKESLSEEEATS 119

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVA----PSGTVKIGDFSVSQVFEDDNDVLRRS 286
           +++ I+ G+ YLH   + H D+KP+N+++     P   +K+ DF ++    +D    +  
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNI 178

Query: 287 PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF 346
            GTP F APE        G  AD W++GV  Y ++ G  PFLG+T Q+T   I   S  F
Sbjct: 179 FGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237

Query: 347 P----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD 384
                   +   ++ +  LL K+  +RLT+ +  +H W+   
Sbjct: 238 DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  206 bits (527), Expect = 4e-64
 Identities = 61/298 (20%), Positives = 120/298 (40%), Gaps = 50/298 (16%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +++  +  +G G++G+VV  R++LD ++YAIK    +          E  ++ +  EV++
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----------EEKLSTILSEVML 55

Query: 178 MKMLQHPNIVNLIEVIDDPN-----------SDHFYMVLEYVEG-----KWDNDGFGQPG 221
           +  L H  +V       +                 ++ +EY E         ++   Q  
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ- 114

Query: 222 AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281
                   +  R I+  L Y+H   ++H D+KP N+ +  S  VKIGDF +++      D
Sbjct: 115 ---RDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171

Query: 282 VLRRSP--------------GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
           +L+                 GT ++ A E   G  +  +  D +++G+  + MI      
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FS 229

Query: 328 LGETLQDTYDKIVNNSLVFP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            G    +   K+ + S+ FP    D      + ++  L+  DP +R     +    W+
Sbjct: 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  211 bits (539), Expect = 7e-64
 Identities = 80/275 (29%), Positives = 131/275 (47%), Gaps = 18/275 (6%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + Y   R +G GS+G+V+L +  + G+  A+K   K  +        +T    + REV +
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK------QKTDKESLLREVQL 79

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +K L HPNI+ L E  +D    +FY+V E   G    D         E  A + +R ++S
Sbjct: 80  LKQLDHPNIMKLYEFFEDKG--YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137

Query: 238 GLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           G+ Y+H + +VH D+KP+NLL+        ++I DF +S  FE  +  ++   GT  + A
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKMKDKIGTAYYIA 196

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAM 350
           PE  L  TY  +  D W+ GV LY ++ G  PF G    D   K+      F       +
Sbjct: 197 PE-VLHGTY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254

Query: 351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN 385
           +   ++L+  +L   P+ R++  D   H W+    
Sbjct: 255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  207 bits (530), Expect = 8e-64
 Identities = 75/281 (26%), Positives = 123/281 (43%), Gaps = 32/281 (11%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
            Y    ++G G++  V        G  +A K  +   LS             + RE  I 
Sbjct: 30  NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-------KLEREARIC 82

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKY 231
           + LQHPNIV L + I + +    Y+V + V G       G             E+ A   
Sbjct: 83  RKLQHPNIVRLHDSIQEES--FHYLVFDLVTG-------GELFEDIVAREFYSEADASHC 133

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           ++ I+  + Y H + +VH ++KP+NLL+A       VK+ DF ++     D++      G
Sbjct: 134 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAG 192

Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP- 347
           TP + +PE      Y  K  D WA GV LY +++G  PF  E     Y +I   +  +P 
Sbjct: 193 TPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 251

Query: 348 ---DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN 385
              D + PE ++L++ +L  +P +R+T +   K  W+    
Sbjct: 252 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 292

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  206 bits (526), Expect = 2e-63
 Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 31/300 (10%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y     IG G +  V    +   G+ +A+K    +  +      +E    D++RE  I  
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE----DLKREASICH 81

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----------KWDNDGFGQPGAIGESMAR 229
           ML+HP+IV L+E          YMV E+++G                +       E++A 
Sbjct: 82  MLKHPHIVELLETYSSDG--MLYMVFEFMDGADLCFEIVKRADAGFVYS------EAVAS 133

Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRS 286
            Y+R I+  L Y H +N++H D+KP  +L+A    S  VK+G F V+    +   V    
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193

Query: 287 PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF 346
            GTP F APE      Y GK  D W  GV L+ ++ G  PF G   +  ++ I+      
Sbjct: 194 VGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKM 251

Query: 347 P----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLRR 402
                  ++   ++L+  +L  DP  R+T+ +   H W+   +    +       ++LR+
Sbjct: 252 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRK 311

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  204 bits (521), Expect = 3e-63
 Identities = 76/283 (26%), Positives = 136/283 (48%), Gaps = 35/283 (12%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
            ++ +  +G+G++ +V L +  L GK +A+K   KS   +          + +  E+ ++
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---------DSSLENEIAVL 60

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKY 231
           K ++H NIV L ++ +     H+Y+V++ V G       G       + G   E  A   
Sbjct: 61  KKIKHENIVTLEDIYEST--THYYLVMQLVSG-------GELFDRILERGVYTEKDASLV 111

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           ++ ++S + YLH + +VH D+KP+NLL      +  + I DF +S++ ++   ++  + G
Sbjct: 112 IQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACG 169

Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP- 347
           TP + APE      Y  KA D W++GV  Y ++ G  PF  ET    ++KI      F  
Sbjct: 170 TPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES 228

Query: 348 ---DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
              D ++   ++ +  LL KDP  R T      H W+ G+   
Sbjct: 229 PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTAL 271

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  204 bits (521), Expect = 4e-63
 Identities = 76/293 (25%), Positives = 119/293 (40%), Gaps = 17/293 (5%)

Query: 98  PVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS 157
           PV +         + G   +  +   +KIG G + +V      LDG   A+K   K  + 
Sbjct: 12  PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALK---KVQIF 68

Query: 158 KLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWD 213
            L       A  D  +E+ ++K L HPN++       +   +   +VLE  +     +  
Sbjct: 69  DL---MDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNIVLELADAGDLSRMI 123

Query: 214 NDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
                Q   I E    KY   + S L ++H   V+H DIKP N+ +  +G VK+GD  + 
Sbjct: 124 KHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183

Query: 274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE--T 331
           + F           GTP + +PE      Y  K +D W++G  LY M   Q PF G+   
Sbjct: 184 RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN 242

Query: 332 LQDTYDKIVNNSL--VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL 382
           L     KI       +  D  + ELR L+   +  DP +R  +  V      +
Sbjct: 243 LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  209 bits (535), Expect = 4e-63
 Identities = 82/275 (29%), Positives = 141/275 (51%), Gaps = 19/275 (6%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
             Y  V+K+G+G+YG+V+L R  +     AIK   K+ +S        ++ + +  EV +
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-------SSNSKLLEEVAV 89

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +K+L HPNI+ L +  +D    ++Y+V+E  +G    D         E  A   ++ ++S
Sbjct: 90  LKLLDHPNIMKLYDFFEDKR--NYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS 147

Query: 238 GLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           G+ YLH HN+VH D+KP+NLL+        +KI DF +S VFE +   ++   GT  + A
Sbjct: 148 GVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERLGTAYYIA 206

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAM 350
           PE  L   Y  +  D W++GV L+ ++ G  PF G+T Q+   K+      F       +
Sbjct: 207 PE-VLRKKY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV 264

Query: 351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN 385
           +   ++L++ +L  D  RR++     +H W+    
Sbjct: 265 SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  203 bits (518), Expect = 6e-63
 Identities = 79/291 (27%), Positives = 139/291 (47%), Gaps = 20/291 (6%)

Query: 103 NKLIRSEDENGTKMINE-YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV 161
           +     E+        E Y  V  +G GS+G+V+  +  +  + YA+K  +K+       
Sbjct: 6   HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65

Query: 162 APSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG 221
           +        + REV ++K L HPNI+ L E+++D +   FY+V E   G    D   +  
Sbjct: 66  S-------TILREVELLKKLDHPNIMKLFEILEDSS--SFYIVGELYTGGELFDEIIKRK 116

Query: 222 AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFED 278
              E  A + ++ + SG+ Y+H HN+VH D+KP+N+L+        +KI DF +S  F+ 
Sbjct: 117 RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176

Query: 279 DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDK 338
           +   ++   GT  + APE  L  TY  +  D W+ GV LY ++ G  PF G+   D   +
Sbjct: 177 N-TKMKDRIGTAYYIAPE-VLRGTY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR 233

Query: 339 IVNNSLVFP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN 385
           +      F       ++ + ++L+  +L   P+ R+T     +H W+   +
Sbjct: 234 VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  203 bits (519), Expect = 9e-63
 Identities = 80/296 (27%), Positives = 129/296 (43%), Gaps = 27/296 (9%)

Query: 98  PVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS 157
           P   S +  +   +   K   ++   + +G GS+  VVL R     + YAIK   K H+ 
Sbjct: 10  PGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII 69

Query: 158 KLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG- 216
           K      +       R+V+    L HP  V L     D   +  Y  L Y +      G 
Sbjct: 70  KEN----KVPYVTRERDVM--SRLDHPFFVKLYFTFQDD--EKLYFGLSYAKN-----GE 116

Query: 217 -FGQ---PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272
                   G+  E+  R Y  +IVS L YLHG  ++H D+KP+N+L+     ++I DF  
Sbjct: 117 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT 176

Query: 273 SQVFEDDNDVLRRSP--GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE 330
           ++V   ++   R +   GT  + +PE     +   K++D WA+G  +Y ++ G  PF   
Sbjct: 177 AKVLSPESKQARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAG 235

Query: 331 TLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLN------DVAKHTW 380
                + KI+     FP+   P+ R+L+E LL  D T+RL          +  H +
Sbjct: 236 NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  208 bits (532), Expect = 1e-62
 Identities = 77/282 (27%), Positives = 135/282 (47%), Gaps = 33/282 (11%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
             Y  V  +G GS+G+V+  +  +  + YA+K  +K+       +        + REV +
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-------TILREVEL 74

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARK 230
           +K L HPNI+ L E+++D +   FY+V E   G       G       +     E  A +
Sbjct: 75  LKKLDHPNIMKLFEILEDSS--SFYIVGELYTG-------GELFDEIIKRKRFSEHDAAR 125

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSP 287
            ++ + SG+ Y+H HN+VH D+KP+N+L+        +KI DF +S  F+ +   ++   
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI 184

Query: 288 GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP 347
           GT  + APE  L  TY  +  D W+ GV LY ++ G  PF G+   D   ++      F 
Sbjct: 185 GTAYYIAPE-VLRGTY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242

Query: 348 ----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN 385
                 ++ + ++L+  +L   P+ R+T     +H W+   +
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  208 bits (532), Expect = 1e-62
 Identities = 87/284 (30%), Positives = 135/284 (47%), Gaps = 16/284 (5%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMT----DVRR 173
             Y  VRK+G+G+YG+V+L +        AIK   KS   K R +     +     ++  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95

Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
           E+ ++K L HPNI+ L +V +D    +FY+V E+ EG    +         E  A   ++
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKK--YFYLVTEFYEGGELFEQIINRHKFDECDAANIMK 153

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
            I+SG+ YLH HN+VH DIKP+N+L+        +KI DF +S  F  D   LR   GT 
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTA 212

Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP--- 347
            + APE      Y  +  D W+ GV +Y ++ G  PF G+  QD   K+      F    
Sbjct: 213 YYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270

Query: 348 -DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
              ++ E + L++ +L  D  +R T  +     W+      I +
Sbjct: 271 WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINK 314

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  201 bits (514), Expect = 4e-62
 Identities = 66/293 (22%), Positives = 114/293 (38%), Gaps = 28/293 (9%)

Query: 110 DENGTKMINE-YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAM 168
             + T    E Y     +G G    V         K YA+K    +          +   
Sbjct: 8   GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELR 67

Query: 169 TDVRREVLIMKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QP 220
               +EV I++ +  HPNI+ L +  +      F++V + ++        G       + 
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKDTYETN--TFFFLVFDLMKK-------GELFDYLTEK 118

Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN 280
             + E   RK +R ++  +  LH  N+VH D+KP+N+L+     +K+ DF  S   +   
Sbjct: 119 VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG- 177

Query: 281 DVLRRSPGTPVFTAPECCLGLTYG-----GKAADTWAVGVTLYYMIIGQYPFLGETLQDT 335
           + LR   GTP + APE             GK  D W+ GV +Y ++ G  PF        
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 237

Query: 336 YDKIVNNSLVFP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD 384
              I++ +  F     D  +  +++L+   L   P +R T  +   H +    
Sbjct: 238 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  201 bits (514), Expect = 5e-62
 Identities = 72/277 (25%), Positives = 114/277 (41%), Gaps = 16/277 (5%)

Query: 107 RSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSET 166
                  +     +  + ++G GSYG+V   RS  DG+ YA+K             P + 
Sbjct: 46  YDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK-----RSMSPFRGPKDR 100

Query: 167 AMTDVRREVLIM-KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGE 225
           A      EV    K+ QHP  V L +  ++      Y+  E               ++ E
Sbjct: 101 ARK--LAEVGSHEKVGQHPCCVRLEQAWEEG--GILYLQTELCGPSLQQHCEAWGASLPE 156

Query: 226 SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR 285
           +    YLRD +  L +LH   +VH D+KP N+ + P G  K+GDF +             
Sbjct: 157 AQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEV 215

Query: 286 SPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIG-QYPFLGETLQDTYDKIVNNSL 344
             G P + APE   G +Y G AAD +++G+T+  +    + P  GE  Q      +    
Sbjct: 216 QEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL--PP 271

Query: 345 VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            F   ++ ELR++L  +L  DP  R T   +     +
Sbjct: 272 EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  201 bits (514), Expect = 7e-62
 Identities = 68/296 (22%), Positives = 123/296 (41%), Gaps = 31/296 (10%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            +Y+    +G G +G V     +   K Y  K        +            V++E+ I
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----------VLVKKEISI 54

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG-----KWDNDGFGQPGAIGESMARKYL 232
           + + +H NI++L E  +        M+ E++ G     + +   F     + E     Y+
Sbjct: 55  LNIARHRNILHLHESFESME--ELVMIFEFISGLDIFERINTSAF----ELNEREIVSYV 108

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVA--PSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
             +   L +LH HN+ H DI+P+N++     S T+KI +F  +       D  R     P
Sbjct: 109 HQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA-RQLKPGDNFRLLFTAP 167

Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAM 350
            + APE          A D W++G  +Y ++ G  PFL ET Q   + I+N    F +  
Sbjct: 168 EYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA 226

Query: 351 NPEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLRR 402
             E+     + ++ LL K+   R+T ++  +H W+      +   +   +  + RR
Sbjct: 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKV--IRTLKHRR 280

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  203 bits (519), Expect = 8e-62
 Identities = 61/312 (19%), Positives = 108/312 (34%), Gaps = 64/312 (20%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + ++    +G G+   V   R    G  +AIK F+     +         +    RE  +
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--------PVDVQMREFEV 60

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG--------FGQPGAIGESMAR 229
           +K L H NIV L  + ++  + H  +++E+        G              + ES   
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC-----GSLYTVLEEPSNAYGLPESEFL 115

Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS----GTVKIGDFSVSQVFEDDNDVLRR 285
             LRD+V G+ +L  + +VH +IKP N++           K+ DF  ++   +D++    
Sbjct: 116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVS 174

Query: 286 SPGTPVFTAPE--------CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL----GETLQ 333
             GT  +  P+              Y G   D W++GVT Y+   G  PF         +
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233

Query: 334 DTYDKIVNN-------------------------SLVFPDAMNPELRNLLEGLLCKDPTR 368
           +   KI+                           S      +   L  +L  +L  D  +
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293

Query: 369 RLTLNDVAKHTW 380
               +     T 
Sbjct: 294 CWGFDQFFAETS 305

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  203 bits (517), Expect = 1e-61
 Identities = 73/296 (24%), Positives = 144/296 (48%), Gaps = 28/296 (9%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + Y  + ++G+G++G V        G+ +  K  +  +               V+ E+ I
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---------KYTVKNEISI 101

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG-----KWDNDGFGQPGAIGESMARKYL 232
           M  L HP ++NL +  +D       ++LE++ G     +   + +     + E+    Y+
Sbjct: 102 MNQLHHPKLINLHDAFEDKY--EMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYM 155

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVA--PSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
           R    GL ++H H++VH DIKP+N++     + +VKI DF ++    + +++++ +  T 
Sbjct: 156 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATA 214

Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP--- 347
            F APE        G   D WA+GV  Y ++ G  PF GE   +T   +      F    
Sbjct: 215 EFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 273

Query: 348 -DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLRR 402
             +++PE ++ ++ LL K+P +RLT++D  +H W+ GD+  +   +   + +++R+
Sbjct: 274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQ 329

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  199 bits (509), Expect = 3e-61
 Identities = 71/275 (25%), Positives = 128/275 (46%), Gaps = 35/275 (12%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           +++G G +  V    S   G+ YA K   K    +   A       ++  E+ ++++ + 
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA-------EILHEIAVLELAKS 87

Query: 184 -PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG---------QPGAIGESMARKYLR 233
            P ++NL EV ++ +     ++LEY  G       G             + E+   + ++
Sbjct: 88  CPRVINLHEVYENTS--EIILILEYAAG-------GEIFSLCLPELAEMVSENDVIRLIK 138

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
            I+ G+ YLH +N+VH D+KP N+L++   P G +KI DF +S+        LR   GTP
Sbjct: 139 QILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELREIMGTP 197

Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP--- 347
            + APE          A D W +G+  Y ++    PF+GE  Q+TY  I   ++ +    
Sbjct: 198 EYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET 256

Query: 348 -DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
             +++    + ++ LL K+P +R T      H+W+
Sbjct: 257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  198 bits (505), Expect = 1e-60
 Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 44/288 (15%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
            +  + +G GS+            + +A+K   K   +            + ++E+  +K
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA------------NTQKEITALK 60

Query: 180 MLQ-HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKY 231
           + + HPNIV L EV  D    H ++V+E + G       G       +     E+ A   
Sbjct: 61  LCEGHPNIVKLHEVFHDQL--HTFLVMELLNG-------GELFERIKKKKHFSETEASYI 111

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           +R +VS + ++H   VVH D+KP+NLL      +  +KI DF  +++   DN  L+    
Sbjct: 112 MRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF 171

Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDT-------YDKIVN 341
           T  + APE      Y  ++ D W++GV LY M+ GQ PF       T         KI  
Sbjct: 172 TLHYAAPELLNQNGY-DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK 230

Query: 342 NSLVFP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN 385
               F       ++ E ++L++GLL  DP +RL ++ +  + W+   +
Sbjct: 231 GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  199 bits (509), Expect = 2e-60
 Identities = 69/340 (20%), Positives = 145/340 (42%), Gaps = 30/340 (8%)

Query: 59  NGEATNTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMIN 118
             + + +   +  E+ ++A  +E +  + +    +    P   +    R        + +
Sbjct: 28  GDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNS 87

Query: 119 EYV--HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
            Y       +G G +G+V     +  G   A K      +             +V+ E+ 
Sbjct: 88  FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---------KEEVKNEIS 138

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG-----KWDNDGFGQPGAIGESMARKY 231
           +M  L H N++ L +  +  N     +V+EYV+G     +  ++ +     + E     +
Sbjct: 139 VMNQLDHANLIQLYDAFESKN--DIVLVMEYVDGGELFDRIIDESY----NLTELDTILF 192

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVA--PSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
           ++ I  G+ ++H   ++H D+KP+N+L     +  +KI DF +++ +    + L+ + GT
Sbjct: 193 MKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY-KPREKLKVNFGT 251

Query: 290 PVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP-- 347
           P F APE  +   +     D W+VGV  Y ++ G  PFLG+   +T + I+         
Sbjct: 252 PEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE 310

Query: 348 --DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN 385
               ++ E +  +  LL K+ + R++ ++  KH W+    
Sbjct: 311 EFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  197 bits (504), Expect = 2e-60
 Identities = 61/290 (21%), Positives = 111/290 (38%), Gaps = 31/290 (10%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y+ ++K+G G +  V L     DG  YA+K        ++     +    + +RE  + +
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALK--------RILC-HEQQDREEAQREADMHR 81

Query: 180 MLQHPNIVNLIEVI--DDPNSDHFYMVLEYVEGK--WD--NDGFGQPGAIGESMARKYLR 233
           +  HPNI+ L+     +       +++L + +    W+       +   + E      L 
Sbjct: 82  LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP------ 287
            I  GL  +H     H D+KP N+L+   G   + D           +  R++       
Sbjct: 142 GICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201

Query: 288 ---GTPVFTAPECCLGLTYG--GKAADTWAVGVTLYYMIIGQYPFLGETLQ-DTYDKIVN 341
               T  + APE     ++    +  D W++G  LY M+ G+ P+     + D+    V 
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261

Query: 342 NSLVFP--DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIP 389
           N L  P     +  L  LL  ++  DP +R  +  +      L    P P
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL--QPPAP 309

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  198 bits (505), Expect = 3e-60
 Identities = 89/340 (26%), Positives = 145/340 (42%), Gaps = 44/340 (12%)

Query: 73  MQNHAKRSEEI------FRERELNGLICRQFPVKESNKLIRSEDENGTKMINE-YVHVRK 125
           M +H   S  +         + ++ +     P   S       D +    +++ +    +
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESE 60

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G+   V   +     K YA+K   K+   K            VR E+ ++  L HPN
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK-----------IVRTEIGVLLRLSHPN 109

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRDIVSG 238
           I+ L E+ + P      +VLE V G       G       + G   E  A   ++ I+  
Sbjct: 110 IIKLKEIFETP--TEISLVLELVTG-------GELFDRIVEKGYYSERDAADAVKQILEA 160

Query: 239 LMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + YLH + +VH D+KP+NLL A   P   +KI DF +S++ E    +++   GTP + AP
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTVCGTPGYCAP 219

Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL-QDTYDKIVNNSLVFP----DAM 350
           E   G  Y G   D W+VG+  Y ++ G  PF  E   Q  + +I+N    F     D +
Sbjct: 220 EILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278

Query: 351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
           +   ++L+  L+  DP +RLT     +H WV G       
Sbjct: 279 SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVH 318

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  197 bits (502), Expect = 6e-60
 Identities = 77/304 (25%), Positives = 125/304 (41%), Gaps = 42/304 (13%)

Query: 101 ESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR 160
             + +++    N  +  + Y     IG GSY              +A+K   KS      
Sbjct: 5   GVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---- 60

Query: 161 VAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG- 218
                    D   E+ I+    QHPNI+ L +V DD    + Y+V E ++G       G 
Sbjct: 61  ---------DPTEEIEILLRYGQHPNIITLKDVYDDG--KYVYVVTELMKG-------GE 102

Query: 219 ------QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA----PSGTVKIG 268
                 +     E  A   L  I   + YLH   VVH D+KP N+L         +++I 
Sbjct: 103 LLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRIC 162

Query: 269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL 328
           DF  ++    +N +L     T  F APE      Y   A D W++GV LY M+ G  PF 
Sbjct: 163 DFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTPFA 221

Query: 329 G---ETLQDTYDKIVNNSLVFP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
               +T ++   +I +          ++++   ++L+  +L  DP +RLT   V +H W+
Sbjct: 222 NGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

Query: 382 LGDN 385
           +  +
Sbjct: 282 VHWD 285

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  195 bits (497), Expect = 8e-60
 Identities = 60/286 (20%), Positives = 117/286 (40%), Gaps = 39/286 (13%)

Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
            +   ++  +  IG+G +G+V   +  +DGK Y IK   +   +               R
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK---RVKYNNE----------KAER 53

Query: 174 EVLIMKMLQHPNIVNLIEVIDD--------------PNSDHFYMVLEYVEG----KWDND 215
           EV  +  L H NIV+     D                 +   ++ +E+ +     +W   
Sbjct: 54  EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113

Query: 216 GFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV 275
             G+   + + +A +    I  G+ Y+H   +++ D+KP N+ +  +  VKIGDF +   
Sbjct: 114 RRGEK--LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171

Query: 276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDT 335
            ++D     RS GT  + +PE      YG +  D +A+G+ L  ++              
Sbjct: 172 LKNDGK-RTRSKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTA--FETSKF 227

Query: 336 YDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           +  + +   +  D  + + + LL+ LL K P  R   +++ +   V
Sbjct: 228 FTDLRDG--IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  197 bits (502), Expect = 1e-59
 Identities = 70/279 (25%), Positives = 116/279 (41%), Gaps = 28/279 (10%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y     IG G    V        G  +A+K    +   +L     E      RRE  I++
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAE-RLSPEQLEEVREATRRETHILR 154

Query: 180 ML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKY 231
            +  HP+I+ LI+  +  +    ++V + +         G       +  A+ E   R  
Sbjct: 155 QVAGHPHIITLIDSYESSS--FMFLVFDLMRK-------GELFDYLTEKVALSEKETRSI 205

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
           +R ++  + +LH +N+VH D+KP+N+L+  +  +++ DF  S   E   + LR   GTP 
Sbjct: 206 MRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELCGTPG 264

Query: 292 FTAPECCLGLTYG-----GKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF 346
           + APE             GK  D WA GV L+ ++ G  PF           I+     F
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324

Query: 347 P----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
                D  +  +++L+  LL  DP  RLT     +H + 
Sbjct: 325 SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  201 bits (514), Expect = 2e-59
 Identities = 76/282 (26%), Positives = 127/282 (45%), Gaps = 30/282 (10%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y    ++G G++G V        G ++A K     H S             VR+E+  M 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---------KETVRKEIQTMS 209

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG------FGQPGAIGESMARKYLR 233
           +L+HP +VNL +  +D N     M+ E++ G     G        +   + E  A +Y+R
Sbjct: 210 VLRHPTLVNLHDAFEDDN--EMVMIYEFMSG-----GELFEKVADEHNKMSEDEAVEYMR 262

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVA--PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
            +  GL ++H +N VH D+KP+N++     S  +K+ DF ++    D    ++ + GT  
Sbjct: 263 QVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT-AHLDPKQSVKVTTGTAE 321

Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN 351
           F APE   G    G   D W+VGV  Y ++ G  PF GE   +T   + +      D+  
Sbjct: 322 FAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 380

Query: 352 PEL----RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIP 389
             +    ++ +  LL  DP  R+T++   +H W+   N P  
Sbjct: 381 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  193 bits (491), Expect = 5e-58
 Identities = 44/332 (13%), Positives = 96/332 (28%), Gaps = 58/332 (17%)

Query: 90  NGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIK 149
           + L+            + SE     +     V    +G       +       G+ + + 
Sbjct: 48  DSLVSTSLWNTGQPFRVESELGERPR---TLVRGTVLGQEDPYAYLEATDQETGESFEVH 104

Query: 150 AFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-------------------------HP 184
             + +        P   A+  ++ EVL +++L+                           
Sbjct: 105 VPYFTER------PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 158

Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG------FGQPGAIGESMARKYLRDIVSG 238
            ++ +     D      + +   ++      G           ++      +    ++  
Sbjct: 159 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 218

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE-- 296
           L  LH + +VH  ++P ++++   G V +  F         +     S  +  F  PE  
Sbjct: 219 LASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV----RDGARVVSSVSRGFEPPELE 274

Query: 297 --------CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD 348
                        T    + D WA+G+ +Y++     P   +      + I  +    P 
Sbjct: 275 ARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIP- 333

Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
                +R LLEG L      RL      +   
Sbjct: 334 ---QPVRALLEGFLRYPKEDRLLPLQAMETPE 362

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  193 bits (491), Expect = 2e-57
 Identities = 65/301 (21%), Positives = 108/301 (35%), Gaps = 35/301 (11%)

Query: 98  PVKESNKLIRSEDENGTKMIN--EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSH 155
           P  E +     ++E    ++    +     +G G+ G +V YR   D +  A+K      
Sbjct: 5   PSLEQDD---GDEETSVVIVGKISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPEC 60

Query: 156 LSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDN 214
            S               REV +++   +HPN++       D      Y+ +E        
Sbjct: 61  FSFAD------------REVQLLRESDEHPNVIRYFCTEKDRQ--FQYIAIELCAATLQE 106

Query: 215 DGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT-----VKIGD 269
               +  A         L+   SGL +LH  N+VH D+KP N+L++           I D
Sbjct: 107 YVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISD 166

Query: 270 FSVSQVFEDDNDVLRRSP---GTPVFTAPECCLGLTYG--GKAADTWAVGVTLYYMI-IG 323
           F + +          R     GT  + APE              D ++ G   YY+I  G
Sbjct: 167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEG 226

Query: 324 QYPFLGETLQDTYDKIVNNSLVFPDA---MNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
            +PF     +     +   SL         +   R L+E ++  DP +R +   V KH +
Sbjct: 227 SHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

Query: 381 V 381
            
Sbjct: 287 F 287

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  189 bits (481), Expect = 2e-57
 Identities = 62/313 (19%), Positives = 120/313 (38%), Gaps = 43/313 (13%)

Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           + + ++  ++ +G G +G V   ++ +D  +YAIK        ++R+   E A   V RE
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIK--------RIRLPNRELAREKVMRE 53

Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSD----------HFYMVLEYVEG----KWDNDGFGQP 220
           V  +  L+HP IV       + N+           + Y+ ++         W N      
Sbjct: 54  VKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE 113

Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN 280
                S+       I   + +LH   ++H D+KP N+       VK+GDF +    + D 
Sbjct: 114 -ERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172

Query: 281 DVLRRSP------------GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL 328
           +                  GT ++ +PE   G +Y  K  D +++G+ L+ ++   YPF 
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPFS 228

Query: 329 GET-LQDTYDKIVNNSL-VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG 386
            +     T   + N           P    +++ +L   P  R    ++ ++     ++ 
Sbjct: 229 TQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF--EDL 286

Query: 387 PIPQYLCWCKRDR 399
             P      +R R
Sbjct: 287 DFPGKTVLRQRSR 299

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  197 bits (503), Expect = 3e-57
 Identities = 71/306 (23%), Positives = 110/306 (35%), Gaps = 54/306 (17%)

Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           T+    +    ++G G +G V+ +     G+  AIK   +    K R             
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--------ERWCL 61

Query: 174 EVLIMKMLQHPNIVNLIEVIDDPN----SDHFYMVLEYVEGKWDNDG--------FGQPG 221
           E+ IMK L HPN+V+  EV D       +D   + +EY EG     G        F    
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEG-----GDLRKYLNQFENCC 116

Query: 222 AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---TVKIGDFSVSQVFED 278
            + E   R  L DI S L YLH + ++H D+KP+N+++ P       KI D   ++   D
Sbjct: 117 GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-D 175

Query: 279 DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDK 338
             ++     GT  + APE      Y     D W+ G   +  I G  PFL       +  
Sbjct: 176 QGELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHG 234

Query: 339 IV--------------NNSLVFPDAMNP----------ELRNLLEGLLCKDPTRRLTLND 374
            V                ++ F   +            +L   L+ +L     +R T   
Sbjct: 235 KVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294

Query: 375 VAKHTW 380
                 
Sbjct: 295 NPNVGC 300

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  188 bits (479), Expect = 2e-56
 Identities = 90/291 (30%), Positives = 137/291 (47%), Gaps = 27/291 (9%)

Query: 100 KESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKL 159
           KE            T  ++++  ++ +G GS+G+V+L +    G HYA+K   K  + KL
Sbjct: 23  KEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82

Query: 160 RVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG--F 217
           +       +     E  I++ +  P +V L     D    + YMV+EYV G     G  F
Sbjct: 83  K------QIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNLYMVMEYVAG-----GEMF 129

Query: 218 GQ---PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
                 G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF  ++
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

Query: 275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQD 334
             +     L    GTP   APE  L   Y  KA D WA+GV +Y M  G  PF  +    
Sbjct: 190 RVKGRTWTLC---GTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

Query: 335 TYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
            Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W
Sbjct: 246 IYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  188 bits (478), Expect = 4e-56
 Identities = 44/302 (14%), Positives = 83/302 (27%), Gaps = 49/302 (16%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
              V  +  G    V L R     + +A+K F            S + +  +        
Sbjct: 64  LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE------NSRSELERLHEATFAAA 117

Query: 180 MLQHPN------------------------IVNLIEVIDDPNSDHFYMVLEYVEG----- 210
            L   +                           L    DD    ++ +++          
Sbjct: 118 RLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELL 177

Query: 211 -KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGD 269
               +  +   G  G          ++     L    +VHG   PDNL + P G + +GD
Sbjct: 178 FSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGD 237

Query: 270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYG-GKAADTWAVGVTLYYMIIGQYPFL 328
            S              S     +   E     T     A + W +G+++Y +     PF 
Sbjct: 238 VSALWK---VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294

Query: 329 GET--LQDTYDKIVNNSLVFPD-------AMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
             T  ++ ++ +                  +   ++ L+   L  D  RRL   +  +  
Sbjct: 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354

Query: 380 WV 381
             
Sbjct: 355 EF 356

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  186 bits (475), Expect = 8e-56
 Identities = 75/263 (28%), Positives = 123/263 (46%), Gaps = 23/263 (8%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+GKV L       + +AIKA  K  +    +   +   T V + VL     +HP 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVV----LMDDDVECTMVEKRVL-SLAWEHPF 79

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRDIVSG 238
           + ++         ++ + V+EY+ G       G              S A  Y  +I+ G
Sbjct: 80  LTHMFCTFQTK--ENLFFVMEYLNG-------GDLMYHIQSCHKFDLSRATFYAAEIILG 130

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L +LH   +V+ D+K DN+L+   G +KI DF + +     +       GTP + APE  
Sbjct: 131 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 190

Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLL 358
           LG  Y   + D W+ GV LY M+IGQ PF G+  ++ +  I  ++  +P  +  E ++LL
Sbjct: 191 LGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 249

Query: 359 EGLLCKDPTRRL-TLNDVAKHTW 380
             L  ++P +RL    D+ +H  
Sbjct: 250 VKLFVREPEKRLGVRGDIRQHPL 272

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  187 bits (477), Expect = 1e-55
 Identities = 68/288 (23%), Positives = 120/288 (41%), Gaps = 44/288 (15%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
            V  + +G G  GKV+   +    + +A+K                      RREV +  
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------------KARREVELHW 109

Query: 180 MLQ-HPNIVNLIEVIDDPNS--DHFYMVLEYVEG--------KWDNDGFGQPGAIGESMA 228
                P+IV +++V ++  +      +V+E ++G           +  F       E  A
Sbjct: 110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT------EREA 163

Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRR 285
            + ++ I   + YLH  N+ H D+KP+NLL     P+  +K+ DF  ++     N  L  
Sbjct: 164 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTT 222

Query: 286 SPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDT----YDKIVN 341
              TP + APE      Y  K+ D W++GV +Y ++ G  PF              +I  
Sbjct: 223 PCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 281

Query: 342 NSLVFP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN 385
               FP      ++ E++ L+  LL  +PT+R+T+ +   H W++   
Sbjct: 282 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  187 bits (477), Expect = 1e-55
 Identities = 40/291 (13%), Positives = 84/291 (28%), Gaps = 34/291 (11%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSH----------------LSKLRVAP 163
            V    +G       +       G+ + +   + +                 L  LR   
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVID---DPNSDHFYMVLEYVEG------KWDN 214
           ++       R +    +++ P    +I V     D      + +   ++       +   
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 215 DGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ 274
                  ++      +    ++  L  LH + +VH  ++P ++++   G V +  F    
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 275 VFEDDNDVLRRSP-GTPVFTAPECCLGLTYG----GKAADTWAVGVTLYYMIIGQYPFLG 329
                           P  TA        +       A DTW +G+ +Y++     P   
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319

Query: 330 ETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
           +      + I  +    P      +R LLEG L      RL      +   
Sbjct: 320 DAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAMETPE 366

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  183 bits (468), Expect = 3e-55
 Identities = 79/267 (29%), Positives = 134/267 (50%), Gaps = 31/267 (11%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+G+V L RS  +G++YA+K   K  + +L+    +   T+  R +L   ++ HP 
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK----QVEHTNDERLML--SIVTHPF 67

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRDIVSG 238
           I+ +     D      +M+++Y+EG       G       +       +A+ Y  ++   
Sbjct: 68  IIRMWGTFQDA--QQIFMIMDYIEG-------GELFSLLRKSQRFPNPVAKFYAAEVCLA 118

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L YLH  ++++ D+KP+N+L+  +G +KI DF  ++   D    L    GTP + APE  
Sbjct: 119 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC---GTPDYIAPEVV 175

Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLL 358
               Y  K+ D W+ G+ +Y M+ G  PF       TY+KI+N  L FP   N ++++LL
Sbjct: 176 STKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 234

Query: 359 EGLLCKDPTRRL-----TLNDVAKHTW 380
             L+ +D ++RL        DV  H W
Sbjct: 235 SRLITRDLSQRLGNLQNGTEDVKNHPW 261

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  184 bits (469), Expect = 7e-55
 Identities = 75/248 (30%), Positives = 120/248 (48%), Gaps = 14/248 (5%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+GKV+L R    G  YA+K   K  +    +   +   T   + +L      HP 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVI----LQDDDVECTMTEKRIL-SLARNHPF 85

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG---QPGAIGESMARKYLRDIVSGLMYL 242
           +  L         D  + V+E+V G    D      +     E+ AR Y  +I+S LM+L
Sbjct: 86  LTQLFCCF--QTPDRLFFVMEFVNG---GDLMFHIQKSRRFDEARARFYAAEIISALMFL 140

Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
           H   +++ D+K DN+L+   G  K+ DF + +    +        GTP + APE    + 
Sbjct: 141 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML 200

Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLL 362
           YG  A D WA+GV LY M+ G  PF  E   D ++ I+N+ +V+P  ++ +   +L+  +
Sbjct: 201 YG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFM 259

Query: 363 CKDPTRRL 370
            K+PT RL
Sbjct: 260 TKNPTMRL 267

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  183 bits (468), Expect = 1e-54
 Identities = 77/252 (30%), Positives = 118/252 (46%), Gaps = 22/252 (8%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+GKV+L       + YA+K   K  +    +   +   T V + VL     + P 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVV----IQDDDVECTMVEKRVL-ALPGKPPF 82

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRDIVSG 238
           +  L         D  Y V+EYV G       G       Q G   E  A  Y  +I  G
Sbjct: 83  LTQLHSCF--QTMDRLYFVMEYVNG-------GDLMYHIQQVGRFKEPHAVFYAAEIAIG 133

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L +L    +++ D+K DN+++   G +KI DF + +    D    +   GTP + APE  
Sbjct: 134 LFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 193

Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLL 358
               YG K+ D WA GV LY M+ GQ PF GE   + +  I+ +++ +P +M+ E   + 
Sbjct: 194 AYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 252

Query: 359 EGLLCKDPTRRL 370
           +GL+ K P +RL
Sbjct: 253 KGLMTKHPGKRL 264

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  183 bits (466), Expect = 1e-54
 Identities = 84/248 (33%), Positives = 127/248 (51%), Gaps = 15/248 (6%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G G++GKV+L R    G++YA+K   K  +    +A  E A T     VL  +  +HP 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVI----IAKDEVAHTVTESRVL--QNTRHPF 66

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESMARKYLRDIVSGLMYL 242
           +  L         D    V+EY  G    + F    +     E  AR Y  +IVS L YL
Sbjct: 67  LTALKYAFQTH--DRLCFVMEYANG---GELFFHLSRERVFTEERARFYGAEIVSALEYL 121

Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
           H  +VV+ DIK +NL++   G +KI DF + +    D   ++   GTP + APE      
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLL 362
           YG +A D W +GV +Y M+ G+ PF  +  +  ++ I+   + FP  ++PE ++LL GLL
Sbjct: 182 YG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240

Query: 363 CKDPTRRL 370
            KDP +RL
Sbjct: 241 KKDPKQRL 248

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  183 bits (466), Expect = 1e-54
 Identities = 71/283 (25%), Positives = 119/283 (42%), Gaps = 45/283 (15%)

Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-H 183
            +G G  GKV+       G+  A+K  + S                 R+EV         
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------------KARQEVDHHWQASGG 81

Query: 184 PNIVNLIEVIDDPN--SDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMARKYLR 233
           P+IV +++V ++ +       +++E +EG        +  +  F       E  A + +R
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFT------EREAAEIMR 135

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
           DI + + +LH HN+ H D+KP+NLL         +K+ DF  ++      + L+    TP
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT--QNALQTPCYTP 193

Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDT----YDKIVNNSLVF 346
            + APE      Y  K+ D W++GV +Y ++ G  PF   T Q        +I      F
Sbjct: 194 YYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252

Query: 347 P----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN 385
           P      ++ + + L+  LL  DPT RLT+     H W+    
Sbjct: 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  184 bits (468), Expect = 2e-54
 Identities = 74/267 (27%), Positives = 130/267 (48%), Gaps = 23/267 (8%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           R IG GS+GKV + + +   K YA+K  +K    +         + +V +E+ IM+ L+H
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERN------EVRNVFKELQIMQGLEH 74

Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESMARKYLRDIVSGLM 240
           P +VNL     D   +  +MV++ + G    D      Q     E   + ++ ++V  L 
Sbjct: 75  PFLVNLWYSFQDE--EDMFMVVDLLLG---GDLRYHLQQNVHFKEETVKLFICELVMALD 129

Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE---C 297
           YL    ++H D+KPDN+L+   G V I DF+++ +   +  +   + GT  + APE    
Sbjct: 130 YLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA-GTKPYMAPEMFSS 188

Query: 298 CLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG---ETLQDTYDKIVNNSLVFPDAMNPEL 354
             G  Y   A D W++GVT Y ++ G+ P+      + ++         + +P A + E+
Sbjct: 189 RKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEM 247

Query: 355 RNLLEGLLCKDPTRRL-TLNDVAKHTW 380
            +LL+ LL  +P +R   L+DV    +
Sbjct: 248 VSLLKKLLEPNPDQRFSQLSDVQNFPY 274

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  184 bits (470), Expect = 3e-54
 Identities = 61/312 (19%), Positives = 113/312 (36%), Gaps = 56/312 (17%)

Query: 108 SEDENGTKMINE-YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSET 166
           +   N  + +    V  + +G GS G VV ++ S  G+  A+K                 
Sbjct: 4   ANIPNFEQSLKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDF----------- 51

Query: 167 AMTDVRREVLIM-KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG------KWDNDGFGQ 219
                  E+ ++ +   HPN++              Y+ LE          +  N     
Sbjct: 52  -CDIALMEIKLLTESDDHPNVIRYYCSETTD--RFLYIALELCNLNLQDLVESKNVSDEN 108

Query: 220 PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-------------TVK 266
                E      LR I SG+ +LH   ++H D+KP N+LV+ S               + 
Sbjct: 109 LKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168

Query: 267 IGDFSVSQVFEDDNDVLRRSP----GTPVFTAPECCLGLTYG------GKAADTWAVGVT 316
           I DF + +  +      R +     GT  + APE               ++ D +++G  
Sbjct: 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228

Query: 317 LYYMI-IGQYPFLGETLQDTYDKIVNNSLVFPD-------AMNPELRNLLEGLLCKDPTR 368
            YY++  G++PF  +  ++    I+       +       ++  E  +L+  ++  DP +
Sbjct: 229 FYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLK 286

Query: 369 RLTLNDVAKHTW 380
           R T   V +H  
Sbjct: 287 RPTAMKVLRHPL 298

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  184 bits (469), Expect = 5e-54
 Identities = 93/339 (27%), Positives = 152/339 (44%), Gaps = 31/339 (9%)

Query: 51  DDDDDNSYNGEATNTADGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSED 110
           +  ++      A  T   DG + Q  A+         + +G    +  + +    +   +
Sbjct: 91  ETPEEREEWTTAIQT-VADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE 149

Query: 111 ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD 170
               K++         G G++GKV+L +    G++YA+K   K  +    VA  E A T 
Sbjct: 150 FEYLKLL---------GKGTFGKVILVKEKATGRYYAMKILKKEVI----VAKDEVAHTL 196

Query: 171 VRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESM 227
               VL  +  +HP +  L         D    V+EY  G    + F    +     E  
Sbjct: 197 TENRVL--QNSRHPFLTALKYSFQTH--DRLCFVMEYANG---GELFFHLSRERVFSEDR 249

Query: 228 ARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS 286
           AR Y  +IVS L YLH   NVV+ D+K +NL++   G +KI DF + +    D   ++  
Sbjct: 250 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 309

Query: 287 PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF 346
            GTP + APE      YG +A D W +GV +Y M+ G+ PF  +  +  ++ I+   + F
Sbjct: 310 CGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF 368

Query: 347 PDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
           P  + PE ++LL GLL KDP +RL        ++ +H +
Sbjct: 369 PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  183 bits (466), Expect = 8e-54
 Identities = 88/272 (32%), Positives = 129/272 (47%), Gaps = 27/272 (9%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           V+ IG G++G+V L R     K YA+K   K  + K     S++A     R+++      
Sbjct: 74  VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR----SDSAFFWEERDIM--AFAN 127

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG--QPGAIGESMARKYLRDIVSGLM 240
            P +V L     D    + YMV+EY+ G    D         + E  AR Y  ++V  L 
Sbjct: 128 SPWVVQLFYAFQDD--RYLYMVMEYMPG---GDLVNLMSNYDVPEKWARFYTAEVVLALD 182

Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP-GTPVFTAPECCL 299
            +H    +H D+KPDN+L+  SG +K+ DF        +  V   +  GTP + +PE   
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242

Query: 300 G----LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFPDAMN-- 351
                  Y G+  D W+VGV LY M++G  PF  ++L  TY KI+N  NSL FPD  +  
Sbjct: 243 SQGGDGYY-GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301

Query: 352 PELRNLLEGLLCKDPTRRLTLNDVA---KHTW 380
            E +NL+   L  D   RL  N V    +H +
Sbjct: 302 KEAKNLICAFLT-DREVRLGRNGVEEIKRHLF 332

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  182 bits (463), Expect = 8e-54
 Identities = 84/266 (31%), Positives = 121/266 (45%), Gaps = 26/266 (9%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IG GS+GKV+L R   +   YA+K   K  +    +   E       R VL+ K ++HP 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAI----LKKKEEKHIMSERNVLL-KNVKHPF 100

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRDIVSG 238
           +V L         D  Y VL+Y+ G       G       +     E  AR Y  +I S 
Sbjct: 101 LVGLHFSFQTA--DKLYFVLDYING-------GELFYHLQRERCFLEPRARFYAAEIASA 151

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L YLH  N+V+ D+KP+N+L+   G + + DF + +   + N       GTP + APE  
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVL 211

Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLL 358
               Y  +  D W +G  LY M+ G  PF      + YD I+N  L     +    R+LL
Sbjct: 212 HKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 270

Query: 359 EGLLCKDPTRRL----TLNDVAKHTW 380
           EGLL KD T+RL       ++  H +
Sbjct: 271 EGLLQKDRTKRLGAKDDFMEIKSHVF 296

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  182 bits (464), Expect = 3e-53
 Identities = 78/272 (28%), Positives = 127/272 (46%), Gaps = 29/272 (10%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IG G++G+V + +     K +A+K  +K  +    +  +ETA     R+VL         
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEM----LKRAETACFREERDVL--VNGDSKW 135

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMY 241
           I  L     D   ++ Y+V++Y  G    D           + E MAR YL ++V  +  
Sbjct: 136 ITTLHYAFQDD--NNLYLVMDYYVG---GDLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190

Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP-GTPVFTAPECCLG 300
           +H  + VH DIKPDN+L+  +G +++ DF       +D  V      GTP + +PE    
Sbjct: 191 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250

Query: 301 LTYG----GKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFP---DAMN 351
           +  G    G   D W++GV +Y M+ G+ PF  E+L +TY KI+N      FP     ++
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVS 310

Query: 352 PELRNLLEGLLCKDPTRRLTLNDVA---KHTW 380
              ++L+  L+C     RL  N +    KH +
Sbjct: 311 ENAKDLIRRLIC-SREHRLGQNGIEDFKKHPF 341

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  181 bits (461), Expect = 4e-53
 Identities = 79/274 (28%), Positives = 118/274 (43%), Gaps = 31/274 (11%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IG G++ +V + +    G+ YA+K  +K  +    +   E +     R+VL+        
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM----LKRGEVSCFREERDVLVN--GDRRW 122

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMY 241
           I  L     D   ++ Y+V+EY  G    D           I   MAR YL +IV  +  
Sbjct: 123 ITQLHFAFQDE--NYLYLVMEYYVG---GDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP-GTPVFTAPECCLG 300
           +H    VH DIKPDN+L+   G +++ DF        D  V      GTP + +PE    
Sbjct: 178 VHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237

Query: 301 LTYG------GKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN--NSLVFP---DA 349
           +  G      G   D WA+GV  Y M  GQ PF  ++  +TY KIV+    L  P   + 
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG 297

Query: 350 MNPELRNLLEGLLCKDPTRRLTLNDVA---KHTW 380
           +  E R+ ++ LLC  P  RL          H +
Sbjct: 298 VPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  184 bits (468), Expect = 5e-53
 Identities = 77/305 (25%), Positives = 132/305 (43%), Gaps = 29/305 (9%)

Query: 76  HAKRSEEIFRERELNGLICR--QFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGK 133
            A   +  F+E   +    R  Q+   E+  +            + ++  R +G G +G+
Sbjct: 151 LAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPM----------GEDWFLDFRVLGRGGFGE 200

Query: 134 VVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI 193
           V   +    GK YA K  +K  L              V +++L    +    IV+L    
Sbjct: 201 VFACQMKATGKLYACKKLNKKRL----KKRKGYQGAMVEKKIL--AKVHSRFIVSLAYAF 254

Query: 194 DDPNSDHFYMVLEYVEG---KWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVH 249
           +        +V+  + G   ++      +      E  A  Y   IVSGL +LH  N+++
Sbjct: 255 ETK--TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIY 312

Query: 250 GDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAAD 309
            D+KP+N+L+   G V+I D  ++   +      +   GTP F APE  LG  Y   + D
Sbjct: 313 RDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY-DFSVD 371

Query: 310 TWAVGVTLYYMIIGQYPFLGE----TLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKD 365
            +A+GVTLY MI  + PF         ++   +++  ++ +PD  +P  ++  E LL KD
Sbjct: 372 YFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKD 431

Query: 366 PTRRL 370
           P +RL
Sbjct: 432 PEKRL 436

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  177 bits (452), Expect = 9e-53
 Identities = 75/301 (24%), Positives = 122/301 (40%), Gaps = 61/301 (20%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HP 184
           +G G++ +V    + +  + YA+K   K               + V REV ++   Q H 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGH---------IRSRVFREVEMLYQCQGHR 71

Query: 185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRDIVS 237
           N++ LIE  ++   D FY+V E + G       G       +     E  A   ++D+ S
Sbjct: 72  NVLELIEFFEEE--DRFYLVFEKMRG-------GSILSHIHKRRHFNELEASVVVQDVAS 122

Query: 238 GLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSP------- 287
            L +LH   + H D+KP+N+L         VKI DF +    + + D    S        
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182

Query: 288 GTPVFTAPE-----CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDT------- 335
           G+  + APE           Y  K  D W++GV LY ++ G  PF+G    D        
Sbjct: 183 GSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241

Query: 336 --------YDKIVNNSLVFP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG 383
                   ++ I      FP      ++   ++L+  LL +D  +RL+   V +H WV G
Sbjct: 242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301

Query: 384 D 384
            
Sbjct: 302 C 302

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  176 bits (450), Expect = 2e-52
 Identities = 79/255 (30%), Positives = 123/255 (48%), Gaps = 25/255 (9%)

Query: 126 IGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +G G YGKV   R       GK +A+K   K+ + +      +TA T   R +L  + ++
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR---NAKDTAHTKAERNIL--EEVK 79

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRDI 235
           HP IV+LI           Y++LEY+ G       G       + G   E  A  YL +I
Sbjct: 80  HPFIVDLIYAFQTG--GKLYLILEYLSG-------GELFMQLEREGIFMEDTACFYLAEI 130

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
              L +LH   +++ D+KP+N+++   G VK+ DF + +    D  V     GT  + AP
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190

Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELR 355
           E  +   +  +A D W++G  +Y M+ G  PF GE  + T DKI+   L  P  +  E R
Sbjct: 191 EILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR 249

Query: 356 NLLEGLLCKDPTRRL 370
           +LL+ LL ++   RL
Sbjct: 250 DLLKKLLKRNAASRL 264

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  177 bits (450), Expect = 4e-52
 Identities = 72/277 (25%), Positives = 115/277 (41%), Gaps = 37/277 (13%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IG GSY KV+L R     + YA+K   K  +        +       + V   +   HP 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELV----NDDEDIDWVQTEKHVF-EQASNHPF 71

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRDIVSG 238
           +V L            + V+EYV G       G       +   + E  AR Y  +I   
Sbjct: 72  LVGLHSCF--QTESRLFFVIEYVNG-------GDLMFHMQRQRKLPEEHARFYSAEISLA 122

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L YLH   +++ D+K DN+L+   G +K+ D+ + +      D      GTP + APE  
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 182

Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFL---------GETLQDTYDKIVNNSLVFPDA 349
            G  Y G + D WA+GV ++ M+ G+ PF            T    +  I+   +  P +
Sbjct: 183 RGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241

Query: 350 MNPELRNLLEGLLCKDPTRRL------TLNDVAKHTW 380
           ++ +  ++L+  L KDP  RL         D+  H +
Sbjct: 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  183 bits (466), Expect = 6e-52
 Identities = 76/248 (30%), Positives = 118/248 (47%), Gaps = 14/248 (5%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           +G GS+GKV+L       + YA+K   K  +    +   +   T V + VL +   + P 
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVV----IQDDDVECTMVEKRVLALPG-KPPF 403

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP---GAIGESMARKYLRDIVSGLMYL 242
           +  L         D  Y V+EYV G    D        G   E  A  Y  +I  GL +L
Sbjct: 404 LTQLHSCF--QTMDRLYFVMEYVNG---GDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 458

Query: 243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLT 302
               +++ D+K DN+++   G +KI DF + +    D    +   GTP + APE      
Sbjct: 459 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP 518

Query: 303 YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLL 362
           YG K+ D WA GV LY M+ GQ PF GE   + +  I+ +++ +P +M+ E   + +GL+
Sbjct: 519 YG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLM 577

Query: 363 CKDPTRRL 370
            K P +RL
Sbjct: 578 TKHPGKRL 585

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  177 bits (452), Expect = 6e-52
 Identities = 71/277 (25%), Positives = 115/277 (41%), Gaps = 37/277 (13%)

Query: 126 IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN 185
           IG GSY KV+L R     + YA++   K  +        +       + V   +   HP 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELV----NDDEDIDWVQTEKHVF-EQASNHPF 114

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRDIVSG 238
           +V L            + V+EYV G       G       +   + E  AR Y  +I   
Sbjct: 115 LVGLHSCFQTE--SRLFFVIEYVNG-------GDLMFHMQRQRKLPEEHARFYSAEISLA 165

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           L YLH   +++ D+K DN+L+   G +K+ D+ + +      D      GTP + APE  
Sbjct: 166 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 225

Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFL---------GETLQDTYDKIVNNSLVFPDA 349
            G  Y G + D WA+GV ++ M+ G+ PF            T    +  I+   +  P +
Sbjct: 226 RGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284

Query: 350 MNPELRNLLEGLLCKDPTRRL------TLNDVAKHTW 380
           ++ +  ++L+  L KDP  RL         D+  H +
Sbjct: 285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  175 bits (445), Expect = 1e-51
 Identities = 72/271 (26%), Positives = 126/271 (46%), Gaps = 34/271 (12%)

Query: 126 IGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHL-SKLRVAPSETAMTDVRREVLIMKML 181
           +G GS+GKV L +        + YA+K   K+ L  + RV    T M     E  I+  +
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV---RTKM-----ERDILVEV 83

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRD 234
            HP IV L            Y++L+++ G       G       +     E   + YL +
Sbjct: 84  NHPFIVKLHYAFQTE--GKLYLILDFLRG-------GDLFTRLSKEVMFTEEDVKFYLAE 134

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           +   L +LH   +++ D+KP+N+L+   G +K+ DF +S+   D         GT  + A
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPEL 354
           PE      +  ++AD W+ GV ++ M+ G  PF G+  ++T   I+   L  P  ++PE 
Sbjct: 195 PEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEA 253

Query: 355 RNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
           ++LL  L  ++P  RL      + ++ +H++
Sbjct: 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  172 bits (438), Expect = 4e-51
 Identities = 64/293 (21%), Positives = 106/293 (36%), Gaps = 41/293 (13%)

Query: 114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           ++   E+  + KIG+G +G V      LDG  YAIK   +S               +  R
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK---RSKKPLA----GSVDEQNALR 59

Query: 174 EV-LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMA 228
           EV     + QH ++V       +   DH  +  EY  G       ++ +       E+  
Sbjct: 60  EVYAHAVLGQHSHVVRYFSAWAE--DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117

Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-------------------TVKIGD 269
           +  L  +  GL Y+H  ++VH DIKP N+ ++ +                      KIGD
Sbjct: 118 KDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177

Query: 270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG 329
                             G   F A E           AD +A+ +T+      +     
Sbjct: 178 LGHVTRISSPQVEE----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP-- 231

Query: 330 ETLQDTYDKIVNNSL-VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
               D + +I    L   P  ++ E   LL+ ++  DP RR +   + KH+ +
Sbjct: 232 -RNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  178 bits (452), Expect = 2e-50
 Identities = 71/281 (25%), Positives = 116/281 (41%), Gaps = 33/281 (11%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
            N +   R +G G +G+V   +    GK YA K   K  +          AM    +++L
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI----KKRKGEAMALNEKQIL 238

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMA 228
             + +    +V+L    +    D   +VL  + G             GF       E+ A
Sbjct: 239 --EKVNSRFVVSLAYAYETK--DALCLVLTLMNGGDLKFHIYHMGQAGFP------EARA 288

Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
             Y  +I  GL  LH   +V+ D+KP+N+L+   G ++I D  ++     +   ++   G
Sbjct: 289 VFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTIKGRVG 347

Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE----TLQDTYDKIVNNSL 344
           T  + APE      Y   + D WA+G  LY MI GQ PF         ++    +     
Sbjct: 348 TVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE 406

Query: 345 VFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
            + +  +P+ R+L   LLCKDP  RL     +  +V +H  
Sbjct: 407 EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  177 bits (451), Expect = 1e-49
 Identities = 78/306 (25%), Positives = 130/306 (42%), Gaps = 25/306 (8%)

Query: 72  EMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSY 131
             +       ++F++   +    R    K           N    +N++   R IG G +
Sbjct: 150 IEEICQNLRGDVFQKFIESDKFTRFCQWKNVEL-------NIHLTMNDFSVHRIIGRGGF 202

Query: 132 GKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL-IMKMLQHPNIVNLI 190
           G+V   R +  GK YA+K   K  +   +       +    R +L ++     P IV + 
Sbjct: 203 GEVYGCRKADTGKMYAMKCLDKKRIKMKQ----GETLALNERIMLSLVSTGDCPFIVCMS 258

Query: 191 EVIDDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESMARKYLRDIVSGLMYLHGHNV 247
                P  D    +L+ + G    D      Q G   E+  R Y  +I+ GL ++H   V
Sbjct: 259 YAFHTP--DKLSFILDLMNG---GDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 313

Query: 248 VHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKA 307
           V+ D+KP N+L+   G V+I D  ++   +        S GT  + APE          +
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGVAYDSS 371

Query: 308 ADTWAVGVTLYYMIIGQYPFLGETLQDT---YDKIVNNSLVFPDAMNPELRNLLEGLLCK 364
           AD +++G  L+ ++ G  PF     +D        +  ++  PD+ +PELR+LLEGLL +
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 431

Query: 365 DPTRRL 370
           D  RRL
Sbjct: 432 DVNRRL 437

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  168 bits (428), Expect = 1e-49
 Identities = 65/288 (22%), Positives = 115/288 (39%), Gaps = 65/288 (22%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM- 178
            V  + +G G  GKV+   +    + +A+K                      RREV +  
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------------KARREVELHW 65

Query: 179 KMLQHPNIVNLIEVIDDPNS--DHFYMVLEYVEG--------KWDNDGFGQPGAIGESMA 228
           +  Q P+IV +++V ++  +      +V+E ++G           +  F       E  A
Sbjct: 66  RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT------EREA 119

Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRR 285
            + ++ I   + YLH  N+ H D+KP+NLL     P+  +K+ DF               
Sbjct: 120 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------- 166

Query: 286 SPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDT----YDKIVN 341
                   A E   G  Y  K+ D W++GV +Y ++ G  PF              +I  
Sbjct: 167 --------AKE-TTGEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 216

Query: 342 NSLVFP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN 385
               FP      ++ E++ L+  LL  +PT+R+T+ +   H W++   
Sbjct: 217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  169 bits (431), Expect = 2e-49
 Identities = 75/277 (27%), Positives = 130/277 (46%), Gaps = 36/277 (12%)

Query: 126 IGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHL-SKLRVAPSETAMTDVRREVLIMKML 181
           +G G+YGKV L R       GK YA+K   K+ +  K +     T  T   R+VL   + 
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK----TTEHTRTERQVL-EHIR 116

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-------QPGAIGESMARKYLRD 234
           Q P +V L            +++L+Y+ G       G       Q     E   + Y+ +
Sbjct: 117 QSPFLVTLHYAFQTE--TKLHLILDYING-------GELFTHLSQRERFTEHEVQIYVGE 167

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSPGTPVFT 293
           IV  L +LH   +++ DIK +N+L+  +G V + DF +S +   D+ +      GT  + 
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227

Query: 294 APECCLGLTYG-GKAADTWAVGVTLYYMIIGQYPFLGE----TLQDTYDKIVNNSLVFPD 348
           AP+   G   G  KA D W++GV +Y ++ G  PF  +    +  +   +I+ +   +P 
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 287

Query: 349 AMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
            M+   ++L++ LL KDP +RL       +++ +H +
Sbjct: 288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  166 bits (422), Expect = 9e-49
 Identities = 60/266 (22%), Positives = 109/266 (40%), Gaps = 21/266 (7%)

Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           +IG GS+  V     +      A        L+K       +     + E  ++K LQHP
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-------SERQRFKEEAEMLKGLQHP 85

Query: 185 NIVNLI--EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYL 242
           NIV                 +V E +          +   +   + R + R I+ GL +L
Sbjct: 86  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 145

Query: 243 HGHN--VVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLRRSP-GTPVFTAPECC 298
           H     ++H D+K DN+ +  P+G+VKIGD  ++ +         ++  GTP F APE  
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPE-- 200

Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS---LVFPDAMNPELR 355
           +      ++ D +A G+ +  M   +YP+          + V +      F     PE++
Sbjct: 201 MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260

Query: 356 NLLEGLLCKDPTRRLTLNDVAKHTWV 381
            ++EG + ++   R ++ D+  H + 
Sbjct: 261 EIIEGCIRQNKDERYSIKDLLNHAFF 286

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  166 bits (422), Expect = 3e-48
 Identities = 61/298 (20%), Positives = 104/298 (34%), Gaps = 42/298 (14%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
               R +  G +  V   +    G+ YA+K    +   K R          + +EV  MK
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR---------AIIQEVCFMK 80

Query: 180 MLQ-HPNIVNLIEVI-----DDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESMARK 230
            L  HPNIV           +       +++L  +      +        G +      K
Sbjct: 81  KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140

Query: 231 YLRDIVSGLMYLHGHN--VVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP- 287
                   + ++H     ++H D+K +NLL++  GT+K+ DF  +       D    +  
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200

Query: 288 -----------GTPVFTAPECC---LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ 333
                       TP++  PE          G K  D WA+G  LY +   Q+PF      
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK-QDIWALGCILYLLCFRQHPFEDGAKL 259

Query: 334 DTYDKIVNNSLVFP--DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIP 389
               +IVN     P  D       +L+  +L  +P  RL++ +V      +     + 
Sbjct: 260 ----RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  160 bits (407), Expect = 2e-46
 Identities = 78/295 (26%), Positives = 121/295 (41%), Gaps = 28/295 (9%)

Query: 102 SNKLIRSEDENGTKMINEYVHVRK-----IGAGSYGKVVLYRSSLDGKHYAIKAFHKSHL 156
           S +     D     +  +Y +        +G G+YG V   R   +    AIK   +   
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60

Query: 157 SKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KW 212
              +          +  E+ + K L+H NIV  +    +       + +E V G      
Sbjct: 61  RYSQ---------PLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKIFMEQVPGGSLSAL 109

Query: 213 DNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV-APSGTVKIGDFS 271
               +G P    E     Y + I+ GL YLH + +VH DIK DN+L+   SG +KI DF 
Sbjct: 110 LRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFG 168

Query: 272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYG-GKAADTWAVGVTLYYMIIGQYPF--L 328
            S+     N       GT  + APE       G GKAAD W++G T+  M  G+ PF  L
Sbjct: 169 TSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228

Query: 329 GETLQDTYDKIVNNSLV--FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           GE     + K+    +    P++M+ E +  +      DP +R   ND+    ++
Sbjct: 229 GEPQAAMF-KVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  157 bits (398), Expect = 1e-44
 Identities = 66/315 (20%), Positives = 117/315 (37%), Gaps = 29/315 (9%)

Query: 101 ESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR 160
              + ++  D    + ++   H  ++G GS+G+V   +    G   A+K        K+R
Sbjct: 41  LLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK--------KVR 92

Query: 161 VAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP 220
           +            E++    L  P IV L   + +       + +E +EG        Q 
Sbjct: 93  LEVFR------VEELVACAGLSSPRIVPLYGAVREG--PWVNIFMELLEGGSLGQLIKQM 144

Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT-VKIGDFSVSQVFEDD 279
           G + E  A  YL   + GL YLH   ++HGD+K DN+L++  G+   + DF  +   + D
Sbjct: 145 GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204

Query: 280 NDVLRRSP-----GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG-ETLQ 333
                        GT    APE  +G     K  D W+    + +M+ G +P+       
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGP 263

Query: 334 DTYDKIVNN---SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
               KI +        P +  P     ++  L K+P  R +  ++ +             
Sbjct: 264 LCL-KIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG-KALQEVGGL 321

Query: 391 YLCWCKRDRLRRDNT 405
              W    +  R N+
Sbjct: 322 KSPWKGEYKEPRGNS 336

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  156 bits (396), Expect = 3e-44
 Identities = 37/302 (12%), Positives = 90/302 (29%), Gaps = 40/302 (13%)

Query: 101 ESNKLIRSEDENGTKMINE-YVHVRKIGAGSYGKVVL-----YRSSLDGKHYAIKAFHKS 154
              KL   + +   ++ ++       +G G++ +V          + + + + +K    +
Sbjct: 47  WQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA 106

Query: 155 HLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG---- 210
           +  +  +           + +  +K       +           +   +V E        
Sbjct: 107 NPWEFYI---------GTQLMERLKPSMQHMFMKFYSAHLFQ--NGSVLVGELYSYGTLL 155

Query: 211 -KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA--------- 260
              +         + + +   +   ++  +  +H   ++HGDIKPDN ++          
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215

Query: 261 --PSGTVKIGDF--SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVT 316
              S  + + D   S+         +      T  F   E      +     D + V  T
Sbjct: 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAAT 274

Query: 317 LYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVA 376
           +Y M+ G Y  +     +   + +   L   D  N         +L       L   D+ 
Sbjct: 275 VYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWN----EFFHVMLNIPDCHHLPSLDLL 330

Query: 377 KH 378
           + 
Sbjct: 331 RQ 332

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  154 bits (391), Expect = 6e-44
 Identities = 70/258 (27%), Positives = 110/258 (42%), Gaps = 29/258 (11%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
            KIGAGS+G V  +R+   G   A+K   +              + +  REV IMK L+H
Sbjct: 43  EKIGAGSFGTV--HRAEWHGSDVAVKILMEQDFH-------AERVNEFLREVAIMKRLRH 93

Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG--------FGQPGAIGESMARKYLRDI 235
           PNIV  +  +  P   +  +V EY+       G         G    + E        D+
Sbjct: 94  PNIVLFMGAVTQP--PNLSIVTEYLSR-----GSLYRLLHKSGAREQLDERRRLSMAYDV 146

Query: 236 VSGLMYLHGHN--VVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
             G+ YLH  N  +VH ++K  NLLV    TVK+ DF +S++        + + GTP + 
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWM 206

Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL--VFPDAMN 351
           APE         K +D ++ GV L+ +   Q P+           +         P  +N
Sbjct: 207 APEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN 265

Query: 352 PELRNLLEGLLCKDPTRR 369
           P++  ++EG    +P +R
Sbjct: 266 PQVAAIIEGCWTNEPWKR 283

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  153 bits (388), Expect = 2e-43
 Identities = 76/306 (24%), Positives = 123/306 (40%), Gaps = 60/306 (19%)

Query: 116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           M+ +Y  + KIG GSYG V   R+   G+  AIK F +S      V     A+    RE+
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP--VIKK-IAL----REI 53

Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLR 233
            ++K L+HPN+VNL+EV         ++V EY +               + E + +    
Sbjct: 54  RMLKQLKHPNLVNLLEVF--RRKRRLHLVFEYCD--HTVLHELDRYQRGVPEHLVKSITW 109

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP--- 290
             +  + + H HN +H D+KP+N+L+     +K+ DF  +++           P      
Sbjct: 110 QTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL--------TGPSDYYDD 161

Query: 291 -VFT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN---- 341
            V T    +PE  +G T  G   D WA+G     ++ G   + G++  D    I      
Sbjct: 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGD 221

Query: 342 ---------------NSLVFPD------------AMNPELRNLLEGLLCKDPTRRLTLND 374
                          + +  PD             ++     LL+G L  DPT RLT   
Sbjct: 222 LIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQ 281

Query: 375 VAKHTW 380
           +  H +
Sbjct: 282 LLHHPY 287

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  153 bits (388), Expect = 3e-43
 Identities = 84/320 (26%), Positives = 143/320 (44%), Gaps = 60/320 (18%)

Query: 102 SNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV 161
           S+ +    +    + + +Y ++  +G GSYG V+  R+   G+  AIK F +S   K  +
Sbjct: 9   SSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK--M 66

Query: 162 APSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQ 219
                AM    RE+ ++K L+H N+VNL+EV        +Y+V E+V+            
Sbjct: 67  VKK-IAM----REIKLLKQLRHENLVNLLEVC--KKKKRWYLVFEFVD--HTILDDLELF 117

Query: 220 PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
           P  +   + +KYL  I++G+ + H HN++H DIKP+N+LV+ SG VK+ DF  ++     
Sbjct: 118 PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL--- 174

Query: 280 NDVLRRSPGTP----VFT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
                 +PG      V T    APE  +G    GKA D WA+G  +  M +G+  F G++
Sbjct: 175 -----AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229

Query: 332 LQDTYDKIVN-------------------NSLVFPD------------AMNPELRNLLEG 360
             D    I+                      +  P+             ++  + +L + 
Sbjct: 230 DIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKK 289

Query: 361 LLCKDPTRRLTLNDVAKHTW 380
            L  DP +R    ++  H +
Sbjct: 290 CLHIDPDKRPFCAELLHHDF 309

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  150 bits (380), Expect = 4e-42
 Identities = 76/315 (24%), Positives = 124/315 (39%), Gaps = 62/315 (19%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE----TAMTDVR 172
           +  Y+ + K+G G+Y  V   +S L     A+K        ++R+   E    TA+    
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALK--------EIRLEHEEGAPCTAI---- 48

Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARK 230
           REV ++K L+H NIV L ++I    S    +V EY++   D   +       I     + 
Sbjct: 49  REVSLLKDLKHANIVTLHDIIHTEKS--LTLVFEYLD--KDLKQYLDDCGNIINMHNVKL 104

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
           +L  ++ GL Y H   V+H D+KP NLL+   G +K+ DF +++                
Sbjct: 105 FLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-----DN 159

Query: 291 -VFT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN---- 341
            V T     P+  LG T      D W VG   Y M  G+  F G T+++    I      
Sbjct: 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGT 219

Query: 342 ---------------NSLVFPD-----------AMNPELRNLLEGLLCKDPTRRLTLNDV 375
                           +  +P             ++ +  +LL  LL  +   R++  D 
Sbjct: 220 PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA 279

Query: 376 AKHTWVLGDNGPIPQ 390
            KH + L     I +
Sbjct: 280 MKHPFFLSLGERIHK 294

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  149 bits (378), Expect = 5e-42
 Identities = 81/325 (24%), Positives = 134/325 (41%), Gaps = 68/325 (20%)

Query: 100 KESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLSK 158
              +     E+     ++ +Y  + K+G G+YG V  Y++    G+  A+K        +
Sbjct: 3   HHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVV--YKAKDSQGRIVALK--------R 52

Query: 159 LRV------APSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKW 212
           +R+       PS TA+    RE+ ++K L HPNIV+LI+VI         +V E++E   
Sbjct: 53  IRLDAEDEGIPS-TAI----REISLLKELHHPNIVSLIDVIHSERC--LTLVFEFME--K 103

Query: 213 DNDGF--GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF 270
           D           + +S  + YL  ++ G+ + H H ++H D+KP NLL+   G +K+ DF
Sbjct: 104 DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADF 163

Query: 271 SVSQVFEDDNDVLRRSPGTP-VFT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQY 325
            +++ F            T  V T    AP+  +G      + D W++G     MI G+ 
Sbjct: 164 GLARAFGIPVRSY-----THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218

Query: 326 PFLGETLQDTYDKIVN-------------------NSLVFPD-----------AMNPELR 355
            F G T  D   KI +                       F                 E  
Sbjct: 219 LFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGI 278

Query: 356 NLLEGLLCKDPTRRLTLNDVAKHTW 380
           +LL  +LC DP +R++  D   H +
Sbjct: 279 DLLSNMLCFDPNKRISARDAMNHPY 303

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  147 bits (374), Expect = 7e-42
 Identities = 44/259 (16%), Positives = 96/259 (37%), Gaps = 32/259 (12%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
            K+     G++  ++    G    +K       S            D   E   +++  H
Sbjct: 16  TKLNENHSGEL--WKGRWQGNDIVVKVLKVRDWS-------TRKSRDFNEECPRLRIFSH 66

Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG-------FGQPGAIGESMARKYLRDIV 236
           PN++ ++     P + H  ++  ++       G        G    + +S A K+  D+ 
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPY-----GSLYNVLHEGTNFVVDQSQAVKFALDMA 121

Query: 237 SGLMYLHGHN--VVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
            G+ +LH     +    +   ++++    T +I    V   F+    +       P + A
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM-----YAPAWVA 176

Query: 295 PECCLGLTYGG--KAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL--VFPDAM 350
           PE           ++AD W+  V L+ ++  + PF   +  +   K+    L    P  +
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGI 236

Query: 351 NPELRNLLEGLLCKDPTRR 369
           +P +  L++  + +DP +R
Sbjct: 237 SPHVSKLMKICMNEDPAKR 255

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  147 bits (373), Expect = 3e-41
 Identities = 72/315 (22%), Positives = 125/315 (39%), Gaps = 73/315 (23%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-----APSETAMTDV 171
            +++  + K+G G+Y  V    +   G + A+K        ++++      PS TA+   
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK--------EVKLDSEEGTPS-TAI--- 51

Query: 172 RREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWD-------NDGFGQPGAIG 224
            RE+ +MK L+H NIV L +VI   N     +V E+++   D             P  + 
Sbjct: 52  -REISLMKELKHENIVRLYDVIHTENK--LTLVFEFMD--NDLKKYMDSRTVGNTPRGLE 106

Query: 225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR 284
            ++ + +   ++ GL + H + ++H D+KP NLL+   G +K+GDF +++ F    +   
Sbjct: 107 LNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF- 165

Query: 285 RSPGTP-VFT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKI 339
               +  V T    AP+  +G      + D W+ G  L  MI G+  F G   ++    I
Sbjct: 166 ----SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

Query: 340 VN----------------------------NSL--VFPDAMNPEL----RNLLEGLLCKD 365
            +                              L  V        L     + L GLL  +
Sbjct: 222 FDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLN 281

Query: 366 PTRRLTLNDVAKHTW 380
           P  RL+      H W
Sbjct: 282 PDMRLSAKQALHHPW 296

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  148 bits (375), Expect = 3e-41
 Identities = 74/302 (24%), Positives = 125/302 (41%), Gaps = 54/302 (17%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREV 175
              Y  +  +G G +  V   R     +  AIK     H S+ +      TA+    RE+
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINR-TAL----REI 63

Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLR 233
            +++ L HPNI+ L++     +  +  +V +++E   D +         +  S  + Y+ 
Sbjct: 64  KLLQELSHPNIIGLLDAF--GHKSNISLVFDFME--TDLEVIIKDNSLVLTPSHIKAYML 119

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP-VF 292
             + GL YLH H ++H D+KP+NLL+  +G +K+ DF +++ F   N        T  V 
Sbjct: 120 MTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-----THQVV 174

Query: 293 T----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL-GETLQDTYDKI-------- 339
           T    APE   G    G   D WAVG  L  +++   PFL G++  D   +I        
Sbjct: 175 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPT 233

Query: 340 ---------------------VNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
                                +    +F  A   +L +L++GL   +P  R+T     K 
Sbjct: 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFS-AAGDDLLDLIQGLFLFNPCARITATQALKM 292

Query: 379 TW 380
            +
Sbjct: 293 KY 294

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  146 bits (370), Expect = 4e-41
 Identities = 70/308 (22%), Positives = 127/308 (41%), Gaps = 67/308 (21%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV------APSETAMTD 170
           + +Y  + KIG G+YG V   ++    +  A+K        ++R+       PS +A+  
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALK--------RVRLDDDDEGVPS-SAL-- 49

Query: 171 VRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMA 228
             RE+ ++K L+H NIV L +V+         +V E+ +   D   +     G +   + 
Sbjct: 50  --REICLLKELKHKNIVRLHDVLHSDKK--LTLVFEFCD--QDLKKYFDSCNGDLDPEIV 103

Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
           + +L  ++ GL + H  NV+H D+KP NLL+  +G +K+ +F +++ F            
Sbjct: 104 KSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY----- 158

Query: 289 TP-VFT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYP-FLGETLQDTYDKI--- 339
           +  V T     P+   G      + D W+ G     +     P F G  + D   +I   
Sbjct: 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218

Query: 340 -------------------------VNNSL--VFPDAMNPELRNLLEGLLCKDPTRRLTL 372
                                       SL  V P  +N   R+LL+ LL  +P +R++ 
Sbjct: 219 LGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVP-KLNATGRDLLQNLLKCNPVQRISA 277

Query: 373 NDVAKHTW 380
            +  +H +
Sbjct: 278 EEALQHPY 285

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  146 bits (371), Expect = 5e-41
 Identities = 66/271 (24%), Positives = 111/271 (40%), Gaps = 31/271 (11%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            E      +G G++G V   ++    K  AIK              SE+       E+  
Sbjct: 8   KEIEVEEVVGRGAFGVV--CKAKWRAKDVAIKQIE-----------SESERKAFIVELRQ 54

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK--WDN-DGFGQPGAIGESMARKYLRD 234
           +  + HPNIV L     +P      +V+EY EG   ++   G         + A  +   
Sbjct: 55  LSRVNHPNIVKLYGACLNP----VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 110

Query: 235 IVSGLMYLHGHN---VVHGDIKPDNLLVAPSGTV-KIGDFSVSQVFEDDNDVLRRSPGTP 290
              G+ YLH      ++H D+KP NLL+   GTV KI DF  +    D    +  + G+ 
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTNNKGSA 167

Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF--LGETLQDTYDKIVNNS-LVFP 347
            + APE   G  Y  K  D ++ G+ L+ +I  + PF  +G         + N +     
Sbjct: 168 AWMAPEVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI 226

Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
             +   + +L+     KDP++R ++ ++ K 
Sbjct: 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  145 bits (368), Expect = 1e-40
 Identities = 81/324 (25%), Positives = 127/324 (39%), Gaps = 65/324 (20%)

Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
           G+   + Y  V +IG G+YG V   R    G   A+K      +           ++ VR
Sbjct: 4   GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK---SVRVPNGGGGGGGLPISTVR 60

Query: 173 REVLIMKMLQ---HPNIVNLIEVIDDPNSDH---FYMVLEYVEG--KWDNDGFGQPGAIG 224
            EV +++ L+   HPN+V L++V     +D      +V E+V+   +   D    PG + 
Sbjct: 61  -EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LP 118

Query: 225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR 284
               +  +R  + GL +LH + +VH D+KP+N+LV   GTVK+ DF            L 
Sbjct: 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG-----------LA 167

Query: 285 RSPGTP------VFT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQD 334
           R           V T    APE  L  TY     D W+VG     M   +  F G +  D
Sbjct: 168 RIYSYQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 226

Query: 335 TYDKIVN--------------------------NSL--VFPDAMNPELRNLLEGLLCKDP 366
              KI +                            +  V P  M      LL  +L  +P
Sbjct: 227 QLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVP-EMEESGAQLLLEMLTFNP 285

Query: 367 TRRLTLNDVAKHTWVLGDNGPIPQ 390
            +R++     +H++ L  +   P+
Sbjct: 286 HKRISAFRALQHSY-LHKDEGNPE 308

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  143 bits (363), Expect = 2e-40
 Identities = 65/263 (24%), Positives = 104/263 (39%), Gaps = 34/263 (12%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
             IG G +GKV  YR+   G   A+KA                 + +VR+E  +  ML+H
Sbjct: 13  EIIGIGGFGKV--YRAFWIGDEVAVKAARHDPDE-----DISQTIENVRQEAKLFAMLKH 65

Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG----FGQPGAIGESMARKYLRDIVSGL 239
           PNI+ L  V       +  +V+E+  G     G          I   +   +   I  G+
Sbjct: 66  PNIIALRGVCLKE--PNLCLVMEFARG-----GPLNRVLSGKRIPPDILVNWAVQIARGM 118

Query: 240 MYLHGHN---VVHGDIKPDNLLV--------APSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
            YLH      ++H D+K  N+L+          +  +KI DF +++ +         + G
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAAG 176

Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG-ETLQDTYDKIVNNS-LVF 346
              + APE      +    +D W+ GV L+ ++ G+ PF G + L   Y   +N   L  
Sbjct: 177 AYAWMAPEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235

Query: 347 PDAMNPELRNLLEGLLCKDPTRR 369
           P         L+E     DP  R
Sbjct: 236 PSTCPEPFAKLMEDCWNPDPHSR 258

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  145 bits (367), Expect = 3e-40
 Identities = 70/315 (22%), Positives = 128/315 (40%), Gaps = 69/315 (21%)

Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV------APSET 166
               I+ Y  + K+G G+YG+V     ++  +  AIK        ++R+       P  T
Sbjct: 29  SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK--------RIRLEHEEEGVPG-T 79

Query: 167 AMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGE 225
           A+    REV ++K LQH NI+ L  VI   +    +++ EY E   D   +  +   +  
Sbjct: 80  AI----REVSLLKELQHRNIIELKSVIHHNHR--LHLIFEYAE--NDLKKYMDKNPDVSM 131

Query: 226 SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV-----APSGTVKIGDFSVSQVFEDDN 280
            + + +L  +++G+ + H    +H D+KP NLL+     + +  +KIGDF +++ F    
Sbjct: 132 RVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191

Query: 281 DVLRRSPGTP-VFT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDT 335
                   T  + T     PE  LG  +   + D W++      M++    F G++  D 
Sbjct: 192 RQF-----THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ 246

Query: 336 YDKI------------------------------VNNSLVFPDAMNPELRNLLEGLLCKD 365
             KI                                   V    ++ E  +LL  +L  D
Sbjct: 247 LFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMD 306

Query: 366 PTRRLTLNDVAKHTW 380
           P +R++  +  +H +
Sbjct: 307 PVKRISAKNALEHPY 321

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  144 bits (365), Expect = 4e-40
 Identities = 53/333 (15%), Positives = 107/333 (32%), Gaps = 74/333 (22%)

Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSH--------------LSKLR 160
           + + ++  ++ +G G +G V   ++ +D  +YAIK     +              L+KL 
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 161 -----------------------------------VAPSETAMTDVRREVLIMKMLQHPN 185
                                                 S + M     ++  M      N
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122

Query: 186 IVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
            V  ++        + Y+ ++         W N            +       I   + +
Sbjct: 123 TVGQLQP--SSPKVYLYIQMQLCRKENLKDWMNRRCSLE-DREHGVCLHIFIQIAEAVEF 179

Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP------------GT 289
           LH   ++H D+KP N+       VK+GDF +    + D +                  GT
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239

Query: 290 PVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL-GETLQDTYDKIVNNSL-VFP 347
            ++ +PE   G  Y  K  D +++G+ L+ ++   Y F            + N    +  
Sbjct: 240 KLYMSPEQIHGNNYSHK-VDIFSLGLILFELL---YSFSTQMERVRIITDVRNLKFPLLF 295

Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
               P+   +++ +L   PT R    D+ ++  
Sbjct: 296 TQKYPQEHMMVQDMLSPSPTERPEATDIIENAI 328

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  142 bits (360), Expect = 1e-39
 Identities = 75/308 (24%), Positives = 125/308 (40%), Gaps = 69/308 (22%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLSKLRV------APSETAMT 169
           + +Y  + KIG G+YG V  Y++ +  G+ +A+K        K+R+       PS T + 
Sbjct: 1   MEKYHGLEKIGEGTYGVV--YKAQNNYGETFALK--------KIRLEKEDEGIPS-TTI- 48

Query: 170 DVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESM 227
              RE+ I+K L+H NIV L +VI         +V E+++   D         G +    
Sbjct: 49  ---REISILKELKHSNIVKLYDVIHTKKR--LVLVFEHLD--QDLKKLLDVCEGGLESVT 101

Query: 228 ARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP 287
           A+ +L  +++G+ Y H   V+H D+KP NLL+   G +KI DF +++ F           
Sbjct: 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY---- 157

Query: 288 GTP-VFT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN- 341
            T  + T    AP+  +G        D W+VG     M+ G   F G +  D   +I   
Sbjct: 158 -THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216

Query: 342 ---------------------------NSL--VFPDAMNPELRNLLEGLLCKDPTRRLTL 372
                                                ++    +LL  +L  DP +R+T 
Sbjct: 217 LGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLK-GLDESGIDLLSKMLKLDPNQRITA 275

Query: 373 NDVAKHTW 380
               +H +
Sbjct: 276 KQALEHAY 283

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  143 bits (362), Expect = 1e-39
 Identities = 65/330 (19%), Positives = 130/330 (39%), Gaps = 42/330 (12%)

Query: 101 ESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR 160
           +    +    +     IN+  ++ ++G+G+ G+V   R    G   A+K        ++R
Sbjct: 8   KQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVK--------QMR 59

Query: 161 VAPSETAMTDVRREVLI-MKMLQHPNIVN-----LIEVIDDPNSDHFYMVLEYVEGKWDN 214
            + ++     +  ++ + +K    P IV      +            ++ +E +    + 
Sbjct: 60  RSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-------TDVFIAMELMGTCAEK 112

Query: 215 DGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
                 G I E +  K    IV  L YL   H V+H D+KP N+L+   G +K+ DF +S
Sbjct: 113 LKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172

Query: 274 QVFED----DNDVLRRSPGTPVFTAPE-----CCLGLTYGGKAADTWAVGVTLYYMIIGQ 324
               D    D        G   + APE           Y  + AD W++G++L  +  GQ
Sbjct: 173 GRLVDDKAKDRSA-----GCAAYMAPERIDPPDPTKPDYDIR-ADVWSLGISLVELATGQ 226

Query: 325 YPFLG-ETLQDTYDKIVNN---SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
           +P+   +T  +   K++      L      + + ++ ++  L KD  +R   N + +H++
Sbjct: 227 FPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286

Query: 381 VLGDNGPIPQYLCWCKRDRLRRDNTTQDSN 410
           +            W K D + +  + +   
Sbjct: 287 IKRYETLEVDVASWFK-DVMAKTESPRSGP 315

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  144 bits (366), Expect = 2e-39
 Identities = 87/382 (22%), Positives = 145/382 (37%), Gaps = 86/382 (22%)

Query: 95  RQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKV--VLYRSSLDGKHYAIKAFH 152
             F VK S++  R ED    +         K+G G+YG V     +   D K YA+K   
Sbjct: 5   YDFKVKLSSERERVEDL--FEYEGC-----KVGRGTYGHVYKAKRKDGKDDKDYALKQIE 57

Query: 153 KSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE--- 209
            + +S        +A     RE+ +++ L+HPN+++L +V         +++ +Y E   
Sbjct: 58  GTGIS-------MSAC----REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDL 106

Query: 210 -----GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-- 262
                    +    +P  +   M +  L  I+ G+ YLH + V+H D+KP N+LV     
Sbjct: 107 WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGP 166

Query: 263 --GTVKIGDFSVSQVFEDDNDVLRRSPGTP-VFT----APECCLGLTYGGKAADTWAVGV 315
             G VKI D   +++F      L  +   P V T    APE  LG  +  KA D WA+G 
Sbjct: 167 ERGRVKIADMGFARLFNSPLKPL--ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC 224

Query: 316 TLYYMIIGQYPFLGET---------LQDTYDKIVN-------------NSL-----VFPD 348
               ++  +  F               D  D+I N               +     +  D
Sbjct: 225 IFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKD 284

Query: 349 --------------------AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI 388
                                 + +  +LL+ LL  DP +R+T     +  + L D  P 
Sbjct: 285 FRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPT 344

Query: 389 PQYLCWCKRDRLRRDNTTQDSN 410
                 C+    +R+  T++  
Sbjct: 345 SDVFAGCQIPYPKREFLTEEEP 366

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  140 bits (356), Expect = 6e-39
 Identities = 72/290 (24%), Positives = 121/290 (41%), Gaps = 39/290 (13%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           ++Y     IG+G+   V     +   +  AIK        ++ +   +T+M ++ +E+  
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIK--------RINLEKCQTSMDELLKEIQA 66

Query: 178 MKMLQHPNIVNLIE--VIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESM 227
           M    HPNIV+     V+ D      ++V++ + G             G  + G + ES 
Sbjct: 67  MSQCHHPNIVSYYTSFVVKD----ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122

Query: 228 ARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP 287
               LR+++ GL YLH +  +H D+K  N+L+   G+V+I DF VS       D+ R   
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182

Query: 288 -----GTPVFTAPECCL-GLTYGGKAADTWAVGVTLYYMIIGQYPFLGE--------TLQ 333
                GTP + APE       Y  K AD W+ G+T   +  G  P+           TLQ
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ 241

Query: 334 DTYDKIVNNSLVFPDAMN--PELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           +    +                 R ++   L KDP +R T  ++ +H + 
Sbjct: 242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  140 bits (354), Expect = 8e-39
 Identities = 54/264 (20%), Positives = 100/264 (37%), Gaps = 38/264 (14%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
           ++IG+GS+G V  Y+    G   A+K  + +        P+   +   + EV +++  +H
Sbjct: 30  QRIGSGSFGTV--YKGKWHG-DVAVKMLNVTA-------PTPQQLQAFKNEVGVLRKTRH 79

Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG--------QPGAIGESMARKYLRDI 235
            NI+  +     P      +V ++ EG                              R  
Sbjct: 80  VNILLFMGYSTAP---QLAIVTQWCEG-------SSLYHHLHASETKFEMKKLIDIARQT 129

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED--DNDVLRRSPGTPVFT 293
             G+ YLH  +++H D+K +N+ +    TVKIGDF ++        +    +  G+ ++ 
Sbjct: 130 ARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189

Query: 294 APECCLGLTYG--GKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKIVNNSL-----V 345
           APE             +D +A G+ LY ++ GQ P+          + +   SL      
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249

Query: 346 FPDAMNPELRNLLEGLLCKDPTRR 369
                   ++ L+   L K    R
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDER 273

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  139 bits (353), Expect = 1e-38
 Identities = 77/271 (28%), Positives = 127/271 (46%), Gaps = 28/271 (10%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y    KIG G+ G V        G+  AI+         L+  P +     +  E+L+M+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQM------NLQQQPKKE---LIINEILVMR 72

Query: 180 MLQHPNIVNLIE--VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
             ++PNIVN ++  ++ D      ++V+EY+ G    D       + E       R+ + 
Sbjct: 73  ENKNPNIVNYLDSYLVGD----ELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQ 127

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSP--GTPVFTA 294
            L +LH + V+H DIK DN+L+   G+VK+ DF    Q+     +  +RS   GTP + A
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMA 184

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKIVNN---SLVFPDAM 350
           PE      YG K  D W++G+    MI G+ P+L E  L+  Y  I  N    L  P+ +
Sbjct: 185 PEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPEKL 242

Query: 351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           +   R+ L   L  D  +R +  ++ +H ++
Sbjct: 243 SAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  140 bits (355), Expect = 1e-38
 Identities = 71/337 (21%), Positives = 131/337 (38%), Gaps = 50/337 (14%)

Query: 99  VKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSK 158
           ++ S KL  S +++      +   + +IG G+YG V        G+  A+K        +
Sbjct: 3   IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVK--------R 54

Query: 159 LRVAPSETAMTDVRREVLI-MKMLQHPNIVNLIEVIDDPNSDHFY----------MVLEY 207
           +R    E     +  ++ + M+    P IV             FY          + +E 
Sbjct: 55  IRSTVDEKEQKQLLMDLDVVMRSSDCPYIV------------QFYGALFREGDCWICMEL 102

Query: 208 VEGKWDND----GFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPS 262
           +   +D             I E +  K     V  L +L     ++H DIKP N+L+  S
Sbjct: 103 MSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS 162

Query: 263 GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE----CCLGLTYGGKAADTWAVGVTLY 318
           G +K+ DF +S    D      R  G   + APE          Y  + +D W++G+TLY
Sbjct: 163 GNIKLCDFGISGQLVDSIA-KTRDAGCRPYMAPERIDPSASRQGYDVR-SDVWSLGITLY 220

Query: 319 YMIIGQYPFLG-ETLQDTYDKIVNN---SLVFPDAMN--PELRNLLEGLLCKDPTRRLTL 372
            +  G++P+    ++ D   ++V      L   +     P   N +   L KD ++R   
Sbjct: 221 ELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKY 280

Query: 373 NDVAKHTWVLGDNGPIPQYLCWCKR--DRLRRDNTTQ 407
            ++ KH ++L       +  C+  +  D++    ++ 
Sbjct: 281 KELLKHPFILMYEERAVEVACYVCKILDQMPATPSSP 317

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  146 bits (369), Expect = 2e-38
 Identities = 58/265 (21%), Positives = 99/265 (37%), Gaps = 31/265 (11%)

Query: 111 ENGTKMINEYVHVRKIGAGSYGKVVLYR---SSLDGKHYAIKAFHKSHLSKLRVAPSETA 167
             G  +  +Y     I  G  G +  Y     +++G+   +K         L  +    A
Sbjct: 73  NPGDIVAGQYEVKGCIAHGGLGWI--YLALDRNVNGRPVVLKG--------LVHSGDAEA 122

Query: 168 MTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIG 224
                 E   +  + HP+IV +   ++  +       Y+V+EYV G+      GQ   + 
Sbjct: 123 QAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVA 182

Query: 225 ESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR 284
           E++A  YL +I+  L YLH   +V+ D+KP+N+++     +K+ D            +  
Sbjct: 183 EAIA--YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYLY- 238

Query: 285 RSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL 344
              GTP F APE          A D + VG TL  + +      G  +    +       
Sbjct: 239 ---GTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDP---- 289

Query: 345 VFPDAMNPELRNLLEGLLCKDPTRR 369
                       LL   +  DP +R
Sbjct: 290 --VLKTYDSYGRLLRRAIDPDPRQR 312

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  140 bits (355), Expect = 2e-38
 Identities = 71/317 (22%), Positives = 124/317 (39%), Gaps = 71/317 (22%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV------APSETAMTD 170
           +++Y  + KIG G++G+V   R    G+  A+K        K+ +       P  TA+  
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK--------KVLMENEKEGFPI-TAL-- 64

Query: 171 VRREVLIMKMLQHPNIVNLIEVIDDPNSDH------FYMVLEYVE----GKWDNDGFGQP 220
             RE+ I+++L+H N+VNLIE+     S +       Y+V ++ E    G   N      
Sbjct: 65  --REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VL 118

Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN 280
                S  ++ ++ +++GL Y+H + ++H D+K  N+L+   G +K+ DF +++ F    
Sbjct: 119 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178

Query: 281 DVLRRSPGTP-VFT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDT 335
           +       T  V T     PE  LG    G   D W  G  +  M        G T Q  
Sbjct: 179 NSQPN-RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 237

Query: 336 YDKIVN-----------------------------NSL--VFPDAMNPEL-RNLLEGLLC 363
              I                                 +       +      +L++ LL 
Sbjct: 238 LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLV 297

Query: 364 KDPTRRLTLNDVAKHTW 380
            DP +R+  +D   H +
Sbjct: 298 LDPAQRIDSDDALNHDF 314

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  139 bits (353), Expect = 2e-38
 Identities = 72/271 (26%), Positives = 125/271 (46%), Gaps = 28/271 (10%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
                KIG GS G V L R    G+  A+K         LR          +  EV+IM+
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM------DLRKQQRRE---LLFNEVVIMR 97

Query: 180 MLQHPNIVNLIE--VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
             QH N+V + +  ++ +      ++++E+++G    D       + E         ++ 
Sbjct: 98  DYQHFNVVEMYKSYLVGE----ELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQ 152

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSP--GTPVFTA 294
            L YLH   V+H DIK D++L+   G VK+ DF    Q+     DV +R    GTP + A
Sbjct: 153 ALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMA 209

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKIVNN---SLVFPDAM 350
           PE      Y  +  D W++G+ +  M+ G+ P+  ++ +Q    ++ ++    L     +
Sbjct: 210 PEVISRSLYATE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRDSPPPKLKNSHKV 267

Query: 351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           +P LR+ LE +L +DP  R T  ++  H ++
Sbjct: 268 SPVLRDFLERMLVRDPQERATAQELLDHPFL 298

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  139 bits (353), Expect = 3e-38
 Identities = 78/337 (23%), Positives = 128/337 (37%), Gaps = 84/337 (24%)

Query: 109 EDENGTKMINEYVHVRKIGAGSYGKVVLYR---SSLDGKHYAIKAFHKSHLSKLRV---- 161
           E +   +   +Y  V +IG G+YGKV  ++       G+  A+K        ++RV    
Sbjct: 2   EKDGLCRADQQYECVAEIGEGAYGKV--FKARDLKNGGRFVALK--------RVRVQTGE 51

Query: 162 --APSETAMTDVRREVLIMKMLQ---HPNIVNLIEVIDDPNSDH---FYMVLEYVEG--K 211
              P  + +    REV +++ L+   HPN+V L +V     +D      +V E+V+    
Sbjct: 52  EGMPL-STI----REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT 106

Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
              D   +PG +     +  +  ++ GL +LH H VVH D+KP N+LV  SG +K+ DF 
Sbjct: 107 TYLDKVPEPG-VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 165

Query: 272 VSQVFEDDNDVLRRSPGTP------VFT----APECCLGLTYGGKAADTWAVGVTLYYMI 321
                      L R           V T    APE  L  +Y     D W+VG     M 
Sbjct: 166 -----------LARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT-PVDLWSVGCIFAEMF 213

Query: 322 IGQYPFLGETLQDTYDKIVN--------------------------NSL--VFPDAMNPE 353
             +  F G +  D   KI++                            +     D ++  
Sbjct: 214 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD-IDEL 272

Query: 354 LRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
            ++LL   L  +P +R++      H +          
Sbjct: 273 GKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKEN 309

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  137 bits (347), Expect = 1e-37
 Identities = 55/278 (19%), Positives = 100/278 (35%), Gaps = 43/278 (15%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
             IG G +G+V  Y     G+  AI+              +E  +   +REV+  +  +H
Sbjct: 39  ELIGKGRFGQV--YHGRWHGE-VAIRLIDIER-------DNEDQLKAFKREVMAYRQTRH 88

Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG--------QPGAIGESMARKYLRDI 235
            N+V  +     P   H  ++    +G                    +  +  R+  ++I
Sbjct: 89  ENVVLFMGACMSP--PHLAIITSLCKG-------RTLYSVVRDAKIVLDVNKTRQIAQEI 139

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE-----DDNDVLRRSPGTP 290
           V G+ YLH   ++H D+K  N+    +G V I DF +  +          D LR   G  
Sbjct: 140 VKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198

Query: 291 VFTAPECCLGLTYGG--------KAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN 342
              APE    L+           K +D +A+G   Y +   ++PF  +  +    ++   
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258

Query: 343 S--LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
               +    M  E+ ++L      +   R T   +   
Sbjct: 259 MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  135 bits (341), Expect = 6e-37
 Identities = 72/278 (25%), Positives = 116/278 (41%), Gaps = 42/278 (15%)

Query: 124 RKIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           ++IG G +G V  ++  L  D    AIK+              +    + +REV IM  L
Sbjct: 25  KQIGKGGFGLV--HKGRLVKDKSVVAIKSLILGDSEGETEMIEK--FQEFQREVFIMSNL 80

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG------FGQPGAIGESMARKYLRDI 235
            HPNIV L  ++ +P      MV+E+V       G        +   I  S+  + + DI
Sbjct: 81  NHPNIVKLYGLMHNP----PRMVMEFVPC-----GDLYHRLLDKAHPIKWSVKLRLMLDI 131

Query: 236 VSGLMYLHGHN--VVHGDIKPDNLLVAPSG-----TVKIGDFSVSQVFEDDNDVLRRSPG 288
             G+ Y+   N  +VH D++  N+ +           K+ DF +SQ        +    G
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---SVHSVSGLLG 188

Query: 289 TPVFTAPECCLG--LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQD--TYDKIVNNSL 344
              + APE       +Y  K ADT++  + LY ++ G+ PF   +       + I    L
Sbjct: 189 NFQWMAPETIGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247

Query: 345 --VFPDAMNPELRNLLEGLLC--KDPTRRLTLNDVAKH 378
               P+   P LRN++E  LC   DP +R   + + K 
Sbjct: 248 RPTIPEDCPPRLRNVIE--LCWSGDPKKRPHFSYIVKE 283

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  135 bits (342), Expect = 6e-37
 Identities = 73/300 (24%), Positives = 134/300 (44%), Gaps = 34/300 (11%)

Query: 98  PVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLS 157
           PV+     +++   +  ++   +  + KIG GS+G+V     +   K  AIK        
Sbjct: 5   PVQSGLPGMQNLKADPEEL---FTKLEKIGKGSFGEVFKGIDNRTQKVVAIK-------- 53

Query: 158 KLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF 217
            + +  +E  + D+++E+ ++     P +               ++++EY+ G       
Sbjct: 54  IIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL--KDTKLWIIMEYLGG------- 104

Query: 218 G------QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
           G      +PG + E+     LR+I+ GL YLH    +H DIK  N+L++  G VK+ DF 
Sbjct: 105 GSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFG 164

Query: 272 VS-QVFEDDNDVLRRSP--GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL 328
           V+ Q+    +  ++R+   GTP + APE      Y  K AD W++G+T   +  G+ P  
Sbjct: 165 VAGQLT---DTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHS 220

Query: 329 GETLQDTYDKIVNNSL-VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
                     I  N+        +  L+  +E  L K+P+ R T  ++ KH ++L +   
Sbjct: 221 ELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK 280

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  136 bits (343), Expect = 1e-36
 Identities = 74/295 (25%), Positives = 115/295 (38%), Gaps = 20/295 (6%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +  +R+IG GS+G V   R   + +  AIK              S     D+ +EV  ++
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKM------SYSGKQSNEKWQDIIKEVRFLQ 109

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
            L+HPN +              ++V+EY  G   +        + E          + GL
Sbjct: 110 KLRHPNTIQYRGCYL--REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE--- 296
            YLH HN++H D+K  N+L++  G VK+GDF  + +    N  +    GTP + APE   
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV----GTPYWMAPEVIL 223

Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFPDAMNPEL 354
                 Y GK  D W++G+T   +   + P            I  N    +     +   
Sbjct: 224 AMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 282

Query: 355 RNLLEGLLCKDPTRRLTLNDVAKHTWVL--GDNGPIPQYLCWCKRDRLRRDNTTQ 407
           RN ++  L K P  R T   + KH +VL       I   +   K      DN   
Sbjct: 283 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQY 337

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  134 bits (339), Expect = 2e-36
 Identities = 69/297 (23%), Positives = 123/297 (41%), Gaps = 24/297 (8%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +  + K+G GSYG V        G+  AIK             P E+ + ++ +E+ IM+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIK-----------QVPVESDLQEIIKEISIMQ 79

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDND-GFGQPGAIGESMARKYLRDIVSG 238
               P++V          +   ++V+EY      +D    +   + E      L+  + G
Sbjct: 80  QCDSPHVVKYYGSYF--KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKG 137

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--GTPVFTAPE 296
           L YLH    +H DIK  N+L+   G  K+ DF V+   +  + + +R+   GTP + APE
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDTMAKRNTVIGTPFWMAPE 195

Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDAMNPE 353
               + Y    AD W++G+T   M  G+ P+           I  N   +   P+  +  
Sbjct: 196 VIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDN 254

Query: 354 LRNLLEGLLCKDPTRRLTLNDVAKHTWV--LGDNGPIPQYLCWCKRDRLRRDNTTQD 408
             + ++  L K P +R T   + +H +V        +   +      +L+R  + Q 
Sbjct: 255 FTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDVKLKRQESQQR 311

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  133 bits (337), Expect = 3e-36
 Identities = 59/281 (20%), Positives = 103/281 (36%), Gaps = 52/281 (18%)

Query: 118 NEYVHVRKIGAGSYGKV--VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
           ++ +H   +G G +G+   V +R +  G+   +K   +           E       +EV
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRET--GEVMVMKELIR---------FDEETQRTFLKEV 58

Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFG--------QPGAIGESM 227
            +M+ L+HPN++  I V+          + EY++G       G               S 
Sbjct: 59  KVMRCLEHPNVLKFIGVLYKD--KRLNFITEYIKG-------GTLRGIIKSMDSQYPWSQ 109

Query: 228 ARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP 287
              + +DI SG+ YLH  N++H D+   N LV  +  V + DF ++++  D+        
Sbjct: 110 RVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169

Query: 288 --------------GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-L 332
                         G P + APE   G +Y  K  D ++ G+ L  +I            
Sbjct: 170 SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPR 228

Query: 333 QDTYDKIVNNS--LVFPDAMNPELRNLLEGLLC--KDPTRR 369
              +   V        P    P    +   + C   DP +R
Sbjct: 229 TMDFGLNVRGFLDRYCPPNCPPSFFPIT--VRCCDLDPEKR 267

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  134 bits (339), Expect = 5e-36
 Identities = 69/354 (19%), Positives = 125/354 (35%), Gaps = 80/354 (22%)

Query: 100 KESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKL 159
           K     +  + + G    +++  + ++GAG+ G V        G   A K         +
Sbjct: 15  KRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARK--------LI 66

Query: 160 RVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFY----------MVLEYVE 209
            +         + RE+ ++     P IV             FY          + +E+++
Sbjct: 67  HLEIKPAIRNQIIRELQVLHECNSPYIV------------GFYGAFYSDGEISICMEHMD 114

Query: 210 GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIG 268
           G   +    + G I E +  K    ++ GL YL   H ++H D+KP N+LV   G +K+ 
Sbjct: 115 GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 174

Query: 269 DFSVSQVFEDDNDVLRRS-PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
           DF VS    D    +  S  GT  + +PE   G  Y  + +D W++G++L  M +G+YP 
Sbjct: 175 DFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPI 230

Query: 328 LGETLQDTY------------------------------------------DKIVNNS-- 343
                ++                                            D IVN    
Sbjct: 231 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP 290

Query: 344 LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKR 397
            +     + E ++ +   L K+P  R  L  +  H ++   +     +  W   
Sbjct: 291 KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCS 344

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  133 bits (338), Expect = 2e-35
 Identities = 80/334 (23%), Positives = 133/334 (39%), Gaps = 71/334 (21%)

Query: 95  RQFPVKESNKLIR---SEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAF 151
           +  P+ + NK+I+   S+ + G +    Y + + IG GS+G V   +     +  AIK  
Sbjct: 14  KLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIK-- 70

Query: 152 HKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI----DDPNSDHFYMVLEY 207
                 K+             RE+ IM++++HPN+V+L        D  +     +VLEY
Sbjct: 71  ------KVLQDKRFKN-----RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119

Query: 208 VEG---KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SG 263
           V     +           +   + + Y+  ++  L Y+H   + H DIKP NLL+ P SG
Sbjct: 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG 179

Query: 264 TVKIGDFSVSQVFEDDNDVLRRSPGTP----VFT----APECCLGLTYGGKAADTWAVGV 315
            +K+ DF  +++            G P    + +    APE   G T      D W+ G 
Sbjct: 180 VLKLIDFGSAKIL---------IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGC 230

Query: 316 TLYYMIIGQYPFLGETLQDTYDKI--------------VNN---------------SLVF 346
            +  ++ GQ  F GE+  D   +I              +N                S VF
Sbjct: 231 VMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVF 290

Query: 347 PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
                P+  +L+  LL   P+ RLT  +   H +
Sbjct: 291 RPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  132 bits (334), Expect = 7e-35
 Identities = 72/304 (23%), Positives = 109/304 (35%), Gaps = 67/304 (22%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y   + IG GS+G V   +    G+  AIK        K+             RE+ IM+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--------KVLQDKRFKN-----RELQIMR 102

Query: 180 MLQHPNIVNLIEVI----DDPNSDHFYMVLEYVEG---KWDNDGFGQPGAIGESMARKYL 232
            L H NIV L        +  +  +  +VL+YV     +           +     + Y+
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 162

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDFSVSQVFEDDNDVLRRSPGTP- 290
             +   L Y+H   + H DIKP NLL+ P +  +K+ DF  ++             G P 
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---------VRGEPN 213

Query: 291 ---VFT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKI---- 339
              + +    APE   G T    + D W+ G  L  +++GQ  F G++  D   +I    
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 273

Query: 340 -------------------------VNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLND 374
                                       + VF     PE   L   LL   PT RLT  +
Sbjct: 274 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 333

Query: 375 VAKH 378
              H
Sbjct: 334 ACAH 337

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  129 bits (326), Expect = 1e-34
 Identities = 72/314 (22%), Positives = 131/314 (41%), Gaps = 32/314 (10%)

Query: 100 KESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKL 159
           +E   + R  D N       +  V ++G G++GKV   ++   G   A K          
Sbjct: 6   REYEHVRRDLDPNEV-----WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK----- 55

Query: 160 RVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDND-GFG 218
               SE  + D   E+ I+    HP IV L+      +    ++++E+  G   +     
Sbjct: 56  ----SEEELEDYIVEIEILATCDHPYIVKLLGAYY--HDGKLWIMIEFCPGGAVDAIMLE 109

Query: 219 QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED 278
               + E   +   R ++  L +LH   ++H D+K  N+L+   G +++ DF VS   ++
Sbjct: 110 LDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA--KN 167

Query: 279 DNDVLRRSP--GTPVFTAPE-----CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET 331
              + +R    GTP + APE           Y  K AD W++G+TL  M   + P     
Sbjct: 168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHELN 226

Query: 332 LQDTYDKIVNN---SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV--LGDNG 386
                 KI  +   +L+ P   + E R+ L+  L K+P  R +   + +H +V  +  N 
Sbjct: 227 PMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286

Query: 387 PIPQYLCWCKRDRL 400
            + + +   K + +
Sbjct: 287 ALRELVAEAKAEVM 300

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  127 bits (321), Expect = 4e-34
 Identities = 63/297 (21%), Positives = 115/297 (38%), Gaps = 34/297 (11%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           ++   + ++G G+YG V   R    G+  A+K        ++R   +      +  ++ I
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVK--------RIRATVNSQEQKRLLMDLDI 58

Query: 178 -MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDN---DGFGQPGAIGESMARKYLR 233
            M+ +  P  V     +        ++ +E ++   D        +   I E +  K   
Sbjct: 59  SMRTVDCPFTVTFYGALFREG--DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAV 116

Query: 234 DIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED----DNDVLRRSPG 288
            IV  L +LH   +V+H D+KP N+L+   G VK+ DF +S    D    D D      G
Sbjct: 117 SIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-----G 171

Query: 289 TPVFTAPE----CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG-ETLQDTYDKIVNN- 342
              + APE          Y  K +D W++G+T+  + I ++P+    T      ++V   
Sbjct: 172 CKPYMAPERINPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP 230

Query: 343 --SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKR 397
              L   D  + E  +     L K+   R T  ++ +H +             + K 
Sbjct: 231 SPQLP-ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDVASFVKL 286

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  127 bits (322), Expect = 1e-33
 Identities = 73/304 (24%), Positives = 114/304 (37%), Gaps = 55/304 (18%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLD--GKHYAIKAFHKSHLSKLRVAPSETAMTDVR--REV 175
           Y   R I +GSYG V    + +D  G   AIK    +      V     +    R  RE+
Sbjct: 24  YTVQRFISSGSYGAVC---AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
            ++    HPNI+ L ++            Y+V E +          Q   I     + ++
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP-V 291
             I+ GL  LH   VVH D+ P N+L+A +  + I DF++++    D +       T  V
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK------THYV 194

Query: 292 FT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN------ 341
                 APE  +      K  D W+ G  +  M   +  F G T  +  +KIV       
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254

Query: 342 -----------------NSL----------VFPDAMNPELRNLLEGLLCKDPTRRLTLND 374
                            NSL          V P A +P   +L+  +L  +P RR++   
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTA-DPVALDLIAKMLEFNPQRRISTEQ 313

Query: 375 VAKH 378
             +H
Sbjct: 314 ALRH 317

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  126 bits (318), Expect = 2e-33
 Identities = 62/272 (22%), Positives = 119/272 (43%), Gaps = 18/272 (6%)

Query: 108 SEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETA 167
           S     + + + Y     +G G   +V L R   D +  A+K    + L++       + 
Sbjct: 2   SHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLAR-----DPSF 55

Query: 168 MTDVRREVLIMKMLQHPNIVNLIEV--IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGE 225
               RRE      L HP IV + +    + P     Y+V+EYV+G    D     G +  
Sbjct: 56  YLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115

Query: 226 SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRR 285
             A + + D    L + H + ++H D+KP N++++ +  VK+ DF +++   D  + + +
Sbjct: 116 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175

Query: 286 SP---GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-----LQDTYD 337
           +    GT  + +PE   G       +D +++G  LY ++ G+ PF G++      Q   +
Sbjct: 176 TAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 234

Query: 338 KIVNNSLVFPDAMNPELRNLLEGLLCKDPTRR 369
             +  S      ++ +L  ++   L K+P  R
Sbjct: 235 DPIPPSARHEG-LSADLDAVVLKALAKNPENR 265

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  125 bits (316), Expect = 2e-33
 Identities = 74/267 (27%), Positives = 120/267 (44%), Gaps = 23/267 (8%)

Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
           G  +   Y  V K+G G    V L   ++     AIKA              E  +    
Sbjct: 6   GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIF-IPP-----REKEETLKRFE 59

Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           REV     L H NIV++I+V ++   D +Y+V+EY+EG   ++     G +    A  + 
Sbjct: 60  REVHNSSQLSHQNIVSMIDVDEE--DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFT 117

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD-----NDVLRRSP 287
             I+ G+ + H   +VH DIKP N+L+  + T+KI DF +++   +      N VL    
Sbjct: 118 NQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL---- 173

Query: 288 GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-----LQDTYDKIVNN 342
           GT  + +PE   G        D +++G+ LY M++G+ PF GET     ++   D + N 
Sbjct: 174 GTVQYFSPEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNV 232

Query: 343 SLVFPDAMNPELRNLLEGLLCKDPTRR 369
           +      +   L N++     KD   R
Sbjct: 233 TTDVRKDIPQSLSNVILRATEKDKANR 259

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  123 bits (310), Expect = 2e-32
 Identities = 62/248 (25%), Positives = 100/248 (40%), Gaps = 27/248 (10%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY----AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +R +G G +GKV L R   +G +     A+K         L+       + D+++E+ I+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVK--------SLKPESGGNHIADLKKEIEIL 77

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVS 237
           + L H NIV    +  +   +   +++E++  G            I      KY   I  
Sbjct: 78  RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PVF-TA 294
           G+ YL     VH D+   N+LV     VKIGDF +++  E D +          PVF  A
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA 197

Query: 295 PECCLGLTYGG--KAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAM-N 351
           PEC   L       A+D W+ GVTL+ ++        ++        +         M  
Sbjct: 198 PEC---LMQSKFYIASDVWSFGVTLHELLT-----YCDSDSSPMALFLKMIGPTHGQMTV 249

Query: 352 PELRNLLE 359
             L N L+
Sbjct: 250 TRLVNTLK 257

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  123 bits (311), Expect = 2e-32
 Identities = 75/314 (23%), Positives = 130/314 (41%), Gaps = 37/314 (11%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +  V  +G G+YG+V   R    G+  AIK           +  +     ++++E+ ++K
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIK----------VMDVTGDEEEEIKQEINMLK 75

Query: 180 ML-QHPNIVNL----IEVIDDPNSDHFYMVLEYVEGKWDND--GFGQPGAIGESMARKYL 232
               H NI       I+       D  ++V+E+       D     +   + E       
Sbjct: 76  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 135

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSP--GT 289
           R+I+ GL +LH H V+H DIK  N+L+  +  VK+ DF VS Q+   D  V RR+   GT
Sbjct: 136 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGT 192

Query: 290 PVFTAPE-----CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS- 343
           P + APE          TY  K +D W++G+T   M  G  P            I  N  
Sbjct: 193 PYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 251

Query: 344 -LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP------IPQYLCWCK 396
             +     + + ++ +E  L K+ ++R     + KH ++            +  ++   K
Sbjct: 252 PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTK 311

Query: 397 RDRLRRDNTTQDSN 410
           + R  +D T  + +
Sbjct: 312 KKRGEKDETEYEYS 325

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  121 bits (305), Expect = 2e-31
 Identities = 69/293 (23%), Positives = 117/293 (39%), Gaps = 58/293 (19%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR-VAPSETAMTDVRREVLIM 178
           Y  VRK+G G Y +V    +  + +   +K         L+ V   +      +RE+ I+
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVK--------ILKPVKKKKI-----KREIKIL 84

Query: 179 KMLQ-HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           + L+  PNI+ L +++ DP S    +V E+V    D     Q   + +   R Y+ +I+ 
Sbjct: 85  ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT-DFKQLYQT--LTDYDIRFYMYEILK 141

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
            L Y H   ++H D+KP N+++      +++ D+ +++ F            +  F  PE
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE 200

Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPF----------------LG-ETLQDTYDKI 339
             +       + D W++G  L  MI  + PF                LG E L D  DK 
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260

Query: 340 -------VNNSL----------VFPDA----MNPELRNLLEGLLCKDPTRRLT 371
                   N+ L                   ++PE  + L+ LL  D   RLT
Sbjct: 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 313

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  120 bits (304), Expect = 2e-31
 Identities = 61/250 (24%), Positives = 91/250 (36%), Gaps = 32/250 (12%)

Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           + ++G G++G V L  Y    D      A+K    S   + R         D +RE+ I+
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---------DFQREIQIL 78

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGF--GQPGAIGESMARKYLRDI 235
           K L    IV    V   P      +V+EY+  G   +  F       +  S    Y   I
Sbjct: 79  KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQI 136

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PVF- 292
             G+ YL     VH D+   N+LV     VKI DF ++++   D D          P+F 
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196

Query: 293 TAPECCLGLTYGG--KAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNSLVFPDA 349
            APE    L+     + +D W+ GV LY +                 + +          
Sbjct: 197 YAPES---LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA-----EFLRMMGCERDVP 248

Query: 350 MNPELRNLLE 359
               L  LLE
Sbjct: 249 ALSRLLELLE 258

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  120 bits (303), Expect = 3e-31
 Identities = 66/284 (23%), Positives = 111/284 (39%), Gaps = 38/284 (13%)

Query: 87  RELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHY 146
              +G +   F       +     +   K I      R +G G +GKV LY         
Sbjct: 9   HHHHGALEVLFQGPGDPTVF---HKRYLKKI------RDLGEGHFGKVSLYCYDPTNDGT 59

Query: 147 ----AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFY 202
               A+K         L+        +  ++E+ I++ L H +I+      +D  +    
Sbjct: 60  GEMVAVK--------ALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111

Query: 203 MVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP 261
           +V+EYV  G      +    +IG +    + + I  G+ YLH  + +H D+   N+L+  
Sbjct: 112 LVMEYVPLG--SLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDN 169

Query: 262 SGTVKIGDFSVSQVFEDDNDVLRRSPGT--PVF-TAPECCLGLTYG--GKAADTWAVGVT 316
              VKIGDF +++   + ++  R       PVF  APEC   L       A+D W+ GVT
Sbjct: 170 DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC---LKEYKFYYASDVWSFGVT 226

Query: 317 LYYMIIGQYPFLGETLQDTYDKIVNNSLV-FPDAMNPELRNLLE 359
           LY ++        ++ Q    K +    +         L  LLE
Sbjct: 227 LYELLT-----HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  120 bits (303), Expect = 6e-31
 Identities = 66/308 (21%), Positives = 118/308 (38%), Gaps = 63/308 (20%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK---AFHKSHLSKLRVAPSETAMTDVRREVL 176
           +     +G G+YG V        G+  AIK    F K   +  R            RE+ 
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL-RTL----------REIK 61

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
           I+K  +H NI+ +  +    + ++F   Y++ E ++   D         + +   + ++ 
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT--DLHRVISTQMLSDDHIQYFIY 119

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF- 292
             +  +  LHG NV+H D+KP NLL+  +  +K+ DF ++++ ++         G     
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 293 -----T----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-- 341
                T    APE  L      +A D W+ G  L  + + +  F G   +     I    
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239

Query: 342 ---------------------NSL----------VFPDAMNPELRNLLEGLLCKDPTRRL 370
                                 SL          +FP   NP+  +LL+ +L  DP +R+
Sbjct: 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRV-NPKGIDLLQRMLVFDPAKRI 298

Query: 371 TLNDVAKH 378
           T  +  +H
Sbjct: 299 TAKEALEH 306

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  118 bits (297), Expect = 2e-30
 Identities = 45/207 (21%), Positives = 82/207 (39%), Gaps = 17/207 (8%)

Query: 172 RREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           +RE      LQ P++V + +  +       Y+ +  + G        + G +    A   
Sbjct: 82  QREARTAGRLQEPHVVPIHDFGEI--DGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAI 139

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD-----NDVLRRS 286
           +R I S L   H     H D+KP+N+LV+      + DF ++    D+      + +   
Sbjct: 140 VRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV--- 196

Query: 287 PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF 346
            GT  + APE         + AD +A+   LY  + G  P+ G+ L       +N ++  
Sbjct: 197 -GTLYYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLSVMG-AHINQAIPR 253

Query: 347 PDAMNP----ELRNLLEGLLCKDPTRR 369
           P  + P        ++   + K+P  R
Sbjct: 254 PSTVRPGIPVAFDAVIARGMAKNPEDR 280

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  120 bits (301), Expect = 2e-30
 Identities = 54/328 (16%), Positives = 103/328 (31%), Gaps = 79/328 (24%)

Query: 118 NEYVHVRKIGAG--SYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV 175
             Y  +  IG G      V L R    G++  ++         L    +E  +T ++ E+
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI------NLEACSNEM-VTFLQGEL 77

Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG-------FGQPGAIGESMA 228
            + K+  HPNIV           +  ++V  ++       G             + E   
Sbjct: 78  HVSKLFNHPNIVPYRATF--IADNELWVVTSFMAY-----GSAKDLICTHFMDGMNELAI 130

Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDD------ND 281
              L+ ++  L Y+H    VH  +K  ++L++  G V +     +  +          +D
Sbjct: 131 AYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190

Query: 282 VLRRSPGTPVFTAPE--CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE--------- 330
             + S     + +PE        Y  K +D ++VG+T   +  G  PF            
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEK 249

Query: 331 ------TLQDTYDKIVNNSLVFPDAMN-------------------------------PE 353
                  L DT         + P                                   P 
Sbjct: 250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPH 309

Query: 354 LRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
             + +E  L ++P  R + + +  H++ 
Sbjct: 310 FHHFVEQCLQRNPDARPSASTLLNHSFF 337

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  118 bits (298), Expect = 2e-30
 Identities = 62/300 (20%), Positives = 104/300 (34%), Gaps = 62/300 (20%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           V++IG G YG+V  +     G+  A+K F            +E A      E+    +++
Sbjct: 42  VKQIGKGRYGEV--WMGKWRGEKVAVKVFF----------TTEEASWFRETEIYQTVLMR 89

Query: 183 HPNIVNLIEVIDDPNSD--HFYMVLEYVEGKWDNDG----FGQPGAIGESMARKYLRDIV 236
           H NI+  I             Y++ +Y E      G    + +   +      K     V
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHEN-----GSLYDYLKSTTLDAKSMLKLAYSSV 144

Query: 237 SGLMYLHGHN--------VVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP- 287
           SGL +LH           + H D+K  N+LV  +GT  I D  ++  F  D + +   P 
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204

Query: 288 ---GTPVFTAPECCLGLTYGG-----KAADTWAVGVTLYYMIIG----------QYPFLG 329
              GT  +  PE                AD ++ G+ L+ +             Q P+  
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264

Query: 330 E-----TLQDTYDKIVNNSL-------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
                 + +D  + +    L          D    ++  L+      +P  RLT   V K
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  117 bits (295), Expect = 2e-30
 Identities = 68/278 (24%), Positives = 109/278 (39%), Gaps = 43/278 (15%)

Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           ++++G G++G V +  Y    D      A+K    S         +E  + D  RE+ I+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---------TEEHLRDFEREIEIL 65

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVS 237
           K LQH NIV    V       +  +++EY+  G   +        I      +Y   I  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PVF-TA 294
           G+ YL     +H D+   N+LV     VKIGDF +++V   D +  +       P+F  A
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185

Query: 295 PECCLGLTYGG--KAADTWAVGVTLY----------------YMIIGQYPFLGETLQDTY 336
           PE    LT      A+D W+ GV LY                  +IG        +    
Sbjct: 186 PES---LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242

Query: 337 DKIVNNS-LVFPDAMNPELRNLLEGLLC--KDPTRRLT 371
           + + NN  L  PD    E+  ++    C   +  +R +
Sbjct: 243 ELLKNNGRLPRPDGCPDEIYMIM--TECWNNNVNQRPS 278

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  118 bits (298), Expect = 4e-30
 Identities = 75/306 (24%), Positives = 125/306 (40%), Gaps = 67/306 (21%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK---AFHKSHLSKLRVAPSETAMTDVRREVL 176
           Y ++  IG G+YG V     +L+    AIK    F      + R            RE+ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTL----------REIK 77

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
           I+   +H NI+ + ++I  P  +     Y+V + +E         Q   +       +L 
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLY 135

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
            I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D       T   T
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD------HTGFLT 189

Query: 294 ---------APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF---------------LG 329
                    APE  L      K+ D W+VG  L  M+  +  F               LG
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 249

Query: 330 ETLQDTYDKIVNN-----------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTL 372
              Q+  + I+N                  + +FP+A + +  +LL+ +L  +P +R+ +
Sbjct: 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEV 308

Query: 373 NDVAKH 378
                H
Sbjct: 309 EQALAH 314

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  117 bits (295), Expect = 5e-30
 Identities = 69/278 (24%), Positives = 112/278 (40%), Gaps = 43/278 (15%)

Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           ++++G G++G V +  Y    D      A+K        KL+ + +E  + D  RE+ I+
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--------KLQHS-TEEHLRDFEREIEIL 96

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVS 237
           K LQH NIV    V       +  +++EY+  G   +        I      +Y   I  
Sbjct: 97  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PVF-TA 294
           G+ YL     +H D+   N+LV     VKIGDF +++V   D +  +       P+F  A
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 216

Query: 295 PECCLGLTYGG--KAADTWAVGVTLY----------------YMIIGQYPFLGETLQDTY 336
           PE    LT      A+D W+ GV LY                  +IG        +    
Sbjct: 217 PES---LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273

Query: 337 DKIVNNS-LVFPDAMNPELRNLLEGLLC--KDPTRRLT 371
           + + NN  L  PD    E+  ++    C   +  +R +
Sbjct: 274 ELLKNNGRLPRPDGCPDEIYMIM--TECWNNNVNQRPS 309

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  116 bits (292), Expect = 1e-29
 Identities = 68/314 (21%), Positives = 115/314 (36%), Gaps = 75/314 (23%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK--AFHKSHLSKLRVAPSETAMTDVRREVLI 177
           Y+ ++ +G G  G V     +   K  AIK          K              RE+ I
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK-HAL----------REIKI 61

Query: 178 MKMLQHPNIVNLIEVIDDPNS------------DHFYMVLEYVEGKWDNDGFGQPGAIGE 225
           ++ L H NIV + E++    S            +  Y+V EY+E   D     + G + E
Sbjct: 62  IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET--DLANVLEQGPLLE 119

Query: 226 SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV-APSGTVKIGDFSVSQVFEDDNDVLR 284
             AR ++  ++ GL Y+H  NV+H D+KP NL +      +KIGDF ++++ +       
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS--- 176

Query: 285 RSPGTPVFT---------APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF-------- 327
                   +         +P   L      KA D WA G     M+ G+  F        
Sbjct: 177 ---HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233

Query: 328 -------LGETLQDTYDKIVNN----------------SLVFPDAMNPELRNLLEGLLCK 364
                  +    ++   ++++                 + + P   + E  + LE +L  
Sbjct: 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGI-SREAVDFLEQILTF 292

Query: 365 DPTRRLTLNDVAKH 378
            P  RLT  +   H
Sbjct: 293 SPMDRLTAEEALSH 306

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  116 bits (293), Expect = 1e-29
 Identities = 79/305 (25%), Positives = 125/305 (40%), Gaps = 70/305 (22%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK----AFHKSHLSKLRVAPSETAMTDVRREV 175
           YV    +G+G+YG V        G+  AIK     F     +K R            RE+
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK-RAY----------REL 74

Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWD-NDGFGQPGAIGESMARK 230
           L++K +QH N++ L++V    +S      FY+V+ +++   D     G      E   + 
Sbjct: 75  LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT--DLQKIMGLK--FSEEKIQY 130

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
            +  ++ GL Y+H   VVH D+KP NL V     +KI DF +++  + +         T 
Sbjct: 131 LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--------TG 182

Query: 291 -VFT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN---- 341
            V T    APE  L   +  +  D W+VG  +  M+ G+  F G+   D   +I+     
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 242

Query: 342 ------------------NSL----------VFPDAMNPELRNLLEGLLCKDPTRRLTLN 373
                              SL          +FP A +P+  +LLE +L  D  +RLT  
Sbjct: 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRA-SPQAADLLEKMLELDVDKRLTAA 301

Query: 374 DVAKH 378
               H
Sbjct: 302 QALTH 306

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  116 bits (292), Expect = 1e-29
 Identities = 47/227 (20%), Positives = 92/227 (40%), Gaps = 24/227 (10%)

Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           ++ +G+G++G V   L+    +      AIK         LR A S  A  ++  E  +M
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--------LREATSPKANKEILDEAYVM 71

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVS 237
             + +P++  L+ +     +    ++ + +  G   +        IG      +   I  
Sbjct: 72  ASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TPVF-TAP 295
           G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P+   A 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

Query: 296 ECCLGLTYGG--KAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKI 339
           E    + +      +D W+ GVT++ ++  G  P+ G    +    +
Sbjct: 189 ES---ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  116 bits (293), Expect = 1e-29
 Identities = 79/325 (24%), Positives = 120/325 (36%), Gaps = 76/325 (23%)

Query: 108 SEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETA 167
           + DE   K ++ +   R  G G++G V L +    G   AIK        K+   P    
Sbjct: 13  AADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK--------KVIQDPR--- 61

Query: 168 MTDVRREVLIMKML---QHPNIVNLIEVIDDPNSDHF-----YMVLEYVEG---KWDNDG 216
                RE+ IM+ L    HPNIV L                  +V+EYV     +   + 
Sbjct: 62  --FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY 119

Query: 217 FGQPGAIGESMARKYLRDIVSGLMYLH--GHNVVHGDIKPDNLLVAPS-GTVKIGDFSVS 273
           + +  A    + + +L  ++  +  LH    NV H DIKP N+LV  + GT+K+ DF  +
Sbjct: 120 YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179

Query: 274 QVFEDDNDVLRRSPGTP----VFT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQY 325
           +           SP  P    + +    APE   G  +   A D W+VG     M++G+ 
Sbjct: 180 KKL---------SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230

Query: 326 PFLGETLQDTYDKI--------------VNN---------------SLVFPDA---MNPE 353
            F G+       +I              +N                S VF D       E
Sbjct: 231 IFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKE 290

Query: 354 LRNLLEGLLCKDPTRRLTLNDVAKH 378
             +LL  LL   P  R+   +   H
Sbjct: 291 AYDLLSALLQYLPEERMKPYEALCH 315

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  116 bits (292), Expect = 2e-29
 Identities = 71/304 (23%), Positives = 120/304 (39%), Gaps = 67/304 (22%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK----AFHKSHLSKLRVAPSETAMTDVRREV 175
           Y  ++ +G+G+YG V        G   AIK     F     +K R            RE+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK-RAY----------REL 75

Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
            ++K ++H N++ L++V     +      FY+V+ ++    D     +   +GE   +  
Sbjct: 76  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT--DLGKLMKHEKLGEDRIQFL 133

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP- 290
           +  ++ GL Y+H   ++H D+KP NL V     +KI DF +++  + +         T  
Sbjct: 134 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM--------TGY 185

Query: 291 VFT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN----- 341
           V T    APE  L      +  D W+VG  +  MI G+  F G    D   +I+      
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 245

Query: 342 -----------------NSL----------VFPDAMNPELRNLLEGLLCKDPTRRLTLND 374
                              L          +  +A +P   NLLE +L  D  +R+T  +
Sbjct: 246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNA-SPLAVNLLEKMLVLDAEQRVTAGE 304

Query: 375 VAKH 378
              H
Sbjct: 305 ALAH 308

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  115 bits (290), Expect = 5e-29
 Identities = 69/333 (20%), Positives = 114/333 (34%), Gaps = 93/333 (27%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y   + +G GS+G V        GK +A+K        K+   P         RE+ IMK
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALK--------KVLQDPRYK-----NRELDIMK 55

Query: 180 MLQHPNIVNLIEVIDDPNSDHF------------------------------------YM 203
           +L H NI+ L++       +                                       +
Sbjct: 56  VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115

Query: 204 VLEYVEG---KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA 260
           ++EYV     K          +I  ++   Y+  +   + ++H   + H DIKP NLLV 
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN 175

Query: 261 P-SGTVKIGDFSVSQVFEDDNDVLRRSPGTP-VFT----APECCLGLTYGGKAADTWAVG 314
               T+K+ DF  ++            P    + +    APE  LG T    + D W++G
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSE------PSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229

Query: 315 VTLYYMIIGQYPFLGETLQDTYDKI--------------VNN---------------SLV 345
                +I+G+  F GET  D   +I              +N                  +
Sbjct: 230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKI 289

Query: 346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            P+       +LLE +L  +P  R+   +   H
Sbjct: 290 LPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  113 bits (284), Expect = 9e-29
 Identities = 72/263 (27%), Positives = 101/263 (38%), Gaps = 32/263 (12%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY-----AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + K+G GS+G V   R   D         A+K      LS         AM D  REV  
Sbjct: 23  LEKLGDGSFGVV--RRGEWDAPSGKTVSVAVKCLKPDVLS------QPEAMDDFIREVNA 74

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIV 236
           M  L H N++ L  V+    +    MV E    G   +      G        +Y   + 
Sbjct: 75  MHSLDHRNLIRLYGVV---LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PVF-T 293
            G+ YL     +H D+   NLL+A    VKIGDF + +    ++D          P    
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191

Query: 294 APECCLGLTYGG--KAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS--LVFPD 348
           APE    L       A+DTW  GVTL+ M   GQ P++G        KI      L  P+
Sbjct: 192 APES---LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 248

Query: 349 AMNPELRNLLEGLLC--KDPTRR 369
               ++ N++  + C    P  R
Sbjct: 249 DCPQDIYNVM--VQCWAHKPEDR 269

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  112 bits (282), Expect = 1e-28
 Identities = 27/260 (10%), Positives = 77/260 (29%), Gaps = 51/260 (19%)

Query: 120 YVHVRKIGAGSYGKVVLYR---SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           Y  +   G     +   ++   ++LD +  A+                +  + +     L
Sbjct: 33  YRLLIFHGGVPPLQF--WQALDTALD-RQVALTFVDPQG------VLPDDVLQETLSRTL 83

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
            +  +  P +  +++V+         +V E++ G    +      +     A + ++ + 
Sbjct: 84  RLSRIDKPGVARVLDVVHT--RAGGLVVAEWIRGGSLQEVADTSPSPVG--AIRAMQSLA 139

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           +     H   V      P  + V+  G V +   +                  P      
Sbjct: 140 AAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM------------PDANP------ 181

Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTY---DKIVNNSLVFPDAMNP- 352
                       D   +G +LY +++ ++P     ++      ++      + P  ++  
Sbjct: 182 ----------QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD 231

Query: 353 ---ELRNLLEGLLCKDPTRR 369
              ++  +    +  D   R
Sbjct: 232 IPFQISAVAARSVQGDGGIR 251

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  114 bits (288), Expect = 1e-28
 Identities = 63/265 (23%), Positives = 106/265 (40%), Gaps = 26/265 (9%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
             +IG G++G+V  +   L   +   A+K          R            +E  I+K 
Sbjct: 119 GEQIGRGNFGEV--FSGRLRADNTLVAVK--------SCRETLPPDLKAKFLQEARILKQ 168

Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVSG 238
             HPNIV LI V         Y+V+E V+G  D   F   +   +      + + D  +G
Sbjct: 169 YSHPNIVRLIGVCTQ--KQPIYIVMELVQGG-DFLTFLRTEGARLRVKTLLQMVGDAAAG 225

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT-PV-FTAPE 296
           + YL     +H D+   N LV     +KI DF +S+   D            PV +TAPE
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE 285

Query: 297 CCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS-LVFPDAMNPEL 354
                 Y  + +D W+ G+ L+    +G  P+   + Q T + +     L  P+     +
Sbjct: 286 ALNYGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV 344

Query: 355 RNLLEGLLC--KDPTRRLTLNDVAK 377
             L+    C   +P +R + + + +
Sbjct: 345 FRLM--EQCWAYEPGQRPSFSTIYQ 367

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  112 bits (283), Expect = 1e-28
 Identities = 66/260 (25%), Positives = 102/260 (39%), Gaps = 32/260 (12%)

Query: 124 RKIGAGSYGKVV--LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
            ++G G++G V   +YR        AIK         L+    +    ++ RE  IM  L
Sbjct: 16  IELGCGNFGSVRQGVYRMRKKQIDVAIKV--------LKQGTEKADTEEMMREAQIMHQL 67

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVSGL 239
            +P IV LI V     ++   +V+E   G      F  G+   I  S   + L  +  G+
Sbjct: 68  DNPYIVRLIGVCQ---AEALMLVMEMAGGG-PLHKFLVGKREEIPVSNVAELLHQVSMGM 123

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PVF-TAPE 296
            YL   N VH D+   N+L+      KI DF +S+    D+           P+   APE
Sbjct: 124 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183

Query: 297 CCLGLTYGGK---AADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS-LVFPDAMN 351
           C   + +  K    +D W+ GVT++  +  GQ P+      +    I     +  P    
Sbjct: 184 C---INF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP 239

Query: 352 PELRNLLEGLLC--KDPTRR 369
           PEL  L+    C       R
Sbjct: 240 PELYALM--SDCWIYKWEDR 257

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  113 bits (284), Expect = 1e-28
 Identities = 54/299 (18%), Positives = 96/299 (32%), Gaps = 60/299 (20%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +     G +G V  +++ L  ++ A+K F             +        EV  +  ++
Sbjct: 29  LEVKARGRFGCV--WKAQLLNEYVAVKIFP----------IQDKQSWQNEYEVYSLPGMK 76

Query: 183 HPNIVNLI--EVIDDPNSDHFYMVLEYVEGK--WDNDGFGQPGAIGESMARKYLRDIVSG 238
           H NI+  I  E          +++  + E     D   F +   +  +        +  G
Sbjct: 77  HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD---FLKANVVSWNELCHIAETMARG 133

Query: 239 LMYLHGH----------NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP- 287
           L YLH             + H DIK  N+L+  + T  I DF ++  FE           
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ 193

Query: 288 -GTPVFTAPE-----CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE----------- 330
            GT  + APE              +  D +A+G+ L+ +        G            
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252

Query: 331 -----TLQDTYDKIVNNSL-------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
                +L+D  + +V+              A    L   +E     D   RL+   V +
Sbjct: 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  114 bits (287), Expect = 1e-28
 Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 25/228 (10%)

Query: 123 VRKIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
            + +GAG +G+V    L   S      AIK         L+V  +E    D   E  IM 
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKT--------LKVGYTEKQRRDFLGEASIMG 101

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVS 237
              HPNI+ L  V+    S    +V EY+E     D F                LR I S
Sbjct: 102 QFDHPNIIRLEGVVTK--SKPVMIVTEYMENG-SLDSFLRKHDAQFTVIQLVGMLRGIAS 158

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PV-FTA 294
           G+ YL     VH D+   N+L+  +   K+ DF + +V EDD +    + G   P+ +T+
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS 218

Query: 295 PECCLGLTYGG--KAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKI 339
           PE    + Y     A+D W+ G+ L+  M  G+ P+   + QD    +
Sbjct: 219 PEA---IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  113 bits (284), Expect = 1e-28
 Identities = 50/228 (21%), Positives = 96/228 (42%), Gaps = 26/228 (11%)

Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           ++ +G+G +G V   ++    +       IK         +       +   V   +L +
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV--------IEDKSGRQSFQAVTDHMLAI 69

Query: 179 KMLQHPNIVNLIEVI-DDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIV 236
             L H +IV L+ +           +V +Y+  G   +      GA+G  +   +   I 
Sbjct: 70  GSLDHAHIVRLLGLCPGSS----LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TPV-FTA 294
            G+ YL  H +VH ++   N+L+     V++ DF V+ +   D+  L  S   TP+ + A
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185

Query: 295 PECCLGLTYGG--KAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKI 339
            E    + +G     +D W+ GVT++ ++  G  P+ G  L +  D +
Sbjct: 186 LES---IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  113 bits (284), Expect = 1e-28
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 27/229 (11%)

Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
            + IG+G  G+V     R         AIKA        L+   +E    D   E  IM 
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA--------LKAGYTERQRRDFLSEASIMG 105

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVS 237
              HPNI+ L  V+         +V EY+E     D F     G          LR + +
Sbjct: 106 QFDHPNIIRLEGVVTR--GRLAMIVTEYMENG-SLDTFLRTHDGQFTIMQLVGMLRGVGA 162

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PV-FTA 294
           G+ YL     VH D+   N+LV  +   K+ DF +S+V EDD D    + G   P+ +TA
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA 222

Query: 295 PECCLGLTYGGK---AADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKI 339
           PE    + +      A+D W+ GV ++ ++  G+ P+   T +D    +
Sbjct: 223 PEA---IAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  112 bits (283), Expect = 1e-28
 Identities = 61/298 (20%), Positives = 108/298 (36%), Gaps = 58/298 (19%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           +  +G G YG+V  +R S  G++ A+K F                      E+    ML+
Sbjct: 13  LECVGKGRYGEV--WRGSWQGENVAVKIFSSRDEKSWFR----------ETELYNTVMLR 60

Query: 183 HPNIVNLI--EVIDDPNSDHFYMVLEYVEGK--WDNDGFGQPGAIGESMARKYLRDIVSG 238
           H NI+  I  ++    +S   +++  Y E    +D   + Q   +      + +  I SG
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD---YLQLTTLDTVSCLRIVLSIASG 117

Query: 239 LMYLHG--------HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--- 287
           L +LH           + H D+K  N+LV  +G   I D  ++ +     + L       
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177

Query: 288 -GTPVFTAPE-----CCLGLTYGGKAADTWAVGVTLYYMIIG----------QYPFLGE- 330
            GT  + APE       +      K  D WA G+ L+ +             + PF    
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237

Query: 331 ----TLQDTYDKIVNNSL--VFPDAMN-----PELRNLLEGLLCKDPTRRLTLNDVAK 377
               + +D    +  +      P+          L  L++    ++P+ RLT   + K
Sbjct: 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  113 bits (286), Expect = 2e-28
 Identities = 72/304 (23%), Positives = 120/304 (39%), Gaps = 67/304 (22%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK----AFHKSHLSKLRVAPSETAMTDVRREV 175
           Y ++  +G+G+YG V     +  G   A+K     F     +K R            RE+
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK-RTY----------REL 79

Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
            ++K ++H N++ L++V     S    +  Y+V   +    +N    Q   + +   +  
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFL 137

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP- 290
           +  I+ GL Y+H  +++H D+KP NL V     +KI DF +++   D+         T  
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM--------TGY 189

Query: 291 VFT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN----- 341
           V T    APE  L   +  +  D W+VG  +  ++ G+  F G    D    I+      
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249

Query: 342 -----------------NSL----------VFPDAMNPELRNLLEGLLCKDPTRRLTLND 374
                             SL          VF  A NP   +LLE +L  D  +R+T   
Sbjct: 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQ 308

Query: 375 VAKH 378
              H
Sbjct: 309 ALAH 312

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  112 bits (283), Expect = 3e-28
 Identities = 58/300 (19%), Positives = 101/300 (33%), Gaps = 62/300 (20%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
              IG G +G+V  +R    G+  A+K F                      E+    ML+
Sbjct: 47  QESIGKGRFGEV--WRGKWRGEEVAVKIFSSREERSWFR----------EAEIYQTVMLR 94

Query: 183 HPNIVNLI--EVIDDPNSDHFYMVLEYVEGKWDNDG----FGQPGAIGESMARKYLRDIV 236
           H NI+  I  +  D+      ++V +Y E      G    +     +      K      
Sbjct: 95  HENILGFIAADNKDNGTWTQLWLVSDYHEH-----GSLFDYLNRYTVTVEGMIKLALSTA 149

Query: 237 SGLMYLHGH--------NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP- 287
           SGL +LH           + H D+K  N+LV  +GT  I D  ++   +   D +  +P 
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209

Query: 288 ---GTPVFTAPECCLGLTYGG-----KAADTWAVGVTLYYMIIG----------QYPFLG 329
              GT  + APE              K AD +A+G+  + +             Q P+  
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269

Query: 330 E-----TLQDTYDKIVNNSL--VFPDAMN-----PELRNLLEGLLCKDPTRRLTLNDVAK 377
                 ++++    +    L    P+          +  ++      +   RLT   + K
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  114 bits (287), Expect = 3e-28
 Identities = 70/317 (22%), Positives = 131/317 (41%), Gaps = 76/317 (23%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK----AFHKSHLSKLRVAPSETAMTDVRREV 175
           Y +++ IG+G+ G V     ++  ++ AIK     F     +K R            RE+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK-RAY----------REL 112

Query: 176 LIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKY 231
           ++MK + H NI++L+ V     +       Y+V+E ++             +        
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL-CQVIQME--LDHERMSYL 169

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP- 290
           L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++       +      TP 
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPY 223

Query: 291 VFT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN----- 341
           V T    APE  LG+ Y  +  D W+VG  +  M+  +  F G    D ++K++      
Sbjct: 224 VVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282

Query: 342 ----------------NSL----------VFPDA-----------MNPELRNLLEGLLCK 364
                            +           +FPD+              + R+LL  +L  
Sbjct: 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 342

Query: 365 DPTRRLTLNDVAKHTWV 381
           DP +R++++D  +H ++
Sbjct: 343 DPAKRISVDDALQHPYI 359

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  112 bits (283), Expect = 4e-28
 Identities = 68/315 (21%), Positives = 131/315 (41%), Gaps = 68/315 (21%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIK----AFHKSHLSKLRVAPSETAMTDVRR 173
             Y +++ IG+G+ G V     ++  ++ AIK     F     +K R            R
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK-RAY----------R 73

Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWD-NDGFGQPGAIGESMA 228
           E+++MK + H NI+ L+ V     S       Y+V+E ++   +          +     
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA--NLCQVIQME--LDHERM 129

Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG 288
              L  ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     
Sbjct: 130 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVV 188

Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN------- 341
           T  + APE  LG+ Y  +  D W+VG  +  MI G   F G    D ++K++        
Sbjct: 189 TRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 247

Query: 342 --------------NSL----------VFPDAM-----------NPELRNLLEGLLCKDP 366
                          +           +FPD +             + R+LL  +L  D 
Sbjct: 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 307

Query: 367 TRRLTLNDVAKHTWV 381
           ++R+++++  +H ++
Sbjct: 308 SKRISVDEALQHPYI 322

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  112 bits (281), Expect = 4e-28
 Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 26/229 (11%)

Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
            + IGAG +G+V   + ++S   K    AIK         L+   +E    D   E  IM
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT--------LKAGYTEKQRVDFLGEAGIM 100

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIV 236
               H NI+ L  VI         ++ EY+E     D F   + G          LR I 
Sbjct: 101 GQFSHHNIIRLEGVISK--YKPMMIITEYMENG-ALDKFLREKDGEFSVLQLVGMLRGIA 157

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PV-FT 293
           +G+ YL   N VH D+   N+LV  +   K+ DF +S+V EDD +    + G   P+ +T
Sbjct: 158 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217

Query: 294 APECCLGLTYGG--KAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKI 339
           APE    ++Y     A+D W+ G+ ++  M  G+ P+   +  +    I
Sbjct: 218 APEA---ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  110 bits (277), Expect = 7e-28
 Identities = 59/258 (22%), Positives = 106/258 (41%), Gaps = 28/258 (10%)

Query: 124 RKIGAGSYGKVV--LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           +++G+G++G V    Y+     K  A+K            A       ++  E  +M+ L
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-------ANDPALKDELLAEANVMQQL 75

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
            +P IV +I + +   ++ + +V+E  E    N    Q   + +    + +  +  G+ Y
Sbjct: 76  DNPYIVRMIGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 132

Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PV-FTAPECC 298
           L   N VH D+   N+L+      KI DF +S+    D +  +       PV + APEC 
Sbjct: 133 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC- 191

Query: 299 LGLTYGGK---AADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS-LVFPDAMNPE 353
             + Y  K    +D W+ GV ++     GQ P+ G    +    +     +  P     E
Sbjct: 192 --INY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 248

Query: 354 LRNLLEGLLC--KDPTRR 369
           + +L+   LC   D   R
Sbjct: 249 MYDLM--NLCWTYDVENR 264

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  110 bits (278), Expect = 1e-27
 Identities = 47/227 (20%), Positives = 93/227 (40%), Gaps = 24/227 (10%)

Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           ++ +G+G++G V   L+    +      AIK         LR A S  A  ++  E  +M
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--------LREATSPKANKEILDEAYVM 71

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIVS 237
             + +P++  L+ +     +    ++ + +  G   +        IG      +   I  
Sbjct: 72  ASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPG-TPV-FTAP 295
           G+ YL    +VH D+   N+LV     VKI DF ++++   +        G  P+ + A 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

Query: 296 ECCLGLTYGG--KAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKI 339
           E    + +      +D W+ GVT++ ++  G  P+ G    +    +
Sbjct: 189 ES---ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  110 bits (276), Expect = 2e-27
 Identities = 63/309 (20%), Positives = 102/309 (33%), Gaps = 73/309 (23%)

Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
            IG G YG V  Y+ SLD +  A+K F  ++        +E       + +  + +++H 
Sbjct: 20  LIGRGRYGAV--YKGSLDERPVAVKVFSFANRQNFI---NE-------KNIYRVPLMEHD 67

Query: 185 NIVNLI---EVIDDPNSDHFYMVLEYVEGKWDNDG----FGQPGAIGESMARKYLRDIVS 237
           NI   I   E +       + +V+EY        G    +          + +    +  
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPN-----GSLXKYLSLHTSDWVSSCRLAHSVTR 122

Query: 238 GLMYLHG---------HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP- 287
           GL YLH            + H D+   N+LV   GT  I DF +S     +  V      
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182

Query: 288 -------GTPVFTAPE------CCLGLTYGGKAADTWAVGVTLYYMIIG----------- 323
                  GT  + APE               K  D +A+G+  + + +            
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242

Query: 324 --QYPFLGE-----TLQDTYDKIVNNSL--VFPDAMNP------ELRNLLEGLLCKDPTR 368
             Q  F  E     T +D    +        FP+A          L+  +E    +D   
Sbjct: 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302

Query: 369 RLTLNDVAK 377
           RLT     +
Sbjct: 303 RLTAQXAEE 311

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  108 bits (272), Expect = 4e-27
 Identities = 73/261 (27%), Positives = 114/261 (43%), Gaps = 33/261 (12%)

Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
            R IG G +G V   +Y S  +     AIK          +   S++      +E L M+
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKT--------CKNCTSDSVREKFLQEALTMR 71

Query: 180 MLQHPNIVNLIEVI-DDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIV 236
              HP+IV LI VI ++P     ++++E      +   F   +  ++  +    Y   + 
Sbjct: 72  QFDHPHIVKLIGVITENP----VWIIMELCTLG-ELRSFLQVRKYSLDLASLILYAYQLS 126

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT-PVF-TA 294
           + L YL     VH DI   N+LV+ +  VK+GDF +S+  ED     + S G  P+   A
Sbjct: 127 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMA 185

Query: 295 PECCLGLTYGG--KAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVN-NSLVFPDAM 350
           PE    + +     A+D W  GV ++ ++  G  PF G    D   +I N   L  P   
Sbjct: 186 PES---INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 242

Query: 351 NPELRNLLEGLLC--KDPTRR 369
            P L +L+    C   DP+RR
Sbjct: 243 PPTLYSLM--TKCWAYDPSRR 261

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  111 bits (278), Expect = 5e-27
 Identities = 57/230 (24%), Positives = 95/230 (41%), Gaps = 48/230 (20%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK----AFHKSHLSKLRVAPSETAMTDVRREV 175
           Y     IG GSYG V      L+ +  AIK     F      K R+           RE+
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK-RIL----------REI 103

Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWD-NDGFGQPGAIGESMARKY 231
            I+  L H ++V +++++   + + F   Y+VLE  +   D    F  P  + E   +  
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD--SDFKKLFRTPVYLTELHIKTL 161

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP- 290
           L +++ G+ Y+H   ++H D+KP N LV    +VK+ DF +++  +   +   + P +P 
Sbjct: 162 LYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221

Query: 291 ----------------------VFT----APECCLGLTYGGKAADTWAVG 314
                                 V T    APE  L      +A D W++G
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  111 bits (278), Expect = 6e-27
 Identities = 64/259 (24%), Positives = 109/259 (42%), Gaps = 34/259 (13%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
             K+G G +G+V  +  + +G    AIK             P   +     +E  +MK L
Sbjct: 189 EVKLGQGCFGEV--WMGTWNGTTRVAIKTLK----------PGTMSPEAFLQEAQVMKKL 236

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGK------WDNDGFGQPGAIGESMARKYLRDI 235
           +H  +V L  V+ +   +  Y+V EY+             G          MA      I
Sbjct: 237 RHEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA----QI 289

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF-TA 294
            SG+ Y+   N VH D++  N+LV  +   K+ DF ++++ ED+    R+    P+  TA
Sbjct: 290 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 349

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN-SLVFPDAMNP 352
           PE  L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++     +  P     
Sbjct: 350 PEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 408

Query: 353 ELRNLLEGLLC--KDPTRR 369
            L +L+    C  K+P  R
Sbjct: 409 SLHDLM--CQCWRKEPEER 425

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  111 bits (280), Expect = 7e-27
 Identities = 71/260 (27%), Positives = 111/260 (42%), Gaps = 31/260 (11%)

Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
            R IG G +G V   +Y S  +     AIK          +   S++      +E L M+
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKT--------CKNCTSDSVREKFLQEALTMR 446

Query: 180 MLQHPNIVNLIEVI-DDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIV 236
              HP+IV LI VI ++P     ++++E      +   F   +  ++  +    Y   + 
Sbjct: 447 QFDHPHIVKLIGVITENP----VWIIMELCTLG-ELRSFLQVRKFSLDLASLILYAYQLS 501

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF-TAP 295
           + L YL     VH DI   N+LV+ +  VK+GDF +S+  ED           P+   AP
Sbjct: 502 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561

Query: 296 ECCLGLTYGG--KAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS-LVFPDAMN 351
           E    + +     A+D W  GV ++ ++  G  PF G    D   +I N   L  P    
Sbjct: 562 ES---INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 618

Query: 352 PELRNLLEGLLC--KDPTRR 369
           P L +L+    C   DP+RR
Sbjct: 619 PTLYSLM--TKCWAYDPSRR 636

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  111 bits (278), Expect = 9e-27
 Identities = 64/259 (24%), Positives = 109/259 (42%), Gaps = 34/259 (13%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
             K+G G +G+V  +  + +G    AIK             P   +     +E  +MK L
Sbjct: 272 EVKLGQGCFGEV--WMGTWNGTTRVAIKTLK----------PGTMSPEAFLQEAQVMKKL 319

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGK------WDNDGFGQPGAIGESMARKYLRDI 235
           +H  +V L  V+ +   +  Y+V EY+             G          MA      I
Sbjct: 320 RHEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA----QI 372

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF-TA 294
            SG+ Y+   N VH D++  N+LV  +   K+ DF ++++ ED+    R+    P+  TA
Sbjct: 373 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 432

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN-SLVFPDAMNP 352
           PE  L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++     +  P     
Sbjct: 433 PEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 491

Query: 353 ELRNLLEGLLC--KDPTRR 369
            L +L+    C  K+P  R
Sbjct: 492 SLHDLM--CQCWRKEPEER 508

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  106 bits (268), Expect = 1e-26
 Identities = 65/262 (24%), Positives = 108/262 (41%), Gaps = 31/262 (11%)

Query: 123 VRKIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
            R +G G +G+V   V      +  + A+K          +   +         E +IMK
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKT--------CKKDCTLDNKEKFMSEAVIMK 68

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVS 237
            L HP+IV LI +I+    +  ++++E      +   +      ++       Y   I  
Sbjct: 69  NLDHPHIVKLIGIIE---EEPTWIIMELYPYG-ELGHYLERNKNSLKVLTLVLYSLQICK 124

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT-PV-FTAP 295
            + YL   N VH DI   N+LVA    VK+GDF +S+  ED+ D  + S    P+ + +P
Sbjct: 125 AMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSP 183

Query: 296 ECCLGLTYGG--KAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS-LVFPDAMN 351
           E    + +     A+D W   V ++ ++  G+ PF     +D    +     L  PD   
Sbjct: 184 ES---INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCP 240

Query: 352 PELRNLLEGLLC--KDPTRRLT 371
           P L  L+    C   DP+ R  
Sbjct: 241 PVLYTLM--TRCWDYDPSDRPR 260

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  110 bits (276), Expect = 1e-26
 Identities = 60/262 (22%), Positives = 105/262 (40%), Gaps = 38/262 (14%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
             K+G G YG+V  Y           A+K   +  +             +  +E  +MK 
Sbjct: 225 KHKLGGGQYGEV--YEGVWKKYSLTVAVKTLKEDTMEV----------EEFLKEAAVMKE 272

Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEG--------KWDNDGFGQPGAIGESMARKYL 232
           ++HPN+V L+ V        FY++ E++          + +         +   MA    
Sbjct: 273 IKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL--YMAT--- 325

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV- 291
             I S + YL   N +H ++   N LV  +  VK+ DF +S++   D          P+ 
Sbjct: 326 -QISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 384

Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN-SLVFPDA 349
           +TAPE      +  K +D WA GV L+ +   G  P+ G  L   Y+ +  +  +  P+ 
Sbjct: 385 WTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 443

Query: 350 MNPELRNLLEGLLC--KDPTRR 369
              ++  L+    C   +P+ R
Sbjct: 444 CPEKVYELM--RACWQWNPSDR 463

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  106 bits (266), Expect = 2e-26
 Identities = 59/261 (22%), Positives = 102/261 (39%), Gaps = 34/261 (13%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           V++IG+G +G V  +      K   AIK   +  +S+           D   E  +M  L
Sbjct: 13  VQEIGSGQFGLV--HLGYWLNKDKVAIKTIREGAMSE----------EDFIEEAEVMMKL 60

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVSGL 239
            HP +V L  V  +       +V E++E       +   Q G            D+  G+
Sbjct: 61  SHPKLVQLYGVCLE--QAPICLVTEFME-HGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 117

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PV-FTAPE 296
            YL    V+H D+   N LV  +  +K+ DF +++   D  D    S GT  PV + +PE
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQYTSSTGTKFPVKWASPE 175

Query: 297 CCLGLTYG--GKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVNNS-LVFPDAMNP 352
                ++      +D W+ GV ++     G+ P+   +  +  + I     L  P   + 
Sbjct: 176 V---FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 232

Query: 353 ELRNLLEGLLC--KDPTRRLT 371
            +  ++    C  + P  R  
Sbjct: 233 HVYQIM--NHCWRERPEDRPA 251

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  109 bits (274), Expect = 4e-26
 Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 25/225 (11%)

Query: 125 KIGAGSYGKVV--LYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           ++G G++G V   +YR        AIK         L+    +    ++ RE  IM  L 
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKV--------LKQGTEKADTEEMMREAQIMHQLD 394

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVSGLM 240
           +P IV LI V     ++   +V+E   G   +  F  G+   I  S   + L  +  G+ 
Sbjct: 395 NPYIVRLIGVCQ---AEALMLVMEMAGGGPLHK-FLVGKREEIPVSNVAELLHQVSMGMK 450

Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PVF-TAPEC 297
           YL   N VH ++   N+L+      KI DF +S+    D+           P+   APEC
Sbjct: 451 YLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 510

Query: 298 CLGLTYG--GKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKI 339
              + +      +D W+ GVT++  +  GQ P+      +    I
Sbjct: 511 ---INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  103 bits (260), Expect = 1e-25
 Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 29/226 (12%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           ++++G+G +G V        G++  A+K   +  +S+           +  +E   M  L
Sbjct: 13  LKELGSGQFGVV--KLGKWKGQYDVAVKMIKEGSMSE----------DEFFQEAQTMMKL 60

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVSGL 239
            HP +V    V         Y+V EY+        +       +  S   +   D+  G+
Sbjct: 61  SHPKLVKFYGVCSK--EYPIYIVTEYIS-NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PV-FTAPE 296
            +L  H  +H D+   N LV     VK+ DF +++   DD  V   S GT  PV ++APE
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV--SSVGTKFPVKWSAPE 175

Query: 297 CCLGLTYG--GKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKI 339
                 Y      +D WA G+ ++ +  +G+ P+   T  +   K+
Sbjct: 176 V---FHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  103 bits (259), Expect = 2e-25
 Identities = 58/266 (21%), Positives = 101/266 (37%), Gaps = 44/266 (16%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           ++++G G +G V        G++  AIK                 +  +   E  +M  L
Sbjct: 29  LKELGTGQFGVV--KYGKWRGQYDVAIKMIK----------EGSMSEDEFIEEAKVMMNL 76

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEG-------KWDNDGFGQPGAIGESMARKYLRD 234
            H  +V L  V         +++ EY+         +     F     +   M +    D
Sbjct: 77  SHEKLVQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE--MCK----D 128

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PV- 291
           +   + YL     +H D+   N LV   G VK+ DF +S+   D  D    S G+  PV 
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSVGSKFPVR 186

Query: 292 FTAPECCLGLTYG--GKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN-SLVFP 347
           ++ PE    L Y      +D WA GV ++ +  +G+ P+   T  +T + I     L  P
Sbjct: 187 WSPPE---VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 243

Query: 348 DAMNPELRNLLEGLLC--KDPTRRLT 371
              + ++  ++    C  +    R T
Sbjct: 244 HLASEKVYTIM--YSCWHEKADERPT 267

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  103 bits (259), Expect = 2e-25
 Identities = 49/273 (17%), Positives = 92/273 (33%), Gaps = 47/273 (17%)

Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY-----AIKAFHKSHLSKLRVAPSETAMTDVRREV 175
              +G G++ K+   + R   D          +K   K+H +                  
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE---------SFFEAA 63

Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLR 233
            +M  L H ++V    V      D   +V E+V+     D +       I      +  +
Sbjct: 64  SMMSKLSHKHLVLNYGVCVC--GDENILVQEFVKFG-SLDTYLKKNKNCINILWKLEVAK 120

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVA--------PSGTVKIGDFSVSQVFEDDNDVLRR 285
            + + + +L  + ++HG++   N+L+             +K+ D  +S       D+L+ 
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-DILQ- 178

Query: 286 SPGTPV-FTAPECCLGLTYGGK---AADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIV 340
                + +  PEC   +        A D W+ G TL+ +   G  P      Q       
Sbjct: 179 ---ERIPWVPPEC---IENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232

Query: 341 NNSLVFPDAMNPELRNLLEGLLC--KDPTRRLT 371
           +     P     EL NL+    C   +P  R +
Sbjct: 233 DRH-QLPAPKAAELANLI--NNCMDYEPDHRPS 262

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  103 bits (259), Expect = 2e-25
 Identities = 67/262 (25%), Positives = 114/262 (43%), Gaps = 40/262 (15%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           V ++GAG +G+V  +    +G    A+K+  +  +S                E  +MK L
Sbjct: 18  VERLGAGQFGEV--WMGYYNGHTKVAVKSLKQGSMSP----------DAFLAEANLMKQL 65

Query: 182 QHPNIVNLIEVI-DDPNSDHFYMVLEYVEGK------WDNDGFGQPGAIGESMARKYLRD 234
           QH  +V L  V+  +P     Y++ EY+E            G          MA      
Sbjct: 66  QHQRLVRLYAVVTQEP----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA----Q 117

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FT 293
           I  G+ ++   N +H D++  N+LV+ + + KI DF ++++ ED+    R     P+ +T
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177

Query: 294 APECCLGLTYGG--KAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN-SLVFPDA 349
           APE    + YG     +D W+ G+ L  ++  G+ P+ G T  +    +     +V PD 
Sbjct: 178 APE---AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234

Query: 350 MNPELRNLLEGLLC--KDPTRR 369
              EL  L+   LC  + P  R
Sbjct: 235 CPEELYQLM--RLCWKERPEDR 254

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  103 bits (259), Expect = 3e-25
 Identities = 72/281 (25%), Positives = 114/281 (40%), Gaps = 51/281 (18%)

Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            R++G G++GKV L    +    K     A+KA        L+   +  A  D +RE  +
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKA--------LKDP-TLAARKDFQREAEL 70

Query: 178 MKMLQHPNIVNLIEV--IDDPNSDHFYMVLEYVEG------------KWDNDGFGQPGAI 223
           +  LQH +IV    V    DP      MV EY++                    GQP   
Sbjct: 71  LTNLQHEHIVKFYGVCGDGDP----LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126

Query: 224 GESMARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
              +    +      I SG++YL   + VH D+   N LV  +  VKIGDF +S+     
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY-S 185

Query: 280 NDVLRRSPGT--PV-FTAPECCLGLTYGG--KAADTWAVGVTLYYMI-IGQYPFLGETLQ 333
            D  R    T  P+ +  PE    + Y      +D W+ GV L+ +   G+ P+   +  
Sbjct: 186 TDYYRVGGHTMLPIRWMPPES---IMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 242

Query: 334 DTYDKIVN-NSLVFPDAMNPELRNLLEGLLC--KDPTRRLT 371
           +  + I     L  P     E+ +++  L C  ++P +RL 
Sbjct: 243 EVIECITQGRVLERPRVCPKEVYDVM--LGCWQREPQQRLN 281

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  103 bits (260), Expect = 3e-25
 Identities = 73/278 (26%), Positives = 115/278 (41%), Gaps = 46/278 (16%)

Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
             ++G G++GKV L    + L  +     A+KA        L+ A SE+A  D +RE  +
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKA--------LKEA-SESARQDFQREAEL 96

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG---------------KWDNDGFGQPGA 222
           + MLQH +IV    V  +       MV EY+                          PG 
Sbjct: 97  LTMLQHQHIVRFFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154

Query: 223 IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
           +G          + +G++YL G + VH D+   N LV     VKIGDF +S+      D 
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-STDY 213

Query: 283 LRRSPGT--PV-FTAPECCLGLTYGG--KAADTWAVGVTLYYMI-IGQYPFLGETLQDTY 336
            R    T  P+ +  PE    + Y      +D W+ GV L+ +   G+ P+   +  +  
Sbjct: 214 YRVGGRTMLPIRWMPPES---ILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270

Query: 337 DKIVN-NSLVFPDAMNPELRNLLEGLLC--KDPTRRLT 371
           D I     L  P A  PE+  ++    C  ++P +R +
Sbjct: 271 DCITQGRELERPRACPPEVYAIM--RGCWQREPQQRHS 306

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  103 bits (258), Expect = 3e-25
 Identities = 69/282 (24%), Positives = 109/282 (38%), Gaps = 52/282 (18%)

Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + ++G   +GKV          G+     AIK         L+         + R E ++
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT--------LKDKAEGPLREEFRHEAML 65

Query: 178 MKMLQHPNIVNLIEVI--DDPNSDHFYMVLEYVEG----------------KWDNDGFGQ 219
              LQHPN+V L+ V+  D P      M+  Y                      +D    
Sbjct: 66  RARLQHPNVVCLLGVVTKDQP----LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121

Query: 220 PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
             A+        +  I +G+ YL  H+VVH D+   N+LV     VKI D  + +     
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY-A 180

Query: 280 NDVLRRSPGT--PV-FTAPECCLGLTYGGK---AADTWAVGVTLYYMI-IGQYPFLGETL 332
            D  +    +  P+ + APE    + Y GK    +D W+ GV L+ +   G  P+ G + 
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEA---IMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 236

Query: 333 QDTYDKIVN-NSLVFPDAMNPELRNLLEGLLC--KDPTRRLT 371
           QD  + I N   L  PD     +  L+  + C  + P+RR  
Sbjct: 237 QDVVEMIRNRQVLPCPDDCPAWVYALM--IECWNEFPSRRPR 276

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  104 bits (262), Expect = 6e-25
 Identities = 56/237 (23%), Positives = 90/237 (37%), Gaps = 43/237 (18%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK----AFHKSHLSKLRVAPSETAMTDVRREV 175
           Y+    IG GSYG V L       K+ AIK     F      K R+           RE+
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK-RIL----------REI 76

Query: 176 LIMKMLQHPNIVNLIEVIDDPNSDHF---YMVLEYVEGKWD-NDGFGQPGAIGESMARKY 231
            I+  L+   I+ L ++I   +   F   Y+VLE  +   D    F  P  + E   +  
Sbjct: 77  TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD--SDLKKLFKTPIFLTEEHIKTI 134

Query: 232 LRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP- 290
           L +++ G  ++H   ++H D+KP N L+    +VK+ DF +++    + D    +     
Sbjct: 135 LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194

Query: 291 -----------------VFT----APECCLGLTYGGKAADTWAVGVTLYYMIIGQYP 326
                            V T    APE  L      K+ D W+ G     ++     
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  103 bits (259), Expect = 1e-24
 Identities = 74/337 (21%), Positives = 124/337 (36%), Gaps = 90/337 (26%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK----AFHKSHLSKLRVAPSETAMTDVR--R 173
           Y  V+K+G G+YG V        G+  A+K    AF  S  ++             R  R
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ-------------RTFR 57

Query: 174 EVLIMK-MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           E++I+  +  H NIVNL+ V+   N    Y+V +Y+E             +     +  +
Sbjct: 58  EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANI--LEPVHKQYVV 115

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF------------SVSQVFEDDN 280
             ++  + YLH   ++H D+KP N+L+     VK+ DF            + +     + 
Sbjct: 116 YQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175

Query: 281 DVLRRSPGTPVFT---------APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF---- 327
           +        P+ T         APE  LG T   K  D W++G  L  ++ G+  F    
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235

Query: 328 -----------LGETLQDTYDKIVNN-------------------------------SLV 345
                      +     +  + I +                                  +
Sbjct: 236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKI 295

Query: 346 FPDA-MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            P A  N E  +LL+ LL  +P +R++ ND  KH +V
Sbjct: 296 NPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFV 332

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  101 bits (254), Expect = 1e-24
 Identities = 56/228 (24%), Positives = 91/228 (39%), Gaps = 31/228 (13%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
             K+G G YG+V  Y           A+K   +  +             +  +E  +MK 
Sbjct: 18  KHKLGGGQYGEV--YEGVWKKYSLTVAVKTLKEDTMEV----------EEFLKEAAVMKE 65

Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESMARKYLRDIVS 237
           ++HPN+V L+ V        FY++ E++    +   +        +   +       I S
Sbjct: 66  IKHPNLVQLLGVCTR--EPPFYIITEFMT-YGNLLDYLRECNRQEVSAVVLLYMATQISS 122

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PVF-TA 294
            + YL   N +H D+   N LV  +  VK+ DF +S++     D      G   P+  TA
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTA 180

Query: 295 PECCLGLTYG--GKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKI 339
           PE    L Y      +D WA GV L+ +   G  P+ G  L   Y+ +
Sbjct: 181 PE---SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  104 bits (260), Expect = 1e-24
 Identities = 53/228 (23%), Positives = 101/228 (44%), Gaps = 33/228 (14%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
            +K+GAG +G+V  + ++ +     A+K             P   ++     E  +MK L
Sbjct: 193 EKKLGAGQFGEV--WMATYNKHTKVAVKTMK----------PGSMSVEAFLAEANVMKTL 240

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGK------WDNDGFGQPGAIGESMARKYLRDI 235
           QH  +V L  V+     +  Y++ E++           ++G  QP       +      I
Sbjct: 241 QHDKLVKLHAVVTK---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA----QI 293

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV-FTA 294
             G+ ++   N +H D++  N+LV+ S   KI DF +++V ED+    R     P+ +TA
Sbjct: 294 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA 353

Query: 295 PECCLGLTYG--GKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKI 339
           PE    + +G     +D W+ G+ L  ++  G+ P+ G +  +    +
Sbjct: 354 PE---AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  101 bits (255), Expect = 2e-24
 Identities = 63/279 (22%), Positives = 112/279 (40%), Gaps = 52/279 (18%)

Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            R++G GS+G V   + +  +  +     AIK         +  A S     +   E  +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT--------VNEAASMRERIEFLNEASV 81

Query: 178 MKMLQHPNIVNLIEV--IDDPNSDHFYMVLEYVEG------------KWDNDGFGQPGAI 223
           MK     ++V L+ V     P      +++E +                 N+    P ++
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQP----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137

Query: 224 GE--SMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281
            +   MA     +I  G+ YL+ +  VH D+   N +VA   TVKIGDF +++   +  D
Sbjct: 138 SKMIQMA----GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET-D 192

Query: 282 VLRRSPGT--PV-FTAPECCLGLTYGG--KAADTWAVGVTLYYMI-IGQYPFLGETLQDT 335
             R+      PV + +PE    L  G     +D W+ GV L+ +  + + P+ G + +  
Sbjct: 193 YYRKGGKGLLPVRWMSPES---LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249

Query: 336 YDKIVN-NSLVFPDAMNPELRNLLEGLLC--KDPTRRLT 371
              ++    L  PD     L  L+   +C   +P  R +
Sbjct: 250 LRFVMEGGLLDKPDNCPDMLFELM--RMCWQYNPKMRPS 286

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 99.3 bits (248), Expect = 2e-23
 Identities = 61/275 (22%), Positives = 101/275 (36%), Gaps = 44/275 (16%)

Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +R +G G++G+V         +       A+K         L    SE    D   E LI
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--------LPEVCSEQDELDFLMEALI 86

Query: 178 MKMLQHPNIVNLIEV--IDDPNSDHFYMVLEYVEG-------KWDNDGFGQPGAIGESMA 228
           +    H NIV  I V     P     ++++E + G       +       QP ++     
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLP----RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142

Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---TVKIGDFSVSQVFEDDNDVLRR 285
               RDI  G  YL  ++ +H DI   N L+   G     KIGDF +++         R+
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRK 201

Query: 286 SPGT--PV-FTAPECCLGLTYGG--KAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKI 339
                 PV +  PE       G      DTW+ GV L+ +  +G  P+  ++ Q+  + +
Sbjct: 202 GGCAMLPVKWMPPEA---FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258

Query: 340 VN-NSLVFPDAMNPELRNLLEGLLC--KDPTRRLT 371
            +   +  P      +  ++    C    P  R  
Sbjct: 259 TSGGRMDPPKNCPGPVYRIM--TQCWQHQPEDRPN 291

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 98.2 bits (245), Expect = 3e-23
 Identities = 60/271 (22%), Positives = 107/271 (39%), Gaps = 35/271 (12%)

Query: 123 VRKIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
            R +G G +G V    L +        A+K              + + + +  RE   MK
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD-------IIASSDIEEFLREAACMK 80

Query: 180 MLQHPNIVNLIEVI--DDPNSDH--FYMVLEYVEGK------WDNDGFGQPGAIGESMAR 229
              HP++  L+ V              ++L +++          +     P  +      
Sbjct: 81  EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140

Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
           +++ DI  G+ YL   N +H D+   N ++A   TV + DF +S+      D  R+   +
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY-SGDYYRQGCAS 199

Query: 290 --PV-FTAPECCLGLTYG--GKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVN-N 342
             PV + A E    L        +D WA GVT++ ++  GQ P+ G    + Y+ ++  N
Sbjct: 200 KLPVKWLALES---LADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256

Query: 343 SLVFPDAMNPELRNLLEGLLC--KDPTRRLT 371
            L  P     E+ +L+    C   DP +R +
Sbjct: 257 RLKQPPECMEEVYDLM--YQCWSADPKQRPS 285

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 98.6 bits (246), Expect = 4e-23
 Identities = 62/275 (22%), Positives = 101/275 (36%), Gaps = 44/275 (16%)

Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +R +G G++G+V         +       A+K         L    SE    D   E LI
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--------LPEVCSEQDELDFLMEALI 127

Query: 178 MKMLQHPNIVNLIEV--IDDPNSDHFYMVLEYVEG-------KWDNDGFGQPGAIGESMA 228
           +    H NIV  I V     P     +++LE + G       +       QP ++     
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLP----RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183

Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---TVKIGDFSVSQVFEDDNDVLRR 285
               RDI  G  YL  ++ +H DI   N L+   G     KIGDF +++         R+
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RAGYYRK 242

Query: 286 SPGT--PV-FTAPECCLGLTYGG--KAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKI 339
                 PV +  PE       G      DTW+ GV L+ +  +G  P+  ++ Q+  + +
Sbjct: 243 GGCAMLPVKWMPPE---AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299

Query: 340 VN-NSLVFPDAMNPELRNLLEGLLC--KDPTRRLT 371
            +   +  P      +  ++    C    P  R  
Sbjct: 300 TSGGRMDPPKNCPGPVYRIM--TQCWQHQPEDRPN 332

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 98.3 bits (245), Expect = 7e-23
 Identities = 56/263 (21%), Positives = 100/263 (38%), Gaps = 30/263 (11%)

Query: 124 RKIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
             IG G +G V    L  +     H A+K+        L        ++    E +IMK 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--------LNRITDIGEVSQFLTEGIIMKD 146

Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVSG 238
             HPN+++L+ +    +     +VL Y++   D   F   +           +   +  G
Sbjct: 147 FSHPNVLSLLGICLR-SEGSPLVVLPYMKHG-DLRNFIRNETHNPTVKDLIGFGLQVAKG 204

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSPGT--PV-FTA 294
           + +L     VH D+   N ++    TVK+ DF ++  +++ + D +    G   PV + A
Sbjct: 205 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264

Query: 295 PECCLGLTYG--GKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVN-NSLVFPDAM 350
            E    L        +D W+ GV L+  M  G  P+      D    ++    L+ P+  
Sbjct: 265 LES---LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 321

Query: 351 NPELRNLLEGLLC--KDPTRRLT 371
              L  ++  L C       R +
Sbjct: 322 PDPLYEVM--LKCWHPKAEMRPS 342

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 97.0 bits (242), Expect = 1e-22
 Identities = 70/290 (24%), Positives = 109/290 (37%), Gaps = 60/290 (20%)

Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           VR IG G++G+V        L  + +   A+K         L+   S     D +RE  +
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM--------LKEEASADMQADFQREAAL 103

Query: 178 MKMLQHPNIVNLIEV--IDDPNSDHFYMVLEYVEG---------------KWDNDGFGQP 220
           M    +PNIV L+ V  +  P      ++ EY+                    +      
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKP----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159

Query: 221 GAIGESMARKYL---------RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
            A   S     L         R + +G+ YL     VH D+   N LV  +  VKI DF 
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 219

Query: 272 VSQVFEDDNDVLRRSPGT--PV-FTAPECCLGLTYGGK---AADTWAVGVTLYYMI-IGQ 324
           +S+      D  +       P+ +  PE    + Y  +    +D WA GV L+ +   G 
Sbjct: 220 LSRNIY-SADYYKADGNDAIPIRWMPPES---IFY-NRYTTESDVWAYGVVLWEIFSYGL 274

Query: 325 YPFLGETLQDTYDKIVN-NSLVFPDAMNPELRNLLEGLLC--KDPTRRLT 371
            P+ G   ++    + + N L  P+    EL NL+   LC  K P  R +
Sbjct: 275 QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLM--RLCWSKLPADRPS 322

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 56/264 (21%), Positives = 98/264 (37%), Gaps = 30/264 (11%)

Query: 123 VRKIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
              IG G +G V    L  +     H A+K+        L        ++    E +IMK
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--------LNRITDIGEVSQFLTEGIIMK 81

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDIVS 237
              HPN+++L+ +          +VL Y++   D   F   +           +   +  
Sbjct: 82  DFSHPNVLSLLGICLRSEG-SPLVVLPYMKHG-DLRNFIRNETHNPTVKDLIGFGLQVAK 139

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSPGT--PV-FT 293
           G+ YL     VH D+   N ++    TVK+ DF ++  +++ +   +    G   PV + 
Sbjct: 140 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199

Query: 294 APECCLGLTYG--GKAADTWAVGVTLY-YMIIGQYPFLGETLQDTYDKIVN-NSLVFPDA 349
           A E    L        +D W+ GV L+  M  G  P+      D    ++    L+ P+ 
Sbjct: 200 ALES---LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 256

Query: 350 MNPELRNLLEGLLC--KDPTRRLT 371
               L  ++  L C       R +
Sbjct: 257 CPDPLYEVM--LKCWHPKAEMRPS 278

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 33/226 (14%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
           ++ IG G +G V        G   A+K       ++               E  +M  L+
Sbjct: 26  LQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQ-----------AFLAEASVMTQLR 72

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESMARKYLRDIVSGL 239
           H N+V L+ VI +      Y+V EY+  K     +        +G     K+  D+   +
Sbjct: 73  HSNLVQLLGVIVE-EKGGLYIVTEYMA-KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PV-FTAPE 296
            YL G+N VH D+   N+LV+     K+ DF +++      +          PV +TAPE
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPE 184

Query: 297 CCLGLTYG--GKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKI 339
               L        +D W+ G+ L+ +   G+ P+    L+D   ++
Sbjct: 185 A---LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 96.6 bits (241), Expect = 5e-22
 Identities = 59/265 (22%), Positives = 100/265 (37%), Gaps = 43/265 (16%)

Query: 91  GLICR--QFPVKESNKLIRSEDENGTKMIN--EYVHVRKIGAGSYGKVVLYRSSLDGKHY 146
           GL  R  +  V E     + E       +N  E   ++ IG G +G V        G   
Sbjct: 162 GLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDV--MLGDYRGNKV 219

Query: 147 AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLE 206
           A+K         ++   ++        E  +M  L+H N+V L+ VI +      Y+V E
Sbjct: 220 AVKC--------IK---NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVTE 267

Query: 207 YVEGK------WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA 260
           Y+                  G      +     D+   + YL G+N VH D+   N+LV+
Sbjct: 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSL----DVCEAMEYLEGNNFVHRDLAARNVLVS 323

Query: 261 PSGTVKIGDFSVSQVFEDDNDVLRRSPGT--PV-FTAPECCLGLTYG--GKAADTWAVGV 315
                K+ DF +++      +          PV +TAPE    L        +D W+ G+
Sbjct: 324 EDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPE---ALREKKFSTKSDVWSFGI 374

Query: 316 TLYYMI-IGQYPFLGETLQDTYDKI 339
            L+ +   G+ P+    L+D   ++
Sbjct: 375 LLWEIYSFGRVPYPRIPLKDVVPRV 399

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 94.3 bits (235), Expect = 7e-22
 Identities = 62/271 (22%), Positives = 105/271 (38%), Gaps = 36/271 (13%)

Query: 123 VRKIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
            + +G G +G V    L +        A+K     + S       +  + +   E   MK
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-------QREIEEFLSEAACMK 91

Query: 180 MLQHPNIVNLIEVI---DDPNSDHFYMVLEYVEGKWDNDGF-------GQPGAIGESMAR 229
              HPN++ L+ V             ++L +++   D   +         P  I      
Sbjct: 92  DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYG-DLHTYLLYSRLETGPKHIPLQTLL 150

Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
           K++ DI  G+ YL   N +H D+   N ++    TV + DF +S+      D  R+    
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY-SGDYYRQGRIA 209

Query: 290 --PV-FTAPECCLGLTYG--GKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVN-N 342
             PV + A E    L        +D WA GVT++ +   G  P+ G    + YD +++ +
Sbjct: 210 KMPVKWIAIES---LADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH 266

Query: 343 SLVFPDAMNPELRNLLEGLLC--KDPTRRLT 371
            L  P+    EL  ++    C   DP  R T
Sbjct: 267 RLKQPEDCLDELYEIM--YSCWRTDPLDRPT 295

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 93.9 bits (234), Expect = 8e-22
 Identities = 61/277 (22%), Positives = 104/277 (37%), Gaps = 58/277 (20%)

Query: 124 RKIGAGSYGKVV--LYRSSLDGKHY-AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
           R IG G +G V    Y      +   AIK+        L        +    RE L+M+ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKS--------LSRITEMQQVEAFLREGLLMRG 78

Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR------- 233
           L HPN++ LI ++  P     +++L Y+            G +      +++R       
Sbjct: 79  LNHPNVLALIGIMLPPEG-LPHVLLPYMCH----------GDL-----LQFIRSPQRNPT 122

Query: 234 ---------DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVL 283
                     +  G+ YL     VH D+   N ++  S TVK+ DF ++  + + +   +
Sbjct: 123 VKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182

Query: 284 RRSPGT--PV-FTAPECCLGLTYG--GKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYD 337
           ++      PV +TA E    L        +D W+ GV L+ ++  G  P+      D   
Sbjct: 183 QQHRHARLPVKWTALES---LQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH 239

Query: 338 KIVN-NSLVFPDAMNPELRNLLEGLLC--KDPTRRLT 371
            +     L  P+     L  ++    C   DP  R T
Sbjct: 240 FLAQGRRLPQPEYCPDSLYQVM--QQCWEADPAVRPT 274

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 93.6 bits (233), Expect = 2e-21
 Identities = 58/339 (17%), Positives = 118/339 (34%), Gaps = 101/339 (29%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD-VRREVLIM 178
           Y+ VRK+G G +  V L +  ++  H A+K           +   +   T+    E+ ++
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMK-----------IVRGDKVYTEAAEDEIKLL 69

Query: 179 KMLQ--------HPNIVNLIEVIDD-----PNSDHFYMVLE------Y-VEGKWDNDGFG 218
           + +              ++++++D      PN  H  MV E        +  K+++ G  
Sbjct: 70  QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129

Query: 219 QPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPS------GTVKIGDFS 271
                     ++  + ++ GL Y+H    ++H DIKP+N+L+           +KI D  
Sbjct: 130 LI------YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG 183

Query: 272 VSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG 329
            +  + D++  + ++    T  + +PE  LG  + G  AD W+    ++ +I G + F  
Sbjct: 184 NA-CWYDEHYTNSIQ----TREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEP 237

Query: 330 ETLQDTYD------------------------------------------------KIVN 341
           +                                                        ++ 
Sbjct: 238 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT 297

Query: 342 NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
               F      E+ + L  +L  DP +R     +  H W
Sbjct: 298 EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW 336

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 91.5 bits (228), Expect = 7e-21
 Identities = 65/288 (22%), Positives = 118/288 (40%), Gaps = 56/288 (19%)

Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            + +G G +GKVV            Y   A+K         L+   S + + D+  E  +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK--------MLKENASPSELRDLLSEFNV 79

Query: 178 MKMLQHPNIVNLIEV--IDDPNSDHFYMVLEYVEG---------------KWDNDGFGQP 220
           +K + HP+++ L      D P      +++EY +                 +   G  + 
Sbjct: 80  LKQVNHPHVIKLYGACSQDGP----LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135

Query: 221 GAIGESMARKYL---------RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
            +  +    + L           I  G+ YL    +VH D+   N+LVA    +KI DF 
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFG 195

Query: 272 VSQ-VFEDDNDVLRRSPGTPV-FTAPECCLGLTYGG--KAADTWAVGVTLYYMI-IGQYP 326
           +S+ V+E+D+ V R     PV + A E    L        +D W+ GV L+ ++ +G  P
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWMAIES---LFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

Query: 327 FLGETLQDTYDKIVN-NSLVFPDAMNPELRNLLEGLLC--KDPTRRLT 371
           + G   +  ++ +   + +  PD  + E+  L+  L C  ++P +R  
Sbjct: 253 YPGIPPERLFNLLKTGHRMERPDNCSEEMYRLM--LQCWKQEPDKRPV 298

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 61/283 (21%), Positives = 111/283 (39%), Gaps = 51/283 (18%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVA-------PSETAMTDVRREV 175
            + +G G +G+VV           A+          + VA        +E  ++D+  E+
Sbjct: 86  GKPLGEGCFGQVV--------MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137

Query: 176 LIMKML-QHPNIVNLIEV--IDDPNSDHFYMVLEYVEG------------KWDNDGFGQP 220
            +MKM+ +H NI+NL+     D P     Y+++EY                     +   
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193

Query: 221 GAIGESMARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QV 275
               E M  K L      +  G+ YL     +H D+   N+LV  +  +KI DF ++  +
Sbjct: 194 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 253

Query: 276 FEDDNDVLRRSPGTPV-FTAPECCLGLTYGG--KAADTWAVGVTLYYMI-IGQYPFLGET 331
              D      +   PV + APE    L        +D W+ GV ++ +  +G  P+ G  
Sbjct: 254 NNIDYYKKTTNGRLPVKWMAPEA---LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310

Query: 332 LQDTYDKIVN-NSLVFPDAMNPELRNLLEGLLC--KDPTRRLT 371
           +++ +  +   + +  P     EL  ++    C    P++R T
Sbjct: 311 VEELFKLLKEGHRMDKPANCTNELYMMM--RDCWHAVPSQRPT 351

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 53/244 (21%), Positives = 95/244 (38%), Gaps = 46/244 (18%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHY----AIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
              IG G++G+V   ++ +         AIK        +++   S+    D   E+ ++
Sbjct: 30  QDVIGEGNFGQV--LKARIKKDGLRMDAAIK--------RMKEYASKDDHRDFAGELEVL 79

Query: 179 KML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEG----------------KWDNDGFGQPG 221
             L  HPNI+NL+   +     + Y+ +EY                              
Sbjct: 80  CKLGHHPNIINLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137

Query: 222 AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND 281
            +       +  D+  G+ YL     +H D+   N+LV  +   KI DF +S+      +
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQE 193

Query: 282 VLRRSPGT--PV-FTAPECCLGLTYGG--KAADTWAVGVTLYYMI-IGQYPFLGETLQDT 335
           V  +      PV + A E    L Y      +D W+ GV L+ ++ +G  P+ G T  + 
Sbjct: 194 VYVKKTMGRLPVRWMAIES---LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 250

Query: 336 YDKI 339
           Y+K+
Sbjct: 251 YEKL 254

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 61/283 (21%), Positives = 112/283 (39%), Gaps = 51/283 (18%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVA-------PSETAMTDVRREV 175
            + +G G++G+VV           A+          + VA        +E  ++D+  E+
Sbjct: 40  GKPLGEGAFGQVV--------MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91

Query: 176 LIMKML-QHPNIVNLIEV--IDDPNSDHFYMVLEYVEG------------KWDNDGFGQP 220
            +MKM+ +H NI+NL+     D P     Y+++EY                     +   
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147

Query: 221 GAIGESMARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QV 275
               E M  K L      +  G+ YL     +H D+   N+LV  +  +KI DF ++  +
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207

Query: 276 FEDDNDVLRRSPGTPV-FTAPECCLGLTYGG--KAADTWAVGVTLYYMI-IGQYPFLGET 331
              D      +   PV + APE    L        +D W+ GV ++ +  +G  P+ G  
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEA---LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264

Query: 332 LQDTYDKIVN-NSLVFPDAMNPELRNLLEGLLC--KDPTRRLT 371
           +++ +  +   + +  P     EL  ++    C    P++R T
Sbjct: 265 VEELFKLLKEGHRMDKPANCTNELYMMM--RDCWHAVPSQRPT 305

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 59/277 (21%), Positives = 115/277 (41%), Gaps = 39/277 (14%)

Query: 123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSK-----LRVAPSETAMTDVRREVLI 177
            + +G G++G+VVL       +   +     + ++K     L+   +E  ++D+  E+ +
Sbjct: 74  GKPLGEGAFGQVVL------AEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 127

Query: 178 MKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEG------------KWDNDGFGQPGAIG 224
           MKM+ +H NI+NL+           Y+++EY                     +       
Sbjct: 128 MKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185

Query: 225 ESMARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDD 279
           E ++ K L      +  G+ YL     +H D+   N+LV     +KI DF ++  +   D
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245

Query: 280 NDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYD 337
                 +   PV + APE      Y  + +D W+ GV L+ +  +G  P+ G  +++ + 
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304

Query: 338 KIVN-NSLVFPDAMNPELRNLLEGLLC--KDPTRRLT 371
            +   + +  P     EL  ++    C    P++R T
Sbjct: 305 LLKEGHRMDKPSNCTNELYMMM--RDCWHAVPSQRPT 339

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 86.1 bits (214), Expect = 4e-19
 Identities = 60/282 (21%), Positives = 108/282 (38%), Gaps = 48/282 (17%)

Query: 123 VRKIGAGSYGKVV--LYRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            + +GAG++GKVV       +        A+K         L+ +   T    +  E+ +
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK--------MLKPSAHLTEREALMSELKV 79

Query: 178 MKML-QHPNIVNLIEV--IDDPNSDHFYMVLEYVEG------------KWDNDGFGQPGA 222
           +  L  H NIVNL+    I  P      ++ EY                +          
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGP----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 223 IGESMARKYL------RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QV 275
             + +A            +  G+ +L   N +H D+   N+L+      KI DF ++  +
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 276 FEDDNDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLG-ETL 332
             D N V++ +   PV + APE      Y  + +D W+ G+ L+ +  +G  P+ G    
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVD 254

Query: 333 QDTYDKIVN-NSLVFPDAMNPELRNLLEGLLC--KDPTRRLT 371
              Y  I     ++ P+    E+ +++    C   DP +R T
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIM--KTCWDADPLKRPT 294

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 86.2 bits (214), Expect = 5e-19
 Identities = 39/222 (17%), Positives = 90/222 (40%), Gaps = 38/222 (17%)

Query: 123 VRKIGAGSYGKVVL-----YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            + +G G++G+V+         +   +  A+K         L+   + +    +  E+ I
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVK--------MLKEGATHSEHRALMSELKI 83

Query: 178 MKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVE------------GKWDNDGFGQPGAIG 224
           +  +  H N+VNL+     P      +++E+ +             ++            
Sbjct: 84  LIHIGHHLNVVNLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142

Query: 225 ESMARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ-VFEDD 279
           + +  ++L      +  G+ +L     +H D+   N+L++    VKI DF +++ +++D 
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202

Query: 280 NDVLRRSPGTPV-FTAPECCLGLTYGG--KAADTWAVGVTLY 318
           + V +     P+ + APE    +        +D W+ GV L+
Sbjct: 203 DYVRKGDARLPLKWMAPET---IFDRVYTIQSDVWSFGVLLW 241

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 59/278 (21%), Positives = 105/278 (37%), Gaps = 44/278 (15%)

Query: 123 VRKIGAGSYGKVVL-----YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            + +GAG++GKVV                A+K         L+          +  E+ I
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK--------MLKSTAHADEKEALMSELKI 102

Query: 178 MKML-QHPNIVNLIEV--IDDPNSDHFYMVLEYVEG----------KWDNDGFGQPGAIG 224
           M  L QH NIVNL+       P      ++ EY                 +         
Sbjct: 103 MSHLGQHENIVNLLGACTHGGP----VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158

Query: 225 ESMARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDD 279
            + + + L      +  G+ +L   N +H D+   N+L+      KIGDF ++  +  D 
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218

Query: 280 NDVLRRSPGTPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLG-ETLQDTY 336
           N +++ +   PV + APE      Y  + +D W+ G+ L+ +  +G  P+ G       Y
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277

Query: 337 DKIVN-NSLVFPDAMNPELRNLLEGLLC--KDPTRRLT 371
             + +   +  P      + +++    C   +PT R T
Sbjct: 278 KLVKDGYQMAQPAFAPKNIYSIM--QACWALEPTHRPT 313

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 83.5 bits (207), Expect = 5e-18
 Identities = 51/231 (22%), Positives = 89/231 (38%), Gaps = 50/231 (21%)

Query: 123 VRKIGAGSYGKVVL--YRSSLDGKHY---AIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            + +G+G++GKV+                A+K         L+     +    +  E+ +
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVK--------MLKEKADSSEREALMSELKM 101

Query: 178 MKML-QHPNIVNLIEV--IDDPNSDHFYMVLEYVEG-------------------KWDND 215
           M  L  H NIVNL+    +  P     Y++ EY                      +++N 
Sbjct: 102 MTQLGSHENIVNLLGACTLSGP----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157

Query: 216 GFGQPGAIGESMARKYL----RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS 271
              +       +  + L      +  G+ +L   + VH D+   N+LV     VKI DF 
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFG 217

Query: 272 VS-QVFEDDNDVLRRSPGTPV-FTAPECCLGLTYGG--KAADTWAVGVTLY 318
           ++  +  D N V+R +   PV + APE    L  G     +D W+ G+ L+
Sbjct: 218 LARDIMSDSNYVVRGNARLPVKWMAPES---LFEGIYTIKSDVWSYGILLW 265

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 77.5 bits (191), Expect = 9e-16
 Identities = 61/260 (23%), Positives = 100/260 (38%), Gaps = 65/260 (25%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIK------AFHKSHLSKLRVAPSETAMTDVRR 173
           Y  ++ IG GS+G+VV        +H A+K       FH+             A      
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHR------------QAAE---- 142

Query: 174 EVLIMKMLQH------PNIVNLIEVIDDPNSDHFYMVLEYVEG-------KWDNDGFGQP 220
           E+ I++ L+        N+++++E     N  H  M  E +         K    GF   
Sbjct: 143 EIRILEHLRKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSL- 199

Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG--TVKIGDFSVSQVFED 278
                 + RK+   I+  L  LH + ++H D+KP+N+L+   G   +K+ DF  S  +E 
Sbjct: 200 -----PLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEH 253

Query: 279 DNDVLRRSPGTPVFT--------APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE 330
                       V+T        APE  LG  Y G   D W++G  L  ++ G     GE
Sbjct: 254 QR----------VYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGE 302

Query: 331 TLQDTYDKIVNNSLVFPDAM 350
              D    ++    +    +
Sbjct: 303 DEGDQLACMIELLGMPSQKL 322

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 74.2 bits (182), Expect = 9e-15
 Identities = 54/278 (19%), Positives = 91/278 (32%), Gaps = 79/278 (28%)

Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
           G      Y  +RK+G G +  V L       K  A+K      + K     +ETA+    
Sbjct: 32  GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK------VVKSAEHYTETAL---- 81

Query: 173 REVLIMKMLQ-----HPNIVNLIEVIDD-----PNSDHFYMVLEYVEGK--WDNDGFGQP 220
            E+ ++K ++      PN   +++++DD      N  H  MV E V G            
Sbjct: 82  DEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNY 140

Query: 221 GAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPS----------------- 262
             +     +K ++ ++ GL YLH    ++H DIKP+N+L++ +                 
Sbjct: 141 QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRS 200

Query: 263 --------------------------------GTVKIGDFSVSQVFEDDNDVLRRSPGTP 290
                                             VKI D   +                 
Sbjct: 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQT 256

Query: 291 -VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF 327
             + + E  +G  Y    AD W+     + +  G Y F
Sbjct: 257 RQYRSLEVLIGSGY-NTPADIWSTACMAFELATGDYLF 293

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 70.7 bits (172), Expect = 1e-13
 Identities = 32/197 (16%), Positives = 58/197 (29%), Gaps = 42/197 (21%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            +     KIG G +G+V  +++  D    AIK         L     +    ++  E++I
Sbjct: 20  EKLQRCEKIGEGVFGEV--FQTIADHTPVAIKIIAI-EGPDLVNGSHQKTFEEILPEIII 76

Query: 178 MKMLQ---------HPNIVNLIEVI----------------------------DDPNSDH 200
            K L              + L  V                             D    D 
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 201 FYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH-GHNVVHGDIKPDNLLV 259
            ++VLE+  G  D +          + A+  L  + + L          H D+   N+L+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195

Query: 260 APSGTVKIGDFSVSQVF 276
             +   K+      +  
Sbjct: 196 KKTSLKKLHYTLNGKSS 212

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 69.1 bits (170), Expect = 3e-13
 Identities = 56/220 (25%), Positives = 91/220 (41%), Gaps = 40/220 (18%)

Query: 125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP 184
           K+G G +G V  Y+  ++    A+K      L+ +    +E       +E+ +M   QH 
Sbjct: 38  KMGEGGFGVV--YKGYVNNTTVAVKK-----LAAMVDITTEELKQQFDQEIKVMAKCQHE 90

Query: 185 NIVNLIEV-IDDPNSDHFYMVLEYVE-GKWDNDGFGQPG------------AIGESMARK 230
           N+V L+    D    D   +V  Y+  G   +      G            A G   A  
Sbjct: 91  NLVELLGFSSDG---DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQG--AAN- 144

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPG 288
                  G+ +LH ++ +H DIK  N+L+  + T KI DF +++  E      +  R  G
Sbjct: 145 -------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVG 197

Query: 289 TPVFTAPECCLG-LTYGGKAADTWAVGVTLYYMIIGQYPF 327
           T  + APE   G +T   K +D ++ GV L  +I G    
Sbjct: 198 TTAYMAPEALRGEITP--K-SDIYSFGVVLLEIITGLPAV 234

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 58/253 (22%), Positives = 96/253 (37%), Gaps = 67/253 (26%)

Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIK------AFHKSHLSKLRVAPSET 166
           G K ++ Y     IG GS+G+VV     ++ +  AIK      AF               
Sbjct: 49  GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN------------Q 96

Query: 167 AMTDVRREVLIMKMLQHP------NIVNLIEVIDDPNSDHFYMVLEYVEG-------KWD 213
           A      EV +++++          IV+L       N  H  +V E +           +
Sbjct: 97  AQI----EVRLLELMNKHDTEMKYYIVHLKRHFMFRN--HLCLVFEMLSYNLYDLLRNTN 150

Query: 214 NDGFGQPGAIGESMARKYLRDIVSGLMYLHGH--NVVHGDIKPDN-LLVAPSGT-VKIGD 269
             G         ++ RK+ + + + L++L     +++H D+KP+N LL  P  + +KI D
Sbjct: 151 FRGVSL------NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204

Query: 270 FSVSQVFEDDNDVLRRSPGTPVFT--------APECCLGLTYGGKAADTWAVGVTLYYMI 321
           F  S                 ++         +PE  LG+ Y   A D W++G  L  M 
Sbjct: 205 FG-SSCQLGQR----------IYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMH 252

Query: 322 IGQYPFLGETLQD 334
            G+  F G    D
Sbjct: 253 TGEPLFSGANEVD 265

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 64/359 (17%), Positives = 114/359 (31%), Gaps = 125/359 (34%)

Query: 120 YVHVRKIGAGSYGKVVL-YRSSLDGKHYAIK------AFHKSHLSKLRVAPSETAMTDVR 172
           Y  V  +G G++GKVV        G+H A+K       + ++            A +   
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEA------------ARS--- 60

Query: 173 REVLIMKMLQHP------NIVNLIEVIDDPNSDHFYMVLE------YVEGKWDNDGFGQP 220
            E+ +++ L           V ++E  +     H  +V E      Y   K +N      
Sbjct: 61  -EIQVLEHLNTTDPNSTFRCVQMLEWFEHHG--HICIVFELLGLSTYDFIK-ENGFLPFR 116

Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG----------------- 263
                   RK    I   + +LH + + H D+KP+N+L   S                  
Sbjct: 117 L----DHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172

Query: 264 --TVKIGDFSVSQVFEDDNDVLRRSPGTPVFT--------APECCLGLTYGGKAADTWAV 313
              +K+ DF  S  ++D++            T        APE  L L +  +  D W++
Sbjct: 173 NPDIKVVDFG-SATYDDEH----------HSTLVSTRHYRAPEVILALGW-SQPCDVWSI 220

Query: 314 GVTLYYMIIGQYPFLGETLQD--------------------------------------T 335
           G  L    +G   F     ++                                       
Sbjct: 221 GCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSA 280

Query: 336 YDKIVNNS------LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI 388
              +          ++  D  +  L +L++ +L  DP +R+TL +  KH +       I
Sbjct: 281 GRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI 339

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 65/354 (18%), Positives = 113/354 (31%), Gaps = 109/354 (30%)

Query: 113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIK------AFHKSHLSKLRVAPSET 166
           G  + N ++ +RK+G G++G+V+L +   + K+YA+K       + +S            
Sbjct: 30  GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRS------------ 77

Query: 167 AMTDVRREVLIMKMLQH-----PNIVNLIEVIDDPNSDHFYMVLE------YVEGKWDND 215
           A      E  I+K +Q+      NIV         +  H  ++ E      Y      N+
Sbjct: 78  AKI----EADILKKIQNDDINNNNIVKYHGKFMYYD--HMCLIFEPLGPSLYEIIT-RNN 130

Query: 216 GFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDN-LLVAPSGTVKIGDFSVSQ 274
             G          + Y  +I+  L YL   ++ H D+KP+N LL  P     +       
Sbjct: 131 YNGFHI----EDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186

Query: 275 VFEDDNDVLRRSP-------GTPVFT--------------APECCLGLTYGGKAADTWAV 313
             +       +S        G   F               APE  L L +   ++D W+ 
Sbjct: 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW-DVSSDMWSF 245

Query: 314 GVTLYYMIIGQYPFLGETLQD--------------------------TYDKIVNNSLVFP 347
           G  L  +  G   F      +                           Y       L +P
Sbjct: 246 GCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWP 305

Query: 348 D--------------------AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           +                      +    + L  +L  DPT R +  ++ KH ++
Sbjct: 306 ENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 54/353 (15%), Positives = 108/353 (30%), Gaps = 127/353 (35%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHY-AIK------AFHKSHLSKLRVAPSETAMTDVR 172
           Y  V  +G G++GKVV       GK   A+K       + ++            A     
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA------------ARL--- 65

Query: 173 REVLIMKMLQHP------NIVNLIEVIDDPNSDHFYMVLE------Y-VEGKWDNDGFGQ 219
            E+ ++K ++          V + +  +     H  +  E      +    + +   +  
Sbjct: 66  -EINVLKKIKEKDKENKFLCVLMSDWFNFHG--HMCIAFELLGKNTFEFLKENNFQPYPL 122

Query: 220 PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---------------- 263
                    R     +   L +LH + + H D+KP+N+L   S                 
Sbjct: 123 ------PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176

Query: 264 ---TVKIGDFSVSQVFEDDNDVLRRSPGTPVFT--------APECCLGLTYGGKAADTWA 312
              ++++ DF  S  F+ ++            T         PE  L L +  +  D W+
Sbjct: 177 KNTSIRVADFG-SATFDHEH----------HTTIVATRHYRPPEVILELGW-AQPCDVWS 224

Query: 313 VGVTLYYMIIGQYPFLGETLQD-------------------------------------- 334
           +G  L+    G   F     ++                                      
Sbjct: 225 IGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSS 284

Query: 335 ------TYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
                    K + + ++     + +L +L+  +L  DP +R+TL +   H + 
Sbjct: 285 DGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 337

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 51/240 (21%), Positives = 97/240 (40%), Gaps = 36/240 (15%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           N++   RKIG+GS+G++ L  +    +  AIK           +   +T    +  E  I
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----------LENVKTKHPQLLYESKI 55

Query: 178 MKMLQ-HPNIVNLIEVIDDPNSDHFYMVLEY----VEGKWDNDGFGQPGAIGESMARKYL 232
            ++LQ    I N+         D+  +V++     +E  ++         +         
Sbjct: 56  YRILQGGTGIPNVRWFG--VEGDYNVLVMDLLGPSLEDLFNF----CSRKLSLKTVLMLA 109

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT---VKIGDFSVSQVFEDDNDVLRRSP-- 287
             +++ + ++H  + +H DIKPDN L+        V I DF +++ + D +         
Sbjct: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169

Query: 288 -----GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG---ETLQDTYDKI 339
                GT  + +    LG+    +  D  ++G  L Y + G  P+ G    T +  Y+KI
Sbjct: 170 NKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 58.9 bits (143), Expect = 7e-10
 Identities = 50/247 (20%), Positives = 88/247 (35%), Gaps = 48/247 (19%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
             Y   R+IG GS+G +    + L+ +  AIK             P  +    +R E   
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----------FEPRRSDAPQLRDEYRT 58

Query: 178 MKMLQH-PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG---------AIGESM 227
            K+L     I N+          H  +V++ + G    D     G            + M
Sbjct: 59  YKLLAGCTGIPNVYYFG--QEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQM 115

Query: 228 ARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT-----VKIGDFSVSQVFEDDNDV 282
                   ++ +  +H  ++V+ DIKPDN L+    +     + + DF + + + D    
Sbjct: 116 --------LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167

Query: 283 LRRSP-------GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG---ETL 332
                       GT  + +    LG     +  D  A+G    Y + G  P+ G    T 
Sbjct: 168 QHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 226

Query: 333 QDTYDKI 339
           +  Y++I
Sbjct: 227 KQKYERI 233

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 59.1 bits (144), Expect = 7e-10
 Identities = 57/231 (24%), Positives = 91/231 (39%), Gaps = 60/231 (25%)

Query: 125 KIGAGSYGKVVLYRSSL-DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
            +G G +GKV  Y+  L DG   A+K        +L+   ++      + EV ++ M  H
Sbjct: 37  ILGRGGFGKV--YKGRLADGTLVAVK--------RLKEERTQGGELQFQTEVEMISMAVH 86

Query: 184 PNIVNL----IEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPG-------------AIGE 225
            N++ L    +            +V  Y+  G   +    +P              A+G 
Sbjct: 87  RNLLRLRGFCMT------PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG- 139

Query: 226 SMARKYLRDIVSGLMYLHGH---NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND- 281
             AR        GL YLH H    ++H D+K  N+L+       +GDF ++++ +  +  
Sbjct: 140 -SAR--------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 190

Query: 282 VLRRSPGTPVFTAPECCLGLTYG--GKA---ADTWAVGVTLYYMIIGQYPF 327
           V     GT    APE      Y   GK+    D +  GV L  +I GQ  F
Sbjct: 191 VTTAVRGTIGHIAPE------YLSTGKSSEKTDVFGYGVMLLELITGQRAF 235

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 58.5 bits (142), Expect = 8e-10
 Identities = 56/240 (23%), Positives = 92/240 (38%), Gaps = 36/240 (15%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           N Y   RKIG+GS+G + L      G+  AIK           +   +T    +  E  I
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----------LECVKTKHPQLHIESKI 57

Query: 178 MKMLQH-PNIVNLIEVIDDPNSDHFYMVLEY----VEGKWDNDGFGQPGAIGESMARKYL 232
            KM+Q    I  +         D+  MV+E     +E  ++                   
Sbjct: 58  YKMMQGGVGIPTIRWCG--AEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLA 111

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT---VKIGDFSVSQVFEDDNDVLRRSP-- 287
             ++S + Y+H  N +H D+KPDN L+        V I DF +++ + D           
Sbjct: 112 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 171

Query: 288 -----GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG---ETLQDTYDKI 339
                GT  + +    LG+    +  D  ++G  L Y  +G  P+ G    T +  Y++I
Sbjct: 172 NKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 35/147 (23%), Positives = 70/147 (47%), Gaps = 10/147 (6%)

Query: 230 KYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS-QVFEDDNDVLRRSPG 288
            Y   +  G+ +L     +H D+   N+L++    VKI DF ++  +++D + V +    
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256

Query: 289 TPV-FTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLG-ETLQDTYDKIVN-NSL 344
            P+ + APE      Y  + +D W+ GV L+ +  +G  P+ G +  ++   ++     +
Sbjct: 257 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 315

Query: 345 VFPDAMNPELRNLLEGLLC--KDPTRR 369
             PD   PE+   +  L C   +P++R
Sbjct: 316 RAPDYTTPEMYQTM--LDCWHGEPSQR 340

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 15/89 (16%), Positives = 36/89 (40%), Gaps = 7/89 (7%)

Query: 124 RKIGAGSYGKVVL-YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML- 181
           + +G G++G+V+      +D          K     L+   + +    +  E+ I+  + 
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKM----LKEGATHSEHRALMSELKILIHIG 83

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEG 210
            H N+VNL+            +++E+ + 
Sbjct: 84  HHLNVVNLLGACTK-PGGPLMVIVEFCKF 111

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 53/247 (21%), Positives = 95/247 (38%), Gaps = 48/247 (19%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
             +   +KIG G++G++ L ++    ++ AIK           + P ++    +  E   
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----------LEPMKSRAPQLHLEYRF 57

Query: 178 MKMLQH-PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG---------AIGESM 227
            K L     I  +      P   +  MVLE + G    D F              I   +
Sbjct: 58  YKQLGSGDGIPQVYYFG--PCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQL 114

Query: 228 ARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT-----VKIGDFSVSQVFEDDNDV 282
                   +S + Y+H  N+++ D+KP+N L+   G      + I DF++++ + D    
Sbjct: 115 --------ISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166

Query: 283 LRRSP-------GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG---ETL 332
                       GT  + +    LG     +  D  A+G    Y + G  P+ G   +TL
Sbjct: 167 KHIPYREHKSLTGTARYMSINTHLGKEQSRR-DDLEALGHMFMYFLRGSLPWQGLKADTL 225

Query: 333 QDTYDKI 339
           ++ Y KI
Sbjct: 226 KERYQKI 232

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 55.7 bits (135), Expect = 8e-09
 Identities = 47/190 (24%), Positives = 77/190 (40%), Gaps = 40/190 (21%)

Query: 124 RKIGAGSYGKVVLYRSSL-DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ 182
             IG G +GKV  Y+  L DG   A+K              S   + +   E+  +   +
Sbjct: 45  FLIGHGVFGKV--YKGVLRDGAKVALKRRTPE---------SSQGIEEFETEIETLSFCR 93

Query: 183 HPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPG-------------AIGESMA 228
           HP++V+LI   D+   +   ++ +Y+E G      +G                 IG   A
Sbjct: 94  HPHLVSLIGFCDE--RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG--AA 149

Query: 229 RKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRS 286
           R        GL YLH   ++H D+K  N+L+  +   KI DF +S+   + +   +    
Sbjct: 150 R--------GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV 201

Query: 287 PGTPVFTAPE 296
            GT  +  PE
Sbjct: 202 KGTLGYIDPE 211

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 35/182 (19%), Positives = 69/182 (37%), Gaps = 30/182 (16%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           N++V  +KIG+G +G + L   +   +  A           ++V   E     +  E+  
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHV--------VKVEYQENGP--LFSELKF 86

Query: 178 MKMLQHPNIVNLIE-----------------VIDDPNSDHFYMVLEYVEGKWDNDGFGQP 220
            + +   + +                     + +     + +MV+E + G       GQ 
Sbjct: 87  YQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN 145

Query: 221 GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP--SGTVKIGDFSVSQVFED 278
           G   +S   +    ++  L Y+H +  VHGDIK  NLL+       V + D+ +S  +  
Sbjct: 146 GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP 205

Query: 279 DN 280
           + 
Sbjct: 206 NG 207

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 50.1 bits (120), Expect = 5e-07
 Identities = 33/260 (12%), Positives = 75/260 (28%), Gaps = 56/260 (21%)

Query: 118 NEYVHVRKIGAGSYGKV--------VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMT 169
            ++         + G +        +   S    + +++K   K    +L    +     
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRA 99

Query: 170 DVRREVLIMKMLQHPNIVNLIEVID--DPNSDHFYMVLEY----VEGKWDNDGFGQPGAI 223
               +V   K L    ++ +   +        + ++VL      ++   D          
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSP------- 152

Query: 224 GESMARKYL---------RDIVSGLMYLHGHNVVHGDIKPDNLLVAPS--GTVKIGDFSV 272
                +  L           ++  L +LH +  VHG++  +N+ V P     V +  +  
Sbjct: 153 -----KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGF 207

Query: 273 SQVF----------EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII 322
           +  +          E          G   F + +   G     + +D  ++G  +   + 
Sbjct: 208 AFRYCPSGKHVAYVEGSRSPHE---GDLEFISMDLHKGCGPSRR-SDLQSLGYCMLKWLY 263

Query: 323 GQYP---FLGETLQDTYDKI 339
           G  P    L  T      K 
Sbjct: 264 GFLPWTNCLPNTEDIMKQKQ 283

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 39/260 (15%), Positives = 76/260 (29%), Gaps = 56/260 (21%)

Query: 118 NEYVHVRKIGAGSYGKV-----VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
             +     IG G +G +         S        +K     +   L             
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-GPLFT----------- 82

Query: 173 REVLIMKMLQHPNIVNLIE-----------------VIDDPNSDHFYMVLEY----VEGK 211
            E+   +    P  +                     + D     + +M+++     ++  
Sbjct: 83  -ELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKI 141

Query: 212 WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP--SGTVKIGD 269
           ++                +    I+  L Y+H H  VHGDIK  NLL+       V + D
Sbjct: 142 YEA----NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVD 197

Query: 270 FSVSQVFEDDNDVLRRSP-------GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII 322
           + ++  +  +      +        GT  FT+ +   G+    +  D   +G  +   + 
Sbjct: 198 YGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRR-GDLEILGYCMIQWLT 256

Query: 323 GQYP---FLGETLQDTYDKI 339
           G  P    L +       KI
Sbjct: 257 GHLPWEDNLKDPKYVRDSKI 276

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.4 bits (109), Expect = 1e-05
 Identities = 57/375 (15%), Positives = 104/375 (27%), Gaps = 149/375 (39%)

Query: 67  DGDGGEMQNHAKRSEEIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKI 126
           D + GE Q   K    +F +  ++   C+   V++  K I S++E               
Sbjct: 8   DFETGEHQYQYKDILSVFEDAFVDNFDCKD--VQDMPKSILSKEE--------------- 50

Query: 127 GAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP-N 185
                         +D            H+       S+ A++   R  L   +L     
Sbjct: 51  --------------ID------------HIIM-----SKDAVSGTLR--LFWTLLSKQEE 77

Query: 186 IVN-LIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG 244
           +V   +E +   N    Y        K+          +   +  +  +  +   MY+  
Sbjct: 78  MVQKFVEEVLRIN----Y--------KF----------LMSPIKTEQRQPSMMTRMYIEQ 115

Query: 245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA-----PECCL 299
            + ++ D                     +QVF   N V R  P   +  A     P   +
Sbjct: 116 RDRLYND---------------------NQVFAKYN-VSRLQPYLKLRQALLELRPAKNV 153

Query: 300 GLTYG----GKAADTWAVGVTL-------------YYMIIGQY---PFLGETLQDTYDKI 339
            +  G    GK   TW                   +++ +        + E LQ    +I
Sbjct: 154 LI-DGVLGSGK---TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQI 209

Query: 340 VNNSLVFPDAMNP------ELRNLLEGLLCKDPTRR--LTLNDVAKHTWVLG--DNGPIP 389
             N     D  +        ++  L  LL   P     L L +V ++       +     
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNV-QNAKAWNAFNLS--- 265

Query: 390 QYLCWCK-----RDR 399
                CK     R +
Sbjct: 266 -----CKILLTTRFK 275

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.9 bits (100), Expect = 2e-04
 Identities = 33/285 (11%), Positives = 79/285 (27%), Gaps = 88/285 (30%)

Query: 8   WIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTAD 67
           W+ ++  C         P+  L  +  L Y+I  ++    D   +               
Sbjct: 186 WL-NLKNC-------NSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI---------- 227

Query: 68  GDGGEMQNHAKRSEEIFRERELNG--LICRQFPVKESNKLIRSEDENGTKMINEYVHVRK 125
                +Q   +R   + + +      L+     V+ + K   + +    K++   +  R 
Sbjct: 228 ---HSIQAELRR---LLKSKPYENCLLVLLN--VQNA-KAWNAFN-LSCKIL---LTTRF 274

Query: 126 IGAGSYGKVVLYRSSLDGKHYAI----KAFHKSHLSKLRVAPSETAMTDVRREV------ 175
                   V  + S+    H ++           +  L +   +    D+ REV      
Sbjct: 275 KQ------VTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPR 328

Query: 176 ---LIMKMLQ----------HPNIVNLIEVID------DPN--SDHFYM----------- 203
              +I + ++          H N   L  +I+      +P      F             
Sbjct: 329 RLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIP 388

Query: 204 --VLEYVEGKWDNDGFGQPGAIGESMARKYL--RDIVSGLMYLHG 244
             +L  +   W +        +   + +  L  +      + +  
Sbjct: 389 TILLSLI---WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS 430

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 40.7 bits (95), Expect = 5e-04
 Identities = 31/186 (16%), Positives = 58/186 (31%), Gaps = 31/186 (16%)

Query: 115 KMINEYVHVRKIGAGSYGK--VVLYRSSLDGKHYAIKAFHKSHLSKLRVAP--------- 163
           +++              GK   V    S       +K     H S  +V           
Sbjct: 84  RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHF 143

Query: 164 SETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAI 223
           S  A+   R E   ++ LQ   +  +     +       +++E ++ K           +
Sbjct: 144 SVLAIRSARNEFRALQKLQGLAVPKVYAWEGN------AVLMELIDAKELYR-------V 190

Query: 224 GESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--- 280
                 + L  I+  +   +   +VHGD+   N+LV+  G   I      Q  E      
Sbjct: 191 RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIID---FPQSVEVGEEGW 247

Query: 281 -DVLRR 285
            ++L R
Sbjct: 248 REILER 253

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	410
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.79
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.4
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.25
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.12
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.99
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.74
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.64
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.58
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.53
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.3
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.27
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.08
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.06
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.81
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.77
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.71
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.59
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.56
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.52
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.39
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.38
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.36
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.2
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.95
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.91
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.45
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.1
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.63
1gxc_A	149	CHK2, CDS1, serine/threonine-protein kinase CHK2;	90.98
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	83.86
1qu5_A	182	Protein kinase SPK1; FHA, RAD53, transferase; NMR	82.76
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	81.3

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.8e-66  Score=485.52  Aligned_cols=263  Identities=33%  Similarity=0.631  Sum_probs=222.2

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      +++|++++.||+|+||+||+|+++.+|+.||||++.+....      .......+.+|+.+|+.++|||||++++++.+ 
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-   84 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA------KSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-   84 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-
Confidence            47899999999999999999999999999999999765332      23345679999999999999999999999987 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       .+.+||||||++ |.|.+.+.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus        85 -~~~~~ivmEy~~-g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  162 (275)
T 3hyh_A           85 -KDEIIMVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM  162 (275)
T ss_dssp             -SSEEEEEEECCC-EEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred             -CCEEEEEEeCCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeec
Confidence             468999999994 577777777788999999999999999999999999999999999999999999999999999875


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN  356 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~  356 (410)
                      ... ....+.+||+.|+|||++.+..+++.++|||||||++|+|+||+.||.+.+.......+..+...+|..+|+++++
T Consensus       163 ~~~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  241 (275)
T 3hyh_A          163 TDG-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAG  241 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred             CCC-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            543 3445678999999999998888777889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhhCCcccCCCCCCchhh
Q 015257          357 LLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL  392 (410)
Q Consensus       357 li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~~  392 (410)
                      ||.+||+.||++|||++|+++||||+.   .+|++|
T Consensus       242 li~~~L~~dP~~R~s~~eil~hpw~k~---~~p~~L  274 (275)
T 3hyh_A          242 LIKRMLIVNPLNRISIHEIMQDDWFKV---DLPEYL  274 (275)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHHCHHHHT---TCCGGG
T ss_pred             HHHHHccCChhHCcCHHHHHcCccccc---CCChhh
Confidence            999999999999999999999999974   467776

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.8e-66  Score=492.38  Aligned_cols=259  Identities=30%  Similarity=0.506  Sum_probs=236.4

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.....      ....+.+.+|+.+|+.++|||||+++++|.+ 
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~------~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-  103 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-  103 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH------TTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-
Confidence            467999999999999999999999999999999998654321      2345679999999999999999999999987 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       .+.+|||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus       104 -~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~  182 (311)
T 4aw0_A          104 -DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL  182 (311)
T ss_dssp             -SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             -CCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence             4689999999999999999988889999999999999999999999999999999999999999999999999999976


Q ss_pred             cCC--ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Q 015257          277 EDD--NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPEL  354 (410)
Q Consensus       277 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l  354 (410)
                      ...  .....+.+||+.|+|||++.+..+ +.++|||||||+||+|++|..||.+.+..+...+|....+.+|..+++++
T Consensus       183 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~  261 (311)
T 4aw0_A          183 SPESKQARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKA  261 (311)
T ss_dssp             CTTTTCCCBCCCCSCGGGCCHHHHHHSCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHH
T ss_pred             CCCCCcccccCcccCcccCCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHH
Confidence            533  334567899999999999987666 77899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcccCCCCCCCHHH------HhhCCcccCC
Q 015257          355 RNLLEGLLCKDPTRRLTLND------VAKHTWVLGD  384 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~e------ll~h~~~~~~  384 (410)
                      ++||.+||++||++|||++|      |++||||++-
T Consensus       262 ~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i  297 (311)
T 4aw0_A          262 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  297 (311)
T ss_dssp             HHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence            99999999999999999988      6899999864

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.6e-65  Score=493.66  Aligned_cols=259  Identities=29%  Similarity=0.548  Sum_probs=227.9

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+...       .....+.+.+|+.+|++++|||||++++++.+ 
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-   94 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-------SSKEREESRREVAVLANMKHPNIVQYRESFEE-   94 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-------CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-
Confidence            4689999999999999999999999999999999976532       34456789999999999999999999999987 


Q ss_pred             CCCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                       .+.+|||||||+||+|.+++..  ...+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+
T Consensus        95 -~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~  173 (350)
T 4b9d_A           95 -NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR  173 (350)
T ss_dssp             -TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEES
T ss_pred             -CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccce
Confidence             4689999999999999998843  3467999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHH
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFPDAMNPE  353 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~  353 (410)
                      ............+||+.|+|||++.+..+ +.++|||||||+||||++|+.||.+.+..+...++..+.. .++..+|++
T Consensus       174 ~~~~~~~~~~~~~GT~~YmAPE~l~~~~y-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~  252 (350)
T 4b9d_A          174 VLNSTVELARACIGTPYYLSPEICENKPY-NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYD  252 (350)
T ss_dssp             CCCHHHHHHHHHHSCCTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             eecCCcccccccCCCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHH
Confidence            77655445567789999999999988766 6789999999999999999999999999999999988775 466789999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      +++||.+||++||++|||++|+|+||||+...
T Consensus       253 ~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence            99999999999999999999999999998653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.9e-65  Score=489.47  Aligned_cols=255  Identities=27%  Similarity=0.432  Sum_probs=228.9

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ..|.++++||+|+||+||+|+++.+|+.||||++......         ..+.+.+|+.+|+.++|||||+++++|.+  
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---------~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--  142 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---------RRELLFNEVVIMRDYQHENVVEMYNSYLV--  142 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---------SGGGGHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---------HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--
Confidence            4699999999999999999999999999999999754321         12357899999999999999999999987  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      .+.+|||||||+||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus       143 ~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  221 (346)
T 4fih_A          143 GDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  221 (346)
T ss_dssp             TTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecC
Confidence            4689999999999999988764 579999999999999999999999999999999999999999999999999999877


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCCCCCHHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL---VFPDAMNPEL  354 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~~~~l  354 (410)
                      .......+.+||+.|+|||++.+..+ +.++|||||||++|||++|..||.+.+..+....+.....   ..+..+++++
T Consensus       222 ~~~~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~  300 (346)
T 4fih_A          222 KEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSL  300 (346)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHH
T ss_pred             CCCCcccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence            66666778899999999999887766 6789999999999999999999999988888888877532   3345789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      ++||.+||++||++|||++|+|+||||+...
T Consensus       301 ~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          301 KGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999999999998754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5e-65  Score=482.14  Aligned_cols=258  Identities=26%  Similarity=0.447  Sum_probs=225.6

Q ss_pred             ccceeeeeeecccCceEEEEEEEc---cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      .++|++++.||+|+||+||+|++.   .+++.||||++.+......       ....+.+|+.+|++++|||||++++++
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-------~~~~~~~E~~il~~l~HpnIv~l~~~~   95 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-------DRVRTKMERDILVEVNHPFIVKLHYAF   95 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-------ECC------CCCCCCCCTTEECEEEEE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-------HHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence            367999999999999999999974   3688999999976543221       123577899999999999999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .+  .+.+|||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus        96 ~~--~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla  173 (304)
T 3ubd_A           96 QT--EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS  173 (304)
T ss_dssp             EE--TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred             EE--CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccc
Confidence            87  4689999999999999999988889999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPE  353 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~  353 (410)
                      +..........+.+||+.|+|||++.+..+ +.++|||||||+||||+||+.||.+.+..+....|....+.+|..+|++
T Consensus       174 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~  252 (304)
T 3ubd_A          174 KESIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE  252 (304)
T ss_dssp             EC-----CCCCSCCCCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             eeccCCCccccccccCcccCCHHHhccCCC-CCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHH
Confidence            876655556667899999999999987766 6779999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHhhCCcccCC
Q 015257          354 LRNLLEGLLCKDPTRRLT-----LNDVAKHTWVLGD  384 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~~  384 (410)
                      +++||.+||++||++|||     ++|+++||||++-
T Consensus       253 ~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             HHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            999999999999999998     5899999999863

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.2e-63  Score=489.36  Aligned_cols=255  Identities=28%  Similarity=0.440  Sum_probs=229.2

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      +.|.+++.||+|+||.||+|+++.+|+.||||++.....         ...+.+.+|+.+|+.++|||||+++++|.+  
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---------~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--  219 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---------QRRELLFNEVVIMRDYQHENVVEMYNSYLV--  219 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---------SSGGGHHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---------hHHHHHHHHHHHHHhCCCCCCCceEEEEEE--
Confidence            579999999999999999999999999999999975421         122457899999999999999999999987  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      .+.+|||||||+||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus       220 ~~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~  298 (423)
T 4fie_A          220 GDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  298 (423)
T ss_dssp             TTEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred             CCEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence            4689999999999999988754 569999999999999999999999999999999999999999999999999999876


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCCCCCCCHHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS---LVFPDAMNPEL  354 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~~~~l  354 (410)
                      .......+.+||+.|||||++.+..+ +.++|||||||++|||++|..||.+.+..+.+..|....   +..+..+++++
T Consensus       299 ~~~~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~  377 (423)
T 4fie_A          299 KEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSL  377 (423)
T ss_dssp             SSCCCBCCCEECTTTCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHH
T ss_pred             CCCccccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHH
Confidence            66666678899999999999887766 678999999999999999999999999888888887753   33456789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      ++||.+||++||.+|||++|+|+||||+...
T Consensus       378 ~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          378 KGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            9999999999999999999999999998754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-62  Score=463.41  Aligned_cols=255  Identities=23%  Similarity=0.408  Sum_probs=218.8

Q ss_pred             ce-eeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC-
Q 015257          119 EY-VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP-  196 (410)
Q Consensus       119 ~y-~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  196 (410)
                      +| ++.+.||+|+||+||+|.+..+++.||||++.....       .....+.+.+|+.+|++++|||||+++++|.+. 
T Consensus        26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~   98 (290)
T 3fpq_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-------TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   98 (290)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-------CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred             ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence            44 677889999999999999999999999999875432       344567899999999999999999999998752 


Q ss_pred             -CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeccCCCCcEEEcC-CCcEEEeeccc
Q 015257          197 -NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHN--VVHGDIKPDNLLVAP-SGTVKIGDFSV  272 (410)
Q Consensus       197 -~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NIll~~-~~~~kl~DfG~  272 (410)
                       ....+|||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|  ||||||||+||||+. +|.+||+|||+
T Consensus        99 ~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGl  178 (290)
T 3fpq_A           99 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             TTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred             CCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcC
Confidence             23578999999999999999988889999999999999999999999998  999999999999984 79999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCC--CCCCC
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ-DTYDKIVNNSL--VFPDA  349 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~i~~~~~--~~p~~  349 (410)
                      |+....  ....+.+|||.|||||++.+ . ++.++|||||||+||||+||+.||.+.... .....+..+..  .++..
T Consensus       179 a~~~~~--~~~~~~~GTp~YmAPE~~~~-~-y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  254 (290)
T 3fpq_A          179 ATLKRA--SFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV  254 (290)
T ss_dssp             GGGCCT--TSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred             CEeCCC--CccCCcccCccccCHHHcCC-C-CCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCcc
Confidence            986433  34457789999999998865 3 477899999999999999999999875544 44555555432  35567


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      +++++++||.+||+.||++|||++|+|+||||++.
T Consensus       255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~  289 (290)
T 3fpq_A          255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence            89999999999999999999999999999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.4e-62  Score=470.89  Aligned_cols=257  Identities=25%  Similarity=0.374  Sum_probs=224.6

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .+.|.+.++||+|+||.||+|+++.+|+.||||+++....              ..+|+.+|+.++|||||++++++.+ 
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------------~~~E~~il~~l~HpnIV~l~~~~~~-  121 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------------RVEELVACAGLSSPRIVPLYGAVRE-  121 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------------CTHHHHTTTTCCCTTBCCEEEEEEE-
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------------HHHHHHHHHhCCCCCCCcEEEEEEE-
Confidence            4578999999999999999999999999999999975422              1379999999999999999999987 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC-cEEEeecccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSVSQV  275 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~-~~kl~DfG~a~~  275 (410)
                       ...+|||||||+|++|.+++...+.+++..++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.
T Consensus       122 -~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~  200 (336)
T 4g3f_A          122 -GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC  200 (336)
T ss_dssp             -TTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred             -CCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence             468999999999999999998888999999999999999999999999999999999999999988 699999999987


Q ss_pred             ccCCcc-----ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCC
Q 015257          276 FEDDND-----VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL---VFP  347 (410)
Q Consensus       276 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p  347 (410)
                      ......     .....+||+.|||||++.+..+ +.++|||||||+||||+||+.||.+.+..+....+.....   .+|
T Consensus       201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  279 (336)
T 4g3f_A          201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP  279 (336)
T ss_dssp             C------------CCCCCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSC
T ss_pred             ccCCCcccceecCCccccCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcC
Confidence            653321     2234689999999999988766 6779999999999999999999998877777777777654   367


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHH-------------hhCCcccCCCCCCch
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDV-------------AKHTWVLGDNGPIPQ  390 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~el-------------l~h~~~~~~~~~~~~  390 (410)
                      +.+++++.+||.+||++||.+|||+.|+             ++|||+....+|-..
T Consensus       280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr~n  335 (336)
T 4g3f_A          280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRGN  335 (336)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCCC-
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCCCC
Confidence            7899999999999999999999999998             579999988777543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.5e-61  Score=470.52  Aligned_cols=261  Identities=26%  Similarity=0.394  Sum_probs=225.2

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC-
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP-  196 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  196 (410)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..       ......+.+.+|+.+|+.++|||||++++++... 
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-------~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  126 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-------DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV  126 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-------cchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence            57999999999999999999999999999999986432       1344556788999999999999999999998643 


Q ss_pred             ---CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          197 ---NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       197 ---~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                         ..+.+|||||||+| .|.+.+...+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|
T Consensus       127 ~~~~~~~~~ivmE~~~g-~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          127 PYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CTTTCCCEEEEEECCSE-EHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ccccCCEEEEEEeCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeeccee
Confidence               23679999999975 57777888889999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCC----ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---
Q 015257          274 QVFEDD----NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF---  346 (410)
Q Consensus       274 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---  346 (410)
                      +.+...    .....+.+||+.|+|||++.+..+++.++|||||||++|||++|++||.+.+..+.+..|......+   
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            865432    2344577899999999999887777888999999999999999999999998888877775421111   


Q ss_pred             ----------------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          347 ----------------------------PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       347 ----------------------------p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                                                  ...+++++++||.+||++||.+|||+.|+|+||||+....
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence                                        1246899999999999999999999999999999987643

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.1e-60  Score=447.70  Aligned_cols=255  Identities=22%  Similarity=0.404  Sum_probs=202.1

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|++++.||+|+||+||+|+++.+|+.||||++....        .....+.+.+|+.+|++++|||||+++++|.+.
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~   75 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--------RELAREKVMREVKALAKLEHPGIVRYFNAWLEK   75 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence            457999999999999999999999999999999986432        344567899999999999999999999998753


Q ss_pred             C----------CCEEEEEEeecCCCCcccccCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC
Q 015257          197 N----------SDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG  263 (410)
Q Consensus       197 ~----------~~~~~lv~e~~~~~~l~~~~~~~~~---l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~  263 (410)
                      +          ...+|||||||+|++|.+++.....   .++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus        76 ~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~  155 (299)
T 4g31_A           76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD  155 (299)
T ss_dssp             C----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred             CccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC
Confidence            3          2257999999999999998876654   45677899999999999999999999999999999999999


Q ss_pred             cEEEeeccccccccCCcc------------ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015257          264 TVKIGDFSVSQVFEDDND------------VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET  331 (410)
Q Consensus       264 ~~kl~DfG~a~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~  331 (410)
                      .+||+|||+|+.......            .....+||+.|||||++.+..+ +.++|||||||++|||++   ||....
T Consensus       156 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyell~---Pf~~~~  231 (299)
T 4g31_A          156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELLY---PFSTQM  231 (299)
T ss_dssp             CEEECCCCCC--------------------------CCCTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC-CCHHHHHHHHHHHHHHcc---CCCCcc
Confidence            999999999987654321            1234579999999999987766 678999999999999996   786532


Q ss_pred             HH-HHHHHHHhCCCCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          332 LQ-DTYDKIVNNSLVFP---DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       332 ~~-~~~~~i~~~~~~~p---~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      .. .....+...  .+|   ...++.+.+||.+||++||.+|||+.|+++||||++..
T Consensus       232 ~~~~~~~~~~~~--~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          232 ERVRTLTDVRNL--KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHHHHHHHHHTT--CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HHHHHHHHHhcC--CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            21 223333333  233   24567789999999999999999999999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.6e-60  Score=447.98  Aligned_cols=259  Identities=26%  Similarity=0.403  Sum_probs=220.5

Q ss_pred             cceeeeeeecccCceEEEEEEEc-----cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      ++|.+.+.||+|+||+||+++..     .++..||||+++..         .....++|.+|+.+|++++|||||+++++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---------~~~~~~~f~~E~~il~~l~HpnIV~l~g~   83 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---------SDNARKDFHREAELLTNLQHEHIVKFYGV   83 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---------CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---------ChHHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence            57999999999999999999864     36789999998642         34556789999999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEE
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQ-------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV  259 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll  259 (410)
                      +.+  .+.++||||||++|+|.+++..             ...+++..+..++.||+.||+|||+++||||||||+||||
T Consensus        84 ~~~--~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl  161 (299)
T 4asz_A           84 CVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV  161 (299)
T ss_dssp             ECS--SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             Eee--CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE
Confidence            986  4579999999999999988753             2469999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 015257          260 APSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTY  336 (410)
Q Consensus       260 ~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~  336 (410)
                      +.++.+||+|||+|+.......  ......||+.|+|||++.+..+ +.++|||||||+||||+| |+.||.+.+..+..
T Consensus       162 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~  240 (299)
T 4asz_A          162 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI  240 (299)
T ss_dssp             CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred             CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            9999999999999987544322  2234468999999999987766 678999999999999998 99999999988888


Q ss_pred             HHHHhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCch
Q 015257          337 DKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ  390 (410)
Q Consensus       337 ~~i~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~  390 (410)
                      ..+..+. ...|..+++++.+|+.+||+.||++|||+++|  |+|+++.....|.
T Consensus       241 ~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~~~~p~  293 (299)
T 4asz_A          241 ECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLAKASPV  293 (299)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHHHHSCC
T ss_pred             HHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHHhcCCc
Confidence            8888765 46788999999999999999999999999999  4577554333333

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.6e-59  Score=476.73  Aligned_cols=264  Identities=28%  Similarity=0.420  Sum_probs=229.9

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ...+++|.+++.||+|+||.||+|+++.+|+.||||++.+..+..   ........+...++.+++.++|||||+++++|
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~---~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f  261 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM---KQGETLALNERIMLSLVSTGDCPFIVCMSYAF  261 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcch---hhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE
Confidence            345688999999999999999999999999999999998764322   11223333344556777888999999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      ++  ...+|||||||+||+|..++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|
T Consensus       262 ~~--~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA  339 (689)
T 3v5w_A          262 HT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA  339 (689)
T ss_dssp             EC--SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EE--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEeccccee
Confidence            97  4689999999999999999988889999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCCCCC
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE---TLQDTYDKIVNNSLVFPDAM  350 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~  350 (410)
                      +.....  ...+.+|||.|+|||++.....++.++|||||||+||||++|.+||.+.   ........+....+.+|..+
T Consensus       340 ~~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~  417 (689)
T 3v5w_A          340 CDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF  417 (689)
T ss_dssp             EECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             eecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccC
Confidence            876543  3456799999999999976555578899999999999999999999763   34456677888888999999


Q ss_pred             CHHHHHHHHHhcccCCCCCCC-----HHHHhhCCcccCC
Q 015257          351 NPELRNLLEGLLCKDPTRRLT-----LNDVAKHTWVLGD  384 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~~  384 (410)
                      |+++++||.+||++||.+|++     ++||++||||++-
T Consensus       418 S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i  456 (689)
T 3v5w_A          418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  456 (689)
T ss_dssp             CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred             CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence            999999999999999999998     7999999999873

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5e-58  Score=440.32  Aligned_cols=250  Identities=29%  Similarity=0.464  Sum_probs=211.3

Q ss_pred             ccceeeeeeecccCceEEEEEEEc-----cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCccccee
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE  191 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  191 (410)
                      .++|.+.++||+|+||.||+++..     .+++.||||+++..         .....+.|.+|+.+|++++|||||++++
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---------~~~~~~~f~~E~~il~~l~HpnIV~l~g  110 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---------SESARQDFQREAELLTMLQHQHIVRFFG  110 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---------SHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---------CHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            357889999999999999999864     36889999998642         3456678999999999999999999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCc
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQ---------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDN  256 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~---------------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N  256 (410)
                      ++.+  ...++||||||++|+|.+++..               .+++++.++..|+.||+.||+|||+++||||||||+|
T Consensus       111 ~~~~--~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~N  188 (329)
T 4aoj_A          111 VCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRN  188 (329)
T ss_dssp             EECS--SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             EEEE--CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhh
Confidence            9986  4579999999999999887643               2469999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 015257          257 LLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQ  333 (410)
Q Consensus       257 Ill~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~  333 (410)
                      |||+.++.+||+|||+|+......  ......+||+.|||||++.+..+ +.++|||||||+||||+| |+.||.+.+..
T Consensus       189 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~  267 (329)
T 4aoj_A          189 CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDVWSFGVVLWEIFTYGKQPWYQLSNT  267 (329)
T ss_dssp             EEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSSCHH
T ss_pred             EEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCC-CccccccchHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999999999998764332  23345679999999999988776 678999999999999999 99999999888


Q ss_pred             HHHHHHHhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          334 DTYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       334 ~~~~~i~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +....+..+. +..|..+++++.+|+.+||+.||++|||++||+++
T Consensus       268 ~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          268 EAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            8888887764 57888999999999999999999999999999875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=9.6e-58  Score=444.25  Aligned_cols=253  Identities=23%  Similarity=0.360  Sum_probs=208.0

Q ss_pred             cccceeeeeeecccCceEEEEEEEc---cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCccccee
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIE  191 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~  191 (410)
                      ..++|++++.||+|+||+||+|+++   .+++.||||++....           ...++.+|+.+|+.+ +|||||++++
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----------~~~~~~~E~~~l~~~~~h~nIv~l~~   87 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----------HPIRIAAELQCLTVAGGQDNVMGVKY   87 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----------CHHHHHHHHHHHHHTCSBTTBCCCSE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----------CHHHHHHHHHHHHHhcCCCCCceEEE
Confidence            4468999999999999999999876   357899999875431           224678999999998 6999999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC-CcEEEeec
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-GTVKIGDF  270 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~-~~~kl~Df  270 (410)
                      +|.+  .+++|||||||+|++|.+.+.   .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+||
T Consensus        88 ~~~~--~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DF  162 (361)
T 4f9c_A           88 CFRK--NDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDF  162 (361)
T ss_dssp             EEEE--TTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEE--CCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcC
Confidence            9987  468999999999999988874   59999999999999999999999999999999999999877 79999999


Q ss_pred             cccccccCCc----------------------------cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh
Q 015257          271 SVSQVFEDDN----------------------------DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII  322 (410)
Q Consensus       271 G~a~~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  322 (410)
                      |+|+......                            ......+||+.|+|||++.+...++.++||||+||++|+|++
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~  242 (361)
T 4f9c_A          163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS  242 (361)
T ss_dssp             TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence            9997543221                            123345799999999999887766888999999999999999


Q ss_pred             CCCCCCCC-CHHHHHHHHHh--------------------------------------CC----------------CCCC
Q 015257          323 GQYPFLGE-TLQDTYDKIVN--------------------------------------NS----------------LVFP  347 (410)
Q Consensus       323 G~~Pf~~~-~~~~~~~~i~~--------------------------------------~~----------------~~~p  347 (410)
                      |+.||... +..+....|..                                      ..                ....
T Consensus       243 G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  322 (361)
T 4f9c_A          243 GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGW  322 (361)
T ss_dssp             TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------C
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccc
Confidence            99999553 33333333221                                      00                0112


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      ..+|+++++||.+||+.||++|||++|+|+||||++-
T Consensus       323 ~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          323 NEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             TTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             ccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            3578999999999999999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5e-58  Score=435.10  Aligned_cols=253  Identities=21%  Similarity=0.322  Sum_probs=207.6

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..+++.+.++||+|+||+||+++..   ..||||+++...       ...+..+.|.+|+.+|++++|||||++++++.+
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-------~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~  103 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-------PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK  103 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC
Confidence            3467889999999999999999754   359999986432       245567789999999999999999999998864


Q ss_pred             CCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                         +.++||||||+||+|.+++.. ...+++..+..++.||+.||+|||+++||||||||+||||+.++.+||+|||+|+
T Consensus       104 ---~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  180 (307)
T 3omv_A          104 ---DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLAT  180 (307)
T ss_dssp             ---SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCB
T ss_pred             ---CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCce
Confidence               358999999999999998754 4679999999999999999999999999999999999999999999999999998


Q ss_pred             cccCC--ccccccCCCcccccccccccCCc--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------
Q 015257          275 VFEDD--NDVLRRSPGTPVFTAPECCLGLT--YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL------  344 (410)
Q Consensus       275 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------  344 (410)
                      .....  .......+||+.|||||++.+..  .++.++|||||||+||||+||+.||.+.+.......+.....      
T Consensus       181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~  260 (307)
T 3omv_A          181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLS  260 (307)
T ss_dssp             C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCST
T ss_pred             ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence            75432  23445678999999999986432  347789999999999999999999988766655544444322      


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          345 VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       345 ~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      ..+..+++++.+||.+||+.||++|||+.||+++...
T Consensus       261 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~  297 (307)
T 3omv_A          261 KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL  297 (307)
T ss_dssp             TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred             cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            2345789999999999999999999999998766443

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6.1e-58  Score=435.80  Aligned_cols=251  Identities=24%  Similarity=0.349  Sum_probs=216.8

Q ss_pred             ccceeeeeeecccCceEEEEEEEc-----cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCccccee
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE  191 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  191 (410)
                      ..+++++++||+|+||+||++...     .+++.||||+++...        .....+.|.+|+.+|++++|||||++++
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--------~~~~~~~f~~E~~il~~l~HpNIV~l~g   96 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--------EGPLREEFRHEAMLRARLQHPNVVCLLG   96 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--------CC-CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--------ChHHHHHHHHHHHHHHhCCCCCCCCcce
Confidence            356888999999999999999853     367899999986432        2234568999999999999999999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCC
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQ----------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPD  255 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~----------------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~  255 (410)
                      ++.+  ...++||||||++|+|.+++..                ...+++..+..++.||+.||+|||+++||||||||+
T Consensus        97 ~~~~--~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~  174 (308)
T 4gt4_A           97 VVTK--DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATR  174 (308)
T ss_dssp             EECS--SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEEE--CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            9986  4578999999999999887743                236899999999999999999999999999999999


Q ss_pred             cEEEcCCCcEEEeeccccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 015257          256 NLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETL  332 (410)
Q Consensus       256 NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~  332 (410)
                      ||||+.++.+||+|||+|+......  ......+||+.|+|||++.+..+ +.++|||||||+||||+| |..||.+.+.
T Consensus       175 NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~-s~ksDVwSfGvvl~El~t~g~~Pf~~~~~  253 (308)
T 4gt4_A          175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSN  253 (308)
T ss_dssp             GEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred             ceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999998764332  33456789999999999987766 678999999999999998 8999999998


Q ss_pred             HHHHHHHHhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          333 QDTYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       333 ~~~~~~i~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .+....+..+. .+.|..+++++.+|+.+||+.||.+|||++||+++
T Consensus       254 ~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          254 QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            88888887765 46788999999999999999999999999999876

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.3e-57  Score=453.17  Aligned_cols=371  Identities=25%  Similarity=0.405  Sum_probs=273.3

Q ss_pred             CcccchhhhccccccccCCccccCCCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCccchhhhhhH
Q 015257            2 FRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTADGDGGEMQNHAKRSE   81 (410)
Q Consensus         2 ~~~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (410)
                      .++.|.+||+..|+++++.+..+....++.+|..|++|.++....+....+..|.|.||++.|......+........++
T Consensus        26 ~~~~~~iGR~~~~~~~~~~~~~~~~~~~~~vS~~H~~i~~~~~~~~~~~~~i~D~S~nGt~vn~~~~~~~~~~~l~~~d~  105 (419)
T 3i6u_A           26 VNDNYWFGRDKSCEYCFDEPLLKRTDKYRTYSKKHFRIFREVGPKNSYIAYIEDHSGNGTFVNTELVGKGKRRPLNNNSE  105 (419)
T ss_dssp             CSSEEEEESSTTSSEETTCTTGGGCSGGGGSCTTCEEEECCEETTTEECCEEEECCSSCEEETTEECCTTCEEECCTTEE
T ss_pred             cCCCEEecCCCccCEEECCcccccccccccccccceEEEEEcCCCCceEEEEEECCcCCceECcccccCCCcccCCCCCE
Confidence            35679999999999999998777777778999999999887554444456778899999999886554443322222111


Q ss_pred             HHHHHhhhcccccccCCccccccccccccccccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeeccccccccc
Q 015257           82 EIFRERELNGLICRQFPVKESNKLIRSEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV  161 (410)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~  161 (410)
                      ..+.......+......       ..........+.++|.+.+.||+|+||.||+|.+..+++.||||++.+...... .
T Consensus       106 i~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-~  177 (419)
T 3i6u_A          106 IALSLSRNKVFVFFDLT-------VDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIG-S  177 (419)
T ss_dssp             EEESSTTCEEEEEEESC-------SSCGGGSCHHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--
T ss_pred             eeeeccccceEEEeccc-------cccccccchhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhccc-c
Confidence            00000000000000000       011112234456789999999999999999999999999999999976532210 0


Q ss_pred             CCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHH
Q 015257          162 APSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMY  241 (410)
Q Consensus       162 ~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~y  241 (410)
                      .........+.+|+.+|++++||||+++++++..   ..+++||||+++++|.+.+...+.+++..++.++.||+.||+|
T Consensus       178 ~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~  254 (419)
T 3i6u_A          178 AREADPALNVETEIEILKKLNHPCIIKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY  254 (419)
T ss_dssp             -------CCHHHHHHHHHHCCCTTBCCCCEEEES---SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec---CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence            1122233458899999999999999999999864   4689999999999999999888899999999999999999999


Q ss_pred             HHhCCcEeccCCCCcEEEcCCC---cEEEeeccccccccCCccccccCCCcccccccccccC--CcCCCchhhHHHHHHH
Q 015257          242 LHGHNVVHGDIKPDNLLVAPSG---TVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG--LTYGGKAADTWAVGVT  316 (410)
Q Consensus       242 LH~~~iiHrDlkp~NIll~~~~---~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~i  316 (410)
                      ||++||+||||||+|||++.++   .+||+|||+++..... ......+||+.|+|||++.+  ...++.++|||||||+
T Consensus       255 LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~i  333 (419)
T 3i6u_A          255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI  333 (419)
T ss_dssp             HHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHH
T ss_pred             HHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHH
Confidence            9999999999999999997654   5999999999876543 34456789999999998854  2333668999999999


Q ss_pred             HHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          317 LYYMIIGQYPFLGETLQ-DTYDKIVNNSLVFP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       317 l~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p----~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      +|+|++|..||...... .....+..+...++    ..+++.+.+||.+||+.||.+|||++|+++||||++.
T Consensus       334 l~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          334 LFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             HHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             HHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            99999999999765433 34445555554443    4689999999999999999999999999999999753

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.2e-57  Score=464.12  Aligned_cols=258  Identities=27%  Similarity=0.528  Sum_probs=231.1

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||+|+++.+|+.||||++...         .....+.+.+|+.+|+.++|||||+++++|.+
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---------~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  225 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---------HESDKETVRKEIQTMSVLRHPTLVNLHDAFED  225 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---------chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            457899999999999999999999999999999998653         23345678999999999999999999999987


Q ss_pred             CCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC--CcEEEeeccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS--GTVKIGDFSV  272 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~--~~~kl~DfG~  272 (410)
                        ...+|||||||+||+|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+  +.+||+|||+
T Consensus       226 --~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~  303 (573)
T 3uto_A          226 --DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL  303 (573)
T ss_dssp             --SSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred             --CCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccc
Confidence              5689999999999999887754 4689999999999999999999999999999999999999864  8999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----C
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----D  348 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~  348 (410)
                      |+.+... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+.+..|......++    .
T Consensus       304 a~~~~~~-~~~~~~~GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  381 (573)
T 3uto_A          304 TAHLDPK-QSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS  381 (573)
T ss_dssp             CEECCTT-SEEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGT
T ss_pred             eeEccCC-CceeeeEECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCccccc
Confidence            9876543 34456789999999999988766 6789999999999999999999999999999999988876655    4


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      .+|+++++||.+||+.||.+|||+.|+|+||||+....
T Consensus       382 ~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          382 GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            68999999999999999999999999999999997644

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.9e-56  Score=432.86  Aligned_cols=252  Identities=19%  Similarity=0.338  Sum_probs=213.7

Q ss_pred             ccceeeeeeecccCceEEEEEEEccC-----CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCC-CCcccce
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLD-----GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH-PNIVNLI  190 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~  190 (410)
                      .++|++.+.||+|+||.||+|.....     ++.||||++....        .....+.+.+|+.+|+++.| ||||+++
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--------~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--------THSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--------CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--------ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            46899999999999999999997654     4679999886432        34456789999999999965 9999999


Q ss_pred             eEEEcCCCCEEEEEEeecCCCCcccccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCC
Q 015257          191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQ----------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKP  254 (410)
Q Consensus       191 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----------------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp  254 (410)
                      ++|.++ ...++||||||++|+|.+++..                ...+++..+..++.||+.||+|||+++||||||||
T Consensus       135 g~~~~~-~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~  213 (353)
T 4ase_A          135 GACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA  213 (353)
T ss_dssp             EEECCT-TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             EEEEec-CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCc
Confidence            999764 3568999999999999887743                24589999999999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEeeccccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 015257          255 DNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGET  331 (410)
Q Consensus       255 ~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~  331 (410)
                      +|||++.++.+||+|||+|+......  ......+||+.|||||++.+..+ +.++|||||||+||||+| |..||.+..
T Consensus       214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y-~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC-CCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999998764432  23345678999999999987766 678999999999999998 999998876


Q ss_pred             HHHH-HHHHHhC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          332 LQDT-YDKIVNN-SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       332 ~~~~-~~~i~~~-~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..+. ...+..+ .+..|..+++++.+||.+||+.||++|||++||++|
T Consensus       293 ~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          293 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            5443 3444443 456788999999999999999999999999999998

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.8e-55  Score=420.90  Aligned_cols=261  Identities=36%  Similarity=0.619  Sum_probs=238.1

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+++.||+|+||.||+|++..+|+.||||++.....       .......+.+|+.+|+.++||||+++++++.
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   84 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-------NPTSLQKLFREVRIMKILNHPNIVKLFEVIE   84 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            456789999999999999999999999999999999875432       3455678899999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      .  ...+|+||||++++++.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        85 ~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  162 (328)
T 3fe3_A           85 T--EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN  162 (328)
T ss_dssp             C--SSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred             E--CCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCce
Confidence            6  46899999999999999988777889999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPEL  354 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l  354 (410)
                      ..... ......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+..+....+..+...+|..+++++
T Consensus       163 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~  241 (328)
T 3fe3_A          163 EFTVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDC  241 (328)
T ss_dssp             GGSSS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             ecCCC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Confidence            65543 34456789999999999988877678899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      .+||.+||+.||.+|||++|+++||||....
T Consensus       242 ~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          242 ENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999999999998653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.8e-54  Score=417.01  Aligned_cols=259  Identities=32%  Similarity=0.562  Sum_probs=233.7

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+++.||+|+||.||++++..+|+.||||++.+....      .......+.+|+.+|+.++||||+++++++.+ 
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-   76 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII------AKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-   76 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH------HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh------hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-
Confidence            46899999999999999999999999999999999764321      12234578899999999999999999999987 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       ...+|+||||++|++|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus        77 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  155 (337)
T 1o6l_A           77 -HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             -SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             -CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence             4689999999999999888877788999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN  356 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~  356 (410)
                      ..........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+
T Consensus       156 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  234 (337)
T 1o6l_A          156 ISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS  234 (337)
T ss_dssp             CCTTCCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             ccCCCcccccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            444445567789999999999887665 6779999999999999999999999988888999999999999999999999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHhhCCcccCC
Q 015257          357 LLEGLLCKDPTRRL-----TLNDVAKHTWVLGD  384 (410)
Q Consensus       357 li~~~L~~dp~~Rp-----t~~ell~h~~~~~~  384 (410)
                      ||.+||+.||.+||     +++++++||||.+-
T Consensus       235 li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence            99999999999999     99999999999763

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.6e-54  Score=421.33  Aligned_cols=260  Identities=30%  Similarity=0.517  Sum_probs=228.3

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID  194 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  194 (410)
                      ..++|.+++.||+|+||.||+|++..+|+.||||++.+....      .......+.+|..+++.+ +||||+++++++.
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~------~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~   94 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL------QDDDVECTMTEKRILSLARNHPFLTQLFCCFQ   94 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH------HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc------chhHHHHHHHHHHHHHhccCCCceeeEEEEEE
Confidence            357899999999999999999999999999999999764321      123446788999999988 7999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      +  ...+|+||||++|++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus        95 ~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~  172 (353)
T 3txo_A           95 T--PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK  172 (353)
T ss_dssp             C--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             e--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEcccccee
Confidence            7  45899999999999999888877889999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPEL  354 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l  354 (410)
                      ............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+......+|..+++++
T Consensus       173 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~  251 (353)
T 3txo_A          173 EGICNGVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDA  251 (353)
T ss_dssp             CSCC---------CCGGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             ecccCCccccccCCCcCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHH
Confidence            65544455567789999999999877665 67899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcccCCCCCCCH------HHHhhCCcccCC
Q 015257          355 RNLLEGLLCKDPTRRLTL------NDVAKHTWVLGD  384 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~------~ell~h~~~~~~  384 (410)
                      .+||.+||+.||.+||++      .++++||||.+-
T Consensus       252 ~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          252 TGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             HHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             HHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            999999999999999999      899999999863

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.3e-53  Score=399.58  Aligned_cols=267  Identities=39%  Similarity=0.667  Sum_probs=224.7

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeeccccccccc-----------------CCChHHHHHHHHHHHH
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-----------------APSETAMTDVRREVLI  177 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~-----------------~~~~~~~~~~~~E~~~  177 (410)
                      ...++|.+.+.||+|+||.||++++..+|+.||||++..........                 .......+.+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            34578999999999999999999999999999999997653221000                 0011234578899999


Q ss_pred             HHhCCCCCcccceeEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcE
Q 015257          178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNL  257 (410)
Q Consensus       178 l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NI  257 (410)
                      ++.++||||+++++++.++....+++||||++++++.+... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            99999999999999998766678999999999998888654 45799999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCccccccCCCcccccccccccCCcC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 015257          258 LVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTY--GGKAADTWAVGVTLYYMIIGQYPFLGETLQDT  335 (410)
Q Consensus       258 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~  335 (410)
                      |++.++.+||+|||+++.............||+.|+|||++.+...  .+.++|||||||++|+|++|..||........
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  248 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL  248 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence            9999999999999999876655545566789999999999876542  36789999999999999999999999888777


Q ss_pred             HHHHHhCCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCccc
Q 015257          336 YDKIVNNSLVFP--DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL  382 (410)
Q Consensus       336 ~~~i~~~~~~~p--~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~  382 (410)
                      ...+......+|  ..+++++.+||.+||+.||.+|||+.|+++||||+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            777777766555  46899999999999999999999999999999996

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=8.8e-53  Score=410.18  Aligned_cols=263  Identities=29%  Similarity=0.508  Sum_probs=232.3

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...+.|.+.+.||+|+||.||++++..+|+.||||++.+......   ......+.+.+|+.+|+.++||||+++++++.
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~   85 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRAS---RRGVCREEIEREVSILRQVLHPNIITLHDVYE   85 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTC---SSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccc---cchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE
Confidence            455789999999999999999999999999999999986543211   11123467899999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC----cEEEeec
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG----TVKIGDF  270 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~----~~kl~Df  270 (410)
                      +  ...+++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+||
T Consensus        86 ~--~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           86 N--RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             C--SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             e--CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            6  468999999999999999998888999999999999999999999999999999999999998877    7999999


Q ss_pred             cccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---
Q 015257          271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP---  347 (410)
Q Consensus       271 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p---  347 (410)
                      |+++..... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+......++   
T Consensus       164 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  241 (361)
T 2yab_A          164 GLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF  241 (361)
T ss_dssp             SSCEECCTT-CCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred             CCceEcCCC-CccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchh
Confidence            999876543 23456779999999999877665 6789999999999999999999999998888888888877665   


Q ss_pred             -CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          348 -DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       348 -~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                       ..+++++++||.+||+.||.+|||+.|+++||||+..
T Consensus       242 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          242 FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence             5789999999999999999999999999999999853

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1e-53  Score=414.20  Aligned_cols=260  Identities=28%  Similarity=0.489  Sum_probs=232.9

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID  194 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  194 (410)
                      ..++|.+++.||+|+||.||+|+++.+|+.||||++.+....      .......+..|..++..+ +||||+++++++.
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~   88 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL------MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ   88 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH------HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh------hhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence            457899999999999999999999999999999999765321      112345678899999876 9999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      +  ...+|+||||++|++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus        89 ~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           89 T--KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             C--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             e--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            7  46899999999999999988877789999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPEL  354 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l  354 (410)
                      ............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+......+|..+++++
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~  245 (345)
T 1xjd_A          167 ENMLGDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA  245 (345)
T ss_dssp             CCCCTTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             hcccCCCcccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHH
Confidence            65444445567789999999999887665 67899999999999999999999999998999999999888999999999


Q ss_pred             HHHHHHhcccCCCCCCCHH-HHhhCCcccCC
Q 015257          355 RNLLEGLLCKDPTRRLTLN-DVAKHTWVLGD  384 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~-ell~h~~~~~~  384 (410)
                      .+||.+||+.||.+||++. ++++||||.+-
T Consensus       246 ~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          246 KDLLVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             HHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence            9999999999999999998 99999999864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-53  Score=406.21  Aligned_cols=255  Identities=30%  Similarity=0.604  Sum_probs=231.4

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+++.||+|+||.||++++..+|+.||||++.+.....      ....+.+.+|+.+++.++||||+++++++.+ 
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-   77 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR------LKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-   77 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH------TTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh------hhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-
Confidence            468999999999999999999999999999999987653211      1234578899999999999999999999986 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       ...+|+||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus        78 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~  156 (318)
T 1fot_A           78 -AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV  156 (318)
T ss_dssp             -SSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred             -CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceec
Confidence             4689999999999999999888888999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN  356 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~  356 (410)
                      ..   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+......+|..+++++.+
T Consensus       157 ~~---~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  232 (318)
T 1fot_A          157 PD---VTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD  232 (318)
T ss_dssp             SS---CBCCCCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             CC---ccccccCCccccCHhHhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            43   2345689999999999887665 6679999999999999999999999998889999999999999999999999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHhhCCcccC
Q 015257          357 LLEGLLCKDPTRRL-----TLNDVAKHTWVLG  383 (410)
Q Consensus       357 li~~~L~~dp~~Rp-----t~~ell~h~~~~~  383 (410)
                      ||.+||+.||.+||     +++++++||||.+
T Consensus       233 li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          233 LLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             HHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             HHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence            99999999999999     9999999999976

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.7e-53  Score=418.08  Aligned_cols=260  Identities=28%  Similarity=0.459  Sum_probs=227.7

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID  194 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  194 (410)
                      ..++|.+++.||+|+||.||+++++.+++.||||++.+....      .......+.+|..++.++ +|||||++++++.
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~------~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~  123 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN------DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ  123 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----------CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc------CHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence            346899999999999999999999999999999999865322      223344678899999876 8999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      +  ...+|+||||++|++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       124 ~--~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          124 T--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             C--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             E--CCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceee
Confidence            7  46899999999999999888877889999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhCCCC
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE---------TLQDTYDKIVNNSLV  345 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~---------~~~~~~~~i~~~~~~  345 (410)
                      ............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...         ........+......
T Consensus       202 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~  280 (396)
T 4dc2_A          202 EGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR  280 (396)
T ss_dssp             CCCCTTCCBCCCCBCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC
T ss_pred             ecccCCCccccccCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC
Confidence            65444455667889999999999987766 67899999999999999999999632         233466778888889


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhhCCcccCC
Q 015257          346 FPDAMNPELRNLLEGLLCKDPTRRLTL------NDVAKHTWVLGD  384 (410)
Q Consensus       346 ~p~~~~~~l~~li~~~L~~dp~~Rpt~------~ell~h~~~~~~  384 (410)
                      +|..+++++.+||.+||+.||.+||++      +|+++||||.+-
T Consensus       281 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          281 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            999999999999999999999999985      899999999763

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=6.9e-53  Score=408.61  Aligned_cols=259  Identities=28%  Similarity=0.467  Sum_probs=229.2

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEEc
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDD  195 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~  195 (410)
                      .++|.+++.||+|+||.||+++++.+|+.||||++.+...      ........+.+|+.+++.+ +||||+++++++.+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~   81 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV------NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT   81 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS------CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh------cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe
Confidence            4689999999999999999999999999999999976532      2345567789999999988 89999999999987


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                        ...+|+||||++|++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus        82 --~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~  159 (345)
T 3a8x_A           82 --ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  159 (345)
T ss_dssp             --SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred             --CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccc
Confidence              468999999999999998887777899999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHHhCCCCC
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG---------ETLQDTYDKIVNNSLVF  346 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~---------~~~~~~~~~i~~~~~~~  346 (410)
                      ...........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..         .........+......+
T Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~  238 (345)
T 3a8x_A          160 GLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI  238 (345)
T ss_dssp             SCCTTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCC
T ss_pred             ccCCCCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCC
Confidence            5444445567789999999999887665 6789999999999999999999965         23344567777888889


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCH------HHHhhCCcccCC
Q 015257          347 PDAMNPELRNLLEGLLCKDPTRRLTL------NDVAKHTWVLGD  384 (410)
Q Consensus       347 p~~~~~~l~~li~~~L~~dp~~Rpt~------~ell~h~~~~~~  384 (410)
                      |..+++++.+||.+||+.||.+||++      .++++||||.+-
T Consensus       239 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          239 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            99999999999999999999999995      899999999763

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.4e-53  Score=411.89  Aligned_cols=260  Identities=29%  Similarity=0.489  Sum_probs=232.6

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVI  193 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  193 (410)
                      ...++|.+++.||+|+||.||++++..+|+.||||++.+....      .......+..|..++..+ +||||+++++++
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~------~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~   90 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI------QDDDVECTMVEKRVLALPGKPPFLTQLHSCF   90 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH------HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------cchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence            3457899999999999999999999999999999999765321      122345788999999888 899999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .+  ...+|+||||++|++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus        91 ~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a  168 (353)
T 2i0e_A           91 QT--MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC  168 (353)
T ss_dssp             EC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             Ec--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence            87  4689999999999999988887778999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPE  353 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~  353 (410)
                      +............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+......+|..++++
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~  247 (353)
T 2i0e_A          169 KENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE  247 (353)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             cccccCCcccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Confidence            865444445567789999999999887665 6789999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHhhCCcccC
Q 015257          354 LRNLLEGLLCKDPTRRLT-----LNDVAKHTWVLG  383 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~  383 (410)
                      +.+||.+||+.||.+||+     ++++++||||.+
T Consensus       248 ~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          248 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             HHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             HHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            999999999999999994     699999999975

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.1e-52  Score=420.16  Aligned_cols=261  Identities=30%  Similarity=0.554  Sum_probs=231.6

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ..+.++|.+++.||+|+||.||++.+..+|+.||+|++.....       .......+.+|+.+++.++|||||++++++
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~   79 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-------SARDHQKLEREARICRLLKHPNIVRLHDSI   79 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-------HHHHHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-------CHHHHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence            4456789999999999999999999999999999999875432       234456789999999999999999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEc---CCCcEEEeec
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDF  270 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~---~~~~~kl~Df  270 (410)
                      .+  ....|+||||++|++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+||
T Consensus        80 ~~--~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DF  157 (444)
T 3soa_A           80 SE--EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADF  157 (444)
T ss_dssp             EC--SSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred             EE--CCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccC
Confidence            86  568999999999999988888788899999999999999999999999999999999999998   4578999999


Q ss_pred             cccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--
Q 015257          271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD--  348 (410)
Q Consensus       271 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--  348 (410)
                      |++..............||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+...+|.  
T Consensus       158 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  236 (444)
T 3soa_A          158 GLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE  236 (444)
T ss_dssp             SSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred             ceeEEecCCCceeecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc
Confidence            999877665555567789999999999877665 67799999999999999999999999988899999888776653  


Q ss_pred             --CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          349 --AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       349 --~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                        .+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       237 ~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          237 WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence              689999999999999999999999999999999753

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.1e-52  Score=397.30  Aligned_cols=260  Identities=23%  Similarity=0.418  Sum_probs=221.0

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|++++.||+|+||.||++++..+|+.||||++.....       .......+.+|+.+++.++||||+++++++.+  
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--   72 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-------DEGVPSSALREICLLKELKHKNIVRLHDVLHS--   72 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-------STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-------cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--
Confidence            579999999999999999999999999999999875421       23455678899999999999999999999987  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+++||||++++++.......+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        73 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  152 (292)
T 3o0g_A           73 DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CCEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence            46899999999987766666667789999999999999999999999999999999999999999999999999998766


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhCC-------------
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYP-FLGETLQDTYDKIVNNS-------------  343 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~P-f~~~~~~~~~~~i~~~~-------------  343 (410)
                      ..........||+.|+|||++.+....+.++|||||||++|+|++|..| |.+....+....+....             
T Consensus       153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             CccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence            5555556678999999999988776567889999999999999988777 55556555555554310             


Q ss_pred             ----------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          344 ----------------LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       344 ----------------~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                                      ......+++++++||.+||+.||.+|||++|+++||||++...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p  291 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence                            0112357899999999999999999999999999999987543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=9.5e-53  Score=408.40  Aligned_cols=257  Identities=32%  Similarity=0.583  Sum_probs=232.6

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+++.||+|+||.||++++..+|+.||||++.+.....      ......+.+|+.+|+.++||||+++++++.
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  111 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK------LKQIEHTLNEKRILQAVNFPFLVKLEFSFK  111 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH------TTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            34578999999999999999999999999999999987653211      223467889999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      +  ...+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       112 ~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~  189 (350)
T 1rdq_E          112 D--NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             C--SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             c--CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccce
Confidence            7  46899999999999999988877789999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPEL  354 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l  354 (410)
                      .....   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+.+..+..+...+|..+++++
T Consensus       190 ~~~~~---~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~  265 (350)
T 1rdq_E          190 RVKGR---TWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL  265 (350)
T ss_dssp             ECSSC---BCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHH
T ss_pred             eccCC---cccccCCccccCHHHhcCCCC-CCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHH
Confidence            65432   245679999999999887665 67899999999999999999999999988999999999999999999999


Q ss_pred             HHHHHHhcccCCCCCCC-----HHHHhhCCcccC
Q 015257          355 RNLLEGLLCKDPTRRLT-----LNDVAKHTWVLG  383 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~  383 (410)
                      .+||.+||+.||.+||+     ++++++||||.+
T Consensus       266 ~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            99999999999999998     999999999976

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.3e-52  Score=396.51  Aligned_cols=257  Identities=27%  Similarity=0.448  Sum_probs=225.0

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||++.+..+|+.||||++.....         ...+.+.+|+.+++.++||||+++++++..
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   88 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---------PKKELIINEILVMRENKNPNIVNYLDSYLV   88 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---------SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---------cHHHHHHHHHHHHhcCCCCCCCeEeEEEEE
Confidence            34689999999999999999999999999999999865421         123568899999999999999999999987


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                        ...+++||||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        89 --~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (297)
T 3fxz_A           89 --GDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ  165 (297)
T ss_dssp             --TTEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             --CCEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCcee
Confidence              45899999999999999887654 699999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCCCCCH
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDAMNP  352 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~~~  352 (410)
                      ............||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+...   ....|..+++
T Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (297)
T 3fxz_A          166 ITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA  244 (297)
T ss_dssp             CCSTTCCBCCCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCH
T ss_pred             cCCcccccCCccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCH
Confidence            6655555566789999999999887766 67899999999999999999999988776665555443   2345668899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      .+.+||.+||+.||.+|||++|+++||||+...
T Consensus       245 ~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          245 IFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence            999999999999999999999999999998653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.4e-52  Score=398.95  Aligned_cols=264  Identities=27%  Similarity=0.458  Sum_probs=217.3

Q ss_pred             ccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       113 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      +..+.++|++++.||+|+||.||++++. +|+.||||++.....       .......+.+|+.+++.++||||++++++
T Consensus        16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   87 (311)
T 3niz_A           16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-------DEGIPSTAIREISLLKELHHPNIVSLIDV   87 (311)
T ss_dssp             EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------------CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-------cchhhHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            3456789999999999999999999985 589999999864321       23345678899999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      +.+  ...+++||||++++++.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        88 ~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  165 (311)
T 3niz_A           88 IHS--ERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGL  165 (311)
T ss_dssp             ECC--SSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             Ecc--CCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcC
Confidence            976  458999999999755554445556799999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCC-----
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN---NSL-----  344 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~---~~~-----  344 (410)
                      ++.............||+.|+|||++.+....+.++|||||||++|+|++|..||.+....+....+..   ...     
T Consensus       166 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  245 (311)
T 3niz_A          166 ARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP  245 (311)
T ss_dssp             CEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred             ceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence            987665545555677999999999987765557889999999999999999999988766555544432   100     


Q ss_pred             ----------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          345 ----------------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       345 ----------------------~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                                            .....+++++.+||.+||+.||.+|||++|+++||||++...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence                                  011347889999999999999999999999999999987543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-52  Score=401.71  Aligned_cols=259  Identities=25%  Similarity=0.457  Sum_probs=229.2

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+.+.||+|+||.||++.+..+++.||+|++...          ......+.+|+.+++.++||||+++++++.+
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   72 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----------GTDQVLVKKEISILNIARHRNILHLHESFES   72 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----------cccHHHHHHHHHHHHhCCCCCCCeEeEEEec
Confidence            457899999999999999999999999999999987532          2344578899999999999999999999987


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC--CCcEEEeeccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP--SGTVKIGDFSV  272 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~--~~~~kl~DfG~  272 (410)
                        ...+++||||++|++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+
T Consensus        73 --~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~  150 (321)
T 1tki_A           73 --MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ  150 (321)
T ss_dssp             --TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred             --CCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence              45899999999999998888665 47999999999999999999999999999999999999997  78999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----C
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----D  348 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~  348 (410)
                      ++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....+....+......++    .
T Consensus       151 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  228 (321)
T 1tki_A          151 ARQLKPGD-NFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK  228 (321)
T ss_dssp             CEECCTTC-EEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred             CeECCCCC-ccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhc
Confidence            98765432 3345668999999999877655 6789999999999999999999999998888888988877666    3


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI  388 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~  388 (410)
                      .+++++.+||.+||..||.+|||+.|+++||||++...+.
T Consensus       229 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  268 (321)
T 1tki_A          229 EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERV  268 (321)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGGS
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCcccc
Confidence            7899999999999999999999999999999998764443

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.2e-53  Score=412.42  Aligned_cols=260  Identities=32%  Similarity=0.617  Sum_probs=226.3

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ..+++|.+.+.||+|+||.||+|.+..+|+.||||++.......      ......+.+|+.+++.++||||+++++++.
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   79 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK------SDMHMRVEREISYLKLLRHPHIIKLYDVIT   79 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH------TTCSHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc------hhHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            45678999999999999999999999999999999987543211      122346889999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      +  ...+++||||+ ++.+.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        80 ~--~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~  156 (336)
T 3h4j_B           80 T--PTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSN  156 (336)
T ss_dssp             C--SSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred             e--CCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccce
Confidence            7  45899999999 56666666666789999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPEL  354 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l  354 (410)
                      ..... ......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.........+......+|..+++++
T Consensus       157 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~  235 (336)
T 3h4j_B          157 IMTDG-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGA  235 (336)
T ss_dssp             TTTTS-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHH
T ss_pred             eccCC-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHH
Confidence            76543 33456789999999999988777678899999999999999999999887665555555556667888999999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      .+||.+||+.||.+|||++|+++||||+..
T Consensus       236 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          236 QSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            999999999999999999999999999864

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.1e-52  Score=402.25  Aligned_cols=261  Identities=30%  Similarity=0.480  Sum_probs=220.2

Q ss_pred             cccceeeeeeecccCceEEEEEEEc---cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      ..++|.+++.||+|+||.||++++.   .+|+.||||++.+.....     .......+.+|+.+|+.++||||++++++
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   89 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR-----NAKDTAHTKAERNILEEVKHPFIVDLIYA   89 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC-------------------HHHHHHHCCCTTBCCEEEE
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhh-----hhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence            3468999999999999999999985   589999999987643211     22334567899999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      +.+  ...+|+||||++|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  167 (327)
T 3a62_A           90 FQT--GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL  167 (327)
T ss_dssp             EEC--SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred             EEc--CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence            986  458999999999999988887777899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCH
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNP  352 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~  352 (410)
                      ++............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..+++
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~  246 (327)
T 3a62_A          168 CKESIHDGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQ  246 (327)
T ss_dssp             C----------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCH
T ss_pred             ccccccCCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCH
Confidence            9865544444556789999999999877665 678999999999999999999999998888889999998889999999


Q ss_pred             HHHHHHHHhcccCCCCCC-----CHHHHhhCCcccCC
Q 015257          353 ELRNLLEGLLCKDPTRRL-----TLNDVAKHTWVLGD  384 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~  384 (410)
                      ++.+||.+||+.||.+||     ++.++++||||.+.
T Consensus       247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            999999999999999999     89999999999763

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.6e-52  Score=420.32  Aligned_cols=264  Identities=34%  Similarity=0.647  Sum_probs=238.3

Q ss_pred             cccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCccccee
Q 015257          112 NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE  191 (410)
Q Consensus       112 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  191 (410)
                      .+....++|.+.+.||+|+||.||++++..+|+.||||++......      ..+....+.+|+.+++.++||||+++++
T Consensus        10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~------~~~~~~~~~~Ei~~l~~l~HpnIv~l~~   83 (476)
T 2y94_A           10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR------SLDVVGKIRREIQNLKLFRHPHIIKLYQ   83 (476)
T ss_dssp             CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH------HTTTHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc------CHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            3455678999999999999999999999999999999998754321      1223467899999999999999999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      ++..  ...+++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        84 ~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG  161 (476)
T 2y94_A           84 VIST--PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG  161 (476)
T ss_dssp             EEEC--SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred             EEEE--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEecc
Confidence            9987  45899999999999999999888899999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCC
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN  351 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~  351 (410)
                      +++..... ......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.........+..+....|..++
T Consensus       162 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s  240 (476)
T 2y94_A          162 LSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLN  240 (476)
T ss_dssp             SCEECCTT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCC
T ss_pred             chhhcccc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCC
Confidence            99876543 33456789999999999988777678899999999999999999999998888888999998888899999


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       352 ~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      +++.+||.+||+.||.+|||+.++++||||+..
T Consensus       241 ~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          241 PSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            999999999999999999999999999999864

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.7e-53  Score=401.14  Aligned_cols=248  Identities=22%  Similarity=0.265  Sum_probs=192.9

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      .+|.+.+.||+|+||+||+++.  +|+.||||++....          ........|+..+..++|||||++++++.+++
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----------~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~   70 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----------ERSWFREAEIYQTVMLRHENILGFIAADNKDN   70 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----------hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC
Confidence            4688999999999999999976  58999999986431          11123345777778899999999999998643


Q ss_pred             C--CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEeccCCCCcEEEcCCCcEEE
Q 015257          198 S--DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH--------NVVHGDIKPDNLLVAPSGTVKI  267 (410)
Q Consensus       198 ~--~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~--------~iiHrDlkp~NIll~~~~~~kl  267 (410)
                      .  ..+|||||||++|+|.+++.. ..+++..+..++.|++.||+|||++        +||||||||+||||+.++.+||
T Consensus        71 ~~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki  149 (303)
T 3hmm_A           71 GTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             CCceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEE
Confidence            2  368999999999999998865 4689999999999999999999987        9999999999999999999999


Q ss_pred             eeccccccccCCcc----ccccCCCcccccccccccCCcC-----CCchhhHHHHHHHHHHHHhCCCCCCCC--------
Q 015257          268 GDFSVSQVFEDDND----VLRRSPGTPVFTAPECCLGLTY-----GGKAADTWAVGVTLYYMIIGQYPFLGE--------  330 (410)
Q Consensus       268 ~DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlG~il~elltG~~Pf~~~--------  330 (410)
                      +|||+|+.......    .....+||+.|+|||++.+...     ++.++|||||||+||||+||.+||...        
T Consensus       150 ~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~  229 (303)
T 3hmm_A          150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             CCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             EeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch
Confidence            99999987654332    2234579999999999876421     256799999999999999997765321        


Q ss_pred             -------CHHHHHHHHHhCCC--CCCCC-----CCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          331 -------TLQDTYDKIVNNSL--VFPDA-----MNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       331 -------~~~~~~~~i~~~~~--~~p~~-----~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                             ........+.....  .+|..     .+..+.+|+.+||+.||++|||+.||++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                   12233333333322  23322     23468899999999999999999999874

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.4e-52  Score=404.98  Aligned_cols=258  Identities=29%  Similarity=0.541  Sum_probs=229.5

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      .+.++|.+.+.||+|+||.||++.+..+|+.||||++.....       .......+.+|+.+++.++||||+++++++.
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~   98 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-------SARDFQKLEREARICRKLQHPNIVRLHDSIQ   98 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            445689999999999999999999999999999999875432       3345678999999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC---cEEEeecc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---TVKIGDFS  271 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~---~~kl~DfG  271 (410)
                      +  ....|+||||++|++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||
T Consensus        99 ~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG  176 (362)
T 2bdw_A           99 E--ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG  176 (362)
T ss_dssp             C--SSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             e--CCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecC
Confidence            7  468999999999999988888888899999999999999999999999999999999999998654   59999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD---  348 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~---  348 (410)
                      ++...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+...+|.   
T Consensus       177 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  254 (362)
T 2bdw_A          177 LAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW  254 (362)
T ss_dssp             TCBCCTTC-CSCCCSCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGG
T ss_pred             cceEecCC-cccccCCCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence            99876543 23456789999999999877665 67899999999999999999999999888888888888776664   


Q ss_pred             -CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          349 -AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       349 -~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                       .+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       255 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          255 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence             57999999999999999999999999999999975

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.9e-52  Score=409.45  Aligned_cols=260  Identities=31%  Similarity=0.515  Sum_probs=225.1

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHH-HHhCCCCCcccceeEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI-MKMLQHPNIVNLIEVI  193 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~l~~~~  193 (410)
                      ...++|.+++.||+|+||.||+++++.+++.||||++.+....      .......+.+|..+ ++.++||||+++++++
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~------~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~  108 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL------KKKEEKHIMSERNVLLKNVKHPFLVGLHFSF  108 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------------CCBCCCCCTTBCCEEEEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh------hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence            3457899999999999999999999999999999999765432      12233456677776 5778999999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .+  ...+|+||||++|++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus       109 ~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a  186 (373)
T 2r5t_A          109 QT--ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC  186 (373)
T ss_dssp             EC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBC
T ss_pred             Ee--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccc
Confidence            87  4689999999999999988887778999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPE  353 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~  353 (410)
                      +............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+.+..+......+|..++++
T Consensus       187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (373)
T 2r5t_A          187 KENIEHNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNS  265 (373)
T ss_dssp             GGGBCCCCCCCSBSCCCCCCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHH
T ss_pred             cccccCCCccccccCCccccCHHHhCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Confidence            865544445567789999999999887665 6789999999999999999999999999999999999988899999999


Q ss_pred             HHHHHHHhcccCCCCCCCH----HHHhhCCcccC
Q 015257          354 LRNLLEGLLCKDPTRRLTL----NDVAKHTWVLG  383 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~----~ell~h~~~~~  383 (410)
                      +.+||.+||+.||.+||++    .++++||||.+
T Consensus       266 ~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          266 ARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             HHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             HHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence            9999999999999999987    69999999976

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6.2e-52  Score=406.97  Aligned_cols=262  Identities=27%  Similarity=0.470  Sum_probs=229.9

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ....++|.+++.||+|+||.||++++..+++.||||++.+....      .......+.+|+.+|+.++|||||++++++
T Consensus        11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~------~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~   84 (384)
T 4fr4_A           11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV------ERNEVRNVFKELQIMQGLEHPFLVNLWYSF   84 (384)
T ss_dssp             CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH------HTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc------cHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            34567899999999999999999999999999999998764321      123446788999999999999999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .+  ...+|+||||+.|++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus        85 ~~--~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a  162 (384)
T 4fr4_A           85 QD--EEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA  162 (384)
T ss_dssp             EC--SSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             Ee--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEecccee
Confidence            87  4589999999999999999988889999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCC--cCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhCCCCCCC
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGL--TYGGKAADTWAVGVTLYYMIIGQYPFLG---ETLQDTYDKIVNNSLVFPD  348 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~elltG~~Pf~~---~~~~~~~~~i~~~~~~~p~  348 (410)
                      +..... ......+||+.|+|||++.+.  ..++.++|||||||++|+|++|..||..   .........+......+|.
T Consensus       163 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~  241 (384)
T 4fr4_A          163 AMLPRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS  241 (384)
T ss_dssp             EECCTT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCT
T ss_pred             eeccCC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCC
Confidence            876443 344567899999999998643  2236789999999999999999999974   3445566777778888999


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCC-HHHHhhCCcccCC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLT-LNDVAKHTWVLGD  384 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt-~~ell~h~~~~~~  384 (410)
                      .+++++.+||.+||+.||.+||+ ++++++||||.+-
T Consensus       242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence            99999999999999999999998 9999999999763

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.2e-52  Score=420.66  Aligned_cols=260  Identities=31%  Similarity=0.559  Sum_probs=224.2

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||++++..+|+.||||++......      .......+.+|+.+++.++||||+++++++.+
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~  219 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV------AKDEVAHTLTENRVLQNSRHPFLTALKYSFQT  219 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------------CCCCCSCTTSCCEEEEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh------hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee
Confidence            457899999999999999999999999999999998754321      22344567899999999999999999999987


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                        ...+++||||+++++|...+.....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++
T Consensus       220 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~  297 (446)
T 4ejn_A          220 --HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK  297 (446)
T ss_dssp             --TTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred             --CCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCce
Confidence              45899999999999998888777889999999999999999999998 999999999999999999999999999998


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPEL  354 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l  354 (410)
                      ............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..+++++
T Consensus       298 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~  376 (446)
T 4ejn_A          298 EGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA  376 (446)
T ss_dssp             TTCC-----CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             eccCCCcccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHH
Confidence            75555555667889999999999877665 67899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcccCCCCCC-----CHHHHhhCCcccCC
Q 015257          355 RNLLEGLLCKDPTRRL-----TLNDVAKHTWVLGD  384 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~  384 (410)
                      .+||.+||+.||.+||     |++|+++||||.+.
T Consensus       377 ~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            9999999999999999     99999999999874

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-51  Score=395.28  Aligned_cols=263  Identities=30%  Similarity=0.533  Sum_probs=229.8

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..+.|.+.+.||+|+||.||++.+..+|+.||||++........   ......+.+.+|+.+|+.++||||+++++++.+
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   85 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSS---RRGVSREDIEREVSILKEIQHPNVITLHEVYEN   85 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTC---SSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccc---cchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            44679999999999999999999999999999999876532211   111234678999999999999999999999986


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC----cEEEeecc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG----TVKIGDFS  271 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~----~~kl~DfG  271 (410)
                        ...+++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||
T Consensus        86 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           86 --KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             --SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             --CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence              468999999999999999998888899999999999999999999999999999999999999887    89999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----  347 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----  347 (410)
                      +++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....+....+......++    
T Consensus       164 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (326)
T 2y0a_A          164 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF  241 (326)
T ss_dssp             TCEECCTTS-CCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred             CCeECCCCC-ccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccc
Confidence            998764332 3345679999999998876665 6779999999999999999999999888888888877666555    


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      ..+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus       242 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            47899999999999999999999999999999998653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.3e-51  Score=396.11  Aligned_cols=260  Identities=26%  Similarity=0.487  Sum_probs=220.9

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      .+.++|++++.||+|+||.||++++..+++.||||++.....        ....+.+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~   75 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--------VDCPENIKKEICINKMLNHENVVKFYGHRR   75 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--------cchHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            356789999999999999999999999999999999864321        223356889999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      +  ....++||||+++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        76 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~  153 (323)
T 3tki_A           76 E--GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT  153 (323)
T ss_dssp             C--SSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             c--CCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccc
Confidence            6  56899999999999999999888889999999999999999999999999999999999999999999999999998


Q ss_pred             cccCC--ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCC--CCC
Q 015257          275 VFEDD--NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ-DTYDKIVNNSLVF--PDA  349 (410)
Q Consensus       275 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~i~~~~~~~--p~~  349 (410)
                      .....  ........||+.|+|||++.+..+.+.++|||||||++|+|++|..||...... .............  ...
T Consensus       154 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (323)
T 3tki_A          154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK  233 (323)
T ss_dssp             ECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGG
T ss_pred             eeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCcccc
Confidence            65432  233446789999999999987776677899999999999999999999875543 2333333332222  246


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      +++.+.+||.+||+.||.+|||+.|+++||||...
T Consensus       234 ~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          234 IDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence            89999999999999999999999999999999864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=8.7e-52  Score=390.44  Aligned_cols=256  Identities=27%  Similarity=0.440  Sum_probs=210.1

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||+|+||.||++++ .+|+.||||++.....       .......+.+|+.+++.++||||+++++++.+  
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--   71 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-------DEGIPSTTIREISILKELKHSNIVKLYDVIHT--   71 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-------GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-------ccccchhHHHHHHHHHhcCCCCEeeeeeEEcc--
Confidence            5799999999999999999998 5789999999864421       11223567899999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ...+++||||+++ ++.+.+. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           72 KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF  150 (288)
T ss_dssp             SSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             CCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence            4579999999997 4444443 3467999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC----------
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--SL----------  344 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--~~----------  344 (410)
                      ...........||+.|+|||++.+....+.++|||||||++|+|++|..||.+....+....+...  ..          
T Consensus       151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence            544444455678999999999877655578899999999999999999999988777666555431  00          


Q ss_pred             -----------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          345 -----------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       345 -----------------~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                                       .+...+++++.+||.+||+.||.+|||++|+++||||++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                             1123578999999999999999999999999999999864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.9e-52  Score=407.00  Aligned_cols=262  Identities=28%  Similarity=0.444  Sum_probs=211.4

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVI  193 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~  193 (410)
                      ...++|.+++.||+|+||.||+|.+..+|+.||||++....       ........+.+|+.+++.+. ||||+++++++
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-------~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~   78 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-------QNSTDAQRTFREIMILTELSGHENIVNLLNVL   78 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---------CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-------cChHHHHHHHHHHHHHHhccCCCCCCeeeeEE
Confidence            45678999999999999999999999999999999985431       23455667889999999997 99999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      ...+...+|+|||||++ .+...+.. ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|
T Consensus        79 ~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           79 RADNDRDVYLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             ECTTSSCEEEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ecCCCCEEEEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence            87666689999999985 45555543 47999999999999999999999999999999999999999999999999999


Q ss_pred             ccccC---------------------CccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 015257          274 QVFED---------------------DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL  332 (410)
Q Consensus       274 ~~~~~---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~  332 (410)
                      +....                     ........+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            86532                     112334568999999999998755567889999999999999999999999887


Q ss_pred             HHHHHHHHhCCC-----------------------------------------------CCCCCCCHHHHHHHHHhcccC
Q 015257          333 QDTYDKIVNNSL-----------------------------------------------VFPDAMNPELRNLLEGLLCKD  365 (410)
Q Consensus       333 ~~~~~~i~~~~~-----------------------------------------------~~p~~~~~~l~~li~~~L~~d  365 (410)
                      .+....+.....                                               ..+..+++++.+||.+||+.|
T Consensus       237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d  316 (388)
T 3oz6_A          237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN  316 (388)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence            777666643100                                               011267899999999999999


Q ss_pred             CCCCCCHHHHhhCCcccCCC
Q 015257          366 PTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       366 p~~Rpt~~ell~h~~~~~~~  385 (410)
                      |.+|||++|+|+||||....
T Consensus       317 P~~R~t~~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          317 PNKRISANDALKHPFVSIFH  336 (388)
T ss_dssp             GGGSCCHHHHTTSTTTTTTC
T ss_pred             cccCCCHHHHhCCHHHHHhc
Confidence            99999999999999997653

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.5e-51  Score=400.21  Aligned_cols=261  Identities=28%  Similarity=0.536  Sum_probs=222.9

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      +.++|.+.+.||+|+||.||++.+..+|+.||||++.......    ......+.+.+|+.+++.++||||+++++++.+
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   97 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTS----SPGLSTEDLKREASICHMLKHPHIVELLETYSS   97 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHT----SSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccc----cccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            4468999999999999999999999999999999987543211    011234678999999999999999999999987


Q ss_pred             CCCCEEEEEEeecCCCCcccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCc---EEEe
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT---VKIG  268 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~---~kl~  268 (410)
                        ...+|+||||++|++|.+.+..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+
T Consensus        98 --~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~  175 (351)
T 3c0i_A           98 --DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLG  175 (351)
T ss_dssp             --TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred             --CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEe
Confidence              4689999999999988765532    345899999999999999999999999999999999999987655   9999


Q ss_pred             eccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-
Q 015257          269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP-  347 (410)
Q Consensus       269 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-  347 (410)
                      |||+++............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. .......+..+...++ 
T Consensus       176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~  253 (351)
T 3c0i_A          176 GFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNP  253 (351)
T ss_dssp             CCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCH
T ss_pred             cCcceeEecCCCeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCc
Confidence            99999877655444556789999999999887665 67899999999999999999999875 4456667777766554 


Q ss_pred             ---CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          348 ---DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       348 ---~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                         ..+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus       254 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          254 RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence               4789999999999999999999999999999999863

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.1e-51  Score=389.54  Aligned_cols=260  Identities=27%  Similarity=0.446  Sum_probs=216.0

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+++.||+|+||.||++++..+|+.||||++....       ........+.+|+.+++.++||||+++++++.+ 
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   73 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-------DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-   73 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-------C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-------cchHHHHHHHHHHHHHHhCCCCCccchhheeec-
Confidence            468999999999999999999999999999999885432       234455678899999999999999999999987 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       ....++||||++++++...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        74 -~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  152 (311)
T 4agu_A           74 -KRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL  152 (311)
T ss_dssp             -TTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             -CCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence             4689999999999999888877788999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------------  342 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--------------  342 (410)
                      ...........||+.|+|||++.+....+.++||||||+++|+|++|..||.+....+....+...              
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (311)
T 4agu_A          153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST  232 (311)
T ss_dssp             C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred             cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence            655555556789999999999877555578899999999999999999999988766655443321              


Q ss_pred             -----CCCCC------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          343 -----SLVFP------------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       343 -----~~~~p------------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                           ....|            ..+++++.+||.+||+.||.+|||++|+++||||++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  292 (311)
T 4agu_A          233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR  292 (311)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence                 00111            35788999999999999999999999999999998753

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.1e-51  Score=408.50  Aligned_cols=260  Identities=32%  Similarity=0.521  Sum_probs=225.0

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||++++..+++.||+|++.+.....      ......+.+|+.+++.++|||||++++++.+
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~------~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK------RSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH------TCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh------hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            4568999999999999999999999999999999987643211      1112347899999999999999999999987


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                        ...+|+||||++|++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus       141 --~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          141 --DRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             --SSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             --CCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence              5689999999999999887754 4699999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCc-cccccCCCcccccccccccCCcC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCC-
Q 015257          276 FEDDN-DVLRRSPGTPVFTAPECCLGLTY---GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVFPD-  348 (410)
Q Consensus       276 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~---~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~-  348 (410)
                      ..... ......+||+.|+|||++.+...   ++.++|||||||++|+|++|..||.+.+....+..+....  +.+|. 
T Consensus       218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  297 (410)
T 3v8s_A          218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD  297 (410)
T ss_dssp             CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTT
T ss_pred             eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCc
Confidence            65433 23456789999999999876542   3578999999999999999999999999888888887643  44553 


Q ss_pred             -CCCHHHHHHHHHhcccCCCC--CCCHHHHhhCCcccCC
Q 015257          349 -AMNPELRNLLEGLLCKDPTR--RLTLNDVAKHTWVLGD  384 (410)
Q Consensus       349 -~~~~~l~~li~~~L~~dp~~--Rpt~~ell~h~~~~~~  384 (410)
                       .+++++++||.+||+.+|.+  ||+++||++||||++-
T Consensus       298 ~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             ccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence             78999999999999999988  9999999999999874

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.1e-51  Score=400.74  Aligned_cols=256  Identities=32%  Similarity=0.591  Sum_probs=212.5

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||++++..+++.||||++.....          ..+.+.+|+.+++.++||||+++++++.+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~hpniv~~~~~~~~   87 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----------IDENVQREIINHRSLRHPNIVRFKEVILT   87 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----------SCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----------ccHHHHHHHHHHHhCCCCCCCcEEEEEee
Confidence            35689999999999999999999999999999999864321          12467899999999999999999999986


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCc--EEEeecccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT--VKIGDFSVS  273 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~--~kl~DfG~a  273 (410)
                        ...+++||||+++++|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++
T Consensus        88 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a  165 (361)
T 3uc3_A           88 --PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS  165 (361)
T ss_dssp             --SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred             --CCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence              4689999999999999988877778999999999999999999999999999999999999987765  999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCCC-
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET----LQDTYDKIVNNSLVFPD-  348 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~-  348 (410)
                      +..... .......||+.|+|||++.+..+.++++|||||||++|+|++|..||.+..    .......+......+|. 
T Consensus       166 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (361)
T 3uc3_A          166 KSSVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD  244 (361)
T ss_dssp             ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT
T ss_pred             cccccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc
Confidence            753322 233456799999999999887776667999999999999999999997743    34555666666666665 


Q ss_pred             -CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          349 -AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       349 -~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                       .+++++.+||.+||+.||.+|||+.|+++||||...
T Consensus       245 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          245 IRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence             689999999999999999999999999999999654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-51  Score=395.47  Aligned_cols=263  Identities=24%  Similarity=0.430  Sum_probs=204.8

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+++.||+|+||.||++.+..+|+.||||++....        .......+.+|+.+++.++||||+++++++.+ 
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-   74 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--------EEGTPSTAIREISLMKELKHENIVRLYDVIHT-   74 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS--------TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--------ccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-
Confidence            357999999999999999999999999999999986542        11223567899999999999999999999976 


Q ss_pred             CCCEEEEEEeecCCCCcccccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeec
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQ------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                       ...+++||||+++ +|.+.+..      ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus        75 -~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  152 (317)
T 2pmi_A           75 -ENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDF  152 (317)
T ss_dssp             -TTEEEEEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             -CCeEEEEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcC
Confidence             4689999999996 45444322      246899999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------
Q 015257          271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS-------  343 (410)
Q Consensus       271 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-------  343 (410)
                      |+++.............||+.|+|||++.+....+.++|||||||++|+|++|..||.+....+....+....       
T Consensus       153 g~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  232 (317)
T 2pmi_A          153 GLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL  232 (317)
T ss_dssp             SSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred             ccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence            9998765544445566799999999998775555788999999999999999999999988777666554310       


Q ss_pred             ---------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCch
Q 015257          344 ---------------------------LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ  390 (410)
Q Consensus       344 ---------------------------~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~  390 (410)
                                                 ...+..+++++.+||.+||+.||.+|||+.|+++||||.+...+..+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~  306 (317)
T 2pmi_A          233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASM  306 (317)
T ss_dssp             CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC----
T ss_pred             hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhc
Confidence                                       00123578899999999999999999999999999999876554433

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1e-51  Score=411.90  Aligned_cols=261  Identities=28%  Similarity=0.479  Sum_probs=224.8

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||++++..+++.||||++.+.....      ......+.+|+.++..++||||+++++++.+
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~------~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK------RAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH------TTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh------HHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            4578999999999999999999999999999999997643211      1112347899999999999999999999987


Q ss_pred             CCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                        ...+|+|||||+|++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus       146 --~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~  223 (437)
T 4aw2_A          146 --DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL  223 (437)
T ss_dssp             --SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             --CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence              4689999999999999998876 5689999999999999999999999999999999999999999999999999997


Q ss_pred             cccCCc-cccccCCCcccccccccccC----CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCC
Q 015257          275 VFEDDN-DVLRRSPGTPVFTAPECCLG----LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--SLVFP  347 (410)
Q Consensus       275 ~~~~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p  347 (410)
                      ...... ......+||+.|+|||++..    ...++.++|||||||++|||++|..||.+.+..+.+..+...  .+.+|
T Consensus       224 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p  303 (437)
T 4aw2_A          224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP  303 (437)
T ss_dssp             ECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred             hcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCC
Confidence            655433 23345689999999999862    233367899999999999999999999999988888888753  34455


Q ss_pred             C---CCCHHHHHHHHHhcccCCCC--CCCHHHHhhCCcccCC
Q 015257          348 D---AMNPELRNLLEGLLCKDPTR--RLTLNDVAKHTWVLGD  384 (410)
Q Consensus       348 ~---~~~~~l~~li~~~L~~dp~~--Rpt~~ell~h~~~~~~  384 (410)
                      .   .+++++++||.+||+.+|.+  ||+++|+++||||.+-
T Consensus       304 ~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          304 TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence            4   48999999999999998888  9999999999999864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.3e-51  Score=382.26  Aligned_cols=262  Identities=29%  Similarity=0.533  Sum_probs=230.5

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      .+.++|.+++.||+|+||.||++.+..+|+.||+|++.....       .......+.+|+.+++.++||||+++++++.
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   75 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-------SARDFQKLEREARICRKLQHPNIVRLHDSIQ   75 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-------CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence            456789999999999999999999999999999999875432       3445678899999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCc---EEEeecc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT---VKIGDFS  271 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~---~kl~DfG  271 (410)
                      +  ....++||||++++++.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||
T Consensus        76 ~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           76 E--ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             C--SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             c--CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence            6  4689999999999998887777778999999999999999999999999999999999999987665   9999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----  347 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----  347 (410)
                      ++....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.........+..+...+|    
T Consensus       154 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T 3kk8_A          154 LAIEVNDSE-AWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW  231 (284)
T ss_dssp             TCEECCSSC-BCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred             eeEEcccCc-cccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhh
Confidence            997655432 3345679999999999887665 6779999999999999999999999988888888887766555    


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                      ..+++++.+||.+||+.||.+|||+.|+++||||.+....
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  271 (284)
T 3kk8_A          232 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV  271 (284)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred             cccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhH
Confidence            3689999999999999999999999999999999876443

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-50  Score=398.19  Aligned_cols=259  Identities=29%  Similarity=0.535  Sum_probs=226.1

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+++.||+|+||.||+|.+..+|+.||+|++....         ......+.+|+.+|+.++||||+++++++.
T Consensus        48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~  118 (387)
T 1kob_A           48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---------PLDKYTVKNEISIMNQLHHPKLINLHDAFE  118 (387)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---------HHHHHHHHHHHHHHTTCCSTTBCCEEEEEE
T ss_pred             ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---------hhhHHHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence            34578999999999999999999999999999999986431         233457889999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC--CCcEEEeecc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP--SGTVKIGDFS  271 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~--~~~~kl~DfG  271 (410)
                      +  ...+++||||++|++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||
T Consensus       119 ~--~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG  196 (387)
T 1kob_A          119 D--KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG  196 (387)
T ss_dssp             C--SSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             e--CCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecc
Confidence            6  56899999999999998887765 47999999999999999999999999999999999999974  4679999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----  347 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----  347 (410)
                      +++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....+....+......++    
T Consensus       197 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  274 (387)
T 1kob_A          197 LATKLNPDE-IVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF  274 (387)
T ss_dssp             TCEECCTTS-CEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTT
T ss_pred             cceecCCCc-ceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence            998765432 3344579999999999877665 6789999999999999999999999888888888877665444    


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      ..+++++.+||.+||+.||.+|||+.|+++||||++...
T Consensus       275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence            468999999999999999999999999999999987643

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.2e-51  Score=395.36  Aligned_cols=264  Identities=25%  Similarity=0.393  Sum_probs=219.1

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||++++..+|+.||||++.....       .......+.+|+.+++.++||||+++++++..
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   87 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-------KEGFPITALREIKILQLLKHENVVNLIEICRT   87 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-------SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-------cccchHHHHHHHHHHHhccCCCcccHhheeec
Confidence            45789999999999999999999999999999999865422       12223467799999999999999999999876


Q ss_pred             CC------CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEee
Q 015257          196 PN------SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGD  269 (410)
Q Consensus       196 ~~------~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~D  269 (410)
                      ..      .+.+++||||++++++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~D  167 (351)
T 3mi9_A           88 KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLAD  167 (351)
T ss_dssp             C--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred             cccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEcc
Confidence            43      357899999999865555555556799999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCC----ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Q 015257          270 FSVSQVFEDD----NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV  345 (410)
Q Consensus       270 fG~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~  345 (410)
                      ||+++.....    ........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.........+......
T Consensus       168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  247 (351)
T 3mi9_A          168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS  247 (351)
T ss_dssp             CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            9999865421    223345678999999999877665578899999999999999999999998877766655442211


Q ss_pred             CCCC--------------------------------CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          346 FPDA--------------------------------MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       346 ~p~~--------------------------------~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      ++..                                .++.+.+||.+||+.||.+|||++|+++||||++...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  320 (351)
T 3mi9_A          248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  320 (351)
T ss_dssp             CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred             CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence            1111                                2678999999999999999999999999999987544

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.3e-51  Score=400.52  Aligned_cols=267  Identities=18%  Similarity=0.269  Sum_probs=217.3

Q ss_pred             ccceeeeeeeccc--CceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          117 INEYVHVRKIGAG--SYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       117 ~~~y~~~~~lG~G--~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      .++|++++.||+|  +||.||++++..+|+.||||++.....       .......+.+|+.+++.++|||||++++++.
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   96 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-------SNEMVTFLQGELHVSKLFNHPNIVPYRATFI   96 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-------ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence            4689999999999  999999999999999999999875422       3456678899999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      +  ...+++||||++++++.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.
T Consensus        97 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~  174 (389)
T 3gni_B           97 A--DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS  174 (389)
T ss_dssp             E--TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGG
T ss_pred             E--CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccc
Confidence            7  45899999999999998887554  6799999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCc-------cccccCCCcccccccccccCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-
Q 015257          273 SQVFEDDN-------DVLRRSPGTPVFTAPECCLGL-TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS-  343 (410)
Q Consensus       273 a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-  343 (410)
                      +.......       .......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+....+....+..+. 
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  254 (389)
T 3gni_B          175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV  254 (389)
T ss_dssp             CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred             ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence            86543211       122334789999999998763 333678999999999999999999998765444333222211 


Q ss_pred             ---------------------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          344 ---------------------------------------------LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       344 ---------------------------------------------~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                                                                   ..++..+++++.+||.+||+.||.+|||++|+|+|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                                                         12345688999999999999999999999999999


Q ss_pred             CcccCCCCCCchhh
Q 015257          379 TWVLGDNGPIPQYL  392 (410)
Q Consensus       379 ~~~~~~~~~~~~~~  392 (410)
                      |||++...+..+.+
T Consensus       335 p~f~~~~~~~~~~~  348 (389)
T 3gni_B          335 SFFKQIKRRASEAL  348 (389)
T ss_dssp             GGGGGC---CCSSH
T ss_pred             HHHHHHhhcchhhh
Confidence            99998765544443

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2e-51  Score=397.88  Aligned_cols=255  Identities=30%  Similarity=0.473  Sum_probs=221.4

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEV  192 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~  192 (410)
                      ..+.++|.+++.||+|+||.||++.+..+|+.||||++.+...             ...+|+.++.++ +||||++++++
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------------~~~~E~~~l~~~~~hp~iv~~~~~   84 (342)
T 2qr7_A           18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------------DPTEEIEILLRYGQHPNIITLKDV   84 (342)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------------CCHHHHHHHHHHTTSTTBCCEEEE
T ss_pred             cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------------ChHHHHHHHHHhcCCCCcCeEEEE
Confidence            3566789999999999999999999999999999999865421             134688888777 79999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC----CcEEEe
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS----GTVKIG  268 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~----~~~kl~  268 (410)
                      +.+  ...+|+||||++|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+..+    +.+||+
T Consensus        85 ~~~--~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~  162 (342)
T 2qr7_A           85 YDD--GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRIC  162 (342)
T ss_dssp             EEC--SSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEEC
T ss_pred             EEc--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEE
Confidence            986  56899999999999999988888889999999999999999999999999999999999998543    359999


Q ss_pred             eccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhCCCC
Q 015257          269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG---ETLQDTYDKIVNNSLV  345 (410)
Q Consensus       269 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~---~~~~~~~~~i~~~~~~  345 (410)
                      |||+++............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+   ....+....+..+.+.
T Consensus       163 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  241 (342)
T 2qr7_A          163 DFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS  241 (342)
T ss_dssp             CCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHH-HHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC
T ss_pred             ECCCcccCcCCCCceeccCCCccccCHHHhcCCCC-CCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc
Confidence            99999876655555567789999999999876554 5689999999999999999999976   4556677778777765


Q ss_pred             CC----CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          346 FP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       346 ~p----~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      ++    ..+++++.+||.+||..||.+|||+.++++||||.+.
T Consensus       242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            54    4689999999999999999999999999999999753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1e-50  Score=383.91  Aligned_cols=265  Identities=29%  Similarity=0.457  Sum_probs=236.4

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+.+.||+|+||.||++.+..+++.||+|++.....      ......+.+.+|+.+++.++||||+++++++.
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   85 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL------LKPHQREKMSMEISIHRSLAHQHVVGFHGFFE   85 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC------CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc------cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec
Confidence            345689999999999999999999999999999999875432      13455678899999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      +  ....++||||++++++.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        86 ~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  163 (294)
T 2rku_A           86 D--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT  163 (294)
T ss_dssp             C--SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             c--CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCce
Confidence            6  46899999999999998888777789999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPEL  354 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l  354 (410)
                      .............||+.|+|||++.+... +.++||||||+++|+|++|..||......+....+......+|..+++.+
T Consensus       164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (294)
T 2rku_A          164 KVEYDGERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA  242 (294)
T ss_dssp             ECCSTTCCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHH
T ss_pred             ecccCccccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHH
Confidence            76544444456679999999999877655 66799999999999999999999998888888888888888899999999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCC
Q 015257          355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI  388 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~  388 (410)
                      .+||.+||+.||.+|||++++++||||.....|.
T Consensus       243 ~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          243 ASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             HHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             HHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence            9999999999999999999999999998765443

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.6e-51  Score=394.36  Aligned_cols=256  Identities=29%  Similarity=0.491  Sum_probs=203.0

Q ss_pred             cccceeee---eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCccccee
Q 015257          116 MINEYVHV---RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIE  191 (410)
Q Consensus       116 ~~~~y~~~---~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~  191 (410)
                      +.++|.+.   +.||+|+||.||++.+..+|+.||||++...            ....+.+|+.+++.+. ||||+++++
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------------~~~~~~~e~~~l~~l~~h~niv~~~~   73 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------------MEANTQKEITALKLCEGHPNIVKLHE   73 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------------GHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------------hhhhHHHHHHHHHHhcCCCCeeEEEE
Confidence            34567765   7899999999999999999999999998543            2356789999999997 999999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC---cEEEe
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---TVKIG  268 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~---~~kl~  268 (410)
                      ++.+  ....++||||+++++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+
T Consensus        74 ~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~  151 (325)
T 3kn6_A           74 VFHD--QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKII  151 (325)
T ss_dssp             EEEC--SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEEC
T ss_pred             EEEc--CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEe
Confidence            9986  468999999999999999888888899999999999999999999999999999999999998766   89999


Q ss_pred             eccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHh
Q 015257          269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET-------LQDTYDKIVN  341 (410)
Q Consensus       269 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-------~~~~~~~i~~  341 (410)
                      |||+++............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+..       ..+....+..
T Consensus       152 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~  230 (325)
T 3kn6_A          152 DFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGY-DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK  230 (325)
T ss_dssp             CCTTCEECCC----------------------CCC-CHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT
T ss_pred             ccccceecCCCCCcccccCCCcCccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc
Confidence            99999876655555567789999999999877665 678999999999999999999997643       3456667777


Q ss_pred             CCCCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          342 NSLVFPD----AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       342 ~~~~~p~----~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      +...++.    .+++++++||.+||+.||.+|||++++++||||++...
T Consensus       231 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          231 GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             TCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred             CCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence            7666553    58999999999999999999999999999999997644

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.7e-51  Score=384.96  Aligned_cols=261  Identities=30%  Similarity=0.520  Sum_probs=228.4

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+.+.||+|+||.||++.+..++..||||++......      .......+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   79 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE------KAGVEHQLRREVEIQSHLRHPNILRLYGYFH   79 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH------HHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc------hhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence            3457899999999999999999999999999999998654321      1223457889999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      +  ....++||||++++++.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        80 ~--~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~  157 (279)
T 3fdn_A           80 D--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV  157 (279)
T ss_dssp             C--SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred             c--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccc
Confidence            6  46899999999999998888777789999999999999999999999999999999999999999999999999986


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPEL  354 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l  354 (410)
                      .....  ......||+.|+|||++.+... +.++||||||+++|+|++|..||......+....+......+|..+++.+
T Consensus       158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (279)
T 3fdn_A          158 HAPSS--RRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA  234 (279)
T ss_dssp             CC----------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHH
T ss_pred             cCCcc--cccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHH
Confidence            54332  2345678999999998877655 66799999999999999999999999988888888888888999999999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      .+||.+||+.||.+|||+.|+++||||+....
T Consensus       235 ~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          235 RDLISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             HHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence            99999999999999999999999999987644

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-51  Score=396.46  Aligned_cols=260  Identities=27%  Similarity=0.409  Sum_probs=208.6

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||+|+||.||++++..+++.||||++......        .....+.+|+.+++.++||||+++++++.+  
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--   71 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--------GAPCTAIREVSLLKDLKHANIVTLHDIIHT--   71 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------------CCCCCCCHHHHSCCCCTTBCCEEEEEEC--
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--------ccchhHHHHHHHHHhcCCCCCCeeeeEEee--
Confidence            5799999999999999999999999999999998643211        111234579999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+++||||+++++..........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           72 EKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKS  151 (324)
T ss_dssp             SSCEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred             CCEEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence            45799999999874433333345579999999999999999999999999999999999999999999999999998765


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----C-------
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-----V-------  345 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-----~-------  345 (410)
                      ..........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.....     .       
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence            5444555667899999999987755557889999999999999999999999887776655543110     0       


Q ss_pred             ------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          346 ------------------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       346 ------------------~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                                        .+..+++++.+||.+||+.||.+|||++|+++||||.+....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence                              112478899999999999999999999999999999876543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.3e-51  Score=429.24  Aligned_cols=260  Identities=29%  Similarity=0.488  Sum_probs=234.3

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID  194 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  194 (410)
                      ..++|.+++.||+|+||.||++++..+++.||||++.+....      .......+..|..+|..+ +||+|+.+++++.
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~------~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~  412 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI------QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ  412 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH------HTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc------cHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE
Confidence            457899999999999999999999999999999999765321      122345678899999887 7999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      +  ...+||||||++|++|..++...+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+
T Consensus       413 ~--~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~  490 (674)
T 3pfq_A          413 T--MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK  490 (674)
T ss_dssp             C--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred             e--CCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceee
Confidence            6  46899999999999999988887889999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPEL  354 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l  354 (410)
                      ............+||+.|+|||++.+..+ +.++|||||||+||||++|..||.+.+..+.+..|....+.+|..+++++
T Consensus       491 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~  569 (674)
T 3pfq_A          491 ENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA  569 (674)
T ss_dssp             ECCCTTCCBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHH
T ss_pred             ccccCCcccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHH
Confidence            65544455667889999999999877766 67899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcccCCCCCCCH-----HHHhhCCcccCC
Q 015257          355 RNLLEGLLCKDPTRRLTL-----NDVAKHTWVLGD  384 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~-----~ell~h~~~~~~  384 (410)
                      .+||.+||+.||.+||++     +||++||||.+-
T Consensus       570 ~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          570 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             HHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             HHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence            999999999999999998     999999999863

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.6e-51  Score=382.23  Aligned_cols=264  Identities=30%  Similarity=0.533  Sum_probs=232.5

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+.+.||+|+||.||++.+..++..||+|++.....         ...+.+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   76 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---------EDVDRFKQEIEIMKSLDHPNIIRLYETFE   76 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---------SCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---------chHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            345689999999999999999999999999999999875421         22457889999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEE---cCCCcEEEeecc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFS  271 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll---~~~~~~kl~DfG  271 (410)
                      +  ....++||||++++++.+.+.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        77 ~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg  154 (277)
T 3f3z_A           77 D--NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFG  154 (277)
T ss_dssp             C--SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             c--CCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence            6  56899999999999998888777789999999999999999999999999999999999999   778999999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD---  348 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~---  348 (410)
                      ++...... .......||+.|+|||++.+.  .+.++||||||+++|+|++|..||......+....+..+...+|.   
T Consensus       155 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  231 (277)
T 3f3z_A          155 LAARFKPG-KMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW  231 (277)
T ss_dssp             TCEECCTT-SCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH
T ss_pred             cceeccCc-cchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh
Confidence            99865543 234456799999999988654  367799999999999999999999998888888888888777764   


Q ss_pred             -CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCchhh
Q 015257          349 -AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL  392 (410)
Q Consensus       349 -~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~~  392 (410)
                       .+++.+.+||.+||+.||.+|||+.++++||||++.....|..|
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~~~l  276 (277)
T 3f3z_A          232 LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL  276 (277)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCSGGGG
T ss_pred             hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccccccccc
Confidence             68999999999999999999999999999999987766655543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.5e-51  Score=394.89  Aligned_cols=260  Identities=26%  Similarity=0.430  Sum_probs=210.2

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+++.||+|+||.||++++..+++.||||++.....       .......+.+|+.+++.++||||+++++++.
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-------EEGVPGTAIREVSLLKELQHRNIIELKSVIH  103 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-------ccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence            456789999999999999999999999999999999864421       2233456789999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEc-----CCCcEEEee
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA-----PSGTVKIGD  269 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~-----~~~~~kl~D  269 (410)
                      +  ...+++||||+++ ++.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++     .++.+||+|
T Consensus       104 ~--~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D  180 (329)
T 3gbz_A          104 H--NHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGD  180 (329)
T ss_dssp             E--TTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred             c--CCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECc
Confidence            7  4689999999986 6777777777899999999999999999999999999999999999994     445699999


Q ss_pred             ccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----
Q 015257          270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV----  345 (410)
Q Consensus       270 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~----  345 (410)
                      ||+++.............||+.|+|||++.+....+.++|||||||++|+|++|..||.+....+....+......    
T Consensus       181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  260 (329)
T 3gbz_A          181 FGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT  260 (329)
T ss_dssp             TTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             CCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence            9999876554445556678999999999987665578899999999999999999999998877766665432100    


Q ss_pred             --------------CC------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          346 --------------FP------------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       346 --------------~p------------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                                    ++            ..+++++.+||.+||+.||.+|||++|+++||||++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence                          00            1267999999999999999999999999999999865

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.2e-51  Score=384.11  Aligned_cols=261  Identities=28%  Similarity=0.504  Sum_probs=201.7

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+.+.||+|+||.||++++..+|+.||||++......      .......+.+|+.+++.++||||+++++++.+ 
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   82 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY------KAGMVQRVQNEVKIHCQLKHPSILELYNYFED-   82 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH------HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh------hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-
Confidence            46799999999999999999999999999999998654321      11234678999999999999999999999986 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                       ....++||||++++++.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        83 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~  161 (278)
T 3cok_A           83 -SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQ  161 (278)
T ss_dssp             -SSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             -CCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence             46899999999999988877654 6799999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELR  355 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~  355 (410)
                      ............||+.|+|||++.+... +.++||||||+++|+|++|..||...........+.......|..++.++.
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (278)
T 3cok_A          162 LKMPHEKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAK  240 (278)
T ss_dssp             CC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHH
T ss_pred             ccCCCCcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHH
Confidence            6544333445679999999998876655 567999999999999999999998877666666666666677888999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          356 NLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      +||.+||+.||.+|||++++++||||.+...
T Consensus       241 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  271 (278)
T 3cok_A          241 DLIHQLLRRNPADRLSLSSVLDHPFMSRNSS  271 (278)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred             HHHHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence            9999999999999999999999999987543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.1e-50  Score=389.43  Aligned_cols=263  Identities=29%  Similarity=0.452  Sum_probs=235.8

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+.+.||+|+||.||++.+..+++.||+|++.....      ......+.+.+|+.+++.++||||+++++++.
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  111 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL------LKPHQREKMSMEISIHRSLAHQHVVGFHGFFE  111 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC------CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh------cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            345689999999999999999999999999999999875432      13455678899999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      +  ...+++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       112 ~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  189 (335)
T 2owb_A          112 D--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT  189 (335)
T ss_dssp             C--SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             c--CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence            6  46899999999999998888777789999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPEL  354 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l  354 (410)
                      .............||+.|+|||++.+..+ +.++||||||+++|+|++|..||......+....+......+|..+++.+
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (335)
T 2owb_A          190 KVEYDGERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA  268 (335)
T ss_dssp             ECCSTTCCBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHH
T ss_pred             ecccCcccccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHH
Confidence            76544444556779999999999877665 67799999999999999999999998888888888888888899999999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      .+||.+||+.||.+|||++|+++||||.....
T Consensus       269 ~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~  300 (335)
T 2owb_A          269 ASLIQKMLQTDPTARPTINELLNDEFFTSGYI  300 (335)
T ss_dssp             HHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence            99999999999999999999999999987643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3e-51  Score=405.69  Aligned_cols=260  Identities=29%  Similarity=0.468  Sum_probs=222.5

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||+++++.+|+.||||++.+.....      ......+.+|..++..++||||+++++++.+
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~------~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLK------RGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH------HGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhh------HHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            4578999999999999999999999999999999997543211      1223457899999999999999999999987


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                        ...+|+||||++|++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       133 --~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~  210 (412)
T 2vd5_A          133 --ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL  210 (412)
T ss_dssp             --SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             --CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence              46899999999999999888654 479999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCcc-ccccCCCcccccccccccC------CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CC
Q 015257          275 VFEDDND-VLRRSPGTPVFTAPECCLG------LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LV  345 (410)
Q Consensus       275 ~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--~~  345 (410)
                      ....... .....+||+.|+|||++..      ...++.++|||||||++|||++|..||.+.+..+.+..+....  ..
T Consensus       211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  290 (412)
T 2vd5_A          211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS  290 (412)
T ss_dssp             ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred             eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC
Confidence            7654332 2345689999999999863      2233678999999999999999999999998888888877532  33


Q ss_pred             CC---CCCCHHHHHHHHHhcccCCCCC---CCHHHHhhCCcccCC
Q 015257          346 FP---DAMNPELRNLLEGLLCKDPTRR---LTLNDVAKHTWVLGD  384 (410)
Q Consensus       346 ~p---~~~~~~l~~li~~~L~~dp~~R---pt~~ell~h~~~~~~  384 (410)
                      +|   ..+++++++||.+||+ +|.+|   |+++|+++||||.+-
T Consensus       291 ~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          291 LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence            44   5799999999999999 99998   599999999999763

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.3e-50  Score=387.07  Aligned_cols=254  Identities=26%  Similarity=0.454  Sum_probs=222.0

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCC
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNS  198 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  198 (410)
                      .|...+.||+|+||.||++++..+|+.||||++....         ....+.+.+|+.+++.++||||+++++++..  .
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~  114 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---------QQRRELLFNEVVIMRDYQHFNVVEMYKSYLV--G  114 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---------CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEE--T
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---------hhHHHHHHHHHHHHHhCCCCCcceEEEEEEE--C
Confidence            4778889999999999999999999999999986432         2234578899999999999999999999987  4


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      ...++||||+++++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus       115 ~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  193 (321)
T 2c30_A          115 EELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK  193 (321)
T ss_dssp             TEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeeccc
Confidence            589999999999999987764 4699999999999999999999999999999999999999999999999999987665


Q ss_pred             CccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCCCCCHHHH
Q 015257          279 DNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL---VFPDAMNPELR  355 (410)
Q Consensus       279 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~~~~l~  355 (410)
                      .........||+.|+|||++.+..+ +.++||||||+++|+|++|..||......+....+.....   ..+..+++.+.
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  272 (321)
T 2c30_A          194 DVPKRKSLVGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLR  272 (321)
T ss_dssp             SSCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHH
T ss_pred             CccccccccCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHH
Confidence            4444556789999999999877665 6679999999999999999999998887777777666543   22346889999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          356 NLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      +||.+||+.||.+|||+.++++||||....
T Consensus       273 ~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          273 DFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             HHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence            999999999999999999999999998654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.1e-50  Score=413.46  Aligned_cols=260  Identities=28%  Similarity=0.451  Sum_probs=228.7

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+++.||+|+||.||++++..+|+.||||++.+.....      ......+.+|+.+|+.++||||+++++++.
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~------~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  255 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK------RKGYQGAMVEKKILAKVHSRFIVSLAYAFE  255 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH------TTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh------hHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            34578999999999999999999999999999999997653221      123457889999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeec
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                      +  ...+|+||||++|++|..++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus       256 ~--~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DF  333 (543)
T 3c4z_A          256 T--KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDL  333 (543)
T ss_dssp             C--SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             e--CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeec
Confidence            7  4689999999999998877644    347999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCCC
Q 015257          271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE----TLQDTYDKIVNNSLVF  346 (410)
Q Consensus       271 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~----~~~~~~~~i~~~~~~~  346 (410)
                      |+++............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.    ........+......+
T Consensus       334 Gla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~  412 (543)
T 3c4z_A          334 GLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY  412 (543)
T ss_dssp             TTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCC
T ss_pred             ceeeeccCCCcccccccCCccccChhhhcCCCC-ChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCC
Confidence            999876655444556789999999999987665 67899999999999999999999775    3456777888888889


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhhCCcccC
Q 015257          347 PDAMNPELRNLLEGLLCKDPTRRLT-----LNDVAKHTWVLG  383 (410)
Q Consensus       347 p~~~~~~l~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~  383 (410)
                      |..+++++.+||.+||+.||.+||+     ++++++||||++
T Consensus       413 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          413 PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence            9999999999999999999999996     589999999987

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.9e-50  Score=385.10  Aligned_cols=263  Identities=29%  Similarity=0.498  Sum_probs=229.9

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+.+.||+|+||.||++++..+|+.||||++........   ......+.+.+|+.+++.++||||+++++++.
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   85 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRAS---RRGVSREEIEREVSILRQVLHHNVITLHDVYE   85 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSC---SSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEeccccccc---ccchhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            455789999999999999999999999999999999876532211   11123567899999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC----cEEEeec
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG----TVKIGDF  270 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~----~~kl~Df  270 (410)
                      +  ...+++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+||
T Consensus        86 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           86 N--RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             C--SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             c--CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            6  468999999999999999988888899999999999999999999999999999999999999888    7999999


Q ss_pred             cccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---
Q 015257          271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP---  347 (410)
Q Consensus       271 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p---  347 (410)
                      |+++...... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+....+....+......++   
T Consensus       164 g~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  241 (321)
T 2a2a_A          164 GLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF  241 (321)
T ss_dssp             TTCEECCTTC-CCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred             ccceecCccc-cccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhh
Confidence            9998765432 3345679999999999877665 6779999999999999999999999888888888877766555   


Q ss_pred             -CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          348 -DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       348 -~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                       ..+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus       242 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          242 FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence             5789999999999999999999999999999999754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.1e-50  Score=390.64  Aligned_cols=259  Identities=31%  Similarity=0.526  Sum_probs=209.5

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ....++|.+.+.||+|+||.||++++..+++.||||++....           ..+.+.+|+.+++.++||||+++++++
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~~  117 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----------DKKIVRTEIGVLLRLSHPNIIKLKEIF  117 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------------CHHHHHCCCTTBCCEEEEE
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----------hHHHHHHHHHHHHhCCCCCCcceeeeE
Confidence            345578999999999999999999999999999999986431           234678999999999999999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC---CCcEEEeec
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP---SGTVKIGDF  270 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~---~~~~kl~Df  270 (410)
                      .+  ...+++||||+++++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+||
T Consensus       118 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Df  195 (349)
T 2w4o_A          118 ET--PTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADF  195 (349)
T ss_dssp             EC--SSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             ec--CCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccC
Confidence            86  4689999999999999998888888999999999999999999999999999999999999976   889999999


Q ss_pred             cccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCC--
Q 015257          271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQD-TYDKIVNNSLVFP--  347 (410)
Q Consensus       271 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~i~~~~~~~p--  347 (410)
                      |+++..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... ....+......++  
T Consensus       196 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~  273 (349)
T 2w4o_A          196 GLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISP  273 (349)
T ss_dssp             C-----------------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTT
T ss_pred             ccccccCcc-cccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCc
Confidence            999865432 23345679999999999887665 678999999999999999999998765444 5666666654433  


Q ss_pred             --CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          348 --DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       348 --~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                        ..++.++.+||.+||+.||.+|||+.|+++||||.+....
T Consensus       274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  315 (349)
T 2w4o_A          274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN  315 (349)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred             hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence              4689999999999999999999999999999999876543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-51  Score=393.85  Aligned_cols=266  Identities=26%  Similarity=0.436  Sum_probs=216.2

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+++.||+|+||.||++++..+|+.||||++.......    ........+.+|+.+++.++||||+++++++.+ 
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-   83 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE----AKDGINRTALREIKLLQELSHPNIIGLLDAFGH-   83 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC----------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcch----hhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-
Confidence            468999999999999999999999999999999986542211    011122467899999999999999999999976 


Q ss_pred             CCCEEEEEEeecCCCCcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                       ....++||||++++ +...+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        84 -~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           84 -KSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             -TTCCEEEEECCSEE-HHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             -CCceEEEEEcCCCC-HHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence             45789999999974 444444 345799999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CC----
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-----VF----  346 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-----~~----  346 (410)
                      ............||+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+....+.....     .+    
T Consensus       162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence            765555556678999999999987766557889999999999999999999999887777666654210     00    


Q ss_pred             -------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCc
Q 015257          347 -------------------PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIP  389 (410)
Q Consensus       347 -------------------p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~  389 (410)
                                         ...+++++.+||.+||+.||.+|||+.|+++||||.+...+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~  303 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP  303 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence                               1346789999999999999999999999999999998765544

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=9.8e-51  Score=408.56  Aligned_cols=257  Identities=25%  Similarity=0.464  Sum_probs=210.4

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|++++.||+|+||.||+|++..+|+.||||++....       ........+.+|+.+|+.++|||||++++++..
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  132 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-------QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP  132 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-------GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-------cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEcc
Confidence            4578999999999999999999999999999999986532       134556788999999999999999999999975


Q ss_pred             CC----CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          196 PN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       196 ~~----~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      ..    ...+|+||||++++++... .  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus       133 ~~~~~~~~~~~lv~E~~~~~l~~~~-~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          133 QKTLEEFQDVYLVMELMDANLCQVI-Q--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             CCSTTTCCEEEEEEECCSEEHHHHH-T--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             CCccccCCeEEEEEeCCCCCHHHHH-h--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEE
Confidence            32    2578999999998754433 2  248999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-------  344 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-------  344 (410)
                      +|+..... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+.+..+.....       
T Consensus       210 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~  287 (464)
T 3ttj_A          210 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  287 (464)
T ss_dssp             CC-----C-CCC----CCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eeeecCCC-cccCCCcccccccCHHHHcCCCC-CHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            99865432 34456789999999999988765 6779999999999999999999999887777666644110       


Q ss_pred             --------------------C----CCCC-----------CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          345 --------------------V----FPDA-----------MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       345 --------------------~----~p~~-----------~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                                          .    +|..           .++++.+||.+||+.||.+|||++|+|+||||...
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence                                0    0100           15679999999999999999999999999999854

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.3e-50  Score=379.45  Aligned_cols=263  Identities=34%  Similarity=0.630  Sum_probs=224.6

Q ss_pred             ccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       113 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      +....++|.+.+.||+|+||.||++.+..+|+.||||++......      .......+.+|+.+++.++||||++++++
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   79 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR------SLDVVGKIKREIQNLKLFRHPHIIKLYQV   79 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH------HTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc------chhHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence            344567899999999999999999999999999999998754221      12334578899999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      +.+  ....++||||+++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        80 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~  157 (276)
T 2h6d_A           80 IST--PTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL  157 (276)
T ss_dssp             EEC--SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCG
T ss_pred             Eec--CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccc
Confidence            986  468999999999999998887777899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCH
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNP  352 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~  352 (410)
                      +....... ......||+.|+|||++.+....+.++||||||+++|+|++|..||...........+......+|..++.
T Consensus       158 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (276)
T 2h6d_A          158 SNMMSDGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNR  236 (276)
T ss_dssp             GGCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCH
T ss_pred             ccccCCCc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCH
Confidence            98654432 23455789999999998877665678999999999999999999999988888888888888888899999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      .+.+||.+||+.||.+|||+.++++||||++.
T Consensus       237 ~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          237 SVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            99999999999999999999999999999764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.6e-50  Score=413.63  Aligned_cols=259  Identities=27%  Similarity=0.437  Sum_probs=226.4

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+++.||+|+||.||++++..+|+.||||++.+.....      ......+.+|+.+|+.++|||||++++++.
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~------~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  254 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK------RKGEAMALNEKQILEKVNSRFVVSLAYAYE  254 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH------TTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence            34578999999999999999999999999999999997653221      123456889999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      +  ...+|+||||++|++|..++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus       255 ~--~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGl  332 (576)
T 2acx_A          255 T--KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL  332 (576)
T ss_dssp             C--SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             e--CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccc
Confidence            7  468999999999999988776543  499999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCCC
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET----LQDTYDKIVNNSLVFPD  348 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~  348 (410)
                      ++...... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+..    .......+......+|.
T Consensus       333 a~~~~~~~-~~~~~~GT~~Y~APEvl~~~~~-~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~  410 (576)
T 2acx_A          333 AVHVPEGQ-TIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE  410 (576)
T ss_dssp             CEECCTTC-CEECCCSCGGGCCHHHHTTCEE-SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCT
T ss_pred             ceecccCc-cccccCCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCc
Confidence            98765433 3345689999999999887665 678999999999999999999998753    34566677777778899


Q ss_pred             CCCHHHHHHHHHhcccCCCCCC-----CHHHHhhCCcccC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTWVLG  383 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~  383 (410)
                      .+++++.+||.+||+.||.+||     +++|+++||||++
T Consensus       411 ~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence            9999999999999999999999     8999999999987

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.2e-49  Score=372.56  Aligned_cols=261  Identities=26%  Similarity=0.487  Sum_probs=223.3

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      +.++|.+++.||+|+||.||++.+..+++.||||++....        .....+.+.+|+.+++.++||||+++++++.+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--------AVDCPENIKKEICINKMLNHENVVKFYGHRRE   76 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG--------CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc--------chhhhHHHHHHHHHHHhcCCCCceeeeeEEEc
Confidence            4578999999999999999999999999999999986542        22345688999999999999999999999986


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                        ....++||||+++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus        77 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  154 (276)
T 2yex_A           77 --GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATV  154 (276)
T ss_dssp             --TTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             --CCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccc
Confidence              468999999999999999998888899999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCC--CCCC
Q 015257          276 FEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ-DTYDKIVNNSLVF--PDAM  350 (410)
Q Consensus       276 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~i~~~~~~~--p~~~  350 (410)
                      .....  .......||+.|+|||++.+....+.++||||||+++|+|++|..||...... .....+.......  +..+
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (276)
T 2yex_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI  234 (276)
T ss_dssp             CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGS
T ss_pred             cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhc
Confidence            54322  23445679999999999887666567899999999999999999999875543 2333333332222  2468


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      ++.+.+||.+||+.||.+|||++|+++||||++...
T Consensus       235 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             CHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence            999999999999999999999999999999987644

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.8e-50  Score=380.29  Aligned_cols=260  Identities=31%  Similarity=0.510  Sum_probs=230.6

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+.+.||+|+||.||++++..+++.||||++.......      ......+.+|+.+++.++||||+++++++.
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   84 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK------EGVEHQLRREIEIQSHLRHPNILRMYNYFH   84 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH------TTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch------HHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence            34578999999999999999999999999999999987543211      123357889999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      +  ...+++||||+++++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        85 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  162 (284)
T 2vgo_A           85 D--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV  162 (284)
T ss_dssp             C--SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             c--CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccc
Confidence            6  46899999999999998888777789999999999999999999999999999999999999999999999999997


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPEL  354 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l  354 (410)
                      .....  ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||......+....+......+|..++.++
T Consensus       163 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T 2vgo_A          163 HAPSL--RRRTMCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGS  239 (284)
T ss_dssp             ECSSS--CBCCCCSCGGGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHH
T ss_pred             cCccc--ccccccCCCCcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHH
Confidence            65432  2345679999999999887665 56799999999999999999999998888888888888888899999999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      .+||.+||+.||.+|||++++++||||+...
T Consensus       240 ~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          240 KDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             HHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence            9999999999999999999999999998653

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2e-50  Score=384.63  Aligned_cols=265  Identities=27%  Similarity=0.427  Sum_probs=210.8

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC---CCCcccce
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ---HPNIVNLI  190 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~  190 (410)
                      ....++|++++.||+|+||.||++++..+|+.||||++.......    ........+.+|+.+++.+.   ||||++++
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~   80 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG----GGGGLPISTVREVALLRRLEAFEHPNVVRLM   80 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCT----TSSCCCHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccc----cccccchhHHHHHHHHHHHhhcCCCCeEEee
Confidence            345578999999999999999999999999999999987543211    01111234567777776664   99999999


Q ss_pred             eEEEcCCCC---EEEEEEeecCCCCcccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcE
Q 015257          191 EVIDDPNSD---HFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTV  265 (410)
Q Consensus       191 ~~~~~~~~~---~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~  265 (410)
                      +++......   .+++||||+++ ++.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           81 DVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             EEEEECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCE
T ss_pred             eeeeccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCE
Confidence            999864322   68999999986 6666655443  49999999999999999999999999999999999999999999


Q ss_pred             EEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-
Q 015257          266 KIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-  344 (410)
Q Consensus       266 kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-  344 (410)
                      ||+|||+++..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....+....+..... 
T Consensus       160 kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (308)
T 3g33_A          160 KLADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL  237 (308)
T ss_dssp             EECSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EEeeCccccccCCC-cccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999999865433 23345678999999999887766 6679999999999999999999999888777766654210 


Q ss_pred             ----C----------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          345 ----V----------------------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       345 ----~----------------------~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                          .                      ....+++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence                0                      1135789999999999999999999999999999998754

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.5e-50  Score=389.69  Aligned_cols=261  Identities=31%  Similarity=0.512  Sum_probs=217.5

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+++.||+|+||.||++++..+|+.||||++....       ........+.+|+.+++.++||||+++++++.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   94 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-------DDKMVKKIAMREIKLLKQLRHENLVNLLEVCK   94 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-------CchHHHHHHHHHHHHHhhCCCCCEeeEEEEee
Confidence            34578999999999999999999999999999999985432       23445567889999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      +  ...+++||||++++++.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        95 ~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  172 (331)
T 4aaa_A           95 K--KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR  172 (331)
T ss_dssp             E--TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred             c--CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCce
Confidence            6  46899999999999988887777789999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN------------  342 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~------------  342 (410)
                      .............||+.|+|||++.+....+.++|||||||++|+|++|..||.+....+....+...            
T Consensus       173 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (331)
T 4aaa_A          173 TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF  252 (331)
T ss_dssp             -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             eecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence            76655555566779999999999877655578899999999999999999999988766655444321            


Q ss_pred             -------CCCCC------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          343 -------SLVFP------------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       343 -------~~~~p------------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                             ....|            ..+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence                   00111            2578999999999999999999999999999999764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.1e-50  Score=408.86  Aligned_cols=262  Identities=29%  Similarity=0.562  Sum_probs=227.5

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      .+.++|.+++.||+|+||.||++++..+|+.||||++.+....       ......+.+|+.+|+.++||||+++++++.
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   91 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-------NKDTSTILREVELLKKLDHPNIMKLFEILE   91 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-------CSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-------chHHHHHHHHHHHHHhCCCCCcCeEEEEEE
Confidence            3557899999999999999999999999999999998754321       123457889999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEc---CCCcEEEeecc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFS  271 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~---~~~~~kl~DfG  271 (410)
                      +  ...+++||||+.+++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        92 ~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  169 (486)
T 3mwu_A           92 D--SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG  169 (486)
T ss_dssp             C--SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred             c--CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECC
Confidence            7  568999999999999988887777899999999999999999999999999999999999995   45679999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----  347 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----  347 (410)
                      +++..... .......||+.|+|||++.+.  ++.++|||||||++|+|++|..||.+....+....+..+...++    
T Consensus       170 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  246 (486)
T 3mwu_A          170 LSTCFQQN-TKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW  246 (486)
T ss_dssp             CTTTBCCC-----CCTTGGGGCCGGGGGSC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGG
T ss_pred             cCeECCCC-CccCCCcCCCCCCCHHHhCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence            99866543 234556799999999998764  47789999999999999999999999998888888888776544    


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCC
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI  388 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~  388 (410)
                      ..+++++++||.+||+.||.+|||+.++|+||||+......
T Consensus       247 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~  287 (486)
T 3mwu_A          247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET  287 (486)
T ss_dssp             GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCC
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccC
Confidence            36899999999999999999999999999999998765544

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-50  Score=392.14  Aligned_cols=259  Identities=25%  Similarity=0.414  Sum_probs=213.4

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||++.+..+|+.||||++....       ........+.+|+.+|+.++||||+++++++..
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~   95 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-------QSELFAKRAYRELRLLKHMRHENVIGLLDVFTP   95 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-------SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECS
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-------cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEec
Confidence            4568999999999999999999999999999999885431       234556788999999999999999999999976


Q ss_pred             CC----CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          196 PN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       196 ~~----~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      ..    ...+|+||||+ +++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  173 (367)
T 1cm8_A           96 DETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG  173 (367)
T ss_dssp             CSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             CCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeee
Confidence            42    14579999999 6677776654 579999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-------  344 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-------  344 (410)
                      +++....   ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+.....       
T Consensus       174 ~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          174 LARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             TCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            9986543   234567899999999988755557789999999999999999999999887776665543110       


Q ss_pred             ------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          345 ------------------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       345 ------------------------~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                                              .+...+++++.+||.+||+.||.+|||+.++++||||.+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence                                    122467899999999999999999999999999999987644

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.6e-50  Score=407.46  Aligned_cols=269  Identities=33%  Similarity=0.568  Sum_probs=228.8

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccC----CChHHHHHHHHHHHHHHhCCCCCcccce
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVA----PSETAMTDVRREVLIMKMLQHPNIVNLI  190 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~l~  190 (410)
                      ...++|.+++.||+|+||.||+|++..+++.||||++........+..    ......+.+.+|+.+|+.++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            456789999999999999999999999999999999976543211000    0113456789999999999999999999


Q ss_pred             eEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC---cEEE
Q 015257          191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---TVKI  267 (410)
Q Consensus       191 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~---~~kl  267 (410)
                      +++.+  ...+++||||++|++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||
T Consensus       113 ~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          113 DVFED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EEEEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEEEc--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            99986  568999999999999988887777899999999999999999999999999999999999999876   6999


Q ss_pred             eeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Q 015257          268 GDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP  347 (410)
Q Consensus       268 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p  347 (410)
                      +|||+++..... .......||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+..+....+..+...++
T Consensus       191 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  267 (504)
T 3q5i_A          191 VDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD  267 (504)
T ss_dssp             CCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             EECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            999999876543 23456679999999998864 33 6789999999999999999999999999999999988877665


Q ss_pred             ----CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCC
Q 015257          348 ----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI  388 (410)
Q Consensus       348 ----~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~  388 (410)
                          ..+++++++||.+||+.||.+|||++|+|+||||+......
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~  312 (504)
T 3q5i_A          268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNI  312 (504)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCC
T ss_pred             ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcc
Confidence                57899999999999999999999999999999998775544

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.4e-50  Score=398.92  Aligned_cols=265  Identities=25%  Similarity=0.370  Sum_probs=212.1

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||+|++..+|+.||||++....       ........+.+|+.+|+.++||||+++++++..
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~   96 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-------EDLIDCKRILREITILNRLKSDYIIRLYDLIIP   96 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-------TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-------cChHHHHHHHHHHHHHHHcCCCCcceEEEEEec
Confidence            4568999999999999999999999999999999986421       234556789999999999999999999999876


Q ss_pred             CCC---CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          196 PNS---DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       196 ~~~---~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      ...   ..+|+||||+++ +|...+.....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A           97 DDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             SCTTTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CCCCcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence            421   579999999985 7777777777899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCc----------------------cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhC-------
Q 015257          273 SQVFEDDN----------------------DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIG-------  323 (410)
Q Consensus       273 a~~~~~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG-------  323 (410)
                      |+......                      ......+||+.|+|||++.....++.++|||||||++|||++|       
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~  255 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND  255 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence            98754332                      1235678999999999876655568889999999999999984       


Q ss_pred             ----CCCCCCCCH-----------------HHHHHHHHh------------------------CCCCCC-------CCCC
Q 015257          324 ----QYPFLGETL-----------------QDTYDKIVN------------------------NSLVFP-------DAMN  351 (410)
Q Consensus       324 ----~~Pf~~~~~-----------------~~~~~~i~~------------------------~~~~~p-------~~~~  351 (410)
                          .++|.+...                 .+....+..                        .....+       ..++
T Consensus       256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  335 (432)
T 3n9x_A          256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS  335 (432)
T ss_dssp             GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred             cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence                444444321                 111111111                        011111       3579


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCC
Q 015257          352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI  388 (410)
Q Consensus       352 ~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~  388 (410)
                      +++.+||.+||+.||.+|||++|+|+||||.+...+.
T Consensus       336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  372 (432)
T 3n9x_A          336 DDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK  372 (432)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence            9999999999999999999999999999999864443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.8e-50  Score=389.32  Aligned_cols=268  Identities=31%  Similarity=0.498  Sum_probs=222.8

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      .+.++|.+++.||+|+||.||++.+..+++.||||++.......    ........+.+|+.+++.++||||+++++++.
T Consensus        23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   98 (345)
T 3hko_A           23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ----INPKDVERIKTEVRLMKKLHHPNIARLYEVYE   98 (345)
T ss_dssp             HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcc----cCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence            34568999999999999999999999999999999987653221    12345568999999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCC----------------------------------------CCCCCHHHHHHHHHH
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQ----------------------------------------PGAIGESMARKYLRD  234 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~----------------------------------------~~~l~~~~~~~i~~q  234 (410)
                      +  ....++||||++|++|.+.+..                                        ...+++..++.++.|
T Consensus        99 ~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q  176 (345)
T 3hko_A           99 D--EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ  176 (345)
T ss_dssp             C--SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred             c--CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence            6  5689999999999988876631                                        113467889999999


Q ss_pred             HHHHHHHHHhCCcEeccCCCCcEEEcCCC--cEEEeeccccccccCCc----cccccCCCcccccccccccCC-cCCCch
Q 015257          235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSG--TVKIGDFSVSQVFEDDN----DVLRRSPGTPVFTAPECCLGL-TYGGKA  307 (410)
Q Consensus       235 i~~gL~yLH~~~iiHrDlkp~NIll~~~~--~~kl~DfG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~  307 (410)
                      |+.||.|||++||+||||||+|||++.++  .+||+|||+++......    .......||+.|+|||++.+. ...+.+
T Consensus       177 i~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          177 IFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            99999999999999999999999998776  89999999998654321    123456799999999998652 334678


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          308 ADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD----AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       308 ~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                      +|||||||++|+|++|..||.+....+....+......++.    .+++++.+||.+||+.||.+|||+.++++||||.+
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~  336 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ  336 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence            99999999999999999999999888888888877665543    47999999999999999999999999999999988


Q ss_pred             CCCCC
Q 015257          384 DNGPI  388 (410)
Q Consensus       384 ~~~~~  388 (410)
                      ....+
T Consensus       337 ~~~~~  341 (345)
T 3hko_A          337 FSDKI  341 (345)
T ss_dssp             TSSCS
T ss_pred             ChHhh
Confidence            76554

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.4e-50  Score=404.26  Aligned_cols=262  Identities=25%  Similarity=0.381  Sum_probs=199.6

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||+|++..+|+.||||++....       ......+.+.+|+.+|+.++|||||++++++..
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  123 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-------EDLIDCKRILREIAILNRLNHDHVVKVLDIVIP  123 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-------cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEec
Confidence            4478999999999999999999999999999999985421       234556789999999999999999999999854


Q ss_pred             CC---CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          196 PN---SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       196 ~~---~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      ..   ...+|+||||+++ .+...+.....+++..++.++.||+.||+|||+.||+||||||+||||+.++.+||+|||+
T Consensus       124 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGl  202 (458)
T 3rp9_A          124 KDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL  202 (458)
T ss_dssp             SCTTTCCCEEEEECCCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CCcccCceEEEEEecccc-chhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeeccccc
Confidence            32   2579999999864 5677777777899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCc---------------------------cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh---
Q 015257          273 SQVFEDDN---------------------------DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII---  322 (410)
Q Consensus       273 a~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt---  322 (410)
                      |+......                           ......+||+.|+|||++.....++.++|||||||+||||++   
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~  282 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK  282 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence            98754221                           123456789999999987655555788999999999999999   


Q ss_pred             --------CCCCCCCCCH--------------------HHHHHHHHh---C--------------------C--------
Q 015257          323 --------GQYPFLGETL--------------------QDTYDKIVN---N--------------------S--------  343 (410)
Q Consensus       323 --------G~~Pf~~~~~--------------------~~~~~~i~~---~--------------------~--------  343 (410)
                              |.++|.+...                    .+....+..   .                    .        
T Consensus       283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (458)
T 3rp9_A          283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL  362 (458)
T ss_dssp             TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred             ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence                    6777766431                    111111111   0                    0        


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          344 LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       344 ~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      ......+++++.+||.+||+.||.+|||++|+|+||||.+..
T Consensus       363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence            001134689999999999999999999999999999998753

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.7e-50  Score=381.73  Aligned_cols=265  Identities=31%  Similarity=0.622  Sum_probs=225.0

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      +.++|.+.+.||+|+||.||++.+..+++.||||++.......     .......+.+|+.+++.++||||+++++++..
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR-----IPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN   77 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH-----STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc-----cchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence            4578999999999999999999999999999999987643221     12345679999999999999999999999876


Q ss_pred             CCCCEEEEEEeecCCCCcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFG--QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .....+++||||+++++ .+.+.  ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        78 ~~~~~~~lv~e~~~~~l-~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~  156 (305)
T 2wtk_C           78 EEKQKMYMVMEYCVCGM-QEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA  156 (305)
T ss_dssp             C---CEEEEEECCSEEH-HHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CCCCeEEEEehhccCCH-HHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccc
Confidence            55668999999999873 33322  2457999999999999999999999999999999999999999999999999999


Q ss_pred             ccccC--CccccccCCCcccccccccccCCc-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCC
Q 015257          274 QVFED--DNDVLRRSPGTPVFTAPECCLGLT-YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAM  350 (410)
Q Consensus       274 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~  350 (410)
                      .....  .........||+.|+|||++.+.. ..+.++||||||+++|+|++|..||.+.........+......+|..+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  236 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDC  236 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSS
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCcc
Confidence            86542  222334567999999999887543 235689999999999999999999999988888888888888889999


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      ++.+.+||.+||+.||.+|||+.++++||||++...
T Consensus       237 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            999999999999999999999999999999987643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=8e-50  Score=376.53  Aligned_cols=256  Identities=29%  Similarity=0.592  Sum_probs=215.5

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+.+.||+|+||.||++++..++..+|+|++.....        ....+.+.+|+.+++.++||||+++++++.
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   90 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--------QVPMEQIEAEIEVLKSLDHPNIIKIFEVFE   90 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--------CSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--------chhHHHHHHHHHHHHhCCCchHHhHHHhee
Confidence            345789999999999999999999999999999999875431        223467899999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEE---cCCCcEEE
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKI  267 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll---~~~~~~kl  267 (410)
                      +  ...+++||||+++++|.+.+..    ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||
T Consensus        91 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl  168 (285)
T 3is5_A           91 D--YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKI  168 (285)
T ss_dssp             C--SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEE
T ss_pred             c--CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEE
Confidence            6  5689999999999988876643    3679999999999999999999999999999999999999   45678999


Q ss_pred             eeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Q 015257          268 GDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP  347 (410)
Q Consensus       268 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p  347 (410)
                      +|||++...... .......||+.|+|||++.+ . .+.++||||||+++|+|++|..||.+....+....+......++
T Consensus       169 ~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~-~-~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (285)
T 3is5_A          169 IDFGLAELFKSD-EHSTNAAGTALYMAPEVFKR-D-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA  245 (285)
T ss_dssp             CCCCCCCC-----------CTTGGGCCHHHHTT-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             EeeecceecCCc-ccCcCcccccCcCChHHhcc-C-CCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc
Confidence            999999865443 23345679999999998754 3 36789999999999999999999999888777766665554433


Q ss_pred             ---CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          348 ---DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       348 ---~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                         ..+++++.+||.+||+.||.+|||+.|+++||||++
T Consensus       246 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          246 VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence               357899999999999999999999999999999975

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.7e-50  Score=382.50  Aligned_cols=259  Identities=27%  Similarity=0.480  Sum_probs=213.8

Q ss_pred             ccccceeee-eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeE
Q 015257          115 KMINEYVHV-RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEV  192 (410)
Q Consensus       115 ~~~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~  192 (410)
                      .+.+.|.+. +.||+|+||.||++++..+++.||||++....         ......+.+|+.++.++ +||||++++++
T Consensus         9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~~~~h~~i~~~~~~   79 (316)
T 2ac3_A            9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---------GHIRSRVFREVEMLYQCQGHRNVLELIEF   79 (316)
T ss_dssp             CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---------SCCHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---------chhHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            456789986 78999999999999999999999999986431         22345788999999885 79999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCc---EEEee
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT---VKIGD  269 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~---~kl~D  269 (410)
                      +.+  ...+++||||+++++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|
T Consensus        80 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~D  157 (316)
T 2ac3_A           80 FEE--EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICD  157 (316)
T ss_dssp             EEE--TTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred             Eee--CCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEE
Confidence            987  4689999999999999988877778999999999999999999999999999999999999998776   99999


Q ss_pred             ccccccccCCc-------cccccCCCcccccccccccCC----cCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------
Q 015257          270 FSVSQVFEDDN-------DVLRRSPGTPVFTAPECCLGL----TYGGKAADTWAVGVTLYYMIIGQYPFLGET-------  331 (410)
Q Consensus       270 fG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~-------  331 (410)
                      ||++.......       .......||+.|+|||++.+.    ...+.++|||||||++|+|++|..||.+..       
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  237 (316)
T 2ac3_A          158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD  237 (316)
T ss_dssp             TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-
T ss_pred             ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc
Confidence            99987653211       122345699999999988641    223567999999999999999999997753       


Q ss_pred             --------HHHHHHHHHhCCCCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          332 --------LQDTYDKIVNNSLVFP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       332 --------~~~~~~~i~~~~~~~p----~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                              .......+..+...+|    ..+++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus       238 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          238 RGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             ---CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             ccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence                    2345566777777666    3689999999999999999999999999999999874

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.1e-50  Score=408.49  Aligned_cols=259  Identities=31%  Similarity=0.557  Sum_probs=228.7

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      .+.++|.+.+.||+|+||.||++++..+|+.||||++......      .......+.+|+.+++.++||||+++++++.
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   96 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK------QKTDKESLLREVQLLKQLDHPNIMKLYEFFE   96 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC------BSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcc------cchHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            4557899999999999999999999999999999998754321      1234567899999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEE---cCCCcEEEeecc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFS  271 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll---~~~~~~kl~DfG  271 (410)
                      +  ...+++||||+.+++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        97 ~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  174 (484)
T 3nyv_A           97 D--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG  174 (484)
T ss_dssp             C--SSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred             e--CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence            7  56899999999999999888888889999999999999999999999999999999999999   467899999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----  347 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----  347 (410)
                      +++...... ......||+.|+|||++.+ . ++.++|||||||++|+|++|..||.+.+..+....+..+...++    
T Consensus       175 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  251 (484)
T 3nyv_A          175 LSTHFEASK-KMKDKIGTAYYIAPEVLHG-T-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW  251 (484)
T ss_dssp             HHHHBCCCC-SHHHHTTGGGTCCHHHHHT-C-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG
T ss_pred             eeEEccccc-ccccCCCCccccCceeecC-C-CCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            998765432 3345679999999998876 3 36789999999999999999999999998888888888876554    


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      ..+++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus       252 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          252 KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence            3689999999999999999999999999999999864

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.3e-51  Score=392.13  Aligned_cols=260  Identities=25%  Similarity=0.429  Sum_probs=221.3

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      .+.++|.+++.||+|+||.||++++..+++.||||++......... .........+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~   99 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC-WIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE   99 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTS-EEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhccccc-ccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            4567899999999999999999999999999999998765321100 001112335678999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCC-CcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGK-WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~-~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      +  ...+++||||+.++ ++..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       100 ~--~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          100 N--QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             C--SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             e--CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            6  56899999999766 88888888888999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPE  353 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~  353 (410)
                      +...... ......||+.|+|||++.+..+.+.++|||||||++|+|++|..||....      .........|..++++
T Consensus       178 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~  250 (335)
T 3dls_A          178 AYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKE  250 (335)
T ss_dssp             EECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHH
T ss_pred             eECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHH
Confidence            8765432 33456799999999999887776788999999999999999999997532      2233445567789999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      +.+||.+||+.||.+|||+.++++||||++.
T Consensus       251 l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            9999999999999999999999999999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=8.6e-50  Score=390.92  Aligned_cols=251  Identities=25%  Similarity=0.466  Sum_probs=214.0

Q ss_pred             eeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCE
Q 015257          121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH  200 (410)
Q Consensus       121 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  200 (410)
                      ...+.||+|+||.||++.+..+|+.||||++...         .....+.+.+|+.+|+.++||||+++++++.+  ...
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~---------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~  160 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR---------GMKDKEEVKNEISVMNQLDHANLIQLYDAFES--KND  160 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECC---------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc---------ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCE
Confidence            3367899999999999999999999999998653         22345678999999999999999999999987  468


Q ss_pred             EEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEE--cCCCcEEEeecccccccc
Q 015257          201 FYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV--APSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       201 ~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll--~~~~~~kl~DfG~a~~~~  277 (410)
                      +++||||+++++|.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+|||+  +.++.+||+|||+++...
T Consensus       161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK  240 (373)
T ss_dssp             EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence            9999999999988776644 3469999999999999999999999999999999999999  567889999999998765


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAMNPE  353 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~  353 (410)
                      ... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+......++    ..++++
T Consensus       241 ~~~-~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  318 (373)
T 2x4f_A          241 PRE-KLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE  318 (373)
T ss_dssp             TTC-BCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHH
T ss_pred             Ccc-ccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHH
Confidence            432 3345579999999998876554 6789999999999999999999999988888888887765544    468999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      +.+||.+||+.||.+|||+.|+++||||.+.
T Consensus       319 ~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          319 AKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            9999999999999999999999999999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.4e-49  Score=387.02  Aligned_cols=255  Identities=24%  Similarity=0.368  Sum_probs=214.7

Q ss_pred             ccccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-----CCC
Q 015257          111 ENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-----HPN  185 (410)
Q Consensus       111 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpn  185 (410)
                      ..+..+.++|.+++.||+|+||.||++++..+++.||||++..          .......+..|+.+++.+.     |||
T Consensus        28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~~~e~~~l~~l~~~~~~h~~   97 (360)
T 3llt_A           28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----------IKKYTRSAKIEADILKKIQNDDINNNN   97 (360)
T ss_dssp             CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----------CHHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred             ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----------chhhhhhhHHHHHHHHHhcccCCCCCC
Confidence            3455667899999999999999999999999999999999853          2344567788999999997     999


Q ss_pred             cccceeEEEcCCCCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC--
Q 015257          186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP--  261 (410)
Q Consensus       186 iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~--  261 (410)
                      |+++++++..  ...+++||||+ +++|.+.+...  ..+++..++.++.||+.||+|||++||+||||||+|||++.  
T Consensus        98 iv~~~~~~~~--~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A           98 IVKYHGKFMY--YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPY  174 (360)
T ss_dssp             BCCEEEEEEE--TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTT
T ss_pred             eecccceeeE--CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccc
Confidence            9999999987  46899999999 77777776543  35999999999999999999999999999999999999975  


Q ss_pred             -----------------------CCcEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHH
Q 015257          262 -----------------------SGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLY  318 (410)
Q Consensus       262 -----------------------~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~  318 (410)
                                             ++.+||+|||+++.....   .....||+.|+|||++.+..+ +.++|||||||++|
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~  250 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLA  250 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCC-CTTHHHHHHHHHHH
T ss_pred             ccccccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCC-CCccchHHHHHHHH
Confidence                                   789999999999864432   345679999999999987766 67799999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------------------------C--------------------CCCH
Q 015257          319 YMIIGQYPFLGETLQDTYDKIVNNSLVFP--------------------------D--------------------AMNP  352 (410)
Q Consensus       319 elltG~~Pf~~~~~~~~~~~i~~~~~~~p--------------------------~--------------------~~~~  352 (410)
                      +|++|..||......+....+......+|                          .                    ..++
T Consensus       251 ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  330 (360)
T 3llt_A          251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE  330 (360)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred             HHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence            99999999998877666555443222221                          1                    1247


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhhCCccc
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWVL  382 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell~h~~~~  382 (410)
                      .+.+||.+||+.||.+|||++|+|+||||+
T Consensus       331 ~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          331 LFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            788999999999999999999999999995

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.6e-50  Score=405.52  Aligned_cols=257  Identities=32%  Similarity=0.600  Sum_probs=221.8

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+++.||+|+||.||+|++..++..||||++.+....       ......+.+|+.+++.++|||||++++++.
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  106 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-------TSSNSKLLEEVAVLKLLDHPNIMKLYDFFE  106 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------------CTTHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-------chHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            3456899999999999999999999999999999998754321       122457889999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC---CcEEEeecc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDFS  271 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~---~~~kl~DfG  271 (410)
                      +  ...+++||||+++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++..   +.+||+|||
T Consensus       107 ~--~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG  184 (494)
T 3lij_A          107 D--KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFG  184 (494)
T ss_dssp             C--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             e--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence            6  46899999999999998888777789999999999999999999999999999999999999764   459999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----  347 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----  347 (410)
                      +++...... .....+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+....+....+..+...++    
T Consensus       185 ~a~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  261 (494)
T 3lij_A          185 LSAVFENQK-KMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEW  261 (494)
T ss_dssp             TCEECBTTB-CBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGG
T ss_pred             CCeECCCCc-cccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhc
Confidence            998765433 3456679999999998764 33 6789999999999999999999999999888888888876655    


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                      ..+++.+++||.+||+.||.+|||+.++|+||||+.
T Consensus       262 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          262 KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             ccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence            368999999999999999999999999999999975

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.1e-49  Score=393.76  Aligned_cols=256  Identities=27%  Similarity=0.511  Sum_probs=209.2

Q ss_pred             cccccceeee-eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHH-HhCCCCCccccee
Q 015257          114 TKMINEYVHV-RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM-KMLQHPNIVNLIE  191 (410)
Q Consensus       114 ~~~~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~  191 (410)
                      ....++|.+. +.||+|+||.||++.+..+|+.||||++...              ..+.+|+.++ +..+||||+++++
T Consensus        57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------------~~~~~E~~~~~~~~~hp~iv~l~~  122 (400)
T 1nxk_A           57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVD  122 (400)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------------hhHHHHHHHHHHhcCCCCcceEeE
Confidence            3456778887 7899999999999999999999999998532              2466888886 5568999999999


Q ss_pred             EEEc--CCCCEEEEEEeecCCCCcccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC---CCc
Q 015257          192 VIDD--PNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP---SGT  264 (410)
Q Consensus       192 ~~~~--~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~---~~~  264 (410)
                      ++..  .+...+||||||++|++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.
T Consensus       123 ~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~  202 (400)
T 1nxk_A          123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI  202 (400)
T ss_dssp             EEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCC
T ss_pred             EEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCcc
Confidence            8864  23457999999999999988886643  5999999999999999999999999999999999999998   789


Q ss_pred             EEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH
Q 015257          265 VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ----DTYDKIV  340 (410)
Q Consensus       265 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~----~~~~~i~  340 (410)
                      +||+|||+++..... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....    .....+.
T Consensus       203 ~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~  280 (400)
T 1nxk_A          203 LKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR  280 (400)
T ss_dssp             EEECCCTTCEECC------------CTTCCGGGSCCCCS-SSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH
T ss_pred             EEEEecccccccCCC-CccccCCCCCCccCHhhcCCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH
Confidence            999999999865432 23456789999999999877665 67899999999999999999999765432    2445566


Q ss_pred             hCCCCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          341 NNSLVFP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       341 ~~~~~~p----~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      .+...+|    ..+++++.+||.+||+.||.+|||+.++++||||.+..
T Consensus       281 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          281 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             HTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             cCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            6666555    46899999999999999999999999999999998653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.3e-49  Score=386.11  Aligned_cols=257  Identities=26%  Similarity=0.398  Sum_probs=218.0

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      +.|.+++.||+|+||.||++++..+|+.||||++.....      ........+.+|+.+++.++||||+++++++.+  
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--  125 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK------QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--  125 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc------cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--
Confidence            469999999999999999999999999999999865321      123455688999999999999999999999987  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ....++||||+.|+++.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       126 ~~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          126 EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             CCeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence            45899999999865433333345679999999999999999999999999999999999999999999999999998654


Q ss_pred             CCccccccCCCcccccccccccC--CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCCCCHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLG--LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--FPDAMNPE  353 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~~~~  353 (410)
                      ..    ....||+.|+|||++.+  ....+.++|||||||++|+|++|..||.+.........+......  .+..+++.
T Consensus       206 ~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (348)
T 1u5q_A          206 PA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY  281 (348)
T ss_dssp             SB----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred             CC----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHH
Confidence            32    34679999999998853  223367899999999999999999999988877766666665432  34578999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      +.+||.+||+.||.+|||++++++||||.....
T Consensus       282 l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~  314 (348)
T 1u5q_A          282 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  314 (348)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred             HHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence            999999999999999999999999999987643

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.6e-50  Score=376.90  Aligned_cols=263  Identities=25%  Similarity=0.441  Sum_probs=226.6

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|++++.||+|+||.||++++..+|+.||+|++.....       .....+.+.+|+.+++.++||||+++++++.+.
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-------TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR   77 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-------CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC
Confidence            4689999999999999999999999999999999865422       344567899999999999999999999988765


Q ss_pred             CCCEEEEEEeecCCCCcccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cEeccCCCCcEEEcCCCcEEE
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGHN-----VVHGDIKPDNLLVAPSGTVKI  267 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~-----iiHrDlkp~NIll~~~~~~kl  267 (410)
                      ....+++||||+++++|.+.+..    ...+++..++.++.||+.||.|||+.|     |+||||||+|||++.++.+||
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl  157 (279)
T 2w5a_A           78 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL  157 (279)
T ss_dssp             GGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEE
T ss_pred             CCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEE
Confidence            56789999999999988887753    345999999999999999999999999     999999999999999999999


Q ss_pred             eeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CC
Q 015257          268 GDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VF  346 (410)
Q Consensus       268 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~  346 (410)
                      +|||+++.............||+.|+|||++.+..+ +.++||||||+++|+|++|..||......+....+..+.. .+
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  236 (279)
T 2w5a_A          158 GDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI  236 (279)
T ss_dssp             CCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             ecCchheeeccccccccccCCCccccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC
Confidence            999999876544333345568999999999877655 6789999999999999999999999888777777777665 56


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          347 PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       347 p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                      |..+++++.+||.+||+.||.+|||+.+|++|+|+.+...+
T Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~  277 (279)
T 2w5a_A          237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHH  277 (279)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGSC
T ss_pred             CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhccc
Confidence            77899999999999999999999999999999999876443

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.4e-49  Score=378.16  Aligned_cols=257  Identities=30%  Similarity=0.575  Sum_probs=223.3

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+.+.||+|+||.||++++..+|+.||||++....         ......+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   76 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---------AFRDSSLENEIAVLKKIKHENIVTLEDIYE   76 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------------HHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---------ccchHHHHHHHHHHHhCCCCCeeehhhhcc
Confidence            34568999999999999999999999999999999987432         112346889999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEE---cCCCcEEEeecc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFS  271 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll---~~~~~~kl~DfG  271 (410)
                      +  ...+++||||+++++|.+.+...+.+++..++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||
T Consensus        77 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg  154 (304)
T 2jam_A           77 S--TTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFG  154 (304)
T ss_dssp             C--SSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred             c--CCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCC
Confidence            6  46899999999999998888777789999999999999999999999999999999999999   778899999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----  347 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----  347 (410)
                      ++......  ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........+..+...++    
T Consensus       155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  231 (304)
T 2jam_A          155 LSKMEQNG--IMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFW  231 (304)
T ss_dssp             TTCCCCCB--TTHHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTT
T ss_pred             cceecCCC--ccccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence            99764332  2334568999999999877655 6789999999999999999999999888888888887765443    


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      ..+++++.+||.+||+.||.+|||+.++++||||.+..
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          232 DDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            56899999999999999999999999999999998753

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.5e-49  Score=374.78  Aligned_cols=269  Identities=24%  Similarity=0.379  Sum_probs=227.7

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVI  193 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~  193 (410)
                      .+.++|.+.+.||+|+||.||++.+..+|+.||||++.................+.+.+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            45678999999999999999999999999999999987543211100011234567889999999995 99999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .+  ....++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        94 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  171 (298)
T 1phk_A           94 ET--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS  171 (298)
T ss_dssp             EC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             cc--CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence            86  5689999999999999998877778999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCcccccccccccC-----CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLG-----LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP-  347 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-  347 (410)
                      ....... ......||+.|+|||++.+     ....+.++||||||+++|+|++|..||...........+......++ 
T Consensus       172 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 1phk_A          172 CQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  250 (298)
T ss_dssp             EECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             hhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence            8654432 3345679999999998752     22236789999999999999999999999888888888877765544 


Q ss_pred             ---CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          348 ---DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       348 ---~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                         ..+++.+.+||.+||+.||.+|||+.++++||||++...
T Consensus       251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (298)
T 1phk_A          251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV  292 (298)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred             ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence               357899999999999999999999999999999987643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.4e-49  Score=386.93  Aligned_cols=259  Identities=24%  Similarity=0.395  Sum_probs=201.8

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||++.+..+|+.||||++....       ........+.+|+.+|+.++||||+++++++..
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   99 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-------QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   99 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-------cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            4478999999999999999999999999999999985431       234456788899999999999999999999975


Q ss_pred             CC----CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          196 PN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       196 ~~----~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      ..    ...+|+|||++ +++|...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       100 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG  177 (367)
T 2fst_X          100 ARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG  177 (367)
T ss_dssp             CSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--
T ss_pred             CCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecc
Confidence            31    25689999999 5667776654 579999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--------  343 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--------  343 (410)
                      +++.....   .....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+....        
T Consensus       178 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          178 LARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             cccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99865432   3456799999999998875555778999999999999999999999988776665554310        


Q ss_pred             ---------------CCC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          344 ---------------LVF--------PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       344 ---------------~~~--------p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                                     ...        ...+++.+.+||.+||+.||.+|||+.|+|+||||.....
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence                           000        1246889999999999999999999999999999987644

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.1e-49  Score=385.58  Aligned_cols=259  Identities=26%  Similarity=0.403  Sum_probs=217.3

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||+|+||.||++++..+++.||||++...        ........+.+|+.+++.++||||+++++++..+.
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   98 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--------EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT   98 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--------TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--------cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence            5899999999999999999999999999999998532        23455678899999999999999999999997532


Q ss_pred             ---CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          198 ---SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       198 ---~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                         ...+++||||+++ ++...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        99 ~~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A           99 IEQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             TTTCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ccccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence               2478999999986 55555543 469999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCcc---ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------
Q 015257          275 VFEDDND---VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-------  344 (410)
Q Consensus       275 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-------  344 (410)
                      .......   ......||+.|+|||++.+....+.++|||||||++|+|++|..||.+....+....+.....       
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  256 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            6543322   234568999999999887666557889999999999999999999998876666555532100       


Q ss_pred             ------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          345 ------------------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       345 ------------------------~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                                              .++..+++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence                                    012457899999999999999999999999999999987643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.1e-50  Score=384.10  Aligned_cols=258  Identities=20%  Similarity=0.370  Sum_probs=208.9

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      .+.++|.+++.||+|+||.||+|++..+|+.||||++....        .....+.+.+|+.+|+.++||||+++++++.
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   74 (332)
T 3qd2_B            3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--------RELAREKVMREVKALAKLEHPGIVRYFNAWL   74 (332)
T ss_dssp             HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--------TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEE
T ss_pred             hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--------chhHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            45678999999999999999999999999999999986432        2345578999999999999999999999886


Q ss_pred             cCCC-------------------------------------------------------CEEEEEEeecCCCCcccccCC
Q 015257          195 DPNS-------------------------------------------------------DHFYMVLEYVEGKWDNDGFGQ  219 (410)
Q Consensus       195 ~~~~-------------------------------------------------------~~~~lv~e~~~~~~l~~~~~~  219 (410)
                      +...                                                       ..+++||||+++++|.+++..
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~  154 (332)
T 3qd2_B           75 ETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR  154 (332)
T ss_dssp             ECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHT
T ss_pred             EeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhc
Confidence            5321                                                       248999999999999988766


Q ss_pred             CC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCc------------cccc
Q 015257          220 PG---AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN------------DVLR  284 (410)
Q Consensus       220 ~~---~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~------------~~~~  284 (410)
                      ..   ..++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......            ....
T Consensus       155 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T 3qd2_B          155 RCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT  234 (332)
T ss_dssp             CCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred             ccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence            54   35667789999999999999999999999999999999999999999999998765432            1223


Q ss_pred             cCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHhcc
Q 015257          285 RSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV-FPDAMNPELRNLLEGLLC  363 (410)
Q Consensus       285 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~~~~l~~li~~~L~  363 (410)
                      ...||+.|+|||++.+..+ +.++|||||||++|+|++|..|+..  .......+.....+ .+...++++.+||.+||+
T Consensus       235 ~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  311 (332)
T 3qd2_B          235 GQVGTKLYMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLS  311 (332)
T ss_dssp             SCC-CGGGSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHC
T ss_pred             ccCCCcCccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHcc
Confidence            4579999999999887665 6789999999999999998777522  11222223332211 113467889999999999


Q ss_pred             cCCCCCCCHHHHhhCCcccC
Q 015257          364 KDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       364 ~dp~~Rpt~~ell~h~~~~~  383 (410)
                      .||.+|||+.|+++||||++
T Consensus       312 ~~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          312 PSPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             SSGGGSCCHHHHHHSTTCCC
T ss_pred             CCCCcCCCHHHHhhchhhhc
Confidence            99999999999999999975

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-49  Score=389.54  Aligned_cols=253  Identities=25%  Similarity=0.396  Sum_probs=211.6

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+++.||+|+||.||+|++..+|+.||||++.....             ...+|+.+++.++|||||++++++...
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------------~~~~E~~il~~l~hpnIv~l~~~~~~~   72 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------------YKNRELDIMKVLDHVNIIKLVDYFYTT   72 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------------SCCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------------hHHHHHHHHHHcCCCCccchhheeeec
Confidence            4689999999999999999999999999999999864321             123799999999999999999988542


Q ss_pred             ------------------------------------CCCEEEEEEeecCCC---CcccccCCCCCCCHHHHHHHHHHHHH
Q 015257          197 ------------------------------------NSDHFYMVLEYVEGK---WDNDGFGQPGAIGESMARKYLRDIVS  237 (410)
Q Consensus       197 ------------------------------------~~~~~~lv~e~~~~~---~l~~~~~~~~~l~~~~~~~i~~qi~~  237 (410)
                                                          ....+++||||++++   .+.........+++..++.++.||+.
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~  152 (383)
T 3eb0_A           73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFR  152 (383)
T ss_dssp             -------------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence                                                234589999999964   23333445678999999999999999


Q ss_pred             HHHHHHhCCcEeccCCCCcEEEc-CCCcEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHH
Q 015257          238 GLMYLHGHNVVHGDIKPDNLLVA-PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVT  316 (410)
Q Consensus       238 gL~yLH~~~iiHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~i  316 (410)
                      ||.|||++||+||||||+|||++ .++.+||+|||+|+...... ......||+.|+|||++.+...++.++|||||||+
T Consensus       153 aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          153 AVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            99999999999999999999998 58899999999998654432 33456789999999998876655788999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhC-----------------CC------------CCCCCCCHHHHHHHHHhcccCCC
Q 015257          317 LYYMIIGQYPFLGETLQDTYDKIVNN-----------------SL------------VFPDAMNPELRNLLEGLLCKDPT  367 (410)
Q Consensus       317 l~elltG~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~p~~~~~~l~~li~~~L~~dp~  367 (410)
                      +|+|++|..||.+....+....+...                 ..            .+|..+++++.+||.+||+.||.
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            99999999999998877776665431                 00            13556889999999999999999


Q ss_pred             CCCCHHHHhhCCcccC
Q 015257          368 RRLTLNDVAKHTWVLG  383 (410)
Q Consensus       368 ~Rpt~~ell~h~~~~~  383 (410)
                      +|||+.|+++||||.+
T Consensus       312 ~R~t~~e~l~hp~f~~  327 (383)
T 3eb0_A          312 LRINPYEAMAHPFFDH  327 (383)
T ss_dssp             GSCCHHHHHTSGGGHH
T ss_pred             hCCCHHHHhcCHHHHH
Confidence            9999999999999975

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=7.3e-49  Score=377.43  Aligned_cols=259  Identities=27%  Similarity=0.486  Sum_probs=219.9

Q ss_pred             ccccceeee-eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeE
Q 015257          115 KMINEYVHV-RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEV  192 (410)
Q Consensus       115 ~~~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~  192 (410)
                      .+.++|.+. +.||+|+||.||++.+..+|+.||||++.....       .......+.+|+.+++.+. ||||++++++
T Consensus        25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~   97 (327)
T 3lm5_A           25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-------GQDCRAEILHEIAVLELAKSCPRVINLHEV   97 (327)
T ss_dssp             HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-------TEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-------chHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            445678888 899999999999999999999999999875432       2233467889999999995 6999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC---CCcEEE
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP---SGTVKI  267 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~---~~~~kl  267 (410)
                      +.+  ...+++||||+.+++|.+.+..  ...+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||
T Consensus        98 ~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL  175 (327)
T 3lm5_A           98 YEN--TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKI  175 (327)
T ss_dssp             EEC--SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEE
T ss_pred             EEe--CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEE
Confidence            986  5689999999999999888754  367999999999999999999999999999999999999998   789999


Q ss_pred             eeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Q 015257          268 GDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP  347 (410)
Q Consensus       268 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p  347 (410)
                      +|||+++...... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+....+....+......++
T Consensus       176 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  253 (327)
T 3lm5_A          176 VDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS  253 (327)
T ss_dssp             CCGGGCEEC----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             eeCccccccCCcc-ccccccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC
Confidence            9999998764432 3345679999999999877665 6779999999999999999999999888887777776554433


Q ss_pred             ----CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          348 ----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       348 ----~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                          ..+++.+.+||.+||+.||.+|||++++++||||++.
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          254 EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW  294 (327)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred             chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence                4689999999999999999999999999999999875

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.7e-49  Score=376.13  Aligned_cols=255  Identities=27%  Similarity=0.402  Sum_probs=203.3

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHH-HhCCCCCcccceeE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM-KMLQHPNIVNLIEV  192 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~  192 (410)
                      ..+.++|+++++||+|+||+||++++..+|+.||||++.....       ..........|+..+ +..+||||++++++
T Consensus        53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~  125 (311)
T 3p1a_A           53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-------GPKDRARKLAEVGSHEKVGQHPCCVRLEQA  125 (311)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-------SHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-------ChHHHHHHHHHHHHHHHhcCCCcEEEEEEE
Confidence            3445789999999999999999999999999999998754321       223333444555554 44599999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      +.+  ...+++||||+++.+..........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus       126 ~~~--~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~  203 (311)
T 3p1a_A          126 WEE--GGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGL  203 (311)
T ss_dssp             EEE--TTEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTT
T ss_pred             EEe--CCEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEcccee
Confidence            986  568999999996644333333355799999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCCC
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL--VFPDAM  350 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~  350 (410)
                      +...... .......||+.|+|||++.+ .+ +.++|||||||++|+|++|..|+.+.   .....+.....  .++..+
T Consensus       204 a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~---~~~~~~~~~~~~~~~~~~~  277 (311)
T 3p1a_A          204 LVELGTA-GAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGG---EGWQQLRQGYLPPEFTAGL  277 (311)
T ss_dssp             CEECC-------CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSH---HHHHHHTTTCCCHHHHTTS
T ss_pred             eeecccC-CCCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHHhccCCCcccccCC
Confidence            9865433 23345679999999998876 33 67899999999999999997766543   22333333322  234678


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                      ++++.+||.+||+.||.+|||++|+++||||++
T Consensus       278 ~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          278 SSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            999999999999999999999999999999976

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.6e-49  Score=370.90  Aligned_cols=261  Identities=31%  Similarity=0.548  Sum_probs=223.3

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+++.||+|+||.||++++..+|+.||+|++........   ......+.+.+|+.+++.++||||+++++++.+ 
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   79 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSS---RRGVSREEIEREVNILREIRHPNIITLHDIFEN-   79 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTC---SSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhcccccc---ccchHHHHHHHHHHHHHhCCCCCeeehhheecC-
Confidence            3579999999999999999999999999999999876543221   112235678999999999999999999999986 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC----cEEEeeccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG----TVKIGDFSV  272 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~----~~kl~DfG~  272 (410)
                       ....++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++    .+||+|||+
T Consensus        80 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           80 -KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             -SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             -CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence             468999999999999999887777899999999999999999999999999999999999999877    899999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----C
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----D  348 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~  348 (410)
                      +....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+....+....+......++    .
T Consensus       159 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T 3bhy_A          159 AHKIEAGN-EFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS  236 (283)
T ss_dssp             CEECC---------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             ceeccCCC-cccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcc
Confidence            98654432 2345569999999998876665 6779999999999999999999999888887777777665544    4


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      .+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus       237 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          237 NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            789999999999999999999999999999999753

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.3e-49  Score=380.84  Aligned_cols=267  Identities=28%  Similarity=0.522  Sum_probs=227.0

Q ss_pred             ccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeeccccccccc--------CCChHHHHHHHHHHHHHHhCCCC
Q 015257          113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV--------APSETAMTDVRREVLIMKMLQHP  184 (410)
Q Consensus       113 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~--------~~~~~~~~~~~~E~~~l~~l~hp  184 (410)
                      .....++|.+++.||+|+||.||++.+  +|+.||||++..........        .........+.+|+.+++.++||
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  103 (348)
T 2pml_X           26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE  103 (348)
T ss_dssp             SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred             cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence            345568999999999999999999998  89999999987653321100        00112236889999999999999


Q ss_pred             CcccceeEEEcCCCCEEEEEEeecCCCCcccc------cCC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCC
Q 015257          185 NIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG------FGQ--PGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPD  255 (410)
Q Consensus       185 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~------~~~--~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~  255 (410)
                      ||+++++++.+  ...+++||||+++++|.++      +..  ...+++..++.++.||+.||.|||+ .||+||||||+
T Consensus       104 ~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~  181 (348)
T 2pml_X          104 YCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS  181 (348)
T ss_dssp             TBCCCSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred             CcceEEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence            99999999987  4689999999999999988      655  5689999999999999999999999 99999999999


Q ss_pred             cEEEcCCCcEEEeeccccccccCCccccccCCCcccccccccccCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-H
Q 015257          256 NLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL-TYGGKAADTWAVGVTLYYMIIGQYPFLGETL-Q  333 (410)
Q Consensus       256 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-~  333 (410)
                      |||++.++.+||+|||++......  ......||+.|+|||++.+. .+.+.++||||||+++|+|++|..||..... .
T Consensus       182 Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          182 NILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             GEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             hEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            999999999999999999875443  34556799999999998876 3433389999999999999999999988766 6


Q ss_pred             HHHHHHHhCCCCCC-------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          334 DTYDKIVNNSLVFP-------------------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       334 ~~~~~i~~~~~~~p-------------------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      +....+......+|                   ..+++++.+||.+||+.||.+|||+.|+++||||++..
T Consensus       260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            77777777766666                   67899999999999999999999999999999998754

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.9e-49  Score=385.21  Aligned_cols=266  Identities=26%  Similarity=0.425  Sum_probs=226.5

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEV  192 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~  192 (410)
                      ..+.++|.+.+.||+|+||.||+|.+..+|+.||||++....... .........+.+.+|+.+++.+ +||||++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERL-SPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCC-CHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc-CHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            345578999999999999999999999999999999986542110 0000123356788999999999 79999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      +..  ....++||||++|++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+
T Consensus       169 ~~~--~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~  246 (365)
T 2y7j_A          169 YES--SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGF  246 (365)
T ss_dssp             EEB--SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             Eee--CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCc
Confidence            986  468999999999999998887777899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCC-----cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGL-----TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP  347 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p  347 (410)
                      +....... ......||+.|+|||++.+.     ...+.++|||||||++|+|++|..||...........+..+...++
T Consensus       247 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  325 (365)
T 2y7j_A          247 SCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS  325 (365)
T ss_dssp             CEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             ccccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            98765432 34567899999999988532     2236679999999999999999999998888777777777766554


Q ss_pred             ----CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          348 ----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       348 ----~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                          ..+++.+.+||.+||+.||.+|||+.++++||||+.
T Consensus       326 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          326 SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence                468899999999999999999999999999999963

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-50  Score=388.98  Aligned_cols=262  Identities=27%  Similarity=0.468  Sum_probs=221.7

Q ss_pred             cccceeeeeeecccCceEEEEEEEc---cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCccccee
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIE  191 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~  191 (410)
                      ..++|.+++.||+|+||.||++++.   .+|+.||||++.......     .......+.+|+.+|+.+ +||||+++++
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  126 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-----KAKTTEHTRTERQVLEHIRQSPFLVTLHY  126 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE-----EESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhh-----hhhHHHHHHHHHHHHHHccCCCceeEEEE
Confidence            3578999999999999999999984   489999999987543211     111223466899999999 6999999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      ++..  ...+++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       127 ~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          127 AFQT--ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             EEEE--TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             EEee--CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCC
Confidence            9987  45899999999999999988877789999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCC-ccccccCCCcccccccccccCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCC
Q 015257          272 VSQVFEDD-NDVLRRSPGTPVFTAPECCLGL-TYGGKAADTWAVGVTLYYMIIGQYPFLGE----TLQDTYDKIVNNSLV  345 (410)
Q Consensus       272 ~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~----~~~~~~~~i~~~~~~  345 (410)
                      +++..... .......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||...    ........+......
T Consensus       205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  284 (355)
T 1vzo_A          205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP  284 (355)
T ss_dssp             EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC
T ss_pred             CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC
Confidence            99865432 2333456799999999998753 33467899999999999999999999643    344556667777778


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhhCCcccCC
Q 015257          346 FPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTWVLGD  384 (410)
Q Consensus       346 ~p~~~~~~l~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~  384 (410)
                      +|..+++.+.+||.+||..||.+||     |++++++||||++.
T Consensus       285 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          285 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            8899999999999999999999999     99999999999864

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9.2e-49  Score=376.40  Aligned_cols=252  Identities=23%  Similarity=0.411  Sum_probs=211.8

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEEEc
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDD  195 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~  195 (410)
                      .++|++++.||+|+||.||++++..+++.||||++...            ....+.+|+.+++.+. ||||+++++++.+
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~  102 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------------KKKKIKREIKILENLRGGPNIITLADIVKD  102 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------------CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------------chHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence            46899999999999999999999999999999998532            2356889999999997 9999999999998


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC-cEEEeeccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSVSQ  274 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~-~~kl~DfG~a~  274 (410)
                      +.....++||||++++++...+.   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus       103 ~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          103 PVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  179 (330)
T ss_dssp             TTTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             CCCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence            66678999999999998887764   489999999999999999999999999999999999999777 89999999998


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHH-------------H
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE-TLQDTYDKI-------------V  340 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~-~~~~~~~~i-------------~  340 (410)
                      ...... ......||+.|+|||++.+....+.++|||||||++|+|++|..||... ...+....+             .
T Consensus       180 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          180 FYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             ECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             EcCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence            654432 3345679999999999887555578899999999999999999999543 222222211             1


Q ss_pred             hCCCCC------------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          341 NNSLVF------------------------PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       341 ~~~~~~------------------------p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      .....+                        +..+++++.+||.+||+.||.+|||++|+|+||||++-
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence            111111                        12379999999999999999999999999999999865

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.7e-49  Score=381.27  Aligned_cols=261  Identities=25%  Similarity=0.446  Sum_probs=212.2

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCC--CCcccceeEEE
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH--PNIVNLIEVID  194 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~  194 (410)
                      .++|.+++.||+|+||.||++.+. +++.||||++....       ........+.+|+.+|+.++|  |||+++++++.
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   79 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   79 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTT-------CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccc-------cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence            357999999999999999999885 68899999986542       234566789999999999987  99999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      +  ...+++||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++
T Consensus        80 ~--~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~  155 (343)
T 3dbq_A           80 T--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN  155 (343)
T ss_dssp             C--SSEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred             e--CCEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccc
Confidence            6  468999999 45678888887778899999999999999999999999999999999999997 7899999999998


Q ss_pred             cccCCcc--ccccCCCcccccccccccC----------CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHh
Q 015257          275 VFEDDND--VLRRSPGTPVFTAPECCLG----------LTYGGKAADTWAVGVTLYYMIIGQYPFLGETL-QDTYDKIVN  341 (410)
Q Consensus       275 ~~~~~~~--~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~i~~  341 (410)
                      .......  ......||+.|+|||++.+          ....+.++|||||||++|+|++|..||..... ......+..
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  235 (343)
T 3dbq_A          156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  235 (343)
T ss_dssp             CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred             ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence            7654322  2345679999999998854          13346789999999999999999999987433 334444443


Q ss_pred             C--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCc
Q 015257          342 N--SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIP  389 (410)
Q Consensus       342 ~--~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~  389 (410)
                      .  ...+|...++++.+||.+||+.||.+|||+.|+++||||+....+..
T Consensus       236 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~  285 (343)
T 3dbq_A          236 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN  285 (343)
T ss_dssp             TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC---
T ss_pred             CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCccc
Confidence            3  34577888999999999999999999999999999999987655543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.7e-49  Score=369.47  Aligned_cols=255  Identities=26%  Similarity=0.380  Sum_probs=213.6

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVI  193 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  193 (410)
                      .+.++|.+++.||+|+||.||++.+..+++.||||++.....       .......+.+|+.++..+ +||||+++++++
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~   80 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-------GSVDEQNALREVYAHAVLGQHSHVVRYFSAW   80 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-------TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-------ccHHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence            455789999999999999999999999999999999875321       233456788999999999 999999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC-------
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQP----GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-------  262 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~-------  262 (410)
                      .+  ...+++||||+++++|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.+       
T Consensus        81 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~  158 (289)
T 1x8b_A           81 AE--DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAAS  158 (289)
T ss_dssp             EE--TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------
T ss_pred             ec--CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccc
Confidence            87  45899999999999999887653    679999999999999999999999999999999999999854       


Q ss_pred             ------------CcEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015257          263 ------------GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE  330 (410)
Q Consensus       263 ------------~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~  330 (410)
                                  ..+||+|||++......    ....||+.|+|||++.+....+.++|||||||++|+|++|.+|+...
T Consensus       159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  234 (289)
T 1x8b_A          159 EEGDEDDWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG  234 (289)
T ss_dssp             -----------CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred             cccccccccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence                        47999999999875443    23458999999999877655567899999999999999999877544


Q ss_pred             CHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          331 TLQDTYDKIVNNSL-VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       331 ~~~~~~~~i~~~~~-~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      .   ....+..+.. .+|..+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus       235 ~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          235 D---QWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             H---HHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             h---HHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence            2   3344444443 56778999999999999999999999999999999998754

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=9.9e-49  Score=369.55  Aligned_cols=256  Identities=23%  Similarity=0.405  Sum_probs=217.3

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC-
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP-  196 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  196 (410)
                      ..|.+.+.||+|+||.||++.+..++..||+|++.....       .......+.+|+.+++.++||||+++++++... 
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   98 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-------TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   98 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-------CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence            358899999999999999999999999999999875432       345567899999999999999999999988652 


Q ss_pred             -CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeccCCCCcEEEc-CCCcEEEeeccc
Q 015257          197 -NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHN--VVHGDIKPDNLLVA-PSGTVKIGDFSV  272 (410)
Q Consensus       197 -~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NIll~-~~~~~kl~DfG~  272 (410)
                       ....+++||||+++++|.+++.....+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||+
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~  178 (290)
T 1t4h_A           99 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             CCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence             34678999999999999998887778999999999999999999999999  99999999999998 789999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCC--CCCCCC
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ-DTYDKIVNNS--LVFPDA  349 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~i~~~~--~~~p~~  349 (410)
                      +......  ......||+.|+|||++.+.  .+.++||||||+++|+|++|..||...... .....+..+.  ..++..
T Consensus       179 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (290)
T 1t4h_A          179 ATLKRAS--FAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV  254 (290)
T ss_dssp             GGGCCTT--SBEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred             ccccccc--ccccccCCcCcCCHHHHhcc--CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCC
Confidence            9754432  33456799999999987643  367899999999999999999999885443 4444444432  234567


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      .++++.+||.+||+.||.+|||++++++||||++.
T Consensus       255 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            88999999999999999999999999999999864

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.8e-49  Score=386.83  Aligned_cols=260  Identities=25%  Similarity=0.449  Sum_probs=213.6

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC--CCCcccceeEEEc
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--HPNIVNLIEVIDD  195 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~  195 (410)
                      ..|.+++.||+|+||.||++.+.. ++.||||++.....       .......+.+|+.+|+.+.  ||||+++++++..
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-------~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~  127 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-------DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT  127 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-------cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence            469999999999999999999875 89999999865421       3456678999999999996  5999999999986


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                        ...+|+||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.
T Consensus       128 --~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~  203 (390)
T 2zmd_A          128 --DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  203 (390)
T ss_dssp             --SSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred             --CCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence              457999999 56677888887777899999999999999999999999999999999999996 68999999999987


Q ss_pred             ccCCc--cccccCCCcccccccccccCC----------cCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhC
Q 015257          276 FEDDN--DVLRRSPGTPVFTAPECCLGL----------TYGGKAADTWAVGVTLYYMIIGQYPFLGET-LQDTYDKIVNN  342 (410)
Q Consensus       276 ~~~~~--~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~i~~~  342 (410)
                      .....  ......+||+.|+|||++.+.          ..++.++|||||||++|+|++|..||.... .......+...
T Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~  283 (390)
T 2zmd_A          204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  283 (390)
T ss_dssp             C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred             ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence            64332  223466799999999998652          234678999999999999999999998753 33445555554


Q ss_pred             C--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCc
Q 015257          343 S--LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIP  389 (410)
Q Consensus       343 ~--~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~  389 (410)
                      .  ..+|...++++.+||.+||+.||.+|||+.|+++||||+....+..
T Consensus       284 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~  332 (390)
T 2zmd_A          284 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN  332 (390)
T ss_dssp             TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC----
T ss_pred             cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCccch
Confidence            3  3567778999999999999999999999999999999987655543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.2e-50  Score=382.54  Aligned_cols=264  Identities=23%  Similarity=0.373  Sum_probs=220.0

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ..+.++|.+.+.||+|+||.||++++..+++.||||++....      .........+.+|+.+++.++||||+++++++
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   81 (311)
T 3ork_A            8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL------ARDPSFYLRFRREAQNAAALNHPAIVAVYDTG   81 (311)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTT------TTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred             ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccc------cCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence            456678999999999999999999999999999999986542      12445667899999999999999999999988


Q ss_pred             EcCCC--CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          194 DDPNS--DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       194 ~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      .....  ...++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg  161 (311)
T 3ork_A           82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFG  161 (311)
T ss_dssp             EEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred             eccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeecc
Confidence            75322  3569999999999999988777789999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCc---cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--
Q 015257          272 VSQVFEDDN---DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF--  346 (410)
Q Consensus       272 ~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~--  346 (410)
                      +++......   .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.........+.......  
T Consensus       162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 3ork_A          162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS  240 (311)
T ss_dssp             CC------------------CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH
T ss_pred             CcccccccccccccccccCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc
Confidence            998654332   12234568999999999887665 678999999999999999999999988777766666654433  


Q ss_pred             --CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          347 --PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       347 --p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                        +..+++++.+||.+||+.||.+||++.+++.|+|+...
T Consensus       241 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          241 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence              24689999999999999999999999999999999754

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.6e-48  Score=370.47  Aligned_cols=258  Identities=26%  Similarity=0.436  Sum_probs=225.7

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .+.|.+++.||+|+||.||++.+..+++.||||++....        .......+.+|+.+++.++||||+++++++.+ 
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   91 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-   91 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT--------CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc--------cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-
Confidence            357999999999999999999999999999999986542        12345689999999999999999999999987 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       ...+++||||++++++.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus        92 -~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  169 (303)
T 3a7i_A           92 -DTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL  169 (303)
T ss_dssp             -TTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             -CCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceec
Confidence             4589999999999998887764 57999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS-LVFPDAMNPELR  355 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~l~  355 (410)
                      ...........||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........+.... ..++..++..+.
T Consensus       170 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  248 (303)
T 3a7i_A          170 TDTQIKRNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLK  248 (303)
T ss_dssp             BTTBCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHH
T ss_pred             CccccccCccCCCcCccCHHHHhcCCC-CchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHH
Confidence            554444456679999999999877665 567999999999999999999998887776666655543 346678999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          356 NLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      +||.+||+.||.+|||+.++++||||.....
T Consensus       249 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  279 (303)
T 3a7i_A          249 EFVEACLNKEPSFRPTAKELLKHKFILRNAK  279 (303)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred             HHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence            9999999999999999999999999986544

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.9e-49  Score=373.44  Aligned_cols=261  Identities=24%  Similarity=0.347  Sum_probs=217.7

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+++.||+|+||.||++.+..+++.||+|++....         ......+.+|+.+++.++||||+++++++.
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---------EEELEDYIVEIEILATCDHPYIVKLLGAYY   86 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---------HHHHHHHHHHHHHHhcCCCCCEeeeeeeee
Confidence            34568999999999999999999999999999999986432         234567889999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      +  ...+++||||++++++..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        87 ~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  164 (302)
T 2j7t_A           87 H--DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS  164 (302)
T ss_dssp             C--C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred             e--CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCC
Confidence            7  4579999999999988877654 457999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCccccccCCCccccccccccc----CCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CC
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCL----GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL---VF  346 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---~~  346 (410)
                      ..............||+.|+|||++.    .....+.++||||||+++|+|++|..||...........+.....   ..
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (302)
T 2j7t_A          165 AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLT  244 (302)
T ss_dssp             HHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSS
T ss_pred             ccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCC
Confidence            65433222334567999999999874    233336789999999999999999999998887777666665543   23


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          347 PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       347 p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      +..++..+.+||.+||+.||.+|||+.++++||||.+...
T Consensus       245 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             ccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence            4578999999999999999999999999999999987543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.2e-49  Score=391.01  Aligned_cols=269  Identities=27%  Similarity=0.430  Sum_probs=199.3

Q ss_pred             cccceeee-eeecccCceEEEEEEEc--cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          116 MINEYVHV-RKIGAGSYGKVVLYRSS--LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       116 ~~~~y~~~-~~lG~G~fg~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      ..+.|.+. ++||+|+||.||+|+..  .+++.||||++.....           ...+.+|+.+|+.++|||||+++++
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~~~~~   86 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----------SMSACREIALLRELKHPNVISLQKV   86 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----------CHHHHHHHHHHHHCCCTTBCCCCEE
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----------CHHHHHHHHHHHhcCCCCeeeEeeE
Confidence            33567764 58999999999999966  5789999999864321           1357899999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCccccc--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEE----c
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGF--------GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV----A  260 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~--------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll----~  260 (410)
                      +.......+++||||++++++....        .....+++..++.++.||+.||.|||++||+||||||+|||+    +
T Consensus        87 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~  166 (405)
T 3rgf_A           87 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGP  166 (405)
T ss_dssp             EEETTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSST
T ss_pred             EecCCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCC
Confidence            9765667999999999875333221        122359999999999999999999999999999999999999    6


Q ss_pred             CCCcEEEeeccccccccCCc---cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----
Q 015257          261 PSGTVKIGDFSVSQVFEDDN---DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL-----  332 (410)
Q Consensus       261 ~~~~~kl~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-----  332 (410)
                      .++.+||+|||+|+......   ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+...     
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  246 (405)
T 3rgf_A          167 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS  246 (405)
T ss_dssp             TTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred             CCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccc
Confidence            77899999999998764322   2334567999999999998766568889999999999999999999976543     


Q ss_pred             ----HHHHHHHHhCCCC--------------------------------------CCCCCCHHHHHHHHHhcccCCCCCC
Q 015257          333 ----QDTYDKIVNNSLV--------------------------------------FPDAMNPELRNLLEGLLCKDPTRRL  370 (410)
Q Consensus       333 ----~~~~~~i~~~~~~--------------------------------------~p~~~~~~l~~li~~~L~~dp~~Rp  370 (410)
                          .+....+......                                      .....++.+.+||.+||+.||.+||
T Consensus       247 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~  326 (405)
T 3rgf_A          247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI  326 (405)
T ss_dssp             CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC
T ss_pred             ccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC
Confidence                1233333221000                                      0012267899999999999999999


Q ss_pred             CHHHHhhCCcccCCCCCCchhhhhh
Q 015257          371 TLNDVAKHTWVLGDNGPIPQYLCWC  395 (410)
Q Consensus       371 t~~ell~h~~~~~~~~~~~~~~~~~  395 (410)
                      |++|+|+||||.+...+.++.+..+
T Consensus       327 ta~e~L~hp~f~~~~~~~~~~~~~~  351 (405)
T 3rgf_A          327 TSEQAMQDPYFLEDPLPTSDVFAGC  351 (405)
T ss_dssp             CHHHHHTSGGGTSSSCCCSSTTTTS
T ss_pred             CHHHHhcChhhccCCCCcccccccC
Confidence            9999999999998877666555443

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.9e-49  Score=386.22  Aligned_cols=271  Identities=24%  Similarity=0.417  Sum_probs=225.0

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ....++|.+++.||+|+||.||++.+..+++.||+|++....        .......+.+|+.+++.++||||+++++++
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  100 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--------KPAIRNQIIRELQVLHECNSPYIVGFYGAF  100 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--------CHHHHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--------CHHHHHHHHHHHHHHHHCCCCCEEEEeEEE
Confidence            344568999999999999999999999999999999986431        345567899999999999999999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      .+  ...+++||||+++++|.+++...+.+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus       101 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  178 (360)
T 3eqc_A          101 YS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV  178 (360)
T ss_dssp             EE--TTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred             EE--CCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCC
Confidence            87  468999999999999999888777899999999999999999999996 999999999999999999999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----------------
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTY----------------  336 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~----------------  336 (410)
                      +......  ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......+..                
T Consensus       179 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  255 (360)
T 3eqc_A          179 SGQLIDS--MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP  255 (360)
T ss_dssp             CHHHHHH--C----CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------
T ss_pred             Ccccccc--cccCCCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCC
Confidence            9755322  2345679999999999877655 67899999999999999999999876544321                


Q ss_pred             --------------------------HHHHhCCC-CC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCC
Q 015257          337 --------------------------DKIVNNSL-VF-PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI  388 (410)
Q Consensus       337 --------------------------~~i~~~~~-~~-p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~  388 (410)
                                                ..+..... .. +..++.++.+||.+||+.||.+|||++|+++||||++.....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  335 (360)
T 3eqc_A          256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE  335 (360)
T ss_dssp             ------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred             CcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhh
Confidence                                      22222221 12 235789999999999999999999999999999999876555


Q ss_pred             chhhhhhhc
Q 015257          389 PQYLCWCKR  397 (410)
Q Consensus       389 ~~~~~~~~~  397 (410)
                      .....|...
T Consensus       336 ~~~~~~~~~  344 (360)
T 3eqc_A          336 VDFAGWLCS  344 (360)
T ss_dssp             CCHHHHHHH
T ss_pred             hhHHHHHhh
Confidence            555555433

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1e-48  Score=373.56  Aligned_cols=257  Identities=26%  Similarity=0.393  Sum_probs=210.3

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+.+.||+|+||.||+++.  +|+.||||++....       ........+.+|+.++++++||||+++++++.+
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~-------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  105 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQD-------FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ  105 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCC-------CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCC-------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            346899999999999999999976  58899999986542       134556789999999999999999999999976


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCC---CCHHHHHHHHHHHHHHHHHHHhCC--cEeccCCCCcEEEcCCCcEEEeec
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGA---IGESMARKYLRDIVSGLMYLHGHN--VVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~---l~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                        ...+++||||+++++|.+++.....   +++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+||
T Consensus       106 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Df  183 (309)
T 3p86_A          106 --PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF  183 (309)
T ss_dssp             --TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred             --CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence              4568999999999999988876553   999999999999999999999999  999999999999999999999999


Q ss_pred             cccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCC
Q 015257          271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV--NNSLVFPD  348 (410)
Q Consensus       271 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~--~~~~~~p~  348 (410)
                      |+++.............||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....+....+.  .....+|.
T Consensus       184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  262 (309)
T 3p86_A          184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPR  262 (309)
T ss_dssp             C-----------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCT
T ss_pred             CCCccccccccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCc
Confidence            999865544444456679999999999887665 667999999999999999999999888777666653  33456788


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhh--CCcccCC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAK--HTWVLGD  384 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~--h~~~~~~  384 (410)
                      .+++++.+||.+||+.||.+|||+.++++  .+++...
T Consensus       263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            99999999999999999999999999997  5666543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.1e-48  Score=381.00  Aligned_cols=271  Identities=25%  Similarity=0.354  Sum_probs=213.0

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccc--cCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLR--VAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      .+.++|.+++.||+|+||.||++.+.. |+.||||++.........  ........+.+.+|+.+++.++||||++++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            345789999999999999999999865 899999998654322110  11234455789999999999999999999999


Q ss_pred             EEc---CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEee
Q 015257          193 IDD---PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGD  269 (410)
Q Consensus       193 ~~~---~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~D  269 (410)
                      +..   +....+++||||++++++.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D  177 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD  177 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence            864   23457999999999765555555556899999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------
Q 015257          270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN-------  342 (410)
Q Consensus       270 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~-------  342 (410)
                      ||+++..... .......||+.|+|||++.+....+.++|||||||++|+|++|..||.+....+....+...       
T Consensus       178 fg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  256 (362)
T 3pg1_A          178 FNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE  256 (362)
T ss_dssp             TTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             cCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence            9999754433 23345678999999999877555578899999999999999999999988776665555321       


Q ss_pred             ----------------C-CC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          343 ----------------S-LV--------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       343 ----------------~-~~--------~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                                      . ..        .+..+++.+.+||.+||+.||.+|||+.|+++||||++...|
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence                            0 00        123568899999999999999999999999999999876443

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9.9e-49  Score=370.93  Aligned_cols=261  Identities=28%  Similarity=0.434  Sum_probs=218.5

Q ss_pred             ccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       113 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      +....++|++++.||+|+||.||++++..+++.||||++....      .......+.+.+|+.+++.++||||++++++
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~   79 (294)
T 4eqm_A            6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPP------REKEETLKRFEREVHNSSQLSHQNIVSMIDV   79 (294)
T ss_dssp             SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCS------SCCHHHHHHHHHHHHHHTTCCBTTBCCEEEE
T ss_pred             hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCc------cccHHHHHHHHHHHHHHhcCCCCCCceEEEe
Confidence            4456678999999999999999999999999999999986432      2245667789999999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      +.+  .+.+++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        80 ~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  157 (294)
T 4eqm_A           80 DEE--DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGI  157 (294)
T ss_dssp             EEC--SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eee--CCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCC
Confidence            986  568999999999999999888778899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCc-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----C
Q 015257          273 SQVFEDDN-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV-----F  346 (410)
Q Consensus       273 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~  346 (410)
                      ++...... .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+................     .
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T 4eqm_A          158 AKALSETSLTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDV  236 (294)
T ss_dssp             STTC-------------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHS
T ss_pred             ccccccccccccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhc
Confidence            98754432 22345679999999999887665 66799999999999999999999998877766555554432     3


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCccc
Q 015257          347 PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL  382 (410)
Q Consensus       347 p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~  382 (410)
                      +..+++.+.++|.+||+.||.+||+..+.+.+.|..
T Consensus       237 ~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          237 RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            467899999999999999999999666666666654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.6e-48  Score=387.91  Aligned_cols=254  Identities=27%  Similarity=0.359  Sum_probs=209.2

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      ..+|.+++.||+|+||.||++++..+|+.||||++.....             ...+|+.+|+.++|||||++++++...
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------------~~~~E~~il~~l~hpniv~l~~~~~~~  119 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------------FKNRELQIMRKLDHCNIVRLRYFFYSS  119 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------------SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------------hHHHHHHHHHHcCCCCccceeeEEecc
Confidence            4579999999999999999999999999999999864321             123799999999999999999988542


Q ss_pred             ----CCCEEEEEEeecCCCCccc---ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC-CcEEEe
Q 015257          197 ----NSDHFYMVLEYVEGKWDND---GFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-GTVKIG  268 (410)
Q Consensus       197 ----~~~~~~lv~e~~~~~~l~~---~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~-~~~kl~  268 (410)
                          ....+++||||++++....   .......+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+
T Consensus       120 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~  199 (420)
T 1j1b_A          120 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLC  199 (420)
T ss_dssp             ETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             CCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEec
Confidence                2235789999998753322   12345679999999999999999999999999999999999999965 568999


Q ss_pred             eccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------
Q 015257          269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN------  342 (410)
Q Consensus       269 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~------  342 (410)
                      |||+++...... ......||+.|+|||++.+...++.++|||||||++|||++|+.||.+....+....+...      
T Consensus       200 DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~  278 (420)
T 1j1b_A          200 DFGSAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR  278 (420)
T ss_dssp             CCTTCEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             cchhhhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            999998754432 2345678999999999877655578899999999999999999999998876666555431      


Q ss_pred             -----------CCC------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          343 -----------SLV------------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       343 -----------~~~------------~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                                 .+.            ++..+++++.+||.+||+.||.+|||+.|+++||||.+.
T Consensus       279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence                       111            234578999999999999999999999999999999754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1e-48  Score=375.31  Aligned_cols=264  Identities=28%  Similarity=0.509  Sum_probs=213.9

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      .+.++|.+.+.||+|+||.||++++..+++.||||++........ ..........+.+|+.+++.++||||+++++++.
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   85 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIG-SAREADPALNVETEIEILKKLNHPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC----------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhc-ccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence            345689999999999999999999999999999999875432110 0112233446889999999999999999999997


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCc---EEEeecc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT---VKIGDFS  271 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~---~kl~DfG  271 (410)
                      ..   .+++||||+++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||
T Consensus        86 ~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           86 AE---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             SS---SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             CC---ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            53   38999999999999988888889999999999999999999999999999999999999987664   9999999


Q ss_pred             ccccccCCccccccCCCccccccccccc--CCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCC-
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCL--GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ-DTYDKIVNNSLVFP-  347 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p-  347 (410)
                      +++...... ......||+.|+|||++.  +....+.++|||||||++|+|++|..||...... .....+..+...++ 
T Consensus       163 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (322)
T 2ycf_A          163 HSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP  241 (322)
T ss_dssp             TCEECCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH
T ss_pred             cceeccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc
Confidence            998764432 233456899999999874  2333467899999999999999999999765432 33444555544332 


Q ss_pred             ---CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          348 ---DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       348 ---~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                         ..+++.+.+||.+||+.||.+|||+.++++||||++
T Consensus       242 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence               468999999999999999999999999999999976

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9e-49  Score=386.51  Aligned_cols=258  Identities=27%  Similarity=0.395  Sum_probs=212.3

Q ss_pred             cccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCccccee
Q 015257          112 NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE  191 (410)
Q Consensus       112 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  191 (410)
                      .+.....+|.+++.||+|+||.||+|++..+++ ||+|++.....             ...+|+.+++.++||||+++++
T Consensus        34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------------~~~~E~~il~~l~h~niv~l~~   99 (394)
T 4e7w_A           34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------------FKNRELQIMRIVKHPNVVDLKA   99 (394)
T ss_dssp             SCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------------SCCHHHHHHHTCCCTTBCCEEE
T ss_pred             CCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------------hHHHHHHHHHhCCCCCcceEEE
Confidence            344556789999999999999999999987666 88888754321             1237999999999999999999


Q ss_pred             EEEcCC----CCEEEEEEeecCCCCcccc---cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEc-CCC
Q 015257          192 VIDDPN----SDHFYMVLEYVEGKWDNDG---FGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA-PSG  263 (410)
Q Consensus       192 ~~~~~~----~~~~~lv~e~~~~~~l~~~---~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~-~~~  263 (410)
                      ++....    ...+++||||++++.+...   ......+++..++.++.||+.||+|||++||+||||||+|||++ .++
T Consensus       100 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~  179 (394)
T 4e7w_A          100 FFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG  179 (394)
T ss_dssp             EEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT
T ss_pred             EEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC
Confidence            986522    2358899999998654432   23356799999999999999999999999999999999999999 789


Q ss_pred             cEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-
Q 015257          264 TVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN-  342 (410)
Q Consensus       264 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~-  342 (410)
                      .+||+|||+|+...... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+... 
T Consensus       180 ~~kL~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~  258 (394)
T 4e7w_A          180 VLKLIDFGSAKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL  258 (394)
T ss_dssp             EEEECCCTTCEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             cEEEeeCCCcccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            99999999998764432 3345678999999999877665678899999999999999999999998877766555431 


Q ss_pred             ----------------CC------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          343 ----------------SL------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       343 ----------------~~------------~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                                      ..            .++..+++++.+||.+||+.||.+|||+.|+++||||.+.
T Consensus       259 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          259 GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             CCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             CCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence                            00            1234588999999999999999999999999999999865

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.3e-48  Score=389.52  Aligned_cols=255  Identities=24%  Similarity=0.369  Sum_probs=210.2

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC------CCCCccc
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML------QHPNIVN  188 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~  188 (410)
                      ....+|.+++.||+|+||.||+|.+..+++.||||++...          ......+.+|+.+++.+      .|+||++
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~  163 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----------KRFHRQAAEEIRILEHLRKQDKDNTMNVIH  163 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCC
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----------cchHHHHHHHHHHHHHHhhccccCCcCEEE
Confidence            3456899999999999999999999999999999998532          33456778899888887      5779999


Q ss_pred             ceeEEEcCCCCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCc--
Q 015257          189 LIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT--  264 (410)
Q Consensus       189 l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~--  264 (410)
                      +++++..  ...+++||||+++ .+.+.+...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  
T Consensus       164 ~~~~~~~--~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~  240 (429)
T 3kvw_A          164 MLENFTF--RNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG  240 (429)
T ss_dssp             EEEEEEE--TTEEEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCC
T ss_pred             EEeeccc--CCeEEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcc
Confidence            9999987  4689999999986 455544332  35999999999999999999999999999999999999999987  


Q ss_pred             EEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Q 015257          265 VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL  344 (410)
Q Consensus       265 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~  344 (410)
                      +||+|||+++....   ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus       241 vkL~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~  316 (429)
T 3kvw_A          241 IKVIDFGSSCYEHQ---RVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG  316 (429)
T ss_dssp             EEECCCTTCEETTC---CCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             eEEeecccceecCC---cccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            99999999976433   2345679999999999987766 6779999999999999999999999887766554442100


Q ss_pred             --------------------C---------------------------------------CCCCCCHHHHHHHHHhcccC
Q 015257          345 --------------------V---------------------------------------FPDAMNPELRNLLEGLLCKD  365 (410)
Q Consensus       345 --------------------~---------------------------------------~p~~~~~~l~~li~~~L~~d  365 (410)
                                          .                                       ++...++++.+||.+||+.|
T Consensus       317 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d  396 (429)
T 3kvw_A          317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD  396 (429)
T ss_dssp             CCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred             CCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence                                0                                       11234788999999999999


Q ss_pred             CCCCCCHHHHhhCCcccCCCC
Q 015257          366 PTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       366 p~~Rpt~~ell~h~~~~~~~~  386 (410)
                      |.+|||++|+|+||||++...
T Consensus       397 P~~Rpta~e~L~Hpw~~~~~~  417 (429)
T 3kvw_A          397 PAVRMTPGQALRHPWLRRRLP  417 (429)
T ss_dssp             TTTSCCHHHHHTSTTTC----
T ss_pred             hhhCCCHHHHhCChhhccCCC
Confidence            999999999999999997643

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-48  Score=373.55  Aligned_cols=263  Identities=24%  Similarity=0.348  Sum_probs=215.0

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEV  192 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~  192 (410)
                      ....++|.+++.||+|+||.||++++..+|+.||||++....          .....+.+|+.+++.+ +||||++++++
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~e~~~l~~l~~h~~i~~~~~~   89 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----------DEEEEIKQEINMLKKYSHHRNIATYYGA   89 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----------STTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----------ccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence            345678999999999999999999999999999999986432          1235788999999999 89999999999


Q ss_pred             EEcCC----CCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEE
Q 015257          193 IDDPN----SDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVK  266 (410)
Q Consensus       193 ~~~~~----~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~k  266 (410)
                      +....    ...+++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEE
T ss_pred             EeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEE
Confidence            97642    46899999999999988877543  5799999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCccccccCCCcccccccccccC----CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q 015257          267 IGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG----LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN  342 (410)
Q Consensus       267 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~  342 (410)
                      |+|||++..............||+.|+|||++..    ....+.++|||||||++|+|++|..||.+.........+...
T Consensus       170 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  249 (326)
T 2x7f_A          170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN  249 (326)
T ss_dssp             ECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred             EeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence            9999999876544334445679999999998863    223367799999999999999999999888776666555554


Q ss_pred             CCC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          343 SLV--FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       343 ~~~--~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      ...  .+..+++.+.+||.+||..||.+|||+.++++||||++...
T Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          250 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence            332  34578999999999999999999999999999999987643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2e-48  Score=371.68  Aligned_cols=266  Identities=27%  Similarity=0.426  Sum_probs=212.8

Q ss_pred             ccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       113 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      +....++|.+++.||+|+||.||++.+..+|+.||||++...         .....+.+.+|+.+++.++||||++++++
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   76 (320)
T 2i6l_A            6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---------DPQSVKHALREIKIIRRLDHDNIVKVFEI   76 (320)
T ss_dssp             CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---------SHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---------ChHHHHHHHHHHHHHHhcCCCCeeEEEEe
Confidence            345567899999999999999999999999999999988543         34556788999999999999999999998


Q ss_pred             EEcC------------CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEc
Q 015257          193 IDDP------------NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA  260 (410)
Q Consensus       193 ~~~~------------~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~  260 (410)
                      +...            ....+++||||+++ ++.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~  154 (320)
T 2i6l_A           77 LGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN  154 (320)
T ss_dssp             ECTTSCBCCC----CCSCSEEEEEEECCSE-EHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE
T ss_pred             ccccccccccccccccccCceeEEeeccCC-CHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence            8532            23688999999985 67766654 5799999999999999999999999999999999999997


Q ss_pred             -CCCcEEEeeccccccccCCc---cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015257          261 -PSGTVKIGDFSVSQVFEDDN---DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTY  336 (410)
Q Consensus       261 -~~~~~kl~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~  336 (410)
                       .++.+||+|||+++......   .......+|+.|+|||++.+....+.++||||||+++|+|++|..||.+....+..
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  234 (320)
T 2i6l_A          155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM  234 (320)
T ss_dssp             TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence             56799999999998654321   12234457999999998876555578899999999999999999999988776665


Q ss_pred             HHHHhCCC------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          337 DKIVNNSL------------------------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       337 ~~i~~~~~------------------------------~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      ..+.....                              ..+..+++++.+||.+||+.||.+|||+.++++||||+....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence            55543211                              012468999999999999999999999999999999987665


Q ss_pred             CCc
Q 015257          387 PIP  389 (410)
Q Consensus       387 ~~~  389 (410)
                      |..
T Consensus       315 p~~  317 (320)
T 2i6l_A          315 PMD  317 (320)
T ss_dssp             ---
T ss_pred             ccC
Confidence            543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.9e-48  Score=378.86  Aligned_cols=258  Identities=27%  Similarity=0.434  Sum_probs=212.6

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      .+.++|.+.+.||+|+||.||++.+..+|+.||||++....       ........+.+|+.+++.++||||+++++++.
T Consensus        39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  111 (371)
T 4exu_A           39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-------QSEIFAKRAYRELLLLKHMQHENVIGLLDVFT  111 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-------cchhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence            45578999999999999999999999999999999986432       23455678899999999999999999999997


Q ss_pred             cCCC----CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeec
Q 015257          195 DPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       195 ~~~~----~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                      ....    ..+++||||+.+ .+...+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       112 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Df  188 (371)
T 4exu_A          112 PASSLRNFYDFYLVMPFMQT-DLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDF  188 (371)
T ss_dssp             SCSSSTTCCCCEEEEECCCE-EHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECST
T ss_pred             ccCCcccceeEEEEEccccc-cHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEec
Confidence            6432    134999999985 4555443  34999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------
Q 015257          271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL------  344 (410)
Q Consensus       271 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------  344 (410)
                      |+++.....   .....||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.....      
T Consensus       189 g~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  265 (371)
T 4exu_A          189 GLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  265 (371)
T ss_dssp             TCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             CcccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence            999865432   34567899999999988755557789999999999999999999998887766655543100      


Q ss_pred             -------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          345 -------------------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       345 -------------------------~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                                               ..+..+++++.+||.+||+.||.+|||+.|+++||||....
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                                     01235789999999999999999999999999999998653

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-48  Score=371.43  Aligned_cols=257  Identities=25%  Similarity=0.393  Sum_probs=216.6

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+++.||+|+||.||++.+..+|+.||||++....           ....+.+|+.+++.++||||+++++++.
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~   94 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----------DLQEIIKEISIMQQCDSPHVVKYYGSYF   94 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----------CCHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----------HHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence            34568999999999999999999999999999999986431           2346889999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .  ...+++||||+++++|.+++. ....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++
T Consensus        95 ~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  172 (314)
T 3com_A           95 K--NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVA  172 (314)
T ss_dssp             E--TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             e--CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccc
Confidence            6  458999999999999888775 3567999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCCCCCC
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS---LVFPDAM  350 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~  350 (410)
                      ..............||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........+....   ...+..+
T Consensus       173 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (314)
T 3com_A          173 GQLTDTMAKRNTVIGTPFWMAPEVIQEIGY-NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW  251 (314)
T ss_dssp             EECBTTBSCBCCCCSCGGGCCHHHHSSSCB-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGS
T ss_pred             hhhhhhccccCccCCCCCccChhhcCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccC
Confidence            876554444456679999999999877665 567999999999999999999998877666555444432   2335568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      ++.+.+||.+||..||.+|||+.++++||||.+..
T Consensus       252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            99999999999999999999999999999998764

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=8.2e-49  Score=383.71  Aligned_cols=257  Identities=25%  Similarity=0.452  Sum_probs=205.3

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||++.+..+|+.||||++....       ........+.+|+.+++.++||||+++++++..
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   95 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-------QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP   95 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-------CChHHHHHHHHHHHHHHhcCCCCccceEEeecc
Confidence            4578999999999999999999999999999999986432       134556778999999999999999999999976


Q ss_pred             CC----CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          196 PN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       196 ~~----~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      ..    ...+++||||++++ +...+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  172 (371)
T 2xrw_A           96 QKSLEEFQDVYIVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  172 (371)
T ss_dssp             CCSTTTCCEEEEEEECCSEE-HHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             ccccccccceEEEEEcCCCC-HHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEee
Confidence            32    23789999999875 444443  358999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV------  345 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~------  345 (410)
                      +++..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+.+..+......      
T Consensus       173 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          173 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             C-----------------CTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred             cccccccc-cccCCceecCCccCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99865432 23345679999999999887665 66799999999999999999999998877766666542110      


Q ss_pred             ------------------------------CCC------CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          346 ------------------------------FPD------AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       346 ------------------------------~p~------~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                                                    +|.      ..++++++||.+||+.||.+|||++|+++||||...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence                                          010      015678999999999999999999999999999864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=8.1e-48  Score=373.83  Aligned_cols=259  Identities=27%  Similarity=0.436  Sum_probs=213.6

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+.+.||+|+||.||++.+..+|+.||||++....       ........+.+|+.+++.++||||+++++++.
T Consensus        21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   93 (353)
T 3coi_A           21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-------QSEIFAKRAYRELLLLKHMQHENVIGLLDVFT   93 (353)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-------cchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence            34578999999999999999999999999999999986432       13445678899999999999999999999997


Q ss_pred             cCCC----CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeec
Q 015257          195 DPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       195 ~~~~----~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                      ....    ..+++||||+++ ++...+..  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus        94 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Df  170 (353)
T 3coi_A           94 PASSLRNFYDFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDF  170 (353)
T ss_dssp             SCSSGGGCCCCEEEEECCSE-EGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECST
T ss_pred             cccccccceeEEEEeccccC-CHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeec
Confidence            6432    246999999985 56655543  5999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------
Q 015257          271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------  342 (410)
Q Consensus       271 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--------  342 (410)
                      |+++.....   .....||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+...        
T Consensus       171 g~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  247 (353)
T 3coi_A          171 GLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  247 (353)
T ss_dssp             TCTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred             ccccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999864432   345678999999999877555577899999999999999999999988776655554321        


Q ss_pred             --------------------C---CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          343 --------------------S---LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       343 --------------------~---~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                                          .   ...+..+++++.+||.+||+.||.+|||++++++||||.....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  314 (353)
T 3coi_A          248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  314 (353)
T ss_dssp             HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence                                0   0123467899999999999999999999999999999987544

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.5e-48  Score=375.84  Aligned_cols=261  Identities=22%  Similarity=0.370  Sum_probs=214.5

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+.+.||+|+||.||++.+..+|+.||||++...        ........+.+|+.+++.++||||+++++++.
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   79 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--------DKPLFALRTLREIKILKHFKHENIITIFNIQR   79 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--------ccchHHHHHHHHHHHHHhCcCCCcCCeeeeec
Confidence            4557899999999999999999999999999999998532        13445567889999999999999999999876


Q ss_pred             cC---CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          195 DP---NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       195 ~~---~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      ..   .....++||||+++ ++...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        80 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (353)
T 2b9h_A           80 PDSFENFNEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFG  157 (353)
T ss_dssp             CSCSTTCCCEEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             ccccCccceEEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecc
Confidence            53   13578999999985 55555543 469999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCcc----------ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015257          272 VSQVFEDDND----------VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN  341 (410)
Q Consensus       272 ~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~  341 (410)
                      +++.......          ......||+.|+|||++.+....+.++|||||||++|+|++|..||.+....+....+..
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  237 (353)
T 2b9h_A          158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG  237 (353)
T ss_dssp             TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence            9986543211          123457899999999887655557889999999999999999999998876655443322


Q ss_pred             C------------------------CCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          342 N------------------------SLV--------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       342 ~------------------------~~~--------~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      .                        ...        .+..+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence            0                        000        1136789999999999999999999999999999998754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.8e-49  Score=376.00  Aligned_cols=255  Identities=24%  Similarity=0.365  Sum_probs=210.3

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+.+.||+|+||.||++++..+|+.||||++.....        ......+.+|+.+++.++||||+++++++.+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   78 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--------LRPVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--------GSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--------cchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence            34689999999999999999999999999999999865422        1234567899999999999999999999987


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEE----cCCCcEEEe
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPG---AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV----APSGTVKIG  268 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~---~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll----~~~~~~kl~  268 (410)
                      .....+++||||+++++|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (319)
T 4euu_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT  158 (319)
T ss_dssp             TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred             CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEc
Confidence            66668999999999999988876543   39999999999999999999999999999999999999    777889999


Q ss_pred             eccccccccCCccccccCCCcccccccccccC-------CcCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHH
Q 015257          269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG-------LTYGGKAADTWAVGVTLYYMIIGQYPFLGET----LQDTYD  337 (410)
Q Consensus       269 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~elltG~~Pf~~~~----~~~~~~  337 (410)
                      |||+++...... ......||+.|+|||++..       ....+.++|||||||++|+|++|..||....    ..+...
T Consensus       159 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  237 (319)
T 4euu_A          159 DFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY  237 (319)
T ss_dssp             CCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred             cCCCceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence            999998765433 3345679999999998752       2233678999999999999999999996432    233444


Q ss_pred             HHHhCCC-------------------C------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCC
Q 015257          338 KIVNNSL-------------------V------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT  379 (410)
Q Consensus       338 ~i~~~~~-------------------~------~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~  379 (410)
                      .+..+..                   .      ++..+++.+.+||.+||+.||.+|||++|+++||
T Consensus       238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            4444322                   1      1123446788999999999999999999999996

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.4e-48  Score=367.89  Aligned_cols=257  Identities=23%  Similarity=0.340  Sum_probs=199.0

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|++++.||+|+||.||++++..+|+.||||++.....       .......+.++...++.++||||+++++++.+ 
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-   77 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-------SQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-   77 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-------HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-------cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-
Confidence            4689999999999999999999999999999999864321       22333445566666888999999999999986 


Q ss_pred             CCCEEEEEEeecCCCCcccc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          197 NSDHFYMVLEYVEGKWDNDG----FGQPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~----~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                       ....++||||+++ ++.+.    ......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus        78 -~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T 3fme_A           78 -EGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG  155 (290)
T ss_dssp             -SSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred             -cCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecC
Confidence             4579999999986 44333    23456899999999999999999999998 99999999999999999999999999


Q ss_pred             ccccccCCccccccCCCccccccccccc---CCcCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhC-CCCC
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCL---GLTYGGKAADTWAVGVTLYYMIIGQYPFLGE-TLQDTYDKIVNN-SLVF  346 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~elltG~~Pf~~~-~~~~~~~~i~~~-~~~~  346 (410)
                      +++...... ......||+.|+|||++.   .....+.++||||||+++|+|++|..||... ............ ....
T Consensus       156 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  234 (290)
T 3fme_A          156 ISGYLVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL  234 (290)
T ss_dssp             ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC
T ss_pred             Ccccccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc
Confidence            998654432 233456999999999862   3333477899999999999999999999863 333444444443 3333


Q ss_pred             C-CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          347 P-DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       347 p-~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      + ..+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            3 4789999999999999999999999999999999854

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.3e-48  Score=384.22  Aligned_cols=257  Identities=22%  Similarity=0.372  Sum_probs=208.9

Q ss_pred             ccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC--------CC
Q 015257          113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--------HP  184 (410)
Q Consensus       113 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------hp  184 (410)
                      +..+.++|.+++.||+|+||.||++++..+++.||||++...          ......+.+|+.+++.++        ||
T Consensus        32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~E~~~l~~l~~~~~~~~~~~  101 (397)
T 1wak_A           32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----------EHYTETALDEIRLLKSVRNSDPNDPNRE  101 (397)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----------HHHHHHHHHHHHHHHHHHHSCTTCGGGG
T ss_pred             hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----------CcchHHHHHHHHHHHHHhhcCCCCCCcc
Confidence            344567899999999999999999999999999999998532          345567889999999996        78


Q ss_pred             CcccceeEEEcC--CCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCcEEEc
Q 015257          185 NIVNLIEVIDDP--NSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVA  260 (410)
Q Consensus       185 niv~l~~~~~~~--~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIll~  260 (410)
                      ||+++++++...  ....+++||||++++++..+.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++
T Consensus       102 ~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~  181 (397)
T 1wak_A          102 MVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS  181 (397)
T ss_dssp             GBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEEC
T ss_pred             eeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEe
Confidence            899999988732  346899999999776666555443 5799999999999999999999998 999999999999999


Q ss_pred             CCC-------------------------------------------------cEEEeeccccccccCCccccccCCCccc
Q 015257          261 PSG-------------------------------------------------TVKIGDFSVSQVFEDDNDVLRRSPGTPV  291 (410)
Q Consensus       261 ~~~-------------------------------------------------~~kl~DfG~a~~~~~~~~~~~~~~gt~~  291 (410)
                      .++                                                 .+||+|||+++.....   .....||+.
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~  258 (397)
T 1wak_A          182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQ  258 (397)
T ss_dssp             CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGG
T ss_pred             ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCc
Confidence            775                                                 7999999999865432   345679999


Q ss_pred             ccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh--C---------------------
Q 015257          292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL------QDTYDKIVN--N---------------------  342 (410)
Q Consensus       292 y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~------~~~~~~i~~--~---------------------  342 (410)
                      |+|||++.+..+ +.++|||||||++|+|++|..||.+...      .+....+..  +                     
T Consensus       259 y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  337 (397)
T 1wak_A          259 YRSLEVLIGSGY-NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG  337 (397)
T ss_dssp             GCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred             ccCChhhcCCCC-CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence            999999987765 6679999999999999999999976441      222222211  0                     


Q ss_pred             -------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          343 -------------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       343 -------------------~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                                         ...++...++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                               01122233567899999999999999999999999999974

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.5e-48  Score=377.85  Aligned_cols=261  Identities=25%  Similarity=0.317  Sum_probs=205.0

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+.+.||+|+||.||++++..+|+.||||++.....          ......+|+..++.++||||+++++++.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~l~~l~h~niv~~~~~~~   89 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----------FRNRELQIMQDLAVLHHPNIVQLQSYFY   89 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT----------CCCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc----------ccHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence            345789999999999999999999999999999998854321          1124567888889999999999999986


Q ss_pred             cCC-----CCEEEEEEeecCCCCcc---cccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcEeccCCCCcEEEcC-CC
Q 015257          195 DPN-----SDHFYMVLEYVEGKWDN---DGFGQPGAIGESMARKYLRDIVSGLMYLH--GHNVVHGDIKPDNLLVAP-SG  263 (410)
Q Consensus       195 ~~~-----~~~~~lv~e~~~~~~l~---~~~~~~~~l~~~~~~~i~~qi~~gL~yLH--~~~iiHrDlkp~NIll~~-~~  263 (410)
                      ...     ...+++||||++++++.   ........+++..++.++.||+.||.|||  ++||+||||||+|||++. ++
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           90 TLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             EECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT
T ss_pred             ccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC
Confidence            522     23488999999987433   33456678999999999999999999999  999999999999999997 89


Q ss_pred             cEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Q 015257          264 TVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS  343 (410)
Q Consensus       264 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~  343 (410)
                      .+||+|||+++...... ......||+.|+|||++.+....+.++|||||||++|+|++|..||.+.........+....
T Consensus       170 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  248 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL  248 (360)
T ss_dssp             EEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             cEEEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence            99999999998765432 33456789999999998776655788999999999999999999999988777666554310


Q ss_pred             --------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          344 --------------------------------LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       344 --------------------------------~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                                                      ...+...++++.+||.+||+.||.+|||+.|+++||||++...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence                                            0111235788999999999999999999999999999987643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.2e-48  Score=366.78  Aligned_cols=258  Identities=29%  Similarity=0.572  Sum_probs=222.8

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      .+.++|.+++.||+|+||.||++++..+++.||||++.....       .......+.+|+.+++.++||||+++++++.
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-------KNKDTSTILREVELLKKLDHPNIMKLFEILE   91 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-------SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence            345689999999999999999999999999999999875432       1223467889999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC---CcEEEeecc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS---GTVKIGDFS  271 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~---~~~kl~DfG  271 (410)
                      +  ...+++||||++++++.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||
T Consensus        92 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg  169 (287)
T 2wei_A           92 D--SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG  169 (287)
T ss_dssp             C--SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred             C--CCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccC
Confidence            6  46899999999999988877666789999999999999999999999999999999999999764   469999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----  347 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----  347 (410)
                      ++....... ......||+.|+|||++.+.  .+.++||||||+++|+|++|..||.+....+....+..+...++    
T Consensus       170 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (287)
T 2wei_A          170 LSTCFQQNT-KMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW  246 (287)
T ss_dssp             GGGTBCCCS-SCSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG
T ss_pred             cceeecCCC-ccccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhh
Confidence            998654432 22334589999999988764  36789999999999999999999999888888888877765443    


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      ..+++++.+||.+||..||.+|||+.++++||||++.
T Consensus       247 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             hhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            4689999999999999999999999999999999754

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.9e-49  Score=371.43  Aligned_cols=261  Identities=25%  Similarity=0.393  Sum_probs=195.8

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+.+.||+|+||.||++.+..+++.||||++....        .......+.+|+.+++.++||||+++++++.
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   83 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--------CQTSMDELLKEIQAMSQCHHPNIVSYYTSFV   83 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------------CCCCCCCTTBCCEEEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh--------cchhHHHHHHHHHHHhhcCCCCEeeEEEEEe
Confidence            34568999999999999999999999899999999886432        1234457889999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEE
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFG--------QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVK  266 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~k  266 (410)
                      .  ....++||||+++++|.+++.        ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        84 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k  161 (303)
T 2vwi_A           84 V--KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ  161 (303)
T ss_dssp             S--SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEE
T ss_pred             e--cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEE
Confidence            7  357999999999998887764        245699999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCc-----cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015257          267 IGDFSVSQVFEDDN-----DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN  341 (410)
Q Consensus       267 l~DfG~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~  341 (410)
                      |+|||++.......     .......||+.|+|||++.+....+.++||||||+++|+|++|..||..............
T Consensus       162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  241 (303)
T 2vwi_A          162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ  241 (303)
T ss_dssp             ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT
T ss_pred             EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc
Confidence            99999987654321     1223456999999999886544346789999999999999999999988766555444443


Q ss_pred             CCC----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          342 NSL----------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       342 ~~~----------~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      ...          ..+..+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence            321          12246789999999999999999999999999999998754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.2e-47  Score=375.32  Aligned_cols=252  Identities=20%  Similarity=0.381  Sum_probs=215.4

Q ss_pred             cccceeeeeeecccCceEEEEEEEc-------cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSS-------LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIV  187 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv  187 (410)
                      ..++|.+.+.||+|+||.||++++.       .++..||||++....        .......+.+|+.+++.+ +||||+
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~hpnIv  150 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--------TEKDLSDLVSEMEMMKMIGKHKNII  150 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--------BHHHHHHHHHHHHHHHHSCCCTTBC
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--------CHHHHHHHHHHHHHHHHhcCCCCEe
Confidence            4578999999999999999999875       245679999986431        345567899999999999 899999


Q ss_pred             cceeEEEcCCCCEEEEEEeecCCCCcccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecc
Q 015257          188 NLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGD  251 (410)
Q Consensus       188 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD  251 (410)
                      ++++++.+  ...+|+||||+++++|.+++...                ..+++..++.++.||+.||.|||++||+|||
T Consensus       151 ~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD  228 (370)
T 2psq_A          151 NLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD  228 (370)
T ss_dssp             CEEEEECS--SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             eEEEEEcc--CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence            99999976  45799999999999988876543                3589999999999999999999999999999


Q ss_pred             CCCCcEEEcCCCcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 015257          252 IKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFL  328 (410)
Q Consensus       252 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~  328 (410)
                      |||+|||++.++.+||+|||+++.......  ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.
T Consensus       229 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~  307 (370)
T 2psq_A          229 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYP  307 (370)
T ss_dssp             CCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            999999999999999999999986544322  2234457889999999877665 678999999999999999 999999


Q ss_pred             CCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          329 GETLQDTYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       329 ~~~~~~~~~~i~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +....+....+..+. ...|..+++++.+||.+||+.||.+|||+.|++++
T Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          308 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             TCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            888777776666654 45677899999999999999999999999999975

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.7e-50  Score=394.06  Aligned_cols=255  Identities=15%  Similarity=0.163  Sum_probs=202.0

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHH---HHHHhCCCCCcccce---
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREV---LIMKMLQHPNIVNLI---  190 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~hpniv~l~---  190 (410)
                      .++|.+.+.||+|+||.||++++..+|+.||||++.....      ......+.+.+|+   .+++.++|||||+++   
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~  145 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER------PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF  145 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-------CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccc------cchHHHHHHHHHHHHHHhccccCCHHHHHHHhhh
Confidence            4689999999999999999999999999999999875421      1234567899999   555566899999998   


Q ss_pred             ----eEEEcCCC----------C-----EEEEEEeecCCCCcccccCCCCCCC-------HHHHHHHHHHHHHHHHHHHh
Q 015257          191 ----EVIDDPNS----------D-----HFYMVLEYVEGKWDNDGFGQPGAIG-------ESMARKYLRDIVSGLMYLHG  244 (410)
Q Consensus       191 ----~~~~~~~~----------~-----~~~lv~e~~~~~~l~~~~~~~~~l~-------~~~~~~i~~qi~~gL~yLH~  244 (410)
                          +++.+++.          .     ..||||||++ ++|.+++...+.++       +..++.++.||+.||+|||+
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  224 (377)
T 3byv_A          146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH  224 (377)
T ss_dssp             CCCSEEEECTTSCSEEEC------CEEESEEEEEECCS-EEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhccCCccccccccCCCceEEEEEEEEEeccC-CCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence                66665321          0     3789999995 67877776544444       48888999999999999999


Q ss_pred             CCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccccccCCCcccccccccccCC----------cCCCchhhHHHHH
Q 015257          245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL----------TYGGKAADTWAVG  314 (410)
Q Consensus       245 ~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwSlG  314 (410)
                      +||+||||||+|||++.++.+||+|||+++....   ......| +.|+|||++.+.          ..++.++||||||
T Consensus       225 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          225 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             TTEECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             CCeecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            9999999999999999999999999999986332   3345678 999999998776          1337789999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          315 VTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       315 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      |++|+|++|..||.+.........+.    ..+..+++++.+||.+||+.||.+|||+.++++||||++...
T Consensus       301 ~il~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  368 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT  368 (377)
T ss_dssp             HHHHHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred             HHHHHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence            99999999999997654333222222    234678999999999999999999999999999999976443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.5e-48  Score=363.49  Aligned_cols=258  Identities=27%  Similarity=0.370  Sum_probs=211.5

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.....||+|+||.||++.+..+++.||||++....         ......+.+|+.+++.++||||+++++++.+ 
T Consensus        21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-   90 (295)
T 2clq_A           21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---------SRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-   90 (295)
T ss_dssp             BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---------C---HHHHHHHHHHHTCCCTTBCCEEEEEEE-
T ss_pred             ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---------hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-
Confidence            345666679999999999999999999999999986431         2344678999999999999999999999986 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC-CCcEEEeeccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQP---GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-SGTVKIGDFSV  272 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~---~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~-~~~~kl~DfG~  272 (410)
                       .+..++||||+++++|.+++...   ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus        91 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~  169 (295)
T 2clq_A           91 -NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGT  169 (295)
T ss_dssp             -TTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred             -CCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccc
Confidence             45899999999999888876543   35679999999999999999999999999999999999987 89999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCc-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-H-H-HHHHhCCCCCCC
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLT-YGGKAADTWAVGVTLYYMIIGQYPFLGETLQD-T-Y-DKIVNNSLVFPD  348 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~-~-~~i~~~~~~~p~  348 (410)
                      +..............||+.|+|||++.+.. ..+.++||||||+++|+|++|..||....... . . .........+|.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (295)
T 2clq_A          170 SKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE  249 (295)
T ss_dssp             CEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCT
T ss_pred             ccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccc
Confidence            987655444445667999999999886543 23678999999999999999999997643222 1 1 122233456778


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      .+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus       250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          250 SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence            8999999999999999999999999999999998654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=368.01  Aligned_cols=253  Identities=27%  Similarity=0.372  Sum_probs=215.1

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCc---eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCccccee
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGK---HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE  191 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  191 (410)
                      ...++|.+.+.||+|+||.||++.+..+++   .||||++...        ........+.+|+.+++.++||||+++++
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~  117 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--------YTERQRRDFLSEASIMGQFDHPNIIRLEG  117 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT--------CCHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC--------CCHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            345689999999999999999999986555   4999998643        13455678999999999999999999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeec
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                      ++.+  ...+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       118 ~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df  195 (325)
T 3kul_A          118 VVTR--GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDF  195 (325)
T ss_dssp             EECG--GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEe--CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCC
Confidence            9976  4578999999999999988754 467999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCcc---ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCC
Q 015257          271 SVSQVFEDDND---VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLV  345 (410)
Q Consensus       271 G~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~  345 (410)
                      |+++.......   ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+..+ ...
T Consensus       196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~  274 (325)
T 3kul_A          196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP  274 (325)
T ss_dssp             SSCEECC----CCEECC---CCGGGSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred             CcccccccCccceeeccCCCCcccccCHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC
Confidence            99987654322   2223346788999999876665 678999999999999999 99999998888887777665 345


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       346 ~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .|..+++.+.+||.+||..||.+|||+.++++.
T Consensus       275 ~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          275 APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            677899999999999999999999999999863

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=6e-48  Score=371.03  Aligned_cols=257  Identities=24%  Similarity=0.402  Sum_probs=210.8

Q ss_pred             ccccccceeeeeeecccCceEEEEEEE-ccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCC------
Q 015257          113 GTKMINEYVHVRKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN------  185 (410)
Q Consensus       113 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------  185 (410)
                      +..+.++|.+++.||+|+||.||++.+ ..+++.||||++..          .......+.+|+.+++.++|++      
T Consensus         9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----------~~~~~~~~~~e~~~l~~l~~~~~~~~~~   78 (339)
T 1z57_A            9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN----------VDRYCEAARSEIQVLEHLNTTDPNSTFR   78 (339)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----------SHHHHHHHHHHHHHHHHHHHHCTTCTTC
T ss_pred             CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec----------CCchhHHHHHHHHHHHHhhhcCCCCcee
Confidence            455667999999999999999999998 55889999999853          2345567889999999997665      


Q ss_pred             cccceeEEEcCCCCEEEEEEeecCCCCcccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC--
Q 015257          186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP--  261 (410)
Q Consensus       186 iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~--  261 (410)
                      |+++++++.+  .+.+++||||+ ++++.+.+...+  .+++..++.++.||+.||+|||++||+||||||+|||++.  
T Consensus        79 i~~~~~~~~~--~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~  155 (339)
T 1z57_A           79 CVQMLEWFEH--HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSD  155 (339)
T ss_dssp             BCCEEEEEEE--TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCC
T ss_pred             eEeeeccccc--CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccc
Confidence            8999999986  45899999999 666666665443  6899999999999999999999999999999999999987  


Q ss_pred             -----------------CCcEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCC
Q 015257          262 -----------------SGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQ  324 (410)
Q Consensus       262 -----------------~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~  324 (410)
                                       ++.+||+|||+++.....   .....||+.|+|||++.+..+ +.++|||||||++|+|++|.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~  231 (339)
T 1z57_A          156 YTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGF  231 (339)
T ss_dssp             EEEEEC----CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSS
T ss_pred             cccccCCccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCC-CcchhhHHHHHHHHHHHhCC
Confidence                             668999999999864332   345679999999999887665 67799999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhCCCCC--------------------------------------------CCCCCHHHHHHHHH
Q 015257          325 YPFLGETLQDTYDKIVNNSLVF--------------------------------------------PDAMNPELRNLLEG  360 (410)
Q Consensus       325 ~Pf~~~~~~~~~~~i~~~~~~~--------------------------------------------p~~~~~~l~~li~~  360 (410)
                      .||...+..+....+......+                                            +...++++.+||.+
T Consensus       232 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  311 (339)
T 1z57_A          232 TVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQK  311 (339)
T ss_dssp             CSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHH
Confidence            9998877665443332211111                                            11235678999999


Q ss_pred             hcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          361 LLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       361 ~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      ||+.||.+|||+.|+++||||+....
T Consensus       312 ~L~~dP~~Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          312 MLEYDPAKRITLREALKHPFFDLLKK  337 (339)
T ss_dssp             HTCSSTTTSCCHHHHTTSGGGGGGGC
T ss_pred             HhCcCcccccCHHHHhcCHHHHHHhc
Confidence            99999999999999999999986443

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.9e-47  Score=356.88  Aligned_cols=248  Identities=22%  Similarity=0.364  Sum_probs=214.9

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+++.||+|+||.||++.+. +++.||||++.....          ..+.+.+|+.++++++||||+++++++.+ 
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   76 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----------SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-   76 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----------CHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----------CHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            368999999999999999999987 577899999865321          22568899999999999999999999976 


Q ss_pred             CCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                       ....++||||++++++.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        77 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  155 (269)
T 4hcu_A           77 -QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF  155 (269)
T ss_dssp             -SSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred             -CCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccc
Confidence             4579999999999999988754 45699999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCc-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCCH
Q 015257          276 FEDDN-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMNP  352 (410)
Q Consensus       276 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~  352 (410)
                      ..... .......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||......+....+.... ...|..+++
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T 4hcu_A          156 VLDDQYTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST  234 (269)
T ss_dssp             BCCHHHHSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred             ccccccccccCcccccccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCH
Confidence            54432 22334557888999999876655 678999999999999999 999999988888887777663 456678899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .+.+|+.+||+.||.+|||+.++++|
T Consensus       235 ~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          235 HVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHH
Confidence            99999999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7.9e-48  Score=364.39  Aligned_cols=256  Identities=24%  Similarity=0.440  Sum_probs=207.7

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      +.++|.+++.||+|+||.||++++..+|+.||||++...          ......+.+|+.+++.++||||+++++++.+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   73 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----------EEKLSTILSEVMLLASLNHQYVVRYYAAWLE   73 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----------HHHHHHHHHHHHHHHhcCchHHHHHHHHHHh
Confidence            446899999999999999999999999999999998532          3455688999999999999999999998865


Q ss_pred             C-----------CCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC
Q 015257          196 P-----------NSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG  263 (410)
Q Consensus       196 ~-----------~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~  263 (410)
                      .           ....+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus        74 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~  153 (303)
T 1zy4_A           74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR  153 (303)
T ss_dssp             CCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS
T ss_pred             hcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC
Confidence            2           23578999999999999888764 34688999999999999999999999999999999999999999


Q ss_pred             cEEEeeccccccccCC--------------ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015257          264 TVKIGDFSVSQVFEDD--------------NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG  329 (410)
Q Consensus       264 ~~kl~DfG~a~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~  329 (410)
                      .+||+|||++......              ........||+.|+|||++.+....+.++|||||||++|+|++   ||..
T Consensus       154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~  230 (303)
T 1zy4_A          154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST  230 (303)
T ss_dssp             CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence            9999999999765422              1223455689999999998766445778999999999999998   5543


Q ss_pred             C-CHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          330 E-TLQDTYDKIVNNSLVFP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       330 ~-~~~~~~~~i~~~~~~~p----~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      . ........+......+|    ...++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          231 GMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             chhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            2 23334455555444444    4567789999999999999999999999999999754

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.6e-48  Score=375.87  Aligned_cols=253  Identities=19%  Similarity=0.355  Sum_probs=211.8

Q ss_pred             cccceeeeeeecccCceEEEEEE-----EccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYR-----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNL  189 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  189 (410)
                      ..++|.+.+.||+|+||.||+++     ...+++.||||++....        .......+.+|+.+++.+ +||||+++
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--------THSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--------CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            45789999999999999999999     55577899999986431        344557899999999999 79999999


Q ss_pred             eeEEEcCCCCEEEEEEeecCCCCcccccCCCCC-----------------------------------------------
Q 015257          190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA-----------------------------------------------  222 (410)
Q Consensus       190 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-----------------------------------------------  222 (410)
                      ++++.+. ...+++||||+++++|.+++.....                                               
T Consensus        92 ~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           92 LGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEECST-TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeecC-CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            9999864 3468999999999988877654322                                               


Q ss_pred             -------------------CCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCc--c
Q 015257          223 -------------------IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--D  281 (410)
Q Consensus       223 -------------------l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~  281 (410)
                                         +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......  .
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  250 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV  250 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence                               8999999999999999999999999999999999999999999999999998654322  2


Q ss_pred             ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH-HHhC-CCCCCCCCCHHHHHHH
Q 015257          282 VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDK-IVNN-SLVFPDAMNPELRNLL  358 (410)
Q Consensus       282 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~-i~~~-~~~~p~~~~~~l~~li  358 (410)
                      ......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+......... +..+ ....|..+++++.+||
T Consensus       251 ~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  329 (359)
T 3vhe_A          251 RKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM  329 (359)
T ss_dssp             EC--CEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred             hccccCCCceeEChhhhcCCCC-CchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            3344568999999998876655 678999999999999998 9999988765444333 3332 3457788999999999


Q ss_pred             HHhcccCCCCCCCHHHHhhC
Q 015257          359 EGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       359 ~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .+||+.||.+|||+.++++|
T Consensus       330 ~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          330 LDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhhCCCHHHHHHH
Confidence            99999999999999999987

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.8e-48  Score=372.26  Aligned_cols=261  Identities=26%  Similarity=0.457  Sum_probs=221.2

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC--CCCccccee
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--HPNIVNLIE  191 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~  191 (410)
                      ....++|.+.+.||+|+||.||++++..+++.||||++..........   ......+.+|+.+++.+.  ||||+++++
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE---LPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEE---CTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhh---hhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            445678999999999999999999999999999999997654321100   011234668999999996  599999999


Q ss_pred             EEEcCCCCEEEEEEeecCC-CCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEc-CCCcEEEee
Q 015257          192 VIDDPNSDHFYMVLEYVEG-KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA-PSGTVKIGD  269 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~-~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~-~~~~~kl~D  269 (410)
                      ++.+  ...+++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus       116 ~~~~--~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          116 WFER--PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             EEEC--SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             EEec--CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence            9986  4689999999976 78888877777899999999999999999999999999999999999999 679999999


Q ss_pred             ccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC
Q 015257          270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA  349 (410)
Q Consensus       270 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~  349 (410)
                      ||+++.....  ......||+.|+|||++.+....+.++||||||+++|+|++|..||...      ..+......++..
T Consensus       194 fg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~------~~~~~~~~~~~~~  265 (320)
T 3a99_A          194 FGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQR  265 (320)
T ss_dssp             CTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSC
T ss_pred             Cccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh------hhhhccccccccc
Confidence            9999876543  3345679999999999877666577899999999999999999999653      2345566677889


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                      +++++.+||.+||+.||.+|||++++++||||++...+
T Consensus       266 ~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~  303 (320)
T 3a99_A          266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP  303 (320)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence            99999999999999999999999999999999887543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-48  Score=371.52  Aligned_cols=266  Identities=25%  Similarity=0.449  Sum_probs=211.6

Q ss_pred             ccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC----CCCCccc
Q 015257          113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML----QHPNIVN  188 (410)
Q Consensus       113 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~hpniv~  188 (410)
                      ...+.++|.+.+.||+|+||.||++++..+++.||||++........   ........+.+|+.+++.+    +||||++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~  102 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGW---SPLSDSVTCPLEVALLWKVGAGGGHPGVIR  102 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC-----------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEeccccccc---ccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence            34566789999999999999999999999999999999865432110   0111223466899999998    8999999


Q ss_pred             ceeEEEcCCCCEEEEEEee-cCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEc-CCCcEE
Q 015257          189 LIEVIDDPNSDHFYMVLEY-VEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA-PSGTVK  266 (410)
Q Consensus       189 l~~~~~~~~~~~~~lv~e~-~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~-~~~~~k  266 (410)
                      +++++.+  ....++|||+ +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus       103 ~~~~~~~--~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          103 LLDWFET--QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EEEEC-------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEE
T ss_pred             EEEEEec--CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEE
Confidence            9999876  4578999999 78889988887777899999999999999999999999999999999999999 789999


Q ss_pred             EeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Q 015257          267 IGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF  346 (410)
Q Consensus       267 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~  346 (410)
                      |+|||++......  ......||+.|+|||++.+....+.++||||||+++|+|++|..||...      ..+......+
T Consensus       181 l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~  252 (312)
T 2iwi_A          181 LIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHF  252 (312)
T ss_dssp             ECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHTCCCC
T ss_pred             EEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhhccCC
Confidence            9999999876543  2345679999999999877666566899999999999999999999653      2345566778


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCchh
Q 015257          347 PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQY  391 (410)
Q Consensus       347 p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~  391 (410)
                      +..+++.+.+||.+||+.||.+|||++|+++||||+...+..|..
T Consensus       253 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~~~~  297 (312)
T 2iwi_A          253 PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN  297 (312)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--------
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhccccc
Confidence            889999999999999999999999999999999999876655543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.4e-47  Score=363.90  Aligned_cols=262  Identities=26%  Similarity=0.413  Sum_probs=213.5

Q ss_pred             ccccceeeeeeecccCceEEEEEEEc-cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC---CCCCcccce
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSS-LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML---QHPNIVNLI  190 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~  190 (410)
                      ...++|.+++.||+|+||.||++++. .+|+.||||++.......       .....+.+|+.+++.+   +||||++++
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~h~~i~~~~   80 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-------GMPLSTIREVAVLRHLETFEHPNVVRLF   80 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-------SCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-------cCCchhhHHHHHHHhhhccCCCCeEeee
Confidence            34578999999999999999999995 678999999987543211       1112355677776665   899999999


Q ss_pred             eEEEc---CCCCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcE
Q 015257          191 EVIDD---PNSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTV  265 (410)
Q Consensus       191 ~~~~~---~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~  265 (410)
                      +++..   .....+++||||+++ ++.+.+..  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~  159 (326)
T 1blx_A           81 DVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI  159 (326)
T ss_dssp             EEEEEEECSSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred             eeeeecccCCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCE
Confidence            99862   134679999999996 56665543  2359999999999999999999999999999999999999999999


Q ss_pred             EEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--
Q 015257          266 KIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--  343 (410)
Q Consensus       266 kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--  343 (410)
                      ||+|||+++..... .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+....+....+....  
T Consensus       160 kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (326)
T 1blx_A          160 KLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  237 (326)
T ss_dssp             EECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EEecCcccccccCC-CCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence            99999999865433 23445678999999999877665 677999999999999999999999988777666665310  


Q ss_pred             -------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          344 -------------------------LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       344 -------------------------~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                                               ..++..+++.+.+||.+||+.||.+|||+.++++||||++...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence                                     0123468899999999999999999999999999999987644

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.2e-47  Score=367.81  Aligned_cols=266  Identities=22%  Similarity=0.343  Sum_probs=200.7

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCc---eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGK---HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      ..++|.+.+.||+|+||.||++++..++.   .||||++.....       .....+.+.+|+.+++.++||||++++++
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   93 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-------ASSDIEEFLREAACMKEFDHPHVAKLVGV   93 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-------CHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence            34689999999999999999999887665   899999865421       23456789999999999999999999999


Q ss_pred             EEcCCCC----EEEEEEeecCCCCcccccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC
Q 015257          193 IDDPNSD----HFYMVLEYVEGKWDNDGFGQ------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS  262 (410)
Q Consensus       193 ~~~~~~~----~~~lv~e~~~~~~l~~~~~~------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~  262 (410)
                      +......    ..++||||+.+++|.+++..      ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus        94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED  173 (323)
T ss_dssp             EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred             eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC
Confidence            9864321    24999999999998877643      2269999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 015257          263 GTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKI  339 (410)
Q Consensus       263 ~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i  339 (410)
                      +.+||+|||+++.......  ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~  252 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL  252 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence            9999999999986543321  2223456888999998877655 678999999999999999 99999998887777777


Q ss_pred             HhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCC-------HHHHhhCCcccCC-CCCCc
Q 015257          340 VNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLT-------LNDVAKHTWVLGD-NGPIP  389 (410)
Q Consensus       340 ~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt-------~~ell~h~~~~~~-~~~~~  389 (410)
                      .... ...+..+++++.+||.+||+.||.+|||       +++++.|||+... ..|+.
T Consensus       253 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~  311 (323)
T 3qup_A          253 IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLY  311 (323)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------------
T ss_pred             hcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCC
Confidence            6654 4677889999999999999999999999       8999999999876 33444

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.5e-48  Score=376.40  Aligned_cols=258  Identities=21%  Similarity=0.281  Sum_probs=217.0

Q ss_pred             ccccceeeeeeecccCceEEEEEE-----EccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccc
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYR-----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNL  189 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  189 (410)
                      ...++|.+++.||+|+||.||+++     +..+++.||||++...        ........+.+|+.+++.++|||||++
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~~E~~~l~~l~hpnIv~~  139 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--------CSEQDELDFLMEALIISKFNHQNIVRC  139 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--------CCHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--------cChhhHHHHHHHHHHHHhCCCCCCCeE
Confidence            345789999999999999999999     4457889999998532        134455678899999999999999999


Q ss_pred             eeEEEcCCCCEEEEEEeecCCCCcccccCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC
Q 015257          190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP-------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS  262 (410)
Q Consensus       190 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~  262 (410)
                      ++++.+  ....++||||+++++|.+++...       ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus       140 ~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~  217 (367)
T 3l9p_A          140 IGVSLQ--SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCP  217 (367)
T ss_dssp             EEEECS--SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS
T ss_pred             EEEEec--CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecC
Confidence            999976  45679999999999888776432       468999999999999999999999999999999999999965


Q ss_pred             C---cEEEeeccccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 015257          263 G---TVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTY  336 (410)
Q Consensus       263 ~---~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~  336 (410)
                      |   .+||+|||+++......  .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||......+..
T Consensus       218 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~  296 (367)
T 3l9p_A          218 GPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL  296 (367)
T ss_dssp             STTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             CCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            5   59999999997543221  22234557999999998876655 678999999999999998 99999998888888


Q ss_pred             HHHHhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          337 DKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       337 ~~i~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                      ..+..+. ...+..+++.+.+||.+||+.||.+|||+.+|+++.|+..
T Consensus       297 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          297 EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            7777654 4567789999999999999999999999999999988754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=365.15  Aligned_cols=247  Identities=21%  Similarity=0.369  Sum_probs=208.2

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+.+.||+|+||.||++.+..+++.||+|++...         .......+.+|+.+++.++||||+++++++.+ 
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-   78 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---------DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-   78 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---------CHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-
Confidence            46899999999999999999999999999999987432         35566789999999999999999999999987 


Q ss_pred             CCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                       ....++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        79 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  157 (310)
T 3s95_A           79 -DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARL  157 (310)
T ss_dssp             -TTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred             -CCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeeccccee
Confidence             4689999999999999988765 56799999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCccc--------------cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HH
Q 015257          276 FEDDNDV--------------LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQD-----TY  336 (410)
Q Consensus       276 ~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-----~~  336 (410)
                      .......              .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......     ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~  236 (310)
T 3s95_A          158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV  236 (310)
T ss_dssp             CC--------------------CCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH
T ss_pred             cccccccccccccccccccccccccCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh
Confidence            5433221              115679999999999887665 677999999999999999999986532111     11


Q ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          337 DKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       337 ~~i~~~~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      .....  ...|..+++.+.+||.+||+.||.+|||+.++++
T Consensus       237 ~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          237 RGFLD--RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             HHHHH--HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcccc--ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            11111  1246788999999999999999999999999987

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.9e-49  Score=386.77  Aligned_cols=260  Identities=17%  Similarity=0.190  Sum_probs=193.0

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC--CCCCcccce----
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML--QHPNIVNLI----  190 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~----  190 (410)
                      ...|.+.+.||+|+||.||++++..+|+.||||++.....      ......+.+.+|+.+++.+  +||||++++    
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~  134 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE------NSRSELERLHEATFAAARLLGESPEEARDRRRLL  134 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST------THHHHHHHHHHHHHHHHHHHC----------CBC
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc------ccccHHHHHHHHHHHHHHhcccChhhhhhceeEE
Confidence            3459999999999999999999999999999999876432      1234556788886555444  699988755    


Q ss_pred             ---eEEEcCCC---------------CEEEEEEeecCCCCcccccCCC-CCCCHHHH------HHHHHHHHHHHHHHHhC
Q 015257          191 ---EVIDDPNS---------------DHFYMVLEYVEGKWDNDGFGQP-GAIGESMA------RKYLRDIVSGLMYLHGH  245 (410)
Q Consensus       191 ---~~~~~~~~---------------~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~------~~i~~qi~~gL~yLH~~  245 (410)
                         +++..+..               ..++|||||++ ++|.+++... ..+++..+      ..++.||+.||+|||++
T Consensus       135 ~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~  213 (371)
T 3q60_A          135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK  213 (371)
T ss_dssp             CCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             eeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC
Confidence               45543221               45899999999 6777776542 23444444      56779999999999999


Q ss_pred             CcEeccCCCCcEEEcCCCcEEEeeccccccccCCccccccCCCcccccccccccCC-cCCCchhhHHHHHHHHHHHHhCC
Q 015257          246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL-TYGGKAADTWAVGVTLYYMIIGQ  324 (410)
Q Consensus       246 ~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~elltG~  324 (410)
                      ||+||||||+|||++.++.+||+|||+|+......   ....+|+.|+|||++.+. ..++.++|||||||++|+|++|.
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999998654322   134567999999998762 23378899999999999999999


Q ss_pred             CCCCCCCHHH--HHHH-----HHhCCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          325 YPFLGETLQD--TYDK-----IVNNSLVFP--DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       325 ~Pf~~~~~~~--~~~~-----i~~~~~~~p--~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                      .||.+.....  .+..     .......++  ..+++.+.+||.+||+.||.+|||+.++++||||++...
T Consensus       291 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  361 (371)
T 3q60_A          291 LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN  361 (371)
T ss_dssp             CSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred             CCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence            9997763221  0000     001122233  478999999999999999999999999999999976443

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.4e-47  Score=369.36  Aligned_cols=256  Identities=20%  Similarity=0.327  Sum_probs=209.7

Q ss_pred             ccccccceeeeeeecccCceEEEEEEEccCC-ceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCC------
Q 015257          113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDG-KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN------  185 (410)
Q Consensus       113 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------  185 (410)
                      +..+.++|.+++.||+|+||.||++.+..++ +.||||++...          ......+.+|+.+++.++|++      
T Consensus        14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~E~~~l~~l~~~~~~~~~~   83 (355)
T 2eu9_A           14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----------GKYREAARLEINVLKKIKEKDKENKFL   83 (355)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----------HHHHHHHHHHHHHHHHHHHHCTTSCSC
T ss_pred             CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----------ccchhHHHHHHHHHHHHhhcCCCCcee
Confidence            4556689999999999999999999998776 78999998532          344567889999999998766      


Q ss_pred             cccceeEEEcCCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEE-----
Q 015257          186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV-----  259 (410)
Q Consensus       186 iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll-----  259 (410)
                      ++.+++++..  ...+++||||++++++..+.... ..+++..++.++.||+.||.|||++||+||||||+|||+     
T Consensus        84 ~~~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~  161 (355)
T 2eu9_A           84 CVLMSDWFNF--HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEF  161 (355)
T ss_dssp             BCCEEEEEEE--TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCE
T ss_pred             EEEeeeeeee--CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccc
Confidence            8888898876  45899999999766555444333 479999999999999999999999999999999999999     


Q ss_pred             --------------cCCCcEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCC
Q 015257          260 --------------APSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQY  325 (410)
Q Consensus       260 --------------~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~  325 (410)
                                    +.++.+||+|||+++.....   .....||+.|+|||++.+..+ +.++|||||||++|+|++|..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~  237 (355)
T 2eu9_A          162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFT  237 (355)
T ss_dssp             EEEECCC-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSC
T ss_pred             cccccccccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCC-CCccchHHHHHHHHHHHhCCC
Confidence                          56789999999999864332   345679999999999887665 677999999999999999999


Q ss_pred             CCCCCCHHHHHHHHHhCCCCCC--------------------------------------------CCCCHHHHHHHHHh
Q 015257          326 PFLGETLQDTYDKIVNNSLVFP--------------------------------------------DAMNPELRNLLEGL  361 (410)
Q Consensus       326 Pf~~~~~~~~~~~i~~~~~~~p--------------------------------------------~~~~~~l~~li~~~  361 (410)
                      ||......+....+......+|                                            ...++++.+||.+|
T Consensus       238 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  317 (355)
T 2eu9_A          238 LFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRM  317 (355)
T ss_dssp             SCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHH
Confidence            9998776654443322111111                                            11245788999999


Q ss_pred             cccCCCCCCCHHHHhhCCcccCC
Q 015257          362 LCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       362 L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      |+.||.+|||+.|+++||||.+.
T Consensus       318 L~~dP~~Rpt~~e~l~hp~f~~~  340 (355)
T 2eu9_A          318 LEFDPAQRITLAEALLHPFFAGL  340 (355)
T ss_dssp             TCSSTTTSCCHHHHTTSGGGGGC
T ss_pred             hcCChhhCcCHHHHhcChhhcCC
Confidence            99999999999999999999865

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.2e-47  Score=374.92  Aligned_cols=257  Identities=25%  Similarity=0.422  Sum_probs=210.2

Q ss_pred             cccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CC-----C
Q 015257          112 NGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HP-----N  185 (410)
Q Consensus       112 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----n  185 (410)
                      .+..+.++|.+.+.||+|+||.||++++..+++.||||++..          .......+.+|+.+++.+. |+     +
T Consensus        48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~~~~~e~~~l~~l~~~~~~~~~~  117 (382)
T 2vx3_A           48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN----------KKAFLNQAQIEVRLLELMNKHDTEMKYY  117 (382)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS----------SHHHHHHHHHHHHHHHHHHHCSSGGGGG
T ss_pred             cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec----------cHHHHHHHHHHHHHHHHHHhccccccee
Confidence            355677899999999999999999999999999999999853          2344567888999998885 55     4


Q ss_pred             cccceeEEEcCCCCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCcEeccCCCCcEEEc-
Q 015257          186 IVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLH--GHNVVHGDIKPDNLLVA-  260 (410)
Q Consensus       186 iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH--~~~iiHrDlkp~NIll~-  260 (410)
                      |+++++++..  ...+++||||+++ +|.+.+...  ..+++..++.++.||+.||.|||  +.||+||||||+|||++ 
T Consensus       118 iv~~~~~~~~--~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~  194 (382)
T 2vx3_A          118 IVHLKRHFMF--RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN  194 (382)
T ss_dssp             BCCEEEEEEE--TTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS
T ss_pred             EEEeeeeecc--CCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec
Confidence            8999999886  4689999999986 566555433  46999999999999999999999  57999999999999995 


Q ss_pred             -CCCcEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015257          261 -PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKI  339 (410)
Q Consensus       261 -~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i  339 (410)
                       .++.+||+|||+++.....   .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+
T Consensus       195 ~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i  270 (382)
T 2vx3_A          195 PKRSAIKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI  270 (382)
T ss_dssp             TTSCCEEECCCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCCcEEEEeccCceecccc---cccccCCccccChHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence             4778999999999875432   345679999999999987765 67899999999999999999999998877766665


Q ss_pred             HhCCCCCC------------------C------------------C----------------------------CCHHHH
Q 015257          340 VNNSLVFP------------------D------------------A----------------------------MNPELR  355 (410)
Q Consensus       340 ~~~~~~~p------------------~------------------~----------------------------~~~~l~  355 (410)
                      .......|                  .                  .                            .++++.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (382)
T 2vx3_A          271 VEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFK  350 (382)
T ss_dssp             HHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHH
T ss_pred             HHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHH
Confidence            43210000                  0                  0                            013789


Q ss_pred             HHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          356 NLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      +||.+||+.||.+|||++|+|+||||++..
T Consensus       351 dli~~mL~~dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          351 DLILRMLDYDPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred             HHHHHhcCCChhhCCCHHHHhcCcccccCC
Confidence            999999999999999999999999998653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.2e-47  Score=355.38  Aligned_cols=251  Identities=20%  Similarity=0.315  Sum_probs=213.3

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+++.||+|+||.||++... ++..||||++.....          ....+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~   89 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----------SEDEFIEEAKVMMNLSHEKLVQLYGVCT   89 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----------CHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----------CHHHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence            34568999999999999999999876 577899999865421          1256889999999999999999999997


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      +  ...+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        90 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~  167 (283)
T 3gen_A           90 K--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS  167 (283)
T ss_dssp             S--SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred             c--CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccc
Confidence            6  4579999999999999888766 457999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCc-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCC
Q 015257          274 QVFEDDN-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAM  350 (410)
Q Consensus       274 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~  350 (410)
                      +...... .......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||......+....+.... ...|..+
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (283)
T 3gen_A          168 RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA  246 (283)
T ss_dssp             GGBCCHHHHSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTC
T ss_pred             ccccccccccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcC
Confidence            8654432 22234457888999999876655 678999999999999998 999999988888777777664 3456788


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhhCC
Q 015257          351 NPELRNLLEGLLCKDPTRRLTLNDVAKHT  379 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt~~ell~h~  379 (410)
                      ++.+.+||.+||+.||.+|||+.++++|-
T Consensus       247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L  275 (283)
T 3gen_A          247 SEKVYTIMYSCWHEKADERPTFKILLSNI  275 (283)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence            99999999999999999999999999873

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-47  Score=367.71  Aligned_cols=253  Identities=24%  Similarity=0.348  Sum_probs=216.5

Q ss_pred             ccccceeeeeeecccCceEEEEEEEc-----cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccc
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNL  189 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  189 (410)
                      ...++|.+++.||+|+||.||++++.     .+++.||||++....        .......+.+|+.+++.++||||+++
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~hp~iv~~  115 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--------SADMQADFQREAALMAEFDNPNIVKL  115 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--------CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--------CHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            34568999999999999999999987     355899999986431        34556789999999999999999999


Q ss_pred             eeEEEcCCCCEEEEEEeecCCCCcccccCCC------------------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 015257          190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP------------------------GAIGESMARKYLRDIVSGLMYLHGH  245 (410)
Q Consensus       190 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~------------------------~~l~~~~~~~i~~qi~~gL~yLH~~  245 (410)
                      ++++.+  ...+++||||+++++|.+++...                        ..+++..++.++.||+.||.|||++
T Consensus       116 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~  193 (343)
T 1luf_A          116 LGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER  193 (343)
T ss_dssp             EEEECS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             EEEEcc--CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            999976  45789999999999988876542                        5799999999999999999999999


Q ss_pred             CcEeccCCCCcEEEcCCCcEEEeeccccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-
Q 015257          246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-  322 (410)
Q Consensus       246 ~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-  322 (410)
                      ||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..+ +.++||||||+++|+|++ 
T Consensus       194 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~  272 (343)
T 1luf_A          194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSY  272 (343)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTT
T ss_pred             CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhc
Confidence            99999999999999999999999999997654322  22334568999999998876655 678999999999999999 


Q ss_pred             CCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          323 GQYPFLGETLQDTYDKIVNNSL-VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       323 G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      |..||.+....+....+..+.. .+|..+++++.+||.+||+.||.+|||+.+++++
T Consensus       273 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          273 GLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             TCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            9999999888887777776654 5678899999999999999999999999999874

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.7e-47  Score=362.02  Aligned_cols=253  Identities=25%  Similarity=0.391  Sum_probs=206.4

Q ss_pred             cccceeeeeeecccCceEEEEEE----EccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCccccee
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE  191 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  191 (410)
                      ..++|++++.||+|+||.||+++    +..+++.||||++...         .......+.+|+.+++.++||||+++++
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~   78 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---------TEEHLRDFEREIEILKSLQHDNIVKYKG   78 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---------CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---------CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            45689999999999999999998    5668999999988532         3455678999999999999999999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeec
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                      ++.......+++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus        79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Df  158 (295)
T 3ugc_A           79 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF  158 (295)
T ss_dssp             EECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred             EEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccC
Confidence            987644456899999999999998876543 5999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCcc---ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------------
Q 015257          271 SVSQVFEDDND---VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ--------------  333 (410)
Q Consensus       271 G~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--------------  333 (410)
                      |+++.......   ......+|+.|+|||++.+..+ +.++||||||+++|+|++|..||......              
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  237 (295)
T 3ugc_A          159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI  237 (295)
T ss_dssp             CSCC-------------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH
T ss_pred             cccccccCCcceeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh
Confidence            99987654321   2234457888999999877665 67899999999999999999998543211              


Q ss_pred             --HHHHHHHh-CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          334 --DTYDKIVN-NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       334 --~~~~~i~~-~~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                        .....+.. .....|..+++++.+||.+||+.||.+|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~  285 (295)
T 3ugc_A          238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR  285 (295)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence              11122222 2345677899999999999999999999999999863

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=6.1e-47  Score=353.08  Aligned_cols=249  Identities=20%  Similarity=0.328  Sum_probs=213.7

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+++.||+|+||.||++... ++..||||++.....          ....+.+|+.+++.++||||+++++++.+ 
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   74 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----------SEDEFFQEAQTMMKLSHPKLVKFYGVCSK-   74 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----------cHHHHHHHHHHHHhCCCCCEeeEEEEEcc-
Confidence            468999999999999999999776 567899999865321          22568899999999999999999999976 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                       ...+++||||++++++.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        75 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  153 (268)
T 3sxs_A           75 -EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY  153 (268)
T ss_dssp             -SSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred             -CCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence             45799999999999988887654 3599999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCc-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCC-CCCCCCCH
Q 015257          276 FEDDN-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSL-VFPDAMNP  352 (410)
Q Consensus       276 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~  352 (410)
                      ..... .......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||...........+..... ..|..+++
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (268)
T 3sxs_A          154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASD  232 (268)
T ss_dssp             CCTTCEEECCSCCCCGGGCCHHHHHHSEE-ETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred             cchhhhhcccCCCcCcccCCHHHHhccCC-chhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChH
Confidence            55432 22334456788999999876665 567999999999999999 9999998888877777766543 45667899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhhCC
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVAKHT  379 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell~h~  379 (410)
                      .+.+||.+||+.||.+|||+.+++++-
T Consensus       233 ~l~~li~~~l~~~p~~Rps~~~ll~~L  259 (268)
T 3sxs_A          233 TIYQIMYSCWHELPEKRPTFQQLLSSI  259 (268)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            999999999999999999999999873

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.9e-47  Score=361.47  Aligned_cols=252  Identities=21%  Similarity=0.370  Sum_probs=215.3

Q ss_pred             cccceeeeeeecccCceEEEEEEEc-----cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccce
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLI  190 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  190 (410)
                      ..++|.+.+.||+|+||.||++.+.     .++..||||++...        ........+.+|+.+++.++||||++++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~iv~~~   92 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--------ASPSELRDLLSEFNVLKQVNHPHVIKLY   92 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--------CCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC--------CCHHHHHHHHHHHHHHhhCCCCceeeEE
Confidence            4568999999999999999999974     35689999998643        1345667899999999999999999999


Q ss_pred             eEEEcCCCCEEEEEEeecCCCCcccccCCCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 015257          191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG------------------------AIGESMARKYLRDIVSGLMYLHGHN  246 (410)
Q Consensus       191 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~------------------------~l~~~~~~~i~~qi~~gL~yLH~~~  246 (410)
                      +++.+  ....++||||+++++|.+++....                        .+++..++.++.||+.||.|||++|
T Consensus        93 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  170 (314)
T 2ivs_A           93 GACSQ--DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK  170 (314)
T ss_dssp             EEECS--SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEec--CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99976  457899999999999888775432                        3899999999999999999999999


Q ss_pred             cEeccCCCCcEEEcCCCcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-C
Q 015257          247 VVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-G  323 (410)
Q Consensus       247 iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G  323 (410)
                      |+||||||+|||++.++.+||+|||+++.......  ......+|+.|+|||++.+..+ +.++||||||+++|+|++ |
T Consensus       171 ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g  249 (314)
T 2ivs_A          171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLG  249 (314)
T ss_dssp             EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTS
T ss_pred             CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999986544322  2234457889999999876655 678999999999999999 9


Q ss_pred             CCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          324 QYPFLGETLQDTYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       324 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..||.+.........+.... ...|..+++++.+||.+||+.||.+|||+.+++++
T Consensus       250 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          250 GNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             CCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999888777766666553 45677899999999999999999999999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=369.01  Aligned_cols=253  Identities=21%  Similarity=0.380  Sum_probs=217.0

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccC-------CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCc
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLD-------GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNI  186 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpni  186 (410)
                      ...++|.+.+.||+|+||.||+|++...       +..||||++...        ........+.+|+.+++.+ +||||
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~~E~~~l~~l~~hpnI  137 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--------ATEKDLSDLISEMEMMKMIGKHKNI  137 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--------CCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--------cCHHHHHHHHHHHHHHHHhcCCchh
Confidence            3446899999999999999999997543       357999998643        2345667899999999999 99999


Q ss_pred             ccceeEEEcCCCCEEEEEEeecCCCCcccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEec
Q 015257          187 VNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHG  250 (410)
Q Consensus       187 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr  250 (410)
                      +++++++.+  ...+++||||+++++|.+++...                ..+++..++.++.||+.||.|||++||+||
T Consensus       138 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  215 (382)
T 3tt0_A          138 INLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR  215 (382)
T ss_dssp             CCEEEEECS--SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             hhheeeecc--CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence            999999976  45789999999999988876543                359999999999999999999999999999


Q ss_pred             cCCCCcEEEcCCCcEEEeeccccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCC
Q 015257          251 DIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPF  327 (410)
Q Consensus       251 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf  327 (410)
                      ||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||
T Consensus       216 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~  294 (382)
T 3tt0_A          216 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPY  294 (382)
T ss_dssp             CCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999998654432  22334567899999999887655 678999999999999999 99999


Q ss_pred             CCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          328 LGETLQDTYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       328 ~~~~~~~~~~~i~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .+....+....+..+. ...|..+++++.+||.+||+.||.+|||+.+|+++
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          295 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             TTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9988888777776653 45677899999999999999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.6e-47  Score=359.27  Aligned_cols=246  Identities=17%  Similarity=0.259  Sum_probs=208.3

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCC-------ceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccc
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDG-------KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNL  189 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  189 (410)
                      .++|.+.+.||+|+||.||++.+..++       ..||+|++...         .....+.+.+|+.+++.++||||+++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~   77 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---------HRNYSESFFEAASMMSKLSHKHLVLN   77 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---------GGGGHHHHHHHHHHHHTSCCTTBCCE
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---------cHHHHHHHHHHHHHHHhCCCCCEeEE
Confidence            468999999999999999999998877       46999998543         23345679999999999999999999


Q ss_pred             eeEEEcCCCCEEEEEEeecCCCCcccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCc----
Q 015257          190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT----  264 (410)
Q Consensus       190 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~----  264 (410)
                      ++++.+  ....++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.    
T Consensus        78 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~  155 (289)
T 4fvq_A           78 YGVCVC--GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTG  155 (289)
T ss_dssp             EEEECC--TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGT
T ss_pred             EEEEEe--CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccc
Confidence            999986  456899999999999998886654 4999999999999999999999999999999999999998887    


Q ss_pred             ----EEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHH
Q 015257          265 ----VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQ-YPFLGETLQDTYDKI  339 (410)
Q Consensus       265 ----~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~-~Pf~~~~~~~~~~~i  339 (410)
                          +||+|||++.......    ...||+.|+|||++.+....+.++||||||+++|+|++|. +||..... .....+
T Consensus       156 ~~~~~kl~Dfg~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-~~~~~~  230 (289)
T 4fvq_A          156 NPPFIKLSDPGISITVLPKD----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQF  230 (289)
T ss_dssp             BCCEEEECCCCSCTTTSCHH----HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHH
T ss_pred             ccceeeeccCcccccccCcc----ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-HHHHHH
Confidence                9999999997653322    2347889999999987555578899999999999999954 55544443 344445


Q ss_pred             HhCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          340 VNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       340 ~~~~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ......+|...++++.+||.+||+.||.+|||+.++++|
T Consensus       231 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          231 YEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             HHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            556667788889999999999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.7e-47  Score=356.02  Aligned_cols=252  Identities=26%  Similarity=0.381  Sum_probs=204.4

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccC---CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCccccee
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE  191 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  191 (410)
                      ...++|.+.+.||+|+||.||++.+..+   +..||||++...        ......+.+.+|+.+++.++||||+++++
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   83 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--------TSDSVREKFLQEALTMRQFDHPHIVKLIG   83 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--------TSHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--------CCHHHHHHHHHHHHHHHhCCCCccceEEE
Confidence            4457899999999999999999998653   457999987532        23455678999999999999999999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeec
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                      ++.+   ...++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus        84 ~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df  160 (281)
T 1mp8_A           84 VITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF  160 (281)
T ss_dssp             EECS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-
T ss_pred             EEcc---CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcc
Confidence            9853   4689999999999988887644 47999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCcc-ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCC
Q 015257          271 SVSQVFEDDND-VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFP  347 (410)
Q Consensus       271 G~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p  347 (410)
                      |+++....... ......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+....+....+.... ..+|
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~  239 (281)
T 1mp8_A          161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP  239 (281)
T ss_dssp             ------------------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred             ccccccCcccccccccCCCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCC
Confidence            99987644321 2233457889999998876555 678999999999999996 999999888777777776654 4577


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..+++.+.+||.+||..||.+|||+.+++++
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8899999999999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.6e-47  Score=373.84  Aligned_cols=251  Identities=24%  Similarity=0.338  Sum_probs=214.2

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+.+.||+|+||.||+++...+++.||||++...        ........+.+|+.+|+.++||||+++++++.+
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  183 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--------LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ  183 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--------SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--------CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence            346899999999999999999999999999999987642        123445578899999999999999999999976


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                        ...+++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus       184 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~  261 (377)
T 3cbl_A          184 --KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR  261 (377)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             --CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence              45789999999999988887654 369999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCcccc--ccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCC
Q 015257          275 VFEDDNDVL--RRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAM  350 (410)
Q Consensus       275 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  350 (410)
                      .........  ....+++.|+|||++.+..+ +.++|||||||++|||++ |..||.+....+....+..+ ....|..+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELC  340 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTC
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            654332211  11235778999999876655 678999999999999998 99999998877776666554 34677889


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          351 NPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ++++.+||.+||+.||.+|||++++++
T Consensus       341 ~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          341 PDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.3e-47  Score=365.94  Aligned_cols=255  Identities=27%  Similarity=0.454  Sum_probs=184.7

Q ss_pred             cccccceeeee-eecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          114 TKMINEYVHVR-KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       114 ~~~~~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      ....++|.+++ .||+|+||.||++++..+|+.||||++...          ..   ...+....++.+.||||++++++
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~---~~~e~~~~~~~~~h~~i~~~~~~   90 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----------PK---ARQEVDHHWQASGGPHIVCILDV   90 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----------HH---HHHHHHHHHHHTTSTTBCCEEEE
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----------HH---HHHHHHHHHHhcCCCChHHHHHH
Confidence            44567899966 699999999999999999999999998532          11   12233344678899999999999


Q ss_pred             EEcC--CCCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC---CcE
Q 015257          193 IDDP--NSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS---GTV  265 (410)
Q Consensus       193 ~~~~--~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~---~~~  265 (410)
                      +...  ....+++||||++|++|.+.+...  ..+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+
T Consensus        91 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~  170 (336)
T 3fhr_A           91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL  170 (336)
T ss_dssp             EEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCE
T ss_pred             HhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceE
Confidence            8752  234689999999999998887654  369999999999999999999999999999999999999864   559


Q ss_pred             EEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHh
Q 015257          266 KIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDT----YDKIVN  341 (410)
Q Consensus       266 kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~----~~~i~~  341 (410)
                      ||+|||+++.....  ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||........    ...+..
T Consensus       171 kl~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  247 (336)
T 3fhr_A          171 KLTDFGFAKETTQN--ALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL  247 (336)
T ss_dssp             EECCCTTCEEC------------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC------------------
T ss_pred             EEeccccceecccc--ccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc
Confidence            99999999865432  3345678999999998866655 5679999999999999999999976554332    222222


Q ss_pred             CCCCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          342 NSLVFP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       342 ~~~~~p----~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      ....++    ..+++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            333233    4689999999999999999999999999999999864

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.4e-47  Score=368.02  Aligned_cols=268  Identities=22%  Similarity=0.373  Sum_probs=193.5

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHH-HHHhCCCCCcccceeEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL-IMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~  193 (410)
                      ...++|.+++.||+|+||.||++.+..+|+.||||++....        .......+..|+. +++.++||||+++++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~   90 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--------DEKEQKQLLMDLDVVMRSSDCPYIVQFYGAL   90 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--------CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEE
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--------CchHHHHHHHHHHHHHHcCCCCcEeeeeeEE
Confidence            34578999999999999999999999999999999986432        2334445556665 77888999999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCcEEEcCCCcEEE
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFG-----QPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKI  267 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIll~~~~~~kl  267 (410)
                      .+  .+..++||||++++ +.+.+.     ....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||
T Consensus        91 ~~--~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl  167 (327)
T 3aln_A           91 FR--EGDCWICMELMSTS-FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL  167 (327)
T ss_dssp             EC--SSEEEEEECCCSEE-HHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred             Ee--CCceEEEEeecCCC-hHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEE
Confidence            87  46899999999974 443332     256799999999999999999999999 9999999999999999999999


Q ss_pred             eeccccccccCCccccccCCCcccccccccccC---CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCC
Q 015257          268 GDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLG---LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ-DTYDKIVNNS  343 (410)
Q Consensus       268 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~i~~~~  343 (410)
                      +|||+++...... ......||+.|+|||++..   ....+.++||||||+++|+|++|..||...... +....+..+.
T Consensus       168 ~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  246 (327)
T 3aln_A          168 CDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD  246 (327)
T ss_dssp             CCCSSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSC
T ss_pred             ccCCCceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCC
Confidence            9999998654432 2234469999999998842   222367899999999999999999999764321 2222222222


Q ss_pred             C-CCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCchhhhh
Q 015257          344 L-VFP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCW  394 (410)
Q Consensus       344 ~-~~p----~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~~~~  394 (410)
                      . .++    ..+++.+.+||.+||+.||.+|||+.++++||||........+..++
T Consensus       247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~~~~~~  302 (327)
T 3aln_A          247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACY  302 (327)
T ss_dssp             CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCCCHHHH
T ss_pred             CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhhHHHHHHH
Confidence            1 122    35899999999999999999999999999999998766555554443

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.7e-46  Score=350.46  Aligned_cols=249  Identities=25%  Similarity=0.420  Sum_probs=201.8

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+.+.||+|+||.||++.+.  |+.||||++......     ......+.+.+|+.+++.++||||+++++++.+ 
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   77 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDE-----DISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-   77 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC---------------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcc-----cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence            468999999999999999999875  889999998654211     123345678999999999999999999999976 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cEeccCCCCcEEEcC--------CCcE
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHN---VVHGDIKPDNLLVAP--------SGTV  265 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlkp~NIll~~--------~~~~  265 (410)
                       ....++||||++++++.+.+. ...+++..++.++.||+.||.|||++|   |+||||||+|||++.        ++.+
T Consensus        78 -~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~  155 (271)
T 3dtc_A           78 -EPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL  155 (271)
T ss_dssp             -C--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred             -CCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence             457899999999999988775 457999999999999999999999999   999999999999986        6789


Q ss_pred             EEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-
Q 015257          266 KIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-  344 (410)
Q Consensus       266 kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-  344 (410)
                      ||+|||+++......  .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.........+..... 
T Consensus       156 kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  232 (271)
T 3dtc_A          156 KITDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA  232 (271)
T ss_dssp             EECCCCC---------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC
T ss_pred             EEccCCccccccccc--ccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC
Confidence            999999998654432  234578999999998876654 6789999999999999999999998887776666665543 


Q ss_pred             -CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          345 -VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       345 -~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                       .+|..+++.+.+||.+||+.||.+|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence             4667899999999999999999999999999976

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=359.87  Aligned_cols=268  Identities=24%  Similarity=0.378  Sum_probs=200.2

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||++++..+|+.||||++.....       .......+.++..+++.++||||+++++++.+
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~   95 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-------KEENKRILMDLDVVLKSHDCPYIVQCFGTFIT   95 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-------HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-------chHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence            45789999999999999999999999999999999865421       12333445566667889999999999999987


Q ss_pred             CCCCEEEEEEeecCCCCcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                        ...+++||||++ +.+..... ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus        96 --~~~~~lv~e~~~-~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  172 (318)
T 2dyl_A           96 --NTDVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGIS  172 (318)
T ss_dssp             --SSEEEEEECCCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             --CCcEEEEEeccC-CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCc
Confidence              458999999994 44443332 246799999999999999999999995 9999999999999999999999999999


Q ss_pred             ccccCCccccccCCCcccccccccccC----CcCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCC-CC
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLG----LTYGGKAADTWAVGVTLYYMIIGQYPFLGE-TLQDTYDKIVNNSLV-FP  347 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~elltG~~Pf~~~-~~~~~~~~i~~~~~~-~p  347 (410)
                      ....... ......||+.|+|||++..    ....+.++||||||+++|+|++|..||... ...+....+...... +|
T Consensus       173 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  251 (318)
T 2dyl_A          173 GRLVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP  251 (318)
T ss_dssp             ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC
T ss_pred             hhccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC
Confidence            7654432 2345578999999999852    233367899999999999999999999873 444555566555432 33


Q ss_pred             --CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC---CCCCchhhhh
Q 015257          348 --DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD---NGPIPQYLCW  394 (410)
Q Consensus       348 --~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~---~~~~~~~~~~  394 (410)
                        ..+++++.+||.+||+.||.+|||++++++||||++.   ...+.+.+..
T Consensus       252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~  303 (318)
T 2dyl_A          252 GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKD  303 (318)
T ss_dssp             SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHSCCCHHHHHHH
T ss_pred             ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcccccchhHHHhhc
Confidence              3589999999999999999999999999999999864   3344444443

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.5e-46  Score=350.10  Aligned_cols=250  Identities=17%  Similarity=0.292  Sum_probs=215.3

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+.+.||+|+||.||++++.  ++.||||++....       ......+.+.+|+.+++.++||||+++++++.
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   77 (271)
T 3kmu_A            7 IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-------WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ   77 (271)
T ss_dssp             CCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT-------CCHHHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred             CCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc-------cCHHHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence            34568999999999999999999985  8899999986532       13455678999999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--cEeccCCCCcEEEcCCCcEEEeec
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHN--VVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                      ++....+++||||+++++|.+++....  .+++..++.++.||+.||.|||++|  |+||||||+|||++.++.++|+||
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~  157 (271)
T 3kmu_A           78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMA  157 (271)
T ss_dssp             TTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred             cCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEec
Confidence            765578999999999999998887654  5899999999999999999999999  999999999999999999999999


Q ss_pred             cccccccCCccccccCCCcccccccccccCCcCCC--chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCC
Q 015257          271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGG--KAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--LVF  346 (410)
Q Consensus       271 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--~~~  346 (410)
                      |++.....     ....||+.|+|||++.+.....  .++||||||+++|+|++|..||.+....+....+....  ..+
T Consensus       158 ~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  232 (271)
T 3kmu_A          158 DVKFSFQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI  232 (271)
T ss_dssp             GSCCTTSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC
T ss_pred             cceeeecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC
Confidence            98764322     2346899999999987754433  37999999999999999999999988877766666543  456


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          347 PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       347 p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      |..+++++.+||.+||+.||.+|||++++++.
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  264 (271)
T 3kmu_A          233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPI  264 (271)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            78899999999999999999999999999863

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.9e-47  Score=371.02  Aligned_cols=254  Identities=23%  Similarity=0.432  Sum_probs=205.2

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-----------CCC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-----------HPN  185 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpn  185 (410)
                      .++|.+++.||+|+||.||++++..+++.||||++...          ......+.+|+.+++.+.           |||
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   87 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANH   87 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----------ccchhhhhHHHHHHHHhhcccccchhccccch
Confidence            46899999999999999999999999999999998632          234467889999999886           899


Q ss_pred             cccceeEEEcC--CCCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCcEEEc
Q 015257          186 IVNLIEVIDDP--NSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGH-NVVHGDIKPDNLLVA  260 (410)
Q Consensus       186 iv~l~~~~~~~--~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIll~  260 (410)
                      |+++++++...  ....+++||||+ +++|.+.+..  ...+++..++.++.||+.||.|||++ ||+||||||+|||++
T Consensus        88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~  166 (373)
T 1q8y_A           88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME  166 (373)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred             HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEe
Confidence            99999998753  234789999999 6677766643  34699999999999999999999998 999999999999995


Q ss_pred             C------CCcEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--
Q 015257          261 P------SGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL--  332 (410)
Q Consensus       261 ~------~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~--  332 (410)
                      .      .+.+||+|||+++.....   .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+...  
T Consensus       167 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~  242 (373)
T 1q8y_A          167 IVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHS  242 (373)
T ss_dssp             EEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             ccCCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence            3      347999999999865432   345579999999999887765 6789999999999999999999976541  


Q ss_pred             ----HHHHHHHH------------------------------------------hCCCCCCCCCCHHHHHHHHHhcccCC
Q 015257          333 ----QDTYDKIV------------------------------------------NNSLVFPDAMNPELRNLLEGLLCKDP  366 (410)
Q Consensus       333 ----~~~~~~i~------------------------------------------~~~~~~p~~~~~~l~~li~~~L~~dp  366 (410)
                          .+....+.                                          .....++..+++++.+||.+||+.||
T Consensus       243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  322 (373)
T 1q8y_A          243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP  322 (373)
T ss_dssp             --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred             cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence                11222221                                          11223344556789999999999999


Q ss_pred             CCCCCHHHHhhCCcccCCC
Q 015257          367 TRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       367 ~~Rpt~~ell~h~~~~~~~  385 (410)
                      .+|||++|+++||||++..
T Consensus       323 ~~Rpt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          323 RKRADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             TTCBCHHHHHTCGGGTTCT
T ss_pred             cccCCHHHHhhChhhhccc
Confidence            9999999999999999763

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.4e-46  Score=357.20  Aligned_cols=262  Identities=25%  Similarity=0.453  Sum_probs=209.2

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC--CCCcccceeEEE
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--HPNIVNLIEVID  194 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~  194 (410)
                      .++|.+++.||+|+||.||++.+. +++.||||++....       ........+.+|+.+++.++  ||||+++++++.
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   98 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   98 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS-------CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc-------ccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence            357999999999999999999886 58899999986532       13456678999999999997  599999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      +  ...+++||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++
T Consensus        99 ~--~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~  174 (313)
T 3cek_A           99 T--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN  174 (313)
T ss_dssp             C--SSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred             c--CCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccc
Confidence            6  458999999 56677888877777899999999999999999999999999999999999996 5899999999998


Q ss_pred             cccCCcc--ccccCCCcccccccccccCC----------cCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHh
Q 015257          275 VFEDDND--VLRRSPGTPVFTAPECCLGL----------TYGGKAADTWAVGVTLYYMIIGQYPFLGETL-QDTYDKIVN  341 (410)
Q Consensus       275 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~i~~  341 (410)
                      .......  ......||+.|+|||++.+.          ...+.++||||||+++|+|++|..||..... ......+..
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  254 (313)
T 3cek_A          175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  254 (313)
T ss_dssp             C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred             cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence            6543322  22345799999999988652          2346789999999999999999999977533 333444444


Q ss_pred             CC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCch
Q 015257          342 NS--LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ  390 (410)
Q Consensus       342 ~~--~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~  390 (410)
                      ..  ..+|...++++.+||.+||+.||.+|||+.++++||||+....+..+
T Consensus       255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~~  305 (313)
T 3cek_A          255 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ  305 (313)
T ss_dssp             TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC------
T ss_pred             cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCchhh
Confidence            32  35677889999999999999999999999999999999987665544

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.4e-47  Score=364.14  Aligned_cols=245  Identities=22%  Similarity=0.306  Sum_probs=204.8

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEEc
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDD  195 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~  195 (410)
                      .++|.+.+.||+|+||.||++++..+|+.||||++.....           ...+.+|+.+++.+ +||||+++++++.+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   76 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----------APQLHLEYRFYKQLGSGDGIPQVYYFGPC   76 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----------SCCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----------hHHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence            4679999999999999999999999999999999864321           12578999999999 99999999999987


Q ss_pred             CCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCc-----EEEee
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT-----VKIGD  269 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~-----~kl~D  269 (410)
                        ....++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.     +||+|
T Consensus        77 --~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~D  153 (330)
T 2izr_A           77 --GKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIID  153 (330)
T ss_dssp             --TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECC
T ss_pred             --CCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEE
Confidence              46899999999 7888877654 467999999999999999999999999999999999999998887     99999


Q ss_pred             ccccccccCCcc-------ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHH
Q 015257          270 FSVSQVFEDDND-------VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE---TLQDTYDKI  339 (410)
Q Consensus       270 fG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~---~~~~~~~~i  339 (410)
                      ||+++.......       ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.   ...+....+
T Consensus       154 Fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i  232 (330)
T 2izr_A          154 FALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI  232 (330)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH
T ss_pred             cccceeeecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH
Confidence            999987544322       1245679999999999887665 77899999999999999999999874   344444555


Q ss_pred             HhCCCCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          340 VNNSLVFP-----DAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       340 ~~~~~~~p-----~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      .......|     ..++ ++.+||..||..||.+||++++|++
T Consensus       233 ~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          233 GDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            44333222     2244 9999999999999999999998886

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.7e-47  Score=365.12  Aligned_cols=250  Identities=22%  Similarity=0.362  Sum_probs=208.9

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCce----EEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKH----YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      .++|++++.||+|+||.||++.+..+++.    ||+|.+....        .......+.+|+.+++.++||||++++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   83 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--------GRQSFQAVTDHMLAIGSLDHAHIVRLLGL   83 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--------SCSCBCSCCHHHHHHHTCCCTTBCCEEEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--------cHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence            36899999999999999999999888877    5556553221        11222356789999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      +.+   ...++||||+.+++|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        84 ~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg  160 (325)
T 3kex_A           84 CPG---SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFG  160 (325)
T ss_dssp             ECB---SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred             EcC---CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCC
Confidence            864   4689999999999998887654 579999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCC
Q 015257          272 VSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFP  347 (410)
Q Consensus       272 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p  347 (410)
                      +++......  .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+... ....|
T Consensus       161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  239 (325)
T 3kex_A          161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP  239 (325)
T ss_dssp             GGGGSCCCTTCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC
T ss_pred             cccccCcccccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC
Confidence            998764432  22345567889999999876665 678999999999999999 99999988777777666665 34567


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..+++++.+||.+||+.||.+|||+.+++++
T Consensus       240 ~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          240 QICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7889999999999999999999999999987

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=9.5e-47  Score=362.67  Aligned_cols=250  Identities=20%  Similarity=0.328  Sum_probs=205.1

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceE----EEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHY----AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      .++|.+++.||+|+||.||++++..+++.+    |+|.+...        ........+.+|+.+++.++||||++++++
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   85 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--------TSPKANKEILDEAYVMASVDNPHVCRLLGI   85 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------------CHHHHHHHHHHHHHCCBTTBCCEEEE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc--------cCHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            357999999999999999999998877765    66655322        123345678999999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      +.+.   ..++|+||+.++++.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        86 ~~~~---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg  162 (327)
T 3poz_A           86 CLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG  162 (327)
T ss_dssp             EESS---SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred             EecC---CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCc
Confidence            9863   47899999999998887755 4679999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCC
Q 015257          272 VSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFP  347 (410)
Q Consensus       272 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p  347 (410)
                      +++.......  ......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+. ...|
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~  241 (327)
T 3poz_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP  241 (327)
T ss_dssp             HHHHHTTTCC-------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred             ceeEccCCcccccccCCCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCC
Confidence            9987644322  2234457889999999887665 678999999999999999 999999887776666655543 4567


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..++.++.+|+.+||+.||.+|||+.+++++
T Consensus       242 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          242 PICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            7899999999999999999999999999976

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.7e-46  Score=354.60  Aligned_cols=254  Identities=23%  Similarity=0.379  Sum_probs=207.4

Q ss_pred             ccccceeeeeeecccCceEEEEEE----EccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccce
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLI  190 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  190 (410)
                      .....|++++.||+|+||.||+++    +..+++.||||++....        .......+.+|+.+++.++||||++++
T Consensus        18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~~~~   89 (302)
T 4e5w_A           18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--------GGNHIADLKKEIEILRNLYHENIVKYK   89 (302)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------------CCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--------cchhHHHHHHHHHHHHhCCCCCeeeee
Confidence            334679999999999999999998    56689999999986432        223446789999999999999999999


Q ss_pred             eEEEcCCCCEEEEEEeecCCCCcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEee
Q 015257          191 EVIDDPNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGD  269 (410)
Q Consensus       191 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~D  269 (410)
                      +++.+.....+++||||+++++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus        90 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~D  169 (302)
T 4e5w_A           90 GICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGD  169 (302)
T ss_dssp             EEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred             eEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECc
Confidence            9998765567999999999999998873 345799999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCc---cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC--------------CH
Q 015257          270 FSVSQVFEDDN---DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE--------------TL  332 (410)
Q Consensus       270 fG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~--------------~~  332 (410)
                      ||++.......   .......||+.|+|||++.+..+ +.++||||||+++|+|++|..|+...              ..
T Consensus       170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  248 (302)
T 4e5w_A          170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKF-YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT  248 (302)
T ss_dssp             CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGH
T ss_pred             ccccccccCCCcceeccCCCCCCccccCCeeecCCCC-CcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccC
Confidence            99998765433   23345568899999998877665 57799999999999999999876321              11


Q ss_pred             H-HHHHHHHh-CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          333 Q-DTYDKIVN-NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       333 ~-~~~~~i~~-~~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      . .....+.. .....|..+++++.+||.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          249 VTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            1 12222222 234567789999999999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.9e-46  Score=354.36  Aligned_cols=255  Identities=23%  Similarity=0.329  Sum_probs=206.3

Q ss_pred             cccceeeeeeecccCceEEEEEEEcc---CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      ..++|.+.+.||+|+||.||++....   ++..||||++....       ........+.+|+.+++.++||||++++++
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  104 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-------SSQREIEEFLSEAACMKDFSHPNVIRLLGV  104 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-------CCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-------cchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence            34689999999999999999998765   45689999986432       134556789999999999999999999999


Q ss_pred             EEcCCCC---EEEEEEeecCCCCccccc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC
Q 015257          193 IDDPNSD---HFYMVLEYVEGKWDNDGF------GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG  263 (410)
Q Consensus       193 ~~~~~~~---~~~lv~e~~~~~~l~~~~------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~  263 (410)
                      +.+....   ..++||||+++++|.+++      .....+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred             EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence            9864322   469999999999988776      3446799999999999999999999999999999999999999999


Q ss_pred             cEEEeeccccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 015257          264 TVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIV  340 (410)
Q Consensus       264 ~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~  340 (410)
                      .+||+|||+++......  .......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.........+.
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  263 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL  263 (313)
T ss_dssp             CEEECSCSCC----------------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred             cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH
Confidence            99999999998654332  12233457889999999877655 678999999999999999 999999888777777776


Q ss_pred             hCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          341 NNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       341 ~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .+. ...|..+++++.+||.+||..||.+|||+.+++++
T Consensus       264 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          264 HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            653 45778899999999999999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.1e-46  Score=357.91  Aligned_cols=252  Identities=20%  Similarity=0.382  Sum_probs=214.3

Q ss_pred             cccceeeeeeecccCceEEEEEEEc-------cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSS-------LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIV  187 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv  187 (410)
                      ..++|.+.+.||+|+||.||++++.       .++..||||++....        .......+.+|+.+++.+ +||||+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~hp~iv  104 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--------TEKDLSDLVSEMEMMKMIGKHKNII  104 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--------CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--------cHHHHHHHHHHHHHHHHhhcCCCEe
Confidence            3468999999999999999999975       357789999986431        345567899999999999 899999


Q ss_pred             cceeEEEcCCCCEEEEEEeecCCCCcccccCCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecc
Q 015257          188 NLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG----------------AIGESMARKYLRDIVSGLMYLHGHNVVHGD  251 (410)
Q Consensus       188 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD  251 (410)
                      ++++++.+  ...+++||||+++++|.+++....                .+++..++.++.||+.||.|||++||+|||
T Consensus       105 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~D  182 (334)
T 2pvf_A          105 NLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD  182 (334)
T ss_dssp             CEEEEECS--SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             eEEEEEcc--CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence            99999976  457899999999999888776543                489999999999999999999999999999


Q ss_pred             CCCCcEEEcCCCcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 015257          252 IKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFL  328 (410)
Q Consensus       252 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~  328 (410)
                      |||+|||++.++.+||+|||+++.......  ......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.
T Consensus       183 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~  261 (334)
T 2pvf_A          183 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYP  261 (334)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcC
Confidence            999999999999999999999986554321  2234457889999998876655 678999999999999999 999999


Q ss_pred             CCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          329 GETLQDTYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       329 ~~~~~~~~~~i~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +....+....+..+. ...+..+++++.+||.+||+.||.+|||+.+++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          262 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             TCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            988877777666654 45677899999999999999999999999999976

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-46  Score=363.04  Aligned_cols=255  Identities=20%  Similarity=0.301  Sum_probs=210.9

Q ss_pred             cccceeeeeeecccCceEEEEEEEc-----cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNL  189 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  189 (410)
                      ..++|.+.+.||+|+||.||++.+.     .++..||||++....        .......+.+|+.+++.+ +||||+++
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~hp~iv~~  114 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--------DSSEREALMSELKMMTQLGSHENIVNL  114 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--------CHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            3468999999999999999999973     356789999986432        223446789999999999 89999999


Q ss_pred             eeEEEcCCCCEEEEEEeecCCCCcccccCCCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 015257          190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG-----------------------AIGESMARKYLRDIVSGLMYLHGHN  246 (410)
Q Consensus       190 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-----------------------~l~~~~~~~i~~qi~~gL~yLH~~~  246 (410)
                      ++++.+  ...+++||||+++++|.+++....                       .+++..++.++.||+.||.|||++|
T Consensus       115 ~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  192 (344)
T 1rjb_A          115 LGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS  192 (344)
T ss_dssp             EEEECS--SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEee--CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999986  457899999999999888775532                       3799999999999999999999999


Q ss_pred             cEeccCCCCcEEEcCCCcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-C
Q 015257          247 VVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-G  323 (410)
Q Consensus       247 iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G  323 (410)
                      |+||||||+|||++.++.+||+|||++........  ......||+.|+|||++.+..+ +.++||||||+++|+|++ |
T Consensus       193 ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g  271 (344)
T 1rjb_A          193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLG  271 (344)
T ss_dssp             EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTS
T ss_pred             cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCC
Confidence            99999999999999999999999999986543322  2234457889999998876655 678999999999999998 9


Q ss_pred             CCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          324 QYPFLGETLQDTYDKIVNNS--LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       324 ~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      ..||.+.........+....  ...|..+++++.+||.+||+.||.+|||+.++++|..-
T Consensus       272 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  331 (344)
T 1rjb_A          272 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  331 (344)
T ss_dssp             CCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence            99998876555554544443  34567889999999999999999999999999987543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2e-46  Score=353.08  Aligned_cols=251  Identities=22%  Similarity=0.366  Sum_probs=217.0

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+.+.||+|+||.||++.+..++..||||++...          ....+.+.+|+.+++.++||||+++++++.
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   79 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT   79 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----------STHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            3456899999999999999999999999999999998542          234567899999999999999999999997


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      +  ...+++||||+++++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        80 ~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~  157 (288)
T 3kfa_A           80 R--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL  157 (288)
T ss_dssp             S--SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred             c--CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcc
Confidence            6  4579999999999999888754  34699999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCc-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCC
Q 015257          273 SQVFEDDN-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDA  349 (410)
Q Consensus       273 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~  349 (410)
                      +....... .......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.........+... ....|..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T 3kfa_A          158 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG  236 (288)
T ss_dssp             GGTSCSSSSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred             ceeccCCccccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCC
Confidence            98765432 22233456888999999876655 678999999999999999 99999988777776666655 3456778


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +++.+.+||.+||..||.+|||+.++++.
T Consensus       237 ~~~~l~~li~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          237 CPEKVYELMRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence            99999999999999999999999999863

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.7e-46  Score=350.99  Aligned_cols=250  Identities=19%  Similarity=0.261  Sum_probs=208.0

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEV  192 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~  192 (410)
                      ....++|.+.+.||+|+||.||++.+..+|+.||||++....           ....+.+|+.+++.+ +|+|+++++++
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~e~~~~~~l~~~~~i~~~~~~   74 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----------DAPQLRDEYRTYKLLAGCTGIPNVYYF   74 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----------TSCCHHHHHHHHHHTTTCTTCCCEEEE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----------ccHHHHHHHHHHHHHhcCCCCCeEEee
Confidence            344568999999999999999999999999999999885432           112477899999999 79999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCc-----EE
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT-----VK  266 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~-----~k  266 (410)
                      +.+  ....++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.     +|
T Consensus        75 ~~~--~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~k  151 (298)
T 1csn_A           75 GQE--GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIY  151 (298)
T ss_dssp             EEE--TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred             cCC--CceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEE
Confidence            976  56899999999 88888877653 46999999999999999999999999999999999999987776     99


Q ss_pred             EeeccccccccCCcc-------ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHH
Q 015257          267 IGDFSVSQVFEDDND-------VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE---TLQDTY  336 (410)
Q Consensus       267 l~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~---~~~~~~  336 (410)
                      |+|||+++.......       ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.   ......
T Consensus       152 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  230 (298)
T 1csn_A          152 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY  230 (298)
T ss_dssp             ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred             EEECccccccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHH
Confidence            999999987654322       2345679999999999877665 77899999999999999999999874   333444


Q ss_pred             HHHHhCCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          337 DKIVNNSL-----VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       337 ~~i~~~~~-----~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..+.....     .....+++++.+||.+||+.||.+|||+++|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          231 ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             HHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            44333221     1234789999999999999999999999999764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-46  Score=349.33  Aligned_cols=251  Identities=24%  Similarity=0.337  Sum_probs=214.4

Q ss_pred             cceeeee-eecccCceEEEEEEEc--cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          118 NEYVHVR-KIGAGSYGKVVLYRSS--LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       118 ~~y~~~~-~lG~G~fg~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ++|.+++ .||+|+||.||++...  .++..||||++...        ......+.+.+|+.+++.++||||+++++++.
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   80 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--------TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ   80 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--------cchhHHHHHHHHHHHHHhCCCCCEeEEEEEec
Confidence            5677777 9999999999999854  46888999998643        13456678999999999999999999999995


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .   ..+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus        81 ~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~  157 (287)
T 1u59_A           81 A---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS  157 (287)
T ss_dssp             S---SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             C---CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccce
Confidence            4   458999999999999888754 456999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCcc---ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCC
Q 015257          274 QVFEDDND---VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPD  348 (410)
Q Consensus       274 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~  348 (410)
                      ........   ......||+.|+|||++.+..+ +.++||||||+++|+|++ |..||......+....+..+. ..+|.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~  236 (287)
T 1u59_A          158 KALGADDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP  236 (287)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT
T ss_pred             eeeccCcceeeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCC
Confidence            87643322   1223456899999998876555 678999999999999998 999999888777777766654 46778


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCc
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW  380 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~  380 (410)
                      .+++++.+||.+||..||.+|||+.+++++.+
T Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            89999999999999999999999999998754

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.8e-46  Score=367.46  Aligned_cols=250  Identities=26%  Similarity=0.364  Sum_probs=201.9

Q ss_pred             ccceeeeeeecccCceEEEEEEEc---cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      .++|.+.+.||+|+||.||+++..   .++..||||++...        ........+.+|+.++++++||||+++++++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  115 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--------YTEKQRRDFLGEASIMGQFDHPNIIRLEGVV  115 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT--------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc--------cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            457999999999999999999887   45778999998543        1345567899999999999999999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      .+  ...+++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus       116 ~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  193 (373)
T 2qol_A          116 TK--SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL  193 (373)
T ss_dssp             CS--SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             ee--CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcc
Confidence            76  45789999999999999888654 4799999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccc---cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCC
Q 015257          273 SQVFEDDNDV---LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFP  347 (410)
Q Consensus       273 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p  347 (410)
                      ++........   .....+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||......+....+..+. ...+
T Consensus       194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~  272 (373)
T 2qol_A          194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF-TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPP  272 (373)
T ss_dssp             --------------------CTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCC
T ss_pred             ccccccCCccceeccCCCcCCCccChhhhccCCc-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            9876543221   122335778999999876655 678999999999999998 999999888877777666553 3456


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ..++..+.+||.+||+.||.+|||+.++++
T Consensus       273 ~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          273 MDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             TTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            678999999999999999999999999886

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.8e-46  Score=354.89  Aligned_cols=255  Identities=22%  Similarity=0.306  Sum_probs=204.8

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ....++|.+.+.||+|+||.||++.+..+++.||||++.....      ........+.+|+.+++.++||||+++++++
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~  103 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS------SDPVFRTRMQREARTAGRLQEPHVVPIHDFG  103 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG------GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc------cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence            3456789999999999999999999999999999999865421      1344567899999999999999999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .+  ...+++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       104 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~  181 (309)
T 2h34_A          104 EI--DGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIA  181 (309)
T ss_dssp             EE--TTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred             ee--CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccC
Confidence            87  4689999999999999998877778999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCc-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCCC
Q 015257          274 QVFEDDN-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL---VFPDA  349 (410)
Q Consensus       274 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~  349 (410)
                      ....... .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.........+.....   ..+..
T Consensus       182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (309)
T 2h34_A          182 SATTDEKLTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPG  260 (309)
T ss_dssp             ---------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTT
T ss_pred             ccccccccccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCC
Confidence            7654432 22335578999999998877655 5679999999999999999999988765544333333221   34567


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-CHHHHhh
Q 015257          350 MNPELRNLLEGLLCKDPTRRL-TLNDVAK  377 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rp-t~~ell~  377 (410)
                      +++++.+||.+||+.||.+|| |++++++
T Consensus       261 ~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          261 IPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             CCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             CCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            899999999999999999999 8888875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.3e-46  Score=346.74  Aligned_cols=248  Identities=22%  Similarity=0.361  Sum_probs=213.9

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+.+.||+|+||.||++.+. +++.||+|++.....          ..+.+.+|+.+++.++||||+++++++.+ 
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   74 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----------SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-   74 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----------CHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----------CHHHHHHHHHHHHhCCCCCEeeEEEEEcc-
Confidence            357999999999999999999986 678899999865421          12578899999999999999999999976 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                       ....++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus        75 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~  153 (267)
T 3t9t_A           75 -QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF  153 (267)
T ss_dssp             -SSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred             -CCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccc
Confidence             45789999999999998887653 5689999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCc-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCCH
Q 015257          276 FEDDN-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMNP  352 (410)
Q Consensus       276 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~  352 (410)
                      ..... .......||+.|+|||++.+..+ +.++||||||+++|+|++ |..||......+....+..+. ...|..+++
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  232 (267)
T 3t9t_A          154 VLDDQYTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST  232 (267)
T ss_dssp             BCCHHHHSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred             cccccccccccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcH
Confidence            54322 22234567889999998876555 678999999999999999 999999988888777777663 345678899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .+.+|+.+||+.||.+|||+.+++++
T Consensus       233 ~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          233 HVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=7.5e-46  Score=353.16  Aligned_cols=257  Identities=28%  Similarity=0.444  Sum_probs=202.1

Q ss_pred             ccccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          113 GTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       113 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      +....++|.+.+.||+|+||.||++.+..+|+.||||++.....      ........+.+|+.+++.++||||++++++
T Consensus        27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~  100 (310)
T 2wqm_A           27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL------MDAKARADCIKEIDLLKQLNHPNVIKYYAS  100 (310)
T ss_dssp             TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS------CCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc------cCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            34456789999999999999999999999999999999864321      134566789999999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEe
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFG----QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIG  268 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~  268 (410)
                      +.+  ....++||||+++++|.+++.    ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus       101 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~  178 (310)
T 2wqm_A          101 FIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLG  178 (310)
T ss_dssp             EEE--TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             EEc--CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEE
Confidence            987  458999999999998887764    35679999999999999999999999999999999999999999999999


Q ss_pred             eccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCC-
Q 015257          269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET--LQDTYDKIVNNSLV-  345 (410)
Q Consensus       269 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~--~~~~~~~i~~~~~~-  345 (410)
                      |||++..............||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+..  .......+...... 
T Consensus       179 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  257 (310)
T 2wqm_A          179 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP  257 (310)
T ss_dssp             CC------------------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC
T ss_pred             eccceeeecCCCccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC
Confidence            99999876554444455678999999998877655 678999999999999999999997643  33444444444322 


Q ss_pred             C-CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          346 F-PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       346 ~-p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      . +..+++++.+||.+||..||.+|||+.+++++
T Consensus       258 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          258 LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            2 25689999999999999999999999999874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.4e-46  Score=359.60  Aligned_cols=251  Identities=24%  Similarity=0.380  Sum_probs=211.0

Q ss_pred             cceeeeeeecccCceEEEEEE----EccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ++|++++.||+|+||.||+++    +..+++.||||++...         .....+.+.+|+.+++.++||||+++++++
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   93 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---------GPDQQRDFQREIQILKALHSDFIVKYRGVS   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---------CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---------CHHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence            589999999999999999998    5668999999998643         344556799999999999999999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      ..+....+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A           94 YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             ECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             ecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccc
Confidence            87667789999999999999888765 34699999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCcc---ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------------H
Q 015257          273 SQVFEDDND---VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ---------------D  334 (410)
Q Consensus       273 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~---------------~  334 (410)
                      ++.......   ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||......               .
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  252 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR  252 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence            987643322   2234568889999999876655 67899999999999999999998543221               1


Q ss_pred             HHHHHHhC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          335 TYDKIVNN-SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       335 ~~~~i~~~-~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ....+..+ ....+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22222222 345677899999999999999999999999999654

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.4e-46  Score=359.49  Aligned_cols=260  Identities=20%  Similarity=0.266  Sum_probs=213.5

Q ss_pred             ccccccceeeeeeecccCceEEEEEE-----EccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcc
Q 015257          113 GTKMINEYVHVRKIGAGSYGKVVLYR-----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIV  187 (410)
Q Consensus       113 ~~~~~~~y~~~~~lG~G~fg~Vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  187 (410)
                      .....++|.+++.||+|+||.||+++     +..+++.||||++...        ........+.+|+.+++.++||||+
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv   96 (327)
T 2yfx_A           25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--------CSEQDELDFLMEALIISKFNHQNIV   96 (327)
T ss_dssp             CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--------CCHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--------cchhhHHHHHHHHHHHhhCCCCCCC
Confidence            34456789999999999999999999     5567889999998532        1344556789999999999999999


Q ss_pred             cceeEEEcCCCCEEEEEEeecCCCCcccccCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEc
Q 015257          188 NLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP-------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA  260 (410)
Q Consensus       188 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~  260 (410)
                      ++++++.+  ....++||||+++++|.+++...       ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus        97 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~  174 (327)
T 2yfx_A           97 RCIGVSLQ--SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT  174 (327)
T ss_dssp             CEEEEECS--SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred             eEEEEEcC--CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEe
Confidence            99999986  45689999999999888877543       3589999999999999999999999999999999999999


Q ss_pred             CC---CcEEEeeccccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 015257          261 PS---GTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQD  334 (410)
Q Consensus       261 ~~---~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~  334 (410)
                      .+   ..+||+|||++.......  .......||+.|+|||++.+..+ +.++||||||+++|+|++ |..||......+
T Consensus       175 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~  253 (327)
T 2yfx_A          175 CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE  253 (327)
T ss_dssp             CSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             cCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHH
Confidence            54   469999999997543322  12233457899999998876655 678999999999999998 999999888777


Q ss_pred             HHHHHHhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          335 TYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       335 ~~~~i~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                      ....+..+. ...+..+++.+.+||.+||+.||.+|||+.++++|.|...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          254 VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            777776653 4566789999999999999999999999999999998754

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.2e-46  Score=356.02  Aligned_cols=253  Identities=20%  Similarity=0.277  Sum_probs=215.8

Q ss_pred             ccccceeeeeeecccCceEEEEEEEc-----cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccc
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNL  189 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  189 (410)
                      ...++|.+.+.||+|+||.||++.+.     .+++.||||++....        .......+.+|+.+++.++||||+++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~~~   93 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--------SMRERIEFLNEASVMKEFNCHHVVRL   93 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--------CHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--------CHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            34568999999999999999999876     367899999986431        33455678999999999999999999


Q ss_pred             eeEEEcCCCCEEEEEEeecCCCCcccccCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEE
Q 015257          190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ----------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV  259 (410)
Q Consensus       190 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll  259 (410)
                      ++++.+  ....++||||+++++|.+++..          ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        94 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli  171 (322)
T 1p4o_A           94 LGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV  171 (322)
T ss_dssp             EEEECS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred             EEEEcc--CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE
Confidence            999976  4578999999999998887653          1457999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 015257          260 APSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTY  336 (410)
Q Consensus       260 ~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~  336 (410)
                      +.++.+||+|||+++.......  ......||+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+....+..
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  250 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL  250 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHH
Confidence            9999999999999986543321  2233457889999998876655 678999999999999999 89999998888777


Q ss_pred             HHHHhCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          337 DKIVNNSL-VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       337 ~~i~~~~~-~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..+..... ..+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          251 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            77766543 5677899999999999999999999999999987

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.1e-46  Score=356.92  Aligned_cols=252  Identities=22%  Similarity=0.357  Sum_probs=211.1

Q ss_pred             cccceeeeeeecccCceEEEEEEE-----ccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRS-----SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNL  189 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  189 (410)
                      ..++|.+.+.||+|+||.||++..     ..+++.||||++....        .....+.+.+|+.+++.+ +||||+++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~~i~~~   92 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--------HLTEREALMSELKVLSYLGNHMNIVNL   92 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--------hHHHHHHHHHHHHHHhhcccCCCeeeE
Confidence            346899999999999999999985     4467899999986432        234557899999999999 99999999


Q ss_pred             eeEEEcCCCCEEEEEEeecCCCCcccccCCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecc
Q 015257          190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG------------------AIGESMARKYLRDIVSGLMYLHGHNVVHGD  251 (410)
Q Consensus       190 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~------------------~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD  251 (410)
                      ++++.+  ....++||||+++++|.+++....                  .+++..++.++.||+.||.|||++||+|||
T Consensus        93 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d  170 (313)
T 1t46_A           93 LGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD  170 (313)
T ss_dssp             EEEECS--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             EEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence            999976  457899999999998888765432                  489999999999999999999999999999


Q ss_pred             CCCCcEEEcCCCcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 015257          252 IKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFL  328 (410)
Q Consensus       252 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~  328 (410)
                      |||+|||++.++.+||+|||+++.......  ......||+.|+|||++.+..+ +.++||||||+++|+|++ |..||.
T Consensus       171 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~  249 (313)
T 1t46_A          171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYP  249 (313)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             CccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999987654322  2234457889999998876655 678999999999999999 999998


Q ss_pred             CCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          329 GETLQDTYDKIVNNS--LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       329 ~~~~~~~~~~i~~~~--~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +..............  ...+..+++++.+||.+||+.||.+|||+.+++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             TCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            876555444443332  33467889999999999999999999999999975

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.6e-46  Score=358.36  Aligned_cols=251  Identities=24%  Similarity=0.357  Sum_probs=211.3

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceE--EEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHY--AIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEV  192 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~v--aiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~  192 (410)
                      ..++|.+.+.||+|+||.||++++..+|..+  |||.+....        .......+.+|+.+++++ +||||++++++
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   94 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--------SKDDHRDFAGELEVLCKLGHHPNIINLLGA   94 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--------chHHHHHHHHHHHHHHhccCCCchhhhcee
Confidence            3468999999999999999999999888865  999876421        223445788999999999 99999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQPG----------------AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDN  256 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N  256 (410)
                      +.+  ...+++||||+++++|.+++....                .+++..++.++.||+.||.|||++||+||||||+|
T Consensus        95 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N  172 (327)
T 1fvr_A           95 CEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN  172 (327)
T ss_dssp             EEE--TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             eee--CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccce
Confidence            987  468999999999999988876543                79999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 015257          257 LLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDT  335 (410)
Q Consensus       257 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~  335 (410)
                      ||++.++.+||+|||+++..... .......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+....+.
T Consensus       173 Il~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~  250 (327)
T 1fvr_A          173 ILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL  250 (327)
T ss_dssp             EEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred             EEEcCCCeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCCCcHHHH
Confidence            99999999999999999743321 12233457889999998876555 678999999999999998 9999999888877


Q ss_pred             HHHHHhCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          336 YDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       336 ~~~i~~~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ...+..+. ...|..+++++.+||.+||+.||.+|||+.+++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          251 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            77766653 45667889999999999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.6e-46  Score=358.91  Aligned_cols=251  Identities=21%  Similarity=0.231  Sum_probs=200.6

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|++++.||+|+||.||+++..  ++.||||++...          ........+|+.+++.++|||||++++++.
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~----------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   88 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ----------DKQSWQNEYEVYSLPGMKHENILQFIGAEK   88 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG----------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC----------chHHHHHHHHHHHHhcCCCCCchhhcceec
Confidence            34468999999999999999999875  789999998543          223345667999999999999999999998


Q ss_pred             cCC--CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CcEeccCCCCcEEEcCC
Q 015257          195 DPN--SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH----------NVVHGDIKPDNLLVAPS  262 (410)
Q Consensus       195 ~~~--~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~----------~iiHrDlkp~NIll~~~  262 (410)
                      +..  ...+++||||+++++|.+++... .+++..++.++.||+.||.|||+.          ||+||||||+|||++.+
T Consensus        89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~  167 (322)
T 3soc_A           89 RGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN  167 (322)
T ss_dssp             EECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT
T ss_pred             cCCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC
Confidence            643  34689999999999999888654 599999999999999999999999          99999999999999999


Q ss_pred             CcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcC----CCchhhHHHHHHHHHHHHhCCCCCCCCC-----
Q 015257          263 GTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTY----GGKAADTWAVGVTLYYMIIGQYPFLGET-----  331 (410)
Q Consensus       263 ~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwSlG~il~elltG~~Pf~~~~-----  331 (410)
                      +.+||+|||+++.......  ......||+.|+|||++.+...    .+.++|||||||++|+|++|..||.+..     
T Consensus       168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  247 (322)
T 3soc_A          168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML  247 (322)
T ss_dssp             CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred             CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence            9999999999987654322  2334679999999999876322    2457899999999999999999996532     


Q ss_pred             -----------HHHHHHHHHhCCCC--CCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          332 -----------LQDTYDKIVNNSLV--FPD-----AMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       332 -----------~~~~~~~i~~~~~~--~p~-----~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                                 .......+......  ++.     ..++++.+||.+||+.||.+|||+.++++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                       22222222222211  111     123559999999999999999999999864

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.7e-45  Score=345.38  Aligned_cols=252  Identities=27%  Similarity=0.377  Sum_probs=207.4

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHH---HHHHHHHHHHHHhCCCCCccccee
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETA---MTDVRREVLIMKMLQHPNIVNLIE  191 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~  191 (410)
                      ...++|.+.+.||+|+||.||++++..+++.||||++......     .....   .+.+.+|+.+++.++||||+++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   90 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSE-----GETEMIEKFQEFQREVFIMSNLNHPNIVKLYG   90 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTT-----CCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccc-----cchhHHHHHHHHHHHHHHHHhCCCCCchhhhe
Confidence            3457899999999999999999999999999999998654221     11111   267899999999999999999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeccCCCCcEEEcCCCc----
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHN--VVHGDIKPDNLLVAPSGT----  264 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NIll~~~~~----  264 (410)
                      ++.+..    ++||||++++++.+.+. ....+++..++.++.||+.||.|||++|  |+||||||+|||++.++.    
T Consensus        91 ~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~  166 (287)
T 4f0f_A           91 LMHNPP----RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPV  166 (287)
T ss_dssp             EETTTT----EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred             eecCCC----eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCce
Confidence            996532    69999999888876654 4457999999999999999999999999  999999999999988876    


Q ss_pred             -EEEeeccccccccCCccccccCCCcccccccccccCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH
Q 015257          265 -VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL-TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDT--YDKIV  340 (410)
Q Consensus       265 -~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~i~  340 (410)
                       +||+|||+++....   ......||+.|+|||++... ...+.++|||||||++|+|++|..||........  ...+.
T Consensus       167 ~~kl~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  243 (287)
T 4f0f_A          167 CAKVADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR  243 (287)
T ss_dssp             CEEECCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH
T ss_pred             eEEeCCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh
Confidence             99999999975433   23456799999999988432 2236789999999999999999999987554332  33333


Q ss_pred             hC--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          341 NN--SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       341 ~~--~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..  ...+|..+++++.+||.+||+.||.+|||++++++.
T Consensus       244 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  283 (287)
T 4f0f_A          244 EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE  283 (287)
T ss_dssp             HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            33  335677899999999999999999999999999863

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.9e-46  Score=358.53  Aligned_cols=254  Identities=19%  Similarity=0.305  Sum_probs=206.1

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+++.||+|+||.||++.+..+++.+|+|+..+...    ..........+.+|+.+++.++||||+++++++...
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~----~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEEC----CCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeec----cccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            3689999999999999999999998888775554332211    111233456789999999999999999999999863


Q ss_pred             CCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                         ..++|+||+.++++.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        90 ---~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           90 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             ---SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             ---CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence               48899999999988887754 45799999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCC
Q 015257          276 FEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMN  351 (410)
Q Consensus       276 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~  351 (410)
                      ......  ......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+.... ...|..++
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT  245 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBC
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCC-ChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCC
Confidence            643322  2234457889999999887665 678999999999999999 999999887777666665553 45677899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          352 PELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       352 ~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +++.+||.+||..||.+|||+.++++.
T Consensus       246 ~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          246 IDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            999999999999999999999999974

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6.8e-46  Score=372.15  Aligned_cols=245  Identities=24%  Similarity=0.423  Sum_probs=209.7

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+++.||+|+||.||++...  |+.||||+++...           ..+.+.+|+.+|++++|||||++++++.
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~~~  256 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----------TAQAFLAEASVMTQLRHSNLVQLLGVIV  256 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----------TSHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----------HHHHHHHHHHHHHhccCCCEEEEEEEEE
Confidence            34578999999999999999998875  7899999986431           2357899999999999999999999987


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      +. ...+++||||+++++|.+++...+  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus       257 ~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~  335 (450)
T 1k9a_A          257 EE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL  335 (450)
T ss_dssp             CT-TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             cC-CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCC
Confidence            63 347999999999999998876543  379999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCC
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAM  350 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  350 (410)
                      ++.....   .....+|+.|+|||++.+..+ +.++|||||||++|||++ |..||.+....+....+..+ ....|..+
T Consensus       336 a~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~  411 (450)
T 1k9a_A          336 TKEASST---QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC  411 (450)
T ss_dssp             CEECC---------CCCTTTSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTC
T ss_pred             ccccccc---ccCCCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcC
Confidence            9854332   223357889999999877665 678999999999999998 99999988777777766665 35677889


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          351 NPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ++++.+||.+||+.||.+|||+.++++
T Consensus       412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          412 PPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999975

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=8.2e-46  Score=349.91  Aligned_cols=250  Identities=21%  Similarity=0.315  Sum_probs=211.7

Q ss_pred             ccceeeee-eecccCceEEEEEEE--ccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          117 INEYVHVR-KIGAGSYGKVVLYRS--SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       117 ~~~y~~~~-~lG~G~fg~Vy~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      .++|.+.+ .||+|+||.||++..  ..+++.||||++....       ......+.+.+|+.+++.++||||+++++++
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   87 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-------NDPALKDELLAEANVMQQLDNPYIVRMIGIC   87 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-------cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            35799988 999999999999954  5578899999986532       1234567899999999999999999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      ..   ...++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        88 ~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  164 (291)
T 1xbb_A           88 EA---ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS  164 (291)
T ss_dssp             ES---SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             CC---CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence            53   468999999999999998887778999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccc---cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCC
Q 015257          274 QVFEDDNDV---LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPD  348 (410)
Q Consensus       274 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~  348 (410)
                      .........   .....+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+....+....+..+. ..+|.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  243 (291)
T 1xbb_A          165 KALRADENYYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA  243 (291)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             eeeccCCCcccccccCCCCceeeChHHhccCCC-ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            876443221   223446789999999876554 578999999999999999 999999988877776666654 45678


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      .+++.+.+||.+||+.||.+|||+.++++
T Consensus       244 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          244 GCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            89999999999999999999999999985

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=369.84  Aligned_cols=254  Identities=24%  Similarity=0.380  Sum_probs=208.9

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+.+.||+|+||.||++++..+|+.||||++.....        ......+.+|+.+++.++||||+++++++.+
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   78 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--------LRPVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--------GSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--------cchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence            34689999999999999999999999999999999865422        1234567899999999999999999999988


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEE----cCCCcEEEe
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPG---AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV----APSGTVKIG  268 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~---~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll----~~~~~~kl~  268 (410)
                      ......++||||+++++|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (396)
T 4eut_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT  158 (396)
T ss_dssp             TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred             CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEe
Confidence            66668999999999999998887643   39999999999999999999999999999999999999    777889999


Q ss_pred             eccccccccCCccccccCCCcccccccccccCC-------cCCCchhhHHHHHHHHHHHHhCCCCCCC----CCHHHHHH
Q 015257          269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGL-------TYGGKAADTWAVGVTLYYMIIGQYPFLG----ETLQDTYD  337 (410)
Q Consensus       269 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwSlG~il~elltG~~Pf~~----~~~~~~~~  337 (410)
                      |||+++...... ......||+.|+|||++.+.       ...+.++|||||||++|+|++|..||..    ....+...
T Consensus       159 DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  237 (396)
T 4eut_A          159 DFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY  237 (396)
T ss_dssp             CGGGCEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred             cCCCceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence            999998765433 33456799999999987642       2225679999999999999999999964    23344555


Q ss_pred             HHHhCCCC-------------------CC------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          338 KIVNNSLV-------------------FP------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       338 ~i~~~~~~-------------------~p------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .+..+...                   +|      ..+++.+.+||.+||+.||.+|||+.+++++
T Consensus       238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            55554321                   11      1234678899999999999999999998654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.1e-45  Score=349.08  Aligned_cols=249  Identities=23%  Similarity=0.316  Sum_probs=205.9

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+.+.||+|+||.||++++..+|+.||||++.....           ...+.+|+.+++.++|++++..+..+..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~e~~~l~~l~~~~~i~~~~~~~~   75 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----------HPQLHIESKIYKMMQGGVGIPTIRWCGA   75 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----------CCHHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----------hhHHHHHHHHHHHhhcCCCCCccccccC
Confidence            45789999999999999999999999999999998764321           1257899999999999998888876654


Q ss_pred             CCCCEEEEEEeecCCCCcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEE---cCCCcEEEeecc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFS  271 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll---~~~~~~kl~DfG  271 (410)
                      . ....++||||+ +++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        76 ~-~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  153 (296)
T 3uzp_A           76 E-GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             E-TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             C-CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence            3 56889999999 778887775 45579999999999999999999999999999999999999   478999999999


Q ss_pred             ccccccCCcc-------ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHh
Q 015257          272 VSQVFEDDND-------VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET---LQDTYDKIVN  341 (410)
Q Consensus       272 ~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~---~~~~~~~i~~  341 (410)
                      +++.......       ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+..   .......+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  232 (296)
T 3uzp_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  232 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence            9987654322       1245679999999999887665 678999999999999999999997632   2223333333


Q ss_pred             CCCCC-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          342 NSLVF-----PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       342 ~~~~~-----p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .....     +..+++++.+|+.+||+.||.+|||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  274 (296)
T 3uzp_A          233 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL  274 (296)
T ss_dssp             HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred             cccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence            32222     36789999999999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.9e-46  Score=355.57  Aligned_cols=252  Identities=19%  Similarity=0.367  Sum_probs=211.4

Q ss_pred             ccceeeeeeecccCceEEEEEEE-----ccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccce
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRS-----SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLI  190 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  190 (410)
                      .++|.+.+.||+|+||.||++++     ..+++.||||++....        .......+.+|+.+++.+ +||||++++
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--------THSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--------CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--------CcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            46899999999999999999985     3467899999986431        344556899999999999 799999999


Q ss_pred             eEEEcCCCCEEEEEEeecCCCCcccccCCCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCcEeccCCC
Q 015257          191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGA----------------IGESMARKYLRDIVSGLMYLHGHNVVHGDIKP  254 (410)
Q Consensus       191 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~----------------l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp  254 (410)
                      +++... ...+++||||+++++|.+++.....                +++..++.++.||+.||.|||++||+||||||
T Consensus        98 ~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp  176 (316)
T 2xir_A           98 GACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA  176 (316)
T ss_dssp             EEECCT-TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             EEEecC-CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCcc
Confidence            998764 3568999999999999888765443                89999999999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 015257          255 DNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGET  331 (410)
Q Consensus       255 ~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~  331 (410)
                      +|||++.++.+||+|||+++.......  ......||+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+..
T Consensus       177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~  255 (316)
T 2xir_A          177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVK  255 (316)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence            999999999999999999986543322  2234457889999998876655 678999999999999998 999998866


Q ss_pred             HHHH-HHHHHhC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          332 LQDT-YDKIVNN-SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       332 ~~~~-~~~i~~~-~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .... ...+..+ ....|..+++++.++|.+||+.||.+|||+.++++|
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4443 3333333 345677899999999999999999999999999987

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.4e-46  Score=351.40  Aligned_cols=255  Identities=23%  Similarity=0.429  Sum_probs=213.0

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ..+..+|.+++.||+|+||.||++++..+|+.||||++....             ..+.+|+.+++.++||||+++++++
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~e~~~l~~l~h~~i~~~~~~~   73 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------------EKAEREVKALAKLDHVNIVHYNGCW   73 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------------GGGHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------------HHHHHHHHHHHhCCCCCEEEEeeeE
Confidence            345578999999999999999999999999999999986431             2466899999999999999999988


Q ss_pred             Ec--------------CCCCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcE
Q 015257          194 DD--------------PNSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNL  257 (410)
Q Consensus       194 ~~--------------~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NI  257 (410)
                      ..              .....+++||||+++++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Ni  153 (284)
T 2a19_B           74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNI  153 (284)
T ss_dssp             EEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             eccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHE
Confidence            54              123468999999999999888753  35799999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015257          258 LVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYD  337 (410)
Q Consensus       258 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~  337 (410)
                      |++.++.+||+|||++....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..|+...  .....
T Consensus       154 l~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~  229 (284)
T 2a19_B          154 FLVDTKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFET--SKFFT  229 (284)
T ss_dssp             EEEETTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHH
T ss_pred             EEcCCCCEEECcchhheeccccc-cccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhH--HHHHH
Confidence            99999999999999998765432 2345579999999999877665 67899999999999999999887432  22333


Q ss_pred             HHHhCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          338 KIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       338 ~i~~~~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                      .+...  .++..+++.+.+||.+||..||.+|||+.++++|.|.......
T Consensus       230 ~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          230 DLRDG--IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             HHHTT--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             Hhhcc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            33333  3567889999999999999999999999999999988765443

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-45  Score=354.87  Aligned_cols=251  Identities=25%  Similarity=0.355  Sum_probs=207.3

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCC----ceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDG----KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      ..+|.+.+.||+|+||.||++....++    ..||||++....        .......+.+|+.+++.++||||++++++
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~  114 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--------TEKQRVDFLGEAGIMGQFSHHNIIRLEGV  114 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--------CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--------CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            457999999999999999999987643    459999986431        34455678999999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      +.+  ...+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       115 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  192 (333)
T 1mqb_A          115 ISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG  192 (333)
T ss_dssp             ECS--SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             Eec--CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCC
Confidence            976  4579999999999999888764 3579999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCcc---ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCC
Q 015257          272 VSQVFEDDND---VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVF  346 (410)
Q Consensus       272 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~  346 (410)
                      +++.......   ......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+....+....+..+ ....
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~  271 (333)
T 1mqb_A          193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT  271 (333)
T ss_dssp             C-----------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred             cchhhccccccccccCCCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC
Confidence            9987644321   1223346888999999876655 678999999999999998 99999988887777777665 3456


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          347 PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       347 p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +..+++.+.+||.+||+.||.+|||+.+++++
T Consensus       272 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            67899999999999999999999999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.2e-46  Score=348.82  Aligned_cols=251  Identities=25%  Similarity=0.346  Sum_probs=209.6

Q ss_pred             cccceeeeeeecccCceEEEEEEEcc---CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      ..++|.+.+.||+|+||.||++....   ++..||||++....        .....+.+.+|+.+++.++||||++++++
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   81 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--------TLDNKEKFMSEAVIMKNLDHPHIVKLIGI   81 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--------CHHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--------CchHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            44689999999999999999998654   34569999876431        34456789999999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      +.+   ...++||||+++++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        82 ~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  158 (281)
T 3cc6_A           82 IEE---EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG  158 (281)
T ss_dssp             ECS---SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred             EcC---CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccC
Confidence            865   3468999999999998887553 469999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCcc-ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCC
Q 015257          272 VSQVFEDDND-VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPD  348 (410)
Q Consensus       272 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~  348 (410)
                      ++........ ......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||......+....+... ....|.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~  237 (281)
T 3cc6_A          159 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPD  237 (281)
T ss_dssp             GGGCC---------CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCT
T ss_pred             CCcccccccccccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCC
Confidence            9986544321 2234457889999998876555 678999999999999998 99999877766666665554 345677


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .+++.+.+||.+||..||.+|||+.+++++
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            899999999999999999999999999976

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=6.9e-46  Score=376.35  Aligned_cols=249  Identities=22%  Similarity=0.368  Sum_probs=215.3

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+.+.||+|+||.||++....++..||||++....          ...+.+.+|+.+|+.++|||||++++++.+
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  287 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR  287 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----------cchHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            3467999999999999999999999999999999986432          124678999999999999999999999976


Q ss_pred             CCCCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                        ...++|||||+++++|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       288 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a  365 (495)
T 1opk_A          288 --EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS  365 (495)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             --CCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccc
Confidence              4578999999999999888754  346899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCc-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCC
Q 015257          274 QVFEDDN-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAM  350 (410)
Q Consensus       274 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  350 (410)
                      +...... .......+|+.|+|||++.+..+ +.++|||||||+||+|++ |..||.+....+....+..+ ....|..+
T Consensus       366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  444 (495)
T 1opk_A          366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC  444 (495)
T ss_dssp             ECCTTCCEECCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred             eeccCCceeecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            8765432 22234456788999999876665 678999999999999999 99999988877776666554 34567889


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          351 NPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ++++.+||.+||+.||.+|||+.+|++
T Consensus       445 ~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          445 PEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            999999999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.1e-45  Score=343.51  Aligned_cols=247  Identities=24%  Similarity=0.380  Sum_probs=211.8

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||++... ++..||||++....          ...+.+.+|+.+++.++||||+++++++.+
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   79 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----------MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ   79 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----------ccHHHHHHHHHHHHhCCCcCcceEEEEEcC
Confidence            3468999999999999999999875 56789999986432          123578899999999999999999999864


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                         ...++||||+++++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        80 ---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  156 (279)
T 1qpc_A           80 ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA  156 (279)
T ss_dssp             ---SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ---CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccc
Confidence               35899999999999999887643  6999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCcc-ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCC
Q 015257          274 QVFEDDND-VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAM  350 (410)
Q Consensus       274 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~  350 (410)
                      ........ ......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+....+....+..+. ...+..+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (279)
T 1qpc_A          157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC  235 (279)
T ss_dssp             EECSSSCEECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             ccccCcccccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccc
Confidence            87654322 2234457889999998876555 678999999999999999 999999888877777766553 3566789


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          351 NPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ++++.+|+.+||..||.+|||++++++
T Consensus       236 ~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          236 PEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            999999999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.9e-46  Score=359.32  Aligned_cols=253  Identities=20%  Similarity=0.270  Sum_probs=205.1

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+.+.||+|+||.||++... +|+.||||++...         .....+.+.+|+.+++.++||||+++++++.
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  105 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE---------SSQGIEEFETEIETLSFCRHPHLVSLIGFCD  105 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC---------CSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred             HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc---------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            45678999999999999999999964 6899999987543         2234568899999999999999999999987


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeec
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPG----AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~----~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                      +  ....++||||+++++|.+++....    .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       106 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          106 E--RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             C--TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCC
T ss_pred             C--CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeec
Confidence            6  457899999999999998886543    5899999999999999999999999999999999999999999999999


Q ss_pred             cccccccCC--ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH-HHHh
Q 015257          271 SVSQVFEDD--NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQD------TYD-KIVN  341 (410)
Q Consensus       271 G~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~------~~~-~i~~  341 (410)
                      |+++.....  ........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+....+      +.. ....
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  262 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN  262 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred             ccccccccccccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence            999864432  222334568999999999876665 677999999999999999999997543211      111 1111


Q ss_pred             CCC----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCc
Q 015257          342 NSL----------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW  380 (410)
Q Consensus       342 ~~~----------~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~  380 (410)
                      +.+          .++...+..+.+++.+||+.||.+|||+.+++++..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            111          111233567899999999999999999999998753

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.1e-45  Score=371.11  Aligned_cols=249  Identities=22%  Similarity=0.347  Sum_probs=213.5

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ....++|.+.+.||+|+||.||++... ++..||||++....          ...+.+.+|+.+|+.++|||||++++++
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~l~~~~  252 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----------MSVEAFLAEANVMKTLQHDKLVKLHAVV  252 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----------BCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----------ccHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence            344578999999999999999999886 46789999986432          1346789999999999999999999998


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      ..   ..+++||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus       253 ~~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG  329 (454)
T 1qcf_A          253 TK---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG  329 (454)
T ss_dssp             CS---SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred             eC---CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCC
Confidence            63   4689999999999999888654  368999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCcc-ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCC
Q 015257          272 VSQVFEDDND-VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPD  348 (410)
Q Consensus       272 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~  348 (410)
                      +++....... ......+|+.|+|||++....+ +.++|||||||+||||++ |..||.+....+....+..+ ....|.
T Consensus       330 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~  408 (454)
T 1qcf_A          330 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE  408 (454)
T ss_dssp             GGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCT
T ss_pred             CceEcCCCceeccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            9987644321 2234456788999999876655 678999999999999999 99999998888877777665 345677


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      .+++++.+||.+||..||.+|||+++|++
T Consensus       409 ~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          409 NCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            89999999999999999999999999975

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.5e-45  Score=352.79  Aligned_cols=253  Identities=24%  Similarity=0.414  Sum_probs=207.8

Q ss_pred             ccccce-eeeeeecccCceEEEEEE----EccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccc
Q 015257          115 KMINEY-VHVRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNL  189 (410)
Q Consensus       115 ~~~~~y-~~~~~lG~G~fg~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  189 (410)
                      .+.++| ++++.||+|+||.||++.    +..+++.||||++....        .......+.+|+.+++.++||||+++
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~   98 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--------GPQHRSGWKQEIDILRTLYHEHIIKY   98 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--------CHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--------ChHHHHHHHHHHHHHHhCCCcchhhE
Confidence            344555 999999999999998875    34478999999986431        34556789999999999999999999


Q ss_pred             eeEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEee
Q 015257          190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGD  269 (410)
Q Consensus       190 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~D  269 (410)
                      ++++.+.....+++||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~D  177 (318)
T 3lxp_A           99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGD  177 (318)
T ss_dssp             EEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECC
Confidence            9999886667899999999999999888654 499999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCcc---ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------------
Q 015257          270 FSVSQVFEDDND---VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ-------------  333 (410)
Q Consensus       270 fG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-------------  333 (410)
                      ||++........   ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||......             
T Consensus       178 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  256 (318)
T 3lxp_A          178 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKF-YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT  256 (318)
T ss_dssp             GGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHH
T ss_pred             ccccccccccccccccccCCCCCceeeChHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchh
Confidence            999987654322   2334568889999999877665 57799999999999999999999653211             


Q ss_pred             --HHHHHHHh-CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          334 --DTYDKIVN-NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       334 --~~~~~i~~-~~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                        .....+.. .....+..+++++.+||.+||+.||.+|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          257 VLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence              11111222 234567789999999999999999999999999985

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.7e-45  Score=347.72  Aligned_cols=248  Identities=24%  Similarity=0.336  Sum_probs=201.6

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+.+.||+|+||.||++++..+++.||||++.....           ...+.+|+.+++.++|++++..+..+..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~e~~~l~~l~~~~~i~~~~~~~~   75 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----------HPQLHIESKIYKMMQGGVGIPTIRWCGA   75 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------------CCCHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----------chHHHHHHHHHHHhcCCCCCCeeeeecC
Confidence            44689999999999999999999999999999998654321           1247899999999999998888877654


Q ss_pred             CCCCEEEEEEeecCCCCcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEE---cCCCcEEEeecc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFS  271 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll---~~~~~~kl~DfG  271 (410)
                      . ....++||||+ +++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        76 ~-~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg  153 (296)
T 4hgt_A           76 E-GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             E-TTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred             C-CCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence            2 56889999999 778877765 34579999999999999999999999999999999999999   788999999999


Q ss_pred             ccccccCCcc-------ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh
Q 015257          272 VSQVFEDDND-------VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL---QDTYDKIVN  341 (410)
Q Consensus       272 ~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~---~~~~~~i~~  341 (410)
                      +++.......       ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+...   ......+..
T Consensus       154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  232 (296)
T 4hgt_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  232 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred             cceeccCcccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc
Confidence            9987654322       2235679999999999887665 6789999999999999999999976432   123333333


Q ss_pred             CCCCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          342 NSLVFP-----DAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       342 ~~~~~p-----~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      .....|     ..+++++.+||.+||+.||.+|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          233 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            222223     678999999999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.2e-46  Score=356.85  Aligned_cols=252  Identities=23%  Similarity=0.376  Sum_probs=210.6

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCc-----eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGK-----HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNL  189 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  189 (410)
                      ..++|.+.+.||+|+||.||++.+..+++     .||+|++....        .......+.+|+.+++.+ +||||+++
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~~iv~~  115 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--------HADEKEALMSELKIMSHLGQHENIVNL  115 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--------ChHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            34689999999999999999999877654     79999886431        344567899999999999 89999999


Q ss_pred             eeEEEcCCCCEEEEEEeecCCCCcccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCC
Q 015257          190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ--------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPD  255 (410)
Q Consensus       190 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--------------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~  255 (410)
                      ++++.+  ...+++||||+++++|.+++..              ...+++..++.++.||+.||.|||++||+||||||+
T Consensus       116 ~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~  193 (333)
T 2i1m_A          116 LGACTH--GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAAR  193 (333)
T ss_dssp             EEEECS--SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             EEEEec--CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccc
Confidence            999976  4578999999999888877643              346899999999999999999999999999999999


Q ss_pred             cEEEcCCCcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 015257          256 NLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETL  332 (410)
Q Consensus       256 NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~  332 (410)
                      |||++.++.+||+|||+++.......  ......||+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+...
T Consensus       194 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~  272 (333)
T 2i1m_A          194 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGLNPYPGILV  272 (333)
T ss_dssp             GCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred             eEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence            99999999999999999986543322  2234457889999998876655 678999999999999998 9999988765


Q ss_pred             HHHHHHHHhCC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          333 QDTYDKIVNNS--LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       333 ~~~~~~i~~~~--~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ......+....  ...|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          273 NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            55544444433  34567789999999999999999999999999874

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-45  Score=343.88  Aligned_cols=250  Identities=22%  Similarity=0.271  Sum_probs=208.7

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCc---eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGK---HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      .|.+.+.||+|+||.||++....++.   .||+|++...        ......+.+.+|+.+++.++||||+++++++.+
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   93 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--------TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP   93 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--------CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--------ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence            57788999999999999999765544   7999987532        234566789999999999999999999999976


Q ss_pred             CCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      . ....++||||+.++++.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        94 ~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  172 (298)
T 3pls_A           94 P-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLAR  172 (298)
T ss_dssp             S-SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred             C-CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence            4 3455899999999999888765 4578999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCc----cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCC
Q 015257          275 VFEDDN----DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPD  348 (410)
Q Consensus       275 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~  348 (410)
                      ......    .......+|+.|+|||.+.+..+ +.++||||||+++|+|++ |.+||......+....+.... ...+.
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (298)
T 3pls_A          173 DILDREYYSVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPE  251 (298)
T ss_dssp             TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCT
T ss_pred             cccCCcccccccCcCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCc
Confidence            654322    22334568899999999877665 678999999999999999 555666666666665555544 45677


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .+++.+.+||.+||+.||.+|||+.++++.
T Consensus       252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          252 YCPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            899999999999999999999999999863

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=352.03  Aligned_cols=255  Identities=21%  Similarity=0.301  Sum_probs=204.4

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC-
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP-  196 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  196 (410)
                      ++|.+++.||+|+||.||++++..+|+.||||++...         .......+.+|+.+++.++||||+++++++... 
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---------EQQDREEAQREADMHRLFNHPNILRLVAYCLRER   99 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---------CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence            5799999999999999999999999999999988542         344567889999999999999999999998632 


Q ss_pred             -CCCEEEEEEeecCCCCcccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          197 -NSDHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       197 -~~~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                       .....++||||+.+++|.+.+..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence             24578999999999988876653    5679999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCcc---------ccccCCCcccccccccccCCcC--CCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH
Q 015257          272 VSQVFEDDND---------VLRRSPGTPVFTAPECCLGLTY--GGKAADTWAVGVTLYYMIIGQYPFLGETL--QDTYDK  338 (410)
Q Consensus       272 ~a~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlG~il~elltG~~Pf~~~~~--~~~~~~  338 (410)
                      ++........         ......||+.|+|||++.+...  .+.++||||||+++|+|++|..||.....  ......
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  259 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA  259 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence            9875432111         1123457999999998865432  36689999999999999999999953110  011111


Q ss_pred             HHh-CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          339 IVN-NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       339 i~~-~~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      +.. .....+..+++++.+||.+||+.||.+|||+.+++++-.-
T Consensus       260 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  303 (317)
T 2buj_A          260 VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA  303 (317)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhh
Confidence            222 1223345789999999999999999999999999997443

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.4e-45  Score=346.47  Aligned_cols=252  Identities=21%  Similarity=0.331  Sum_probs=195.9

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ....++|.+.+.||+|+||.||+++..   ..||||++....       ......+.+.+|+.+++.++||||++++++.
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   89 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-------PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS   89 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-------CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec
Confidence            344568999999999999999998754   359999986432       2345667899999999999999999999976


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      ..   ..+++||||+++++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        90 ~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  166 (289)
T 3og7_A           90 TA---PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL  166 (289)
T ss_dssp             CS---SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred             cC---CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEcccee
Confidence            43   458999999999998887754 45799999999999999999999999999999999999999999999999999


Q ss_pred             cccccC--CccccccCCCcccccccccccC--CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhCCCC--
Q 015257          273 SQVFED--DNDVLRRSPGTPVFTAPECCLG--LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTY-DKIVNNSLV--  345 (410)
Q Consensus       273 a~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-~~i~~~~~~--  345 (410)
                      ++....  .........||+.|+|||++..  ....+.++||||||+++|+|++|..||......+.. ..+..+...  
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  246 (289)
T 3og7_A          167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD  246 (289)
T ss_dssp             -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC
T ss_pred             ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc
Confidence            976542  1223345679999999998862  222366899999999999999999999886554443 333333322  


Q ss_pred             ---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          346 ---FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       346 ---~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                         ++..+++.+.+||.+||+.||.+|||+.++++.
T Consensus       247 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  282 (289)
T 3og7_A          247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE  282 (289)
T ss_dssp             TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence               234788999999999999999999999999863

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.3e-45  Score=345.85  Aligned_cols=252  Identities=18%  Similarity=0.229  Sum_probs=208.6

Q ss_pred             ccceeeeeeecccCceEEEEEEEccC---CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ..+|.+.+.||+|+||.||++....+   ...+|+|.+...        ........+.+|+.+++.++||||+++++++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   95 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC   95 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--------CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--------CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEE
Confidence            35799999999999999999997543   346899987542        2345667899999999999999999999987


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      ... ....++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~  174 (298)
T 3f66_A           96 LRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGL  174 (298)
T ss_dssp             CCS-SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred             EcC-CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccc
Confidence            653 4578999999999999988765 45689999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCc----cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCC-CC
Q 015257          273 SQVFEDDN----DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSL-VF  346 (410)
Q Consensus       273 a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~  346 (410)
                      ++......    .......||+.|+|||++.+..+ +.++||||||+++|+|++ |.+||......+....+..... ..
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (298)
T 3f66_A          175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ  253 (298)
T ss_dssp             GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC
T ss_pred             cccccccchhccccccCCCCCccccChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC
Confidence            98654332    12234557889999999876655 678999999999999999 6778877766666666666544 45


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          347 PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       347 p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      |..+++.+.+|+.+||+.||.+|||+.++++.
T Consensus       254 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  285 (298)
T 3f66_A          254 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  285 (298)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            67889999999999999999999999999863

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=367.75  Aligned_cols=250  Identities=25%  Similarity=0.351  Sum_probs=191.9

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEEcC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDP  196 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  196 (410)
                      .+|.+.+.||+|+||+|+ +....+|+.||||++......            .+.+|+.+|+.+ +|||||++++++.+ 
T Consensus        24 ~~y~~~~~LG~G~~G~V~-~~~~~~~~~vAvK~~~~~~~~------------~~~~E~~~l~~l~~HpnIv~l~~~~~~-   89 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFS------------FADREVQLLRESDEHPNVIRYFCTEKD-   89 (432)
T ss_dssp             EEEEEEEEEEECGGGCEE-EEEESSSSEEEEEEECTTTEE------------ECHHHHHHHHHSCCCTTBCCEEEEEEE-
T ss_pred             EEEecCCeeecCcCEEEE-EEEEeCCeEEEEEEECHHHHH------------HHHHHHHHHHhccCCCCcCeEEEEEec-
Confidence            369999999999999986 566678999999998653221            245899999999 79999999999986 


Q ss_pred             CCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC-----CcEEEeec
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-----GTVKIGDF  270 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~-----~~~kl~Df  270 (410)
                       ...+||||||++| +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+     ..+||+||
T Consensus        90 -~~~~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DF  167 (432)
T 3p23_A           90 -RQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDF  167 (432)
T ss_dssp             -TTEEEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred             -CCEEEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence             4689999999986 55555543 3356666778999999999999999999999999999999532     35889999


Q ss_pred             cccccccCCc---cccccCCCcccccccccccCC--cCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCC
Q 015257          271 SVSQVFEDDN---DVLRRSPGTPVFTAPECCLGL--TYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSL  344 (410)
Q Consensus       271 G~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~  344 (410)
                      |+++......   .......||+.|+|||++.+.  ...+.++|||||||++|+|++ |..||...........+.....
T Consensus       168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~  247 (432)
T 3p23_A          168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL  247 (432)
T ss_dssp             TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCC
T ss_pred             cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCc
Confidence            9998765332   233456799999999998742  233568999999999999999 9999966544333222111111


Q ss_pred             C---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          345 V---FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       345 ~---~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                      .   .+...+..+.+||.+||+.||.+|||+.++++||||.+
T Consensus       248 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          248 DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            1   11234566899999999999999999999999999975

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.3e-44  Score=342.71  Aligned_cols=249  Identities=24%  Similarity=0.330  Sum_probs=198.2

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHh--CCCCCcccceeE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM--LQHPNIVNLIEV  192 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~  192 (410)
                      ...++|.+++.||+|+||.||+++.  +|+.||||++...            ....+.+|.+++..  ++||||++++++
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------------~~~~~~~e~~~~~~~~l~h~niv~~~~~   70 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------------DEKSWFRETELYNTVMLRHENILGFIAS   70 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------------GHHHHHHHHHHHHHTCCCCTTBCCEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------------cchhhHHHHHHHHHhhccCcCeeeEEEe
Confidence            3457899999999999999999987  6899999998542            22455667777776  799999999998


Q ss_pred             EEcC--CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEeccCCCCcEEEcCC
Q 015257          193 IDDP--NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH--------GHNVVHGDIKPDNLLVAPS  262 (410)
Q Consensus       193 ~~~~--~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH--------~~~iiHrDlkp~NIll~~~  262 (410)
                      +.+.  ....+++||||+++++|.+++.. ..+++..++.++.||+.||.|||        +.||+||||||+|||++.+
T Consensus        71 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~  149 (301)
T 3q4u_A           71 DMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN  149 (301)
T ss_dssp             EEEEETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT
T ss_pred             eccccCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC
Confidence            6542  23578999999999999998854 47999999999999999999999        9999999999999999999


Q ss_pred             CcEEEeeccccccccCCccc----cccCCCcccccccccccCCcCC-----CchhhHHHHHHHHHHHHhC----------
Q 015257          263 GTVKIGDFSVSQVFEDDNDV----LRRSPGTPVFTAPECCLGLTYG-----GKAADTWAVGVTLYYMIIG----------  323 (410)
Q Consensus       263 ~~~kl~DfG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwSlG~il~elltG----------  323 (410)
                      +.+||+|||+++........    .....||+.|+|||++.+....     +.++|||||||++|+|++|          
T Consensus       150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~  229 (301)
T 3q4u_A          150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY  229 (301)
T ss_dssp             SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence            99999999999765443222    2344799999999998765322     3579999999999999999          


Q ss_pred             CCCCCCCC----HHHHHHHHHhCC---CCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          324 QYPFLGET----LQDTYDKIVNNS---LVFP-----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       324 ~~Pf~~~~----~~~~~~~i~~~~---~~~p-----~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..||....    ............   ..+|     ...++++.+||.+||+.||.+|||+.++++.
T Consensus       230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~  296 (301)
T 3q4u_A          230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT  296 (301)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            88885532    222233332221   1222     1245789999999999999999999999863

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=355.76  Aligned_cols=260  Identities=20%  Similarity=0.206  Sum_probs=199.6

Q ss_pred             ccceeeeeeecccCceEEEEEEEcc---CCceEEEEeeecccccccccC--CChHHHHHHHHHHHHHHhCCCCCccccee
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSL---DGKHYAIKAFHKSHLSKLRVA--PSETAMTDVRREVLIMKMLQHPNIVNLIE  191 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~  191 (410)
                      .++|.+.+.||+|+||.||++.+..   ++..+|||++...........  ........+.+|+.+++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3689999999999999999999987   788999999875421100000  00001124668899999999999999999


Q ss_pred             EEEc--CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC--cEEE
Q 015257          192 VIDD--PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG--TVKI  267 (410)
Q Consensus       192 ~~~~--~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~--~~kl  267 (410)
                      ++..  .....+++||||+ +++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL  194 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL  194 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence            9876  2346899999999 889999888777899999999999999999999999999999999999999887  9999


Q ss_pred             eeccccccccCCc-------cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHH
Q 015257          268 GDFSVSQVFEDDN-------DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE--TLQDTYDK  338 (410)
Q Consensus       268 ~DfG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~--~~~~~~~~  338 (410)
                      +|||+++......       .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.  ........
T Consensus       195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  273 (345)
T 2v62_A          195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA  273 (345)
T ss_dssp             CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred             EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence            9999998654321       11245579999999999887655 77899999999999999999999652  22222111


Q ss_pred             HHhCCCCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          339 IVNNSLVFP---------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       339 i~~~~~~~p---------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .......+|         ..+++++.+||.+||+.||.+|||+.+|++.
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            111111122         2789999999999999999999999999874

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.1e-45  Score=366.95  Aligned_cols=250  Identities=24%  Similarity=0.382  Sum_probs=192.6

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEEE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVID  194 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  194 (410)
                      ..+.|.+.+.||+|+||+||.+ ...+|+.||||++...            ..+.+.+|+.+|+.+ +|||||++++++.
T Consensus        13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~------------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~   79 (434)
T 2rio_A           13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID------------FCDIALMEIKLLTESDDHPNVIRYYCSET   79 (434)
T ss_dssp             CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG------------GHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH------------HHHHHHHHHHHHHhccCCCCcCeEEEEEe
Confidence            3456777899999999999864 5568999999988542            234578999999876 8999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCC-------CHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC-----
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAI-------GESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-----  262 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l-------~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~-----  262 (410)
                      +  ...+++||||++| +|.+++......       ++..++.++.||+.||+|||++||+||||||+|||++.+     
T Consensus        80 ~--~~~~~lv~E~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~  156 (434)
T 2rio_A           80 T--DRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTA  156 (434)
T ss_dssp             C--SSEEEEEECCCSE-EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHS
T ss_pred             c--CCeEEEEEecCCC-CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccc
Confidence            6  5689999999975 777777654332       233457899999999999999999999999999999754     


Q ss_pred             --------CcEEEeeccccccccCCcc----ccccCCCcccccccccccCC------cCCCchhhHHHHHHHHHHHHh-C
Q 015257          263 --------GTVKIGDFSVSQVFEDDND----VLRRSPGTPVFTAPECCLGL------TYGGKAADTWAVGVTLYYMII-G  323 (410)
Q Consensus       263 --------~~~kl~DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwSlG~il~ellt-G  323 (410)
                              +.+||+|||+++.......    ......||+.|+|||++.+.      ...+.++|||||||++|+|++ |
T Consensus       157 ~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g  236 (434)
T 2rio_A          157 DQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG  236 (434)
T ss_dssp             CCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             ccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCC
Confidence                    4899999999987654322    12345799999999998652      334778999999999999999 9


Q ss_pred             CCCCCCCCHHHHHHHHHhCCCCCCC-------CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          324 QYPFLGETLQDTYDKIVNNSLVFPD-------AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       324 ~~Pf~~~~~~~~~~~i~~~~~~~p~-------~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                      ..||.......  ..+..+...++.       .+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       237 ~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          237 KHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             CCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             CCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            99997654433  344444433322       23578999999999999999999999999999964

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.3e-45  Score=346.16  Aligned_cols=244  Identities=24%  Similarity=0.424  Sum_probs=202.3

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||++...  |+.||||++...           ...+.+.+|+.+++.++||||+++++++.+
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----------ATAQAFLAEASVMTQLRHSNLVQLLGVIVE   85 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----------C--HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch-----------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence            3468999999999999999999874  889999997532           134578899999999999999999998765


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      . ...+++||||+++++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        86 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~  164 (278)
T 1byg_A           86 E-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT  164 (278)
T ss_dssp             C---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             C-CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccc
Confidence            3 347899999999999888876543  3899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCCC
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMN  351 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~  351 (410)
                      ......   .....+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||......+....+..+ ....+..++
T Consensus       165 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (278)
T 1byg_A          165 KEASST---QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP  240 (278)
T ss_dssp             --------------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCC
T ss_pred             cccccc---ccCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCC
Confidence            764432   223457889999998876555 678999999999999998 99999988777777666554 345677899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          352 PELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       352 ~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      +.+.+||.+||..||.+|||+.++++
T Consensus       241 ~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          241 PAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            99999999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.7e-46  Score=361.99  Aligned_cols=259  Identities=16%  Similarity=0.182  Sum_probs=198.4

Q ss_pred             ccceeeeeeecccCceEEEEEEEccC-----CceEEEEeeecccccccccC--CChHHHHHHHHHHHHHHhCCCCCcccc
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLD-----GKHYAIKAFHKSHLSKLRVA--PSETAMTDVRREVLIMKMLQHPNIVNL  189 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l  189 (410)
                      .++|.+.+.||+|+||.||++.+..+     ++.||||++...........  ........+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            35899999999999999999998764     58899999865421000000  000011134456777888899999999


Q ss_pred             eeEEEcCC--CCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEc--CCCc
Q 015257          190 IEVIDDPN--SDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA--PSGT  264 (410)
Q Consensus       190 ~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~--~~~~  264 (410)
                      ++++....  ....+|||||+ |++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++  .++.
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~  192 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ  192 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence            99887632  25689999999 88888877654 6799999999999999999999999999999999999999  8899


Q ss_pred             EEEeeccccccccCCcc-------ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015257          265 VKIGDFSVSQVFEDDND-------VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYD  337 (410)
Q Consensus       265 ~kl~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~  337 (410)
                      +||+|||+++.......       ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+........
T Consensus       193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~  271 (364)
T 3op5_A          193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV  271 (364)
T ss_dssp             EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred             EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence            99999999986543321       1134459999999999887665 778999999999999999999998632222111


Q ss_pred             HHHh----CC-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          338 KIVN----NS-------LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       338 ~i~~----~~-------~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ....    ..       ...+..+++++.+|+..||..||.+|||+.+|++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            1100    00       0112577999999999999999999999999885

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-45  Score=359.61  Aligned_cols=251  Identities=18%  Similarity=0.231  Sum_probs=201.1

Q ss_pred             cceeeeeeecccCceEEEEEEEccCC---ceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDG---KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ..|.+.+.||+|+||.||++....++   ..||||.+...        ........+.+|+.+++.++||||+++++++.
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~  160 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL  160 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--------SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            35888999999999999999876432   46899987532        13455678999999999999999999999876


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .. .+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       161 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a  239 (373)
T 3c1x_A          161 RS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA  239 (373)
T ss_dssp             CC-SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             cC-CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccc
Confidence            53 35689999999999999888654 46899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCcc----ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCC
Q 015257          274 QVFEDDND----VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFP  347 (410)
Q Consensus       274 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p  347 (410)
                      +.......    ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |.+||......+....+..+. ...|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p  318 (373)
T 3c1x_A          240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP  318 (373)
T ss_dssp             ------------------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCC
T ss_pred             ccccccccccccccCCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            86543221    1233457889999999876655 678999999999999999 788888776666655565554 3456


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       319 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          319 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7899999999999999999999999999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.5e-45  Score=367.13  Aligned_cols=253  Identities=23%  Similarity=0.347  Sum_probs=209.9

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+.+.||+|+||.||++.... +..||||++.....          ..+.+.+|+.+|+.++||||+++++++.
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~hp~iv~~~~~~~  249 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----------SPEAFLQEAQVMKKLRHEKLVQLYAVVS  249 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----------CHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            345689999999999999999999874 46799999864321          2357899999999999999999999986


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      +   ..+++||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus       250 ~---~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~  326 (452)
T 1fmk_A          250 E---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL  326 (452)
T ss_dssp             S---SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             C---CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCcc
Confidence            5   4589999999999999888742  4689999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCcc-ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCC
Q 015257          273 SQVFEDDND-VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDA  349 (410)
Q Consensus       273 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~  349 (410)
                      ++....... ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+..+ ....|..
T Consensus       327 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~  405 (452)
T 1fmk_A          327 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE  405 (452)
T ss_dssp             TC--------------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             ceecCCCceecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            987644321 2233457888999998876655 678999999999999999 99999998888877777665 3456788


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhC--Cccc
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKH--TWVL  382 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h--~~~~  382 (410)
                      +++.+.+||.+||+.||.+|||+++|++.  .++.
T Consensus       406 ~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          406 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            99999999999999999999999999863  4544

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=345.40  Aligned_cols=252  Identities=24%  Similarity=0.387  Sum_probs=202.2

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+.+.||+|+||.||+++..  ++.||||++..           ....+.+.+|+.+++.++||||+++++++.+ 
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-----------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-   72 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-----------ESERKAFIVELRQLSRVNHPNIVKLYGACLN-   72 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS-----------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC-----------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence            468999999999999999999875  78899998742           2345678999999999999999999998863 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCcEeccCCCCcEEEcCCCc-EEEee
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPG---AIGESMARKYLRDIVSGLMYLHG---HNVVHGDIKPDNLLVAPSGT-VKIGD  269 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~---~l~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlkp~NIll~~~~~-~kl~D  269 (410)
                         ..++||||+++++|.+++....   .+++..+..++.||+.||.|||+   +||+||||||+|||++.++. +||+|
T Consensus        73 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~D  149 (307)
T 2eva_A           73 ---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD  149 (307)
T ss_dssp             ---TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECC
T ss_pred             ---CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcc
Confidence               3789999999999998876654   47899999999999999999999   89999999999999998886 79999


Q ss_pred             ccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHh-CCCCC
Q 015257          270 FSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL--QDTYDKIVN-NSLVF  346 (410)
Q Consensus       270 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~--~~~~~~i~~-~~~~~  346 (410)
                      ||++......   .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....  ......+.. .....
T Consensus       150 fg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  225 (307)
T 2eva_A          150 FGTACDIQTH---MTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL  225 (307)
T ss_dssp             CCC---------------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCC
T ss_pred             cccccccccc---cccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCc
Confidence            9999764332   234568999999999877655 6789999999999999999999976432  223333333 23456


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhh-----CCcccCCCCCCc
Q 015257          347 PDAMNPELRNLLEGLLCKDPTRRLTLNDVAK-----HTWVLGDNGPIP  389 (410)
Q Consensus       347 p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~-----h~~~~~~~~~~~  389 (410)
                      +..+++.+.+||.+||+.||.+|||++++++     ..++.+...|.+
T Consensus       226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~  273 (307)
T 2eva_A          226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ  273 (307)
T ss_dssp             BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCC
T ss_pred             ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCccc
Confidence            6789999999999999999999999999998     466665554443

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.4e-46  Score=356.66  Aligned_cols=263  Identities=21%  Similarity=0.269  Sum_probs=207.1

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+.+.||+|+||.||+++.. +|+.||||++......        .....+.+|+.+++.++||||+++++++.+
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   98 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ--------GGELQFQTEVEMISMAVHRNLLRLRGFCMT   98 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------------CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred             HhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc--------hHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence            3468999999999999999999754 6899999998654211        111258899999999999999999999976


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcEeccCCCCcEEEcCCCcEEEe
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQP----GAIGESMARKYLRDIVSGLMYLHGH---NVVHGDIKPDNLLVAPSGTVKIG  268 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~----~~l~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlkp~NIll~~~~~~kl~  268 (410)
                        ....++||||+++++|.+.+...    ..+++..++.++.||+.||.|||++   ||+||||||+|||++.++.+||+
T Consensus        99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           99 --PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             --SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             --CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence              45689999999999988877543    3599999999999999999999999   99999999999999999999999


Q ss_pred             eccccccccCC-ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHH
Q 015257          269 DFSVSQVFEDD-NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE--------TLQDTYDKI  339 (410)
Q Consensus       269 DfG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~--------~~~~~~~~i  339 (410)
                      |||+++..... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||...        ...+.....
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             cCccccccCcccccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            99999876533 233445569999999998876665 67899999999999999999999521        111111111


Q ss_pred             HhCCC-----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCch
Q 015257          340 VNNSL-----------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ  390 (410)
Q Consensus       340 ~~~~~-----------~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~  390 (410)
                      .....           .++...++.+.+|+.+||+.||.+|||+.+|++|.+-.+...+.++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~  317 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEE  317 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC-
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhh
Confidence            11100           1111233679999999999999999999999999876666555544

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.7e-45  Score=344.69  Aligned_cols=252  Identities=29%  Similarity=0.416  Sum_probs=203.6

Q ss_pred             ccceeeeeeecccCceEEEEEEEcc-CCc--eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSL-DGK--HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      .++|++++.||+|+||.||+++... +++  .||||++......      .....+.+.+|+.+++.++||||+++++++
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   90 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS------QPEAMDDFIREVNAMHSLDHRNLIRLYGVV   90 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC------CHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence            3589999999999999999998654 333  6999998654221      235667899999999999999999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      .+.   ..++||||++++++.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        91 ~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~  167 (291)
T 1u46_A           91 LTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL  167 (291)
T ss_dssp             CSS---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             ccC---CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccc
Confidence            763   378999999999888877553 5699999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCcc---ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC--CCC
Q 015257          273 SQVFEDDND---VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS--LVF  346 (410)
Q Consensus       273 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~--~~~  346 (410)
                      +........   ......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+....+....+....  ...
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  246 (291)
T 1u46_A          168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR  246 (291)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC
T ss_pred             cccccccccchhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC
Confidence            987644322   2234457889999998876655 678999999999999999 999999988888877776654  345


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          347 PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       347 p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +..+++++.++|.+||..||.+|||+.+++++
T Consensus       247 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          247 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            56899999999999999999999999999974

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.9e-45  Score=378.90  Aligned_cols=243  Identities=21%  Similarity=0.338  Sum_probs=206.9

Q ss_pred             eeecccCceEEEEEEE--ccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEE
Q 015257          124 RKIGAGSYGKVVLYRS--SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHF  201 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  201 (410)
                      +.||+|+||.||++..  ..+++.||||++.....       .....+.+.+|+.+|+.++|||||++++++.+   ..+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~  444 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-------DPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESW  444 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-------CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCE
Confidence            4799999999999954  45678999999865421       23445789999999999999999999999974   358


Q ss_pred             EEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCcc
Q 015257          202 YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND  281 (410)
Q Consensus       202 ~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  281 (410)
                      ++||||+++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       445 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~  524 (635)
T 4fl3_A          445 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  524 (635)
T ss_dssp             EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred             EEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence            99999999999999988888899999999999999999999999999999999999999999999999999987644322


Q ss_pred             ---ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHH
Q 015257          282 ---VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMNPELRN  356 (410)
Q Consensus       282 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~l~~  356 (410)
                         ......+|+.|+|||++.+..+ +.++|||||||+||||++ |..||.+....+....+..+. ...|..+++++.+
T Consensus       525 ~~~~~~~~~~t~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  603 (635)
T 4fl3_A          525 YYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD  603 (635)
T ss_dssp             ----------CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ccccccCCCCceeeeChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence               2233456889999999876665 678999999999999998 999999988888777777654 4578889999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhh
Q 015257          357 LLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       357 li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ||.+||..||.+|||+.+|++
T Consensus       604 li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          604 LMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHH
Confidence            999999999999999999975

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.2e-45  Score=354.00  Aligned_cols=244  Identities=14%  Similarity=0.199  Sum_probs=200.1

Q ss_pred             cceeeeeeecccCceEEEEEEEcc--------CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCccc-
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSL--------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVN-  188 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~-  188 (410)
                      ++|.+.+.||+|+||.||++++..        .++.||||++...              ..+.+|+.+++.++||||++ 
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------------~~~~~E~~~l~~l~h~niv~~  107 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------------GRLFNEQNFFQRAAKPLQVNK  107 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------------STHHHHHHHHHHHCCHHHHHH
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------------chHHHHHHHHHHhcccchhhh
Confidence            689999999999999999999987        4889999998643              25779999999999999998 


Q ss_pred             --------------ceeEEEcCCCCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccC
Q 015257          189 --------------LIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDI  252 (410)
Q Consensus       189 --------------l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl  252 (410)
                                    +++++.. ....+++||||+ +++|.+++...  ..+++..++.++.||+.||.|||++||+||||
T Consensus       108 ~~~~~~~~~~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Di  185 (352)
T 2jii_A          108 WKKLYSTPLLAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNV  185 (352)
T ss_dssp             HHHHTTCTTCSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCC
T ss_pred             hhhhccCCccCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence                          5666654 246899999999 88999888765  68999999999999999999999999999999


Q ss_pred             CCCcEEEcCCC--cEEEeeccccccccCCcc-------ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhC
Q 015257          253 KPDNLLVAPSG--TVKIGDFSVSQVFEDDND-------VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIG  323 (410)
Q Consensus       253 kp~NIll~~~~--~~kl~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG  323 (410)
                      ||+|||++.++  .+||+|||+++.......       ......||+.|+|||++.+..+ +.++|||||||++|+|++|
T Consensus       186 kp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g  264 (352)
T 2jii_A          186 TAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYG  264 (352)
T ss_dssp             CGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHS
T ss_pred             CHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhC
Confidence            99999999998  899999999986543321       1234479999999998877655 6789999999999999999


Q ss_pred             CCCCCCCC--HHHHH---HHHHhCCCCCCC------CCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          324 QYPFLGET--LQDTY---DKIVNNSLVFPD------AMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       324 ~~Pf~~~~--~~~~~---~~i~~~~~~~p~------~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..||....  .....   ..+......++.      .+++++.+||.+||+.||.+|||++++++.
T Consensus       265 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          265 FLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             CCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             CCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            99998753  22222   222223222222      568999999999999999999999999864

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1e-44  Score=343.99  Aligned_cols=234  Identities=26%  Similarity=0.503  Sum_probs=191.3

Q ss_pred             cccccceeee-eeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHH-HhCCCCCccccee
Q 015257          114 TKMINEYVHV-RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM-KMLQHPNIVNLIE  191 (410)
Q Consensus       114 ~~~~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~  191 (410)
                      ....++|.++ +.||+|+||.||++.+..+++.||||++...              ..+.+|+.++ +.++||||+++++
T Consensus        13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~e~~~~~~~~~h~~i~~~~~   78 (299)
T 3m2w_A           13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVD   78 (299)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------------HHHHHHHHHHHHhccCCCchhHHh
Confidence            3456778887 7899999999999999999999999998532              3567888887 7779999999999


Q ss_pred             EEEc--CCCCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC---CCc
Q 015257          192 VIDD--PNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP---SGT  264 (410)
Q Consensus       192 ~~~~--~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~---~~~  264 (410)
                      ++..  .....+++||||+++++|.+.+...  ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++.
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~  158 (299)
T 3m2w_A           79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI  158 (299)
T ss_dssp             EEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCC
T ss_pred             hhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCc
Confidence            8865  2345799999999999998887654  36999999999999999999999999999999999999998   788


Q ss_pred             EEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHH
Q 015257          265 VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYD----KIV  340 (410)
Q Consensus       265 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~----~i~  340 (410)
                      +||+|||++.....                      .. .+.++|||||||++|+|++|..||..........    .+.
T Consensus       159 ~kl~Dfg~a~~~~~----------------------~~-~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  215 (299)
T 3m2w_A          159 LKLTDFGFAKETTG----------------------EK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR  215 (299)
T ss_dssp             EEECCCTTCEECTT----------------------CG-GGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSC
T ss_pred             EEEecccccccccc----------------------cc-CCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHh
Confidence            99999999865322                      11 2567999999999999999999997754433221    111


Q ss_pred             hCCCCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          341 NNSLVFP----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       341 ~~~~~~p----~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      .....+|    ..+++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          216 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence            2222333    4689999999999999999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=348.07  Aligned_cols=253  Identities=23%  Similarity=0.345  Sum_probs=187.3

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEEEc-
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDD-  195 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~-  195 (410)
                      .+|++.+.||+|+||.||++++..+|+.||||++...         .......+.+|+.+++.+. ||||+++++++.. 
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~   98 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---------EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG   98 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---------SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---------chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence            4799999999999999999999999999999988543         3445567899999999996 9999999999852 


Q ss_pred             -----CCCCEEEEEEeecCCCCcccccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeccCCCCcEEEcCCCcE
Q 015257          196 -----PNSDHFYMVLEYVEGKWDNDGFG---QPGAIGESMARKYLRDIVSGLMYLHGHN--VVHGDIKPDNLLVAPSGTV  265 (410)
Q Consensus       196 -----~~~~~~~lv~e~~~~~~l~~~~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NIll~~~~~~  265 (410)
                           .....+++||||++| +|.+.+.   ..+.+++..++.++.||+.||.|||+.|  |+||||||+|||++.++.+
T Consensus        99 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A           99 KEESDTGQAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TTTSTTSSEEEEEEEECCSE-EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred             ccccccCCceEEEEEEecCC-CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence                 234578999999985 4444443   3567999999999999999999999999  9999999999999999999


Q ss_pred             EEeeccccccccCCccc------------cccCCCccccccccccc--CCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015257          266 KIGDFSVSQVFEDDNDV------------LRRSPGTPVFTAPECCL--GLTYGGKAADTWAVGVTLYYMIIGQYPFLGET  331 (410)
Q Consensus       266 kl~DfG~a~~~~~~~~~------------~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~  331 (410)
                      ||+|||+++........            .....||+.|+|||++.  .....+.++|||||||++|+|++|..||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            99999999875432211            11445899999999883  22233678999999999999999999997654


Q ss_pred             HHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCccc
Q 015257          332 LQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL  382 (410)
Q Consensus       332 ~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~  382 (410)
                      ........  .....+...++.+.+||.+||+.||.+|||+.|+++|.+-.
T Consensus       258 ~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~  306 (337)
T 3ll6_A          258 KLRIVNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI  306 (337)
T ss_dssp             ----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhhcCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            43322221  11233456788899999999999999999999999986543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-44  Score=373.84  Aligned_cols=248  Identities=23%  Similarity=0.344  Sum_probs=206.5

Q ss_pred             cceeeee-eecccCceEEEEEEEcc--CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          118 NEYVHVR-KIGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       118 ~~y~~~~-~lG~G~fg~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      +++.+.+ .||+|+||.||++....  ++..||||+++...        .....+.+.+|+.+|+.++|||||++++++.
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  406 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--------EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ  406 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--------SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEec
Confidence            3455555 89999999999998763  56679999986431        2334568999999999999999999999997


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      .   ..+++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       407 ~---~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla  483 (613)
T 2ozo_A          407 A---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS  483 (613)
T ss_dssp             S---SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred             c---CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence            5   358999999999999988764 456999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccc---cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCC
Q 015257          274 QVFEDDNDV---LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPD  348 (410)
Q Consensus       274 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~  348 (410)
                      +........   .....+|+.|+|||++.+..+ +.++|||||||+||||++ |..||.+....+....+..+. ..+|.
T Consensus       484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~  562 (613)
T 2ozo_A          484 KALGADDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP  562 (613)
T ss_dssp             TTCC--------------CCTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCT
T ss_pred             ccccCCCceeeeccCCCCccceeCHhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            876433221   122335688999999876655 678999999999999998 999999988888777777654 46778


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      .+++++.+||.+||..||.+|||+.+|++
T Consensus       563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          563 ECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             TCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            89999999999999999999999999853

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=347.87  Aligned_cols=251  Identities=25%  Similarity=0.397  Sum_probs=206.1

Q ss_pred             ccceeeeeeecccCceEEEEEE----EccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          117 INEYVHVRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      .++|++++.||+|+||.||+++    +..+|+.||||++...         .......+.+|+.+++.++||||++++++
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~  110 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---------TEEHLRDFEREIEILKSLQHDNIVKYKGV  110 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---------CSHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---------CHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            4579999999999999999998    4568999999998642         34456789999999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      +.......+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg  190 (326)
T 2w1i_A          111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG  190 (326)
T ss_dssp             ECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             EEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCc
Confidence            8765555789999999999998887654 469999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCcc---ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------------H---
Q 015257          272 VSQVFEDDND---VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL------------Q---  333 (410)
Q Consensus       272 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~------------~---  333 (410)
                      ++........   ......+|+.|+|||++.+..+ +.++||||||+++|+|++|..||.....            .   
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~  269 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV  269 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH
T ss_pred             chhhccccccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH
Confidence            9987654332   1233457888999998876655 6789999999999999999998854210            0   


Q ss_pred             -HHHHHHHh-CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          334 -DTYDKIVN-NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       334 -~~~~~i~~-~~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                       .....+.. .....|..+++++.+||.+||+.||.+|||+.++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             11112222 234567789999999999999999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.9e-44  Score=369.13  Aligned_cols=249  Identities=23%  Similarity=0.346  Sum_probs=213.2

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+.+.||+|+||.||++.... +..||||++.....          ..+.+.+|+.+|+.++|||||++++++.
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~hpniv~~~~~~~  332 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----------SPEAFLQEAQVMKKLRHEKLVQLYAVVS  332 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----------CHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            345689999999999999999999874 46799999865321          2357899999999999999999999986


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      +   ..++|||||+.+++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus       333 ~---~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~  409 (535)
T 2h8h_A          333 E---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL  409 (535)
T ss_dssp             S---SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred             e---ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccccc
Confidence            5   4689999999999999888742  4689999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCcc-ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCC
Q 015257          273 SQVFEDDND-VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDA  349 (410)
Q Consensus       273 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~  349 (410)
                      ++....... ......+|..|+|||++....+ +.++|||||||+||||++ |..||.+....+....+..+. ...|..
T Consensus       410 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~  488 (535)
T 2h8h_A          410 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE  488 (535)
T ss_dssp             TTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             ceecCCCceecccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            987653321 2234457888999998876655 678999999999999999 999999988888777776653 456788


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +++.+.+||.+||+.||.+|||+++|++.
T Consensus       489 ~~~~l~~li~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          489 CPESLHDLMCQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            99999999999999999999999999864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-44  Score=347.59  Aligned_cols=249  Identities=25%  Similarity=0.367  Sum_probs=195.0

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHh--CCCCCcccceeE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM--LQHPNIVNLIEV  192 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~  192 (410)
                      ...++|++++.||+|+||.||+++..  |+.||||++...            ....+.+|.+++..  ++||||++++++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------------~~~~~~~e~~~~~~~~~~h~~i~~~~~~   99 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------------EEASWFRETEIYQTVLMRHENILGFIAA   99 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------------GHHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------------ccchhhhHHHHHHHHhhcCCCeeeEEEE
Confidence            44578999999999999999999875  899999998532            12334455555554  499999999999


Q ss_pred             EEcCCC--CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEeccCCCCcEEEcCC
Q 015257          193 IDDPNS--DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH--------NVVHGDIKPDNLLVAPS  262 (410)
Q Consensus       193 ~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~--------~iiHrDlkp~NIll~~~  262 (410)
                      +.+...  ..+++||||+++++|.+++... .+++..++.++.||+.||.|||+.        ||+||||||+|||++.+
T Consensus       100 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~  178 (337)
T 3mdy_A          100 DIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN  178 (337)
T ss_dssp             EEESCGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred             EccCCCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence            886422  6899999999999999888543 699999999999999999999999        99999999999999999


Q ss_pred             CcEEEeeccccccccCCccc----cccCCCcccccccccccCCcCCCc-----hhhHHHHHHHHHHHHhC----------
Q 015257          263 GTVKIGDFSVSQVFEDDNDV----LRRSPGTPVFTAPECCLGLTYGGK-----AADTWAVGVTLYYMIIG----------  323 (410)
Q Consensus       263 ~~~kl~DfG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~-----~~DiwSlG~il~elltG----------  323 (410)
                      +.+||+|||+++........    .....||+.|+|||++.+......     ++|||||||++|+|++|          
T Consensus       179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~  258 (337)
T 3mdy_A          179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY  258 (337)
T ss_dssp             SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence            99999999999765433221    235579999999999876654332     48999999999999999          


Q ss_pred             CCCCCCCC----HHHHHHHHH-hCC--CCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          324 QYPFLGET----LQDTYDKIV-NNS--LVFPD-----AMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       324 ~~Pf~~~~----~~~~~~~i~-~~~--~~~p~-----~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..||....    ......... ...  ..+|.     .+++++.+||.+||+.||.+|||+.++++|
T Consensus       259 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            77775431    112222222 221  22332     455779999999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.9e-44  Score=342.80  Aligned_cols=248  Identities=23%  Similarity=0.290  Sum_probs=199.7

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  199 (410)
                      |...+.||+|+||.||++..  +++.||||++.....     .........+.+|+.+++.++||||+++++++.+  ..
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~  103 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVD-----ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD--GD  103 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTT-----SCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccC-----cchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec--CC
Confidence            45568999999999999876  588999999864321     1134456789999999999999999999999976  45


Q ss_pred             EEEEEEeecCCCCcccccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          200 HFYMVLEYVEGKWDNDGFGQ---PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ..++||||+++++|.+.+..   ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  183 (307)
T 2nru_A          104 DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS  183 (307)
T ss_dssp             SCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccc
Confidence            78999999999988877653   356999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCC------
Q 015257          277 EDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ----DTYDKIVNNSL------  344 (410)
Q Consensus       277 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~----~~~~~i~~~~~------  344 (410)
                      ....  .......||+.|+|||++.+. + +.++||||||+++|+|++|..||......    .....+.....      
T Consensus       184 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (307)
T 2nru_A          184 EKFAQTVMTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYI  261 (307)
T ss_dssp             CSCSSCEECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHS
T ss_pred             ccccccccccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhc
Confidence            4322  223456799999999988654 3 67899999999999999999999764322    22222222111      


Q ss_pred             -----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          345 -----VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       345 -----~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                           ..+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus       262 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          262 DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                 1222345678999999999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=351.98  Aligned_cols=257  Identities=14%  Similarity=0.147  Sum_probs=201.1

Q ss_pred             ccceeeeeeecccCceEEEEE-----EEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC---CCCccc
Q 015257          117 INEYVHVRKIGAGSYGKVVLY-----RSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ---HPNIVN  188 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~  188 (410)
                      .++|.+.+.||+|+||.||+|     .+..+++.||||++...            ....+.+|+.+++.++   |+||++
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------------~~~~~~~e~~~~~~l~~~~~~~iv~  131 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------------NPWEFYIGTQLMERLKPSMQHMFMK  131 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------------CHHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------------ChhHHHHHHHHHHHhhhhhhhhhhh
Confidence            467999999999999999999     46778999999998543            2346788888888887   999999


Q ss_pred             ceeEEEcCCCCEEEEEEeecCCCCcccccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC--
Q 015257          189 LIEVIDDPNSDHFYMVLEYVEGKWDNDGFG-----QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP--  261 (410)
Q Consensus       189 l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~--  261 (410)
                      +++++..  .+..++||||+++++|.+++.     ....+++..++.++.||+.||+|||++||+||||||+|||++.  
T Consensus       132 ~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~  209 (365)
T 3e7e_A          132 FYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGF  209 (365)
T ss_dssp             EEEEEEC--SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGG
T ss_pred             hheeeec--CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccc
Confidence            9999986  457899999999999998875     3567999999999999999999999999999999999999998  


Q ss_pred             ---------CCcEEEeecccccccc--CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015257          262 ---------SGTVKIGDFSVSQVFE--DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE  330 (410)
Q Consensus       262 ---------~~~~kl~DfG~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~  330 (410)
                               ++.+||+|||+|+...  .........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...
T Consensus       210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~  288 (365)
T 3e7e_A          210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKN  288 (365)
T ss_dssp             TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred             cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCccccC
Confidence                     8999999999997543  22344566789999999999988765 67899999999999999999999543


Q ss_pred             CHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhh---CCcccCCCCCCchhhh
Q 015257          331 TLQDTYDKIVNNSLVFP-DAMNPELRNLLEGLLCKDPTRRLTLNDVAK---HTWVLGDNGPIPQYLC  393 (410)
Q Consensus       331 ~~~~~~~~i~~~~~~~p-~~~~~~l~~li~~~L~~dp~~Rpt~~ell~---h~~~~~~~~~~~~~~~  393 (410)
                      .....     .....++ ...++.+.+++..||+.+|.+|++..+.+.   ..|+..........|.
T Consensus       289 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~~~~~~l~  350 (365)
T 3e7e_A          289 EGGEC-----KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALR  350 (365)
T ss_dssp             ETTEE-----EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTTTTHHHHH
T ss_pred             CCCce-----eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhhhchHHHH
Confidence            21110     0001111 134677899999999999999965444443   3455444333333333

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.9e-44  Score=345.01  Aligned_cols=257  Identities=21%  Similarity=0.318  Sum_probs=192.7

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHH--HHHHHhCCCCCcccceeE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE--VLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E--~~~l~~l~hpniv~l~~~  192 (410)
                      ...++|.+++.||+|+||.||+++.  +++.||||++....            ...+..|  +..+..++||||+++++.
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------------~~~~~~e~~~~~~~~~~h~~i~~~~~~   75 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------------RQNFINEKNIYRVPLMEHDNIARFIVG   75 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------------HHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------------hhhHHHHHHHHHHHhccCcchhhheec
Confidence            3457899999999999999999965  68999999986431            1233344  444556899999999975


Q ss_pred             EEc---CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcEeccCCCCcEEEc
Q 015257          193 IDD---PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH---------NVVHGDIKPDNLLVA  260 (410)
Q Consensus       193 ~~~---~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~---------~iiHrDlkp~NIll~  260 (410)
                      +..   .....+++||||+++++|.+++... .+++..++.++.||+.||.|||+.         ||+||||||+|||++
T Consensus        76 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~  154 (336)
T 3g2f_A           76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK  154 (336)
T ss_dssp             EEEECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC
T ss_pred             ccccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc
Confidence            542   2344789999999999999887544 458999999999999999999999         999999999999999


Q ss_pred             CCCcEEEeeccccccccCC--------ccccccCCCcccccccccccCC------cCCCchhhHHHHHHHHHHHHhCCCC
Q 015257          261 PSGTVKIGDFSVSQVFEDD--------NDVLRRSPGTPVFTAPECCLGL------TYGGKAADTWAVGVTLYYMIIGQYP  326 (410)
Q Consensus       261 ~~~~~kl~DfG~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwSlG~il~elltG~~P  326 (410)
                      .++.+||+|||+++.....        ........||+.|+|||++.+.      ...+.++|||||||++|+|++|..|
T Consensus       155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p  234 (336)
T 3g2f_A          155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD  234 (336)
T ss_dssp             TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred             CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence            9999999999999865432        1222345799999999998763      1224679999999999999999776


Q ss_pred             CCCC-C----------------HHHHHHHHHhC---CCCCCCC------CCHHHHHHHHHhcccCCCCCCCHHHH-----
Q 015257          327 FLGE-T----------------LQDTYDKIVNN---SLVFPDA------MNPELRNLLEGLLCKDPTRRLTLNDV-----  375 (410)
Q Consensus       327 f~~~-~----------------~~~~~~~i~~~---~~~~p~~------~~~~l~~li~~~L~~dp~~Rpt~~el-----  375 (410)
                      |... .                ...........   ...+|..      +++++.+||.+||+.||.+|||+.|+     
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~  314 (336)
T 3g2f_A          235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA  314 (336)
T ss_dssp             GSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             CCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence            5321 1                01111112211   2233333      33579999999999999999999999     


Q ss_pred             -hhCCcccCCCC
Q 015257          376 -AKHTWVLGDNG  386 (410)
Q Consensus       376 -l~h~~~~~~~~  386 (410)
                       +-++|-++...
T Consensus       315 ~ll~~~~~~~~~  326 (336)
T 3g2f_A          315 ELMMIWERNKSV  326 (336)
T ss_dssp             HHHHCCCC----
T ss_pred             HHHHHHHhcccC
Confidence             55788776543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.2e-43  Score=355.93  Aligned_cols=248  Identities=20%  Similarity=0.309  Sum_probs=201.9

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||++++..+++.||||++.....           ...+.+|+.+++.+.|++++..+.++..
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----------~~~~~~E~~il~~L~~~~~i~~i~~~~~   73 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----------HPQLLYESKIYRILQGGTGIPNVRWFGV   73 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----------SCCHHHHHHHHHHTTTSTTCCCEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----------cHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence            45789999999999999999999999999999998764321           1247799999999998666655544433


Q ss_pred             CCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEE---cCCCcEEEeecc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV---APSGTVKIGDFS  271 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll---~~~~~~kl~DfG  271 (410)
                       .....+|||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||   +.++.+||+|||
T Consensus        74 -~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG  151 (483)
T 3sv0_A           74 -EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG  151 (483)
T ss_dssp             -ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             -eCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCC
Confidence             256899999999 7778877753 5679999999999999999999999999999999999999   588999999999


Q ss_pred             ccccccCCcc-------ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHh
Q 015257          272 VSQVFEDDND-------VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET---LQDTYDKIVN  341 (410)
Q Consensus       272 ~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~---~~~~~~~i~~  341 (410)
                      +++.......       ......||+.|+|||++.+..+ +.++|||||||+||+|++|..||.+..   ....+..+..
T Consensus       152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~  230 (483)
T 3sv0_A          152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE  230 (483)
T ss_dssp             TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH
T ss_pred             cceeccCCccccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh
Confidence            9987654322       1225679999999999887765 678999999999999999999998743   2333333333


Q ss_pred             CCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          342 NSL-----VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       342 ~~~-----~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ...     .++..+++++.+||..||+.||.+||++.+|++
T Consensus       231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          231 KKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            221     233578999999999999999999999998775

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.8e-43  Score=369.51  Aligned_cols=251  Identities=26%  Similarity=0.384  Sum_probs=211.5

Q ss_pred             cccceeeeeeecccCceEEEEEEEccC---CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEV  192 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  192 (410)
                      ..++|.+.+.||+|+||.||++....+   +..||||++...        ......+.+.+|+.+++.++||||++++++
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~  459 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--------TSDSVREKFLQEALTMRQFDHPHIVKLIGV  459 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--------TCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--------CCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            356899999999999999999998653   467999987532        234556789999999999999999999999


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      +.+   +.+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       460 ~~~---~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          460 ITE---NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             ECS---SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             Eec---CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecC
Confidence            854   3589999999999998887644 469999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCcc-ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCC
Q 015257          272 VSQVFEDDND-VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPD  348 (410)
Q Consensus       272 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~  348 (410)
                      +++....... ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+..+. ..+|.
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  615 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP  615 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCT
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            9987644321 2233457889999999876655 678999999999999997 999999988888877776654 46788


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .+++.+.+||.+||..||.+|||+.++++.
T Consensus       616 ~~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          616 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            899999999999999999999999999864

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.4e-44  Score=341.98  Aligned_cols=252  Identities=21%  Similarity=0.273  Sum_probs=205.4

Q ss_pred             cccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          114 TKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       114 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ....++|.+.+.||+|+||.||++....   .+|+|++......       ....+.+.+|+.+++.++||||+++++++
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   98 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-------EDQLKAFKREVMAYRQTRHENVVLFMGAC   98 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-------CCCCCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-------HHHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence            3445789999999999999999998753   4999998654221       12223567899999999999999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      .+  ...+++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus        99 ~~--~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B           99 MS--PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             EC--SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             ec--CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCC
Confidence            87  357999999999999998887654 799999999999999999999999999999999999998 78999999999


Q ss_pred             cccccCC-----ccccccCCCcccccccccccCC--------cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015257          273 SQVFEDD-----NDVLRRSPGTPVFTAPECCLGL--------TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKI  339 (410)
Q Consensus       273 a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i  339 (410)
                      ++.....     ........||+.|+|||++...        ...+.++||||||+++|+|++|..||...........+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  255 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM  255 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence            8754321     1223345689999999988652        22367899999999999999999999988887777776


Q ss_pred             HhCCCCC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          340 VNNSLVF--PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       340 ~~~~~~~--p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..+....  +..++.++.+||.+||..||.+|||+.++++.
T Consensus       256 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          256 GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             HTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             ccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            6654332  23688999999999999999999999999974

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7.4e-45  Score=375.72  Aligned_cols=259  Identities=26%  Similarity=0.379  Sum_probs=205.9

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|.+.+.||+|+||.||++.+..+|+.||||++...        ........+.+|+.+++.++||||+++++++.
T Consensus        11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--------~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~   82 (676)
T 3qa8_A           11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--------LSPKNRERWCLEIQIMKKLNHPNVVSAREVPD   82 (676)
T ss_dssp             ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--------CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCT
T ss_pred             CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--------CCHHHHHHHHHHHHHHHhCCCCCCCceeeeec
Confidence            3457899999999999999999999999999999987542        13455678999999999999999999999875


Q ss_pred             c----CCCCEEEEEEeecCCCCcccccCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCc---
Q 015257          195 D----PNSDHFYMVLEYVEGKWDNDGFGQPG---AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGT---  264 (410)
Q Consensus       195 ~----~~~~~~~lv~e~~~~~~l~~~~~~~~---~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~---  264 (410)
                      .    ......++||||++|++|.+++....   .+++..++.++.||+.||.|||+.||+||||||+|||++.++.   
T Consensus        83 ~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~  162 (676)
T 3qa8_A           83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLI  162 (676)
T ss_dssp             TTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCE
T ss_pred             ccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCcee
Confidence            4    12467899999999999988776533   6999999999999999999999999999999999999997765   


Q ss_pred             EEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------
Q 015257          265 VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDK------  338 (410)
Q Consensus       265 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~------  338 (410)
                      +||+|||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+......+..      
T Consensus       163 vKL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~  240 (676)
T 3qa8_A          163 HKIIDLGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKS  240 (676)
T ss_dssp             EEECSCCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC---
T ss_pred             EEEccccccccccccc-ccccccCCcccCChHHhccCCC-CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhccc
Confidence            9999999998765432 3355679999999999877665 6679999999999999999999976533221100      


Q ss_pred             ---H-----HhCCCCC------C----CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          339 ---I-----VNNSLVF------P----DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       339 ---i-----~~~~~~~------p----~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                         +     ..+...+      |    ..+++.+.+||.+||..||.+|||+.++++||||..
T Consensus       241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence               0     0111111      1    235688999999999999999999999999999965

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.3e-43  Score=337.74  Aligned_cols=248  Identities=23%  Similarity=0.318  Sum_probs=201.3

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHh--CCCCCcccceeEE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM--LQHPNIVNLIEVI  193 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~  193 (410)
                      ..++|.+.+.||+|+||.||+++.  +|+.||||++...            ....+.+|+.++..  ++||||+++++++
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~  105 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------------EERSWFREAEIYQTVMLRHENILGFIAAD  105 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------------GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred             ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------------hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence            346899999999999999999987  4899999998532            23467789999888  7999999999999


Q ss_pred             EcCCC--CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEeccCCCCcEEEcCCC
Q 015257          194 DDPNS--DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH--------GHNVVHGDIKPDNLLVAPSG  263 (410)
Q Consensus       194 ~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH--------~~~iiHrDlkp~NIll~~~~  263 (410)
                      .....  ..+++||||+++++|.+++.. ..+++..++.++.||+.||.|||        +.||+||||||+|||++.++
T Consensus       106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~  184 (342)
T 1b6c_B          106 NKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  184 (342)
T ss_dssp             ECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred             cccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence            87432  379999999999999988764 46899999999999999999999        89999999999999999999


Q ss_pred             cEEEeeccccccccCCcc----ccccCCCcccccccccccCCcCC-----CchhhHHHHHHHHHHHHhC----------C
Q 015257          264 TVKIGDFSVSQVFEDDND----VLRRSPGTPVFTAPECCLGLTYG-----GKAADTWAVGVTLYYMIIG----------Q  324 (410)
Q Consensus       264 ~~kl~DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwSlG~il~elltG----------~  324 (410)
                      .+||+|||++........    ......||+.|+|||++.+....     +.++|||||||++|+|++|          .
T Consensus       185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~  264 (342)
T 1b6c_B          185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  264 (342)
T ss_dssp             CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence            999999999987654332    23455799999999998765322     2579999999999999999          7


Q ss_pred             CCCCCCC-----HHHHHHHHHhCCC--CCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          325 YPFLGET-----LQDTYDKIVNNSL--VFPD-----AMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       325 ~Pf~~~~-----~~~~~~~i~~~~~--~~p~-----~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .||....     .......+.....  .+|.     ..+..+.+||.+||+.||.+|||+.++++|
T Consensus       265 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            8886642     2333333333322  2222     233578999999999999999999999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=9.9e-44  Score=342.73  Aligned_cols=250  Identities=17%  Similarity=0.216  Sum_probs=193.3

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC---------CCCcc
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ---------HPNIV  187 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---------hpniv  187 (410)
                      .++|.+++.||+|+||.||++++  +|+.||||++......... .......+.+.+|+.+++.++         |||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVN-GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBT-TBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccc-cccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            46799999999999999999988  6899999999865322110 012334467889999999886         66666


Q ss_pred             cceeEE-----------------EcC-----------CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHH
Q 015257          188 NLIEVI-----------------DDP-----------NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL  239 (410)
Q Consensus       188 ~l~~~~-----------------~~~-----------~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL  239 (410)
                      ++.+++                 .+.           ....+||||||++++.+.+.+.. ..+++..++.++.||+.||
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence            666554                 220           14689999999998866555543 5789999999999999999


Q ss_pred             HHHH-hCCcEeccCCCCcEEEcCCC--------------------cEEEeeccccccccCCccccccCCCcccccccccc
Q 015257          240 MYLH-GHNVVHGDIKPDNLLVAPSG--------------------TVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC  298 (410)
Q Consensus       240 ~yLH-~~~iiHrDlkp~NIll~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~  298 (410)
                      .||| ++||+||||||+|||++.++                    .+||+|||+|+.....     ..+||+.|+|||++
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~  249 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLF  249 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGG
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhh
Confidence            9999 99999999999999999887                    8999999999876543     34689999999998


Q ss_pred             cCCcCCCchhhHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHhCC-C--CC----CCCCCHHHHHHHHHhcccCCCCC
Q 015257          299 LGLTYGGKAADTWAVGVT-LYYMIIGQYPFLGETL-QDTYDKIVNNS-L--VF----PDAMNPELRNLLEGLLCKDPTRR  369 (410)
Q Consensus       299 ~~~~~~~~~~DiwSlG~i-l~elltG~~Pf~~~~~-~~~~~~i~~~~-~--~~----p~~~~~~l~~li~~~L~~dp~~R  369 (410)
                      .+..  +.++||||||++ .+++++|..||..... ......+.... .  ..    +..+++++.+||.+||+.|    
T Consensus       250 ~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----  323 (336)
T 2vuw_A          250 TGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----  323 (336)
T ss_dssp             CCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred             cCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence            8665  678999998777 7778889999854221 12223333221 1  11    1246789999999999977    


Q ss_pred             CCHHHHh-hCCccc
Q 015257          370 LTLNDVA-KHTWVL  382 (410)
Q Consensus       370 pt~~ell-~h~~~~  382 (410)
                       |++|+| +||||+
T Consensus       324 -sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 -SATDLLCQHSLFK  336 (336)
T ss_dssp             -SHHHHHHHCGGGC
T ss_pred             -CHHHHHhcCCCcC
Confidence             999999 999995

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.6e-44  Score=355.74  Aligned_cols=253  Identities=16%  Similarity=0.168  Sum_probs=193.5

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCC-CCcc---------
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH-PNIV---------  187 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv---------  187 (410)
                      ..|...+.||+|+||.||++.+..+|+.||||++.....      ......+.+.+|+.+++.+.| +|..         
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~------~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~  151 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER------PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  151 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC------ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence            468889999999999999999999999999998763321      122345678999999999987 3221         


Q ss_pred             cceeE------------EEcCC---CCEEEEEEeecCCCCccccc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 015257          188 NLIEV------------IDDPN---SDHFYMVLEYVEGKWDNDGF-------GQPGAIGESMARKYLRDIVSGLMYLHGH  245 (410)
Q Consensus       188 ~l~~~------------~~~~~---~~~~~lv~e~~~~~~l~~~~-------~~~~~l~~~~~~~i~~qi~~gL~yLH~~  245 (410)
                      ...+.            +....   ...++++|+++. ++|.+++       .....+++..+..++.||+.||+|||++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  230 (413)
T 3dzo_A          152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY  230 (413)
T ss_dssp             CCCEEEECCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cchhhcccCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            11111            11111   234677888765 4455444       1234578889999999999999999999


Q ss_pred             CcEeccCCCCcEEEcCCCcEEEeeccccccccCCccccccCCCccccccccccc---------CCcCCCchhhHHHHHHH
Q 015257          246 NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL---------GLTYGGKAADTWAVGVT  316 (410)
Q Consensus       246 ~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~~DiwSlG~i  316 (410)
                      ||+||||||+|||++.++.+||+|||+++.....   ....+| +.|+|||++.         ....++.++|||||||+
T Consensus       231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             CcccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            9999999999999999999999999999865432   455678 9999999883         22223678999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          317 LYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       317 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      +|+|++|+.||...........+...    ...+++++.+||.+||+.||.+|||+.++++||||....
T Consensus       307 l~elltg~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~  371 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  371 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCSGGGGSS----CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHHCCCCCCCcchhhhHHHHHhh----cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence            99999999999876554433333222    246789999999999999999999999999999997643

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.3e-42  Score=362.37  Aligned_cols=247  Identities=23%  Similarity=0.288  Sum_probs=201.3

Q ss_pred             ccccccceeeeeeecccCceEEEEEEEcc-CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCccccee
Q 015257          113 GTKMINEYVHVRKIGAGSYGKVVLYRSSL-DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE  191 (410)
Q Consensus       113 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  191 (410)
                      +....++|.+++.||+|+||.||++.+.. +|+.||||++...        ........+.+|+.+++.++|||||++++
T Consensus        75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~  146 (681)
T 2pzi_A           75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--------GDAEAQAMAMAERQFLAEVVHPSIVQIFN  146 (681)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--------CCHHHHHHHHHHHGGGGGCCCTTBCCEEE
T ss_pred             CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--------CCHHHHHHHHHHHHHHHhcCCCCcCeEee
Confidence            44556899999999999999999999976 7999999987532        13455668899999999999999999999


Q ss_pred             EEEcCCC---CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEe
Q 015257          192 VIDDPNS---DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIG  268 (410)
Q Consensus       192 ~~~~~~~---~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~  268 (410)
                      ++.+...   ...||||||++|++|.+.+..  .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+
T Consensus       147 ~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~  223 (681)
T 2pzi_A          147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLI  223 (681)
T ss_dssp             EEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEEC
T ss_pred             eEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEE
Confidence            9986422   127999999999999887655  79999999999999999999999999999999999999974 99999


Q ss_pred             eccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC
Q 015257          269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD  348 (410)
Q Consensus       269 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~  348 (410)
                      |||+++.....    ....||+.|+|||++.+..  +.++|||||||++|+|++|..||.+.......      ......
T Consensus       224 DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------~~~~~~  291 (681)
T 2pzi_A          224 DLGAVSRINSF----GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------EDDPVL  291 (681)
T ss_dssp             CCTTCEETTCC----SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------TTCHHH
T ss_pred             ecccchhcccC----CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCccccccccc------cccccc
Confidence            99999865443    4567999999999886543  67899999999999999999998653111000      000001


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCccc
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL  382 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~  382 (410)
                      ..++.+.+||.+||+.||.+||+..+.+.|+|+.
T Consensus       292 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          292 KTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            2357899999999999999999999999998874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.6e-41  Score=320.27  Aligned_cols=225  Identities=10%  Similarity=0.122  Sum_probs=186.6

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ...++|++.+.||+|+||.||++++..+|+.||||++.....      ........+.+|+.+++.++||||+++++++.
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~  101 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV------LPDDVLQETLSRTLRLSRIDKPGVARVLDVVH  101 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC------SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccc------cCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence            344689999999999999999999999999999999875421      23456678999999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      +  .+..|+||||++|++|.+++...  ..+..+..++.||+.||.|||++||+||||||+|||++.+|.+||+++|   
T Consensus       102 ~--~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---  174 (286)
T 3uqc_A          102 T--RAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---  174 (286)
T ss_dssp             E--TTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC---
T ss_pred             E--CCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc---
Confidence            7  46899999999999999888543  4666788999999999999999999999999999999999999998443   


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhCCC----CCC
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTY---DKIVNNSL----VFP  347 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~---~~i~~~~~----~~p  347 (410)
                                       |++|        .+.++|||||||++|+|++|..||.+.+.....   ........    .++
T Consensus       175 -----------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T 3uqc_A          175 -----------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADID  229 (286)
T ss_dssp             -----------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHC
T ss_pred             -----------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcc
Confidence                             3343        267899999999999999999999876543211   01111111    123


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..+++++.+||.+||+.||.+| |+.|+++.
T Consensus       230 ~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          230 RDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             cCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            5789999999999999999999 99999874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=9.4e-37  Score=313.44  Aligned_cols=194  Identities=14%  Similarity=0.094  Sum_probs=139.8

Q ss_pred             eecccCceEEEEEEEccCCceEEEEeeeccccccccc-CCChHHHHHHHHHHHHHHhC-CCCCcccceeEEEcCCCCEEE
Q 015257          125 KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRV-APSETAMTDVRREVLIMKML-QHPNIVNLIEVIDDPNSDHFY  202 (410)
Q Consensus       125 ~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~  202 (410)
                      ..+.|+.|.+..++....|+.||+|++.+........ ...+...+++.+|+++|+++ .|+||+++++++++  ...+|
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~y  318 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSGW  318 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEEE
Confidence            4678888888777777789999999998664322111 11234556799999999999 79999999999987  56899


Q ss_pred             EEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccc
Q 015257          203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV  282 (410)
Q Consensus       203 lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  282 (410)
                      |||||++|++|.+.+...+++++.   .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+........
T Consensus       319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~  395 (569)
T 4azs_A          319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW  395 (569)
T ss_dssp             EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred             EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence            999999999999999988888875   47899999999999999999999999999999999999999999887665555


Q ss_pred             cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCC
Q 015257          283 LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQY  325 (410)
Q Consensus       283 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~  325 (410)
                      ..+.+||+.|+|||++.+..  ..++|+||+|+++++|.++..
T Consensus       396 ~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          396 PTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             SHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred             ccCceechhhccHHHhCCCC--CCcccccccccchhhhccccc
Confidence            66778999999999987653  456999999999888766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=2.1e-29  Score=257.37  Aligned_cols=191  Identities=18%  Similarity=0.176  Sum_probs=141.5

Q ss_pred             eeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCE
Q 015257          121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDH  200 (410)
Q Consensus       121 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  200 (410)
                      ...+.||+|+||.||++  ...++.+|+|+........ .........+.+.+|+.+|++++||||+++..++..  ...
T Consensus       339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~-~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRD-ERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD--LDN  413 (540)
T ss_dssp             ---------CCEEEEEE--ECSSCEEEEEEECCCTTSC-HHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE--TTT
T ss_pred             CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccc-hhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe--CCc
Confidence            34568999999999999  4467889999865432110 000112234568999999999999999955554444  235


Q ss_pred             EEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCc
Q 015257          201 FYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN  280 (410)
Q Consensus       201 ~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~  280 (410)
                      .+|||||++|++|.+++..        +..++.||+.||.|||++||+||||||+|||++.  .+||+|||+++......
T Consensus       414 ~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          414 KRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             TEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             cEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            6999999999999988776        5689999999999999999999999999999998  99999999998765432


Q ss_pred             c-------ccccCCCcccccccccccC--CcCCCchhhHHHHHHHHHHHHhCCCCC
Q 015257          281 D-------VLRRSPGTPVFTAPECCLG--LTYGGKAADTWAVGVTLYYMIIGQYPF  327 (410)
Q Consensus       281 ~-------~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~elltG~~Pf  327 (410)
                      .       ......||+.|+|||++..  ..+ +..+|+||..+-..+-+-++.+|
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y-~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGY-KSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHH-HHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHH-HHHHhHHHHHHHHHHHHHhcccc
Confidence            2       1245679999999999865  233 45689999988888877776665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=1.2e-25  Score=211.20  Aligned_cols=152  Identities=20%  Similarity=0.137  Sum_probs=117.3

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCCh---------HHHHHHHHHHHHHHhCCCCCcccce
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSE---------TAMTDVRREVLIMKMLQHPNIVNLI  190 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~---------~~~~~~~~E~~~l~~l~hpniv~l~  190 (410)
                      |.+.+.||+|+||.||++.+ .+|+.||||++..............         .....+.+|+.+|+.++  | +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            34459999999999999999 7899999999865422111111111         24567899999999999  5 6777


Q ss_pred             eEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeec
Q 015257          191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       191 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                      +++..   ...++||||++|++|.+ +..      .....++.||+.||.|||+.||+||||||+|||++ ++.+||+||
T Consensus       168 ~~~~~---~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF  236 (282)
T 1zar_A          168 KVYAW---EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF  236 (282)
T ss_dssp             CEEEE---ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred             eEEec---cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence            76653   34699999999998887 422      23457999999999999999999999999999999 999999999


Q ss_pred             cccccccCCccccccCCCccccccccccc
Q 015257          271 SVSQVFEDDNDVLRRSPGTPVFTAPECCL  299 (410)
Q Consensus       271 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~  299 (410)
                      |+|+.             +..+.|||++.
T Consensus       237 G~a~~-------------~~~~~a~e~l~  252 (282)
T 1zar_A          237 PQSVE-------------VGEEGWREILE  252 (282)
T ss_dssp             TTCEE-------------TTSTTHHHHHH
T ss_pred             CCCeE-------------CCCCCHHHHHH
Confidence            99963             34478888763

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=3e-22  Score=185.53  Aligned_cols=146  Identities=15%  Similarity=0.162  Sum_probs=107.7

Q ss_pred             eeeeeeecccCceEEEEEEEccCCce--EEEEeeecccccccc----------c-----CCChHHHHHHHHHHHHHHhCC
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKH--YAIKAFHKSHLSKLR----------V-----APSETAMTDVRREVLIMKMLQ  182 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~--vaiK~~~~~~~~~~~----------~-----~~~~~~~~~~~~E~~~l~~l~  182 (410)
                      |.+.+.||+|+||.||++.+..+|+.  ||||++.........          .     .........+.+|+.+|+.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67889999999999999999778999  999987543211000          0     000122246889999999999


Q ss_pred             CCCc--ccceeEEEcCCCCEEEEEEeecCC-C----CcccccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcEeccCCC
Q 015257          183 HPNI--VNLIEVIDDPNSDHFYMVLEYVEG-K----WDNDGFGQPGAIGESMARKYLRDIVSGLMYLH-GHNVVHGDIKP  254 (410)
Q Consensus       183 hpni--v~l~~~~~~~~~~~~~lv~e~~~~-~----~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH-~~~iiHrDlkp  254 (410)
                      |+++  ..+++.  .    ..+|||||+++ +    .+.+....   .++..+..++.||+.||.||| +.||+||||||
T Consensus       129 ~~~i~~p~~~~~--~----~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          129 EAGVSVPQPYTY--M----KNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             HTTCCCCCEEEE--E----TTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             hCCCCCCeEEEc--C----CCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            8865  333332  1    35899999952 3    33333221   235567899999999999999 99999999999


Q ss_pred             CcEEEcCCCcEEEeeccccccc
Q 015257          255 DNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       255 ~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      +|||++.  .++|+|||+|...
T Consensus       200 ~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEET
T ss_pred             HHEEEcC--cEEEEECcccccC
Confidence            9999997  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.79  E-value=4.8e-19  Score=171.46  Aligned_cols=146  Identities=19%  Similarity=0.228  Sum_probs=103.2

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccC--------CC-hHHH----HHHHHHHHHHHhCCCCCc
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVA--------PS-ETAM----TDVRREVLIMKMLQHPNI  186 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~--------~~-~~~~----~~~~~E~~~l~~l~hpni  186 (410)
                      |.+.+.||+|+||.||+|.+. +|+.||||+++..........        .. .+..    ....+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999985 699999999865432110000        00 0111    113457777777755544


Q ss_pred             ccceeEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC---
Q 015257          187 VNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG---  263 (410)
Q Consensus       187 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~---  263 (410)
                      ....-+...    ..+|||||++|..+......      ..+..++.||+.+|.|||+.|||||||||.|||++.+|   
T Consensus       176 ~vp~p~~~~----~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          176 PVPEPIAQS----RHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             SCCCEEEEE----TTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCCeeeecc----CceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence            322222221    12799999999877665332      23467889999999999999999999999999999877   


Q ss_pred             -------cEEEeeccccccc
Q 015257          264 -------TVKIGDFSVSQVF  276 (410)
Q Consensus       264 -------~~kl~DfG~a~~~  276 (410)
                             .+.|+||+.+...
T Consensus       246 d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEET
T ss_pred             cccccccceEEEEeCCcccC
Confidence                   3899999987643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.40  E-value=6.2e-13  Score=122.61  Aligned_cols=141  Identities=17%  Similarity=0.190  Sum_probs=108.8

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEEEc
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDD  195 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~  195 (410)
                      +..|.+...+|.|+.+.||++...  +..+++|+......         .....+.+|+.+++.+. +..+.+++++..+
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~---------~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~   81 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK---------GTTYDVEREKDMMLWLEGKLPVPKVLHFERH   81 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT---------TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC---------CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec
Confidence            356889999999999999988643  68899998754211         01124789999999985 6777889988875


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-------------------------------  244 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-------------------------------  244 (410)
                        .+..|+||||++|..+.....     +......++.+++.+|..||+                               
T Consensus        82 --~~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (263)
T 3tm0_A           82 --DGWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD  154 (263)
T ss_dssp             --TTEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCS
T ss_pred             --CCceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccc
Confidence              457899999999988776532     112234778899999999998                               


Q ss_pred             ----------------------------CCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          245 ----------------------------HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       245 ----------------------------~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                                                  ..++|+|++|.|||++.++.+.|+||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                        3489999999999998655567999998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.31  E-value=2.1e-11  Score=111.71  Aligned_cols=135  Identities=16%  Similarity=0.152  Sum_probs=98.2

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCC--cccceeEEEc
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN--IVNLIEVIDD  195 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~  195 (410)
                      ..|.+....+.|..+.||++.. .+|..+++|+....            ....+.+|+.+++.+.+.+  +.+++++..+
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~   86 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------------ALNELQDEAARLSWLATTGVPCAAVLDVVTE   86 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------------cchhhhHHHHHHHHHHhCCCCCCeEEEeccC
Confidence            4455544445666799998854 46778999986432            1134778999999886545  4567887765


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHN-----------------------------  246 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-----------------------------  246 (410)
                        .+..++||||++|..+.  ...   ..   ...++.+++..|..||+..                             
T Consensus        87 --~~~~~~v~e~i~G~~l~--~~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (264)
T 1nd4_A           87 --AGRDWLLLGEVPGQDLL--SSH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQD  156 (264)
T ss_dssp             --SSCEEEEEECCSSEETT--TSC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTT
T ss_pred             --CCCCEEEEEecCCcccC--cCc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccch
Confidence              34689999999998774  211   12   2357788888899998754                             


Q ss_pred             -----------------------------cEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          247 -----------------------------VVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       247 -----------------------------iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                                                   ++|+|++|.|||++.++.+.|+|||.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          157 DLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             SCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                         99999999999998766677999999853

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.25  E-value=4.2e-11  Score=115.64  Aligned_cols=144  Identities=19%  Similarity=0.334  Sum_probs=106.8

Q ss_pred             eeeeeecccCceEEEEEEEccCCceEEEEeee--cccccccccCCChHHHHHHHHHHHHHHhCCC--CCcccceeEEEcC
Q 015257          121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFH--KSHLSKLRVAPSETAMTDVRREVLIMKMLQH--PNIVNLIEVIDDP  196 (410)
Q Consensus       121 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~  196 (410)
                      ..++.|+.|.++.||++...  +..+++|+..  ....        ......+.+|+.+++.+..  ..+.+++.++.+.
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--------~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~  110 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--------LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE  110 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred             ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--------CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence            34788999999999988754  4679999764  2210        1122467899999999974  4577888887653


Q ss_pred             CC-CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------
Q 015257          197 NS-DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-------------------------------  244 (410)
Q Consensus       197 ~~-~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-------------------------------  244 (410)
                      .. +..++||||++|..+.+...  ..+++.....++.+++.+|..||+                               
T Consensus       111 ~~~g~~~~vme~v~G~~l~~~~~--~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (359)
T 3dxp_A          111 SVIGRAFYIMEFVSGRVLWDQSL--PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL  188 (359)
T ss_dssp             TTTSSCEEEEECCCCBCCCCTTC--TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred             CccCCeEEEEEecCCeecCCCcc--ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence            21 45789999999987754222  347888889999999999999997                               


Q ss_pred             ---------------------------CCcEeccCCCCcEEEcCCCc--EEEeeccccccc
Q 015257          245 ---------------------------HNVVHGDIKPDNLLVAPSGT--VKIGDFSVSQVF  276 (410)
Q Consensus       245 ---------------------------~~iiHrDlkp~NIll~~~~~--~kl~DfG~a~~~  276 (410)
                                                 ..++|+|++|.|||++.++.  +.|+||+.+...
T Consensus       189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                       35899999999999997753  689999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.12  E-value=1e-10  Score=110.28  Aligned_cols=184  Identities=15%  Similarity=0.170  Sum_probs=120.3

Q ss_pred             eeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCc--ccceeEEEcCC-C
Q 015257          123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNI--VNLIEVIDDPN-S  198 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpni--v~l~~~~~~~~-~  198 (410)
                      ++.++.|....||++.     ..+++|+..           .......+.+|+.+|+.+. +..+  .+++....... .
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~-----------~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~   88 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPK-----------HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY   88 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEES-----------SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecC-----------CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence            4569999999998763     569999743           1234567899999998884 4333  23333322211 1


Q ss_pred             CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------
Q 015257          199 DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG----------------------------------  244 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~----------------------------------  244 (410)
                      ...|+||++++|..+.....  ..++..+...++.|++..|..||+                                  
T Consensus        89 ~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (304)
T 3sg8_A           89 QMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELK  166 (304)
T ss_dssp             SCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSC
T ss_pred             CcceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCC
Confidence            24488999999987764222  346778888889999999999985                                  


Q ss_pred             ------------------------CCcEeccCCCCcEEEcC--CCcEEEeeccccccccCCccccccCCC----ccc---
Q 015257          245 ------------------------HNVVHGDIKPDNLLVAP--SGTVKIGDFSVSQVFEDDNDVLRRSPG----TPV---  291 (410)
Q Consensus       245 ------------------------~~iiHrDlkp~NIll~~--~~~~kl~DfG~a~~~~~~~~~~~~~~g----t~~---  291 (410)
                                              ..++|+|++|.||+++.  .+.+.|+||+.+.......+.......    .+.   
T Consensus       167 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~  246 (304)
T 3sg8_A          167 GPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVS  246 (304)
T ss_dssp             HHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHH
T ss_pred             cccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHH
Confidence                                    13699999999999998  456889999998753221111111100    000   


Q ss_pred             -----c--cc-cccccCCcCCCchhhHHHHHHHHHHHHhCCCCC
Q 015257          292 -----F--TA-PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF  327 (410)
Q Consensus       292 -----y--~a-PE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf  327 (410)
                           |  .. |+.....   ....+.|++|.++|.+.+|..+|
T Consensus       247 ~~l~~Y~~~~~~~~~~r~---~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          247 KILNHYKHKDIPTVLEKY---RMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHTCSCHHHHHHHH---HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHcCCCCcHHHHHHH---HHHHHHHHHHHHHHHHHcCCHHH
Confidence                 1  11 2211111   01268999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.74  E-value=1.2e-07  Score=89.28  Aligned_cols=135  Identities=16%  Similarity=0.264  Sum_probs=96.5

Q ss_pred             eeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCC---CcccceeEEEcCCCC
Q 015257          123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP---NIVNLIEVIDDPNSD  199 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~~~~~~  199 (410)
                      ++.++.|....||++     |..+++|+-.           .......+.+|+.+|+.+.+.   .+.+++.+... ..+
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-----------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g   86 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK-----------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDG   86 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES-----------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTS
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC-----------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCC
Confidence            567899999999887     5779999732           223456789999999999753   24556666543 245


Q ss_pred             EEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------
Q 015257          200 HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGH----------------------------------  245 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~----------------------------------  245 (410)
                      ..++||||++|..+.....  ..++......++.++...|..||+.                                  
T Consensus        87 ~~~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l  164 (306)
T 3tdw_A           87 NPFVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL  164 (306)
T ss_dssp             CEEEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred             ceEEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence            6789999999987654211  1245666666667777776666642                                  


Q ss_pred             --------------------------CcEeccCCCCcEEEcC---CCc-EEEeeccccccc
Q 015257          246 --------------------------NVVHGDIKPDNLLVAP---SGT-VKIGDFSVSQVF  276 (410)
Q Consensus       246 --------------------------~iiHrDlkp~NIll~~---~~~-~kl~DfG~a~~~  276 (410)
                                                .++|+|++|.|||++.   ++. +.|+||+.+...
T Consensus       165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                      3499999999999997   455 489999988653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.64  E-value=1.2e-07  Score=87.27  Aligned_cols=133  Identities=17%  Similarity=0.218  Sum_probs=95.2

Q ss_pred             eecccCce-EEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEEEcCCCCEEE
Q 015257          125 KIGAGSYG-KVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDDPNSDHFY  202 (410)
Q Consensus       125 ~lG~G~fg-~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~  202 (410)
                      .+..|..| .||+......+..+++|+-..            .....+.+|...|+.+. +--+.+++.++.++  +..+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~   96 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG------------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAW   96 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET------------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC------------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEE
Confidence            34445554 688888777788899997532            13346889999998885 22356777877763  5789


Q ss_pred             EEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 015257          203 MVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG--------------------------------------  244 (410)
Q Consensus       203 lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~--------------------------------------  244 (410)
                      +|||+++|..+.+....    .......+..++...|.-||.                                      
T Consensus        97 lvme~l~G~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (272)
T 4gkh_A           97 LLTTAIPGKTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN  172 (272)
T ss_dssp             EEEECCCSEEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred             EEEEeeCCccccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence            99999998765543221    122334566777888888885                                      


Q ss_pred             --------------------CCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          245 --------------------HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       245 --------------------~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                                          ..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus       173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                1279999999999999777777999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.30  E-value=3.3e-06  Score=80.90  Aligned_cols=88  Identities=8%  Similarity=0.140  Sum_probs=55.6

Q ss_pred             eeeee-cccCceEEEEEEEcc------CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCC---CCccccee
Q 015257          122 HVRKI-GAGSYGKVVLYRSSL------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH---PNIVNLIE  191 (410)
Q Consensus       122 ~~~~l-G~G~fg~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~l~~  191 (410)
                      .++.| +.|....+|++....      ++..+++|+........  ..    ....+.+|+.+++.+..   ..+.+++.
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~--~~----~~~~~~~E~~~l~~L~~~~~vpvP~v~~   97 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVP--VF----PTYRLDHQFEVIRLVGELTDVPVPRVRW   97 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCC--SS----SCCCHHHHHHHHHHHHHHCCSCCCCEEE
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccc--cC----chhHHHHHHHHHHHHhhcCCCCCCcEEE
Confidence            45778 889999999876541      26689999754321000  00    01246788888888742   34667777


Q ss_pred             EEEcCC-CCEEEEEEeecCCCCccc
Q 015257          192 VIDDPN-SDHFYMVLEYVEGKWDND  215 (410)
Q Consensus       192 ~~~~~~-~~~~~lv~e~~~~~~l~~  215 (410)
                      +..+.. .+..++||||++|..+.+
T Consensus        98 ~~~~~~~~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A           98 IETTGDVLGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             EECSSTTTSSCEEEEECCCCBCCCB
T ss_pred             EccCCCccCCceEEEEecCCCChhh
Confidence            765431 134689999999876654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.27  E-value=1.2e-06  Score=85.27  Aligned_cols=84  Identities=15%  Similarity=0.121  Sum_probs=49.4

Q ss_pred             eeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCC--CCcc-cceeEEEcCCC
Q 015257          122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH--PNIV-NLIEVIDDPNS  198 (410)
Q Consensus       122 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv-~l~~~~~~~~~  198 (410)
                      .++.||.|.++.||++....+++.++||.......  ...........++..|..+|+.+..  |..+ +++.+ ..   
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r--~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d~---  107 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAK--VVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DT---  107 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC---------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ET---
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhc--ccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-cC---
Confidence            36789999999999997666678899998653210  0000000112356778888887742  4444 45543 32   


Q ss_pred             CEEEEEEeecCCC
Q 015257          199 DHFYMVLEYVEGK  211 (410)
Q Consensus       199 ~~~~lv~e~~~~~  211 (410)
                      ...++|||+++|.
T Consensus       108 ~~~~lvmE~l~g~  120 (397)
T 2olc_A          108 EMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTEEEECCCTTS
T ss_pred             CccEEEEEeCCCc
Confidence            2357999999873

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.08  E-value=0.0001  Score=69.67  Aligned_cols=31  Identities=19%  Similarity=0.278  Sum_probs=27.9

Q ss_pred             CCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       245 ~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      ..++|+|+++.|||++.++.+.|+||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            5799999999999998888999999998753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.06  E-value=3.5e-05  Score=72.46  Aligned_cols=76  Identities=17%  Similarity=0.225  Sum_probs=57.4

Q ss_pred             eeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC---CCCcccceeEEEcCCC
Q 015257          122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ---HPNIVNLIEVIDDPNS  198 (410)
Q Consensus       122 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~  198 (410)
                      .++.|+.|....+|++..  ++..+++|+....            ....+..|...|+.|.   ...+.+++.+...  .
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~  103 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------------YRSMFRAEADQLALLAKTNSINVPLVYGIGNS--Q  103 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--S
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--C
Confidence            467899999999998874  4678999975421            2356788999988884   3567788887765  3


Q ss_pred             CEEEEEEeecCCCCc
Q 015257          199 DHFYMVLEYVEGKWD  213 (410)
Q Consensus       199 ~~~~lv~e~~~~~~l  213 (410)
                      +..++||||++|...
T Consensus       104 g~~~lvme~l~G~~~  118 (312)
T 3jr1_A          104 GHSFLLLEALNKSKN  118 (312)
T ss_dssp             SEEEEEEECCCCCCC
T ss_pred             CceEEEEEeccCCCC
Confidence            578999999998653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.81  E-value=0.00014  Score=67.34  Aligned_cols=78  Identities=17%  Similarity=0.125  Sum_probs=52.3

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCC---CcccceeEEEc
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHP---NIVNLIEVIDD  195 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~~  195 (410)
                      +...+..+|.|..+.||++... +|+.|.+|+.....         ......+..|+..|+.|.-.   -+.+++.+.  
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~---------~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--   83 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDA---------PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--   83 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTC---------CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--
T ss_pred             CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCC---------cchhhHHHHHHHHHHHHHhhCCCCcceEEecc--
Confidence            3456889999999999988754 78999999754321         11113477899999988532   233444432  


Q ss_pred             CCCCEEEEEEeecCCCC
Q 015257          196 PNSDHFYMVLEYVEGKW  212 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~  212 (410)
                      .    -++||||+.+..
T Consensus        84 ~----~~lv~e~l~~~~   96 (288)
T 3f7w_A           84 D----RTLAMEWVDERP   96 (288)
T ss_dssp             T----TEEEEECCCCCC
T ss_pred             C----ceEEEEeecccC
Confidence            1    278999987643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.77  E-value=5.7e-05  Score=70.46  Aligned_cols=122  Identities=15%  Similarity=0.075  Sum_probs=74.3

Q ss_pred             eeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCc-ccceeEEEcCCCCEE
Q 015257          123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNI-VNLIEVIDDPNSDHF  201 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~  201 (410)
                      ++.|+.|....+|++      ..+++|+......          ..-...+|+.+++.+...++ .+++.+..+    .-
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----------~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~----~~   82 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----------EYINRANEAVAAREAAKAGVSPEVLHVDPA----TG   82 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC--------------CCCHHHHHHHHHHHHHTTSSCCEEEECTT----TC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCcc----------ceeCHHHHHHHHHHHHHcCCCCceEEEECC----CC
Confidence            788999999999988      5699998653210          00123467777777653333 355554321    23


Q ss_pred             EEEEeec-CCCCcccccCCCCCCCHHHH---HHHHHHHHHHHHHHHh---------------------------------
Q 015257          202 YMVLEYV-EGKWDNDGFGQPGAIGESMA---RKYLRDIVSGLMYLHG---------------------------------  244 (410)
Q Consensus       202 ~lv~e~~-~~~~l~~~~~~~~~l~~~~~---~~i~~qi~~gL~yLH~---------------------------------  244 (410)
                      ++|+||+ +|..+..          ...   ..++.+++..|+-||+                                 
T Consensus        83 ~~v~e~i~~g~~l~~----------~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (301)
T 3dxq_A           83 VMVTRYIAGAQTMSP----------EKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGY  152 (301)
T ss_dssp             CEEEECCTTCEECCH----------HHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTH
T ss_pred             EEEEeecCCCccCCH----------hhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhH
Confidence            6899999 6654421          000   0122223333333332                                 


Q ss_pred             --------------------CCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          245 --------------------HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       245 --------------------~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                                          ..++|+|+.|.||| ..++.+.|+||..+..
T Consensus       153 ~~l~~~~~~l~~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          153 HDVVREAGGVRSALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             HHHHHHHHHHHHHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence                                13799999999999 5577889999998864

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.71  E-value=0.00011  Score=71.91  Aligned_cols=80  Identities=11%  Similarity=0.004  Sum_probs=47.8

Q ss_pred             HhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccccccCC-CcccccccccccCCcC--CCchhhHHHHHHHHHH
Q 015257          243 HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP-GTPVFTAPECCLGLTY--GGKAADTWAVGVTLYY  319 (410)
Q Consensus       243 H~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~-gt~~y~aPE~~~~~~~--~~~~~DiwSlG~il~e  319 (410)
                      +...++|+|++|.|||++.++ +.|+||+.+.......+...... -...|++|+.......  .....++.++...+|.
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            456799999999999999776 99999999875432211111000 0234666664432111  0123455577777777


Q ss_pred             HHhC
Q 015257          320 MIIG  323 (410)
Q Consensus       320 lltG  323 (410)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.59  E-value=0.00035  Score=65.55  Aligned_cols=140  Identities=16%  Similarity=0.184  Sum_probs=77.4

Q ss_pred             eeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCC--cccceeE------
Q 015257          121 VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN--IVNLIEV------  192 (410)
Q Consensus       121 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~------  192 (410)
                      ..++.|+.|....||++...  +..+++|+.....           ....+..|+.+++.+....  +.+++..      
T Consensus        25 ~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~-----------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~   91 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV-----------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELL   91 (322)
T ss_dssp             EEEEEECC---EEEEEEEES--SCCEEEEEECC--------------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSC
T ss_pred             eEeeccCCCcccceEEEEeC--CccEEEEEeCCCC-----------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEE
Confidence            34677888999999988653  3368999875420           1124556777776664222  2333321      


Q ss_pred             EEcCCCCEEEEEEeecCCCCcccc------------------cCC---C--CCCC---HHHHH-H-----------HHHH
Q 015257          193 IDDPNSDHFYMVLEYVEGKWDNDG------------------FGQ---P--GAIG---ESMAR-K-----------YLRD  234 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~l~~~------------------~~~---~--~~l~---~~~~~-~-----------i~~q  234 (410)
                      ...  .+..+++|+|++|..+...                  ...   .  ....   +.... .           +...
T Consensus        92 ~~~--~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~  169 (322)
T 2ppq_A           92 GEL--SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREE  169 (322)
T ss_dssp             EEE--TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHH
T ss_pred             EEE--CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHH
Confidence            111  2467899999998654210                  000   0  0011   11100 0           0011


Q ss_pred             HHHHHHHHHh-------CCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          235 IVSGLMYLHG-------HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       235 i~~gL~yLH~-------~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                      +...+..|+.       .+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            3344555552       3689999999999999766668999998754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.56  E-value=0.0002  Score=69.22  Aligned_cols=137  Identities=14%  Similarity=0.190  Sum_probs=81.6

Q ss_pred             eeeecccCceEEEEEEEcc-------CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCc-ccceeEEE
Q 015257          123 VRKIGAGSYGKVVLYRSSL-------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNI-VNLIEVID  194 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~  194 (410)
                      ++.|..|-...+|++....       +++.|++|+....          ......+.+|..+++.+.-.++ .++++++.
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----------~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~  124 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----------LQGVDSLVLESVMFAILAERSLGPQLYGVFP  124 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----------cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC
Confidence            5678888888999887642       3578999975221          1123455689999888853333 56666653


Q ss_pred             cCCCCEEEEEEeecCCCCcccc-cC-----------------C----CCCC--CHHHHHHHHHHHHH-------------
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDG-FG-----------------Q----PGAI--GESMARKYLRDIVS-------------  237 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~-~~-----------------~----~~~l--~~~~~~~i~~qi~~-------------  237 (410)
                      +      .+||||++|..+... +.                 .    ....  -+..+..++.++..             
T Consensus       125 ~------g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~  198 (379)
T 3feg_A          125 E------GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLE  198 (379)
T ss_dssp             T------EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHH
T ss_pred             C------ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhh
Confidence            2      289999998554311 00                 0    1111  23455555544422             


Q ss_pred             ------HHHHHH----h----CCcEeccCCCCcEEEcCC----CcEEEeecccccc
Q 015257          238 ------GLMYLH----G----HNVVHGDIKPDNLLVAPS----GTVKIGDFSVSQV  275 (410)
Q Consensus       238 ------gL~yLH----~----~~iiHrDlkp~NIll~~~----~~~kl~DfG~a~~  275 (410)
                            .+..|.    .    ..++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       199 ~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          199 MYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             hHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                  233332    2    248999999999999876    7899999998864

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.52  E-value=0.0013  Score=57.87  Aligned_cols=134  Identities=14%  Similarity=0.085  Sum_probs=86.4

Q ss_pred             cccccC-CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCcEEEcCCCcEEEeeccccccccCCccccccCCCcc
Q 015257          213 DNDGFG-QPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTP  290 (410)
Q Consensus       213 l~~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  290 (410)
                      |.+.+. ...+++|.++|.++.|.+.+|.-+-. ..-..+=+.|..|+|..+|.|-+.+ +.+.            ....
T Consensus        35 L~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~~  101 (229)
T 2yle_A           35 LEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AGEP  101 (229)
T ss_dssp             HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-------------------
T ss_pred             HHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------cccc
Confidence            444443 35689999999999999999877621 1111333457899999999998864 2211            0122


Q ss_pred             cccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhccc------
Q 015257          291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRNLLEGLLCK------  364 (410)
Q Consensus       291 ~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~li~~~L~~------  364 (410)
                      .+.|||....  ..+.+.=|||||++||..+--..|=                 .-+..+|+.|..||..|...      
T Consensus       102 ~~~~pe~~~~--~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~~~~d~~~  162 (229)
T 2yle_A          102 PPVAGKLGYS--QCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMANTVEADGS  162 (229)
T ss_dssp             -----CCSSS--SSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTTCCC----
T ss_pred             CCCChhhccc--cchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHhccccccc
Confidence            3678886532  2246789999999999988422221                 12457899999999999755      


Q ss_pred             -------------------CCCCCCCHHHHhhC
Q 015257          365 -------------------DPTRRLTLNDVAKH  378 (410)
Q Consensus       365 -------------------dp~~Rpt~~ell~h  378 (410)
                                         .+..|+|+++|++.
T Consensus       163 ~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~  195 (229)
T 2yle_A          163 NDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKL  195 (229)
T ss_dssp             ----------------CCSCCCCCCSHHHHHHH
T ss_pred             ccccccccccccccccccccccCcCCHHHHHHH
Confidence                               24678899888753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.39  E-value=0.0013  Score=61.73  Aligned_cols=138  Identities=12%  Similarity=0.188  Sum_probs=77.8

Q ss_pred             eeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCC--cccceeE-----EEc
Q 015257          123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN--IVNLIEV-----IDD  195 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~-----~~~  195 (410)
                      +..|+ |....||++... +|+.+++|+......          ....+..|..+++.+....  +++++..     ...
T Consensus        31 ~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~----------~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~   98 (328)
T 1zyl_A           31 LTPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW----------TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNH   98 (328)
T ss_dssp             CEEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS----------CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEE
T ss_pred             EEeec-CcccceEEEEcC-CCCEEEEEEcCCCCC----------CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEE
Confidence            34566 888899876543 566899998753211          1235667888777774222  3444433     111


Q ss_pred             CCCCEEEEEEeecCCCCcccc------------------cCC-----CCCCCHHHH----------------------HH
Q 015257          196 PNSDHFYMVLEYVEGKWDNDG------------------FGQ-----PGAIGESMA----------------------RK  230 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~------------------~~~-----~~~l~~~~~----------------------~~  230 (410)
                        .+..++||+|++|..+...                  ...     ...++....                      ..
T Consensus        99 --~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  176 (328)
T 1zyl_A           99 --QGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLK  176 (328)
T ss_dssp             --TTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHH
T ss_pred             --CCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHH
Confidence              3467899999998543210                  000     011111110                      01


Q ss_pred             HHHHHHHHHHHH----HhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          231 YLRDIVSGLMYL----HGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       231 i~~qi~~gL~yL----H~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      .+.+++..+.-+    ....++|+|+++.|||++ + .+.|+||+.+...
T Consensus       177 ~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          177 ATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             HHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             HHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence            111222222222    224589999999999999 4 8999999987643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.38  E-value=0.00051  Score=65.93  Aligned_cols=75  Identities=13%  Similarity=0.134  Sum_probs=44.3

Q ss_pred             eeeeecccCceEEEEEEEcc--------CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCc-ccceeE
Q 015257          122 HVRKIGAGSYGKVVLYRSSL--------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNI-VNLIEV  192 (410)
Q Consensus       122 ~~~~lG~G~fg~Vy~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~  192 (410)
                      .+..|+.|....||++....        .+..+++|+.....          ........|..+++.+...++ .++++.
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~----------~~~~~~~~E~~~l~~L~~~g~~P~~~~~  106 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV----------DELYNTISEFEVYKTMSKYKIAPQLLNT  106 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG----------GGTSCHHHHHHHHHHHHHTTSSCCEEEE
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc----------cceecHHHHHHHHHHHHhcCCCCceEEe
Confidence            36778889889999987653        13679999764321          111123578888877753343 466654


Q ss_pred             EEcCCCCEEEEEEeecCCCC
Q 015257          193 IDDPNSDHFYMVLEYVEGKW  212 (410)
Q Consensus       193 ~~~~~~~~~~lv~e~~~~~~  212 (410)
                      .  + +   ++||||++|..
T Consensus       107 ~--~-~---~~v~e~i~G~~  120 (369)
T 3c5i_A          107 F--N-G---GRIEEWLYGDP  120 (369)
T ss_dssp             E--T-T---EEEEECCCSEE
T ss_pred             c--C-C---cEEEEEecCCc
Confidence            4  1 1   68999999854

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.36  E-value=0.00052  Score=67.43  Aligned_cols=75  Identities=15%  Similarity=0.264  Sum_probs=50.0

Q ss_pred             eeeeecccCceEEEEEEEcc-------CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCc-ccceeEE
Q 015257          122 HVRKIGAGSYGKVVLYRSSL-------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNI-VNLIEVI  193 (410)
Q Consensus       122 ~~~~lG~G~fg~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~  193 (410)
                      .++.|+.|....||++....       ++..+++|+....         ..  ...+.+|..+++.+...++ .++++.+
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---------~~--~~~li~E~~~l~~L~~~g~~P~l~~~~  145 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---------ET--ESHLVAESVIFTLLSERHLGPKLYGIF  145 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---------CC--HHHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---------Cc--HHHHHHHHHHHHHHHhCCCCCcEEEEe
Confidence            46789999999999987642       2578999986321         00  1244578888888854444 5666655


Q ss_pred             EcCCCCEEEEEEeecCCCCc
Q 015257          194 DDPNSDHFYMVLEYVEGKWD  213 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l  213 (410)
                      .  +    .+|+||++|..+
T Consensus       146 ~--~----g~v~e~l~G~~l  159 (429)
T 1nw1_A          146 S--G----GRLEEYIPSRPL  159 (429)
T ss_dssp             T--T----EEEECCCCEEEC
T ss_pred             C--C----CEEEEEeCCccc
Confidence            3  2    289999987443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.20  E-value=0.004  Score=61.60  Aligned_cols=76  Identities=17%  Similarity=0.185  Sum_probs=49.1

Q ss_pred             eeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCc-ccceeEEEcCCCCE
Q 015257          122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNI-VNLIEVIDDPNSDH  200 (410)
Q Consensus       122 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~  200 (410)
                      .++.|+.|-...+|++.....+..|++|+.......    ..      ...+|..+++.|...++ .++++++.  +   
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~----~i------dR~~E~~vl~~L~~~gl~P~ll~~~~--~---  176 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE----II------NREREKKISCILYNKNIAKKIYVFFT--N---  176 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS----CS------CHHHHHHHHHHHTTSSSBCCEEEEET--T---
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh----hc------CHHHHHHHHHHHHhcCCCCCEEEEeC--C---
Confidence            467899999999999886544578999986432100    00      12588999998875555 46666662  2   


Q ss_pred             EEEEEeecCCCCc
Q 015257          201 FYMVLEYVEGKWD  213 (410)
Q Consensus       201 ~~lv~e~~~~~~l  213 (410)
                       .+||||++|..+
T Consensus       177 -G~v~e~I~G~~l  188 (458)
T 2qg7_A          177 -GRIEEFMDGYAL  188 (458)
T ss_dssp             -EEEEECCCSEEC
T ss_pred             -eEEEEeeCCccC
Confidence             259999998543

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.95  E-value=0.00052  Score=64.76  Aligned_cols=33  Identities=30%  Similarity=0.386  Sum_probs=28.2

Q ss_pred             CCcEeccCCCCcEEEcCC----CcEEEeecccccccc
Q 015257          245 HNVVHGDIKPDNLLVAPS----GTVKIGDFSVSQVFE  277 (410)
Q Consensus       245 ~~iiHrDlkp~NIll~~~----~~~kl~DfG~a~~~~  277 (410)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+....
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            469999999999999875    689999999887543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.91  E-value=0.0053  Score=58.11  Aligned_cols=32  Identities=25%  Similarity=0.348  Sum_probs=28.1

Q ss_pred             CCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       245 ~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            35899999999999998889999999987653

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.10  E-value=0.017  Score=56.46  Aligned_cols=76  Identities=17%  Similarity=0.233  Sum_probs=48.0

Q ss_pred             eeeeecccCceEEEEEEEccC-------CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCc-ccceeEE
Q 015257          122 HVRKIGAGSYGKVVLYRSSLD-------GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNI-VNLIEVI  193 (410)
Q Consensus       122 ~~~~lG~G~fg~Vy~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~  193 (410)
                      .++.|..|-...+|++.....       +..|++++.....          +..-...+|..+++.+.-.++ .++++.+
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----------~~~idR~~E~~~l~~L~~~gi~P~l~~~~  143 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----------GKFYDSKVELDVFRYLSNINIAPNIIADF  143 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----------CCCCHHHHHHHHHHHHHTTSSCCEEEEE
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----------chhcCHHHHHHHHHHHHhcCCCCCEEEEc
Confidence            467788888899999886521       5789999853321          000123478888877753333 4555543


Q ss_pred             EcCCCCEEEEEEeecCCCCc
Q 015257          194 DDPNSDHFYMVLEYVEGKWD  213 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l  213 (410)
                      .  +    ++||||++|..+
T Consensus       144 ~--~----~~I~efI~G~~l  157 (424)
T 3mes_A          144 P--E----GRIEEFIDGEPL  157 (424)
T ss_dssp             T--T----EEEEECCCSEEC
T ss_pred             C--C----CEEEEEeCCccC
Confidence            2  1    689999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.63  E-value=0.048  Score=52.77  Aligned_cols=29  Identities=24%  Similarity=0.394  Sum_probs=25.0

Q ss_pred             cEeccCCCCcEEE------cCCCcEEEeecccccc
Q 015257          247 VVHGDIKPDNLLV------APSGTVKIGDFSVSQV  275 (410)
Q Consensus       247 iiHrDlkp~NIll------~~~~~~kl~DfG~a~~  275 (410)
                      ++|+|+.+.|||+      +.++.+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999      3456799999998864

>1gxc_A CHK2, CDS1, serine/threonine-protein kinase CHK2; phosphoprotein-binding domain, checkpoint kinase, transferase; HET: TPO; 2.7A {Homo sapiens} SCOP: b.26.1.2

Probab=90.98  E-value=0.031  Score=46.15  Aligned_cols=64  Identities=25%  Similarity=0.270  Sum_probs=44.5

Q ss_pred             cccchhhhccccccccCCccccCCCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCC
Q 015257            3 RKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTA   66 (410)
Q Consensus         3 ~~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~   66 (410)
                      ...+++||+..|+.+++....+....+..+|..|.+|.+.-..+........|.|.||++.|..
T Consensus        47 ~~~~~IGR~~~~di~l~d~~~~~~~~~~~VSr~Ha~I~~~~~~~~~~~~~i~D~StNGT~VNg~  110 (149)
T 1gxc_A           47 NDNYWFGRDKSCEYCFDEPLLKRTDKYRTYSKKHFRIFREVGPKNSYIAYIEDHSGNGTFVNTE  110 (149)
T ss_dssp             SSEEEEESSTTCSEECCCGGGGGSSGGGGSCTTCEEEEEEECTTSSEEEEEEECCSSCEEETTE
T ss_pred             CCCEEecCCCCCCEEECCccccccccCCcCchhheEEEEECCCCceeEEEEEECCCCCeEECCE
Confidence            3568999999999999877543333455699999999875322111123456679999999875

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=83.86  E-value=0.097  Score=51.68  Aligned_cols=64  Identities=13%  Similarity=0.058  Sum_probs=18.3

Q ss_pred             eeeeecccCceEEEEEEEccCCceEEE------EeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          122 HVRKIGAGSYGKVVLYRSSLDGKHYAI------KAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       122 ~~~~lG~G~fg~Vy~~~~~~~~~~vai------K~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      +.+.||   ||.||++........|||      |......       ...+....+.+|..+++.++|||+++.+++...
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~-------~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDG-------VSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC------------------------------------------CBCCCEEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCcccccccc-------ccccccccccccccccccccccccCCCcceEEe
Confidence            455676   999998877654567888      5543221       123445578889999999999999999887653

>1qu5_A Protein kinase SPK1; FHA, RAD53, transferase; NMR {Saccharomyces cerevisiae} SCOP: b.26.1.2

Probab=82.76  E-value=0.42  Score=40.65  Aligned_cols=56  Identities=11%  Similarity=-0.159  Sum_probs=38.8

Q ss_pred             cchhhhccccccccCCccccCCCCCCCCCCCccccccccccCCC----------CCCCCCCCCCCCCCCCCCCCC
Q 015257            5 TCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDD----------IDDDDDDNSYNGEATNTADGD   69 (410)
Q Consensus         5 ~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~   69 (410)
                      .+++||+..|+.+++..         .+|..|.+|...-...+.          ..-...|.|.||++.|.....
T Consensus        52 ~~~IGR~~~~di~l~d~---------~VSr~HA~I~~~~~~~g~~~~e~~~~~~~~~~l~DlStNGT~VNg~ri~  117 (182)
T 1qu5_A           52 PFFIGRSEDCNCKIEDN---------RLSRVHCFIFKKRHAVGKSMYESPAQGLDDIWYCHTGTNVSYLNNNRMI  117 (182)
T ss_dssp             SEEESSSTTSSSCCCCT---------TSCSSCEEEEEECCCCCSSCCSSCCCSCCEEEECCCSSSCCEETTEECC
T ss_pred             eEEECCCCCCCEEECCC---------CcChHHeEEEEecCccccccccccccccceEEEEECCcCCeEECCEEcC
Confidence            38999999999998866         688899999764321111          112345668999998875433

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=81.30  E-value=3.1  Score=36.14  Aligned_cols=116  Identities=14%  Similarity=0.115  Sum_probs=74.9

Q ss_pred             CCCCCcccceeEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEc
Q 015257          181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA  260 (410)
Q Consensus       181 l~hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~  260 (410)
                      ..||+++.. .+-.+  .+.+.+.++.-+...-...+   ..++....++++.+|+....+++  .=+|-=|.|+||+++
T Consensus        42 ~~~~~Fl~~-~I~e~--eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~  113 (215)
T 4ann_A           42 QHSPYFIDA-ELTEL--RDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFT  113 (215)
T ss_dssp             SCCTTBCCE-EEEEC--SSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEEC
T ss_pred             ccCCcccce-EEEEc--ccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEc
Confidence            368988877 44443  34566666554322212112   24678889999999988775554  346778999999999


Q ss_pred             CCCcEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCC
Q 015257          261 PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPF  327 (410)
Q Consensus       261 ~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf  327 (410)
                      .++.+++.=.|+-..+                 +|.-+      +...=.-.+=+++..+++++..|
T Consensus       114 ~~~~p~i~~RGik~~l-----------------~P~~~------~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          114 RDGLPIAKTRGLQNVV-----------------DPLPV------SEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             TTSCEEESCCEETTTB-----------------SCCCC------CHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             CCCCEEEEEccCccCC-----------------CCCCC------CHHHHHHHHHHHHHHHHcCCCCH
Confidence            9999999877764322                 22211      12122335667888899888776

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	410
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-74
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-71
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-71
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-70
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-70
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-69
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-69
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-67
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-66
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-65
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-64
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-63
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-63
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-62
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-62
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-62
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-62
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-61
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-61
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-60
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-60
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-59
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-58
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-57
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-56
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-55
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-55
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-55
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-54
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-54
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-53
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-53
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-53
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-53
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-52
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-52
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-52
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-51
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-51
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-51
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-50
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-50
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-49
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-48
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-48
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-48
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-47
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-47
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-45
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-45
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-44
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-44
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	9e-44
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-43
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-43
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-42
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-41
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-40
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-33
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-19

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (587), Expect = 3e-74
 Identities = 79/269 (29%), Positives = 123/269 (45%), Gaps = 11/269 (4%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           + ++   R +G G +G V L R        A+K   K+ L K            +RREV 
Sbjct: 5   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK------AGVEHQLRREVE 58

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           I   L+HPNI+ L     D      Y++LEY           +     E     Y+ ++ 
Sbjct: 59  IQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 116

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           + L Y H   V+H DIKP+NLL+  +G +KI DF  S      +       GT  +  PE
Sbjct: 117 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPE 174

Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
              G  +  +  D W++GV  Y  ++G+ PF   T Q+TY +I      FPD +    R+
Sbjct: 175 MIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 233

Query: 357 LLEGLLCKDPTRRLTLNDVAKHTWVLGDN 385
           L+  LL  +P++R  L +V +H W+  ++
Sbjct: 234 LISRLLKHNPSQRPMLREVLEHPWITANS 262

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (568), Expect = 5e-71
 Identities = 79/270 (29%), Positives = 127/270 (47%), Gaps = 11/270 (4%)

Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
           K   ++   + +G GS+  VVL R     + YAIK   K H+ K      E  +  V RE
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK------ENKVPYVTRE 58

Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
             +M  L HP  V L     D   +  Y  L Y +         + G+  E+  R Y  +
Sbjct: 59  RDVMSRLDHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 116

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS--PGTPVF 292
           IVS L YLHG  ++H D+KP+N+L+     ++I DF  ++V   ++   R +   GT  +
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176

Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNP 352
            +PE     +   K++D WA+G  +Y ++ G  PF        + KI+     FP+   P
Sbjct: 177 VSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP 235

Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWVL 382
           + R+L+E LL  D T+RL   ++  +  + 
Sbjct: 236 KARDLVEKLLVLDATKRLGCEEMEGYGPLK 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (568), Expect = 5e-71
 Identities = 72/295 (24%), Positives = 125/295 (42%), Gaps = 23/295 (7%)

Query: 111 ENGTKMIN---EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETA 167
           E+ T+ +N    +  + ++G G++GKV   ++       A K              SE  
Sbjct: 2   EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---------SEEE 52

Query: 168 MTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK-WDNDGFGQPGAIGES 226
           + D   E+ I+    HPNIV L++     N  + ++++E+  G   D         + ES
Sbjct: 53  LEDYMVEIDILASCDHPNIVKLLDAFYYEN--NLWILIEFCAGGAVDAVMLELERPLTES 110

Query: 227 MARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS 286
             +   +  +  L YLH + ++H D+K  N+L    G +K+ DF VS             
Sbjct: 111 QIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 170

Query: 287 PGTPVFTAPECCLGLTYGGK----AADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN 342
            GTP + APE  +  T   +     AD W++G+TL  M   + P           KI  +
Sbjct: 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS 230

Query: 343 ---SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD-NGPIPQYLC 393
              +L  P   +   ++ L+  L K+   R T + + +H +V  D N PI + + 
Sbjct: 231 EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIA 285

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (563), Expect = 2e-70
 Identities = 68/273 (24%), Positives = 119/273 (43%), Gaps = 18/273 (6%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           +Y  +  IG GSYG+    R   DGK    K      ++       E     +  EV ++
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-------EAEKQMLVSEVNLL 57

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----KWDNDGFGQPGAIGESMARKYLRD 234
           + L+HPNIV   + I D  +   Y+V+EY EG         G  +   + E    + +  
Sbjct: 58  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117

Query: 235 IVSGLMYLH-----GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGT 289
           +   L   H     GH V+H D+KP N+ +     VK+GDF ++++   D    +   GT
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGT 177

Query: 290 PVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV-FPD 348
           P + +PE    ++Y  K +D W++G  LY +     PF   + ++   KI        P 
Sbjct: 178 PYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 236

Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
             + EL  ++  +L      R ++ ++ ++  +
Sbjct: 237 RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (559), Expect = 7e-70
 Identities = 70/279 (25%), Positives = 128/279 (45%), Gaps = 18/279 (6%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           + ++  V+ +G G+YG+V L  + +  +  A+K                    ++++E+ 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--------ENIKKEIC 55

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           I KML H N+V       + N    Y+ LEY  G    D       + E  A+++   ++
Sbjct: 56  INKMLNHENVVKFYGHRREGN--IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM 113

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTA 294
           +G++YLHG  + H DIKP+NLL+     +KI DF ++ VF  +N   +L +  GT  + A
Sbjct: 114 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF---PDAMN 351
           PE      +  +  D W+ G+ L  M+ G+ P+   +              +      ++
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 233

Query: 352 PELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
                LL  +L ++P+ R+T+ D+ K  W    N P+ +
Sbjct: 234 SAPLALLHKILVENPSARITIPDIKKDRWY---NKPLKK 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  219 bits (559), Expect = 2e-69
 Identities = 71/272 (26%), Positives = 114/272 (41%), Gaps = 16/272 (5%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           +  +R+IG GS+G V   R   + +  AIK    S         S     D+ +EV  ++
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ------SNEKWQDIIKEVRFLQ 70

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
            L+HPN +         +    ++V+EY  G   +        + E          + GL
Sbjct: 71  KLRHPNTIQYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
            YLH HN++H D+K  N+L++  G VK+GDF  + +    N  +    GTP + APE  L
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV----GTPYWMAPEVIL 184

Query: 300 GLTYG--GKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL--VFPDAMNPELR 355
            +  G      D W++G+T   +   + P            I  N    +     +   R
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 244

Query: 356 NLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
           N ++  L K P  R T   + KH +VL +  P
Sbjct: 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (557), Expect = 3e-69
 Identities = 69/265 (26%), Positives = 113/265 (42%), Gaps = 16/265 (6%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y    KIG G+ G V        G+  AI+  +     K            +  E+L+M+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE---------LIINEILVMR 72

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGL 239
             ++PNIVN ++       D  ++V+EY+ G            + E       R+ +  L
Sbjct: 73  ENKNPNIVNYLDSYLVG--DELWVVMEYLAGG-SLTDVVTETCMDEGQIAAVCRECLQAL 129

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCL 299
            +LH + V+H DIK DN+L+   G+VK+ DF        +        GTP + APE   
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189

Query: 300 GLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDAMNPELRN 356
              Y G   D W++G+    MI G+ P+L E        I  N    L  P+ ++   R+
Sbjct: 190 RKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248

Query: 357 LLEGLLCKDPTRRLTLNDVAKHTWV 381
            L   L  D  +R +  ++ +H ++
Sbjct: 249 FLNRCLDMDVEKRGSAKELLQHQFL 273

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  216 bits (551), Expect = 1e-67
 Identities = 75/278 (26%), Positives = 131/278 (47%), Gaps = 20/278 (7%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           ++ Y    ++G G++G V        G ++A K     H S             VR+E+ 
Sbjct: 25  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE---------TVRKEIQ 75

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDG-FGQPGAIGESMARKYLRDI 235
            M +L+HP +VNL +  +D N     M+ E++ G    +    +   + E  A +Y+R +
Sbjct: 76  TMSVLRHPTLVNLHDAFEDDN--EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 133

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAP--SGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
             GL ++H +N VH D+KP+N++     S  +K+ DF ++    D    ++ + GT  F 
Sbjct: 134 CKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFA 192

Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA---- 349
           APE   G    G   D W+VGV  Y ++ G  PF GE   +T   + +      D+    
Sbjct: 193 APEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 251

Query: 350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
           ++ + ++ +  LL  DP  R+T++   +H W+   N P
Sbjct: 252 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  213 bits (543), Expect = 2e-66
 Identities = 74/303 (24%), Positives = 147/303 (48%), Gaps = 20/303 (6%)

Query: 115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRRE 174
            + + Y  + ++G+G++G V        G+ +  K  +  +               V+ E
Sbjct: 26  SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---------TVKNE 76

Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLR 233
           + IM  L HP ++NL +  +D       ++LE++ G    D    +   + E+    Y+R
Sbjct: 77  ISIMNQLHHPKLINLHDAFEDKY--EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR 134

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVA--PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
               GL ++H H++VH DIKP+N++     + +VKI DF ++    + +++++ +  T  
Sbjct: 135 QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATAE 193

Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP---- 347
           F APE        G   D WA+GV  Y ++ G  PF GE   +T   +      F     
Sbjct: 194 FAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF 252

Query: 348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLRRDNTTQ 407
            +++PE ++ ++ LL K+P +RLT++D  +H W+ GD+  +   +   + +++R+    +
Sbjct: 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEK 312

Query: 408 DSN 410
            ++
Sbjct: 313 YAD 315

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  208 bits (530), Expect = 5e-65
 Identities = 77/269 (28%), Positives = 136/269 (50%), Gaps = 17/269 (6%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           + ++  +R +G GS+G+V L RS  +G++YA+K   K  + +L+       +     E L
Sbjct: 3   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK------QVEHTNDERL 56

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           ++ ++ HP I+ +     D      +M+++Y+EG        +       +A+ Y  ++ 
Sbjct: 57  MLSIVTHPFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC 114

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
             L YLH  ++++ D+KP+N+L+  +G +KI DF  ++   D         GTP + APE
Sbjct: 115 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPE 171

Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
                 Y  K+ D W+ G+ +Y M+ G  PF       TY+KI+N  L FP   N ++++
Sbjct: 172 VVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 230

Query: 357 LLEGLLCKDPTRRL-----TLNDVAKHTW 380
           LL  L+ +D ++RL        DV  H W
Sbjct: 231 LLSRLITRDLSQRLGNLQNGTEDVKNHPW 259

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  207 bits (527), Expect = 1e-64
 Identities = 76/275 (27%), Positives = 126/275 (45%), Gaps = 19/275 (6%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + Y     +G G++ +V+L       K  AIK   K  L              +  E+ +
Sbjct: 9   DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--------GSMENEIAV 60

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +  ++HPNIV L ++ +     H Y++++ V G    D   + G   E  A + +  ++ 
Sbjct: 61  LHKIKHPNIVALDDIYESGG--HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 118

Query: 238 GLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
            + YLH   +VH D+KP+NLL         + I DF +S+  ED   VL  + GTP + A
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVA 177

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DAM 350
           PE      Y  KA D W++GV  Y ++ G  PF  E     +++I+     F     D +
Sbjct: 178 PEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236

Query: 351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN 385
           +   ++ +  L+ KDP +R T     +H W+ GD 
Sbjct: 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 5e-63
 Identities = 82/272 (30%), Positives = 135/272 (49%), Gaps = 15/272 (5%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + Y    ++G+G +  V   R    G  YA K   K      R      +  D+ REV I
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR---RGVSREDIEREVSI 66

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +K +QHPN++ L EV ++       ++LE V G    D   +  ++ E  A ++L+ I++
Sbjct: 67  LKEIQHPNVITLHEVYENKT--DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124

Query: 238 GLMYLHGHNVVHGDIKPDNLLVA----PSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
           G+ YLH   + H D+KP+N+++     P   +KI DF ++   +  N+  +   GTP F 
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFV 183

Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA---- 349
           APE        G  AD W++GV  Y ++ G  PFLG+T Q+T   +   +  F D     
Sbjct: 184 APEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242

Query: 350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
            +   ++ +  LL KDP +R+T+ D  +H W+
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  201 bits (513), Expect = 7e-63
 Identities = 65/271 (23%), Positives = 111/271 (40%), Gaps = 13/271 (4%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y     +G G    V         K YA+K    +          +       +EV I++
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 180 MLQ-HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
            +  HPNI+ L +  +      F++V + ++     D   +   + E   RK +R ++  
Sbjct: 65  KVSGHPNIIQLKDTYETNT--FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           +  LH  N+VH D+KP+N+L+     +K+ DF  S    D  + LR   GTP + APE  
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEII 181

Query: 299 LGLTYG-----GKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----DA 349
                      GK  D W+ GV +Y ++ G  PF           I++ +  F     D 
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241

Query: 350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
            +  +++L+   L   P +R T  +   H +
Sbjct: 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 1e-62
 Identities = 72/277 (25%), Positives = 131/277 (47%), Gaps = 19/277 (6%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           ++Y     +G+G +G V       D    AIK   K  +S     P+    T V  EV++
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN---GTRVPMEVVL 60

Query: 178 MKMLQ--HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRD 234
           +K +      ++ L++  + P  D F ++LE  E   D   F  + GA+ E +AR +   
Sbjct: 61  LKKVSSGFSGVIRLLDWFERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPS-GTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
           ++  + + H   V+H DIK +N+L+  + G +K+ DF    + +D         GT V++
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYS 176

Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPE 353
            PE      Y G++A  W++G+ LY M+ G  PF  +      ++I+   + F   ++ E
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSE 230

Query: 354 LRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
            ++L+   L   P+ R T  ++  H W+   +  +PQ
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWM--QDVLLPQ 265

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 1e-62
 Identities = 67/294 (22%), Positives = 116/294 (39%), Gaps = 34/294 (11%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
             +G G +  V   R     +  AIK     H S+ +    +       RE+ +++ L H
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAK----DGINRTALREIKLLQELSH 59

Query: 184 PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLH 243
           PNI+ L++        +  +V +++E   +         +  S  + Y+   + GL YLH
Sbjct: 60  PNIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117

Query: 244 GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTY 303
            H ++H D+KP+NLL+  +G +K+ DF +++ F   N        T  + APE   G   
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177

Query: 304 GGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD--------------- 348
            G   D WAVG  L  +++      G++  D   +I        +               
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 349 -------------AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIP 389
                        A   +L +L++GL   +P  R+T     K  +     GP P
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 291

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  203 bits (517), Expect = 2e-62
 Identities = 76/277 (27%), Positives = 128/277 (46%), Gaps = 15/277 (5%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +N++   R IG G +G+V   R +  GK YA+K   K  +   +    ET   + R  + 
Sbjct: 3   MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ---GETLALNERIMLS 59

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           ++     P IV +      P  D    +L+ + G   +    Q G   E+  R Y  +I+
Sbjct: 60  LVSTGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 117

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
            GL ++H   VV+ D+KP N+L+   G V+I D  ++  F         S GT  + APE
Sbjct: 118 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPE 175

Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYD---KIVNNSLVFPDAMNPE 353
                     +AD +++G  L+ ++ G  PF     +D ++     +  ++  PD+ +PE
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235

Query: 354 LRNLLEGLLCKDPTRRLTL-----NDVAKHTWVLGDN 385
           LR+LLEGLL +D  RRL        +V +  +    +
Sbjct: 236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 3e-62
 Identities = 65/269 (24%), Positives = 118/269 (43%), Gaps = 21/269 (7%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y+    +G G +G V     +   K Y  K        ++ V          ++E+ I+ 
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV----------KKEISILN 56

Query: 180 MLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSG 238
           + +H NI++L E  +    +   M+ E++ G    +        + E     Y+  +   
Sbjct: 57  IARHRNILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEA 114

Query: 239 LMYLHGHNVVHGDIKPDNLLVAP--SGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           L +LH HN+ H DI+P+N++     S T+KI +F  ++      D  R     P + APE
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRLLFTAPEYYAPE 173

Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA----MNP 352
                     A D W++G  +Y ++ G  PFL ET Q   + I+N    F +     ++ 
Sbjct: 174 VHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232

Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWV 381
           E  + ++ LL K+   R+T ++  +H W+
Sbjct: 233 EAMDFVDRLLVKERKSRMTASEALQHPWL 261

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 1e-61
 Identities = 83/274 (30%), Positives = 138/274 (50%), Gaps = 14/274 (5%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +N++ +++ +G G++GKV+L R    G++YA+K   K  +       ++  +     E  
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII------AKDEVAHTVTESR 57

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           +++  +HP +  L         D    V+EY  G        +     E  AR Y  +IV
Sbjct: 58  VLQNTRHPFLTALKYAFQTH--DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           S L YLH  +VV+ DIK +NL++   G +KI DF + +    D   ++   GTP + APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175

Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
                 Y G+A D W +GV +Y M+ G+ PF  +  +  ++ I+   + FP  ++PE ++
Sbjct: 176 VLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 234

Query: 357 LLEGLLCKDPTRRL-----TLNDVAKHTWVLGDN 385
           LL GLL KDP +RL        +V +H + L  N
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 5e-61
 Identities = 71/265 (26%), Positives = 126/265 (47%), Gaps = 9/265 (3%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I +++  + +G GS+GKV L       + +AIKA  K  +        +     +  + +
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-----DDDVECTMVEKRV 55

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIV 236
           +    +HP + ++         ++ + V+EY+ G               S A  Y  +I+
Sbjct: 56  LSLAWEHPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 113

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
            GL +LH   +V+ D+K DN+L+   G +KI DF + +     +       GTP + APE
Sbjct: 114 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173

Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN 356
             LG  Y   + D W+ GV LY M+IGQ PF G+  ++ +  I  ++  +P  +  E ++
Sbjct: 174 ILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 232

Query: 357 LLEGLLCKDPTRRLTL-NDVAKHTW 380
           LL  L  ++P +RL +  D+ +H  
Sbjct: 233 LLVKLFVREPEKRLGVRGDIRQHPL 257

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 3e-60
 Identities = 65/309 (21%), Positives = 114/309 (36%), Gaps = 58/309 (18%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +++  + ++GAG+ G V        G   A K  H      +R          + RE+ +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR--------NQIIRELQV 57

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +     P IV               + +E+++G   +    + G I E +  K    ++ 
Sbjct: 58  LHECNSPYIVGFYGAFYSDG--EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 115

Query: 238 GLMYLH-GHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           GL YL   H ++H D+KP N+LV   G +K+ DF VS    D   +     GT  + +PE
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPE 173

Query: 297 CCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQD---------------------- 334
              G  Y    +D W++G++L  M +G+YP      ++                      
Sbjct: 174 RLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232

Query: 335 --------------------TYDKIVNN--SLVFPDAMNPELRNLLEGLLCKDPTRRLTL 372
                                 D IVN     +     + E ++ +   L K+P  R  L
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292

Query: 373 NDVAKHTWV 381
             +  H ++
Sbjct: 293 KQLMVHAFI 301

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 6e-60
 Identities = 60/281 (21%), Positives = 112/281 (39%), Gaps = 24/281 (8%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            +    ++IG+GS+G V  Y+    G   A+K  + +       AP+   +   + EV +
Sbjct: 8   GQITVGQRIGSGSFGTV--YKGKWHGD-VAVKMLNVT-------APTPQQLQAFKNEVGV 57

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK-WDNDGFGQPGAIGESMARKYLRDIV 236
           ++  +H NI+  +     P      +V ++ EG    +                  R   
Sbjct: 58  LRKTRHVNILLFMGYSTAP---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTA 294
            G+ YLH  +++H D+K +N+ +    TVKIGDF ++ V    +      +  G+ ++ A
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174

Query: 295 PECCLGLTYG--GKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMN- 351
           PE             +D +A G+ LY ++ GQ P+     +D    +V    + PD    
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234

Query: 352 -----PELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP 387
                  ++ L+   L K    R     +     +L  + P
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 1e-59
 Identities = 61/265 (23%), Positives = 110/265 (41%), Gaps = 19/265 (7%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH 183
            +IG GS+  V     +      A        L+K       +     + E  ++K LQH
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-------SERQRFKEEAEMLKGLQH 67

Query: 184 PNIVNLIEVIDDP--NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
           PNIV   +  +          +V E +          +   +   + R + R I+ GL +
Sbjct: 68  PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 127

Query: 242 LH--GHNVVHGDIKPDN-LLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECC 298
           LH     ++H D+K DN  +  P+G+VKIGD  ++ +        +   GTP F APE  
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMY 185

Query: 299 LGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV---FPDAMNPELR 355
               Y  ++ D +A G+ +  M   +YP+          + V + +    F     PE++
Sbjct: 186 EE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243

Query: 356 NLLEGLLCKDPTRRLTLNDVAKHTW 380
            ++EG + ++   R ++ D+  H +
Sbjct: 244 EIIEGCIRQNKDERYSIKDLLNHAF 268

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  188 bits (479), Expect = 6e-58
 Identities = 62/278 (22%), Positives = 118/278 (42%), Gaps = 16/278 (5%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           + Y     +G G   +V L R     +  A+K                +     RRE   
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR------DPSFYLRFRREAQN 60

Query: 178 MKMLQHPNIVNLIEVI--DDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
              L HP IV + +    + P     Y+V+EYV+G    D     G +    A + + D 
Sbjct: 61  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 120

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS---PGTPVF 292
              L + H + ++H D+KP N++++ +  VK+ DF +++   D  + + ++    GT  +
Sbjct: 121 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180

Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----D 348
            +PE   G +   + +D +++G  LY ++ G+ PF G++      + V    + P    +
Sbjct: 181 LSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239

Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG 386
            ++ +L  ++   L K+P  R       +   V   NG
Sbjct: 240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 277

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  188 bits (479), Expect = 5e-57
 Identities = 88/298 (29%), Positives = 142/298 (47%), Gaps = 19/298 (6%)

Query: 95  RQFPVKESNKLIR--SEDENGTKMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFH 152
           ++F  K     ++        T  ++++  ++ +G GS+G+V+L +    G HYA+K   
Sbjct: 16  KEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75

Query: 153 KSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKW 212
           K  + KL+       +     E  I++ +  P +V L     D +  + YMV+EYV G  
Sbjct: 76  KQKVVKLK------QIEHTLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYVAGGE 127

Query: 213 DNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV 272
                 + G   E  AR Y   IV    YLH  ++++ D+KP+NLL+   G +++ DF  
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187

Query: 273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL 332
           ++  +     L    GTP   APE  L   Y  KA D WA+GV +Y M  G  PF  +  
Sbjct: 188 AKRVKGRTWTL---CGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQP 243

Query: 333 QDTYDKIVNNSLVFPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTWVLGDN 385
              Y+KIV+  + FP   + +L++LL  LL  D T+R       +ND+  H W    +
Sbjct: 244 IQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 9e-57
 Identities = 58/266 (21%), Positives = 104/266 (39%), Gaps = 22/266 (8%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           + E   ++ IG G +G V        G   A+K       ++               E  
Sbjct: 6   MKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQ-----------AFLAEAS 52

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRD 234
           +M  L+H N+V L+ VI +      Y+V EY+      D     G   +G     K+  D
Sbjct: 53  VMTQLRHSNLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 111

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           +   + YL G+N VH D+   N+LV+     K+ DF +++      D          +TA
Sbjct: 112 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKLPVKWTA 168

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN-SLVFPDAMNP 352
           PE      +    +D W+ G+ L+ +   G+ P+    L+D   ++     +  PD   P
Sbjct: 169 PEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 227

Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAKH 378
            +  +++     D   R +   + + 
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 4e-56
 Identities = 73/295 (24%), Positives = 131/295 (44%), Gaps = 38/295 (12%)

Query: 115 KMINEY-VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
            +I++Y V  + +G G  GKV+   +    + +A+K                      RR
Sbjct: 8   AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------------KARR 53

Query: 174 EVLIM-KMLQHPNIVNLIEVIDDP--NSDHFYMVLEYVEG----KWDNDGFGQPGAIGES 226
           EV +  +  Q P+IV +++V ++         +V+E ++G        D   Q     E 
Sbjct: 54  EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTER 111

Query: 227 MARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSVSQVFEDDNDVL 283
            A + ++ I   + YLH  N+ H D+KP+NLL     P+  +K+ DF  ++     N + 
Sbjct: 112 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL- 170

Query: 284 RRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLG----ETLQDTYDKI 339
                TP + APE      Y  K+ D W++GV +Y ++ G  PF              +I
Sbjct: 171 TTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 229

Query: 340 VNNSLVFPDA----MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ 390
                 FP+     ++ E++ L+  LL  +PT+R+T+ +   H W++  +  +PQ
Sbjct: 230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM-QSTKVPQ 283

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 3e-55
 Identities = 76/304 (25%), Positives = 124/304 (40%), Gaps = 39/304 (12%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +  +  V KIG G+YG V   R+ L G+  A+K       +       E   +   RE+ 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-------EGVPSTAIREIS 53

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDN-DGFGQPGAIGESMARKYLRDI 235
           ++K L HPNIV L++VI   N    Y+V E++               I   + + YL  +
Sbjct: 54  LLKELNHPNIVKLLDVIHTEN--KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 111

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAP 295
           + GL + H H V+H D+KP NLL+   G +K+ DF +++ F            T  + AP
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA------ 349
           E  LG  Y   A D W++G     M+  +  F G++  D   +I        +       
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231

Query: 350 -----------------------MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG 386
                                  ++ + R+LL  +L  DP +R++      H +      
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

Query: 387 PIPQ 390
           P+P 
Sbjct: 292 PVPH 295

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 3e-55
 Identities = 67/301 (22%), Positives = 119/301 (39%), Gaps = 47/301 (15%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
             Y ++  IG G+YG V     +++    AIK        K+     +T      RE+ I
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK--------KISPFEHQTYCQRTLREIKI 59

Query: 178 MKMLQHPNIVNLIEVIDDPNSD---HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
           +   +H NI+ + ++I  P  +     Y+V   +          +   +       +L  
Sbjct: 60  LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK--LLKTQHLSNDHICYFLYQ 117

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGTPV 291
           I+ GL Y+H  NV+H D+KP NLL+  +  +KI DF +++V + D+D    L     T  
Sbjct: 118 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA-- 349
           + APE  L      K+ D W+VG  L  M+  +  F G+   D  + I+           
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237

Query: 350 -----------------------------MNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
                                         + +  +LL+ +L  +P +R+ +     H +
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297

Query: 381 V 381
           +
Sbjct: 298 L 298

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 4e-55
 Identities = 69/318 (21%), Positives = 121/318 (38%), Gaps = 51/318 (16%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +++Y  + KIG G++G+V   R    G+  A+K     +         E       RE+ 
Sbjct: 9   VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-------EGFPITALREIK 61

Query: 177 IMKMLQHPNIVNLIEVIDDPNS------DHFYMVLEYVEGKWDNDGFGQPGAIGESMARK 230
           I+++L+H N+VNLIE+     S         Y+V ++ E                S  ++
Sbjct: 62  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121

Query: 231 YLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP--- 287
            ++ +++GL Y+H + ++H D+K  N+L+   G +K+ DF +++ F    +         
Sbjct: 122 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181

Query: 288 -GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF 346
             T  +  PE  LG    G   D W  G  +  M        G T Q     I       
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241

Query: 347 PDAM--------------------------------NPELRNLLEGLLCKDPTRRLTLND 374
              +                                +P   +L++ LL  DP +R+  +D
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301

Query: 375 VAKHTWVLGDNGPIPQYL 392
              H +   D  P+P  L
Sbjct: 302 ALNHDFFWSD--PMPSDL 317

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 1e-54
 Identities = 54/262 (20%), Positives = 100/262 (38%), Gaps = 18/262 (6%)

Query: 124 RKIGAGSYGKVVL--YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
           +++G+G++G V    Y+     K  A+K                    ++  E  +M+ L
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-------PALKDELLAEANVMQQL 65

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMY 241
            +P IV +I + +    + + +V+E  E    N    Q   + +    + +  +  G+ Y
Sbjct: 66  DNPYIVRMIGICEA---ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122

Query: 242 LHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP---GTPVFTAPECC 298
           L   N VH D+   N+L+      KI DF +S+    D +  +          + APEC 
Sbjct: 123 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 299 LGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS-LVFPDAMNPELRN 356
               +  K +D W+ GV ++     GQ P+ G    +    +     +  P     E+ +
Sbjct: 183 NYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 241

Query: 357 LLEGLLCKDPTRRLTLNDVAKH 378
           L+      D   R     V   
Sbjct: 242 LMNLCWTYDVENRPGFAAVELR 263

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 1e-54
 Identities = 63/265 (23%), Positives = 114/265 (43%), Gaps = 20/265 (7%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
                V ++GAG +G+V +   +      A+K+  +  +S                E  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP----------DAFLAEANL 61

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESM--ARKYLRDI 235
           MK LQH  +V L  V+     +  Y++ EY+E     D    P  I  ++         I
Sbjct: 62  MKQLQHQRLVRLYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPGTPVFTA 294
             G+ ++   N +H D++  N+LV+ + + KI DF ++++ ED+    R  +     +TA
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN-SLVFPDAMNP 352
           PE     T+  K +D W+ G+ L  ++  G+ P+ G T  +    +     +V PD    
Sbjct: 179 PEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237

Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAK 377
           EL  L+     + P  R T + +  
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRS 262

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 2e-53
 Identities = 73/276 (26%), Positives = 103/276 (37%), Gaps = 20/276 (7%)

Query: 114 TKMINE--YVHVRKIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAM 168
           T +I E     + K+G GS+G V        S      A+K      LS         AM
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS------QPEAM 55

Query: 169 TDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDND-GFGQPGAIGESM 227
            D  REV  M  L H N++ L  V+  P      MV E        D      G      
Sbjct: 56  DDFIREVNAMHSLDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGT 112

Query: 228 ARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRR 285
             +Y   +  G+ YL     +H D+   NLL+A    VKIGDF + +    ++D  V++ 
Sbjct: 113 LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 172

Query: 286 SPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN-- 342
               P        L       A+DTW  GVTL+ M   GQ P++G        KI     
Sbjct: 173 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 232

Query: 343 SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            L  P+    ++ N++       P  R T   +   
Sbjct: 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 3e-53
 Identities = 66/298 (22%), Positives = 118/298 (39%), Gaps = 47/298 (15%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
             Y  ++ +G+G+YG V        G   AIK  ++   S       E       RE+ +
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-------ELFAKRAYRELRL 70

Query: 178 MKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
           +K ++H N++ L++V     +      FY+V+ ++          +   +GE   +  + 
Sbjct: 71  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK--LMKHEKLGEDRIQFLVY 128

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
            ++ GL Y+H   ++H D+KP NL V     +KI DF +++  + +   +     T  + 
Sbjct: 129 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRWYR 185

Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAM--- 350
           APE  L      +  D W+VG  +  MI G+  F G    D   +I+  +   P      
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245

Query: 351 ----------------------------NPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
                                       +P   NLLE +L  D  +R+T  +   H +
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  176 bits (448), Expect = 4e-53
 Identities = 66/270 (24%), Positives = 106/270 (39%), Gaps = 16/270 (5%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           I+     + IGAG +G+V      L GK     A     +  L+   +E    D   E  
Sbjct: 25  ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVA-----IKTLKSGYTEKQRRDFLSEAS 79

Query: 177 IMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK-WDNDGFGQPGAIGESMARKYLRDI 235
           IM    HPN+++L  V+         ++ E++E    D+      G          LR I
Sbjct: 80  IMGQFDHPNVIHLEGVVTKS--TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGI 137

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS-----PGTP 290
            +G+ YL   N VH D+   N+LV  +   K+ DF +S+  EDD      +         
Sbjct: 138 AAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197

Query: 291 VFTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS-LVFPD 348
            +TAPE      +    +D W+ G+ ++ ++  G+ P+   T QD  + I  +  L  P 
Sbjct: 198 RWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256

Query: 349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
                L  L+     KD   R     +   
Sbjct: 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 7e-53
 Identities = 70/298 (23%), Positives = 106/298 (35%), Gaps = 51/298 (17%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK 179
           Y   + IG GS+G V   +    G+  AIK   +    K              RE+ IM+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------------NRELQIMR 68

Query: 180 MLQHPNIVNLIEVIDDPNSD----HFYMVLEYVEGKWDN---DGFGQPGAIGESMARKYL 232
            L H NIV L              +  +VL+YV                 +     + Y+
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSVSQVFEDDNDVLRRSPGTPV 291
             +   L Y+H   + H DIKP NLL+ P    +K+ DF  ++        +        
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 187

Query: 292 FTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------- 342
           + APE   G T    + D W+ G  L  +++GQ  F G++  D   +I+           
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247

Query: 343 --------------------SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
                               + VF     PE   L   LL   PT RLT  +   H++
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 9e-53
 Identities = 63/263 (23%), Positives = 98/263 (37%), Gaps = 20/263 (7%)

Query: 124 RKIGAGSYGKV--VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML 181
            ++G G++G V   +YR        AIK         L+    +    ++ RE  IM  L
Sbjct: 15  IELGCGNFGSVRQGVYRMRKKQIDVAIK--------VLKQGTEKADTEEMMREAQIMHQL 66

Query: 182 QHPNIVNLIEVIDDPNSDHFYMVLEYVEGK-WDNDGFGQPGAIGESMARKYLRDIVSGLM 240
            +P IV LI V          +V+E   G        G+   I  S   + L  +  G+ 
Sbjct: 67  DNPYIVRLIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 123

Query: 241 YLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS---PGTPVFTAPEC 297
           YL   N VH D+   N+L+      KI DF +S+    D+              + APEC
Sbjct: 124 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183

Query: 298 CLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN-SLVFPDAMNPELR 355
                +  + +D W+ GVT++  +  GQ P+      +    I     +  P    PEL 
Sbjct: 184 INFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 242

Query: 356 NLLEGLLCKDPTRRLTLNDVAKH 378
            L+          R     V + 
Sbjct: 243 ALMSDCWIYKWEDRPDFLTVEQR 265

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  175 bits (444), Expect = 1e-52
 Identities = 69/292 (23%), Positives = 116/292 (39%), Gaps = 39/292 (13%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            +Y  + KIG G+YG V   +++  G+ +A+K               E   +   RE+ I
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-------EGIPSTTIREISI 53

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +K L+H NIV L +VI         +V E+++           G +    A+ +L  +++
Sbjct: 54  LKELKHSNIVKLYDVIHTKK--RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN 111

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPEC 297
           G+ Y H   V+H D+KP NLL+   G +KI DF +++ F            T  + AP+ 
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171

Query: 298 CLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN---------------- 341
            +G        D W+VG     M+ G   F G +  D   +I                  
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231

Query: 342 -------------NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
                            F   ++    +LL  +L  DP +R+T     +H +
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-52
 Identities = 56/296 (18%), Positives = 108/296 (36%), Gaps = 14/296 (4%)

Query: 119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM 178
           E+  ++ +G+G++G V       +G+   I    K    +LR A S  A  ++  E  +M
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK----ELREATSPKANKEILDEAYVM 65

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSG 238
             + +P++  L+ +          +      G   +        IG      +   I  G
Sbjct: 66  ASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123

Query: 239 LMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPE 296
           + YL    +VH D+   N+LV     VKI DF ++++   +              + A E
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 297 CCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNNS-LVFPDAMNPEL 354
             L   Y  ++   W+ GVT++ ++  G  P+ G    +    +     L  P     ++
Sbjct: 184 SILHRIYTHQSDV-WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 242

Query: 355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYLCWCKRDRLRRDNTTQDSN 410
             ++      D   R    ++      +  +   PQ     + D      +  DSN
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIEFSKMARD---PQRYLVIQGDERMHLPSPTDSN 295

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 3e-52
 Identities = 53/265 (20%), Positives = 100/265 (37%), Gaps = 18/265 (6%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            +   ++++G G +G V   +        AIK   +  +S+           +   E  +
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----------DEFIEEAKV 52

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIV 236
           M  L H  +V L  V         +++ EY+  G   N               +  +D+ 
Sbjct: 53  MMNLSHEKLVQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 110

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND-VLRRSPGTPVFTAP 295
             + YL     +H D+   N LV   G VK+ DF +S+   DD       S     ++ P
Sbjct: 111 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170

Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN-SLVFPDAMNPE 353
           E  +   +  K +D WA GV ++ +  +G+ P+   T  +T + I     L  P   + +
Sbjct: 171 EVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 229

Query: 354 LRNLLEGLLCKDPTRRLTLNDVAKH 378
           +  ++     +    R T   +  +
Sbjct: 230 VYTIMYSCWHEKADERPTFKILLSN 254

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 1e-51
 Identities = 60/265 (22%), Positives = 106/265 (40%), Gaps = 20/265 (7%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
                  K+G G +G+V +   +      AIK      +S               +E  +
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP----------EAFLQEAQV 65

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF--GQPGAIGESMARKYLRDI 235
           MK L+H  +V L  V+ +   +  Y+V EY+      D         +           I
Sbjct: 66  MKKLRHEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 122

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS-PGTPVFTA 294
            SG+ Y+   N VH D++  N+LV  +   K+ DF ++++ ED+    R+       +TA
Sbjct: 123 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 182

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNP 352
           PE  L   +  K +D W+ G+ L  +   G+ P+ G   ++  D++     +  P     
Sbjct: 183 PEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 241

Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAK 377
            L +L+     K+P  R T   +  
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQA 266

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 3e-51
 Identities = 63/311 (20%), Positives = 120/311 (38%), Gaps = 47/311 (15%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
             Y ++  +G+G+YG V     +  G   A+K   +   S +             RE+ +
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK-------RTYRELRL 70

Query: 178 MKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLR 233
           +K ++H N++ L++V     S    +  Y+V   +    +N    +   + +   +  + 
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLTDDHVQFLIY 128

Query: 234 DIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFT 293
            I+ GL Y+H  +++H D+KP NL V     +KI DF +++  +D+         T  + 
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYR 185

Query: 294 APECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAM--- 350
           APE  L   +  +  D W+VG  +  ++ G+  F G    D    I+         +   
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245

Query: 351 ----------------------------NPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL 382
                                       NP   +LLE +L  D  +R+T      H +  
Sbjct: 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305

Query: 383 GDNGPIPQYLC 393
             + P  + + 
Sbjct: 306 QYHDPDDEPVA 316

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 8e-51
 Identities = 61/293 (20%), Positives = 113/293 (38%), Gaps = 39/293 (13%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            +Y  + KIG G+YG V   ++    +  A+K               E   +   RE+ +
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-------EGVPSSALREICL 54

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
           +K L+H NIV L +V+         +V E+ +           G +   + + +L  ++ 
Sbjct: 55  LKELKHKNIVRLHDVLHSDK--KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPEC 297
           GL + H  NV+H D+KP NLL+  +G +K+ +F +++ F            T  +  P+ 
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172

Query: 298 CLGLTYGGKAADTWAVGVTLYYMIIGQYP-FLGETLQDTYDKIVNNSLVFPDA------- 349
             G      + D W+ G     +     P F G  + D   +I        +        
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232

Query: 350 ----------------------MNPELRNLLEGLLCKDPTRRLTLNDVAKHTW 380
                                 +N   R+LL+ LL  +P +R++  +  +H +
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 1e-50
 Identities = 58/265 (21%), Positives = 104/265 (39%), Gaps = 18/265 (6%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           +E   V++IG+G +G V L    L+    AIK   +  +S+           D   E  +
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSE----------EDFIEEAEV 53

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIV 236
           M  L HP +V L  V  +       +V E++E G   +    Q G            D+ 
Sbjct: 54  MMKLSHPKLVQLYGVCLEQ--APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 111

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS-PGTPVFTAP 295
            G+ YL    V+H D+   N LV  +  +K+ DF +++   DD             + +P
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171

Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDKIVNN-SLVFPDAMNPE 353
           E      Y  K +D W+ GV ++ +   G+ P+   +  +  + I     L  P   +  
Sbjct: 172 EVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 230

Query: 354 LRNLLEGLLCKDPTRRLTLNDVAKH 378
           +  ++     + P  R   + + + 
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 2e-50
 Identities = 62/264 (23%), Positives = 104/264 (39%), Gaps = 11/264 (4%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
                 R IG G +G V               A     +   +   S++      +E L 
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVA-----IKTCKNCTSDSVREKFLQEALT 61

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVE-GKWDNDGFGQPGAIGESMARKYLRDIV 236
           M+   HP+IV LI VI +   +  ++++E    G+  +    +  ++  +    Y   + 
Sbjct: 62  MRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118

Query: 237 SGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPE 296
           + L YL     VH DI   N+LV+ +  VK+GDF +S+  ED           P+     
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 297 CCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMNPEL 354
             +       A+D W  GV ++ +++ G  PF G    D   +I N   L  P    P L
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 238

Query: 355 RNLLEGLLCKDPTRRLTLNDVAKH 378
            +L+      DP+RR    ++   
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELKAQ 262

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 3e-49
 Identities = 52/290 (17%), Positives = 104/290 (35%), Gaps = 35/290 (12%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
                 + +G+G++GKV+   +    K           +  L+     +    +  E+ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVA---VKMLKEKADSSEREALMSELKM 93

Query: 178 MKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEG-----------------------KWD 213
           M  L  H NIVNL+           Y++ EY                          +  
Sbjct: 94  MTQLGSHENIVNLLGACTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151

Query: 214 NDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
            +       +       +   +  G+ +L   + VH D+   N+LV     VKI DF ++
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 211

Query: 274 QVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGE 330
           +    D++  V   +     + APE      Y  K +D W+ G+ L+ +  +G  P+ G 
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGI 270

Query: 331 TLQDTYDKIVNNSLVF--PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            +   + K++ N      P     E+  +++     D  +R +  ++   
Sbjct: 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  165 bits (418), Expect = 1e-48
 Identities = 55/265 (20%), Positives = 103/265 (38%), Gaps = 18/265 (6%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
            +     K+G G YG+V            A+K   +  +             +  +E  +
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----------EEFLKEAAV 66

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDND--GFGQPGAIGESMARKYLRDI 235
           MK ++HPN+V L+ V        FY++ E++      D         +   +       I
Sbjct: 67  MKEIKHPNLVQLLGVCTRE--PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLR-RSPGTPVFTA 294
            S + YL   N +H D+   N LV  +  VK+ DF +S++   D       +     +TA
Sbjct: 125 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQY-PFLGETLQDTYDKIVNN-SLVFPDAMNP 352
           PE      +  K+   WA GV L+ +      P+ G  L   Y+ +  +  +  P+    
Sbjct: 185 PESLAYNKFSIKSDV-WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 243

Query: 353 ELRNLLEGLLCKDPTRRLTLNDVAK 377
           ++  L+      +P+ R +  ++ +
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEIHQ 268

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 1e-48
 Identities = 71/279 (25%), Positives = 131/279 (46%), Gaps = 22/279 (7%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           I  +  ++ +G G+YGKV L R       GK YA+K   K+ + +             R 
Sbjct: 23  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-----KAKTTEHTRT 77

Query: 174 EVLIMKMLQH-PNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           E  +++ ++  P +V L            +++L+Y+ G        Q     E   + Y+
Sbjct: 78  ERQVLEHIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEHEVQIYV 135

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED-DNDVLRRSPGTPV 291
            +IV  L +LH   +++ DIK +N+L+  +G V + DF +S+ F   + +      GT  
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195

Query: 292 FTAPECCLGLTYG-GKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL----VF 346
           + AP+   G   G  KA D W++GV +Y ++ G  PF  +  +++  +I    L     +
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255

Query: 347 PDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTW 380
           P  M+   ++L++ LL KDP +RL       +++ +H +
Sbjct: 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 3e-48
 Identities = 72/301 (23%), Positives = 120/301 (39%), Gaps = 44/301 (14%)

Query: 115 KMINEYVHVRKIGAGSYGKVVLYRS-SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           +   +Y  V +IG G+YGKV   R     G+  A+K               E       R
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-------EGMPLSTIR 56

Query: 174 EVLIMKML---QHPNIVNLIEVIDDPNSD---HFYMVLEYVEGKWDNDGFGQP-GAIGES 226
           EV +++ L   +HPN+V L +V     +D      +V E+V+          P   +   
Sbjct: 57  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 116

Query: 227 MARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRS 286
             +  +  ++ GL +LH H VVH D+KP N+LV  SG +K+ DF +++++      L   
Sbjct: 117 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSV 175

Query: 287 PGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV- 345
             T  + APE  L  +Y     D W+VG     M   +  F G +  D   KI++   + 
Sbjct: 176 VVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234

Query: 346 --------------------------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT 379
                                     F   ++   ++LL   L  +P +R++      H 
Sbjct: 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 294

Query: 380 W 380
           +
Sbjct: 295 Y 295

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  162 bits (411), Expect = 2e-47
 Identities = 62/304 (20%), Positives = 116/304 (38%), Gaps = 56/304 (18%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
            ++Y  VRK+G G Y +V    +  + +   +K        K            ++RE+ 
Sbjct: 34  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------------IKREIK 81

Query: 177 IMKMLQ-HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
           I++ L+  PNI+ L +++ DP S    +V E+V      D       + +   R Y+ +I
Sbjct: 82  ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEI 138

Query: 236 VSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSVSQVFEDDNDVLRRSPGTPVFTA 294
           +  L Y H   ++H D+KP N+++      +++ D+ +++ +    +   R   +  F  
Sbjct: 139 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKG 197

Query: 295 PECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL-GETLQDTYDKIVN------------ 341
           PE  +       + D W++G  L  MI  + PF  G    D   +I              
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257

Query: 342 -------------------------NSLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVA 376
                                            ++PE  + L+ LL  D   RLT  +  
Sbjct: 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317

Query: 377 KHTW 380
           +H +
Sbjct: 318 EHPY 321

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (405), Expect = 8e-47
 Identities = 59/293 (20%), Positives = 104/293 (35%), Gaps = 44/293 (15%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
           N   +VR IG G++G+V   R+            A+K   +   + ++         D +
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ--------ADFQ 64

Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK--------------------- 211
           RE  +M    +PNIV L+ V          ++ EY+                        
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 212 ---WDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIG 268
                      P  +  +      R + +G+ YL     VH D+   N LV  +  VKI 
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 182

Query: 269 DFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQY- 325
           DF +S+     +             +  PE      Y  + +D WA GV L+ +      
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQ 241

Query: 326 PFLGETLQDTYDKIVNNSLV-FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
           P+ G   ++    + + +++  P+    EL NL+     K P  R +   + +
Sbjct: 242 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 1e-45
 Identities = 56/281 (19%), Positives = 105/281 (37%), Gaps = 29/281 (10%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
            N+      IG G++G+V+  R   DG            + +++   S+    D   E+ 
Sbjct: 9   WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAA------IKRMKEYASKDDHRDFAGELE 62

Query: 177 IMKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEG----------------KWDNDGFGQ 219
           ++  L  HPNI+NL+   +     + Y+ +EY                            
Sbjct: 63  VLCKLGHHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120

Query: 220 PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDD 279
              +       +  D+  G+ YL     +H D+   N+LV  +   KI DF +S+  ++ 
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEV 179

Query: 280 NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGETLQDTYDK 338
                       + A E      Y    +D W+ GV L+ ++ +G  P+ G T  + Y+K
Sbjct: 180 YVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 238

Query: 339 IVNN-SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
           +     L  P   + E+ +L+     + P  R +   +   
Sbjct: 239 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 2e-45
 Identities = 66/311 (21%), Positives = 132/311 (42%), Gaps = 58/311 (18%)

Query: 117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVL 176
           +  Y +++ IG+G+ G V     ++  ++ AIK   +   +       +T      RE++
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-------QTHAKRAYRELV 68

Query: 177 IMKMLQHPNIVNLIEVIDDPNS----DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYL 232
           +MK + H NI++L+ V     +       Y+V+E ++         +            L
Sbjct: 69  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLL 125

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVF 292
             ++ G+ +LH   ++H D+KP N++V    T+KI DF +++     + ++     T  +
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYY 184

Query: 293 TAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---------- 342
            APE  LG+ Y     D W+VG  +  M+  +  F G    D ++K++            
Sbjct: 185 RAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243

Query: 343 ---------------------SLVFPDAMNP-----------ELRNLLEGLLCKDPTRRL 370
                                  +FPD++ P           + R+LL  +L  DP +R+
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303

Query: 371 TLNDVAKHTWV 381
           +++D  +H ++
Sbjct: 304 SVDDALQHPYI 314

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 5e-44
 Identities = 55/289 (19%), Positives = 108/289 (37%), Gaps = 39/289 (13%)

Query: 118 NEYVHVRKIGAGSYGKVVLYR-------SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTD 170
           +  V  + +G G++G+VVL                 A+K         L+   +E  ++D
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK--------MLKSDATEKDLSD 64

Query: 171 VRREVLIMKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEG----------------KWD 213
           +  E+ +MKM+ +H NI+NL+           Y+++EY                      
Sbjct: 65  LISEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSY 122

Query: 214 NDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
           N        +           +  G+ YL     +H D+   N+LV     +KI DF ++
Sbjct: 123 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 182

Query: 274 QVFEDDNDVLR--RSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMI-IGQYPFLGE 330
           +     +   +         + APE      Y  + +D W+ GV L+ +  +G  P+ G 
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGV 241

Query: 331 TLQDTYDKIVNNS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
            +++ +  +     +  P     EL  ++       P++R T   + + 
Sbjct: 242 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 7e-44
 Identities = 64/270 (23%), Positives = 101/270 (37%), Gaps = 21/270 (7%)

Query: 118 NEYVHVRKIGAGSYGKVVLYR----SSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRR 173
           +     + IGAG +G+V        S       AIK     +  K RV        D   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--------DFLG 58

Query: 174 EVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDND-GFGQPGAIGESMARKYL 232
           E  IM    H NI+ L  VI         ++ EY+E    +     + G          L
Sbjct: 59  EAGIMGQFSHHNIIRLEGVISKY--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 116

Query: 233 RDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND---VLRRSPGT 289
           R I +G+ YL   N VH D+   N+LV  +   K+ DF +S+V EDD +           
Sbjct: 117 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176

Query: 290 PVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDA 349
             +TAPE      +    +D W+ G+ ++ ++        E       K +N+    P  
Sbjct: 177 IRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 235

Query: 350 MN--PELRNLLEGLLCKDPTRRLTLNDVAK 377
           M+    +  L+     ++  RR    D+  
Sbjct: 236 MDCPSAIYQLMMQCWQQERARRPKFADIVS 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 9e-44
 Identities = 52/289 (17%), Positives = 108/289 (37%), Gaps = 40/289 (13%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRS-----SLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
           N     + +GAG++GKVV   +     S      A+K         L+ +   T    + 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK--------MLKPSAHLTEREALM 74

Query: 173 REVLIMKML-QHPNIVNLIEVIDDPNSDHFYMVLEYVEG------------------KWD 213
            E+ ++  L  H NIVNL+            ++ EY                        
Sbjct: 75  SELKVLSYLGNHMNIVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132

Query: 214 NDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS 273
                   A+       +   +  G+ +L   N +H D+   N+L+      KI DF ++
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192

Query: 274 QVFEDDNDVLRRSP--GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYP-FLGE 330
           +  ++D++ + +        + APE      Y  + +D W+ G+ L+ +       + G 
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGM 251

Query: 331 TLQDTYDKIVNNS--LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
            +   + K++     ++ P+    E+ ++++     DP +R T   + +
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (384), Expect = 1e-43
 Identities = 57/278 (20%), Positives = 94/278 (33%), Gaps = 31/278 (11%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
           N Y   RKIG+GS+G + L      G+  AIK               +T    +  E  I
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----------KTKHPQLHIESKI 55

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
            KM+Q    +  I        D+  MV+E +    ++                    ++S
Sbjct: 56  YKMMQGGVGIPTIRWCGAEG-DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMIS 114

Query: 238 GLMYLHGHNVVHGDIKPDNLLVAPSG---TVKIGDFSVSQVFEDDND-------VLRRSP 287
            + Y+H  N +H D+KPDN L+        V I DF +++ + D            +   
Sbjct: 115 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174

Query: 288 GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL--- 344
           GT  + +    LG+    +  D  ++G  L Y  +G  P+ G        K    S    
Sbjct: 175 GTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233

Query: 345 -----VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK 377
                V       E    L          +   + + +
Sbjct: 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 3e-43
 Identities = 47/265 (17%), Positives = 95/265 (35%), Gaps = 20/265 (7%)

Query: 124 RKIGAGSYGKV---VLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKM 180
             IG G +G V    L  +     H A+K+ ++              ++    E +IMK 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--------DIGEVSQFLTEGIIMKD 84

Query: 181 LQHPNIVNLIEVIDDPNSDHFYMVLEYVEGK-WDNDGFGQPGAIGESMARKYLRDIVSGL 239
             HPN+++L+ +          +VL Y++     N    +           +   +  G+
Sbjct: 85  FSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 143

Query: 240 MYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND----VLRRSPGTPVFTAP 295
            +L     VH D+   N ++    TVK+ DF +++   D           +     + A 
Sbjct: 144 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 296 ECCLGLTYGGKAADTWAVGVTLYYMIIGQY-PFLGETLQDTYDKIVNN-SLVFPDAMNPE 353
           E      +  K +D W+ GV L+ ++     P+      D    ++    L+ P+     
Sbjct: 204 ESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 262

Query: 354 LRNLLEGLLCKDPTRRLTLNDVAKH 378
           L  ++          R + +++   
Sbjct: 263 LYEVMLKCWHPKAEMRPSFSELVSR 287

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 1e-42
 Identities = 50/280 (17%), Positives = 102/280 (36%), Gaps = 30/280 (10%)

Query: 118 NEYVHVRKIGAGSYGKVVL-----YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
            +    R++G GS+G V                 AIK  +++   + R+        +  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--------EFL 71

Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEG----------KWDNDGFGQPGA 222
            E  +MK     ++V L+ V+         +++E +            +           
Sbjct: 72  NEASVMKEFNCHHVVRLLGVVSQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129

Query: 223 IGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDV 282
              S   +   +I  G+ YL+ +  VH D+   N +VA   TVKIGDF +++   + +  
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 189

Query: 283 LRRSP--GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIG-QYPFLGETLQDTYDKI 339
            +         + +PE      +   +   W+ GV L+ +    + P+ G + +     +
Sbjct: 190 RKGGKGLLPVRWMSPESLKDGVFTTYSDV-WSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248

Query: 340 VNNSLV-FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
           +   L+  PD     L  L+      +P  R +  ++   
Sbjct: 249 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 2e-41
 Identities = 48/287 (16%), Positives = 108/287 (37%), Gaps = 35/287 (12%)

Query: 118 NEYVHVRKIGAGSYGKVVL-----YRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR 172
           +     + +G G++G+V+         +   +  A+K   +        A        + 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-------LMS 65

Query: 173 REVLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDND----------------G 216
              +++ +  H N+VNL+     P      +++E+ +    +                  
Sbjct: 66  ELKILIHIGHHLNVVNLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124

Query: 217 FGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF 276
                 +       Y   +  G+ +L     +H D+   N+L++    VKI DF +++  
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 184

Query: 277 EDDNDVLRRSP--GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQY-PFLGETLQ 333
             D D +R+        + APE      Y  + +D W+ GV L+ +      P+ G  + 
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKID 243

Query: 334 DTYDKIVNNS--LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH 378
           + + + +     +  PD   PE+   +      +P++R T +++ +H
Sbjct: 244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 1e-40
 Identities = 58/301 (19%), Positives = 98/301 (32%), Gaps = 54/301 (17%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
              V    IG G +G+V  +R    G+  A+K F                      E+  
Sbjct: 3   RTIVLQESIGKGRFGEV--WRGKWRGEEVAVKIFSSREERSWFR----------EAEIYQ 50

Query: 178 MKMLQHPNIVNLIEVIDDPNSD--HFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDI 235
             ML+H NI+  I   +  N      ++V +Y E       +     +      K     
Sbjct: 51  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG-SLFDYLNRYTVTVEGMIKLALST 109

Query: 236 VSGLMYLHGH--------NVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDNDVLRRSP 287
            SGL +LH           + H D+K  N+LV  +GT  I D  ++   +   D +  +P
Sbjct: 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 169

Query: 288 ----GTPVFTAPECCLGLTYG-----GKAADTWAVGVTLYYMIIGQYPF----------- 327
               GT  + APE              K AD +A+G+  + +                  
Sbjct: 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229

Query: 328 ---LGETLQDTYDKIVNNSLVFPDAMN--------PELRNLLEGLLCKDPTRRLTLNDVA 376
                +   +   K+V    + P+  N          +  ++      +   RLT   + 
Sbjct: 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

Query: 377 K 377
           K
Sbjct: 290 K 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  143 bits (362), Expect = 2e-40
 Identities = 42/272 (15%), Positives = 83/272 (30%), Gaps = 33/272 (12%)

Query: 118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLI 177
             Y   R+IG GS+G +    + L+ +  AIK   +   +             +R E   
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-----------QLRDEYRT 53

Query: 178 MKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVS 237
            K+L     +  +         H  +V++ +    ++                  + +++
Sbjct: 54  YKLLAGCTGIPNVYYFGQ-EGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLA 112

Query: 238 GLMYLHGHNVVHGDIKPDNLLVA-----PSGTVKIGDFSVSQVFEDDNDVLRRSP----- 287
            +  +H  ++V+ DIKPDN L+       +  + + DF + + + D              
Sbjct: 113 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 172

Query: 288 --GTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV 345
             GT  + +    LG     +  D  A+G    Y + G  P+ G        K       
Sbjct: 173 LSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231

Query: 346 --------FPDAMNPELRNLLEGLLCKDPTRR 369
                          E    +           
Sbjct: 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  127 bits (318), Expect = 1e-33
 Identities = 51/321 (15%), Positives = 108/321 (33%), Gaps = 63/321 (19%)

Query: 120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVR-REVLIM 178
           Y+ VRK+G G +  V L +  ++  H A+K      +           +  V   +    
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 179 KMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGF---GQPGAIGESMARKYLRDI 235
             +   +I+ L++  +    +  ++V+ +     +        +   I     ++  + +
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 236 VSGLMYL-HGHNVVHGDIKPDNLLVAPSGT------VKIGDFSVSQVFEDDNDVLRRSPG 288
           + GL Y+     ++H DIKP+N+L+    +      +KI D   +  +++       S  
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY---TNSIQ 191

Query: 289 TPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYD----------- 337
           T  + +PE  LG  + G  AD W+    ++ +I G + F  +                  
Sbjct: 192 TREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250

Query: 338 -------------------------------------KIVNNSLVFPDAMNPELRNLLEG 360
                                                 ++     F      E+ + L  
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310

Query: 361 LLCKDPTRRLTLNDVAKHTWV 381
           +L  DP +R     +  H W+
Sbjct: 311 MLQLDPRKRADAGGLVNHPWL 331

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 84.1 bits (207), Expect = 1e-19
 Identities = 34/173 (19%), Positives = 60/173 (34%), Gaps = 26/173 (15%)

Query: 124 RKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAP---------SETAMTDVRRE 174
           + +G G    V    S        +K     H S  +V           S  A+   R E
Sbjct: 6   KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 175 VLIMKMLQHPNIVNLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRD 234
              ++ LQ   +  +         +   +++E ++ K                  + L  
Sbjct: 65  FRALQKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVR-------VENPDEVLDM 111

Query: 235 IVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF--SVSQVFEDDNDVLRR 285
           I+  +   +   +VHGD+   N+LV+  G + I DF  SV    E   ++L R
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILER 163

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	410
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.59
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.22
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.17
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.32
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.16
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.74
d1gxca_	116	Chk2 kinase {Human (Homo sapiens) [TaxId: 9606]}	96.51
d1lgpa_	113	Cell cycle checkpoint protein Chfr {Human (Homo sa	88.35
d1dmza_	158	Phosphotyrosine binding domain of Rad53 {Baker's y	86.41
d1g6ga_	127	Phosphotyrosine binding domain of Rad53 {Baker's y	82.87

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-64  Score=466.47  Aligned_cols=257  Identities=31%  Similarity=0.536  Sum_probs=233.7

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      +++|++++.||+|+||.||+|+++.+|+.||||++.+.....      ......+.+|+.+++.++|||||++++++.+ 
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-   77 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK------AGVEHQLRREVEIQSHLRHPNILRLYGYFHD-   77 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH------TTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC------hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-
Confidence            468999999999999999999999999999999987653321      2234578899999999999999999999987 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       ...+|||||||++++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus        78 -~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~  156 (263)
T d2j4za1          78 -ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  156 (263)
T ss_dssp             -SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred             -CCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeec
Confidence             4689999999999999998888788999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN  356 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~  356 (410)
                      ...  .....+||+.|+|||++.+..+ +.++|||||||+||+|++|+.||.+.+..+....+....+.+|..+++++++
T Consensus       157 ~~~--~~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  233 (263)
T d2j4za1         157 PSS--RRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD  233 (263)
T ss_dssp             CCC--CCEETTEEGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHH
T ss_pred             CCC--cccccCCCCcccCHHHHcCCCC-CchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHH
Confidence            443  3345789999999999988766 6779999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          357 LLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       357 li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      ||.+||+.||.+|||++|+++||||++.
T Consensus       234 li~~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         234 LISRLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence            9999999999999999999999999753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-63  Score=463.58  Aligned_cols=259  Identities=26%  Similarity=0.477  Sum_probs=221.9

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++.....        .+..+.+.+|+.+|++++|||||++++++.+
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--------~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~   74 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--------VDCPENIKKEICINKMLNHENVVKFYGHRRE   74 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------------CHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--------chHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence            45789999999999999999999999999999999875421        2233568899999999999999999999987


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                        ...+||||||++|++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus        75 --~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~  152 (271)
T d1nvra_          75 --GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATV  152 (271)
T ss_dssp             --TTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             --CceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhhee
Confidence              468999999999999999998888999999999999999999999999999999999999999999999999999987


Q ss_pred             ccCC--ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC--CCCCC
Q 015257          276 FEDD--NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQD-TYDKIVNNSLV--FPDAM  350 (410)
Q Consensus       276 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~i~~~~~~--~p~~~  350 (410)
                      ....  .......+||+.|+|||++.+..++++++|||||||++|+|++|+.||....... ....+......  .+..+
T Consensus       153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (271)
T d1nvra_         153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI  232 (271)
T ss_dssp             CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGS
T ss_pred             eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccC
Confidence            6433  2334567899999999999888776788999999999999999999997755433 33333333222  22478


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          351 NPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      ++++.+||.+||+.||++|||++|+++||||+..
T Consensus       233 s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         233 DSAPLALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence            9999999999999999999999999999999753

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-62  Score=461.42  Aligned_cols=253  Identities=27%  Similarity=0.458  Sum_probs=225.0

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.....         ...+.+.+|+.+|+.++|||||++++++.+  
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---------~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--   88 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---------PKKELIINEILVMRENKNPNIVNYLDSYLV--   88 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---------SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---------hHHHHHHHHHHHHHhCCCCCEeeEeEEEEE--
Confidence            479999999999999999999999999999999875421         123578999999999999999999999987  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+|||||||+|++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus        89 ~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~  167 (293)
T d1yhwa1          89 GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (293)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeec
Confidence            4589999999999999887654 479999999999999999999999999999999999999999999999999999876


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCCCCCHHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---SLVFPDAMNPEL  354 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~~~~l  354 (410)
                      .........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+...   .+..|..+++++
T Consensus       168 ~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  246 (293)
T d1yhwa1         168 PEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF  246 (293)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHSSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHH
T ss_pred             cccccccccccCCCccChhhhcCCCC-CchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHH
Confidence            65556667789999999999988766 67899999999999999999999988877766665543   234567799999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          355 RNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       355 ~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                      ++||.+||+.||.+|||++|+|+||||+.
T Consensus       247 ~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         247 RDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            99999999999999999999999999974

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-62  Score=458.46  Aligned_cols=256  Identities=25%  Similarity=0.451  Sum_probs=215.6

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.....       .....+.+.+|+.+|++++|||||++++++.+..
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   76 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-------TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT   76 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-------CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-------CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC
Confidence            579999999999999999999999999999999875432       3445677999999999999999999999998755


Q ss_pred             CCEEEEEEeecCCCCcccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cEeccCCCCcEEEcCCCcEEEe
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ----PGAIGESMARKYLRDIVSGLMYLHGHN-----VVHGDIKPDNLLVAPSGTVKIG  268 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~-----iiHrDlkp~NIll~~~~~~kl~  268 (410)
                      ...+|||||||+|++|.+++..    ...+++..++.++.||+.||+|||++|     |+||||||+|||++.++.+||+
T Consensus        77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~  156 (269)
T d2java1          77 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG  156 (269)
T ss_dssp             --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEEC
T ss_pred             CCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEe
Confidence            6679999999999999887643    467999999999999999999999876     9999999999999999999999


Q ss_pred             eccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCC
Q 015257          269 DFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-VFP  347 (410)
Q Consensus       269 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p  347 (410)
                      |||+|+.............||+.|+|||++.+..+ +.++|||||||++|+|+||..||.+.+..+....+..+.. .+|
T Consensus       157 DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~  235 (269)
T d2java1         157 DFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP  235 (269)
T ss_dssp             CHHHHHHC-----------CCCSCCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC
T ss_pred             eccceeecccCCCccccCCCCcccCCHHHHcCCCC-ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            99999987665555667889999999999877665 6789999999999999999999999988888888887765 467


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcc
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWV  381 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~  381 (410)
                      ..+|+++.+||.+||+.||.+|||++|+++|||+
T Consensus       236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            8899999999999999999999999999999996

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-62  Score=467.30  Aligned_cols=258  Identities=32%  Similarity=0.567  Sum_probs=237.3

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+++.||+|+||.||+|+++.+|+.||||++.+.....      ....+.+.+|+.+|+.++|||||++++++.+ 
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~------~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-   76 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA------KDEVAHTVTESRVLQNTRHPFLTALKYAFQT-   76 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH------TTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC------HHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-
Confidence            468999999999999999999999999999999998653321      2345678899999999999999999999997 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       ...+|+|||||+|++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus        77 -~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~  155 (337)
T d1o6la_          77 -HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             -SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             -ccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccc
Confidence             5689999999999999999888889999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN  356 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~  356 (410)
                      ..........+||+.|+|||++.+..+ +.++|||||||++|||++|++||.+.+..+....+....+.+|..+|+++++
T Consensus       156 ~~~~~~~~~~~GT~~Y~aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~d  234 (337)
T d1o6la_         156 ISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS  234 (337)
T ss_dssp             CCTTCCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             ccCCcccccceeCHHHhhhhhccCCCC-ChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHH
Confidence            655556667889999999999988777 6679999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHhhCCcccC
Q 015257          357 LLEGLLCKDPTRRL-----TLNDVAKHTWVLG  383 (410)
Q Consensus       357 li~~~L~~dp~~Rp-----t~~ell~h~~~~~  383 (410)
                      ||.+||++||.+||     ++.|+++||||.+
T Consensus       235 li~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHhhccCCchhhcccccccHHHHHcCccccc
Confidence            99999999999999     4999999999976

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-62  Score=460.90  Aligned_cols=258  Identities=30%  Similarity=0.508  Sum_probs=230.0

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+....      .......+.+|+.+|++++|||||++++++.+  
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--   79 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII------KENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--   79 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH------HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc------CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE--
Confidence            5799999999999999999999999999999999765322      12344678999999999999999999999987  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+|||||||+|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus        80 ~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  159 (288)
T d1uu3a_          80 DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS  159 (288)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecc
Confidence            46899999999999999988888899999999999999999999999999999999999999999999999999998765


Q ss_pred             CC--ccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Q 015257          278 DD--NDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELR  355 (410)
Q Consensus       278 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~  355 (410)
                      ..  .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+...++....+.+|..++++++
T Consensus       160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  238 (288)
T d1uu3a_         160 PESKQARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR  238 (288)
T ss_dssp             ----------CCCCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHH
T ss_pred             cCCcccccccccCCccccCceeeccCCC-CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHH
Confidence            33  233456789999999999987766 678999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcccCCCCCCCHHH------HhhCCcccCC
Q 015257          356 NLLEGLLCKDPTRRLTLND------VAKHTWVLGD  384 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt~~e------ll~h~~~~~~  384 (410)
                      +||.+||+.||.+|||++|      +++||||.+-
T Consensus       239 ~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             HHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            9999999999999999988      5889999763

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-62  Score=457.48  Aligned_cols=257  Identities=24%  Similarity=0.356  Sum_probs=225.8

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      +.|++++.||+|+||+||+|++..+|+.||||++....         ....+.+.+|+.+|++++|||||++++++.+  
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---------~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--   80 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---------EEELEDYMVEIDILASCDHPNIVKLLDAFYY--   80 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---------SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--
Confidence            46999999999999999999999999999999986542         2334578899999999999999999999987  


Q ss_pred             CCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      .+.++||||||+|++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus        81 ~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~  160 (288)
T d2jfla1          81 ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN  160 (288)
T ss_dssp             TTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhcc
Confidence            4589999999999999887654 457999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCccccccCCCcccccccccccC----CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCCC
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLG----LTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL---VFPDA  349 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~  349 (410)
                      ..........+||+.|+|||++..    ...++.++|||||||++|+|++|..||.+.+..+....+.....   ..|..
T Consensus       161 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (288)
T d2jfla1         161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR  240 (288)
T ss_dssp             HHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGG
T ss_pred             CCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccc
Confidence            554445567789999999998853    22346789999999999999999999999888888888887653   34567


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      +++++++||.+||+.||.+|||++|+++||||+...
T Consensus       241 ~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~  276 (288)
T d2jfla1         241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS  276 (288)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            899999999999999999999999999999998543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.3e-61  Score=456.62  Aligned_cols=257  Identities=29%  Similarity=0.547  Sum_probs=212.9

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..+.|.+++.||+|+||+||+|+++.+|+.||||++.+....        .....+.+|+.+|+.++|||||++++++.+
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   78 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--------GKEGSMENEIAVLHKIKHPNIVALDDIYES   78 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------------CHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--------hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            446799999999999999999999999999999998765321        223467899999999999999999999987


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEc---CCCcEEEeeccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA---PSGTVKIGDFSV  272 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~---~~~~~kl~DfG~  272 (410)
                        .+.+|||||||+|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+.   .++.+||+|||+
T Consensus        79 --~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~  156 (307)
T d1a06a_          79 --GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGL  156 (307)
T ss_dssp             --SSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred             --CCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccce
Confidence              468999999999999999998888999999999999999999999999999999999999995   478999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----C
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----D  348 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~  348 (410)
                      |+..... ....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....+....+......++    .
T Consensus       157 a~~~~~~-~~~~~~~GT~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  234 (307)
T d1a06a_         157 SKMEDPG-SVLSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD  234 (307)
T ss_dssp             -----------------CTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTT
T ss_pred             eEEccCC-CeeeeeeeCccccCcHHHcCCCC-CcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCcccc
Confidence            9865433 34456789999999999987766 6789999999999999999999999998888888888766544    4


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      .+|+++.+||.+||++||++|||++|+++||||++.
T Consensus       235 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         235 DISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            789999999999999999999999999999999865

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.8e-61  Score=455.90  Aligned_cols=256  Identities=30%  Similarity=0.589  Sum_probs=233.5

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.....      ....+.+.+|+.+|+.++|||||++++++.+ 
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-   75 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR------LKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-   75 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH------TTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccC------HHHHHHHHHHHHHHHhccCcChhheeeeEee-
Confidence            468999999999999999999999999999999997653321      2345678999999999999999999999987 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       ...+|+|||||+|+++...+.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus        76 -~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~  154 (316)
T d1fota_          76 -AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV  154 (316)
T ss_dssp             -SSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred             -CCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEe
Confidence             4689999999999999998888889999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN  356 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~  356 (410)
                      ...   ....+||+.|+|||++.+..+ +.++|||||||+||+|++|+.||.+.+..+...++..+...+|..+++++.+
T Consensus       155 ~~~---~~~~~Gt~~Y~APE~l~~~~y-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  230 (316)
T d1fota_         155 PDV---TYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD  230 (316)
T ss_dssp             SSC---BCCCCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             ccc---cccccCcccccCHHHHcCCCC-CchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            543   346789999999999987766 5679999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHhhCCcccCC
Q 015257          357 LLEGLLCKDPTRRL-----TLNDVAKHTWVLGD  384 (410)
Q Consensus       357 li~~~L~~dp~~Rp-----t~~ell~h~~~~~~  384 (410)
                      +|.+||+.||.+|+     |++++++||||++-
T Consensus       231 li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         231 LLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             HHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence            99999999999996     99999999999863

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.6e-60  Score=457.53  Aligned_cols=261  Identities=28%  Similarity=0.535  Sum_probs=230.3

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|++++.||+|+||.||+|++..+|+.||||++....         ......+.+|+.+|++++|||||+++++|.+
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   97 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---------PLDKYTVKNEISIMNQLHHPKLINLHDAFED   97 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---------HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---------hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            4568999999999999999999999999999999986532         2334578899999999999999999999987


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEc--CCCcEEEeeccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQP-GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVA--PSGTVKIGDFSV  272 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~--~~~~~kl~DfG~  272 (410)
                        ...+|||||||+|++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+||||+  .++.+||+|||+
T Consensus        98 --~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGl  175 (352)
T d1koba_          98 --KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL  175 (352)
T ss_dssp             --SSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             --CCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeeccc
Confidence              56899999999999998766554 4799999999999999999999999999999999999998  568999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----C
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----D  348 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~  348 (410)
                      |+..... .......||+.|+|||++.+..+ +.++|||||||++|+|+||..||.+.+..+....+......+|    .
T Consensus       176 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  253 (352)
T d1koba_         176 ATKLNPD-EIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS  253 (352)
T ss_dssp             CEECCTT-SCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTT
T ss_pred             ceecCCC-CceeeccCcccccCHHHHcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence            9876543 34456779999999999987766 6789999999999999999999999999888889988776655    4


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCc
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIP  389 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~  389 (410)
                      .+++++.+||.+||+.||.+|||+.|+|+||||++....++
T Consensus       254 ~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~~~  294 (352)
T d1koba_         254 SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLT  294 (352)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTCC
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcchhc
Confidence            68999999999999999999999999999999987654433

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-60  Score=453.10  Aligned_cols=258  Identities=27%  Similarity=0.413  Sum_probs=226.0

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ..|..++.||+|+||+||+|++..+|+.||||++......      .....+.+.+|+.+|++++|||||++++++.+  
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--   86 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ------SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--   86 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSC------HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhcc------CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE--
Confidence            3599999999999999999999999999999998754321      34556789999999999999999999999987  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ...+|||||||.++++...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus        87 ~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~  166 (309)
T d1u5ra_          87 EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (309)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             CCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence            46899999999999887777777789999999999999999999999999999999999999999999999999998654


Q ss_pred             CCccccccCCCcccccccccccCC--cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCCCCHH
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGL--TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--FPDAMNPE  353 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~~~~  353 (410)
                      .    .....||+.|+|||++.+.  ..++.++|||||||++|+|++|..||.+.+..+....+......  .+..+|++
T Consensus       167 ~----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~  242 (309)
T d1u5ra_         167 P----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY  242 (309)
T ss_dssp             S----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHH
T ss_pred             C----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHH
Confidence            3    2356799999999998643  23467899999999999999999999998888877777776543  33468999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                      +++||.+||+.||.+|||++|+|+||||+....+
T Consensus       243 ~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~  276 (309)
T d1u5ra_         243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  276 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred             HHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCCc
Confidence            9999999999999999999999999999876443

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-60  Score=446.61  Aligned_cols=261  Identities=30%  Similarity=0.536  Sum_probs=231.1

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+++.||+|+||+||+|+++.+|+.||||++.+.....   .......+.+.+|+.+|++++|||||++++++.+ 
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~---~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-   84 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKS---SRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-   84 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTT---CSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcch---hhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-
Confidence            357999999999999999999999999999999998654322   1122345689999999999999999999999987 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC----cEEEeeccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG----TVKIGDFSV  272 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~----~~kl~DfG~  272 (410)
                       ...+|||||||+|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++    .+||+|||+
T Consensus        85 -~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          85 -KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             -SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             -CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence             468999999999999999988878899999999999999999999999999999999999998876    599999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----C
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFP----D  348 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~  348 (410)
                      |+...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+......++    .
T Consensus       164 a~~~~~~~-~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  241 (293)
T d1jksa_         164 AHKIDFGN-EFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS  241 (293)
T ss_dssp             CEECTTSC-BCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             hhhcCCCc-cccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC
Confidence            98765433 3456679999999999987666 6779999999999999999999999999998888888876655    5


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      .+|+++++||.+||+.||.+|||++|+++||||++.
T Consensus       242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            789999999999999999999999999999999864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7.4e-60  Score=454.97  Aligned_cols=257  Identities=28%  Similarity=0.538  Sum_probs=228.8

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|.+++.||+|+||.||+|++..+|+.||||++...         .....+.+.+|+.+|++++|||||++++++.+
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   94 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---------HESDKETVRKEIQTMSVLRHPTLVNLHDAFED   94 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---------SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---------chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            457899999999999999999999999999999998643         23345678999999999999999999999987


Q ss_pred             CCCCEEEEEEeecCCCCcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC--CCcEEEeeccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP--SGTVKIGDFSV  272 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~--~~~~kl~DfG~  272 (410)
                        .+.+|||||||+|++|.+.+. ..+.+++..++.++.||+.||+|||++|||||||||+|||++.  ++.+||+|||+
T Consensus        95 --~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~  172 (350)
T d1koaa2          95 --DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL  172 (350)
T ss_dssp             --TTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred             --CCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecch
Confidence              468999999999999988774 4567999999999999999999999999999999999999964  57899999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD----  348 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----  348 (410)
                      |+..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+.+..+......++.    
T Consensus       173 a~~~~~~-~~~~~~~gT~~Y~aPEv~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  250 (350)
T d1koaa2         173 TAHLDPK-QSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS  250 (350)
T ss_dssp             CEECCTT-SCEEEECSCTTTCCHHHHHTCCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGG
T ss_pred             heecccc-cccceecCcccccCHHHHcCCCC-ChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence            9876543 33456789999999999988766 67899999999999999999999999988899999887766553    


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      .+++++++||.+||+.||++|||++|+|+||||+...
T Consensus       251 ~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         251 GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             GCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            5899999999999999999999999999999998754

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.6e-60  Score=442.30  Aligned_cols=264  Identities=24%  Similarity=0.391  Sum_probs=230.8

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEEEc
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDD  195 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~  195 (410)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.+...............+.+.+|+.++++++ |||||++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            478999999999999999999999999999999998764332211112334457889999999997 9999999999987


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                        .+.+|||||||+|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        82 --~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          82 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             --CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence              568999999999999999998888999999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCccccccCCCcccccccccccCC-----cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGL-----TYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD--  348 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--  348 (410)
                      ..... ......||+.|+|||++.+.     ..++.++||||+||++|+|++|..||.+.+.......+..+...++.  
T Consensus       160 ~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  238 (277)
T d1phka_         160 LDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE  238 (277)
T ss_dssp             CCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred             ccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            65433 34567899999999988532     22367899999999999999999999999988888888887665443  


Q ss_pred             --CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          349 --AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       349 --~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                        .+|+++++||.+||++||++|||++|+++||||+.
T Consensus       239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence              68999999999999999999999999999999975

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-59  Score=438.39  Aligned_cols=253  Identities=23%  Similarity=0.418  Sum_probs=217.3

Q ss_pred             ce-eeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC-
Q 015257          119 EY-VHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP-  196 (410)
Q Consensus       119 ~y-~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  196 (410)
                      +| ++.+.||+|+||+||+|++..+++.||+|++.....       .....+.+.+|+.+|++++|||||++++++.+. 
T Consensus         9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   81 (270)
T d1t4ha_           9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-------TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   81 (270)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred             CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-------CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence            44 667789999999999999999999999999875432       334566899999999999999999999998752 


Q ss_pred             -CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeccCCCCcEEEc-CCCcEEEeeccc
Q 015257          197 -NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHN--VVHGDIKPDNLLVA-PSGTVKIGDFSV  272 (410)
Q Consensus       197 -~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NIll~-~~~~~kl~DfG~  272 (410)
                       +...+||||||+++++|.+++.+...+++..++.++.||+.||+|||+++  |+||||||+|||++ .++.+||+|||+
T Consensus        82 ~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl  161 (270)
T d1t4ha_          82 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL  161 (270)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             ccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence             34578999999999999999888888999999999999999999999998  99999999999996 478999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC--CCCCC
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL-QDTYDKIVNNSL--VFPDA  349 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~i~~~~~--~~p~~  349 (410)
                      |+.....  .....+||+.|+|||++.+.  ++.++|||||||++|+|++|+.||.+... ......+..+..  .++..
T Consensus       162 a~~~~~~--~~~~~~GT~~Y~aPE~~~~~--~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  237 (270)
T d1t4ha_         162 ATLKRAS--FAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV  237 (270)
T ss_dssp             GGGCCTT--SBEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred             ceeccCC--ccCCcccCccccCHHHhCCC--CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCcc
Confidence            9864332  34567899999999988653  47789999999999999999999987544 444555555432  34567


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhhCCccc
Q 015257          350 MNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL  382 (410)
Q Consensus       350 ~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~  382 (410)
                      .++++.+||.+||+.||++|||++|+++||||+
T Consensus       238 ~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            899999999999999999999999999999996

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.5e-60  Score=456.10  Aligned_cols=256  Identities=32%  Similarity=0.587  Sum_probs=233.1

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      +++|++++.||+|+||.||+|+++.+|+.||||++.+.....      ....+.+.+|+.+|+.++|||||++++++.+ 
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-  112 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK------LKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-  112 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH------TTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC------HHHHHHHHHHHHHHHHcCCCcEeeccccccc-
Confidence            578999999999999999999999999999999987653221      2344678999999999999999999999987 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       ...+++||||+.|+++...+...+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+..
T Consensus       113 -~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~  191 (350)
T d1rdqe_         113 -NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             -SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             -ccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence             4689999999999999998888888999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELRN  356 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~~  356 (410)
                      ...   ....+||+.|+|||++.+..+ +.++|||||||++|+|+||..||.+.+.......+......+|..+++++.+
T Consensus       192 ~~~---~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  267 (350)
T d1rdqe_         192 KGR---TWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKD  267 (350)
T ss_dssp             SSC---BCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHH
T ss_pred             ccc---cccccCccccCCHHHHcCCCC-CccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHH
Confidence            543   345679999999999988766 6779999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHhhCCcccCC
Q 015257          357 LLEGLLCKDPTRRL-----TLNDVAKHTWVLGD  384 (410)
Q Consensus       357 li~~~L~~dp~~Rp-----t~~ell~h~~~~~~  384 (410)
                      ||.+||+.||.+|+     |++++++||||++.
T Consensus       268 li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence            99999999999994     99999999999864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-60  Score=449.91  Aligned_cols=258  Identities=28%  Similarity=0.493  Sum_probs=232.4

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHH-HhCCCCCcccceeEEEc
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIM-KMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~  195 (410)
                      +++|.+++.||+|+||+||+|+++.+|+.||||++.+.....      ....+.+..|+.++ +.++|||||++++++.+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~------~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~   74 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM------DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT   74 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH------TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC------hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc
Confidence            368999999999999999999999999999999997653221      12334566676665 47899999999999987


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                        .+.+|||||||+||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus        75 --~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~  152 (320)
T d1xjda_          75 --KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  152 (320)
T ss_dssp             --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             --CCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhh
Confidence              468999999999999999998888999999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNPELR  355 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~l~  355 (410)
                      ...........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+...++..+.+.+|..+|+++.
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~  231 (320)
T d1xjda_         153 NMLGDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAK  231 (320)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             cccccccccccCCCCCcCCHHHHcCCCC-CchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHH
Confidence            6655556667789999999999988776 578999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcccCCCCCCCHH-HHhhCCcccC
Q 015257          356 NLLEGLLCKDPTRRLTLN-DVAKHTWVLG  383 (410)
Q Consensus       356 ~li~~~L~~dp~~Rpt~~-ell~h~~~~~  383 (410)
                      +||.+||++||.+|||+. ++++||||++
T Consensus       232 dli~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         232 DLLVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             HHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence            999999999999999995 8999999976

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-60  Score=447.49  Aligned_cols=263  Identities=26%  Similarity=0.435  Sum_probs=223.0

Q ss_pred             eeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEE
Q 015257          122 HVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHF  201 (410)
Q Consensus       122 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  201 (410)
                      .+++||+|+||+||+|+++.+|+.||||++.......    ......+.+.+|+.+|+.++|||||++++++.+  .+.+
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~   75 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE----AKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNI   75 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC----------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhh----hhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCce
Confidence            4789999999999999999999999999987543221    111223468899999999999999999999987  4579


Q ss_pred             EEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCcc
Q 015257          202 YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND  281 (410)
Q Consensus       202 ~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  281 (410)
                      ||||||+.++.+.........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus        76 ~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          76 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             eehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            99999999998888887788899999999999999999999999999999999999999999999999999987766555


Q ss_pred             ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------------
Q 015257          282 VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-----------------  344 (410)
Q Consensus       282 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------  344 (410)
                      .....+||+.|+|||++.....++.++|||||||++|+|++|..||.+.+..+....+.....                 
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence            566778999999999988776668899999999999999999999999888887766653100                 


Q ss_pred             ---CC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCch
Q 015257          345 ---VF--------PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ  390 (410)
Q Consensus       345 ---~~--------p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~  390 (410)
                         .+        ...+++++.+||.+||+.||++|||++|+|+||||++.+.|.|.
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~  292 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG  292 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCS
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCC
Confidence               00        12468899999999999999999999999999999988777665

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-61  Score=458.14  Aligned_cols=258  Identities=25%  Similarity=0.449  Sum_probs=216.7

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|++++.||+|+||+||+|++..+|+.||||+++...        .......+.+|+.+|+.++|||||+++++|.+ 
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-   75 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-   75 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--------CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-
Confidence            368999999999999999999999999999999986532        23345678999999999999999999999987 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                       ...+|||||||+|++|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.
T Consensus        76 -~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~  154 (322)
T d1s9ja_          76 -DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  154 (322)
T ss_dssp             -SSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             -CCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence             45899999999999999998888889999999999999999999997 5999999999999999999999999999986


Q ss_pred             ccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------------------
Q 015257          276 FEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTY-------------------  336 (410)
Q Consensus       276 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-------------------  336 (410)
                      ...  ....+.+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.+.....                   
T Consensus       155 ~~~--~~~~~~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (322)
T d1s9ja_         155 LID--SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  231 (322)
T ss_dssp             HHH--HTC---CCSSCCCCHHHHHCSCC-CTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred             cCC--CccccccCCccccCchHHcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence            543  23456789999999999988776 67799999999999999999999765432210                   


Q ss_pred             -----------------------HHHHhCC-CCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCC
Q 015257          337 -----------------------DKIVNNS-LVFP-DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGP  387 (410)
Q Consensus       337 -----------------------~~i~~~~-~~~p-~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~  387 (410)
                                             ..+.... ...| ..+|+++.+||.+||+.||.+|||++|+|+||||++....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~  307 (322)
T d1s9ja_         232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  307 (322)
T ss_dssp             --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcc
Confidence                                   1111111 1112 2468999999999999999999999999999999865433

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-59  Score=441.68  Aligned_cols=264  Identities=29%  Similarity=0.517  Sum_probs=225.9

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|++++.||+|+||+||+|++..+|+.||||++.....       .......+.+|+.+|++++|||||++++++.+  
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-------~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--   72 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-------TEGVPSTAIREISLLKELNHPNIVKLLDVIHT--   72 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-------ChHHHHHHHHHHHHHHhCCCCcEEEecccccc--
Confidence            689999999999999999999999999999999865421       12234578899999999999999999999987  


Q ss_pred             CCEEEEEEeecCCCCccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGF-GQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ...+|+||||+.++.+.... .....+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+..
T Consensus        73 ~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~  152 (298)
T d1gz8a_          73 ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF  152 (298)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred             ccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceec
Confidence            46899999999887555443 34567999999999999999999999999999999999999999999999999999887


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL------------  344 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------------  344 (410)
                      ...........||+.|+|||++....+.+.++|||||||++|+|++|+.||.+.+..+....+.....            
T Consensus       153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence            66666666778999999999988777778899999999999999999999998887776665543100            


Q ss_pred             ------CCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCch
Q 015257          345 ------VFP-----------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQ  390 (410)
Q Consensus       345 ------~~p-----------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~  390 (410)
                            .++           ..+++++++||.+||+.||++|||++|+++||||++-..|+|.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p~  295 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH  295 (298)
T ss_dssp             STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCCC
T ss_pred             ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCCC
Confidence                  011           2467899999999999999999999999999999999999984

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-59  Score=444.37  Aligned_cols=256  Identities=25%  Similarity=0.472  Sum_probs=228.3

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      .+.++|.+++.||+|+||+||+|+++.+|+.||||++....          .....+.+|+.+|+.++|||||+++++|.
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   71 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----------TDQVLVKKEISILNIARHRNILHLHESFE   71 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----------HHHHHHHHHHHHHHHSCCTTBCCEEEEEE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----------ccHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            35678999999999999999999999999999999986532          22346889999999999999999999998


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC--CcEEEeecc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPG-AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS--GTVKIGDFS  271 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~--~~~kl~DfG  271 (410)
                      +  .+.+|||||||+|++|.+.+...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.+  +.+||+|||
T Consensus        72 ~--~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG  149 (321)
T d1tkia_          72 S--MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             E--TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             E--CCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccc
Confidence            7  468999999999999999887654 79999999999999999999999999999999999999854  479999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPD---  348 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~---  348 (410)
                      +++...... ......||+.|+|||.+.+..+ +.++|||||||++|+|++|..||.+.+..+.+..|......++.   
T Consensus       150 ~~~~~~~~~-~~~~~~~t~~y~ape~~~~~~~-~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  227 (321)
T d1tkia_         150 QARQLKPGD-NFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF  227 (321)
T ss_dssp             TCEECCTTC-EEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred             hhhccccCC-cccccccccccccchhccCCCC-CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhc
Confidence            998764432 3445678999999998877766 67899999999999999999999999999999999998877764   


Q ss_pred             -CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          349 -AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       349 -~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                       .+|+++++||.+||+.||.+|||++|+++||||++.
T Consensus       228 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         228 KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence             789999999999999999999999999999999764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7.3e-59  Score=450.52  Aligned_cols=261  Identities=28%  Similarity=0.430  Sum_probs=222.4

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+++.||+|+||.||+|++..+|+.||||++.+.....   ........+..+|+.+++.++|||||++++++.+ 
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~---~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~-   78 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM---KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-   78 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---HTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcch---hhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-
Confidence            468999999999999999999999999999999987653321   1112222233455777788899999999999987 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                       .+.+|+|||||+|++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus        79 -~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          79 -PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             -SSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             -CCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence             4689999999999999999888888999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCCCCCCHH
Q 015257          277 EDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQ---DTYDKIVNNSLVFPDAMNPE  353 (410)
Q Consensus       277 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~---~~~~~i~~~~~~~p~~~~~~  353 (410)
                      ...  .....+||+.|+|||++.....++.++|||||||+||+|+||+.||.+....   .....+......+|..++++
T Consensus       158 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  235 (364)
T d1omwa3         158 SKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE  235 (364)
T ss_dssp             SSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHH
T ss_pred             CCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHH
Confidence            543  3456689999999999876655578899999999999999999999775433   33344455566788899999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHhhCCcccCC
Q 015257          354 LRNLLEGLLCKDPTRRLT-----LNDVAKHTWVLGD  384 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~~  384 (410)
                      +++||.+||++||.+|||     ++|+++||||++-
T Consensus       236 ~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             HHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             HHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            999999999999999999     7999999999863

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-59  Score=433.53  Aligned_cols=256  Identities=27%  Similarity=0.458  Sum_probs=220.4

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC--CCCcccceeEEE
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ--HPNIVNLIEVID  194 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~  194 (410)
                      .++|++.+.||+|+||.||+|++..+|+.||||++.+........   .....++.+|+.+|++++  |||||++++++.
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~---~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~   79 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE---LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE   79 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEE---CTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhh---hhHHHHHHHHHHHHHHhccCCCCccEEEEEEe
Confidence            368999999999999999999999999999999998654332111   111224668999999997  899999999998


Q ss_pred             cCCCCEEEEEEeecCC-CCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCC-CcEEEeeccc
Q 015257          195 DPNSDHFYMVLEYVEG-KWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPS-GTVKIGDFSV  272 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~-~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~-~~~kl~DfG~  272 (410)
                      +  .+.+|+||||+.+ +++.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus        80 ~--~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          80 R--PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             C--SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             e--CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccc
Confidence            7  4689999999976 5666677677789999999999999999999999999999999999999855 7999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCH
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVFPDAMNP  352 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~  352 (410)
                      |+.....  ......||+.|+|||++.+..++++++|||||||++|+|++|+.||.+.      ..+..+...++..+|+
T Consensus       158 a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~~~s~  229 (273)
T d1xwsa_         158 GALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSS  229 (273)
T ss_dssp             CEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCCCH
T ss_pred             ceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCCCCCH
Confidence            9865432  3456789999999999987777678899999999999999999999753      3466777889999999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                      ++++||.+||+.||++|||++|+++||||++..
T Consensus       230 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         230 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            999999999999999999999999999998653

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.5e-57  Score=425.34  Aligned_cols=256  Identities=27%  Similarity=0.431  Sum_probs=218.0

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||+|+||+||+|+++ +|+.||||++.....       .....+.+.+|+.+|++++|||||++++++.+  
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--   71 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-------DEGIPSTTIREISILKELKHSNIVKLYDVIHT--   71 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-------GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-------ChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc--
Confidence            68999999999999999999986 789999999865422       12234678899999999999999999999987  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ....+++||++.++++.......+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|....
T Consensus        72 ~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~  151 (286)
T d1ob3a_          72 KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG  151 (286)
T ss_dssp             SSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             CCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecc
Confidence            45799999999999888888888899999999999999999999999999999999999999999999999999998766


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS--------------  343 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--------------  343 (410)
                      ..........||+.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+..+...++....              
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (286)
T d1ob3a_         152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL  231 (286)
T ss_dssp             C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             cCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence            555455566789999999999877777889999999999999999999999888777666554310              


Q ss_pred             ---------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccC
Q 015257          344 ---------------LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLG  383 (410)
Q Consensus       344 ---------------~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~  383 (410)
                                     ..++..+++++.+||.+||++||++|||++|+++||||++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                           0123457899999999999999999999999999999974

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-57  Score=434.78  Aligned_cols=254  Identities=27%  Similarity=0.497  Sum_probs=213.1

Q ss_pred             ccccceeeee-eecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHH-hCCCCCcccceeE
Q 015257          115 KMINEYVHVR-KIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMK-MLQHPNIVNLIEV  192 (410)
Q Consensus       115 ~~~~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~l~~~  192 (410)
                      ...++|.+++ .||+|+||.||+|++..+|+.||||++...              ..+.+|+.++. .++|||||+++++
T Consensus         8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------------~~~~~E~~~~~~~~~hpnIv~l~~~   73 (335)
T d2ozaa1           8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVDV   73 (335)
T ss_dssp             CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred             CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------------HHHHHHHHHHHHhcCCCCCCeEEEE
Confidence            4567899886 599999999999999999999999998532              35678998865 5589999999999


Q ss_pred             EEc--CCCCEEEEEEeecCCCCcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC---CCcE
Q 015257          193 IDD--PNSDHFYMVLEYVEGKWDNDGFGQP--GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP---SGTV  265 (410)
Q Consensus       193 ~~~--~~~~~~~lv~e~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~---~~~~  265 (410)
                      |.+  .....+|||||||+||+|.+++...  ..+++.+++.++.||+.||+|||++||+||||||+|||++.   .+.+
T Consensus        74 ~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~  153 (335)
T d2ozaa1          74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL  153 (335)
T ss_dssp             EEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCE
T ss_pred             EeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccc
Confidence            875  2346799999999999999888653  47999999999999999999999999999999999999986   4679


Q ss_pred             EEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHh
Q 015257          266 KIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYD----KIVN  341 (410)
Q Consensus       266 kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~----~i~~  341 (410)
                      ||+|||+|+...... .....+||+.|+|||++.+..+ +.++|||||||+||+|+||..||.+.+......    .+..
T Consensus       154 Kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y-~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~  231 (335)
T d2ozaa1         154 KLTDFGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM  231 (335)
T ss_dssp             EECCCTTCEECCCCC-CCCCCSCCCSSCCCCCCCGGGG-SHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS
T ss_pred             cccccceeeeccCCC-ccccccCCcccCCcHHHcCCCC-CHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc
Confidence            999999998765433 3456789999999999887665 678999999999999999999997765444333    3333


Q ss_pred             CCCCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          342 NSLVFPD----AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       342 ~~~~~p~----~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      ....+|.    .+|+++.+||.+||+.||++|||+.|+++||||++.
T Consensus       232 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         232 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            4445553    578999999999999999999999999999999764

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-56  Score=424.47  Aligned_cols=269  Identities=25%  Similarity=0.412  Sum_probs=220.7

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ..+++|.+++.||+|+||+||+|++..+|+.||||++.....       .......+.+|+.+|+.++||||+++++++.
T Consensus         7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-------~~~~~~~~~~E~~il~~l~h~nii~~~~~~~   79 (318)
T d3blha1           7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-------KEGFPITALREIKILQLLKHENVVNLIEICR   79 (318)
T ss_dssp             CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-------TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-------chHHHHHHHHHHHHHHHhcCCCccceEeeee
Confidence            346899999999999999999999999999999999865432       1223456889999999999999999999886


Q ss_pred             cCC------CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEe
Q 015257          195 DPN------SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIG  268 (410)
Q Consensus       195 ~~~------~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~  268 (410)
                      ...      ...+++||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        80 ~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~  159 (318)
T d3blha1          80 TKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLA  159 (318)
T ss_dssp             C----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             cccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEee
Confidence            531      34689999999988877777777789999999999999999999999999999999999999999999999


Q ss_pred             eccccccccCCc----cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Q 015257          269 DFSVSQVFEDDN----DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL  344 (410)
Q Consensus       269 DfG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~  344 (410)
                      |||+++......    ......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus       160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~  239 (318)
T d3blha1         160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  239 (318)
T ss_dssp             CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999997654322    2233457999999999988776667889999999999999999999998877766555543211


Q ss_pred             CCCC--------------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCchhh
Q 015257          345 VFPD--------------------------------AMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQYL  392 (410)
Q Consensus       345 ~~p~--------------------------------~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~~  392 (410)
                      .++.                                ..++++++||.+||++||++|||++|+|+||||+.  .|.|+.|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~--~p~p~~~  317 (318)
T d3blha1         240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS--DPMPSDL  317 (318)
T ss_dssp             CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS--SSCCCCC
T ss_pred             CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc--CCCCCCC
Confidence            1111                                13678899999999999999999999999999985  4667655

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-56  Score=419.87  Aligned_cols=260  Identities=27%  Similarity=0.412  Sum_probs=214.4

Q ss_pred             cccceeeeeeecccCceEEEEEEEccC-CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC---CCCCccccee
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLD-GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML---QHPNIVNLIE  191 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~  191 (410)
                      ..++|++++.||+|+||+||+|++..+ ++.||||++.......       .....+.+|+.+|+.+   +|||||++++
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~~E~~~l~~l~~~~HpnIv~~~~   77 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-------GMPLSTIREVAVLRHLETFEHPNVVRLFD   77 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-------SCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-------hHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence            446899999999999999999999765 6789999987653221       1112355677776655   8999999999


Q ss_pred             EEEcC---CCCEEEEEEeecCCCCcccc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEE
Q 015257          192 VIDDP---NSDHFYMVLEYVEGKWDNDG-FGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKI  267 (410)
Q Consensus       192 ~~~~~---~~~~~~lv~e~~~~~~l~~~-~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl  267 (410)
                      +|...   ....++++|||+.++.+... ......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus        78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl  157 (305)
T d1blxa_          78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKL  157 (305)
T ss_dssp             EEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             eecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeee
Confidence            98642   23578999999998876533 344567999999999999999999999999999999999999999999999


Q ss_pred             eeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----
Q 015257          268 GDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNS----  343 (410)
Q Consensus       268 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~----  343 (410)
                      +|||+++..... .......||+.|+|||++.+..+ +.++|||||||++|||++|..||.+.+..+....+....    
T Consensus       158 ~dfg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  235 (305)
T d1blxa_         158 ADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  235 (305)
T ss_dssp             CSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cchhhhhhhccc-ccCCCcccChhhcCcchhcCCCC-ChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc
Confidence            999999865433 34567789999999999988776 677999999999999999999999988877776664310    


Q ss_pred             -----------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          344 -----------------------LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       344 -----------------------~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                                             ..++..+++.+++||.+||++||++|||++|+|+||||++-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                                   01234678999999999999999999999999999999864

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-55  Score=417.40  Aligned_cols=251  Identities=27%  Similarity=0.390  Sum_probs=205.5

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCc---eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGK---HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      .++|++.+.||+|+||+||+++++.+|+   .||||.+...        ......+.+.+|+.+|++++|||||++++++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~   96 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--------YTEKQRRDFLSEASIMGQFDHPNVIHLEGVV   96 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--------cCHHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            3579999999999999999999987665   5888876532        2345567899999999999999999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      .+  .+.+++|||||++++|.+++.. .+.+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+
T Consensus        97 ~~--~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGl  174 (299)
T d1jpaa_          97 TK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGL  174 (299)
T ss_dssp             CS--SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             ee--CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCccc
Confidence            76  4579999999999999887665 45799999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccc-----cccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CC
Q 015257          273 SQVFEDDNDV-----LRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LV  345 (410)
Q Consensus       273 a~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~  345 (410)
                      |+........     .....||+.|+|||++.+..+ +.++|||||||+||||+| |..||.+....+....+..+. .+
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~  253 (299)
T d1jpaa_         175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP  253 (299)
T ss_dssp             ---------------------CGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred             ceEccCCCCcceeeecccccCCccccCHHHHhcCCC-CcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            9876543221     122457999999999887665 678999999999999998 899999988888888777654 46


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       346 ~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .|..+++++.+||.+||+.||.+|||++||+++
T Consensus       254 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            777899999999999999999999999999876

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.8e-56  Score=415.06  Aligned_cols=261  Identities=22%  Similarity=0.363  Sum_probs=216.3

Q ss_pred             ccccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      .+.++|++.+.||+|+||.||+|++..+|+.||||++.+...      ........+.+|+.+|+.++|||||++++++.
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~   77 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA------RDPSFYLRFRREAQNAAALNHPAIVAVYDTGE   77 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT------TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc------cCHHHHHHHHHHHHHHHhcCCCCCCcccceee
Confidence            355789999999999999999999999999999999875432      23456678999999999999999999999887


Q ss_pred             cCC--CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          195 DPN--SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       195 ~~~--~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      ...  ...+||||||++|++|...+...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.
T Consensus        78 ~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~  157 (277)
T d1o6ya_          78 AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI  157 (277)
T ss_dssp             EECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred             eccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhh
Confidence            532  346899999999999998888888999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCc---cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---
Q 015257          273 SQVFEDDN---DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLVF---  346 (410)
Q Consensus       273 a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---  346 (410)
                      +.......   ......+||+.|+|||++.+..+ +.++|||||||++|+|+||..||.+.+..+...++.......   
T Consensus       158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  236 (277)
T d1o6ya_         158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA  236 (277)
T ss_dssp             CEECC----------------TTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGG
T ss_pred             hhhhccccccccccccccCcccccCHHHHcCCCC-CcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCch
Confidence            87653322   23445679999999999887665 678999999999999999999999998888887777765433   


Q ss_pred             -CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCccc
Q 015257          347 -PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVL  382 (410)
Q Consensus       347 -p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~  382 (410)
                       +..+|+++.+||.+||++||.+||+..+.+.|+|.+
T Consensus       237 ~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         237 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence             357899999999999999999999544444566653

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-56  Score=413.28  Aligned_cols=252  Identities=23%  Similarity=0.373  Sum_probs=216.1

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|++.+.||+|+||.||++... +++.||||++....          ...+.+.+|+.+|++++|||||++++++.+ 
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-   79 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----------MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-   79 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----------CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence            468999999999999999999976 57889999986432          123578999999999999999999998864 


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                        +.+++||||+++|+|.+.+....  .+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+
T Consensus        80 --~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~  157 (272)
T d1qpca_          80 --EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR  157 (272)
T ss_dssp             --SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             --CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceE
Confidence              35799999999999988665543  69999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCc-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhCC-CCCCCCCC
Q 015257          275 VFEDDN-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIG-QYPFLGETLQDTYDKIVNNS-LVFPDAMN  351 (410)
Q Consensus       275 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG-~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~  351 (410)
                      ...... .......||+.|+|||++.+..+ +.++|||||||++|||+|| .+||......+....+..+. ...|..++
T Consensus       158 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~  236 (272)
T d1qpca_         158 LIEDNEYTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP  236 (272)
T ss_dssp             ECSSSCEECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             EccCCccccccccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccCh
Confidence            775443 33445678999999999877665 6789999999999999995 56666677777777776653 45778899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhh--CCcccC
Q 015257          352 PELRNLLEGLLCKDPTRRLTLNDVAK--HTWVLG  383 (410)
Q Consensus       352 ~~l~~li~~~L~~dp~~Rpt~~ell~--h~~~~~  383 (410)
                      +++.+||.+||+.||++|||+++|++  |+||..
T Consensus       237 ~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            99999999999999999999999998  788854

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.5e-56  Score=415.34  Aligned_cols=248  Identities=22%  Similarity=0.353  Sum_probs=212.4

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++....          ...+++.+|+.+|++++|||||++++++.+ 
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----------~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-   84 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-   84 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----------chHHHHHHHHHHHHhCCCCCEecCCccEee-
Confidence            468999999999999999999999999999999986432          224578999999999999999999999986 


Q ss_pred             CCCEEEEEEeecCCCCcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFG--QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                       ...++||||||++|++...+.  ....+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+
T Consensus        85 -~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~  163 (287)
T d1opja_          85 -EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR  163 (287)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred             -CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEcccccee
Confidence             457899999999999888764  34679999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCc-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhC-CCCCCCCCC
Q 015257          275 VFEDDN-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYP-FLGETLQDTYDKIVNN-SLVFPDAMN  351 (410)
Q Consensus       275 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~P-f~~~~~~~~~~~i~~~-~~~~p~~~~  351 (410)
                      ...... .......||+.|+|||++.+..+ +.++|||||||++|||++|..| |.+.+.......+..+ ...+|..++
T Consensus       164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~  242 (287)
T d1opja_         164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP  242 (287)
T ss_dssp             TCCSSSSEEETTEEECGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             ecCCCCceeeccccccccccChHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccch
Confidence            765443 23334458899999999887766 6789999999999999996555 5555555555555444 346778899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          352 PELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       352 ~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      +++.+||.+||+.||.+|||++||++
T Consensus       243 ~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         243 EKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            99999999999999999999999976

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-56  Score=413.82  Aligned_cols=250  Identities=21%  Similarity=0.303  Sum_probs=205.6

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|.+.+.||+|+||+||+++..   ..||||+++....       .....+.+.+|+.+|++++|||||++++++.+ 
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-   75 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-------TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-   75 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-------CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-------CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-
Confidence            467999999999999999999743   3599999865422       34466789999999999999999999998764 


Q ss_pred             CCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                        ..++||||||++++|.+++.. ...+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.
T Consensus        76 --~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~  153 (276)
T d1uwha_          76 --PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV  153 (276)
T ss_dssp             --SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred             --cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceee
Confidence              358999999999999988754 46799999999999999999999999999999999999999999999999999987


Q ss_pred             ccCC--ccccccCCCcccccccccccCCc--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hCCC-----C
Q 015257          276 FEDD--NDVLRRSPGTPVFTAPECCLGLT--YGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIV-NNSL-----V  345 (410)
Q Consensus       276 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~-~~~~-----~  345 (410)
                      ....  ........||+.|+|||++.+..  .++.++|||||||+||||+||+.||.+.+......... .+..     .
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~  233 (276)
T d1uwha_         154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK  233 (276)
T ss_dssp             ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGG
T ss_pred             ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchh
Confidence            6432  23445678999999999986532  24778999999999999999999998876555443333 3321     2


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCC
Q 015257          346 FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHT  379 (410)
Q Consensus       346 ~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~  379 (410)
                      ++..+++++.+||.+||+.||++|||++||+++-
T Consensus       234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~L  267 (276)
T d1uwha_         234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASI  267 (276)
T ss_dssp             SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            4567899999999999999999999999999874

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-56  Score=414.48  Aligned_cols=247  Identities=21%  Similarity=0.342  Sum_probs=210.4

Q ss_pred             eeecccCceEEEEEEEc--cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCCEE
Q 015257          124 RKIGAGSYGKVVLYRSS--LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSDHF  201 (410)
Q Consensus       124 ~~lG~G~fg~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  201 (410)
                      ++||+|+||.||++...  .+++.||||++.....       .....+.+.+|+.+|++++|||||++++++.+   +..
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~   82 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-------DPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESW   82 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-------CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCE
Confidence            57999999999999764  3567899999864321       23455789999999999999999999999975   347


Q ss_pred             EEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccCCcc
Q 015257          202 YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND  281 (410)
Q Consensus       202 ~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  281 (410)
                      +|||||+++++|.+++.....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.......
T Consensus        83 ~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~  162 (277)
T d1xbba_          83 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  162 (277)
T ss_dssp             EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             EEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence            89999999999999988888899999999999999999999999999999999999999999999999999987643322


Q ss_pred             ---ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHH
Q 015257          282 ---VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMNPELRN  356 (410)
Q Consensus       282 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~l~~  356 (410)
                         ......||+.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+..+....+..+. +.+|..+++++.+
T Consensus       163 ~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~  241 (277)
T d1xbba_         163 YYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD  241 (277)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ccccccccCCCceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence               2234568999999999877665 678999999999999998 899999988888777777654 5678899999999


Q ss_pred             HHHHhcccCCCCCCCHHHHh---hCCcc
Q 015257          357 LLEGLLCKDPTRRLTLNDVA---KHTWV  381 (410)
Q Consensus       357 li~~~L~~dp~~Rpt~~ell---~h~~~  381 (410)
                      ||.+||+.||.+|||+++|+   +|+|+
T Consensus       242 li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         242 LMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            99999999999999999984   56654

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-55  Score=412.03  Aligned_cols=253  Identities=23%  Similarity=0.338  Sum_probs=216.4

Q ss_pred             cceeeeee-ecccCceEEEEEEEcc--CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          118 NEYVHVRK-IGAGSYGKVVLYRSSL--DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       118 ~~y~~~~~-lG~G~fg~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ++|.+... ||+|+||.||++....  ++..||||+++..        ......+++.+|+.+|++++|||||++++++.
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--------~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~   79 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--------TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ   79 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--------cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec
Confidence            45777774 9999999999997754  4568999998643        23456678999999999999999999999997


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      +   +.+|||||||++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus        80 ~---~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla  156 (285)
T d1u59a_          80 A---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS  156 (285)
T ss_dssp             S---SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             c---CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhh
Confidence            5   358999999999999987654 567999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCcc---ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCC
Q 015257          274 QVFEDDND---VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPD  348 (410)
Q Consensus       274 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~  348 (410)
                      +.......   ......||+.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+..+....+..+. +.+|.
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~  235 (285)
T d1u59a_         157 KALGADDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP  235 (285)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT
T ss_pred             hcccccccccccccccccCccccChHHHhCCCC-CccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            87654322   2234568999999999877665 678999999999999998 999999988878777777664 56788


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHH---hhCCccc
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDV---AKHTWVL  382 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~el---l~h~~~~  382 (410)
                      .+++++.+||.+||+.||++|||+.+|   |+|+|+.
T Consensus       236 ~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            999999999999999999999999888   5677763

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=408.96  Aligned_cols=247  Identities=22%  Similarity=0.364  Sum_probs=204.3

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|.+++.||+|+||.||+++.. +++.||||++....          ...+++.+|+.++++++|||||++++++.+  
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~----------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--   71 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----------MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE--   71 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS----------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc----------CcHHHHHHHHHHHHhcCCCCcccccceecc--
Confidence            47999999999999999999876 57789999986432          123578999999999999999999999986  


Q ss_pred             CCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ...+++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus        72 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  151 (263)
T d1sm2a_          72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  151 (263)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred             CCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheec
Confidence            3578999999999999887644 467899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCc-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHH
Q 015257          277 EDDN-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMNPE  353 (410)
Q Consensus       277 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~  353 (410)
                      .... .......||+.|+|||++.+..+ +.++|||||||++|||+| |.+||......+....+..+. ...|..++++
T Consensus       152 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~  230 (263)
T d1sm2a_         152 LDDQYTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH  230 (263)
T ss_dssp             -------------CTTSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             cCCCceeecceecCcccCChHHhcCCCC-CchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHH
Confidence            5433 23334678999999999887765 678999999999999999 577787777777777777654 4567889999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +.+||.+||+.||.+|||++||++|
T Consensus       231 l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         231 VYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHHH
Confidence            9999999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-55  Score=410.53  Aligned_cols=260  Identities=23%  Similarity=0.421  Sum_probs=223.9

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|++++.||+|+||+||+|++..+|+.||||+++...       ........+.+|+.+|+.++|||||++++++.+  
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--   72 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-------DDEGVPSSALREICLLKELKHKNIVRLHDVLHS--   72 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-------SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-------CChHHHHHHHHHHHHHHhcCcCCEEeecccccc--
Confidence            58999999999999999999999999999999986542       134456789999999999999999999999987  


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFE  277 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~  277 (410)
                      ....++|++++.++.+...+...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+...
T Consensus        73 ~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~  152 (292)
T d1unla_          73 DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             SSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhccc
Confidence            45899999999999988888888899999999999999999999999999999999999999999999999999998876


Q ss_pred             CCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCC-------------
Q 015257          278 DDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFL-GETLQDTYDKIVNNS-------------  343 (410)
Q Consensus       278 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~-~~~~~~~~~~i~~~~-------------  343 (410)
                      ..........+++.|+|||++......+.++|||||||++|+|++|..||. +.+..+....+....             
T Consensus       153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             CCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence            655555566788999999998877766888999999999999999999864 445555554443210             


Q ss_pred             ----------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCC
Q 015257          344 ----------------LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNG  386 (410)
Q Consensus       344 ----------------~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~  386 (410)
                                      ...+..+++.+.+||.+||+.||.+|||++|+|+||||++...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence                            0122356889999999999999999999999999999986543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-55  Score=421.84  Aligned_cols=258  Identities=25%  Similarity=0.407  Sum_probs=211.8

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDD  195 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  195 (410)
                      ..++|++++.||+|+||+||+|.+..+|+.||||++.+..       ......+.+.+|+.+|+.++|||||+++++|..
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-------~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~   88 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-------QSELFAKRAYRELRLLKHMRHENVIGLLDVFTP   88 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-------SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECS
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-------cChHHHHHHHHHHHHHHhcCCCCeeEEEEEecc
Confidence            5578999999999999999999999999999999986432       134556789999999999999999999999976


Q ss_pred             CC----CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          196 PN----SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       196 ~~----~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      .+    ...+|+||||++ .++.... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~~~~~~~lv~e~~~-~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_          89 DETLDDFTDFYLVMPFMG-TDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             CSSTTTCCCCEEEEECCS-EEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             CccccccceEEEEEeccc-ccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccccccc
Confidence            42    236799999994 4444443 34579999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------
Q 015257          272 VSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSL-------  344 (410)
Q Consensus       272 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-------  344 (410)
                      +|+....   ......||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.....       
T Consensus       167 ~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         167 LARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             TCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ceeccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            9986543   235677999999999998776667889999999999999999999998876655443322100       


Q ss_pred             ------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCC
Q 015257          345 ------------------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDN  385 (410)
Q Consensus       345 ------------------------~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~  385 (410)
                                              .....+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                                    12246789999999999999999999999999999998753

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=421.62  Aligned_cols=250  Identities=21%  Similarity=0.328  Sum_probs=210.4

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCc-----eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCccccee
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGK-----HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIE  191 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~  191 (410)
                      ++|++.+.||+|+||+||+|+...+++     .||||.+....        .......+.+|+.+|.++ +|||||++++
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~HpnIv~l~~  108 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--------DSSEREALMSELKMMTQLGSHENIVNLLG  108 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--------CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence            579999999999999999999876543     69999875432        223345788999999988 8999999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcE
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQP-----------------------GAIGESMARKYLRDIVSGLMYLHGHNVV  248 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----------------------~~l~~~~~~~i~~qi~~gL~yLH~~~ii  248 (410)
                      ++.+  .+.++||||||++|+|.+++...                       ..+++..++.++.||+.||+|||+++||
T Consensus       109 ~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~Ii  186 (325)
T d1rjba_         109 ACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV  186 (325)
T ss_dssp             EECS--SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEee--CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            9987  45789999999999998877543                       3589999999999999999999999999


Q ss_pred             eccCCCCcEEEcCCCcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCC
Q 015257          249 HGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQY  325 (410)
Q Consensus       249 HrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~  325 (410)
                      ||||||+|||++.++.+||+|||+|+.......  ...+..||+.|+|||++.+..+ +.++|||||||+||||+| |..
T Consensus       187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwS~Gvil~emlt~g~~  265 (325)
T d1rjba_         187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVN  265 (325)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCC
T ss_pred             eccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC-CcceeccchhHHHHHHHhCCCC
Confidence            999999999999999999999999987654332  2335568999999999877665 678999999999999997 899


Q ss_pred             CCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          326 PFLGETLQDTYDKIVNNS--LVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       326 Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ||.+........+++...  +..|..+++++++||.+||+.||++|||++||++|
T Consensus       266 Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         266 PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             SSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            999877666666665553  45677899999999999999999999999999987

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-55  Score=404.42  Aligned_cols=247  Identities=20%  Similarity=0.328  Sum_probs=216.5

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|+++++||+|+||+||+++.+ +++.||||++++...          ..+.+.+|+.++++++|||||++++++.+  
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----------~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~--   70 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----------SEDEFIEEAKVMMNLSHEKLVQLYGVCTK--   70 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----------CHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----------CHHHHHHHHHHHHhcCCCceeeEEEEEee--
Confidence            57899999999999999999985 778999999875422          22578999999999999999999999976  


Q ss_pred             CCEEEEEEeecCCCCcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVF  276 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~  276 (410)
                      ...+++||||+++|++..++. ....+++..++.++.||++||+|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus        71 ~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~  150 (258)
T d1k2pa_          71 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  150 (258)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBC
T ss_pred             CCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheec
Confidence            457999999999998877744 4567999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCc-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHH
Q 015257          277 EDDN-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAMNPE  353 (410)
Q Consensus       277 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~  353 (410)
                      .... .......||+.|+|||++.+..+ +.++|||||||++|||+| |+.||.+.+..+....+..+. ...|...+++
T Consensus       151 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~  229 (258)
T d1k2pa_         151 LDDEYTSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK  229 (258)
T ss_dssp             SSSSCCCCCCSCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             cCCCceeecccCCCCCcCCcHHhcCCCC-CcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHH
Confidence            5432 23335678999999999887665 678999999999999998 899999999888888887753 4677889999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          354 LRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       354 l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      +.+||.+||+.||.+|||++++++|
T Consensus       230 l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         230 VYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHHH
Confidence            9999999999999999999999987

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=419.40  Aligned_cols=252  Identities=27%  Similarity=0.366  Sum_probs=212.3

Q ss_pred             ceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC--
Q 015257          119 EYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP--  196 (410)
Q Consensus       119 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--  196 (410)
                      +|..+++||+|+||+||+|++..+|+.||||++.....             ...+|+.+|++++|||||+++++|...  
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------------~~~~Ei~il~~l~h~niv~~~~~~~~~~~   87 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------------FKNRELQIMRKLDHCNIVRLRYFFYSSGE   87 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------------SCCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------------HHHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence            69999999999999999999999999999999865421             123799999999999999999998642  


Q ss_pred             --CCCEEEEEEeecCCCCccc---ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC-cEEEeec
Q 015257          197 --NSDHFYMVLEYVEGKWDND---GFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDF  270 (410)
Q Consensus       197 --~~~~~~lv~e~~~~~~l~~---~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~-~~kl~Df  270 (410)
                        +..+++||||||+++++..   .......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus        88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DF  167 (350)
T d1q5ka_          88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF  167 (350)
T ss_dssp             CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCC
T ss_pred             cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecc
Confidence              3457899999999875333   234566899999999999999999999999999999999999999875 8999999


Q ss_pred             cccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------
Q 015257          271 SVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN--------  342 (410)
Q Consensus       271 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--------  342 (410)
                      |+++...... ......||+.|+|||.+.+...++.++|||||||++|||++|..||...+..+....+...        
T Consensus       168 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~  246 (350)
T d1q5ka_         168 GSAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ  246 (350)
T ss_dssp             TTCEECCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cchhhccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence            9998765433 3455679999999999887666688899999999999999999999988877766555421        


Q ss_pred             ---------CCC------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          343 ---------SLV------------FPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       343 ---------~~~------------~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                               ...            .....++++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence                     011            123578999999999999999999999999999999865

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-54  Score=415.70  Aligned_cols=261  Identities=26%  Similarity=0.403  Sum_probs=212.5

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|++++.||+|+||+||+|++..+|+.||||++.+..        .....+.+.+|+.+|+.++|||||++++++..+.
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--------~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~   79 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPT   79 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--------ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc
Confidence            57999999999999999999999999999999986431        3455678899999999999999999999997542


Q ss_pred             ---CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          198 ---SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       198 ---~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                         ...++++ +++.+++|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+
T Consensus        80 ~~~~~~~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          80 IEQMKDVYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             TTTCCCEEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ccccceEEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence               1234555 55667888887754 469999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCc---cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------
Q 015257          275 VFEDDN---DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNN---------  342 (410)
Q Consensus       275 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~---------  342 (410)
                      ......   ......+||+.|+|||++.....++.++||||+||++|+|++|+.||.+....+........         
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            654332   23455679999999999877666678899999999999999999999887765544333210         


Q ss_pred             ---------------C--C-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCC
Q 015257          343 ---------------S--L-----VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPI  388 (410)
Q Consensus       343 ---------------~--~-----~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~  388 (410)
                                     .  .     .....+++++++||.+||+.||.+|||++|+|+||||+....+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~  305 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS  305 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCc
Confidence                           0  0     01235788999999999999999999999999999998665543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6e-54  Score=411.00  Aligned_cols=252  Identities=23%  Similarity=0.407  Sum_probs=211.0

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEEEc
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVIDD  195 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~  195 (410)
                      .++|+++++||+|+||+||+|++..+|+.||||++...            ..+++.+|+.+|+.+. ||||++++++|..
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~  101 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------------KKKKIKREIKILENLRGGPNIITLADIVKD  101 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------------CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------------HHHHHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence            46899999999999999999999999999999998542            2356889999999995 9999999999987


Q ss_pred             CCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCC-cEEEeeccccc
Q 015257          196 PNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSG-TVKIGDFSVSQ  274 (410)
Q Consensus       196 ~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~-~~kl~DfG~a~  274 (410)
                      +....+++|||||+++++....   +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus       102 ~~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         102 PVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             TTTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             cCCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccce
Confidence            6667899999999999887653   4699999999999999999999999999999999999998765 69999999998


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHh------------
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETL-QDTYDKIVN------------  341 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~i~~------------  341 (410)
                      ...... .....+||+.|+|||.+.+...++.++|||||||++|+|++|..||..... .+....+..            
T Consensus       179 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  257 (328)
T d3bqca1         179 FYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  257 (328)
T ss_dssp             ECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             eccCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence            765432 345667999999999988777668889999999999999999999976432 222211110            


Q ss_pred             -CCC------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          342 -NSL------------------------VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       342 -~~~------------------------~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                       ...                        .....+++++.+||.+||+.||.+|||++|+|+||||++-
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred             hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence             000                        0112468999999999999999999999999999999863

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=413.70  Aligned_cols=261  Identities=27%  Similarity=0.470  Sum_probs=221.8

Q ss_pred             cccceeeeeeecccCceEEEEEEEc---cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCC-CCccccee
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSS---LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH-PNIVNLIE  191 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~  191 (410)
                      ..++|++++.||+|+||+||+|++.   .+|+.||||++++.....     .....+.+.+|+.+|++++| |||+++++
T Consensus        22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~-----~~~~~~~~~~E~~il~~l~h~pnIv~~~~   96 (322)
T d1vzoa_          22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-----KAKTTEHTRTERQVLEHIRQSPFLVTLHY   96 (322)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE-----EESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred             chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhcc-----chHHHHHHHHHHHHHHhccCCCeEEEeee
Confidence            3578999999999999999999974   468999999987654321     11223457899999999976 89999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecc
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFS  271 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG  271 (410)
                      ++.+  ...+++||||+.+++|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus        97 ~~~~--~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG  174 (322)
T d1vzoa_          97 AFQT--ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG  174 (322)
T ss_dssp             EEEE--TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             eecc--CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeecc
Confidence            9987  45899999999999999998888889999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCC-ccccccCCCcccccccccccCCc-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCC
Q 015257          272 VSQVFEDD-NDVLRRSPGTPVFTAPECCLGLT-YGGKAADTWAVGVTLYYMIIGQYPFLGETLQ----DTYDKIVNNSLV  345 (410)
Q Consensus       272 ~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~----~~~~~i~~~~~~  345 (410)
                      +|+..... ........||+.|+|||.+.+.. .++.++|||||||+||+|++|..||.+....    ............
T Consensus       175 ~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~  254 (322)
T d1vzoa_         175 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP  254 (322)
T ss_dssp             EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC
T ss_pred             chhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC
Confidence            99865433 33345667999999999987654 3467899999999999999999999775433    344555566777


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhhCCcccC
Q 015257          346 FPDAMNPELRNLLEGLLCKDPTRRL-----TLNDVAKHTWVLG  383 (410)
Q Consensus       346 ~p~~~~~~l~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~  383 (410)
                      +|..+++++.+||.+||++||.+||     |++|+++||||++
T Consensus       255 ~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         255 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            8889999999999999999999999     5899999999976

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-54  Score=415.18  Aligned_cols=264  Identities=23%  Similarity=0.355  Sum_probs=218.1

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|++++.||+|+||+||+|++..+|+.||||++.+..       .+....+.+.+|+.+|+.++|||||++++++...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-------~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~   89 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-------QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   89 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-------cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeec
Confidence            468999999999999999999999999999999986532       1344556789999999999999999999998743


Q ss_pred             ---CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          197 ---NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       197 ---~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                         +....+++|+|+.|++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++
T Consensus        90 ~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          90 RSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             SSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             cccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchh
Confidence               12344566777788888887754 47999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------
Q 015257          274 QVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVNNSLV--------  345 (410)
Q Consensus       274 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--------  345 (410)
                      .....   ......||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+......        
T Consensus       169 ~~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         169 RHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             -CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            75432   3345679999999999887776678899999999999999999999988877666555432111        


Q ss_pred             ---------------C--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCCCCCCchh
Q 015257          346 ---------------F--------PDAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGDNGPIPQY  391 (410)
Q Consensus       346 ---------------~--------p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~  391 (410)
                                     .        ...+++++++||.+||+.||.+|||++|+|+||||++...+.++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~  314 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP  314 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCC
T ss_pred             ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCC
Confidence                           1        125789999999999999999999999999999999875554443

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-54  Score=402.37  Aligned_cols=249  Identities=26%  Similarity=0.397  Sum_probs=205.2

Q ss_pred             cceeeeeeecccCceEEEEEEEccC---CceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLD---GKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ++|++.+.||+|+||.||+|++..+   +..||||.+...        ......+.+.+|+.+|++++|||||++++++.
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--------~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~   78 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--------TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT   78 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--------TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--------cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            5899999999999999999998654   356888876432        23455678999999999999999999999996


Q ss_pred             cCCCCEEEEEEeecCCCCcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      +   +.+++||||++++++..++. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|
T Consensus        79 ~---~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a  155 (273)
T d1mp8a_          79 E---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS  155 (273)
T ss_dssp             S---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred             c---CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhh
Confidence            4   46899999999998887653 4557999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCc-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCC
Q 015257          274 QVFEDDN-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPDAM  350 (410)
Q Consensus       274 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~  350 (410)
                      +...... .......||+.|+|||++.+..+ +.++|||||||++|||++ |.+||.+.+..+....+..+. .++|..+
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~-~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~  234 (273)
T d1mp8a_         156 RYMEDSTYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC  234 (273)
T ss_dssp             ---------------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred             eeccCCcceeccceecCcccchhhHhccCCC-CCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            8765432 23345568999999999877665 678999999999999998 899999988888888887765 4688899


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          351 NPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       351 ~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ++++.+||.+||+.||.+|||+.||++|
T Consensus       235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999999986

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=398.76  Aligned_cols=249  Identities=24%  Similarity=0.346  Sum_probs=202.8

Q ss_pred             cceeeeeeecccCceEEEEEEEccCC----ceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDG----KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      +.|.+.++||+|+||.||+|....++    ..||||++....        .......+.+|+.+|++++|||||++++++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~~E~~il~~l~H~nIv~~~g~~   78 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--------TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI   78 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--------CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--------ChHHHHHHHHHHHHHHhcCCCCEeeeeEEE
Confidence            46999999999999999999987654    479999885432        344556799999999999999999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      .+  ...+++||||+.++++.+.+. ....+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+
T Consensus        79 ~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGl  156 (283)
T d1mqba_          79 SK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL  156 (283)
T ss_dssp             CS--SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             ec--CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccch
Confidence            76  457899999999988877654 346799999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCcc---ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhCC-CCCC
Q 015257          273 SQVFEDDND---VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIG-QYPFLGETLQDTYDKIVNNS-LVFP  347 (410)
Q Consensus       273 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG-~~Pf~~~~~~~~~~~i~~~~-~~~p  347 (410)
                      |+.......   ......||+.|+|||++.+..+ +.++|||||||++|||++| .+|+......+....+..+. .+.|
T Consensus       157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~  235 (283)
T d1mqba_         157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP  235 (283)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred             hhcccCCCccceEeccCCCCccccCHHHHccCCC-CCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCc
Confidence            987654322   2234568999999999887766 6789999999999999995 55555566666666666543 4567


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ..+++++.+||.+||+.||++|||+.||++
T Consensus       236 ~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         236 MDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             TTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            789999999999999999999999999987

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=400.47  Aligned_cols=254  Identities=22%  Similarity=0.345  Sum_probs=210.6

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|++.+.||+|+||+||++++..+ +.||||++.....          ..+.+.+|+.+|++++|||||++++++.+ 
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----------~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-   83 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-   83 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----------CHHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence            46899999999999999999998754 5799999864321          23578999999999999999999999864 


Q ss_pred             CCCEEEEEEeecCCCCcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQ--PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                        +.+++||||+++|++...+..  ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+
T Consensus        84 --~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~  161 (285)
T d1fmka3          84 --EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR  161 (285)
T ss_dssp             --SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             --CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhh
Confidence              357899999999988877654  3469999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCc-cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhCC-CCCCCCCC
Q 015257          275 VFEDDN-DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIG-QYPFLGETLQDTYDKIVNNS-LVFPDAMN  351 (410)
Q Consensus       275 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG-~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~  351 (410)
                      ...... .......||+.|+|||++.+..+ +.++|||||||++|||++| .+|+......+....+..+. ...|..++
T Consensus       162 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~  240 (285)
T d1fmka3         162 LIEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP  240 (285)
T ss_dssp             --------------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSC
T ss_pred             hccCCCceeeccccccccccChHHHhCCCC-CcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccC
Confidence            764332 23344678999999999987766 6789999999999999995 55566677777777776553 46788999


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhh--CCcccCCC
Q 015257          352 PELRNLLEGLLCKDPTRRLTLNDVAK--HTWVLGDN  385 (410)
Q Consensus       352 ~~l~~li~~~L~~dp~~Rpt~~ell~--h~~~~~~~  385 (410)
                      +++++||.+||+.||++|||+++|++  ++||....
T Consensus       241 ~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            99999999999999999999999998  89997653

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-53  Score=410.52  Aligned_cols=256  Identities=25%  Similarity=0.446  Sum_probs=204.8

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|+++++||+|+||+||+|+++.+|+.||||++.....       +.....++.+|+.+|++++|||||+++++|...
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-------~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~   88 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ   88 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-------CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecc
Confidence            3789999999999999999999999999999999865421       345566899999999999999999999999753


Q ss_pred             ----CCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          197 ----NSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       197 ----~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                          ...++|+||||+.++++....   ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+
T Consensus        89 ~~~~~~~~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          89 KTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             CSTTTCCEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             cccccCceeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhh
Confidence                246899999999887766542   4689999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Q 015257          273 SQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKIVN-----------  341 (410)
Q Consensus       273 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~-----------  341 (410)
                      ++..... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+.......+..           
T Consensus       166 ~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~-~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         166 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             hhccccc-cccccccccccccChhhhcCCCC-CCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence            8865443 33455679999999999987665 6679999999999999999999988876665544432           


Q ss_pred             -----------CCCCCC--------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhhCCcccCC
Q 015257          342 -----------NSLVFP--------------------DAMNPELRNLLEGLLCKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       342 -----------~~~~~p--------------------~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                                 ......                    ...++++.+||.+||+.||++|||++|||+||||+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence                       111000                    0135678999999999999999999999999999863

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-53  Score=404.46  Aligned_cols=250  Identities=20%  Similarity=0.326  Sum_probs=207.0

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCc----eEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGK----HYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVI  193 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  193 (410)
                      ++|++++.||+|+||+||++++..+|+    .||||.+...        ......+++.+|+.+|++++|||||++++++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~   80 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--------TSPKANKEILDEAYVMASVDNPHVCRLLGIC   80 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------------CTHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--------cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            469999999999999999999988876    4677766432        1233456899999999999999999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccc
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSV  272 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~  272 (410)
                      .+.   ..+++|||+.++.+.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~---~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGl  157 (317)
T d1xkka_          81 LTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL  157 (317)
T ss_dssp             ESS---SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSH
T ss_pred             ecC---CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeecccc
Confidence            863   4678889988877766554 456899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCC
Q 015257          273 SQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNS-LVFPD  348 (410)
Q Consensus       273 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~  348 (410)
                      |+.......  ......||+.|+|||++.+..+ +.++|||||||+||||+| |.+||.+.+..+....+..+. +..|.
T Consensus       158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~  236 (317)
T d1xkka_         158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP  236 (317)
T ss_dssp             HHHTTTTCC--------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCT
T ss_pred             ceecccccccccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            987654322  2334568999999999887765 778999999999999998 899999888777777776654 56788


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhhCC
Q 015257          349 AMNPELRNLLEGLLCKDPTRRLTLNDVAKHT  379 (410)
Q Consensus       349 ~~~~~l~~li~~~L~~dp~~Rpt~~ell~h~  379 (410)
                      .+++++.+||.+||+.||.+|||+.||++|.
T Consensus       237 ~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence            8999999999999999999999999999884

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.6e-53  Score=397.76  Aligned_cols=250  Identities=24%  Similarity=0.359  Sum_probs=213.9

Q ss_pred             ccceeeeeeecccCceEEEEEEEcc-----CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCccccee
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIE  191 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  191 (410)
                      .++|++++.||+|+||+||+|+...     +++.||||+++...        .....+.+.+|+.+|++++||||+++++
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--------~~~~~~~~~~E~~il~~l~h~niv~~~~   83 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--------SADMQADFQREAALMAEFDNPNIVKLLG   83 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--------CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--------ChHHHHHHHHHHHHHHhcCCCCccccee
Confidence            4679999999999999999999753     56789999986432        3445678999999999999999999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCC------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQ------------------------PGAIGESMARKYLRDIVSGLMYLHGHNV  247 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~------------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~i  247 (410)
                      ++.+  ...+++||||+++++|.+++..                        ...+++..+..++.||+.||+|||+++|
T Consensus        84 ~~~~--~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~i  161 (301)
T d1lufa_          84 VCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF  161 (301)
T ss_dssp             EECS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             eecc--CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCe
Confidence            9986  4578999999999988876632                        2248999999999999999999999999


Q ss_pred             EeccCCCCcEEEcCCCcEEEeeccccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCC-
Q 015257          248 VHGDIKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQ-  324 (410)
Q Consensus       248 iHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~-  324 (410)
                      |||||||+|||++.++.+||+|||+|+......  .......||+.|+|||++.+..+ +.++|||||||++|||++|. 
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-t~ksDVwS~Gvvl~ell~~~~  240 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGL  240 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCC-ChhhhhccchhhHHHHHccCC
Confidence            999999999999999999999999998654432  23345678999999999887665 67899999999999999985 


Q ss_pred             CCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          325 YPFLGETLQDTYDKIVNNSL-VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       325 ~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      +||.+....+....+..+.. ..|..+++++.+||.+||+.||++|||+.||++
T Consensus       241 ~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         241 QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             CTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            68998888888888887764 467889999999999999999999999999975

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-53  Score=398.21  Aligned_cols=251  Identities=19%  Similarity=0.343  Sum_probs=200.5

Q ss_pred             cceeeeeeecccCceEEEEEEEcc-----CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCccccee
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIE  191 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~  191 (410)
                      ++|++.+.||+|+||.||+|....     +++.||||++....        .....+.+.+|+.++.++ +|||||.+++
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--------~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--------THSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------------CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--------CcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            679999999999999999999754     45789999986432        334456777888877666 6899999999


Q ss_pred             EEEcCCCCEEEEEEeecCCCCcccccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCC
Q 015257          192 VIDDPNSDHFYMVLEYVEGKWDNDGFGQ----------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPD  255 (410)
Q Consensus       192 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~----------------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~  255 (410)
                      ++.++ ...+++|||||++++|.+++..                ...+++..+..++.||+.||.|||+++|+||||||+
T Consensus        85 ~~~~~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~  163 (299)
T d1ywna1          85 ACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  163 (299)
T ss_dssp             EECST-TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             eeccC-CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence            88764 4578999999999998887642                235899999999999999999999999999999999


Q ss_pred             cEEEcCCCcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhC-CCCCCCCCH
Q 015257          256 NLLVAPSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIG-QYPFLGETL  332 (410)
Q Consensus       256 NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG-~~Pf~~~~~  332 (410)
                      ||||+.++.+||+|||+|+.......  ......||+.|+|||++.+..+ +.++|||||||++|||+|| .+||.+...
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999986544322  3345679999999999887665 6789999999999999986 568877655


Q ss_pred             HHHHHHH-HhC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          333 QDTYDKI-VNN-SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       333 ~~~~~~i-~~~-~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      .+....+ ..+ .+..|..+++++.+||.+||+.||.+|||++||++|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4444333 333 456778899999999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-53  Score=394.02  Aligned_cols=250  Identities=28%  Similarity=0.398  Sum_probs=203.4

Q ss_pred             cceeeeeeecccCceEEEEEEEcc-CC--ceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEE
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSL-DG--KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVID  194 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~-~~--~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  194 (410)
                      ++|++++.||+|+||.||+|+... ++  ..||||++.+....      ..+..+.+.+|+.+|++++|||||++++++.
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~------~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~   81 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS------QPEAMDDFIREVNAMHSLDHRNLIRLYGVVL   81 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcC------CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            579999999999999999998654 33  36899998754321      3455678999999999999999999999997


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeecccc
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVS  273 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a  273 (410)
                      +   ..+++||||++++++.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        82 ~---~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~  158 (273)
T d1u46a_          82 T---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM  158 (273)
T ss_dssp             S---SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             e---cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhh
Confidence            5   357899999998887766543 457999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCcc---ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCC--CCC
Q 015257          274 QVFEDDND---VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNNSL--VFP  347 (410)
Q Consensus       274 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~--~~p  347 (410)
                      +.......   ......||+.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+..+....+.....  ..|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~  237 (273)
T d1u46a_         159 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP  237 (273)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC
T ss_pred             hhcccCCCcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCc
Confidence            87644322   2234457889999999987665 677999999999999998 8999999999998888877654  456


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          348 DAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       348 ~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ..+++++.+||.+||..||++|||+++|++
T Consensus       238 ~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         238 EDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            789999999999999999999999999974

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-53  Score=389.93  Aligned_cols=244  Identities=24%  Similarity=0.427  Sum_probs=205.6

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcC
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDP  196 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  196 (410)
                      .++|++.+.||+|+||.||+++.+  |..||||+++...           ..+.+.+|+.++++++|||||++++++.+.
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~   72 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE   72 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----------HHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence            467999999999999999999874  7899999986431           335789999999999999999999998653


Q ss_pred             CCCEEEEEEeecCCCCcccccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFGQPG--AIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                       ...+++||||+++++|.+++....  .+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++
T Consensus        73 -~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~  151 (262)
T d1byga_          73 -KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK  151 (262)
T ss_dssp             ---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             -CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccce
Confidence             346899999999999999876543  58999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCCCH
Q 015257          275 VFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLGETLQDTYDKIVNN-SLVFPDAMNP  352 (410)
Q Consensus       275 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~  352 (410)
                      .....   .....+|+.|+|||++.+..+ ++++|||||||++|||+| |.+||......+....+..+ ...+|..+++
T Consensus       152 ~~~~~---~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  227 (262)
T d1byga_         152 EASST---QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP  227 (262)
T ss_dssp             -------------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCH
T ss_pred             ecCCC---CccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCH
Confidence            65432   234568999999999887665 778999999999999998 79999988888888887764 4568889999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ++.+||.+||+.||.+|||+.+|+++
T Consensus       228 ~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         228 AVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            99999999999999999999999875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-52  Score=395.84  Aligned_cols=250  Identities=24%  Similarity=0.349  Sum_probs=211.0

Q ss_pred             ccceeeeeeecccCceEEEEEEEccCCce--EEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccceeEE
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSSLDGKH--YAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLIEVI  193 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  193 (410)
                      .++|++.++||+|+||.||+|+++.+|..  ||||.+....        ..+..+.+.+|+.+|+++ +|||||++++++
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~   80 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--------SKDDHRDFAGELEVLCKLGHHPNIINLLGAC   80 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--------ChHHHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence            46899999999999999999999888875  6677654321        223445789999999998 799999999999


Q ss_pred             EcCCCCEEEEEEeecCCCCcccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcE
Q 015257          194 DDPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNL  257 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NI  257 (410)
                      .+  .+.+++||||+++|+|.+++...                ..+++..+..++.||+.||.|||+++|+||||||+||
T Consensus        81 ~~--~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NI  158 (309)
T d1fvra_          81 EH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI  158 (309)
T ss_dssp             EE--TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             ec--CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceE
Confidence            87  46899999999999999887543                5799999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCC-CCCCCCCHHHHH
Q 015257          258 LVAPSGTVKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQ-YPFLGETLQDTY  336 (410)
Q Consensus       258 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~-~Pf~~~~~~~~~  336 (410)
                      |++.++.+||+|||+|+..... .......||+.|+|||.+.+..+ +.++|||||||++|||++|. +||.+.+..+..
T Consensus       159 L~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~  236 (309)
T d1fvra_         159 LVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY  236 (309)
T ss_dssp             EECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred             EEcCCCceEEcccccccccccc-ccccceecCCcccchHHhccCCC-CccceeehhHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            9999999999999999864432 22234568999999999987766 67899999999999999964 678888888888


Q ss_pred             HHHHhC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          337 DKIVNN-SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       337 ~~i~~~-~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                      ..+..+ .+.+|..+++++.+||.+||+.||++|||+++|++|
T Consensus       237 ~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         237 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            777665 456778899999999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=390.15  Aligned_cols=251  Identities=21%  Similarity=0.389  Sum_probs=210.6

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCC-------ceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcc
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDG-------KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIV  187 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv  187 (410)
                      ..++|.+.+.||+|+||.||+|+...++       ..||||++++..        .......+.+|+..+.++ +|||||
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~~e~~~l~~~~~HpnIv   82 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--------TEKDLSDLISEMEMMKMIGKHKNII   82 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--------CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--------ChHHHHHHHHHHHHHHHhcCCCeEE
Confidence            3478999999999999999999976543       479999986532        345567788899888888 899999


Q ss_pred             cceeEEEcCCCCEEEEEEeecCCCCcccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecc
Q 015257          188 NLIEVIDDPNSDHFYMVLEYVEGKWDNDGFGQP----------------GAIGESMARKYLRDIVSGLMYLHGHNVVHGD  251 (410)
Q Consensus       188 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD  251 (410)
                      ++++++.+  .+.+++||||+.+|++.+++...                ..+++.++..++.||+.||+|||+++|+|||
T Consensus        83 ~~~~~~~~--~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrD  160 (299)
T d1fgka_          83 NLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD  160 (299)
T ss_dssp             CEEEEECS--SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             eccccccc--CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeee
Confidence            99999986  45799999999999998877533                3589999999999999999999999999999


Q ss_pred             CCCCcEEEcCCCcEEEeeccccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 015257          252 IKPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFL  328 (410)
Q Consensus       252 lkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~  328 (410)
                      |||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..+ ++++|||||||++|||++ |.+||.
T Consensus       161 iKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y-~~k~DiwS~Gvvl~ell~~g~~p~~  239 (299)
T d1fgka_         161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYP  239 (299)
T ss_dssp             CSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC-CchhhhHHhHHHHHHhccCCCCCCC
Confidence            99999999999999999999998765432  23345678999999999887665 778999999999999998 799999


Q ss_pred             CCCHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          329 GETLQDTYDKIVNN-SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       329 ~~~~~~~~~~i~~~-~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      +.+..+.+..+..+ .+.+|..+++++.+||.+||+.||.+|||+.||++
T Consensus       240 ~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         240 GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            88888777776665 35678889999999999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=389.63  Aligned_cols=252  Identities=20%  Similarity=0.270  Sum_probs=216.0

Q ss_pred             ccccceeeeeeecccCceEEEEEEEcc-----CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccc
Q 015257          115 KMINEYVHVRKIGAGSYGKVVLYRSSL-----DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNL  189 (410)
Q Consensus       115 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  189 (410)
                      ...++|.+.+.||+|+||.||+|.+..     ++..||||+++...        .......+.+|+.++++++|||||++
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--------~~~~~~~~~~E~~il~~l~h~nIv~~   88 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--------SMRERIEFLNEASVMKEFNCHHVVRL   88 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--------CHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--------ChHHHHHHHHHHHHHHHcCCCCEeee
Confidence            345789999999999999999998753     46789999986432        34455678999999999999999999


Q ss_pred             eeEEEcCCCCEEEEEEeecCCCCcccccCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEE
Q 015257          190 IEVIDDPNSDHFYMVLEYVEGKWDNDGFGQ----------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLV  259 (410)
Q Consensus       190 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll  259 (410)
                      ++++..  ...+++||||+++|++.+++..          ...+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus        89 ~~~~~~--~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl  166 (308)
T d1p4oa_          89 LGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV  166 (308)
T ss_dssp             EEEECS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred             eeEEec--CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee
Confidence            999976  4578999999999988876532          2357899999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCcc--ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHH
Q 015257          260 APSGTVKIGDFSVSQVFEDDND--VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIG-QYPFLGETLQDTY  336 (410)
Q Consensus       260 ~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG-~~Pf~~~~~~~~~  336 (410)
                      +.++++||+|||+|+.......  ......||+.|+|||.+.+..+ +.++|||||||++|||+|| .+||.+.+..+.+
T Consensus       167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~-~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~  245 (308)
T d1p4oa_         167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL  245 (308)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred             cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCC-CcccccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999987654322  2334568999999999887766 5679999999999999998 5889888888888


Q ss_pred             HHHHhCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          337 DKIVNNSL-VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       337 ~~i~~~~~-~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ..+..+.. ..|..+++.+.+||.+||+.||.+|||+++|++
T Consensus       246 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         246 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            88877653 567889999999999999999999999999998

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-51  Score=387.34  Aligned_cols=250  Identities=22%  Similarity=0.348  Sum_probs=210.0

Q ss_pred             ccceeeeeeecccCceEEEEEEEc-----cCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhC-CCCCcccce
Q 015257          117 INEYVHVRKIGAGSYGKVVLYRSS-----LDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKML-QHPNIVNLI  190 (410)
Q Consensus       117 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  190 (410)
                      .++|++.+.||+|+||.||+|+..     .+++.||||+++...        .......+.+|+.+++.+ +|||||+++
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--------~~~~~~~~~~E~~~~~~l~~HpnIv~~~   93 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--------HLTEREALMSELKVLSYLGNHMNIVNLL   93 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--------CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--------CHHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            468999999999999999999863     367799999986432        344556799999999999 699999999


Q ss_pred             eEEEcCCCCEEEEEEeecCCCCcccccCC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccC
Q 015257          191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQ------------------PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDI  252 (410)
Q Consensus       191 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl  252 (410)
                      +++.+  ...++||||||+++++.+++..                  ...+++..+..++.||+.||+|||+++|+||||
T Consensus        94 g~~~~--~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDL  171 (311)
T d1t46a_          94 GACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL  171 (311)
T ss_dssp             EEECS--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             EEEee--CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccc
Confidence            99986  4568999999999988776543                  236899999999999999999999999999999


Q ss_pred             CCCcEEEcCCCcEEEeeccccccccCCc--cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 015257          253 KPDNLLVAPSGTVKIGDFSVSQVFEDDN--DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMII-GQYPFLG  329 (410)
Q Consensus       253 kp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~  329 (410)
                      ||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..+ +.++|||||||++|||+| |.+||..
T Consensus       172 Kp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~  250 (311)
T d1t46a_         172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPG  250 (311)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             ccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999998765432  23345678999999999876655 678999999999999998 6777777


Q ss_pred             CCHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh
Q 015257          330 ETLQDTYDKIVNN--SLVFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK  377 (410)
Q Consensus       330 ~~~~~~~~~i~~~--~~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~  377 (410)
                      ....+.+..++..  ....|..+++.+.+||.+||+.||.+|||+++|++
T Consensus       251 ~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         251 MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             CCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6665555555443  33456788999999999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-50  Score=381.45  Aligned_cols=256  Identities=18%  Similarity=0.227  Sum_probs=207.6

Q ss_pred             eeeecccCceEEEEEEEccCC---ceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCCCC
Q 015257          123 VRKIGAGSYGKVVLYRSSLDG---KHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPNSD  199 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  199 (410)
                      .++||+|+||+||+++...++   ..||||+++..        ......+++.+|+++|++++|||||++++++.+. ..
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--------~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~  102 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EG  102 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--------CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TT
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--------cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CC
Confidence            578999999999999986543   36899988532        1455668899999999999999999999998753 35


Q ss_pred             EEEEEEeecCCCCcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeeccccccccC
Q 015257          200 HFYMVLEYVEGKWDNDGFGQ-PGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDFSVSQVFED  278 (410)
Q Consensus       200 ~~~lv~e~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  278 (410)
                      .+++|||||+++++.+++.. ...+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++....
T Consensus       103 ~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~  182 (311)
T d1r0pa_         103 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  182 (311)
T ss_dssp             EEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred             ceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence            89999999999999887664 44678899999999999999999999999999999999999999999999999987643


Q ss_pred             Ccc----ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhC-CCCCCCCCCH
Q 015257          279 DND----VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE-TLQDTYDKIVNN-SLVFPDAMNP  352 (410)
Q Consensus       279 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~-~~~~~~~~i~~~-~~~~p~~~~~  352 (410)
                      ...    ......||+.|+|||.+.+..+ +.++||||||+++|||+||..||... +..+....+..+ .+..|..+++
T Consensus       183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~  261 (311)
T d1r0pa_         183 KEFDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD  261 (311)
T ss_dssp             TTCCCTTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCH
T ss_pred             cccccceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcH
Confidence            321    2234568999999999877665 77899999999999999977776553 344455555554 3456788999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhhC------CcccCCCCCC
Q 015257          353 ELRNLLEGLLCKDPTRRLTLNDVAKH------TWVLGDNGPI  388 (410)
Q Consensus       353 ~l~~li~~~L~~dp~~Rpt~~ell~h------~~~~~~~~~~  388 (410)
                      ++.+||.+||+.||++|||+.||++|      +|..+....+
T Consensus       262 ~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~~~~  303 (311)
T d1r0pa_         262 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHV  303 (311)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBCCC
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhhchhc
Confidence            99999999999999999999999998      5555443333

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.1e-50  Score=378.63  Aligned_cols=254  Identities=22%  Similarity=0.269  Sum_probs=202.6

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      ++|++++.||+|+||.||+|++..+|+.||||++.....           ..++.+|+.+++.++|+|+|..+..+... 
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----------~~~~~~E~~i~~~l~~~~~i~~~~~~~~~-   74 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----------HPQLHIESKIYKMMQGGVGIPTIRWCGAE-   74 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----------SCCHHHHHHHHHHSTTSTTCCCEEEEEEE-
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----------CHHHHHHHHHHHHccCCCcccEEEEEEec-
Confidence            579999999999999999999999999999998764321           12477899999999988877766555432 


Q ss_pred             CCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC---CCcEEEeeccccc
Q 015257          198 SDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP---SGTVKIGDFSVSQ  274 (410)
Q Consensus       198 ~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~---~~~~kl~DfG~a~  274 (410)
                      ....++||||++++...........+++..+..++.||+.||+|||++||+||||||+|||++.   +..+||+|||+|+
T Consensus        75 ~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~  154 (299)
T d1ckia_          75 GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  154 (299)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred             CCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence            5689999999987766665566678999999999999999999999999999999999999864   4579999999998


Q ss_pred             cccCCcc-------ccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh---
Q 015257          275 VFEDDND-------VLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGETLQDTYDKI---VN---  341 (410)
Q Consensus       275 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i---~~---  341 (410)
                      .......       ......||+.|+|||++.+..+ ++++|||||||++|||++|..||...........+   ..   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ckia_         155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  233 (299)
T ss_dssp             ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCC-CHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred             eccccccccceeccccCCcCCCccccCHHHHhCCCC-CChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence            7654321       2345679999999999887765 77899999999999999999999875544322211   11   


Q ss_pred             -CC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHH---HHhhCCcccCC
Q 015257          342 -NS-LVFPDAMNPELRNLLEGLLCKDPTRRLTLN---DVAKHTWVLGD  384 (410)
Q Consensus       342 -~~-~~~p~~~~~~l~~li~~~L~~dp~~Rpt~~---ell~h~~~~~~  384 (410)
                       .. ...+..+|+++.+||..||+.||.+||+++   ++|+|+|....
T Consensus       234 ~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence             11 123457899999999999999999999987   55788876543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.7e-48  Score=365.68  Aligned_cols=262  Identities=18%  Similarity=0.244  Sum_probs=205.6

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCC-CCcccceeEEEcC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQH-PNIVNLIEVIDDP  196 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~  196 (410)
                      ++|++++.||+|+||+||+|++..+|+.||||++.....           ...+.+|+.+++.+.| +|++.+++++.+ 
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-   72 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----------APQLRDEYRTYKLLAGCTGIPNVYYFGQE-   72 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----------SCCHHHHHHHHHHTTTCTTCCCEEEEEEE-
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----------cHHHHHHHHHHHHhcCCCCCCEEEEEeec-
Confidence            579999999999999999999999999999998754321           1246789999999976 899999999886 


Q ss_pred             CCCEEEEEEeecCCCCcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcC-----CCcEEEeec
Q 015257          197 NSDHFYMVLEYVEGKWDNDGFG-QPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAP-----SGTVKIGDF  270 (410)
Q Consensus       197 ~~~~~~lv~e~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~-----~~~~kl~Df  270 (410)
                       ....++||||++ +++.+.+. ....+++..+..++.|++.||+|||++||+||||||+|||++.     ++.+||+||
T Consensus        73 -~~~~~~vme~~~-~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DF  150 (293)
T d1csna_          73 -GLHNVLVIDLLG-PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF  150 (293)
T ss_dssp             -TTEEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             -CCccEEEEEecC-CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccc
Confidence             568999999995 45555554 3457999999999999999999999999999999999999974     578999999


Q ss_pred             cccccccCCc-------cccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHH
Q 015257          271 SVSQVFEDDN-------DVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGET---LQDTYDKIV  340 (410)
Q Consensus       271 G~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~---~~~~~~~i~  340 (410)
                      |+|+......       .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+..   .......+.
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~  229 (293)
T d1csna_         151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG  229 (293)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred             ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCC-ChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH
Confidence            9998764321       12335679999999999987665 778999999999999999999997643   223333332


Q ss_pred             hCCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhh--CCcccCCCCCCchhhhh
Q 015257          341 NNSL-----VFPDAMNPELRNLLEGLLCKDPTRRLTLNDVAK--HTWVLGDNGPIPQYLCW  394 (410)
Q Consensus       341 ~~~~-----~~p~~~~~~l~~li~~~L~~dp~~Rpt~~ell~--h~~~~~~~~~~~~~~~~  394 (410)
                      ....     ..+..+++++.+++..|+..+|.+||+++.+.+  +..+........+-+.|
T Consensus       230 ~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw  290 (293)
T d1csna_         230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW  290 (293)
T ss_dssp             HHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred             hccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            2211     133578999999999999999999999877654  33343333333344444

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=368.05  Aligned_cols=248  Identities=22%  Similarity=0.265  Sum_probs=191.7

Q ss_pred             cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcccceeEEEcCC
Q 015257          118 NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIVNLIEVIDDPN  197 (410)
Q Consensus       118 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  197 (410)
                      .+|.+.+.||+|+||.||+++.  +|+.||||++....          ........|+..+..++|||||++++++.+.+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~   70 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----------ERSWFREAEIYQTVMLRHENILGFIAADNKDN   70 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC
Confidence            4688999999999999999985  58999999885431          11122334566667889999999999997643


Q ss_pred             C--CEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcEeccCCCCcEEEcCCCcEEE
Q 015257          198 S--DHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG--------HNVVHGDIKPDNLLVAPSGTVKI  267 (410)
Q Consensus       198 ~--~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~--------~~iiHrDlkp~NIll~~~~~~kl  267 (410)
                      .  ..+++|||||++++|.+++.+. .+++..+..++.|++.||.|||+        +||+||||||+||||+.++.+||
T Consensus        71 ~~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl  149 (303)
T d1vjya_          71 GTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             CcceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence            2  3789999999999999988754 68999999999999999999996        59999999999999999999999


Q ss_pred             eeccccccccCCcc----ccccCCCcccccccccccCCcC-----CCchhhHHHHHHHHHHHHhCCCCCCCC--------
Q 015257          268 GDFSVSQVFEDDND----VLRRSPGTPVFTAPECCLGLTY-----GGKAADTWAVGVTLYYMIIGQYPFLGE--------  330 (410)
Q Consensus       268 ~DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlG~il~elltG~~Pf~~~--------  330 (410)
                      +|||+++.......    ......||+.|+|||++.+...     .+.++|||||||+||||+||..||...        
T Consensus       150 ~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~  229 (303)
T d1vjya_         150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             CCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             EecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence            99999987654332    2345679999999998865421     245799999999999999998876321        


Q ss_pred             -------CHHHHHHHHHhCCC--CCCCC-----CCHHHHHHHHHhcccCCCCCCCHHHHhhC
Q 015257          331 -------TLQDTYDKIVNNSL--VFPDA-----MNPELRNLLEGLLCKDPTRRLTLNDVAKH  378 (410)
Q Consensus       331 -------~~~~~~~~i~~~~~--~~p~~-----~~~~l~~li~~~L~~dp~~Rpt~~ell~h  378 (410)
                             ........+.....  .+|..     ....+.+|+.+||+.||++|||+.||+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                   12222222322222  22222     22458899999999999999999999874

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.3e-47  Score=368.57  Aligned_cols=258  Identities=21%  Similarity=0.404  Sum_probs=198.9

Q ss_pred             ccccc-cceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC---------
Q 015257          113 GTKMI-NEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ---------  182 (410)
Q Consensus       113 ~~~~~-~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---------  182 (410)
                      |..+. .+|+++++||+|+||+||+|++..+|+.||||++++.          ....+.+.+|+.+++.++         
T Consensus         7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----------~~~~~~~~~Ei~~l~~l~~~~~~~~~~   76 (362)
T d1q8ya_           7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----------KVYTEAAEDEIKLLQRVNDADNTKEDS   76 (362)
T ss_dssp             TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----------HHHHHHHHHHHHHHHHHHHTCCSHHHH
T ss_pred             CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----------ccchHHHHHHHHHHHHhcchhhhhhhh
Confidence            34444 3699999999999999999999999999999998643          223456788999988875         


Q ss_pred             --CCCcccceeEEEcCCCCEEEEEEeecCCCCc---ccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCc
Q 015257          183 --HPNIVNLIEVIDDPNSDHFYMVLEYVEGKWD---NDGFGQPGAIGESMARKYLRDIVSGLMYLHG-HNVVHGDIKPDN  256 (410)
Q Consensus       183 --hpniv~l~~~~~~~~~~~~~lv~e~~~~~~l---~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~N  256 (410)
                        |+|||++++++........+++|+++.....   .........+++..++.++.||+.||.|||+ .||+||||||+|
T Consensus        77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~N  156 (362)
T d1q8ya_          77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN  156 (362)
T ss_dssp             HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred             cCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhH
Confidence              5789999998875445567777777754332   2223445678999999999999999999997 899999999999


Q ss_pred             EEEcCCCc------EEEeeccccccccCCccccccCCCcccccccccccCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015257          257 LLVAPSGT------VKIGDFSVSQVFEDDNDVLRRSPGTPVFTAPECCLGLTYGGKAADTWAVGVTLYYMIIGQYPFLGE  330 (410)
Q Consensus       257 Ill~~~~~------~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~  330 (410)
                      ||++.++.      ++++|||.|.....   ......||+.|+|||++....+ +.++|||||||++++|++|+.||...
T Consensus       157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~pF~~~  232 (362)
T d1q8ya_         157 VLMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPD  232 (362)
T ss_dssp             EEEEEEETTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             eeeeccCcccccceeeEeeccccccccc---ccccccccccccChhhccccCC-CccccccchHHHHHHHHHCCCCCCCC
Confidence            99987654      99999999976433   3345679999999999887766 56799999999999999999999654


Q ss_pred             CHH------HHHHHH---Hh---------------------------------------CCCCCCCCCCHHHHHHHHHhc
Q 015257          331 TLQ------DTYDKI---VN---------------------------------------NSLVFPDAMNPELRNLLEGLL  362 (410)
Q Consensus       331 ~~~------~~~~~i---~~---------------------------------------~~~~~p~~~~~~l~~li~~~L  362 (410)
                      ...      +.....   +.                                       ....++...++++.+||.+||
T Consensus       233 ~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL  312 (362)
T d1q8ya_         233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML  312 (362)
T ss_dssp             ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred             ccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHC
Confidence            321      111111   00                                       011112234578999999999


Q ss_pred             ccCCCCCCCHHHHhhCCcccCC
Q 015257          363 CKDPTRRLTLNDVAKHTWVLGD  384 (410)
Q Consensus       363 ~~dp~~Rpt~~ell~h~~~~~~  384 (410)
                      +.||.+|||++|+|+||||++.
T Consensus       313 ~~dP~~Rpta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         313 QLDPRKRADAGGLVNHPWLKDT  334 (362)
T ss_dssp             CSSTTTCBCHHHHHTCGGGTTC
T ss_pred             CCChhHCcCHHHHhcCcccCCC
Confidence            9999999999999999999854

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=2.4e-26  Score=201.35  Aligned_cols=144  Identities=20%  Similarity=0.173  Sum_probs=109.5

Q ss_pred             eeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccC---------CChHHHHHHHHHHHHHHhCCCCCcccce
Q 015257          120 YVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVA---------PSETAMTDVRREVLIMKMLQHPNIVNLI  190 (410)
Q Consensus       120 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~---------~~~~~~~~~~~E~~~l~~l~hpniv~l~  190 (410)
                      +.+.++||+|+||+||+|++. +|+.||||+++..........         ..........+|+..+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            456789999999999999885 689999998764322110000         0112234556789999999999999988


Q ss_pred             eEEEcCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCcEEEcCCCcEEEeec
Q 015257          191 EVIDDPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHGHNVVHGDIKPDNLLVAPSGTVKIGDF  270 (410)
Q Consensus       191 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIll~~~~~~kl~Df  270 (410)
                      ++..      .+++|||+++..+..       +++..+..++.||+.||.|||++||+||||||+|||++.+ .++|+||
T Consensus        81 ~~~~------~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          81 AWEG------NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             EEET------TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             EecC------CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence            7642      279999999865543       3445567899999999999999999999999999999954 5899999


Q ss_pred             cccccccC
Q 015257          271 SVSQVFED  278 (410)
Q Consensus       271 G~a~~~~~  278 (410)
                      |+|.....
T Consensus       147 G~a~~~~~  154 (191)
T d1zara2         147 PQSVEVGE  154 (191)
T ss_dssp             TTCEETTS
T ss_pred             CCcccCCC
Confidence            99976543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.59  E-value=6.3e-08  Score=86.46  Aligned_cols=142  Identities=16%  Similarity=0.186  Sum_probs=96.4

Q ss_pred             cccceeeeeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-CCCcccceeEEE
Q 015257          116 MINEYVHVRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-HPNIVNLIEVID  194 (410)
Q Consensus       116 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~  194 (410)
                      ....|+.++..+.++.+.||++.  .++..++||+.......         ....+.+|..++..+. +--+.+++.+..
T Consensus        12 ~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~---------~~~~~~~E~~~l~~l~~~vpvP~vl~~~~   80 (263)
T d1j7la_          12 LIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG---------TTYDVEREKDMMLWLEGKLPVPKVLHFER   80 (263)
T ss_dssp             HHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT---------STTCHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred             hhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc---------chhhHHHHHHHHHHHhccCCCCcEEEEEe
Confidence            34567777776666668898764  45677889986543211         1124678888888774 333566777766


Q ss_pred             cCCCCEEEEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------
Q 015257          195 DPNSDHFYMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG------------------------------  244 (410)
Q Consensus       195 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~------------------------------  244 (410)
                      +  .+..++||++++|..+.......     .....++.++...+..||+                              
T Consensus        81 ~--~~~~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (263)
T d1j7la_          81 H--DGWSNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV  153 (263)
T ss_dssp             E--TTEEEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred             c--CCceEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence            5  35789999999997765433211     1233455667777777775                              


Q ss_pred             -----------------------------CCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          245 -----------------------------HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       245 -----------------------------~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                                                   ..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                         1379999999999999766667999998864

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.22  E-value=6.9e-06  Score=72.34  Aligned_cols=128  Identities=15%  Similarity=0.170  Sum_probs=83.7

Q ss_pred             eecccCc-eEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCC--cccceeEEEcCCCCEE
Q 015257          125 KIGAGSY-GKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPN--IVNLIEVIDDPNSDHF  201 (410)
Q Consensus       125 ~lG~G~f-g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~~  201 (410)
                      .+..|.. +.||++... .+..+++|......            ...+..|...|+.+....  +.+++.+..+  .+..
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~------------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~   81 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA------------LNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRD   81 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT------------TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCE
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC------------HhHHHHHHHHHHHHHhcCCCCCceeeeccc--ccce
Confidence            4455543 678877643 46678899754321            123667888887774333  4566777665  3468


Q ss_pred             EEEEeecCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 015257          202 YMVLEYVEGKWDNDGFGQPGAIGESMARKYLRDIVSGLMYLHG-------------------------------------  244 (410)
Q Consensus       202 ~lv~e~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-------------------------------------  244 (410)
                      ++||++++|..+....     +...   ..+.++...|.-||+                                     
T Consensus        82 ~~v~~~i~G~~~~~~~-----~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (255)
T d1nd4a_          82 WLLLGEVPGQDLLSSH-----LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  153 (255)
T ss_dssp             EEEEECCSSEETTTSC-----CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             EEEEEeeecccccccc-----ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchh
Confidence            9999999987654321     2221   223455566666664                                     


Q ss_pred             ---------------------CCcEeccCCCCcEEEcCCCcEEEeecccccc
Q 015257          245 ---------------------HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQV  275 (410)
Q Consensus       245 ---------------------~~iiHrDlkp~NIll~~~~~~kl~DfG~a~~  275 (410)
                                           ..++|+|+.|.|||++.+..+-|+||+.+..
T Consensus       154 ~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         154 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                                 1379999999999999766678999998853

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.17  E-value=2.3e-06  Score=81.05  Aligned_cols=84  Identities=14%  Similarity=0.061  Sum_probs=48.6

Q ss_pred             eeeecccCceEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCC-C-C-CcccceeEEEcCCCC
Q 015257          123 VRKIGAGSYGKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQ-H-P-NIVNLIEVIDDPNSD  199 (410)
Q Consensus       123 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-p-niv~l~~~~~~~~~~  199 (410)
                      .+.||.|....||++.+..+++.|+||.-.....  .....-.....+...|...|+.+. + | .+.+++.+. .   .
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r--~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-~---~  104 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAK--VVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-T---E  104 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGG--C--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-T---T
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhc--ccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-C---C
Confidence            5679999999999999887788999997543211  000000112234567888887663 2 3 344555443 2   2


Q ss_pred             EEEEEEeecCCCC
Q 015257          200 HFYMVLEYVEGKW  212 (410)
Q Consensus       200 ~~~lv~e~~~~~~  212 (410)
                      ..++|||++++..
T Consensus       105 ~~~lvmE~L~~~~  117 (392)
T d2pula1         105 MAVTVMEDLSHLK  117 (392)
T ss_dssp             TTEEEECCCTTSE
T ss_pred             CCEEEEeccCCcc
Confidence            3478999998643

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.32  E-value=0.00039  Score=63.37  Aligned_cols=68  Identities=12%  Similarity=0.327  Sum_probs=42.3

Q ss_pred             eEEEEEEEccCCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCcc--cce-----eEEEcCCCCEEEEE
Q 015257          132 GKVVLYRSSLDGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNIV--NLI-----EVIDDPNSDHFYMV  204 (410)
Q Consensus       132 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv--~l~-----~~~~~~~~~~~~lv  204 (410)
                      -.||++... +|..|++|+......          ..+++..|...+..|....|.  ..+     ..+..  .+..+.+
T Consensus        36 N~vy~v~~~-dg~~~VlK~~rp~~~----------s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~--~~~~~~l  102 (325)
T d1zyla1          36 NRVYQFQDE-DRRRFVVKFYRPERW----------TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNH--QGFYFAV  102 (325)
T ss_dssp             SEEEEECCT-TCCCEEEEEECTTTS----------CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEE--TTEEEEE
T ss_pred             ceeEEEEcC-CCCEEEEEEeCCCCC----------CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeee--eeEEEEE
Confidence            578887763 688899998754321          224577888888777532221  111     11121  3578899


Q ss_pred             EeecCCCC
Q 015257          205 LEYVEGKW  212 (410)
Q Consensus       205 ~e~~~~~~  212 (410)
                      +++++|..
T Consensus       103 ~~~~~G~~  110 (325)
T d1zyla1         103 FPSVGGRQ  110 (325)
T ss_dssp             EECCCCEE
T ss_pred             EeecCCcC
Confidence            99998854

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.16  E-value=0.00082  Score=62.88  Aligned_cols=75  Identities=16%  Similarity=0.281  Sum_probs=50.0

Q ss_pred             eeeeecccCceEEEEEEEcc-------CCceEEEEeeecccccccccCCChHHHHHHHHHHHHHHhCCCCCc-ccceeEE
Q 015257          122 HVRKIGAGSYGKVVLYRSSL-------DGKHYAIKAFHKSHLSKLRVAPSETAMTDVRREVLIMKMLQHPNI-VNLIEVI  193 (410)
Q Consensus       122 ~~~~lG~G~fg~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~  193 (410)
                      .++.|+.|-.-.+|++....       .++.|.+++....          . ..-...+|..+++.+.-.++ .++++++
T Consensus        46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----------~-~~idr~~E~~i~~~ls~~gl~Pkll~~~  114 (395)
T d1nw1a_          46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----------E-TESHLVAESVIFTLLSERHLGPKLYGIF  114 (395)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----------C-CHHHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred             EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----------c-hhhHHHHHHHHHHHHHhCCCCCeEEEEc
Confidence            46789999999999988653       2356777765311          1 12245688888888853444 4777776


Q ss_pred             EcCCCCEEEEEEeecCCCCc
Q 015257          194 DDPNSDHFYMVLEYVEGKWD  213 (410)
Q Consensus       194 ~~~~~~~~~lv~e~~~~~~l  213 (410)
                      .+      .+||||++|..+
T Consensus       115 ~~------g~I~efi~g~~l  128 (395)
T d1nw1a_         115 SG------GRLEEYIPSRPL  128 (395)
T ss_dssp             TT------EEEECCCCEEEC
T ss_pred             CC------ceEEEEeccccC
Confidence            32      589999987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.74  E-value=0.0015  Score=58.85  Aligned_cols=30  Identities=23%  Similarity=0.328  Sum_probs=26.9

Q ss_pred             CCcEeccCCCCcEEEcCCCcEEEeeccccc
Q 015257          245 HNVVHGDIKPDNLLVAPSGTVKIGDFSVSQ  274 (410)
Q Consensus       245 ~~iiHrDlkp~NIll~~~~~~kl~DfG~a~  274 (410)
                      .|+||+|+.++||+++.+...-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            479999999999999988777899999885

>d1gxca_ b.26.1.2 (A:) Chk2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: SMAD/FHA domain
superfamily: SMAD/FHA domain
family: FHA domain
domain: Chk2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.51  E-value=0.00014  Score=55.88  Aligned_cols=66  Identities=24%  Similarity=0.243  Sum_probs=51.1

Q ss_pred             CcccchhhhccccccccCCccccCCCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCC
Q 015257            2 FRKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTAD   67 (410)
Q Consensus         2 ~~~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~   67 (410)
                      .++.|.+||+..|+++++.+..........+|..|.+|.++.....+...+.+|.|.||+..|...
T Consensus        18 ~~~~~~iGR~~~cdi~l~~~~~~~~~~~~~ISr~H~~I~~~~~~~~~~~~~i~d~S~NGT~vN~~~   83 (116)
T d1gxca_          18 VNDNYWFGRDKSCEYCFDEPLLKRTDKYRTYSKKHFRIFREVGPKNSYIAYIEDHSGNGTFVNTEL   83 (116)
T ss_dssp             CSSEEEEESSTTCSEECCCGGGGGSSGGGGSCTTCEEEEEEECTTSSEEEEEEECCSSCEEETTEE
T ss_pred             CCCCEEeeeCCCCCeEecCCccccccccceEecceEEEEEecccCCCCEEEEECCCccCceECCEE
Confidence            356799999999999998876555455668999999998875554444556788899999998753

>d1lgpa_ b.26.1.2 (A:) Cell cycle checkpoint protein Chfr {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: SMAD/FHA domain
superfamily: SMAD/FHA domain
family: FHA domain
domain: Cell cycle checkpoint protein Chfr
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.35  E-value=0.12  Score=38.42  Aligned_cols=57  Identities=21%  Similarity=0.197  Sum_probs=40.0

Q ss_pred             cccchhhhccccccccCCccccCCCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCCC
Q 015257            3 RKTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTADGDG   70 (410)
Q Consensus         3 ~~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   70 (410)
                      ...+++||+..|+.++...     .   .+|..|.+|..+.   ++.....+|.|.||+..|......
T Consensus        23 ~~~~~iGR~~~~di~l~d~-----~---~iSr~Ha~I~~~~---~~~~~~~~d~S~nGT~vNg~~i~~   79 (113)
T d1lgpa_          23 KREWTIGRRRGCDLSFPSN-----K---LVSGDHCRIVVDE---KSGQVTLEDTSTSGTVINKLKVVK   79 (113)
T ss_dssp             SSEEEEESSTTSSEECTTC-----T---TSCTTCEEEEECT---TTCCEEEEECSSSCCCCCCCCCCC
T ss_pred             CCCEeeCCCCCCCeEecCC-----C---CcChHHeEEEEcc---ceeeEEecCCCceeeEECCEEcCC
Confidence            3568999999999987532     1   5889999997631   122234577899999998865543

>d1dmza_ b.26.1.2 (A:) Phosphotyrosine binding domain of Rad53 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All beta proteins
fold: SMAD/FHA domain
superfamily: SMAD/FHA domain
family: FHA domain
domain: Phosphotyrosine binding domain of Rad53
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=86.41  E-value=0.065  Score=42.58  Aligned_cols=57  Identities=11%  Similarity=-0.178  Sum_probs=40.0

Q ss_pred             ccchhhhccccccccCCccccCCCCCCCCCCCccccccccccCC----------CCCCCCCCCCCCCCCCCCCCCC
Q 015257            4 KTCSWIRDMGCCSCFGFTRRKPKQALRPITGLNYRISRDFLLGD----------DIDDDDDDNSYNGEATNTADGD   69 (410)
Q Consensus         4 ~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~   69 (410)
                      +.|++||+..|++++..+         .+|..|..|.+.-....          ....+..|.|.||++.|.....
T Consensus        27 ~~~~iGR~~~~d~~i~~~---------~vS~~H~~I~~~~~~~~~~~~~~~~~~~~~~~l~D~S~NGt~vN~~~~~   93 (158)
T d1dmza_          27 NPFFIGRSEDCNCKIEDN---------RLSRVHCFIFKKRHAVGKSMYESPAQGLDDIWYCHTGTNVSYLNNNRMI   93 (158)
T ss_dssp             SCEEEESSTTSSEECCCT---------TSCSSSEEEEEEECCCCCCCSSCSCSSCEEEEEEECSTTCCEETTEECC
T ss_pred             CcEEecCCcCccEEECCC---------cccCcceEEEEeccccccccccccccCCCcEEEEecCCCCeEECCEEcC
Confidence            358999999999998865         68899999987532211          1112235678999999886443

>d1g6ga_ b.26.1.2 (A:) Phosphotyrosine binding domain of Rad53 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All beta proteins
fold: SMAD/FHA domain
superfamily: SMAD/FHA domain
family: FHA domain
domain: Phosphotyrosine binding domain of Rad53
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=82.87  E-value=0.14  Score=38.89  Aligned_cols=51  Identities=22%  Similarity=0.231  Sum_probs=37.0

Q ss_pred             ccchhhhccccccccCC-ccccCCCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCC
Q 015257            4 KTCSWIRDMGCCSCFGF-TRRKPKQALRPITGLNYRISRDFLLGDDIDDDDDDNSYNGEATNTAD   67 (410)
Q Consensus         4 ~~~~~~~~~~c~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~   67 (410)
                      ..|++||+..|+.++.. +         .+|..|.+|..+    ++.....++.|.||+..|...
T Consensus        36 ~~~~iGR~~~~d~~l~d~~---------~VSr~Ha~i~~~----~~~~~~~d~~S~NGT~vNg~~   87 (127)
T d1g6ga_          36 KVWTFGRNPACDYHLGNIS---------RLSNKHFQILLG----EDGNLLLNDISTNGTWLNGQK   87 (127)
T ss_dssp             EEEEEESSTTSSEECCSCT---------TSCSSCEEEEEC----TTSCEEEEECCSSCCEETTEE
T ss_pred             ccEEEccCcccCccCCCcc---------hhhHHHHHeeec----ccEEEEEECCCcceeEECCEE
Confidence            56899999999988753 3         578899999653    122234567789999988753